PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Seguin, CA; Draper, JS; Nagy, A; Rossant, J				Seguin, Cheryle A.; Draper, Jonathan S.; Nagy, Andras; Rossant, Janet			Establishment of endoderm progenitors by SOX transcription factor expression in human embryonic stem cells	CELL STEM CELL			English	Article							VISCERAL ENDODERM; PARIETAL ENDODERM; MOUSE EMBRYO; DIFFERENTIATION; LIVER; MEMBRANE; PANCREAS; LINEAGE; PLAYS; GENE	In this study, we explore endoderm cell fate regulation through the expression of lineage-determining transcription factors. We demonstrate that stable endoderm progenitors can be established from human ES cells by constitutive expression of SOX7 or SOX17, producing extraembryonic endoderm and definitive endoderm progenitors, respectively. In teratoma assays and growth factor-mediated differentiation, SOX7 cells appear restricted to the extraembryonic endoderm, and SOX17 cells demonstrate a mesendodermal phenotype in teratomas and the ability to undergo endoderm maturation in vitro in the absence of cytokine-mediated endoderm induction. These endoderm progenitor cells maintain a stable phenotype through many passages in culture, thereby providing new tools to explore the pathways of endoderm differentiation.	[Seguin, Cheryle A.; Draper, Jonathan S.; Rossant, Janet] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada; [Draper, Jonathan S.; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Nagy, Andras; Rossant, Janet] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Seguin, CA (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada.	cseguin@sickkids.ca; janet.rossant@sickkids.ca	Seguin, Cheryle A/G-4511-2013; Nagy, Andras/G-6465-2013	Nagy, Andras/0000-0003-4311-0413; Draper, Jonathan/0000-0002-3241-7009; Seguin, Cheryle/0000-0001-6503-9107	Natural Sciences and Engineering Research Council of Canada; Stem Cell Network; Juvenile Diabetes Research Foundation; Biotechnology and Biological Sciences Research Council, UK; Canadian Institutes of Health Research [31210016364]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Stem Cell Network; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	C.A.S. was funded by the Natural Sciences and Engineering Research Council of Canada, the Stem Cell Network, and the Juvenile Diabetes Research Foundation. J.S.D. was funded by the Biotechnology and Biological Sciences Research Council, UK. This work was supported by grants from the Canadian Institutes of Health Research (grant #31210016364) and the Stem Cell Network. We would like to thank Marina Gertenstein and Jorge Cabezas for assistance with teratoma assays; Nina Nouraeyan, Alison Hirukawa, and Malgosia Kownacka for cell culture; Brian Cox for assistance in microarray analysis; and Geoffrey Wood for histological evaluation of teratomas.	Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; Ber I, 2003, J BIOL CHEM, V278, P31950, DOI 10.1074/jbc.M303127200; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Debacker C, 1999, MECH DEVELOP, V85, P183, DOI 10.1016/S0925-4773(99)00088-X; Deutsch G, 2001, DEVELOPMENT, V128, P871; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Futaki S, 2004, MOL CELL BIOL, V24, P10492, DOI 10.1128/MCB.24.23.10492-10503.2004; Futaki S, 2003, J BIOL CHEM, V278, P50691, DOI 10.1074/jbc.M304985200; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Grapin-Botton A, 2007, MECH DEVELOP, V124, P253, DOI 10.1016/j.mod.2007.01.001; Hart AH, 2002, DEVELOPMENT, V129, P3597; HOGAN BLM, 1980, DEV BIOL, V80, P289, DOI 10.1016/0012-1606(80)90405-4; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; Hui HX, 2002, EUR J ENDOCRINOL, V146, P129, DOI 10.1530/eje.0.1460129; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; KISPERT A, 1994, DEV BIOL, V161, P179, DOI 10.1006/dbio.1994.1019; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Lavon N, 2004, DIFFERENTIATION, V72, P230, DOI 10.1111/j.1432-0436.2004.07205002.x; Lavon N, 2006, STEM CELLS, V24, P1923, DOI 10.1634/stemcells.2005-0397; LAWSON KA, 1987, DEVELOPMENT, V101, P627; LAWSON KA, 1986, DEV BIOL, V115, P325, DOI 10.1016/0012-1606(86)90253-8; LevinsonDushnik M, 1997, MOL CELL BIOL, V17, P3817, DOI 10.1128/MCB.17.7.3817; Liew CG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001783; Lin HT, 2007, WORLD J GASTROENTERO, V13, P1672, DOI 10.3748/wjg.v13.i11.1672; Lioubinski O, 2003, DEV DYNAM, V227, P402, DOI 10.1002/dvdy.10311; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; MASON IJ, 1986, EMBO J, V5, P1465, DOI 10.1002/j.1460-2075.1986.tb04383.x; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Rossant J, 2004, DEV CELL, V7, P155, DOI 10.1016/j.devcel.2004.07.012; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Schwartz RE, 2005, STEM CELLS DEV, V14, P643, DOI 10.1089/scd.2005.14.643; SEMOFF S, 1982, EMBO J, V1, P1171, DOI 10.1002/j.1460-2075.1982.tb00009.x; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Shimoda M, 2007, J CELL SCI, V120, P3859, DOI 10.1242/jcs.007856; Shirahashi H, 2004, CELL TRANSPLANT, V13, P197, DOI 10.3727/000000004783984016; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tam PPL, 2006, CURR OPIN GENET DEV, V16, P419, DOI 10.1016/j.gde.2006.06.008; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Wells JM, 2000, DEVELOPMENT, V127, P1563; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; YODER MC, 1994, BLOOD, V83, P2436; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang C, 2007, DIFFERENTIATION, V75, P536, DOI 10.1111/j.1432-0436.2007.00190.x	58	148	153	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2008	3	2					182	195		10.1016/j.stem.2008.06.018	http://dx.doi.org/10.1016/j.stem.2008.06.018			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	338QT	18682240	Bronze			2022-12-24	WOS:000258523300013
J	Li, MF; Chang, TH; Silberberg, SD; Swartz, KJ				Li, Mufeng; Chang, Tsg-Hui; Silberberg, Shai D.; Swartz, Kenton J.			Gating the pore of P2X receptor channels	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE-GATED CHANNELS; TRANSMEMBRANE DOMAIN; POTASSIUM CHANNELS; STRUCTURAL MOTIF; CELL-SURFACE; ION CHANNELS; K+ CHANNEL; RESIDUES; REARRANGEMENTS; SELECTIVITY	Three families of ligand-activated ion channels mediate synaptic communication between excitable cells in mammals. For pentameric channels related to nicotinic acetylcholine receptors and tetrameric channels such as glutamate receptors, the pore-forming and gate regions have been studied extensively. In contrast, little is known about the structure of trimeric P2X receptor channels, a family of channels that are activated by ATP and are important in neuronal signaling, pain transmission and inflammation. To identify the pore-forming and gate regions in P2X receptor channels, we introduced cysteine residues throughout the two transmembrane (TM) segments and studied their accessibility to thiol-reactive compounds and ions. Our results show that TM2 lines the central ion-conduction pore, TM1 is positioned peripheral to TM2 and the flow of ions is minimized in the closed state by a gate formed by the external region of TM2.	[Li, Mufeng; Chang, Tsg-Hui; Silberberg, Shai D.; Swartz, Kenton J.] US Natl Inst Neurol Disorders & Stroke, Mol Phys & Biophys Sect, Porter Neurosci Res Ctr, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Silberberg, SD (corresponding author), US Natl Inst Neurol Disorders & Stroke, Mol Phys & Biophys Sect, Porter Neurosci Res Ctr, US Natl Inst Hlth, 35 Convent Dr,MSC 3701, Bethesda, MD 20892 USA.	silberbs@ninds.nih.gov; swartzk@ninds.nih.gov	Li, Mufeng/A-7859-2010; Silberberg, Shai/ABA-2778-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003018] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA NS003018-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1974, Q REV BIOPHYS, V7, P179, DOI 10.1017/S0033583500001402; Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Cao LS, 2007, J NEUROSCI, V27, P12916, DOI 10.1523/JNEUROSCI.4036-07.2007; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Contreras JE, 2008, P NATL ACAD SCI USA, V105, P3310, DOI 10.1073/pnas.0709809105; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Egan TM, 1998, J NEUROSCI, V18, P2350; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; EVANS RJ, 2008, EUR BIOPHYS J   0205; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Haines WR, 2001, J NEUROSCI, V21, P5885, DOI 10.1523/JNEUROSCI.21-16-05885.2001; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang LH, 2003, J NEUROSCI, V23, P8903; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Li ZY, 2004, J NEUROSCI, V24, P7378, DOI 10.1523/JNEUROSCI.1423-04.2004; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Stoop R, 1999, MOL PHARMACOL, V56, P973, DOI 10.1124/mol.56.5.973; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	36	85	89	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					883	887		10.1038/nn.2151	http://dx.doi.org/10.1038/nn.2151			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18587390	Green Accepted			2022-12-24	WOS:000257969100012
J	Williams, SR; Mitchell, SJ				Williams, Stephen R.; Mitchell, Simon J.			Direct measurement of somatic voltage clamp errors in central neurons	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; CAT SPINAL MOTONEURONES; ACTION-POTENTIAL OUTPUT; DENDRITIC SPINES; SYNAPSE LOCATION; TIME-COURSE; FEEDFORWARD INHIBITION; FLUCTUATION ANALYSIS; EXCITATORY SYNAPSES; QUANTAL ANALYSIS	The somatic voltage clamp technique has revolutionized understanding of synaptic physiology and the excitability of neurons. Although computer simulations have indicated that the somatic voltage clamp poorly controls voltage in the dendritic tree of neurons, where the majority of synaptic contacts are made, there has not been an experimental description of the performance of the somatic voltage clamp. Here, we directly quantify errors in the measurement of dendritic synaptic input by the somatic voltage clamp using simultaneous whole-cell recordings from the soma and apical dendrite of rat neocortical pyramidal neurons. The somatic voltage clamp did not control voltage at sites other than the soma and distorted measurement of the amplitude, kinetics, slope conductance and reversal potential of synaptic inputs in a dendritic distance-dependent manner. These errors question the use of the somatic voltage clamp as a quantitative tool in dendritic neurons.	[Williams, Stephen R.; Mitchell, Simon J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Williams, SR (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	srw@mrc-lmb.cam.ac.uk		Williams, Stephen/0000-0001-5352-7947	Medical Research Council [MC_U105170644] Funding Source: Medline; MRC [MC_U105170644] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Araya R, 2006, P NATL ACAD SCI USA, V103, P17961, DOI 10.1073/pnas.0608755103; ARMSTRONG CM, 1992, METHOD ENZYMOL, V207, P100; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FINKEL AS, 1983, J PHYSIOL-LONDON, V342, P615, DOI 10.1113/jphysiol.1983.sp014872; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hausser M, 1997, J NEUROSCI, V17, P7606; JACK JJB, 1990, COLD SPRING HARB SYM, V55, P57; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; JOHNSTON D, 1983, J NEUROPHYSIOL, V50, P464, DOI 10.1152/jn.1983.50.2.464; JOHNSTON D, 1980, NATURE, V286, P391, DOI 10.1038/286391a0; kandel, 1977, NERVOUS SYSTEM, V1; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Migliore M, 2005, NAT REV NEUROSCI, V6, P810, DOI 10.1038/nrn1769; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; REDMAN S, 1983, J PHYSIOL-LONDON, V343, P117, DOI 10.1113/jphysiol.1983.sp014884; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Sakmann B., 1995, SINGLE CHANNEL RECOR; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; SMITH TG, 1984, VOLTAGE PATCH CLAMPI; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; Stuart G, 1998, J NEUROSCI, V18, P3501; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; Williams SR, 2003, J NEUROSCI, V23, P7358; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	50	258	262	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					790	798		10.1038/nn.2137	http://dx.doi.org/10.1038/nn.2137			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18552844				2022-12-24	WOS:000257089400016
J	Liu, CH; Heynen, AJ; Shuler, MGH; Bear, MF				Liu, Cheng-Hang; Heynen, Arnold J.; Shuler, Marshall G. Hussain; Bear, Mark F.			Cannabinoid receptor blockade reveals parallel plasticity mechanisms in different layers of mouse visual cortex	NEURON			English	Article							MONOCULAR DEPRIVATION; OCULAR DOMINANCE; POSTNATAL-DEVELOPMENT; SELECTIVITY; DEPRESSION; EXPERIENCE; RESPONSES; RECOVERY	The ocular dominance (OD) shift that occurs in visual cortex after brief monocular deprivation (MD) is a classic model of experience-dependent cortical plasticity. It has been suggested that OD plasticity in layer 2/3 of visual cortex precedes and is necessary for plasticity in the thalamocortical input layer 4. Here, we show in mouse visual cortex that rapid OD plasticity occurs simultaneously in layers 2/3 and 4. Remarkably, pharmacological blockade of cannabinoid receptors completely prevents the OD shift in layer 2/3, leaving plasticity intact in layer 4. Thus, experience-dependent cortical modifications in layers 2/3 and 4 can occur in parallel, via distinct mechanisms. These findings simplify the mechanistic description of plasticity in layer 4, force a revision in the interpretation of previous studies in which laminar differences, in OD plasticity mechanisms were unrecognized, and have important implications for the therapeutic use of cannabinoid receptor antagonists in humans.	[Liu, Cheng-Hang; Heynen, Arnold J.; Shuler, Marshall G. Hussain; Bear, Mark F.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health	Bear, MF (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Howard Hughes Med Inst, E25-618, Cambridge, MA 02139 USA.	mbear@mit.edu		Bear, Mark/0000-0002-9903-2541	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Antonini A, 1999, J NEUROSCI, V19, P4388; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Crozier RA, 2007, P NATL ACAD SCI USA, V104, P1383, DOI 10.1073/pnas.0609596104; Deshmukh S, 2007, NEUROSCIENCE, V145, P279, DOI 10.1016/j.neuroscience.2006.11.033; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gatley SJ, 1996, EUR J PHARMACOL, V307, P331, DOI 10.1016/0014-2999(96)00279-8; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hashimotodani Y, 2007, NEUROSCIENTIST, V13, P127, DOI 10.1177/1073858406296716; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hill EL, 2007, J NEUROPHYSIOL, V97, P2580, DOI 10.1152/jn.00603.2006; Krahe TE, 2005, NEURON, V48, P329, DOI 10.1016/j.neuron.2005.09.016; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Mitchell DE, 2001, P NATL ACAD SCI USA, V98, P11662, DOI 10.1073/pnas.201392698; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Patel PN, 2007, AM J HEALTH-SYST PH, V64, P481, DOI 10.2146/060258; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Thompson I, 2000, CURR BIOL, V10, pR348, DOI 10.1016/S0960-9822(00)00464-4; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980	24	83	83	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 8	2008	58	3					340	345		10.1016/j.neuron.2008.02.020	http://dx.doi.org/10.1016/j.neuron.2008.02.020			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	300HP	18466745	Bronze			2022-12-24	WOS:000255815200008
J	Yuval-Greenberg, S; Tomer, O; Keren, AS; Nelken, I; Deouell, LY				Yuval-Greenberg, Shlomit; Tomer, Orr; Keren, Alon S.; Nelken, Israel; Deouell, Leon Y.			Transient induced gamma-band response in EEG as a manifestation of miniature saccades	NEURON			English	Article							VISUAL-CORTEX; OCULOMOTOR CONTROL; EVOKED-POTENTIALS; PHASE SYNCHRONY; BRAIN ACTIVITY; EYE-MOVEMENTS; MICROSACCADES; ATTENTION; OSCILLATIONS; ORIENTATION	The induced gamma-band EEG response (iGBR) recorded on the scalp is widely assumed to reflect synchronous neural oscillation associated with object representation, attention, memory, and consciousness. The most commonly reported EEG iGBR is a broadband transient increase in power at the gamma range similar to 200-300 ms following stimulus onset. A conspicuous feature of this iGBR is the trial-to-trial poststimulus latency variability, which has been insufficiently addressed. Here, we show, using single-trial analysis of concomitant EEG and eye tracking, that this iGBR is tightly time locked to the onset of involuntary miniature eye movements and reflects a saccadic "spike potential." The time course of the iGBR is related to an increase in the rate of saccades following a period of poststimulus saccadic inhibition. Thus, whereas neuronal gamma-band oscillations were shown conclusively with other methods, the broadband transient iGBR recorded by scalp EEG reflects properties of miniature saccade dynamics rather than neuronal oscillations.	[Yuval-Greenberg, Shlomit; Tomer, Orr; Deouell, Leon Y.] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; [Keren, Alon S.; Nelken, Israel; Deouell, Leon Y.] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91905 Jerusalem, Israel; [Nelken, Israel] Hebrew Univ Jerusalem, Dept Neurobiol, IL-91905 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Yuval-Greenberg, S (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel.	shlomit.greenberg@mail.huji.ac.il	Deouell, Leon Y./W-9624-2019; Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X				Abadi R, 2004, VISION RES, V44, P2675, DOI 10.1016/j.visres.2004.05.009; [Anonymous], 1978, VISUAL PSYCHOPHYSICS; BLINN KA, 1955, CLIN NEUROPHYSIOL, V7, P299; BOYLAN C, 1989, CLIN NEUROPHYSIOL, V73, P264; Busch NA, 2006, NEUROIMAGE, V33, P1169, DOI 10.1016/j.neuroimage.2006.07.034; Canolty RT, 2007, FRONT NEUROSCI-SWITZ, V1, P185, DOI 10.3389/neuro.01.1.1.014.2007; Csibra G, 2000, SCIENCE, V290, P1582, DOI 10.1126/science.290.5496.1582; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2006, PROG BRAIN RES, V154, P177, DOI 10.1016/S0079-6123(06)54009-9; Gowen E, 2007, BRAIN RES, V1141, P154, DOI 10.1016/j.brainres.2007.01.047; Gowen E, 2005, COGNITIVE BRAIN RES, V25, P810, DOI 10.1016/j.cogbrainres.2005.09.002; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gruber T, 2005, CEREB CORTEX, V15, P109, DOI 10.1093/cercor/bhh113; Gruber T, 2004, NEUROREPORT, V15, P1837, DOI 10.1097/01.wnr.0000137077.26010.12; Gruber T, 2002, COGNITIVE BRAIN RES, V13, P377, DOI 10.1016/S0926-6410(01)00130-6; Hafed ZM, 2002, VISION RES, V42, P2533, DOI 10.1016/S0042-6989(02)00263-8; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; KATILA T, 1981, J APPL PHYS, V52, P2565, DOI 10.1063/1.329000; Keil A, 2001, NEUROSCI BIOBEHAV R, V25, P527, DOI 10.1016/S0149-7634(01)00031-8; KOWLER E, 1980, VISION RES, V20, P273, DOI 10.1016/0042-6989(80)90113-3; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Lachaux JP, 2000, EUR J NEUROSCI, V12, P2608, DOI 10.1046/j.1460-9568.2000.00163.x; Laubrock J, 2005, VISION RES, V45, P721, DOI 10.1016/j.visres.2004.09.029; LUTZENBERGER W, 1995, NEUROSCI LETT, V183, P39, DOI 10.1016/0304-3940(94)11109-V; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Pantev Christo, 1995, Brain Topography, V7, P321, DOI 10.1007/BF01195258; Picton TW, 2000, J PSYCHOPHYSIOL, V14, P210, DOI 10.1027//0269-8803.14.4.210; Reingold EM, 2002, J COGNITIVE NEUROSCI, V14, P371, DOI 10.1162/089892902317361903; Reva NV, 2004, INT J PSYCHOPHYSIOL, V51, P215, DOI 10.1016/j.ijpsycho.2003.09.005; RIEMSLAG FCC, 1988, ELECTROEN CLIN NEURO, V70, P281, DOI 10.1016/0013-4694(88)90046-6; RIGGS LA, 1974, VISION RES, V14, P997, DOI 10.1016/0042-6989(74)90169-2; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rolfs M, 2005, EXP BRAIN RES, V166, P427, DOI 10.1007/s00221-005-2382-y; Rolfs M, 2004, PSYCHOL SCI, V15, P705, DOI 10.1111/j.0956-7976.2004.00744.x; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Rucci M, 2007, NATURE, V447, P851, DOI 10.1038/nature05866; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TallonBaudry C, 1997, J NEUROSCI, V17, P722; THICKBROOM GW, 1987, BRAIN RES, V422, P377, DOI 10.1016/0006-8993(87)90948-6; THICKBROOM GW, 1986, ELECTROEN CLIN NEURO, V64, P211, DOI 10.1016/0013-4694(86)90167-7; THICKBROOM GW, 1985, BRAIN RES, V339, P271, DOI 10.1016/0006-8993(85)90092-7; Trautner P, 2006, NEUROIMAGE, V32, P790, DOI 10.1016/j.neuroimage.2006.04.203; Trujillo LT, 2005, CLIN NEUROPHYSIOL, V116, P172, DOI 10.1016/j.clinph.2004.07.025; Turatto M, 2007, NEUROREPORT, V18, P1015, DOI 10.1097/WNR.0b013e32815b615b; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Valsecchi M, 2007, EXP BRAIN RES, V177, P196, DOI 10.1007/s00221-006-0665-6; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vidal JR, 2006, J COGNITIVE NEUROSCI, V18, P1850, DOI 10.1162/jocn.2006.18.11.1850; WINTERSON BJ, 1976, VISION RES, V16, P1387, DOI 10.1016/0042-6989(76)90156-5; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008; Yeung N, 2004, PSYCHOPHYSIOLOGY, V41, P822, DOI 10.1111/j.1469-8986.2004.00239.x; Yuval-Greenberg S, 2007, J NEUROSCI, V27, P1090, DOI 10.1523/JNEUROSCI.4828-06.2007; Zion-Golumbic E, 2007, CEREB CORTEX, V17, P1741, DOI 10.1093/cercor/bhl100	61	556	595	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2008	58	3					429	441		10.1016/j.neuron.2008.03.027	http://dx.doi.org/10.1016/j.neuron.2008.03.027			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	300HP	18466752	Bronze			2022-12-24	WOS:000255815200015
J	Fu, YB; Kefalov, V; Luo, DG; Xue, T; Yau, KW				Fu, Yingbin; Kefalov, Vladimir; Luo, Dong-Gen; Xue, Tian; Yau, King-Wai			Quantal noise from human red cone pigment	NATURE NEUROSCIENCE			English	Article							MONKEY MACACA-FASCICULARIS; ROD PHOTORECEPTOR CELLS; VISUAL PIGMENT; DARK NOISE; RETINAL CONES; LIGHT ADAPTATION; SENSITIVITY REGULATION; MOLECULAR-MECHANISMS; RHODOPSIN; SALAMANDER	The rod pigment, rhodopsin, shows spontaneous isomerization activity. This quantal noise produces a dark light of similar to 0.01 photons s(-1) rod(-1) in human, setting the threshold for rod vision. The spontaneous isomerization activity of human cone pigments has long remained a mystery because the effect of a single isomerized pigment molecule in cones, unlike that in rods, is small and beyond measurement. We have now overcome this problem by expressing human red cone pigment transgenically in mouse rods in order to exploit their large single-photon response, especially after genetic removal of a key negative-feedback regulation. Extrapolating the measured quantal noise of transgenic cone pigment to native human red cones, we obtained a dark rate of similar to 10 false events s(-1) cone(-1), almost 10(3)-fold lower than the overall dark transduction noise previously reported in primate cones. Our measurements provide a rationale for why mammalian red, green and blue cones have comparable sensitivities, unlike their amphibian counterparts.	[Fu, Yingbin; Kefalov, Vladimir; Luo, Dong-Gen; Xue, Tian; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Yau, King-Wai] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Fu, Yingbin; Kefalov, Vladimir; Luo, Dong-Gen; Xue, Tian; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Yau, KW (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	kwyau@mail.jhmi.edu	Luo, Donggen/D-5990-2011; Xue, Tian/G-9009-2018	Kefalov, Vladimir/0000-0002-1659-008X	NEI NIH HHS [R01 EY006837-18, R37 EY006837, R01 EY006837-19, R37 EY006837-15, R01 EY014596-07, R01 EY006837-16A1, R01 EY006837-20A1, EY 06837, R01 EY006837-17, R01 EY014596-05, R01 EY014596-01, R37 EY006837-14, R01 EY006837-21, F32 EY006837, R37 EY006837-15S1, R37 EY006837-13, R01 EY014596-06, R01 EY014596-02, R01 EY014596-03, R01 EY006837, R01 EY014596] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904, R01 DC006904-03, R01 DC006904-01, R01 DC006904-04, R01 DC006904-02] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY006837, R01EY006837, R01EY014596, R37EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ala-Laurila P, 2007, J PHYSIOL-LONDON, V585, P57, DOI 10.1113/jphysiol.2007.142935; BARLOW HB, 1957, J PHYSIOL-LONDON, V136, P469, DOI 10.1113/jphysiol.1957.sp005774; BARLOW HB, 1958, VISUAL PROBLEMS COLO, V2, P617; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BRIDGES CDB, 1967, VISION RES, V7, P349, DOI 10.1016/0042-6989(67)90044-2; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; DONNER K, 1990, J PHYSIOL-LONDON, V428, P673, DOI 10.1113/jphysiol.1990.sp018234; DONNER K, 1992, VISION RES, V32, P853, DOI 10.1016/0042-6989(92)90028-H; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; Holcman D, 2005, J GEN PHYSIOL, V125, P641, DOI 10.1085/jgp.200509277; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; LAMB TD, 1977, J PHYSIOL-LONDON, V272, P435, DOI 10.1113/jphysiol.1977.sp012053; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; Luo DG, 2005, J GEN PHYSIOL, V126, P263, DOI 10.1085/jgp.200509342; Ma JX, 2001, NEURON, V32, P451, DOI 10.1016/S0896-6273(01)00482-2; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Miller James L., 1994, Current Opinion in Neurobiology, V4, P488, DOI 10.1016/0959-4388(94)90048-5; MOLDAY LL, 1990, J BIOL CHEM, V265, P18690; NAKATANI K, 1989, J PHYSIOL-LONDON, V409, P525, DOI 10.1113/jphysiol.1989.sp017511; NAKATANI K, 1991, J GEN PHYSIOL, V97, P413, DOI 10.1085/jgp.97.3.413; OKADA T, 1994, BIOCHEMISTRY-US, V33, P4940, DOI 10.1021/bi00182a024; PERRY RJ, 1991, J PHYSIOL-LONDON, V433, P561, DOI 10.1113/jphysiol.1991.sp018444; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Sakurai K, 2007, J GEN PHYSIOL, V130, P21, DOI 10.1085/jgp.200609729; Sampath AP, 2002, BIOPHYS J, V83, P184, DOI 10.1016/S0006-3495(02)75160-6; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; Schneeweis DM, 2000, VISUAL NEUROSCI, V17, P659, DOI 10.1017/S0952523800175017; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; Tachibanaki S, 2007, PHOTOCHEM PHOTOBIOL, V83, P19, DOI 10.1562/2006-02-28-IR-823; TAMURA T, 1991, J GEN PHYSIOL, V98, P95, DOI 10.1085/jgp.98.1.95; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068	41	58	60	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					565	571		10.1038/nn.2110	http://dx.doi.org/10.1038/nn.2110			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18425122	Green Accepted			2022-12-24	WOS:000255327300015
J	Soon, CS; Brass, M; Heinze, HJ; Haynes, JD				Soon, Chun Siong; Brass, Marcel; Heinze, Hans-Jochen; Haynes, John-Dylan			Unconscious determinants of free decisions in the human brain	NATURE NEUROSCIENCE			English	Article							VOLUNTARY MOVEMENTS; CONSCIOUS WILL; COGNITION; INTENTION	There has been a long controversy as to whether subjectively 'free' decisions are determined by brain activity ahead of time. We found that the outcome of a decision can be encoded in brain activity of prefrontal and parietal cortex up to 10 s before it enters awareness. This delay presumably reflects the operation of a network of high-level control areas that begin to prepare an upcoming decision long before it enters awareness.	[Soon, Chun Siong; Brass, Marcel; Haynes, John-Dylan] Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany; [Soon, Chun Siong; Haynes, John-Dylan] Charite Univ Med Berlin, Bernstein Ctr Computat Neurosci, D-10115 Berlin, Germany; [Brass, Marcel] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; Univ Ghent, Ghent Inst Funct & Metab Imaging, B-9000 Ghent, Belgium; [Heinze, Hans-Jochen] Otto VonGuericke Univ Magdegurg, Dept Neurol 2, D-39120 Magdeburg, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ghent University; Ghent University; Otto von Guericke University	Haynes, JD (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Stephanstr 1A, D-04103 Leipzig, Germany.	haynes@bccn-berlin.de	Soon, Chun Siong/O-8409-2017; Haynes, John-Dylan/Q-1148-2016; Brass, Marcel/J-7082-2012	Haynes, John-Dylan/0000-0003-1786-6954; Brass, Marcel/0000-0002-3364-4019; Soon, Chun Siong/0000-0003-2073-4557				Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; ECCLES JC, 1982, ARCH PSYCHIAT NERVEN, V231, P423, DOI 10.1007/BF00342722; GLYNN IM, 1990, NATURE, V348, P477, DOI 10.1038/348477a0; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Haggard P, 1999, EXP BRAIN RES, V126, P128, DOI 10.1007/s002210050722; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Joordens S, 2002, CONSCIOUS COGN, V11, P231, DOI 10.1006/ccog.2002.0559; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; van de Grind W, 2002, CONSCIOUS COGN, V11, P241, DOI 10.1006/ccog.2002.0560; Wegner DM, 2003, TRENDS COGN SCI, V7, P65, DOI 10.1016/S1364-6613(03)00002-0	15	830	852	10	275	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					543	545		10.1038/nn.2112	http://dx.doi.org/10.1038/nn.2112			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18408715				2022-12-24	WOS:000255327300012
J	Ibata, K; Sun, Q; Turrigiano, GG				Ibata, Keiji; Sun, Qian; Turrigiano, Gina G.			Rapid synaptic scaling induced by changes in postsynaptic firing	NEURON			English	Article							ACTIVITY-DEPENDENT REGULATION; KINASE TYPE IV/GR; HOMEOSTATIC PLASTICITY; AMPA RECEPTORS; GLUTAMATE RECEPTORS; QUANTAL AMPLITUDE; GENE-EXPRESSION; NERVOUS-SYSTEM; SYNAPSES; NEURONS	Homeostatic synaptic scaling adjusts a neuron's excitatory synaptic strengths up or down to compensate for perturbations in activity. Little is known about the molecular pathway(s) involved, nor is it clear which aspect of "activity"-local synaptic signaling, postsynaptic firing, or large-scale changes in network activity-is required to induce synaptic scaling. Here, we selectively block either postsynaptic firing in individual neurons or a fraction of presynaptic inputs, while optically monitoring changes in synaptic strength. We find that synaptic scaling is rapidly induced by block of postsynaptic firing, but not by local synaptic blockade, and is mediated through a drop in somatic calcium influx, reduced activation of CaMKIV, and an increase in transcription. Cortical neurons thus homeostatically adjust synaptic strengths in response to changes in their own firing rate, a mechanism with the computational advantage of efficiently normalizing synaptic strengths without interfering with synapse-specific mechanisms of information storage.	[Ibata, Keiji; Sun, Qian; Turrigiano, Gina G.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Ibata, Keiji; Sun, Qian; Turrigiano, Gina G.] Brandeis Univ, Ctr Behav Genom, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Turrigiano, GG (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.		Ibata, Keiji/L-5802-2013; JIANG, YUQIU/C-7806-2014; Sun, Qian/B-8424-2014	Sun, Qian/0000-0001-5623-6213	NINDS NIH HHS [NS 36853] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036853, R56NS036853] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Boyden ES, 2006, NEURON, V51, P823, DOI 10.1016/j.neuron.2006.08.026; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; GODDARD CA, 2007, NAT NEUROSCI, V9, P1001; Grunwald ME, 2004, P NATL ACAD SCI USA, V101, P3190, DOI 10.1073/pnas.0306156101; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Harms KJ, 2005, J NEUROSCI, V25, P6379, DOI 10.1523/JNEUROSCI.0302-05.2005; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Liu Z, 1998, J NEUROSCI, V18, P2309; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; NAKAMURA Y, 1995, NEUROSCIENCE, V68, P181, DOI 10.1016/0306-4522(95)00092-W; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Pratt KG, 2003, NEURON, V39, P269, DOI 10.1016/S0896-6273(03)00422-7; Rabinowitch I, 2006, J NEUROPHYSIOL, V96, P276, DOI 10.1152/jn.00074.2006; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wierenga CJ, 2006, J NEUROPHYSIOL, V96, P2127, DOI 10.1152/jn.00107.2006	46	302	302	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 27	2008	57	6					819	826		10.1016/j.neuron.2008.02.031	http://dx.doi.org/10.1016/j.neuron.2008.02.031			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281LV	18367083	Bronze			2022-12-24	WOS:000254500000006
J	Shiau, CE; Lwigale, PY; Das, RM; Wilson, SA; Bronner-Fraser, M				Shiau, Celia E.; Lwigale, Peter Y.; Das, Raman M.; Wilson, Stuart A.; Bronner-Fraser, Marianne			Robo2-Slit1 dependent cell-cell interactions mediate assembly of the trigeminal ganglion	NATURE NEUROSCIENCE			English	Article							REPULSIVE AXON GUIDANCE; NEURAL CREST; EXPRESSION PATTERNS; ADHESION MOLECULES; GENE FAMILY; SLIT; MIGRATION; ROBO; RECEPTORS; MIDLINE	Vertebrate cranial sensory ganglia, responsible for sensation of touch, taste and pain in the face and viscera, are composed of both ectodermal placode and neural crest cells. The cellular and molecular interactions allowing generation of complex ganglia remain unknown. Here, we show that proper formation of the trigeminal ganglion, the largest of the cranial ganglia, relies on reciprocal interactions between placode and neural crest cells in chick, as removal of either population resulted in severe defects. We demonstrate that ingressing placode cells express the Robo2 receptor and early migrating cranial neural crest cells express its cognate ligand Slit1. Perturbation of this receptor-ligand interaction by blocking Robo2 function or depleting either Robo2 or Slit1 using RNA interference disrupted proper ganglion formation. The resultant disorganization mimics the effects of neural crest ablation. Thus, our data reveal a novel and essential role for Robo2-Slit1 signaling in mediating neural crest-placode interactions during trigeminal gangliogenesis.	[Shiau, Celia E.; Lwigale, Peter Y.; Bronner-Fraser, Marianne] CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA; [Das, Raman M.; Wilson, Stuart A.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	California Institute of Technology; University of Sheffield	Bronner-Fraser, M (corresponding author), CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA.	mbronner@caltech.edu	Lwigale, Peter/AAV-2563-2020; Lwigale, Peter/A-3353-2011; Shiau, Celia/C-7679-2015	Lwigale, Peter/0000-0003-1799-4905; Shiau, Celia/0000-0002-9347-9158; Bronner, Marianne/0000-0003-4274-1862; Das, Raman/0000-0003-3375-619X; wilson, stuart/0000-0003-3073-258X	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/B/13578] Funding Source: Medline; NIDCR NIH HHS [DE16459, DE016459-07] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07616] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKITAYA T, 1992, DEV DYNAM, V194, P12, DOI 10.1002/aja.1001940103; Anselmo MA, 2003, GENE EXPR PATTERNS, V3, P13, DOI 10.1016/S1567-133X(02)00095-9; Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156; Begbie J, 2002, MOL CELL NEUROSCI, V21, P502, DOI 10.1006/mcne.2002.1197; Begbie J, 2001, SCIENCE, V294, P595, DOI 10.1126/science.1062028; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; CHEDOTAL A, 2007, SLITS THEIR RECEPTOR; Chen HX, 2000, DISCRETE EVENT DYN S, V10, P233, DOI 10.1023/A:1008397810443; Coles EG, 2006, DEV BIOL, V289, P218, DOI 10.1016/j.ydbio.2005.10.031; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; DAMICOMARTEL A, 1980, J EMBRYOL EXP MORPH, V55, P167; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Fouquet C, 2007, J NEUROSCI, V27, P3037, DOI 10.1523/JNEUROSCI.0172-07.2007; GAMMILL LS, 2006, J NEUROBIOL, V67, P47, DOI DOI 10.1002/NEU.20326; HAMBURGER V, 1961, J EXP ZOOL, V148, P91, DOI 10.1002/jez.1401480202; Hammond R, 2005, DEVELOPMENT, V132, P4483, DOI 10.1242/dev.02038; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Kasemeier-Kulesa JC, 2006, DEVELOPMENT, V133, P4839, DOI 10.1242/dev.02662; Kee Y, 2001, MECH DEVELOP, V109, P331, DOI 10.1016/S0925-4773(01)00574-3; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kil SH, 1998, DEV BIOL, V202, P29, DOI 10.1006/dbio.1998.8985; Knecht AK, 2002, NAT REV GENET, V3, P453, DOI 10.1038/nrg819; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Krull CE, 1997, CURR BIOL, V7, P571, DOI 10.1016/S0960-9822(06)00256-9; Loes S, 2001, MECH DEVELOP, V107, P155, DOI 10.1016/S0925-4773(01)00454-3; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lwigale PY, 2001, DEV BIOL, V239, P323, DOI 10.1006/dbio.2001.0450; Ma L, 2007, J NEUROSCI, V27, P6843, DOI 10.1523/JNEUROSCI.1479-07.2007; McLarren KW, 2003, DEV BIOL, V259, P34, DOI 10.1016/S0012-1606(03)00177-5; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; NORTHCUTT RG, 1995, J COMP NEUROL, V355, P427, DOI 10.1002/cne.903550309; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Parsons L, 2003, DEV BIOL, V264, P363, DOI 10.1016/j.ydbio.2003.08.020; Piotrowski T, 1996, BRAIN BEHAV EVOLUT, V47, P55, DOI 10.1159/000113229; Piper M, 2000, MECH DEVELOP, V94, P213, DOI 10.1016/S0925-4773(00)00313-0; Rhee J, 2002, NAT CELL BIOL, V4, P798, DOI 10.1038/ncb858; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Santiago-Martinez E, 2006, P NATL ACAD SCI USA, V103, P12441, DOI 10.1073/pnas.0605284103; Schlosser G, 2005, J EXP ZOOL PART B, V304B, P347, DOI 10.1002/jez.b.21055; Strickland P, 2006, DEVELOPMENT, V133, P823, DOI 10.1242/dev.02261; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; Taneyhill LA, 2007, DEVELOPMENT, V134, P1481, DOI 10.1242/dev.02834; Vargesson N, 2001, MECH DEVELOP, V106, P175, DOI 10.1016/S0925-4773(01)00430-0; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zinn K, 1999, CELL, V97, P1, DOI 10.1016/S0092-8674(00)80707-2	47	61	64	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					269	276		10.1038/nn2051	http://dx.doi.org/10.1038/nn2051			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18278043				2022-12-24	WOS:000253548300009
J	Ponce, CR; Lomber, SG; Born, RT				Ponce, Carlos R.; Lomber, Stephen G.; Born, Richard T.			Integrating motion and depth via parallel pathways	NATURE NEUROSCIENCE			English	Article							CORTICAL AREAS MT; MACAQUE VISUAL-CORTEX; HORIZONTAL DISPARITY; EYE-MOVEMENTS; DIRECTION SELECTIVITY; CHEMICAL LESIONS; STRIATE CORTEX; TEMPORAL AREA; ALERT MACAQUE; NEURONS	Processing of visual information is both parallel and hierarchical, with each visual area richly interconnected with other visual areas. An example of the parallel architecture of the primate visual system is the existence of two principal pathways providing input to the middle temporal visual area (MT): namely, a direct projection from striate cortex (V1), and a set of indirect projections that also originate in V1 but then relay through V2 and V3. Here we have reversibly inactivated the indirect pathways while recording from MT neurons and measuring eye movements in alert monkeys, a procedure that has enabled us to assess whether the two different input pathways are redundant or whether they carry different kinds of information. We find that this inactivation causes a disproportionate degradation of binocular disparity tuning relative to direction tuning in MT neurons, suggesting that the indirect pathways are important in the recovery of depth in three-dimensional scenes.	[Ponce, Carlos R.] Harvard Univ, Sch Med, MIT, Div Hlth Sci & Technol, Boston, MA 02115 USA; [Ponce, Carlos R.; Born, Richard T.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Lomber, Stephen G.] Univ Western Ontario, Robarts Res Inst, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada; [Lomber, Stephen G.] Univ Western Ontario, Robarts Res Inst, Dept Psychol, London, ON N6A 5K8, Canada	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Western University (University of Western Ontario); Western University (University of Western Ontario)	Ponce, CR (corresponding author), Harvard Univ, Sch Med, MIT, Div Hlth Sci & Technol, 260 Longwood Ave, Boston, MA 02115 USA.	carlos_ponce@hms.harvard.edu	Born, Richard/M-6454-2019; Lomber, Stephen/B-6820-2015	Born, Richard/0000-0003-4360-427X; Lomber, Stephen/0000-0002-3001-7909; Ponce, Carlos/0000-0002-9887-3234	NEI NIH HHS [R01 EY11379, EY12196, P30 EY012196-109001, R01 EY011379-12, P30 EY012196, R01 EY011379] Funding Source: Medline; NINDS NIH HHS [F31NS052926, F31 NS052926] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011379, P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS052926] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Anzai A, 2001, NAT NEUROSCI, V4, P513, DOI 10.1038/87462; Berzhanskaya J, 2007, SPATIAL VISION, V20, P337, DOI 10.1163/156856807780919000; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Broca P., 1863, B SOC ANTHR, V4, P200, DOI DOI 10.1515/9783110807783-002; Busettini C, 1996, NATURE, V380, P342, DOI 10.1038/380342a0; Busettini C, 1996, J NEUROPHYSIOL, V75, P1392, DOI 10.1152/jn.1996.75.4.1392; CHEN G, 2006, SOC NEUROSCI ABST; Churchland MM, 2005, J NEUROPHYSIOL, V93, P1235, DOI 10.1152/jn.00767.2004; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; DeAngelis GC, 2003, J NEUROPHYSIOL, V89, P1094, DOI 10.1152/jn.00717.2002; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DEYOE EA, 1985, NATURE, V317, P58, DOI 10.1038/317058a0; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; DURSTELER MR, 1988, J NEUROPHYSIOL, V60, P940, DOI 10.1152/jn.1988.60.3.940; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fritsch G, 1870, ARCH ANAT PHYSL WISS, V37, P300, DOI 10.1007/bf01759916; GATTASS R, 1988, J NEUROSCI, V8, P1831; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GIRARD P, 1992, J NEUROPHYSIOL, V67, P1437, DOI 10.1152/jn.1992.67.6.1437; Grossberg S, 2000, TRENDS COGN SCI, V4, P233, DOI 10.1016/S1364-6613(00)01464-9; HUBEL DH, 1987, J NEUROSCI, V7, P3378; Hupe JM, 2001, J NEUROPHYSIOL, V85, P146, DOI 10.1152/jn.2001.85.1.146; Inoue Y, 1998, EXP BRAIN RES, V121, P135, DOI 10.1007/s002210050445; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Lomber SG, 1999, J NEUROSCI METH, V86, P179, DOI 10.1016/S0165-0270(98)00165-4; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Movshon JA, 1996, J NEUROSCI, V16, P7733; NEWSOME WT, 1985, J NEUROSCI, V5, P825; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; ORBAN GA, 1986, J NEUROPHYSIOL, V56, P462, DOI 10.1152/jn.1986.56.2.462; Pack CC, 2006, J NEUROSCI, V26, P893, DOI 10.1523/JNEUROSCI.3226-05.2006; Pack CC, 2003, NEURON, V37, P525, DOI 10.1016/S0896-6273(02)01187-X; PETERHANS E, 1993, EUR J NEUROSCI, V5, P509, DOI 10.1111/j.1460-9568.1993.tb00517.x; Prince SJD, 2002, J NEUROPHYSIOL, V87, P209, DOI 10.1152/jn.00466.2000; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; Qian N, 1997, VISION RES, V37, P1683, DOI 10.1016/S0042-6989(96)00164-2; SANDELL JH, 1982, J NEUROPHYSIOL, V48, P38, DOI 10.1152/jn.1982.48.1.38; SHIPP S, 1989, EUR J NEUROSCI, V1, P333, DOI 10.1111/j.1460-9568.1989.tb00799.x; Sincich LC, 2003, J NEUROSCI, V23, P5684; Takemura A, 2001, J NEUROPHYSIOL, V85, P2245, DOI 10.1152/jn.2001.85.5.2245; Takemura A, 2007, J NEUROSCI, V27, P529, DOI 10.1523/JNEUROSCI.3455-06.2007; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Yabuta NH, 2001, SCIENCE, V292, P297, DOI 10.1126/science.1057916; ZAR JH, 1999, BIOSTAT ANAL, P380	48	84	85	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					216	223		10.1038/nn2039	http://dx.doi.org/10.1038/nn2039			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18193039	Green Accepted, Green Submitted			2022-12-24	WOS:000252712100016
J	Aamodt, S				Aamodt, Sandra			Focus on glia and disease	NATURE NEUROSCIENCE			English	Editorial Material																			0	7	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1349	1349		10.1038/nn1107-1349	http://dx.doi.org/10.1038/nn1107-1349			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17965653				2022-12-24	WOS:000250508400007
J	Lobo, MK; Cui, Y; Ostlund, SB; Balleine, BW; Yang, XW				Lobo, Mary Kay; Cui, Yijun; Ostlund, Sean B.; Balleine, Bernard W.; Yang, X. William			Genetic control of instrumental conditioning by striatopallidal neuron - specific S1P receptor Gpr6	NATURE NEUROSCIENCE			English	Article							DISEASE MODELS; BASAL GANGLIA; REWARD; ADDICTION; LIGAND; MOUSE	Instrumental conditioning allows animals to learn about the consequences of their own actions, but the underpinning molecular mechanisms remain elusive. Here we show that the sphingosine-1-phosphate (S1P) receptor Gpr6 is selectively expressed in the striatopallidal neurons in the striatum. Gpr6-deficient mice showed reduced striatal cyclic AMP production in vitro and selective alterations in instrumental conditioning in vivo. Thus, Gpr6 is the first striatopallidal neuron-specific genetic regulator of instrumental conditioning in a mammal.	Univ Calif Los Angeles, Ctr Neurobeh Genet, Jane & Terry Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yang, XW (corresponding author), Univ Calif Los Angeles, Ctr Neurobeh Genet, Jane & Terry Semel Inst Neurosci & Human Behav, 695 Charles Young Dr S, Los Angeles, CA 90095 USA.	balleine@psych.ucla.edu; xwyang@mednet.ucla.edu	Lobo, Mary Kay/K-7734-2015; Ostlund, Sean/D-6000-2017	Lobo, Mary Kay/0000-0002-9419-2079; Balleine, Bernard/0000-0001-8618-7950	NICHD NIH HHS [5T32HD007032] Funding Source: Medline; NIDA NIH HHS [P50 DA005010, P50DA05010] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ignatov A, 2003, BIOCHEM BIOPH RES CO, V311, P329, DOI 10.1016/j.bbrc.2003.10.006; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4	14	68	70	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1395	1397		10.1038/nn1987	http://dx.doi.org/10.1038/nn1987			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17934457				2022-12-24	WOS:000250508400014
J	Shen, W; Tian, X; Day, M; Ulrich, S; Tkatch, T; Nathanson, NM; Surmeier, DJ				Shen, Weixing; Tian, Xinyong; Day, Michelle; Ulrich, Sasha; Tkatch, Tatiana; Nathanson, Neil M.; Surmeier, D. James			Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons	NATURE NEUROSCIENCE			English	Article							MEDIUM SPINY NEURONS; RECTIFYING POTASSIUM CHANNELS; RECTIFIER K+ CHANNEL; MUSCARINIC RECEPTORS; PARKINSONS-DISEASE; BASAL GANGLIA; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; STRIATAL NEURONS; MESSENGER-RNAS; RAT STRIATUM	Dopamine-depleting lesions of the striatum that mimic Parkinson's disease induce a profound pruning of spines and glutamatergic synapses in striatopallidal medium spiny neurons, leaving striatonigral medium spiny neurons intact. The mechanisms that underlie this cell type-specific loss of connectivity are poorly understood. The Kir2 K+ channel is an important determinant of dendritic excitability in these cells. Here we show that opening of these channels is potently reduced by signaling through M1 muscarinic receptors in striatopallidal neurons, but not in striatonigral neurons. This asymmetry could be attributed to differences in the subunit composition of Kir2 channels. Dopamine depletion alters the subunit composition further, rendering Kir2 channels in striatopallidal neurons even more susceptible to modulation. Reduced opening of Kir2 channels enhances dendritic excitability and synaptic integration. This cell type-specific enhancement of dendritic excitability is an essential trigger for synaptic pruning after dopamine depletion, as pruning was prevented by genetic deletion of M1 muscarinic receptors.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Inst Neurosci, Chicago, IL 60611 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu		Nathanson, Neil/0000-0002-9216-121X; Tkatch, Tatiana/0000-0001-6626-7435	NINDS NIH HHS [NS 34696] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R37NS034696] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ANDERSON JJ, 1994, J PHARMACOL EXP THER, V269, P1144; BARBEAU A, 1962, CAN MED ASSOC J, V87, P802; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Calabresi P, 1998, EUR J NEUROSCI, V10, P3020, DOI 10.1046/j.1460-9568.1998.00348.x; Calabresi P, 1999, NEUROPHARMACOLOGY, V38, P323, DOI 10.1016/S0028-3908(98)00199-3; Chuang HH, 1997, CELL, V89, P1121, DOI 10.1016/S0092-8674(00)80299-8; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Delmas P, 2004, TRENDS NEUROSCI, V27, P41, DOI 10.1016/j.tins.2003.10.013; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Figueroa A, 2002, SYNAPSE, V46, P215, DOI 10.1002/syn.10114; Galarraga E, 1999, J NEUROSCI, V19, P3629, DOI 10.1523/jneurosci.19-09-03629.1999; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; HERSCH SM, 1994, J NEUROSCI, V14, P3351; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HOWE AR, 1995, J NEUROSCI, V15, P458; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Inanobe A, 2002, AM J PHYSIOL-CELL PH, V282, pC1396, DOI 10.1152/ajpcell.00615.2001; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Karschin C, 1996, J NEUROSCI, V16, P3559; KOCH C, 1993, J NEUROSCI, V13, P413; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; MANDEL RJ, 1994, BRAIN RES, V653, P57, DOI 10.1016/0006-8993(94)90372-7; MCNEILL TH, 1988, BRAIN RES, V455, P148, DOI 10.1016/0006-8993(88)90124-2; Mermelstein PG, 1998, J NEUROSCI, V18, P6650; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Pruss H, 2005, MOL BRAIN RES, V139, P63, DOI 10.1016/j.molbrainres.2005.05.006; Pruss H, 2003, MOL BRAIN RES, V110, P203, DOI 10.1016/S0169-328X(02)00649-6; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; ROBERTSON GS, 1992, EUR J PHARMACOL, V219, P323, DOI 10.1016/0014-2999(92)90313-S; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Segal M, 2003, EUR J NEUROSCI, V17, P2573, DOI 10.1046/j.1460-9568.2003.02696.x; Shen WX, 2005, J NEUROSCI, V25, P7449, DOI 10.1523/JNEUROSCI.1381-05.2005; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Tillerson JL, 2001, J NEUROSCI, V21, P4427, DOI 10.1523/JNEUROSCI.21-12-04427.2001; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; Topert C, 1998, J NEUROSCI, V18, P4096; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; WILSON CJ, 2004, SYNAPTIC ORG BRAIN, P361, DOI DOI 10.1093/ACPROF:0S0/9780195159561.003.0009; WOOTEN G, 1990, NEUROBIOLOGY DIS; Yan Z, 2001, NEUROSCIENCE, V103, P1017, DOI 10.1016/S0306-4522(01)00039-2	50	181	185	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1458	1466		10.1038/nn1972	http://dx.doi.org/10.1038/nn1972			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17906621				2022-12-24	WOS:000250508400024
J	Suh, H; Consiglio, A; Ray, J; Sawai, T; D'Amour, KA; Gage, FH				Suh, Hoonkyo; Consiglio, Antonella; Ray, Jasodhara; Sawai, Toru; D'Amour, Kevin A.; Gage, Fred H.			In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2(+) neural stem cells in the adult hippocampus	CELL STEM CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; MOUSE DENTATE GYRUS; PROGENITOR CELLS; TRANSGENIC MICE; NEUROGENESIS; NEURONS; EXPRESSION; CNS; BRAIN; GLIA	To characterize the properties of adult neural stem cells (NSCs), we generated and analyzed Sox2-GFP transgenic mice. Sox2-GFP cells in the subgranular zone (SGZ) express markers specific for progenitors, but they represent two morphologically distinct populations that differ in proliferation levels. Lentivirus- and retrovirus-mediated fate-tracing studies showed that Sox2(+) cells in the SGZ have potential to give rise to neurons and astrocytes, revealing their multipotency at the population as well as at a single-cell level. A subpopulation of Sox2(+) cells gives rise to cells that retain Sox2, highlighting Sox2(+) cells as a primary source for adult NSCs. In response to mitotic signals, increased proliferation of Sox2 cells is coupled with the generation of Sox2(+) NSCs as well as neuronal precursors. An asymmetric contribution of Sox2(+) NSCs may play an important role in maintaining the constant size of the NSC pool and producing newly born neurons during adult neurogenesis.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	consiglio, antonella/G-1815-2016; consiglio, antonella/AAA-5864-2019	consiglio, antonella/0000-0002-3988-6254; consiglio, antonella/0000-0002-3988-6254; Suh, Hoonkyo/0000-0002-4227-2982	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050217, R01NS052842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020938] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG020938, R01 AG020938-05, AG-020938] Funding Source: Medline; NINDS NIH HHS [NS-050217, NS-052842, R01 NS050217, R01 NS050217-03, R01 NS052842, R01 NS052842-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Consiglio A, 2004, P NATL ACAD SCI USA, V101, P14835, DOI 10.1073/pnas.0404180101; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Fukuda S, 2003, J NEUROSCI, V23, P9357; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Palmer TD, 2002, NEURON, V34, P856, DOI 10.1016/S0896-6273(02)00738-9; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Roy NS, 2000, NAT MED, V6, P271; Sakakibara S, 1997, J NEUROSCI, V17, P8300; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	41	591	610	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV	2007	1	5					515	528		10.1016/j.stem.2007.09.002	http://dx.doi.org/10.1016/j.stem.2007.09.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236AX	18371391	Bronze, Green Accepted			2022-12-24	WOS:000251276500010
J	Dombeck, DA; Khabbaz, AN; Collman, F; Adelman, TL; Tank, DW				Dombeck, Daniel A.; Khabbaz, Anton N.; Collman, Forrest; Adelman, Thomas L.; Tank, David W.			Imaging large-scale neural activity with cellular resolution in awake, mobile mice	NEURON			English	Article							DENDRITIC CALCIUM DYNAMICS; NEOCORTEX IN-VIVO; PYRAMIDAL NEURONS; ONE-PHOTON; BRAIN; MICROSCOPY; VOLTAGE; CORTEX; SPINES; NETWORKS	We report a technique for two-photon fluorescence imaging with cellular resolution in awake, behaving mice with minimal motion artifact. The apparatus combines an upright, table-mounted two-photon microscope with a spherical treadmill consisting of a large, air-supported Styrofoam ball. Mice, with implanted cranial windows, are head restrained under the objective while their limbs rest on the ball's upper surface. Following adaptation to head restraint, mice maneuver on the spherical treadmill as their heads remain motionless. Image sequences demonstrate that running-associated brain motion is limited to similar to 2-5 lam. In addition, motion is predominantly in the focal plane, with little out-of-plane motion, making the application of a custom-designed Hidden-Markov-Model-based motion correction algorithm useful for postprocessing. Behaviorally correlated calcium transients from large neuronal and astrocytic populations were routinely measured, with an estimated motion-induced false positive error rate of < 5%.	Princeton Univ, Carl Icahn Labs, Dept Biol Mol, Princeton, NJ 08544 USA; Princeton Univ, Carl Icahn Labs, Dept Phys, Princeton, NJ 08544 USA	Princeton University; Princeton University	Tank, DW (corresponding author), Princeton Univ, Carl Icahn Labs, Dept Biol Mol, Princeton, NJ 08544 USA.	dwtank@princeton.edu		Dombeck, Daniel/0000-0003-2576-5918; Collman, Forrest/0000-0002-0280-7022	NIDA NIH HHS [R90 DA023419, R90 DA023419-01] Funding Source: Medline; NIGMS NIH HHS [T32 GM007388-31, T32 GM007388] Funding Source: Medline; NIMH NIH HHS [K25 MH067876-01, R01 MH083686] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K25MH067876, R01MH083686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R90DA023419] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BERGJOHNSEN J, 1992, ACTA ANAESTH SCAND, V36, P350, DOI 10.1111/j.1399-6576.1992.tb03480.x; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRITT RH, 1982, J NEUROSCI METH, V6, P219, DOI 10.1016/0165-0270(82)90085-1; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; DAHMEN HJ, 1980, EXPERIENTIA, V36, P685, DOI 10.1007/BF01970140; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Destexhe A, 2007, TRENDS NEUROSCI, V30, P334, DOI 10.1016/j.tins.2007.04.006; Dombeck DA, 2005, J NEUROPHYSIOL, V94, P3628, DOI 10.1152/jn.00416.2005; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Fee MS, 2000, NEURON, V27, P461, DOI 10.1016/S0896-6273(00)00057-X; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Flusberg BA, 2005, OPT LETT, V30, P2272, DOI 10.1364/OL.30.002272; Gobel W, 2007, NAT METHODS, V4, P73, DOI 10.1038/NMETH989; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; KHABBAZ AN, 2004, SOC NEUR; Kleinfeld D, 2005, PLOS BIOL, V3, P1685, DOI 10.1371/journal.pbio.0030355; Kuhn B, 2004, BIOPHYS J, V87, P631, DOI 10.1529/biophysj.104.040477; Levene MJ, 2004, J NEUROPHYSIOL, V91, P1908, DOI 10.1152/jn.01007.2003; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; Mason AC, 2001, NATURE, V410, P686, DOI 10.1038/35070564; Nagayama S, 2007, NEURON, V53, P789, DOI 10.1016/j.neuron.2007.02.018; Nevian T, 2007, PFLUG ARCH EUR J PHY, V454, P675, DOI 10.1007/s00424-007-0234-2; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rose CR, 1999, PFLUG ARCH EUR J PHY, V439, P201, DOI 10.1007/s004240051145; Saggau P, 2006, CURR OPIN NEUROBIOL, V16, P543, DOI 10.1016/j.conb.2006.08.011; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Shoham S, 2006, J COMP PHYSIOL A, V192, P777, DOI 10.1007/s00359-006-0117-6; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Turner MJ, 2005, PHYSIOL GENOMICS, V22, P76, DOI 10.1152/physiolgenomics.00243.2004; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Wilson JM, 2007, J NEUROPHYSIOL, V97, P3118, DOI 10.1152/jn.01207.2006; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	54	680	691	2	84	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 4	2007	56	1					43	57		10.1016/j.neuron.2007.08.003	http://dx.doi.org/10.1016/j.neuron.2007.08.003			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920014	Bronze, Green Accepted			2022-12-24	WOS:000250289800009
J	George, L; Chaverra, M; Todd, V; Lansford, R; Lefcort, F				George, Lynn; Chaverra, Marta; Todd, Valerie; Lansford, Rusty; Lefcort, Frances			Nociceptive sensory neurons derive from contralaterally migrating, fate-restricted neural crest cells	NATURE NEUROSCIENCE			English	Article							DORSAL-ROOT-GANGLIA; CHICK-EMBRYO; NEUROTROPHIN RECEPTORS; REGULATES DEVELOPMENT; NERVOUS-SYSTEM; AVIAN EMBRYO; STEM-CELLS; IN-VIVO; EXPRESSION; LINEAGE	Neural crest cells (NCCs) are a transient population of multipotent progenitors that give rise to numerous cell types in the embryo. An unresolved issue is the degree to which the fate of NCCs is specified prior to their emigration from the neural tube. In chick embryos, we identified a subpopulation of NCCs that, upon delamination, crossed the dorsal midline to colonize spatially discrete regions of the contralateral dorsal root ganglia (DRG), where they later gave rise to nearly half of the nociceptor sensory neuron population. Our data indicate that before emigration, this NCC subset is phenotypically distinct, with an intrinsic lineage potential that differs from its temporally synchronized, but ipsilaterally migrating, cohort. These findings not only identify a major source of progenitor cells for the pain- and temperature-sensing afferents, but also reveal a previously unknown migratory pathway for sensory-fated NCCs that requires the capacity to cross the embryonic midline.	Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA; CALTECH, Beckman Imaging Ctr, Pasadena, CA 91125 USA	Montana State University System; Montana State University Bozeman; California Institute of Technology	Lefcort, F (corresponding author), Montana State Univ, Dept Cell Biol & Neurosci, Leon Johnson Hall,Rm 512, Bozeman, MT 59717 USA.	lefcort@montana.edu	Lansford, Rusty/C-6956-2014	George, Lynn/0000-0002-8125-2319; Lansford, Rusty/0000-0002-2159-3699	NINDS NIH HHS [F32 NS054529] Funding Source: Medline; PHS HHS [R01 35714, NRSA 7055571] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS054529, R15NS090384] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BHATTACHARYYA A, 1991, NEURON, V7, P831, DOI 10.1016/0896-6273(91)90285-8; BRONNERFRASER M, 1989, NEURON, V3, P755, DOI 10.1016/0896-6273(89)90244-4; CARR VM, 1978, J COMP NEUROL, V182, P741; Cayouette M, 2006, TRENDS NEUROSCI, V29, P563, DOI 10.1016/j.tins.2006.08.003; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Couly G, 1996, DEVELOPMENT, V122, P3393; Dupin E, 2006, ADV EXP MED BIOL, V589, P96; ERICKSON CA, 1992, DEV BIOL, V151, P251, DOI 10.1016/0012-1606(92)90231-5; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; FRANK E, 1991, DEVELOPMENT, V111, P895; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Henion PD, 1997, DEVELOPMENT, V124, P4351; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; LALLIER TE, 1988, DEV BIOL, V127, P99, DOI 10.1016/0012-1606(88)90192-3; LAWSON SN, 1979, J NEUROCYTOL, V8, P265, DOI 10.1007/BF01236122; Le Douarin NM, 1999, NEURAL CREST, V2; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Lo LC, 2005, P NATL ACAD SCI USA, V102, P7192, DOI 10.1073/pnas.0502581102; LORING JF, 1987, DEV BIOL, V121, P220, DOI 10.1016/0012-1606(87)90154-0; Ma QF, 1997, J NEUROSCI, V17, P3644; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Montelius A, 2007, DIFFERENTIATION, V75, P404, DOI 10.1111/j.1432-0436.2006.00154.x; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P376, DOI 10.1006/bbrc.1996.5882; Nelson BR, 2002, MECH DEVELOP, V119, pS11, DOI 10.1016/S0925-4773(03)00084-4; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Pannese E, 1974, Adv Anat Embryol Cell Biol, V47, P7; Perez SE, 1999, DEVELOPMENT, V126, P1715; Raible DW, 2005, SEMIN CELL DEV BIOL, V16, P673, DOI 10.1016/j.semcdb.2005.06.008; Rifkin JT, 2000, DEV BIOL, V227, P465, DOI 10.1006/dbio.2000.9841; SCHWEIZER G, 1983, CELL DIFFER DEV, V13, P191, DOI 10.1016/0045-6039(83)90089-1; SCOTT SA, 1992, NEURONS DEV DIVERSIT; SERBEDZIJA GN, 1990, DEVELOPMENT, V108, P605; SERBEDZIJA GN, 1989, DEVELOPMENT, V106, P809; Snider WD, 1996, PHILOS T ROY SOC B, V351, P395, DOI 10.1098/rstb.1996.0034; Swartz M, 2001, DEV BIOL, V233, P13, DOI 10.1006/dbio.2001.0181; Teddy JM, 2005, BIOTECHNIQUES, V39, P703, DOI 10.2144/000112017; TEILLET M-A, 1971, Annales d'Embryologie et de Morphogenese, V4, P95; TOSNEY KW, 1978, DEV BIOL, V62, P317, DOI 10.1016/0012-1606(78)90219-1; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; WESTON JA, 1963, DEV BIOL, V6, P279, DOI 10.1016/0012-1606(63)90016-2; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	49	34	38	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1287	1293		10.1038/nn1962	http://dx.doi.org/10.1038/nn1962			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828258				2022-12-24	WOS:000249720800015
J	Sato, S; Omori, Y; Katoh, K; Kondo, M; Kanagawa, M; Miyata, K; Funabiki, K; Koyasu, T; Kajimura, N; Miyoshi, T; Sawai, H; Kobayashi, K; Tani, A; Toda, T; Usukura, J; Tano, Y; Fujikado, T; Furukawa, T				Sato, Shigeru; Omori, Yoshihiro; Katoh, Kimiko; Kondo, Mineo; Kanagawa, Motoi; Miyata, Kentaro; Funabiki, Kazuo; Koyasu, Toshiyuki; Kajimura, Naoko; Miyoshi, Tomomitsu; Sawai, Hajime; Kobayashi, Kazuhiro; Tani, Akiko; Toda, Tatsushi; Usukura, Jiro; Tano, Yasuo; Fujikado, Takashi; Furukawa, Takahisa			Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation	NATURE NEUROSCIENCE			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; BETA-DYSTROGLYCAN; ALPHA-DYSTROGLYCAN; MOUSE RETINA; LOCALIZATION; PERLECAN; LAMININ; BINDING; MATRIX; IDENTIFICATION	Exquisitely precise synapse formation is crucial for the mammalian CNS to function correctly. Retinal photoreceptors transfer information to bipolar and horizontal cells at a specialized synapse, the ribbon synapse. We identified pikachurin, an extracellular matrix-like retinal protein, and observed that it localized to the synaptic cleft in the photoreceptor ribbon synapse. Pikachurin null-mutant mice showed improper apposition of the bipolar cell dendritic tips to the photoreceptor ribbon synapses, resulting in alterations in synaptic signal transmission and visual function. Pikachurin colocalized with both dystrophin and dystroglycan at the ribbon synapses. Furthermore, we observed direct biochemical interactions between pikachurin and dystroglycan. Together, our results identify pikachurin as a dystroglycan-interacting protein and demonstrate that it has an essential role in the precise interactions between the photoreceptor ribbon synapse and the bipolar dendrites. This may also advance our understanding of the molecular mechanisms underlying the retinal electrophysiological abnormalities observed in muscular dystrophy patients.	Osaka Biosci Inst, Dept Dev Biol, Osaka 5650874, Japan; Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Visual Sci, Suita, Osaka 5650871, Japan; Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Showa Ku, Nagoya, Aichi 4668550, Japan; Osaka Univ, Grad Sch Med, Dept Med Genet, Div Clin Genet, Suita, Osaka 5650871, Japan; Osaka Biosci Inst, Dept Syst Biol, Osaka 5650874, Japan; Osaka Univ, Res Ctr Ultrahigh Voltage Elect Microscopy, Osaka 5670047, Japan; Osaka Univ, Grad Sch Med, Dept Physiol, Suita, Osaka 5650871, Japan; Nagoya Univ, Grad Sch Engn, Dept Mat Phys & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Osaka University; Osaka University; Nagoya University; Osaka University; Osaka University; Osaka University; Nagoya University	Furukawa, T (corresponding author), Osaka Biosci Inst, Dept Dev Biol, 6-2-4 Furuedai, Osaka 5650874, Japan.	furukawa@obi.or.jp	Kobayashi, Kazuhiro/AAH-8638-2021; Kajimura, Naoko/R-9267-2019	Kobayashi, Kazuhiro/0000-0001-7801-147X; Usukura, Jiro/0000-0003-2286-5403; Toda, Tatsushi/0000-0002-0717-1123; Kanagawa, Motoi/0000-0003-0984-6398				BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; CIBIS GW, 1993, INVEST OPHTH VIS SCI, V34, P3646; Dalloz C, 2001, MOL CELL NEUROSCI, V17, P908, DOI 10.1006/mcne.2001.0978; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2006, CELL TISSUE RES, V326, P339, DOI 10.1007/s00441-006-0234-0; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FITZGERALD KM, 1994, J CLIN INVEST, V93, P2425, DOI 10.1172/JCI117250; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Holzfeind PJ, 2002, HUM MOL GENET, V11, P2673, DOI 10.1093/hmg/11.21.2673; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; IWASAKI M, 1992, J COMP NEUROL, V319, P277, DOI 10.1002/cne.903190207; Jastrow H, 2006, INVEST OPHTH VIS SCI, V47, P17, DOI 10.1167/iovs.05-0597; Kanagawa M, 2005, FEBS LETT, V579, P4792, DOI 10.1016/j.febslet.2005.07.059; Koike C, 2007, MOL CELL BIOL, V27, P8318, DOI 10.1128/MCB.01209-07; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Pillers DAM, 1999, MOL GENET METAB, V68, P304, DOI 10.1006/mgme.1999.2929; PILLERS DAM, 1993, NAT GENET, V4, P82, DOI 10.1038/ng0593-82; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; RAO MR, 1995, NEURON, V14, P561; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837, DOI 10.1017/S0952523800009408; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schmitz F, 1997, HISTOCHEM CELL BIOL, V108, P249, DOI 10.1007/s004180050165; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; SIGESMUND DA, 1994, OPHTHALMOLOGY, V101, P856; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Ueda H, 1998, J HISTOCHEM CYTOCHEM, V46, P185, DOI 10.1177/002215549804600207; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Winder SJ, 2001, TRENDS BIOCHEM SCI, V26, P118, DOI 10.1016/S0968-0004(00)01731-X; Zaccaria ML, 2001, NEUROSCIENCE, V104, P311, DOI 10.1016/S0306-4522(01)00092-6	42	206	211	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					923	931		10.1038/nn.2160	http://dx.doi.org/10.1038/nn.2160			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18641643				2022-12-24	WOS:000257969100018
J	Serguera, C; Triaca, V; Kelly-Barrett, J; Al Banchaabouchi, M; Minichiello, L				Serguera, Che; Triaca, Viviana; Kelly-Barrett, Jakki; Al Banchaabouchi, Mumna; Minichiello, Liliana			Increased dopamine after mating impairs olfaction and prevents odor interference with pregnancy	NATURE NEUROSCIENCE			English	Article							SEXUALLY DIMORPHIC ACTIVATION; TYROSINE-HYDROXYLASE; FEMALE MICE; RECEPTOR ACTIVATION; VOMERONASAL SYSTEM; PROLACTIN SURGES; TRANSGENIC MICE; MESSENGER-RNA; MOUSE MAIN; BULB	In rodents, social odor sensing influences female reproductive status by affecting neuroendocrine cascades. The odor of male mouse urine can induce ovulation or block pregnancy within 3d post coitus. Females avoid the action of such olfactory stimuli after embryonic implantation. The mechanisms underlying these changes are unknown. Here we report that shortly after mating, a surge in dopamine in the mouse main olfactory bulb impairs the perception of social odors contained in male urine. Treatment of females at 6.5 d post coitus with a dopamine D2 receptor antagonist restores social odor sensing and favors disruption of pregnancy by inhibition of prolactin release, when administered in the presence of alien male urine odors. These results show that an active sensory barrier blocks social olfactory cues detrimental to pregnancy, consistent with the main olfactory bulb being a major relay through which social odor modulates reproductive status.	[Serguera, Che; Triaca, Viviana; Kelly-Barrett, Jakki; Al Banchaabouchi, Mumna; Minichiello, Liliana] Mol Biol Lab, Mol Biol Unit, I-00015 Monterotondo, Italy		Minichiello, L (corresponding author), Mol Biol Lab, Mol Biol Unit, Via Ramarini 32, I-00015 Monterotondo, Italy.	minichiello@embl.it	Minichiello, Liliana/AAA-7190-2022; Serguera, Ché/J-8918-2012; Triaca, Viviana/P-8794-2018	Triaca, Viviana/0000-0001-8290-7279; Serguera, Che/0000-0002-9210-0636				ARBOGAST LA, 1993, NEUROENDOCRINOLOGY, V58, P501, DOI 10.1159/000126583; AREY BJ, 1989, ENDOCRINOLOGY, V124, P119, DOI 10.1210/endo-124-1-119; ARKARAVICHIEN W, 1990, J REPROD FERTIL, V90, P63; BAKER H, 1986, J COMP NEUROL, V252, P206, DOI 10.1002/cne.902520206; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Chung HJ, 1997, BIOL REPROD, V57, P312, DOI 10.1095/biolreprod57.2.312; COOPERSMITH R, 1991, BRAIN RES, V564, P149, DOI 10.1016/0006-8993(91)91365-8; Dluzen DE, 2002, MOL BRAIN RES, V108, P121, DOI 10.1016/S0169-328X(02)00520-X; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; ERSKINE MS, 1995, ENDOCR REV, V16, P508, DOI 10.1210/er.16.4.508; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; GALOSY SS, 1995, ENDOCRINOLOGY, V136, P3993, DOI 10.1210/en.136.9.3993; HALASZ N, 1981, J NEUROCYTOL, V10, P251, DOI 10.1007/BF01257970; Halem HA, 2001, EUR J NEUROSCI, V13, P389, DOI 10.1046/j.1460-9568.2001.01382.x; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; Harley Carolyn W., 2004, Neural Plasticity, V11, P191, DOI 10.1155/NP.2004.191; Keller M, 2006, CHEM SENSES, V31, P315, DOI 10.1093/chemse/bjj035; Keller M, 2006, EUR J NEUROSCI, V23, P521, DOI 10.1111/j.1460-9568.2005.04589.x; KEVERNE EB, 1982, NATURE, V296, P148, DOI 10.1038/296148a0; LAMOND D. R., 1958, AUSTRALIAN JOUR EXPTL BIOL AND MED SCI, V36, P103, DOI 10.1038/icb.1958.12; LAVAQUE TJ, 1975, PHYSIOL BEHAV, V14, P59, DOI 10.1016/0031-9384(75)90142-0; Lehmann ML, 2005, NEUROSCIENCE, V136, P55, DOI 10.1016/j.neuroscience.2005.02.053; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; LLOYDTHOMAS A, 1982, NEUROSCIENCE, V7, P907, DOI 10.1016/0306-4522(82)90051-3; Ma D, 2002, EUR J NEUROSCI, V16, P2317, DOI 10.1046/j.1460-9568.2002.02303.x; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Marchlewska-Koj A., 1984, Oxford Reviews of Reproductive Biology, V6, P266; Martel KL, 2007, EUR J NEUROSCI, V26, P463, DOI 10.1111/j.1460-9568.2007.05651.x; MATHIASEN JR, 1992, NEUROENDOCRINOLOGY, V56, P704, DOI 10.1159/000126296; Meisami E, 1998, MICROSC RES TECHNIQ, V43, P476, DOI 10.1002/(SICI)1097-0029(19981215)43:6<476::AID-JEMT2>3.3.CO;2-M; Meredith M, 1998, ANN NY ACAD SCI, V855, P349, DOI 10.1111/j.1749-6632.1998.tb10593.x; Milligan SR, 1997, HUM REPROD, V12, P602; Pierman S, 2008, EUR J NEUROSCI, V27, P423, DOI 10.1111/j.1460-9568.2007.06016.x; Pro-Sistiaga P, 2007, J COMP NEUROL, V504, P346, DOI 10.1002/cne.21455; RAJENDREN G, 1986, INDIAN J EXP BIOL, V24, P573; Robarts DW, 2007, HORM BEHAV, V51, P104, DOI 10.1016/j.yhbeh.2006.08.009; ROSSER AE, 1989, J REPROD FERTIL, V87, P553, DOI 10.1530/jrf.0.0870553; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; TASHIRO Y, 1990, BRAIN RES, V531, P159, DOI 10.1016/0006-8993(90)90769-8; Thanky NR, 2002, MOL BRAIN RES, V104, P220, DOI 10.1016/S0169-328X(02)00383-2; Wei CJ, 2006, BEHAV NEUROSCI, V120, P393, DOI 10.1037/0735-7044.120.2.393; Wersinger SR, 1997, BIOL REPROD, V56, P1407, DOI 10.1095/biolreprod56.6.1407; WHITTEN WK, 1956, J ENDOCRINOL, V14, P160, DOI 10.1677/joe.0.0140160; Xu FQ, 2005, J COMP NEUROL, V489, P491, DOI 10.1002/cne.20652; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Yue EL, 2004, BEHAV NEUROSCI, V118, P184, DOI 10.1037/0735-7044.118.1.184	50	44	46	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					949	956		10.1038/nn.2154	http://dx.doi.org/10.1038/nn.2154			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18641644				2022-12-24	WOS:000257969100021
J	Knutsen, PM; Biess, A; Ahissar, E				Knutsen, Per Magne; Biess, Armin; Ahissar, Ehud			Vibrissal kinematics in 3D: Tight coupling of azimuth, elevation, and torsion across different whisking modes	NEURON			English	Article							TRIGEMINAL GANGLION NEURONS; TACTILE DISCRIMINATION; RODENT WHISKING; ACTIVE TOUCH; RAT; MOVEMENTS; RESPONSES; SYSTEM; INNERVATION; BEHAVIOR	Perception is usually an active process by which action selects and affects sensory information. During rodent active touch, whisker kinematics influences how objects activate sensory receptors. In order to fully characterize whisker motion, we reconstructed whisker position in 3D and decomposed whisker motion to all its degrees of freedom. We found that, across behavioral modes, in both head-fixed and freely moving rats, whisker motion is characterized by translational movements and three rotary components: azimuth, elevation, and torsion. Whisker torsion, which has not previously been described, was large (up to 1000), and torsional angles were highly correlated with whisker azimuths. The coupling of azimuth and torsion was consistent across whisking epochs and rats and was similar along rows but systematically varied across rows such that rows A and E counterrotated. Torsional rotation of the whiskers enables contact information to be mapped onto the circumference of the whisker follicles in a predictable manner across protraction-retraction cycles.	[Knutsen, Per Magne; Ahissar, Ehud] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Biess, Armin] Weizmann Inst Sci, Dept Math, IL-76100 Rehovot, Israel; [Biess, Armin] Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany	Weizmann Institute of Science; Weizmann Institute of Science; Max Planck Society	Ahissar, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ehud.ahissar@weizmann.ac.il		Biess, Armin/0000-0002-0087-3675				Andermann ML, 2004, NEURON, V42, P451, DOI 10.1016/S0896-6273(04)00198-9; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Bermejo R, 2002, SOMATOSENS MOT RES, V19, P341, DOI 10.1080/0899022021000037809; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; CARVELL GE, 1990, J NEUROSCI, V10, P2638; DORFL J, 1985, J ANAT, V142, P173; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; GIBSON JM, 1983, SOMATOSENS RES, V1, P51, DOI 10.3109/07367228309144540; Hartley R., 2000, MULTIPLE VIEW GEOMET, V2; HERFST LJ, 2008, J NEUROPHYS IN PRESS; Jones LM, 2004, SCIENCE, V304, P1986, DOI 10.1126/science.1097779; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Krupa DJ, 2004, SCIENCE, V304, P1989, DOI 10.1126/science.1093318; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; LICHTENSTEIN SH, 1990, SOMATOSENS MOT RES, V7, P47, DOI 10.3109/08990229009144697; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Szwed M, 2006, J NEUROPHYSIOL, V95, P791, DOI 10.1152/jn.00571.2005; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Timofeeva E, 2003, J NEUROSCI, V23, P10717; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; WAITE PME, 1992, J COMP NEUROL, V322, P233, DOI 10.1002/cne.903220209; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124	26	90	90	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 10	2008	59	1					35	42		10.1016/j.neuron.2008.05.013	http://dx.doi.org/10.1016/j.neuron.2008.05.013			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	327KU	18614027	Bronze			2022-12-24	WOS:000257728800006
J	Nishiyama, M; von Schimmelmann, MJ; Togashi, K; Findley, WM; Hong, K				Nishiyama, Makoto; von Schimmelmann, Melanie J.; Togashi, Kazunobu; Findley, William M.; Hong, Kyonsoo			Membrane potential shifts caused by diffusible guidance signals direct growth-cone turning	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH; SEMAPHORIN 3A; CHEMOTROPIC GUIDANCE; AXONAL REPULSION; CALCIUM; NETRIN-1; ATTRACTION; COLLAPSE; MECHANISMS; RECEPTORS	Plasma membrane potentials gate the ion channel conductance that controls external signal-induced neuronal functions. We found that diffusible guidance molecules caused membrane potential shifts that resulted in repulsion or attraction of Xenopus laevis spinal neuron growth cones. The repellents Sema3A and Slit2 caused hyperpolarization, and the attractants netrin-1 and BDNF caused depolarization. Clamping the growth-cone potential at the resting state prevented Sema3A-induced repulsion; depolarizing potentials converted the repulsion to attraction, whereas hyperpolarizing potentials had no effect. Sema3A increased the intracellular concentration of guanosine 3',5'-cyclic monophosphate ([cGMP](i)) by soluble guanylyl cyclase, resulting in fast onset and long-lasting hyperpolarization. Pharmacological increase of [cGMP](i) caused protein kinase G (PKG)-mediated depolarization, switching Sema3A-induced repulsion to attraction. This bimodal switch required activation of either Cl- or Na+ channels, which, in turn, regulated the differential intracellular Ca2+ concentration increase across the growth cone. Thus, the polarity of growth-cone potential shifts imposes either attraction or repulsion, and Sema3A achieves this through cGMP signaling.	[Nishiyama, Makoto; von Schimmelmann, Melanie J.; Togashi, Kazunobu; Findley, William M.; Hong, Kyonsoo] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	New York University	Hong, K (corresponding author), NYU, Sch Med, Dept Biochem, 550 1st Ave, New York, NY 10016 USA.	hongk02@nyumc.org						Ayoob JC, 2004, J NEUROSCI, V24, P6639, DOI 10.1523/JNEUROSCI.1104-04.2004; Behar O, 1999, P NATL ACAD SCI USA, V96, P13501, DOI 10.1073/pnas.96.23.13501; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Chen CK, 2005, REV PHYSIOL BIOCH P, V154, P101, DOI 10.1007/s10254-005-0004-5; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Goshima Y, 1997, J NEUROBIOL, V33, P316, DOI 10.1002/(SICI)1097-4695(199709)33:3<316::AID-NEU9>3.0.CO;2-4; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; HE Z, 2002, SCI STKE, V119, pRE1, DOI DOI 10.1126/STKE.2002.119.RE1; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; ODOWD DK, 1988, J NEUROSCI, V8, P792; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; PATEL NB, 1984, J NEUROSCI, V4, P2939; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Spitzer NC, 2002, CURR OPIN NEUROBIOL, V12, P315, DOI 10.1016/S0959-4388(02)00330-6; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Terman JR, 2004, SCIENCE, V303, P1204, DOI 10.1126/science.1092121; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOGASHI K, NEURON IN PRESS; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zecevic D, 1996, NATURE, V381, P322, DOI 10.1038/381322a0; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	46	73	77	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					762	771		10.1038/nn.2130	http://dx.doi.org/10.1038/nn.2130			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18536712				2022-12-24	WOS:000257089400013
J	O'Connor-Giles, KM; Ho, LL; Ganetzky, B				O'Connor-Giles, Kate M.; Ho, Ling Ling; Ganetzky, Barry			Nervous wreck interacts with thickveins and the endocytic machinery to attenuate retrograde BMP signaling during synaptic growth	NEURON			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; II RECEPTOR; PROTEIN; DYNAMIN; CELL; DPP; ENDOSOMES; MEMBRANE; MUTANTS; RAB11	Regulation of synaptic growth is fundamental to the formation and plasticity of neural circuits. Here, we demonstrate that Nervous wreck (Nwk), a negative regulator of synaptic growth at Drosophila NMJs, interacts functionally and physically with components of the endocytic machinery, including dynamin and Dap160/intersectin, and negatively regulates retrograde BMP growth signaling through a direct interaction with the BMP receptor, thickveins. Synaptic overgrowth in nwk is sensitive to BMP signaling levels, and loss of Nwk facilitates BMP-induced overgrowth. Conversely, Nwk overexpression suppresses BMP-induced synaptic overgrowth. We observe analogous genetic interactions between dap160 and the BMP pathway, confirming that endocytosis regulates BMP signaling at NMJs. Finally, we demonstrate a correlation between synaptic growth and pMAD levels and show that Nwk regulates these levels. We propose that Nwk functions at the interface of endocytosis and BMP signaling to ensure proper synaptic growth by negatively regulating Tkv to set limits on this positive growth signal.	[O'Connor-Giles, Kate M.; Ho, Ling Ling; Ganetzky, Barry] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	O'Connor-Giles, KM (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	oconnorgiles@wisc.edu		O'Connor-Giles, Kate/0000-0002-2259-8408	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015390] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-15390, R01 NS015390, R01 NS015390-28] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Bokel C, 2006, SCIENCE, V314, P1135, DOI 10.1126/science.1132524; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Chen YJ, 1998, DEVELOPMENT, V125, P1759; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Dudu V, 2006, CURR BIOL, V16, P625, DOI 10.1016/j.cub.2006.02.061; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Estes PS, 1996, J NEUROSCI, V16, P5443; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Hoang B, 2001, DEV BIOL, V229, P55, DOI 10.1006/dbio.2000.9983; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Keshishian H, 2004, TRENDS NEUROSCI, V27, P143, DOI 10.1016/j.tins.2004.01.004; Khodosh R, 2006, DEVELOPMENT, V133, P4655, DOI 10.1242/dev.02650; Kim Y, 2006, MOL NEUROBIOL, V34, P129, DOI 10.1385/MN:34:2:129; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Nakayama H, 2006, J NEUROBIOL, V66, P929, DOI 10.1002/neu.20292; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; Schenck A, 2004, DEV BIOL, V274, P260, DOI 10.1016/j.ydbio.2004.07.009; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Sigrist SJ, 2002, J NEUROSCI, V22, P7362; Smythe E, 2006, J CELL SCI, V119, P4589, DOI 10.1242/jcs.03247; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wang XN, 2007, NAT NEUROSCI, V10, P177, DOI 10.1038/nn1841; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494	54	110	111	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 22	2008	58	4					507	518		10.1016/j.neuron.2008.03.007	http://dx.doi.org/10.1016/j.neuron.2008.03.007			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304PD	18498733	Bronze, Green Accepted			2022-12-24	WOS:000256120500006
J	Vashlishan, AB; Madison, JM; Dybbs, M; Bai, J; Sieburth, D; Ch'ng, Q; Tavazoie, M; Kaplan, JM				Vashlishan, Amy B.; Madison, Jon M.; Dybbs, Mike; Bai, Jihong; Sieburth, Derek; Ch'ng, Queelim; Tavazoie, Masoud; Kaplan, Joshua M.			An RNAi screen identifies genes that regulate GABA synapses	NEURON			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC-ACID; CAENORHABDITIS-ELEGANS; SYNAPTIC-TRANSMISSION; NEUROPEPTIDE-Y; ALPHA-SUBUNIT; MICE LACKING; MOUSE MODEL; BODY-SIZE; RECEPTOR	GABA synapses play a critical role in many aspects of circuit development and function. For example, conditions that perturb GABA transmission have been implicated in epilepsy. To identify genes that regulate GABA transmission, we performed an RNAi screen for genes whose inactivation increases the activity of C. elegans body muscles, which receive direct input from GABAergic motor neurons. We identified 90 genes, 21 of which were previously implicated in seizure syndromes, suggesting that this screen has effectively identified candidate genes for epilepsy. Electrophysiological recordings and imaging of excitatory and inhibitory synapses indicate that several genes alter muscle activity by selectively regulating GABA transmission. In particular, we identify two humoral pathways and several protein kinases that modulate GABA transmission but have little effect on excitatory transmission at cholinergic neuromuscular junctions. Our data suggest these conserved genes are components of signaling pathways that regulate GABA transmission and consequently may play a role in epilepsy and other cognitive or psychiatric disorders.	[Vashlishan, Amy B.; Madison, Jon M.; Dybbs, Mike; Bai, Jihong; Sieburth, Derek; Ch'ng, Queelim; Tavazoie, Masoud; Kaplan, Joshua M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Vashlishan, Amy B.; Kaplan, Joshua M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Dybbs, Mike] Univ Calif Berkeley, Dept Mol Cell Biol, Berkeley, CA 94720 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Berkeley	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu	Ch'ng, QueeLim/C-5348-2009	Ch'ng, QueeLim/0000-0003-1941-3828	Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [G9900989] Funding Source: Medline; MRC [G9900989] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054728] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Bamber BA, 1999, J NEUROSCI, V19, P5348; Baraban SC, 1997, J NEUROSCI, V17, P8927, DOI 10.1523/jneurosci.17-23-08927.1997; Bargmann C, 2005, NATURE, V436, P473, DOI 10.1038/436473a; Brecht S, 2005, EUR J NEUROSCI, V21, P363, DOI 10.1111/j.1460-9568.2005.03857.x; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Bronson RT, 2001, J NEUROPATH EXP NEUR, V60, P724, DOI 10.1093/jnen/60.7.724; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; BUTLER LS, 1995, P NATL ACAD SCI USA, V92, P6852, DOI 10.1073/pnas.92.15.6852; Campos VE, 2004, BIOCHEM BIOPH RES CO, V320, P606, DOI 10.1016/j.bbrc.2004.05.204; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Eastman C, 1999, J NEUROSCI, V19, P6225; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El Bahh B, 2005, EUR J NEUROSCI, V22, P1417, DOI 10.1111/j.1460-9568.2005.04338.x; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Freeman JM, 1998, PEDIATRICS, V102, P1358, DOI 10.1542/peds.102.6.1358; Gold SJ, 1997, J NEUROSCI, V17, P8024; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Gunn TM, 2001, GENETICS, V158, P1683; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Haqq AM, 2003, BIOCHEM J, V376, P595, DOI 10.1042/BJ20031241; He L, 2003, SCIENCE, V299, P710, DOI 10.1126/science.1079694; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Ingi T, 1998, J NEUROSCI, V18, P7178; Jacoby AS, 2002, MOL BRAIN RES, V107, P195, DOI 10.1016/S0169-328X(02)00451-5; Jeon SH, 2000, EXP MOL MED, V32, P227, DOI 10.1038/emm.2000.37; Jiang GL, 2005, J BIOL CHEM, V280, P2065, DOI 10.1074/jbc.M408470200; Jin YS, 1999, J NEUROSCI, V19, P539; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; KAMATH R, 2003, GENOME WIDE RNAI SCR; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kano M, 1996, P NATL ACAD SCI USA, V93, P13351, DOI 10.1073/pnas.93.23.13351; KAPLAN PB, 2005, IMITATORS EPILEPSY; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Kuramoto T, 2001, P NATL ACAD SCI USA, V98, P559, DOI 10.1073/pnas.98.2.559; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; LeBoeuf B, 2007, PLOS GENET, V3, P1622, DOI 10.1371/journal.pgen.0030156; Lee YS, 2000, J NEUROCHEM, V75, P1800, DOI 10.1046/j.1471-4159.2000.0751800.x; Li H, 2002, NEUROSCIENCE, V115, P505, DOI 10.1016/S0306-4522(02)00380-9; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Liu Q, 2007, J NEUROSCI, V27, P10404, DOI 10.1523/JNEUROSCI.5634-06.2007; LNENICKA GA, 1983, J PHYSIOL-LONDON, V345, P261, DOI 10.1113/jphysiol.1983.sp014977; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; Luo J, 2006, P NATL ACAD SCI USA, V103, P18326, DOI 10.1073/pnas.0605077103; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Mazarati AM, 1998, J NEUROSCI, V18, P10070; Mazarati AM, 2000, J NEUROSCI, V20, P6276, DOI 10.1523/JNEUROSCI.20-16-06276.2000; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; McNamara James O, 2006, Sci STKE, V2006, pre12, DOI 10.1126/stke.3562006re12; Mesples B, 2005, NEUROBIOL DIS, V18, P193, DOI 10.1016/j.nbd.2004.09.018; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Morita K, 1999, DEVELOPMENT, V126, P1337; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Natarajan L, 2004, DEV BIOL, V272, P536, DOI 10.1016/j.ydbio.2004.05.027; Noe F, 2007, PEPTIDES, V28, P377, DOI 10.1016/j.peptides.2006.07.025; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Perrimon N, 2007, GENETICS, V175, P7, DOI 10.1534/genetics.106.069963; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Reece-Hoyes JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2168-8-27; Reiner DJ, 1999, NATURE, V402, P199, DOI 10.1038/46072; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Robatzek M, 2000, GENETICS, V156, P1069; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Shinoda S, 2003, EUR J NEUROSCI, V17, P2065, DOI 10.1046/j.1460-9568.2003.02655.x; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; SNODGRASS SR, 1992, J CHILD NEUROL, V7, P77, DOI 10.1177/088307389200700114; Suzuki Y, 1999, DEVELOPMENT, V126, P241; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Tanaka-Hino M, 2002, EMBO REP, V3, P56, DOI 10.1093/embo-reports/kvf001; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Thiele EA, 2003, EPILEPSIA, V44, P26, DOI 10.1046/j.1528-1157.44.s7.4.x; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wang JJ, 2002, DEVELOPMENT, V129, P4989; WANG RA, 1995, J NEUROPHYSIOL, V73, P2099, DOI 10.1152/jn.1995.73.5.2099; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Williams SN, 2004, HUM MOL GENET, V13, P2043, DOI 10.1093/hmg/ddh209; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	110	90	129	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2008	58	3					346	361		10.1016/j.neuron.2008.02.019	http://dx.doi.org/10.1016/j.neuron.2008.02.019			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	300HP	18466746	Bronze			2022-12-24	WOS:000255815200009
J	Keleman, K; Kruttner, S; Alenius, M; Dickson, BJ				Keleman, Krystyna; Kruettner, Sebastian; Alenius, Mattias; Dickson, Barry J.			Function of the Drosophila CPEB protein Orb2 in long-term courtship memory	NATURE NEUROSCIENCE			English	Article							CYTOPLASMIC POLYADENYLATION; CONSOLIDATED MEMORY; SYNAPTIC PLASTICITY; NEURONAL ISOFORM; NEURAL CIRCUITRY; MESSENGER-RNA; BEHAVIOR; GENE; SEX; LOCALIZATION	Both long-term behavioral memory and synaptic plasticity require protein synthesis, some of which may occur locally at specific synapses. Cytoplasmic polyadenylation element-binding (CPEB) proteins are thought to contribute to the local protein synthesis that underlies long-term changes in synaptic efficacy, but a role has not been established for them in the formation of long-term behavioral memory. We found that the Drosophila melanogaster CPEB protein Orb2 is acutely required for long-term conditioning of male courtship behavior. Deletion of the N-terminal glutamine-rich region of Orb2 resulted in flies that were impaired in their ability to form long-term, but not short-term, memory. Memory was restored by expressing Orb2 selectively in fruitless (fru)positive c neurons of the mushroom bodies and by providing Orb2 function in mushroom bodies only during and shortly after training. Our data thus demonstrate that a CPEB protein is important in long-term memory and map the molecular, spatial and temporal requirements for its function in memory formation.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Keleman, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	keleman@imp.ac.at; dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X				Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; Berger-Sweeney J, 2006, LEARN MEMORY, V13, P4, DOI 10.1101/lm.73706; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; Chang JS, 2001, DEVELOPMENT, V128, P3169; CHRISTERSON LB, 1994, GENE DEV, V8, P614, DOI 10.1101/gad.8.5.614; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dukas R, 2005, ANIM BEHAV, V69, P1203, DOI 10.1016/j.anbehav.2004.08.012; Dukas R, 2006, ANIM BIOL, V56, P125, DOI 10.1163/157075606777304258; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GAILEY DA, 1985, GENETICS, V111, P795; GAILEY DA, 1984, GENETICS, V106, P613; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Kamyshev NG, 1999, LEARN MEMORY, V6, P1; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; LANTZ V, 1992, DEVELOPMENT, V115, P75; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Mehren JE, 2004, CURR OPIN NEUROBIOL, V14, P745, DOI 10.1016/j.conb.2004.10.012; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; Reif M, 2002, ANIM BEHAV, V63, P143, DOI 10.1006/anbe.2001.1876; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schlote, 1984, DROS INFORM SERV, V60, P210; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Sitnik N A, 2003, Neurosci Behav Physiol, V33, P67, DOI 10.1023/A:1021131415653; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tuite MF, 2000, CELL, V100, P289, DOI 10.1016/S0092-8674(00)80663-7; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; VANNATEERS WV, 2007, DROSOPHILA CURR BIOL, V17, P606; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	50	188	192	0	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1587	1593		10.1038/nn1996	http://dx.doi.org/10.1038/nn1996			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17965711				2022-12-24	WOS:000251172900016
J	Renthal, W; Maze, I; Krishnan, V; Covington, HE; Xiao, GH; Kumar, A; Russo, SJ; Graham, A; Tsankova, N; Kippin, TE; Kerstetter, KA; Neve, RL; Haggarty, SJ; McKinsey, TA; Bassel-Duby, R; Olson, EN; Nestler, EJ				Renthal, William; Maze, Ian; Krishnan, Vaishnav; Covington, Herbert E., III; Xiao, Guanghua; Kumar, Arvind; Russo, Scott J.; Graham, Ami; Tsankova, Nadia; Kippin, Tod E.; Kerstetter, Kerry A.; Neve, Rachael L.; Haggarty, Stephen J.; McKinsey, Timothy A.; Bassel-Duby, Rhonda; Olson, Eric N.; Nestler, Eric J.			Histone deacetylase 5 epigenetically controls Behavioral adaptations to chronic emotional stimuli	NEURON			English	Article							ELEMENT-BINDING PROTEIN; NUCLEUS-ACCUMBENS; TRANSCRIPTION FACTOR; NEUROTROPHIC FACTOR; SEEKING BEHAVIOR; DELTA-FOSB; HISTONE H3; LYSINE 9; COCAINE; STRESS	Previous work has identified alterations in histone acetylation in animal models of drug addiction and depression. However, the mechanisms which integrate drugs and stress with changes in chromatin structure remain unclear. Here, we identify the activity-dependent class II histone deacetylase, HDAC5, as a central integrator of these stimuli with changes in chromatin structure and gene expression. Chronic, but not acute, exposure to cocaine or stress decreases HDAC5 function in the nucleus accumbens (NAc), a major brain reward region, which allows for increased histone acetylation and transcription of HDAC5 target genes. This regulation is behaviorally important, as loss of HDAC5 causes hypersensitive responses to chronic, not acute, cocaine or stress. These findings suggest that proper balance of histone acetylation is a crucial factor in the saliency of a given stimulus and that disruption of this balance is involved in the transition from an acute adaptive response to a chronic psychiatric illness.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Clin Sci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA; Harvard Univ, Sch Med, Belmont, MA 02178 USA; McLean Hosp, Belmont, MA 02178 USA; Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Myogen Inc, Gilead Colorado Inc, Westminster, CO 80021 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Santa Barbara; Harvard University; Harvard University; McLean Hospital; Harvard University	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Maze, Ian/P-8077-2018; Haggarty, Stephen J/M-9495-2016; Kumar, Arvind/B-6094-2009; Russo, Scott/R-7107-2019	Haggarty, Stephen J/0000-0002-7872-168X; Russo, Scott/0000-0002-6470-1805; Kumar, Arvind/0000-0003-2879-3826; Krishnan, Vaishnav/0000-0002-2847-0069; Renthal, William/0000-0003-0206-2101; Maze, Ian/0000-0003-1490-7781				Ahmed SH, 1997, PSYCHOPHARMACOLOGY, V132, P289, DOI 10.1007/s002130050347; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Ang E, 2001, J NEUROCHEM, V79, P221, DOI 10.1046/j.1471-4159.2001.00563.x; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Breslow R., 1993, PTC Int. Appl, Patent No. [9307148, WO 93/07148]; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Erb S, 1996, PSYCHOPHARMACOLOGY, V128, P408, DOI 10.1007/s002130050150; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Green TA, 2006, J NEUROSCI, V26, P8235, DOI 10.1523/JNEUROSCI.0880-06.2006; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; KALIVAS PW, 1984, NEUROSCI LETT, V48, P55, DOI 10.1016/0304-3940(84)90288-X; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kombian SB, 2003, J NEUROPHYSIOL, V89, P728, DOI 10.1152/jn.00854.2002; Koob G, 2007, AM J PSYCHIAT, V164, P1149, DOI 10.1176/appi.ajp.2007.05030503; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee JH, 2002, MOL CELL BIOL, V22, P7658, DOI 10.1128/MCB.22.21.7658-7666.2002; Levine AA, 2005, P NATL ACAD SCI USA, V102, P19186, DOI 10.1073/pnas.0509735102; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Lu L, 2006, TRENDS NEUROSCI, V29, P695, DOI 10.1016/j.tins.2006.10.005; Mattson BJ, 2005, J NEUROCHEM, V95, P1481, DOI 10.1111/j.1471-4159.2005.03500.x; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McLaughlin JP, 2006, NEUROPSYCHOPHARMACOL, V31, P1241, DOI 10.1038/sj.npp.1300872; MERMELSTEIN P, 2007, NEUROBIOLOGY ADDICTI; Murtra P, 2000, NATURE, V405, P180, DOI 10.1038/35012069; Nazarian A, 2004, BRAIN RES BULL, V63, P295, DOI 10.1016/j.brainresbull.2004.03.004; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Newton SS, 2002, J NEUROSCI, V22, P10883; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Placenza FM, 2005, NEUROSCI LETT, V390, P42, DOI 10.1016/j.neulet.2005.07.050; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; PULVIRENTI L, 1992, BRAIN RES, V594, P327, DOI 10.1016/0006-8993(92)91145-5; Ruiz-Velasco V, 2002, PHYSIOL GENOMICS, V8, P41, DOI 10.1152/physiolgenomics.00085.2001; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	56	477	507	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 8	2007	56	3					517	529		10.1016/j.neuron.2007.09.032	http://dx.doi.org/10.1016/j.neuron.2007.09.032			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	229AV	17988634	Bronze			2022-12-24	WOS:000250774600010
J	Liu, Q; Zerbinatti, CV; Zhang, J; Hoe, HS; Wang, B; Cole, SL; Herz, J; Muglia, L; Bu, GJ				Liu, Qiang; Zerbinatti, Celina V.; Zhang, Juan; Hoe, Hyang-Sook; Wang, Baiping; Cole, Sarah L.; Herz, Joachim; Muglia, Louis; Bu, Guojun			Amyloid precursor protein regulates brain apolipoprotein e and cholesterol metabolism through lipoprotein receptor LRP1	NEURON			English	Article							DEPENDENT TRANSCRIPTIONAL CONTROL; DEGRADING ENZYME NEPRILYSIN; ALZHEIMERS-DISEASE; INTRACELLULAR DOMAINS; INTRAMEMBRANE PROTEOLYSIS; GENE-EXPRESSION; BETA-SECRETASE; MICE LACKING; APP; PRESENILIN	Mutations in the amyloid precursor protein (APP) cause early-onset Alzheimer's disease (AD), but the only genetic risk factor for late-onset AD is the epsilon 4 allele of apolipoprotein E (apoE), a major cholesterol carrier. Using Crelox conditional knockout mice, we demonstrate that lipoprotein receptor LRP1 expression regulates apoE and cholesterol levels within the CNS. We also found that deletion of APP and its homolog APLP2, or components of the gamma-secretase complex, significantly enhanced the expression and function of LRP1, which was reversed by forced expression of the APP intracellular domain (AICD). We further show that AICD, together with Fe65 and Tip60, interacts with the LRP1 promoter and suppresses its transcription. Together, our findings support that the gamma-secretase cleavage of APP plays a central role in regulating apoE and cholesterol metabolism in the CNS via LRP1 and establish a biological linkage between APP and apoE, the two major genetic determinants of AD.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA; Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Georgetown University; Baylor College of Medicine; Baylor College of Medicine; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bu, GJ (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	bu@wusti.edu	Liu, Qiang/E-9245-2011; Zhang, Jane/E-9064-2011; LIU, Qiang/A-3044-2012		NHLBI NIH HHS [R37 HL063762] Funding Source: Medline; NIA NIH HHS [R01 AG027924, P01 AG030128, R01 AG027924-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG030128, R01AG027924] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Borg JP, 1996, MOL CELL BIOL, V16, P6229; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; BU GJ, 1993, J BIOL CHEM, V268, P13002; Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chen AC, 2007, NEURON, V46, P541; Chen AC, 2007, NEURON, V53, P479, DOI 10.1016/j.neuron.2007.01.023; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101; Fryer JD, 2005, J BIOL CHEM, V280, P25754, DOI 10.1074/jbc.M502143200; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Hamanaka H, 2000, HUM MOL GENET, V9, P353, DOI 10.1093/hmg/9.3.353; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2007, NEURON, V53, P477, DOI 10.1016/j.neuron.2007.02.001; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Huang J, 2004, J BIOL INORG CHEM, V9, P627, DOI 10.1007/s00775-004-0556-x; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Ledesma MD, 2006, FEBS LETT, V580, P5525, DOI 10.1016/j.febslet.2006.06.038; Ledesma MD, 2003, EMBO REP, V4, P1190, DOI 10.1038/sj.embor.7400021; Li YH, 2005, J CELL SCI, V118, P5305, DOI 10.1242/jcs.02651; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; Muller T, 2007, MOL BIOL CELL, V18, P201, DOI 10.1091/mbc.E06-04-0283; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pardossi-Piquard R, 2007, NEURON, V53, P483, DOI 10.1016/j.neuron.2007.01.024; Park IH, 2003, NEUROBIOL AGING, V24, P637, DOI 10.1016/S0197-4580(02)00155-0; Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Saganich MJ, 2006, J NEUROSCI, V26, P13428, DOI 10.1523/JNEUROSCI.4180-06.2006; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shobab LA, 2005, LANCET NEUROL, V4, P841, DOI 10.1016/S1474-4422(05)70248-9; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Zerbinatti CV, 2006, J BIOL CHEM, V281, P36180, DOI 10.1074/jbc.M604436200; Zerbinatti CV, 2005, REV NEUROSCIENCE, V16, P123; Zerbinatti CV, 2004, P NATL ACAD SCI USA, V101, P1075, DOI 10.1073/pnas.0305803101; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	62	279	285	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2007	56	1					66	78		10.1016/j.neuron.2007.08.008	http://dx.doi.org/10.1016/j.neuron.2007.08.008			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920016	Green Accepted, Bronze			2022-12-24	WOS:000250289800011
J	Miller, FD				Miller, Freda D.			Riding the waves: Neural and nonneural origins for mesenchymal stem cells	CELL STEM CELL			English	Editorial Material							MARROW; DIFFERENTIATION; BONE	The role of endogenous mesenchymal stem cells (MSCs) is enigmatic. Recently in Cell, Takashima et al. (2007) addressed the biological origin of MSCs and showed that they are generated in waves, with the neuroepithelium unexpectedly providing the first wave and a second wave of nonneural-derived MSCs taking precedence in the adult.	Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Miller, FD (corresponding author), Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 1L7, Canada.	fredam@sickkids.ca						Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Dennis JE, 2002, STEM CELLS, V20, P205, DOI 10.1634/stemcells.20-3-205; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; GRONTHOS S, 1994, BLOOD, V84, P4164, DOI 10.1182/blood.V84.12.4164.bloodjournal84124164; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Ogawa M, 2006, BLOOD, V108, P2893, DOI 10.1182/blood-2006-04-016600; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028	10	15	25	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG	2007	1	2					129	130		10.1016/j.stem.2007.07.007	http://dx.doi.org/10.1016/j.stem.2007.07.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XS	18371342	Bronze			2022-12-24	WOS:000251055100002
J	Cardin, JA; Palmer, LA; Contreras, D				Cardin, Jessica A.; Palmer, Larry A.; Contreras, Diego			Cellular mechanisms underlying stimulus-dependent gain modulation in primary visual cortex neurons in vivo	NEURON			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; CENTRAL-NERVOUS-SYSTEM; MACAQUE AREA V4; CORTICAL-NEURONS; SHUNTING INHIBITION; RESPONSE GAIN; ORIENTATION SELECTIVITY; CONTRAST INVARIANCE; SPATIAL ATTENTION; SINGLE CELLS	Gain modulation is a widespread neuronal phenomenon that modifies response amplitude without changing selectivity. Computational and in vitro studies have proposed cellular mechanisms of gain modulation based on the postsynaptic effects of background synaptic activation, but these mechanisms have not been studied in vivo. Here, we used intracellular recordings from cat primary visual cortex to measure neuronal gain while changing background synaptic activity with visual stimulation. We found that increases in the membrane fluctuations associated with increases in synaptic input do not obligatorily result in gain modulation in vivo. However, visual stimuli that evoked sustained changes in resting membrane potential, input resistance, and membrane fluctuations robustly modulated neuronal gain. The magnitude of gain modulation depended critically on the spatiotemporal properties of the visual stimulus. Gain modulation in vivo may thus be determined on a moment-to-moment basis by sensory context and the consequent dynamics of synaptic activation.	[Cardin, Jessica A.; Palmer, Larry A.; Contreras, Diego] Univ Penn, Dept Neurosci, Sch Med, Philadelphia, PA 19106 USA	University of Pennsylvania	Contreras, D (corresponding author), Univ Penn, Dept Neurosci, Sch Med, 215 Stemmler Hall, Philadelphia, PA 19106 USA.	diegoc@mail.med.upenn.edu			NATIONAL EYE INSTITUTE [R01EY013984, K99EY018407, R01EY016430, F32EY017501] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY017501, K99 EY018407, R01 EY013984, R01 EY016430, R01 EY016430-02, R01 EY013984-05, F32 EY017501-02] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alitto HJ, 2004, J NEUROPHYSIOL, V91, P2797, DOI 10.1152/jn.00943.2003; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; Cardin JA, 2005, J NEUROSCI, V25, P5339, DOI 10.1523/JNEUROSCI.0374-05.2005; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Conner CE, 1997, J NEUROSCI, V17, P3201; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; Contreras D, 2003, J NEUROSCI, V23, P6936; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; FOX K, 1992, J NEUROSCI, V12, P2672; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Higgs MH, 2006, J NEUROSCI, V26, P8787, DOI 10.1523/JNEUROSCI.1792-06.2006; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; Kim YJ, 2007, NAT NEUROSCI, V10, P117, DOI 10.1038/nn1821; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Krieger G, 2000, SPATIAL VISION, V13, P201, DOI 10.1163/156856800741216; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Murphy BK, 2003, J NEUROSCI, V23, P10040; Nase G, 2003, J NEUROPHYSIOL, V90, P1115, DOI 10.1152/jn.00480.2002; Nowak LG, 2005, J NEUROSCI, V25, P1866, DOI 10.1523/JNEUROSCI.3897-04.2005; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Oviedo H, 2005, J NEUROSCI, V25, P4985, DOI 10.1523/JNEUROSCI.0562-05.2005; Prescott SA, 2003, P NATL ACAD SCI USA, V100, P2076, DOI 10.1073/pnas.0337591100; Salinas E, 2001, NEUROSCIENTIST, V7, P430, DOI 10.1177/107385840100700512; SCLAR G, 1982, EXP BRAIN RES, V46, P457; Shu YS, 2003, J NEUROSCI, V23, P10388; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Smith MR, 2002, J NEUROPHYSIOL, V87, P2031, DOI 10.1152/jn.00821.2001; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Tateno T, 2006, J NEUROPHYSIOL, V95, P2650, DOI 10.1152/jn.00683.2005; Thomson AM, 2002, PHILOS T R SOC B, V357, P1781, DOI 10.1098/rstb.2002.1163; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; WEYAND TG, 1993, J NEUROPHYSIOL, V69, P2258, DOI 10.1152/jn.1993.69.6.2258; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Winkowski DE, 2006, NATURE, V439, P336, DOI 10.1038/nature04411	54	60	61	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 10	2008	59	1					150	160		10.1016/j.neuron.2008.05.002	http://dx.doi.org/10.1016/j.neuron.2008.05.002			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	327KU	18614036	Green Accepted, Bronze			2022-12-24	WOS:000257728800015
J	Alexander, CM				Alexander, Caroline M.			Base behavior behind budding breasts: Integrins and mammary stem cell activity	CELL STEM CELL			English	Editorial Material							BETA-1-INTEGRIN; ADHESION; GLAND	In a recent Nature Cell Biology paper, Taddei et al. (2008) reveal that deletion of beta 1 integrin from K5-expressing mammary epithelial basal cells specifically attenuates ductal stem cell activity, without dramatically altering the basal cell layer, or morphogenesis overall.	Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Alexander, CM (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	alexander@oncology.wisc.edu						Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Katz E, 2007, INT J BIOCHEM CELL B, V39, P715, DOI 10.1016/j.biocel.2006.11.004; Levy L, 2000, MOL BIOL CELL, V11, P453, DOI 10.1091/mbc.11.2.453; Paguirigan A, 2007, CELL PROLIFERAT, V40, P106; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Tanentzapf G, 2007, NAT CELL BIOL, V9, P1413, DOI 10.1038/ncb1660; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025	11	3	3	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL	2008	3	1					5	6		10.1016/j.stem.2008.06.006	http://dx.doi.org/10.1016/j.stem.2008.06.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	325XO	18593551	Bronze			2022-12-24	WOS:000257622300003
J	Ledran, MH; Krassowska, A; Armstrong, L; Dimmick, I; Renstrom, J; Lang, R; Yung, S; Santibanez-Coref, M; Dzierzak, E; Stojkovic, M; Oostendorp, RAJ; Forrester, L; Lako, M				Ledran, Maria H.; Krassowska, Anna; Armstrong, Lyle; Dimmick, Ian; Renstroem, Jonas; Lang, Roland; Yung, Sun; Santibanez-Coref, Mauro; Dzierzak, Elaine; Stojkovic, Miodrag; Oostendorp, Robert A. J.; Forrester, Lesley; Lako, Majlinda			Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches	CELL STEM CELL			English	Article							HEMANGIOBLAST; MAINTENANCE; ENGRAFTMENT; GENERATION; COCULTURE; LINES	Hematopoietic stem cells derived from human embryonic stem cells (hESCs) could provide a therapeutic alternative to bone marrow transplants, but the efficiency of currently available derivation protocols is low. In this study, we investigated whether coculture with monolayers; of cells derived from mouse AGM and fetal liver, or with stromal cell lines derived from these tissues, can enhance hESC hematopoietic differentiation. We found that under such conditions hESC-derived differentiating cells formed early hematopoietic progenitors, with a peak at day 18-21 of differentiation that corresponded to the highest CD34 expression. These hESC-derived hematopoietic cells were capable of primary and secondary hematopoietic engraftment into immunocompromised mice at substantially higher levels than described previously. Transcriptional and functional analysis identified TGF-beta 1 and TGF-beta 3 as positive enhancers of hESC hematopoietic differentiation that can further stimulate this process when added to the culture. Overall, our findings represent significant progress toward the goal of deriving functional hematopoietic stem cells from hESCs.	[Ledran, Maria H.; Armstrong, Lyle; Dimmick, Ian; Yung, Sun; Lako, Majlinda] Newcastle Univ, NE Inst Stem Cell Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ledran, Maria H.; Armstrong, Lyle; Dimmick, Ian; Yung, Sun; Santibanez-Coref, Mauro; Lako, Majlinda] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Krassowska, Anna; Forrester, Lesley] Univ Edinburgh, Queens Med Res Inst, John Hughes Bennett Labs, Edinburgh, Midlothian, Scotland; [Renstroem, Jonas; Oostendorp, Robert A. J.] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin, D-8000 Munich, Germany; [Lang, Roland] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Dzierzak, Elaine] Erasmus Univ, Dept Cell Biol & Genet, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Oostendorp, Robert A. J.] Ctr Invest Principe Felipe, Valencia, Spain	Newcastle University - UK; Newcastle University - UK; University of Edinburgh; Technical University of Munich; Technical University of Munich; Erasmus University Rotterdam; Erasmus MC; Prince Felipe Research Center	Lako, M (corresponding author), Newcastle Univ, NE Inst Stem Cell Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	majlinda.lako@ncl.ac.uk	Lako, Majlinda/B-6297-2013; Armstrong, Lyle/B-7812-2013; Tuluc, Petronel/C-2527-2011; Oostendorp, Robert A. J./K-9841-2018; Lang, Roland/C-3287-2011	Oostendorp, Robert A. J./0000-0002-4947-0412; armstrong, lyle/0000-0002-7234-9362; Lang, Roland/0000-0003-0502-3677; lako, majlinda/0000-0003-1327-8573; Stojkovic, Miodrag/0000-0001-7526-6573	BBSRC [BB/E012841/1] Funding Source: UKRI; MRC [G9900837, G0301182, G9826762] Funding Source: UKRI; Medical Research Council [G0700711B] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/E012841/1] Funding Source: Medline; Medical Research Council [G9900837, G9826762, G0301182] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Basu S, 2005, BLOOD, V106, P485, DOI 10.1182/blood-2004-10-4145; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chang KH, 2006, BLOOD, V108, P1515, DOI 10.1182/blood-2005-11-011874; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; HEDMAN K, 1979, J CELL BIOL, V81, P83, DOI 10.1083/jcb.81.1.83; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Krassowska A, 2006, EXP CELL RES, V312, P3595, DOI 10.1016/j.yexcr.2006.08.001; Marshall CJ, 2007, BRIT J HAEMATOL, V139, P321, DOI 10.1111/j.1365-2141.2007.06795.x; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Narayan AD, 2006, BLOOD, V107, P2180, DOI 10.1182/blood-2005-05-1922; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Oostendorp RAJ, 2005, STEM CELLS, V23, P842, DOI 10.1634/stemcells.2004-0120; Oostendorp RAJ, 2002, J CELL SCI, V115, P2099; Oostendorp RAJ, 2002, BLOOD, V99, P1183, DOI 10.1182/blood.V99.4.1183; Oostendorp Robert A J, 2005, Methods Mol Biol, V290, P163; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Perlingeiro RCR, 2007, DEVELOPMENT, V134, P3041, DOI 10.1242/dev.002907; Qiu CH, 2005, EXP HEMATOL, V33, P1450, DOI 10.1016/j.exphem.2005.09.003; Ruscetti FW, 2005, ONCOGENE, V24, P5751, DOI 10.1038/sj.onc.1208921; Schiedlmeier B, 2007, P NATL ACAD SCI USA, V104, P16952, DOI 10.1073/pnas.0703082104; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takeuchi M, 2002, BLOOD, V99, P1190, DOI 10.1182/blood.V99.4.1190; Tian XH, 2004, EXP HEMATOL, V32, P1000, DOI 10.1016/j.exphem.2004.06.013; Tian XH, 2006, STEM CELLS, V24, P1370, DOI 10.1634/stemcells.2005-0340; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	32	222	244	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL	2008	3	1					85	98		10.1016/j.stem.2008.06.001	http://dx.doi.org/10.1016/j.stem.2008.06.001			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	325XO	18593561	Bronze			2022-12-24	WOS:000257622300012
J	Pan, XC; Sawa, K; Tsuda, I; Tsukada, M; Sakagami, M				Pan, Xiaochuan; Sawa, Kosuke; Tsuda, Ichiro; Tsukada, Minoru; Sakagami, Masamichi			Reward prediction based on stimulus categorization in primate lateral prefrontal cortex	NATURE NEUROSCIENCE			English	Article							MIXED-STRATEGY GAME; DECISION-MAKING; BEHAVIORAL-CONTROL; NEURONAL-ACTIVITY; EXPECTED REWARD; FRONTAL-CORTEX; VISUAL-STIMULI; MACAQUE; REPRESENTATION; MONKEYS	To adapt to changeable or unfamiliar environments, it is important that animals develop strategies for goal-directed behaviors that meet the new challenges. We used a sequential paired-association task with asymmetric reward schedule to investigate how prefrontal neurons integrate multiple already-acquired associations to predict reward. Two types of reward-related neurons were observed in the lateral prefrontal cortex: one type predicted reward independent of physical properties of visual stimuli and the other encoded the reward value specific to a category of stimuli defined by the task requirements. Neurons of the latter type were able to predict reward on the basis of stimuli that had not yet been associated with reward, provided that another stimulus from the same category was paired with reward. The results suggest that prefrontal neurons can represent reward information on the basis of category and propagate this information to category members that have not been linked directly with any experience of reward.	[Pan, Xiaochuan; Tsukada, Minoru; Sakagami, Masamichi] Tamagawa Univ, Brian Sci Inst, Tokyo 194610, Japan; [Sawa, Kosuke] Senshu Univ, Dept Psychol, Tama Ku, Kanagawa 2148580, Japan; [Tsuda, Ichiro] Hokkaido Univ, Res Inst Elect Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University	Sakagami, M (corresponding author), Tamagawa Univ, Brian Sci Inst, Tamagawagakuen 6-1-1, Tokyo 194610, Japan.	sakagami@lab.tamagawa.ac.jp		Sawa, Kosuke/0000-0002-1807-9277				Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Blaisdell AP, 2006, SCIENCE, V311, P1020, DOI 10.1126/science.1121872; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2003, J NEUROSCI, V23, P5235; FUSTER JM, 1997, PERFRONTAL CORTEX AN; Genovesio A, 2005, NEURON, V47, P307, DOI 10.1016/j.neuron.2005.06.006; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hauser M, 2006, P NATL ACAD SCI USA, V103, P7181, DOI 10.1073/pnas.0601247103; HERRNSTEIN RJ, 1979, J EXP PSYCHOL ANIM B, V5, P116, DOI 10.1037/0097-7403.5.2.116; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Hoshi E, 2006, NEUROSCI RES, V54, P73, DOI 10.1016/j.neures.2005.10.013; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Kobayashi S, 2006, NEURON, V51, P861, DOI 10.1016/j.neuron.2006.08.031; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; MCGONIGLE BO, 1977, NATURE, V267, P694, DOI 10.1038/267694a0; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Miyachi S, 2005, J NEUROSCI, V25, P2547, DOI 10.1523/JNEUROSCI.4186-04.2005; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; PASSINGHAM RE, 1998, PREFRONTAL CORTEX EX, P131; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Sakagami M, 1999, NEUROSCI RES, V34, P79, DOI 10.1016/S0168-0102(99)00038-3; SAKAGAMI M, 1994, EXP BRAIN RES, V97, P423; Sakagami M, 2007, ANN NY ACAD SCI, V1104, P89, DOI 10.1196/annals.1390.010; Sakagami M, 2006, NEURAL NETWORKS, V19, P1255, DOI 10.1016/j.neunet.2006.05.040; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Shima K, 2007, NATURE, V445, P315, DOI 10.1038/nature05470; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Watanabe M, 2007, CURR OPIN NEUROBIOL, V17, P213, DOI 10.1016/j.conb.2007.02.007; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Zentall TR, 2002, J EXP ANAL BEHAV, V78, P237, DOI 10.1901/jeab.2002.78-237; Zentall TR, 1998, ANIM LEARN BEHAV, V26, P363, DOI 10.3758/BF03199229	46	58	62	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					703	712		10.1038/nn.2128	http://dx.doi.org/10.1038/nn.2128			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18500338				2022-12-24	WOS:000256133700017
J	Goldberg, EM; Clark, BD; Zagha, E; Nahmani, M; Erisir, A; Rudy, B				Goldberg, Ethan M.; Clark, Brian D.; Zagha, Edward; Nahmani, Mark; Erisir, Alev; Rudy, Bernardo			K+ channels at the axon initial segment dampen near-threshold excitability of neocortical fast-spiking GABAergic interneurons	NEURON			English	Article							POTASSIUM CHANNELS; INHIBITORY INTERNEURONS; PYRAMIDAL CELLS; NEURONS; DIVERSITY; FREQUENCY; EPILEPSY; KV1.1; GENE; INTEGRATION	Fast-spiking cells (FS cells) are a prominent subtype of neocortical GABAergic interneurons with important functional roles. Multiple FS cell properties are coordinated for rapid response. Here, we describe an FS cell feature that serves to gate the powerful inhibition produced by FS cell activity. We show that FS cells in layer 2/3 barrel cortex possess a dampening mechanism mediated by Kv1.1-containing potassium channels localized to the axon initial segment. These channels powerfully regulate action potential threshold and allow FS cells to respond preferentially to large inputs that are fast enough to "outrun" Kv1 activation. In addition, Kv1.1 channel blockade converts the delay-type discharge pattern of FS cells to one of continuous fast spiking without influencing the high-frequency firing that defines FS cells. Thus, Kv1 channels provide a key counterbalance to the established rapid-response characteristics of FS cells, regulating excitability through a unique combination of electrophysiological properties and discrete subcellular localization.	[Goldberg, Ethan M.; Clark, Brian D.; Zagha, Edward; Rudy, Bernardo] NYU, Sch Med, Smilow Neurosci Program, New York, NY 10016 USA; [Goldberg, Ethan M.; Clark, Brian D.; Zagha, Edward] NYU, Sch Med, Med Sci Training Program, New York, NY 10016 USA; [Goldberg, Ethan M.; Clark, Brian D.; Zagha, Edward; Rudy, Bernardo] NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; [Rudy, Bernardo] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Nahmani, Mark; Erisir, Alev] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA	New York University; New York University; New York University; New York University; University of Virginia	Rudy, B (corresponding author), NYU, Sch Med, Smilow Neurosci Program, Smilow Res Bldg,6th Floor,522 1st Ave, New York, NY 10016 USA.	rudyb01@med.nyu.edu	Goldberg, Ethan/J-8332-2012; Erisir, Alev/A-5952-2014	Goldberg, Ethan/0000-0002-7404-735X; Erisir, Alev/0000-0002-7538-7911; Nahmani, Marc/0000-0002-5840-2462; Rudy, Bernardo/0000-0001-5748-6900	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045217, F30NS047882, R01NS030989] Funding Source: NIH RePORTER; NINDS NIH HHS [F30 NS47882, R01 NS030989-10, NS30989, F30 NS047882-02, R01 NS045217-05, F30 NS047882, R01 NS045217-04, R01 NS045217, R01 NS030989, R01 NS030989-09, NS045217, R01 NS030989-11, F30 NS047882-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Bruno RM, 2002, J NEUROSCI, V22, P10966; Chow A, 1999, J NEUROSCI, V19, P9332; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Contreras D, 2004, NEURAL NETWORKS, V17, P633, DOI 10.1016/j.neunet.2004.04.003; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Dodson PD, 2002, J NEUROSCI, V22, P6953; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Goldberg EM, 2005, J NEUROSCI, V25, P5230, DOI 10.1523/JNEUROSCI.0722-05.2005; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Henze DA, 2001, NEUROSCIENCE, V105, P121, DOI 10.1016/S0306-4522(01)00167-1; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; KITA H, 1990, BRAIN RES, V536, P1, DOI 10.1016/0006-8993(90)90002-S; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Lau D, 2000, J NEUROSCI, V20, P9071; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Liguori R, 2001, MUSCLE NERVE, V24, P630, DOI 10.1002/mus.1048; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Miller KD, 2001, CURR OPIN NEUROBIOL, V11, P488, DOI 10.1016/S0959-4388(00)00239-7; NOBLE D, 1966, PHYSIOL REV, V46, P1; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Peters A., 1984, CEREBRAL CORTEX FUNC, P107, DOI [10.1007/978-3-662-03733-1_15, DOI 10.1007/978-3-662-03733-1_15]; Pongs O, 1999, ANN NY ACAD SCI, V868, P344, DOI 10.1111/j.1749-6632.1999.tb11296.x; Robertson B, 1996, FEBS LETT, V383, P26, DOI 10.1016/0014-5793(96)00211-6; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tateno T, 2004, J NEUROPHYSIOL, V92, P2283, DOI 10.1152/jn.00109.2004; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; WANG H, 1994, J NEUROSCI, V14, P4588; WU RL, 1992, J NEUROSCI, V12, P2235; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	54	181	182	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2008	58	3					387	400		10.1016/j.neuron.2008.03.003	http://dx.doi.org/10.1016/j.neuron.2008.03.003			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	300HP	18466749	Green Accepted, Bronze			2022-12-24	WOS:000255815200012
J	Correia, SS; Bassani, S; Brown, TC; Lise, MF; Backos, DS; El-Husseini, A; Passafaro, M; Esteban, JA				Correia, Susana S.; Bassani, Silvia; Brown, Tyler C.; Lise, Marie-France; Backos, Donald S.; El-Husseini, Alaa; Passafaro, Maria; Esteban, Jose A.			Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation	NATURE NEUROSCIENCE			English	Article							MYOSIN-VA; SYNAPTIC-TRANSMISSION; DENDRITIC SPINES; RECYCLING ENDOSOMES; GRISCELLI-DISEASE; ACTIN-FILAMENTS; TRAFFICKING; PLASTICITY; SYNAPSES; NEURONS	The regulated trafficking of neurotransmitter receptors at synapses is critical for synaptic function and plasticity. However, the molecular machinery that controls active transport of receptors into synapses is largely unknown. We found that, in rat hippocampus, the insertion of AMPA receptors (AMPARs) into spines during synaptic plasticity requires a specific motor protein, which we identified as myosin Va. We found that myosin Va associates with AMPARs through its cargo binding domain. This interaction was enhanced by active, GTP-bound Rab11, which is also transported by the motor protein. Myosin Va mediated the CaMKII-triggered translocation of GluR1 receptors from the dendritic shaft into spines, but it was not required for constitutive GluR2 trafficking. Accordingly, myosin Va was specifically required for long-term potentiation, but not for basal synaptic transmission. In summary, we identified the specific motor protein and organelle acceptor that catalyze the directional transport of AMPARs into spines during activity-dependent synaptic plasticity.	[Correia, Susana S.; Brown, Tyler C.; Backos, Donald S.; Esteban, Jose A.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Bassani, Silvia; Passafaro, Maria] Univ Milan, Dept Pharmacol, Dulbecco Telethon Inst, Consiglio Nazl Ric Inst Neurosci, I-20129 Milan, Italy; [Brown, Tyler C.; Esteban, Jose A.] Univ Michigan, Sch Med, Neurosci Program, Ann Arbor, MI 48109 USA; [Lise, Marie-France; El-Husseini, Alaa] Univ British Columbia, Dept Psychiat, Brain Res Ctr, Fac Med, Vancouver, BC V6T 1Z3, Canada	University of Michigan System; University of Michigan; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Milan; University of Michigan System; University of Michigan; University of British Columbia	Esteban, JA (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	estebanj@umich.edu	Esteban, Jose/L-4944-2014; Backos, Donald/Q-4791-2018; Bassani, Silvia/A-7241-2012; Backos, Donald/N-5265-2019	Esteban, Jose/0000-0002-3759-3300; Backos, Donald/0000-0001-6735-6210; Bassani, Silvia/0000-0003-0553-7168; Backos, Donald/0000-0001-6735-6210; Brown, Tyler/0000-0001-9543-8555	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH070205, R01MH070417] Funding Source: NIH RePORTER; NIMH NIH HHS [MH070417, F31-MH070205] Funding Source: Medline; Telethon [TCR07006] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Telethon(Fondazione Telethon)		Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Brown JR, 2001, BIOL BULL, V201, P240, DOI 10.2307/1543343; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Cao TT, 2004, MOL BIOL CELL, V15, P151, DOI 10.1091/mbc.E03-07-0504; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Gerges NZ, 2005, METHOD ENZYMOL, V403, P153, DOI 10.1016/S0076-6879(05)03013-2; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Petralia RS, 2001, EUR J NEUROSCI, V13, P1722, DOI 10.1046/j.0953-816x.2001.01553.x; Piccini A, 2002, J NEUROSCI, V22, P5387; Rodriguez OC, 2002, J CELL SCI, V115, P991; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Sanal O, 2000, J NEUROL, V247, P570, DOI 10.1007/s004150070162; Schnell E, 2001, J NEUROPHYSIOL, V85, P1498, DOI 10.1152/jn.2001.85.4.1498; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Tabb JS, 1998, J CELL SCI, V111, P3221; Takagishi Y, 1996, NEUROSCI LETT, V215, P169, DOI 10.1016/S0304-3940(96)12967-0; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	50	192	196	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					457	466		10.1038/nn2063	http://dx.doi.org/10.1038/nn2063			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18311135	Green Submitted			2022-12-24	WOS:000254359300018
J	Agosto, J; Choi, JC; Parisky, KM; Stilwell, G; Rosbash, M; Griffith, LC				Agosto, Jose; Choi, James C.; Parisky, Katherine M.; Stilwell, Geoffrey; Rosbash, Michael; Griffith, Leslie C.			Modulation of GABA(A) receptor desensitization uncouples sleep onset and maintenance in Drosophila	NATURE NEUROSCIENCE			English	Article							GABA(A) RECEPTORS; ANTIEPILEPTIC DRUGS; INSECTICIDE RESISTANCE; CYCLODIENE RESISTANCE; MUSHROOM BODIES; REDUCED SLEEP; A RECEPTOR; MELANOGASTER; CARBAMAZEPINE; MECHANISMS	Many lines of evidence indicate that GABA and GABA(A) receptors make important contributions to human sleep regulation. Pharmacological manipulation of these receptors has differential effects on sleep onset and sleep maintenance insomnia. Here we show that sleep is regulated by GABA in Drosophila and that a mutant GABAA receptor, Rdl(A302S), specifically decreases sleep latency. The drug carbamazepine (CBZ) has the opposite effect on sleep; it increases sleep latency as well as decreasing sleep. Behavioral and physiological experiments indicated that Rdl(A302S) mutant flies are resistant to the effects of CBZ on sleep latency and that mutant RDLA302S channels are resistant to the effects of CBZ on desensitization, respectively. These results suggest that this biophysical property of the channel, specifically channel desensitization, underlies the regulation of sleep latency in flies. These experiments uncouple the regulation of sleep latency from that of sleep duration and suggest that the kinetics of GABA(A) receptor signaling dictate sleep latency.	[Choi, James C.; Parisky, Katherine M.; Griffith, Leslie C.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Agosto, Jose; Rosbash, Michael] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02254 USA; [Agosto, Jose; Choi, James C.; Parisky, Katherine M.; Rosbash, Michael; Griffith, Leslie C.] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Stilwell, Geoffrey] Cambria Biosci, Woburn, MA 01801 USA	Brandeis University; Brandeis University; Howard Hughes Medical Institute; Brandeis University	Griffith, LC (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	griffith@brandeis.edu		Griffith, Leslie/0000-0003-3164-9876	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067284] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [T32 GM007122] Funding Source: Medline; NIMH NIH HHS [R01 MH067284-06A1, R01 MH067284, MH 067284] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ambrosio AF, 2002, NEUROCHEM RES, V27, P121, DOI 10.1023/A:1014814924965; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Aronstein K, 1996, INVERTEBR NEUROSCI, V2, P115, DOI 10.1007/BF02214114; ARONSTEIN K, 1994, PESTIC BIOCHEM PHYS, V48, P229, DOI 10.1006/pest.1994.1024; Bazil CW, 2003, CNS DRUGS, V17, P719, DOI 10.2165/00023210-200317100-00003; Boileau AJ, 2002, NEUROPHARMACOLOGY, V43, P695, DOI 10.1016/S0028-3908(02)00036-9; BRAND AH, 1995, CURR OPIN NEUROBIOL, V5, P572, DOI 10.1016/0959-4388(95)80061-1; BREWSTER ME, 1991, J PHARM SCI, V80, P380, DOI 10.1002/jps.2600800420; Buhr A, 2002, HUM GENET, V111, P154, DOI 10.1007/s00439-002-0766-7; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; FFRENCHCONSTANT RH, 1991, P NATL ACAD SCI USA, V88, P7209, DOI 10.1073/pnas.88.16.7209; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gottesmann C, 2002, NEUROSCIENCE, V111, P231, DOI 10.1016/S0306-4522(02)00034-9; GRANGER P, 1995, MOL PHARMACOL, V47, P1189; GREENLEAF AL, 1979, CELL, V18, P613, DOI 10.1016/0092-8674(79)90116-8; Greenspan RJ, 2004, HUM MOL GENET, V13, pR267, DOI 10.1093/hmg/ddh248; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Hodge JJL, 2005, J NEUROBIOL, V63, P235, DOI 10.1002/neu.20126; Holbrook AM, 2000, CAN MED ASSOC J, V162, P225; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Lancel M, 1999, SLEEP, V22, P33, DOI 10.1093/sleep/22.1.33; Lee D, 2003, J NEUROSCI, V23, P4625; Masson M, 2005, CHEM PHARM BULL, V53, P958, DOI 10.1248/cpb.53.958; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Priestley CM, 2003, BRIT J PHARMACOL, V140, P1363, DOI 10.1038/sj.bjp.0705542; Rosenberg Russell P, 2006, Ann Clin Psychiatry, V18, P49, DOI 10.1080/10401230500464711; Roth T, 2005, J CLIN PSYCHIAT, V66, P10; ROTH T, 2005, J CLIN PSYCHIAT S9, V9, P42; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; SMITH GB, 1995, TRENDS PHARMACOL SCI, V16, P162, DOI 10.1016/S0165-6147(00)89009-4; Spina E, 2004, EPILEPTIC DISORD, V6, P57; STILWELL GE, 1995, J MOL BIOL, V253, P223, DOI 10.1006/jmbi.1995.0547; van Swinderen B, 2004, CURR BIOL, V14, P81, DOI 10.1016/j.cub.2003.12.057; ZHANG HG, 1994, J PHYSIOL-LONDON, V479, P65, DOI 10.1113/jphysiol.1994.sp020278	39	134	135	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					354	359		10.1038/nn2046	http://dx.doi.org/10.1038/nn2046			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18223647	Green Accepted			2022-12-24	WOS:000253548300019
J	Orger, MB; Kampff, AR; Severi, KE; Bollmann, JH; Engert, F				Orger, Michael B.; Kampff, Adam R.; Severi, Kristen E.; Bollmann, Johann H.; Engert, Florian			Control of visually guided behavior by distinct populations of spinal projection neurons	NATURE NEUROSCIENCE			English	Article							IDENTIFIED RETICULOSPINAL NEURONS; LARVAL ZEBRAFISH; MAUTHNER CELL; PREY CAPTURE; DECISION-MAKING; LASER-ABLATION; MOTOR CONTROL; HINDBRAIN; INTERNEURONS; ORGANIZATION	A basic question in the field of motor control is how different actions are represented by activity in spinal projection neurons. We used a new behavioral assay to identify visual stimuli that specifically drive basic motor patterns in zebrafish. These stimuli evoked consistent patterns of neural activity in the neurons projecting to the spinal cord, which we could map throughout the entire population using in vivo two-photon calcium imaging. We found that stimuli that drive distinct behaviors activated distinct subsets of projection neurons, consisting, in some cases, of just a few cells. This stands in contrast to the distributed activation seen for more complex behaviors. Furthermore, targeted cell by cell ablations of the neurons associated with evoked turns abolished the corresponding behavioral response. This description of the functional organization of the zebrafish motor system provides a framework for identifying the complete circuit underlying a vertebrate behavior.	[Orger, Michael B.; Kampff, Adam R.; Bollmann, Johann H.; Engert, Florian] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Severi, Kristen E.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Harvard University; Northeastern University	Orger, MB (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	morger@mcb.harvard.edu	Severi, Kristen/AAB-8943-2019	Severi, Kristen/0000-0002-4568-1538; Kampff, Adam/0000-0003-3079-019X; Orger, Michael/0000-0002-9763-8902	NATIONAL EYE INSTITUTE [R01EY014429] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014429-01A2, R01 EY014429-05, R01 EY014429] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bhatt DH, 2007, NEURON, V53, P91, DOI 10.1016/j.neuron.2006.11.011; Bizzi E, 2002, NEUROSCIENTIST, V8, P437, DOI 10.1177/107385802236969; Borla MA, 2002, BRAIN BEHAV EVOLUT, V60, P207, DOI 10.1159/000066699; Bosch TJ, 2001, J COMP NEUROL, V439, P306, DOI 10.1002/cne.1352; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Budick SA, 2000, J EXP BIOL, V203, P2565; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Chong M, 2007, DEV NEUROBIOL, V67, P933, DOI 10.1002/dneu.20398; Chung SH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-30; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Deliagina TG, 2002, BRAIN RES REV, V40, P166, DOI 10.1016/S0165-0173(02)00199-6; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Gahtan E, 2004, J NEUROBIOL, V59, P147, DOI 10.1002/neu.20000; Gahtan E, 2003, J COMP NEUROL, V459, P186, DOI 10.1002/cne.10621; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Gahtan E, 2001, J NEUROSCI METH, V108, P97, DOI 10.1016/S0165-0270(01)00382-X; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; Kimura Y, 2006, J NEUROSCI, V26, P5684, DOI 10.1523/JNEUROSCI.4993-05.2006; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; LEE RKK, 1991, J COMP NEUROL, V304, P34; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Lister JA, 1999, DEVELOPMENT, V126, P3757; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; MENDELSON B, 1986, J COMP NEUROL, V251, P172, DOI 10.1002/cne.902510204; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; NISSANOV J, 1990, BRAIN RES, V517, P88, DOI 10.1016/0006-8993(90)91012-6; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Orger MB, 2000, NAT NEUROSCI, V3, P1128, DOI 10.1038/80649; Orlovsky G., 1999, NEURONAL CONTROL LOC; PEARSON KG, 1993, ANNU REV NEUROSCI, V16, P265, DOI 10.1146/annurev.ne.16.030193.001405; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Sato T, 2007, J NEUROSCI, V27, P5271, DOI 10.1523/JNEUROSCI.0883-07.2007; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; WIERSMA CAG, 1964, COMP BIOCHEM PHYSIOL, V12, P509, DOI 10.1016/0010-406X(64)90153-7; WU J, 1994, SCIENCE, V263, P820, DOI 10.1126/science.8303300; Zelenin PV, 2007, J NEUROSCI, V27, P1024, DOI 10.1523/JNEUROSCI.4925-06.2007; Zelenin PV, 2005, EUR J NEUROSCI, V22, P2271, DOI 10.1111/j.1460-9568.2005.04395.x; Zottoli SJ, 1999, J COMP PHYSIOL A, V184, P207, DOI 10.1007/s003590050319	45	169	173	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					327	333		10.1038/nn2048	http://dx.doi.org/10.1038/nn2048			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18264094	Green Accepted, Green Published			2022-12-24	WOS:000253548300016
J	Acuna-Goycolea, C; Brenowitz, SD; Regehr, WG				Acuna-Goycolea, Claudio; Brenowitz, Stephan D.; Regehr, Wade G.			Active dendritic conductances dynamically regulate GABA release from thalamic Interneurons	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; BACKPROPAGATING ACTION-POTENTIALS; FEEDFORWARD INHIBITION; PYRAMIDAL NEURONS; OLFACTORY-BULB; GRANULE CELLS; RETINOGENICULATE SYNAPSE; BASAL DENDRITES; PURKINJE-CELLS; CALCIUM SPIKES	Inhibitory interneurons in the dorsal lateral geniculate nucleus (dLGN) process visual information by precisely controlling spike timing and by refining the receptive fields of thalamocortical (TC) neurons. Previous studies indicate that dLGN interneurons inhibit TC neurons by releasing GABA from both axons and dendrites. However, the mechanisms controlling GABA release are poorly understood. Here, using simultaneous whole-cell recordings from interneurons and TC neurons and two-photon calcium imaging, we find that synchronous activation of multiple retinal ganglion cells (RGCs) triggers sodium spikes that propagate throughout interneuron axons and dendrites, and calcium spikes that invade dendrites but not axons. These distinct modes of interneuron firing can trigger both a rapid and a sustained component of inhibition onto TC neurons. Our studies suggest that active conductances make LGN interneurons flexible circuit-elements that can shift their spatial and temporal properties of GABA release in response to coincident activation of functionally related subsets of RGCs.	[Acuna-Goycolea, Claudio; Brenowitz, Stephan D.; Regehr, Wade G.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	wade_regehr@hms.harvard.edu			NINDS NIH HHS [R37-NS322405] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Augustine G J, 1992, Curr Opin Neurobiol, V2, P302, DOI 10.1016/0959-4388(92)90119-6; BERARDI N, 1984, J PHYSIOL-LONDON, V357, P505, DOI 10.1113/jphysiol.1984.sp015514; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; BLOOMFIELD SA, 1989, P NATL ACAD SCI USA, V86, P3911, DOI 10.1073/pnas.86.10.3911; Brenowitz SD, 2006, J NEUROSCI, V26, P6841, DOI 10.1523/JNEUROSCI.1280-06.2006; Callaway EM, 2004, NEURAL NETWORKS, V17, P625, DOI 10.1016/j.neunet.2004.04.004; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Christie JM, 2003, J NEUROPHYSIOL, V89, P2466, DOI 10.1152/jn.00997.2002; Cox CL, 1998, NATURE, V394, P478, DOI 10.1038/28855; Cox CL, 2000, NEURON, V27, P597, DOI 10.1016/S0896-6273(00)00069-6; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; CRUNELLI V, 1988, J PHYSIOL-LONDON, V399, P153; CUCCHIARO JB, 1991, J COMP NEUROL, V310, P316, DOI 10.1002/cne.903100304; CUCCHIARO JB, 1993, J COMP NEUROL, V334, P618, DOI 10.1002/cne.903340409; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Egger V, 2005, J NEUROSCI, V25, P3521, DOI 10.1523/JNEUROSCI.4746-04.2005; Egger V, 2003, J NEUROSCI, V23, P7551; FAMIGLIETTI EV, 1970, BRAIN RES, V20, P181, DOI 10.1016/0006-8993(70)90287-8; FAMIGLIETTI EV, 1972, J COMP NEUROL, V144, P285, DOI 10.1002/cne.901440304; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Godwin DW, 1996, J NEUROSCI, V16, P8181; Goldberg JH, 2005, TRENDS NEUROSCI, V28, P158, DOI 10.1016/j.tins.2005.01.005; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Goldberg JH, 2004, J PHYSIOL-LONDON, V558, P465, DOI 10.1113/jphysiol.2004.064519; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P49, DOI 10.1113/jphysiol.2003.042580; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Govindaiah, 2004, NEURON, V41, P611, DOI 10.1016/S0896-6273(04)00013-3; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; HUBEL DH, 1979, SCI AM, V241, P150, DOI 10.1038/scientificamerican0979-150; Kampa BM, 2006, J NEUROSCI, V26, P7424, DOI 10.1523/JNEUROSCI.3062-05.2006; LICHTMAN JW, 1977, J PHYSIOL-LONDON, V273, P155, DOI 10.1113/jphysiol.1977.sp012087; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; MARIANI J, 1981, J NEUROSCI, V1, P696, DOI 10.1523/JNEUROSCI.01-07-00696.1981; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; MCCORMICK DA, 1986, NATURE, V319, P402, DOI 10.1038/319402a0; MCCORMICK DA, 1988, NATURE, V334, P246, DOI 10.1038/334246a0; MONTERO VM, 1986, J COMP NEUROL, V254, P228, DOI 10.1002/cne.902540207; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; NORTON TT, 1992, PROG BRAIN RES, V90, P193; NORTON TT, 1989, BRAIN RES, V488, P348, DOI 10.1016/0006-8993(89)90728-2; PAPE HC, 1995, NEUROSCIENCE, V68, P1105, DOI 10.1016/0306-4522(95)00205-W; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; RAFOLS JA, 1973, J COMP NEUROL, V150, P303, DOI 10.1002/cne.901500305; RALSTON HJ, 1971, NATURE, V230, P585, DOI 10.1038/230585a0; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Sherman SM, 2004, TRENDS NEUROSCI, V27, P670, DOI 10.1016/j.tins.2004.08.003; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; SILLITO AM, 1983, BRAIN RES, V277, P63, DOI 10.1016/0006-8993(83)90908-3; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Waters J, 2005, PROG BIOPHYS MOL BIO, V87, P145, DOI 10.1016/j.pbiomolbio.2004.06.009; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Xiong WH, 2002, NEURON, V34, P115, DOI 10.1016/S0896-6273(02)00628-1; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Zelles T, 2006, J NEUROSCI, V26, P30, DOI 10.1523/JNEUROSCI.1419-05.2006; Zhu JJ, 1999, NEUROSCIENCE, V91, P1445, DOI 10.1016/S0306-4522(98)00665-4; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	67	51	51	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 7	2008	57	3					420	431		10.1016/j.neuron.2007.12.022	http://dx.doi.org/10.1016/j.neuron.2007.12.022			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261JQ	18255034	Bronze			2022-12-24	WOS:000253075300011
J	Kucenas, S; Takada, N; Park, HC; Woodruff, E; Broadie, K; Appel, B				Kucenas, Sarah; Takada, Norio; Park, Hae-Chul; Woodruff, Elvin; Broadie, Kendal; Appel, Bruce			CNS-derived glia ensheath peripheral nerves and mediate motor root development	NATURE NEUROSCIENCE			English	Article							TRANSCRIPTION FACTOR SOX10; NEURAL CREST CELLS; TUBE VENT CELLS; NERVOUS-SYSTEM; FINE-STRUCTURE; DROSOPHILA-MELANOGASTER; SONIC-HEDGEHOG; SCHWANN-CELLS; FLOOR PLATE; ZEBRAFISH	Motor function requires that motor axons extend from the spinal cord at regular intervals and that they are myelinated by Schwann cells. Little attention has been given to another cellular structure, the perineurium, which ensheaths the motor nerve, forming a flexible, protective barrier. Consequently, the origin of perineurial cells and their roles in motor nerve formation are poorly understood. Using time-lapse imaging in zebrafish, we show that perineurial cells are born in the CNS, arising as ventral spinal-cord glia before migrating into the periphery. In embryos lacking perineurial glia, motor neurons inappropriately migrated outside of the spinal cord and had aberrant axonal projections, indicating that perineurial glia carry out barrier and guidance functions at motor axon exit points. Additionally, reciprocal signaling between perineurial glia and Schwann cells was necessary for motor nerve ensheathment by both cell types. These insights reveal a new class of CNS-born glia that critically contributes to motor nerve development.	[Kucenas, Sarah; Takada, Norio; Woodruff, Elvin; Broadie, Kendal; Appel, Bruce] Vanderbilt Univ, Dept Biol Sci, Vanderbilt Kennedy Ctr Res Human Dev, Vanderbilt Program Dev Biol, Nashville, TN 37235 USA; [Kucenas, Sarah; Takada, Norio; Woodruff, Elvin; Broadie, Kendal; Appel, Bruce] Vanderbilt Univ, Vanderbilt Ctr Mol Neurosci, Nashville, TN 37235 USA; [Park, Hae-Chul] Korea Univ, Sch Med, Ansan 425707, Gyeonggido, South Korea	Vanderbilt University; Vanderbilt University; Korea University; Korea University Medicine (KU Medicine)	Appel, B (corresponding author), Vanderbilt Univ, Dept Biol Sci, Vanderbilt Kennedy Ctr Res Human Dev, Vanderbilt Program Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	b.appel@vanderbilt.edu	Appel, Bruce/X-6418-2019	Appel, Bruce/0000-0003-4500-0672; Kucenas, Sarah/0000-0002-1950-751X	NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046668] Funding Source: NIH RePORTER; NCRR NIH HHS [P40 RR012546] Funding Source: Medline; NIGMS NIH HHS [R01 GM054544] Funding Source: Medline; NIMH NIH HHS [T32 MH065215, MH65215-03] Funding Source: Medline; NINDS NIH HHS [R01 NS046668, R01 NS046668-04] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKERT K, 1976, CELL TISSUE RES, V165, P281; ALLT G, 1969, J ANAT, V105, P283; Berger P, 2006, GLIA, V54, P243, DOI 10.1002/glia.20386; Boot MJ, 2003, ANAT EMBRYOL, V206, P327, DOI 10.1007/s00429-002-0302-5; Bourne GH, 1968, STRUCTURE FUNCTION N; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; BUNGE MB, 1989, SCIENCE, V243, P229, DOI 10.1126/science.2492115; BURKEL WE, 1967, ANAT RECORD, V158, P177, DOI 10.1002/ar.1091580207; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dickinson DP, 2004, J ANAT, V205, P79, DOI 10.1111/j.0021-8782.2004.00319.x; DuPlessis DG, 1996, J ANAT, V189, P631; Dutton KA, 2001, DEVELOPMENT, V128, P4113; ERLANDSON RA, 1991, ULTRASTRUCT PATHOL, V15, P335, DOI 10.3109/01913129109016243; Freeman MR, 2006, TRENDS NEUROSCI, V29, P82, DOI 10.1016/j.tins.2005.12.002; GAMBLE HJ, 1964, J ANAT, V98, P655; GUYTON AC, 1972, STRUCTURE FUNCTION N; HALLER FR, 1971, AM J ANAT, V131, P1, DOI 10.1002/aja.1001310102; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Jones DS, 1937, ANAT REC, V70, P45, DOI 10.1002/ar.1090700106; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; KLAMBT C, 1991, GLIA, V4, P205, DOI 10.1002/glia.440040212; KRISTENSSON K, 1971, ACTA NEUROPATHOL, V17, P127, DOI 10.1007/BF00687488; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Macarenco RS, 2007, ARCH PATHOL LAB MED, V131, P625; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; NORDLANDER RH, 1981, J COMP NEUROL, V199, P535, DOI 10.1002/cne.901990407; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; OLSSON Y, 1990, CRIT REV NEUROBIOL, V5, P265; Ono F, 2004, J NEUROSCI, V24, P5475, DOI 10.1523/JNEUROSCI.0851-04.2004; Paratore C, 2001, DEVELOPMENT, V128, P3949; Parker RJ, 2006, SEMIN CELL DEV BIOL, V17, P66, DOI 10.1016/j.semcdb.2005.11.012; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; Raven CP, 1937, J COMP NEUROL, V67, P221, DOI 10.1002/cne.900670205; Schafer M, 2007, DEV BIOL, V301, P117, DOI 10.1016/j.ydbio.2006.09.018; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Sepp KJ, 2000, GLIA, V30, P122, DOI 10.1002/(SICI)1098-1136(200004)30:2<122::AID-GLIA2>3.0.CO;2-B; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Ungos JM, 2003, DEVELOPMENT, V130, P5351, DOI 10.1242/dev.00722; Vermeren M, 2003, NEURON, V37, P403, DOI 10.1016/S0896-6273(02)01188-1; WESTON JA, 1963, DEV BIOL, V6, P279, DOI 10.1016/0012-1606(63)90016-2; Yaneza M, 2002, DEV DYNAM, V223, P163, DOI 10.1002/dvdy.1241; Zuchner S, 2006, NAT CLIN PRACT NEURO, V2, P45, DOI 10.1038/ncpneuro0071; ZUHORSTE GM, 2006, CURR OPIN NEUROL, V19, P464	50	166	169	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					143	151		10.1038/nn2025	http://dx.doi.org/10.1038/nn2025			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18176560	Green Accepted			2022-12-24	WOS:000252712100008
J	Boudkkazi, S; Carlier, E; Ankri, N; Caillard, O; Giraud, P; Fronzaroli-Molinieres, L; Debanne, D				Boudkkazi, Sami; Carlier, Edmond; Ankri, Norbert; Caillard, Olivier; Giraud, Pierre; Fronzaroli-Molinieres, Laure; Debanne, Dominique			Release-dependent variations in synaptic latency: A putative code for short- and long-term synaptic dynamics	NEURON			English	Article							TRANSMITTER RELEASE; CALCIUM SENSITIVITY; PAIRED-PULSE; TEMPORAL FIDELITY; PYRAMIDAL NEURONS; TRANSMISSION; DEPRESSION; FACILITATION; CONNECTIONS; PLASTICITY	In the cortex, synaptic latencies display small variations (similar to 1-2 ms) that are generally considered to be negligible. We show here that the synaptic latency at monosynaptically connected pairs of L5 and CA3 pyramidal neurons is determined by the presynaptic release probability (Pr): synaptic latency being inversely correlated with the amplitude of the postsynaptic current and sensitive to manipulations of Pr. Changes in synaptic latency were also observed when Pr was physiologically regulated in short- and long-term synaptic plasticity. Paired-pulse depression and facilitation were respectively associated with increased and decreased synaptic latencies. Similarly, latencies were prolonged following induction of presynaptic LTD and reduced after LTIP induction. We show using the dynamic-clamp technique that the observed covariation in latency and synaptic strength is a synergistic combination that significantly affects postsynaptic spiking. In conclusion, amplitude-related variation in latency represents a putative code for short- and long-term synaptic dynamics in cortical networks.	[Boudkkazi, Sami; Carlier, Edmond; Ankri, Norbert; Caillard, Olivier; Giraud, Pierre; Fronzaroli-Molinieres, Laure; Debanne, Dominique] INSERM, U641, F-13916 Marseille, France; [Boudkkazi, Sami; Carlier, Edmond; Ankri, Norbert; Caillard, Olivier; Giraud, Pierre; Fronzaroli-Molinieres, Laure; Debanne, Dominique] Univ Mediterranee, Fac Med Secteur Nord, IFR 11, F-13916 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Debanne, D (corresponding author), INSERM, U641, F-13916 Marseille, France.	dominique.debanne@univmed.fr	Debanne, Dominique/O-4673-2016	Debanne, Dominique/0000-0001-8581-5695				ANDERSEN P, 1980, J PHYSIOL-LONDON, V302, P463; Auger C, 1998, J NEUROSCI, V18, P4532; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Bollmann JH, 2005, NAT NEUROSCI, V8, P426, DOI 10.1038/nn1417; Bush P, 1996, J COMPUT NEUROSCI, V3, P91, DOI 10.1007/BF00160806; Carlier E, 2006, J PHYSIOL-LONDON, V577, P141, DOI 10.1113/jphysiol.2006.118026; Daoudal G, 2002, P NATL ACAD SCI USA, V99, P14512, DOI 10.1073/pnas.222546399; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Fedchyshyn MJ, 2007, J PHYSIOL-LONDON, V581, P581, DOI 10.1113/jphysiol.2007.129833; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; FETZ EE, 1983, J PHYSIOL-LONDON, V341, P387, DOI 10.1113/jphysiol.1983.sp014812; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Grande LA, 2005, PHYSIOLOGY, V20, P201, DOI 10.1152/physiol.00006.2005; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; KATZ B, 1967, J PHYSIOL-LONDON, V192, P407, DOI 10.1113/jphysiol.1967.sp008307; KOMATSU Y, 1988, J NEUROPHYSIOL, V59, P124, DOI 10.1152/jn.1988.59.1.124; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Lin JW, 2002, TRENDS NEUROSCI, V25, P449, DOI 10.1016/S0166-2236(02)02212-9; Maex R, 2003, J NEUROSCI, V23, P10503; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Meinrenken CJ, 2003, J PHYSIOL-LONDON, V547, P665, DOI 10.1113/jphsiol.2002.032714; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Millar AG, 2005, J NEUROSCI, V25, P3113, DOI 10.1523/JNEUROSCI.4717-04.2005; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Poncer JC, 2001, NAT NEUROSCI, V4, P989, DOI 10.1038/nn719; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Reyes A, 1999, J NEUROSCI, V19, P3827; Rieke F., 1997, SPIKES EXPLORING NEU; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Sourdet V, 2003, J NEUROSCI, V23, P10238; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Vyshedskiy A, 2000, J NEUROSCI, V20, P6326, DOI 10.1523/JNEUROSCI.20-17-06326.2000; Waldeck RF, 2000, J NEUROSCI, V20, P5312, DOI 10.1523/JNEUROSCI.20-14-05312.2000; Xu-Friedman MA, 2005, J NEUROPHYSIOL, V94, P2512, DOI 10.1152/jn.01307.2004; Zsiros V, 2005, J NEUROPHYSIOL, V93, P3248, DOI 10.1152/jn.01027.2004; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	51	57	57	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 20	2007	56	6					1048	1060		10.1016/j.neuron.2007.10.037	http://dx.doi.org/10.1016/j.neuron.2007.10.037			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	248FP	18093526	Bronze, Green Submitted			2022-12-24	WOS:000252138000013
J	Li, H; Khirug, S; Cai, C; Ludwig, A; Blaesse, P; Kolikova, J; Afzalov, R; Coleman, SK; Lauri, S; Airaksinen, MS; Keinanen, K; Khiroug, L; Saarma, M; Kaila, K; Rivera, C				Li, Hong; Khirug, Stanislav; Cai, Chunlin; Ludwig, Anastasia; Blaesse, Peter; Kolikova, Julia; Afzalov, Ramil; Coleman, Sarah K.; Lauri, Sari; Airaksinen, Matti S.; Keinanen, Kari; Khiroug, Leonard; Saarma, Mart; Kaila, Kai; Rivera, Claudio			KCC2 interacts with the dendritic cytoskeleton to promote spine development	NEURON			English	Article							CL-COTRANSPORTER KCC2; PROTEIN 4.1 FAMILY; MOLECULAR CHARACTERIZATION; HIPPOCAMPAL-NEURONS; SYNAPTIC INHIBITION; SURFACE EXPRESSION; CORTICAL-NEURONS; RAT HIPPOCAMPUS; AMPA RECEPTOR; UP-REGULATION	The neuron-specific K-Cl cotransporter, KCC2, induces a developmental shift to render GABAergic transmission from depolarizing to hyperpolarizing. Now we demonstrate that KCC2, independently of its Cl- transport function, is a key factor in the maturation of dendritic spines. This morphogenic role of KCC2 in the development of excitatory synapses is mediated by structural interactions between KCC2 and the spine cytoskeleton. Here, the binding of KCC2 C-terminal domain to the cytoskeleton-associated protein 4.1 N may play an important role. A more general conclusion based on our data is that KCC2 acts as a synchronizing factor in the functional development of glutamatergic and GABAergic synapses in cortical neurons and networks.	[Li, Hong; Ludwig, Anastasia; Saarma, Mart; Rivera, Claudio] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Khirug, Stanislav; Cai, Chunlin; Blaesse, Peter; Coleman, Sarah K.; Lauri, Sari; Keinanen, Kari; Kaila, Kai] Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; [Kolikova, Julia; Afzalov, Ramil; Lauri, Sari; Airaksinen, Matti S.; Khiroug, Leonard; Kaila, Kai] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Rivera, C (corresponding author), Univ Helsinki, Inst Biotechnol, Viikinkaari 4, FIN-00014 Helsinki, Finland.	claudio.rivera@helsinki.fi	Ludwig, Anastasia/N-1837-2016; Kaila, Kai K/R-8528-2016; Lauri, Sari/AAD-6417-2021; Rivera, Claudio/ABE-2499-2021; Keinanen, Kari/E-9122-2010	Ludwig, Anastasia/0000-0003-4849-8074; Kaila, Kai K/0000-0003-0668-5955; Lauri, Sari/0000-0002-5895-1357; Rivera, Claudio/0000-0003-2462-6561; Coleman, Sarah/0000-0002-1066-8296; Airaksinen, Matti/0000-0002-7199-4984				Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1989, BIOCHIM BIOPHYS ACTA, V988, P107, DOI 10.1016/0304-4157(89)90006-3; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Chudotvorova I, 2005, J PHYSIOL-LONDON, V566, P671, DOI 10.1113/jphysiol.2005.089821; Coleman SK, 2003, J NEUROSCI, V23, P798; Denker SP, 2002, CURR OPIN CELL BIOL, V14, P214, DOI 10.1016/S0955-0674(02)00304-6; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Gulyas AI, 2001, EUR J NEUROSCI, V13, P2205, DOI 10.1046/j.0953-816x.2001.01600.x; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hoover KB, 2000, CURR OPIN CELL BIOL, V12, P229, DOI 10.1016/S0955-0674(99)00080-0; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kirov SA, 2004, NEUROPHARMACOLOGY, V47, P640, DOI 10.1016/j.neuropharm.2004.07.039; Kubota Y, 2007, J NEUROSCI, V27, P1139, DOI 10.1523/JNEUROSCI.3846-06.2007; Lee H, 2005, EUR J NEUROSCI, V21, P2593, DOI 10.1111/j.1460-9568.2005.04084.x; Ludwig A, 2003, EUR J NEUROSCI, V18, P3199, DOI 10.1111/j.1460-9568.2003.03069.x; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Pinder J C, 1981, Prog Clin Biol Res, V55, P343; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Rivera C, 2005, J PHYSIOL-LONDON, V562, P27, DOI 10.1113/jphysiol.2004.077495; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Scott C, 2001, EUR J BIOCHEM, V268, P1084, DOI 10.1046/j.1432-1327.2001.01968.x; SCOTT C, 1998, BIOCHEM SOC T, V2, pS106; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Shen L, 2000, J NEUROSCI, V20, P7932; Sipila ST, 2006, J PHYSIOL-LONDON, V573, P765, DOI 10.1113/jphysiol.2006.107086; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tornberg J, 2005, EUR J NEUROSCI, V21, P1327, DOI 10.1111/j.1460-9568.2005.03959.x; Vilen H, 2001, TRANSGENIC RES, V10, P69, DOI 10.1023/A:1008959231644; Walensky LD, 1999, J NEUROSCI, V19, P6457; Williams JR, 2004, AM J PHYSIOL-CELL PH, V287, pC919, DOI 10.1152/ajpcell.00005.2004; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Yamakawa H, 1999, MOL BRAIN RES, V70, P197, DOI 10.1016/S0169-328X(99)00139-4; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	58	211	213	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 20	2007	56	6					1019	1033		10.1016/j.neuron.2007.10.039	http://dx.doi.org/10.1016/j.neuron.2007.10.039			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	248FP	18093524	Bronze			2022-12-24	WOS:000252138000011
J	Ajami, B; Bennett, JL; Krieger, C; Tetzlaff, W; Rossi, FMV				Ajami, Bahareh; Bennett, Jami L.; Krieger, Charles; Tetzlaff, Wolfram; Rossi, Fabio M. V.			Local self-renewal can sustain CNS microglia maintenance and function throughout adult life	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; HEMATOPOIETIC STEM-CELLS; MOUSE MODEL; ORIGIN; TRANSPLANTATION; DEGENERATION; ENGRAFTMENT; ACTIVATION; PRECURSORS; PROGENITOR	Microgliosis is a common response to multiple types of damage in the CNS. However, the origin of the cells involved in this process is still controversial and the relative importance of local expansion versus recruitment of microglia progenitors from the bloodstream is unclear. Here, we investigated the origin of microglia using chimeric animals obtained by parabiosis. We found no evidence of microglia progenitor recruitment from the circulation in denervation or CNS neurodegenerative disease, suggesting that maintenance and local expansion of microglia are solely dependent on the self-renewal of CNS resident cells in these models.	Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; Simon Fraser Univ, Dept Kinesiol, Burnaby, BC V5A 1S6, Canada; Vancouver Hosp & Hlth Sci Ctr, Dept Med, Div Neurol, Neuromuscular Dis Unit, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Zool, Dept Surg, Int Collaborat Repair Discoveries, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; Simon Fraser University; University of British Columbia; University of British Columbia	Rossi, FMV (corresponding author), Univ British Columbia, Biomed Res Ctr, 2222 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	fabio@brc.ubc.ca	Tetzlaff, Wolfram/AAY-4430-2020; Rossi, Fabio MV/B-5587-2013; Ajami, Bahareh/AAA-7262-2019	Rossi, Fabio MV/0000-0002-0368-2620; 				Abkowitz JL, 2003, BLOOD, V102, P1249, DOI 10.1182/blood-2003-01-0318; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Asheuer M, 2004, P NATL ACAD SCI USA, V101, P3557, DOI 10.1073/pnas.0306431101; Biffi A, 2004, J CLIN INVEST, V113, P1118, DOI 10.1172/JCI200419205; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Diserbo M, 2002, CAN J PHYSIOL PHARM, V80, P670, DOI 10.1139/Y02-070; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Flugel A, 2001, J NEUROSCI RES, V66, P74, DOI 10.1002/jnr.1198; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; GRAEBER MB, 1988, NEUROSCI LETT, V85, P317, DOI 10.1016/0304-3940(88)90585-X; Graeber MB, 1998, BRAIN RES, V813, P241, DOI 10.1016/S0006-8993(98)00859-2; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hess DC, 2004, EXP NEUROL, V186, P134, DOI 10.1016/j.expneurol.2003.11.005; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; JENSEN MB, 1994, EXP BRAIN RES, V98, P245; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; KRALL WJ, 1994, BLOOD, V83, P2737; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Lehrmann E, 1997, J COMP NEUROL, V386, P461; Li SP, 2004, MOL BRAIN RES, V125, P156, DOI 10.1016/j.molbrainres.2004.02.025; Li YQ, 2004, RADIAT RES, V161, P143, DOI 10.1667/RR3117; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; McPhail LT, 2004, EXP NEUROL, V188, P331, DOI 10.1016/j.expneurol.2004.04.010; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Solomon JN, 2006, GLIA, V53, P744, DOI 10.1002/glia.20331; STREIT WJ, 1988, J COMP NEUROL, V268, P248, DOI 10.1002/cne.902680209; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	44	1083	1101	2	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1538	1543		10.1038/nn2014	http://dx.doi.org/10.1038/nn2014			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	18026097				2022-12-24	WOS:000251172900010
J	Manns, JR; Howard, MW; Eichenbaum, H				Manns, Joseph R.; Howard, Marc W.; Eichenbaum, Howard			Gradual changes in hippocampal activity support remembering the order of events	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; PREFRONTAL CORTEX; WORKING-MEMORY; PATH-INTEGRATION; INFORMATION; MODELS; NAVIGATION; SEQUENCES; CONTEXT	The hippocampus is thought to contribute to episodic memory in part by binding stimuli to their spatiotemporal context. The present study examined how hippocampal neuronal populations encode spatial and temporal context as rats performed a task in which they were required to remember the order of trial-unique sequences of odors. The results suggest that a gradual change in the pattern of hippocampal activity served as a temporal context for odor-sampling events and was important for successful subsequent memory of the order of those odors.	Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA; Syracuse Univ, Dept Psychol, Syracuse, NY 13244 USA	Boston University; Syracuse University	Eichenbaum, H (corresponding author), Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA.	hbe@bu.edu	Howard, Marc/E-2518-2012		NIMH NIH HHS [MH051570, P50 MH071702, F32 MH068982, MH068982, R01 MH051570, P50 MH071702-020002] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH068982, P50MH071702, R01MH051570] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Burgess N, 2001, PHILOS T R SOC B, V356, P1493, DOI 10.1098/rstb.2001.0948; Burgess N, 2005, TRENDS COGN SCI, V9, P535, DOI 10.1016/j.tics.2005.09.011; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; ESTES WK, 1955, PSYCHOL REV, V62, P145, DOI 10.1037/h0048509; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Funahashi S, 1997, BEHAV BRAIN RES, V84, P203, DOI 10.1016/S0166-4328(96)00151-9; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; HIRSH R, 1974, BEHAV BIOL, V12, P421, DOI 10.1016/S0091-6773(74)92231-7; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; HOWARD MW, 2007, IN PRESS PSYCHON B R; Jeffery KJ, 2004, NEUROSCI BIOBEHAV R, V28, P201, DOI 10.1016/j.neubiorev.2003.12.002; KAHANA MJ, 2007, IN PRESS LEARNING ME; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; KESNER RP, 1994, NEUROPSYCHOLOGIA, V32, P881, DOI 10.1016/0028-3932(94)90040-X; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; Marshuetz C, 2000, J COGNITIVE NEUROSCI, V12, P130, DOI 10.1162/08989290051137459; Marshuetz C, 2005, PSYCHOL BULL, V131, P323, DOI 10.1037/0033-2909.131.3.323; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Morris RGM, 2001, PHILOS T R SOC B, V356, P1453, DOI 10.1098/rstb.2001.0945; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P751, DOI 10.1152/jn.1995.74.2.751; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1970, ANNU REV PSYCHOL, V21, P437, DOI 10.1146/annurev.ps.21.020170.002253; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; [No title captured]	29	251	253	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 8	2007	56	3					530	540		10.1016/j.neuron.2007.08.017	http://dx.doi.org/10.1016/j.neuron.2007.08.017			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	229AV	17988635	Bronze, Green Accepted			2022-12-24	WOS:000250774600011
J	Arinobu, Y; Mizuno, SI; Chong, Y; Shigematsu, H; Lino, T; Iwasaki, H; Graf, T; Mayfield, R; Chan, S; Kastner, P; Akashi, K				Arinobu, Yojiro; Mizuno, Shin-ichi; Chong, Yong; Shigematsu, Hirokazu; Lino, Tadafumi; Iwasaki, Hiromi; Graf, Thomas; Mayfield, Robin; Chan, Susan; Kastner, Philippe; Akashi, Koichi			Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages	CELL STEM CELL			English	Article							SELF-RENEWAL CAPACITY; BONE-MARROW; TRANSCRIPTION FACTORS; COMMITTED PROGENITORS; RAG1 LOCUS; COMMITMENT; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; BLOOD	A hierarchical hematopoietic development with myeloid versus lymphoid bifurcation has been proposed downstream of the multipotent progenitor (MPP) stage, based on prospective isolation of progenitors capable of generating only myeloerythroid cells (common myeloid progenitor, CMP) or only lymphocytes (common lymphoid progenitor, CLP). By utilizing GATA-1 and PU.1 transcription factor reporters, here we identified progenitor populations that are precursors for either CMPs or CLPs. Two independent populations expressing either GATA-1 or PU.1 resided within the CD34(+)Sca-1(+)c-Kit(+) MPP fraction. The GATA-1(+) MPP displayed potent myeloerythroid potential without giving rise to lymphocytes, whereas the PU.l(+) MPP showed granulocyte/monocyte/lymphoid-restricted progenitor activity without megakaryocyte/erythroid differentiation. Furthermore, GATA-1+ and PU.1(+) MPPs possessed huge expansion potential and differentiated into the original CMPS and CLPs, respectively. Thus, the reciprocal activation of GATA-1 and PU.1 primarily organizes the hematopoietic lineage fate decision to form the earliest hematopoietic branchpoint that comprises isolatable myeloerythroid and myelo-lymphoid progenitor populations.	Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; Kyushu Univ Hosp, Ctr Cellular & Mol Med, Fukuoka 8128582, Japan; Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Univ Strasbourg 1, F-67000 Strasbourg, France; Inst Genet & Biol Mol & Cellulaire, INSERM, U596, CNRS,UMR 7104, Illkirch Graffenstaden, France	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Kyushu University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Akashi, K (corresponding author), Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA.	koichi_akashi@dfci.harvard.edu	Graf, Thomas/B-4252-2015	Graf, Thomas/0000-0003-2774-4117	NATIONAL CANCER INSTITUTE [P01CA072009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061320, P01DK050654] Funding Source: NIH RePORTER; NCI NIH HHS [CA072009] Funding Source: Medline; NIDDK NIH HHS [DK061320, DK050654] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2005, CELL, V121, P160, DOI 10.1016/j.cell.2005.04.005; Back J, 2005, EXP HEMATOL, V33, P395, DOI 10.1016/j.exphem.2004.12.010; Back J, 2004, BLOOD, V103, P3615, DOI 10.1182/blood-2003-11-4089; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Hock H, 2005, NATURE, V435, P573, DOI 10.1038/435573a; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Iwasaki H, 2005, J EXP MED, V201, P1891, DOI 10.1084/jem.20050548; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Kuwata N, 1999, J IMMUNOL, V163, P6355; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Schmitz JM, 2002, ADDICTIVE DISORDERS, V1, P17, DOI DOI 10.1097/01.ADT.0000013364.29088.59; Schulze H, 2006, BLOOD, V107, P3868, DOI 10.1182/blood-2005-07-2755; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Spangrude GJ, 2002, IMMUNOL REV, V187, P40, DOI 10.1034/j.1600-065X.2002.18704.x; SPANGRUDE GJ, 1991, BLOOD, V78, P1395; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Zhang P, 2000, BLOOD, V96, P2641; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	47	226	231	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT	2007	1	4					416	427		10.1016/j.stem.2007.07.004	http://dx.doi.org/10.1016/j.stem.2007.07.004			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XU	18371378	Bronze			2022-12-24	WOS:000251055300011
J	Viswanathan, A; Freeman, RD				Viswanathan, Ahalya; Freeman, Ralph D.			Neurometabolic coupling in cerebral cortex reflects synaptic more than spiking activity	NATURE NEUROSCIENCE			English	Article							RAT CEREBELLAR CORTEX; MONKEY VISUAL-CORTEX; BLOOD-FLOW; SENSORY STIMULATION; HUMAN BRAIN; TISSUE OXYGENATION; FIELD POTENTIALS; NEURAL ACTIVITY; SIGNAL; SELECTIVITY	In noninvasive neuroimaging, neural activity is inferred from local fluctuations in deoxyhemoglobin. A fundamental question of functional magnetic resonance imaging (fMRI) is whether the inferred neural activity is driven primarily by synaptic or spiking activity. The answer is critical for the interpretation of the blood oxygen level-dependent (BOLD) signal in fMRI. Here, we have used well-established visual-system circuitry to create a stimulus that elicits synaptic activity without associated spike discharge. In colocalized recordings of neural and metabolic activity in cat primary visual cortex, we observed strong coupling between local field potentials (LFPs) and changes in tissue oxygen concentration in the absence of spikes. These results imply that the BOLD signal is more closely coupled to synaptic activity.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Freeman, RD (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA.	freeman@neurovision.berkeley.edu			NEI NIH HHS [EY01175, EY03716] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY003716, R01EY001175] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Caesar K, 2003, P NATL ACAD SCI USA, V100, P16000, DOI 10.1073/pnas.2635195100; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; Duong TQ, 2001, P NATL ACAD SCI USA, V98, P10904, DOI 10.1073/pnas.191101098; Fatt I, 1976, POLAROGRAPHIC OXYGEN; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; Henrie JA, 2005, J NEUROPHYSIOL, V94, P479, DOI 10.1152/jn.00919.2004; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Kim DS, 2004, NEUROIMAGE, V21, P876, DOI 10.1016/j.neuroimage.2003.10.018; Kim SG, 1997, J NEUROSCI METH, V74, P229, DOI 10.1016/S0165-0270(97)02252-8; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Maex R, 1996, J NEUROPHYSIOL, V75, P1515, DOI 10.1152/jn.1996.75.4.1515; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Offenhauser N, 2005, J PHYSIOL-LONDON, V565, P279, DOI 10.1113/jphysiol.2005.082776; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; Thompson JK, 2005, J NEUROSCI, V25, P9046, DOI 10.1523/JNEUROSCI.2127-05.2005; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103; Zheng Y, 2002, NEUROIMAGE, V16, P617, DOI 10.1006/nimg.2002.1078	32	290	292	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1308	1312		10.1038/nn1977	http://dx.doi.org/10.1038/nn1977			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828254				2022-12-24	WOS:000249720800018
J	Delgado, MR; Gillis, MM; Phelps, EA				Delgado, Mauricio R.; Gillis, M. Meredith; Phelps, Elizabeth A.			Regulating the expectation of reward via cognitive strategies	NATURE NEUROSCIENCE			English	Article							EMOTION REGULATION; NEGATIVE EMOTION; NEURAL BASES; ANTICIPATION; STRIATUM; FMRI	Previous emotion regulation research has been successful in altering aversive emotional reactions. It is unclear, however, whether such strategies can also efficiently regulate expectations of reward arising from conditioned stimuli, which can at times be maladaptive ( for example, drug cravings). Using a monetary reward-conditioning procedure with cognitive strategies, we observed attenuation in both the physiological ( skin conductance) and neural correlates ( striatum) of reward expectation as participants engaged in emotion regulation.	[Gillis, M. Meredith; Phelps, Elizabeth A.] NYU, Dept Psychol, New York, NY 10003 USA; [Delgado, Mauricio R.] Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA	New York University; Rutgers State University Newark; Rutgers State University New Brunswick	Phelps, EA (corresponding author), NYU, Dept Psychol, 6 Washington Pl,Room 863, New York, NY 10003 USA.	liz.phelps@nyu.edu	sarinopoulos, isidoros/B-5453-2010		NIDA NIH HHS [T32 DA022981-01A2, R03 DA022998, T32 DA022981, DA022998] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA022981, R03DA022998] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Delgado MR, 2006, SOC COGN AFFECT NEUR, V1, P250, DOI 10.1093/scan/nsl025; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Potenza Marc N, 2003, J Gambl Stud, V19, P7, DOI 10.1023/A:1021219012324; ROBBINS TW, 1992, SEMIN NEUROSCI, V4, P119; Sinha R, 2005, PSYCHOPHARMACOLOGY, V183, P171, DOI 10.1007/s00213-005-0147-8	15	167	169	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					880	881		10.1038/nn.2141	http://dx.doi.org/10.1038/nn.2141			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	330UU	18587392	Green Accepted			2022-12-24	WOS:000257969100011
J	Leatherman, JL; DiNardo, S				Leatherman, Judith L.; DiNardo, Stephen			Zfh-1 controls somatic stem cell self-renewal in the Drosophila testis and nonautonomously influences germline stem cell self-renewal	CELL STEM CELL			English	Article							BAG-OF-MARBLES; ZINC-FINGER; SUPPORT CELLS; NICHE; SPERMATOGENESIS; DIFFERENTIATION; PROLIFERATION; MAINTENANCE; PROTEINS; OVARY	The ability of adult stem cells to maintain their undifferentiated state depends upon residence in their niche. While simple models of a single self-renewal signal are attractive, niche-stem cell interactions are likely to be more complex. Many niches have multiple cell types, and the Drosophila testis is one such complex niche with two stem cell types, germline stem cells (GSCs) and somatic cyst progenitor cells (CPCs). These stem cells require chemokine activation of Jak/STAT signaling for self-renewal. We identified the transcriptional repressor Zfh-1 as a presumptive somatic target of Jak/STAT signaling, demonstrating that it is necessary and sufficient to maintain CPCs. Surprisingly, sustained Ah-1 expression or intrinsic STAT activation in somatic cells caused neighboring germ cells to self-renew outside their niche. In contrast, germline-intrinsic STAT activation was insufficient for GSC renewal. These data reveal unexpected complexity in cell interactions in the niche, implicating CPCs in GSC self-renewal.	[Leatherman, Judith L.; DiNardo, Stephen] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Leatherman, Judith L.; DiNardo, Stephen] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	DiNardo, S (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	sdinardo@mail.med.upenn.edu	Leatherman, Judith/HDN-5767-2022	DiNardo, Stephen/0000-0003-4131-5511	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074549, R01GM060804] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM060804-09A1, F32 GM074549, R01 GM060804, GM60804] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Broihier HT, 1998, DEVELOPMENT, V125, P655; Chen HW, 2002, GENE DEV, V16, P388, DOI 10.1101/gad.955202; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Fabrizio JJ, 2003, DEV BIOL, V258, P117, DOI 10.1016/S0012-1606(03)00127-1; FORTINI ME, 1991, MECH DEVELOP, V34, P113, DOI 10.1016/0925-4773(91)90048-B; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Gonczy P, 1997, DEVELOPMENT, V124, P4361; HANRATTY WP, 1993, MOL GEN GENET, V238, P33, DOI 10.1007/BF00279527; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Liu M, 2006, DEV GENES EVOL, V216, P683, DOI 10.1007/s00427-006-0096-1; Matunis E, 1997, DEVELOPMENT, V124, P4383; MCGUIRE SE, 2004, SCI STKE, P16; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Perry JM, 2007, CELL, V129, P1045, DOI 10.1016/j.cell.2007.05.053; Postigo AA, 1999, MOL CELL BIOL, V19, P7255; Postigo AA, 1997, EMBO J, V16, P3924, DOI 10.1093/emboj/16.13.3924; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Sarkar A, 2007, CURR BIOL, V17, P1253, DOI 10.1016/j.cub.2007.06.048; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Schulz C, 2002, DEVELOPMENT, V129, P4523; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tazuke SI, 2002, DEVELOPMENT, V129, P2529; Terry NA, 2006, DEV BIOL, V294, P246, DOI 10.1016/j.ydbio.2006.02.048; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Wang LW, 2008, J CELL BIOL, V180, P721, DOI 10.1083/jcb.200711022; Ward EJ, 2006, CURR BIOL, V16, P2352, DOI 10.1016/j.cub.2006.10.022; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zimmerman JE, 2000, GENETICS, V154, P237; Zweier C, 2002, AM J MED GENET, V108, P177, DOI 10.1002/ajmg.10226	50	216	220	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL	2008	3	1					44	54		10.1016/j.stem.2008.05.001	http://dx.doi.org/10.1016/j.stem.2008.05.001			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	325XO	18593558	Green Accepted, Bronze			2022-12-24	WOS:000257622300009
J	Tsivilis, D; Vann, SD; Denby, C; Roberts, N; Mayes, AR; Montaldi, D; Aggleton, JP				Tsivilis, Dimitris; Vann, Seralynne D.; Denby, Christine; Roberts, Neil; Mayes, Andrew R.; Montaldi, Daniela; Aggleton, John P.			A disproportionate role for the fornix and mammillary bodies in recall versus recognition memory	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; MACAQUE MONKEYS; COLLOID CYST; HIPPOCAMPAL REGION; ANTERIOR FORNIX; AMNESIA; DAMAGE; LESIONS; RECOLLECTION; FAMILIARITY	Uncovering the functional relationship between temporal lobe amnesia and diencephalic amnesia depends on determining the role of the fornix, the major interlinking fiber tract. In this study relating fornix volume with memory, we made magnetic resonance imaging-based volume estimates of 13 brain structures in 38 individuals with surgically removed colloid cysts. Fornix status was assessed directly by overall volume and indirectly by mammillary body volume (which atrophies after fornix damage). Mammillary body volume significantly correlated with 13 out of 14 tests of episodic memory recall, but correlated poorly with recognition memory. Furthermore, as the volumes of the left fornix and the left mammillary bodies decreased, the difference between recall and recognition scores increased. No other structure was consistently associated with memory. These findings support models of diencephalic memory mechanisms that require hippocampal inputs for recall, but not for key elements of recognition.	[Tsivilis, Dimitris; Denby, Christine; Mayes, Andrew R.; Montaldi, Daniela] Univ Manchester, Sch Psychol Sci, Manchester M13 9PL, Lancs, England; [Vann, Seralynne D.; Aggleton, John P.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AT, Wales; [Roberts, Neil] Univ Liverpool, Magnet Resonance & Image Anal Res Ctr, Liverpool L69 3GE, Merseyside, England	University of Manchester; Cardiff University; University of Liverpool	Tsivilis, D (corresponding author), Univ Manchester, Sch Psychol Sci, Zochonis Bldg,Brunswick St, Manchester M13 9PL, Lancs, England.	dimitris.tsivilis@manchester.ac.uk	Vann, Seralynne/A-1601-2010	Aggleton, John/0000-0002-5573-1308; Vann, Seralynne/0000-0002-6709-8773	Medical Research Council [G0001371] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aggleton JP, 2006, TRENDS COGN SCI, V10, P455, DOI 10.1016/j.tics.2006.08.003; Aggleton JP, 2005, EUR J NEUROSCI, V22, P2519, DOI 10.1111/j.1460-9568.2005.04450.x; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Aggleton JP, 2000, BRAIN, V123, P800, DOI 10.1093/brain/123.4.800; Baddeley A.D., 1994, DOORS PEOPLE TEST TE; Baxter MG, 1999, CURR OPIN NEUROBIOL, V9, P178, DOI 10.1016/S0959-4388(99)80024-5; Bilir E, 1998, NEURORADIOLOGY, V40, P138, DOI 10.1007/s002340050554; Bowles B, 2007, P NATL ACAD SCI USA, V104, P16382, DOI 10.1073/pnas.0705273104; Carlesimo GA, 2007, NEUROPSYCHOLOGIA, V45, P2467, DOI 10.1016/j.neuropsychologia.2007.03.025; COOK MJ, 1992, BRAIN, V115, P1001, DOI 10.1093/brain/115.4.1001; Cruz-Orive LM, 1993, B INT STAT I, V55, P451; DENBY C, 2008, NEUROSCI IM IN PRESS; DESPOSITO M, 1995, NEUROLOGY, V45, P1546, DOI 10.1212/WNL.45.8.1546; Dunn JC, 2004, PSYCHOL REV, V111, P524, DOI 10.1037/0033-295X.111.2.524; DUSOIR H, 1990, BRAIN, V113, P1695, DOI 10.1093/brain/113.6.1695; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; GAFFAN EA, 1991, BRAIN, V114, P1297, DOI 10.1093/brain/114.3.1297; Garcia-Finana M, 2003, NEUROIMAGE, V18, P505, DOI 10.1016/S1053-8119(02)00021-6; GARCIABENGOCHEA F, 1987, SURG NEUROL, V27, P361, DOI 10.1016/0090-3019(87)90012-7; Harding A, 2000, BRAIN, V123, P141, DOI 10.1093/brain/123.1.141; Hildebrandt H, 2001, J CLIN EXP NEUROPSYC, V23, P490, DOI 10.1076/jcen.23.4.490.1234; HODGES JR, 1991, J NEUROL NEUROSUR PS, V54, P633, DOI 10.1136/jnnp.54.7.633; Howard MA, 2003, BRAIN RES PROTOC, V10, P125, DOI 10.1016/S1385-299X(02)00202-7; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Kapur N, 1998, NEUROCASE, V4, P509, DOI 10.1093/neucas/4.6.509; KOPELMAN MD, 1995, BRIT J PSYCHIAT, V166, P154, DOI 10.1192/bjp.166.2.154; Kopelman MD, 2007, NEUROPSYCHOLOGIA, V45, P1232, DOI 10.1016/j.neuropsychologia.2006.10.005; Loftus M, 2000, EXP NEUROL, V163, P180, DOI 10.1006/exnr.2000.7361; Manns JR, 1999, HIPPOCAMPUS, V9, P495, DOI 10.1002/(SICI)1098-1063(1999)9:5<495::AID-HIPO2>3.0.CO;2-O; MAYES AR, 1997, CASE STUDIES NEUROPS; MCMACKIN D, 1995, ACTA NEUROCHIR, V135, P12, DOI 10.1007/BF02307408; Park SA, 2000, NEUROLOGY, V54, P1379, DOI 10.1212/WNL.54.6.1379; POLETTI CE, 1977, J COMP NEUROL, V175, P101, DOI 10.1002/cne.901750107; Poreh A, 2006, NEUROPSYCHOLOGIA, V44, P2241, DOI 10.1016/j.neuropsychologia.2006.05.020; Pruessner JC, 2002, CEREB CORTEX, V12, P1342, DOI 10.1093/cercor/12.12.1342; Saunders RC, 2007, HIPPOCAMPUS, V17, P396, DOI 10.1002/hipo.20276; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; Vann SD, 2004, NAT REV NEUROSCI, V5, P35, DOI 10.1038/nrn1299; Vann SD, 2007, EUR J NEUROSCI, V26, P1575, DOI 10.1111/j.1460-9568.2007.05773.x; Victor M, 1987, Int J Neurol, V21-22, P51; VONCRAMON DY, 1985, BRAIN, V108, P993, DOI 10.1093/brain/108.4.993; Warrington EK., 1984, RECOGNITION MEMORY T; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1997, WECHSLER ADULT INTEL; WOOLSEY RM, 1975, ARCH NEUROL-CHICAGO, V32, P566, DOI 10.1001/archneur.1975.00490500086012; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Zahajszky J, 2001, SCHIZOPHR RES, V47, P87, DOI 10.1016/S0920-9964(00)00051-7	50	202	205	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					834	842		10.1038/nn.2149	http://dx.doi.org/10.1038/nn.2149			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18552840				2022-12-24	WOS:000257089400021
J	Sayles, M; Winter, IM				Sayles, Mark; Winter, Ian M.			Reverberation challenges the temporal representation of the pitch of complex sounds	NEURON			English	Article							CONCURRENT VOWEL IDENTIFICATION; AUDITORY-NERVE FIBERS; COCHLEAR NUCLEUS; SPEECH-INTELLIGIBILITY; FUNDAMENTAL-FREQUENCY; UNRESOLVED HARMONICS; AMPLITUDE-MODULATION; PHASE-LOCKING; SINGLE UNITS; PERCEPTION	Accurate neural coding of the pitch of complex sounds is an essential part of auditory scene analysis; differences in pitch help segregate concurrent sounds, while similarities in pitch can help group sounds from a common source. In quiet, nonreverberant backgrounds, pitch can be derived from timing information in broadband high-frequency auditory channels and/or from frequency and timing information carried in narrowband low-frequency auditory channels. Recording from single neurons in the cochlear nucleus of anesthetized guinea pigs, we show that the neural representation of pitch based on timing information is severely degraded in the presence of reverberation. This degradation increases with both increasing reverberation strength and channel bandwidth. In a parallel human psychophysical pitch-discrimination task, reverberation impaired the ability to distinguish a high-pass harmonic sound from noise. Together, these findings explain the origin of perceptual difficulties experienced by both normal-hearing and hearing-impaired listeners in reverberant spaces.	[Sayles, Mark; Winter, Ian M.] Physiol Lab, Ctr Neural Basis Hearing, Cambridge CB2 3EG, England	University of Cambridge	Winter, IM (corresponding author), Physiol Lab, Ctr Neural Basis Hearing, Downing St, Cambridge CB2 3EG, England.	imw1001@cam.ac.uk		Sayles, Mark/0000-0002-4313-6878	BBSRC [BB/E017398/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E017398/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ASSMANN PF, 1990, J ACOUST SOC AM, V88, P680, DOI 10.1121/1.399772; Bekesy G. V., 1938, AKUST Z, V3, P21; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bregman A.S., 1990, AUDITORY SCENE ANAL; BROKX JPL, 1982, J PHONETICS, V10, P23, DOI 10.1016/S0095-4470(19)30909-X; Bronkhorst AW, 1999, NATURE, V397, P517, DOI 10.1038/17374; BROWN GJ, 2006, COMPUTATIONAL AUDITO, P209; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1717, DOI 10.1152/jn.1996.76.3.1717; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1698, DOI 10.1152/jn.1996.76.3.1698; CARLYON RP, 1994, J ACOUST SOC AM, V95, P3541, DOI 10.1121/1.409971; Cedolin L, 2005, J NEUROPHYSIOL, V94, P347, DOI 10.1152/jn.01114.2004; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; CULLING JF, 1994, SPEECH COMMUN, V14, P71, DOI 10.1016/0167-6393(94)90058-2; Culling JF, 2003, J ACOUST SOC AM, V114, P2871, DOI 10.1121/1.1616922; CULLING JF, 1993, PERCEPT PSYCHOPHYS, V54, P303, DOI 10.3758/BF03205265; Dai HP, 2000, J ACOUST SOC AM, V107, P953, DOI 10.1121/1.428276; Darwin CJ, 2000, J ACOUST SOC AM, V108, P335, DOI 10.1121/1.429468; Darwin CJ, 2005, SPR HDB AUD, V24, P278; de Cheveigne A, 2005, SPR HDB AUD, V24, P169; deCheveigne A, 1997, J ACOUST SOC AM, V101, P2839, DOI 10.1121/1.418517; deCheveigne A, 1997, J ACOUST SOC AM, V101, P2848, DOI 10.1121/1.419476; EVANS EF, 1978, AUDIOLOGY, V17, P369; FRISINA RD, 1990, HEARING RES, V44, P99, DOI 10.1016/0378-5955(90)90074-Y; GELFAND SA, 1979, J ACOUST SOC AM, V66, P22, DOI 10.1121/1.383075; GLASBERG BR, 1986, J ACOUST SOC AM, V79, P1020, DOI 10.1121/1.393374; HELFER KS, 1990, J SPEECH HEAR RES, V33, P149, DOI 10.1044/jshr.3301.149; Hodgson M, 2002, J ACOUST SOC AM, V111, P931, DOI 10.1121/1.1428264; HOUTGAST T, 1980, ACUSTICA, V46, P60; HOUTSMA AJM, 1990, J ACOUST SOC AM, V87, P304, DOI 10.1121/1.399297; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; Joris PX, 2006, HEARING RES, V216, P19, DOI 10.1016/j.heares.2006.03.010; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Knudsen VO, 1929, J ACOUST SOC AM, V1, P56, DOI 10.1121/1.1901470; Koppl C, 1997, J NEUROSCI, V17, P3312; Ladd RobertD., 1996, INTONATIONAL PHONOLO; LOCHNER JPA, 1961, ACUSTICA, V7, P195; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; MEDDIS R, 1991, J ACOUST SOC AM, V89, P2866, DOI 10.1121/1.400725; Meddis R, 1997, J ACOUST SOC AM, V102, P1811, DOI 10.1121/1.420088; Micheyl C, 1998, J ACOUST SOC AM, V104, P1039, DOI 10.1121/1.423322; Moore B., 2003, INTRO PSYCHOL HEARIN; Moore B. C. J., 1998, COCHLEAR HEARING LOS; MOORE BCJ, 1985, J ACOUST SOC AM, V77, P1853, DOI 10.1121/1.391936; MOORE BCJ, 1973, J ACOUST SOC AM, V54, P610, DOI 10.1121/1.1913640; Moore BCJ, 2005, SPR HDB AUD, V24, P234; Moore BCJ, 1996, J ACOUST SOC AM, V100, P2320, DOI 10.1121/1.417941; Moore BCJ, 2003, HEARING RES, V182, P153, DOI 10.1016/S0378-5955(03)00191-6; NABELEK AK, 1989, J ACOUST SOC AM, V86, P1259, DOI 10.1121/1.398740; Nelson PB, 2003, J ACOUST SOC AM, V113, P961, DOI 10.1121/1.1531983; OSHAUGHNESSY D, 1983, J ACOUST SOC AM, V74, P1155, DOI 10.1121/1.390039; Padgham M, 2004, J ACOUST SOC AM, V115, P402, DOI 10.1121/1.1629304; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Penagos H, 2004, J NEUROSCI, V24, P6810, DOI 10.1523/JNEUROSCI.0383-04.2004; Plack CJ, 2005, SPR HDB AUD, V24, P7; PLOMP R, 1967, J ACOUST SOC AM, V41, P1526, DOI 10.1121/1.1910515; PLOMP R, 1973, ACUSTICA, V28, P50; PLOMP R, 1976, ACUSTICA, V34, P201; Poissant SF, 2006, J ACOUST SOC AM, V119, P1606, DOI 10.1121/1.2168428; Qin MK, 2005, EAR HEARING, V26, P451, DOI 10.1097/01.aud.0000179689.79868.06; RHODE WS, 1994, J NEUROPHYSIOL, V71, P1797, DOI 10.1152/jn.1994.71.5.1797; RITSMA RJ, 1967, J ACOUST SOC AM, V42, P191, DOI 10.1121/1.1910550; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; Ruggero MA, 2005, P NATL ACAD SCI USA, V102, P18614, DOI 10.1073/pnas.0509323102; Ruggero MA, 2007, JARO-J ASSOC RES OTO, V8, P153, DOI 10.1007/s10162-007-0081-z; Sayles M, 2007, BRAIN RES, V1171, P52, DOI 10.1016/j.brainres.2007.06.098; Schouten JF, 1938, P K NED AKAD WETENSC, V41, P1086; Seebeck A., 1841, ANN PHYS CHEM, V53, P417, DOI [10.1002/andp.18411290702, DOI 10.1002/ANDP.18411290702]; SHACKLETON TM, 1994, J ACOUST SOC AM, V95, P3529, DOI 10.1121/1.409970; Shera CA, 2002, P NATL ACAD SCI USA, V99, P3318, DOI 10.1073/pnas.032675099; STAGRAY JR, 1992, J SPEECH HEAR RES, V35, P1406, DOI 10.1044/jshr.3506.1406; Watkins AJ, 2005, J ACOUST SOC AM, V118, P249, DOI 10.1121/1.1923369; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; WINTER IM, 1990, HEARING RES, V44, P161, DOI 10.1016/0378-5955(90)90078-4; ZUREK P, 2000, NAT NEUROSCI, V4, P78	75	56	56	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 12	2008	58	5					789	801		10.1016/j.neuron.2008.03.029	http://dx.doi.org/10.1016/j.neuron.2008.03.029			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	315IA	18549789	Bronze			2022-12-24	WOS:000256870800015
J	Churchland, AK; Kiani, R; Shadlen, MN				Churchland, Anne K.; Kiani, Roozbeh; Shadlen, Michael N.			Decision-making with multiple alternatives	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; MACAQUE AREA LIP; PERCEPTUAL DECISION; VISUAL-MOTION; DISCRIMINATION TASK; SUPERIOR COLLICULUS; TIME; MICROSTIMULATION; REPRESENTATION; RESPONSES	Simple perceptual tasks have laid the groundwork for understanding the neurobiology of decision-making. Here, we examined this foundation to explain how decision-making circuitry adjusts in the face of a more difficult task. We measured behavioral and physiological responses of monkeys on a two-and four-choice direction-discrimination decision task. For both tasks, firing rates in the lateral intraparietal area appeared to reflect the accumulation of evidence for or against each choice. Evidence accumulation began at a lower firing rate for the four-choice task, but reached a common level by the end of the decision process. The larger excursion suggests that the subjects required more evidence before making a choice. Furthermore, on both tasks, we observed a time-dependent rise in firing rates that may impose a deadline for deciding. These physiological observations constitute an effective strategy for handling increased task difficulty. The differences appear to explain subjects' accuracy and reaction times.	[Churchland, Anne K.; Kiani, Roozbeh; Shadlen, Michael N.] Univ Washington, Sch Med, Dept Physiol & Biophys, Natl Primate Res Ctr,Howard Hughes Med Inst, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Churchland, AK (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Natl Primate Res Ctr,Howard Hughes Med Inst, Seattle, WA 98195 USA.	anne99@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [RR00166, P51 RR000166] Funding Source: Medline; NEI NIH HHS [R01 EY011378-11A1, EY011378, R01 EY011378] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arai K, 2004, J NEUROPHYSIOL, V91, P890, DOI 10.1152/jn.00818.2003; Basso MA, 1998, J NEUROSCI, V18, P7519; Bogacz R, 2007, PHILOS T R SOC B, V362, P1655, DOI 10.1098/rstb.2007.2059; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Churchland AK, 2003, NEURON, V37, P1001, DOI 10.1016/S0896-6273(03)00145-4; COLD JI, 2007, ANNU REV NEUROSCI, V30, P535; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Hamed SB, 2002, CEREB CORTEX, V12, P234, DOI 10.1093/cercor/12.3.234; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Jazayeri M, 2007, NATURE, V446, P912, DOI 10.1038/nature05739; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Laming DR, 1968, INFORM THEORY CHOICE; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Luce RD, 1986, RESPONSE TIMES THEIR; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McMillen T, 2006, J MATH PSYCHOL, V50, P30, DOI 10.1016/j.jmp.2005.10.003; Nichols MJ, 2002, J NEUROSCI, V22, P9530; Niwa M, 2008, J NEUROSCI, V28, P4435, DOI 10.1523/JNEUROSCI.5564-07.2008; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Platt ML, 1998, EXP BRAIN RES, V121, P65, DOI 10.1007/s002210050438; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Ratcliff R, 2007, J NEUROPHYSIOL, V97, P1756, DOI 10.1152/jn.00393.2006; Reddi BAJ, 2003, J NEUROPHYSIOL, V90, P3538, DOI 10.1152/jn.00689.2002; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Risken H., 1989, FOKKER PLANCK EQUATI, DOI DOI 10.1007/978-3-642-61544-3; Roitman JD, 2002, J NEUROSCI, V22, P9475; SALZMAN CD, 1994, SCIENCE, V264, P231, DOI 10.1126/science.8146653; Sato T, 2001, EXP BRAIN RES, V139, P53, DOI 10.1007/s002210100750; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Thier P, 1996, P NATL ACAD SCI USA, V93, P4962, DOI 10.1073/pnas.93.10.4962; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Van Essen DC, 2004, NEUROIMAGE, V23, pS97, DOI 10.1016/j.neuroimage.2004.07.024; Vickers D., 1979, DECISION PROCESSES V; Walker R, 1997, J NEUROPHYSIOL, V78, P1108, DOI 10.1152/jn.1997.78.2.1108	50	416	419	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					693	702		10.1038/nn.2123	http://dx.doi.org/10.1038/nn.2123			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18488024	Green Accepted			2022-12-24	WOS:000256133700016
J	Chen, Z; Gore, BB; Long, H; Ma, L; Tessier-Lavigne, M				Chen, Zhe; Gore, Bryan B.; Long, Hua; Ma, Le; Tessier-Lavigne, Marc			Alternative splicing of the Robo3 axon guidance receptor governs the midline switch from attraction to repulsion	NEURON			English	Article							INTERMEDIATE TARGET; CNS MIDLINE; SLIT; ISOFORMS; DIVERSITY; DSCAM; MOUSE; GENE; CHEMOATTRACTANT; RESPONSIVENESS	Alternative splicing provides a means to increase the complexity of gene function in numerous biological processes, including nervous system wiring. Navigating axons switch responses from attraction to repulsion at intermediate targets, allowing them to grow to each intermediate target and then to move on. The mechanisms underlying this switch remain poorly characterized. We previously showed that the Slit receptor Robo3 is required for spinal commissural axons to enter and cross the midline intermediate target. We report here the existence of two functionally antagonistic isoforms of Robo3 with distinct carboxy termini arising from alternative splicing. Robo3.1 is deployed on the precrossing and crossing portions of commissural axons and allows midline crossing by silencing Slit repulsion. Robo3.2 becomes expressed on the postcrossing portion and blocks midline recrossing, favoring Slit repulsion. The tight spatial regulation of opponent splice variants helps ensure high-fidelity transition of axonal responses from attraction to repulsion at the midline.	[Chen, Zhe; Gore, Bryan B.; Long, Hua; Tessier-Lavigne, Marc] Genentech Inc, Div Res, San Francisco, CA 94080 USA; [Gore, Bryan B.; Long, Hua; Ma, Le] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Roche Holding; Genentech; Stanford University	Tessier-Lavigne, M (corresponding author), Genentech Inc, Div Res, 1 DNA Way, San Francisco, CA 94080 USA.	marctl@gene.com	Ma, Le/A-3733-2013; Chen, Zhe/AAI-3485-2020	Ma, Le/0000-0003-2769-9416; CHEN, ZHE/0000-0003-0683-9491				Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Camurri L, 2005, MOL CELL NEUROSCI, V30, P485, DOI 10.1016/j.mcn.2005.07.014; Challa AK, 2005, MECH DEVELOP, V122, P1073, DOI 10.1016/j.mod.2005.06.006; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Clark K, 2002, FEBS LETT, V523, P12, DOI 10.1016/S0014-5793(02)02904-6; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalkic E, 2006, DEV GENES EVOL, V216, P555, DOI 10.1007/s00427-006-0070-y; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Garbe DS, 2004, CRIT REV BIOCHEM MOL, V39, P319, DOI 10.1080/10409230490906797; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Kadison SR, 2006, J NEUROSCI, V26, P8909, DOI 10.1523/JNEUROSCI.1569-06.2006; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Little M, 2002, INT J DEV BIOL, V46, P385; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Marillat V, 2004, NEURON, V43, P69, DOI 10.1016/j.neuron.2004.06.018; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Ozaita A, 2002, J NEUROPHYSIOL, V88, P394, DOI 10.1152/jn.2002.88.1.394; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Tanno T, 2004, J BIOCHEM, V136, P575, DOI 10.1093/jb/mvh164; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Yuan SSF, 1999, DEV BIOL, V207, P62, DOI 10.1006/dbio.1998.9141; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	38	174	176	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2008	58	3					325	332		10.1016/j.neuron.2008.02.016	http://dx.doi.org/10.1016/j.neuron.2008.02.016			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	300HP	18466743	Bronze			2022-12-24	WOS:000255815200006
J	Dallos, P; Wu, XD; Cheatham, MA; Gao, JG; Zheng, J; Anderson, CT; Jia, SP; Wang, X; Cheng, WHY; Sengupta, S; He, DZZ; Zuo, J				Dallos, Peter; Wu, Xudong; Cheatham, Mary Ann; Gao, Jiangang; Zheng, Jing; Anderson, Charles T.; Jia, Shuping; Wang, Xiang; Cheng, Wendy H. Y.; Sengupta, Soma; He, David Z. Z.; Zuo, Jian			Prestin-based outer hair cell motility is necessary for mammalian cochlear amplification	NEURON			English	Article							SINGLE UNIT THRESHOLDS; GUINEA-PIG COCHLEA; RECEPTOR POTENTIALS; BUNDLE MOTION; MOTOR PROTEIN; TRANSDUCTION; AMPLIFIER; MICE; RESPONSES; MEMBRANE	It is a central tenet of cochlear neurobiology that mammalian ears rely on a local, mechanical amplification process for their high sensitivity and sharp frequency selectivity. While it is generally agreed that outer hair cells provide the amplification, two mechanisms have been proposed: stereociliary motility and somatic motility. The latter is driven by the motor protein prestin. Electrophysiological phenotyping of a prestin knockout mouse intimated that somatic motility is the amplifier. However, outer hair cells of knockout mice have significantly altered mechanical properties, making this mouse model unsatisfactory. Here, we study a mouse model without alteration to outer hair cell and organ of Corti mechanics or to mechanoelectric transduction, but with diminished prestin function. These animals have knockout-like behavior, demonstrating that prestin-based electromotility is required for cochlear amplification.	[Dallos, Peter] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Wu, Xudong; Gao, Jiangang; Cheng, Wendy H. Y.; Zuo, Jian] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Jia, Shuping; Wang, Xiang; He, David Z. Z.] Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA; [Dallos, Peter; Cheatham, Mary Ann; Zheng, Jing; Anderson, Charles T.; Sengupta, Soma] Northwestern Univ, Hugh Knowles Ctr, Dept Commun Sci & Disorders, Evanston, IL 60208 USA	Northwestern University; St Jude Children's Research Hospital; Creighton University; Northwestern University	Dallos, P (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	p-dallos@northwestern.edu; jian.zuo@stjude.org	Carriero, Alessandra/D-7893-2013; Zheng, Jing/F-5273-2017; Dallos, Peter/Q-9360-2019	Carriero, Alessandra/0000-0001-8103-4795; Zheng, Jing/0000-0003-2790-1143; Dallos, Peter/0000-0002-9731-6591; He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634; Anderson, Charles/0000-0003-3353-0182	NATIONAL CANCER INSTITUTE [P30CA021765, R25CA023944] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696, R01DC006471, R01DC000089, R01DC006412] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765, CA023944, R25 CA023944, P30 CA021765, P30 CA021765-28, R25 CA023944-24] Funding Source: Medline; NCRR NIH HHS [UL1 RR025741] Funding Source: Medline; NIDCD NIH HHS [R01 DC000089, R01 DC006471-05, R01 DC004696, DC00089, R01 DC006471, R01 DC000089-38, DC006412, R01 DC006412, DC06471, DC 004696, R01 DC006412-03, R01 DC004696-08] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ashmore J F, 1990, Neurosci Res Suppl, V12, pS39, DOI 10.1016/0921-8696(90)90007-P; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Cheatham MA, 2007, AUDIOL NEURO-OTOL, V12, P378, DOI 10.1159/000106481; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; Cheatham MA, 2005, J PHYSIOL-LONDON, V569, P229, DOI 10.1113/jphysiol.2005.093518; CHEATHAM MA, 1993, HEARING RES, V68, P107, DOI 10.1016/0378-5955(93)90069-D; CODY AR, 1987, J PHYSIOL-LONDON, V383, P551; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; DALLOS P, 1991, NATURE, V350, P155, DOI 10.1038/350155a0; DALLOS P, 1985, J NEUROSCI, V5, P1591; DALLOS P, 1978, J ACOUST SOC AM, V64, P151, DOI 10.1121/1.381980; DALLOS P, 1992, J NEUROSCI, V12, P4575; DALLOS P, 1978, J NEUROPHYSIOL, V41, P365, DOI 10.1152/jn.1978.41.2.365; DALLOS P, 1976, J ACOUST SOC AM, V59, P591, DOI 10.1121/1.380903; Dallos P, 2006, J PHYSIOL-LONDON, V576, P37, DOI 10.1113/jphysiol.2006.114652; DEBOER E, 1986, J PHYSIOL-LONDON, V576, P29; Frank G, 1999, P NATL ACAD SCI USA, V96, P4420, DOI 10.1073/pnas.96.8.4420; Gao JG, 2007, P NATL ACAD SCI USA, V104, P12542, DOI 10.1073/pnas.0700356104; GOLD T, 1948, PROC R SOC SER B-BIO, V135, P492, DOI 10.1098/rspb.1948.0025; He DZZ, 2006, J MEMBRANE BIOL, V209, P119, DOI 10.1007/s00232-005-0833-9; He DZZ, 2004, NATURE, V429, P766, DOI 10.1038/nature02591; He DZZ, 1999, P NATL ACAD SCI USA, V96, P8223, DOI 10.1073/pnas.96.14.8223; HOWARD J, 1986, HEARING RES, V23, P93, DOI 10.1016/0378-5955(86)90178-4; Hudspeth AJ, 1997, NEURON, V19, P947, DOI 10.1016/S0896-6273(00)80385-2; Jia SP, 2007, J NEUROSCI, V27, P1006, DOI 10.1523/JNEUROSCI.5452-06.2007; Jia SP, 2005, NAT NEUROSCI, V8, P1028, DOI 10.1038/nn1509; JOHNSTONE JR, 1979, J ACOUST SOC AM, V65, P254, DOI 10.1121/1.382244; Keiler S, 2001, HEARING RES, V162, P91, DOI 10.1016/S0378-5955(01)00374-4; Kennedy HJ, 2006, J NEUROSCI, V26, P2757, DOI 10.1523/JNEUROSCI.3808-05.2006; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Manley GA, 2001, J NEUROPHYSIOL, V86, P541, DOI 10.1152/jn.2001.86.2.541; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Narayan SS, 1998, SCIENCE, V282, P1882, DOI 10.1126/science.282.5395.1882; NEELY ST, 1983, HEARING RES, V9, P123, DOI 10.1016/0378-5955(83)90022-9; Patuzzi R., 1996, COCHLEA, P186; Ricci AJ, 2005, J NEUROSCI, V25, P7831, DOI 10.1523/JNEUROSCI.1127-05.2005; Ricci Anthony, 2003, J Am Acad Audiol, V14, P325; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; RUSSELL IJ, 1983, J PHYSIOL-LONDON, V338, P179, DOI 10.1113/jphysiol.1983.sp014668; RYAN A, 1975, NATURE, V253, P44, DOI 10.1038/253044a0; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; TSUTAKAWA RK, 1978, BIOMETRICS, V34, P391, DOI 10.2307/2530601; Wu XD, 2004, MOL BRAIN RES, V126, P30, DOI 10.1016/j.molbrainres.2004.03.020; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2005, J CELL SCI, V118, P2987, DOI 10.1242/jcs.02431; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	51	255	267	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2008	58	3					333	339		10.1016/j.neuron.2008.02.028	http://dx.doi.org/10.1016/j.neuron.2008.02.028			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	300HP	18466744	Green Accepted, Bronze			2022-12-24	WOS:000255815200007
J	Baumgartel, K; Genoux, D; Welzl, H; Tweedie-Cullen, RY; Koshibu, K; Livingstone-Zatchej, M; Mamie, C; Mansuy, IM				Baumgaertel, Karsten; Genoux, David; Welzl, Hans; Tweedie-Cullen, Ry Y.; Koshibu, Kyoko; Livingstone-Zatchej, Magdalena; Mamie, Celine; Mansuy, Isabelle M.			Control of the establishment of aversive memory by calcineurin and Zif268	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; GENE-EXPRESSION; SYNAPTIC PLASTICITY; FEAR MEMORY; SERINE/THREONINE PHOSPHATASES; PROTEIN PHOSPHATASE-1; TRANSCRIPTION FACTOR; NEURONAL PLASTICITY; ANCHORING PROTEIN; TASTE-AVERSION	Emotional memory is a rapidly acquired and persistent form of memory, and its robustness is in part determined by the initial strength of the memory. Here, we provide new evidence that the protein phosphatase calcineurin (CaN), a potent negative regulator of neuronal signaling that is known to constrain learning and memory, critically regulates the establishment of emotional memory through mechanisms involving the immediate early gene Zif268 (also known as Egr1). We found that CaN is inhibited in the amygdala during the establishment of aversive memory, but Zif268 is activated. Using inducible transgenesis in mice, we further saw that CaN inhibition and Zif268 overexpression during memory establishment strengthen the memory trace and enhance its resistance to extinction. We found that CaN inhibition correlates with increased Zif268 expression and that a common pool of proteins is regulated in the amygdala after CaN inhibition and Zif268 overexpression. Together, these findings reveal a previously unknown mechanism for the control of emotional memory that depends on CaN and Zif268.	[Baumgaertel, Karsten; Genoux, David; Tweedie-Cullen, Ry Y.; Koshibu, Kyoko; Livingstone-Zatchej, Magdalena; Mamie, Celine; Mansuy, Isabelle M.] Univ Zurich, Fac Med, Brain Res Inst, CH-8057 Zurich, Switzerland; Swiss Fed Inst Technol, Dept Biol, CH-8057 Zurich, Switzerland; [Welzl, Hans] Univ Zurich, Inst Anat, Div Neuroanat & Behav, CH-8057 Zurich, Switzerland	University of Geneva; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Mansuy, IM (corresponding author), Univ Zurich, Fac Med, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	mansuy@hifo.uzh.ch	Mansuy, Isabelle M/N-3042-2015	Mansuy, Isabelle M/0000-0001-7785-5371; Koshibu, Kyoko/0000-0002-9809-0299				Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Ahi J, 2004, BEHAV BRAIN RES, V149, P17, DOI 10.1016/S0166-4328(03)00207-9; Antoni F A, 1998, Adv Second Messenger Phosphoprotein Res, V32, P153; Bahar A, 2003, EUR J NEUROSCI, V17, P1527, DOI 10.1046/j.1460-9568.2003.02551.x; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Cammarota M, 2005, NEUROSCIENCE, V132, P273, DOI 10.1016/j.neuroscience.2005.01.022; Cannich A, 2004, LEARN MEMORY, V11, P625, DOI 10.1101/lm.77904; Chan GCK, 2005, J NEUROSCI, V25, P9913, DOI 10.1523/JNEUROSCI.2376-05.2005; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Dash PK, 2005, J NEUROCHEM, V93, P269, DOI 10.1111/j.1471-4159.2004.03016.x; Dodge KL, 2003, BIOCHEM BIOPH RES CO, V311, P1111, DOI 10.1016/j.bbrc.2003.09.040; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Hogan PG, 2005, CURR BIOL, V15, pR442, DOI 10.1016/j.cub.2005.06.006; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kingsbury TJ, 2007, J NEUROCHEM, V103, P761, DOI 10.1111/j.1471-4159.2007.04801.x; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; Lin CH, 2003, J NEUROSCI, V23, P8310; Lin CH, 2003, J NEUROSCI, V23, P1574; Liu JO, 2003, BIOCHEM BIOPH RES CO, V311, P1103, DOI 10.1016/j.bbrc.2003.10.020; Malkani S, 2004, LEARN MEMORY, V11, P617, DOI 10.1101/lm.73104; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Mansuy IM, 2006, TRENDS NEUROSCI, V29, P679, DOI 10.1016/j.tins.2006.10.004; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Michalon A, 2005, GENESIS, V43, P205, DOI 10.1002/gene.20175; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Munton RP, 2004, FEBS LETT, V567, P121, DOI 10.1016/j.febslet.2004.03.121; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; RESCORLA RA, 1967, J COMP PHYSIOL PSYCH, V64, P114, DOI 10.1037/h0024810; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Runyan JD, 2005, LEARN MEMORY, V12, P103, DOI 10.1101/lm.89405; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Wang XT, 1996, NATURE, V383, P434, DOI 10.1038/383434a0; Welzl H, 2001, BEHAV BRAIN RES, V125, P205, DOI 10.1016/S0166-4328(01)00302-3; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Yakel JL, 1997, TRENDS PHARMACOL SCI, V18, P124, DOI 10.1016/S0165-6147(97)01046-8; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	49	103	105	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					572	578		10.1038/nn.2113	http://dx.doi.org/10.1038/nn.2113			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18425121				2022-12-24	WOS:000255327300016
J	O'Keeffe, GW; Gutierrez, H; Pandolfi, PP; Riccardi, C; Davies, AM				O'Keeffe, Gerard W.; Gutierrez, Humberto; Pandolfi, Pier Paolo; Riccardi, Carlo; Davies, Alun M.			NGF-promoted axon growth and target innervation requires GITRL-GITR signaling	NATURE NEUROSCIENCE			English	Article							SYMPATHETIC NEURON DEVELOPMENT; KAPPA-B ACTIVATION; NEUROTROPHIC FACTOR; TNF RECEPTOR; T-CELLS; SURVIVAL; PATHWAY; DEATH; TRKA; CONTRIBUTES	Nerve growth factor (NGF) has an important role in regulating sympathetic neuron survival and target field innervation during development. Here we show that glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR), a member of the TNF superfamily, and its ligand (GITRL) are co-expressed in mouse sympathetic neurons when their axons are innervating their targets under the influence of target-derived NGF. In culture, GITRL enhanced NGF-promoted neurite growth from neonatal sympathetic neurons, and preventing GITR-GITRL interaction in these neurons or knocking down GITR inhibited NGF-promoted neurite growth without affecting neuronal survival. Tnfrsf18(-/-) (Gitr) neonates have reduced sympathetic innervation density in vivo compared with Gitr(+/+) littermates. GITR activation is required for the phosphorylation of extracellular signal-regulated kinases 1 and 2 by NGF that is necessary for neurite growth. Our results reveal a previously unknown signaling loop in developing sympathetic neurons that is crucial for NGF-dependent axon growth and target innervation.	[O'Keeffe, Gerard W.; Gutierrez, Humberto; Davies, Alun M.] Sch Biosci, Cardiff CF10 3US, Wales; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Genet Program, Boston, MA 02115 USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Riccardi, Carlo] Univ Perugia, Dept Clin & Expt Med, Pharmacol Sect, I-06100 Perugia, Italy	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Perugia	Davies, AM (corresponding author), Sch Biosci, Biomed Bldg,Museum Ave, Cardiff CF10 3US, Wales.	daviesalun@cf.ac.uk	Riccardi, Carlo/N-4610-2014; Davies, Alun M/A-4334-2010	Riccardi, Carlo/0000-0001-9257-3997; Davies, Alun M/0000-0001-5841-8176; O'Keeffe, Gerard/0000-0001-5149-0933; Gutierrez, Humberto/0000-0002-5021-8636	Wellcome Trust [071251] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; Belliveau DJ, 1997, J CELL BIOL, V136, P375, DOI 10.1083/jcb.136.2.375; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254; DAVIES AM, 1986, DEV BIOL, V115, P56, DOI 10.1016/0012-1606(86)90227-7; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; Esparza EM, 2006, J BIOL CHEM, V281, P8559, DOI 10.1074/jbc.M512915200; Esparza EM, 2005, J IMMUNOL, V174, P7875, DOI 10.4049/jimmunol.174.12.7875; Forgie A, 2003, DEVELOPMENT, V130, P995, DOI 10.1242/dev.00329; Gallagher D, 2007, J NEUROSCI, V27, P9664, DOI 10.1523/JNEUROSCI.0608-07.2007; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Glebova NO, 2005, ANNU REV NEUROSCI, V28, P191, DOI 10.1146/annurev.neuro.28.061604.135659; Goold RG, 2005, MOL CELL NEUROSCI, V28, P524, DOI 10.1016/j.mcn.2004.11.005; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Krausz LT, 2007, THESCIENTIFICWORLDJO, V7, P533, DOI 10.1100/tsw.2007.106; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Maina F, 1998, NEURON, V20, P835, DOI 10.1016/S0896-6273(00)80466-3; Ronchetti S, 2004, EUR J IMMUNOL, V34, P613, DOI 10.1002/eji.200324804; SHOLL DA, 1953, J ANAT, V87, P387; Suttles J, 1999, J BIOL CHEM, V274, P5835, DOI 10.1074/jbc.274.9.5835; Thompson J, 2004, MOL CELL NEUROSCI, V27, P441, DOI 10.1016/j.mcn.2004.07.007; WRIGHT LL, 1983, J NEUROCYTOL, V12, P727, DOI 10.1007/BF01258147; Wyatt S, 1997, EMBO J, V16, P3115, DOI 10.1093/emboj/16.11.3115; Yang XM, 1998, J NEUROSCI, V18, P8369; Zheng B, 2003, BLOOD, V102, P1019, DOI 10.1182/blood-2002-11-3507; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882	30	50	52	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					135	142		10.1038/nn2034	http://dx.doi.org/10.1038/nn2034			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18176559	Green Accepted			2022-12-24	WOS:000252712100007
J	Takubo, K; Ohmura, M; Azuma, M; Nagamatsu, G; Yamada, W; Arai, F; Hirao, A; Suda, T				Takubo, Keiyo; Ohmura, Masako; Azuma, Masaki; Nagamatsu, Go; Yamada, Wakako; Arai, Fumio; Hirao, Atsushi; Suda, Toshio			Stem cell defects in ATM-deficient undifferentiated spermatogonia through DNA damage-induced cell-cycle arrest	CELL STEM CELL			English	Article							ATAXIA-TELANGIECTASIA; MOUSE TESTIS; GERM-LINE; SELF-RENEWAL; PROPHASE I; MICE; SPERMATOGENESIS; PROLIFERATION; TRANSPLANTATION; MAINTENANCE	Mammalian spermatogenesis is maintained by stem cell capacity within undifferentiated spermatogonial subpopulation. Here, using a combination of surface markers, we describe a purification method for undifferentiated spermatogonia. Flow cytometric analysis revealed that this population is composed of Plzf-positive cells and exhibits quiescence and the side population phenotype, fulfilling general stem cell criteria. We then applied this method to analyze undifferentiated spermatogonia and stem cell activity of Atm(-/-) mice. Atm(-/-) testis shows progressive depletion of undifferentiated spermatogonia accompanied by cell-cycle arrest. In Atm(-/-) undifferentiated spermatogonia, a self-renewal defect was observed in vitro and in vivo. Accumulation of DNA damage and activation of the p19(Arf)-p53-p21(Cip1/Waf1) pathway were observed in Atm(-/-) undifferentiated spermatogonia. Moreover, suppression of p21(Cip1/Waf1) in an Atm(-/-) background restored transplantation ability of undifferentiated spermatogonia, indicating that ATM plays an essential role in maintenance of undifferentiated spermatogonia and their stem cell capacity by suppressing DNA damage-induced cell-cycle arrest.	[Takubo, Keiyo; Azuma, Masaki; Nagamatsu, Go; Yamada, Wakako; Arai, Fumio; Suda, Toshio] Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat, Tokyo 1608582, Japan; [Ohmura, Masako; Hirao, Atsushi] Kanazawa Univ, Canc Res Inst, Dept Mol Oncol, Div Mol Genet, Kanazawa, Ishikawa 9200934, Japan; [Hirao, Atsushi] Japan Sci & Technol Agcy, Kawaguchi Ctr, Core Res Evolut Sci & Tehcnol, Kawaguchi, Saitama 3320012, Japan	Keio University; Kanazawa University; Japan Science & Technology Agency (JST)	Takubo, K (corresponding author), Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat, 35 Shinano,Shinjuku, Tokyo 1608582, Japan.	keiyot@gmail.com; sudato@sc.itc.keio.ac.jp	Arai, Fumio/J-5241-2013; Suda, Toshio/H-6761-2013; Takubo, Keiyo/AAX-5546-2020	Arai, Fumio/0000-0003-1936-4907; Suda, Toshio/0000-0001-7540-1771; Takubo, Keiyo/0000-0002-1736-7592				Anderson R, 1999, J REPROD FERTIL, V116, P379, DOI 10.1530/jrf.0.1160379; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barlow C, 1998, DEVELOPMENT, V125, P4007; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barlow C, 1997, NAT GENET, V17, P462, DOI 10.1038/ng1297-462; Bastos H, 2005, CYTOM PART A, V65A, P40, DOI 10.1002/cyto.a.20129; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; de Rooij DG, 2004, ENDOCRINOLOGY, V145, P4009, DOI 10.1210/en.2004-0578; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Falciatori I, 2003, FASEB J, V17, P376, DOI 10.1096/fj.03-0744fje; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Hamer G, 2004, BIOL REPROD, V70, P1206, DOI 10.1095/biolreprod.103.024950; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Lassalle B, 2004, DEVELOPMENT, V131, P479, DOI 10.1242/dev.00918; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Oatley JM, 2006, METHOD ENZYMOL, V419, P259, DOI 10.1016/S0076-6879(06)19011-4; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Ogawa T, 2003, BIOL REPROD, V68, P316, DOI 10.1095/biolreprod.102.004549; OLSON MO, 2004, SCI STKE, P10; ORRICK LR, 1973, P NATL ACAD SCI USA, V70, P1316, DOI 10.1073/pnas.70.5.1316; Pandita TK, 1999, MOL CELL BIOL, V19, P5096; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Scherthan H, 2000, MOL CELL BIOL, V20, P7773, DOI 10.1128/MCB.20.20.7773-7783.2000; Shen KC, 2005, CANCER RES, V65, P8747, DOI 10.1158/0008-5472.CAN-05-1471; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Takubo K, 2006, BIOCHEM BIOPH RES CO, V351, P993, DOI 10.1016/j.bbrc.2006.10.145; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Viglietto G, 2000, INT J ONCOL, V16, P689; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316	48	101	101	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB	2008	2	2					170	182		10.1016/j.stem.2007.10.023	http://dx.doi.org/10.1016/j.stem.2007.10.023			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	264PW	18371438	Bronze			2022-12-24	WOS:000253301900012
J	Cheng, S; Frank, LM				Cheng, Sen; Frank, Loren M.			New experiences enhance coordinated neural activity in the hippocampus	NEURON			English	Article							LONG-TERM POTENTIATION; RECEPTIVE-FIELD PLASTICITY; CA1 PYRAMIDAL CELLS; SHARP WAVES; SEQUENTIAL EXPERIENCE; ENTORHINAL CORTEX; AWAKE STATE; SEQUENCES; MEMORY; REPLAY	The acquisition of new memories for places and events requires synaptic plasticity in the hippocampus, and plasticity depends on temporal coordination among neurons. Spatial activity in the hippocampus is relatively disorganized during the initial exploration of a novel environment, however, and it is unclear how neural activity during the initial stages of learning drives synaptic plasticity. Here we show that pairs of CA1 cells that represent overlapping novel locations are initially more coactive and more precisely coordinated than are cells representing overlapping familiar locations. This increased coordination occurrs specifically during brief, high-frequency events (HFEs) in the local field potential that are similar to ripples and is not associated with better coordination of place-specific neural activity outside of HFEs. As novel locations become more familiar, correlations between cell pairs decrease. Thus, hippocampal neural activity during learning has a unique structure that is well suited to induce synaptic plasticity and to allow for rapid storage of new memories.	[Cheng, Sen; Frank, Loren M.] Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, Sloan Swartz Ctr Theoret Neurobiol, San Francisco, CA 94143 USA; [Cheng, Sen; Frank, Loren M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Frank, LM (corresponding author), Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, Sloan Swartz Ctr Theoret Neurobiol, San Francisco, CA 94143 USA.	loren@phy.ucsf.edu	Cheng, Sen/A-5722-2009	Cheng, Sen/0000-0002-6719-8029; Frank, Loren/0000-0002-1752-5677	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080283, R01MH059733, P50MH077970] Funding Source: NIH RePORTER; NIMH NIH HHS [MH077970, R01 MH080283, R01 MH080283-01, R01 MH059733, P50 MH077970-02, P50 MH077970, MH080283, R01 MH059733-06, MH059733] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amaral David G., 1995, P443; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Brown EN, 2002, NEURAL COMPUT, V14, P325, DOI 10.1162/08997660252741149; Brown EN, 2001, P NATL ACAD SCI USA, V98, P12261, DOI 10.1073/pnas.201409398; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Frank LM, 2002, J NEUROSCI, V22, P3817; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hebb Donald O., 1949, ORG BEHAV; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jackson JC, 2006, J NEUROSCI, V26, P12415, DOI 10.1523/JNEUROSCI.4118-06.2006; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lorincz A, 2000, ANN NY ACAD SCI, V911, P83; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Sheskin D., 2011, HDB PARAMETRIC NONPA, V5th; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Tatsuno M, 2006, J NEUROSCI, V26, P10727, DOI 10.1523/JNEUROSCI.3317-06.2006; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Yun SH, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-05-j0003.2002; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	49	169	169	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 24	2008	57	2					303	313		10.1016/j.neuron.2007.11.035	http://dx.doi.org/10.1016/j.neuron.2007.11.035			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256VQ	18215626	Green Accepted, Bronze			2022-12-24	WOS:000252758400013
J	Mendelsohn, A; Chalamish, Y; Solomonovich, A; Dudai, Y				Mendelsohn, Avi; Chalamish, Yossi; Solomonovich, Alexander; Dudai, Yadin			Mesmerizing memories: Brain substrates of episodic memory suppression. in posthypnotic amnesia	NEURON			English	Article							PREFRONTAL CORTEX AREA-10; CONSCIOUS RECOLLECTION; FUNCTIONAL NEUROANATOMY; RETRIEVAL; HYPNOSIS; REPRESENTATION; REACTIVATION; EXPLICIT; IMPLICIT	Two groups of participants, one susceptible to posthypnotic amnesia (PHA) and the other not, viewed a movie. A week later, they underwent hypnosis in the fMRI scanner and received a suggestion to forget the movie details after hypnosis until receiving a reversal cue. The participants were tested twice for memory for the movie and for the context in which it was shown, under the posthypnotic suggestion and after its reversal, while their brain was scanned. The PHA group showed reduced memory for movie but not for context while under suggestion. Activity in occipital, temporal, and prefrontal areas differed among the groups, and, in the PHA group, between suggestion and reversal conditions. We propose that whereas some of these regions subserve retrieval of long-term episodic memory, others are involved in inhibiting retrieval, possibly already in a preretrieval monitoring stage. Similar mechanisms may also underlie other forms of functional amnesia.	[Mendelsohn, Avi; Chalamish, Yossi; Dudai, Yadin] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Solomonovich, Alexander] Wolfson Med Ctr, Hypnosis Unit, Holon, Israel	Weizmann Institute of Science	Dudai, Y (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	yadin.dudai@weizmann.ac.il		Mendelsohn, Avi/0000-0003-4582-2668				Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; ANDERSON MC, 1994, J EXP PSYCHOL LEARN, V20, P1063, DOI 10.1037/0278-7393.20.5.1063; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; [Anonymous], 1983, CANADIAN PSYCHOL; Barnier AJ, 2002, PSYCHOL SCI, V13, P232, DOI 10.1111/1467-9280.00443; Barnier AJ, 2001, INT J CLIN EXP HYP, V49, P286, DOI 10.1080/00207140108410079; BJORK RA, 1968, PSYCHON SCI, V10, P55; BJORK RA, 2007, MEMORY CONCEPTS, P307; BRAID J, 1845, LANCET, V1, P627, DOI DOI 10.1016/S0140-6736(02)65024-X; Bryant RA, 1999, INT J CLIN EXP HYP, V47, P46, DOI 10.1080/00207149908410022; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Bulevich JB, 2006, MEM COGNITION, V34, P1569, DOI 10.3758/BF03195920; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; COE WC, 1989, J PERS SOC PSYCHOL, V56, P189; Conway MA, 2003, CORTEX, V39, P667, DOI 10.1016/S0010-9452(08)70859-1; Cox RE, 2003, MEMORY, V11, P307, DOI 10.1080/09658210244000108; David D, 2000, INT J CLIN EXP HYP, V48, P267, DOI 10.1080/00207140008415246; Evans F. J., 1988, HYPNOSIS MEMORY, P157; Fink GR, 1996, J NEUROSCI, V16, P4275; Gallagher HL, 2004, NEUROPSYCHOLOGIA, V42, P1725, DOI 10.1016/j.neuropsychologia.2004.05.006; GARDINER JM, 2007, MEMORY CONCEPTS, P221; Gauld Alan, 1995, HIST HYPNOTISM; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gilboa A, 2006, BRAIN, V129, P1399, DOI 10.1093/brain/awl093; Glisky EL, 2004, NEUROPSYCHOLOGIA, V42, P1132, DOI 10.1016/j.neuropsychologia.2003.08.016; Graham KS, 2003, COGN AFFECT BEHAV NE, V3, P234, DOI 10.3758/CABN.3.3.234; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; HASSON U, 2008, IN PRESS NEURON, V57; Heckers S, 1998, NAT NEUROSCI, V1, P318, DOI 10.1038/1137; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; HILGARD ER, 1975, ANNU REV PSYCHOL, V26, P19, DOI 10.1146/annurev.ps.26.020175.000315; Johnson JD, 2007, CEREB CORTEX, V17, P2507, DOI 10.1093/cercor/bhl156; Kihlstrom JF, 1997, PHILOS T ROY SOC B, V352, P1727, DOI 10.1098/rstb.1997.0155; KIHLSTROM JF, 1985, ANNU REV PSYCHOL, V36, P385, DOI 10.1146/annurev.ps.36.020185.002125; KIRSCH I, 1995, AM PSYCHOL, V50, P846, DOI 10.1037/0003-066X.50.10.846; KIRSCH I, 1998, HUPNOSIS, V15, P166; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Levy BJ, 2002, TRENDS COGN SCI, V6, P299, DOI 10.1016/S1364-6613(02)01923-X; Lichtenberg P, 2004, INT J CLIN EXP HYP, V52, P47, DOI 10.1076/iceh.52.1.47.23922; Maguire EA, 1999, HIPPOCAMPUS, V9, P54, DOI 10.1002/(SICI)1098-1063(1999)9:1<54::AID-HIPO6>3.0.CO;2-O; Maguire EA, 1999, BRAIN, V122, P1839, DOI 10.1093/brain/122.10.1839; Markowitsch HJ, 2003, NEUROIMAGE, V20, pS132, DOI 10.1016/j.neuroimage.2003.09.010; Markowitsch HJ, 1999, MEMORY, V7, P561, DOI 10.1080/096582199387751; MORRIS CD, 1977, J VERB LEARN VERB BE, V16, P519, DOI 10.1016/S0022-5371(77)80016-9; Naghavi HR, 2005, CONSCIOUS COGN, V14, P390, DOI 10.1016/j.concog.2004.10.003; Nyberg L, 2000, J COGNITIVE NEUROSCI, V12, P163, DOI 10.1162/089892900561805; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Racsmany M, 2006, J EXP PSYCHOL LEARN, V32, P44, DOI 10.1037/0278-7393.32.1.44; Raz A, 2006, J PHYSIOL-PARIS, V99, P483, DOI 10.1016/j.jphysparis.2006.03.003; Roediger H.L., 2007, SCI MEMORY CONCEPTS, DOI [10.1093/acprof:oso/9780195310443.001.0001, DOI 10.1093/ACPROF:OSO/9780195310443.001.0001]; Rosen VM, 1998, J MEM LANG, V39, P418, DOI 10.1006/jmla.1998.2590; Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5; Sakai K, 2003, REV NEUROSCIENCE, V14, P241; Schacter DL, 1998, NEUROBIOL LEARN MEM, V70, P284, DOI 10.1006/nlme.1998.3854; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; Schnider A, 2003, NAT REV NEUROSCI, V4, P662, DOI 10.1038/nrn1179; Sohn MH, 2003, P NATL ACAD SCI USA, V100, P7412, DOI 10.1073/pnas.0832374100; Spiegel H., 2004, TRANCE TREATMENT CLI; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; STERN DB, 1979, AM J CLIN HYPN, V21, P109; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Talairach J., 1988, COPLANAR STEREOTAXIC; Vaidya CJ, 2002, NEUROPSYCHOLOGIA, V40, P2136, DOI 10.1016/S0028-3932(02)00053-2; Wagstaff G.F., 1998, CONT HYPN, V15, P149, DOI [https://doi.org/10.1002/ch.125, DOI 10.1002/CH.125]; WAGSTAFF GF, 2001, INT J PSYCHOL PSYCHO, V1, P57; Weitzenhoffer A. M., 1962, STANFORD HYPNOTIC SU; WILLIAMSEN JOHN A., 1965, J ABNOR PSYCHOL, V70, P123, DOI 10.1037/h0021934; Yancey SW, 2001, J CLIN EXP NEUROPSYC, V23, P32, DOI 10.1076/jcen.23.1.32.1220; Yasuno F, 2000, PSYCHIAT RES-NEUROIM, V99, P43, DOI 10.1016/S0925-4927(00)00057-3	72	65	67	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 10	2008	57	1					159	170		10.1016/j.neuron.2007.11.022	http://dx.doi.org/10.1016/j.neuron.2007.11.022			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	250YZ	18184572	Bronze			2022-12-24	WOS:000252338600017
J	Benchaouir, R; Meregalli, M; Farini, A; D'Antona, G; Belicchi, M; Goyenvalle, A; Battistelli, M; Bresolin, N; Bottinelli, R; Garcia, L; Torrente, Y				Benchaouir, Rachid; Meregalli, Mirella; Farini, Andrea; D'Antona, Giuseppe; Belicchi, Marzia; Goyenvalle, Aurelie; Battistelli, Maurizio; Bresolin, Nereo; Bottinelli, Roberto; Garcia, Luis; Torrente, Yvan			Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice	CELL STEM CELL			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; GENE-THERAPY; MDX MOUSE; MYOBLAST TRANSPLANTATION; MUSCLE REGENERATION; EXPRESSION; VECTORS; LENGTH	Duchenne muscular dystrophy (DMD) is a hereditary disease caused by mutations that disrupt the dystrophin mRNA reading frame. In some cases, forced exclusion (skipping) of a single exon can restore the reading frame, giving rise to a shorter, but still functional, protein. In this study, we constructed lentiviral vectors expressing antisense oligonucleotides in order to induce an efficient exon skipping and to correct the initial frameshift caused by the DMD deletion of CD133+ stem cells. The intramuscular and intra-arterial delivery of genetically corrected CD133 expressing myogenic progenitors isolated from the blood and muscle of DMD patients results in a significant recovery of muscle morphology, function, and dystrophin expression in scid/mdx mice. These data demonstrate that autologous engrafting of blood or muscle-derived CD133+ cells, previously genetically modified to reexpress a functional dystrophin, represents a promising approach for DMD.	[Garcia, Luis] Genethon, CNRS, UMR 8115, Grp Maladie Duchenne, F-91000 Evry, France; [Garcia, Luis] Univ Paris 06, INSERM, Fac Med, UMR S787, F-75634 Paris, France; [Benchaouir, Rachid; Meregalli, Mirella; Farini, Andrea; Belicchi, Marzia; Battistelli, Maurizio; Bresolin, Nereo; Torrente, Yvan] Univ Milan, Fdn IRCCS, Osped Maggiore Policlin, Ctr Dino Ferrari,Stem Cell Lab,Dept Neurol Sci, I-20122 Milan, Italy; [Torrente, Yvan] Univ Milan, Ctr Interdipartimentale Ric Cellule Staminali, UNISTEM, I-20133 Milan, Italy; [Goyenvalle, Aurelie; Garcia, Luis] Univ Pavia, Human Physiol Unit, Dept Expt Med, I-27100 Pavia, Italy	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; University of Pavia	Garcia, L (corresponding author), Genethon, CNRS, UMR 8115, Grp Maladie Duchenne, 1 Bis Rue Int, F-91000 Evry, France.	luis.garcia@chups.jussieu.fr; yvan.torrente@unimi.it	Bottinelli, Roberto/AAC-1904-2020; Goyenvalle, Aurelie/G-3402-2016; Goyenvalle, Aurélie/GPF-7917-2022; canepari, Monica MC/D-7677-2015; TORRENTE, YVAN/A-2964-2015	Bottinelli, Roberto/0000-0002-4960-7490; Goyenvalle, Aurélie/0000-0003-3938-1165; TORRENTE, YVAN/0000-0002-2705-3984; Farini, Andrea/0000-0002-8514-4921; Bresolin, Nereo/0000-0001-6694-3595; Meregalli, Mirella/0000-0002-5151-607X; D'Antona, Giuseppe/0000-0002-0683-5565				Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Aartsma-Rus A, 2005, OLIGONUCLEOTIDES, V15, P284, DOI 10.1089/oli.2005.15.284; Acsadi G, 1996, HUM GENE THER, V7, P129, DOI 10.1089/hum.1996.7.2-129; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Bello L, 2004, CLIN CANCER RES, V10, P4527, DOI 10.1158/1078-0432.CCR-04-0194; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Charrier S, 2005, GENE THER, V12, P597, DOI 10.1038/sj.gt.3302440; Denti MA, 2006, P NATL ACAD SCI USA, V103, P3758, DOI 10.1073/pnas.0508917103; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Dickinson K, 2002, SIGHT SOUND, V12, P40; Dreyfus PA, 2004, AM J PATHOL, V164, P773, DOI 10.1016/S0002-9440(10)63165-3; FARINI A, 2007, IN PRESS J PATHOL, V212; Goncalves MAFV, 2006, HUM MOL GENET, V15, P213, DOI 10.1093/hmg/ddi438; Goodell MA, 2001, ANN NY ACAD SCI, V938, P208; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Gregorevic P, 2003, EXPERT OPIN BIOL TH, V3, P803, DOI 10.1517/14712598.3.5.803; Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hartigan-O'Connor D, 2000, MICROSC RES TECHNIQ, V48, P223, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<223::AID-JEMT10>3.0.CO;2-L; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HUARD J, 1992, MUSCLE NERVE, V15, P550, DOI 10.1002/mus.880150504; HUARD J, 1994, J CLIN INVEST, V93, P586, DOI 10.1172/JCI117011; Jackson KA, 2002, J CELL BIOCHEM, P1, DOI 10.1002/jcb.10045; Lai Y, 2005, NAT BIOTECHNOL, V23, P1435, DOI 10.1038/nbt1153; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Li S, 2006, HUM MOL GENET, V15, P1610, DOI 10.1093/hmg/ddl082; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Riviere C, 2006, GENE THER, V13, P1300, DOI 10.1038/sj.gt.3302766; Roberts ML, 2002, HUM MOL GENET, V11, P1719, DOI 10.1093/hmg/11.15.1719; Rossi R, 2001, AM J PHYSIOL-CELL PH, V281, pC585, DOI 10.1152/ajpcell.2001.281.2.C585; Scott JM, 2002, NEUROMUSCULAR DISORD, V12, pS23, DOI 10.1016/S0960-8966(02)00078-0; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; Skuk D, 2006, J NEUROPATH EXP NEUR, V65, P371, DOI 10.1097/01.jnen.0000218443.45782.81; Smythe GM, 2001, EXP CELL RES, V267, P267, DOI 10.1006/excr.2001.5257; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; TREMBLAY JP, 1993, CELL TRANSPLANT, V2, P99, DOI 10.1177/096368979300200203; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; VandenDriessche T, 2002, METHOD ENZYMOL, V346, P573; VILQUIN JT, 1995, J CELL BIOL, V131, P975, DOI 10.1083/jcb.131.4.975; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	44	162	170	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC	2007	1	6					646	657		10.1016/j.stem.2007.09.016	http://dx.doi.org/10.1016/j.stem.2007.09.016			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	243GU	18371406	Bronze			2022-12-24	WOS:000251784300011
J	Friedman, MJ; Shah, AG; Fang, ZH; Ward, EG; Warren, ST; Li, SH; Li, XJ				Friedman, Meyer J.; Shah, Anjali G.; Fang, Zhi-Hui; Ward, Elizabeth G.; Warren, Stephen T.; Li, Shihua; Li, Xiao-Jiang			Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration	NATURE NEUROSCIENCE			English	Article							TATA-BINDING PROTEIN; DOMINANT CEREBELLAR-ATAXIA; NEURONS IN-VITRO; REPEAT EXPANSION; CELL-DEATH; HEAT-SHOCK-PROTEIN-27; TRANSCRIPTION; DISEASE; HUNTINGTIN; EXPRESSION	Expansion of the polyglutamine (polyQ) tract in human TATA-box binding protein (TBP) causes the neurodegenerative disease spinocerebellar ataxia 17 (SCA17). It remains unclear how the polyQ tract regulates normal protein function and induces selective neuropathology in SCA17. We generated transgenic mice expressing polyQ-expanded TBP. These mice showed weight loss, progressive neurological symptoms and neurodegeneration before early death. Expanded polyQ tracts reduced TBP dimerization but enhanced the interaction of TBP with the general transcription factor IIB (TFIIB). In SCA17 transgenic mice, the small heat shock protein HSPB1, a potent neuroprotective factor, was downregulated, and TFIIB occupancy of the Hspb1 promoter was decreased. Overexpression of HSPB1 or TFIIB alleviated mutant TBP-induced neuritic defects. These findings implicate the polyQ domain of TBP in transcriptional regulation and provide insight into the molecular pathogenesis of SCA17.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Emory University	Li, XJ (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	xiaoli@genetics.emory.edu	Warren, Stephen T/A-2498-2012		NIA NIH HHS [AG19206, R01 AG031153] Funding Source: Medline; NIGMS NIH HHS [T32 GM008490] Funding Source: Medline; NINDS NIH HHS [NS41669, NS36232, NS045016, R01 NS045016, R01 NS041669] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041669, R01NS036232, R01NS045016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019206, R01AG031153] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; Armstrong CL, 2001, J COMP NEUROL, V434, P262, DOI 10.1002/cne.1176; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Bondareva AA, 2003, MOL BIOL EVOL, V20, P1932, DOI 10.1093/molbev/msg205; Bruni AC, 2004, ARCH NEUROL-CHICAGO, V61, P1314, DOI 10.1001/archneur.61.8.1314; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Chang WH, 2005, BIOCHEM BIOPH RES CO, V336, P258, DOI 10.1016/j.bbrc.2005.08.065; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fujigasaki H, 2001, BRAIN, V124, P1939, DOI 10.1093/brain/124.10.1939; GAESTEL M, 1993, GENE, V128, P279, DOI 10.1016/0378-1119(93)90575-N; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Jackson-Fisher AJ, 1999, MOL CELL, V3, P717, DOI 10.1016/S1097-2765(01)80004-6; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lasek K, 2006, BRAIN, V129, P2341, DOI 10.1093/brain/awl148; Lee M, 1997, MOL CELL BIOL, V17, P1336, DOI 10.1128/MCB.17.3.1336; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Maltecca F, 2003, NEUROLOGY, V61, P1441, DOI 10.1212/01.WNL.0000094123.09098.A0; Michalik A, 2001, BIOTECHNIQUES, V31, P250, DOI 10.2144/01312bm02; Mittal V, 1997, SCIENCE, V275, P1136, DOI 10.1126/science.275.5303.1136; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Parker JA, 2001, P NATL ACAD SCI USA, V98, P13318, DOI 10.1073/pnas.231476398; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rolfs A, 2003, ANN NEUROL, V54, P367, DOI 10.1002/ana.10676; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schmidt EE, 2003, J BIOL CHEM, V278, P6168, DOI 10.1074/jbc.M211205200; SEIPEL K, 1994, MOL REPROD DEV, V39, P215, DOI 10.1002/mrd.1080390215; Sharp P, 2006, EXP NEUROL, V198, P511, DOI 10.1016/j.expneurol.2005.12.031; Taggart AKP, 1996, SCIENCE, V272, P1331, DOI 10.1126/science.272.5266.1331; Tansey WP, 1997, SCIENCE, V275, P829, DOI 10.1126/science.275.5301.829; Toyoshima Y, 2004, ANN NEUROL, V55, P281, DOI 10.1002/ana.10824; Tsai HF, 2005, BIOCHEM BIOPH RES CO, V334, P1279, DOI 10.1016/j.bbrc.2005.06.207; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; Williams KL, 2006, J NEUROSCI RES, V84, P716, DOI 10.1002/jnr.20983; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	45	127	131	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1519	1528		10.1038/nn2011	http://dx.doi.org/10.1038/nn2011			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17994014				2022-12-24	WOS:000251172900008
J	Glasscock, E; Qian, J; Yoo, JW; Noebels, JL				Glasscock, Edward; Qian, Jing; Yoo, Jong W.; Noebels, Jeffrey L.			Masking epilepsy by combining two epilepsy genes	NATURE NEUROSCIENCE			English	Article							SIMPLE MENDELIAN DISORDERS; CHANNEL SUBUNIT KV1.1; COMPLEX TRAITS; MICE LACKING; MUTANT MOUSE; DEPENDENT MODULATION; ABSENCE EPILEPSY; EPISODIC ATAXIA; HYPEREXCITABILITY; TRANSMISSION	Inherited errors in ion channel genes comprise the largest subset of monogenic causes of idiopathic epilepsy, and pathogenic variants contribute to genetic risk in the complex inheritance of this common disorder. We generated a digenic mouse model of human idiopathic epilepsy by combining two epilepsy-associated ion channel mutations with mutually opposing excitability defects and overlapping subcellular localization. We found that increasing membrane excitability by removing Shaker-like K+ channels, which are encoded by the Kcna1 gene, masked the absence epilepsy caused by a P/Q-type Ca2+ channelopathy due to a missense mutation in the Cacna1a gene. Conversely, decreasing network excitability by impairing Cacna1a Ca2+-channel function attenuated limbic seizures and sudden death in Kcna1-null mice. We also identified intermediate excitability phenotypes at the network and axonal levels. Protective interactions between pathogenic ion channel variants may markedly alter the clinical expression of epilepsy, highlighting the need for comprehensive profiling of this candidate gene set to improve the accuracy of genetic risk assessment of this complex disease.	Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Human Mol Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Noebels, JL (corresponding author), Baylor Coll Med, Dept Neurol, One Baylor Plaza, Houston, TX 77030 USA.	jnoebels@bcm.tmc.edu		Noebels, Jeffrey/0000-0002-2887-0839	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029709, T32NS043124] Funding Source: NIH RePORTER; NINDS NIH HHS [NS43124, NS29709] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Brew HM, 2003, J PHYSIOL-LONDON, V548, P1, DOI 10.1113/jphysiol.2002.035568; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Dipple KM, 2000, MOL GENET METAB, V71, P43, DOI 10.1006/mgme.2000.3052; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Gourfinkel-An I, 2004, LANCET NEUROL, V3, P209, DOI 10.1016/S1474-4422(04)00706-9; Imbrici P, 2004, BRAIN, V127, P2682, DOI 10.1093/brain/awh301; Kearney JA, 2006, HUM MOL GENET, V15, P1043, DOI 10.1093/hmg/ddl019; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Liguori R, 2001, MUSCLE NERVE, V24, P630, DOI 10.1002/mus.1048; Lopantsev V, 2003, EPILEPSIA, V44, P1506, DOI 10.1111/j.0013-9580.2003.44602.x; Nadeau JH, 2006, NAT GENET, V38, P1095, DOI 10.1038/ng1006-1095; NOEBELS JL, 1990, BRAIN RES, V524, P225, DOI 10.1016/0006-8993(90)90695-8; NOEBELS JL, 1979, SCIENCE, V204, P1334, DOI 10.1126/science.572084; Pereira S, 2004, NEUROLOGY, V63, P191, DOI 10.1212/01.WNL.0000132844.20654.C1; Qian J, 2000, J NEUROSCI, V20, P163, DOI 10.1523/JNEUROSCI.20-01-00163.2000; Qian J, 1999, J PHYSIOL-LONDON, V519, P427, DOI 10.1111/j.1469-7793.1999.0427m.x; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; TANOUYE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6548, DOI 10.1073/pnas.78.10.6548; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; WANG H, 1994, J NEUROSCI, V14, P4588; Zhang CL, 1999, J NEUROSCI, V19, P2852; Zhou YD, 2003, J PHYSIOL-LONDON, V547, P497, DOI 10.1113/jphysiol.2002.033415; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	25	100	102	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1554	1558		10.1038/nn1999	http://dx.doi.org/10.1038/nn1999			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17982453				2022-12-24	WOS:000251172900012
J	Shcherbata, HR; Ward, EJ; Fischer, KA; Yu, JY; Reynolds, SH; Chen, CH; Xu, PZ; Hay, BA; Ruohola-Baker, H				Shcherbata, Halyna R.; Ward, Ellen J.; Fischer, Karin A.; Yu, Jenn-Yah; Reynolds, Steven H.; Chen, Chun-Hong; Xu, Peizhang; Hay, Bruce A.; Ruohola-Baker, Hannele			Stage-specific differences in the requirements for germline stem cell maintenance in the Drosophila ovary	CELL STEM CELL			English	Article							MICRORNA PATHWAY; BANTAM MICRORNA; NICHE; RNAI; PROLIFERATION; DIVISION; NEURODEGENERATION; TRANSCRIPTION; APOPTOSIS; COMPLEX	In this study, we uncover a role for microRNAs (miRNAs) in Drosophila germline stem cell (GSC) maintenance. Disruption of Dicer-1 function in GSCs during adult life results in GSC loss. Surprisingly, however, loss of Dicer-1 during development does not result in a GSC maintenance defect, although a defect is seen if both Dicer-1 and Dicer-2 function are disrupted. Loss of the bantam miRNA mimics the Dicer-1 maintenance defect when induced in adult GSCs, suggesting that bantam plays a key role in GSC self-renewal. Mad, a component of the TGF-beta pathway, behaves similarly to Dicer-1: adult GSC maintenance requires Mad if it is lost during adult life, but not if it is lost during pupal development. Overall, these results show stage-specific differential sensitivity of GSC maintenance to certain perturbations and suggest that there may be a Dicer-2-dependent GSC maintenance mechanism during development that is lost in later life.	[Shcherbata, Halyna R.; Ward, Ellen J.; Fischer, Karin A.; Yu, Jenn-Yah; Reynolds, Steven H.; Ruohola-Baker, Hannele] Univ Washington, Inst Stem Cell & Regenerat Med, Dept Biochem, Seattle, WA 98195 USA; [Chen, Chun-Hong; Xu, Peizhang; Hay, Bruce A.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Xu, Peizhang] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Xu, Peizhang] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of Washington; University of Washington Seattle; California Institute of Technology; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ruohola-Baker, H (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Dept Biochem, Seattle, WA 98195 USA.	hannele@u.washington.edu	Shcherbata, Halyna/J-5712-2017; Yu, Jenn-Yah/AAA-3740-2022; xu, huanfang/I-4315-2012; Chen, Chun-Hong/E-3990-2010	Shcherbata, Halyna/0000-0002-3855-0345; CHEN, CHUN-HONG/0000-0002-3028-5508; Yu, Jenn-Yah/0000-0002-4006-3458	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083867, R01GM062748] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM062748-10, R01 GM062748-11, R01 GM083867, R01 GM062748] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gilboa L, 2006, NATURE, V443, P97, DOI 10.1038/nature05068; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; HATFIELD S, 2007, MICRORNAS BIOL FUNCT, P221; HATFIELD S, 2007, IN PRESS CELL TISSUE; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jin ZG, 2007, CURR BIOL, V17, P539, DOI 10.1016/j.cub.2007.01.050; Jordan KC, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-16; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li ZX, 2006, TRENDS BIOCHEM SCI, V31, P589, DOI 10.1016/j.tibs.2006.08.001; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Shcherbata HR, 2006, CELL CYCLE, V5, P172, DOI 10.4161/cc.5.2.2343; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Ward EJ, 2006, CURR BIOL, V16, P2352, DOI 10.1016/j.cub.2006.10.022; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; XU T, 1993, DEVELOPMENT, V117, P1223; Zhu CH, 2003, DEVELOPMENT, V130, P2579, DOI 10.1242/dev.00499	32	49	51	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC	2007	1	6					698	709		10.1016/j.stem.2007.11.007	http://dx.doi.org/10.1016/j.stem.2007.11.007			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	243GU	18213359	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000251784300015
J	Yoshihara, H; Arai, F; Hosokawa, K; Hagiwara, T; Takubo, K; Nakamura, Y; Gomei, Y; Iwasaki, H; Matsuoka, S; Miyamoto, K; Miyazaki, H; Takahashi, T; Suda, T				Yoshihara, Hiroki; Arai, Fumio; Hosokawa, Kentaro; Hagiwara, Tetsuya; Takubo, Keiyo; Nakamura, Yuka; Gomei, Yumiko; Iwasaki, Hiroko; Matsuoka, Sahoko; Miyamoto, Kana; Miyazaki, Hiroshi; Takahashi, Takao; Suda, Toshio			Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche	CELL STEM CELL			English	Article							C-MPL; PROGENITOR CELLS; SELF-RENEWAL; TYROSINE PHOSPHORYLATION; MICE LACKING; RECEPTOR; MEGAKARYOCYTOPOIESIS; PROLIFERATION; DIFFERENTIATION; IDENTIFICATION	Maintenance of hematopoietic stem cells (HSCs) depends on interaction with their niche. Here we show that the long-term (LT)-HSCs expressing the thrombopoietin (THPO) receptor, MPL, are a quiescent population in adult bone marrow (BM) and are closely associated with THPO-producing osteoblastic cells. THPO/MPIL signaling upregulated beta 1-integrin and cyclin-dependent kinase inhibitors in HSCs. Furthermore, inhibition and stimulation of THPO/MPL pathway by treatments with anti-MPL neutralizing antibody, AMM2, and with THPO showed reciprocal regulation of quiescence of LT-HSC. AMM2 treatment reduced the number of quiescent LT-HSCs and allowed exogenous HSC engraftment without irradiation. By contrast, exogenous THPO transiently increased quiescent HSC population and subsequently induced HSC proliferation in vivo. Altogether, these observations suggest that THPO/MPL signaling plays a critical role of LT-HSC regulation in the osteoblastic niche.	[Yoshihara, Hiroki; Arai, Fumio; Hosokawa, Kentaro; Takubo, Keiyo; Nakamura, Yuka; Gomei, Yumiko; Iwasaki, Hiroko; Matsuoka, Sahoko; Miyamoto, Kana; Suda, Toshio] Keio Univ, Dept Cell Differentiat, Sakaguchi Lab Dev Biol, Shinjuku Ku, Tokyo 1608582, Japan; [Yoshihara, Hiroki; Takahashi, Takao] Keio Univ, Sch Med, Dept Pediat, Shinjuku Ku, Tokyo 1608582, Japan; [Miyazaki, Hiroshi] Kirin Pharma Co Ltd, Discovery Res Labs, Takasaki, Gunma 3701295, Japan	Keio University; Keio University	Arai, F (corresponding author), Keio Univ, Dept Cell Differentiat, Sakaguchi Lab Dev Biol, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	farai@sc.itc.keio.ac.jp; sudato@sc.itc.keio.ac.jp	Takubo, Keiyo/AAX-5546-2020; Suda, Toshio/H-6761-2013; Iwasaki, Hiroko/D-1702-2009; Arai, Fumio/J-5241-2013	Takubo, Keiyo/0000-0002-1736-7592; Suda, Toshio/0000-0001-7540-1771; Iwasaki, Hiroko/0000-0001-9661-0919; Arai, Fumio/0000-0003-1936-4907; Yoshihara, Hiroki/0000-0001-5128-4515				Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; BERARDI AC, 1995, SCIENCE, V267, P104, DOI 10.1126/science.7528940; Borge OJ, 1996, BLOOD, V88, P2859, DOI 10.1182/blood.V88.8.2859.bloodjournal8882859; Buza-Vidas N, 2006, GENE DEV, V20, P2018, DOI 10.1101/gad.385606; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CarverMoore K, 1996, BLOOD, V88, P803; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cui L, 1997, J IMMUNOL, V159, P1961; DESAUVAGE FJ, 1994, NATURE, V369, P533, DOI 10.1038/369533a0; deSauvage FJ, 1996, J EXP MED, V183, P651, DOI 10.1084/jem.183.2.651; DORSCH M, 1995, BIOCHEM BIOPH RES CO, V214, P424, DOI 10.1006/bbrc.1995.2304; DRACHMAN JG, 1995, J BIOL CHEM, V270, P4979, DOI 10.1074/jbc.270.10.4979; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Fox N, 2002, J CLIN INVEST, V110, P389, DOI 10.1172/JCI200215430; Geddis AE, 2001, J BIOL CHEM, V276, P34473, DOI 10.1074/jbc.M105178200; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Hsu HC, 2000, BLOOD, V96, P3757, DOI 10.1182/blood.V96.12.3757.h8003757_3757_3762; Huttmann A, 2001, EXP HEMATOL, V29, P1109, DOI 10.1016/S0301-472X(01)00684-1; KAUSHANSKY K, 1995, THROMB HAEMOSTASIS, V74, P521; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; KODAMA H, 1992, J EXP MED, V176, P351, DOI 10.1084/jem.176.2.351; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li ZX, 2006, TRENDS BIOCHEM SCI, V31, P589, DOI 10.1016/j.tibs.2006.08.001; LOK S, 1994, NATURE, V369, P565, DOI 10.1038/369565a0; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Rojnuckarin P, 1999, BLOOD, V94, P1273, DOI 10.1182/blood.V94.4.1273.416k04_1273_1282; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Sitnicka E, 1996, BLOOD, V87, P4998, DOI 10.1182/blood.V87.12.4998.bloodjournal87124998; Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; WENDLING F, 1994, NATURE, V369, P571, DOI 10.1038/369571a0; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	49	534	562	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC	2007	1	6					685	697		10.1016/j.stem.2007.10.020	http://dx.doi.org/10.1016/j.stem.2007.10.020			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	243GU	18371409	Bronze			2022-12-24	WOS:000251784300014
J	Vilchez, D; Ros, S; Cifuentes, D; Pujadas, L; Valles, J; Garcia-Fojeda, B; Criado-Garcia, O; Fernandez-Sanchez, E; Medrano-Fernandez, I; Dominguez, J; Garcia-Rocha, M; Soriano, E; De Cordoba, SR; Guinovart, JJ				Vilchez, David; Ros, Susana; Cifuentes, Daniel; Pujadas, Lluis; Valles, Jordi; Garcia-Fojeda, Belen; Criado-Garcia, Olga; Fernandez-Sanchez, Elena; Medrano-Fernandez, Iria; Dominguez, Jorge; Garcia-Rocha, Mar; Soriano, Eduardo; De Cordoba, Santiago Rodriguez; Guinovart, Joan J.			Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy	NATURE NEUROSCIENCE			English	Article							LAFORA-DISEASE; PHOSPHORYLATION SITES; CORPORA-AMYLACEA; SYNTHASE; PROTEIN; PHOSPHATASE; GLUCOSE-6-PHOSPHATE; ACTIVATION; MUTATIONS; CELLS	Glycogen synthesis is normally absent in neurons. However, inclusion bodies resembling abnormal glycogen accumulate in several neurological diseases, particularly in progressive myoclonus epilepsy or Lafora disease. We show here that mouse neurons have the enzymatic machinery for synthesizing glycogen, but that it is suppressed by retention of muscle glycogen synthase (MGS) in the phosphorylated, inactive state. This suppression was further ensured by a complex of laforin and malin, which are the two proteins whose mutations cause Lafora disease. The laforin-malin complex caused proteasome-dependent degradation both of the adaptor protein targeting to glycogen, PTG, which brings protein phosphatase 1 to MGS for activation, and of MGS itself. Enforced expression of PTG led to glycogen deposition in neurons and caused apoptosis. Therefore, the malin-laforin complex ensures a blockade of neuronal glycogen synthesis even under intense glycogenic conditions. Here we explain the formation of polyglucosan inclusions in Lafora disease by demonstrating a crucial role for laforin and malin in glycogen synthesis.	Univ Barcelona, E-08028 Barcelona, Spain; Inst Res Biomed, E-08028 Barcelona, Spain; CSIC, Ctr Invest Biol, E-28040 Madrid, Spain	University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	De Cordoba, SR (corresponding author), Univ Barcelona, Barcelona Sci Pk,Josep Samitier 1-5, E-08028 Barcelona, Spain.	SRdeCordoba@cib.csic.es	Ros, Susana/B-6350-2019; García-Fojeda, Belén/G-4214-2015; de Cordoba, Santiago Rodriguez/K-6727-2014; Medraño-Fernandez, Iria/AAN-4357-2020; Vilchez, David/A-8446-2008; Pujadas, Lluís/O-7442-2015; PUJADAS, LLUÍS/AAE-1595-2020; Soriano, Eduardo/AAB-3216-2019	García-Fojeda, Belén/0000-0002-9558-3020; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; Medraño-Fernandez, Iria/0000-0002-7956-9915; Vilchez, David/0000-0002-0801-0743; Pujadas, Lluís/0000-0003-3890-8279; PUJADAS, LLUÍS/0000-0003-3890-8279; Soriano, Eduardo/0000-0002-3204-9285; Garcia-Rocha, Mar/0000-0003-2467-2090; Fernandez Sanchez, Maria Elena/0000-0001-8083-8863; Ros, Susana/0000-0002-5451-1880; Criado, Olga/0000-0003-1200-6365; Cifuentes Buira, Daniel/0000-0001-5442-4843				ACHARYA JN, 1995, EPILEPSIA, V36, P429, DOI 10.1111/j.1528-1157.1995.tb00482.x; Allaman I, 2000, GLIA, V30, P382, DOI 10.1002/(SICI)1098-1136(200006)30:4<382::AID-GLIA70>3.3.CO;2-S; Baba O, 1993, Kokubyo Gakkai Zasshi, V60, P264; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; BERKOVIC SF, 1986, NEW ENGL J MED, V315, P296, DOI 10.1056/NEJM198607313150506; BERKOVIC SF, 1993, EPILEPSIA, V34, pS19; Berman HK, 1998, J BIOL CHEM, V273, P26421, DOI 10.1074/jbc.273.41.26421; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Cavanagh JB, 1999, BRAIN RES REV, V29, P265, DOI 10.1016/S0165-0173(99)00003-X; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Cid E, 2005, FEBS J, V272, P3197, DOI 10.1111/j.1742-4658.2005.04738.x; COLLINS GH, 1968, ARCH PATHOL, V86, P239; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; Ferrer JC, 1997, FEBS LETT, V415, P249, DOI 10.1016/S0014-5793(97)01136-8; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; Fong NM, 2000, J BIOL CHEM, V275, P35034, DOI 10.1074/jbc.M005541200; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Gomis RR, 2002, J BIOL CHEM, V277, P23246, DOI 10.1074/jbc.M111208200; GUINOVART JJ, 1979, FEBS LETT, V106, P284, DOI 10.1016/0014-5793(79)80515-3; Hojlund K, 2003, DIABETES, V52, P1393, DOI 10.2337/diabetes.52.6.1393; KOBAYASHI K, 1990, EPILEPSIA, V31, P194, DOI 10.1111/j.1528-1167.1990.tb06306.x; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Lafora GR, 1911, VIRCHOWS ARCH A, V205, P295, DOI 10.1007/BF01989438; LANG G, 1974, METHOD ENZYMAT AN, V6, P1238; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; MacAulay K, 2003, EUR J BIOCHEM, V270, P3829, DOI 10.1046/j.1432-1033.2003.03777.x; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2000, NEUROLOGY, V55, P341, DOI 10.1212/WNL.55.3.341; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; SCHLAMOWITZ M, 1951, J BIOL CHEM, V190, P519; Seoane J, 1996, J BIOL CHEM, V271, P23756, DOI 10.1074/jbc.271.39.23756; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Shahwan A, 2005, LANCET NEUROL, V4, P239, DOI 10.1016/S1474-4422(05)70043-0; Simo S, 2007, CEREB CORTEX, V17, P294, DOI 10.1093/cercor/bhj147; SKURAT AV, 1994, J BIOL CHEM, V269, P25534; Skurat AV, 2000, DIABETES, V49, P1096, DOI 10.2337/diabetes.49.7.1096; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; VANHEYCOP TH, 1974, CLIN NEUROL, V15, P382; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200	46	254	255	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1407	1413		10.1038/nn1998	http://dx.doi.org/10.1038/nn1998			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17952067	Green Submitted			2022-12-24	WOS:000250508400018
J	Anzai, A; Peng, XM; Van Essen, DC				Anzai, Akiyuki; Peng, Xinmiao; Van Essen, David C.			Neurons inmonkey visual area V2 encode combinations of orientations	NATURE NEUROSCIENCE			English	Article							OF-FIT TESTS; RECEPTIVE-FIELDS; STRIATE-CORTEX; FUNCTIONAL ARCHITECTURE; SIMPLE CELLS; MONKEY; STEREOPSIS; RESPONSES; CAT	Contours and textures are important attributes of object surfaces, and are often described by combinations of local orientations in visual images. To elucidate the neural mechanisms underlying contour and texture processing, we examined receptive field (RF) structures of neurons in visual area V2 of the macaque monkey for encoding combinations of orientations. By measuring orientation tuning at several locations within the classical RF, we found that a majority (70%) of V2 neurons have similar orientation tuning throughout the RF. However, many others have RFs containing subregions tuned to different orientations, most commonly about 90 degrees apart. By measuring interactions between two positions within the RF, we found that approximately one-third of neurons show inhibitory interactions that make them selective for combinations of orientations. These results indicate that V2 neurons could play an important role in analyzing contours and textures and could provide useful cues for surface segmentation.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Anzai, A (corresponding author), Univ Rochester, Ctr Visual Sci, Meliora Hall 248, Rochester, NY 14627 USA.	aanzai@cvs.rochester.edu	Van Essen, David/ABA-8888-2020		NATIONAL EYE INSTITUTE [R01EY002091] Funding Source: NIH RePORTER; NEI NIH HHS [EY 02091] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Berry D.A., 1996, STAT BAYESIAN PERSPE; BROWN BM, 1994, J R STAT SOC B, V56, P275; Carandini M, 1997, J NEUROSCI, V17, P8621; DEANGELIS GC, 1995, PERCEPTION, V24, P3, DOI 10.1068/p240003; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DEVALOIS RL, 1985, J OPT SOC AM A, V2, P1115, DOI 10.1364/JOSAA.2.001115; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fisher NI, 2001, BIOMETRIKA, V88, P499, DOI 10.1093/biomet/88.2.499; FSHER NI, 1993, STAT ANAL CIRCULAR D; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Hegde J, 2000, J NEUROSCI, V20, part. no.; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1987, J NEUROSCI, V7, P3378; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; HUBEL DH, 1970, NATURE, V225, P41, DOI 10.1038/225041a0; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; KUYPERS HGJ, 1965, EXP NEUROL, V11, P245, DOI 10.1016/0014-4886(65)90016-6; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; Mahon LE, 2001, VISUAL NEUROSCI, V18, P973, DOI 10.1017/S0952523801186141; NAKAYAMA K, 1995, INVITATION COGNITIVE, V2, P1; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; POLAT U, 1994, VISION RES, V34, P73, DOI 10.1016/0042-6989(94)90258-5; PRESS WH, 1988, MODELING DATA NUMERI, P517; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rubin N, 2001, PERCEPTION, V30, P339, DOI 10.1068/p3173; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; SILVERMAN BW, 1981, J ROY STAT SOC B MET, V43, P97; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; VANESSEN DC, 1986, J COMP NEUROL, V244, P541; Walker GA, 2002, J NEUROSCI, V22, P5659; WATSON GS, 1961, BIOMETRIKA, V48, P109, DOI 10.2307/2333135	37	170	171	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1313	1321		10.1038/nn1975	http://dx.doi.org/10.1038/nn1975			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17873872				2022-12-24	WOS:000249720800019
J	Armentano, M; Chou, SJ; Tomassy, GS; Leingaertner, A; O'Leary, DDM; Studer, M				Armentano, Maria; Chou, Shen-Ju; Tomassy, Giulio Srubek; Leingaertner, Axel; O'Leary, Dennis D. M.; Studer, Michele			COUP-TFI regulates the balance of cortical patterning between frontal/motor and sensory areas	NATURE NEUROSCIENCE			English	Article							THALAMOCORTICAL AXONS; CEREBRAL-CORTEX; DIFFERENTIAL EXPRESSION; DEVELOPING NEOCORTEX; EMX2; PAX6; REGIONALIZATION; SPECIFICATION; FOREBRAIN; NEURONS	We used cortex-specific deletion of the transcription factor gene COUP-TFI (also known as Nr2f1) in mice to demonstrate previously unknown fundamental roles for it in patterning mammalian neocortex into areas. The highest COUP-TFI expression is observed in the cortical progenitors and progeny in parietal and occipital cortex that form sensory areas, and the lowest expression was observed in frontal cortex that includes motor areas. Cortical deletion of COUP-TFI resulted in massive expansion of frontal areas, including motor, to occupy most of neocortex, paralleled by marked compression of sensory areas to caudal occipital cortex. These area patterning changes are preceded and paralleled by corresponding changes in molecular markers of area identity and altered axonal projections to maintain patterned area-specific input and output connections. We conclude that COUP-TFI is required for balancing patterning of neocortex into frontal/motor and sensory areas by acting in its expression domain to repress frontal/motor area identities and to specify sensory area identities.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; TIGEM, Dev Disorders Program, I-80131 Naples, Italy	Salk Institute; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	doleary@salk.edu; studer@tigem.it	Studer, Michele/P-4580-2016	Studer, Michele/0000-0001-7105-2957	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031558, R01NS050646] Funding Source: NIH RePORTER; NINDS NIH HHS [R37 NS31558, R01 NS50646] Funding Source: Medline; Telethon [TGM06S01, TGM06A04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		Armentano M, 2006, DEVELOPMENT, V133, P4151, DOI 10.1242/dev.02600; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; FUJIMIYA M, 1986, J COMP NEUROL, V246, P191, DOI 10.1002/cne.902460205; Fukuchi-Shimogori T, 2003, NAT NEUROSCI, V6, P825, DOI 10.1038/nn1093; Gorski JA, 2002, J NEUROSCI, V22, P6309; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; Hamasaki T, 2004, NEURON, V43, P359, DOI 10.1016/j.neuron.2004.07.016; Leingartner A, 2003, CEREB CORTEX, V13, P648, DOI 10.1093/cercor/13.6.648; Liu Q, 2000, J NEUROSCI, V20, P7682; Mackenzie D J, 1999, J Craniomaxillofac Trauma, V5, P9; Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Manuel M, 2007, DEVELOPMENT, V134, P545, DOI 10.1242/dev.02764; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Molnar Z, 1998, J NEUROSCI, V18, P5723; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Nakagawa Y, 2003, DEV NEUROSCI-BASEL, V25, P234, DOI 10.1159/000072271; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rash BG, 2006, CURR OPIN NEUROBIOL, V16, P25, DOI 10.1016/j.conb.2006.01.004; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Stoykova A, 2000, J NEUROSCI, V20, P8042; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Takeuchi A, 2007, CEREB CORTEX, V17, P1531, DOI 10.1093/cercor/bhl064; Tripodi M, 2004, DEVELOPMENT, V131, P6119, DOI 10.1242/dev.01530; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	33	164	166	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1277	1286		10.1038/nn1958	http://dx.doi.org/10.1038/nn1958			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828260				2022-12-24	WOS:000249720800014
J	Cho, CH; St-Gelais, F; Zhang, W; Tomita, S; Howe, JR				Cho, Chang-Hoon; St-Gelais, Fannie; Zhang, Wei; Tomita, Susumu; Howe, James R.			Two families of TARP isoforms that have distinct effects on the kinetic properties of AMPA receptors and synaptic currents	NEURON			English	Article							ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID RECEPTORS; RAT HIPPOCAMPAL SLICES; GLUTAMATE RECEPTORS; KAINATE RECEPTORS; INWARD RECTIFICATION; EXCITATORY SYNAPSES; NMDA RECEPTORS; ION-CHANNEL; DESENSITIZATION; STARGAZIN	Transmembrane AMPA receptor regulatory proteins (TARPs) are auxiliary AMPA receptor subunits that regulate both the trafficking and gating properties of AMPA receptors, and different TARP isoforms display distinct expression patterns in brain. Here, we compared the effects of four TARP isoforms on the kinetics of AMPA receptor currents. Each isoform slowed the deactivation of GluRl currents, but the slowing was greatest with gamma-4 and gamma-8. Isoform-specific differences in desensitization were also observed that correlated with effects on deactivation. TARP isoforms also differentially modulated responses to trains of glutamate applications designed to mimic high-frequency presynaptic firing. Importantly, whereas both stargazin and gamma-4 rescued excitatory synaptic transmission in cerebellar granule cells from stargazer mice, the decay of miniature EPSCs was 2-fold slower in neurons expressing gamma-4. The results show that heterogeneity in the composition of AMPA receptor/TARP complexes contributes to synapse-specific differences in EPSC decays and frequency-dependent modulation of neurotransmission.	Yale Univ, Dept Pharm, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University	Howe, JR (corresponding author), Yale Univ, Dept Pharm, 333 Cedar St, New Haven, CT 06520 USA.	james.howe@yale.edu	zhang, wei/V-6712-2018	zhang, wei/0000-0001-9825-0371	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047712] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-047712] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bellingham MC, 1998, J PHYSIOL-LONDON, V511, P861, DOI 10.1111/j.1469-7793.1998.861bg.x; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Conti F, 1999, TRENDS NEUROSCI, V22, P451, DOI 10.1016/S0166-2236(99)01445-9; Diamond JS, 1997, J NEUROSCI, V17, P4672; Dingledine R, 1999, PHARMACOL REV, V51, P7; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Fukaya M, 2005, NEUROSCI RES, V53, P376, DOI 10.1016/j.neures.2005.08.009; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Korber C, 2007, J NEUROSCI, V27, P8442, DOI 10.1523/JNEUROSCI.0424-07.2007; Korber C, 2007, J BIOL CHEM, V282, P18758, DOI 10.1074/jbc.M611182200; Kott S, 2007, J NEUROSCI, V27, P3780, DOI 10.1523/JNEUROSCI.4185-06.2007; LIVSEY CT, 1993, J NEUROSCI, V13, P5324, DOI 10.1523/JNEUROSCI.13-12-05324.1993; Losi G, 2003, J PHYSIOL-LONDON, V548, P21, DOI 10.1113/jphysiol.2002.034918; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Osten P, 2006, CURR OPIN NEUROBIOL, V16, P275, DOI 10.1016/j.conb.2006.04.002; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; RAMAN IM, 1995, BIOPHYS J, V68, P137, DOI 10.1016/S0006-3495(95)80168-2; Robert A, 2003, J NEUROSCI, V23, P847; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Silver RA, 1996, J PHYSIOL-LONDON, V493, P167, DOI 10.1113/jphysiol.1996.sp021372; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Tomita S, 2006, P NATL ACAD SCI USA, V103, P10064, DOI 10.1073/pnas.0603128103; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; VYKLICKY L, 1991, NEURON, V7, P971, DOI 10.1016/0896-6273(91)90342-W; Wall MJ, 2002, EUR J NEUROSCI, V15, P785, DOI 10.1046/j.1460-9568.2002.01910.x; Washburn MS, 1997, J NEUROSCI, V17, P9393; Yamazaki M, 2004, NEUROSCI RES, V50, P369, DOI 10.1016/j.neures.2004.10.002; Zhang W, 2006, BIOPHYS J, V91, P1336, DOI 10.1529/biophysj.106.084426; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	50	132	138	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 20	2007	55	6					890	904		10.1016/j.neuron.2007.08.024	http://dx.doi.org/10.1016/j.neuron.2007.08.024			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	219IQ	17880893	Bronze			2022-12-24	WOS:000250078500007
J	Tsao, DY; Schweers, N; Moeller, S; Freiwald, WA				Tsao, Doris Y.; Schweers, Nicole; Moeller, Sebastian; Freiwald, Winrich A.			Patches of face-selective cortex in the macaque frontal lobe	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; FUNCTIONAL MRI; PERCEPTION; MONKEY; RESPONSES; AREA	In primates, specialized occipital-temporal face areas support the visual analysis of faces, but it is unclear whether similarly specialized areas exist in the frontal lobe. Using functional magnetic resonance imaging in alert macaques, we identified three discrete regions of highly face-selective cortex in ventral prefrontal cortex, one of which was strongly lateralized to the right hemisphere. These prefrontal face patches may constitute dedicated modules for retrieving and responding to facial information.	[Tsao, Doris Y.] Univ Bremen, Inst Brain Res, D-28334 Bremen, Germany; Univ Bremen, Ctr Adv Imaging, D-28334 Bremen, Germany	University of Bremen; University of Bremen	Tsao, DY (corresponding author), Univ Bremen, Inst Brain Res, POB 330440, D-28334 Bremen, Germany.	doris@nmr.mgh.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Denys K, 2004, J COGNITIVE NEUROSCI, V16, P1505, DOI 10.1162/0898929042568505; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hoffman KL, 2007, CURR BIOL, V17, P766, DOI 10.1016/j.cub.2007.03.040; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; O Scalaidhe SP, 1999, CEREB CORTEX, V9, P459, DOI 10.1093/cercor/9.5.459; Petrides M, 2005, NATURE, V435, P1235, DOI 10.1038/nature03628; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Pinsk MA, 2005, P NATL ACAD SCI USA, V102, P6996, DOI 10.1073/pnas.0502605102; Rolls ET, 2006, EXP BRAIN RES, V170, P74, DOI 10.1007/s00221-005-0191-y; ROLLS ET, 1999, BRAIN EMOTION; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111	15	166	166	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					877	879		10.1038/nn.2158	http://dx.doi.org/10.1038/nn.2158			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18622399	Green Accepted			2022-12-24	WOS:000257969100010
J	Ward, A; Liu, J; Feng, ZY; Xu, XZS				Ward, Alex; Liu, Jie; Feng, Zhaoyang; Xu, X. Z. Shawn			Light-sensitive neurons and channels mediate phototaxis in C-elegans	NATURE NEUROSCIENCE			English	Article							NUCLEOTIDE-GATED CHANNEL; CAENORHABDITIS-ELEGANS; TOUCH SENSITIVITY; GUANYLYL CYCLASE; CYCLIC-GMP; PHOTOTRANSDUCTION; BEHAVIOR; NEMATODE; EYE; PHOTORECEPTORS	Phototaxis behavior is commonly observed in animals with light-sensing organs. C. elegans, however, is generally believed to lack phototaxis, as this animal lives in darkness ( soil) and does not possess eyes. Here, we found that light stimuli elicited negative phototaxis in C. elegans and that this behavior is important for survival. We identified a group of ciliary sensory neurons as candidate photoreceptor cells for mediating phototaxis. Furthermore, we found that light excited photoreceptor cells by evoking a depolarizing conductance carried by cyclic guanosine monophosphate (cGMP)-sensitive cyclic nucleotide-gated (CNG) channels, revealing a conservation in phototransduction between worms and vertebrates. These results identify a new sensory modality in C. elegans and suggest that animals living in dark environments without light-sensing organs may not be presumed to be light insensitive. We propose that urbilaterians, the last common ancestor of bilaterians, might have already evolved a visual system that employs CNG channels and the second messenger cGMP for phototransduction.	[Ward, Alex; Liu, Jie; Feng, Zhaoyang; Xu, X. Z. Shawn] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Ward, Alex; Xu, X. Z. Shawn] Univ Michigan, Grad Program Neurosci, Ann Arbor, MI 48109 USA; [Xu, X. Z. Shawn] Univ Michigan, Dept Mol & Integrat Phys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, XZS (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu	liu, jie/B-4901-2011	liu, jie/0000-0002-1215-5814	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078276, R01GM083241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adoutte A, 1999, TRENDS GENET, V15, P104, DOI 10.1016/S0168-9525(98)01671-0; Arendt D, 2002, DEVELOPMENT, V129, P1143; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Bounoutas A, 2007, PFLUG ARCH EUR J PHY, V454, P691, DOI 10.1007/s00424-006-0187-x; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; BURR AH, 1985, PHOTOCHEM PHOTOBIOL, V41, P577, DOI 10.1111/j.1751-1097.1985.tb03529.x; CHALFIE M, 1985, J NEUROSCI, V5, P956; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; CHITWOOD B. G., 1964, TRANS AMER MICROSCOP SOC, V83, P311, DOI 10.2307/3224742; Cho SW, 2005, MOL CELLS, V19, P149; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; CROLL NA, 1966, NEMATOLOGICA, V12, P610, DOI 10.1163/187529266X00464; DANZIGER RS, 1993, BIOCHEM BIOPH RES CO, V195, P958, DOI 10.1006/bbrc.1993.2137; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Finn JT, 1997, NATURE, V385, P815, DOI 10.1038/385815a0; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Gabel CV, 2007, J NEUROSCI, V27, P7586, DOI 10.1523/JNEUROSCI.0775-07.2007; Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; KANDEL ER, 2000, PRINCIPLES NEURAL SC, P5; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Miranda-Vizuete A, 2006, FEBS LETT, V580, P484, DOI 10.1016/j.febslet.2005.12.046; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MULSCH A, 1989, N-S ARCH PHARMACOL, V340, P119; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; STERN JH, 1986, P NATL ACAD SCI USA, V83, P1163, DOI 10.1073/pnas.83.4.1163; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	43	187	192	1	63	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					916	922		10.1038/nn.2155	http://dx.doi.org/10.1038/nn.2155			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18604203	Green Accepted			2022-12-24	WOS:000257969100017
J	Dunn, NR				Dunn, N. Ray			Self-renewal made simple	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; PLURIPOTENCY; ACTIVATION; STAT3	Embryonic stem cells (ESCs) are prone to differentiation in culture, suggesting that maintenance of the pluripotent state must be actively induced. In a recent issue of Nature, Ying et al. (2008) use soluble small molecules to inhibit pro-differentiation signals and reveal ESC self-renewal as a default cell fate.	ASTAR, Inst Med Biol, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Dunn, NR (corresponding author), ASTAR, Inst Med Biol, 8A Biomed Grove,06-06 Immunos, Singapore 138648, Singapore.	ray.dunn@imb.a-star.edu.sg	Dunn, Norris Ray/W-5124-2019					Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	10	1	2	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL	2008	3	1					7	8		10.1016/j.stem.2008.06.007	http://dx.doi.org/10.1016/j.stem.2008.06.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	325XO	18593552	Bronze			2022-12-24	WOS:000257622300004
J	Togashi, K; von Schimmelmann, MJ; Nishiyama, M; Lim, CS; Yoshida, N; Yun, B; Molday, RS; Goshima, Y; Hong, K				Togashi, Kazunobu; von Schimmelmann, Melanie J.; Nishiyama, Makoto; Lim, Chae-Seok; Yoshida, Norihiro; Yun, Bokyoung; Molday, Robert S.; Goshima, Yoshio; Hong, Kyonsoo			Cyclic GMP-gated CNG channels function in Sema3A-induced growth cone repulsion	NEURON			English	Article							MEDIATED AXONAL REPULSION; NERVE GROWTH; SEMAPHORIN 3A; ION CHANNELS; C-ELEGANS; XENOPUS-LAEVIS; SPINAL-CORD; GUIDANCE; COLLAPSE; CALCIUM	Cyclic nucleotide-gated channels (CNGCs) transduce external signals required for sensory processes, e.g., photoreception, olfaction, and taste. Nerve growth cone guidance by diffusible attractive and repulsive molecules is regulated by differential growth cone Ca2+ signaling. However, the Ca2+ conducting ion channels that transduce guidance molecule signals are largely unknown. We show that rod-type CNGC-like channels function in the repulsion of cultured Xenopus spinal neuron growth cones by Sema3A, which triggers the production of the cGMP that activates the Xenopus CNGA1 (xCNGA1) subunit-containing channels in interneurons. Downregulation of xCNGA1 or overexpression of a mutant xCNGA1 incapable of binding cGMP abolished CNG currents and converted growth cone repulsion to attraction in response to Sema3A. We also show that Ca2+ entry through xCNGCs is required to mediate the repulsive Sema3A signal. These studies extend our knowledge of the function of CNGCs by demonstrating their requirement for signal transduction in growth cone guidance.	[Togashi, Kazunobu; von Schimmelmann, Melanie J.; Nishiyama, Makoto; Lim, Chae-Seok; Yoshida, Norihiro; Yun, Bokyoung; Hong, Kyonsoo] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Molday, Robert S.] Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Goshima, Yoshio] Yokohama City Univ, Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan	New York University; University of British Columbia; Yokohama City University	Hong, K (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.	hongk02@med.nyu.edu						Ayoob JC, 2004, J NEUROSCI, V24, P6639, DOI 10.1523/JNEUROSCI.1104-04.2004; Behar O, 1999, P NATL ACAD SCI USA, V96, P13501, DOI 10.1073/pnas.96.23.13501; Ben-Zvi A, 2008, CELL SIGNAL, V20, P467, DOI 10.1016/j.cellsig.2007.10.023; BONIGK W, 1993, NEURON, V10, P865, DOI 10.1016/0896-6273(93)90202-3; Brady JD, 2004, MOL PHARMACOL, V65, P503, DOI 10.1124/mol.65.3.503; Brown RL, 2006, CURR PHARM DESIGN, V12, P3597; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Cheng CH, 2002, MOL BIOL CELL, V13, P3696, DOI 10.1091/mbc.E02-03-0127; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; CORBIN JD, 1986, J BIOL CHEM, V261, P1208; Frietsch S, 2007, P NATL ACAD SCI USA, V104, P14531, DOI 10.1073/pnas.0701781104; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; GORDON SE, 1995, J PHYSIOL-LONDON, V486, P533, DOI 10.1113/jphysiol.1995.sp020832; Goshima Y, 1997, J NEUROBIOL, V33, P316, DOI 10.1002/(SICI)1097-4695(199709)33:3<316::AID-NEU9>3.0.CO;2-4; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hackos DH, 1999, J GEN PHYSIOL, V113, P799, DOI 10.1085/jgp.113.6.799; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HE Z, 2002, SCI STKE, V119, pRE1, DOI DOI 10.1126/STKE.2002.119.RE1; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jimenez-Gonzalez C, 2003, EUR J NEUROSCI, V18, P2175, DOI 10.1046/j.1460-9568.2003.02955.x; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kramer RH, 1996, J NEUROSCI, V16, P1285; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Lucas KA, 2000, PHARMACOL REV, V52, P375; Mann F, 2003, J NEUROBIOL, V57, P323, DOI 10.1002/neu.10303; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Nadella M, 2005, P NATL ACAD SCI USA, V102, P16830, DOI 10.1073/pnas.0504838102; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; NISHIYAMA M, 2008, NAT NEUROSC IN PRESS, V11; Partridge M, 1996, ANTISENSE NUCLEIC A, V6, P169, DOI 10.1089/oli.1.1996.6.169; Pasterkamp RJ, 2006, MOL CELL NEUROSCI, V31, P52, DOI 10.1016/j.mcn.2005.09.001; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rebrik TI, 2000, J GEN PHYSIOL, V116, P521, DOI 10.1085/jgp.116.4.521; ROBERTS A, 1988, DEVELOPMENT, V103, P447; Shewan D, 2002, NAT NEUROSCI, V5, P955, DOI 10.1038/nn919; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; STERN JH, 1986, P NATL ACAD SCI USA, V83, P1163, DOI 10.1073/pnas.83.4.1163; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Togashi H, 2006, J NEUROSCI, V26, P4961, DOI 10.1523/JNEUROSCI.0704-06.2006; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wang Q, 1998, J NEUROSCI, V18, P4973; Wolin MS, 2005, AM J PHYSIOL-LUNG C, V289, pL159, DOI 10.1152/ajplung.00060.2005; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; ZIMMERMAN AL, 1986, NATURE, V321, P70, DOI 10.1038/321070a0; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	62	64	65	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 12	2008	58	5					694	707		10.1016/j.neuron.2008.03.017	http://dx.doi.org/10.1016/j.neuron.2008.03.017			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	315IA	18549782	Bronze			2022-12-24	WOS:000256870800008
J	Yan, ZQ; Tan, J; Qin, C; Lu, Y; Ding, C; Luo, MM				Yan, Zhiqiang; Tan, Jie; Qin, Chang; Lu, Yao; Ding, Cheng; Luo, Minmin			Precise circuitry links bilaterally symmetric olfactory maps	NEURON			English	Article							INTRABULBAR ASSOCIATIONAL SYSTEM; TOPOGRAPHIC ORGANIZATION; ODORANT RECEPTORS; PIRIFORM CORTEX; PARS EXTERNA; BULB; MOUSE; REPRESENTATION; NUCLEUS; NEURONS	Olfactory sensory neurons expressing a common receptor gene converge onto one or a few glomeruli with stereotyped positions within the mouse main olfactory bulb (MOB), producing a map of similar to 1800 olfactory columns representing similar to 1000 odorant receptors. Here, we report that this precise olfactory map is maintained over several synapses that ultimately cross MOB hemispheres to link bilateral isofunctional olfactory columns. Focal injection of tracer into genetically identified glomeruli revealed an exquisite topography that involves a bilateral connection via the anterior olfactory nucleus pars externa (AONpE) that links isofunctional olfactory columns in the contralateral MOB. Physiological and behavioral assays revealed an important role for the AONpE in bilateral exchange of odorant-specific information. These results indicate that the interbulbar link through the AONpE integrates bilateral olfactory sensory maps and exchanges olfactory information, positioning it as a unique model system for studying interhemispheric connections.	[Yan, Zhiqiang; Tan, Jie; Qin, Chang; Lu, Yao; Ding, Cheng; Luo, Minmin] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Yan, Zhiqiang; Tan, Jie] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS	Luo, MM (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	luominmin@nibs.ac.cn	Ding, Cheng/N-6735-2016	Luo, Minmin/0000-0003-3535-6624; Yan, Zhiqiang/0000-0003-4714-2076				Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; DAVIS BJ, 1981, J COMP NEUROL, V203, P475, DOI 10.1002/cne.902030310; GAZZANIGA MS, 1995, NEURON, V14, P217, DOI 10.1016/0896-6273(95)90280-5; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; HABERLY LB, 1978, J COMP NEUROL, V178, P711, DOI 10.1002/cne.901780408; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; KUCHARSKI D, 1987, SCIENCE, V238, P786, DOI 10.1126/science.3672125; KUCHARSKI D, 1988, BEHAV NEUROSCI, V102, P340, DOI 10.1037/0735-7044.102.3.340; LIU WL, 1994, J COMP NEUROL, V346, P541, DOI 10.1002/cne.903460407; Lodovichi C, 2003, NEURON, V38, P265, DOI 10.1016/S0896-6273(03)00194-6; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; Mainland JD, 2002, NATURE, V419, P802, DOI 10.1038/419802a; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marks CA, 2006, J NEUROSCI, V26, P11257, DOI 10.1523/JNEUROSCI.2805-06.2006; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MYERS RE, 1958, ARCH NEURO PSYCHIATR, V80, P298, DOI 10.1001/archneurpsyc.1958.02340090034004; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; Rajan R, 2006, SCIENCE, V311, P666, DOI 10.1126/science.1122096; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; REYHER CKH, 1988, BRAIN RES BULL, V20, P549, DOI 10.1016/0361-9230(88)90214-6; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schaefer ML, 2001, J NEUROSCI, V21, P2481, DOI 10.1523/JNEUROSCI.21-07-02481.2001; SCHOENFELD TA, 1984, J COMP NEUROL, V227, P121, DOI 10.1002/cne.902270113; SCHOENFELD TA, 1985, J COMP NEUROL, V235, P503, DOI 10.1002/cne.902350408; SCOTT JW, 1985, J COMP NEUROL, V242, P415, DOI 10.1002/cne.902420309; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Sobel N, 1999, NATURE, V402, P35, DOI 10.1038/46944; STOKSTED P, 1953, Acta Otolaryngol Suppl, V109, P159; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	43	76	78	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 22	2008	58	4					613	624		10.1016/j.neuron.2008.03.012	http://dx.doi.org/10.1016/j.neuron.2008.03.012			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304PD	18498741	Bronze			2022-12-24	WOS:000256120500014
J	Yoon, KJ; Koo, BK; Im, SK; Jeong, HW; Ghirn, J; Kwon, MC; Moon, JS; Miyata, T; Kong, YY				Yoon, Ki-Jun; Koo, Bon-Kyoung; Im, Sun-Kyoung; Jeong, Hyun-Woo; Ghirn, Jaewang; Kwon, Min-chul; Moon, Jin-Sook; Miyata, Takaki; Kong, Young-Yun			Mind bomb 1-expressing intermediate progenitors generate Notch signaling to maintain radial glial cells	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; DEVELOPING MOUSE-BRAIN; NEURAL STEM-CELLS; ADHERENS JUNCTIONS; CORTICAL-NEURONS; UBIQUITIN LIGASE; NEUROGENESIS; PROTEIN; FATE; ACTIVATION	Notch signaling is critical for the sternness of radial glial cells (RGCs) during embryonic neurogenesis. Although Notch-signal-receiving events in RGCs have been well characterized; the signal-sending mechanism by the adjacent cells is poorly understood. Here, we report that conditional inactivation of mind bomb-1 (mib1), an essential component for Notch ligand endocytosis, in mice using the nestin and hGFAP promoters resulted in complete loss of Notch activation, which leads to depletion of RGCs, and premature differentiation into intermediate progenitors (IPs) and finally neurons, which were reverted by the introduction of active Notch1. Interestingly, Mib1 expression is restricted in the migrating IPs and newborn neurons, but not in RGCs. Moreover, sorted Mib1(+) IPs and neurons can send the Notch signal to neighboring cells. Our results reveal that not only newborn neurons but also IPs are essential Notch-ligand-presenting cells for maintaining RGC sternness during both symmetric and asymmetric divisions.	[Yoon, Ki-Jun; Koo, Bon-Kyoung; Im, Sun-Kyoung; Jeong, Hyun-Woo; Ghirn, Jaewang; Kwon, Min-chul; Moon, Jin-Sook; Kong, Young-Yun] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea; [Miyata, Takaki] Nagoya Univ, Grad Sch Med, Dept Anat & Cell Biol, Showa Ku, Aichi 4668550, Japan	Pohang University of Science & Technology (POSTECH); Nagoya University	Kong, YY (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbuk, South Korea.	ykong@postech.ac.kr	Koo, Bon-Kyoung/V-5219-2017; MIYATA, TAKAKI/I-7066-2014; Yoon, Ki-Jun/S-8170-2018	Koo, Bon-Kyoung/0000-0002-4134-8033; Yoon, Ki-Jun/0000-0003-2985-2541; Jeong, Hyun-Woo/0000-0002-6976-6739; Moon, Jin-Sook/0000-0002-7231-328X				AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Bardin AJ, 2004, CURR OPIN NEUROBIOL, V14, P6, DOI 10.1016/j.conb.2003.12.002; Campos LS, 2001, J NEUROSCI RES, V64, P590, DOI 10.1002/jnr.1111.abs; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Itoh M, 1999, J BIOL CHEM, V274, P5981, DOI 10.1074/jbc.274.9.5981; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Miyata Takaki, 2007, Prog Mol Subcell Biol, V45, P121; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Ruan YL, 2001, P NATL ACAD SCI USA, V98, P9907, DOI 10.1073/pnas.171321098; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vollrath B, 2001, MOL CELL BIOL, V21, P7481, DOI 10.1128/MCB.21.21.7481-7494.2001; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	49	158	158	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2008	58	4					519	531		10.1016/j.neuron.2008.03.018	http://dx.doi.org/10.1016/j.neuron.2008.03.018			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304PD	18498734	Bronze			2022-12-24	WOS:000256120500007
J	Lomber, SG; Malhotra, S				Lomber, Stephen G.; Malhotra, Shveta			Double dissociation of 'what' and 'where' processing in auditory cortex	NATURE NEUROSCIENCE			English	Article							VISUAL WORKING-MEMORY; SOUND-LOCALIZATION; COOLING DEACTIVATION; HEMISPHERIC LESIONS; CORTICAL PATHWAYS; COMPLEX SOUNDS; HUMAN BRAIN; CAT; FIELD; OBJECT	Studies of cortical connections or neuronal function in different cerebral areas support the hypothesis that parallel cortical processing streams, similar to those identified in visual cortex, may exist in the auditory system. However, this model has not yet been behaviorally tested. We used reversible cooling deactivation to investigate whether the individual regions in cat nonprimary auditory cortex that are responsible for processing the pattern of an acoustic stimulus or localizing a sound in space could be doubly dissociated in the same animal. We found that bilateral deactivation of the posterior auditory field resulted in deficits in a sound-localization task, whereas bilateral deactivation of the anterior auditory field resulted in deficits in a pattern-discrimination task, but not vice versa. These findings support a model of cortical organization that proposes that identifying an acoustic stimulus ('what') and its spatial location ('where') are processed in separate streams in auditory cortex.	[Lomber, Stephen G.] Univ Western Ontario, Ctr Brain & Mind, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada; [Lomber, Stephen G.] Univ Western Ontario, Fac Sch Sci, Dept Psychol, London, ON N6A 5C2, Canada; [Lomber, Stephen G.] Univ Western Ontario, Fac Hlth Sci, Natl Ctr Audiol, London, ON N6G 1H1, Canada; [Malhotra, Shveta] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75080 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Texas System; University of Texas Dallas	Lomber, SG (corresponding author), Univ Western Ontario, Ctr Brain & Mind, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada.	steve.lomber@uwo.ca	Lomber, Stephen/B-6820-2015	Lomber, Stephen/0000-0002-3001-7909				Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; Bullier Jean, 1994, Cerebral Cortex, V10, P301; Cavina-Pratesi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000424; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; Clarke S, 2002, EXP BRAIN RES, V147, P8, DOI 10.1007/s00221-002-1203-9; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; De Santis L, 2007, CEREB CORTEX, V17, P9, DOI 10.1093/cercor/bhj119; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Griffiths TD, 2004, NAT REV NEUROSCI, V5, P887, DOI 10.1038/nrn1538; Griffiths TD, 1998, NAT NEUROSCI, V1, P422, DOI 10.1038/1637; Heffner HE, 2005, J NEUROPHYSIOL, V94, P3653, DOI 10.1152/jn.00720.2005; Jones EG, 1985, THALAMUS; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; KELLY JB, 1971, J NEUROPHYSIOL, V34, P802, DOI 10.1152/jn.1971.34.5.802; KNIGHT PL, 1977, BRAIN RES, V130, P447, DOI 10.1016/0006-8993(77)90108-1; Krumbholz K, 2005, CEREB CORTEX, V15, P317, DOI 10.1093/cercor/bhh133; Lee CC, 2008, J COMP NEUROL, V507, P1879, DOI 10.1002/cne.21611; Loftus WC, 2001, J NEUROPHYSIOL, V86, P475, DOI 10.1152/jn.2001.86.1.475; Lomber SG, 1999, J NEUROSCI METH, V86, P179, DOI 10.1016/S0165-0270(98)00165-4; Lomber SG, 1996, CEREB CORTEX, V6, P673, DOI 10.1093/cercor/6.5.673; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Malhotra S, 2004, J NEUROPHYSIOL, V92, P1625, DOI 10.1152/jn.01205.2003; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; MOREL A, 1987, J COMP NEUROL, V265, P119, DOI 10.1002/cne.902650109; MOREL A, 1990, VISUAL NEUROSCI, V4, P555, DOI 10.1017/S0952523800005769; Neff WD, 1975, HDB SENSORY PHYSIOLO, P307; Petrides M, 2000, J NEUROSCI, V20, P7496; PHILLIPS DP, 1995, J NEUROPHYSIOL, V73, P674, DOI 10.1152/jn.1995.73.2.674; Populin LC, 1998, J NEUROSCI, V18, P2147; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; Rauschecker JP, 1997, ACTA OTO-LARYNGOL, P34; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; REINOSOSUAREZ F, 1961, TOPOGRAPHICAL ATLAS; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Stecker GC, 2003, J NEUROPHYSIOL, V89, P2889, DOI 10.1152/jn.00980.2002; Teuber HL, 1955, ANNU REV PSYCHOL, V6, P267, DOI 10.1146/annurev.ps.06.020155.001411; TIAN B, 1994, J NEUROPHYSIOL, V71, P1959, DOI 10.1152/jn.1994.71.5.1959; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; UNGERLEIDER LG, 1982, ANAL VISUAL BEHAV, P486; Warrington E K, 1970, Cortex, V6, P87; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Yang XF, 2006, NEUROBIOL DIS, V23, P637, DOI 10.1016/j.nbd.2006.05.006	50	202	204	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					609	616		10.1038/nn.2108	http://dx.doi.org/10.1038/nn.2108			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18408717				2022-12-24	WOS:000255327300021
J	Fleming, HE; Janzen, V; Lo Celso, C; Guo, J; Leahy, KM; Kronenberg, HM; Scadden, DT				Fleming, Heather E.; Janzen, Viktor; Lo Celso, Cristina; Guo, Jun; Leahy, Kathleen M.; Kronenberg, Henry M.; Scadden, David T.			Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo	CELL STEM CELL			English	Article							BETA-CATENIN; PROGENITOR CELLS; GAMMA-CATENIN; EX-VIVO; DIFFERENTIATION; ENGRAFTMENT; BONE; 5-FLUOROURACIL; REPOPULATION; ACTIVATION	Wingless (Wnt) is a potent morphogen demonstrated in multiple cell lineages to promote the expansion and maintenance of stem and progenitor cell populations. Writ effects are highly context dependent, and varying effects of Wnt signaling on hematopoietic stem cells (HSCs) have been reported. We explored the impact of Wnt signaling in vivo, specifically in the context of the HSC niche by using an osteoblast-specific promoter driving expression of the paninhibitor of canonical Wnt signaling, Dickkopf1 (Dkk1). Here we report that Wnt signaling was markedly inhibited in HSCs and, unexpectedly given prior reports, reduction in HSC Wnt signaling resulted in reduced p21Cip1 expression, increased cell cycling, and a progressive decline in regenerative function after transplantation. This effect was microenvironment determined, but irreversible if the cells were transferred to a normal host. Wnt pathway activation in the niche is required to limit HSC proliferation and preserve the reconstituting function of endogenous hematopoietic stem cells.	[Fleming, Heather E.; Janzen, Viktor; Lo Celso, Cristina; Leahy, Kathleen M.; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Guo, Jun; Kronenberg, Henry M.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Fleming, Heather E.; Janzen, Viktor; Lo Celso, Cristina; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	scadden.david@mgh.harvard.edu		Lo Celso, Cristina/0000-0002-1163-4207	NHLBI NIH HHS [R01 HL044851-20, R01 HL044851-09, U54 HL081030-01, R01 HL044851-16A1, R01 HL044851-13, R01 HL044851-18, HL044851, R01 HL044851-15, HL081030, R01 HL044851-14, R01 HL044851, R01 HL044851-10, R01 HL044851-19, HL07623, R01 HL044851-12, R01 HL044851-18W1, R01 HL044851-17, U54 HL081030, R01 HL044851-11] Funding Source: Medline; NIDDK NIH HHS [DK050234] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623, R01HL044851, U54HL081030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Akala OO, 2006, CURR OPIN GENET DEV, V16, P496, DOI 10.1016/j.gde.2006.08.011; Baba Y, 2006, J IMMUNOL, V177, P2294, DOI 10.4049/jimmunol.177.4.2294; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Delaney C, 2005, BLOOD, V106, P2693, DOI 10.1182/blood-2005-03-1131; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Grotewold L, 1999, MECH DEVELOP, V89, P151, DOI 10.1016/S0925-4773(99)00194-X; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Jung YH, 2007, BLOOD, V110, P82, DOI 10.1182/blood-2006-05-021352; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koc ON, 1999, EXP HEMATOL, V27, P1675, DOI 10.1016/S0301-472X(99)00101-0; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Miyake N, 2006, STEM CELLS, V24, P653, DOI 10.1634/stemcells.2005-0328; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Nemeth MJ, 2007, CELL RES, V17, P746, DOI 10.1038/cr.2007.69; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Nemeth MJ, 2006, P NATL ACAD SCI USA, V103, P13783, DOI 10.1073/pnas.0604006103; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Trowbridge JJ, 2006, P NATL ACAD SCI USA, V103, P14134, DOI 10.1073/pnas.0604568103; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; VANZANT G, 1984, J EXP MED, V159, P679, DOI 10.1084/jem.159.3.679; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; YEAGER AM, 1983, EXP HEMATOL, V11, P944; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	54	372	387	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR	2008	2	3					274	283		10.1016/j.stem.2008.01.003	http://dx.doi.org/10.1016/j.stem.2008.01.003			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	274RD	18371452	Bronze, Green Accepted			2022-12-24	WOS:000254017700014
J	Humphreys, BD; Valerius, MT; Kobayashi, A; Mugford, JW; Soeung, S; Duffield, JS; McMahon, AP; Bonventre, JV				Humphreys, Benjamin D.; Valerius, M. Todd; Kobayashi, Akio; Mugford, Joshua W.; Soeung, Savuth; Duffield, Jeremy S.; McMahon, Andrew P.; Bonventre, Joseph V.			Intrinsic epithelial cells repair the kidney after injury	CELL STEM CELL			English	Article							STEM-CELLS; POSTISCHEMIC KIDNEY; ADULT KIDNEY; RENAL REPAIR; MOUSE; NEPHRON; REGENERATION; EXPRESSION; TUBULES	Understanding the mechanisms of nephron repair is critical for the design of new therapeutic approaches to treat kidney disease. The kidney can repair after even a severe insult, but whether adult stem or progenitor cells contribute to epithelial renewal after injury and the cellular origin of regenerating cells remain controversial. Using genetic fate-mapping techniques, we generated transgenic mice in which 94%-95% of tubular epithelial cells, but no interstitial cells, were labeled with either beta-galactosidase (lacZ) or red fluorescent protein (RFP). Two days after ischemia-reperfusion injury (IRI), 50.5% of outer medullary epithelial cells coexpress Ki67 and RFP, indicating that differentiated epithelial cells that survived injury undergo proliferative expansion. After repair was complete, 66.9% of epithelial cells had incorporated BrdU, compared to only 3.5% of cells in the uninjured kidney. Despite this extensive cell proliferation, no dilution of either cell-fate marker was observed after repair. These results indicate that regeneration by surviving tubular epithelial cells is the predominant mechanism of repair after ischemic tubular injury in the adult mammalian kidney.	[Humphreys, Benjamin D.; Soeung, Savuth; Duffield, Jeremy S.; Bonventre, Joseph V.] Harvard Inst Med, Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Valerius, M. Todd; Kobayashi, Akio; Mugford, Joshua W.; McMahon, Andrew P.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Humphreys, Benjamin D.; McMahon, Andrew P.; Bonventre, Joseph V.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Bonventre, Joseph V.] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT)	Humphreys, BD (corresponding author), Harvard Inst Med, Brigham & Womens Hosp, Dept Med, Div Renal, Room 550,4 Blackfan Circle, Boston, MA 02115 USA.	bhumphreys@partners.org; amcmahon@mcb.harvard.edu; joseph-bonventre@hms.harvard.edu	Valerius, M. Todd/AAK-3063-2020; McMahon, Andrew P/ABE-7520-2020	Valerius, M. Todd/0000-0001-8143-9231; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039773, R37DK054364, K08DK073299, K08DK073628, R01DK054364, R37DK039773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033642] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK73628, DK054364, DK39773, DK73299] Funding Source: Medline; NINDS NIH HHS [R37 NS033642] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Dekel B, 2006, J AM SOC NEPHROL, V17, P3300, DOI 10.1681/ASN.2005020195; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Elger M, 2003, J AM SOC NEPHROL, V14, P1506; Gupta S, 2006, J AM SOC NEPHROL, V17, P3028, DOI 10.1681/ASN.2006030275; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Humphreys BD, 2007, NEPHROL THER, V3, P3, DOI 10.1016/j.nephro.2006.12.002; Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002; Imai E, 2007, J AM SOC NEPHROL, V18, P2423, DOI 10.1681/ASN.2007070769; Inoue T, 2005, KIDNEY INT, V67, P2488, DOI 10.1111/j.1523-1755.2005.00358.x; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kitamura S, 2005, FASEB J, V19, P1789, DOI 10.1096/fj.05-3942com; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Lin FM, 2005, J CLIN INVEST, V115, P1756, DOI 10.1172/JCI23015; Little MH, 2006, J AM SOC NEPHROL, V17, P2390, DOI 10.1681/ASN.2006030218; Maeshima A, 2003, J AM SOC NEPHROL, V14, P3138, DOI 10.1097/01.ASN.0000098685.43700.28; Maeshima A, 2006, J AM SOC NEPHROL, V17, P188, DOI 10.1681/ASN.2005040370; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Park KM, 2002, J BIOL CHEM, V277, P2040, DOI 10.1074/jbc.M107525200; Salice CJ, 2001, COMPARATIVE MED, V51, P56; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Vigneau C, 2007, J AM SOC NEPHROL, V18, P1709, DOI 10.1681/ASN.2006101078; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214	31	616	653	6	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR	2008	2	3					284	291		10.1016/j.stem.2008.01.014	http://dx.doi.org/10.1016/j.stem.2008.01.014			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	274RD	18371453	Bronze			2022-12-24	WOS:000254017700015
J	Stadtfeld, M; Maherali, N; Breault, DT; Hochedlinger, K				Stadtfeld, Matthias; Maherali, Nimet; Breault, David T.; Hochedlinger, Konrad			Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; SOMATIC-CELLS; EXPRESSION; GENERATION; VIRUS; DIFFERENTIATION; ADHESION; EMBRYO; FETAL; MICE	Ectopic expression of the transcription factors Oct4, Sox2, c-Myc, and Klf4 in fibroblasts generates induced pluripotent stem (iPS) cells. Little is known about the nature and sequence of molecular events accompanying nuclear reprogramming. Using doxycycline-inducible vectors, we have shown that exogenous factors are required for about 10 days, after which cells enter a self-sustaining pluripotent state. We have identified markers that define cell populations prior to and during this transition period. While downregulation of Thy1 and subsequent upregulation of SSEA-1 occur at early time points, reactivation of endogenous Oct4, Sox2, telomerase, and the silent X chromosome mark late events in the reprogramming process. Cell sorting with these markers allows for a significant enrichment of cells with the potential to become iPS cells. Our results suggest that factor-induced reprogramming is a gradual process with defined intermediate cell populations that contain the majority of cells poised to become iPS cells.	[Stadtfeld, Matthias; Maherali, Nimet; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02115 USA; [Stadtfeld, Matthias; Maherali, Nimet; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02115 USA; [Stadtfeld, Matthias; Maherali, Nimet; Hochedlinger, Konrad] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Maherali, Nimet] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Breault, David T.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Breault, David T.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 185 Cambridge St, Boston, MA 02115 USA.	khochedlinger@helix.mgh.harvard.edu	Breault, David/HDN-6048-2022	Stadtfeld, Matthias/0000-0002-5852-9906	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD058013] Funding Source: Medline; NIH HHS [DP2 OD003266, DP2 OD003266-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Armstrong L, 2000, MECH DEVELOP, V97, P109, DOI 10.1016/S0925-4773(00)00423-8; BARKLIS E, 1986, CELL, V47, P391, DOI 10.1016/0092-8674(86)90596-9; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Cui L, 2004, J HISTOCHEM CYTOCHEM, V52, P1447, DOI 10.1369/jhc.3A6241.2004; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rege TA, 2006, BBA-MOL CELL RES, V1763, P991, DOI 10.1016/j.bbamcr.2006.08.008; ROBERTSON EJ, 1983, J EMBRYOL EXP MORPH, V74, P297; Tada M, 2003, DEV DYNAM, V227, P504, DOI 10.1002/dvdy.10337; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TEICH NM, 1977, CELL, V12, P973, DOI 10.1016/0092-8674(77)90162-3; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wang RH, 2003, J EXP BOT, V54, P54; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	35	610	718	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR	2008	2	3					230	240		10.1016/j.stem.2008.02.001	http://dx.doi.org/10.1016/j.stem.2008.02.001			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	274RD	18371448	Green Accepted, Bronze			2022-12-24	WOS:000254017700010
J	Awh, E; Vogel, EK				Awh, Edward; Vogel, Edward K.			The bouncer in the brain	NATURE NEUROSCIENCE			English	Editorial Material							WORKING-MEMORY CAPACITY; SHORT-TERM-MEMORY; BASAL GANGLIA; INDIVIDUAL-DIFFERENCES; ATTENTION; INHIBITION; MECHANISMS; CORTEX	Efficiency variations in the filtering of relevant from irrelevant information could contribute to individual differences in working memory. A new functional imaging study suggests that the basal ganglia act as this filter because activity in this region before stimulus presentation was inversely correlated with unnecessary storage.	[Awh, Edward; Vogel, Edward K.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Oregon	Awh, E (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	awh@uoregon.edu; vogel@uoregon.edu	Vogel, Edward K/AAW-9466-2021	Awh, Edward/0000-0002-5211-5278				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; Hayes AE, 1998, J COGNITIVE NEUROSCI, V10, P178, DOI 10.1162/089892998562645; Hazy TE, 2007, PHILOS T R SOC B, V362, P1601, DOI 10.1098/rstb.2007.2055; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Mayr U, 2000, J EXP PSYCHOL GEN, V129, P4, DOI 10.1037/0096-3445.129.1.4; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262	15	91	95	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					5	6		10.1038/nn0108-5	http://dx.doi.org/10.1038/nn0108-5			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18160954				2022-12-24	WOS:000252117900002
J	Feng, CG; Weksberg, DC; Taylor, GA; Sher, A; Goodell, MA				Feng, Carl G.; Weksberg, David C.; Taylor, Gregory A.; Sher, Alan; Goodell, Margaret A.			The p47 GTPase Lrg-47 (Irgm1) links host defense and hematopoietic stem cell proliferation	CELL STEM CELL			English	Article							INTERFERON-GAMMA; PROGENITOR CELLS; GENE-EXPRESSION; MICE DEFICIENT; BONE-MARROW; RESISTANCE; MULTIPLE; FAMILY; RECEPTORS; AUTOPHAGY	Hematopoietic stem cells (HSCs) are self-renewing bone marrow cells that give rise to all blood lineages and retain a remarkable capacity to proliferate in response to insult. Although some controls on HSC activation are known, little is understood about how this process is linked to natural signals. We report that the interferon-inducible GTPase Lrg-47 (Irgm1), previously shown to play a critical role in host defense, inhibits baseline HSC proliferation and is required for a normal HSC response to chemical and infectious stimuli. Overproliferating Lrg-47(-/-) HSCs are severely impaired in functional repopulation assays, and when challenged with hematopoietic ablation by 5-fluorouracil or infection with Mycobacterium avium, Lrg-47(-/-) mice fail to achieve the expected expansion response in stem and progenitor cell populations. Our results establish a link between the response to infection and HSC activation and demonstrate a novel function for a member of the p47 GTPase family.	[Feng, Carl G.; Sher, Alan] NIAID, NIH, Parasit Dis Lab, Immunobiol Sect, Bethesda, MD 20892 USA; [Weksberg, David C.; Goodell, Margaret A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Weksberg, David C.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Taylor, Gregory A.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Dept Med, Durham, NC 27710 USA; [Taylor, Gregory A.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Taylor, Gregory A.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Dept Immunol, Durham, NC 27710 USA; [Taylor, Gregory A.] VA Med Ctr, GRECC, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Baylor College of Medicine; Baylor College of Medicine; Duke University; Duke University; Duke University; Geriatric Research Education & Clinical Center	Sher, A (corresponding author), NIAID, NIH, Parasit Dis Lab, Immunobiol Sect, 9000 Rockville Pike, Bethesda, MD 20892 USA.	asher@niaid.nih.gov; goodell@bcm.edu		Goodell, Margaret A./0000-0003-1111-2932; feng, carl/0000-0003-4301-4640	Intramural NIH HHS [Z01 AI000843-09] Funding Source: Medline; NHLBI NIH HHS [T32 HL092332, T32 HL092332-07] Funding Source: Medline; NIAID NIH HHS [R01 AI057831] Funding Source: Medline; NIDDK NIH HHS [DK58192, DK63588, T32 DK064717, U01 DK063588, T32 DK64717-02, R01 DK058192] Funding Source: Medline; NIGMS NIH HHS [T32GM008307, T32 GM008307] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL092332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057831, Z01AI000843, Z01AI001044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK064717, R01DK058192, U01DK063588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Dufour C, 2001, BRIT J HAEMATOL, V115, P1023, DOI 10.1046/j.1365-2141.2001.03212.x; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Haneline LS, 1998, BLOOD, V91, P4092; HARRISON DE, 1991, BLOOD, V78, P1237; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kaiser F, 2004, J CELL SCI, V117, P1747, DOI 10.1242/jcs.01039; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; Murray PJ, 1998, BLOOD, V91, P2914, DOI 10.1182/blood.V91.8.2914.2914_2914_2924; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; NISTICO A, 1994, ANN INTERN MED, V120, P463, DOI 10.7326/0003-4819-120-6-199403150-00003; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Santiago HC, 2005, J IMMUNOL, V175, P8165, DOI 10.4049/jimmunol.175.12.8165; Selleri C, 1996, BLOOD, V87, P4149, DOI 10.1182/blood.V87.10.4149.bloodjournal87104149; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; SORACE JM, 1995, J LEUKOCYTE BIOL, V58, P477, DOI 10.1002/jlb.58.4.477; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; VANZANT G, 1984, J EXP MED, V159, P679, DOI 10.1084/jem.159.3.679; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Whitney MA, 1996, BLOOD, V88, P49; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104	34	94	95	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN	2008	2	1					83	89		10.1016/j.stem.2007.10.007	http://dx.doi.org/10.1016/j.stem.2007.10.007			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	254RT	18371424	Green Accepted, Bronze			2022-12-24	WOS:000252606400014
J	Levine, JD				Levine, Joel D.			Glia and romance	NATURE NEUROSCIENCE			English	Editorial Material							DROSOPHILA; BEHAVIOR; BRAIN; GENE	Drosophila courtship is a complex behavior. A new study shows that glia modulate neurotransmission to influence male preference, but the authors should have resisted the temptation to describe their results in tabloid language.	Univ Toronto, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Levine, JD (corresponding author), Univ Toronto, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada.	jlevine@utm.utoronto.ca						Augustin H, 2007, J NEUROSCI, V27, P111, DOI 10.1523/JNEUROSCI.4770-06.2007; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; BURR C, 1997, ATLANTIC MONTHLY JUN, V279; EWER J, 1992, J NEUROSCI, V12, P3321; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Grosjean Y, 2008, NAT NEUROSCI, V11, P54, DOI 10.1038/nn2019; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; LACROIX A, 2007, PHILOSOPHIE MAGZ MAR, V8; Lazareva AA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030016; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; SOLAIRE F, 2007, AGORA VOX       0411; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Vosshall LB, 2007, NATURE, V450, P193, DOI 10.1038/nature06335	14	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					8	10		10.1038/nn0108-8	http://dx.doi.org/10.1038/nn0108-8			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18160956				2022-12-24	WOS:000252117900004
J	Melnick, I; Pronchuk, N; Cowley, MA; Grove, KL; Colmers, WF				Melnick, Igor; Pronchuk, Nina; Cowley, Michael A.; Grove, Kevin L.; Colmers, William F.			Developmental switch in neuropeptide Y and melanocortin effects in the paraventricular nucleus of the hypothalamus	NEURON			English	Article							MESSENGER-RIBONUCLEIC-ACID; PRESYNAPTIC INHIBITION; MAGNOCELLULAR NEURONS; ARCUATE NUCLEUS; RAT; INCREASES; CURRENTS; LEPTIN; SYSTEM; NPY	Homeostatic regulation of energy balance in rodents changes dramatically during the first 3 postnatal weeks. Neuropeptide Y (NPY) and melanocortin neurons in the arcuate nucleus, a primary energy homeostatic center in adults, do not fully innervate the paraventricular nucleus (PVN) until the third postnatal week. We have identified two classes of PVN neurons responsive to these neuropeptides, tonically firing neurosecretory (NS) and burst-firing preautonomic (PA) cells. In neonates, NPY could inhibit GABAergic inputs to nearly all NS and PA neurons, while melanocortin regulation was minimal. However, there was a dramatic, age-dependent decrease in NPY responses specifically in the PA neurons, and a 3-fold increase in melanocortin responses in NS cells. These age-dependent changes were accompanied by changes in spontaneous GABAergic currents onto these neurons. This primarily NPYergic regulation in the neonates likely promotes the positive energy balance necessary for growth, while the developmental switch correlates with maturation of homeostatic regulation of energy balance.	[Cowley, Michael A.; Grove, Kevin L.] Oregon Hlth & Sci Univ, Oregon Natl Reg Primate Res Ctr, Beaverton, OR 97006 USA; [Melnick, Igor; Pronchuk, Nina; Colmers, William F.] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada	Oregon Health & Science University; Oregon National Primate Research Center; University of Alberta	Grove, KL (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Reg Primate Res Ctr, Beaverton, OR 97006 USA.	grovek@ohsu.edu; william.colmers@ualberta.ca	Cowley, Michael A/B-9428-2008; Colmers, William/C-3106-2013	Cowley, Michael A/0000-0001-7811-134X; Colmers, William/0000-0001-7902-3560; Melnick, Igor/0000-0003-4069-8717	NCRR NIH HHS [RR00163] Funding Source: Medline; NIDDK NIH HHS [R01-DK060685] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060685] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; ARLETTI R, 1990, PHYSIOL BEHAV, V48, P825, DOI 10.1016/0031-9384(90)90234-U; Badoer E, 2001, CLIN EXP PHARMACOL P, V28, P95, DOI 10.1046/j.1440-1681.2001.03413.x; BICKNELL RJ, 1981, NEUROENDOCRINOLOGY, V33, P295, DOI 10.1159/000123248; BILLINGTON CJ, 1991, AM J PHYSIOL, V260, pR321, DOI 10.1152/ajpregu.1991.260.2.R321; Boudaba C, 1997, J NEUROPHYSIOL, V77, P3396, DOI 10.1152/jn.1997.77.6.3396; Boudaba C, 1996, J NEUROSCI, V16, P7151; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; CAPUANO CA, 1993, NEUROPEPTIDES, V24, P177, DOI 10.1016/0143-4179(93)90083-M; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; CULLCANDY SG, 1986, J PHYSIOL-LONDON, V374, P179, DOI 10.1113/jphysiol.1986.sp016074; DAIKOKU S, 1984, CELL TISSUE RES, V238, P539; Dallman MF, 1995, ANN NY ACAD SCI, V771, P730, DOI 10.1111/j.1749-6632.1995.tb44724.x; EGAWA M, 1991, AM J PHYSIOL, V260, pR328, DOI 10.1152/ajpregu.1991.260.2.R328; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Glavas MM, 2007, ENDOCRINOLOGY, V148, P3279, DOI 10.1210/en.2007-0184; Grove KL, 2005, PHYSIOL BEHAV, V86, P646, DOI 10.1016/j.physbeh.2005.08.063; Grove KL, 2003, NEUROSCIENCE, V116, P393, DOI 10.1016/S0306-4522(02)00668-1; HAAS DA, 1987, LIFE SCI, V41, P2725, DOI 10.1016/0024-3205(87)90465-6; Haskell-Luevano C, 1996, Drug Des Discov, V14, P197; HOFFMAN NW, 1991, J COMP NEUROL, V307, P405, DOI 10.1002/cne.903070306; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; KAGOTANI Y, 1989, INT J DEV NEUROSCI, V7, P359, DOI 10.1016/0736-5748(89)90057-9; Kiwaki K, 2004, AM J PHYSIOL-ENDOC M, V286, pE551, DOI 10.1152/ajpendo.00126.2003; Loum-Ribot E, 2004, BRAIN RES, V1030, P294, DOI 10.1016/j.brainres.2004.09.011; LUITEN PGM, 1987, PROG NEUROBIOL, V28, P1, DOI 10.1016/0301-0082(87)90004-9; Luther JA, 2000, J PHYSIOL-LONDON, V523, P193, DOI 10.1111/j.1469-7793.2000.t01-1-00193.x; Luther JA, 2002, J NEUROENDOCRINOL, V14, P929, DOI 10.1046/j.1365-2826.2002.00867.x; MERCHENTHALER I, 1991, NEUROSCIENCE, V44, P655, DOI 10.1016/0306-4522(91)90085-3; Mistry AM, 1999, AM J PHYSIOL-REG I, V277, pR742, DOI 10.1152/ajpregu.1999.277.3.R742; PENG YY, 1993, NEURON, V10, P465, DOI 10.1016/0896-6273(93)90334-N; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; POULAIN P, 1987, BRAIN RES BULL, V19, P453, DOI 10.1016/0361-9230(87)90149-3; Pronchuk N, 2002, ENDOCRINOLOGY, V143, P535, DOI 10.1210/en.143.2.535; Proulx K, 2002, ENDOCRINOLOGY, V143, P4683, DOI 10.1210/en.2002-220593; Qian J, 1997, J NEUROSCI, V17, P8169; Rinaman L, 1998, J COMP NEUROL, V399, P101, DOI 10.1002/(SICI)1096-9861(19980914)399:1<101::AID-CNE8>3.0.CO;2-5; Riul TR, 1999, BRAZ J MED BIOL RES, V32, P975, DOI 10.1590/S0100-879X1999000800007; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Spitzer NC, 2000, BRAIN RES BULL, V53, P547, DOI 10.1016/S0361-9230(00)00388-9; Stanley B.G., 1993, BIOL NEUROPEPTIDE RE, P457, DOI [10.1007/978-1-59259-465-8_11, DOI 10.1007/978-1-59259-465-8_11]; STANLEY BG, 1989, BRAIN RES, V501, P32, DOI 10.1016/0006-8993(89)91023-8; Stern JE, 2001, J PHYSIOL-LONDON, V537, P161, DOI 10.1111/j.1469-7793.2001.0161k.x; Stocker SD, 2004, AM J PHYSIOL-REG I, V287, pR1172, DOI 10.1152/ajpregu.00394.2004; SUDA T, 1993, MOL BRAIN RES, V18, P311, DOI 10.1016/0169-328X(93)90094-6; Swithers SE, 2003, PHYSIOL BEHAV, V79, P71, DOI 10.1016/S0031-9384(03)00106-9; TASKER JG, 1991, J PHYSIOL-LONDON, V434, P271, DOI 10.1113/jphysiol.1991.sp018469; TOTH PT, 1993, NATURE, V364, P635, DOI 10.1038/364635a0; WAHLESTEDT C, 1987, BRAIN RES, V417, P33, DOI 10.1016/0006-8993(87)90176-4; WOODHAMS PL, 1985, NEUROSCIENCE, V15, P173, DOI 10.1016/0306-4522(85)90131-9; Zorrilla EP, 2003, TRENDS PHARMACOL SCI, V24, P421, DOI 10.1016/S0165-6147(03)00177-9	51	62	63	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 20	2007	56	6					1103	1115		10.1016/j.neuron.2007.10.034	http://dx.doi.org/10.1016/j.neuron.2007.10.034			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	248FP	18093530	Bronze			2022-12-24	WOS:000252138000017
J	Roelfsema, PR; Tolboom, M; Khayat, PS				Roelfsema, Pieter R.; Tolboom, Michiel; Khayat, Paul S.			Different processing phases for features, figures, and selective attention in the primary visual cortex	NEURON			English	Article							CORTICAL AREAS V1; STIMULUS-DRIVEN; GROUND SEGREGATION; MACAQUE MONKEY; SEARCH; MODULATION; RESPONSES; V2; DISCRIMINATION; REPRESENTATION	Our visual system imposes structure onto images that usually contain a diversity of surfaces, contours, and colors. Psychological theories propose that there are multiple steps in this process that occur in hierarchically organized regions of the cortex: early visual areas register basic features, higher areas bind them into objects, and yet higher areas select the objects that are relevant for behavior. Here we test these theories by recording from the primary visual cortex (area V1) of monkeys. We demonstrate that the V1 neurons first register the features (at a latency of 48 ms), then segregate figures from the background (after 57 ms), and finally select relevant figures over irrelevant ones (after 137 ms). We conclude that the psychological processing stages map onto distinct time episodes that unfold in the visual cortex after the presentation of a new stimulus, so that area V1 may contribute to all these processing steps.	[Roelfsema, Pieter R.; Tolboom, Michiel; Khayat, Paul S.] Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Vis & Cognit, NL-1105 BA Amsterdam, Netherlands; [Roelfsema, Pieter R.] Vrije Univ Amsterdam, Dept Expt Neurophysiol, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands; [Tolboom, Michiel] Univ Utrecht, Helmholtz Inst, Dept Funct Neurobiol, NL-3584 CH Utrecht, Netherlands; [Khayat, Paul S.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam; Utrecht University; McGill University	Roelfsema, PR (corresponding author), Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Vis & Cognit, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.	p.roelfsema@nin.knaw.nl	Roelfsema, Pieter/J-6903-2013	Roelfsema, Pieter/0000-0002-1625-0034				ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; [Anonymous], 1990, PERCEPTRONS; BERGEN JR, 1983, NATURE, V303, P696, DOI 10.1038/303696a0; CAVANAGH P, 1990, J EXP PSYCHOL HUMAN, V16, P479, DOI 10.1037/0096-1523.16.3.479; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DEWEERD P, 1994, J NEUROSCI, V14, P929, DOI 10.1523/JNEUROSCI.14-03-00929.1994; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Fecteau JH, 2004, J NEUROPHYSIOL, V92, P1728, DOI 10.1152/jn.00184.2004; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; GROSSBERG S, 1985, PSYCHOL REV, V92, P173, DOI 10.1037/0033-295X.92.2.173; Houtkamp R, 2003, PERCEPT PSYCHOPHYS, V65, P1136, DOI 10.3758/BF03194840; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; Kanizsa G., 1976, VISION ARTIFACT, P25; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Koffka K, 1935, PRINCIPLES GESTALT P; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; MALIK J, 1990, J OPT SOC AM A, V7, P923, DOI 10.1364/JOSAA.7.000923; Marcus DS, 2002, J NEUROPHYSIOL, V88, P2648, DOI 10.1152/jn.00916.2001; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MUMFORD D, 1987, P NATL ACAD SCI USA, V84, P7354, DOI 10.1073/pnas.84.20.7354; Neisser U., 1967, COGNITIVE PSYCHOL; NOTHDURFT HC, 1993, VISION RES, V33, P839, DOI 10.1016/0042-6989(93)90202-8; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Roelfsema PR, 2006, ANNU REV NEUROSCI, V29, P203, DOI 10.1146/annurev.neuro.29.051605.112939; Roelfsema PR, 2003, P NATL ACAD SCI USA, V100, P5467, DOI 10.1073/pnas.0431051100; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; Roelfsema PR, 2001, NEURON, V31, P853, DOI 10.1016/S0896-6273(01)00408-1; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Serences JT, 2007, CEREB CORTEX, V17, P284, DOI 10.1093/cercor/bhj146; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; van Zoest W, 2004, J EXP PSYCHOL HUMAN, V30, P746, DOI 10.1037/0096-1523.30.4.749; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037/0096-1523.16.1.121; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000; Zipser K, 1996, J NEUROSCI, V16, P7376	46	86	87	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 6	2007	56	5					785	792		10.1016/j.neuron.2007.10.006	http://dx.doi.org/10.1016/j.neuron.2007.10.006			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241MA	18054856	Bronze			2022-12-24	WOS:000251659300006
J	Suzuki, S; Grabowecky, M				Suzuki, Satoru; Grabowecky, Marcia			Long-term speeding in perceptual switches mediated by attention-dependent plasticity in cortical visual processing	NEURON			English	Article							MONKEY STRIATE CORTEX; BINOCULAR-RIVALRY SUPPRESSION; SINGLE-CELL PROPERTIES; RECEPTIVE-FIELDS; INFEROTEMPORAL CORTEX; PREFRONTAL CORTEX; AREA V4; ORIENTATION DISCRIMINATION; FUNCTIONAL ARCHITECTURE; MAGNIFICATION FACTOR	Binocular rivalry has been extensively studied to understand the mechanisms that control switches in visual awareness and much has been revealed about the contributions of stimulus and cognitive factors. Because visual processes are fundamentally adaptive, however, it is also important to understand how experience alters the dynamics of perceptual switches. When observers viewed binocular rivalry repeatedly over many days, the rate of perceptual switches increased as much as 3-fold. This long-term rivalry speeding exhibited a pattern of image-feature specificity that ruled out primary contributions from strategic and nonsensory factors and implicated neural plasticity occurring in both low- and high-level visual processes in the ventral stream. Furthermore, the speeding occurred only when the rivaling patterns were voluntarily attended, suggesting that the underlying neural plasticity selectively engages when stimuli are behaviorally relevant. Long-term rivalry speeding may thus reflect broader mechanisms that facilitate quick assessments of signals that contain multiple behaviorally relevant interpretations.	Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Suzuki, S (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.	satoru@northwestern.edu			NEI NIH HHS [EY14110] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014110] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; Ahissar M, 1996, VISION RES, V36, P3487, DOI 10.1016/0042-6989(96)00036-3; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Ahissar M, 2000, VISION RES, V40, P1349, DOI 10.1016/S0042-6989(00)00002-X; Alais, 2005, BINOCULAR RIVALRY, DOI 10.7551/mitpress/1605.001.0001; ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Aslin C, 2002, VISION RES, V42, P3019, DOI 10.1016/S0042-6989(02)00386-3; ATTNEAVE F, 1971, SCI AM, V225, P62, DOI 10.1038/scientificamerican1271-62; BLAKE R, 1980, PERCEPTION, V9, P223, DOI 10.1068/p090223; BLAKE R, 1992, VISUAL NEUROSCI, V8, P469, DOI 10.1017/S0952523800004971; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R, 2006, P NATL ACAD SCI USA, V103, P4783, DOI 10.1073/pnas.0509634103; Blake R, 2003, NEURON, V39, P869, DOI 10.1016/S0896-6273(03)00495-1; BLAKE R, 1979, PERCEPTION, V8, P143, DOI 10.1068/p080143; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Brascamp JW, 2005, J VISION, V5, P287, DOI 10.1167/5.4.1; CAMPBELL FW, 1972, J PHYSIOL-LONDON, V225, pP19; CAMPBELL FW, 1973, PERCEPTION, V2, P123, DOI 10.1068/p020123; Cave CB, 1998, PSYCHOL SCI, V9, P299, DOI 10.1111/1467-9280.00059; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; DiCarlo JJ, 2003, J NEUROPHYSIOL, V89, P3264, DOI 10.1152/jn.00358.2002; DOW BM, 1981, EXP BRAIN RES, V44, P213; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Fahle M, 2004, J VISION, V4, P879, DOI 10.1167/4.10.4; FAHLE M, 1994, PERCEPTION, V23, P411, DOI 10.1068/p230411; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Freeman AW, 2005, J NEUROPHYSIOL, V94, P4412, DOI 10.1152/jn.00557.2005; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; George RW, 1936, J GEN PSYCHOL, V15, P39, DOI 10.1080/00221309.1936.9917904; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Hauser MD, 1999, CURR OPIN NEUROBIOL, V9, P214, DOI 10.1016/S0959-4388(99)80030-0; Hikosaka K, 1999, BEHAV BRAIN RES, V100, P67, DOI 10.1016/S0166-4328(98)00114-4; HUBEL DH, 1969, J PHYSIOL-LONDON, V202, P251, DOI 10.1113/jphysiol.1969.sp008808; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; ITO M, 1994, CEREB CORTEX, V4, P499, DOI 10.1093/cercor/4.5.499; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Kim YJ, 2006, VISION RES, V46, P392, DOI 10.1016/j.visres.2005.08.009; Lack L.C., 1978, SELECTIVE ATTENTION; LACK LC, 1974, PERCEPT PSYCHOPHYS, V15, P193, DOI 10.3758/BF03205846; Laing CR, 2002, J COMPUT NEUROSCI, V12, P39, DOI 10.1023/A:1014942129705; Lamme VAF, 1999, CEREB CORTEX, V9, P406, DOI 10.1093/cercor/9.4.406; LEHKY SR, 1995, P ROY SOC B-BIOL SCI, V259, P71, DOI 10.1098/rspb.1995.0011; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Levelt W., 1965, BINOCULAR RIVALRY; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Meng M, 2004, J VISION, V4, P539, DOI 10.1167/4.7.2; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; Nagahama Y, 1998, NEUROREPORT, V9, P2633, DOI 10.1097/00001756-199808030-00038; Nguyen VA, 2003, VISION RES, V43, P2003, DOI 10.1016/S0042-6989(03)00314-6; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; ONO H, 1985, VISION RES, V25, P289, DOI 10.1016/0042-6989(85)90121-X; Paffen CLE, 2006, PSYCHOL SCI, V17, P752, DOI 10.1111/j.1467-9280.2006.01777.x; Pearson J, 2005, PSYCHOL SCI, V16, P516, DOI 10.1111/j.0956-7976.2005.01566.x; POLAT U, 1994, P NATL ACAD SCI USA, V91, P1206, DOI 10.1073/pnas.91.4.1206; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Putnam NM, 2005, J VISION, V5, P632, DOI 10.1167/5.7.3; SATO T, 1980, EXP BRAIN RES, V38, P313; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1320; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; STEINMAN RM, 1973, SCIENCE, V181, P810, DOI 10.1126/science.181.4102.810; Suzuki S, 2003, PERCEPT PSYCHOPHYS, V65, P632, DOI 10.3758/BF03194588; Suzuki S, 2002, VISION RES, V42, P2669, DOI 10.1016/S0042-6989(02)00326-7; Suzuki S, 2002, NEURON, V36, P143, DOI 10.1016/S0896-6273(02)00934-0; SUZUKI S, 2003, J VIS, V3, pA595; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Uka T, 2000, J NEUROPHYSIOL, V84, P120, DOI 10.1152/jn.2000.84.1.120; van Dam LCJ, 2006, VISION RES, V46, P787, DOI 10.1016/j.visres.2005.10.011; van Ee R, 2005, VISION RES, V45, P41, DOI 10.1016/j.visres.2004.07.030; van Ee R, 2005, VISION RES, V45, P29, DOI 10.1016/j.visres.2004.07.039; VOGELS R, 1994, J NEUROPHYSIOL, V71, P1428, DOI 10.1152/jn.1994.71.4.1428; WADE NJ, 1975, PERCEPTION, V4, P85, DOI 10.1068/p040085; Watanabe M, 2002, J NEUROPHYSIOL, V87, P1960, DOI 10.1152/jn.00780.2000; Watanabe T, 2002, NAT NEUROSCI, V5, P1003, DOI 10.1038/nn915; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; Wilson HR, 2000, NAT NEUROSCI, V3, P170, DOI 10.1038/72115; Yoshor D, 2007, CEREB CORTEX, V17, P2293, DOI 10.1093/cercor/bhl138; Zipser K, 1996, J NEUROSCI, V16, P7376	96	42	42	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 21	2007	56	4					741	753		10.1016/j.neuron.2007.09.028	http://dx.doi.org/10.1016/j.neuron.2007.09.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	236MH	18031689	Bronze			2022-12-24	WOS:000251306600015
J	Parikh, V; Kozak, R; Martinez, V; Sarter, M				Parikh, Vinay; Kozak, Rouba; Martinez, Vicente; Sarter, Martin			Prefrontal acetylcholine release controls cue detection on multiple timescales	NEURON			English	Article							FOREBRAIN CHOLINERGIC SYSTEM; VISUAL ATTENTIONAL TASK; REACTION-TIME-TASK; BASAL FOREBRAIN; CORTICAL ACETYLCHOLINE; NUCLEUS-ACCUMBENS; NEURONAL-ACTIVITY; PERFORMANCE; LESIONS; CORTEX	Cholinergic neurons originating from the basal forebrain innervate the entire cortical mantle. Choline-sensitive microelectrodes were used to measure the synaptic release of cortical acetylcholine (ACh) at a subsecond resolution in rats performing a task involving the detection of cues. Cues that were detected, defined behaviorally, evoked transient increases in cholinergic activity (at the scale of seconds) in the medial prefrontal cortex (mPFC), but not in a nonassociational control region (motor cortex). In trials involving missed cues, cholinergic transients were not observed. Cholinergic deafferentation of the mPFC, but not motor cortex, impaired cue detection. Furthermore, decreases and increases in precue cholinergic activity predicted subsequent cue detection or misses, respectively. Finally, cue-evoked cholinergic transients were superimposed over slower (at the timescale of minutes) changes in cholinergic activity. Cortical cholinergic neurotransmission is regulated on multiple timescales to mediate the detection of behaviorally significant cues and to support cognitive performance.	Univ Michigan, Dept Psychol & Neurosci Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sarter, M (corresponding author), Univ Michigan, Dept Psychol & Neurosci Program, Ann Arbor, MI 48109 USA.	msarter@umich.edu	Parikh, Vinay/M-1439-2016		NIMH NIH HHS [1 K02 MH01072, K02 MH001072, K02 MH001072-09, R03 MH073600, 2 R03 MH073600, R03 MH073600-02] Funding Source: Medline; NINDS NIH HHS [R01 NS037026-09, 5 R01 NS37026, R01 NS037026] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001072, R03MH073600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037026] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arnold HM, 2002, NEUROSCIENCE, V114, P451, DOI 10.1016/S0306-4522(02)00292-0; ASHE JH, 1989, SYNAPSE, V4, P44, DOI 10.1002/syn.890040106; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Braff DL, 2004, PSYCHOPHARMACOLOGY, V174, P75, DOI 10.1007/s00213-004-1848-0; Burmeister JJ, 2003, TRAC-TREND ANAL CHEM, V22, P498, DOI 10.1016/S0165-9936(03)00904-X; Burmeister JJ, 2003, ANAL CHIM ACTA, V481, P65, DOI 10.1016/S0003-2670(03)00067-9; CHIBA AA, 1995, J NEUROSCI, V15, P7315; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; Dalley JW, 2004, CEREB CORTEX, V14, P922, DOI 10.1093/cercor/bhh052; Dalley JW, 2001, J NEUROSCI, V21, P4908, DOI 10.1523/JNEUROSCI.21-13-04908.2001; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Detari L, 1999, PROG NEUROBIOL, V58, P249, DOI 10.1016/S0301-0082(98)00084-7; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Gill TM, 2000, J NEUROSCI, V20, P4745, DOI 10.1523/JNEUROSCI.20-12-04745.2000; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Himmelheber AM, 2000, COGNITIVE BRAIN RES, V9, P313, DOI 10.1016/S0926-6410(00)00012-4; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; HOLLAND PC, 1993, CURR OPIN NEUROBIOL, V3, P230, DOI 10.1016/0959-4388(93)90215-K; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; McGaughy J, 2002, J NEUROSCI, V22, P1905, DOI 10.1523/JNEUROSCI.22-05-01905.2002; McGaughy J, 1996, BEHAV NEUROSCI, V110, P247, DOI 10.1037/0735-7044.110.2.247; McGaughy J, 2000, BEHAV BRAIN RES, V115, P251, DOI 10.1016/S0166-4328(00)00262-X; Mesulam M, 2004, LEARN MEMORY, V11, P43, DOI 10.1101/lm.69204; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; MUIR JL, 1992, EXP BRAIN RES, V89, P611; MUIR JL, 1994, J NEUROSCI, V14, P2313; Neigh GN, 2004, NEUROSCIENCE, V123, P635, DOI 10.1016/j.neuroscience.2003.10.006; Parikh V, 2006, NEUROSCIENCE, V141, P379, DOI 10.1016/j.neuroscience.2006.03.055; Parikh V, 2006, J NEUROCHEM, V97, P488, DOI 10.1111/j.1471-4159.2006.03766.x; Parikh V, 2004, EUR J NEUROSCI, V20, P1545, DOI 10.1111/j.1460-9568.2004.03614.x; Passetti F, 2000, EUR J NEUROSCI, V12, P3051, DOI 10.1046/j.1460-9568.2000.00183.x; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; RICHARDSON RT, 1990, J NEUROSCI, V10, P2528; Sarter M, 2005, SCHIZOPHRENIA BULL, V31, P117, DOI 10.1093/schbul/sbi006; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sarter M, 1997, BRAIN RES REV, V23, P28, DOI 10.1016/S0165-0173(96)00009-4; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; TREMBLAY N, 1990, J NEUROPHYSIOL, V64, P1199, DOI 10.1152/jn.1990.64.4.1199; Turchi J, 1997, COGNITIVE BRAIN RES, V6, P147, DOI 10.1016/S0926-6410(97)00027-X; VOYTKO ML, 1994, J NEUROSCI, V14, P167; WAITE JJ, 1994, NEUROSCI LETT, V169, P154, DOI 10.1016/0304-3940(94)90379-4; Weinberger NM, 2003, NEUROBIOL LEARN MEM, V80, P268, DOI 10.1016/S1074-7427(03)00072-8; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; WILSON FAW, 1990, J NEUROSCI, V10, P1254; Zaborszky L, 1999, ANN NY ACAD SCI, V877, P339, DOI 10.1111/j.1749-6632.1999.tb09276.x; Zaborszky L, 2002, PROG BRAIN RES, V136, P359; Zmarowski A, 2005, EUR J NEUROSCI, V22, P1731, DOI 10.1111/j.1460-9568.2005.04333.x; Zmarowski A, 2007, SYNAPSE, V61, P115, DOI 10.1002/syn.20354	50	423	425	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2007	56	1					141	154		10.1016/j.neuron.2007.08.025	http://dx.doi.org/10.1016/j.neuron.2007.08.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920021	Bronze, Green Accepted			2022-12-24	WOS:000250289800016
J	Rister, J; Pauls, D; Schnell, B; Ting, CY; Lee, CH; Sinakevitch, I; Morante, J; Strausfeld, NJ; Ito, K; Heisenberg, M				Rister, Jens; Pauls, Dennis; Schnell, Bettina; Ting, Chun-Yuan; Lee, Chi-Hon; Sinakevitch, Irina; Morante, Javier; Strausfeld, Nicholas J.; Ito, Kei; Heisenberg, Martin			Dissection of the peripheral motion channel in the visual system of Drosophila melanogaster	NEURON			English	Article							LARGE MONOPOLAR CELLS; WILD-TYPE; SYNAPTIC TRANSMISSION; ORIENTATION BEHAVIOR; LAMINA GANGLIONARIS; COURTSHIP BEHAVIOR; OPTIC LOBE; FLY; MOVEMENT; ORGANIZATION	In the eye, visual information is segregated into modalities such as color and motion, these being transferred to the central brain through separate channels. Here, we genetically dissect the achromatic motion channel in the fly Drosophila melanogaster at the level of the first relay station in the brain, the lamina, where it is split into four parallel pathways (L1-L3, amc/T1). The functional relevance of this divergence is little understood. We now show that the two most prominent pathways, L1 and L2, together are necessary and largely sufficient for motion-dependent behavior. At high pattern contrast, the two pathways are redundant. At intermediate contrast, they mediate motion stimuli of opposite polarity, L2 front-to-back, L1 back-to-front motion. At low contrast, L1 and L2 depend upon each other for motion processing. Of the two minor pathways, amc/T1 specifically enhances the L1 pathway at intermediate contrast. L3 appears not to contribute to motion but to orientation behavior.	Univ Wurzburg, Lehrstuhl Genet & Neurobiol, D-97074 Wurzburg, Germany; NICHD, Lab Gene Regulat & Dev, Bethesda, MD 20892 USA; Univ Arizona, Div Neurobiol, Tucson, AZ 85721 USA; NYU, Dept Biol, New York, NY 10003 USA; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	University of Wurzburg; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Arizona; New York University; University of Tokyo	Heisenberg, M (corresponding author), Univ Wurzburg, Lehrstuhl Genet & Neurobiol, D-97074 Wurzburg, Germany.	heisenberg@biozentrum.uni-wuerzburg.de	Ting, chun-yuan/F-6448-2013; Strausfeld, Nicholas James/AAF-4566-2021; Morante, Javier/E-3292-2014; Lee, Chi-Hon/G-9190-2012; Morante, Javier/P-2976-2019	Ting, chun-yuan/0000-0002-2302-4203; Strausfeld, Nicholas James/0000-0002-1115-1774; Morante, Javier/0000-0002-5594-0644; Morante, Javier/0000-0002-5594-0644; Lee, Chi-Hon/0000-0002-6138-711X; Rister, Jens/0000-0002-0023-7417; Schnell, Bettina/0000-0001-7700-2600; Pauls, Dennis/0000-0001-8330-8120	NCRR NIH HHS [R01 RR08688] Funding Source: Medline; NICHD NIH HHS [HD008748-03] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008776] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR008688] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ARNETT DW, 1972, J NEUROPHYSIOL, V35, P429, DOI 10.1152/jn.1972.35.4.429; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; BAUSENWEIN B, 1986, J NEUROGENET, V3, P87, DOI 10.3109/01677068609106897; BLONDEAU J, 1982, J COMP PHYSIOL, V145, P321, DOI 10.1007/BF00619336; Borst A, 2002, J COMP PHYSIOL A, V188, P419, DOI 10.1007/s00359-002-0316-8; BORST A, 1989, TRENDS NEUROSCI, V12, P297, DOI 10.1016/0166-2236(89)90010-6; BOSCHEK CB, 1971, Z ZELLFORSCH MIK ANA, V118, P369; BRAITENB.V, 1974, J COMP PHYSIOL, V90, P25, DOI 10.1007/BF00698364; BRAITENBERG V, 1967, EXP BRAIN RES, V3, P271; BRAITENBERG V, 1972, EXP BRAIN RES, V16, P184; BRAITENBERG V, 1970, KYBERNETIK, V7, P235; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUCHNER E, 1976, BIOL CYBERN, V24, P85, DOI 10.1007/BF00360648; BUCHNER E, 1984, J COMP PHYSIOL, V155, P471, DOI 10.1007/BF00611912; CAMPOSOR.JA, 1973, BRAIN RES, V59, P119, DOI 10.1016/0006-8993(73)90255-2; COOMBE PE, 1986, J NEUROGENET, V3, P135, DOI 10.3109/01677068609106845; COOMBE PE, 1989, J COMP PHYSIOL A, V166, P23, DOI 10.1007/BF00190206; Di AK, 2003, MOL BIOL CELL, V14, P2016, DOI 10.1091/mbc.e02-09-0626; Douglass JK, 2003, MICROSC RES TECHNIQ, V62, P132, DOI 10.1002/jemt.10367; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FISCHBACH KF, 1981, NATURWISSENSCHAFTEN, V68, P332, DOI 10.1007/BF01047481; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FRANCESCHINI N, 1975, PHOTORECEPTOR OPTICS, P97; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; Gorska-Andrzejak J, 2005, PHOTOCH PHOTOBIO SCI, V4, P721, DOI 10.1039/b417023g; GOTZ KG, 1964, KYBERNETIK, V2, P77, DOI 10.1007/BF00288561; GOTZ KG, 1983, GENETIC DEFECTS VISU; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HARDIE RC, 1990, J COMP PHYSIOL A, V167, P723, DOI 10.1007/BF00189763; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; HEISENBERG M, 1972, J COMP PHYSIOL, V80, P119, DOI 10.1007/BF00696485; Heisenberg M., 1984, VISION DROSOPHILA GE; HENGSTENBERG R, 1993, REV OCULOMOTOR RES, P285; JANSONIUS NM, 1991, J COMP PHYSIOL A, V168, P631, DOI 10.1007/BF00224353; Kaiser W., 1975, P359; Kern R, 2006, J EXP BIOL, V209, P1251, DOI 10.1242/jeb.02127; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LAUGHLIN SB, 1989, J EXP BIOL, V144, P113; LAUGHLIN SB, 1981, PHOTORECEPTION VISIO, P457; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; MENNE D, 1977, J COMP PHYSIOL, V114, P301, DOI 10.1007/BF00657325; Mollereau B, 2000, MECH DEVELOP, V93, P151, DOI 10.1016/S0925-4773(00)00287-2; PICK B, 1979, J COMP PHYSIOL, V134, P45, DOI 10.1007/BF00610276; PICK B, 1974, Z NATURFORSCH C, VC 29, P310; REICHARDT W, 1976, Q REV BIOPHYS, V9, P311, DOI 10.1017/S0033583500002523; REICHARDT W, 1970, NEUROSCIENCES 2ND ST, P494; Rister J, 2006, J NEUROBIOL, V66, P1271, DOI 10.1002/neu.20284; SHAW SR, 1984, J EXP BIOL, V112, P225; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; STRAUSFE.NJ, 1970, Z VERGL PHYSIOL, V70, P95, DOI 10.1007/BF00297712; STRAUSFELD NJ, 1977, SCIENCE, V195, P894, DOI 10.1126/science.841315; STRAUSFELD NJ, 1971, Z ZELLFORSCH MIK ANA, V121, P377, DOI 10.1007/BF00337640; Yang ZY, 2001, J BIOL CHEM, V276, P4251, DOI 10.1074/jbc.M006371200	63	177	177	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2007	56	1					155	170		10.1016/j.neuron.2007.09.014	http://dx.doi.org/10.1016/j.neuron.2007.09.014			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920022	Bronze			2022-12-24	WOS:000250289800017
J	Gaillard, A; Prestoz, L; Dumartin, B; Cantereau, A; Morel, F; Roger, M; Jaber, M				Gaillard, Afsaneh; Prestoz, Laetitia; Dumartin, Brigitte; Cantereau, Anne; Morel, Franck; Roger, Michel; Jaber, Mohamed			Reestablishment of damaged adult motor pathways by grafted embryonic cortical neurons	NATURE NEUROSCIENCE			English	Article							FRONTAL-CORTEX; PURKINJE NEURONS; BRAIN INFARCTS; RATS; TRANSPLANTS; MICE; NEOCORTEX; TISSUE; CELLS; CONNECTIONS	Damage to the adult motor cortex leads to severe and frequently irreversible deficits in motor function. Transplantation of embryonic cortical neurons into the damaged adult motor cortex was previously shown to induce partial recovery, but reports on graft efferents have varied from no efferent projections to sparse innervation. Here, we grafted embryonic cortical tissue from transgenic mice overexpressing a green fluorescent protein into the damaged motor cortex of adult mice. Grafted neurons developed efferent projections to appropriate cortical and subcortical host targets, including the thalamus and spinal cord. These projections were not a result of cell fusion between the transplant and the host neurons. Host and transplanted neurons formed synaptic contacts and numerous graft efferents were myelinated. These findings demonstrate that there is substantial anatomical reestablishment of cortical circuitry following embryonic cortex grafting into the adult brain. They suggest that there is an unsuspected potential for neural cell transplantation to promote reconstruction after brain injury.	Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, F-86022 Poitiers, France; Univ Bordeaux 2, Lab Mouvement Adaptat Cognit, CNRS, F-33077 Bordeaux, France; Univ Poitiers, Lab Cytokines & Inflammat, EA 3806, F-86022 Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Universite de Poitiers	Gaillard, A (corresponding author), Univ Poitiers, CNRS, Inst Physiol & Biol Cellulaires, 40 Ave Recteur Pineau, F-86022 Poitiers, France.	Afsaneh.Gaillard@univ-poitiers.fr	Morel, Franck/AAI-4274-2021	Morel, Franck/0000-0003-3812-9304; Jaber, Mohamed/0000-0003-2536-1913; prestoz, Laetitia/0000-0002-2407-195X				Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; BRAGIN AG, 1988, NEUROSCIENCE, V25, P751, DOI 10.1016/0306-4522(88)90034-6; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Chen KA, 2006, EXP NEUROL, V198, P129, DOI 10.1016/j.expneurol.2005.11.016; DAS GD, 1972, BRAIN RES, V38, P233, DOI 10.1016/0006-8993(72)90710-X; Dumartin B, 2000, P NATL ACAD SCI USA, V97, P1879, DOI 10.1073/pnas.97.4.1879; DUNNETT SB, 1987, BEHAV NEUROSCI, V101, P489, DOI 10.1037/0735-7044.101.4.489; EBRAHIMIGAILLAR.A, 1994, BRAIN RES DEV BRAIN, V18, P271; EBRAHIMIGAILLARD A, 1995, NEUROSCIENCE, V64, P49, DOI 10.1016/0306-4522(94)00396-M; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Fricker-Gates RA, 2002, J NEUROSCI, V22, P4045, DOI 10.1523/JNEUROSCI.22-10-04045.2002; Gaillard A, 2000, CEREB CORTEX, V10, P443, DOI 10.1093/cercor/10.5.443; Gaillard A, 1998, ADV ANAT EMBRYOL CEL, V148, P1; Gaillard F, 2004, NEUROSCIENCE, V126, P631, DOI 10.1016/j.neuroscience.2004.04.011; Gates M A, 2000, Prog Brain Res, V127, P115; GONZALEZ MF, 1988, EXP NEUROL, V99, P154, DOI 10.1016/0014-4886(88)90135-5; GRABOWSKI M, 1993, ANN NEUROL, V34, P362, DOI 10.1002/ana.410340310; GUITET J, 1994, NEUROSCI LETT, V180, P265, DOI 10.1016/0304-3940(94)90535-5; HernitGrant CS, 1996, EXP NEUROL, V139, P131, DOI 10.1006/exnr.1996.0088; ISACSON O, 1988, PROG BRAIN RES, V78, P13; Kingsbury MA, 2005, P NATL ACAD SCI USA, V102, P6143, DOI 10.1073/pnas.0408171102; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pinaudeau C, 2000, EUR J NEUROSCI, V12, P2486, DOI 10.1046/j.1460-9568.2000.00148.x; PLUMET J, 1993, RESTOR NEUROL NEUROS, V6, P9, DOI 10.3233/RNN-1993-6102; Riolobos AS, 2001, NEUROBIOL LEARN MEM, V75, P274, DOI 10.1006/nlme.2000.3979; Roger M, 1994, Rev Neurosci, V5, P11; Sorensen JC, 1996, EXP NEUROL, V138, P227, DOI 10.1006/exnr.1996.0061; STEIN DG, 1987, ANN NY ACAD SCI, V495, P444, DOI 10.1111/j.1749-6632.1987.tb23693.x; Uematsu J, 1996, BRAIN DEV-JPN, V18, P29, DOI 10.1016/0387-7604(95)00102-6; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; Zhou WB, 1998, BRAIN RES, V792, P97, DOI 10.1016/S0006-8993(98)00125-5	36	127	130	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1294	1299		10.1038/nn1970	http://dx.doi.org/10.1038/nn1970			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828256				2022-12-24	WOS:000249720800016
J	Lengner, CJ; Camargo, FD; Hochedlinger, K; Welstead, GG; Zaidi, S; Gokhale, S; Scholer, HR; Tomilin, A; Jaenisch, R				Lengner, Christopher J.; Camargo, Fernando D.; Hochedlinger, Konrad; Welstead, G. Grant; Zaidi, Sarnir; Gokhale, Surnita; Scholer, Hans R.; Tomilin, Alexey; Jaenisch, Rudolf			Oct4 expression is not required for mouse somatic stem cell self-renewal	CELL STEM CELL			English	Article							MARROW STROMAL CELLS; BONE-MARROW; PROGENITOR CELLS; GERM-CELLS; DIFFERENTIATION; PROLIFERATION; PLURIPOTENCY; POPULATION; MARKERS; NETWORK	The Pou domain containing transcription factor Oct4 is a well-established regulator of pluripotency in the inner cell mass of the mammalian blastocyst as well as in embryonic stem cells. While it has been shown that the Oct4 gene is inactivated through a series of epigenetic modifications following implantation, recent studies have detected Oct4 activity in a variety of somatic stem cells and tumor cells. Based on these observations it has been suggested that Oct4 may also function in maintaining self-renewal of somatic stem cells and, in addition, may promote tumor formation. We employed a genetic approach to determine whether Oct4 is important for maintaining pluripotency in the stem cell compartments of several somatic tissues, including the intestinal epithelium, bone marrow (hematopoietic and mesenchymal lineages), hair follicle, brain, and liver. Oct4 gene ablation in these tissues revealed no abnormalities in homeostasis or regenerative capacity. We conclude that Oct4 is dispensable for both self-renewal and maintenance of somatic stem cells in the adult mammal.	MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Harvard Stem Cell Inst, Ctr Regenerat Med, Boston, MA 02114 USA; Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Max Planck Society; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Tomilin, Alexey/AAA-8774-2022; , HS/AAB-4434-2019; Tomilin, Alexey N/C-3361-2014; Tomilin, Alexey/AAK-3068-2021	Tomilin, Alexey/0000-0002-1137-7167; , HS/0000-0003-2643-5136; Tomilin, Alexey N/0000-0002-1137-7167; Lengner, Christopher/0000-0002-0574-5189	NATIONAL CANCER INSTITUTE [R01CA087869, F32CA119647, R37CA084198] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA084198, R01 CA087869, R37-CA084198, F32-CA119647, R01-CA087869, F32 CA119647-01, F32 CA119647] Funding Source: Medline; NICHD NIH HHS [R01-HD0445022] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Belting HG, 2001, DEVELOPMENT, V128, P4165; BELTRAMI AP, 2007, IN PRESS BLOOD; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Cervello I, 2007, HUM REPROD, V22, P45, DOI 10.1093/humrep/del332; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061; Davis SF, 2006, STEM CELLS DEV, V15, P191, DOI 10.1089/scd.2006.15.191; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; FERRARIS RP, 1992, AM J PHYSIOL, V262, pG1047, DOI 10.1152/ajpgi.1992.262.6.G1047; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Goolsby J, 2003, P NATL ACAD SCI USA, V100, P14926, DOI 10.1073/pnas.2434383100; Gritti A, 2001, PROTOCOLS NEURAL CEL, P173, DOI DOI 10.1385/1-59259-207-4:173; Gupta S, 2006, J AM SOC NEPHROL, V17, P3028, DOI 10.1681/ASN.2006030275; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Keating A, 2006, CURR OPIN HEMATOL, V13, P419, DOI 10.1097/01.moh.0000245697.54887.6f; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kues WA, 2005, BIOL REPROD, V72, P1020, DOI 10.1095/biolreprod.104.031229; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lamoury FMJ, 2006, CYTOTHERAPY, V8, P228, DOI 10.1080/14653240600735875; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Lengner CJ, 2004, J CELL PHYSIOL, V200, P327, DOI 10.1002/jcp.20118; Ling TY, 2006, P NATL ACAD SCI USA, V103, P9530, DOI 10.1073/pnas.0510232103; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Matthai C, 2006, MOL HUM REPROD, V12, P7, DOI 10.1093/molehr/gah254; Mongan NP, 2006, MOL CARCINOGEN, V45, P887, DOI 10.1002/mc.20186; Moriscot C, 2005, STEM CELLS, V23, P594, DOI 10.1634/stemcells.2004-0123; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nayernia K, 2006, LAB INVEST, V86, P654, DOI 10.1038/labinvest.3700429; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Okuda T, 2004, MOL BRAIN RES, V132, P18, DOI 10.1016/j.molbrainres.2004.08.021; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; Pallante BA, 2007, CIRC RES, V100, pE1, DOI 10.1161/01.RES.0000253487.02398.85; Pochampally RR, 2004, BLOOD, V103, P1647, DOI 10.1182/blood-2003-06-1967; Redvers RP, 2006, P NATL ACAD SCI USA, V103, P13168, DOI 10.1073/pnas.0602579103; Ren HY, 2006, BIOCHEM BIOPH RES CO, V347, P12, DOI 10.1016/j.bbrc.2006.05.169; Romagnani P, 2005, CIRC RES, V97, P314, DOI 10.1161/01.RES.0000177670.72216.9b; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Schneider A, 2003, AM J PHYSIOL-RENAL, V284, pF411, DOI 10.1152/ajprenal.00235.2002; Serafini M, 2007, J EXP MED, V204, P129, DOI 10.1084/jem.20061115; Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Thomas T, 2006, THYROID, V16, P537, DOI 10.1089/thy.2006.16.537; Tondreau T, 2005, STEM CELLS, V23, P1105, DOI 10.1634/stemcells.2004-0330; Walkup MH, 2006, STEM CELLS, V24, P1833, DOI 10.1634/stemcells.2006-0063; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang RN, 2004, J ENDOCRINOL, V182, P113, DOI 10.1677/joe.0.1820113; Yamaguchi S, 2005, GENE CHROMOSOME CANC, V43, P217, DOI 10.1002/gcc.20171; Yu H, 2006, AM J PATHOL, V168, P1879, DOI 10.2353/ajpath.2006.051170; Zhang SH, 2005, CELL TRANSPLANT, V14, P787, DOI 10.3727/000000005783982558	62	307	326	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT	2007	1	4					403	415		10.1016/j.stem.2007.07.020	http://dx.doi.org/10.1016/j.stem.2007.07.020			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XU	18159219	Green Accepted, Bronze			2022-12-24	WOS:000251055300010
J	Lockhart, DB; Ting, LH				Lockhart, Daniel B.; Ting, Lena H.			Optimal sensorimotor transformations for balance	NATURE NEUROSCIENCE			English	Article							AUTOMATIC POSTURAL RESPONSES; MUSCLE SYNERGIES; MOTOR CONTROL; STANCE; FORCE; PERTURBATIONS; INFORMATION; MOVEMENT; MODEL; CAT	Here we have identified a sensorimotor transformation that is used by a mammalian nervous system to produce a multijoint motor behavior. Using a simple biomechanical model, a delayed-feedback rule based on an optimal tradeoff between postural error and neural effort explained patterns of muscle activation in response to a sudden loss of balance in cats. Following the loss of large sensory afferents, changes in these muscle-activation patterns reflected an optimal reweighting of sensory feedback gains to minimize postural instability. Specifically, a loss of center-of-mass-acceleration information, which allowed for a rapid initial rise in the muscle activity in intact animals, was absent after large-fiber sensory neuropathy. Our results demonstrate that a simple and flexible neural feedback control strategy coordinates multiple muscles over time via a small set of extrinsic, task-level variables during complex multijoint natural movements.	Emory Univ, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA	Emory University; University System of Georgia; Georgia Institute of Technology	Ting, LH (corresponding author), Emory Univ, Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.	lting@emory.edu	Ting, Lena H/I-9311-2014		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046922] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD046922] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alexandrov AV, 2001, BIOL CYBERN, V84, P425, DOI 10.1007/PL00007986; Bosco G, 2000, J NEUROPHYSIOL, V83, P2931, DOI 10.1152/jn.2000.83.5.2931; BOYD IA, 1954, J PHYSIOL-LONDON, V124, P476, DOI 10.1113/jphysiol.1954.sp005122; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Chhabra M, 2006, NEURAL COMPUT, V18, P2320, DOI 10.1162/neco.2006.18.10.2320; d'Avella A, 2005, P NATL ACAD SCI USA, V102, P3076, DOI 10.1073/pnas.0500199102; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Deliagina TG, 2007, PHYSIOL BEHAV, V92, P148, DOI 10.1016/j.physbeh.2007.05.023; DIENER HC, 1988, J NEUROPHYSIOL, V59, P1888, DOI 10.1152/jn.1988.59.6.1888; Flash T, 2005, CURR OPIN NEUROBIOL, V15, P660, DOI 10.1016/j.conb.2005.10.011; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GOLLHOFER A, 1989, NEUROSCI LETT, V105, P73, DOI 10.1016/0304-3940(89)90014-1; Graziano M, 2006, ANNU REV NEUROSCI, V29, P105, DOI 10.1146/annurev.neuro.29.051605.112924; HE JP, 1991, P 28 IEEE C DEC CONT, V1, P518; Horak F, 1996, HDB PHYSIOL 12, V12, P255; Hyngstrom AS, 2007, NAT NEUROSCI, V10, P363, DOI 10.1038/nn1852; INGLIS JT, 1994, EXP BRAIN RES, V101, P159; INGLIS JT, 1995, J NEUROPHYSIOL, V73, P1181, DOI 10.1152/jn.1995.73.3.1181; Jeka J, 2004, J NEUROPHYSIOL, V92, P2368, DOI 10.1152/jn.00983.2003; Jo S, 2004, BIOL CYBERN, V91, P188, DOI 10.1007/s00422-004-0497-z; JOHANSSON RS, 1992, EXP BRAIN RES, V89, P181, DOI 10.1007/BF00229015; Kuo AD, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S07; Lin DC, 2000, J NEUROPHYSIOL, V83, P652, DOI 10.1152/jn.2000.83.2.652; Loeb GE, 1999, EXP BRAIN RES, V126, P1, DOI 10.1007/s002210050712; Macpherson JM, 2007, J NEUROPHYSIOL, V97, P4357, DOI 10.1152/jn.01338.2006; MACPHERSON JM, 1988, J NEUROPHYSIOL, V60, P218, DOI 10.1152/jn.1988.60.1.218; MACPHERSON JM, 1994, EXP BRAIN RES, V101, P397; Macpherson JM, 1999, J NEUROPHYSIOL, V82, P3066, DOI 10.1152/jn.1999.82.6.3066; NASHNER LM, 1977, EXP BRAIN RES, V30, P13; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Poggio T, 2004, NATURE, V431, P768, DOI 10.1038/nature03014; Poppele R, 2003, TRENDS NEUROSCI, V26, P269, DOI 10.1016/S0166-2236(03)00073-0; Risher DW, 1997, J BIOMECH ENG-T ASME, V119, P417, DOI 10.1115/1.2798288; Runge CF, 1998, EXP BRAIN RES, V122, P403, DOI 10.1007/s002210050528; SCHAFER SS, 1967, EXPERIENTIA, V23, P1026, DOI 10.1007/BF02136428; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; SOECHTING JF, 1988, J NEUROPHYSIOL, V59, P1296, DOI 10.1152/jn.1988.59.4.1296; Stapley PJ, 2002, J NEUROSCI, V22, P5803; Ting LH, 2007, PROG BRAIN RES, V165, P299, DOI 10.1016/S0079-6123(06)65019-X; Ting LH, 2005, J NEUROPHYSIOL, V93, P609, DOI 10.1152/jn.00681.2004; Ting LH, 2004, J NEUROPHYSIOL, V92, P808, DOI 10.1152/jn.00773.2003; Todorov E, 2005, J ROBOTIC SYST, V22, P691, DOI 10.1002/rob.20093; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Torres-Oviedo G, 2006, J NEUROPHYSIOL, V96, P1530, DOI 10.1152/jn.00810.2005; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; van Antwerp KW, 2007, J BIOMECH, V40, P3570, DOI 10.1016/j.jbiomech.2007.06.001; van der Kooij H, 1999, BIOL CYBERN, V80, P299, DOI 10.1007/s004220050527	50	151	157	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1329	1336		10.1038/nn1986	http://dx.doi.org/10.1038/nn1986			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17873869				2022-12-24	WOS:000249720800021
J	Shetty, G; Meistrich, ML				Shetty, Gunapala; Meistrich, Marvin L.			The missing niche for spermatogonial stem cells: Do blood vessels point the way?	CELL STEM CELL			English	Editorial Material							UNDIFFERENTIATED SPERMATOGONIA; MOUSE; RENEWAL	Although spermatogonial stem cell niches have been defined in lower organisms, their definitive localization in mammalian seminiferous tubules has been elusive. In a recent Science paper, Yoshida et al. (2007) elegantly,demonstrated a vascular and interstitial tissue-associated niche for undifferentiated spermatogonia in the mouse.	Univ Texas Houston, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Shetty, G (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	sgunapal@mdanderson.org		Shetty, Gunapala/0000-0001-5786-0667				Chiarini-Garcia H, 2003, REPRODUCTION, V126, P669, DOI 10.1530/reprod/126.5.669; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; De Rooij DG, 2000, J ANDROL, V21, P776; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	10	26	27	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT	2007	1	4					361	363		10.1016/j.stem.2007.09.013	http://dx.doi.org/10.1016/j.stem.2007.09.013			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XU	18371373	Bronze			2022-12-24	WOS:000251055300005
J	Kim, K; Ng, K; Rugg-Gunn, PJ; Shieh, JH; Kirak, O; Jaenisch, R; Wakayama, T; Moore, MA; Pedersen, RA; Daley, GQ				Kim, Kitai; Ng, Kitwa; Rugg-Gunn, Peter J.; Shieh, Jae-Hung; Kirak, Oktay; Jaenisch, Rudolf; Wakayama, Teruhiko; Moore, Malcolm A.; Pedersen, Roger A.; Daley, George Q.			Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer	CELL STEM CELL			English	Article							HUMAN OOCYTES; MOUSE OOCYTES; GENOME; LINES; INSTABILITY; GENE; DNA; ESTABLISHMENT; METHYLATION; INHIBITION	Parthenogenesis and somatic cell nuclear transfer (SCNT) are two methods for deriving embryonic stem (ES) cells that are genetically matched to the oocyte donor or somatic cell donor, respectively. Using genome-wide single nucleotide polymorphism (SNP) analysis, we demonstrate distinct signatures of genetic recombination that distinguish parthenogenetic ES cells from those generated by SCNT. We applied SNP analysis to the human ES cell line SCNT-hES-1, previously claimed to have been derived by SCNT, and present evidence that it represents a human parthenogenetic ES cell line. Genome-wide SNP analysis represents a means to validate the genetic provenance of an ES cell line.	Childrens Hosp, Div Pediat Hematol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Harvard Stem Cell Inst, Boston, MA 02115 USA; Univ Cambridge, Dept Surg, Cambridge CB2 2XY, England; Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; RIKEN Kobe, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; University of Cambridge; University of Cambridge; Memorial Sloan Kettering Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute; RIKEN	Daley, GQ (corresponding author), Childrens Hosp, Div Pediat Hematol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Kirak, Oktay/H-6347-2013	Kirak, Oktay/0000-0002-6524-4685; Rugg-Gunn, Peter/0000-0002-9601-5949	Medical Research Council [G0300723B] Funding Source: researchfish; MRC [G0300723, G0600275] Funding Source: UKRI; Medical Research Council [G0600275, G0300723] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; Colinas RJ, 2000, CLIN CHEM, V46, P996; Dean W, 1998, DEVELOPMENT, V125, P2273; DESUTTER P, 1992, J ASSIST REPROD GEN, V9, P328, DOI 10.1007/BF01203955; Donahue SL, 2006, P NATL ACAD SCI USA, V103, P11642, DOI 10.1073/pnas.0510741103; Eckardt S, 2007, GENE DEV, V21, P409, DOI 10.1101/gad.1524207; Feil R, 1997, J BIOL CHEM, V272, P20893, DOI 10.1074/jbc.272.33.20893; Goncalves R, 2002, FORENSIC SCI INT, V129, P78, DOI 10.1016/S0379-0738(02)00204-9; Hernandez L, 2003, P NATL ACAD SCI USA, V100, P13344, DOI 10.1073/pnas.2234026100; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; Kennedy Donald, 2006, Science, V311, P335; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; KUBIAK J, 1991, DEVELOPMENT, V111, P763; Liu J, 2003, BIOL REPROD, V68, P186, DOI 10.1095/biolreprod.102.008243; Mitalipov S, 2007, STEM CELLS, V25, P581, DOI 10.1634/stemcells.2006-0120; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; ROBERTSON EJ, 1983, J EMBRYOL EXP MORPH, V74, P297; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Rugg-Gunn PJ, 2005, CELL CYCLE, V4, P1323, DOI 10.4161/cc.4.10.2076; Santos TA, 2003, J ASSIST REPROD GEN, V20, P122, DOI 10.1023/A:1022630924236; *SEOUL NAT U, 2006, INV COMM REP; *SEOUL NATL U INV, 2006, FIN REP PROF WOO SUK; STRAIN L, 1995, NAT GENET, V11, P164, DOI 10.1038/ng1095-164; SZOLLOSI MS, 1993, J CELL SCI, V104, P861; TAYLOR AS, 1994, HUM REPROD, V9, P2389, DOI 10.1093/oxfordjournals.humrep.a138457; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Wakayama S, 2007, STEM CELLS, V25, P986, DOI 10.1634/stemcells.2006-0615; Wu Q, 2006, REPRODUCTION, V131, P481, DOI 10.1530/rep.1.00933	33	111	120	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2007	1	3					346	352		10.1016/j.stem.2007.07.001	http://dx.doi.org/10.1016/j.stem.2007.07.001			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XT	18371368	Bronze			2022-12-24	WOS:000251055200016
J	Miyamoto, K; Araki, KY; Naka, K; Arai, F; Takubo, K; Yamazaki, S; Matsuoka, S; Miyamoto, T; Ito, K; Ohmura, M; Chen, C; Hosokawa, K; Nakauchi, H; Nakayama, K; Nakayama, KI; Harada, M; Motoyama, N; Suda, T; Hirao, A				Miyamoto, Kana; Araki, Kiyomi Y.; Naka, Kazuhito; Arai, Fumio; Takubo, Keiyo; Yamazaki, Satoshi; Matsuoka, Sahoko; Miyamoto, Takeshi; Ito, Keisuke; Ohmura, Masako; Chen, Chen; Hosokawa, Kentaro; Nakauchi, Hiromitsu; Nakayama, Keiko; Nakayama, Keiichi I.; Harada, Mine; Motoyama, Noboru; Suda, Toshio; Hirao, Atsushi			Foxo3a is essential for maintenance of the hematopoietic stem cell pool	CELL STEM CELL			English	Article							FORKHEAD TRANSCRIPTION FACTOR; PROTEIN-KINASE B; OXIDATIVE STRESS; FACTOR FKHR-L1; ACTIVATION; DIFFERENTIATION; SURVIVAL; MICE; SUPPRESSION; QUIESCENCE	Hematopoietic stem cells (HSCs) are maintained in an undifferentiated quiescent state within a bone marrow niche. Here we show that Foxo3a, a forkhead transcription factor that acts downstream of the PTEN/PI3K/Akt pathway, is critical for HSC self-renewal. We generated gene-targeted Foxo3a(-/-) mice and showed that, although the proliferation and differentiation of Foxo3a(-/-) hematopoietic progenitors were normal, the number of colony-forming cells present in long-term cocultures of Foxo3a(-/-) bone marrow cells and stromal cells was reduced. The ability of Foxo3a(-/-) HSCs to support long-term reconstitution of hematopoiesis in a competitive transplantation assay was also impaired. Foxo3a(-/-) HSCs also showed increased phosphorylation of p38MAPK, an elevation of ROS, defective maintenance of quiescence, and heightened sensitivity to cell-cycle-specific myelotoxic injury. Finally, HSC frequencies were significantly decreased in aged Foxo3a(-/-) mice compared to the littermate controls. Our results demonstrate that Foxo3a plays a pivotal role in maintaining the HSC pool.	Kanazawa Univ, Ctr Canc & Stem Cell Res, Canc Res Inst, Div Mol Genet, Kanazawa, Ishikawa 9200934, Japan; Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol, Tokyo 1608582, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan; Natl Ctr Geriatr & Gerontol, Natl Inst Longet Sci, Dept Geriatr Med, Aichi, Japan; Univ Tokyo, Ctr Med Expt, Inst Med Sci, Lab Stem Cell Therapy,Minato Ku, Tokyo 1088639, Japan; Tohoku Univ, Ctr Translat And Adv Anim Res Human Dis, Grad Sch Med, Dept Dev Genet, Sendai, Miyagi 9808575, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cell Biol, Fukuoka 8128582, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Kanazawa University; Keio University; Kyushu University; National Center for Geriatrics & Gerontology; University of Tokyo; Tohoku University; Kyushu University; Japan Science & Technology Agency (JST)	Motoyama, N (corresponding author), Kanazawa Univ, Ctr Canc & Stem Cell Res, Canc Res Inst, Div Mol Genet, Kanazawa, Ishikawa 9200934, Japan.	motoyama@nils.go.jp; sudato@sc.itc.keio.ac.jp; ahirao@kenroku.kanazawa-u.ac.jp	Arai, Fumio/J-5241-2013; Takubo, Keiyo/AAX-5546-2020; Naka, Kazuhito/X-3756-2019; Suda, Toshio/H-6761-2013	Arai, Fumio/0000-0003-1936-4907; Takubo, Keiyo/0000-0002-1736-7592; Naka, Kazuhito/0000-0001-6646-6004; Suda, Toshio/0000-0001-7540-1771				Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bakker WJ, 2004, J CELL BIOL, V164, P175, DOI 10.1083/jcb.200307056; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Huttmann A, 2001, EXP HEMATOL, V29, P1109, DOI 10.1016/S0301-472X(01)00684-1; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kaestner KH, 2000, GENE DEV, V14, P142; Kobayashi Y, 2005, INT J MOL MED, V16, P237; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; van Pelt K, 2005, EXP HEMATOL, V33, P226, DOI 10.1016/j.exphem.2004.10.013; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	38	656	683	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL	2007	1	1					101	112		10.1016/j.stem.2007.02.001	http://dx.doi.org/10.1016/j.stem.2007.02.001			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	230JK	18371339	Bronze, Green Submitted			2022-12-24	WOS:000250872600005
J	Goyama, S; Yamamoto, G; Shimabe, M; Sato, T; Ichikawa, M; Ogawa, S; Chiba, S; Kurokawa, M				Goyama, Susumu; Yamamoto, Go; Shimabe, Munetake; Sato, Tomohiko; Ichikawa, Motoshi; Ogawa, Seishi; Chiba, Shigeru; Kurokawa, Mineo			Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; ZINC-FINGER GENE; MYELODYSPLASTIC SYNDROME; EXPRESSION; DOMAIN; IDENTIFICATION; PROTOONCOGENE; PROGENITORS; INTEGRATION; ACTIVATION	Evi-1 has been recognized as one of the dominant oncogenes associated with murine and human myeloid leukemia. Here, we show that hematopoietic stem cells (HSCs) in Evi-1-deficient embryos are severely reduced in number with defective proliferative and repopulating capacity. Selective ablation of EVIL 1 in Tie2(+) cells mimics Evi-1 deficiency, suggesting that Evi-1 function is required in Tie2(+) hemtopoietic stem/progenitors. Conditional deletion of Evi-1 in the adult hematopoietic system revealed that Evi-1-deficient bone marrow HSCs cannot maintain hematopoiesis and lose their repopulating ability. In contrast, Evi-1 is dispensable for blood cell lineage commitment. Evi-1(+/-) mice exhibit the intermediate phenotype for HSC activity, suggesting a gene dosage requirement for Evi-1. We further demonstrate that disruption of Evi-1 in transformed leukemic cells leads to significant loss of their proliferative activity both in vitro and in vivo. Thus, Evi-1 is a common and critical regulator essential for proliferation of embryonic/adult HSCs and transformed leukemic cells.	[Goyama, Susumu; Yamamoto, Go; Shimabe, Munetake; Sato, Tomohiko; Ichikawa, Motoshi; Ogawa, Seishi; Chiba, Shigeru; Kurokawa, Mineo] Univ Tokyo, Tokyo Univ Hosp, Grad Sch Med, Dept Hermatol & Oncol,Bunkyo Ku, Tokyo 1138655, Japan; [Ogawa, Seishi; Chiba, Shigeru] Univ Tokyo, Tokyo Univ Hosp, Grad Sch Med, Dept Cell Therapy & Transplantat Med,Bunkyo Ku, Tokyo 1138655, Japan; [Ogawa, Seishi] Univ Tokyo, Tokyo Univ Hosp, Grad Sch Med, Dept Regenerat Med Hematopoiesis,Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Kurokawa, M (corresponding author), Univ Tokyo, Tokyo Univ Hosp, Grad Sch Med, Dept Hermatol & Oncol,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurokawa-tky@umin.ac.jp	Ogawa, Seishi/AAE-7088-2019	Sato, Tomohiko/0000-0002-8244-075X; Ichikawa, Motoshi/0000-0001-6497-0848	Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research [19679004] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Kitamura for Plat-E packaging cells and pMXs retroviral vector; H. Nakauchi and M. Onodera for pGCDNsam-eGFP retroviral vector; T. Nakano for OP9 stromal cells; R. Ono and T. Nosaka for MLL/ENL cDNA; T. Inaba for E2A/HLF cDNA; R. Sprengel for iCre cDNA; M.H. Tomasson for cMyc-bcl2 cDNA; N. Watanabe, Y. Kato, and A. Iwama for technical advice; R. Takizawa for help with the generation of Evi-1 mutant mice; Y. Shimamura and Y. Sawamoto for expert technical assistance; and Kirin Brewery Pharmaceutical Research Laboratory for cytokines. This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and by Health and Labour Sciences Research grants from the Ministry of Health, Labour and Welfare.	Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; BORDEREAUX D, 1990, ONCOGENE, V5, P925; Buonamici S, 2004, J CLIN INVEST, V114, P713, DOI 10.1172/JCI200421716; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; DELWEL R, 1993, MOL CELL BIOL, V13, P4291, DOI 10.1128/MCB.13.7.4291; Fears S, 1996, P NATL ACAD SCI USA, V93, P1642, DOI 10.1073/pnas.93.4.1642; Goyama S, 2004, BLOOD, V104, P3558, DOI 10.1182/blood-2004-04-1535; Hirai H, 1999, INT J BIOCHEM CELL B, V31, P1367, DOI 10.1016/S1357-2725(99)00064-3; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li Z, 2006, BLOOD, V107, P106, DOI 10.1182/blood-2005-05-1955; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; MORISHITA K, 1992, MOL CELL BIOL, V12, P183, DOI 10.1128/MCB.12.1.183; MORISHITA K, 1990, ONCOGENE, V5, P1419; MUCENSKI ML, 1988, MOL CELL BIOL, V8, P301, DOI 10.1128/MCB.8.1.301; Nitta E, 2005, ONCOGENE, V24, P6165, DOI 10.1038/sj.onc.1208754; Ogawa S, 1996, Hum Cell, V9, P323; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; PINTADO T, 1985, CANCER, V55, P535, DOI 10.1002/1097-0142(19850201)55:3<535::AID-CNCR2820550311>3.0.CO;2-4; Smith KS, 2002, MOL CELL BIOL, V22, P7678, DOI 10.1128/MCB.22.21.7678-7688.2002; Sood R, 1999, LEUKEMIA, V13, P348, DOI 10.1038/sj.leu.2401360; Sugita M, 2000, CANCER GENET CYTOGEN, V117, P9, DOI 10.1016/S0165-4608(99)00135-1; SUZUKAWA K, 1994, BLOOD, V84, P2681; TANAKA T, 1994, J BIOL CHEM, V269, P24020; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418	38	208	215	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2008	3	2					207	220		10.1016/j.stem.2008.06.002	http://dx.doi.org/10.1016/j.stem.2008.06.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	338QT	18682242	Bronze			2022-12-24	WOS:000258523300015
J	Janzen, V; Fleming, HE; Riedt, T; Karlsson, G; Riese, MJ; Lo Celso, C; Reynolds, G; Milne, CD; Paige, CJ; Karlsson, S; Woo, M; Scadden, DT				Janzen, Viktor; Fleming, Heather E.; Riedt, Tamara; Karlsson, Goeran; Riese, Matthew J.; Lo Celso, Cristina; Reynolds, Griffin; Milne, Craig D.; Paige, Christopher J.; Karlsson, Stefan; Woo, Minna; Scadden, David T.			Hematopoietic stem cell responsiveness to exogenous signals is limited by Caspase-3	CELL STEM CELL			English	Article							BONE-MARROW CELLS; DIFFERENTIATION; APOPTOSIS; ACTIVATION; PROLIFERATION; CONSEQUENCE; INHIBITOR; SUBSTRATE; PATHWAY; ERK2	Limited responsiveness to inflammatory cytokines is a feature of adult hematopoietic stem cells and contributes to the relative quiescence and durability of the stem cell population in vivo. Here we report that the executioner Caspase, Caspase-3, unexpectedly participates in that process. Mice deficient in Caspase-3 had increased numbers of immunophenotypic long-term repopulating stem cells in association with multiple functional changes, most prominently cell cycling. Though these changes were cell autonomous, they reflected altered activation by exogenous signals. Caspase-3(-/-) cells exhibited cell type-specific changes in phosphorylated members of the Ras-Raf-MEK-ERK pathway in response to specific cytokines, while notably, members of other pathways, such as pSTAT3, pSTAT5, pAKT, pp38 MAPK, pSmad2, and pSmad3, were unaffected. Caspase-3 contributes to stem cell quiescence, dampening specific signaling events and thereby cell responsiveness to microenvironmental stimuli.	[Janzen, Viktor; Fleming, Heather E.; Riese, Matthew J.; Lo Celso, Cristina; Reynolds, Griffin; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med,Canc Ctr, Boston, MA 02114 USA; [Janzen, Viktor; Fleming, Heather E.; Lo Celso, Cristina; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Janzen, Viktor; Riedt, Tamara] Univ Tubingen, Dept Internal Med 2, Div Hematol Oncol & Immunol, D-72076 Tubingen, Germany; [Karlsson, Goeran; Karlsson, Stefan] Univ Lund Hosp, Inst Lab Med, Dept Mol Med & Gene Therapy, SE-22184 Lund, Sweden; [Karlsson, Goeran; Karlsson, Stefan] Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, SE-22184 Lund, Sweden; [Milne, Craig D.; Paige, Christopher J.] Univ Toronto, Ontario Canc Inst, Dept Immunol, Univ Hlth Network, Toronto, ON M5G 2M9, Canada; [Woo, Minna] Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Eberhard Karls University of Tubingen; Lund University; Skane University Hospital; Lund University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Scadden, DT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med,Canc Ctr, Boston, MA 02114 USA.	scadden.david@mgh.harvard.edu		Riese, Matthew/0000-0002-2423-0017; Lo Celso, Cristina/0000-0002-1163-4207; Karlsson, Goran/0000-0001-8197-754X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK050234-11A2, R01 DK050234-14, R01 DK050234-13, R01 DK050234-12, R01 DK050234] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguila HL, 1996, BLOOD, V87, P1225, DOI 10.1182/blood.V87.4.1225.bloodjournal8741225; Akbarzadeh S, 2002, BLOOD, V99, P879, DOI 10.1182/blood.V99.3.879; BERARDI AC, 1995, SCIENCE, V267, P104, DOI 10.1126/science.7528940; Bryder D, 2001, J EXP MED, V194, P941, DOI 10.1084/jem.194.7.941; Carlile GW, 2004, BLOOD, V103, P4310, DOI 10.1182/blood-2003-09-3362; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheng T, 1996, P NATL ACAD SCI USA, V93, P13158, DOI 10.1073/pnas.93.23.13158; de Botton S, 2002, BLOOD, V100, P1310, DOI 10.1182/blood-2002-03-0686; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; JALAL, 2004, J RAD RES TOKYO, V45, P557; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; KADHIM MA, 1995, INT J RADIAT BIOL, V67, P287, DOI 10.1080/09553009514550341; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Milne CD, 2004, IMMUNOL REV, V197, P75, DOI 10.1111/j.0105-2896.2004.0103.x; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; Nonami A, 2004, J BIOL CHEM, V279, P52543, DOI 10.1074/jbc.M405189200; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Rouyez MC, 1997, MOL CELL BIOL, V17, P4991, DOI 10.1128/MCB.17.9.4991; Uchida M, 2001, INT J HEMATOL, V73, P78, DOI 10.1007/BF02981906; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; WILLIAMS GT, 1990, NATURE, V343, P76, DOI 10.1038/343076a0; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247	34	92	95	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN	2008	2	6					584	594		10.1016/j.stem.2008.03.012	http://dx.doi.org/10.1016/j.stem.2008.03.012			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	315HT	18522851	Green Accepted, Bronze			2022-12-24	WOS:000256870000016
J	Berman, DE; Dall'Armi, C; Voronov, SV; McIntire, LBJ; Zhang, H; Moore, AZ; Staniszewski, A; Arancio, O; Kim, TW; Di Paolo, G				Berman, Diego E.; Dall'Armi, Claudia; Voronov, Sergey V.; McIntire, Laura Beth J.; Zhang, Hong; Moore, Ann Z.; Staniszewski, Agniezka; Arancio, Ottavio; Kim, Tae-Wan; Di Paolo, Gilbert			Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; NERVE-TERMINALS; IN-VIVO; SECRETED OLIGOMERS; PRECURSOR PROTEIN; ION CHANNELS; MEMORY; SYNAPTOJANIN-1; NEURODEGENERATION	Synaptic dysfunction caused by oligomeric assemblies of amyloid-beta peptide (A beta) has been linked to cognitive deficits in Alzheimer's disease. Here we found that incubation of primary cortical neurons with oligomeric A beta decreases the level of phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P-2), a phospholipid that regulates key aspects of neuronal function. The destabilizing effect of A beta on PtdIns(4,5)P-2 metabolism was Ca2+-dependent and was not observed in neurons that were derived from mice that are haploinsufficient for Synj1. This gene encodes synaptojanin 1, the main PtdIns(4,5)P-2 phosphatase in the brain and at the synapses. We also found that the inhibitory effect of A beta on hippocampal long-term potentiation was strongly suppressed in slices from Synj1(+/-) mice, suggesting that A beta-induced synaptic dysfunction can be ameliorated by treatments that maintain the normal PtdIns(4,5)P-2 balance in the brain.	[Berman, Diego E.; Dall'Armi, Claudia; Voronov, Sergey V.; McIntire, Laura Beth J.; Zhang, Hong; Moore, Ann Z.; Staniszewski, Agniezka; Arancio, Ottavio; Kim, Tae-Wan; Di Paolo, Gilbert] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, Coll Phys & Surg,Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University	Kim, TW (corresponding author), Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, Coll Phys & Surg,Dept Pathol & Cell Biol, 630 West 168th St, New York, NY 10032 USA.	twk16@columbia.edu; gil.dipaolo@columbia.edu	arancio, ottavio/AAB-7959-2019	arancio, ottavio/0000-0001-6335-164X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD047733] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442, R01NS056049, R01NS043467] Funding Source: NIH RePORTER; NCCIH NIH HHS [R01 AT002643, AT002643] Funding Source: Medline; NICHD NIH HHS [R21 HD047733, HD047733, R21 HD047733-02, R21 HD047733-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS049442, R01 NS056049-02, R01 NS056049, NS056049, R01 NS056049-01, R01 NS043467, NS049442, NS043467] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; Banker G., 1991, CULTURING NERVE CELL; Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Irie F, 2005, NAT CELL BIOL, V7, P501, DOI 10.1038/ncb1252; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kim JH, 2001, J NEUROSCI, V21, P1327; Kim WT, 2002, P NATL ACAD SCI USA, V99, P17143, DOI 10.1073/pnas.222657399; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Lott IT, 2001, MENT RETARD DEV D R, V7, P172, DOI 10.1002/mrdd.1025; Maloney MT, 2007, MOL NEUROBIOL, V35, P21, DOI 10.1007/BF02700622; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; Marjaux E, 2004, NEURON, V42, P189, DOI 10.1016/S0896-6273(04)00218-1; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Puzzo D, 2005, J NEUROSCI, V25, P6887, DOI 10.1523/JNEUROSCI.5291-04.2005; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; STOKES CE, 1987, J NEUROCHEM, V48, P1018, DOI 10.1111/j.1471-4159.1987.tb05619.x; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Townsend M, 2006, ANN NEUROL, V60, P668, DOI 10.1002/ana.21051; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	48	147	154	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					547	554		10.1038/nn.2100	http://dx.doi.org/10.1038/nn.2100			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18391946	Green Accepted			2022-12-24	WOS:000255327300013
J	Falk, S; Wurdak, H; Ittner, LM; Ille, F; Sumara, G; Schmid, MT; Draganova, K; Lang, KS; Paratore, C; Leveen, P; Suter, U; Karlsson, S; Born, W; Ricci, R; Gotz, M; Sommer, L				Falk, Sven; Wurdak, Heiko; Ittner, Lars M.; Ille, Fabian; Sumara, Grzegorz; Schmid, Marie-Theres; Draganova, Kalina; Lang, Karl S.; Paratore, Christian; Leveen, Per; Suter, Ueli; Karlsson, Stefan; Born, Walter; Ricci, Romeo; Goetz, Magdalena; Sommer, Lukas			Brain area-specific effect of TGF-beta signaling on Wnt-dependent neural stem cell expansion	CELL STEM CELL			English	Article							NEURONS ARISE; CYCLE EXIT; GROWTH; PROLIFERATION; EXPRESSION; DIFFERENTIATION; INTEGRATION; DISRUPTION; CLONING; LEADS	Regulating the choice between neural stem cell maintenance versus differentiation determines growth and size of the developing brain. Here we identify TGF-beta signaling as a crucial factor controlling these processes. At early developmental stages, TGF-beta signal activity is localized close to the ventricular surface of the neuroepithelium. In the midbrain, but not in the forebrain, Tgfbr2 ablation results in ectopic expression of Wnt1/beta-catenin and FGF8, activation of Wnt target genes, and increased proliferation and horizontal expansion of neuroepithelial cells due to shortened cell-cycle length and decreased cell-cycle exit. Consistent with this phenotype, self-renewal of mutant neuroepithelial stem cells is enhanced in the presence of FGF and requires Wnt signaling. Moreover, TGF-beta signal activation counteracts Wnt-incluced proliferation of midbrain neuroepithelial cells. Thus, TGF-beta signaling controls the size of a specific brain area, the dorsal midbrain, by antagonizing canonical Wnt signaling and negatively regulating self-renewal of neuroepithelial stem cells.	[Ittner, Lars M.; Born, Walter] Orthoped Univ, Hosp Balgrist, CH-8008 Zurich, Switzerland; [Schmid, Marie-Theres; Goetz, Magdalena] Natl Res Ctr Environm Hlth, HelmholtzZentrum Munchen, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Goetz, Magdalena] Univ Munich, D-80539 Munich, Germany; [Goetz, Magdalena] Ctr Integrated Prot Sci Munich, D-80633 Munich, Germany; [Lang, Karl S.] Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Leveen, Per; Karlsson, Stefan] Lund Univ, Dept Mol Med & Gene Therapy, S-22184 Lund, Sweden; [Leveen, Per; Karlsson, Stefan] Lund Univ, Dept Cell & Mol Biol, S-22184 Lund, Sweden; [Falk, Sven; Wurdak, Heiko; Ille, Fabian; Sumara, Grzegorz; Paratore, Christian; Suter, Ueli; Ricci, Romeo; Sommer, Lukas] ETH Honggerberg, Inst Cell Biol, CH-8093 Zurich, Switzerland	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Zurich; University Zurich Hospital; Lund University; Lund University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sommer, L (corresponding author), Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland.	lukas.sommer@anatom.uzh.ch	Ricci, Romeo/K-3009-2013; Lang, Karl S/R-2505-2016; Suter, Ueli/A-1624-2010	Ricci, Romeo/0000-0002-9766-4369; Wurdak, Heiko/0000-0003-4385-4324; Lang, Karl/0000-0001-9783-7605; Ille, Fabian/0000-0001-9084-1011; Falk, Sven/0000-0003-4194-9274; Ittner, Lars/0000-0001-6738-3825; Draganova, Kalina/0000-0002-0287-0937; Sumara, Grzegorz/0000-0003-1502-6265				Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Farkas LM, 2003, J NEUROSCI, V23, P5178; FEIJEN A, 1994, DEVELOPMENT, V120, P3621; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Ille F, 2007, DEV BIOL, V304, P394, DOI 10.1016/j.ydbio.2006.12.045; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Ittner L., 2005, J BIOL, V4, P111; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Kleber M, 2004, CURR OPIN CELL BIOL, V16, P681, DOI 10.1016/j.ceb.2004.08.006; Krieglstein K, 2000, NAT NEUROSCI, V3, P1085, DOI 10.1038/80598; Leveen P, 2002, BLOOD, V100, P560, DOI 10.1182/blood.V100.2.560; Megason SG, 2002, DEVELOPMENT, V129, P2087; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; ROWITCH DH, 1995, MECH DEVELOP, V52, P3, DOI 10.1016/0925-4773(95)00380-J; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Siegenthaler JA, 2005, J NEUROSCI, V25, P8627, DOI 10.1523/JNEUROSCI.1876-05.2005; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; TANAKA A, 1992, P NATL ACAD SCI USA, V89, P8928, DOI 10.1073/pnas.89.19.8928; Unsicker K, 2006, CELL SIGNALING AND GROWTH FACTORS IN DEVELOPMENT: FROM MOLECULES TO ORGANOGENESIS, pXXVII; Wurdak H, 2005, GENE DEV, V19, P530, DOI 10.1101/gad.317405; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005	40	102	104	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY	2008	2	5					472	483		10.1016/j.stem.2008.03.006	http://dx.doi.org/10.1016/j.stem.2008.03.006			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	300BM	18462697	Bronze, Green Accepted			2022-12-24	WOS:000255799300012
J	Kaneko-Goto, T; Yoshihara, S; Miyazaki, H; Yoshihara, Y				Kaneko-Goto, Tomomi; Yoshihara, Sei-ichi; Miyazaki, Haruko; Yoshihara, Yoshihiro			BIG-2 mediates olfactory axon convergence to target glomeruli	NEURON			English	Article							IMMUNOGLOBULIN SUPERFAMILY; TYROSINE-HYDROXYLASE; CONTACTIN-4 CNTN4; ODORANT RECEPTORS; MICE DEFICIENT; MOUSE; BULB; GENE; EXPRESSION; MAP	Olfactory sensory neurons expressing a given odorant receptor converge axons onto a few topographically fixed glomeruli in the olfactory bulb, leading to establishment of the odor map. Here, we report that BIG-2/contactin-4, an axonal glycoprotein belonging to the immunoglobulin superfamily, is expressed in a subpopulation of mouse olfactory sensory neurons. A mosaic pattern of glomerular arrangement is observed with strongly BIG-2-positive, weakly positive, and negative axon terminals in the olfactory bulb, which is overlapping but not identical with those of Kirrel2 and ephrin-A5. There is a close correlation between the BIG-2 expression level and the odorant receptor choice in individual sensory neurons. In BIG-2-deficient mice, olfactory sensory neurons expressing a given odorant receptor frequently innervate multiple glomeruli at ectopic locations. These results suggest that BIG-2 is one of the axon guidance molecules crucial for the formation and maintenance of functional odor map in the olfactory bulb.	[Kaneko-Goto, Tomomi; Yoshihara, Sei-ichi; Miyazaki, Haruko; Yoshihara, Yoshihiro] RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan; [Yoshihara, Yoshihiro] Japan Sci & Technol Agcy, CREST, Osaka 5600082, Japan	RIKEN; Japan Science & Technology Agency (JST)	Yoshihara, Y (corresponding author), RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yoshihara@brain.riken.jp	Yoshihara, Yoshihiro/N-6481-2015	Yoshihara, Yoshihiro/0000-0002-0319-7166				Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Denaxa M, 2005, DEV BIOL, V288, P87, DOI 10.1016/j.ydbio.2005.09.021; FaivreSarrailh C, 1997, MOL CELL NEUROSCI, V9, P109, DOI 10.1006/mcne.1997.0609; Falk J, 2002, BIOL CELL, V94, P327, DOI 10.1016/S0248-4900(02)00006-0; Fernandez T, 2004, AM J HUM GENET, V74, P1286, DOI 10.1086/421474; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Hansford LM, 2003, CYTOGENET GENOME RES, V101, P17, DOI 10.1159/000073412; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Li H, 2003, EUR J NEUROSCI, V17, P929, DOI 10.1046/j.1460-9568.2003.02514.x; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Manic B, 1999, CELL, V96, P713; McBride K, 2003, CHEM SENSES, V28, P659, DOI 10.1093/chemse/bjg053; Miura S, 2006, NEUROLOGY, V67, P1236, DOI 10.1212/01.wnl.0000238510.84932.82; Miyasaka N, 2005, DEVELOPMENT, V132, P1283, DOI 10.1242/dev.01698; Miyasaka N, 2007, DEVELOPMENT, V134, P2459, DOI 10.1242/dev.001958; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Murai KK, 2002, CURR BIOL, V12, P181, DOI 10.1016/S0960-9822(02)00680-2; NADI NS, 1981, BRAIN RES, V213, P365, DOI 10.1016/0006-8993(81)90241-9; Nagai Y, 2005, GENESIS, V43, P12, DOI 10.1002/gene.20146; Nagao H, 2000, NEUROREPORT, V11, P3023, DOI 10.1097/00001756-200009110-00039; Nakajima D, 2001, MOL BRAIN RES, V94, P85; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; Philpot BD, 1997, J NEUROSCI, V17, P9596; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rutishauser U, 2000, J CELL BIOL, V149, P757, DOI 10.1083/jcb.149.4.757; Schaefer ML, 2001, J COMP NEUROL, V436, P351; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; STONE DM, 1990, MOL BRAIN RES, V8, P291, DOI 10.1016/0169-328X(90)90042-C; Strotmann J, 2004, J NEUROSCI, V24, P7754, DOI 10.1523/JNEUROSCI.2588-04.2004; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; Takeda Y, 2003, J NEUROBIOL, V56, P252, DOI 10.1002/neu.10222; Taniguchi M, 2003, J NEUROSCI, V23, P1390, DOI 10.1523/JNEUROSCI.23-04-01390.2003; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; YOSHIHARA Y, 1991, J CELL BIOL, V115, P731, DOI 10.1083/jcb.115.3.731; YOSHIHARA Y, 1995, J NEUROBIOL, V28, P51, DOI 10.1002/neu.480280106; Zeng L, 2002, J HUM GENET, V47, P497, DOI 10.1007/s100380200073; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	58	115	118	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2008	57	6					834	846		10.1016/j.neuron.2008.01.023	http://dx.doi.org/10.1016/j.neuron.2008.01.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281LV	18367085	Bronze			2022-12-24	WOS:000254500000008
J	Sehgal, A				Sehgal, Amita			Ac-ing the clock	NEURON			English	Editorial Material							DROSOPHILA CIRCADIAN CLOCK; CRYPTOCHROME PROTEINS; PERIOD; DEGRADATION; OSCILLATION; REVEALS; FBXL3	Circadian clock proteins are modified in many different ways. The best-studied posttranslational modification is phosphorylation, with well-known kinases and phosphatases regulating the function and stability of clock proteins. Degradation of these proteins usually involves ubiquitylation or sumoylation, and some of the relevant E3 ligases are known. In addition, Hirayama et al. recently identified acetylation as a clock regulatory mechanism.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Sehgal, A (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu			NINDS NIH HHS [5R01NS48471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048471] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Fan YZ, 2007, CURR BIOL, V17, P1091, DOI 10.1016/j.cub.2007.05.048; Fang YS, 2007, GENE DEV, V21, P1506, DOI 10.1101/gad.1541607; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Kim EY, 2007, MOL CELL BIOL, V27, P5014, DOI 10.1128/MCB.02339-06; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	15	8	9	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 10	2008	57	1					8	10		10.1016/j.neuron.2007.12.018	http://dx.doi.org/10.1016/j.neuron.2007.12.018			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	250YZ	18184560	Bronze			2022-12-24	WOS:000252338600004
J	Ting, CY; Herman, T; Yonekura, S; Gao, S; Wang, J; Serpe, M; O'Connor, MB; Zipursky, SL; Lee, CH				Ting, Chun-Yuan; Herman, Tory; Yonekura, Shinichi; Gao, Shuying; Wang, Jian; Serpe, Mihaela; O'Connor, Michael B.; Zipursky, S. Lawrence; Lee, Chi-Hon			Tiling of R7 axons in the Drosophila visual system is mediated both by transduction of an activin signal to the nucleus and by mutual repulsion	NEURON			English	Article							TGF-BETA; TARGET SPECIFICITY; LIPRIN-ALPHA; OPTIC LOBE; C-ELEGANS; GUIDANCE; MELANOGASTER; RECEPTOR; BMP; EXPRESSION	The organization of neuronal wiring into layers and columns is a common feature of both vertebrate and invertebrate brains. In the Drosophila visual system, each R7 photoreceptor axon projects within a single column to a specific layer of the optic lobe. We refer to the restriction of terminals to single columns as tiling. In a genetic screen based on an R7-dependent behavior, we identified the Activin receptor Baboon and the nuclear import adaptor Importin-alpha 3 as being required to prevent R7 axon terminals from overlapping with the terminals of R7s in neighboring columns. This tiling function requires the Baboon ligand, dActivin, the transcription factor, dSmad2, and retrograde transport from the growth cone to the R7 nucleus. We propose that dActivin is an autocrine signal that restricts R7 growth cone motility, and we demonstrate that it acts in parallel with a paracrine signal that mediates repulsion between R7 terminals.	[Herman, Tory] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Ting, Chun-Yuan; Yonekura, Shinichi; Gao, Shuying; Lee, Chi-Hon] NICHHD, Unit Neuronal Connect, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20817 USA; [Wang, Jian] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Serpe, Mihaela; O'Connor, Michael B.] Univ Minnesota, Howard Hughes Med Inst, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Zipursky, S. Lawrence] Univ Calif Los Angeles, Los Angeles Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA	University of Oregon; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Maryland; University of Maryland College Park; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Herman, T (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	herman@molbio.uoregon.edu; leechih@mail.nih.gov	Lee, Chi-Hon/G-9190-2012; Ting, chun-yuan/F-6448-2013; O'Connor, Michael B/C-9977-2014; Gao, Shuying/D-8183-2011	Ting, chun-yuan/0000-0002-2302-4203; O'Connor, Michael B/0000-0002-3067-5506; Serpe, Mihaela/0000-0002-9205-8589; Lee, Chi-Hon/0000-0002-6138-711X; Zipursky, Stephen/0000-0001-5630-7181	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008748] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS [Z01 HD008748, Z01 HD008748-06] Funding Source: Medline; NICHD NIH HHS [HD008748-03] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ambron RT, 1996, MOL NEUROBIOL, V13, P61, DOI 10.1007/BF02740752; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; ASHLEY JA, 1994, DEVELOPMENT, V120, P1537; BAUSENWEIN B, 1992, CELL TISSUE RES, V267, P17, DOI 10.1007/BF00318687; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Chen HB, 2005, J BIOL CHEM, V280, P21329, DOI 10.1074/jbc.M500362200; Choe KM, 2005, CURR TOP DEV BIOL, V69, P187, DOI 10.1016/S0070-2153(05)69007-2; Choe KM, 2006, P NATL ACAD SCI USA, V103, P11601, DOI 10.1073/pnas.0601185103; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Grigliati T., 1986, DROSOPHILA PRACTICAL, P39; Grueber WB, 2004, CURR OPIN NEUROBIOL, V14, P74, DOI 10.1016/j.conb.2004.01.001; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hanz S, 2004, NEUROSCIENTIST, V10, P404, DOI 10.1177/1073858404267884; Hofmeyer K, 2006, P NATL ACAD SCI USA, V103, P11595, DOI 10.1073/pnas.0604766103; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; Kunes Samuel, 1993, Current Opinion in Neurobiology, V3, P53, DOI 10.1016/0959-4388(93)90035-W; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li Chinglu, 1997, Invertebrate Neuroscience, V3, P57, DOI 10.1007/BF02481715; LI CL, 1995, J NEUROBIOL, V28, P363, DOI 10.1002/neu.480280309; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; Mason DA, 2003, GENETICS, V165, P1943; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Meinertzhagen Ian A., 1993, P1363; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; Nash B, 2000, GENE DEV, V14, P2486, DOI 10.1101/gad.831500; Nern A, 2005, P NATL ACAD SCI USA, V102, P12944, DOI 10.1073/pnas.0502888102; Newsome TP, 2000, DEVELOPMENT, V127, P851; Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036; Parker L, 2004, PROG MOLEC, V34, P73; Parker L, 2006, DEVELOPMENT, V133, P4981, DOI 10.1242/dev.02673; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Sanyal S, 2004, NEURON, V41, P845, DOI 10.1016/S0896-6273(04)00152-7; Serpe M, 2006, DEVELOPMENT, V133, P4969, DOI 10.1242/dev.02711; Stavenga D.G., 1989, FACETS VISION; Ting CY, 2007, CURR OPIN NEUROBIOL, V17, P65, DOI 10.1016/j.conb.2006.12.004; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; Xiao Z, 2000, J BIOL CHEM, V275, P23425, DOI 10.1074/jbc.C000345200; Xiao Z, 2003, ONCOGENE, V22, P1057, DOI 10.1038/sj.onc.1206212; Xu L, 2003, J BIOL CHEM, V278, P42569, DOI 10.1074/jbc.M307601200; Yonekura S, 2006, MOL CELL BIOL, V26, P6598, DOI 10.1128/MCB.00241-06; Zheng XY, 2006, EMBO J, V25, P615, DOI 10.1038/sj.emboj.7600962; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	53	72	72	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 6	2007	56	5					793	806		10.1016/j.neuron.2007.09.033	http://dx.doi.org/10.1016/j.neuron.2007.09.033			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241MA	18054857	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000251659300007
J	Nienborg, H; Cumming, BG				Nienborg, Hendrikje; Cumming, Bruce G.			Psychophysically measured task strategy for disparity discrimination is reflected in V2 neurons	NATURE NEUROSCIENCE			English	Article							FEATURE-BASED ATTENTION; MACAQUE VISUAL-CORTEX; AREA MT; DEPTH DISCRIMINATION; REVERSE-CORRELATION; APPARENT MOTION; CHOICE; MONKEY; PERCEPTION; RESPONSES	In perceptual tasks, subjects attempt to rely on their most informative cues. Such strategic choices should be reflected in the types of sensory neurons that are used. We investigated this in a binocular-disparity discrimination task. Using psychophysical reverse-correlation, also known as image classification, we identified the perceptual strategies of two macaques (Macaca mulatta). Correlations between reported disparity signs and disparity noise samples for each trial yielded detection 'filters'. Filter amplitude was greater at near disparities than at far disparities, indicating that the subjects relied more on near disparities. Recordings from both macaques' disparity-selective V2 neurons showed a correlation between neuronal responses and perceptual judgment in near-preferring, but not far-preferring, units, mirroring the psychophysically measured strategy. After one monkey learned to weight near and far disparities equally, activity in its far-preferring neurons correlated with choice. Thus, the pattern of correlations between neuronal activity and perceptual reports indicates how subjects use their neuronal signals.	Natl Inst Hlth, NEI, Sensorimotor Res Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Nienborg, H (corresponding author), Natl Inst Hlth, NEI, Sensorimotor Res Lab, 49-2A50 Convent Dr, Bethesda, MD 20892 USA.	hn@lsr.nei.nih.gov			NATIONAL EYE INSTITUTE [Z01EY000404] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 EY000404-06, Z01 EY000404-07] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		AHUMADA AJ, 1996, PERCEPTION, V26, P18; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Broadbent D.E., 1958, PERCEPTION COMMUNICA; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Davison AC, 1997, BOOTSTRAP METHODS TH; DeAngelis GC, 2004, PLOS BIOL, V2, P394, DOI 10.1371/journal.pbio.0020077; DEUTSCH JA, 1963, PSYCHOL REV, V70, P80, DOI 10.1037/h0039515; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Krug K, 2004, PHILOS T R SOC B, V359, P929, DOI 10.1098/rstb.2003.1415; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; Neri P, 1999, NATURE, V401, P695, DOI 10.1038/44409; Neri P, 2006, VISION RES, V46, P2465, DOI 10.1016/j.visres.2006.02.002; Nienborg H, 2005, J NEUROSCI, V25, P10207, DOI 10.1523/JNEUROSCI.2342-05.2005; Nienborg H, 2006, J NEUROSCI, V26, P9567, DOI 10.1523/JNEUROSCI.2256-06.2006; NORCIA AM, 1984, VISION RES, V24, P395, DOI 10.1016/0042-6989(84)90037-3; Palmer C, 2007, J NEUROSCI, V27, P8122, DOI 10.1523/JNEUROSCI.1940-07.2007; Parker AJ, 2002, PHILOS T ROY SOC B, V357, P1053, DOI 10.1098/rstb.2002.1112; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Read JCA, 2004, J NEUROPHYSIOL, V91, P1271, DOI 10.1152/jn.00588.2003; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Uka T, 2005, J NEUROSCI, V25, P10796, DOI 10.1523/JNEUROSCI.1637-05.2005; Uka T, 2004, NEURON, V42, P297, DOI 10.1016/S0896-6273(04)00186-2; Uka T, 2003, J NEUROSCI, V23, P3515; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055	35	38	39	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1608	1614		10.1038/nn1991	http://dx.doi.org/10.1038/nn1991			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17965712	Green Accepted			2022-12-24	WOS:000251172900019
J	Conway, BR; Moeller, S; Tsao, DY				Conway, Bevil R.; Moeller, Sebastian; Tsao, Doris Y.			Specialized color modules in macaque extrastriate cortex	NEURON			English	Article							AREA V4; VISUAL-CORTEX; CONE INPUTS; CORTICAL CONNECTIONS; SELECTIVE CELLS; CONTRAST AGENT; NEURONS; AWAKE; FMRI; ORGANIZATION	Imaging studies are consistent with the existence of brain regions specialized for color, but electrophysiological studies have produced conflicting results. Here we address the neural basis for color, using targeted single-unit recording in alert macaque monkeys, guided by functional magnetic resonance imaging (fMRI) of the same subjects. Distributed within posterior inferior temporal cortex, a large region encompassing V4, PITd, and posterior TEO that some have proposed functions as a single visual complex, we found color-biased fMRI hotspots that we call "globs," each several millimeters wide. Almost all cells located in globs showed strong luminance-invariant color tuning and some shape selectivity. Cells in different globs represented distinct visual field locations, consistent with the coarse retinotopy of this brain region. Cells in "interglob" regions were not color tuned, but were more strongly shape selective. Neither population was direction selective. These results suggest that color perception is mediated by specialized neurons that are clustered within the extrastriate brain.	Wellesley Coll, Neurosci Program, Wellesley, MA 02481 USA; Univ Bremen, Inst Brain Res, D-28359 Bremen, Germany; Univ Bremen, Ctr Adv Imaging, D-28359 Bremen, Germany	Wellesley College; University of Bremen; University of Bremen	Conway, BR (corresponding author), Wellesley Coll, Neurosci Program, Wellesley, MA 02481 USA.	bconway@wellesley.edu	Conway, Bevil/AAG-2412-2020	Conway, Bevil/0000-0001-7715-9253	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Beauchamp MS, 1999, CEREB CORTEX, V9, P257, DOI 10.1093/cercor/9.3.257; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Brewer AA, 2002, J NEUROSCI, V22, P10416; Conway BR, 2006, J NEUROSCI, V26, P10826, DOI 10.1523/JNEUROSCI.2091-06.2006; Conway BR, 2006, CEREB CORTEX, V16, P1604, DOI 10.1093/cercor/bhj099; Conway BR, 2001, J NEUROSCI, V21, P2768, DOI 10.1523/JNEUROSCI.21-08-02768.2001; Conway BR, 2002, CEREB CORTEX, V12, P915, DOI 10.1093/cercor/12.9.915; Cowey A, 2001, EUR J NEUROSCI, V14, P1555, DOI 10.1046/j.0953-816x.2001.01774.x; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; DESIMONE R, 1985, VISION RES, V25, P441, DOI 10.1016/0042-6989(85)90069-0; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; DISTLER C, 1993, J COMP NEUROL, V334, P125, DOI 10.1002/cne.903340111; Dobkins KR, 2000, J OPT SOC AM A, V17, P545, DOI 10.1364/JOSAA.17.000545; Felleman DJ, 1997, J NEUROSCI, V17, P3185; Fize D, 2003, J NEUROSCI, V23, P7395; Gegenfurtner KR, 2003, ANNU REV NEUROSCI, V26, P181, DOI 10.1146/annurev.neuro.26.041002.131116; Girard P, 2002, CEREB CORTEX, V12, P1146, DOI 10.1093/cercor/12.11.1146; Gustavsen K, 2003, CURR BIOL, V13, pR234, DOI 10.1016/S0960-9822(03)00159-3; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Hegde J, 2005, J NEUROPHYSIOL, V93, P620, DOI 10.1152/jn.00039.2004; HEYWOOD CA, 1995, EUR J NEUROSCI, V7, P1064, DOI 10.1111/j.1460-9568.1995.tb01093.x; HEYWOOD CA, 1992, J NEUROSCI, V12, P4056; Hinkle DA, 2002, NAT NEUROSCI, V5, P665, DOI 10.1038/nn875; Horwitz GD, 2007, J NEUROPHYSIOL, V97, P3070, DOI 10.1152/jn.00965.2006; HUBEL DH, 1987, J NEUROSCI, V7, P3378; Johnson EN, 2004, J NEUROPHYSIOL, V91, P2501, DOI 10.1152/jn.01043.2003; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; KOMATSU H, 1992, J NEUROSCI, V12, P408; KRUGER J, 1980, J NEUROPHYSIOL, V43, P1055, DOI 10.1152/jn.1980.43.4.1055; Kusunoki M, 2006, J NEUROPHYSIOL, V95, P3047, DOI 10.1152/jn.00597.2005; Leite FP, 2002, NEUROIMAGE, V16, P283, DOI 10.1006/nimg.2002.1110; LENNIE P, 1990, J NEUROSCI, V10, P649; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; Lu HD, 2008, CEREB CORTEX, V18, P516, DOI 10.1093/cercor/bhm081; Mirabella G, 2007, NEURON, V54, P303, DOI 10.1016/j.neuron.2007.04.007; Motter BC, 2006, J NEUROSCI, V26, P9683, DOI 10.1523/JNEUROSCI.5495-05.2006; Nelissen K, 2006, J NEUROSCI, V26, P5929, DOI 10.1523/JNEUROSCI.0824-06.2006; Pack CC, 2001, NATURE, V414, P905, DOI 10.1038/414905a; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pollen DA, 2002, CEREB CORTEX, V12, P601, DOI 10.1093/cercor/12.6.601; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; SCHEIN SJ, 1982, J NEUROPHYSIOL, V47, P193, DOI 10.1152/jn.1982.47.2.193; SCHEIN SJ, 1990, J NEUROSCI, V10, P3369; Schiller PH, 1996, BEHAV BRAIN RES, V76, P21, DOI 10.1016/0166-4328(95)00186-7; SCHILLER PH, 1993, VISUAL NEUROSCI, V10, P717, DOI 10.1017/S0952523800005423; Shipp S, 1995, J ANAT, V187, P547; Smirnakis SM, 2007, J CEREBR BLOOD F MET, V27, P1248, DOI 10.1038/sj.jcbfm.9600434; Solomon SG, 2007, NAT REV NEUROSCI, V8, P276, DOI 10.1038/nrn2094; Solomon SG, 2005, J NEUROSCI, V25, P4779, DOI 10.1523/JNEUROSCI.5316-04.2005; Stepniewska I, 2005, CEREB CORTEX, V15, P809, DOI 10.1093/cercor/bhh182; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; TANAKA M, 1986, EXP BRAIN RES, V65, P11; Tootell RBH, 2004, CEREB CORTEX, V14, P353, DOI 10.1093/cercor/bhh001; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; VANESSEN DC, 1978, J PHYSIOL-LONDON, V277, P193; Wachtler T, 2003, NEURON, V37, P681, DOI 10.1016/S0896-6273(03)00035-7; Wade AR, 2002, PHILOS T R SOC B, V357, P963, DOI 10.1098/rstb.2002.1108; WALSH V, 1993, BEHAV BRAIN RES, V53, P51, DOI 10.1016/S0166-4328(05)80265-7; Xiao YP, 1999, CEREB CORTEX, V9, P792, DOI 10.1093/cercor/9.8.792; YOSHIOKA T, 1992, J NEUROSCI, V12, P2785; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeki S, 1996, P ROY SOC B-BIOL SCI, V263, P1539, DOI 10.1098/rspb.1996.0225; ZEKI SM, 1973, BRAIN RES, V53, P422, DOI 10.1016/0006-8993(73)90227-8; ZEKI SM, 1977, PROC R SOC SER B-BIO, V197, P195, DOI 10.1098/rspb.1977.0065; Zhao FQ, 2006, NEUROIMAGE, V30, P1149, DOI 10.1016/j.neuroimage.2005.11.013	68	169	169	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 8	2007	56	3					560	573		10.1016/j.neuron.2007.10.008	http://dx.doi.org/10.1016/j.neuron.2007.10.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	229AV	17988638	Green Accepted, Bronze			2022-12-24	WOS:000250774600014
J	Qiu, FTT; Sugihara, T; von der Heydt, R				Qiu, Fangtu T.; Sugihara, Tadashi; von der Heydt, Ruediger			Figure-ground mechanisms provide structure for selective attention	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; CORTICAL AREAS V1; NEURAL MECHANISMS; V4; V2; SEGMENTATION; MONKEY; ORGANIZATION; OBJECTS	Attention depends on figure- ground organization: figures draw attention, whereas shapes of the ground tend to be ignored. Recent research has revealed mechanisms for figure- ground organization in the visual cortex, but how these mechanisms relate to the attention process remains unclear. Here we show that the influences of figure- ground organization and volitional ( top- down) attention converge in single neurons of area V2 in Macaca mulatta. Although we found assignment of border ownership for attended and for ignored figures, attentional modulation was stronger when the attended figure was located on the neuron's preferred side of border ownership. When the border between two overlapping figures was placed in the receptive field, responses depended on the side of attention, and enhancement was generally found on the neuron's preferred side of border ownership. This correlation suggests that the neural network that creates figure- ground organization also provides the interface for the top- down selection process.	Johns Hopkins Univ, Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Qiu, FTT (corresponding author), Johns Hopkins Univ, Krieger Mind Brain Inst, 3400 N Charles St, Baltimore, MD 21218 USA.	von.der.heydt@jhu.edu		von der Heydt, Rudiger/0000-0002-8741-813X	NATIONAL EYE INSTITUTE [R01EY002966, R01EY016281] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY002966, EY16281, R01 EY016281, R01 EY002966-29A1, EY02966] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; Conner CE, 1997, J NEUROSCI, V17, P3201; Craft E, 2007, J NEUROPHYSIOL, V97, P4310, DOI 10.1152/jn.00203.2007; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Driver J, 1996, COGNITIVE PSYCHOL, V31, P248, DOI 10.1006/cogp.1996.0018; Driver J, 2001, COGNITION, V80, P61, DOI 10.1016/S0010-0277(00)00151-7; Friedman HS, 2003, J PHYSIOL-LONDON, V548, P593, DOI 10.1113/jphysiol.2002.033555; Girard P, 2001, J NEUROPHYSIOL, V85, P1328, DOI 10.1152/jn.2001.85.3.1328; Goldberg ME, 2006, PROG BRAIN RES, V155, P157, DOI 10.1016/S0079-6123(06)55010-1; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Koffka K, 1935, PRINCIPLES GESTALT P; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MACK A, 1992, COGNITIVE PSYCHOL, V24, P475, DOI 10.1016/0010-0285(92)90016-U; Marcus DS, 2002, J NEUROPHYSIOL, V88, P2648, DOI 10.1152/jn.00916.2001; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MOTTER BC, 1994, J NEUROSCI, V14, P2190; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; Qiu FTT, 2007, NAT NEUROSCI, V10, P283, DOI 10.1038/nn1853; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Rubin E., 1921, VISUELL WAHRGENOMMEN; SCHILLER PH, 1993, VISUAL NEUROSCI, V10, P717, DOI 10.1017/S0952523800005423; SCHUETZE H, 2003, J VIS, V3, P114; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000; Zipser K, 1996, J NEUROSCI, V16, P7376	29	156	159	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1492	1499		10.1038/nn1989	http://dx.doi.org/10.1038/nn1989			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	225HT	17922006	Green Accepted			2022-12-24	WOS:000250508400028
J	Wu, JI; Lessard, J; Olave, IA; Qiu, Z; Ghosh, A; Graef, IA; Crabtree, GR				Wu, Jiang I.; Lessard, Julie; Olave, Ivan A.; Qiu, Zilong; Ghosh, Anirvan; Graef, Isabella A.; Crabtree, Gerald R.			Regulation of dendritic development by NeuronSpecific chromatin remodeling complexes	NEURON			English	Article							ACTIN-RELATED PROTEIN; NUCLEAR ACTIN; RHO-GTPASES; GROWTH; BINDING; BRG1; SUBUNIT; PROLIFERATION; MORPHOGENESIS; INVOLVEMENT	The diversity of dendritic patterns is one of the fundamental characteristics of neurons and is in part regulated by transcriptional programs initiated by electrical activity. We show that dendritic outgrowth requires a family of combinatorially assembled, neuron-specific chromatin remodeling complexes (nBAF complexes) distinguished by the actin-related protein BAF53b and based on the Brg/Brm ATPases. nBAF complexes bind tightly to the Ca2+, -responsive dendritic regulator CREST and directly regulate genes essential for dendritic outgrowth. BAF53b is not required for nBAF complex assembly or the interaction with CREST, yet is required for their recruitment to the promoters of specific target genes. The highly homologous BAF53a protein, which is a component of neural progenitor and nonneural BAF complexes, cannot replace BAF53b's role in dendritic development. Remarkably, we find that this functional specificity is conferred by the actin fold subdomain 2 of BAF53b. These studies suggest that the genes encoding the individual subunits of BAF complexes function like letters in a ten-letter word to produce biologically specific meanings (in this case dendritic outgrowth) by combinatorial assembly of their products.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; University of California System; University of California San Diego	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, 279 Campus Dr, Stanford, CA 94305 USA.	crabtree@stanford.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789] Funding Source: NIH RePORTER; NINDS NIH HHS [NS046789] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Blessing CA, 2004, TRENDS CELL BIOL, V14, P435, DOI 10.1016/j.tcb.2004.07.009; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chen YC, 2005, J NEUROBIOL, V64, P4, DOI 10.1002/neu.20150; Chi TH, 2003, IMMUNITY, V19, P169, DOI 10.1016/S1074-7613(03)00199-7; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jiang YW, 1996, GENE DEV, V10, P604, DOI 10.1101/gad.10.5.604; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Muller J, 2005, MOL BIOL CELL, V16, P5736, DOI 10.1091/mbc.E05-06-0508; Olave I, 2002, GENE DEV, V16, P2509, DOI 10.1101/gad.992102; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Oma Y, 2003, BIOCHEM BIOPH RES CO, V301, P521, DOI 10.1016/S0006-291X(02)03073-5; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Rando OJ, 2002, P NATL ACAD SCI USA, V99, P2824, DOI 10.1073/pnas.032662899; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	56	290	296	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2007	56	1					94	108		10.1016/j.neuron.2007.08.021	http://dx.doi.org/10.1016/j.neuron.2007.08.021			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920018	Bronze			2022-12-24	WOS:000250289800013
J	Pronk, CJH; Rossi, DJ; Mansson, R; Attema, JL; Norddahl, GL; Chan, CKF; Sigvardsson, M; Weissman, IL; Bryder, D				Pronk, Cornelis J. H.; Rossi, Derrick J.; Mansson, Robert; Attema, Joanne L.; Norddahl, Gudmundur Logi; Chan, Charles Kwok Fai; Sigvardsson, Mikael; Weissman, Irving L.; Bryder, David			Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; GENE-EXPRESSION; LINEAGE COMMITMENT; BONE-MARROW; IDENTIFICATION; TRANSCRIPTION; DIFFERENTIATION; SPECIFICATION; MICE; PU.1	The major myeloid blood cell lineages are generated from hematopoietic stem cells by differentiation through a series of increasingly committed progenitor cells. Precise characterization of intermediate progenitors is important for understanding fundamental differentiation processes and a variety of disease states, including leukemia. Here, we evaluated the functional in vitro and in vivo potentials of a range of prospectively isolated myeloid precursors with differential expression of CD150, Endoglin, and CD41. Our studies revealed a hierarchy of myeloerythroid progenitors with distinct lineage potentials. The global gene expression signatures of these subsets were consistent with their functional capacities, and hierarchical clustering analysis suggested likely lineage relationships. These studies provide valuable tools for understanding myeloid lineage commitment, including isolation of an early erythroid-restricted precursor, and add to existing models of hematopoietic differentiation by suggesting that progenitors of the innate and adaptive immune system can separate late, following the divergence of megakaryocytic/erythroid potential.	Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, S-22184 Lund, Sweden; Lund Univ, Immunol Unit, Inst Expt Med Sci, S-22184 Lund, Sweden; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Lund University; Lund University; Stanford University; Stanford University; Stanford University	Bryder, D (corresponding author), Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, BMC I13, S-22184 Lund, Sweden.	david.bryder@med.lu.se	Bryder, David/Q-6292-2019; Mansson, Robert/D-4372-2014	Mansson, Robert/0000-0003-0738-0328; Sigvardsson, Mikael/0000-0001-8527-7276; Bryder, David/0000-0002-8761-4237				Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; BAINES P, 1982, LEUKEMIA RES, V6, P81, DOI 10.1016/0145-2126(82)90046-7; Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Bradford GB, 1997, EXP HEMATOL, V25, P445; BRADY G, 1995, CURR BIOL, V5, P909, DOI 10.1016/S0960-9822(95)00181-3; Bryder D, 2000, BLOOD, V96, P1748, DOI 10.1182/blood.V96.5.1748.h8001748_1748_1755; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Chen CZ, 2002, P NATL ACAD SCI USA, V99, P15468, DOI 10.1073/pnas.202614899; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Drynan LF, 2005, EMBO J, V24, P3136, DOI 10.1038/sj.emboj.7600760; Fukuchi Y, 2006, EMBO J, V25, P3398, DOI 10.1038/sj.emboj.7601199; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Imamura T, 2002, BRIT J HAEMATOL, V119, P119, DOI 10.1046/j.1365-2141.2002.03803.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Medina KL, 2001, NAT IMMUNOL, V2, P718, DOI 10.1038/90659; Metcalf D, 2002, STEM CELLS, V20, P552, DOI 10.1002/stem.200552; METCALF D, 2004, BLOOD LINES INTRO CH; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Nakorn TN, 2003, P NATL ACAD SCI USA, V100, P205, DOI 10.1073/pnas.262655099; Nanda N, 2005, BLOOD, V106, P3028, DOI 10.1182/blood-2005-01-0333; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; ROKHLIN OW, 1995, J IMMUNOL, V154, P4456; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Singh H, 1996, CURR OPIN IMMUNOL, V8, P160, DOI 10.1016/S0952-7915(96)80053-7; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Terszowski G, 2005, BLOOD, V105, P1937, DOI 10.1182/blood-2004-09-3459; UCHIDA N, 1994, BLOOD, V83, P3758; Wagers AJ, 2002, EXP HEMATOL, V30, P176, DOI 10.1016/S0301-472X(01)00777-9; Wang GG, 2005, BLOOD, V106, P254, DOI 10.1182/blood-2004-12-4664; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314	49	442	447	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT	2007	1	4					428	442		10.1016/j.stem.2007.07.005	http://dx.doi.org/10.1016/j.stem.2007.07.005			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XU	18371379	Bronze			2022-12-24	WOS:000251055300012
J	Brette, R; Piwkowska, Z; Monier, C; Rudolph-Lilith, M; Fournier, J; Levy, M; Fregnac, Y; Bal, T; Destexhe, A				Brette, Romain; Piwkowska, Zuzanna; Monier, Cyril; Rudolph-Lilith, Michelle; Fournier, Julien; Levy, Manuel; Fregnac, Yves; Bal, Thierry; Destexhe, Alain			High-resolution intracellular recordings using a real-time computational model of the electrode	NEURON			English	Article							MEMBRANE-POTENTIAL FLUCTUATIONS; NEURONS IN-VIVO; CORTICAL-NEURONS; VOLTAGE-CLAMP; SYNAPTIC CONDUCTANCES; NEOCORTICAL NEURONS; DISCONTINUOUS FEEDBACK; DYNAMIC CLAMP; PATCH-CLAMP; CORTEX	Intracellular recordings of neuronal membrane potential are a central tool in neurophysiology. In many situations, especially in vivo, the traditional limitation of such recordings is the high electrode resistance and capacitance, which may cause significant measurement errors during current injection. We introduce a computer-aided technique, Active Electrode Compensation (AEC), based on a digital model of the electrode interfaced in real time with the electrophysiological setup. The characteristics of this model are first estimated using white noise current injection. The electrode and membrane contribution are digitally separated, and the recording is then made by online subtraction of the electrode contribution. Tests performed in vitro and in vivo demonstrate that AEC enables high-frequency recordings in demanding conditions, such as injection of conductance noise in dynamic-clamp mode, not feasible with a single high-resistance electrode until now. AEC should be particularly useful to characterize fast neuronal phenomena intracellularly in vivo.	[Brette, Romain] Ecole Normale Super, Dept Informat, Equipe Odyssee ENS INRIA ENPC, F-75230 Paris 05, France; [Brette, Romain; Piwkowska, Zuzanna; Monier, Cyril; Rudolph-Lilith, Michelle; Fournier, Julien; Levy, Manuel; Fregnac, Yves; Bal, Thierry; Destexhe, Alain] CNRS, UNIC, F-91198 Gif Sur Yvette, France	Ecole des Ponts ParisTech; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Brette, R (corresponding author), CNRS, UNIC, F-91198 Gif Sur Yvette, France.	brette@di.ens.fr	Piwkowska, Zuzanna/AAK-4295-2020; Brette, Romain/I-7120-2016; Brette, Romain/F-6670-2012	Brette, Romain/0000-0003-0110-1623; Fournier, Julien/0000-0001-7167-8132; levy, manuel/0000-0003-1117-5028; Piwkowska, Zuzanna/0000-0001-7962-7225; /0000-0002-8540-7808; Destexhe, Alain/0000-0001-7405-0455	CNRS; ANR; ACI; HFSP; European Community (FACETS) [FP6 15879]; FRM	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); ACI; HFSP(Human Frontier Science Program); European Community (FACETS)(European Commission); FRM(Fondation pour la Recherche Medicale)	We thank Paul Galloux, Gerard Sadoc, Jose Gomez, and Leonel Gomez for help with the real-time system and for stimulating discussions. This work was supported by CNRS, ANR (HR-CORTEX grant), ACI, HFSP, and the European Community (FACETS grant FP6 15879). Z.P. gratefully acknowledges the support of the FRM.	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BRENNECKE R, 1974, REV SCI INSTRUM, V45, P656, DOI 10.1063/1.1686708; BRENNECKE R, 1974, REV SCI INSTRUM, V45, P184, DOI 10.1063/1.1686583; BRENNECKE R, 1971, LIFE SCI, V1, P53; Brette R, 2007, NEUROCOMPUTING, V70, P1597, DOI 10.1016/j.neucom.2006.10.039; BRYANT HL, 1976, J PHYSIOL-LONDON, V260, P279, DOI 10.1113/jphysiol.1976.sp011516; Crochet S, 2006, CEREB CORTEX, V16, P618, DOI 10.1093/cercor/bhj008; Davie JT, 2006, NAT PROTOC, V1, P1235, DOI 10.1038/nprot.2006.164; de Polavieja GG, 2005, J NEUROSCI, V25, P5657, DOI 10.1523/JNEUROSCI.0242-05.2005; de Sa VR, 2001, NEUROCOMPUTING, V38, P1651, DOI 10.1016/S0925-2312(01)00525-2; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Destexhe A, 2004, J COMPUT NEUROSCI, V17, P327, DOI 10.1023/B:JCNS.0000044875.90630.88; FINKEL AS, 1984, J NEUROSCI METH, V11, P101, DOI 10.1016/0165-0270(84)90029-3; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Higley MJ, 2007, J NEUROPHYSIOL, V97, P647, DOI 10.1152/jn.00777.2006; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Mainen T.J., 1998, METHODS NEURONAL MOD, V2, P1; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Mokeichev A, 2007, NEURON, V53, P413, DOI 10.1016/j.neuron.2007.01.017; Monier C, 2008, J NEUROSCI METH, V169, P323, DOI 10.1016/j.jneumeth.2007.11.008; Muller A, 1999, AM J PHYSIOL-CELL PH, V276, pC980, DOI 10.1152/ajpcell.1999.276.4.C980; Paz JT, 2007, J NEUROSCI, V27, P929, DOI 10.1523/JNEUROSCI.4677-06.2007; Pospischil M, 2007, J NEUROPHYSIOL, V97, P2544, DOI 10.1152/jn.01000.2006; PRESS WH, 1993, C ART SCI COMPUTING; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; PURVES RD, 1981, MICROELECTRODE METHO; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; Roelfsema MRG, 2001, J EXP BOT, V52, P1933, DOI 10.1093/jexbot/52.362.1933; Rudolph M, 2004, J NEUROPHYSIOL, V91, P2884, DOI 10.1152/jn.01223.2003; Rudolph M, 2003, NEURAL COMPUT, V15, P2577, DOI 10.1162/089976603322385081; SHARP AA, 1993, TRENDS NEUROSCI, V16, P389, DOI 10.1016/0166-2236(93)90004-6; Sherman AJ, 1999, BIOPHYS J, V77, P2590, DOI 10.1016/S0006-3495(99)77093-1; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Shu YS, 2003, J NEUROSCI, V23, P10388; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STRICKHOLM A, 1995, J NEUROSCI METH, V61, P47, DOI 10.1016/0165-0270(95)00022-M; THOMAS MV, 1977, MED BIOL ENG COMPUT, V15, P450, DOI 10.1007/BF02458001; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Wilent WB, 2005, J NEUROSCI, V25, P2983, DOI 10.1523/JNEUROSCI.4906-04.2005; Wolfart J, 2005, NAT NEUROSCI, V8, P1760, DOI 10.1038/nn1591; XING P, 1991, NEUROREPORT, V2, P485	47	43	50	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 14	2008	59	3					379	391		10.1016/j.neuron.2008.06.021	http://dx.doi.org/10.1016/j.neuron.2008.06.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339GG	18701064	Green Submitted, Bronze			2022-12-24	WOS:000258565500007
J	Toni, N; Laplagne, DA; Zhao, C; Lombardi, G; Ribak, CE; Gage, FH; Schinder, AF				Toni, Nicolas; Laplagne, Diego A.; Zhao, Chunmei; Lombardi, Gabriela; Ribak, Charles E.; Gage, Fred H.; Schinder, Alejandro F.			Neurons born in the adult dentate gyrus form functional synapses with target cells	NATURE NEUROSCIENCE			English	Article							MOSSY FIBER SYNAPSES; ENHANCED SYNAPTIC PLASTICITY; NEWLY GENERATED NEURONS; CA3 PYRAMIDAL CELLS; GRANULE CELLS; RAT HIPPOCAMPUS; INTRACELLULAR-RECORDINGS; NEUROGENESIS; INHIBITION; ACTIVATION	Adult neurogenesis occurs in the hippocampus and the olfactory bulb of the mammalian CNS. Recent studies have demonstrated that newborn granule cells of the adult hippocampus are postsynaptic targets of excitatory and inhibitory neurons, but evidence of synapse formation by the axons of these cells is still lacking. By combining retroviral expression of green fluorescent protein in adult-born neurons of the mouse dentate gyrus with immuno-electron microscopy, we found output synapses that were formed by labeled terminals on appropriate target cells in the CA3 area and the hilus. Furthermore, retroviral expression of channelrhodopsin-2 allowed us to light-stimulate newborn granule cells and identify postsynaptic target neurons by whole-cell recordings in acute slices. Our structural and functional evidence indicates that axons of adult-born granule cells establish synapses with hilar interneurons, mossy cells and CA3 pyramidal cells and release glutamate as their main neurotransmitter.	[Toni, Nicolas; Zhao, Chunmei; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Laplagne, Diego A.; Lombardi, Gabriela; Schinder, Alejandro F.] Consejo Nacl Invest Cient & Tecn, Leloir Inst, Lab Neuronal Plast, RA-1405 Buenos Aires, DF, Argentina; [Ribak, Charles E.] Univ Calif Irvine, Sch Med, Dept Anat & Neurobiol, Irvine, CA 92697 USA	Salk Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of California System; University of California Irvine	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu; aschinder@leloir.org.ar	Laplagne, Diego A/I-4462-2014; Toni, Nicolas/M-2057-2014	Laplagne, Diego A/0000-0001-5860-1667; Toni, Nicolas/0000-0001-5585-268X; Schinder, Alejandro/0000-0003-4863-8348	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050217, R01NS038331] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS050217-04, R01 NS050217, NS050217, NS038331, R01 NS038331] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acsady L, 1998, J NEUROSCI, V18, P3386; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; AMARAL DG, 1979, ANAT EMBRYOL, V155, P241, DOI 10.1007/BF00317638; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; FROTSCHER M, 1989, EXP BRAIN RES, V75, P441; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gutierrez R, 2005, TRENDS NEUROSCI, V28, P297, DOI 10.1016/j.tins.2005.04.005; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; KNEISLER TB, 1995, HIPPOCAMPUS, V5, P151, DOI 10.1002/hipo.450050302; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Laplagne DA, 2007, EUR J NEUROSCI, V25, P2973, DOI 10.1111/j.1460-9568.2007.05549.x; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; SCHARFMAN HE, 1990, NEUROSCIENCE, V37, P693, DOI 10.1016/0306-4522(90)90100-I; SCHARFMAN HE, 1995, J NEUROPHYSIOL, V74, P179, DOI 10.1152/jn.1995.74.1.179; SCHARFMAN HE, 1994, J NEUROPHYSIOL, V72, P2167, DOI 10.1152/jn.1994.72.5.2167; Schinder AF, 2004, PHYSIOLOGY, V19, P253, DOI 10.1152/physiol.00012.2004; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; SERESS L, 1995, HIPPOCAMPUS, V5, P217, DOI 10.1002/hipo.450050308; Shapiro LA, 2007, BRAIN RES, V1149, P30, DOI 10.1016/j.brainres.2006.07.032; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; SORIANO E, 1993, J COMP NEUROL, V333, P435, DOI 10.1002/cne.903330309; STANDEN NB, 1978, J PHYSIOL-LONDON, V280, P169, DOI 10.1113/jphysiol.1978.sp012379; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	37	528	551	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					901	907		10.1038/nn.2156	http://dx.doi.org/10.1038/nn.2156			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18622400	Green Submitted, Green Accepted, Green Published			2022-12-24	WOS:000257969100015
J	Kim, S; Hwang, J; Lee, D				Kim, Soyoun; Hwang, Jaewon; Lee, Daeyeol			Prefrontal coding of temporally discounted values during intertemporal choice	NEURON			English	Article							ORBITOFRONTAL CORTEX; NEURONAL-ACTIVITY; DECISION-MAKING; ANTERIOR CINGULATE; CONTRASTING ROLES; EYE FIELDS; REWARD; TIME; DELAY; IMMEDIATE	Reward from a particular action is seldom immediate, and the influence of such delayed outcome on choice decreases with delay. It has been postulated that when faced with immediate and delayed rewards, decision makers choose the option with maximum temporally discounted value. We examined the preference of monkeys for delayed reward in an intertemporal choice task and the neural basis for real-time computation of temporally discounted values in the dorsolateral prefrontal cortex. During this task, the locations of the targets associated with small or large rewards and their corresponding delays were randomly varied. We found that prefrontal neurons often encoded the temporally discounted value of reward expected from a particular option. Furthermore, activity tended to increase when discounted values for targets were presented in the neuron's preferred direction, suggesting that activity related to temporally discounted values in the prefrontal cortex might determine the animal's behavior during intertemporal choice.	[Kim, Soyoun; Lee, Daeyeol] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Hwang, Jaewon] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	Yale University; University of Rochester	Lee, D (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA.	daeyeol.lee@yale.edu	Kim, Soyoun/A-2237-2010; Lee, Daeyeol/A-6794-2008	Lee, Daeyeol/0000-0003-3474-019X; Kim, Soyoun/0000-0003-1348-6401; Hwang, Jaewon/0000-0002-6847-0573	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048328] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS048328, P01 NS048328-040003] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Averbeck BB, 2006, NAT NEUROSCI, V9, P276, DOI 10.1038/nn1634; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cardinal RN, 2002, NEURAL NETWORKS, V15, P617, DOI 10.1016/S0893-6080(02)00053-9; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Hariri AR, 2006, J NEUROSCI, V26, P13213, DOI 10.1523/JNEUROSCI.3446-06.2006; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kalenscher T, 2005, CURR BIOL, V15, P594, DOI 10.1016/j.cub.2005.02.052; Kalenscher T, 2008, PROG NEUROBIOL, V84, P284, DOI 10.1016/j.pneurobio.2007.11.004; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Lee D, 2007, J NEUROSCI, V27, P8170, DOI 10.1523/JNEUROSCI.1561-07.2007; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Mazur J.E., 1987, QUANTITATIVE ANAL BE, V5, P55; Mazur JE, 2000, BEHAV PROCESS, V49, P1, DOI 10.1016/S0376-6357(00)00070-X; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Neter J., 1996, APPL LINEAR STAT MOD; PAWITAN Y., 2001, ALL LIKELIHOOD; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Richards JB, 1997, J EXP ANAL BEHAV, V67, P353, DOI 10.1901/jeab.1997.67-353; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Roesch MR, 2005, J NEUROPHYSIOL, V94, P2457, DOI 10.1152/jn.00373.2005; Roesch MR, 2005, J NEUROPHYSIOL, V94, P1469, DOI 10.1152/jn.00064.2005; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rosati AG, 2007, CURR BIOL, V17, P1663, DOI 10.1016/j.cub.2007.08.033; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Samuelson PA, 1936, REV ECON STUD, V4, P155; Schweighofer N, 2006, PLOS COMPUT BIOL, V2, P1349, DOI 10.1371/journal.pcbi.0020152; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Sohn JW, 2007, J NEUROSCI, V27, P13655, DOI 10.1523/JNEUROSCI.2982-07.2007; Stephens D.W., 1986, pi; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tobin H, 1996, ANIM LEARN BEHAV, V24, P168, DOI 10.3758/BF03198964; Tsujimoto S, 2005, J NEUROPHYSIOL, V93, P3687, DOI 10.1152/jn.01149.2004; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004; Wittmann M, 2008, TRENDS COGN SCI, V12, P7, DOI 10.1016/j.tics.2007.10.004; Wittmann M, 2007, EXP BRAIN RES, V179, P643, DOI 10.1007/s00221-006-0822-y; Zar JH, 1999, BIOSTATISTICAL ANAL	47	159	165	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 10	2008	59	1					161	172		10.1016/j.neuron.2008.05.010	http://dx.doi.org/10.1016/j.neuron.2008.05.010			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	327KU	18614037	Green Accepted, Bronze			2022-12-24	WOS:000257728800016
J	Lindsley, RC; Gill, JG; Murphy, TL; Langer, EM; Cai, M; Mashayekhi, M; Wang, W; Niwa, N; Nerbonne, JM; Kyba, M; Murphy, KM				Lindsley, R. Coleman; Gill, Jennifer G.; Murphy, Theresa L.; Langer, Ellen M.; Cai, Mi; Mashayekhi, Mona; Wang, Wei; Niwa, Noriko; Nerbonne, Jeanne M.; Kyba, Michael; Murphy, Kenneth M.			Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELL; SMOOTH-MUSCLE-CELL; CARDIAC GENE-EXPRESSION; PROGENITOR CELLS; BETA-CATENIN; PRECURSOR CELLS; HEART; MYOCARDIN; CARDIOMYOCYTE; CARDIOGENESIS	Wnt signaling is required for development of mesoderm-derived lineages and expression of transcription factors associated with the primitive streak. In a functional screen, we examined the mesoderm-inducing capacity of transcription factors whose expression was Wnt-dependent in differentiating ESCs. In contrast to many inactive factors, we found that mesoderm posterior 1 (Mesp1) promoted mesoderm development independently of Writ signaling. Transient Mesp1 expression in ESCs promotes changes associated with epithelial-mesenchymal transition (EMT) and induction of Snail, consistent with a role in gastrulation. Mesp1 expression also restricted the potential fates derived from ESCs, generating mesoderm progenitors with cardiovascular, but not hematopoietic, potential. Thus, in addition to its effects on EMT, Mesp1 may be capable of generating the recently identified multipotent cardiovascular progenitor from ESCs in vitro.	[Lindsley, R. Coleman; Gill, Jennifer G.; Murphy, Theresa L.; Langer, Ellen M.; Cai, Mi; Mashayekhi, Mona; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Wang, Wei; Niwa, Noriko; Nerbonne, Jeanne M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Kyba, Michael] Univ Texas SW Med Ctr Dallas, Ctr Dev Biol, Dallas, TX 75390 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	murphy@pathology.wustl.edu	Lindsley, Coleman/AAA-3040-2021; Cai, Mi/A-3380-2015; Cai, Mi/O-5355-2014	Gill, Jennifer/0000-0001-7167-7359; Kyba, Michael/0000-0002-5579-7534; Mashayekhi, Mona/0000-0003-0331-2395; Lindsley, Coleman/0000-0001-9822-806X	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL034161-20, R01-HL-34161, R01 HL081186, R01 HL034161] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081186, R01HL034161] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ai D, 2007, P NATL ACAD SCI USA, V104, P9319, DOI 10.1073/pnas.0701212104; Ball SG, 2007, INT J BIOCHEM CELL B, V39, P379, DOI 10.1016/j.biocel.2006.09.005; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cohen ED, 2007, J CLIN INVEST, V117, P1794, DOI 10.1172/JCI31731; COOPER TA, 1985, J BIOL CHEM, V260, P1140; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; D'Souza SL, 2005, BLOOD, V105, P3862, DOI 10.1182/blood-2004-09-3611; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Davidson B, 2005, DEVELOPMENT, V132, P4811, DOI 10.1242/dev.02051; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Eisenberg LM, 2006, DEV BIOL, V293, P305, DOI 10.1016/j.ydbio.2006.02.014; Filipeanu CM, 2001, EUR J PHARMACOL, V420, P9, DOI 10.1016/S0014-2999(01)01004-4; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Hukriede NA, 2003, DEV CELL, V4, P83, DOI 10.1016/S1534-5807(02)00398-2; Jin JP, 1996, GENE, V168, P217, DOI 10.1016/0378-1119(95)00803-9; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kelly RG, 2005, TRENDS CARDIOVAS MED, V15, P51, DOI 10.1016/j.tcm.2005.02.001; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Kyba M, 2003, P NATL ACAD SCI USA, V100, P11904, DOI 10.1073/pnas.1734140100; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Lien CL, 1999, DEVELOPMENT, V126, P75; Lin LZ, 2007, P NATL ACAD SCI USA, V104, P9313, DOI 10.1073/pnas.0700923104; Lindskog H, 2006, ARTERIOSCL THROM VAS, V26, P1457, DOI 10.1161/01.ATV.0000222925.49817.17; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lugus JJ, 2007, DEVELOPMENT, V134, P393, DOI 10.1242/dev.02731; Maeda J, 2006, DEV DYNAM, V235, P701, DOI 10.1002/dvdy.20686; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Minegishi N, 2003, BLOOD, V102, P896, DOI 10.1182/blood-2002-12-3809; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nakajima Y, 2006, DEVELOPMENT, V133, P2517, DOI 10.1242/dev.02422; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Nishimura G, 2006, DEV CELL, V11, P93, DOI 10.1016/j.devcel.2006.05.011; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; ROHWEDEL J, 1995, EXP CELL RES, V220, P92, DOI 10.1006/excr.1995.1295; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; RUZICKA DL, 1988, J CELL BIOL, V107, P2575, DOI 10.1083/jcb.107.6.2575; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Saga Y, 1996, DEVELOPMENT, V122, P2769; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Satou Y, 2004, DEVELOPMENT, V131, P2533, DOI 10.1242/dev.01145; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Searcy RD, 1998, DEVELOPMENT, V125, P4461; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takahashi Y, 2005, DEVELOPMENT, V132, P787, DOI 10.1242/dev.01597; Takahashi Y, 2007, DEV BIOL, V304, P593, DOI 10.1016/j.ydbio.2007.01.007; Tam PPL, 1997, DEVELOPMENT, V124, P1631; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tzahor E, 2007, DEV CELL, V13, P10, DOI 10.1016/j.devcel.2007.06.006; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; WOBUS AM, 1991, DIFFERENTIATION, V48, P173, DOI 10.1111/j.1432-0436.1991.tb00255.x; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093	70	154	163	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL	2008	3	1					55	68		10.1016/j.stem.2008.04.004	http://dx.doi.org/10.1016/j.stem.2008.04.004			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	325XO	18593559	Green Accepted, Bronze			2022-12-24	WOS:000257622300010
J	Elstrott, J; Anishchenko, A; Greschner, M; Sher, A; Litke, AM; Chichilnisky, EJ; Feller, MB				Elstrott, Justin; Anishchenko, Anastasia; Greschner, Martin; Sher, Alexander; Litke, Alan M.; Chichilnisky, E. J.; Feller, Marla B.			Direction selectivity in the retina is established independent of visual experience and cholinergic retinal waves	NEURON			English	Article							DEVELOPING MAMMALIAN RETINA; STARBURST AMACRINE CELLS; GANGLION-CELLS; RABBIT RETINA; MOUSE RETINA; MICE LACKING; SYSTEM DEVELOPMENT; RECEPTIVE-FIELDS; PRIMATE RETINA; IMAGE MOTION	Direction selectivity in the retina requires the asymmetric wiring of inhibitory inputs onto four subtypes of On-Off direction-selective ganglion cells (DSGCs), each preferring motion in one of four cardinal directions. The primary model for the development of direction selectivity is that patterned activity plays an instructive role. Here, we use a unique, large-scale multielectrocle array to demonstrate that DSGCs are present at eye opening, in mice that have been reared in darkness and in mice that lack cholinergic retinal waves. These data suggest that direction selectivity in the retina is established largely independent of patterned activity and is therefore likely to emerge as a result of complex molecular interactions.	[Elstrott, Justin] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; [Anishchenko, Anastasia] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Greschner, Martin; Chichilnisky, E. J.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Sher, Alexander; Litke, Alan M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Feller, Marla B.] Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; University of California System; University of California Santa Cruz; University of California System; University of California Berkeley	Elstrott, J (corresponding author), Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA.	jelstrott@gmail.com		Sher, Alexander/0000-0001-6655-6456; Elstrott, Justin/0000-0001-6694-5929; Chichilnisky, E.J./0000-0002-5613-0248	NEI NIH HHS [R01 EY018003, R01EY13528, R01 EY019498-01, R01 EY013528, EY018003, R01 EY013528-02, R01 EY019498] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013528, R01EY018003, R01EY019498] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMTHOR FR, 1995, P NATL ACAD SCI USA, V92, P4002, DOI 10.1073/pnas.92.9.4002; Bansal A, 2000, J NEUROSCI, V20, P7672; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BOWEANDERS C, 1975, BRAIN RES, V87, P61, DOI 10.1016/0006-8993(75)90779-9; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; DAW NW, 1974, J PHYSIOL-LONDON, V240, P309, DOI 10.1113/jphysiol.1974.sp010612; Demas J, 2003, J NEUROSCI, V23, P2851; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Faulstich BM, 2004, VISION RES, V44, P3419, DOI 10.1016/j.visres.2004.09.006; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Frechette ES, 2005, J NEUROPHYSIOL, V94, P119, DOI 10.1152/jn.01175.2004; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Grubb MS, 2004, CURR OPIN NEUROBIOL, V14, P503, DOI 10.1016/j.conb.2004.06.006; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Jeon CJ, 2002, J COMP NEUROL, V449, P195, DOI 10.1002/cne.10288; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; MASLAND RH, 1977, J COMP NEUROL, V175, P275, DOI 10.1002/cne.901750303; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; McMullen CA, 2004, J NEUROSCI, V24, P161, DOI 10.1523/JNEUROSCI.3234-03.2004; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; RUSOFF AC, 1977, J NEUROPHYSIOL, V40, P1188, DOI 10.1152/jn.1977.40.5.1188; Sernagor E, 2001, PROG RETIN EYE RES, V20, P139, DOI 10.1016/S1350-9462(00)00024-0; Sernagor E, 1996, CURR BIOL, V6, P1503, DOI 10.1016/S0960-9822(96)00755-5; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13, DOI 10.1146/annurev.ne.07.030184.000305; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Stahl JS, 2004, VISION RES, V44, P3401, DOI 10.1016/j.visres.2004.09.011; STEWART DL, 1971, J NEUROPHYSIOL, V34, P139, DOI 10.1152/jn.1971.34.1.139; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tian N, 2001, NEURON, V32, P439, DOI 10.1016/S0896-6273(01)00470-6; TOOTLE JS, 1993, J NEUROPHYSIOL, V69, P1645, DOI 10.1152/jn.1993.69.5.1645; Torborg C, 2004, VISION RES, V44, P3347, DOI 10.1016/j.visres.2004.08.015; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; VANEY DI, 1981, BRAIN RES, V212, P447, DOI 10.1016/0006-8993(81)90476-5; Vaney DI, 2002, CURR OPIN NEUROBIOL, V12, P405, DOI 10.1016/S0959-4388(02)00337-9; Wang GY, 2001, J NEUROSCI, V21, P4310, DOI 10.1523/JNEUROSCI.21-12-04310.2001; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Xu W, 1999, J NEUROSCI, V19, P9298; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015; Zhou ZJ, 1998, J NEUROSCI, V18, P4155	60	100	103	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 22	2008	58	4					499	506		10.1016/j.neuron.2008.03.013	http://dx.doi.org/10.1016/j.neuron.2008.03.013			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304PD	18498732	Bronze, Green Accepted			2022-12-24	WOS:000256120500005
J	Ficara, F; Murphy, MJ; Lin, M; Cleary, ML				Ficara, Francesca; Murphy, Mark J.; Lin, Min; Cleary, Michael L.			Pbx1 regulates self-renewal of long-term hematopoietic stem cells by maintaining their quiescence	CELL STEM CELL			English	Article							MOUSE BONE-MARROW; GENE-EXPRESSION; MICE; DIFFERENTIATION; BETA; PROTOONCOGENE; PROLIFERATION; PROGENITORS; HIBERNATION; MODEL	Self-renewal is a defining characteristic of stem cells; however, the molecular pathways underlying its regulation are poorly understood. Here, we demonstrate that conditional inactivation of the Pbx1 proto-oncogene in the hematopoietic compartment results in a progressive loss of long-term hematopoietic stem cells (LT-HSCs) that is associated with concomitant reduction in their quiescence, leading to a defect in the maintenance of self-renewal as assessed by serial transplantation. Transcriptional profiling revealed that multiple stem cell maintenance factors are perturbed in Pbx1-deficient LT-HSCs, which prematurely express a large subset of genes, including cell-cycle regulators, normally expressed in non-self-renewing multipotent progenitors. A significant proportion of Pbx1-dependent genes is associated with the TGF-beta pathway, which serves a major role in maintaining HSC quiescence. Prospectively isolated, Pbx1-deficient LT-HSCs display altered transcriptional responses to TGF-beta stimulation in vitro, suggesting a possible mechanism through which Pbx1 maintenance of stem cell quiescence may in part be achieved.	[Ficara, Francesca; Murphy, Mark J.; Lin, Min; Cleary, Michael L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University	Cleary, ML (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	mcleary@stanford.edu	Ficara, Francesca/M-4624-2016	Ficara, Francesca/0000-0003-1873-1189	NCI NIH HHS [CA90735, R01 CA090735-08, R01 CA090735-06, CA42971, R01 CA090735-07, R37 CA042971, R01 CA090735] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090735, R01CA042971, R37CA042971] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akala OO, 2006, CURR OPIN GENET DEV, V16, P496, DOI 10.1016/j.gde.2006.08.011; Bailey JS, 2004, MOL ENDOCRINOL, V18, P1158, DOI 10.1210/me.2003-0442; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Blank U, 2006, BLOOD, V108, P4246, DOI 10.1182/blood-2006-02-005611; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Brendolan A, 2005, DEVELOPMENT, V132, P3113, DOI 10.1242/dev.01884; Bromleigh VC, 2000, GENE DEV, V14, P2581, DOI 10.1101/gad.817100; Cellot S, 2007, CELL, V129, P239, DOI 10.1016/j.cell.2007.04.002; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim SK, 2002, NAT GENET, V30, P430, DOI 10.1038/ng860; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krosl J, 2003, IMMUNITY, V18, P561, DOI 10.1016/S1074-7613(03)00090-6; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Manley NR, 2004, DEV BIOL, V276, P301, DOI 10.1016/j.ydbio.2004.08.030; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Sanyal M, 2007, BLOOD, V109, P4191, DOI 10.1182/blood-2006-10-054213; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Schnabel CA, 2003, GENESIS, V37, P123, DOI 10.1002/gene.10235; Schnabel CA, 2003, DEV BIOL, V254, P262, DOI 10.1016/S0012-1606(02)00038-6; Selleri L, 2001, DEVELOPMENT, V128, P3543; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Umemoto T, 2005, BIOCHEM BIOPH RES CO, V337, P14, DOI 10.1016/j.bbrc.2005.09.008; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Yamazaki S, 2007, ANN NY ACAD SCI, V1106, P54, DOI 10.1196/annals.1392.017; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Zhong JF, 2005, P NATL ACAD SCI USA, V102, P2448, DOI 10.1073/pnas.0409459102	42	165	169	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY	2008	2	5					484	496		10.1016/j.stem.2008.03.004	http://dx.doi.org/10.1016/j.stem.2008.03.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	300BM	18462698	Bronze, Green Accepted			2022-12-24	WOS:000255799300013
J	Izuma, K; Saito, DN; Sadato, N				Izuma, Keise; Saito, Daisuke N.; Sadato, Norihiro			Processing of social and monetary rewards in the human striatum	NEURON			English	Article							EVENT-RELATED FMRI; NEURAL BASIS; ORBITOFRONTAL CORTEX; PREDICTION ERRORS; DECISION-MAKING; MUSIC CORRELATE; BRAIN-REGIONS; RESPONSES; DOPAMINE; SELF	Despite an increasing focus on the neural basis of human decision making in neuroscience, relatively little attention has been paid to decision making in social settings. Moreover, although human social decision making has been explored in a social psychology context, few neural explanations for the observed findings have been considered. To bridge this gap and improve models of human social decision making, we investigated whether acquiring a good reputation, which is an important incentive in human social behaviors, activates the same reward circuitry as monetary rewards. In total, 19 subjects participated in functional magnetic resonance imaging (fMRI) experiments involving monetary and social rewards. The acquisition of one's good reputation robustly activated reward-related brain areas, notably the striatum, and these overlapped with the areas activated by monetary rewards. Our findings support the idea of a "common neural currency" for rewards and represent an important first step toward a neural explanation for complex human social behaviors.	[Izuma, Keise; Saito, Daisuke N.; Sadato, Norihiro] Natl Inst Physiol Sci, Dept Cerebral Res, Div Cerebral Integrat, Aichi, Japan; [Izuma, Keise; Sadato, Norihiro] Grad Univ Adv Studies, Dept Physiol Sci, Sch Life Sci, Kanagawa, Japan; [Saito, Daisuke N.; Sadato, Norihiro] Japan Sci & Technol Agcy, Res Inst Sci & Technol Soc RISTEX, Tokyo, Japan; [Sadato, Norihiro] Univ Fukui, BIRC, Fukui 910, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); University of Fukui	Sadato, N (corresponding author), Natl Inst Physiol Sci, Dept Cerebral Res, Div Cerebral Integrat, Aichi, Japan.	sadato@nips.ac.jp	sarinopoulos, isidoros/B-5453-2010	Sadato, Norihiro/0000-0002-9786-3907				Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; Bandura A., 1971, SOCIAL LEARNING THEO; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Benabou R, 2006, AM ECON REV, V96, P1652, DOI 10.1257/aer.96.5.1652; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Costa Jr P. T., 1989, NEO PI FFI MANUAL S; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Hamann S, 2002, NEUROREPORT, V13, P15, DOI 10.1097/00001756-200201210-00008; HOMANS GC, 1958, AM J SOCIOL, V63, P597, DOI 10.1086/222355; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; KREPS DM, 1982, J ECON THEORY, V27, P253, DOI 10.1016/0022-0531(82)90030-8; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Kurzban R, 2007, EVOL HUM BEHAV, V28, P75, DOI 10.1016/j.evolhumbehav.2006.06.001; Kwan VSY, 2004, PSYCHOL REV, V111, P94, DOI 10.1037/0033-295X.111.1.94; Lawler EJ, 1999, ANNU REV SOCIOL, V25, P217, DOI 10.1146/annurev.soc.25.1.217; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Milinski M, 2001, P ROY SOC B-BIOL SCI, V268, P2495, DOI 10.1098/rspb.2001.1809; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; PAULHUS DL, 1984, J PERS SOC PSYCHOL, V46, P598, DOI 10.1037/0022-3514.46.3.598; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; ROSENGERG M, 1965, SOC ADOLESCENT SELF; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Thibaut J., 1959, SOCIAL PSYCHOL GROUP; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Volkow ND, 2002, SYNAPSE, V44, P175, DOI 10.1002/syn.10075; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zald DH, 2004, J NEUROSCI, V24, P4105, DOI 10.1523/JNEUROSCI.4643-03.2004	76	540	557	2	109	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 24	2008	58	2					284	294		10.1016/j.neuron.2008.03.020	http://dx.doi.org/10.1016/j.neuron.2008.03.020			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292YX	18439412	Bronze			2022-12-24	WOS:000255303100015
J	Zink, CF; Tong, YX; Chen, Q; Bassett, DS; Stein, JL; Meyer-Lindenberg, A				Zink, Caroline F.; Tong, Yunxia; Chen, Qiang; Bassett, Danielle S.; Stein, Jason L.; Meyer-Lindenberg, Andreas			Know your place: Neural processing of social hierarchy in humans	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; RHESUS MACAQUES; MOTOR AREAS; FMRI; ACTIVATION; DOMINANCE; HEALTH; AGGRESSION	Social hierarchies guide behavior in many species, including humans, where status also has an enormous impact on motivation and health. However, little is known about the underlying neural representation of social hierarchies in humans. In the present study, we identify dissociable neural responses to perceived social rank using functional magnetic resonance imaging (fMRI) in an interactive, simulated social context. In both stable and unstable social hierarchies, viewing a superior individual differentially engaged perceptual-attentional, saliency, and cognitive systems, notably dorsolateral prefrontal cortex. In the unstable hierarchy setting, additional regions related to emotional processing (amygdala), social cognition (medial prefrontal cortex), and behavioral readiness were recruited. Furthermore, social hierarchical consequences of performance were neurally dissociable and of comparable salience to monetary reward, providing a neural basis for the high motivational value of status. Our results identify neural mechanisms that may mediate the enormous influence of social status on human behavior and health.	[Zink, Caroline F.; Tong, Yunxia; Bassett, Danielle S.; Stein, Jason L.; Meyer-Lindenberg, Andreas] NIMH, Unit Syst Neurosci Psychiat, Genes Cognit & Psychosis Program, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Chen, Qiang; Stein, Jason L.; Meyer-Lindenberg, Andreas] NIMH, Neuroimaging Core Facil, Genes Cognit & Psychosis Program, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Meyer-Lindenberg, Andreas] Cent Inst Mental Hlth, D-68159 Mannheim, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Central Institute of Mental Health	Zink, CF (corresponding author), NIMH, Unit Syst Neurosci Psychiat, Genes Cognit & Psychosis Program, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	zinkc@mail.nih.gov; a.meyer-lindenberg@zi-mannheim.de	chen, qiang/GWZ-7308-2022; chen, qiang/HGU-5418-2022; Tong, Yunxia/C-1276-2010; Meyer-Lindenberg, Andreas/H-1076-2011	Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Stein, Jason/0000-0003-4829-0513	Intramural NIH HHS [Z99 MH999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abler B, 2005, NEUROREPORT, V16, P669, DOI 10.1097/00001756-200505120-00003; Adolphs R, 2003, ANN NY ACAD SCI, V985, P326; Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; ARNODIO DM, 2006, NAT REV NEUROSCI, V7, P268; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Boyce WT, 2004, ANN NY ACAD SCI, V1036, P47, DOI 10.1196/annals.1330.003; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; Britton JC, 2006, NEUROIMAGE, V31, P397, DOI 10.1016/j.neuroimage.2005.11.027; Cummins DD, 2000, SYNTHESE, V122, P3, DOI 10.1023/A:1005263825428; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Karafin MS, 2004, J COGNITIVE NEUROSCI, V16, P1796, DOI 10.1162/0898929042947856; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Lotze M, 2007, NEUROIMAGE, V34, P470, DOI 10.1016/j.neuroimage.2006.09.028; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Mehrabian A, 1996, CURR PSYCHOL, V14, P261, DOI 10.1007/BF02686918; Mehrabian A, 1994, MANUAL REVISED TRAIT; Mitchell JP, 2005, NEUROIMAGE, V26, P251, DOI 10.1016/j.neuroimage.2005.01.031; Moors A, 2005, EXP PSYCHOL, V52, P296, DOI 10.1027/1618-3169.52.4.296; Moskowitz DS, 2001, NEUROPSYCHOPHARMACOL, V25, P277, DOI 10.1016/S0893-133X(01)00219-6; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; PORK MR, 1991, JAPANESE KOREAN LING, V1; Rilling JK, 2004, BIOL PSYCHIAT, V56, P364, DOI 10.1016/j.biopsych.2004.06.027; Sapolsky RM, 2004, ANNU REV ANTHROPOL, V33, P393, DOI 10.1146/annurev.anthro.33.070203.144000; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Talairach J., 1988, COPLANAR STEREOTAXIC; WHEELER L, 1966, J EXP SOC PSYCHOL, V2, P1, DOI 10.1016/0022-1031(66)90002-3; Zink CF, 2006, NEUROIMAGE, V29, P977, DOI 10.1016/j.neuroimage.2005.08.006	35	364	370	6	92	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 24	2008	58	2					273	283		10.1016/j.neuron.2008.01.025	http://dx.doi.org/10.1016/j.neuron.2008.01.025			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292YX	18439411	Green Accepted, Bronze			2022-12-24	WOS:000255303100014
J	Pennuto, M; Tinelli, E; Malaguti, M; Del Carro, U; D'Antonio, M; Ron, D; Quattrini, A; Feltri, ML; Wrabetz, L				Pennuto, Maria; Tinelli, Elisa; Malaguti, MariaChiara; Del Carro, Ubaldo; D'Antonio, Maurizio; Ron, David; Quattrini, Angelo; Feltri, M. Laura; Wrabetz, Lawrence			Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1 B mice	NEURON			English	Article							UNFOLDED PROTEIN RESPONSE; DISEASE HEREDITARY MOTOR; PERIPHERAL-NERVE MYELIN; NEUROPATHY TYPE-III; FACTOR 2B COMPLEX; ENDOPLASMIC-RETICULUM; SCHWANN-CELLS; TRANSGENIC MICE; MESSENGER-RNA; STRESS	Deletion of serine 63 from PO glycoprotein (POS63del) causes Charcot-Marie-Tooth 1 B neuropathy in humans, and POS63del produces a similar demyelinating neuropathy in transgenic mice. POS63del is retained in the endoplasmic reticulum and fails to be incorporated into myelin. Here we report that POS63clel is mis-folded and Schwann cells mount a consequential canonical unfolded protein response (UPR), including expression of the transcription factor CHOP, previously associated with apoptosis in ER-stressed cells. UPR activation and CHOP expression respond dynamically to POS63del levels and are reversible but are associated with only limited apoptosis of Schwann cells. Nonetheless, Chop ablation in S63del mice completely rescues their motor deficit and reduces active demyelination 2-fold. This indicates that signaling through the CHOP arm of the UPR provokes demyelination in inherited neuropathy. S63del mice also provide an opportunity to explore how cells can dysfunction yet survive in prolonged ER stress-important for neurodegeneration related to misfolded proteins.	[Pennuto, Maria; Tinelli, Elisa; D'Antonio, Maurizio; Feltri, M. Laura; Wrabetz, Lawrence] Ist Sci San Raffaele, DIBIT, I-20132 Milan, Italy; [Malaguti, MariaChiara; Del Carro, Ubaldo; Quattrini, Angelo] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy; [Ron, David] NYU, Sch Med, Skirball Inst, New York, NY 10016 USA	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; New York University	Wrabetz, L (corresponding author), Ist Sci San Raffaele, DIBIT, Via Olgettina 58, I-20132 Milan, Italy.	wrabetz.lawrence@hsr.it	Feltri, Maria Laura/J-5286-2018; D'Antonio, Maurizio/AHI-1781-2022; Del Carro, Ubaldo/AAO-3457-2020; Pennuto, Maria/E-3270-2019; Quattrini, Angelo/J-8373-2018	D'Antonio, Maurizio/0000-0003-0637-8971; Del Carro, Ubaldo/0000-0003-3301-5412; Pennuto, Maria/0000-0001-8634-0767; Quattrini, Angelo/0000-0002-8226-8320; Ron, David/0000-0002-3014-5636	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK047119, R01DK047119, R37DK047119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055256, R01NS045630] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47119, R37 DK047119-14, R37 DK047119, R01 DK047119] Funding Source: Medline; NIEHS NIH HHS [R01 ES008681-12, ES08681, R01 ES008681] Funding Source: Medline; NINDS NIH HHS [R01 NS045630, R01 NS055256-03, R01 NS055256, R01 NS045630-09, NS55256, NS45630, R01 NS045630-05A1] Funding Source: Medline; Telethon [GGP07100] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; BlanquetGrossard F, 1995, CLIN GENET, V48, P281; Bolino A, 2004, J CELL BIOL, V167, P711, DOI 10.1083/jcb.200407010; Bolis A, 2005, J NEUROSCI, V25, P8567, DOI 10.1523/JNEUROSCI.2493-05.2005; Court FA, 2008, GLIA, V56, P471, DOI 10.1002/glia.20620; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; Fortun J, 2003, J NEUROSCI, V23, P10672; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; HAYASAKA K, 1993, NAT GENET, V5, P266, DOI 10.1038/ng1193-266; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Ikegami T, 1996, BIOCHEM BIOPH RES CO, V222, P107, DOI 10.1006/bbrc.1996.0705; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kirschner D. A., 2004, MYELIN BIOL DISORDER, V1, P523; KNAPP PE, 1986, J NEUROSCI, V6, P2813; KULKENS T, 1993, NAT GENET, V5, P35, DOI 10.1038/ng0993-35; Li W, 2004, MOL CELL BIOL, V24, P3295, DOI 10.1128/MCB.24.8.3295-3306.2004; Lin WS, 2005, J CELL BIOL, V169, P603, DOI 10.1083/jcb.200502086; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; McLaughlin M, 2007, NEUROCHEM RES, V32, P167, DOI 10.1007/s11064-006-9122-y; MESSING A, 1992, NEURON, V8, P507, DOI 10.1016/0896-6273(92)90279-M; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Occhi S, 2005, J NEUROSCI, V25, P9418, DOI 10.1523/JNEUROSCI.2068-05.2005; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Pareek S, 1997, J NEUROSCI, V17, P7754; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; Previtali SC, 2000, J CELL BIOL, V151, P1035, DOI 10.1083/jcb.151.5.1035; Quattrini A, 1996, GLIA, V17, P294, DOI 10.1002/(SICI)1098-1136(199608)17:4<294::AID-GLIA4>3.0.CO;2-#; Richardson JP, 2004, MOL CELL BIOL, V24, P2352, DOI 10.1128/MCB.24.6.2352-2363.2004; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Sancho S, 2001, BRAIN, V124, P2177, DOI 10.1093/brain/124.11.2177; Shames I, 2003, J NEUROPATH EXP NEUR, V62, P751, DOI 10.1093/jnen/62.7.751; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; Sharma R, 2007, J NEUROCHEM, V101, P889, DOI 10.1111/j.1471-4159.2007.04541.x; Shy ME, 2005, PERIPHERAL NEUROPATH, P1681; Southwood CM, 2002, NEURON, V36, P585, DOI 10.1016/S0896-6273(02)01045-0; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Taveggia C, 1998, J BIOL CHEM, V273, P27741, DOI 10.1074/jbc.273.42.27741; Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016/j.molcel.2004.08.029; TRAPP BD, 1988, J NEUROSCI, V8, P3515; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Wood M, 2007, PLOS GENET, V3, P845, DOI 10.1371/journal.pgen.0030109; Wrabetz L, 2006, J NEUROSCI, V26, P2358, DOI 10.1523/JNEUROSCI.3819-05.2006; Wrabetz L, 2000, J CELL BIOL, V148, P1021, DOI 10.1083/jcb.148.5.1021; WRABETZ L, 2004, MYELIN BIOL DISORDER, P905; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yin X, 2000, J CELL BIOL, V148, P1009, DOI 10.1083/jcb.148.5.1009; Yin XH, 2004, J NEUROSCI, V24, P3890, DOI 10.1523/JNEUROSCI.4617-03.2004; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	64	201	206	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 7	2008	57	3					393	405		10.1016/j.neuron.2007.12.021	http://dx.doi.org/10.1016/j.neuron.2007.12.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261JQ	18255032	Bronze, Green Accepted			2022-12-24	WOS:000253075300009
J	Wang, T; Wang, XY; Xie, Q; Montell, C				Wang, Tao; Wang, Xiaoyue; Xie, Qiang; Montell, Craig			The SOCS box protein STOPS is required for phototransduction through its effects on phospholipase C	NEURON			English	Article							GTPASE-ACTIVATING PROTEIN; IN-VIVO; DROSOPHILA PHOTOTRANSDUCTION; RETINAL DEGENERATION; LIGHT RESPONSE; PDZ-DOMAIN; NORPA GENE; CELL-DEATH; VITAMIN-A; KINASE-C	Phosphoinositide-specific phospholipase C (PLC) isozymes play roles in a diversity of processes including Drosophila phototransduction. In fly photoreceptor cells, the PLC P encoded by norpA is critical for activation of TRP channels. Here, we describe a PLC beta regulator, STOPS, which encodes a SOCS box protein. Mutation of stops resulted in a reduced concentration of NORPA and a defect in stopping signaling following cessation of the light stimulus. NORPA has been proposed to have dual roles as a PLC- and GTPase-activating protein (GAP). We found that the slow termination resulting from expressing low levels of wild-type NORPA was suppressed by addition of normal amounts of an altered NORPA, which had wild-type GAP activity, but no PLC activity. STOPS is the first protein identified that specifically regulates PLC beta protein concentration. Moreover, this work demonstrates that a PLC beta derivative that does not promote TRP channel activation, still contributes to signaling in vivo.	[Wang, Tao; Wang, Xiaoyue; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Biol Chem & Neurosci, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Xie, Qiang] Indiana Univ, Sch Optometry, Bloomington, IN 47405 USA	Johns Hopkins University; Indiana University System; Indiana University Bloomington	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem & Neurosci, Ctr Sensory Biol, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Wang, Xiaoyue/D-1046-2010; Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Wang, Tao/0000-0002-2395-3483	NEI NIH HHS [EY08117, R01 EY010852-14, R01 EY008117-19, EY10852, R01 EY008117, R01 EY010852] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010852, R01EY008117] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Cook B, 2000, NAT CELL BIOL, V2, P296, DOI 10.1038/35010571; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Gu G, 2004, J BIOL CHEM, V279, P18608, DOI 10.1074/jbc.M400323200; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; HARDIE RC, 1991, J NEUROSCI, V11, P3079; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hilton DJ, 1999, CELL MOL LIFE SCI, V55, P1568, DOI 10.1007/s000180050396; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; KIM S, 1995, J BIOL CHEM, V270, P14376, DOI 10.1074/jbc.270.24.14376; Kimple ME, 2001, EMBO J, V20, P4414, DOI 10.1093/emboj/20.16.4414; Lee SB, 1996, BLOOD, V88, P1684; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; PAK WL, 1976, SCIENCE, V194, P956, DOI 10.1126/science.824732; Paulssen RH, 1996, J BIOL CHEM, V271, P26622, DOI 10.1074/jbc.271.43.26622; Pearn MT, 1996, J BIOL CHEM, V271, P4937; Popescu DC, 2006, J NEUROSCI, V26, P8570, DOI 10.1523/JNEUROSCI.1478-06.2006; Sagoo MS, 1997, NATURE, V389, P392, DOI 10.1038/38750; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Shieh BH, 1997, P NATL ACAD SCI USA, V94, P12682, DOI 10.1073/pnas.94.23.12682; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stowers RS, 1999, GENETICS, V152, P1631; Thummel CS, 1992, DROS INF SERV, V71, P150; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wang T, 2005, NEURON, V45, P367, DOI 10.1016/j.neuron.2004.12.046; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang T, 2007, J CELL BIOL, V177, P305, DOI 10.1083/jcb.200610081; Wang T, 2006, J NEUROSCI, V26, P12816, DOI 10.1523/JNEUROSCI.3673-06.2006; Wes PD, 1999, NAT NEUROSCI, V2, P447, DOI 10.1038/8116; Wilcox A, 2004, J BIOL CHEM, V279, P38881, DOI 10.1074/jbc.M406101200; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Xu H, 2004, EMBO J, V23, P811, DOI 10.1038/sj.emboj.7600112; Yang J, 2007, MOL CELL NEUROSCI, V35, P49, DOI 10.1016/j.mcn.2007.02.001; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; ZHU LQ, 1993, J BIOL CHEM, V268, P15994	51	18	18	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 10	2008	57	1					56	68		10.1016/j.neuron.2007.11.020	http://dx.doi.org/10.1016/j.neuron.2007.11.020			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	250YZ	18184564	Green Accepted, Bronze			2022-12-24	WOS:000252338600009
J	Nielsen, KJ; Callaway, EM				Nielsen, Kristina J.; Callaway, Edward M.			More than a feeling: sensation from cortical stimulation	NATURE NEUROSCIENCE			English	Editorial Material							EYE-MOVEMENTS; MICROSTIMULATION	Changes in neuronal firing underlie sensation, but how many neurons are needed to perceive these activity shifts? Two new studies in Nature suggest that the experimental modulation of only a few neurons can influence perception.	[Nielsen, Kristina J.; Callaway, Edward M.] Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA	Salk Institute	Nielsen, KJ (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	callaway@salk.edu	Nielsen, Kristina/M-2298-2016; Callaway, Edward/D-4336-2011	Nielsen, Kristina/0000-0002-9155-2972; Callaway, Edward/0000-0002-6366-5267	NEI NIH HHS [R01 EY010742-16, R01 EY010742] Funding Source: Medline; NIMH NIH HHS [R01 MH063912-08, R01 MH063912] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Fritsch G, 1870, ARCH ANAT PHYSL WISS, V37, P300, DOI 10.1007/bf01759916; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; HOUWELING AR, 2007, NATURE ADV ONLINE PU; HUBER D, 2007, NATURE ADV ONLINE PU; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	15	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					10	12		10.1038/nn0108-10	http://dx.doi.org/10.1038/nn0108-10			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18160957	Green Accepted			2022-12-24	WOS:000252117900005
J	Jinushi-Nakao, S; Arvind, R; Amikura, R; Kinameri, E; Liu, AW; Moore, AW				Jinushi-Nakao, Shiho; Arvind, Ramanathan; Amikura, Reiko; Kinameri, Emi; Liu, Andrew Winston; Moore, Adrian Walton			Knot/Collier and cut control different aspects of dendrite cytoskeleton and synergize to define final arbor shape	NEURON			English	Article							HEREDITARY SPASTIC PARAPLEGIA; TRANSCRIPTION FACTORS; SENSORY NEURONS; DROSOPHILA; PROTEIN; MICROTUBULE; MECHANISMS; GROWTH; GENE; EXPRESSION	In a complex nervous system, neuronal functional diversity is reflected in the wide variety of dendritic arbor shapes. Different neuronal classes are defined by class-specific transcription factor combinatorial codes. We show that the combination of the transcription factors Knot and Cut is particular to Drosophila class IV dendritic arborization (da) neurons. Knot and Cut control different aspects of the dendrite cytoskeleton, promoting microtubule- and actin-based dendritic arbors, respectively. Knot delineates class IV arbor morphology by simultaneously synergizing with Cut to promote complexity and repressing Cut-mediated promotion of dendritic filopodia/spikes. Knot increases dendritic arbor outgrowth through promoting the expression of Spastin, a microtubule-severing protein disrupted in autosomal dominant hereditary spastic paraplegia (AD-HSP). Knot and Cut may modulate cellular mechanisms that are conserved between Drosophila and vertebrates. Hence, this study gives significant general insight into how multiple transcription factors combine to control class-specific dendritic arbor morphology through controlling different aspects of the cytoskeleton.	[Jinushi-Nakao, Shiho; Arvind, Ramanathan; Amikura, Reiko; Kinameri, Emi; Liu, Andrew Winston; Moore, Adrian Walton] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan	RIKEN	Moore, AW (corresponding author), RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan.	adrianm@brain.riken.jp	Moore, Adrian W/A-3339-2013; Moore, Adrian Walton/AAN-5656-2021	Moore, Adrian W/0000-0002-8242-301X; Moore, Adrian Walton/0000-0002-8242-301X				Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Andersen R, 2005, J NEUROSCI, V25, P8878, DOI 10.1523/JNEUROSCI.2005-05.2005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Croci L, 2006, DEVELOPMENT, V133, P2719, DOI 10.1242/dev.02437; Crozatier M, 1996, CURR BIOL, V6, P707, DOI 10.1016/S0960-9822(09)00452-7; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dubois L, 2001, MECH DEVELOP, V108, P3, DOI 10.1016/S0925-4773(01)00486-5; Dutta D, 2002, GENESIS, V34, P146, DOI 10.1002/gene.10113; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Grabham PW, 2003, J CELL SCI, V116, P3739, DOI 10.1242/jcs.00686; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Iulianella A, 2003, GENE EXPR PATTERNS, V3, P571, DOI 10.1016/S1567-133X(03)00123-6; Kammermeier L, 2003, DEV GENES EVOL, V213, P412, DOI 10.1007/s00427-003-0340-x; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Lai EC, 2004, DEV BIOL, V269, P1, DOI 10.1016/j.ydbio.2004.01.032; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li WJ, 2004, NEURON, V43, P823, DOI 10.1016/j.neuron.2004.08.040; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; McMonagle P, 2004, NEUROLOGY, V62, P407, DOI 10.1212/01.WNL.0000108629.04434.05; Nestoras K, 1997, GENETICS, V147, P1203; Orgogozo V, 2004, MECH DEVELOP, V121, P427, DOI 10.1016/j.mod.2004.04.001; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Sugimura K, 2004, NEURON, V43, P809, DOI 10.1016/j.neuron.2004.08.016; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; Wang SS, 1997, J NEUROSCI, V17, P4149; Wang XN, 2007, NAT NEUROSCI, V10, P177, DOI 10.1038/nn1841; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Williams DW, 2004, J NEUROSCI, V24, P1541, DOI 10.1523/JNEUROSCI.4521-03.2004; Wood JD, 2006, HUM MOL GENET, V15, P2763, DOI 10.1093/hmg/ddl212; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011	41	134	135	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 20	2007	56	6					963	978		10.1016/j.neuron.2007.10.031	http://dx.doi.org/10.1016/j.neuron.2007.10.031			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	248FP	18093520	Bronze			2022-12-24	WOS:000252138000007
J	Foffani, G; Uzcategui, YG; Gal, B; de la Prida, LM				Foffani, Guglielmo; Uzcategui, Yoryani G.; Gal, Beatriz; de la Prida, Liset Menendez			Reduced spike-timing reliability correlates with the emercience of fast ripples in the rat epileptic hippocampus	NEURON			English	Article							HIGH-FREQUENCY OSCILLATIONS; TEMPORAL-LOBE EPILEPSY; DENTATE GRANULE CELLS; PYRAMIDAL CELLS; IN-VITRO; SLEEP SPINDLES; BEHAVING RAT; KAINIC ACID; H-CHANNELS; NETWORK	Ripples are sharp-wave-associated field oscillations (100-300 Hz) recorded in the hippocampus during behavioral immobility and slow-wave sleep. In epileptic rats and humans, a different and faster oscillation (200-600Hz), termed fast ripples, has been described. However, the basic mechanisms are unknown. Here, we propose that fast ripples emerge from a disorganized ripple pattern caused by unreliable firing in the epileptic hippocampus. Enhanced synaptic activity is responsible for the irregular bursting of CA3 pyramidal cells due to large membrane potential fluctuations. Lower field interactions and a reduced spike-timing reliability concur with decreased spatial synchronization and the emergence of fast ripples. Reducing synaptically driven membrane potential fluctuations improves both spike-timing reliability and spatial synchronization and restores ripples in the epileptic hippocampus. Conversely, a lower spike-timing reliability, with reduced potassium currents, is associated with ripple shuffling in normal hippocampus. Therefore, fast ripples may reflect a pathological desynchronization of the normal ripple pattern.	Hosp Ramon & Cajal, E-28034 Madrid, Spain; Fdn Hosp Nacl Paraplejicos Invest Intergracion, SESCAM, Toledo 45071, Spain; Univ Europea Madrid, Madrid 28670, Spain	Hospital Universitario Ramon y Cajal; European University of Madrid	de la Prida, LM (corresponding author), CSIC, Inst Cajal, Av Doctor Arce 37, E-28002 Madrid, Spain.	lmprida@cajal.csic.es	de la Prida, Liset M/O-1342-2013; Gal, Beatriz/J-3530-2018; Foffani, Guglielmo/ABD-5897-2020	de la Prida, Liset M/0000-0002-0160-6472; Gal, Beatriz/0000-0001-5189-1147; Foffani, Guglielmo/0000-0001-7289-6668				Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; Bragin A, 2002, J NEUROSCI, V22, P2012, DOI 10.1523/JNEUROSCI.22-05-02012.2002; Bragin A, 2000, EPILEPSIA, V41, pS144, DOI 10.1111/j.1528-1157.2000.tb01573.x; Brown W., 1987, SURGICAL TREATMENT E, P511; Buzsaki G, 2005, NAT NEUROSCI, V8, P1418, DOI 10.1038/nn1105-1418; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; CLARK JW, 1970, BIOPHYS J, V10, P937, DOI 10.1016/S0006-3495(70)86344-5; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; de la Prida LM, 2004, J NEUROSCI, V24, P5525, DOI 10.1523/JNEUROSCI.0309-04.2004; de la Prida LM, 2006, NEURON, V49, P131, DOI 10.1016/j.neuron.2005.10.034; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Dzhala VI, 2004, J NEUROSCI, V24, P8896, DOI 10.1523/JNEUROSCI.3112-04.2004; ESCLAPEZ M, 1979, J STAT PHYSL, V21, P669; Foffani G, 2003, BRAIN, V126, P2153, DOI 10.1093/brain/awg229; FOX SE, 1981, EXP BRAIN RES, V41, P399; Grenier FO, 2001, J NEUROPHYSIOL, V86, P1884, DOI 10.1152/jn.2001.86.4.1884; Hirsch JC, 1999, NAT NEUROSCI, V2, P499, DOI 10.1038/9142; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Jirsch JD, 2006, BRAIN, V129, P1593, DOI 10.1093/brain/awl085; Jones MS, 1999, J NEUROPHYSIOL, V82, P1599, DOI 10.1152/jn.1999.82.3.1599; Kandel A, 1997, J NEUROSCI, V17, P6783; Khosravani H, 2005, EPILEPSIA, V46, P1188, DOI 10.1111/j.1528-1167.2005.65604.x; KLEE R, 1995, J NEUROPHYSIOL, V74, P1982, DOI 10.1152/jn.1995.74.5.1982; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Kubota D, 2003, J NEUROPHYSIOL, V89, P81, DOI 10.1152/jn.00542.2002; Lopez-Aguado L, 2001, NEUROSCIENCE, V108, P249, DOI 10.1016/S0306-4522(01)00417-1; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; NADLER JV, 1980, BRAIN RES, V182, P1; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shao LR, 2005, J NEUROPHYSIOL, V94, P952, DOI 10.1152/jn.01342.2004; Siddiqui AH, 2005, BRAIN RES, V1066, P129, DOI 10.1016/j.brainres.2005.10.066; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; SNOW RW, 1986, BRAIN RES, V367, P292, DOI 10.1016/0006-8993(86)91605-7; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; STORM JF, 1990, PROG BRAIN RES, V83, P161; SUZUKI SS, 1988, ELECTROEN CLIN NEURO, V69, P532, DOI 10.1016/0013-4694(88)90165-4; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Traub RD, 2000, J NEUROSCI, V20, P2086; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WONG RKS, 1981, J NEUROPHYSIOL, V45, P86, DOI 10.1152/jn.1981.45.1.86; YLINEN A, 1995, J NEUROSCI, V15, P30	52	179	183	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 20	2007	55	6					930	941		10.1016/j.neuron.2007.07.040	http://dx.doi.org/10.1016/j.neuron.2007.07.040			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	219IQ	17880896	Bronze			2022-12-24	WOS:000250078500010
J	Lu, J; Helton, TD; Blanpied, TA; Racz, B; Newpher, TM; Weinberg, RJ; Ehlers, MD				Lu, Jiuyi; Helton, Thomas D.; Blanpied, Thomas A.; Racz, Bence; Newpher, Thomas M.; Weinberg, Richard J.; Ehlers, Michael D.			Postsynaptic positioning of endocytic zones and AMPA receptor cycling by physical coupling of dynamin-3 to homer	NEURON			English	Article							DENDRITIC SPINES; GLUTAMATE RECEPTORS; SYNAPTIC-TRANSMISSION; RECYCLING ENDOSOMES; DENSITY PROTEINS; NMDA RECEPTORS; ACTIN DYNAMICS; TRAFFICKING; PLASTICITY; SYNAPSES	Endocytosis; of AMPA receptors and other postsynaptic cargo occurs at endocytic zones (EZs), stably positioned sites of clathrin adjacent to the postsynaptic density (PSD). The tight localization of postsynaptic endocytosis is thought to control spine composition and regulate synaptic transmission. However, the mechanisms that situate the EZ near the PSD and the role of spine endocytosis in synaptic transmission are unknown. Here, we report that a physical link between dynamin-3 and the postsynaptic adaptor Homer positions the EZ near the PSD. Disruption of dynamin-3 or its interaction with Homer uncouples the PSD from the EZ, resulting in synapses lacking postsynaptic clathrin. Loss of the EZ leads to a loss of synaptic AMPA receptors and reduced excitatory synaptic transmission that corresponds with impaired synaptic recycling. Thus, a physical link between the PSD and the EZ ensures localized endocytosis and recycling by recapturing and maintaining a proximate pool of cycling AMPA receptors.	Szent Istvan Univ, Fac Vet Sci, Dept Anat & Histol, H-1078 Budapest, Hungary; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA	Hungarian University of Agriculture & Life Sciences; Duke University; Howard Hughes Medical Institute; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Ehlers, MD (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	ehlers@neuro.duke.edu	Weinberg, Richard/AAC-1898-2020; Rácz, Bence/J-4220-2019	Rácz, Bence/0000-0002-1933-5332; Blanpied, Thomas/0000-0003-4957-557X; Weinberg, Richard/0000-0001-9689-7278	NIA NIH HHS [R01 AG024492, R01 AG024492-05, R01 AG024492-01, R01 AG024492-04, R01 AG024492-03, R01 AG024492-02] Funding Source: Medline; NINDS NIH HHS [R01 NS047574-04, R01 NS039402, R01 NS039402-08, R01 NS047574-01A2, R01 NS047574-02, R01 NS047574-03, R01 NS047574, R01 NS039402-09, R01 NS039402-07] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047574, R01NS039402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024492] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Gray NW, 2005, J CELL SCI, V118, P1279, DOI 10.1242/jcs.01711; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Hayashi MK, 2006, J NEUROSCI, V26, P8492, DOI 10.1523/JNEUROSCI.2731-06.2006; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; NAKATA T, 1991, NEURON, V7, P461, DOI 10.1016/0896-6273(91)90298-E; Okamoto PM, 1999, J BIOL CHEM, V274, P10277, DOI 10.1074/jbc.274.15.10277; Okamoto PM, 2001, J BIOL CHEM, V276, P48458, DOI 10.1074/jbc.M104927200; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Scott DB, 2004, J NEUROSCI, V24, P7096, DOI 10.1523/JNEUROSCI.0780-04.2004; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004	49	195	201	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 20	2007	55	6					874	889		10.1016/j.neuron.2007.06.041	http://dx.doi.org/10.1016/j.neuron.2007.06.041			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	219IQ	17880892	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000250078500006
J	Fasano, CA; Dimos, JT; Ivanova, NB; Lowry, N; Lemischka, IR; Temple, S				Fasano, Christopher A.; Dimos, John T.; Ivanova, Natalia B.; Lowry, Natalia; Lemischka, Ihor R.; Temple, Sally			shRNA knockdown of Bmi-1 reveals a critical role for p21-rb pathway in NSC self-renewal during development	CELL STEM CELL			English	Article							NEURAL STEM-CELLS; CYCLE EXIT; EXPRESSION; BETA; DIFFERENTIATION; PROLIFERATION; NEUROGENESIS; LINEAGES; GROWTH	Knockout studies have shown that the polycomb gene Bmi-1 is important for postnatal, but not embryonic, neural stem cell (NSC) self-renewal and have identified the cell-cycle inhibitors p16/p19 as molecular targets. Here, using lentiviral-delivered shRNAs in vitro and in vivo, we determined that Bmi-1 is also important for NSC self-renewal in the embryo. We found that neural progenitors depend increasingly on Bmi-1 for proliferation as development proceeds from embryonic through adult stages. Acute shRNA-mediated Bmi-1 reduction causes defects in embryonic and adult NSC proliferation and self-renewal that, unexpectedly, are mediated by a different cell-cycle inhibitor, p21. Gene array analyses revealed developmental differences in Bmi-1-controlled expression of genes in the p21-Rb cell cycle regulatory pathway. Our data therefore implicate p21 as an important Bmi-1 target in NSCs, potentially with stage-related differences. Understanding stage-related mechanisms underlying NSC self-renewal has important implications for development of stem cell-based therapies.	Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Albany Medical College; Princeton University; Harvard University	Temple, S (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	temples@mail.amc.edu			NIDDK NIH HHS [5R37DK042989] Funding Source: Medline; NINDS NIH HHS [R37NS033529] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033529] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bartek J, 1996, CURR OPIN CELL BIOL, V8, P805, DOI 10.1016/S0955-0674(96)80081-0; Blagosklonny MV, 2004, CELL DEATH DIFFER, V11, P249, DOI 10.1038/sj.cdd.4401361; Buszczak M, 2006, CELL, V125, P233, DOI 10.1016/j.cell.2006.04.004; Chagraoui J, 2006, GENE DEV, V20, P2110, DOI 10.1101/gad.1453406; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fajas L, 2000, P NATL ACAD SCI USA, V97, P7738, DOI 10.1073/pnas.130198397; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; HARPER JW, 1993, CELL, V75, P805; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jennings MT, 1998, J NEURO-ONCOL, V36, P123, DOI 10.1023/A:1005863419880; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Liu L, 2006, ONCOGENE, V25, P4370, DOI 10.1038/sj.onc.1209454; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; NEUMAN T, 1993, DEV BIOL, V160, P186, DOI 10.1006/dbio.1993.1297; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Qiu JH, 2004, J EXP MED, V199, P937, DOI 10.1084/jem.20031385; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Siegenthaler JA, 2005, J NEUROSCI, V25, P8627, DOI 10.1523/JNEUROSCI.1876-05.2005; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	42	252	266	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL	2007	1	1					87	99		10.1016/j.stem.2007.04.001	http://dx.doi.org/10.1016/j.stem.2007.04.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	230JK	18371338	Bronze			2022-12-24	WOS:000250872600004
J	Bateup, HS; Svenningsson, P; Kuroiwa, M; Gong, S; Nishi, A; Heintz, N; Greengard, P				Bateup, Helen S.; Svenningsson, Per; Kuroiwa, Mahomi; Gong, Shiaoching; Nishi, Akinori; Heintz, Nathaniel; Greengard, Paul			Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs	NATURE NEUROSCIENCE			English	Article							DOPAMINE-RECEPTORS; ADENOSINE A(2A); STRIATOPALLIDAL NEURONS; CYCLIC-AMP; ACTIVATION; D-1; D1; BRAIN; MICE	DARPP-32 is a dual-function protein kinase/phosphatase inhibitor that is involved in striatal signaling. The phosphorylation of DARPP-32 at threonine 34 is essential for mediating the effects of both psychostimulant and antipsychotic drugs; however, these drugs are known to have opposing behavioral and clinical effects. We hypothesized that these drugs exert differential effects on striatonigral and striatopallidal neurons, which comprise distinct output pathways of the basal ganglia. To directly test this idea, we developed bacterial artificial chromosome transgenic mice that allowed the analysis of DARPP-32 phosphorylation selectively in striatonigral and striatopallidal neurons. Using this new methodology, we found that cocaine, a psychostimulant, and haloperidol, a sedation-producing antipsychotic, exert differential effects on DARPP-32 phosphorylation in the two neuronal populations that can explain their opposing behavioral effects. Furthermore, we found that a variety of drugs that target the striatum have cell type-specific effects that previous methods were not able to discern.	[Bateup, Helen S.; Svenningsson, Per; Nishi, Akinori; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Svenningsson, Per] Karolinska Inst, Dept Physiol & Pharmacol, Ctr Mol Med, S-17177 Stockholm, Sweden; [Kuroiwa, Mahomi; Nishi, Akinori] Kurume Univ, Sch Med, Dept Pharmacol, Fukuoka 8300011, Japan; [Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, Mol Biol Lab, New York, NY 10065 USA; [Gong, Shiaoching; Heintz, Nathaniel] Rockefeller Univ, GENSAT Project, New York, NY 10065 USA	Rockefeller University; Karolinska Institutet; Kurume University; Rockefeller University; Rockefeller University	Greengard, P (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10065 USA.	greengard@rockefeller.edu	Svenningsson, Per JL/K-5210-2014	Greengard, Paul/0000-0002-4437-0893	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [P01 DA010044, P01 DA010044-05, P01 DA010044-040002, P01 DA010044-04, P01 DA010044-050002, P01 DA010044-030002, DA10044, P01 DA010044-020002] Funding Source: Medline; NIMH NIH HHS [P50 MH074866-02, P50 MH074866-04, P50 MH074866, P50 MH074866-01, MH074866, P50 MH074866-03] Funding Source: Medline; PHS HHS [90AZ2791] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ade KK, 2008, J NEUROSCI, V28, P1185, DOI 10.1523/JNEUROSCI.3908-07.2008; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; CAMERON DL, 1993, NATURE, V366, P344, DOI 10.1038/366344a0; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538; FINK JS, 1992, MOL BRAIN RES, V14, P186, DOI 10.1016/0169-328X(92)90173-9; Fredholm BB, 1999, PHARMACOL REV, V51, P83; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hakansson K, 2006, J NEUROCHEM, V96, P482, DOI 10.1111/j.1471-4159.2005.03558.x; HEMMINGS HC, 1986, J NEUROSCI, V6, P1469; Jin LQ, 2001, J NEUROCHEM, V78, P981, DOI 10.1046/j.1471-4159.2001.00470.x; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; LeMoine C, 1997, J NEUROSCI, V17, P8038; Lindskog M, 2002, NATURE, V418, P774, DOI 10.1038/nature00817; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Nishi A, 2005, P NATL ACAD SCI USA, V102, P1199, DOI 10.1073/pnas.0409138102; Nishi A, 1997, J NEUROSCI, V17, P8147; Pothos EN, 1998, J NEUROSCI, V18, P5575; Pozzi L, 2003, J NEUROCHEM, V86, P451, DOI 10.1046/j.1471-4159.2003.01851.x; Schmitz Y, 2002, J NEUROSCI, V22, P8002; Stoof JC, 1981, NATURE, V294, P366, DOI 10.1038/294366a0; Svenningsson P, 1999, PROG NEUROBIOL, V59, P355, DOI 10.1016/S0301-0082(99)00011-8; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Svenningsson P, 1998, NEUROSCIENCE, V84, P223, DOI 10.1016/S0306-4522(97)00510-1; Svenningsson P, 1998, J COMP NEUROL, V399, P229, DOI 10.1002/(SICI)1096-9861(19980921)399:2<229::AID-CNE6>3.0.CO;2-2; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Zachariou V, 2006, NEUROPSYCHOPHARMACOL, V31, P555, DOI 10.1038/sj.npp.1300832; Zhang Y, 2006, J NEUROSCI, V26, P2645, DOI 10.1523/JNEUROSCI.3923-05.2006	38	172	178	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					932	939		10.1038/nn.2153	http://dx.doi.org/10.1038/nn.2153			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18622401	Green Accepted			2022-12-24	WOS:000257969100019
J	Lander, B; Thorsteinsdottir, H; Singer, PA; Daar, AS				Lander, Bryn; Thorsteinsdottir, Halla; Singer, Peter A.; Daar, Abdallah S.			Harnessing stem cells for health needs in India	CELL STEM CELL			English	Article							LIMBAL	While industrialized countries' stem cell research will be transferable to the developing world, research conducted by developing countries offers the potential to target innovation to local context, make treatments more affordable, and aid in economic development. India demonstrates that stem cell research and development (R&D) is not confined to industrialized countries and has begun to harness stem cells to address its own health needs.	[Lander, Bryn; Thorsteinsdottir, Halla; Singer, Peter A.; Daar, Abdallah S.] McLaughlin Rotman Ctr Global Hlth, Univ Hlth Network, Toronto, ON M5G 1L7, Canada; [Lander, Bryn; Thorsteinsdottir, Halla; Singer, Peter A.; Daar, Abdallah S.] Univ Toronto, Toronto, ON M5G 1L7, Canada	University of Toronto; University Health Network Toronto; University of Toronto	Thorsteinsdottir, H (corresponding author), McLaughlin Rotman Ctr Global Hlth, Univ Hlth Network, Toronto, ON M5G 1L7, Canada.	halla.thorsteinsdottir@utoronto.ca						Banerjee M, 2005, BIOCHEM BIOPH RES CO, V328, P318, DOI 10.1016/j.bbrc.2004.12.176; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Fatima A, 2008, EYE, V22, P1161, DOI 10.1038/sj.eye.6702895; Frew SE, 2007, NAT BIOTECHNOL, V25, P403, DOI 10.1038/nbt0407-403; Greenwood HL, 2006, PLOS MED, V3, P1496, DOI 10.1371/journal.pmed.0030381; Isasi RM, 2006, EUR J HEALTH LAW, V13, P9, DOI 10.1163/157180906777036328; Kanga U, 2007, TRANSPL P, V39, P719, DOI 10.1016/j.transproceed.2007.01.057; Kumada N, 2004, PHYSICA E, V22, P36, DOI 10.1016/j.physe.2003.11.210; Olin JW, 2000, NEW ENGL J MED, V343, P864, DOI 10.1056/NEJM200009213431207; Salter B, 2007, REGEN MED, V2, P75, DOI 10.2217/17460751.2.1.75; Sangwan VS, 2005, ARCH OPHTHALMOL-CHIC, V123, P334, DOI 10.1001/archopht.123.3.334; Sangwan VS, 2003, BIOSCIENCE REP, V23, P169, DOI 10.1023/B:BIRE.0000007690.43273.73; Seth S, 2006, J AM COLL CARDIOL, V48, P2350, DOI 10.1016/j.jacc.2006.07.057; Sharma A., 2006, ASIAN BIOTECHNOLOGY, V8, P43; SHARMA S, 2006, J INDIAN ASS PEDIAT, V11, P211; Thorsteinsdottir H, 2004, NAT BIOTECHNOL, V22, pDC48, DOI 10.1038/nbt1204supp-DC48	16	15	16	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL	2008	3	1					11	15		10.1016/j.stem.2008.06.015	http://dx.doi.org/10.1016/j.stem.2008.06.015			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	325XO	18593554	Bronze			2022-12-24	WOS:000257622300006
J	Chiu, SL; Chen, CM; Cline, HT				Chiu, Shu-Ling; Chen, Chih-Ming; Cline, Hollis T.			Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo	NEURON			English	Article							DEVELOPING TECTAL NEURONS; TYROSINE PHOSPHORYLATION; NMDA RECEPTOR; SUBSTRATE; BRAIN; CDC42; RAT; ELECTROPORATION; ENDOCYTOSIS; EXOCYTOSIS	Insulin receptor signaling has been postulated to play a role in synaptic plasticity; however, the function of the insulin receptor in CNS is not clear. To test whether insulin receptor signaling affects visual system function, we recorded light-evoked responses in optic tectal neurons in living Xenopus tadpoles. Tectal neurons transfected with dominant-negative insulin receptor (dnIR), which reduces insulin receptor phosphorylation, or morpholino against insulin receptor, which reduces total insulin receptor protein level, have significantly smaller light-evoked responses than controls. dnIR-expressing neurons have reduced synapse density as assessed by EM, decreased AMPA mEPSC frequency, and altered experience-dependent dendritic arbor structural plasticity, although synaptic vesicle release probability, assessed by paired-pulse responses, synapse maturation, assessed by AMPA/NMDA ratio and ultrastructural criteria, are unaffected by dnIR expression. These data indicate that insulin receptor signaling regulates circuit function and plasticity by controlling synapse density.	[Chiu, Shu-Ling; Chen, Chih-Ming; Cline, Hollis T.] Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Cline, HT (corresponding author), Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA.	cline@cshl.edu	Chiu, Shu-Ling/AAC-9478-2022; Chiu, Shu-Ling/F-3613-2014	Chiu, Shu-Ling/0000-0003-4429-7830	NEI NIH HHS [R01 EY011261-12, R01 EY011261-10, R01 EY011261-14S1, R01 EY011261-08, R01 EY011261, R01 EY011261-11, R01 EY011261-14, R01 EY011261-09, R01 EY011261-13] Funding Source: Medline; NIH HHS [DP1 OD000458] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011261] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000458] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999; Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Aizenman CD, 2007, J NEUROPHYSIOL, V97, P2949, DOI 10.1152/jn.00452.2006; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; BARON V, 1992, J BIOL CHEM, V267, P23290; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bestman JE, 2006, NAT PROTOC, V1, P1267, DOI 10.1038/nprot.2006.186; Chen CF, 2003, J NEUROSCI, V23, P3130; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; CLARKE DW, 1986, J NEUROCHEM, V47, P831; Cline HT, 1996, COLD SPRING HARB SYM, V61, P95; Dou JT, 2005, LEARN MEMORY, V12, P646, DOI 10.1101/lm.88005; EBINA Y, 1987, P NATL ACAD SCI USA, V84, P704, DOI 10.1073/pnas.84.3.704; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; Haas K, 2006, P NATL ACAD SCI USA, V103, P12127, DOI 10.1073/pnas.0602670103; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Hori K, 2005, J NEUROSCI, V25, P2670, DOI 10.1523/JNEUROSCI.3638-04.2005; Kanezaki Y, 2004, ENDOCR J, V51, P133, DOI 10.1507/endocrj.51.133; KENNER KA, 1995, BIOCHEM BIOPH RES CO, V217, P304, DOI 10.1006/bbrc.1995.2778; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Ruthazer ES, 2002, REAL-TIME IMAGING, V8, P175, DOI 10.1006/rtim.2002.0284; Sanchez AL, 2006, DEVELOPMENT, V133, P2477, DOI 10.1242/dev.02409; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Skeberdis VA, 2001, P NATL ACAD SCI USA, V98, P3561, DOI 10.1073/pnas.051634698; Soltau M, 2002, MOL CELL NEUROSCI, V21, P575, DOI 10.1006/mcne.2002.1201; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; UNGER J, 1989, NEUROSCIENCE, V31, P143, DOI 10.1016/0306-4522(89)90036-5; Valenciano AI, 2006, J NEUROCHEM, V99, P524, DOI 10.1111/j.1471-4159.2006.04043.x; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893	42	297	306	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 12	2008	58	5					708	719		10.1016/j.neuron.2008.04.014	http://dx.doi.org/10.1016/j.neuron.2008.04.014			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	315IA	18549783	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000256870800009
J	Poghosyan, V; Ioannides, AA				Poghosyan, Vahe; Ioannides, Andreas A.			Attention modulates earliest responses in the primary auditory and visual cortices	NEURON			English	Article							SPATIAL SELECTIVE ATTENTION; LATERAL GENICULATE-NUCLEUS; TOP-DOWN CONTROL; RETINOTOPIC ORGANIZATION; STIMULUS-DRIVEN; FEEDBACK CONNECTIONS; NEURONAL RESPONSES; VOLUME MEASUREMENT; EVOKED-POTENTIALS; FUNCTIONAL MRI	A fundamental question about the neural correlates of attention concerns the earliest sensory processing stage that it can affect. We addressed this issue by recording magnetoencephalography (MEG) signals while subjects performed detection tasks, which required employment of spatial or nonspatial attention, in auditory or visual modality. Using distributed source analysis of MEG signals, we found that, contrary to previous studies that used equivalent current dipole (ECD) analysis, spatial attention enhanced the initial feedforward response in the primary visual cortex (V1) at 55-90 ms. We also found attentional modulation of the putative primary auditory cortex (All) activity at 30-50 ms. Furthermore, we reproduced our findings using ECD modeling guided by the results of distributed source analysis and suggest a reason why earlier studies using ECD analysis failed to identify the modulation of earliest V1 activity.	[Poghosyan, Vahe; Ioannides, Andreas A.] AAI Sci Cultural Serv Ltd, Lab Human Brain Dynam, Off 501, CY-1065 Nicosia, Cyprus; [Poghosyan, Vahe; Ioannides, Andreas A.] RIKEN, BSI, Lab Human Brain Dynam, Wako, Saitama 3510198, Japan	RIKEN	Ioannides, AA (corresponding author), AAI Sci Cultural Serv Ltd, Lab Human Brain Dynam, Off 501, Galaxias Bldg Block A,33 Arch Makarios III Ave, CY-1065 Nicosia, Cyprus.	ioannides@riken.jp	Poghosyan, Vahe/AAY-2175-2020					Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BACON WF, 1994, PERCEPT PSYCHOPHYS, V55, P485, DOI 10.3758/BF03205306; Bullier J, 2001, PROG BRAIN RES, V134, P193; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; CRICK F, 1990, COLD SH Q B, V55, P953; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Fink GR, 1997, BRAIN, V120, P2013, DOI 10.1093/brain/120.11.2013; Fisher NI, 1995, STAT ANAL CIRCULAR D; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; FOX PT, 1987, J NEUROSCI, V7, P913; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Godey B, 2001, CLIN NEUROPHYSIOL, V112, P1850, DOI 10.1016/S1388-2457(01)00636-8; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hillyard SA, 1998, CURR OPIN NEUROBIOL, V8, P202, DOI 10.1016/S0959-4388(98)80141-4; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hoormann J, 2000, PSYCHOPHYSIOLOGY, V37, P29, DOI 10.1111/1469-8986.3710029; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Ioannides A. A., 1993, Brain Topography, V6, P27; Ioannides AA, 2005, J NEUROSCI, V25, P7950, DOI 10.1523/JNEUROSCI.1091-05.2005; IOANNIDES AA, 1990, INVERSE PROBL, V6, P523, DOI 10.1088/0266-5611/6/4/005; IOANNIDES AA, 1993, PHYSIOL MEAS, V14, P121, DOI 10.1088/0967-3334/14/2/003; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Mangun GR, 2001, VISION RES, V41, P1423, DOI 10.1016/S0042-6989(01)00046-3; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Martinez A, 2001, VISION RES, V41, P1437, DOI 10.1016/S0042-6989(00)00267-4; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Maunsell JHR, 1999, VISUAL NEUROSCI, V16, P1, DOI 10.1017/S0952523899156177; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; Mehta SD, 2000, CEREB CORTEX, V10, P343, DOI 10.1093/cercor/10.4.343; Moradi F, 2003, NEUROIMAGE, V18, P595, DOI 10.1016/S1053-8119(02)00053-8; Navalpakkam V, 2005, VISION RES, V45, P205, DOI 10.1016/j.visres.2004.07.042; Niebur E, 1994, J Comput Neurosci, V1, P141, DOI 10.1007/BF00962722; Niebur E, 2002, CURR OPIN NEUROBIOL, V12, P190, DOI 10.1016/S0959-4388(02)00310-0; Noesselt T, 2002, NEURON, V35, P575, DOI 10.1016/S0896-6273(02)00781-X; Nothdurft HC, 2002, VISION RES, V42, P1287, DOI 10.1016/S0042-6989(02)00016-0; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Pessoa L, 2003, J NEUROSCI, V23, P3990; Poghosyan V, 2005, EUR J NEUROSCI, V22, P225, DOI 10.1111/j.1460-9568.2005.04181.x; Poghosyan V, 2007, NEUROIMAGE, V35, P759, DOI 10.1016/j.neuroimage.2006.11.052; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; RIF J, 1991, ELECTROEN CLIN NEURO, V79, P464, DOI 10.1016/0013-4694(91)90166-2; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shibata K, 2008, CEREB CORTEX, V18, P1664, DOI 10.1093/cercor/bhm194; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Talairach J., 1988, COPLANAR STEREOTAXIC; Talavage TM, 2004, J NEUROPHYSIOL, V91, P1282, DOI 10.1152/jn.01125.2002; Taylor JG, 1999, IEEE T MED IMAGING, V18, P151, DOI 10.1109/42.759120; THEEUWES J, 1994, J EXP PSYCHOL HUMAN, V20, P799, DOI 10.1037/0096-1523.20.4.799; Tzelepi A, 2001, NEUROIMAGE, V13, P702, DOI 10.1006/nimg.2000.0735; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Van Zoest W, 2006, SPATIAL VISION, V19, P61, DOI 10.1163/156856806775009205; van Zoest W, 2004, J EXP PSYCHOL HUMAN, V30, P746, DOI 10.1037/0096-1523.30.4.749; Vidyasagar TR, 1998, NEUROREPORT, V9, P1947, DOI 10.1097/00001756-199806220-00006; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Woldorff MG, 2002, COGNITIVE BRAIN RES, V15, P1, DOI 10.1016/S0926-6410(02)00212-4; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Yoshor D, 2007, J NEUROSCI, V27, P13205, DOI 10.1523/JNEUROSCI.2944-07.2007	80	97	102	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 12	2008	58	5					802	813		10.1016/j.neuron.2008.04.013	http://dx.doi.org/10.1016/j.neuron.2008.04.013			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	315IA	18549790	Bronze			2022-12-24	WOS:000256870800016
J	Young, P; Qiu, L; Wang, DQ; Zhao, SL; Gross, J; Feng, GP				Young, Paul; Qiu, Li; Wang, Dongqing; Zhao, Shengli; Gross, James; Feng, Guoping			Single-neuron labeling with inducible Cre-mediated knockout in transgenic mice	NATURE NEUROSCIENCE			English	Article							IN-VIVO; NEUROMUSCULAR-JUNCTION; SYNAPTIC PLASTICITY; MOSAIC ANALYSIS; EXPRESSION; STABILITY; SYNAPSES; PROTEINS; DYNAMICS	To facilitate a functional analysis of neuronal connectivity in a mammalian nervous system that is tightly packed with billions of cells, we developed a new technique that uses inducible genetic manipulations in fluorescently labeled single neurons in mice. Our technique, single-neuron labeling with inducible Cre-mediated knockout (SLICK), is achieved by coexpressing a drug-inducible form of Cre recombinase and a fluorescent protein in a small subsets of neurons, thus combining the powerful Cre recombinase system for conditional genetic manipulation with fluorescent labeling of single neurons for imaging. Here, we demonstrate efficient inducible genetic manipulation in several types of neurons using SLICK. Furthermore, we applied SLICK to eliminate synaptic transmission in a small subset of neuromuscular junctions. Our results provide evidence for the long-term stability of inactive neuromuscular synapses in adult animals and demonstrate a Cre-loxP compatible system for dissecting gene functions in single identifiable neurons.	[Young, Paul; Qiu, Li; Wang, Dongqing; Zhao, Shengli; Gross, James; Feng, Guoping] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Young, Paul] Natl Univ Ireland Univ Coll Cork, Dept Biochem, Biosci Inst, Cork, Ireland; [Gross, James] Duke Univ, Med Ctr, Duke Neurotransgen Lab, Durham, NC 27710 USA; [Feng, Guoping] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University; University College Cork; Duke University; Duke University	Feng, GP (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Res Dr, Durham, NC 27710 USA.	feng@neuro.duke.edu	Young, Paul/A-4874-2015; Feng, Guoping/Y-2827-2019	Young, Paul/0000-0002-1307-0249; 	NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH073121] Funding Source: NIH RePORTER; NIMH NIH HHS [R21 MH073121-02, R21 MH073121] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Brecht M, 2004, J NEUROSCI, V24, P9223, DOI 10.1523/JNEUROSCI.3344-04.2004; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HOGAN B, 1994, MANIPULATING MOUSE E, P217; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Johns DC, 1999, J NEUROSCI, V19, P1691; Kasthuri N, 2004, CURR OPIN NEUROBIOL, V14, P105, DOI 10.1016/j.conb.2004.01.013; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Marek KW, 2003, CURR OPIN NEUROBIOL, V13, P607, DOI 10.1016/j.conb.2003.09.001; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Miyawaki A, 2003, CURR OPIN NEUROBIOL, V13, P591, DOI 10.1016/j.conb.2003.09.005; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SON YJ, 1995, NEURON, V14, P133, DOI 10.1016/0896-6273(95)90247-3; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wang XY, 2006, J NEUROSCI, V26, P8983, DOI 10.1523/JNEUROSCI.2493-06.2006; Wang XY, 2005, J NEUROSCI, V25, P343, DOI 10.1523/JNEUROSCI.3252-04.2005; Young P, 2004, CURR OPIN NEUROBIOL, V14, P642, DOI 10.1016/j.conb.2004.08.007; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	37	116	119	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					721	728		10.1038/nn.2118	http://dx.doi.org/10.1038/nn.2118			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18454144	Green Accepted			2022-12-24	WOS:000256133700019
J	Seeburg, DP; Feliu-Mojer, M; Gaiottino, J; Pak, DTS; Sheng, M				Seeburg, Daniel P.; Feliu-Mojer, Monica; Gaiottino, Johanna; Pak, Daniel T. S.; Sheng, Morgan			Critical role of CDK5 and Polo-like kinase 2 in homeostatic synaptic plasticity during elevated activity	NEURON			English	Article							POLO-BOX DOMAIN; AMPA RECEPTOR TRAFFICKING; INTEGRIN-BINDING PROTEIN; QUANTAL AMPLITUDE; MOLECULAR-BASIS; KINASE; GENE; EXPRESSION; PHOSPHORYLATION; PLK1	Homeostatic plasticity keeps neuronal spiking output within an optimal range in the face of chronically altered levels of network activity. Little is known about the underlying molecular mechanisms, particularly in response to elevated activity. We report that, in hippocampal neurons experiencing heightened activity, the activity-inducible protein kinase Polo-like kinase 2 (Plk2, also known as SNK) was required for synaptic scaling-a principal mechanism underlying homeostatic plasticity. Synaptic scaling also required CDK5, which acted as a "priming" kinase for the phospho-dependent binding of Plk2 to its substrate SPAR, a postsynaptic RapGAP and scaffolding molecule that is degraded following phosphorylation by Plk2. RNAi knockdown of SPAR weakened synapses, and overexpression of a SPAR mutant resistant to Pik2-dependent degradation prevented synaptic scaling. Thus, priming phosphorylation of the Plk2 binding site in SPAR by CDK5, followed by Plk2 recruitment and SPAR phosphorylation-degradation, constitutes a molecular pathway for neuronal homeostatic plasticity during chronically elevated activity.	[Seeburg, Daniel P.; Feliu-Mojer, Monica; Gaiottino, Johanna; Sheng, Morgan] MIT, Howard Hughes Med Inst, RIKEN, Neurosci Res Ctr,Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Pak, Daniel T. S.] Georgetown Univ, Dept Pharmacol, Washington, DC 20057 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Georgetown University	Sheng, M (corresponding author), MIT, Howard Hughes Med Inst, RIKEN, Neurosci Res Ctr,Picower Inst Learning & Memory, Cambridge, MA 02139 USA.	msheng@mit.edu		Sheng, Morgan/0000-0002-8703-5366; Feliu-Mojer, Monica/0000-0001-8799-1959	Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS048085-04, R01 NS048085] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048085] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez A, 2001, EXP CELL RES, V264, P266, DOI 10.1006/excr.2001.5152; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bui CJ, 2006, BRAIN RES, V1119, P13, DOI 10.1016/j.brainres.2006.08.043; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; Goldberg JH, 2005, TRENDS NEUROSCI, V28, P158, DOI 10.1016/j.tins.2005.01.005; Gong B, 2007, EUR J NEUROSCI, V26, P275, DOI 10.1111/j.1460-9568.2007.05669.x; Gonzalez-Islas C, 2006, NEURON, V49, P563, DOI 10.1016/j.neuron.2006.01.017; Guan Z, 2005, NEURON, V48, P91, DOI 10.1016/j.neuron.2005.08.036; Hevroni D, 1998, J MOL NEUROSCI, V10, P75, DOI 10.1007/BF02737120; Hosokawa T, 2006, J NEUROSCI RES, V84, P747, DOI 10.1002/jnr.20975; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Jiang N, 2006, J BIOL CHEM, V281, P10577, DOI 10.1074/jbc.M513156200; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lowery DM, 2004, CELL CYCLE, V3, P128; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; Ma S, 2003, MOL CANCER RES, V1, P376; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Niethammer M, 1998, METHOD ENZYMOL, V293, P104; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; ROSS WN, 1989, ANNU REV PHYSIOL, V51, P491, DOI 10.1146/annurev.physiol.51.1.491; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; SIMMONS DL, 1992, MOL CELL BIOL, V12, P4164, DOI 10.1128/MCB.12.9.4164; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Thiagarajan TC, 2007, NEUROPHARMACOLOGY, V52, P156, DOI 10.1016/j.neuropharm.2006.07.030; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Town T, 2002, J NEUROSCI RES, V69, P362, DOI 10.1002/jnr.10299; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wei FY, 2005, J NEUROCHEM, V93, P502, DOI 10.1111/j.1471-4159.2005.03058.x; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037	62	175	180	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2008	58	4					571	583		10.1016/j.neuron.2008.03.021	http://dx.doi.org/10.1016/j.neuron.2008.03.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304PD	18498738	Green Accepted, Bronze			2022-12-24	WOS:000256120500011
J	Kazama, H; Wilson, RI				Kazama, Hokto; Wilson, Rachel I.			Homeostatic matching and nonlinear amplification at identified central synapses	NEURON			English	Article							DROSOPHILA ANTENNAL LOBE; SYNAPTIC PLASTICITY; NEUROMUSCULAR-JUNCTION; EXCITATORY SYNAPSES; RELEASE PROBABILITY; QUANTAL ANALYSIS; MUSCLE-FIBERS; TRANSMISSION; GROWTH; VARIABILITY	Here we describe the properties of a synapse in the Drosophila antennal lobe and show how they can explain certain sensory computations in this brain region. The synapse between olfactory receptor neurons (ORNs) and projection neurons (PNs) is very strong, reflecting a large number of release sites and high release probability. This is likely one reason why weak ORN odor responses are amplified in PNs. Furthermore, the amplitude of unitary synaptic currents in a PN is matched to the size of its dendritic arbor. This matching may compensate for a lower input resistance of larger dendrites to produce uniform depolarization across PN types. Consistent with this idea, a genetic manipulation that lowers input resistance increases unitary synaptic currents. Finally, strong stimuli produce short-term depression at this synapse. This helps explain why PN odor responses are transient, and why strong ORN odor responses are not amplified as powerfully as weak responses.	[Kazama, Hokto; Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu	Wilson, Rachel/E-2227-2012; Kazama, Hokto/N-7505-2015	Kazama, Hokto/0000-0002-3239-1873; Wilson, Rachel/0000-0001-8573-9266	NIDCD NIH HHS [R01 DC008174-03, R01 DC008174, 1R01DC008174-01] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Biro AA, 2005, J NEUROSCI, V25, P223, DOI 10.1523/JNEUROSCI.3688-04.2005; Bucher D, 2005, J NEUROSCI, V25, P1611, DOI 10.1523/JNEUROSCI.3679-04.2005; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Clements JD, 2003, J NEUROSCI METH, V130, P115, DOI 10.1016/j.jneumeth.2003.09.019; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; Comer CM, 2001, PROG NEUROBIOL, V63, P409, DOI 10.1016/S0301-0082(00)00051-4; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DEROSA RA, 1978, NATURE, V273, P676, DOI 10.1038/273676a0; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Elmore T, 2003, J NEUROSCI, V23, P9906; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; KATZ B, 1957, J PHYSIOL-LONDON, V137, P267, DOI 10.1113/jphysiol.1957.sp005811; Katz B., 1969, RELEASE NEURAL TRANS; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Laissue PP, 1999, J COMP NEUROL, V405, P543; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; LAURENT G, 1988, J NEUROSCI, V8, P4349; Lnenicka GA, 2000, J NEUROBIOL, V43, P186, DOI 10.1002/(SICI)1097-4695(200005)43:2<186::AID-NEU8>3.3.CO;2-E; LNENICKA GA, 1983, J PHYSIOL-LONDON, V345, P261, DOI 10.1113/jphysiol.1983.sp014977; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Meyer AC, 2001, J NEUROSCI, V21, P7889, DOI 10.1523/JNEUROSCI.21-20-07889.2001; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Murphy GJ, 2004, J NEUROSCI, V24, P3023, DOI 10.1523/JNEUROSCI.5745-03.2004; Nakayama H, 2006, J NEUROBIOL, V66, P929, DOI 10.1002/neu.20292; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; PAWSON PA, 1988, J NEUROPHYSIOL, V60, P2211, DOI 10.1152/jn.1988.60.6.2211; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pulver SR, 2005, J NEUROBIOL, V62, P47, DOI 10.1002/neu.20066; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; RAU P, 1929, T ACAD SCI ST LOUIS, V26, P80; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sargent PB, 2005, J NEUROSCI, V25, P8173, DOI 10.1523/JNEUROSCI.2051-05.2005; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; SCHNEIDER D, 1968, NATURWISSENSCHAFTEN, V55, P395, DOI 10.1007/BF00593307; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Silver RA, 2003, J NEUROSCI METH, V130, P127, DOI 10.1016/j.jneumeth.2003.09.030; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wood SJ, 2001, PROG NEUROBIOL, V64, P393, DOI 10.1016/S0301-0082(00)00055-1; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	68	114	117	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2008	58	3					401	413		10.1016/j.neuron.2008.02.030	http://dx.doi.org/10.1016/j.neuron.2008.02.030			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	300HP	18466750	Green Accepted, Bronze			2022-12-24	WOS:000255815200013
J	Chung, MK; Guler, AD; Caterina, MJ				Chung, Man-Kyo; Gueler, Ali D.; Caterina, Michael J.			TRPV1 shows dynamic ionic selectivity during agonist stimulation	NATURE NEUROSCIENCE			English	Article							P2X(2) CHANNEL PERMEABILITY; CAPSAICIN RECEPTOR TRPV1; PRIMARY SENSORY NEURONS; GATED CATION CHANNELS; VANILLOID RECEPTOR; GANGLION NEURONS; PROTEIN; KINASE; CELLS; ACTIVATION	Transient receptor potential vanilloid 1 (TRPV1) is an ion channel that is gated by noxious heat, capsaicin and other diverse stimuli. It is a nonselective cation channel that prefers Ca2+ over Na+. These permeability characteristics, as in most channels, are widely presumed to be static. On the contrary, we found that activation of native or recombinant rat TRPV1 leads to time- and agonist concentration-dependent increases in relative permeability to large cations and changes in Ca2+ permeability. Using the substituted cysteine accessibility method, we saw that these changes were attributable to alterations in the TRPV1 selectivity filter. TRPV1 agonists showed different capabilities for evoking ionic selectivity changes. Furthermore, protein kinase C-dependent phosphorylation of Ser800 in the TRPV1 C terminus potentiated agonist-evoked ionic selectivity changes. Thus, the qualitative signaling properties of TRPV1 are dynamically modulated during channel activation, a process that probably shapes TRPV1 participation in pain, cytotoxicity and neurotransmitter release.	[Chung, Man-Kyo; Gueler, Ali D.; Caterina, Michael J.] Johns Hopkins Sch Med, Ctr Sensory Biol, Dept Biol Chem & Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Caterina, MJ (corresponding author), Johns Hopkins Sch Med, Ctr Sensory Biol, Dept Biol Chem & Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	caterina@jhmi.edu	Chung, Man-Kyo/S-7433-2019	Chung, Man-Kyo/0000-0001-7637-1148; Guler, Ali Deniz/0000-0001-8218-850X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051551, R01NS054902] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS051551, R01 NS054902] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahern GP, 2006, J BIOL CHEM, V281, P8991, DOI 10.1074/jbc.M513429200; Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Alam A, 2007, P NATL ACAD SCI USA, V104, P15334, DOI 10.1073/pnas.0707324104; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; BLEAKMAN D, 1990, BRIT J PHARMACOL, V101, P423, DOI 10.1111/j.1476-5381.1990.tb12725.x; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Chancellor MB, 1999, J UROLOGY, V162, P3, DOI 10.1097/00005392-199907000-00002; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; DWYER TM, 1980, J GEN PHYSIOL, V75, P469, DOI 10.1085/jgp.75.5.469; Eickhorst AN, 2002, J GEN PHYSIOL, V120, P119, DOI 10.1085/jgp.20028535; Evans AR, 1996, BRAIN RES, V712, P265, DOI 10.1016/0006-8993(95)01447-0; Flynn GE, 2001, NAT REV NEUROSCI, V2, P643, DOI 10.1038/35090015; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Hellwig N, 2004, J BIOL CHEM, V279, P34553, DOI 10.1074/jbc.M402966200; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; JANCSO G, 1992, EXP PHYSIOL, V77, P405, DOI 10.1113/expphysiol.1992.sp003603; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Khakh BS, 1999, NEURON, V23, P653, DOI 10.1016/S0896-6273(01)80025-8; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Liu L, 1996, J NEUROPHYSIOL, V76, P1858, DOI 10.1152/jn.1996.76.3.1858; Liu L, 1997, J NEUROSCI, V17, P4101; Marinelli S, 2002, J PHYSIOL-LONDON, V543, P531, DOI 10.1113/jphysiol.2002.022863; McNamara FN, 2005, BRIT J PHARMACOL, V144, P781, DOI 10.1038/sj.bjp.0706040; Meyers JR, 2003, J NEUROSCI, V23, P4054; Myrdal SE, 2005, HEARING RES, V204, P170, DOI 10.1016/j.heares.2005.02.005; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobczyk A, 2007, NEURON, V53, P17, DOI 10.1016/j.neuron.2006.11.016; SUPRENANT A, 1996, SCIENCE, V272, P735; SZALLASI A, 1994, GEN PHARMACOL-VASC S, V25, P223, DOI 10.1016/0306-3623(94)90049-3; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Welch JM, 2000, P NATL ACAD SCI USA, V97, P13889, DOI 10.1073/pnas.230146497; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Yeh BI, 2005, EMBO J, V24, P3224, DOI 10.1038/sj.emboj.7600795; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004	47	241	246	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					555	564		10.1038/nn.2102	http://dx.doi.org/10.1038/nn.2102			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18391945				2022-12-24	WOS:000255327300014
J	Sampath, P; Pritchard, DK; Pabon, L; Reinecke, H; Schwartz, SM; Morris, DR; Murry, CE				Sampath, Prabha; Pritchard, David K.; Pabon, Lil; Reinecke, Hans; Schwartz, Stephen M.; Morris, David R.; Murry, Charles E.			A hierarchical network controls protein translation during murine embryonic stem cell self-renewal and differentiation	CELL STEM CELL			English	Article							NEURAL PROGENITOR CELLS; GENE-EXPRESSION; MOUSE; TRANSCRIPTOME; INTERFERENCE; MICROARRAYS; MECHANISMS; INITIATION; INHIBITION; MAINTAINS	Stem cell differentiation involves changes in transcription, but little is known about translational control during differentiation. We comprehensively profiled gene expression during differentiation of murine embryonic stem cells (ESCs) into embryoid bodies by integrating transcriptome analysis with global assessment of ribosome loading. While protein synthesis was parsimonious during self-renewal, differentiation induced an anabolic switch, with global increases in transcript abundance, polysome content, protein synthesis, and protein content. Furthermore, 78% of transcripts showed increased ribosome loading, thereby enhancing translational efficiency. Transcripts under exclusive translational control included the transcription factor ATF5, the tumor suppressor DCC, and the beta-catenin agonist Wnt1. We show that a hierarchy of translational regulators, including mTOR, 4EBP1, and the RNA-binding proteins DAZL and GRSF1, control global and selective protein synthesis during ESC differentiation. Parsimonious translation in pluripotent state and hierarchical translational regulation during differentiation may be important quality controls for self-renewal and choice of fate in ESCs:	[Morris, David R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Sampath, Prabha; Pabon, Lil; Reinecke, Hans; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Morris, DR (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dmorris@u.washington.edu; murry@u.washington.edu	Morris, David/G-4503-2011		NATIONAL CANCER INSTITUTE [R33CA089807] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061553, R01HL064387, R01HL072370, R24HL064387, R01HL084642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM069983] Funding Source: NIH RePORTER; NCI NIH HHS [CA89807] Funding Source: Medline; NHLBI NIH HHS [HL84642, HL072370, HL3171, HL61553, HL64387] Funding Source: Medline; NIGMS NIH HHS [GM69983] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali NN, 2002, TISSUE ENG, V8, P541, DOI 10.1089/107632702760240463; Angelastro JM, 2003, J NEUROSCI, V23, P4590; Angelastro JM, 2005, J NEUROSCI, V25, P3889, DOI 10.1523/JNEUROSCI.3447-04.2005; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Arava Yoav, 2003, Methods Mol Biol, V224, P79; Bader A, 2000, CIRC RES, V86, P787, DOI 10.1161/01.RES.86.7.787; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cai LH, 2007, CELL RES, V17, P62, DOI 10.1038/sj.cr.7310138; Chinzei R, 2002, HEPATOLOGY, V36, P22, DOI 10.1053/jhep.2002.34136; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Day DA, 1998, J ENDOCRINOL, V157, P361, DOI 10.1677/joe.0.1570361; de Moor CH, 2001, INT REV CYTOL, V203, P567; Dvash T, 2004, HUM REPROD, V19, P2875, DOI 10.1093/humrep/deh529; Forrai A, 2006, STEM CELLS, V24, P604, DOI 10.1634/stemcells.2005-0323; Garcia-Sanz JA, 1998, FASEB J, V12, P299, DOI 10.1096/fasebj.12.3.299; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; GOSS DJ, 1984, J BIOL CHEM, V259, P7374; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Gross VS, 2005, MOL REPROD DEV, V70, P324, DOI 10.1002/mrd.20212; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gunji W, 2004, BIOCHEM BIOPH RES CO, V325, P265, DOI 10.1016/j.bbrc.2004.10.025; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jiao XF, 2002, BIOL REPROD, V66, P475, DOI 10.1095/biolreprod66.2.475; Joaquin M, 2003, CELL MOL LIFE SCI, V60, P2389, DOI 10.1007/s00018-003-3037-4; Kash JC, 2002, J VIROL, V76, P10417, DOI 10.1128/JVI.76.20.10417-10426.2002; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Lickert H, 2005, DEVELOPMENT, V132, P2599, DOI 10.1242/dev.01842; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; MacKay VL, 2004, MOL CELL PROTEOMICS, V3, P478, DOI 10.1074/mcp.M300129-MCP200; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; NILSEN TW, 1982, J BIOL CHEM, V257, P4593; Parsa AT, 2004, TRENDS MOL MED, V10, P607, DOI 10.1016/j.molmed.2004.10.009; Potireddy S, 2006, DEV BIOL, V298, P155, DOI 10.1016/j.ydbio.2006.06.024; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rodrigues S, 2007, ONCOGENE, V26, P5615, DOI 10.1038/sj.onc.1210347; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Serikawa KA, 2003, MOL CELL PROTEOMICS, V2, P191, DOI 10.1074/mcp.D200002-MCP200; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yen PH, 2004, INT J ANDROL, V27, P125, DOI 10.1111/j.1365-2605.2004.00469.x; Zong Q, 1999, P NATL ACAD SCI USA, V96, P10632, DOI 10.1073/pnas.96.19.10632	55	193	197	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY	2008	2	5					448	460		10.1016/j.stem.2008.03.013	http://dx.doi.org/10.1016/j.stem.2008.03.013			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	300BM	18462695	Bronze			2022-12-24	WOS:000255799300010
J	Britanova, O; de Juan Romero, C; Cheung, A; Kwan, KY; Schwark, M; Gyorgy, A; Vogel, T; Akopov, S; Mitkovski, M; Agoston, D; Sestan, N; Molnar, Z; Tarabykin, V				Britanova, Olga; de Juan Romero, Camino; Cheung, Amanda; Kwan, Kenneth Y.; Schwark, Manuela; Gyorgy, Andrea; Vogel, Tanja; Akopov, Sergey; Mitkovski, Mico; Agoston, Denes; Sestan, Nenad; Molnar, Zoltan; Tarabykin, Victor			Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex	NEURON			English	Article							MAR-BINDING PROTEIN; CEREBRAL-CORTEX; PROJECTION NEURONS; DENDRITIC MORPHOLOGY; SUBVENTRICULAR ZONE; PYRAMIDAL NEURONS; GENE-EXPRESSION; CELL-CYCLE; DIFFERENTIATION; MIGRATION	Pyramidal neurons of the neocortex can be subdivided into two major groups: deep- (DL) and upperlayer(UL) neurons. Here we report that the expression of the AT-rich DNA-binding protein Satb2 defines two subclasses of UL neurons: UL1 (Satb2 positive) and UL2 (Satb2 negative). In the absence of Satb2, UL1 neurons lose their identity and activate DL- and UL2-specific genetic programs. UL1 neurons in Satb2 mutants fail to migrate to superficial layers and do not contribute to the corpus callosum but to the corticospinal tract, which is normally populated by DL axons. Ctip2, a gene required for the formation of the corticospinal tract, is ectopically expressed in all UL1 neurons in the absence of Satb2. Satb2 protein interacts with the Ctip2 genomic region and controls chromatin remodeling at this locus. Satb2 therefore is required for the initiation of the UL2-specific genetic program and for the inactivation of DL- and UL2-specific genes.	[Britanova, Olga; de Juan Romero, Camino; Schwark, Manuela; Mitkovski, Mico; Tarabykin, Victor] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [de Juan Romero, Camino; Tarabykin, Victor] DFG Res Ctr Mol Physiol Brain CMPB, D-37073 Gottingen, Germany; [Britanova, Olga; Akopov, Sergey] Shemiakin & Ovchinnikov Inst Bioorgan Chem RAS, Moscow 117871, Russia; [Cheung, Amanda; Molnar, Zoltan] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Kwan, Kenneth Y.; Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Vogel, Tanja] Univ Gottingen, Dept Anat, D-3400 Gottingen, Germany; [Gyorgy, Andrea] USU, Dept Anat Physiol & Genet, Sch Med, Bethesda, MD 20814 USA	Max Planck Society; German Research Foundation (DFG); Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University of Oxford; Yale University; University of Gottingen	Tarabykin, V (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	tarabykin@em.mpg.de	de Juan Romero, Camino/G-9934-2015; Tarabykin, Victor/F-9467-2014; Molnar, Zoltan/J-7281-2012; Kwan, Kenneth/AAI-2841-2021; Kwan, Kenneth Y/F-8489-2011	Molnar, Zoltan/0000-0002-6852-6004; Kwan, Kenneth/0000-0003-4711-071X; Kwan, Kenneth Y/0000-0003-4711-071X; Tarabykin, Viktor/0000-0001-8931-7263; de Juan, Camino/0000-0001-7890-8447; Mitkovski, Miso/0000-0001-9195-2434	MRC [G0700377, G0300200] Funding Source: UKRI; Medical Research Council [G0700377, G0300200] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alvarez JD, 2000, GENE DEV, V14, P521; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Britanova O, 2006, AM J HUM GENET, V79, P668, DOI 10.1086/508214; Britanova O, 2006, DEV BIOL, V298, P299, DOI 10.1016/j.ydbio.2006.06.040; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; COCKERILL PN, 1986, FEBS LETT, V204, P5, DOI 10.1016/0014-5793(86)81377-1; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; Desai AR, 2000, DEVELOPMENT, V127, P2863; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Fukuda T, 1997, J COMP NEUROL, V382, P141; GYORGY A, 2008, IN PRESS EUR J NEURO; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; IZAURRALDE E, 1988, J MOL BIOL, V200, P111, DOI 10.1016/0022-2836(88)90337-3; Mallamaci A, 2006, EUR J NEUROSCI, V23, P847, DOI 10.1111/j.1460-9568.2006.04634.x; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Miquelajauregui A, 2007, P NATL ACAD SCI USA, V104, P12919, DOI 10.1073/pnas.0609863104; Molnar ZN, 2002, J NEUROSCI, V22, P10313; Molnar Z, 2006, NEUROSCI RES, V55, P105, DOI 10.1016/j.neures.2006.02.008; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Rash BG, 2001, J COMP NEUROL, V434, P147, DOI 10.1002/cne.1170; Roy K, 2004, J NEUROSCI, V24, P8333, DOI 10.1523/JNEUROSCI.1148-04.2004; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	35	451	458	2	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 7	2008	57	3					378	392		10.1016/j.neuron.2007.12.028	http://dx.doi.org/10.1016/j.neuron.2007.12.028			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261JQ	18255031	Bronze			2022-12-24	WOS:000253075300008
J	Maccarrone, M; Rossi, S; Bari, M; De Chiara, V; Fezza, F; Musella, A; Gasperi, V; Prosperetti, C; Bernardi, G; Finazzi-Agro, A; Cravatt, BF; Centonze, D				Maccarrone, Mauro; Rossi, Silvia; Bari, Monica; De Chiara, Valentina; Fezza, Filomena; Musella, Alessandra; Gasperi, Valeria; Prosperetti, Chiara; Bernardi, Giorgio; Finazzi-Agro, Alessandro; Cravatt, Benjamin F.; Centonze, Diego			Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; ENDOGENOUS CANNABINOIDS; METABOTROPIC GLUTAMATE; PHOSPHOLIPASE-D; ENDOCANNABINOID RELEASE; RECEPTOR; ACTIVATION; STIMULATION; MODULATION; 2-ARACHIDONOYL-GLYCEROL	Of the endocannabinoids (eCBs), anandamide (AEA) and 2-arachidonoylglycerol (2-AG) have received the most study. A functional interaction between these molecules has never been described. Using mouse brain slices, we found that stimulation of metabotropic glutamate 5 receptors by 3,5-dihydroxyphenylglycine (DHPG) depressed inhibitory transmission in the striatum through selective involvement of 2-AG metabolism and stimulation of presynaptic CB1 receptors. Elevation of AEA concentrations by pharmacological or genetic inhibition of AEA degradation reduced the levels, metabolism and physiological effects of 2-AG. Exogenous AEA and the stable AEA analog methanandamide inhibited basal and DHPG-stimulated 2-AG production, confirming that AEA is responsible for the downregulation of the other eCB. AEA is an endovanilloid substance, and the stimulation of transient receptor potential vanilloid 1 (TRPV1) channels mimicked the effects of endogenous AEA on 2-AG metabolism through a previously unknown glutathione-dependent pathway. Consistently, the interaction between AEA and 2-AG was lost after pharmacological and genetic inactivation of TRPV1 channels.	[Maccarrone, Mauro; Gasperi, Valeria] Univ Teramo, Dipartimento Sci Biomed, I-64100 Teramo, Italy; [Maccarrone, Mauro; Rossi, Silvia; De Chiara, Valentina; Fezza, Filomena; Musella, Alessandra; Prosperetti, Chiara; Bernardi, Giorgio; Centonze, Diego] CERC, Fdn Santa Lucia, I-00143 Rome, Italy; [Rossi, Silvia; De Chiara, Valentina; Musella, Alessandra; Prosperetti, Chiara; Bernardi, Giorgio; Cravatt, Benjamin F.; Centonze, Diego] Univ Roma Tor Vergata, Dipartimento Neurosci, Neurol Clin, I-00133 Rome, Italy; [Bari, Monica; Fezza, Filomena; Finazzi-Agro, Alessandro] Univ Roma Tor Vergata, Dipartimento Med Sperimentale & Sci Biochim, I-00133 Rome, Italy; [Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Cravatt, Benjamin F.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of Teramo; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata; Scripps Research Institute; Scripps Research Institute	Maccarrone, M (corresponding author), Univ Teramo, Dipartimento Sci Biomed, Piazza Aldo Moro 45, I-64100 Teramo, Italy.	mmaccarrone@unite.it; centonze@uniroma2.it	gasperi, valeria/AGO-4500-2022; Gasperi, Valeria/AAN-9210-2021; musella, alessandra/K-6372-2016; Maccarrone, Mauro/K-5398-2012; Centonze, Diego/J-7767-2016	gasperi, valeria/0000-0003-3200-8093; musella, alessandra/0000-0001-7889-9253; Maccarrone, Mauro/0000-0002-3990-2963; Centonze, Diego/0000-0002-8390-8545; Rossi, Silvia/0000-0003-3257-8248; Prosperetti, Chiara/0000-0001-8069-2163				Bari M, 2006, MINI-REV MED CHEM, V6, P257, DOI 10.2174/138955706776073466; Barinaga M, 2001, SCIENCE, V291, P2530, DOI 10.1126/science.291.5513.2530; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 2006, BBA-MOL CELL BIOL L, V1761, P205, DOI 10.1016/j.bbalip.2005.12.009; Bisogno T, 1999, BIOCHEM BIOPH RES CO, V256, P377, DOI 10.1006/bbrc.1999.0254; Cartoni A, 2004, TETRAHEDRON LETT, V45, P2723, DOI 10.1016/j.tetlet.2004.02.045; Centonze D, 2005, BIOL PSYCHIAT, V57, P1583, DOI 10.1016/j.biopsych.2005.03.008; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; de Lago E, 2005, BIOCHEM PHARMACOL, V70, P446, DOI 10.1016/j.bcp.2005.05.011; Di Marzo V, 2000, FASEB J, V14, P1432, DOI 10.1096/fj.14.10.1432; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Evans RM, 2004, BRIT J PHARMACOL, V141, P1223, DOI 10.1038/sj.bjp.0705723; Fezza F, 2005, ANAL BIOCHEM, V339, P113, DOI 10.1016/j.ab.2004.12.005; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Glaser ST, 2005, LIFE SCI, V77, P1584, DOI 10.1016/j.lfs.2005.05.007; Gubellini P, 2002, J NEUROSCI, V22, P6900; Guo Y, 2005, J BIOL CHEM, V280, P23429, DOI 10.1074/jbc.C500168200; Hermann A, 2006, AAPS J, V8, pE409, DOI 10.1007/BF02854913; Jhaveri MD, 2006, J NEUROSCI, V26, P13318, DOI 10.1523/JNEUROSCI.3326-06.2006; Jung KM, 2005, MOL PHARMACOL, V68, P1196, DOI 10.1124/mol.105.013961; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Kushmerick C, 2004, J NEUROSCI, V24, P5955, DOI 10.1523/JNEUROSCI.0768-04.2004; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Maione S, 2006, J PHARMACOL EXP THER, V316, P969, DOI 10.1124/jpet.105.093286; Makara JK, 2005, NAT NEUROSCI, V8, P1139, DOI 10.1038/nn1521; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Melis M, 2004, J NEUROSCI, V24, P10707, DOI 10.1523/JNEUROSCI.3502-04.2004; Melis M, 2006, NEUROBIOL DIS, V24, P15, DOI 10.1016/j.nbd.2006.04.010; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; PELLMAR TC, 1992, BRAIN RES, V583, P194, DOI 10.1016/S0006-8993(10)80024-1; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pisani A, 2001, NEUROPHARMACOLOGY, V40, P460, DOI 10.1016/S0028-3908(00)00184-2; Rouach N, 2003, EUR J NEUROSCI, V18, P1017, DOI 10.1046/j.1460-9568.2003.02823.x; Sagara Y, 1998, J NEUROSCI, V18, P6662; Sarnataro D, 2005, FEBS LETT, V579, P6343, DOI 10.1016/j.febslet.2005.10.016; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; SUGIURA T, 2002, FATTY ACIDS, V66, P173; Szabo B, 2006, J PHYSIOL-LONDON, V577, P263, DOI 10.1113/jphysiol.2006.119362; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Valenti M, 2004, CELL MOL LIFE SCI, V61, P945, DOI 10.1007/s00018-003-3453-5; Wang Y, 2001, ANAL BIOCHEM, V294, P73, DOI 10.1006/abio.2001.5015; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	50	242	244	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					152	159		10.1038/nn2042	http://dx.doi.org/10.1038/nn2042			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18204441				2022-12-24	WOS:000252712100009
J	Lewcock, JW; Genoud, N; Lettieri, K; Pfaff, SL				Lewcock, Joseph W.; Genoud, Nicolas; Lettieri, Karen; Pfaff, Samuel L.			The ubiquitin ligase phr1 regulates axon outgrowth through modulation of microtubule dynamics	NEURON			English	Article							INTERFERENCE CONTRAST MICROSCOPY; GROWTH CONE GUIDANCE; MOTOR-NEURONS; C-ELEGANS; PATHWAY SELECTION; SYNAPTIC GROWTH; SURVIVAL FACTOR; TIME-LAPSE; PROTEIN; GENE	To discover new genes involved in axon navigation, we conducted a forward genetic screen for recessive alleles affecting motor neuron pathfinding in GFP reporter mice mutagenized with ENU. In Magellan mutant embryos, motor axons were error prone and wandered inefficiently at choice points within embryos, but paradoxically responded to guidance cues with normal sensitivity in vitro. We mapped the Magellan mutation to the Phr1 gene encoding a large multidomain E3 ubiquitin ligase. Phr1 is associated with the microtubule cytoskeleton within neurons and selectively localizes to axons but is excluded from growth cones. Motor and sensory neurons from Magellan mutants display abnormal morphologies due to a breakdown in the polarized distribution of components that segregate between axons and growth cones. The Magellan phenotype can be reversed by stabilizing microtubules with taxol or inhibiting p38MAPK activity. Thus, efficacious pathfinding requires Phr1 activity for coordinating the cytoskeletal organization that distinguishes axons from growth cones.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pfaff@salk.edu						AHMAD FJ, 1993, J NEUROSCI, V13, P856; ALETTA JM, 1988, J NEUROSCI, V8, P1425; Bielas SL, 2007, CELL, V129, P579, DOI 10.1016/j.cell.2007.03.023; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; BROWN A, 1993, J CELL SCI, V104, P339; Buck KB, 2002, J NEUROSCI, V22, P9358; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Concepcion D, 2004, GENETICS, V168, P953, DOI 10.1534/genetics.104.029843; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GOLDBERG DJ, 1986, J CELL BIOL, V103, P1921, DOI 10.1083/jcb.103.5.1921; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; HARRIS WA, 1987, DEVELOPMENT, V101, P123; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Helmbacher F, 2003, NEURON, V39, P767, DOI 10.1016/S0896-6273(03)00493-8; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; LANDMESSER LT, 1980, ANNU REV NEUROSCI, V3, P279, DOI 10.1146/annurev.ne.03.030180.001431; Lee SK, 2004, DEVELOPMENT, V131, P3295, DOI 10.1242/dev.01179; Lieberam I, 2005, NEURON, V47, P667, DOI 10.1016/j.neuron.2005.08.011; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; MATUS A, 1994, TRENDS NEUROSCI, V17, P19, DOI 10.1016/0166-2236(94)90030-2; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Novak KD, 2000, J NEUROSCI, V20, P326, DOI 10.1523/JNEUROSCI.20-01-00326.2000; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Santos TM, 2006, J NEUROSCI RES, V83, P222, DOI 10.1002/jnr.20723; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Shirasaki R, 2006, NEURON, V50, P841, DOI 10.1016/j.neuron.2006.04.030; Song MR, 2006, DEVELOPMENT, V133, P4945, DOI 10.1242/dev.02694; Suter DM, 2004, CURR BIOL, V14, P1194, DOI 10.1016/j.cub.2004.06.049; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; Uemura O, 2005, DEV BIOL, V278, P587, DOI 10.1016/j.ydbio.2004.11.031; Van Vactor D, 1998, CURR OPIN NEUROBIOL, V8, P80, DOI 10.1016/S0959-4388(98)80011-1; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Williamson T, 1996, P NATL ACAD SCI USA, V93, P15221, DOI 10.1073/pnas.93.26.15221; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Yamamoto Y, 1997, DEVELOPMENT, V124, P2903; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhou FQ, 2004, J NEUROBIOL, V58, P84, DOI 10.1002/neu.10278	66	158	159	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 21	2007	56	4					604	620		10.1016/j.neuron.2007.09.009	http://dx.doi.org/10.1016/j.neuron.2007.09.009			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	236MH	18031680	Bronze			2022-12-24	WOS:000251306600006
J	Shapiro, L				Shapiro, Lawrence			Self-recognition at the atomic level: Understanding the astonishing molecular diversity of homophilic Dscams	NEURON			English	Editorial Material							CELL-ADHESION; AXON GUIDANCE; CRYSTAL-STRUCTURE; DROSOPHILA DSCAM; MORPHOGENESIS; ORGANIZATION; AVOIDANCE; PROTEINS; RECEPTOR; BINDING	The Drosophila Dscams are immunoglobulin superfamily members produced from a single gene that is diversified by alternative splicing to produce a family of cell-surface proteins with over 19,000 different ectodomain isoforms. Dscams are critical for neuronal wiring, and mounting evidence suggests that they play a key role in self-avoidance between sister branches from neurons, which depends on homophilic self-recognition by Dscams. Two recent papers shed new light on Dscam recognition: first by showing that the vast majority of Dscam isoforms mediate specific homophilic binding and second by revealing the essence of the molecular basis of homophilic recognition by Dscams through high-resolution structural studies.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Edward S Harkness Eye Inst, New York, NY 10032 USA	Columbia University; Columbia University	Shapiro, L (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	Iss8@columbia.edu	Shapiro, Lawrence/AAE-7172-2019		NIGMS NIH HHS [R01 GM062270] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062270] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; MEIJERS R, 2007, IN PRESS NATURE; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020	17	7	8	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2007	56	1					10	13		10.1016/j.neuron.2007.09.024	http://dx.doi.org/10.1016/j.neuron.2007.09.024			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920010	Bronze			2022-12-24	WOS:000250289800005
J	Spitzer, M; Fischbacher, U; Herrnberger, B; Gron, G; Fehr, E				Spitzer, Manfred; Fischbacher, Urs; Herrnberger, Baerbel; Groen, Georg; Fehr, Ernst			The neural signature of social norm compliance	NEURON			English	Article							HUMAN ORBITOFRONTAL CORTEX; COGNITIVE NEUROSCIENCE; ALTRUISTIC PUNISHMENT; PREFRONTAL CORTEX; DECISION-MAKING; FRONTAL-CORTEX; BRAIN; REWARD; FAIRNESS; BEHAVIOR	All known human societies establish social order by punishing violators of social norms. However, little is known about how the brain processes the punishment threat associated with norm violations. We use fMRI to study the neural circuitry behind social norm compliance by comparing a treatment in which norm violations can be punished with a control treatment in which punishment is impossible. Individuals' increase in norm compliance when punishment is possible exhibits a strong positive correlation with activations in the lateral orbitofrontal cortex and right dorsolateral prefrontal cortex. Moreover, lateral orbitofrontal cortex activity is strongly correlated with Machiavellian personality characteristics. These findings indicate a neural network involved in social norm compliance that might constitute an important basis for human sociality. Different activations of this network reveal individual differences in the behavioral response to the punishment threat and might thus provide a deeper understanding of the neurobiological sources of pathologies such as antisocial personality disorder.	Univ Ulm, Univ Hosp Psychiat, D-89075 Ulm, Germany; Transfer Ctr Neurosci & Learning, D-89075 Ulm, Germany; Univ Zurich, Inst Emprical Res Econ, CH-8006 Zurich, Switzerland; Coll Helveticum, CH-8092 Zurich, Switzerland	Ulm University; University of Zurich	Spitzer, M (corresponding author), Univ Ulm, Univ Hosp Psychiat, Leimgrubenweg 1214, D-89075 Ulm, Germany.	manfred.spitzer@uni-ulm.de; efehr@iew.uzh.ch	Fischbacher, Urs/H-2693-2014	Fischbacher, Urs/0000-0002-5115-8815; Gron, Georg/0000-0002-0282-3575				ADENAES J, 1974, PUNISHMENT DETERRENC; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Andreoni J, 2003, AM ECON REV, V93, P893, DOI 10.1257/000282803322157142; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Christie R, 1970, STUDIES MACHIAVELLIS; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Damasio A, 1995, DESCARTES ERROR EMOT; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Elster J., 1989, CEMENT SOC STUDY SOC; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Garland B, 2006, CURR OPIN NEUROBIOL, V16, P130, DOI 10.1016/j.conb.2006.03.011; Glimcher PW, 2005, GAME ECON BEHAV, V52, P213, DOI 10.1016/j.geb.2004.06.011; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; KAHNEMAN D, 1986, AM ECON REV, V76, P728; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moll J, 2003, NEUROREPORT, V14, P299, DOI 10.1097/01.wnr.0000057866.05120.28; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Ochsner KN, 2004, CURR OPIN NEUROBIOL, V14, P254, DOI 10.1016/j.conb.2004.03.011; PREHN K, 2007, IN PRESS MORAL BRAIN; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sapolsky RM, 2004, PHILOS T R SOC B, V359, P1787, DOI 10.1098/rstb.2004.1547; Schmitz BL, 2005, AM J NEURORADIOL, V26, P2229; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schultz W, 2003, TRENDS NEUROSCI, V26, P321, DOI 10.1016/S0166-2236(03)00122-X; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Sober E., 1998, OTHERS EVOLUTION PSY; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Veit R, 2002, NEUROSCI LETT, V328, P233, DOI 10.1016/S0304-3940(02)00519-0	55	348	358	6	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2007	56	1					185	196		10.1016/j.neuron.2007.09.011	http://dx.doi.org/10.1016/j.neuron.2007.09.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920024	Bronze, Green Accepted			2022-12-24	WOS:000250289800019
J	Xie, ZG; Moy, LY; Sanada, K; Zhou, Y; Buchman, JJ; Tsai, LH				Xie, Zhigang; Moy, Lily Y.; Sanada, Kamon; Zhou, Ying; Buchman, Joshua J.; Tsai, Li-Huei			Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool	NEURON			English	Article							NEURONAL MIGRATION; SPINDLE REGULATION; TUMOR-SUPPRESSOR; CYTOCHALASIN-B; COILED-COIL; ZYG-9 FORM; ASPM GENE; PROTEIN; MOUSE; LIS1	Centrosome- and microtubule-associated proteins have been shown to be important for maintaining the neural progenitor pool during neocortical development by regulating the mitotic spindle. It remains unclear whether these proteins may control neurogenesis by regulating other microtubule-dependent processes such as nuclear migration. Here, we identify Cep120, a centrosomal protein preferentially expressed in neural progenitors during neocortical development. We demonstrate that silencing Cep120 in the developing neocortex impairs both interkinetic nuclear migration (INM), a characteristic pattern of nuclear movement in neural progenitors, and neural progenitor self-renewal. Furthermore, we show that Cep120 interacts with transforming acidic coiled-coil proteins (TACCs) and that silencing TACCs also causes defects in INM and neural progenitor self-renewal. Our data suggest a critical role for Cep120 and TACCs in both INM and neurogenesis. We propose that sustaining INM may be a mechanism by which microtubule-regulating proteins maintain the neural progenitor pool during neocortical development.	MIT, RIKEN MIT Neurosci Res Ctr, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Howard Hughes Med Inst, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Tsai, LH (corresponding author), MIT, RIKEN MIT Neurosci Res Ctr, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave,Bldg 46,Room 4235A, Cambridge, MA 02139 USA.	lhtsai@mit.edu	SANADA, YOSHIKADO/G-5014-2014	Sanada, Kamon/0000-0002-0280-8957; Xie, Zhigang/0000-0002-7190-992X	NINDS NIH HHS [R01 NS037007-09, R01 NS037007, NS37007] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037007] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aitola M, 2003, J HISTOCHEM CYTOCHEM, V51, P455, DOI 10.1177/002215540305100407; Astrom K E, 1991, Adv Anat Embryol Cell Biol, V123, P1; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Bellanger JM, 2003, CURR BIOL, V13, P1488, DOI 10.1016/S0960-9822(03)00582-7; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Buchman JJ, 2007, NAT REV NEUROSCI, V8, P89, DOI 10.1038/nrn2058; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chen HM, 2000, MOL BIOL CELL, V11, P1357, DOI 10.1091/mbc.11.4.1357; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Gergely F, 2002, BIOESSAYS, V24, P915, DOI 10.1002/bies.10162; Gergely F, 2000, EMBO J, V19, P241, DOI 10.1093/emboj/19.2.241; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; HINDS JW, 1971, Z ZELLFORSCH MIK ANA, V115, P226, DOI 10.1007/BF00391127; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; KARFUNKEL P, 1972, J EXP ZOOL, V181, P289, DOI 10.1002/jez.1401810302; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Lauffart B, 2006, DEV DYNAM, V235, P1638, DOI 10.1002/dvdy.20724; Le Bot N, 2003, CURR BIOL, V13, P1499, DOI 10.1016/S0960-9822(03)00577-3; MESSIER PE, 1973, J EMBRYOL EXP MORPH, V30, P661; MESSIER PE, 1974, DEV BIOL, V36, P218, DOI 10.1016/0012-1606(74)90206-1; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; O'Brien LL, 2005, MOL BIOL CELL, V16, P2836, DOI 10.1091/mbc.e04-10-0926; Peset I, 2005, J CELL BIOL, V170, P1057, DOI 10.1083/jcb.200504037; Piekorz RP, 2002, EMBO J, V21, P653, DOI 10.1093/emboj/21.4.653; Rakic P, 2006, CEREB CORTEX, V16, pI3, DOI 10.1093/cercor/bhk036; Reinsch S, 1998, J CELL SCI, V111, P2283; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Schuendeln MM, 2004, MOL CELL BIOL, V24, P6403, DOI 10.1128/MCB.24.14.6403-6409.2004; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Srayko M, 2003, CURR BIOL, V13, P1506, DOI 10.1016/S0960-9822(03)00597-9; Still IH, 1999, ONCOGENE, V18, P4032, DOI 10.1038/sj.onc.1202801; Still IH, 1999, GENOMICS, V58, P165, DOI 10.1006/geno.1999.5829; Takahashi T, 1999, J NEUROSCI, V19, P10357; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; WEBSTER W, 1978, AM J ANAT, V152, P209, DOI 10.1002/aja.1001520204; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Zhong XY, 2005, CELL CYCLE, V4, P1227, DOI 10.4161/cc.4.9.2029	52	128	134	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2007	56	1					79	93		10.1016/j.neuron.2007.08.026	http://dx.doi.org/10.1016/j.neuron.2007.08.026			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920017	Green Accepted, Bronze			2022-12-24	WOS:000250289800012
J	Engblom, D; Bilbao, A; Sanchis-Segura, C; Dahan, L; Perreau-Lenz, S; Balland, B; Parkitna, JR; Lujan, R; Halbout, B; Mameli, M; Parlato, R; Sprengel, R; Luscher, C; Schutz, G; Spanagel, R				Engblom, David; Bilbao, Ainhoa; Sanchis-Segura, Carles; Dahan, Lionel; Perreau-Lenz, Stephanie; Balland, Benedicte; Parkitna, Jan Rodriguez; Lujan, Rafael; Halbout, Briac; Mameli, Manuel; Parlato, Rosanna; Sprengel, Rolf; Luescher, Christian; Schuetz, Guenther; Spanagel, Rainer			Glutamate receptors on dopamine neurons control the persistence of cocaine seeking	NEURON			English	Article							VENTRAL TEGMENTAL AREA; CONDITIONED PLACE PREFERENCE; LONG-TERM POTENTIATION; BEHAVIORAL SENSITIZATION; SYNAPTIC PLASTICITY; NMDA RECEPTORS; IN-VIVO; AMPA RECEPTORS; MICE; EXPRESSION	Cocaine strengthens excitatory synapses onto midbrain dopamine neurons through the synaptic delivery of GluR1-containing AMPA receptors. This cocaine-evoked plasticity depends on NMDA receptor activation, but its behavioral significance in the context of addiction remains elusive. Here, we generated mice lacking the GluR1, GluR2, or NR1 receptor subunits selectively in dopamine neurons. We report that in midbrain slices of cocaine-treated mice, synaptic transmission was no longer strengthened when GluR1 or NR1 was abolished, while in the respective mice the drug still induced normal conditioned place preference and locomotor sensitization. In contrast, extinction of drug-seeking behavior was absent in mice lacking GluR1, while in the NR1 mutant mice reinstatement was abolished. In conclusion, cocaine-evoked synaptic plasticity does not mediate concurrent short-term behavioral effects of the drug but may initiate adaptive changes eventually leading to the persistence of drug-seeking behavior.	[Dahan, Lionel; Balland, Benedicte; Mameli, Manuel; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Engblom, David; Parkitna, Jan Rodriguez; Parlato, Rosanna; Schuetz, Guenther] German Canc Res Ctr, Div Mol Biol Cell 1, D-69120 Heidelberg, Germany; [Bilbao, Ainhoa; Sanchis-Segura, Carles; Perreau-Lenz, Stephanie; Halbout, Briac; Spanagel, Rainer] Cent Inst Mental Hlth, Dept Psychopharmacol, D-68159 Mannheim, Germany; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, CH-1211 Geneva, Switzerland; [Lujan, Rafael] Univ Castilla La Mancha, Dept Ciencias Med, Fac Med CRIB, Albacete 02006, Spain; [Sprengel, Rolf] Max Planck Inst Med Res, Dept Mol Neurosci, D-69120 Heidelberg, Germany	University of Geneva; Helmholtz Association; German Cancer Research Center (DKFZ); Central Institute of Mental Health; University of Geneva; Universidad de Castilla-La Mancha; Max Planck Society	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch; rainer.spanagel@zi-mannheim.de	Lüscher, Christian/A-2496-2011; Halbout, Briac/I-4646-2019; Parlato, Rosanna/AAH-4429-2020; Dahan, Lionel/C-2760-2009; Rodriguez, Jan/I-2910-2012; Bilbao, Ainhoa/AAW-6230-2020; Sanchis-Segura, Carla/C-5222-2012; Lujan, Rafael/G-2555-2015; Perreau-Lenz, Stephanie/D-2309-2014; s, c/Y-9655-2019; Parlato, Rosanna/G-8768-2015	Lüscher, Christian/0000-0001-7917-4596; Parlato, Rosanna/0000-0001-6682-9645; Rodriguez, Jan/0000-0003-0367-2331; Sanchis-Segura, Carla/0000-0002-6951-5972; Perreau-Lenz, Stephanie/0000-0001-9529-6403; s, c/0000-0002-6951-5972; Mameli, Manuel/0000-0002-0570-6964; Lujan Miras, Rafael/0000-0003-2001-9545; Dahan, Lionel/0000-0001-7810-6233	EU; BMBF/NGFN; SFB [636/B1, 636/A3, 636/A4]; EMBO fellowship; Swedish Research Council;  [PA108-0174-6967]	EU(European Commission); BMBF/NGFN(Federal Ministry of Education & Research (BMBF)); SFB(Austrian Science Fund (FWF)); EMBO fellowship(European Molecular Biology Organization (EMBO)); Swedish Research Council(Swedish Research CouncilEuropean Commission); 	We thank T. Arnsperger for technical assistance. This work was supported by an EU grant (PHECOMP) and a BMBF/NGFN grant to R. Spanagel and G.S., and SFB grants 636/B1, 636/A3, and 636/A4 to R. Spanagel, G.S., and R. Sprengel. R.L. was supported with grant PA108-0174-6967. D.E. was supported by an EMBO fellowship and the Swedish Research Council.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; DI CG, 1988, P NATL ACAD SCI USA, V85, P5274; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; Erdmann G, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-63; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Grignaschi G, 2004, EUR J NEUROSCI, V20, P2833, DOI 10.1111/j.1460-9568.2004.03712.x; Hall BJ, 2007, J NEUROSCI, V27, P13446, DOI 10.1523/JNEUROSCI.3793-07.2007; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P73, DOI 10.1038/sj.npp.1300011; Heusner CL, 2005, J NEUROSCI, V25, P6651, DOI 10.1523/JNEUROSCI.1474-05.2005; Itzhak Y, 2002, NEUROPSYCHOPHARMACOL, V26, P130, DOI 10.1016/S0893-133X(01)00303-7; KALIVAS PW, 1993, J PHARMACOL EXP THER, V267, P486; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Lu WX, 2002, NEUROPSYCHOPHARMACOL, V26, P1, DOI 10.1016/S0893-133X(01)00272-X; Luscher C, 2008, NAT NEUROSCI, V11, P737, DOI 10.1038/nn0708-737; Luscher C, 2006, PLOS MED, V3, P2005, DOI 10.1371/journal.pmed.0030437; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mead AN, 2005, PSYCHOPHARMACOLOGY, V179, P164, DOI 10.1007/s00213-004-2071-8; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; Parlato R, 2006, GENESIS, V44, P454, DOI 10.1002/dvg.20236; RAMSEY AJ, 2008, NEUROPSYCHO IN PRESS; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Schmidt HD, 2005, EUR J PHARMACOL, V526, P65, DOI 10.1016/j.ejphar.2005.09.068; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shimshek DR, 2006, J NEUROSCI, V26, P8428, DOI 10.1523/JNEUROSCI.5410-05.2006; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; Spielewoy C, 2000, BEHAV PHARMACOL, V11, P279, DOI 10.1097/00008877-200006000-00011; Stephens DN, 2003, TRENDS NEUROSCI, V26, P181, DOI 10.1016/S0166-2236(03)00080-8; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vogt MA, 2008, EXP NEUROL, V211, P25, DOI 10.1016/j.expneurol.2007.12.012; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020; Zushida K, 2007, J NEUROSCI, V27, P158, DOI 10.1523/JNEUROSCI.3842-06.2007	47	179	182	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 14	2008	59	3					497	508		10.1016/j.neuron.2008.07.010	http://dx.doi.org/10.1016/j.neuron.2008.07.010			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339GG	18701074	Bronze			2022-12-24	WOS:000258565500017
J	Posson, DJ; Selvin, PR				Posson, David J.; Selvin, Paul R.			Extent of voltage sensor movement during gating of Shaker K+ channels	NEURON			English	Article							GATED ION CHANNELS; LUMINESCENCE ENERGY-TRANSFER; FOCUSED ELECTRIC-FIELD; POTASSIUM CHANNEL; LIPID-MEMBRANE; SENSING DOMAIN; S4 SEGMENT; CHARGE; RESIDUES; FLUORESCENCE	Voltage-driven activation of Kv channels results from conformational changes of four voltage sensor domains (VSDs) that surround the K+ selective pore domain. How the VSD helices rearrange during gating is an area of active research. Luminescence resonance energy transfer (LRET) is a powerful spectroscopic ruler uniquely suitable for addressing the conformational trajectory of these helices. Using a geometric analysis of numerous LRET measurements, we were able to estimate LRET probe positions relative to existing structural models. The experimental movement of helix S4 does not support a large 15-20 angstrom transmembrane "paddle-type" movement or a near-zero A vertical "transporter-type" model. Rather, our measurements demonstrate a moderate S4 displacement of 10 +/- 5 angstrom, with a vertical component of 5 +/- 2 angstrom. The S3 segment moves 2 +/- 1 angstrom in the opposite direction and is therefore not moving as an S3-S4 rigid body.	[Posson, David J.; Selvin, Paul R.] Univ Illinois, Dept Phys & Biophys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Selvin, PR (corresponding author), Univ Illinois, Dept Phys & Biophys, Urbana, IL 61801 USA.	selvin@uiuc.edu			NIGMS NIH HHS [R01 GM074770, R01 GM074770-03, GM074770, R01 GM074770-01, R01 GM074770-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074770] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Ahern CA, 2004, TRENDS NEUROSCI, V27, P303, DOI 10.1016/j.tins.2004.03.008; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Baumgartner W, 1999, BIOPHYS J, V77, P1980, DOI 10.1016/S0006-3495(99)77039-6; Bezanilla F, 2005, IEEE T NANOBIOSCI, V4, P34, DOI 10.1109/TNB.2004.842463; Bezanilla F, 1998, METHOD ENZYMOL, V293, P331; Blunck R, 2004, BIOPHYS J, V86, P3966, DOI 10.1529/biophysj.103.034512; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Chakrabarty T, 2002, P NATL ACAD SCI USA, V99, P6011, DOI 10.1073/pnas.082024299; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Chanda B, 2004, J GEN PHYSIOL, V123, P217, DOI 10.1085/jgp.200308971; Chen JY, 1999, BIOCONJUGATE CHEM, V10, P311, DOI 10.1021/bc980113w; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Clegg Robert M., 1995, Current Opinion in Biotechnology, V6, P103, DOI 10.1016/0958-1669(95)80016-6; Darman RB, 2006, J GEN PHYSIOL, V128, P687, DOI 10.1085/jgp.200609624; Eriksson MAL, 2002, BIOPHYS J, V83, P2595, DOI 10.1016/S0006-3495(02)75270-3; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Gonzalez C, 2005, P NATL ACAD SCI USA, V102, P5020, DOI 10.1073/pnas.0501051102; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Heyduk T, 2001, ANAL BIOCHEM, V289, P60, DOI 10.1006/abio.2000.4925; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kumanovics A, 2002, FASEB J, V16, P1623, DOI 10.1096/fj.02-0238hyp; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Nimigean CM, 2004, J GEN PHYSIOL, V124, P203, DOI 10.1085/jgp.200409133; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Purdy MD, 2002, ACTA CRYSTALLOGR D, V58, P1111, DOI 10.1107/S0907444902006509; Reifenberger JG, 2003, J PHYS CHEM B, V107, P12862, DOI 10.1021/jp0357424; Richardson J, 2006, P NATL ACAD SCI USA, V103, P15865, DOI 10.1073/pnas.0607532103; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SHIMONY E, 1994, PROTEIN ENG, V7, P503, DOI 10.1093/protein/7.4.503; Smith PL, 2002, J GEN PHYSIOL, V119, P275, DOI 10.1085/jgp.119.3.275; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Sonnleitner A, 2002, P NATL ACAD SCI USA, V99, P12759, DOI 10.1073/pnas.192261499; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837	65	56	56	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 10	2008	59	1					98	109		10.1016/j.neuron.2008.05.006	http://dx.doi.org/10.1016/j.neuron.2008.05.006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	327KU	18614032	Green Accepted, Bronze			2022-12-24	WOS:000257728800011
J	Fujisawa, S; Amarasingham, A; Harrison, MT; Buzsaki, G				Fujisawa, Shigeyoshi; Amarasingham, Asohan; Harrison, Matthew T.; Buzsaki, Gyoergy			Behavior-dependent short-term assembly dynamics in the medial prefrontal cortex	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY; GABAERGIC INTERNEURONS; FEEDFORWARD INHIBITION; SYNAPTIC PLASTICITY; UNIT-ACTIVITY; IN-VIVO; NEURONS; RAT; CELLS; HIPPOCAMPUS	Although short-term plasticity is believed to play a fundamental role in cortical computation, empirical evidence bearing on its role during behavior is scarce. Here we looked for the signature of short-term plasticity in the fine-timescale spiking relationships of a simultaneously recorded population of physiologically identified pyramidal cells and interneurons, in the medial prefrontal cortex of the rat, in a working memory task. On broader timescales, sequentially organized and transiently active neurons reliably differentiated between different trajectories of the rat in the maze. On finer timescales, putative monosynaptic interactions reflected short-term plasticity in their dynamic and predictable modulation across various aspects of the task, beyond a statistical accounting for the effect of the neurons' co-varying firing rates. Seeking potential mechanisms for such effects, we found evidence for both firing pattern-dependent facilitation and depression, as well as for a supralinear effect of presynaptic coincidence on the firing of postsynaptic targets.	[Fujisawa, Shigeyoshi; Amarasingham, Asohan; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Harrison, Matthew T.] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Carnegie Mellon University	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Fujisawa, Shigeyoshi/N-6439-2015	Fujisawa, Shigeyoshi/0000-0003-3963-4281; Buzsaki, Gyorgy/0000-0002-3100-4800	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064537, R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH054671, R01 MH064537, MH064537, R01 MH054671-10, MH54671] Funding Source: Medline; NINDS NIH HHS [NS34994, R01 NS034994-11, R01 NS034994] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Baeg EH, 2007, J NEUROSCI, V27, P909, DOI 10.1523/JNEUROSCI.4759-06.2007; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; BATUEV AS, 1990, BEHAV BRAIN RES, V41, P95, DOI 10.1016/0166-4328(90)90145-5; BEAULIEU C, 1993, BRAIN RES, V609, P284, DOI 10.1016/0006-8993(93)90884-P; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; EICHENBAUM H, 1983, EXP NEUROL, V79, P434, DOI 10.1016/0014-4886(83)90224-8; Euston DR, 2006, J NEUROSCI, V26, P13143, DOI 10.1523/JNEUROSCI.3803-06.2006; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Good P, 2005, PERMUTATION PARAMETR; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hatsopoulos N, 2003, NEUROCOMPUTING, V52-4, P25, DOI 10.1016/S0925-2312(02)00773-7; Hebb Donald O., 1949, ORG BEHAV; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Hirabayashi T, 2005, J NEUROSCI, V25, P10299, DOI 10.1523/JNEUROSCI.3036-05.2005; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jung MW, 1998, CEREB CORTEX, V8, P437, DOI 10.1093/cercor/8.5.437; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kargo WJ, 2007, J NEUROSCI, V27, P3548, DOI 10.1523/JNEUROSCI.3604-06.2007; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sussillo D, 2007, J NEUROPHYSIOL, V97, P4079, DOI 10.1152/jn.01357.2006; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Ventura V, 2005, J NEUROPHYSIOL, V94, P2928, DOI 10.1152/jn.00644.2004; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	50	411	413	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					823	833		10.1038/nn.2134	http://dx.doi.org/10.1038/nn.2134			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18516033	Green Accepted			2022-12-24	WOS:000257089400020
J	Plested, AJR; Vijayan, R; Biggin, PC; Mayer, ML				Plested, Andrew J. R.; Vijayan, Ranjit; Biggin, Philip C.; Mayer, Mark L.			Molecular basis of kainate receptor modulation by sodium	NEURON			English	Article							GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURES; BINDING-SITES; CHANNEL; AMPA; NA+; DESENSITIZATION; ACTIVATION; MECHANISMS; MEDIATE	Membrane proteins function in a polarized ionic environment with sodium-rich extracellular and potassium-rich intracellular solutions. Glutamate receptors that mediate excitatory synaptic transmission in the brain show unusual sensitivity to external ions, resulting in an apparent requirement for sodium in order for glutamate to activate kainate receptors. Here, we solve the structure of the Na+-binding sites and determine the mechanism by which allosteric anions and cations. regulate ligand-binding dimer stability, and hence the rate of desensitization and receptor availability for gating by glutamate. We establish a stoichiometry for binding of 2 Na+ to 1 Cl- and show that allosteric anions and cations bind at physically discrete sites with strong electric fields, that the binding sites are not saturated in CSF, and that the requirement of kainate receptors for Na+ occurs simply because other cations bind with lower affinity and have lower efficacy compared to Na+.	[Plested, Andrew J. R.; Mayer, Mark L.] NICHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH,DHHS, Bethesda, MD 20892 USA; [Vijayan, Ranjit; Biggin, Philip C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Vijayan, Ranjit] Life Sci Interface Doctoral Training Ctr, Oxford OX1 3QD, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Oxford; University of Oxford	Mayer, ML (corresponding author), NICHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH,DHHS, Bethesda, MD 20892 USA.	mlm@helix.nih.gov	Vijayan, Ranjit/AAH-6015-2019; Mayer, Mark/AAE-7356-2019; Vijayan, Ranjit/GXF-4345-2022; Mayer, Mark L/H-5500-2013	Vijayan, Ranjit/0000-0002-3830-7409; Mayer, Mark/0000-0003-4378-8451; Vijayan, Ranjit/0000-0002-3830-7409; Biggin, Philip/0000-0001-5100-8836; Plested, Andrew/0000-0001-6062-0832	Intramural NIH HHS [Z01 HD000707-23] Funding Source: Medline; Wellcome Trust Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000707] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bowie D, 2002, J PHYSIOL-LONDON, V539, P725, DOI 10.1113/jphysiol.2001.013407; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Muller P, 2003, ACTA CRYSTALLOGR D, V59, P32, DOI 10.1107/S0907444902018000; Nagem RAP, 2001, ACTA CRYSTALLOGR D, V57, P996, DOI 10.1107/S0907444901007260; Naur P, 2007, P NATL ACAD SCI USA, V104, P14116, DOI 10.1073/pnas.0703718104; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paternain AV, 2003, J NEUROSCI, V23, P8641; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; Priel A, 2006, NEURON, V52, P1037, DOI 10.1016/j.neuron.2006.12.006; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Vivithanaporn P, 2007, J NEUROSCI, V27, P10423, DOI 10.1523/JNEUROSCI.2674-07.2007; Weston MC, 2006, J NEUROSCI, V26, P7650, DOI 10.1523/JNEUROSCI.1519-06.2006; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wollmuth LP, 2000, J NEUROSCI, V20, P5973, DOI 10.1523/JNEUROSCI.20-16-05973.2000; Wong AYC, 2007, J NEUROSCI, V27, P6800, DOI 10.1523/JNEUROSCI.0284-07.2007; Wong AYC, 2006, J NEUROSCI, V26, P5750, DOI 10.1523/JNEUROSCI.0301-06.2006	43	72	73	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 12	2008	58	5					720	735		10.1016/j.neuron.2008.04.001	http://dx.doi.org/10.1016/j.neuron.2008.04.001			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	315IA	18549784	Bronze, Green Accepted			2022-12-24	WOS:000256870800010
J	Wickramasinghe, SR; Alvania, RS; Ramanan, N; Wood, JN; Mandai, K; Ginty, DD				Wickramasinghe, S. Rasika; Alvania, Rebecca S.; Ramanan, Narendrakumar; Wood, John N.; Mandai, Kenji; Ginty, David D.			Serum response factor mediates NGF-dependent target innervation by embryonic DRG sensory neurons	NEURON			English	Article							AXON GROWTH; TRANSCRIPTIONAL COACTIVATOR; GENE-EXPRESSION; FACTOR SRF; IN-VIVO; OUTGROWTH; ELEMENT; DOMAIN; DIFFERENTIATION; STIMULATION	Serum response factor (SRF) is a prototypic transcription factor that mediates stimulus-dependent gene expression. Here, we show that SRF mediates NGF signaling, axonal growth, branching, and target innervation by embryonic DRG sensory neurons. Conditional deletion of the murine SRF gene in DRGs results in no deficits in neuronal viability or differentiation but causes defects in extension and arborization of peripheral axonal projections in the target field in vivo, similar to the target innervation defects observed in mice lacking NGF. Moreover, SRF is both necessary and sufficient for NGF-dependent axonal outgrowth in vitro, and NGF regulates SRF-dependent gene expression and axonal outgrowth through activation of both MEK/ERK and MAL signaling pathways. These findings show that SRF is a major effector of both MEK/ERK and MAL signaling by NGF and that SRF is a key mediator of NGF-dependent target innervation by embryonic sensory neurons.	[Wickramasinghe, S. Rasika; Alvania, Rebecca S.; Ramanan, Narendrakumar; Mandai, Kenji; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Wood, John N.] UCL, Dept Biol, Mol Nocicept Grp, London WC1E 6BT, England	Howard Hughes Medical Institute; Johns Hopkins University; University of London; University College London	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, 725 N Wolfe St,PCTB 1015, Baltimore, MD 21205 USA.	dginty@jhmi.edu	RAMANAN, NARENDRAKUMAR/L-7487-2018	Mandai, Kenji/0000-0002-0115-6635; Alvania, Rebecca/0000-0002-3846-0702	Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [G9717869] Funding Source: Medline; NINDS NIH HHS [R01 NS034814, R37 NS034814, R37 NS034814-14, NS34814] Funding Source: Medline; MRC [G9717869] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034814, R37NS034814, R29NS034814] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Becker T, 2002, MECH DEVELOP, V117, P75, DOI 10.1016/S0925-4773(02)00178-8; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; JOHANSEN FE, 1994, MOL CELL BIOL, V14, P5920, DOI 10.1128/MCB.14.9.5920; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LEVIMONTALCINI R, 1956, P NATL ACAD SCI USA, V42, P695, DOI 10.1073/pnas.42.9.695; Lonze BE, 2002, NEURON, V34, P371, DOI 10.1016/S0896-6273(02)00686-4; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MISRA RP, 1991, MOL CELL BIOL, V11, P4545, DOI 10.1128/MCB.11.9.4545; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; RIVERA VM, 1990, GENE DEV, V4, P255, DOI 10.1101/gad.4.2.255; Segawa H, 2001, NEURON, V30, P423, DOI 10.1016/S0896-6273(01)00283-5; Seijffers R, 2006, MOL CELL NEUROSCI, V32, P143, DOI 10.1016/j.mcn.2006.03.005; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Selvaraj A, 2003, J BIOL CHEM, V278, P41977, DOI 10.1074/jbc.M305679200; Shiota J, 2006, J NEUROCHEM, V98, P1778, DOI 10.1111/j.1471-4159.2006.03992.x; Snider WD, 1996, PHILOS T ROY SOC B, V351, P395, DOI 10.1098/rstb.1996.0034; Tabuchi A, 2005, J NEUROCHEM, V94, P169, DOI 10.1111/j.1471-4159.2005.03179.x; Tonge DA, 1997, EXP NEUROL, V146, P81, DOI 10.1006/exnr.1997.6498; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; VAN AL, 1997, GENE DEV, V11, P2295; VISVADER J, 1988, P NATL ACAD SCI USA, V85, P9474, DOI 10.1073/pnas.85.24.9474; White FA, 1996, J NEUROSCI, V16, P4662; Wiebel FF, 2002, GENESIS, V32, P124, DOI 10.1002/gene.10049; Zhong J, 2007, NAT NEUROSCI, V10, P598, DOI 10.1038/nn1898; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	40	102	102	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 22	2008	58	4					532	545		10.1016/j.neuron.2008.03.006	http://dx.doi.org/10.1016/j.neuron.2008.03.006			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304PD	18498735	Green Accepted, Bronze			2022-12-24	WOS:000256120500008
J	Lau, B; Glimcher, PW				Lau, Brian; Glimcher, Paul W.			Value representations in the primate striatum during matching behavior	NEURON			English	Article							DOPAMINE NEURONS ENCODE; MONKEY CAUDATE NEURONS; BASAL GANGLIA; PREFRONTAL CORTEX; EYE-MOVEMENTS; FUNCTIONAL-PROPERTIES; REWARD EXPECTATION; DECISION-MAKING; PARIETAL CORTEX; NUCLEUS	Choosing the most valuable course of action requires knowing the outcomes associated with the available alternatives. The striatum may be important for representing the values of actions. We examined this in monkeys performing an oculomotor choice task. The activity of phasically active neurons (PANs) in the striatum covaried with two classes of information: action-values and chosen-values. Action-value PANs were correlated with value estimates for one of the available actions, and these signals were frequently observed before movement execution. Chosen-value PANs were correlated with the value of the action that had been chosen, and these signals were primarily observed later in the task, immediately before or persistently after movement execution. These populations may serve distinct functions mediated by the striatum: some PANs may participate in choice by encoding the values of the available actions, while other PANs may participate in evaluative updating by encoding the reward value of chosen actions.	[Lau, Brian; Glimcher, Paul W.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Lau, B (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	blau@cns.nyu.edu; pglimcher@cns.nyu.edu	Lau, Brian/D-6991-2011	Lau, Brian/0000-0001-8615-8244; Glimcher, Paul/0000-0001-7872-3856	NATIONAL EYE INSTITUTE [R01EY010536] Funding Source: NIH RePORTER; NEI NIH HHS [EY010536, R01 EY010536-12, R01 EY010536] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; AOSAKI T, 1994, J NEUROSCI, V14, P3969; APICELLA P, 1991, EXP BRAIN RES, V85, P491; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Davison M., 1988, ERLBAUM; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Ding L, 2006, J NEUROSCI, V26, P6695, DOI 10.1523/JNEUROSCI.0836-06.2006; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; GERFEN CR, 1987, J NEUROSCI, V7, P3915; Glimcher PW, 2001, J NEUROSCI METH, V108, P131, DOI 10.1016/S0165-0270(01)00365-X; Graybiel A. M., 1999, HDB CHEM NEUROANAT 3, P227; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Hassani OK, 2001, J NEUROPHYSIOL, V85, P2477, DOI 10.1152/jn.2001.85.6.2477; HERMSTEIN RJ, 1961, J EXPT ANAL BEHAV, V4, P267; Herrnstein RJ., 1980, LIMITS ACTION ALLOCA, P143; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Houk JC, 1995, MODELS INFORMATION P, P249; Itoh H, 2003, J NEUROPHYSIOL, V89, P1774, DOI 10.1152/jn.00630.2002; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; KIMURA M, 1984, P NATL ACAD SCI-BIOL, V81, P4998, DOI 10.1073/pnas.81.15.4998; Kobayashi S, 2007, EXP BRAIN RES, V176, P341, DOI 10.1007/s00221-006-0622-4; LARSEN WA, 1972, TECHNOMETRICS, V14, P781, DOI 10.2307/1267305; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Lau B, 2007, J NEUROSCI, V27, P14502, DOI 10.1523/JNEUROSCI.3060-07.2007; Lauwereyns J, 2002, NEURON, V33, P463, DOI 10.1016/S0896-6273(02)00571-8; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Luce R, 1959, INDIVIDUAL CHOICE BE; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; NEVIN JA, 1969, J EXP ANAL BEHAV, V12, P875, DOI 10.1901/jeab.1969.12-875; Niv Y, 2006, NAT NEUROSCI, V9, P987, DOI 10.1038/nn0806-987; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Paulin MG, 2001, NEURAL NETWORKS, V14, P877, DOI 10.1016/S0893-6080(01)00058-2; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SELEMON LD, 1985, J NEUROSCI, V5, P776; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tremblay L, 1998, J NEUROPHYSIOL, V80, P964, DOI 10.1152/jn.1998.80.2.964; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Watanabe K, 2003, J NEUROSCI, V23, P10052; WILD RJ, 2000, CHANGE ENCOUNTERS 1; WILLIAMS BA, 1988, STEVENS HDB EXPT PSY, P167; Williams ZM, 2006, NAT NEUROSCI, V9, P562, DOI 10.1038/nn1662	61	270	271	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 8	2008	58	3					451	463		10.1016/j.neuron.2008.02.021	http://dx.doi.org/10.1016/j.neuron.2008.02.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	300HP	18466754	Bronze, Green Accepted			2022-12-24	WOS:000255815200017
J	Cantor, RM; Geschwind, DH				Cantor, Rita M.; Geschwind, Daniel H.			Schizophrenia: Genome, interrupted	NEURON			English	Editorial Material							CHROMOSOMAL REARRANGEMENTS; MENTAL-RETARDATION; AUTISM; ASSOCIATION; DISORDERS; GENETICS	Structural chromosomal variation is increasingly recognized as an important contributor to human diseases, particularly those of neurodevelopment, such as autism. A current paper makes a significant advance to schizophrenia genetics by establishing an association with rare copy number variants (CNV), which are over-represented in neurodevelopmental genes.	[Cantor, Rita M.; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Cantor, Rita M.; Geschwind, Daniel H.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Cantor, RM (corresponding author), Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA.	rcantor@mednet.ucla.edu; dhg@ucla.edu						de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mehan Michael R., 2004, Human Genomics, V1, P335; Munafo MR, 2006, MOL PSYCHIATR, V11, P539, DOI 10.1038/sj.mp.4001817; Norton N, 2006, CURR OPIN PSYCHIATR, V19, P158, DOI 10.1097/01.yco.0000214341.52249.59; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Sullivan PF, 2008, CURR OPIN PSYCHIATR, V21, P157, DOI 10.1097/YCO.0b013e3282f4efde; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; WALSH T, 2008, IN PRESS SCIENCE; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	15	20	20	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2008	58	2					165	167		10.1016/j.neuron.2008.04.007	http://dx.doi.org/10.1016/j.neuron.2008.04.007			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292YX	18439401	Bronze			2022-12-24	WOS:000255303100004
J	Scolnick, JA; Cui, K; Duggan, CD; Xuan, S; Yuan, XB; Efstratiadis, A; Ngai, J				Scolnick, Jonathan A.; Cui, Kai; Duggan, Cynthia D.; Xuan, Shouhong; Yuan, Xiao-Bing; Efstratiadis, Argiris; Ngai, John			Role of IGF signaling in olfactory sensory map formation and axon guidance	NEURON			English	Article							GROWTH CONE GUIDANCE; RECEPTOR GENE-EXPRESSION; FACTOR-II GENE; ODORANT RECEPTOR; TOPOGRAPHIC MAP; MICE DEFICIENT; MOTOR-NEURONS; BULB; SYSTEM; GLOMERULI	Olfactory neurons project their axons to spatially invariant glomeruli in the olfactory bulb, forming an ordered pattern of innervation comprising the olfactory sensory map. A mirror symmetry exists within this map, such that neurons expressing a given receptor typically project to one glomerulus on the medial face and one glomerulus on the lateral face of the bulb. The mechanisms underlying an olfactory neuron's choice to project medially versus laterally remain largely unknown, however. Here we demonstrate that insulin-like growth factor (IGF) signaling is required for sensory innervation of the lateral olfactory bulb. Mutations that eliminate IGF signaling cause axons destined for targets in the lateral bulb to shift to ectopic sites on the ventral-medial surface. Using primary cultures of olfactory and cerebellar neurons, we further show that IGF is a chemoattractant for axon growth cones. Together these observations reveal a role of IGF signaling in sensory map formation and axon guidance.	[Scolnick, Jonathan A.; Duggan, Cynthia D.; Ngai, John] Univ Calif Berkeley, Helen Wills Neurosci Inst, Funct Genom Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Cui, Kai; Yuan, Xiao-Bing] Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; [Cui, Kai] Chinese Acad Sci, Grad Sch Chinese Acad Sci, Shanghai 200031, Peoples R China; [Xuan, Shouhong; Efstratiadis, Argiris] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA	University of California System; University of California Berkeley; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Columbia University	Ngai, J (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Funct Genom Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	jngai@socrates.berkeley.edu	scolnick, jonathan/AAY-2878-2020	Yuan, Xiaobing/0000-0002-1632-8460	NCI NIH HHS [1P01 CA97403, P01 CA097403] Funding Source: Medline; NIDCD NIH HHS [R01 DC007235-02, R01 DC007235-01, R01 DC007235-03, R01 DC007235, R01 DC007235-04] Funding Source: Medline; NIGMS NIH HHS [T32 GM007048-27, T32 GM007048-28, T32 GM007048] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA097403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007235] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Cho JH, 2007, J NEUROSCI, V27, P9094, DOI 10.1523/JNEUROSCI.2217-07.2007; Chrysis D, 2001, J NEUROSCI, V21, P1481, DOI 10.1523/JNEUROSCI.21-05-01481.2001; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Efstratiadis A, 1998, INT J DEV BIOL, V42, P955; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Ferrari CC, 2003, NEUROCHEM RES, V28, P29, DOI 10.1023/A:1021639926941; Imai T, 2007, CURR OPIN NEUROBIOL, V17, P507, DOI 10.1016/j.conb.2007.08.002; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S; Laurino L, 2005, J CELL SCI, V118, P3653, DOI 10.1242/jcs.02490; Levai O, 2003, J COMP NEUROL, V458, P209, DOI 10.1002/cne.10559; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Lin DM, 2004, P NATL ACAD SCI USA, V101, P12718, DOI 10.1073/pnas.0404872101; Lin DM, 1999, CURR OPIN NEUROBIOL, V9, P74, DOI 10.1016/S0959-4388(99)80009-9; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Nagao H, 2000, NEUROREPORT, V11, P3023, DOI 10.1097/00001756-200009110-00039; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Puche AC, 1996, DEV BIOL, V179, P274, DOI 10.1006/dbio.1996.0257; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Royal SJ, 2002, BRAIN RES, V932, P1, DOI 10.1016/S0006-8993(01)03384-4; Royal SJ, 1999, J NEUROSCI, V19, P9856; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; St John JA, 2002, INT J DEV BIOL, V46, P639; St John JA, 2003, J COMP NEUROL, V464, P131, DOI 10.1002/cne.10777; STYLIANOPOULOU F, 1988, P NATL ACAD SCI USA, V85, P141, DOI 10.1073/pnas.85.1.141; Suzuki Y, 2002, ANAT EMBRYOL, V205, P401, DOI 10.1007/s00429-002-0266-5; Taniguchi M, 2003, J NEUROSCI, V23, P1390, DOI 10.1523/JNEUROSCI.23-04-01390.2003; Tisay KT, 2000, J COMP NEUROL, V428, P656, DOI 10.1002/1096-9861(20001225)428:4<656::AID-CNE6>3.0.CO;2-7; Treloar H, 1997, J NEUROBIOL, V32, P643, DOI 10.1002/(SICI)1097-4695(19970620)32:7<643::AID-NEU1>3.0.CO;2-4; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vincent AM, 2004, NEUROMOL MED, V6, P79, DOI 10.1385/NMM:6:2-3:079; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Walz A, 2006, MOL CELL NEUROSCI, V32, P1, DOI 10.1016/j.mcn.2006.01.013; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; YAMAMOTO K, 1992, ENDOCRINOLOGY, V130, P1490, DOI 10.1210/en.130.3.1490; Ye P, 1996, DEV BRAIN RES, V95, P44; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	60	70	71	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2008	57	6					847	857		10.1016/j.neuron.2008.01.027	http://dx.doi.org/10.1016/j.neuron.2008.01.027			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281LV	18367086	Bronze, Green Accepted			2022-12-24	WOS:000254500000009
J	Han, MK; Song, EK; Guo, Y; Ou, X; Mantel, C; Broxmeyer, HE				Han, Myung-Kwan; Song, Eun-Kyung; Guo, Ying; Ou, Xuan; Mantel, Charlie; Broxmeyer, Hal E.			SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization	CELL STEM CELL			English	Article							OXIDATIVE STRESS; DNA-BINDING; ACTIVATION; GENE; SURVIVAL; PROTEIN; PHOSPHORYLATION; DIFFERENTIATION; INHIBITION; DISRUPTION	Nuclear tumor suppressor p53 transactivates proapoptotic genes or antioxidant genes depending on stress severity, while cytoplasmic p53 induces mitochondrial-dependent apoptosis without gene transactivation. Although SIRT1, a p53 deacetylase, inhibits p53-mediated transactivation, how SIRT1 regulates these p53 multifunctions is unclear. Here we show that SIRT1 blocks nuclear translocation of cytoplasmic p53 in response to endogenous reactive oxygen species (ROS) and triggers mitochondrial-dependent apoptosis in mouse embryonic stem (mES) cells. ROS generated by antioxidant-free culture caused p53 translocation into mitochondria in wild-type mES cells but induced p53 translocation into the nucleus in SIRT1(-/-) mES cells. Endogenous ROS triggered apoptosis of wild-type mES through mitochondrial translocation of p53 and BAX but inhibited Nanog expression of SIRT1(-/-) mES, indicating that SIRT1 makes mES cells sensitive to ROS and inhibits p53-mediated suppression of Nanog expression. Our results suggest that endogenous ROS control is important for mES cell maintenance in culture.	[Han, Myung-Kwan; Guo, Ying; Ou, Xuan; Mantel, Charlie; Broxmeyer, Hal E.] Indiana Univ, Sch Med, Walther Oncol Ctr, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Han, Myung-Kwan; Song, Eun-Kyung] Chonbuk Natl Univ, Sch Med, Dept Microbiol & Immunol, Jeonju 561182, South Korea	Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Jeonbuk National University	Han, MK (corresponding author), Indiana Univ, Sch Med, Walther Oncol Ctr, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	hbroxmey@iupui.edu; iamtom@chonbuk.ac.kr	Ou, Xuan/C-4871-2012; Ou, Xuan/F-4026-2012	Han, Myung-Kwan/0000-0003-1931-8898	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056416, P01HL053586, R01HL067384] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL053586-150005, R01 HL056416, R01 HL056416-08, R01 HL067384-08, R01 HL067384, P01 HL053586] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Arai M, 2000, CIRC RES, V86, P8, DOI 10.1161/01.RES.86.1.8; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chehab NH, 2000, GENE DEV, V14, P278; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Huang CS, 1999, CARCINOGENESIS, V20, P237, DOI 10.1093/carcin/20.2.237; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Jin SK, 2001, J CELL SCI, V114, P4139; Kamel C, 2006, AGING CELL, V5, P81, DOI 10.1111/j.1474-9726.2006.00191.x; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Kume S, 2006, FREE RADICAL BIO MED, V40, P2175, DOI 10.1016/j.freeradbiomed.2006.02.014; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; McBurney MW, 2003, MOL CANCER RES, V1, P402; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1995, CELL, V80, P293; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Pluquet O, 2001, CANCER LETT, V174, P1, DOI 10.1016/S0304-3835(01)00698-X; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sansome C, 2001, FEBS LETT, V488, P110, DOI 10.1016/S0014-5793(00)02368-1; SAWAI S, 1991, NEW BIOL, V3, P861; She QB, 2001, CANCER RES, V61, P1604; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tan MJ, 1999, J BIOL CHEM, V274, P12061, DOI 10.1074/jbc.274.17.12061; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Werner Erica, 2003, Sci STKE, V2003, pPL3, DOI 10.1126/stke.2003.168.pl3	44	289	304	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR	2008	2	3					241	251		10.1016/j.stem.2008.01.002	http://dx.doi.org/10.1016/j.stem.2008.01.002			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	274RD	18371449	Green Accepted, Bronze			2022-12-24	WOS:000254017700011
J	Petkov, CI; Kayser, C; Steudel, T; Whittingstall, K; Augath, M; Logothetis, NK				Petkov, Christopher I.; Kayser, Christoph; Steudel, Thomas; Whittingstall, Kevin; Augath, Mark; Logothetis, Nikos K.			A voice region in the monkey brain	NATURE NEUROSCIENCE			English	Article							HUMAN AUDITORY-CORTEX; RHESUS-MONKEY; TEMPORAL-LOBE; INFEROTEMPORAL CORTEX; MACACA-MULATTA; MACAQUE; FACE; VOCALIZATIONS; ADAPTATION; PRIMATES	For vocal animals, recognizing species-specific vocalizations is important for survival and social interactions. In humans, a voice region has been identified that is sensitive to human voices and vocalizations. As this region also strongly responds to speech, it is unclear whether it is tightly associated with linguistic processing and is thus unique to humans. Using functional magnetic resonance imaging of macaque monkeys (Old World primates, Macaca mulatta) we discovered a high-level auditory region that prefers species-specific vocalizations over other vocalizations and sounds. This region not only showed sensitivity to the 'voice' of the species, but also to the vocal identify of conspecific individuals. The monkey voice region is located on the superior-temporal plane and belongs to an anterior auditory 'what' pathway. These results establish functional relationships with the human voice region and support the notion that, for different primate species, the anterior temporal regions of the brain are adapted for recognizing communication signals from conspecifics.	[Petkov, Christopher I.; Kayser, Christoph; Steudel, Thomas; Whittingstall, Kevin; Augath, Mark; Logothetis, Nikos K.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Logothetis, Nikos K.] Univ Manchester, Imaging Sci & Biomed Engn, Manchester N13 9PT, Lancs, England	Max Planck Society; University of Manchester	Petkov, CI (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.		Logothetis, Nikos/U-9282-2019; Petkov, Christopher/O-5318-2015; Kayser, Christoph/A-3203-2012	Petkov, Christopher/0000-0002-4932-7907; Kayser, Christoph/0000-0001-7362-5704				Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Altmann CF, 2007, CEREB CORTEX, V17, P2601, DOI 10.1093/cercor/bhl167; Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 2006, PHILOS T R SOC B, V361, P2091, DOI 10.1098/rstb.2006.1933; Fecteau S, 2004, NEUROIMAGE, V23, P840, DOI 10.1016/j.neuroimage.2004.09.019; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Fullerton BC, 2007, J COMP NEUROL, V504, P470, DOI 10.1002/cne.21432; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2007, CURR BIOL, V17, P425, DOI 10.1016/j.cub.2007.01.029; Ghazanfar AA, 2006, CURR BIOL, V16, pR879, DOI 10.1016/j.cub.2006.09.026; Gil-Da-Costa R, 2004, P NATL ACAD SCI USA, V101, P17516, DOI 10.1073/pnas.0408077101; Gil-Da-Costa R, 2006, NAT NEUROSCI, V9, P1064, DOI 10.1038/nn1741; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; HAUSER MD, 1993, BEHAV ECOL, V4, P194, DOI 10.1093/beheco/4.3.194; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kaas JH, 1999, NAT NEUROSCI, V2, P1045, DOI 10.1038/15967; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kayser C, 2005, NEURON, V48, P373, DOI 10.1016/j.neuron.2005.09.018; Kayser C, 2007, J NEUROSCI, V27, P1824, DOI 10.1523/JNEUROSCI.4737-06.2007; Leopold DA, 2006, NATURE, V442, P572, DOI 10.1038/nature04951; MASATAKA N, 1985, DEV PSYCHOBIOL, V18, P107, DOI 10.1002/dev.420180203; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Obleser J, 2006, HUM BRAIN MAPP, V27, P562, DOI 10.1002/hbm.20201; PANDYA DN, 1973, Z ANAT ENTWICKLUNGS, V139, P127, DOI 10.1007/BF00523634; Petkov CI, 2006, PLOS BIOL, V4, P1213, DOI 10.1371/journal.pbio.0040215; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rendall D, 1998, J ACOUST SOC AM, V103, P602, DOI 10.1121/1.421104; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Sereno MI, 2005, CURR OPIN NEUROBIOL, V15, P135, DOI 10.1016/j.conb.2005.03.014; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SUGA N, 1987, J NEUROPHYSIOL, V58, P643, DOI 10.1152/jn.1987.58.4.643; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Uppenkamp S, 2006, NEUROIMAGE, V31, P1284, DOI 10.1016/j.neuroimage.2006.01.004; Van Lancker D R, 1982, Brain Cogn, V1, P185, DOI 10.1016/0278-2626(82)90016-1; VANLANCKER DR, 1988, CORTEX, V24, P195, DOI 10.1016/S0010-9452(88)80029-7; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; WINTER P, 1973, EXP BRAIN RES, V18, P489	50	252	258	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					367	374		10.1038/nn2043	http://dx.doi.org/10.1038/nn2043			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18264095				2022-12-24	WOS:000253548300021
J	Garcia, NVDM; Jessell, TM				Garcia, Natalia V. De Marco; Jessell, Thomas M.			Early motor neuron pool identity and muscle nerve trajectory defined by postmitotic restrictions in Nkx6.1 activity	NEURON			English	Article							MOTONEURON SUBTYPE IDENTITY; ETS GENE PEA3; SPINAL MOTONEURONS; GROWTH CONE; EXPRESSION; INNERVATION; LIMB; CONNECTIVITY; ORGANIZATION; ACTIVATION	The fidelity with which spinal motor neurons innervate their limb target muscles helps to coordinate motor behavior, but the mechanisms that determine precise patterns of nerve-muscle connectivity remain obscure. We show that Nkx6 proteins, a set of Hox-regulated homeodomain transcription factors, are expressed by motor pools soon after motor neurons leave the cell cycle, before the formation of muscle nerve side branches in the limb. Using mouse genetics, we show that the status of Nkx6.1 expression in certain motor neuron pools regulates muscle nerve formation, and the pattern of innervation of individual muscles. Our findings provide genetic evidence that neurons within. motor pools possess an early transcriptional identity that controls target muscle specificity.	[Garcia, Natalia V. De Marco; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Med Ctr, New York, NY 10032 USA; [Garcia, Natalia V. De Marco; Jessell, Thomas M.] Columbia Univ, Dept Neurosci, Med Ctr, New York, NY 10032 USA; [Garcia, Natalia V. De Marco; Jessell, Thomas M.] Columbia Univ, Dept Biochem & Mol Biophys, Med Ctr, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Med Ctr, New York, NY 10032 USA.	tmj1@columbia.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033245] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS033245-08, R01 NS033245] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Broihier HT, 2004, DEVELOPMENT, V131, P5233, DOI 10.1242/dev.01394; Carpenter EM, 2002, DEV NEUROSCI-BASEL, V24, P24, DOI 10.1159/000064943; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; ENGLISH AW, 1993, PHYS THER, V73, P857, DOI 10.1093/ptj/73.12.857; Greene E.C., 1935, T AM PHILOS SOC, V27, P1; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hanson MG, 2006, J NEUROSCI, V26, P12769, DOI 10.1523/JNEUROSCI.4170-06.2006; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; HOLLYDAY M, 1980, J COMP NEUROL, V194, P143, DOI 10.1002/cne.901940108; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Hutchinson SA, 2007, DEVELOPMENT, V134, P1671, DOI 10.1242/dev.02826; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Krouchev N, 2006, J NEUROPHYSIOL, V96, P1991, DOI 10.1152/jn.00241.2006; LANCEJONES C, 1982, DEV BRAIN RES, V4, P473, DOI 10.1016/0165-3806(82)90192-4; LANCEJONES C, 1979, J MORPHOL, V162, P275; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1994, PROG BRAIN RES, V103, P67; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Milner LD, 1999, J NEUROSCI, V19, P3007; Muller M, 2003, DEVELOPMENT, V130, P5815, DOI 10.1242/dev.00815; ROMANES GJ, 1951, J COMP NEUROL, V94, P313, DOI 10.1002/cne.900940209; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Shah V, 2004, DEV DYNAM, V231, P43, DOI 10.1002/dvdy.20103; SWANSON GJ, 1982, J EMBRYOL EXP MORPH, V71, P121; TOSNEY KW, 1985, J NEUROSCI, V5, P2336; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Vanderhorst VGJM, 1997, J COMP NEUROL, V382, P46; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yakovenko S, 2002, J NEUROPHYSIOL, V87, P1542, DOI 10.1152/jn.00479.2001; Yamamoto Y, 1999, DEV BIOL, V214, P60, DOI 10.1006/dbio.1999.9413; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2	37	67	68	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 24	2008	57	2					217	231		10.1016/j.neuron.2007.11.033	http://dx.doi.org/10.1016/j.neuron.2007.11.033			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256VQ	18215620	Green Accepted, Bronze			2022-12-24	WOS:000252758400007
J	Jin, ZG; Kirilly, D; Weng, CJ; Kawase, E; Song, XQ; Smith, S; Schwartz, J; Xie, T				Jin, Zhigang; Kirilly, Daniel; Weng, Changjiang; Kawase, Eihachiro; Song, Xiaoqing; Smith, Sarah; Schwartz, Joel; Xie, Ting			Differentiation-defective stem cells outcompete normal stem cells for niche occupancy in the Drosophila ovary	CELL STEM CELL			English	Article							BAG-OF-MARBLES; SELF-RENEWAL; CYST FORMATION; GENE-PRODUCT; GERMLINE; TRANSCRIPTION; EXPRESSION; DIVISION; GROWTH; DMYC	Rapid progress has recently been made regarding how the niche controls stem cell function, but little is yet known about how stem cells in the same niche interact with one another. In this study, we show that differentiation-defective Drosophila ovarian germline stem cells (GSCs) can outcompete normal ones for niche occupancy in a cadherin-dependent manner. The differentiation-defective bam or bgcn mutant GSCs invade the niche space of neighboring wildtype GSCs and gradually push them out of the niche by upregulating E-cadherin expression. Furthermore, the bam/bgcn-mediated GSC competition requires E-cadherin and normal GSC division, but not the self-renewal-promoting BMP niche signal, while different E-cadherin levels can sufficiently stimulate GSC competition. Therefore, we propose that GSCs have a competitive relationship for niche occupancy, which may serve as a quality control mechanism to ensure that accidentally differentiated stem cells are rapidly removed from the niche and replaced by functional ones.	[Jin, Zhigang; Kirilly, Daniel; Weng, Changjiang; Kawase, Eihachiro; Song, Xiaoqing; Smith, Sarah; Schwartz, Joel; Xie, Ting] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Kirilly, Daniel; Xie, Ting] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Xie, T (corresponding author), Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA.	tgx@stowers-institute.org	weng, changjiang/HHR-8479-2022	Smith, Sarah/0000-0003-1570-5700	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064428] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM064428, 1R01 GM64428-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asano M, 1996, GENE DEV, V10, P1422, DOI 10.1101/gad.10.11.1422; Casanueva MO, 2004, DEVELOPMENT, V131, P1881, DOI 10.1242/dev.01076; Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kai T, 2005, DEV BIOL, V283, P486, DOI 10.1016/j.ydbio.2005.04.018; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Korenjak M, 2005, CURR OPIN GENET DEV, V15, P520, DOI 10.1016/j.gde.2005.07.001; Lavoie CA, 1999, DEV BIOL, V212, P405, DOI 10.1006/dbio.1999.9346; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; LIN HF, 1994, DEVELOPMENT, V120, P947; Maines JZ, 2004, DEVELOPMENT, V131, P775, DOI 10.1242/dev.00932; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Ohlstein B, 2000, GENETICS, V155, P1809; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Van Doren M, 1998, CURR BIOL, V8, P243; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 2005, DEV DYNAM, V232, P775, DOI 10.1002/dvdy.20317; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Zhu CH, 2003, DEVELOPMENT, V130, P2579, DOI 10.1242/dev.00499	37	137	142	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN	2008	2	1					39	49		10.1016/j.stem.2007.10.021	http://dx.doi.org/10.1016/j.stem.2007.10.021			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	254RT	18371420	Green Accepted, Bronze			2022-12-24	WOS:000252606400010
J	McMahon, KA; Hiew, SYL; Hadjur, S; Veiga-Fernandes, H; Menzel, U; Price, AJ; Kioussis, D; Williams, O; Brady, HJM				McMahon, Kathryn A.; Hiew, Samantha Y. -L.; Hadjur, Suzana; Veiga-Fernandes, Henrique; Menzel, Ursula; Price, Amanda J.; Kioussis, Dimitris; Williams, Owen; Brady, Hugh J. M.			MII has a critical role in fetal and adult hematopoietic stem cell self-renewal	CELL STEM CELL			English	Article							MLL-MUTANT MICE; METHYLTRANSFERASE ACTIVITY; GENE; EXPRESSION; LEUKEMIA; DIFFERENTIATION; PROLIFERATION; EXPANSION	The Mixed Lineage Leukemia (Mll) gene is a homolog of Drosophila Trithorax commonly rearranged in infant leukemia. Comprehensive analysis of the role of Mll in hematopoiesis in fetal and adult knockout mice has been prevented by the lethality of Mll(-l-) mice. We have established a conditional deletion model that allows us to study adult hematopoiesis in the absence of Mll. In this study, Mll(-l-) embryos survive to E16.5 and have reduced numbers of HSCs. The quiescent fraction of these HSCs is greatly reduced, and they are unable to compete with wild-type cells in transplantation assays. Mice with Mll expression conditionally deleted in the hematopoietic system have grossly normal hematopoiesis in bone marrow, thymus, and spleen. However, transplanted Mll-deficient bone marrow cells are highly compromised in their ability to competitively reconstitute irradiated recipients. These results suggest a critical role for Mll in regulating stem cell self-renewal.	UCL, Inst Child Hlth, Mol Haematol & Canc Biol Unit, London WC1N 1EH, England; Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England	University of London; University College London; MRC National Institute for Medical Research	Brady, HJM (corresponding author), UCL, Inst Child Hlth, Mol Haematol & Canc Biol Unit, London WC1N 1EH, England.	h.brady@ich.ucl.ac.uk	Williams, Owen/B-5003-2013	Williams, Owen/0000-0002-1760-6880; Veiga-Fernandes, Henrique/0000-0001-6216-1836; Brady, Hugh/0000-0002-3152-067X	Medical Research Council [MC_U117512796] Funding Source: Medline; MRC [MC_U117512796] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ayton P, 2001, GENESIS, V30, P201, DOI 10.1002/gene.1066; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hess JL, 1997, BLOOD, V90, P1799, DOI 10.1182/blood.V90.5.1799; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nygren JM, 2006, J IMMUNOL, V177, P201, DOI 10.4049/jimmunol.177.1.201; Ohta H, 2002, J EXP MED, V195, P759, DOI 10.1084/jem.20011911; Randall TD, 1996, BLOOD, V87, P4057, DOI 10.1182/blood.V87.10.4057.bloodjournal87104057; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; Yagi H, 1998, BLOOD, V92, P108, DOI 10.1182/blood.V92.1.108.413k11_108_117; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	23	201	208	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP	2007	1	3					338	345		10.1016/j.stem.2007.07.002	http://dx.doi.org/10.1016/j.stem.2007.07.002			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XT	18371367	Bronze			2022-12-24	WOS:000251055200015
J	Chen, Y; Martinez-Conde, S; Macknik, SL; Bereshpolova, Y; Swadlow, HA; Alonso, JM				Chen, Yao; Martinez-Conde, Susana; Macknik, Stephen L.; Bereshpolova, Yulia; Swadlow, Harvey A.; Alonso, Jose-Manuel			Task difficulty modulates the activity of specific neuronal populations in primary visual cortex	NATURE NEUROSCIENCE			English	Article							AREA V4; SELECTIVE ATTENTION; SPATIAL ATTENTION; MACAQUE MONKEYS; CONTRAST SENSITIVITY; NEURAL MECHANISMS; EYE-MOVEMENTS; RESPONSES; LOAD; PERFORMANCE	Spatial attention enhances our ability to detect stimuli at restricted regions of the visual field. This enhancement is thought to depend on the difficulty of the task being performed, but the underlying neuronal mechanisms for this dependency remain largely unknown. We found that task difficulty modulates neuronal firing rate at the earliest stages of cortical visual processing (area V1) in monkey (Macaca mulatta). These modulations were spatially specific: increasing task difficulty enhanced V1 neuronal firing rate at the focus of attention and suppressed it in regions surrounding the focus. Moreover, we found that response enhancement and suppression are mediated by distinct populations of neurons that differ in direction selectivity, spike width, interspike-interval distribution and contrast sensitivity. Our results provide strong support for center-surround models of spatial attention and suggest that task difficulty modulates the activity of specific populations of neurons in the primary visual cortex.	[Chen, Yao; Alonso, Jose-Manuel] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA; [Martinez-Conde, Susana; Macknik, Stephen L.] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Bereshpolova, Yulia; Swadlow, Harvey A.] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA	State University of New York (SUNY) System; SUNY Optometry; Barrow Neurological Institute; University of Connecticut	Alonso, JM (corresponding author), SUNY Coll Optometry, Dept Biol Sci, 33W 42nd St, New York, NY 10036 USA.	jalonso@sunyopt.edu	Macknik, Stephen L./H-7704-2019	Macknik, Stephen L./0000-0002-3143-9230	NATIONAL EYE INSTITUTE [R03EY014345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059753] Funding Source: NIH RePORTER; NEI NIH HHS [R03 EY014345-03, R03 EY014345, EY14345] Funding Source: Medline; NIMH NIH HHS [MH-64024, R01 MH064024] Funding Source: Medline; NINDS NIH HHS [R21 NS059753, R21 NS059753-01A1] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ardid S, 2007, J NEUROSCI, V27, P8486, DOI 10.1523/JNEUROSCI.1145-07.2007; Bahrami B, 2007, CURR BIOL, V17, P509, DOI 10.1016/j.cub.2007.01.070; Bichot NP, 2001, J NEUROSCI, V21, P713, DOI 10.1523/JNEUROSCI.21-02-00713.2001; Boudreau CE, 2006, J NEUROPHYSIOL, V96, P2377, DOI 10.1152/jn.01072.2005; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; Carrasco M, 2006, PROG BRAIN RES, V154, P33; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hasegawa RP, 2004, J NEUROPHYSIOL, V92, P1524, DOI 10.1152/jn.01110.2003; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Kelley TA, 2008, CEREB CORTEX, V18, P114, DOI 10.1093/cercor/bhm036; LABERGE D, 1991, J EXP PSYCHOL HUMAN, V17, P65, DOI 10.1037/0096-1523.17.1.65; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lavie N, 1997, PSYCHOL SCI, V8, P395, DOI 10.1111/j.1467-9280.1997.tb00432.x; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Martinez-Conde S, 2006, PROG BRAIN RES, V154, P151; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; MAUNSELL JHR, 2004, VISUAL NEUROSCIENCES, P1538; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Movshon JA, 1996, J NEUROSCI, V16, P7733; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Pestilli F, 2005, VISION RES, V45, P1867, DOI 10.1016/j.visres.2005.01.019; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Ringach DL, 2002, J NEUROSCI, V22, P5639; Roelfsema PR, 2004, NAT NEUROSCI, V7, P982, DOI 10.1038/nn1304; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; SPITZER H, 1991, EXP BRAIN RES, V83, P340; Super H, 2005, PROG BRAIN RES, V147, P263, DOI 10.1016/S0079-6123(04)47020-4; Swadlow HA, 2005, J NEUROPHYSIOL, V93, P2959, DOI 10.1152/jn.01141.2004; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Yantis S., 1996, CONVERGING OPERATION, P45, DOI DOI 10.1037/10187-002; Yoshor D, 2007, J NEUROSCI, V27, P13205, DOI 10.1523/JNEUROSCI.2944-07.2007	50	156	156	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					974	982		10.1038/nn.2147	http://dx.doi.org/10.1038/nn.2147			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18604204	Green Accepted			2022-12-24	WOS:000257969100024
J	Van Der Giessen, RS; Koekkoek, SK; van Dorp, S; De Gruijl, JR; Cupido, A; Khosrovani, S; Dortland, B; Wellershaus, K; Degen, J; Deuchars, J; Fuchs, EC; Monyer, H; Willecke, K; De Jeu, MTG; De Zeeuw, CI				Van Der Giessen, Ruben S.; Koekkoek, Sebastiaan K.; van Dorp, Stijn; De Gruijl, Jornt R.; Cupido, Alexander; Khosrovani, Sara; Dortland, Bjorn; Wellershaus, Kerstin; Degen, Joachim; Deuchars, Jim; Fuchs, Elke C.; Monyer, Hannah; Willecke, Klaus; De Jeu, Marcel T. G.; De Zeeuw, Chris I.			Role of olivary electrical coupling in cerebellar motor learning	NEURON			English	Article							CONDITIONED EYELID RESPONSES; JUNCTION GENE CONNEXIN36; INFERIOR OLIVE; MAMMALIAN BRAIN; GAP-JUNCTIONS; IN-VIVO; LURCHER MICE; MOUSE; RAT; OSCILLATIONS	The level of electrotonic coupling in the inferior olive is extremely high, but its functional role in cerebellar motor control remains elusive. Here, we subjected mice that lack olivary coupling to paradigms that require learning-depend ent timing. Cx36-deficient mice showed impaired timing of both locomotion and eye-blink responses that were conditioned to a tone. The latencies of their olivary spike activities in response to the unconditioned stimulus were significantly more variable than those in wild-types. Whole-cell recordings of olivary neurons in vivo showed that these differences in spike timing result at least in part from altered interactions with their subthreshold oscillations. These results, combined with analyses of olivary activities in computer simulations at both the cellular and systems level, suggest that electrotonic coupling among olivary neurons by gap junctions is essential for proper timing of their action potentials and thereby for learning-dependent timing in cerebellar motor control.	[Van Der Giessen, Ruben S.; Koekkoek, Sebastiaan K.; De Gruijl, Jornt R.; Cupido, Alexander; Khosrovani, Sara; Dortland, Bjorn; De Jeu, Marcel T. G.; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands; [Wellershaus, Kerstin; Degen, Joachim; Willecke, Klaus] Univ Bonn, Div Mol Genet, Inst Genet, D-53117 Bonn, Germany; [Deuchars, Jim] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Fuchs, Elke C.; Monyer, Hannah] Interdisciplinary Ctr Neurosci, Dept Clin Neurobiol, D-69120 Heidelberg, Germany; [van Dorp, Stijn; De Gruijl, Jornt R.; De Zeeuw, Chris I.] Royal Acad Arts & Sci, Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Bonn; University of Leeds; Ruprecht Karls University Heidelberg; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	De Zeeuw, CI (corresponding author), Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands.	c.dezeeuw@erasmusmc.nl	Oka, Yoshitaka/C-9670-2010; Deuchars, Jim/L-3740-2019	Oka, Yoshitaka/0000-0002-3482-3051; Deuchars, Jim/0000-0002-4445-654X	BBSRC [BB/E001831/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E001831/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bengtsson F, 2006, CEREBELLUM, V5, P7, DOI 10.1080/14734220500462757; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Blenkinsop TA, 2006, J NEUROSCI, V26, P1739, DOI 10.1523/JNEUROSCI.3677-05.2006; Buhl DL, 2003, J NEUROSCI, V23, P1013; Bullock TH, 2005, SCIENCE, V310, P791, DOI 10.1126/science.1114394; Chorev E, 2007, J NEUROSCI, V27, P5043, DOI 10.1523/JNEUROSCI.5187-06.2007; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Condorelli DF, 1998, EUR J NEUROSCI, V10, P1202, DOI 10.1046/j.1460-9568.1998.00163.x; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; De Zeeuw CI, 2003, J NEUROSCI, V23, P4700; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Degen J, 2004, J COMP NEUROL, V473, P511, DOI 10.1002/cne.20085; DEZEEUW CI, 1995, J NEUROSCI, V15, P1587; Frisch C, 2005, BEHAV BRAIN RES, V157, P177, DOI 10.1016/j.bbr.2004.06.023; Garcia KS, 1998, NEUROPHARMACOLOGY, V37, P471, DOI 10.1016/S0028-3908(98)00055-0; Gareri P, 2005, NEUROPHARMACOLOGY, V49, P551, DOI 10.1016/j.neuropharm.2005.04.012; Guldenagel M, 2001, J NEUROSCI, V21, P6036, DOI 10.1523/JNEUROSCI.21-16-06036.2001; Hesslow G, 1999, NEURON, V24, P179, DOI 10.1016/S0896-6273(00)80831-4; HESSLOW G, 1994, J PHYSIOL-LONDON, V476, P229, DOI 10.1113/jphysiol.1994.sp020126; Kenyon GT, 1998, J COMPUT NEUROSCI, V5, P17, DOI 10.1023/A:1008874209991; Khosrovani S, 2007, P NATL ACAD SCI USA, V104, P15911, DOI 10.1073/pnas.0702727104; Kistler WM, 2002, ANN NY ACAD SCI, V978, P391, DOI 10.1111/j.1749-6632.2002.tb07582.x; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Koekkoek SKE, 2002, J NEUROPHYSIOL, V88, P2124, DOI 10.1152/jn.2002.88.4.2124; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; Lang EJ, 1996, J NEUROPHYSIOL, V76, P255, DOI 10.1152/jn.1996.76.1.255; Leznik E, 2005, J NEUROPHYSIOL, V94, P2447, DOI 10.1152/jn.00353.2005; Leznik E, 2002, J NEUROSCI, V22, P2804, DOI 10.1523/JNEUROSCI.22-07-02804.2002; LLINAS R, 1989, EUR J NEUROSCI, V1, P587, DOI 10.1111/j.1460-9568.1989.tb00365.x; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P549, DOI 10.1113/jphysiol.1981.sp013763; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; Long MA, 2002, J NEUROSCI, V22, P10898; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Margineanu DG, 2006, BRAIN RES BULL, V71, P23, DOI 10.1016/j.brainresbull.2006.07.011; Marshall SP, 2007, CEREBELLUM, V6, P287, DOI 10.1080/14734220601100801; Martin FC, 2006, MOVEMENT DISORD, V21, P1641, DOI 10.1002/mds.20940; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; MAUK MD, 1986, P NATL ACAD SCI USA, V83, P5349, DOI 10.1073/pnas.83.14.5349; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; PERRETT SP, 1993, J NEUROSCI, V13, P1708; Pijpers A, 2005, J COMP NEUROL, V492, P193, DOI 10.1002/cne.20707; Placantonakis DG, 2004, P NATL ACAD SCI USA, V101, P7164, DOI 10.1073/pnas.0400322101; Placantonakis DG, 2006, J NEUROSCI, V26, P5008, DOI 10.1523/JNEUROSCI.0146-06.2006; Porras-Garcia E, 2005, EUR J NEUROSCI, V21, P979, DOI 10.1111/j.1460-9568.2005.03940.x; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Rozental R, 2001, METH MOL B, V154, P447; Ruigrok TJH, 2000, J COMP NEUROL, V426, P209, DOI 10.1002/1096-9861(20001016)426:2<209::AID-CNE4>3.0.CO;2-0; RUIGROK TJH, 1995, EUR J NEUROSCI, V7, P679, DOI 10.1111/j.1460-9568.1995.tb00672.x; RULGROK TJ, 2007, NAT PROTOC, V2, P1869; Saffitz JE, 2000, CIRC RES, V86, P723, DOI 10.1161/01.RES.86.7.723; Schweighofer N, 1999, J NEUROPHYSIOL, V82, P804, DOI 10.1152/jn.1999.82.2.804; SETOOHSHIMA A, 1989, EXP BRAIN RES, V75, P653; SIMPSON JI, 1996, BEHAV BRAIN SCI, V19, P380; Sohl G, 1998, FEBS LETT, V428, P27, DOI 10.1016/S0014-5793(98)00479-7; Theis M, 2000, METHODS, V20, P205, DOI 10.1006/meth.1999.0938; Van Alphen AM, 2002, ANN NY ACAD SCI, V978, P413; Van Der Giessen RS, 2006, J COMP NEUROL, V495, P173, DOI 10.1002/cne.20873; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792	65	145	146	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 22	2008	58	4					599	612		10.1016/j.neuron.2008.03.016	http://dx.doi.org/10.1016/j.neuron.2008.03.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304PD	18498740	Bronze			2022-12-24	WOS:000256120500013
J	Song, Y; Cygnar, KD; Sagdullaev, B; Valley, M; Hirsh, S; Stephan, A; Reisert, J; Zhao, H				Song, Yijun; Cygnar, Katherine D.; Sagdullaev, Botir; Valley, Matthew; Hirsh, Sarah; Stephan, Aaron; Reisert, Johannes; Zhao, Haiqing			Olfactory CNG channel desensitization by Ca2+/CaM via the B1b subunit affects response termination but not sensitivity to recurring stimulation	NEURON			English	Article							NUCLEOTIDE-GATED CHANNEL; RECEPTOR NEURONS; ROD PHOTORECEPTOR; ION CHANNELS; BETA-SUBUNIT; CALCIUM-CALMODULIN; CONE PHOTORECEPTORS; SIGNAL-TRANSDUCTION; ADENYLYL-CYCLASE; ODOR ADAPTATION	Ca2+/calmodulin-mediated negative feedback is a prototypical regulatory mechanism for Ca2+-permeable ion channels. In olfactory sensory neurons (OSNs), such regulation on the cyclic nucleotide-gated (CNG) channel is considered a major mechanism of OSN adaptation. To determine the role of Ca2+/calmodulin desensitization of the olfactory CNG channel, we introduced a mutation in the channel subunit CNGB1b in mice that rendered the channel resistant to fast desensitization by Ca2+/calmodulin. Contrary to expectations, mutant OSNs showed normal receptor current adaptation to repeated stimulation. Rather, they displayed slower response termination and, consequently, reduced ability to transmit olfactory information to the olfactory bulb. They also displayed reduced response decline during sustained odorant exposure. These results suggest that Ca2+/calmodulin-mediated CNG channel fast desensitization is less important in regulating the sensitivity to recurring stimulation than previously thought and instead functions primarily to terminate OSN responses.	[Song, Yijun; Cygnar, Katherine D.; Hirsh, Sarah; Stephan, Aaron; Zhao, Haiqing] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Song, Yijun] Tianjin Med Univ Gen Hosp, Tianjin Neurolog Inst, Tianjin 300052, Peoples R China; [Song, Yijun] Tianjin Med Univ Gen Hosp, Dept Neurol, Tianjin 300052, Peoples R China; [Sagdullaev, Botir; Valley, Matthew] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Reisert, Johannes] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Johns Hopkins University; Tianjin Medical University; Tianjin Medical University; Columbia University; Monell Chemical Senses Center	Zhao, H (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	jreisert@monell.org; hzhao@jhu.edu		Valley, Matthew/0000-0002-7204-5457; Cygnar, Katherine/0000-0002-2056-1353; Sagdullaev, Botir/0000-0002-0611-1479	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007395, R03DC006178] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC007395-01A2, DC006178, DC007395, R03 DC006178-03, R03 DC006178, R01 DC007395] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Balasubramanian S, 1996, J MEMBRANE BIOL, V152, P13, DOI 10.1007/s002329900081; Boccaccio A, 2006, J GEN PHYSIOL, V128, P171, DOI 10.1085/jgp.200609555; Bonigk W, 1999, J NEUROSCI, V19, P5332; BORISY FF, 1992, J NEUROSCI, V12, P915; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; FIRESTEIN S, 1991, NEURON, V6, P825, DOI 10.1016/0896-6273(91)90178-3; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; GORDON SE, 1995, J PHYSIOL-LONDON, V486, P533, DOI 10.1113/jphysiol.1995.sp020832; Grunwald ME, 1998, J BIOL CHEM, V273, P9148, DOI 10.1074/jbc.273.15.9148; Hackos DH, 1997, J GEN PHYSIOL, V110, P515, DOI 10.1085/jgp.110.5.515; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KLEENE SJ, 1993, NEURON, V11, P123, DOI 10.1016/0896-6273(93)90276-W; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; Leinders-Zufall T, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-14-j0005.1999; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Lorig TS, 1999, BEHAV RES METH INS C, V31, P370, DOI 10.3758/BF03207734; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Michalakis S, 2006, J BIOL CHEM, V281, P35156, DOI 10.1074/jbc.M606409200; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Rebrik TI, 1998, J GEN PHYSIOL, V112, P537, DOI 10.1085/jgp.112.5.537; Reidl J, 2006, BIOPHYS J, V90, P1147, DOI 10.1529/biophysj.104.058545; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Scott JW, 2002, MICROSC RES TECHNIQ, V58, P152, DOI 10.1002/jemt.10133; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Trotier Didier, 1994, Seminars in Cell Biology, V5, P47, DOI 10.1006/scel.1994.1007; Trudeau MC, 2003, J BIOL CHEM, V278, P18705, DOI 10.1074/jbc.R300001200; Trudeau MC, 2002, P NATL ACAD SCI USA, V99, P8424, DOI 10.1073/pnas.122015999; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9; Weitz D, 1998, EMBO J, V17, P2273, DOI 10.1093/emboj/17.8.2273; YAN C, 1995, P NATL ACAD SCI USA, V92, P9677, DOI 10.1073/pnas.92.21.9677; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	51	66	67	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 8	2008	58	3					374	386		10.1016/j.neuron.2008.02.029	http://dx.doi.org/10.1016/j.neuron.2008.02.029			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	300HP	18466748	Green Accepted, Bronze			2022-12-24	WOS:000255815200011
J	Pielage, J; Cheng, L; Fetter, RD; Carlton, PM; Sedat, JW; Davis, GW				Pielage, Jan; Cheng, Ling; Fetter, Richard D.; Carlton, Pete M.; Sedat, John W.; Davis, Graeme W.			A presynaptic giant ankyrin stabilizes the NMJ through regulation of presynaptic microtubules and transsynaptic cell adhesion	NEURON			English	Article							UBIQUITIN-PROTEASOME SYSTEM; AXON INITIAL SEGMENTS; SYNAPTIC GROWTH; 440-KD ANKYRIN(B); WALLERIAN DEGENERATION; MEMBRANE SKELETON; DROSOPHILA; SPECTRIN; PROTEIN; RANVIER	In a forward genetic screen for mutations that destabilize the neuromuscular junction, we identified a novel long isoform of Drosophila ankyrin2 (ank2-L). We demonstrate that loss of presynaptic Ank2-L not only causes synapse disassembly and retraction but also disrupts neuronal excitability and NMJ morphology. We provide genetic evidence that ank2-L is necessary to generate the membrane constrictions that normally separate individual synaptic boutons and is necessary to achieve the normal spacing of subsynaptic protein domains, including the normal organization of synaptic cell adhesion molecules. Mechanistically, synapse organization is correlated with a lattice-like organization of Ank2-L, visualized using extended high-resolution structured-illumination microscopy. The stabilizing functions of Ank2-L can be mapped to the extended C-terminal domain that we demonstrate can directly bind and organize synaptic microtubules. We propose that a presynaptic Ank2-L lattice links synaptic membrane proteins and spectrin to the underlying microtubule cytoskeleton to organize and stabilize the presynaptic terminal.	[Pielage, Jan; Cheng, Ling; Fetter, Richard D.; Carlton, Pete M.; Sedat, John W.; Davis, Graeme W.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	gdavis@biochem.ucsf.edu	Carlton, Peter/AAD-2403-2021	Carlton, Peter/0000-0002-5320-6024; Pielage, Jan/0000-0002-5115-5884	NINDS NIH HHS [R01 NS047342-05, NS047342, R01 NS059867-04, R37 NS047342, R01 NS047342, R01 NS059867] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059867, R01NS047342, R37NS047342] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Boiko T, 2007, J NEUROSCI, V27, P590, DOI 10.1523/JNEUROSCI.4302-06.2007; Bouley M, 2000, J NEUROSCI, V20, P4515, DOI 10.1523/JNEUROSCI.20-12-04515.2000; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; CHAN W, 1993, J CELL BIOL, V123, P1463, DOI 10.1083/jcb.123.6.1463; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; DUBREUIL RR, 1994, P NATL ACAD SCI USA, V91, P10285, DOI 10.1073/pnas.91.22.10285; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; GUSTAFSSON MG, 2008, IN PRESS BIOPHYS J; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hortsch M, 2002, MOL CELL NEUROSCI, V20, P43, DOI 10.1006/mcne.2002.1113; Jenkins SM, 2002, P NATL ACAD SCI USA, V99, P2303, DOI 10.1073/pnas.042601799; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Koch I, 2008, NEURON, V58, P210, DOI 10.1016/j.neuron.2008.03.019; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Kunimoto M, 1995, J CELL BIOL, V131, P1821, DOI 10.1083/jcb.131.6.1821; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; LIU SC, 1987, J CELL BIOL, V104, P527, DOI 10.1083/jcb.104.3.527; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Mi WQ, 2005, BRAIN, V128, P405, DOI 10.1093/brain/awh368; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang H, 2001, J UNIV SCI TECHNOL B, V8, P161; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Yamamoto M, 2006, CURR BIOL, V16, P1678, DOI 10.1016/j.cub.2006.06.061; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	47	125	125	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 24	2008	58	2					195	209		10.1016/j.neuron.2008.02.017	http://dx.doi.org/10.1016/j.neuron.2008.02.017			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292YX	18439405	Green Accepted, Bronze			2022-12-24	WOS:000255303100008
J	Nagoshi, N; Shibata, S; Kubota, Y; Nakamura, M; Nagai, Y; Satoh, E; Morikawa, S; Okada, Y; Mabuchi, Y; Katoh, H; Okada, S; Fukuda, K; Suda, T; Matsuzaki, Y; Toyama, Y; Okano, H				Nagoshi, Narihito; Shibata, Shinsuke; Kubota, Yoshiaki; Nakamura, Masaya; Nagai, Yasuo; Satoh, Etsuko; Morikawa, Satoru; Okada, Yohei; Mabuchi, Yo; Katoh, Hiroyuki; Okada, Seiji; Fukuda, Keiichi; Suda, Toshio; Matsuzaki, Yumi; Toyama, Yoshiaki; Okano, Hideyuki			Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad	CELL STEM CELL			English	Article							SMOOTH-MUSCLE-CELLS; PROGENITOR CELLS; TRANSCRIPTION FACTOR; NERVOUS-SYSTEM; SELF-RENEWAL; BOUNDARY CAP; SPINAL-CORD; ADULT SKIN; IN-VITRO; DIFFERENTIATION	Although recent reports have described multipotent, self-renewing, neural crest-derived stem cells (NCSCs), the NCSCs in various adult rodent tissues have not been well characterized or compared. Here we identified NCSCs in the bone marrow (BM), dorsal root ganglia, and whisker pad and prospectively isolated them from adult transgenic mice encoding neural crest-specific PO-Cre/Floxed-EGFP and Wntl-Cre/Floxed-EGFP. Cultured EGFP-positive cells formed neurosphere-like structures that expressed NCSC genes and could differentiate into neurons, glial cells, and myofibroblasts, but the frequency of the cell types was tissue source dependent. Interestingly, we observed NCSCs in the aortagonad-mesonephros region, circulating blood, and liver at the embryonic stage, suggesting that NCSCs migrate through the bloodstream to the BM and providing an explanation for how neural cells are generated from the BM. The identification of NCSCs in accessible adult tissue provides a new potential source for autologous cell therapy after nerve injury or disease.	[Nagoshi, Narihito; Shibata, Shinsuke; Nagai, Yasuo; Satoh, Etsuko; Morikawa, Satoru; Okada, Yohei; Mabuchi, Yo; Okada, Seiji; Matsuzaki, Yumi; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan; [Nagoshi, Narihito; Nakamura, Masaya; Katoh, Hiroyuki; Toyama, Yoshiaki] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Kubota, Yoshiaki; Suda, Toshio] Keio Univ, Sch Med, Dept Cell Differentiat, Shinjuku Ku, Tokyo 1608582, Japan; [Morikawa, Satoru] Keio Univ, Sch Med, Dept Dent & Oral Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Fukuda, Keiichi] Keio Univ, Sch Med, Dept Regenerat Med & Adv Cardiac Therapeut, Shinjuku Ku, Tokyo 1608582, Japan; [Okada, Yohei] Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Okada, Seiji] Kyushu Univ, Grad Sch Med Sci, SSP Stem Cell Unit, Higashi Ku, Fukuoka 8128582, Japan	Keio University; Keio University; Keio University; Keio University; Keio University; Nagoya University; Kyushu University	Okano, H (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hidokano@sc.itc.keio.ac.jp	Fukuda, Keiichi/L-3777-2013; Shibata, Shinsuke/AAM-6620-2020; Suda, Toshio/H-6761-2013; Toyama, Yoshiaki/K-5743-2013; Okada, Yohei/L-1662-2013; Mabuchi, Yo/L-1535-2013; Nakamura, Masaya/K-4111-2013; Kubota, Yoshiaki/L-2231-2013; Okano, Hideyuki/I-7584-2019; Morikawa, Satoru/AFL-5621-2022	Suda, Toshio/0000-0001-7540-1771; Mabuchi, Yo/0000-0001-8008-3966; Morikawa, Satoru/0000-0001-8859-2888; Matsuzaki, Yumi/0000-0002-3729-2997; Okada, Seiji/0000-0002-5107-8209				Abzhanov A, 2003, DEVELOPMENT, V130, P4567, DOI 10.1242/dev.00673; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; BHATTACHARYYA A, 1991, NEURON, V7, P831, DOI 10.1016/0896-6273(91)90285-8; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Couly G, 2002, DEVELOPMENT, V129, P1061; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Fernandez CI, 2004, ANN NY ACAD SCI, V1019, P48, DOI 10.1196/annals.1297.011; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; FUNK PE, 1994, BLOOD, V83, P361; Hjerling-Leffler J, 2005, DEVELOPMENT, V132, P2623, DOI 10.1242/dev.01852; Hulspas R, 1997, EXP NEUROL, V148, P147, DOI 10.1006/exnr.1997.6672; Jensen J, 1996, J BIOL CHEM, V271, P18749, DOI 10.1074/jbc.271.31.18749; Jessberger S, 2007, STEM CELLS, V25, P871, DOI 10.1634/stemcells.2006-0620; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; KOBAYASHI K, 1993, P NATL ACAD SCI USA, V90, P7391, DOI 10.1073/pnas.90.15.7391; Kohyama J, 2001, DIFFERENTIATION, V68, P235, DOI 10.1046/j.1432-0436.2001.680411.x; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; Le Douarin NM, 1999, NEURAL CREST, V2; Leimeroth R, 2002, DEV BIOL, V246, P245, DOI 10.1006/dbio.2002.0670; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li HY, 2007, STEM CELLS, V25, P2053, DOI 10.1634/stemcells.2007-0080; Lwigale PY, 2004, DEVELOPMENT, V131, P1979, DOI 10.1242/dev.01106; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mendes SC, 2005, DEVELOPMENT, V132, P1127, DOI 10.1242/dev.01615; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Niederlander C, 1996, DEVELOPMENT, V122, P2367; Paratore C, 2001, DEVELOPMENT, V128, P3949; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ross JJ, 2006, J CLIN INVEST, V116, P3139, DOI 10.1172/JCI28184; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Stolt CC, 2004, DEVELOPMENT, V131, P2349, DOI 10.1242/dev.01114; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Trainor PA, 2002, SCIENCE, V295, P1288, DOI 10.1126/science.1064540; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156	56	275	282	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR	2008	2	4					392	403		10.1016/j.stem.2008.03.005	http://dx.doi.org/10.1016/j.stem.2008.03.005			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	293HT	18397758	Bronze			2022-12-24	WOS:000255327000015
J	Matsumoto, T; Rauskolb, S; Polack, M; Klose, J; Kolbeck, R; Korte, M; Barde, YA				Matsumoto, Tomoya; Rauskolb, Stefanie; Polack, Martin; Klose, Johannes; Kolbeck, Roland; Korte, Martin; Barde, Yves-Alain			Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; NEUROTROPHIC FACTOR; BRAIN; P75(NTR); ACTIVATION; GENE; MICE	Pro- and mature BDNF activate very different receptors and intracellular pathways, potentially leading to either neuronal death or survival. Here we examined the biochemistry of endogenous BDNF in mouse neurons using sensitive reagents and found that pro-BDNF is rapidly converted intracellularly to mature BDNF, the latter being stored and released by excitatory input.	[Matsumoto, Tomoya; Rauskolb, Stefanie; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Polack, Martin; Korte, Martin] Tech Univ Carolo Wilhelmina Braunschweig, D-38106 Braunschweig, Germany; [Klose, Johannes; Kolbeck, Roland; Barde, Yves-Alain] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Kolbeck, Roland] Medimmune Inc, Gaithersburg, MD 20878 USA	University of Basel; Braunschweig University of Technology; Max Planck Society; AstraZeneca; Medimmune	Barde, YA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	yves.barde@unibas.ch	Barde, Yves/F-6019-2011	Barde, Yves/0000-0002-7627-461X; Rauskolb, Stefanie/0000-0002-8936-5414				BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005	15	263	272	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					131	133		10.1038/nn2038	http://dx.doi.org/10.1038/nn2038			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18204444				2022-12-24	WOS:000252712100006
J	Mochida, S; Few, AP; Scheuer, T; Catterall, WA				Mochida, Sumiko; Few, Alexandra P.; Scheuer, Todd; Catterall, William A.			Regulation of presynaptic Ca(V)2.1 channels by Ca2+ sensor proteins mediates short-term synaptic plasticity	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; POST-TETANIC POTENTIATION; READILY RELEASABLE POOL; VISININ-LIKE PROTEIN-2; TRANSMITTER RELEASE; CALCIUM-CHANNELS; POSTTETANIC POTENTIATION; N-TYPE; DEPENDENT FACILITATION; INTERACTION SITE	Short-term synaptic plasticity shapes the postsynaptic response to bursts of impulses and is crucial for encoding information in neurons, but the molecular mechanisms are unknown. Here we show that activity-dependent modulation of presynaptic Ca(v)2.1 channels mediated by neuronal Ca2+ sensor proteins (CaS) induces synaptic plasticity in cultured superior cervical ganglion (SCG) neurons. A mutation of the IQ-like motif in the C terminus that blocks Ca2(+)/CaS-dependent facilitation of the P/Q-type Ca2+ current markedly reduces facilitation of synaptic transmission. Deletion of the nearby calmodulin-binding domain, which inhibits CaS-dependent inactivation, substantially reduces depression of synaptic transmission. These results demonstrate that residual Ca2+ in presynaptic terminals can act through CaS-dependent regulation of Ca(v)2.1 channels to induce short-term synaptic facilitation and rapid synaptic depression. Activity-dependent regulation of presynaptic Ca(v)2.1 channels by CaS proteins may therefore be a primary determinant of short-term synaptic plasticity and information-processing in the nervous system.	[Few, Alexandra P.; Scheuer, Todd; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Mochida, Sumiko] Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan	University of Washington; University of Washington Seattle; Tokyo Medical University	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@u.washington.edu			NIMH NIH HHS [F31 MH078345] Funding Source: Medline; NINDS NIH HHS [R01 NS22625] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH078345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; Beierlein M, 2007, NEURON, V54, P949, DOI 10.1016/j.neuron.2007.06.002; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Brager DH, 2003, NAT NEUROSCI, V6, P551, DOI 10.1038/nn1067; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P173, DOI 10.1113/jphysiol.1982.sp014067; Chaudhuri D, 2005, J NEUROSCI, V25, P8282, DOI 10.1523/JNEUROSCI.2253-05.2005; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Inchauspe CG, 2004, J NEUROSCI, V24, P10379, DOI 10.1523/JNEUROSCI.2104-04.2004; Ishikawa T, 2005, J PHYSIOL-LONDON, V568, P199, DOI 10.1113/jphysiol.2005.089912; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; MAGLEBY KL, 1973, J PHYSIOL-LONDON, V234, P353, DOI 10.1113/jphysiol.1973.sp010349; MAGLEBY KL, 1975, J PHYSIOL-LONDON, V245, P163, DOI 10.1113/jphysiol.1975.sp010839; MOCHIDA S, 1995, NEUROSCIENCE, V65, P905, DOI 10.1016/0306-4522(94)00508-3; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Stevens CF, 1999, NEURON, V22, P139, DOI 10.1016/S0896-6273(00)80685-6; Sullivan JM, 2007, J NEUROPHYSIOL, V97, P948, DOI 10.1152/jn.00554.2006; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Ting JT, 2006, J NEUROSCI, V26, P372, DOI 10.1523/JNEUROSCI.3997-05.2006; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	41	115	117	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 24	2008	57	2					210	216		10.1016/j.neuron.2007.11.036	http://dx.doi.org/10.1016/j.neuron.2007.11.036			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256VQ	18215619	Bronze			2022-12-24	WOS:000252758400006
J	Grosjean, Y; Grillet, M; Augustin, H; Ferveur, JF; Featherstone, DE				Grosjean, Yael; Grillet, Micheline; Augustin, Hrvoje; Ferveur, Jean-Francois; Featherstone, David E.			A glial amino-acid transporter controls synapse strength and courtship in Drosophila	NATURE NEUROSCIENCE			English	Article							VESICULAR GLUTAMATE TRANSPORTER; MALE SEXUAL-BEHAVIOR; NUCLEUS-ACCUMBENS; EXPRESSION; GENE; WHITE; RECEPTORS; DOPAMINE; MUTATION; CENTERS	Mate choice is an evolutionarily critical decision that requires the detection of multiple sex-specific signals followed by central integration of these signals to direct appropriate behavior. The mechanisms controlling mate choice remain poorly understood. Here, we show that the glial amino-acid transporter genderblind controls whether Drosophila melanogaster males will attempt to mate with other males. Genderblind (gb) mutant males showed no alteration in heterosexual courtship or copulation, but were attracted to normally unappealing male species-specific chemosensory cues. As a result, genderblind mutant males courted and attempted to copulate with other Drosophila males. This homosexual behavior could be induced within hours using inducible RNAi, suggesting that genderblind controls nervous system function rather than its development. Consistent with this, and indicating that glial genderblind regulates ambient extracellular glutamate to suppress glutamatergic synapse strength in vivo, homosexual behavior could be turned on and off by altering glutamatergic transmission pharmacologically and/or genetically.	[Grillet, Micheline; Ferveur, Jean-Francois] Univ Bourgogne, CNRS 5548, UMR 5548, F-21000 Dijon, France; [Grosjean, Yael; Augustin, Hrvoje; Featherstone, David E.] Univ Illinois, Chicago, IL USA	Universite de Bourgogne; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Featherstone, DE (corresponding author), Univ Lausanne, Inst Integrat Genom, Genopode Bldg,Room 3033, CH-1015 Lausanne, Switzerland.	def@uic.edu	Grosjean, Yael/E-2634-2017; AUGUSTIN, Hrvoje/AAK-9188-2020	Grosjean, Yael/0000-0003-0689-8344; Augustin, H/0000-0002-2041-3844; Grillet, Micheline/0000-0001-8992-3255	NINDS NIH HHS [R01 NS045628-03, R01 NS045628-04, R01 NS045628, R01 NS 045628] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045628] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adachi A, 2002, GLIA, V39, P268, DOI 10.1002/glia.10109; An X, 2000, J NEUROGENET, V14, P227, DOI 10.3109/01677060009084500; Augustin H, 2007, J NEUROSCI, V27, P111, DOI 10.1523/JNEUROSCI.4770-06.2007; Baker DA, 2002, J NEUROSCI, V22, P9134; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; BAKER DA, 2007, PSYCHOPHARMACOLOGY, DOI DOI 10.1038/SJ.NPP.1301532; Balakireva M, 1998, J NEUROSCI, V18, P4335; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Bogdanik L, 2004, J NEUROSCI, V24, P9105, DOI 10.1523/JNEUROSCI.2724-04.2004; Burdo J, 2006, J HISTOCHEM CYTOCHEM, V54, P549, DOI 10.1369/jhc.5A6840.2006; Castaneda TR, 2004, J PINEAL RES, V36, P177, DOI 10.1046/j.1600-079X.2003.00114.x; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Featherstone DE, 2008, NEUROSCIENTIST, V14, P171, DOI 10.1177/1073858407308518; Featherstone DE, 2005, J NEUROSCI, V25, P3199, DOI 10.1523/JNEUROSCI.4201-04.2005; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Grosjean Y, 2001, GENET RES, V77, P239; Hing ALY, 1996, J NEUROBIOL, V30, P454; HORZ HP, 2004, MJ RES APPL NOTE, V3, P1; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; JUHASZ G, 1991, EUR J PHARMACOL, V209, P131, DOI 10.1016/0014-2999(91)90024-K; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lee Y, 2007, PSYCHOPHARMACOLOGY, V191, P55, DOI 10.1007/s00213-006-0652-4; Lena I, 2005, J NEUROSCI RES, V81, P891, DOI 10.1002/jnr.20602; Lim J, 2005, INVEST OPHTH VIS SCI, V46, P2869, DOI 10.1167/iovs.05-0156; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Marcillac F, 2005, GENETICS, V171, P1617, DOI 10.1534/genetics.104.033159; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; Masuda-Nakagawa LM, 2005, P NATL ACAD SCI USA, V102, P19027, DOI 10.1073/pnas.0509643102; PIYANKARAGE SC, 2008, IN PRESS ANAL CHEM; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Roberts D. B., 1998, DROSOPHILA PRACTICAL; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Schuster Christoph M., 1993, Experientia Supplementum (Basel), V63, P234; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Shirangi TR, 2007, DEV BIOL, V306, P10, DOI 10.1016/j.ydbio.2007.03.022; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Svetec N, 2005, GENET RES, V85, P183, DOI 10.1017/S0016672305007536; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Winther AME, 2006, MOL CELL NEUROSCI, V31, P399, DOI 10.1016/j.mcn.2005.10.010; WOODARD C, 1989, GENETICS, V123, P315; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; ZHANG SD, 1995, P NATL ACAD SCI USA, V92, P5525, DOI 10.1073/pnas.92.12.5525	49	80	85	0	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					54	61		10.1038/nn2019	http://dx.doi.org/10.1038/nn2019			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18066061	Green Accepted, Green Submitted			2022-12-24	WOS:000252117900012
J	Padoa-Schioppa, C; Assad, JA				Padoa-Schioppa, Camillo; Assad, John A.			The representation of economic value in the orbitofrontal cortex is invariant for changes of menu	NATURE NEUROSCIENCE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; NEURONAL-ACTIVITY; REWARD VALUE; FRONTOTEMPORAL DEMENTIA; DECISION-MAKING; PARIETAL CORTEX; CHOICE; TRANSITIVITY; PREFERENCE; MONKEYS	Economic choice entails assigning values to the available options and is impaired by lesions to the orbitofrontal cortex (OFC). Recent results show that some neurons in the OFC encode the values that monkeys (Macaca mulatta) assign to different goods when they choose between them. A broad and fundamental question is how this neuronal representation of value depends on the behavioral context. Here we show that neuronal responses in the OFC are typically invariant for changes of menu. In other words, the activity of a neuron in response to one particular good usually does not depend on what other goods are available at the same time. Neurons in the OFC encode economic value, not relative preference. The fact that their responses are menu invariant suggests that transitivity, a fundamental trait of economic choice, may be rooted in the activity of individual neurons.	[Padoa-Schioppa, Camillo; Assad, John A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Padoa-Schioppa, C (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	camillo@alum.mit.edu		Padoa-Schioppa, Camillo/0000-0002-7519-8790	NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH080852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041000] Funding Source: NIH RePORTER; NIMH NIH HHS [K99 MH 080852, K99 MH080852-01, K99 MH080852] Funding Source: Medline; NINDS NIH HHS [R01 NS041000-05, R01 NS041000, R01 NS 41000] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLINGHAM M, 2002, CHOICE THEORY VERY S, V125; Arana FS, 2003, J NEUROSCI, V23, P9632; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Blair K, 2006, J NEUROSCI, V26, P11379, DOI 10.1523/JNEUROSCI.1640-06.2006; CAMPIONE JC, 1969, J EXP CHILD PSYCHOL, V7, P387, DOI 10.1016/0022-0965(69)90001-0; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; CHOI S, IN PRESS AM EC REV; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Cromwell HC, 2005, EXP BRAIN RES, V162, P520, DOI 10.1007/s00221-005-2223-z; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; Fellows Lesley K, 2004, Behav Cogn Neurosci Rev, V3, P159; Glimcher PW, 2005, GAME ECON BEHAV, V52, P213, DOI 10.1016/j.geb.2004.06.011; GRACE RC, 1993, J EXP ANAL BEHAV, V60, P185, DOI 10.1901/jeab.1993.60-185; Hodges JR, 2001, NEUROLOGY, V56, pS6, DOI 10.1212/WNL.56.suppl_4.S6; Hosokawa T, 2007, NEUROSCI RES, V57, P434, DOI 10.1016/j.neures.2006.12.003; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; KREPS DM, 1990, COURSE MICROECONOMIC, V850; LOGAN FA, 1965, J COMP PHYSIOL PSYCH, V59, P1, DOI 10.1037/h0021633; Luce R, 1959, INDIVIDUAL CHOICE BE; MAZUR JE, 1987, J EXP ANAL BEHAV, V47, P287, DOI 10.1901/jeab.1987.47-287; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; NAVARICK DJ, 1972, J EXP ANAL BEHAV, V18, P389, DOI 10.1901/jeab.1972.18-389; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2006, COGNITION, V99, pB1, DOI 10.1016/j.cognition.2005.04.008; PADOASCHIOPPA C, 2007, ANN NY ACAD SCI, DOI DOI 10.1196/ANNALS.1404.011; Pasquier F, 1997, EUR NEUROL, V38, P1, DOI 10.1159/000112894; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; Pritchard TC, 2005, J NEUROSCI, V25, P6047, DOI 10.1523/JNEUROSCI.0430-05.2005; Rahman S, 1999, BRAIN, V122, P1469, DOI 10.1093/brain/122.8.1469; Roesch MR, 2005, J NEUROPHYSIOL, V94, P1469, DOI 10.1152/jn.00064.2005; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; ROLLS ET, 1989, EUR J NEUROSCI, V1, P53, DOI 10.1111/j.1460-9568.1989.tb00774.x; Shafir S, 2002, BEHAV ECOL SOCIOBIOL, V51, P180, DOI 10.1007/s00265-001-0420-8; SHAFIR S, 1994, ANIM BEHAV, V48, P55, DOI 10.1006/anbe.1994.1211; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; TVERSKY A, 1969, PSYCHOL REV, V76, P31, DOI 10.1037/h0026750; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x	47	258	262	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					95	102		10.1038/nn2020	http://dx.doi.org/10.1038/nn2020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18066060	Green Accepted			2022-12-24	WOS:000252117900017
J	Wu, CL; Xia, S; Fu, TF; Wang, H; Chen, YH; Leong, D; Chiang, AS; Tully, T				Wu, Chia-Lin; Xia, Shouzhen; Fu, Tsai-Feng; Wang, Huaien; Chen, Ying-Hsiu; Leong, Daniel; Chiang, Ann-Shyn; Tully, Tim			Specific requirement of NMDA receptors for long-term memory consolidation in Drosophila ellipsoid body	NATURE NEUROSCIENCE			English	Article							DOUBLE-STRANDED-RNA; MUSHROOM BODIES; CENTRAL COMPLEX; NEURONS; GENE; MELANOGASTER; BRAIN; ORGANIZATION; INTERFERENCE; EXPRESSION	In humans and many other animals, memory consolidation occurs through multiple temporal phases and usually involves more than one neuroanatomical brain system. Genetic dissection of Pavlovian olfactory learning in Drosophila melanogaster has revealed multiple memory phases, but the predominant view holds that all memory phases occur in mushroom body neurons. Here, we demonstrate an acute requirement for NMDA receptors (NMDARs) outside of the mushroom body during long-term memory (LTM) consolidation. Targeted dsRNA-mediated silencing of Nmdar1 and Nmdar2 (also known as dNR1 or dNR2, respectively) in cholinergic R4m-subtype large-field neurons of the ellipsoid body specifically disrupted LTM consolidation, but not retrieval. Similar silencing of functional NMDARs in the mushroom body disrupted an earlier memory phase, leaving LTM intact. Our results clearly establish an anatomical site outside of the mushroom body involved with LTM consolidation, thus revealing both a distributed brain system subserving olfactory memory formation and the existence of a system-level memory consolidation in Drosophila.	Natl Tsing Hua Univ, Inst Biotechnol, Dept Life Sci, Hsinchu 30013, Taiwan; Natl Tsing Hua Univ, Univ Syst Taiwan, Brain Res Ctr, Hsinchu 30013, Taiwan; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Natl Chi Nan Univ, Dept Appl Chem, Nantou 545, Taiwan	National Tsing Hua University; National Tsing Hua University; Cold Spring Harbor Laboratory; National Chi Nan University	Chiang, AS (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Dept Life Sci, Sect 2,Kuang-Fu Rd, Hsinchu 30013, Taiwan.	aschiang@life.nthu.edu.tw; tully@cshl.edu		Fu, Tsai-Feng/0000-0002-0343-3018; Chiang, Ann-Shyn/0000-0001-9668-7115; Wu, Chia-Lin/0000-0002-7906-2364	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066910] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH066910-03] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akalal DBG, 2006, LEARN MEMORY, V13, P659, DOI 10.1101/lm.221206; ALLWEIS C, 1991, NEURAL BEHAV PLASTIC, P370; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0; Comas D, 2004, NATURE, V430, P460, DOI 10.1038/nature02726; Dash PK, 2004, BRAIN RES REV, V45, P30, DOI 10.1016/j.brainresrev.2004.02.001; Davis J, 2002, OXFORD REV EDUC, V28, P275, DOI 10.1080/03054980220143423; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; EICHENBAUM H, 2001, CONDITIONING CONSCIO, P583; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Flockhart I, 2006, NUCLEIC ACIDS RES, V34, pD489, DOI 10.1093/nar/gkj114; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Lee T, 1999, DEVELOPMENT, V126, P4065; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Pascual A, 2004, NATURE, V427, P605, DOI 10.1038/427605a; Renn SCP, 1999, J NEUROBIOL, V41, P189; Roberts AC, 2003, TRENDS NEUROSCI, V26, P662, DOI 10.1016/j.tins.2003.09.014; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Xia S, 2007, PLOS BIOL, V5, P2398, DOI 10.1371/journal.pbio.0050264; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037	48	128	136	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1578	1586		10.1038/nn2005	http://dx.doi.org/10.1038/nn2005			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17982450	Green Accepted			2022-12-24	WOS:000251172900015
J	Kwiatkowski, AV; Rubinson, DA; Dent, EW; van Veen, JE; Leslie, JD; Zhang, JY; Mebane, LM; Philippar, U; Pinheiro, EM; Burds, AA; Bronson, RT; Mori, S; Fassler, R; Gertler, FB				Kwiatkowski, Adam V.; Rubinson, Douglas A.; Dent, Erik W.; van Veen, J. Edward; Leslie, Jonathan D.; Zhang, Jiangyang; Mebane, Leslie M.; Philippar, Ulrike; Pinheiro, Elaine M.; Burds, Aurora A.; Bronson, Roderick T.; Mori, Susumu; Faessler, Reinhard; Gertler, Frank B.			EnaNASP is required for neuritogenesis in the developing cortex	NEURON			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; ENA/VASP PROTEINS; NEURONAL MIGRATION; ACTIN CYTOSKELETON; FILOPODIA; MICROTUBULES; CELLS; VASP; MENA; RNA	Mammalian cortical development involves neuronal migration and neuritogenesis; this latter process forms the structural precursors to axons and dendrites. Elucidating the pathways that regulate the cytoskeleton to drive these processes is fundamental to our understanding of cortical development. Here we show that loss of all three murine Ena/VASP proteins, a family of actin regulatory proteins, causes neuronal ectopias, alters intralayer positioning in the cortical plate, and, surprisingly, blocks axon fiber tract formation during corticogenesis. Cortical fiber tract defects in the absence of Ena/VASP arise from a failure in neurite initiation, a prerequisite for axon formation. Neurite initiation defects in Ena/VASP-deficient neurons are preceded by a failure to form bundled actin filaments and filopodia. These findings provide insight into the regulation of neurite formation and the role of the actin cytoskeleton during cortical development.	Tufts Univ, Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Johns Hopkins Univ, Sch Med, Dept Radiol, Div Nucl Magnet Resonance Res, Baltimore, MD USA; Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany	Tufts University; Massachusetts Institute of Technology (MIT); Johns Hopkins University; Max Planck Society	Gertler, FB (corresponding author), Tufts Univ, Sch Vet Med, Dept Biomed Sci, 200 Westboro Rd, North Grafton, MA 01536 USA.	fgertler@mit.edu	Rubinson, Douglas/G-3502-2019; Dent, Erik/L-6208-2019	Rubinson, Douglas/0000-0002-5337-5231; Dent, Erik/0000-0001-8525-7136; Zhang, Jiangyang/0000-0003-0740-2662; van Veen, J. Edward/0000-0003-1798-3210; Connor, Aurora/0000-0003-2705-5100; Zhang, Jiangyang/0000-0003-4146-8163	NIA NIH HHS [AG20012] Funding Source: Medline; NIBIB NIH HHS [EB003543] Funding Source: Medline; NIGMS NIH HHS [U54 GM064346, GM58801] Funding Source: Medline; NINDS NIH HHS [F32-NS45366] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058801, U54GM064346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS045366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020012] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Applewhite DA, 2007, MOL BIOL CELL, V18, P2579, DOI 10.1091/mbc.e06-11-0990; Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; de Rouvroit CL, 2001, MECH DEVELOP, V105, P47, DOI 10.1016/S0925-4773(01)00396-3; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; DeLima AD, 1997, J COMP NEUROL, V382, P230, DOI 10.1002/(SICI)1096-9861(19970602)382:2<230::AID-CNE7>3.0.CO;2-4; DENT EW, 2007, IN PRESS NAT CELL BI; Dwivedy A, 2007, DEVELOPMENT, V134, P2137, DOI 10.1242/dev.002345; Elder GA, 1998, J CELL BIOL, V141, P727, DOI 10.1083/jcb.141.3.727; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; FURMAN C, 2007, IN PRESS J CELL BIOL; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Goh KL, 2002, CURR BIOL, V12, P565, DOI 10.1016/S0960-9822(02)00725-X; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Gressens P, 2006, CURR OPIN NEUROL, V19, P135, DOI 10.1097/01.wco.0000218228.73678.e1; Halfter W, 2002, J NEUROSCI, V22, P6029; Han YH, 2002, J BIOL CHEM, V277, P49877, DOI 10.1074/jbc.M209107200; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Loureiro JJ, 2002, MOL BIOL CELL, V13, P2533, DOI 10.1091/mbc.E01-10-0102; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Menzies AS, 2004, J NEUROSCI, V24, P8029, DOI 10.1523/JNEUROSCI.1057-04.2004; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Niewmierzycka A, 2005, J NEUROSCI, V25, P7022, DOI 10.1523/JNEUROSCI.1695-05.2005; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; SIEVERS J, 1994, J NEUROCYTOL, V23, P135, DOI 10.1007/BF01183867; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Zhang JY, 2005, NEUROIMAGE, V26, P1042, DOI 10.1016/j.neuroimage.2005.03.009	60	161	163	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 8	2007	56	3					441	455		10.1016/j.neuron.2007.09.008	http://dx.doi.org/10.1016/j.neuron.2007.09.008			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	229AV	17988629	Green Published, Bronze			2022-12-24	WOS:000250774600005
J	Jacob, J; Ferri, AL; Milton, C; Prin, F; Pla, P; Lin, W; Gavalas, A; Ang, SL; Briscoe, J				Jacob, John; Ferri, Anna L.; Milton, Christopher; Prin, Fabrice; Pla, Patrick; Lin, Wei; Gavalas, Anthony; Ang, Siew-Lan; Briscoe, James			Transcriptional repression coordinates the temporal switch from motor to serotonergic neurogenesis	NATURE NEUROSCIENCE			English	Article							HOMEOBOX GENE PHOX2B; FLOOR PLATE; OLIGODENDROCYTE DIFFERENTIATION; SEROTONINERGIC NEURONS; NEURAL-TUBE; SPECIFICATION; IDENTITY; HEDGEHOG; EXPRESSION; NKX2.2	In many regions of the developing CNS, distinct cell types are born at different times. The means by which discrete and stereotyped temporal switches in cellular identities are acquired remains poorly understood. To address this, we have examined how visceral motor neurons (VMNs) and serotonergic neurons, two neuronal subtypes, are sequentially generated from a common progenitor pool in the vertebrate hindbrain. We found that the forkhead transcription factor Foxa2, acting in progenitors, is essential for the transition from VMN to serotonergic neurogenesis. Loss-of-function and gain-of-function experiments indicated that Foxa2 activates the switch through a temporal cross-repressive interaction with paired-like homeobox 2b (Phox2b), the VMN progenitor determinant. This mechanism bears a marked resemblance to the cross-repression between neighboring domains of transcription factors that establish discrete progenitor identities along the spatial axes. Moreover, the subsequent differentiation of central serotonergic neurons required both the suppression of VMN neurogenesis and the induction of downstream intrinsic determinants of serotonergic identity by Foxa2.	Natl Inst Med Res, Ridgeway, London NW7 1AA, England; UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Ecole Normale Super, CNRS, UMR8542, Dept Biol, F-75005 Paris, France; Acad Athens, Biomed Res Fdn, Dev Biol Lab, Athens 11527, Greece	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Academy of Athens	Briscoe, J (corresponding author), Natl Inst Med Res, Ridgeway, Mill Hill, London NW7 1AA, England.	sang@nimr.mrc.ac.uk; jbrisco@nimr.mrc.ac.uk	Ferri, Luca Angelo/AAC-5890-2022; Gavalas, Anthony/F-5817-2015	Ferri, Luca Angelo/0000-0001-9031-6284; Briscoe, James/0000-0002-1020-5240; Pla, Patrick/0000-0002-5957-2340; Gavalas, Anthony/0000-0003-4897-0359	Medical Research Council [G108/527, MC_U117570533, MC_U117560541] Funding Source: Medline; MRC [MC_U117560541, G108/527] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALTABA ARI, 1995, MOL CELL NEUROSCI, V6, P106, DOI 10.1006/mcne.1995.1011; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Cheng LP, 2003, J NEUROSCI, V23, P9961; Cordes SP, 2001, NAT REV NEUROSCI, V2, P611, DOI 10.1038/35090039; COVELL DA, 1989, J COMP NEUROL, V286, P488, DOI 10.1002/cne.902860407; Craven SE, 2004, DEVELOPMENT, V131, P1165, DOI 10.1242/dev.01024; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Hallonet M, 2002, DEV BIOL, V243, P20, DOI 10.1006/dbio.2001.0536; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hendricks T, 1999, J NEUROSCI, V19, P10348; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Isaka F, 1999, EUR J NEUROSCI, V11, P2582, DOI 10.1046/j.1460-9568.1999.00699.x; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Jacob J, 2000, MOL CELL NEUROSCI, V16, P14, DOI 10.1006/mcne.2000.0855; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Jeong Y, 2003, DEVELOPMENT, V130, P3891, DOI 10.1242/dev.00590; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Pattyn A, 2004, NAT NEUROSCI, V7, P589, DOI 10.1038/nn1247; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Pierce E T, 1973, Prog Brain Res, V40, P53; Placzek M, 2005, NAT REV NEUROSCI, V6, P230, DOI 10.1038/nrn1628; Qi YC, 2001, DEVELOPMENT, V128, P2723; Rand CM, 2007, PEDIATR RES, V62, P180, DOI 10.1203/PDR.0b013e3180a725a0; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; SAKO H, 1986, J COMP NEUROL, V253, P61, DOI 10.1002/cne.902530106; Samad OA, 2004, DEVELOPMENT, V131, P4071, DOI 10.1242/dev.01282; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Tiveron MC, 2003, DEV BIOL, V260, P46, DOI 10.1016/S0012-1606(03)00213-6; VALLET V, 1995, MOL CELL BIOL, V15, P5453; van Doorninck J H, 1999, J Neurosci, V19, pRC12; WALLACE JA, 1985, J COMP NEUROL, V236, P443, DOI 10.1002/cne.902360403; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	50	66	66	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1433	1439		10.1038/nn1985	http://dx.doi.org/10.1038/nn1985			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17922007				2022-12-24	WOS:000250508400021
J	Pathak, MM; Yarov-Yarovoy, V; Agarwal, G; Roux, B; Barth, P; Kohout, S; Tombola, F; Isacoff, EY				Pathak, Medha M.; Yarov-Yarovoy, Vladimir; Agarwal, Gautam; Roux, Benoit; Barth, Patrick; Kohout, Susy; Tombola, Francesco; Isacoff, Ehud Y.			Closing in on the resting state of the shaker K+ channel	NEURON			English	Article							GATED ION CHANNELS; VOLTAGE SENSOR MOVEMENT; FOCUSED ELECTRIC-FIELD; POTASSIUM CHANNEL; GATING-CHARGE; TRANSMEMBRANE MOVEMENT; STRUCTURE PREDICTION; STRUCTURAL MODELS; SODIUM-CHANNELS; ACTIVATION GATE	Membrane depolarization causes voltage-gated ion channels to transition from a resting/ closed conformation to an activated/open conformation. We used voltage-clamp fluorometry to measure protein motion at specific regions of the Shaker Kv channel. This enabled us to construct new structural models of the resting/ closed and activated/open states based on the Kv1.2 crystal structure using the Rosetta-Membrane method and molecular dynamics simulations. Our models account for the measured gating charge displacement and suggest a molecular mechanism of activation in which the primary voltage sensors, S4s, rotate by similar to 1800 degrees as they move "outward" by 6-8 angstrom. A subsequent tilting motion of the S4s and the pore domain helices, S5s, of all four subunits induces a concerted movement of the channel's S4-S5 linkers and S6 helices, allowing ion conduction. Our models are compatible with a wide body of data and resolve apparent contradictions that previously led to several distinct models of voltage sensing.	Univ Calif Berkeley, Biophys Grad Program, Berkeley, CA 94720 USA; Univ Calif Berkeley, Grad Program Neurosci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Chicago, Inst Mol Pediat Sci, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Sci Mat, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago; University of Chicago; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Biophys Grad Program, Berkeley, CA 94720 USA.	ehud@berkeley.edu	isacoff, ehud/AAP-1459-2020; Tombola, Francesco/ABA-6002-2020; Yarov-Yarovoy, Vladimir/ABE-5454-2020; Tombola, Francesco/C-7311-2011	Tombola, Francesco/0000-0002-9315-0352; Yarov-Yarovoy, Vladimir/0000-0002-2325-4834; Isacoff, Ehud Y./0000-0003-4775-9359; Agarwal, Gautam/0000-0001-7300-7586; Kohout, Susy/0000-0002-8159-8934	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH067625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015751, R01NS035549] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM062342, GM62342] Funding Source: Medline; NIMH NIH HHS [K01 MH67625] Funding Source: Medline; NINDS NIH HHS [R01 NS15751, R01 NS035549] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; BARTH P, 2007, IN PRESS P NATL ACAD; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; CATTERALL WA, 1986, TRENDS NEUROSCI, V9, P7, DOI 10.1016/0166-2236(86)90004-4; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Darman RB, 2006, J GEN PHYSIOL, V128, P687, DOI 10.1085/jgp.200609624; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; del Camino D, 2005, J GEN PHYSIOL, V126, P419, DOI 10.1085/jgp.200509385; Durell SR, 2004, BIOPHYS J, V87, P2116, DOI 10.1529/biophysj.104.040618; Durell SR, 1998, J STRUCT BIOL, V121, P263, DOI 10.1006/jsbi.1998.3962; Gandhi CS, 2000, NEURON, V27, P585, DOI 10.1016/S0896-6273(00)00068-4; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gonzalez C, 2005, P NATL ACAD SCI USA, V102, P5020, DOI 10.1073/pnas.0501051102; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lecar H, 2003, BIOPHYS J, V85, P2854, DOI 10.1016/S0006-3495(03)74708-0; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Mannuzzu LM, 2000, J GEN PHYSIOL, V115, P257, DOI 10.1085/jgp.115.3.257; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	64	236	239	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 4	2007	56	1					124	140		10.1016/j.neuron.2007.09.023	http://dx.doi.org/10.1016/j.neuron.2007.09.023			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920020	Bronze			2022-12-24	WOS:000250289800015
J	Huberman, AD; Manu, M; Koch, SM; Susman, MW; Lutz, AB; Ullian, EM; Baccus, SA; Barres, BA				Huberman, Andrew D.; Manu, Mihai; Koch, Selina M.; Susman, Michael W.; Lutz, Amanda Brosius; Ullian, Erik M.; Baccus, Stephen A.; Barres, Ben A.			Architecture and activity-mediated refinement of axonal projections from a mosaic of genetically identified retinal ganglion cells	NEURON			English	Article							OCULAR DOMINANCE COLUMNS; EYE-SPECIFIC SEGREGATION; RETINOTOPIC MAP REFINEMENT; MICE LACKING; MORPHOLOGICAL CLASSIFICATION; SUPERIOR COLLICULUS; VISUAL-CORTEX; N-CADHERIN; MOUSE; EXPRESSION	Our understanding of how mammalian sensory circuits are organized and develop has long been hindered by the lack of genetic markers of neurons with discrete functions. Here, we report a transgenic mouse selectively expressing GFP in a complete mosaic of transient OFF-alpha retinal ganglion cells (tOFF-alpha RGCs). This enabled us to relate the mosaic spacing, dendritic anatomy, and electrophysiology of these RGCs to their complete map of projections in the brain. We find that tOFF-alpha RGCs project exclusively to the superior colliculus (SC) and dorsal lateral geniculate nucleus and are restricted to a specific laminar depth within each of these targets. The axons of tOFF-alpha RGC are also organized into columns in the SC. Both laminar and columnar specificity develop through axon refinement. Disruption of cholinergic retinal waves prevents the emergence of columnar-but not laminar-specific tOFF-alpha RGC connections. Our findings reveal that in a genetically identified sensory map, spontaneous activity promotes synaptic specificity by segregating axons arising from RGCs of the same subtype.	[Huberman, Andrew D.; Manu, Mihai; Susman, Michael W.; Lutz, Amanda Brosius; Baccus, Stephen A.; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Koch, Selina M.; Ullian, Erik M.] Univ Calif San Francisco, Dept Ophthalmol & Physiol, San Francisco, CA 94117 USA	Stanford University; University of California System; University of California San Francisco	Huberman, AD (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Fairchild Sci Bldg D235, Stanford, CA 94305 USA.	adh1@stanford.edu		Manu, Mihai/0000-0001-7776-4736	March of Dimes Basil O'Connor Award; Research to Prevent Blindness Young Investigator Award [NIH EY02162, NIH R21MH083090, T32 EY07120]; Helen Hay Whitney Postdoctoral Fellowship;  [NIH RO1 EY011310-13];  [NIH R21 EY018320];  [NIH R01 EY016842]; NATIONAL EYE INSTITUTE [P30EY002162, R01EY011310, R21EY018320, T32EY007120, R01EY016842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083090] Funding Source: NIH RePORTER	March of Dimes Basil O'Connor Award(March of Dimes); Research to Prevent Blindness Young Investigator Award(Research to Prevent Blindness (RPB)); Helen Hay Whitney Postdoctoral Fellowship; ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to D. Feldheim, T. Clandinin, T. Cutforth, and J. Krey for helpful comments and suggestions. We thank B. Chapman for use of her microscope and J. Yamada and M. Martin for genotyping. This work was supported by NIH RO1 EY011310-13, NIH R21 EY018320 (B.A.B.), NIH R01 EY016842 (S.A.B.), a March of Dimes Basil O'Connor Award (E.M.U), Research to Prevent Blindness Young Investigator Award (E.M.U.), NIH EY02162 (E.M.U.), NIH R21MH083090 (E.M.U.), and T32 EY07120 (S.K.). A.D.H. was supported by a Helen Hay Whitney Postdoctoral Fellowship.	Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; Baccus SA, 2008, J NEUROSCI, V28, P6807, DOI 10.1523/JNEUROSCI.4206-07.2008; Bansal A, 2000, J NEUROSCI, V20, P7672; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Berson D., 2008, SENSES COMPREHENSIVE, P491, DOI DOI 10.1016/B978-012370880-9.00280-2; BERSON DM, 1988, PROG BRAIN RES, V75, P17; BOWLING DB, 1980, NATURE, V286, P899, DOI 10.1038/286899a0; Callaway EM, 2005, J PHYSIOL-LONDON, V566, P13, DOI 10.1113/jphysiol.2005.088047; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Chen PL, 2008, NEURON, V58, P26, DOI 10.1016/j.neuron.2008.01.007; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; DRAGER UC, 1976, J NEUROPHYSIOL, V39, P91, DOI 10.1152/jn.1976.39.1.91; EDWARDS MA, 1986, J COMP NEUROL, V248, P395, DOI 10.1002/cne.902480308; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Farah MH, 2005, J COMP NEUROL, V489, P120, DOI 10.1002/cne.20615; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GRUBB MS, 2003, NEURON, V30, P1151; Hiesinger PR, 2006, CURR BIOL, V16, P1835, DOI 10.1016/j.cub.2006.07.047; HOFBAUER A, 1985, J COMP NEUROL, V234, P465, DOI 10.1002/cne.902340405; Hu EH, 2000, J NEUROSCI METH, V103, P209, DOI 10.1016/S0165-0270(00)00319-8; Huang L, 2001, J NEUROPHYSIOL, V86, P1179, DOI 10.1152/jn.2001.86.3.1179; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2002, J NEUROSCI, V22, P9419; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Kerschensteiner D, 2008, NEURON, V58, P851, DOI 10.1016/j.neuron.2008.04.025; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kim TJ, 2006, INVEST OPHTH VIS SCI, V47, P2757, DOI 10.1167/iovs.05-1442; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Lee EJ, 2004, J COMP NEUROL, V470, P372, DOI 10.1002/cne.20010; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Meinertzhagen Ian A., 1993, P1363; MOONEY RD, 1990, J NEUROSCI, V10, P3164; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Nern A, 2008, NEURON, V58, P34, DOI 10.1016/j.neuron.2008.03.022; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; PEICHL L, 1991, VISUAL NEUROSCI, V7, P155, DOI 10.1017/S0952523800011020; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; REESE BE, 1988, BRAIN RES REV, V13, P119, DOI 10.1016/0165-0173(88)90017-3; REH TA, 1985, J NEUROSCI, V5, P1132; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; SACHS GM, 1986, J COMP NEUROL, V246, P395, DOI 10.1002/cne.902460308; Schubert T, 2005, J COMP NEUROL, V485, P191, DOI 10.1002/cne.20510; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stacy RC, 2005, J NEUROSCI, V25, P9347, DOI 10.1523/JNEUROSCI.1800-05.2005; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; TAMAMAKI N, 1995, J COMP NEUROL, V354, P583, DOI 10.1002/cne.903540408; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; Volgyi B, 2005, J COMP NEUROL, V492, P66, DOI 10.1002/cne.20700; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Xu W, 1999, J NEUROSCI, V19, P9298; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533	64	207	212	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 14	2008	59	3					425	438		10.1016/j.neuron.2008.07.018	http://dx.doi.org/10.1016/j.neuron.2008.07.018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339GG	18701068	Bronze, Green Accepted			2022-12-24	WOS:000258565500011
J	Knutson, B; Wimmer, GE; Rick, S; Hollon, NG; Prelec, D; Loewenstein, G				Knutson, Brian; Wimmer, G. Elliott; Rick, Scott; Hollon, Nick G.; Prelec, Drazen; Loewenstein, George			Neural antecedents of the endowment effect	NEURON			English	Article							LOSS AVERSION; DECISION-MAKING; HUMAN BRAIN; REWARD; EXPERIENCE; ANTICIPATION; RESPONSES	The "endowment effect" refers to the tendency to place greater value on items that one owns-an anomaly that violates the reference-independence assumption of rational choice theories. We investigated neural antecedents of the endowment effect in an event-related functional magnetic resonance imaging (MRI) study. During scanning, 24 subjects considered six products paired with 18 different prices under buying, choosing, or selling conditions. Subjects showed greater nucleus accumbens (NAcc) activation for preferred products across buy and sell conditions combined, but greater mesial prefrontal cortex (MPFC) activation in response to low prices when buying versus selling. During selling, right insular activation for preferred products predicted individual differences in susceptibility to the endowment effect. These findings are consistent with a reference-dependent account in which ownership increases value by enhancing the salience of the possible loss of preferred products.	[Knutson, Brian; Wimmer, G. Elliott; Hollon, Nick G.] Stanford Univ, Stanford, CA 94305 USA; [Rick, Scott] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Prelec, Drazen] MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA; [Loewenstein, George] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA	Stanford University; University of Pennsylvania; Massachusetts Institute of Technology (MIT); Carnegie Mellon University	Knutson, B (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	knutson@psych.stanford.edu	Rick, Scott/A-6296-2011; Wimmer, G. Elliott/AAJ-8537-2020; Loewenstein, George/G-7616-2014	Rick, Scott/0000-0002-0306-2376; Wimmer, G. Elliott/0000-0002-2227-119X; Loewenstein, George/0000-0003-2790-0474; Hollon, Nick/0000-0003-4827-1582; Knutson, Brian/0000-0002-7669-426X				Ariely D, 2003, Q J ECON, V118, P73, DOI 10.1162/00335530360535153; Bateman I, 2005, J PUBLIC ECON, V89, P1561, DOI 10.1016/j.jpubeco.2004.06.013; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; BEGGAN JK, 1992, J PERS SOC PSYCHOL, V62, P229, DOI 10.1037/0022-3514.62.2.229; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Brenner L, 2007, J CONSUM RES, V34, P369, DOI 10.1086/518545; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; Camerer C. F., 2001, CHOICES VALUES FRAME, P288; Carmon Z, 2000, J CONSUM RES, V27, P360, DOI 10.1086/317590; COASE RH, 1960, J LAW ECON, V3, P1, DOI 10.1086/466560; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Harbaugh WT, 2001, ECON LETT, V70, P175, DOI 10.1016/S0165-1765(00)00359-1; KAHNEMAN D, 1991, J ECON PERSPECT, V5, P193, DOI 10.1257/jep.5.1.193; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; KNUTSON B, 2007, ANN NY ACAD SCI, V104, P54, DOI DOI 10.1196/ANNALS.1390.020; Knutson B, 2007, J NEUROSCI, V27, P8174, DOI 10.1523/JNEUROSCI.1564-07.2007; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; List JA, 2003, Q J ECON, V118, P41, DOI 10.1162/00335530360535144; LOEWENSTEIN G, 1995, ECON J, V105, P929, DOI 10.2307/2235159; LOEWENSTEIN G, 2008, NEUROECONOMICS ANN R, V59, P647; Nayakankuppam D, 2005, J CONSUM RES, V32, P390, DOI 10.1086/497550; Novemsky N, 2005, J MARKETING RES, V42, P139, DOI 10.1509/jmkr.42.2.139.62295; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Peters E, 2003, J BEHAV DECIS MAKING, V16, P309, DOI 10.1002/bdm.448; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Pochon JB, 2008, J NEUROSCI, V28, P3468, DOI 10.1523/JNEUROSCI.4195-07.2008; Poldrack RA, 1999, NEUROPSYCHOLOGY, V13, P564, DOI 10.1037/0894-4105.13.4.564; Prelec D, 1998, MARKET SCI, V17, P4, DOI 10.1287/mksc.17.1.4; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; THALER R, 1980, J ECON BEHAV ORGAN, V1, P39, DOI 10.1016/0167-2681(80)90051-7; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; Weber B, 2007, NEUROIMAGE, V35, P441, DOI 10.1016/j.neuroimage.2006.11.034	45	97	102	9	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 12	2008	58	5					814	822		10.1016/j.neuron.2008.05.018	http://dx.doi.org/10.1016/j.neuron.2008.05.018			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	315IA	18549791	Green Submitted, Bronze			2022-12-24	WOS:000256870800017
J	Xu, W; Schluter, OM; Steiner, P; Czervionke, BL; Sabatini, B; Malenka, RC				Xu, Weifeng; Schlueter, Oliver M.; Steiner, Pascal; Czervionke, Brian L.; Sabatini, Bernardo; Malenka, Robert C.			Molecular dissociation of the role of PSD-95 in regulating synaptic strength and LTD	NEURON			English	Article							LONG-TERM DEPRESSION; AMPA RECEPTOR TRAFFICKING; DENSITY PROTEIN PSD-95; GLUTAMATE RECEPTORS; KINASE-A; PLASTICITY; MULTIMERIZATION; POTENTIATION; SYNAPSES; SUBUNITS	The postsynaptic density protein PSD-95 influences synaptic AMPA receptor (AMPAR) content and may play a critical role in LTD. Here we demonstrate that the effects of PSD-95 on AMPAR-mediated synaptic responses and LTD can be dissociated. Our findings suggest that N-terminal-domain-mediated dimerization is important for PSD-95's effect on basal synaptic AMPAR function, whereas the C-terminal SH3-GK domains are also necessary for localizing PSD-95 to synapses. We identify PSD-95 point mutants (Q15A, E17R) that maintain PSD-95's influence on basal AMPAR synaptic responses yet block LTD. These point mutants increase the proteolysis of PSD-95 within its N-terminal domain, resulting in a C-terminal fragment that functions as a dominant negative likely by scavenging critical signaling proteins required for LTD. Thus, the C-terminal portion of PSD-95 serves a dual function. It is required to localize PSD-95 at synapses and as a scaffold for signaling proteins that are required for LTD.	[Xu, Weifeng; Schlueter, Oliver M.; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA; [Schlueter, Oliver M.] Univ Gottingen, Sch Med, European Neurosci Inst, D-37077 Gottingen, Germany; [Schlueter, Oliver M.] Max Planck Soc, D-37077 Gottingen, Germany; [Steiner, Pascal; Czervionke, Brian L.; Sabatini, Bernardo] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02459 USA	Stanford University; University of Gottingen; Max Planck Society; Harvard University; Harvard Medical School	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.	malenka@stanford.edu			NIMH NIH HHS [K99 MH080310, K99 MH080310-01, MH063394, MH075220, R01 MH118298, R00 MH080310, MH080310, R01 MH063394, F32 MH075220, R37 MH063394] Funding Source: Medline; NINDS NIH HHS [R01 NS052707-03, R01 NS052707] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063394, R00MH080310, F32MH075220, K99MH080310, R01MH063394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052707] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AEL DE, 2002, CELL, V108, P849; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Christopherson KS, 2003, J CELL SCI, V116, P3213, DOI 10.1242/jcs.00617; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Hsueh YP, 1999, J BIOL CHEM, V274, P532, DOI 10.1074/jbc.274.1.532; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; Moran LB, 2004, NEUROGENETICS, V5, P95, DOI 10.1007/s10048-004-0172-5; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Niethammer M, 1996, J NEUROSCI, V16, P2157; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Stein V, 2003, J NEUROSCI, V23, P5503; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469	48	143	147	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 24	2008	57	2					248	262		10.1016/j.neuron.2007.11.027	http://dx.doi.org/10.1016/j.neuron.2007.11.027			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256VQ	18215622	Green Accepted, Bronze			2022-12-24	WOS:000252758400009
J	Alitto, HJ; Usrey, WM				Alitto, Henry J.; Usrey, W. Martin			Origin and dynamics of extraclassical suppression in the lateral geniculate nucleus of the macaque monkey	NEURON			English	Article							CLASSICAL RECEPTIVE-FIELD; PRIMARY VISUAL-CORTEX; CONTRAST GAIN-CONTROL; SPATIAL SUMMATION; STRIATE CORTEX; RETINAL INPUTS; CORTICOFUGAL FEEDBACK; SIMPLE CELLS; RELAY CELLS; CAT	In addition to the classical, center/surround receptive field of neurons in the lateral geniculate nucleus (LGN), there is an extraclassical, nonlinear surround that can strongly suppress LGN responses. This form of suppression likely plays an important role in adjusting the gain of LGN responses to visual stimuli. We performed experiments in alert and anesthetized macaque monkies to quantify extraclassical suppression in the LGN and determine the roles of feedforward and feedback pathways in the generation of LGN suppression. Results show that suppression is significantly stronger among magnocellular neurons than parvocellular neurons and that suppression arises too quickly for involvement from cortical feedback. Furthermore, the amount of suppression supplied by the retina is not significantly different from that in the LGN. These results indicate that extraclassical suppression in the macaque LGN relies on feedforward mechanisms and suggest that suppression in the cortex likely includes a component established in the retina.	[Alitto, Henry J.; Usrey, W. Martin] Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA; [Alitto, Henry J.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Berkeley	Usrey, WM (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA.	wmusrey@ucdavis.edu			NEI NIH HHS [EY12576, EY15387, R01 EY013588-06, R01 EY013588, EY13588, R01 EY013588-07A1] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY015387, R01EY013588, P30EY012576] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Angelucci A, 2006, J COMP NEUROL, V498, P330, DOI 10.1002/cne.21060; Bair W, 2003, J NEUROSCI, V23, P7690; Benardete EA, 1999, VISUAL NEUROSCI, V16, P355, DOI 10.1017/S0952523899162151; BENARDETE EA, 1992, VISUAL NEUROSCI, V8, P483, DOI 10.1017/S0952523800004995; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; BOURASSA J, 1995, NEUROSCIENCE, V66, P253, DOI 10.1016/0306-4522(95)00009-8; Briggs Farran, 2005, Thalamus & Related Systems, V3, P133, DOI 10.1017/S1472928807000131; Briggs F, 2007, J NEUROSCI, V27, P5431, DOI 10.1523/JNEUROSCI.1035-07.2007; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Cudeiro J, 1996, J PHYSIOL-LONDON, V490, P481, DOI 10.1113/jphysiol.1996.sp021159; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; Erisir A, 1998, J COMP NEUROL, V390, P247; Felisberti F, 1999, VISUAL NEUROSCI, V16, P943, DOI 10.1017/S0952523899165143; Fitzpatrick D, 2000, CURR OPIN NEUROBIOL, V10, P438, DOI 10.1016/S0959-4388(00)00113-6; Funke K, 1998, VISUAL NEUROSCI, V15, P711, DOI 10.1017/S0952523898154111; Girardin CC, 2002, EUR J NEUROSCI, V16, P2149, DOI 10.1046/j.1460-9568.2002.02278.x; GRIEVE KL, 1995, J NEUROSCI, V15, P4868; GUILLERY RW, 1969, Z ZELLFORSCH MIK ANA, V96, P39, DOI 10.1007/BF00321475; Hirsch JA, 1998, J NEUROSCI, V18, P8086; Jones HE, 2002, J NEUROPHYSIOL, V88, P2796, DOI 10.1152/jn.00403.2001; Jones HE, 2000, EXP BRAIN RES, V135, P279, DOI 10.1007/s002210000574; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; Kaplan E, 2001, PROG BRAIN RES, V134, P17; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KUFFLER SW, 1952, COLD SPRING HARB SYM, V17, P281, DOI 10.1101/SQB.1952.017.01.026; LAMME VAF, 1995, J NEUROSCI, V15, P1605; LEVICK WR, 1972, INVEST OPHTH VISUAL, V11, P302; Levine MW, 2001, BRAIN RES, V902, P244, DOI 10.1016/S0006-8993(01)02411-8; Levitt JB, 2002, VISUAL NEUROSCI, V19, P439, DOI 10.1017/S0952523802194065; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; MASTRONARDE DN, 1987, J NEUROPHYSIOL, V57, P381, DOI 10.1152/jn.1987.57.2.381; MONTERO VM, 1991, EXP BRAIN RES, V86, P257; Murphy PC, 1996, J NEUROSCI, V16, P1180; Nolt MJ, 2007, J NEUROPHYSIOL, V98, P1167, DOI 10.1152/jn.01019.2006; Nolt MJ, 2004, J NEUROPHYSIOL, V92, P1708, DOI 10.1152/jn.00176.2004; Przybyszewski AW, 2000, VISUAL NEUROSCI, V17, P485, DOI 10.1017/S0952523800174012; Ruksenas O, 2000, VISUAL NEUROSCI, V17, P855, DOI 10.1017/S0952523800176059; Sceniak MP, 2006, J NEUROPHYSIOL, V96, P3474, DOI 10.1152/jn.00734.2006; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; Sillito AM, 2002, PHILOS T R SOC B, V357, P1739, DOI 10.1098/rstb.2002.1170; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Sincich LC, 2007, J NEUROSCI, V27, P2683, DOI 10.1523/JNEUROSCI.5077-06.2007; Smith MA, 2006, J NEUROSCI, V26, P4826, DOI 10.1523/JNEUROSCI.5542-06.2006; Solomon SG, 2006, J NEUROSCI, V26, P8715, DOI 10.1523/JNEUROSCI.0821-06.2006; Solomon SG, 2002, J NEUROSCI, V22, P338, DOI 10.1523/JNEUROSCI.22-01-00338.2002; TSUMOTO T, 1980, J COMP NEUROL, V193, P223, DOI 10.1002/cne.901930115; Usrey WM, 1998, NATURE, V395, P384, DOI 10.1038/26487; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; Webb BS, 2005, J NEUROPHYSIOL, V94, P1789, DOI 10.1152/jn.00826.2004; Webb BS, 2002, VISUAL NEUROSCI, V19, P583, DOI 10.1017/S0952523802195046; WEBER AJ, 1989, J COMP NEUROL, V289, P156, DOI 10.1002/cne.902890113; Weyand TG, 2007, J NEUROPHYSIOL, V98, P769, DOI 10.1152/jn.00929.2006; Yeh TY, 1995, J NEUROSCI, V15, P7892	61	107	107	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 10	2008	57	1					135	146		10.1016/j.neuron.2007.11.019	http://dx.doi.org/10.1016/j.neuron.2007.11.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	250YZ	18184570	Bronze, Green Accepted			2022-12-24	WOS:000252338600015
J	Samuels, BA; Hsueh, YP; Shu, TZ; Liang, HY; Tseng, HC; Hong, CJ; Su, SC; Volker, J; Neve, RL; Yue, DT; Tsai, LH				Samuels, Benjamin Adam; Hsueh, Yi-Ping; Shu, Tianzhi; Liang, Haoya; Tseng, Huang-Chun; Hong, Chen-Jei; Su, Susan C.; Volker, Janet; Neve, Rachael L.; Yue, David T.; Tsai, Li-Huei			Cdk5 promotes synaptogenesis by regulating the subcellular distribution of the MAGUK family member CASK	NEURON			English	Article							CYCLIN-DEPENDENT KINASE-5; PRESYNAPTIC CALCIUM-CHANNELS; SYNAPTIC VESICLE EXOCYTOSIS; MODULAR ADAPTER PROTEINS; LIPRIN-ALPHA; CELL-ADHESION; C-ELEGANS; TRANSMITTER RELEASE; HIPPOCAMPAL-NEURONS; MENTAL-RETARDATION	Synaptogenesis is a highly regulated process that underlies formation of neural circuitry. Considerable work has demonstrated the capability of some adhesion molecules, such as SynCAM and Neurexins/Neuroligins, to induce synapse formation in vitro. Furthermore, Cdk5 gain of function results in an increased number of synapses in vivo. To gain a better understanding of how Cdk5 might promote synaptogenesis, we investigated potential crosstalk between Cdk5 and the cascade of events mediated by synapse-inducing proteins. One protein recruited to developing terminals by SynCAM and Neurexins/Neuroligins is the MAGUK family member CASK. We found that Cdk5 phosphorylates and regulates CASK distribution to membranes. In the absence of Cdk5-dependent phosphorylation, CASK is not recruited to developing synapses and thus fails to interact with essential presynaptic components. Functional consequences include alterations in calcium influx. Mechanistically, Cdk5 regulates the interaction between CASK and liprin-alpha. These results provide a molecular explanation of how Cdk5 can promote synaptogenesis.	[Samuels, Benjamin Adam; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Samuels, Benjamin Adam; Shu, Tianzhi; Tseng, Huang-Chun; Su, Susan C.; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Samuels, Benjamin Adam] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Volker, Janet] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Hsueh, Yi-Ping; Hong, Chen-Jei] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Liang, Haoya; Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Liang, Haoya; Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Neve, Rachael L.] McLean Hosp, Dept Psychiat, Belmont, MA 02178 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Academia Sinica - Taiwan; Johns Hopkins University; Johns Hopkins University; Harvard University; McLean Hospital	Tsai, LH (corresponding author), MIT, Howard Hughes Med Inst, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Hsueh, Yi-Ping/ABH-5052-2020	Hsueh, Yi-Ping/0000-0002-0866-6275	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051874, R37NS051874] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS051874, R01 NS051874-10A1, NS051874, R01 NS051874-12, R01 NS051874-11] Funding Source: Medline; PHS HHS [R01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Agler HL, 2005, NEURON, V46, P891, DOI 10.1016/j.neuron.2005.05.011; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Barclay JW, 2004, J BIOL CHEM, V279, P41495, DOI 10.1074/jbc.M406670200; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; Floyd SR, 2001, J BIOL CHEM, V276, P8104, DOI 10.1074/jbc.M008932200; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hata Y, 1996, J NEUROSCI, V16, P2488; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; Hong CJ, 2006, BIOCHEM BIOPH RES CO, V351, P771, DOI 10.1016/j.bbrc.2006.10.113; Hoogenraad CC, 2007, DEV CELL, V12, P587, DOI 10.1016/j.devcel.2007.02.006; Hsueh YP, 2006, CURR MED CHEM, V13, P1915, DOI 10.2174/092986706777585040; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Khanna R, 2006, NEUROSCIENCE, V138, P1115, DOI 10.1016/j.neuroscience.2005.12.050; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Lin YX, 2004, J NEUROPHYSIOL, V92, P2820, DOI 10.1152/jn.00048.2004; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; Maximov A, 2002, J NEUROSCI, V22, P6939; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Olsen O, 2006, CURR OPIN CELL BIOL, V18, P223, DOI 10.1016/j.ceb.2006.02.010; Olsen O, 2005, J CELL BIOL, V170, P1127, DOI 10.1083/jcb.200503011; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Rosales CR, 2005, EUR J NEUROSCI, V22, P2381, DOI 10.1111/j.1460-9568.2005.04400.x; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shin H, 2003, J BIOL CHEM, V278, P11393, DOI 10.1074/jbc.M211874200; Shuang RQ, 1998, J BIOL CHEM, V273, P4957, DOI 10.1074/jbc.273.9.4957; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Venturin M, 2006, NEUROGENETICS, V7, P59, DOI 10.1007/s10048-005-0026-9; Wang GS, 2004, NEURON, V42, P113, DOI 10.1016/S0896-6273(04)00139-4; Wang TF, 2004, J NEUROCHEM, V91, P1483, DOI 10.1111/j.1471-4159.2004.02845.x; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zamponi GW, 2003, J PHARMACOL SCI, V92, P79; Zhang Y, 2001, FEBS LETT, V497, P99, DOI 10.1016/S0014-5793(01)02450-4; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	70	85	89	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 6	2007	56	5					823	837		10.1016/j.neuron.2007.09.035	http://dx.doi.org/10.1016/j.neuron.2007.09.035			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241MA	18054859	Green Accepted, Bronze			2022-12-24	WOS:000251659300009
J	Kable, JW; Glimcher, PW				Kable, Joseph W.; Glimcher, Paul W.			The neural correlates of subjective value during intertemporal choice	NATURE NEUROSCIENCE			English	Article							POSTERIOR CINGULATE CORTEX; DECISION-MAKING; PARIETAL CORTEX; ORBITOFRONTAL CORTEX; PRIMATE STRIATUM; MONETARY REWARDS; VENTRAL STRIATUM; PREFERENCE; RESPONSES; RISK	Neuroimaging studies of decision-making have generally related neural activity to objective measures (such as reward magnitude, probability or delay), despite choice preferences being subjective. However, economic theories posit that decision-makers behave as though different options have different subjective values. Here we use functional magnetic resonance imaging to show that neural activity in several brain regions-particularly the ventral striatum, medial prefrontal cortex and posterior cingulate cortex-tracks the revealed subjective value of delayed monetary rewards. This similarity provides unambiguous evidence that the subjective value of potential rewards is explicitly represented in the human brain.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Kable, JW (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl,Room 809, New York, NY 10003 USA.	kable@cns.nyu.edu; glimcher@cns.nyu.edu			NIMH NIH HHS [F32-MH75544, F32 MH075544] Funding Source: Medline; NINDS NIH HHS [R01 NS054775-02, R01 NS054775, R01-NS054775] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH075544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054775] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; BENHABIB J, 2006, PESENT BIAS QUASI HY; BERNOULLI D, 1982, WORKS; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Camerer CF, 1999, J RISK UNCERTAINTY, V19, P7, DOI 10.1023/A:1007850605129; Coller M., 1999, Experimental Economics, V2, P107, DOI 10.1007/BF01673482; Cromwell HC, 2005, EXP BRAIN RES, V162, P520, DOI 10.1007/s00221-005-2223-z; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; GUI F, 2005, CASE MINDLESS EC; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Johnson KO, 2002, NEUROSCIENTIST, V8, P111, DOI 10.1177/107385840200800207; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Mazur J.E., 1987, QUANTITATIVE ANAL BE, V5, P55; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; Neumann J., 1944, THEORY GAMES EC BEHA; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Paulus MP, 2006, NEUROIMAGE, V30, P668, DOI 10.1016/j.neuroimage.2005.09.061; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012; SAMUELSON P. A., 1947, FDN EC ANAL; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; SMITH VL, 1993, ECON INQ, V31, P245, DOI 10.1111/j.1465-7295.1993.tb00881.x; STEVENS SS, 1970, SCIENCE, V170, P1043, DOI 10.1126/science.170.3962.1043; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; TELLER DY, 1983, LINKING PROPOSITIONS, P577; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Weber E. H., 1834, PULSU RESORPTIONE AU; WERNERM GERHARD, 1968, P112; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	49	1194	1220	8	195	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1625	1633		10.1038/nn2007	http://dx.doi.org/10.1038/nn2007			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17982449	Green Accepted			2022-12-24	WOS:000251172900021
J	Majeti, R; Park, CY; Weissman, IL				Majeti, Ravindra; Park, Christopher Y.; Weissman, Irving L.			Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; STEM-CELL COMPARTMENT; LONG-TERM; PERIPHERAL-BLOOD; NOD/SCID MICE; SCID MICE; IN-VIVO; TRANSPLANTATION; PURIFICATION; CANCER	Mouse hematopoiesis is initiated by long-term hematopoietic stem cells (HSC) that differentiate into a series of multipotent progenitors that exhibit progressively diminished self-renewal ability. In human hematopoiesis, populations enriched for HSC activity have been identified, as have downstream lineage-committed progenitors, but multipotent progenitor activity has not been uniquely isolated. Previous reports indicate that human HSC are enriched in Lin-CD34+CD38- cord blood and bone marrow and express CD90. We demonstrate that the Lin-CD34+CD38- fraction of cord blood and bone marrow can be subdivided into three subpopulations: CD90+CD45RA-, CD90-CD45RA-, and CD90-CD45RA+. Utilizing in vivo transplantation studies and complementary in vitro assays, we demonstrate that the Lin-CD34+CD38-CD90+CD45RA- cord blood fraction contains HSC and isolate this activity to as few as 10 purified cells. Furthermore, we report the first prospective isolation of a population of candidate human multipotent progenitors, Lin-CD34+CD38-CD90-CD45RA cord blood.	[Majeti, Ravindra] Stanford Univ, Dept Internal Med, Div Hematol, Palo Alto, CA 94304 USA; [Park, Christopher Y.; Weissman, Irving L.] Stanford Univ, Dept Pathol, Palo Alto, CA 94304 USA; [Majeti, Ravindra; Park, Christopher Y.; Weissman, Irving L.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University	Majeti, R (corresponding author), Stanford Univ, Dept Internal Med, Div Hematol, Palo Alto, CA 94304 USA.	rmajeti@stanford.edu		Majeti, Ravindra/0000-0002-5814-0984	NATIONAL CANCER INSTITUTE [R01CA086017] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA86017, R01 CA086017-07, R01 CA086017-06, R01 CA086017] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Blair A, 1997, BLOOD, V89, P3104, DOI 10.1182/blood.V89.9.3104; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Cashman JD, 1997, BLOOD, V89, P4307, DOI 10.1182/blood.V89.12.4307; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; CRAIG W, 1993, J EXP MED, V177, P1331, DOI 10.1084/jem.177.5.1331; Dick JE, 2001, ANN NY ACAD SCI, V938, P184; Guenechea G, 2001, NAT IMMUNOL, V2, P75, DOI 10.1038/83199; Hogan CJ, 2002, P NATL ACAD SCI USA, V99, P413, DOI 10.1073/pnas.012336799; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Mazurier F, 2004, BLOOD, V103, P545, DOI 10.1182/blood-2003-05-1558; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Michallet M, 2000, EXP HEMATOL, V28, P858, DOI 10.1016/S0301-472X(00)00169-7; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; MURRAY L, 1995, BLOOD, V85, P368; Negrin RS, 2000, BIOL BLOOD MARROW TR, V6, P262, DOI 10.1016/S1083-8791(00)70008-5; PEAULT B, 1993, LEUKEMIA, V7, pS98; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SUTHERLAND HJ, 1989, BLOOD, V74, P1563; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Vose JM, 2001, BIOL BLOOD MARROW TR, V7, P680, DOI 10.1053/bbmt.2001.v7.pm11787531; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004	32	372	406	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC	2007	1	6					635	645		10.1016/j.stem.2007.10.001	http://dx.doi.org/10.1016/j.stem.2007.10.001			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	243GU	18371405	Green Accepted, Bronze			2022-12-24	WOS:000251784300010
J	Diba, K; Buzsaki, G				Diba, Kamran; Buzsaki, Gyoergy			Forward and reverse hippocampal place-cell sequences during ripples	NATURE NEUROSCIENCE			English	Article							MEMORY; EXPERIENCE; SLEEP; ENSEMBLE; REPLAY; MODEL; RAT	We report that temporal spike sequences from hippocampal place neurons of rats on an elevated track recurred in reverse order at the end of a run, but in forward order in anticipation of the run, coinciding with sharp waves. Vector distances between the place fields were reflected in the temporal structure of these sequences. This bidirectional re-enactment of temporal sequences may contribute to the establishment of higher-order associations in episodic memory.	Rutgers State Univ, Ctr Mol & Behav Neurobiol, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Diba, K (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurobiol, 197 Univ Ave, Newark, NJ 07102 USA.	diba@andromeda.rutgers.edu; buzsaki@axon.rutgers.edu		Diba, Kamran/0000-0001-5128-4478; Buzsaki, Gyorgy/0000-0002-3100-4800	NIMH NIH HHS [R01 MH054671, R01 MH054671-04, R01 MH054671-08, MH54671, R01 MH054671-07, R01 MH054671-05, R01 MH054671-09, R01 MH054671-06, R01 MH054671-03] Funding Source: Medline; NINDS NIH HHS [R01 NS034994-07, R01 NS034994-06, NS34994, R01 NS034994-11, R01 NS034994, R01 NS034994-04, R01 NS034994-09, R01 NS034994-07S1, R01 NS034994-08, R01 NS034994-05, R01 NS034994-05S1, R01 NS034994-10] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Drosopoulos S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000376; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Kahana MJ, 1996, MEM COGNITION, V24, P103, DOI 10.3758/BF03197276; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	15	619	626	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1241	1242		10.1038/nn1961	http://dx.doi.org/10.1038/nn1961			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828259	Green Accepted			2022-12-24	WOS:000249720800008
J	Lunn, ML; Nassirpour, R; Arrabit, C; Tan, J; Mcleod, I; Arias, CM; Sawchenko, PE; Yates, JR; Slesinger, PA				Lunn, Marie-Louise; Nassirpour, Rounak; Arrabit, Christine; Tan, Joshua; Mcleod, Ian; Arias, Carlos M.; Sawchenko, Paul E.; Yates, John R., III; Slesinger, Paul A.			A unique sorting nexin regulates trafficking of potassium channels via a PDZ domain interaction	NATURE NEUROSCIENCE			English	Article							RECTIFYING K+ CHANNELS; MESSENGER-RNAS; PROTEINS; BINDING; RECEPTORS; MODULATION; ACTIVATE; SUBUNITS; HOMOLOG; NEURONS	G protein-gated potassium (Kir3) channels are important for controlling neuronal excitability in the brain. Using a proteomics approach, we have identified a unique rodent intracellular protein, sorting nexin 27 (SNX27), which regulates the trafficking of Kir3 channels. Like most sorting nexins, SNX27 possesses a functional PX domain that selectively binds the membrane phospholipid phosphatidylinositol-3-phosphate (P13P) and is important for trafficking to the early endosome. SNX27, however, is the only sorting nexin to contain a PDZ domain. This PDZ domain discriminates between channels with similar class I PDZ-binding motifs, associating with the C-terminal end of Kir3.3 and Kir3.2c (-ESKV), but not with that of Kir2.1 (-ESEI) or Kv1.4 (-ETDV). SNX27 promotes the endosomal movement of Kir3 channels, leading to reduced surface expression, increased degradation and smaller Kir3 potassium currents. The regulation of endosomal trafficking via sorting nexins reveals a previously unknown mechanism for controlling potassium channel surface expression.	Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Neuronal Struct & Funct Lab, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Salk Institute	Slesinger, PA (corresponding author), Salk Inst Biol Studies, Peptide Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slesinger@salk.edu			NINDS NIH HHS [R01 NS37682] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037682] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Chuang HH, 1998, P NATL ACAD SCI USA, V95, P11727, DOI 10.1073/pnas.95.20.11727; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; DiMagno L, 1996, PFLUG ARCH EUR J PHY, V431, P335, DOI 10.1007/BF02207270; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hibino H, 2000, EMBO J, V19, P78, DOI 10.1093/emboj/19.1.78; Horazdovsky BF, 1997, MOL BIOL CELL, V8, P1529, DOI 10.1091/mbc.8.8.1529; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Inanobe A, 1999, J NEUROSCI, V19, P1006; Jelacic TM, 1999, J MEMBRANE BIOL, V169, P123, DOI 10.1007/s002329900524; Joubert L, 2004, J CELL SCI, V117, P5367, DOI 10.1242/jcs.01379; Kajii Y, 2003, MOL PSYCHIATR, V8, P434, DOI 10.1038/sj.mp.4001258; Karschin C, 1996, J NEUROSCI, V16, P3559; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; Leyland ML, 2004, J BIOL CHEM, V279, P43427, DOI 10.1074/jbc.M407575200; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Marker CL, 2005, J NEUROSCI, V25, P3551, DOI 10.1523/JNEUROSCI.4899-04.2005; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Slesinger PA, 1997, P NATL ACAD SCI USA, V94, P12210, DOI 10.1073/pnas.94.22.12210; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; Sun QQ, 2001, J PHYSIOL-LONDON, V531, P67, DOI 10.1111/j.1469-7793.2001.0067j.x; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	46	121	128	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1249	1259		10.1038/nn1953	http://dx.doi.org/10.1038/nn1953			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828261				2022-12-24	WOS:000249720800011
J	Li, Y; Luikart, BW; Birnbaum, S; Chen, J; Kwon, CH; Kernie, SG; Bassel-Duby, R; Parada, LF				Li, Yun; Luikart, Bryan W.; Birnbaum, Shari; Chen, Jian; Kwon, Chang-Hyuk; Kernie, Steven G.; Bassel-Duby, Rhonda; Parada, Luis F.			TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment	NEURON			English	Article							ELEMENT-BINDING PROTEIN; FACTOR VAL66MET POLYMORPHISM; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; NEUROTROPHIC FACTOR; DENTATE GYRUS; ADULT NEUROGENESIS; CONDITIONAL DELETION; SIGNALING PATHWAYS; CHRONIC FLUOXETINE	Adult hippocampal neurogenesis is stimulated by chronic administration of antidepressants (ADs) and by voluntary exercise. Neural progenitor cells (NPCs) in the dentate gyrus (DG) that are capable of continuous proliferation and neuronal differentiation are the source of such structural plasticity. Here we report that mice lacking the receptor tyrosine kinase TrkB in hippocampal NPCs have impaired proliferation and neurogenesis. When exposed to chronic ADs or wheel-running, no increase in proliferation or neurogenesis is observed. Ablation of TrkB also renders these mice behaviorally insensitive to antidepressive treatment in depression- and anxiety-like paradigms. In contrast, mice lacking TrkB only in differentiated DG neurons display typical neurogenesis and respond normally to chronic ADs. Thus, our data establish an essential cell-autonomous role for TrkB in regulating hippocampal neurogenesis and behavioral sensitivity to antidepressive treatments, and support the notion that impairment of the neurogenic niche is an etiological factor for refractory responses to an antidepressive regimen.	[Li, Yun; Luikart, Bryan W.; Chen, Jian; Kwon, Chang-Hyuk; Kernie, Steven G.; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA; [Birnbaum, Shari] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Kernie, Steven G.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Bassel-Duby, Rhonda] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Parada, LF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA.	luis.parada@utsouthwestern.edu	Luikart, Bryan/D-2683-2012; Kwon, Chang-hyuk/E-3450-2011; Li, Yun/C-3367-2011; Kernie, Steven/AAT-9912-2020; Parada, luis F/B-9400-2014	Li, Yun/0000-0002-5849-5910; Kernie, Steven/0000-0003-1371-0549	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033199] Funding Source: NIH RePORTER; NICHD NIH HHS [K08 HD001470] Funding Source: Medline; NIMH NIH HHS [P50MH66172, P50 MH066172-070002, P50 MH066172, P50 MH066172-060002] Funding Source: Medline; NINDS NIH HHS [R37 NS033199-11, R37NS033199, R37 NS033199, R37 NS033199-10, R37 NS033199-09, R37 NS033199-08] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; ALVAREZBUYLLA A, 1992, EXP NEUROL, V115, P110, DOI 10.1016/0014-4886(92)90232-F; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Choi MJ, 2006, BRAIN RES, V1118, P176, DOI 10.1016/j.brainres.2006.08.012; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; Conti AC, 2002, J NEUROSCI, V22, P3262, DOI 10.1523/JNEUROSCI.22-08-03262.2002; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Fagiolini A, 2003, BIOL PSYCHIAT, V53, P640, DOI 10.1016/S0006-3223(02)01670-0; Frazer A, 1997, J CLIN PSYCHOPHARM, V17, pS2, DOI 10.1097/00004714-199704001-00002; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jiang XY, 2005, NEUROPSYCHOPHARMACOL, V30, P1353, DOI 10.1038/sj.npp.1300703; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; KLEIN R, 1990, DEVELOPMENT, V109, P845; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Lei L, 2005, GENE DEV, V19, P1354, DOI 10.1101/gad.1227705; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Liebl DJ, 2000, P NATL ACAD SCI USA, V97, P2297, DOI 10.1073/pnas.040562597; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Luikart BW, 2005, J NEUROSCI, V25, P3774, DOI 10.1523/JNEUROSCI.0041-05.2005; Lush ME, 2008, J NEUROSCI, V28, P1580, DOI 10.1523/JNEUROSCI.5236-07.2008; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Morilak DA, 2004, INT J NEUROPSYCHOPH, V7, P193, DOI 10.1017/S1461145704004080; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/S0006-8993(96)00273-9; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nibuya M, 1996, J NEUROSCI, V16, P2365; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Perera TD, 2007, J NEUROSCI, V27, P4894, DOI 10.1523/JNEUROSCI.0237-07.2007; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; PORSOLT RD, 1987, ARCH INT PHARMACOD T, V288, P11; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Saarelainen T, 2003, J NEUROSCI, V23, P349; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Scharfman HE, 2007, SCIENCE, V315, P336, DOI 10.1126/science.1138711; Schule C, 2006, PSYCHONEUROENDOCRINO, V31, P1019, DOI 10.1016/j.psyneuen.2006.06.002; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Smith ME, 2005, HIPPOCAMPUS, V15, P798, DOI 10.1002/hipo.20102; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; Thase Michael E., 1995, P1081; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wang JW, 2008, BIOL PSYCHIAT, V63, P640, DOI 10.1016/j.biopsych.2008.01.008; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Yu TS, 2005, GENESIS, V41, P147, DOI 10.1002/gene.20110; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; ZHOU XF, 1993, BRAIN RES, V622, P63, DOI 10.1016/0006-8993(93)90802-T	72	456	468	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 14	2008	59	3					399	412		10.1016/j.neuron.2008.06.023	http://dx.doi.org/10.1016/j.neuron.2008.06.023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339GG	18701066	Bronze, Green Accepted			2022-12-24	WOS:000258565500009
J	Zweifel, LS; Argilli, E; Bonci, A; Palmiter, RD				Zweifel, Larry S.; Argilli, Emanuela; Bonci, Antonello; Palmiter, Richard D.			Role of NMDA receptors in dopamine neurons for plasticity and addictive behaviors	NEURON			English	Article							VENTRAL TEGMENTAL AREA; COCAINE-INDUCED POTENTIATION; MIDBRAIN DOPAMINE; IN-VIVO; SYNAPTIC STRENGTH; GENE-EXPRESSION; SENSITIZATION; AMPA; GLUTAMATE; MORPHINE	A single exposure to drugs of abuse produces an NMDA receptor (NMDAR)-dependent long-term potentiation (LTP) of AMPA receptor (AMPAR) currents in DA neurons; however, the importance of LTP for various aspects of drug addiction is unclear. To test the role of NMDAR-dependent plasticity in addictive behavior, we genetically inactivated functional NMDAR signaling exclusively in DA neurons (KO mice). Inactivation of NMDARs results in increased AMPAR-mediated transmission that is indistinguishable from the increases associated with a single cocaine exposure, yet locomotor responses to multiple drugs of abuse were unaltered in the KO mice. The initial phase of locomotor sensitization to cocaine is intact; however, the delayed sensitization that occurs with prolonged cocaine withdrawal did not occur. Conditioned behavioral responses for cocaine-testing environment were also absent in the KO mice. These findings provide evidence for a role of NMDAR signaling in DA neurons for specific behavioral modifications associated with drug seeking behaviors.	[Zweifel, Larry S.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Zweifel, Larry S.; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Argilli, Emanuela; Bonci, Antonello] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA; [Argilli, Emanuela; Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94110 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco	Zweifel, LS (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	larryz@u.washington.edu	Zweifel, Larry/O-3284-2017	Zweifel, Larry/0000-0003-3465-5331	National Institutes of Health [F32DA022829, 1RO1DA15096-01]; University of California, San Francisco; Wheeler Center for the Neurobiology of Addiction; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015096, F32DA022829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco(University of California System); Wheeler Center for the Neurobiology of Addiction; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. Joe Tsien for the Grin1<SUP>lox</SUP> mice, Dr. Xiaoxi Zhuang for the Slc6a3<SUP>Cre</SUP> mice, Dr. Matt During for the AAV-Cre-GFP, Glenda Froelick for technical assistance, and members of the Palmiter and Bonci labs for helpful discussions during these studies. This work was supported by grants from the National Institute on Drug Abuse through the National Institutes of Health (to R.D.P. and L.S.Z. F32DA022829 and A.B. 1RO1DA15096-01); the state of California for medical research on alcohol and substance abuse through the University of California, San Francisco and the Wheeler Center for the Neurobiology of Addiction (A.B. and E.A.).	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Berhow MT, 1996, J NEUROSCI, V16, P4707; BERHOW MT, 1995, NEUROSCIENCE, V68, P969, DOI 10.1016/0306-4522(95)00207-Y; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bonci A, 1997, J NEUROSCI, V17, P796; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Chiamulera C, 2001, NAT NEUROSCI, V4, P873, DOI 10.1038/nn0901-873; Coulter CL, 1996, DEV BRAIN RES, V92, P172, DOI 10.1016/0165-3806(96)00004-1; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; Dunn JM, 2005, PSYCHOPHARMACOLOGY, V179, P172, DOI 10.1007/s00213-004-2054-9; ETTENBERG A, 1989, NEUROSCI BIOBEHAV R, V13, P105, DOI 10.1016/S0149-7634(89)80018-1; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; FUJITA M, 1993, MOL BRAIN RES, V19, P222, DOI 10.1016/0169-328X(93)90031-J; GAWIN FH, 1986, ARCH GEN PSYCHIAT, V43, P107; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Harris GC, 2004, NEUROSCIENCE, V129, P841, DOI 10.1016/j.neuroscience.2004.09.018; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P73, DOI 10.1038/sj.npp.1300011; Heidbreder CA, 1996, J PHARMACOL EXP THER, V278, P490; Heusner CL, 2005, J NEUROSCI, V25, P6651, DOI 10.1523/JNEUROSCI.1474-05.2005; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; KALIVAS PW, 1993, J PHARMACOL EXP THER, V267, P486; Kim DS, 2002, J NEUROSCI, V22, P9841; Korotkova TM, 2004, MOL NEUROBIOL, V29, P243, DOI 10.1385/MN:29:3:243; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Loftis JM, 2000, J NEUROCHEM, V75, P2040, DOI 10.1046/j.1471-4159.2000.0752040.x; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Messer CJ, 2000, NEURON, V26, P247, DOI 10.1016/S0896-6273(00)81154-X; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Narayanan S, 1996, PHARMACOL BIOCHEM BE, V54, P565, DOI 10.1016/0091-3057(95)02220-1; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Olson VG, 2007, SYNAPSE, V61, P87, DOI 10.1002/syn.20345; Olson VG, 2005, J NEUROSCI, V25, P5553, DOI 10.1523/JNEUROSCI.0345-05.2005; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Ranaldi R, 2000, PSYCHOPHARMACOLOGY, V151, P192, DOI 10.1007/s002130000480; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Schenk S, 1997, BRAIN RES, V769, P225, DOI 10.1016/S0006-8993(97)00712-9; Schilstrom B, 2006, J NEUROSCI, V26, P8549, DOI 10.1523/JNEUROSCI.5179-05.2006; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Tang WX, 2003, J NEUROCHEM, V85, P911, DOI 10.1046/j.1471-4159.2003.01740.x; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Turiault M, 2007, FEBS J, V274, P3568, DOI 10.1111/j.1742-4658.2007.05886.x; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Tzschentke TM, 2000, PSYCHOPHARMACOLOGY, V151, P142, DOI 10.1007/s002130000395; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vezina P, 2000, PSYCHOPHARMACOLOGY, V151, P184, DOI 10.1007/s002130000463; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x; Zhang XF, 1997, J PHARMACOL EXP THER, V281, P699; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	61	154	156	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 14	2008	59	3					486	496		10.1016/j.neuron.2008.05.028	http://dx.doi.org/10.1016/j.neuron.2008.05.028			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339GG	18701073	Green Accepted, Bronze			2022-12-24	WOS:000258565500016
J	Miyamoto, T; Amrein, H				Miyamoto, Tetsuya; Amrein, Hubert			Suppression of male courtship by a Drosophila pheromone receptor	NATURE NEUROSCIENCE			English	Article							MELANOGASTER; PERCEPTION; BEHAVIOR; NEURONS; FRUIT; BRAIN	In male Drosophila, chemosensory cues control many aspects of social behavior. We found that males with a mutated Gustatory receptor 32a gene (Gr32a) show high courtship toward males and mated females, indicating that GR32a functions as a pheromone receptor for a male inhibitory pheromone. Notably, we discovered that tarsal Gr32a-expressing neurons were essential for courtship suppression and projected to the ventrolateral protocerebrum, implying direct communication of chemosensory neurons with a higher-order brain structure.	[Miyamoto, Tetsuya; Amrein, Hubert] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Miyamoto, T (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	hoa1@duke.edu	Amrein, Hubert/AAG-9480-2021	Amrein, Hubert/0000-0001-8799-7250	NIDCD NIH HHS [R01 DC009014, 01DC005606, 01DC009014, R01 DC005606] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009014, R01DC005606] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Amrein H, 2004, CURR OPIN NEUROBIOL, V14, P435, DOI 10.1016/j.conb.2004.07.008; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Rong YS, 2001, GENETICS, V157, P1307; SCOTT D, 1986, P NATL ACAD SCI USA, V83, P8429, DOI 10.1073/pnas.83.21.8429; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7	14	135	138	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					874	876		10.1038/nn.2161	http://dx.doi.org/10.1038/nn.2161			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18641642	Green Accepted			2022-12-24	WOS:000257969100009
J	Kayser, MS; Nolt, MJ; Dalva, MB				Kayser, Matthew S.; Nolt, Mark J.; Dalva, Matthew B.			EphB receptors couple dendritic filopodia motility to synapse formation	NEURON			English	Article							FRAGILE-X-SYNDROME; SPINE DEVELOPMENT; VISUAL-CORTEX; MOLECULAR-MECHANISMS; HIPPOCAMPAL-NEURONS; EXCITATORY SYNAPSES; CALCIUM INFLUX; SYNAPTOGENESIS; MORPHOGENESIS; MATURATION	Motile dendritic filopodial processes are thought to be precursors of spine synapses, but how motility relates to cell-surface cues required for axon-dendrite recognition and synaptogenesis remains unclear. We demonstrate with dynamic imaging that loss of EphBs results in reduced motility of filopodia in cultured cortical neurons and brain slice. EphB knockdown and rescue experiments during different developmental time windows show that EphBs are required for synaptogenesis only when filopodia are most abundant and motile. In the context of EphB knockdown and reduced filopodia motility, independent rescue of either motility with PAK or of Eph-ephrin binding with an EphB2 kinase mutant is not sufficient to restore synapse formation. Strikingly, the combination of PAK and kinase-inactive EphB2 rescues synaptogenesis. Deletion of the ephrin-binding domain from EphB2 precludes rescue, indicating that both motility and trans-cellular interactions are required. Our findings provide a mechanistic link between dendritic filopodia motility and synapse differentiation.	[Kayser, Matthew S.; Nolt, Mark J.; Dalva, Matthew B.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Dalva, MB (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 1114 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	dalva@mail.med.upenn.edu		Kayser, Matthew/0000-0003-2359-4967; Dalva, Matthew/0000-0002-7737-8787	NICHD NIH HHS [5T32HD007516, HD-026979-0, T32 HD007516, P30 HD026979] Funding Source: Medline; NIDA NIH HHS [R01 DA022727-01A1, R01 DA022727, DA022727] Funding Source: Medline; NIMH NIH HHS [R01 MH073357, R01 MH073357-03, MH073357] Funding Source: Medline; NINDS NIH HHS [NS051894-01, F30 NS051894] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516, P30HD026979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS051894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022727] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; Ding M, 2007, SCIENCE, V317, P947, DOI 10.1126/science.1145727; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Fiala JC, 1998, J NEUROSCI, V18, P8900; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; PAPA M, 1995, J NEUROSCI, V15, P1; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Rao A, 1998, J NEUROSCI, V18, P1217; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	41	152	158	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 10	2008	59	1					56	69		10.1016/j.neuron.2008.05.007	http://dx.doi.org/10.1016/j.neuron.2008.05.007			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	327KU	18614029	Bronze, Green Accepted			2022-12-24	WOS:000257728800008
J	Cingolani, LA; Thalhammer, A; Yu, LMY; Catalano, M; Ramos, T; Colicos, MA; Goda, Y				Cingolani, Lorenzo A.; Thalhammer, Agnes; Yu, Lily M. Y.; Catalano, Myriam; Ramos, Timothy; Colicos, Michael A.; Goda, Yukiko			Activity-dependent regulation of synaptic AMPA receptor composition and abundance by beta 3 integrins	NEURON			English	Article							GLUTAMATE RECEPTORS; TRANSMITTER RELEASE; HIPPOCAMPAL-NEURONS; NMDA RECEPTOR; SMALL GTPASES; PLASTICITY; TRANSMISSION; MODULATION; TRAFFICKING; EXPRESSION	At synapses, cell adhesion molecules (CAMs) provide the molecular framework for coordinating signaling events across the synaptic cleft. Among synaptic CAMs, the integrins, receptors for extracellular matrix proteins and counterreceptors on adjacent cells, are implicated in synapse maturation and plasticity and memory formation. However, little is known about the molecular mechanisms of integrin action at central synapses. Here, we report that postsynaptic beta 3 integrins control synaptic strength by regulating AMPA receptors (AMPARs) in a subunit-specific manner. Pharmacological perturbation targeting beta 3 integrins promotes endocytosis of GluR2-containing AMPARs via Rap1 signaling, and expression of beta 3 integrins produces robust changes in the abundance and composition of synaptic AMPARs without affecting dendritic spine structure. Importantly, homeostatic synaptic scaling induced by activity deprivation elevates surface expression of beta 3 integrins, and in turn, beta 3 integrins are required for synaptic scaling. Our findings demonstrate a key role for integrins in the feedback regulation of excitatory synaptic strength.	[Cingolani, Lorenzo A.; Yu, Lily M. Y.; Catalano, Myriam; Goda, Yukiko] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England; UCL, Cell Biol Unit, London WC1E 6BT, England; [Yu, Lily M. Y.; Goda, Yukiko] UCL, Div Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Thalhammer, Agnes] UCL, LMP Div Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Ramos, Timothy; Colicos, Michael A.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada	MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of Calgary	Cingolani, LA (corresponding author), UCL, MRC Lab Mol Cell Biol, Gower St, London WC1E 6BT, England.	l.cingolani@ucl.ac.uk; y.goda@ucl.ac.uk	Goda, Yukiko/AAR-5641-2020; Goda, Yukiko/A-6576-2016; Cingolani, Lorenzo A/ABH-1364-2021; Cingolani, Lorenzo/J-1530-2012	Goda, Yukiko/0000-0003-0352-9498; Goda, Yukiko/0000-0003-0352-9498; Cingolani, Lorenzo A/0000-0001-9538-1659; Catalano, Myriam/0000-0003-4638-9202; Thalhammer, Agnes/0000-0002-4658-4174	MRC [MC_U122669937] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066676] Funding Source: NIH RePORTER; Medical Research Council [MC_U122669937] Funding Source: Medline; NIMH NIH HHS [R01 MH066676, R01 MH066676-05, R01MH66676] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Blaess S, 1998, J NEUROCHEM, V71, P2615, DOI 10.1046/j.1471-4159.1998.71062615.x; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bourgin C, 2007, J CELL BIOL, V178, P1295, DOI 10.1083/jcb.200610139; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chan CS, 2006, J NEUROSCI, V26, P223, DOI 10.1523/JNEUROSCI.4110-05.2006; Chan CS, 2003, J NEUROSCI, V23, P7107, DOI 10.1523/JNEUROSCI.23-18-07107.2003; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Chen BM, 1997, J NEUROSCI, V17, P904; CHEN BM, 1995, SCIENCE, V269, P1578, DOI 10.1126/science.7667637; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Dityatev A, 2003, NAT REV NEUROSCI, V4, P456, DOI 10.1038/nrn1115; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; Gao BC, 2002, AM J PHYSIOL-CELL PH, V283, pC1196, DOI 10.1152/ajpcell.00064.2002; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Huang Z, 2006, J NEUROSCI, V26, P11208, DOI 10.1523/JNEUROSCI.3526-06.2006; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; LAFLAMME SE, 1994, J CELL BIOL, V126, P1287, DOI 10.1083/jcb.126.5.1287; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lissin DV, 1999, J NEUROSCI, V19, P1263; Liu SC, 2000, J CELL SCI, V113, P3563; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MATSUI T, 1995, J NEUROCHEM, V65, P454; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Staubli U, 1998, J NEUROSCI, V18, P3460; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Webb DJ, 2007, J BIOL CHEM, V282, P6929, DOI 10.1074/jbc.M610981200; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wu X, 1998, J CELL BIOL, V143, P241, DOI 10.1083/jcb.143.1.241; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037	68	165	166	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 12	2008	58	5					749	762		10.1016/j.neuron.2008.04.011	http://dx.doi.org/10.1016/j.neuron.2008.04.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	315IA	18549786	Green Accepted, Bronze			2022-12-24	WOS:000256870800012
J	Sowell, ER; Kan, E; Yoshii, J; Thompson, PM; Bansal, R; Xu, DR; Toga, AW; Peterson, BS				Sowell, Elizabeth R.; Kan, Eric; Yoshii, June; Thompson, Paul M.; Bansal, Ravi; Xu, Dongrong; Toga, Arthur W.; Peterson, Bradley S.			Thinning of sensorimotor cortices in children with Tourette syndrome	NATURE NEUROSCIENCE			English	Article							BASAL GANGLIA; BRAIN; VOLUMES; MRI	The basal ganglia portions of cortico-striato-thalamo-cortical (CSTC) circuits have consistently been implicated in the pathogenesis of Tourette syndrome, whereas motor and sensorimotor cortices in these circuits have been relatively overlooked. Using magnetic resonance imaging, we detected cortical thinning in frontal and parietal lobes in groups of Tourette syndrome children relative to controls. This thinning was most prominent in ventral portions of the sensory and motor homunculi that control the facial, orolingual and laryngeal musculature that is commonly involved in tic symptoms. Correlations of cortical thickness in sensorimotor regions with tic symptoms suggest that these brain regions are important in the pathogenesis of Tourette syndrome.	[Bansal, Ravi; Xu, Dongrong; Peterson, Bradley S.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Bansal, Ravi; Xu, Dongrong; Peterson, Bradley S.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Sowell, Elizabeth R.; Kan, Eric; Yoshii, June; Thompson, Paul M.; Toga, Arthur W.] Univ Calif Los Angeles, Dept Neurol, Lab Neuro Imaging, Los Angeles, CA 90095 USA	Columbia University; New York State Psychiatry Institute; University of California System; University of California Los Angeles	Peterson, BS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Psychiat, 1051 Riversisde Dr,Unit 74, New York, NY 10032 USA.	petersob@child.cpmc.columbia.edu	Thompson, Paul M/C-4194-2018	Thompson, Paul M/0000-0002-4720-8867	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR021813, P41RR013642, R21RR019771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB001561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH074677, R01MH068318, K01MH001733, R01MH059139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016570] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM005639] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR013642, R21 RR019771, U54 RR021813, RR019771, U54 RR021813-01, P41 RR013642-11] Funding Source: Medline; NIA NIH HHS [P50 AG016570, P50 AG016570-100004, P50 AG016570-10, AG016570] Funding Source: Medline; NIBIB NIH HHS [EB01651, R21 EB001561-03, R21 EB001561] Funding Source: Medline; NIMH NIH HHS [MH068318, MH59139, K02 MH074677-04, R01 MH068318-05, K01 MH01733, K01 MH001733-04, K02 MH074677, R01 MH059139, R01 MH059139-04, R01 MH068318, R01 MH068318-04] Funding Source: Medline; NINDS NIH HHS [NS3753] Funding Source: Medline; NLM NIH HHS [R01 LM005639, LM05639] Funding Source: Medline; PHS HHS [MHK02-74677] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Albin RL, 2006, TRENDS NEUROSCI, V29, P175, DOI 10.1016/j.tins.2006.01.001; Fredericksen KA, 2002, NEUROLOGY, V58, P85, DOI 10.1212/WNL.58.1.85; HYDE TM, 1995, NEUROLOGY, V45, P1176, DOI 10.1212/WNL.45.6.1176; Kalanithi PSA, 2005, P NATL ACAD SCI USA, V102, P13307, DOI 10.1073/pnas.0502624102; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Peterson BS, 2003, ARCH GEN PSYCHIAT, V60, P415, DOI 10.1001/archpsyc.60.4.415; Peterson BS, 2001, ARCH GEN PSYCHIAT, V58, P427, DOI 10.1001/archpsyc.58.5.427; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; SINGER HS, 1993, NEUROLOGY, V43, P950, DOI 10.1212/WNL.43.5.950; Singh PJ, 2003, INT J FATIGUE, V25, P1, DOI 10.1016/S0142-1123(02)00067-1; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; SPESSOT AL, 2006, MANUAL DEV PSYCHOPAT, P436; Thompson PM, 2004, NEUROIMAGE, V23, pS2, DOI 10.1016/j.neuroimage.2004.07.071; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Ziemann U, 1997, AM J PSYCHIAT, V154, P1277	15	171	173	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					637	639		10.1038/nn.2121	http://dx.doi.org/10.1038/nn.2121			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18488025	Green Accepted			2022-12-24	WOS:000256133700009
J	Yu, XB; Zou, JZ; Ye, ZH; Hammond, H; Chen, GB; Tokunaga, A; Mali, P; Li, YM; Civin, C; Gaiano, N; Cheng, LZ				Yu, Xiaobing; Zou, Jizhong; Ye, Zhaohui; Hammond, Holly; Chen, Guibin; Tokunaga, Akinori; Mali, Prashant; Li, Yue-Ming; Civin, Curt; Gaiano, Nicholas; Cheng, Linzhao			Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment	CELL STEM CELL			English	Article							SELF-RENEWAL; DIFFERENTIATION; WNT; INDUCTION; INTEGRATION; EXPRESSION; PATHWAY; NUMBERS; GENES	The Notch signaling pathway plays important roles in cell-fate determination during embryonic development and adult life. In this study, we focus on the role of Notch signaling in governing cell-fate choices in human embryonic stem cells (hESCs). Using genetic and pharmacological approaches, we achieved both blockade and conditional activation of Notch signaling in several hESC lines. We report here that activation of Notch signaling is required for undifferentiated hESCs to form the progeny of all three embryonic germ layers, but not trophoblast cells. In addition, transient Notch signaling pathway activation enhanced generation of hematopoietic cells from committed hESCs. These new insights into the roles of Notch in hESC-fate determination may help to efficiently direct hESC differentiation into therapeutically relevant cell types.	[Yu, Xiaobing; Zou, Jizhong; Ye, Zhaohui; Hammond, Holly; Chen, Guibin; Mali, Prashant; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA; [Yu, Xiaobing; Zou, Jizhong; Ye, Zhaohui; Hammond, Holly; Chen, Guibin; Mali, Prashant; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Yu, Xiaobing; Hammond, Holly; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Resources Ctr, Baltimore, MD 21205 USA; [Ye, Zhaohui; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Grad Program Immunol, Baltimore, MD 21205 USA; [Tokunaga, Akinori; Gaiano, Nicholas] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neural Repair & Regenerat Program, Baltimore, MD 21205 USA; [Tokunaga, Akinori; Gaiano, Nicholas] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Gaiano, Nicholas] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Civin, Curt; Gaiano, Nicholas] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Mali, Prashant] Johns Hopkins Univ, Sch Med, Grad Biomed Engn Program, Baltimore, MD 21205 USA; [Li, Yue-Ming] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Civin, Curt] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Can Ctr John Hopkins, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Johns Hopkins University	Yu, XB (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA.	xyu7@jhmi.edu; Icheng2@jhmi.edu	LI, Yue/GRS-8071-2022; Zou, Jizhong/B-4902-2011	Ye, Zhaohui/0000-0001-5272-9168; Tokunaga, Akinori/0000-0001-9560-0516; Zou, Jizhong/0000-0003-1021-0549	NHLBI NIH HHS [R01 HL073781-03, R01 HL073781, R01 HL073781-05, R01 HL073781-02, R01 HL073781-04, R01 HL073781-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073781] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Brandenberger Ralph, 2004, BMC Developmental Biology, V4, P1; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cai LH, 2007, CELL RES, V17, P62, DOI 10.1038/sj.cr.7310138; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; EHEBAUER M, 2006, SCI STKE, pCM7, DOI DOI 10.1126/STKE.3642006CM7; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Fox V, 2008, STEM CELLS, V26, P715, DOI 10.1634/stemcells.2007-0368; Gerami-Naini B, 2004, ENDOCRINOLOGY, V145, P1517, DOI 10.1210/en.2003-1241; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Noggle SA, 2006, STEM CELLS, V24, P1646, DOI 10.1634/stemcells.2005-0314; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Schroeder T, 2006, MECH DEVELOP, V123, P570, DOI 10.1016/j.mod.2006.05.002; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; Walsh J, 2003, APMIS, V111, P197, DOI 10.1034/j.1600-0463.2003.1110124.x; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598; Zhou BY, 2007, STEM CELLS, V25, P779, DOI 10.1634/stemcells.2006-0128	36	79	80	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY	2008	2	5					461	471		10.1016/j.stem.2008.03.001	http://dx.doi.org/10.1016/j.stem.2008.03.001			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	300BM	18462696	Bronze, Green Accepted			2022-12-24	WOS:000255799300011
J	Nakamura, K; Morrison, SF				Nakamura, Kazuhiro; Morrison, Shaun F.			A thermosensory pathway that controls body temperature	NATURE NEUROSCIENCE			English	Article							PROSTAGLANDIN EP3 RECEPTOR; BROWN ADIPOSE-TISSUE; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; SYMPATHETIC PREMOTOR NEURONS; PARABRACHIAL NUCLEUS; DORSOMEDIAL HYPOTHALAMUS; EFFERENT PROJECTIONS; PREOPTIC AREA; THERMOREGULATORY FUNCTIONS; EVOKED THERMOGENESIS	Defending body temperature against environmental thermal challenges is one of the most fundamental homeostatic functions that are governed by the nervous system. Here we describe a somatosensory pathway that essentially constitutes the afferent arm of the thermoregulatory reflex that is triggered by cutaneous sensation of environmental temperature changes. Using in vivo electrophysiological and anatomical approaches in the rat, we found that lateral parabrachial neurons are pivotal in this pathway by glutamatergically transmitting cutaneous thermosensory signals received from spinal somatosensory neurons directly to the thermoregulatory command center, the preoptic area. This feedforward pathway mediates not only sympathetic and shivering thermogenic responses but also metabolic and cardiac responses to skin cooling challenges. Notably, this 'thermoregulatory afferent' pathway exists in parallel with the spinothalamocortical somatosensory pathway that mediates temperature perception. These findings make an important contribution to our understanding of both the somatosensory system and thermal homeostasis-two mechanisms that are fundamental to the nervous system and to our survival.	[Nakamura, Kazuhiro; Morrison, Shaun F.] Oregon Hlth & Sci Univ, Inst Neurol Sci, Beaverton, OR 97006 USA	Oregon Health & Science University	Nakamura, K (corresponding author), Oregon Hlth & Sci Univ, Inst Neurol Sci, 505 NW 185th Ave, Beaverton, OR 97006 USA.	nakamura@ohsu.edu	Nakamura, Kazuhiro/A-5431-2008; Morrison, Shaun F./T-5869-2017	Nakamura, Kazuhiro/0000-0002-6095-8996; Morrison, Shaun F./0000-0002-8813-8359	NCRR NIH HHS [RR 016858, S10 RR016858-01] Funding Source: Medline; NIDDK NIH HHS [R01 DK057838-07, DK 57838, R01 DK057838] Funding Source: Medline; NINDS NIH HHS [R01 NS040987-07, NS 40987, R01 NS040987] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040987] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERNARD JF, 1995, J COMP NEUROL, V353, P480, DOI 10.1002/cne.903530403; BESTER H, 1995, J NEUROPHYSIOL, V73, P568, DOI 10.1152/jn.1995.73.2.568; Bester H, 1997, J COMP NEUROL, V383, P245, DOI 10.1002/(SICI)1096-9861(19970707)383:3<245::AID-CNE1>3.0.CO;2-3; Bester H, 2000, J NEUROPHYSIOL, V83, P2239, DOI 10.1152/jn.2000.83.4.2239; Blomqvist A, 1996, EXP BRAIN RES, V108, P33; BOULANT JA, 1977, BRAIN RES, V120, P367, DOI 10.1016/0006-8993(77)90916-7; BOULANT JA, 1974, J PHYSIOL-LONDON, V240, P639, DOI 10.1113/jphysiol.1974.sp010627; Bratincsak A, 2005, NEUROSCIENCE, V135, P525, DOI 10.1016/j.neuroscience.2005.06.028; BROMAN J, 1992, J NEUROSCI, V12, P204; CECHETTO DF, 1985, J COMP NEUROL, V240, P153, DOI 10.1002/cne.902400205; Chen XM, 1998, J PHYSIOL-LONDON, V512, P883, DOI 10.1111/j.1469-7793.1998.883bd.x; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; CRAIG AD, 1994, NATURE, V372, P770, DOI 10.1038/372770a0; Craig AD, 2001, J NEUROPHYSIOL, V86, P856, DOI 10.1152/jn.2001.86.2.856; FEIL K, 1995, J COMP NEUROL, V353, P506, DOI 10.1002/cne.903530404; FULWILER CE, 1984, BRAIN RES REV, V7, P229, DOI 10.1016/0165-0173(84)90012-2; Gauriau C, 2004, J COMP NEUROL, V468, P24, DOI 10.1002/cne.10873; HAMMEL HT, 1968, ANNU REV PHYSIOL, V30, P641, DOI 10.1146/annurev.ph.30.030168.003233; HELLON RF, 1975, J PHYSIOL-LONDON, V248, P349, DOI 10.1113/jphysiol.1975.sp010978; Hensel H, 1981, Monogr Physiol Soc, V38, P1; HORI T, 1988, BRAIN RES BULL, V20, P879, DOI 10.1016/0361-9230(88)90105-0; HUCKABA C E, 1971, International Journal of Biometeorology, V15, P141, DOI 10.1007/BF01803888; HYLDEN JLK, 1989, NEUROSCIENCE, V28, P27, DOI 10.1016/0306-4522(89)90229-7; Johnston GAR, 1996, PHARMACOL THERAPEUT, V69, P173, DOI 10.1016/0163-7258(95)02043-8; Kobayashi A, 2003, PFLUG ARCH EUR J PHY, V446, P760, DOI 10.1007/s00424-003-1119-7; KRUKOFF TL, 1993, BRAIN RES BULL, V30, P163, DOI 10.1016/0361-9230(93)90054-F; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Madden CJ, 2004, AM J PHYSIOL-REG I, V286, pR320, DOI 10.1152/ajpregu.00515.2003; Madden CJ, 2003, NEUROSCIENCE, V122, P5, DOI 10.1016/S0306-4522(03)00527-X; Morrison SF, 2000, AM J PHYSIOL-REG I, V279, pR1763, DOI 10.1152/ajpregu.2000.279.5.R1763; Morrison SR, 2004, NEWS PHYSIOL SCI, V19, P67, DOI 10.1152/nips.01502.2003; Nagashima K, 2000, AUTON NEUROSCI-BASIC, V85, P18, DOI 10.1016/S1566-0702(00)00216-2; Nakamura K, 2005, NEUROSCI RES, V51, P1, DOI 10.1016/j.neures.2004.09.007; Nakamura K, 2004, J THERM BIOL, V29, P339, DOI 10.1016/j.jtherbio.2004.08.001; Nakamura K, 2000, J COMP NEUROL, V421, P543, DOI 10.1002/(SICI)1096-9861(20000612)421:4<543::AID-CNE6>3.0.CO;2-3; Nakamura K, 2004, J NEUROSCI, V24, P5370, DOI 10.1523/JNEUROSCI.1219-04.2004; Nakamura K, 2002, J NEUROSCI, V22, P4600, DOI 10.1523/JNEUROSCI.22-11-04600.2002; Nakamura K, 2001, NEUROSCIENCE, V103, P763, DOI 10.1016/S0306-4522(01)00027-6; Nakamura K, 1999, NEUROSCI LETT, V260, P117, DOI 10.1016/S0304-3940(98)00962-8; Nakamura K, 2007, AM J PHYSIOL-REG I, V292, pR127, DOI 10.1152/ajpregu.00427.2006; Nakamura Y, 2005, EUR J NEUROSCI, V22, P3137, DOI 10.1111/j.1460-9568.2005.04515.x; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; SAPER CB, 1980, BRAIN RES, V197, P291, DOI 10.1016/0006-8993(80)91117-8; Savage MV, 1996, J APPL PHYSIOL, V80, P1249, DOI 10.1152/jappl.1996.80.4.1249; Zaretskaia MV, 2003, NEUROSCI LETT, V340, P1, DOI 10.1016/S0304-3940(03)00047-8; Zhang XJ, 2006, J NEUROSCI, V26, P5215, DOI 10.1523/JNEUROSCI.0701-06.2006	50	282	292	3	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					62	71		10.1038/nn2027	http://dx.doi.org/10.1038/nn2027			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18084288	Green Accepted			2022-12-24	WOS:000252117900013
J	Xu, JH; McNeil, B; Wu, W; Nees, D; Bai, L; Wu, LG				Xu, Jianhua; McNeil, Benjamin; wu, Wei; Nees, David; Bai, Li; Wu, Ling-Gang			GTP-independent rapid and slow endocytosis at a central synapse	NATURE NEUROSCIENCE			English	Article							RETINAL BIPOLAR CELLS; SHORT-TERM DEPRESSION; VESICLE ENDOCYTOSIS; MEMBRANE RETRIEVAL; CHROMAFFIN CELLS; MEDIAL NUCLEUS; TRAPEZOID BODY; 2 MODES; DYNAMIN; CALYX	Vesicle endocytosis is essential for maintaining synaptic transmission. Its key step, membrane scission, is thought to be mediated by the GTPase dynamin in all forms of endocytosis at synapses. Our findings indicate that GTP-independent and probably dynamin-independent endocytosis co-exist with GTP- and dynamin-dependent endocytosis at the same synaptic nerve terminal, the calyx of Held, in rats. This previously undescribed form of endocytosis could be slow (tens of seconds) and/or rapid (a few seconds), similar to GTP- and dynamin-dependent endocytosis. It was activated during intense stimulation, whereas GTP- and dynamin-dependent endocytosis dominated during mild stimulation. These results establish a new model, in which vesicles are divided into two pools depending on their requirement for GTP and dynamin for retrieval. The GTP- and dynamin-dependent pool has higher priority for release and retrieval, but limited capacity, saturation of which leads to release and thus retrieval of GTP- and dynamin-independent vesicles.	[Xu, Jianhua; McNeil, Benjamin; wu, Wei; Nees, David; Bai, Li; Wu, Ling-Gang] NINDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wu, LG (corresponding author), NINDS, 35 Convent Dr,Bldg 35,Rm 2B-1012, Bethesda, MD 20892 USA.	wul@ninds.nih.gov	Gimenez, Luis E Diaz/D-9291-2011	McNeil, Benjamin/0000-0001-7545-3598; Xu, Jianhua/0000-0003-0084-8856	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Artalejo CR, 2002, P NATL ACAD SCI USA, V99, P6358, DOI 10.1073/pnas.082658499; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; Betz WJ, 1998, ANNU REV PHYSIOL, V60, P347, DOI 10.1146/annurev.physiol.60.1.347; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; Boraud T, 2002, PROG NEUROBIOL, V66, P265, DOI 10.1016/S0301-0082(01)00033-8; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Dautry-Varsat A, 2001, ENDOCYTOSIS, P26; De Camilli P, 2001, SYNAPSES, P217; de Lange RPJ, 2003, J NEUROSCI, V23, P10164; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fernandez-Alfonso T, 2006, TRENDS CELL BIOL, V16, P413, DOI 10.1016/j.tcb.2006.06.007; Graham ME, 2002, P NATL ACAD SCI USA, V99, P7124, DOI 10.1073/pnas.102645099; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; He LM, 2006, NATURE, V444, P102, DOI 10.1038/nature05250; Heidelberger R, 2001, J NEUROSCI, V21, P6467, DOI 10.1523/JNEUROSCI.21-17-06467.2001; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Satzler K, 2002, J NEUROSCI, V22, P10567; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Sun JY, 2004, J NEUROSCI METH, V134, P121, DOI 10.1016/j.jneumeth.2003.11.018; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Wong AYC, 2003, J NEUROSCI, V23, P4868; Wu W, 2005, J NEUROSCI, V25, P11676, DOI 10.1523/JNEUROSCI.2972-05.2005; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503; Zhang C, 2004, NEURON, V42, P225, DOI 10.1016/S0896-6273(04)00189-8	48	65	66	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					45	53		10.1038/nn2021	http://dx.doi.org/10.1038/nn2021			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18066059				2022-12-24	WOS:000252117900011
J	Huntwork, S; Littleton, JT				Huntwork, Sarah; Littleton, J. Troy			A complexin fusion clamp regulates spontaneous neurotransmitter release and synaptic growth	NATURE NEUROSCIENCE			English	Article							VESICLE EXOCYTOSIS; PROTEINS; EVENTS	Neuronal signaling occurs through both action potential triggered synaptic vesicle fusion and spontaneous release, although the fusion clamp machinery that prevents premature exocytosis of synaptic vesicles in the absence of calcium is unknown. Here we demonstrate that spontaneous release at synapses is regulated by complexin, a SNARE complex-binding protein. Analysis of Drosophila melanogaster complexin null mutants showed a marked increase in spontaneous fusion and a profound overgrowth of synapses, suggesting that complexin functions as the fusion clamp in vivo and may modulate structural remodeling of neuronal connections by controlling the rate of spontaneous release.	MIT, Dept Biol, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT)	Littleton, JT (corresponding author), MIT, Dept Biol, Picower Inst Learning & Memory, Bldg 46,Room 3243, Cambridge, MA 02139 USA.	troy@mit.edu		Littleton, J. Troy/0000-0001-5576-2887	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040296] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS040296, R01 NS040296-07] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Guan Z, 2005, NEURON, V48, P91, DOI 10.1016/j.neuron.2005.08.036; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Sawada K, 2005, ARCH GEN PSYCHIAT, V62, P263, DOI 10.1001/archpsyc.62.3.263; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541	15	191	192	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1235	1237		10.1038/nn1980	http://dx.doi.org/10.1038/nn1980			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17873870				2022-12-24	WOS:000249720800006
J	Van Buskirk, C; Sternberg, PW				Van Buskirk, Cheryl; Sternberg, Paul W.			Epidermal growth factor signaling induces behavioral quiescence in Caenorhabditis elegans	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; VULVAR INDUCTION; TYROSINE KINASE; FACTOR RECEPTOR; NERVOUS-SYSTEM; LET-23; GENE; EXPRESSION; NEUREGULIN; SYNAPSES	The epidermal growth factor receptor (EGFR)/ErbB receptor tyrosine kinases regulate several aspects of development, including the development of the mammalian nervous system. ErbB signaling also has physiological effects on neuronal function, with influences on synaptic plasticity and daily cycles of activity. However, little is known about the effectors of EGFR activation in neurons. Here we show that EGF signaling has a nondevelopmental effect on behavior in Caenorhabditis elegans. Ectopic expression of the EGF-like ligand LIN-3 at any stage induces a reversible cessation of feeding and locomotion. These effects are mediated by neuronal EGFR ( also called LET-23) and phospholipase C-gamma (PLC-gamma), diacylglycerol-binding proteins, and regulators of synaptic vesicle release. Activation of EGFR within a single neuron, ALA, is sufficient to induce a quiescent state. This pathway modulates the cessation of pharyngeal pumping and locomotion that normally occurs during the lethargus period that precedes larval molting. Our results reveal an evolutionarily conserved role for EGF signaling in the regulation of behavioral quiescence.	CALTECH, Div Biol 156 29, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Sternberg, PW (corresponding author), CALTECH, Div Biol 156 29, Howard Hughes Med Inst, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	pws@caltech.edu		Sternberg, Paul/0000-0002-7699-0173; Van Buskirk, Cheryl/0000-0003-1929-5948	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018341] Funding Source: NIH RePORTER; NIDA NIH HHS [DA018341] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; AROIAN RV, 1994, EMBO J, V13, P360, DOI 10.1002/j.1460-2075.1994.tb06269.x; AROIAN RV, 1990, NATURE, V348, P693, DOI 10.1038/348693a0; AVERY L, 1993, GENETICS, V133, P897; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; Avery Leon, 1993, Genetics, V134, P455; BRENNER S, 1974, GENETICS, V77, P71; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chang C, 1999, CURR BIOL, V9, P237, DOI 10.1016/S0960-9822(99)80112-2; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; Dutt A, 2004, PLOS BIOL, V2, P1799, DOI 10.1371/journal.pbio.0020334; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; HILL RJ, 1992, NATURE, V358, P470, DOI 10.1038/358470a0; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Hwang BJ, 2004, DEVELOPMENT, V131, P143, DOI 10.1242/dev.00924; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; Keane J, 2003, GENETICS, V164, P153; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; Lesa GM, 1997, MOL BIOL CELL, V8, P779, DOI 10.1091/mbc.8.5.779; Majewski H, 1998, PROG NEUROBIOL, V55, P463, DOI 10.1016/S0301-0082(98)00017-3; Moghal N, 2003, EXP CELL RES, V284, P150, DOI 10.1016/S0014-4827(02)00097-6; Nonet ML, 1998, J NEUROSCI, V18, P70; OKKEMA PG, 1993, GENETICS, V135, P385; Popovici C, 2002, NEUROSCI LETT, V329, P116, DOI 10.1016/S0304-3940(02)00595-5; Pujol N, 2000, DEVELOPMENT, V127, P3361; Raizen DM, 2006, GENETICS, V173, P177, DOI 10.1534/genetics.106.057380; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Snodgrass-Belt P, 2005, BRAIN RES, V1038, P171, DOI 10.1016/j.brainres.2005.01.030; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Tabuse Y, 2002, J BIOCHEM, V132, P519, DOI 10.1093/oxfordjournals.jbchem.a003251; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; TREININ M, 1995, NEURON, V14, P871, DOI 10.1016/0896-6273(95)90231-7; van der Linden AM, 2003, CURR BIOL, V13, P516, DOI 10.1016/S0960-9822(03)00164-7; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Yin XY, 2004, MOL BIOL CELL, V15, P3938, DOI 10.1091/mbc.E04-03-0198	49	149	186	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1300	1307		10.1038/nn1981	http://dx.doi.org/10.1038/nn1981			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17891142				2022-12-24	WOS:000249720800017
J	Jude, CD; Climer, L; Xu, D; Artinger, E; Fisher, JK; Ernst, P				Jude, Craig D.; Climer, Leslie; Xu, Diyong; Artinger, Erika; Fisher, Jill K.; Ernst, Patricia			Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors	CELL STEM CELL			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; GENE-EXPRESSION PROFILE; ACUTE MYELOID-LEUKEMIA; PROTO-ONCOPROTEIN MLL; DROSOPHILA-TRITHORAX; EPIGENETIC INHERITANCE; MUTANT MICE; BONE-MARROW; FUSION GENE; FAMILY	The Mixed Lineage Leukemia (MLL) gene is essential for embryonic hematopoietic stem cell (HSC) development, but its role during adult hematopoiesis is unknown. Using an inducible knockout model, we demonstrate that Mll is essential for the maintenance of adult HSCs and progenitors, with fatal bone marrow failure occurring within 3 weeks of Mll deletion. Mll-deficient cells are selectively lost from mixed bone marrow chimeras, demonstrating their failure to self-renew even in an intact bone marrow environment. Surprisingly, HSCs lacking MY exhibit ectopic cell-cycle entry, resulting in the depletion of quiescent HSCs. In contrast, Mll deletion in myelo-erythroid progenitors results in reduced proliferation and reduced response to cytokine-induced cell-cycle entry. Committed lymphoid and myeloid cells no longer require Mll, defining the early multipotent stages of hematopoiesis as Mll dependent. These studies demonstrate that Mll plays selective and independent roles within the hematopoietic system, maintaining quiescence in HSCs and promoting proliferation in progenitors.	Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; Dartmouth Med Sch, Norris Cotton Canc Ctr, Hanover, NH 03755 USA; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Ernst, P (corresponding author), Dartmouth Med Sch, Dept Genet, 725 Remsen,HB7400, Hanover, NH 03755 USA.	patricia.ernst@dartmouth.edu		Ernst, Patricia/0000-0001-7638-2939	NCRR NIH HHS [P20 RR016437] Funding Source: Medline; NHLBI NIH HHS [R01 HL090036, R01 HL090036-01A2] Funding Source: Medline; NIAID NIH HHS [R01 AI051427] Funding Source: Medline; NIDDK NIH HHS [DK067119, K01 DK067119, K01 DK067119-04] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016437] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK067119] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton P, 2001, GENESIS, V30, P201, DOI 10.1002/gene.1066; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Bijl J, 2006, BLOOD, V108, P116, DOI 10.1182/blood-2005-06-2245; Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; Brun ACM, 2004, BLOOD, V103, P4126, DOI 10.1182/blood-2003-10-3557; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Daser A, 2005, SEMIN CANCER BIOL, V15, P175, DOI 10.1016/j.semcancer.2005.01.007; DJABALI M, 1993, NAT GENET, V4, P431, DOI 10.1038/ng0893-431b; DOMER PH, 1993, P NATL ACAD SCI USA, V90, P7884, DOI 10.1073/pnas.90.16.7884; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Drynan LF, 2005, EMBO J, V24, P3136, DOI 10.1038/sj.emboj.7600760; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; FitzGerald KT, 1999, GENOMICS, V59, P187, DOI 10.1006/geno.1999.5860; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Horton SJ, 2005, CANCER RES, V65, P9245, DOI 10.1158/0008-5472.CAN-05-1691; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Prasad R, 1997, ONCOGENE, V15, P549, DOI 10.1038/sj.onc.1201211; Pui CH, 2000, BRIT J HAEMATOL, V109, P13, DOI 10.1046/j.1365-2141.2000.01843.x; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xia ZB, 2005, P NATL ACAD SCI USA, V102, P14028, DOI 10.1073/pnas.0506464102; Yagi H, 1998, BLOOD, V92, P108, DOI 10.1182/blood.V92.1.108.413k11_108_117; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	52	226	234	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP	2007	1	3					324	337		10.1016/j.stem.2007.05.019	http://dx.doi.org/10.1016/j.stem.2007.05.019			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XT	18371366	Bronze, Green Accepted			2022-12-24	WOS:000251055200014
J	Maherali, N; Sridharan, R; Xie, W; Utikal, J; Eminli, S; Arnold, K; Stadtfeld, M; Yachechko, R; Tchieu, J; Jaenisch, R; Plath, K; Hochedlinger, K				Maherali, Nimet; Sridharan, Rupa; Xie, Wei; Utikal, Jochen; Eminli, Sarah; Arnold, Katrin; Stadtfeld, Matthias; Yachechko, Robin; Tchieu, Jason; Jaenisch, Rudolf; Plath, Kathrin; Hochedlinger, Konrad			Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; INACTIVE X-CHROMOSOME; DEVELOPMENTAL REGULATORS; SOMATIC-CELLS; ES CELLS; MOUSE; PLURIPOTENCY; METHYLATION; NANOG; POLYCOMB	Ectopic expression of the four transcription factors Oct4, Sox2, c-Myc, and Klf4 is sufficient to confer a pluripotent state upon the fibroblast genome, generating induced pluripotent stem (PS) cells. It remains unknown if nuclear reprogramming induced by these four factors globally resets epigenetic differences between differentiated and pluripotent cells. Here, using novel selection approaches, we have generated PS cells from fibroblasts to characterize their epigenetic state. Female PS cells showed reactivation of a somatically silenced X chromosome and underwent random X inactivation upon differentiation. Genome-wide analysis of two key histone modifications indicated that PS cells are highly similar to ES cells. Consistent with these observations, PS cells gave rise to viable high-degree chimeras with contribution to the germline. These data show that transcription factor-induced reprogramming leads to the global reversion of the somatic epigenome into an ES-like state. Our results provide a paradigm for studying the epigenetic modifications that accompany nuclear reprogramming and suggest that abnormal epigenetic reprogramming does not pose a problem for the potential therapeutic applications of PS cells.	Univ Calif Los Angeles, Johnson Comprehensive Canc Ctr, Inst Stem Cell Biol & Med, Sch Med, Los Angeles, CA 90095 USA; Massachusetts Gen Hosp, Ctr Canc, Ctr Regenerat Med, Harvard Stem Cell Inst, Boston, MA 02114 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; MIT, Whitehead Inst, Dept Biol, Cambridge, MA 02142 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Plath, K (corresponding author), Univ Calif Los Angeles, Johnson Comprehensive Canc Ctr, Inst Stem Cell Biol & Med, Sch Med, Los Angeles, CA 90095 USA.	kplath@mednet.ucla.edu; khochedlinger@helix.mgh.harvard.edu	Tchieu, Jason/AAG-1551-2020; Xie, Wei/J-1380-2017	Tchieu, Jason/0000-0002-9793-9836; Xie, Wei/0000-0003-2126-3849; Plath, Kathrin/0000-0001-7796-3372; Utikal, Jochen/0000-0001-5316-0241; Stadtfeld, Matthias/0000-0002-5852-9906	NIH HHS [DP2 OD003266] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thorvaldsen JL, 2006, DEV BIOL, V298, P344, DOI 10.1016/j.ydbio.2006.07.011; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; WERNIG M, 2007, IN PRESS NATURE; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	35	1291	1483	3	158	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL	2007	1	1					55	70		10.1016/j.stem.2007.05.014	http://dx.doi.org/10.1016/j.stem.2007.05.014			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	230JK	18371336	Bronze			2022-12-24	WOS:000250872600002
J	Jessberger, S; Toni, N; Clemenson, GD; Ray, J; Gage, FH				Jessberger, Sebastian; Toni, Nicolas; Clemenson, Gregory D., Jr.; Ray, Jasodhara; Gage, Fred H.			Directed differentiation of hippocampal stem/progenitor cells in the adult brain	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; NEWLY GENERATED NEURONS; IN-VIVO ANALYSIS; DENTATE GYRUS; SPINAL-CORD; OLFACTORY-BULB; NEUROGENESIS; PROGENITORS; OLIGODENDROCYTES; MULTIPOTENT	Adult neurogenesis is a lifelong feature of brain plasticity; however, the potency of adult neural stem/progenitor cells in vivo remains unclear. We found that retrovirus-mediated overexpression of a single gene, the bHLH transcription factor Ascl1, redirected the fate of the proliferating adult hippocampal stem/progenitor (AHP) progeny and lead to the exclusive generation of cells of the oligodendrocytic lineage at the expense of newborn neurons, demonstrating that AHPs in the adult mouse brain are not irrevocably specified in vivo. These data indicate that AHPs have substantial plasticity, which might have important implications for the potential use of endogenous AHPs in neurological disease.	[Jessberger, Sebastian; Toni, Nicolas; Clemenson, Gregory D., Jr.; Ray, Jasodhara; Gage, Fred H.] Salk Inst Biol Studies, Lab Genet, La Jolla, CA 92037 USA; [Jessberger, Sebastian] Swiss Fed Inst Technol ETH Zurich, Dept Biol, Inst Cell Biol, CH-8093 Zurich, Switzerland	Salk Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gage, FH (corresponding author), Salk Inst Biol Studies, Lab Genet, 10010 N Torrey Pines, La Jolla, CA 92037 USA.	jessberger@cell.biol.ethz.ch; gage@salk.edu	Toni, Nicolas/M-2057-2014; Jessberger, Sebastian/AAJ-4032-2020	Toni, Nicolas/0000-0001-5585-268X; Jessberger, Sebastian/0000-0002-0056-8275	NINDS NIH HHS [R01 NS050217, R01 NS052842, R01 NS050217-03, R01 NS052842-03, R01 NS050217-04] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052842, R01NS050217] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Battiste J, 2007, DEVELOPMENT, V134, P285, DOI 10.1242/dev.02727; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Consiglio A, 2004, P NATL ACAD SCI USA, V101, P14835, DOI 10.1073/pnas.0404180101; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; Kondo T, 2000, DEVELOPMENT, V127, P2989; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Parras CM, 2007, J NEUROSCI, V27, P4233, DOI 10.1523/JNEUROSCI.0126-07.2007; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Poitras L, 2007, DEVELOPMENT, V134, P1755, DOI 10.1242/dev.02845; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; Sugimori M, 2008, DEVELOPMENT, V135, P1271, DOI 10.1242/dev.015370; Sugimori M, 2007, DEVELOPMENT, V134, P1617, DOI 10.1242/dev.001255; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	46	198	204	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					888	893		10.1038/nn.2148	http://dx.doi.org/10.1038/nn.2148			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18587391	Green Accepted			2022-12-24	WOS:000257969100013
J	Lagarde, MMM; Drexl, M; Lukashkina, VA; Lukashkin, AN; Russell, IJ				Lagarde, Marcia M. Mellado; Drexl, Markus; Lukashkina, Victoria A.; Lukashkin, Andrei N.; Russell, Ian J.			Outer hair cell somatic, not hair bundle, motility is the basis of the cochlear amplifier	NATURE NEUROSCIENCE			English	Article							MAMMALIAN COCHLEA; AMPLIFICATION; MOTION; MEMBRANE; ANIONS; CORTI; ORGAN	Sensitivity, dynamic range and frequency tuning of the cochlea are attributed to amplification involving outer hair cell stereocilia and/or somatic motility. We measured acoustically and electrically elicited basilar membrane displacements from the cochleae of wild-type and Tecta(Delta ENT/Delta ENT) mice, in which stereocilia are unable to contribute to amplification near threshold. Electrically elicited responses from Tecta(Delta ENT/Delta ENT) mice were markedly similar to acoustically and electrically elicited responses from wild-type mice. We conclude that somatic, and not stereocilia, motility is the basis of cochlear amplification.	[Lagarde, Marcia M. Mellado; Drexl, Markus; Lukashkina, Victoria A.; Lukashkin, Andrei N.; Russell, Ian J.] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Russell, IJ (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	I.J.Russell@sussex.ac.uk	Lukashkin, Andrei N/N-1447-2017	Lukashkin, Andrei N/0000-0003-4577-8716; Lukashkina, Victoria/0000-0002-9154-8746; Russell, Ian/0000-0002-4915-2772	Medical Research Council [G0301057, G0801693] Funding Source: Medline; MRC [G0301057] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALLEN JB, 1993, J ACOUST SOC AM, V94, P809, DOI 10.1121/1.408182; Chan DK, 2005, BIOPHYS J, V89, P4382, DOI 10.1529/biophysj.105.070474; Dallos P., 1996, COCHLEA, P1; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Karavitaki KD, 2007, BIOPHYS J, V92, P3294, DOI 10.1529/biophysj.106.083634; Kennedy HJ, 2006, J NEUROSCI, V26, P2757, DOI 10.1523/JNEUROSCI.3808-05.2006; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Lukashkin AN, 2007, CURR BIOL, V17, P1340, DOI 10.1016/j.cub.2007.06.061; Murugasu E., 1995, AUDIT NEUROSCI, V1, P139; Nowotny M, 2006, P NATL ACAD SCI USA, V103, P2120, DOI 10.1073/pnas.0511125103; Nuttall AL, 1995, HEARING RES, V92, P170, DOI 10.1016/0378-5955(95)00216-2; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006	15	52	54	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					746	748		10.1038/nn.2129	http://dx.doi.org/10.1038/nn.2129			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18516034				2022-12-24	WOS:000257089400009
J	Reddy, GD; Kelleher, K; Fink, R; Saggau, P				Reddy, Gaddum Duemani; Kelleher, Keith; Fink, Rudy; Saggau, Peter			Three-dimensional random access multiphoton microscopy for functional imaging of neuronal activity	NATURE NEUROSCIENCE			English	Article							FLUORESCENCE MICROSCOPY; HIGH-SPEED; 2-PHOTON EXCITATION; TEMPORAL DISPERSION; OBLIQUE DENDRITES; CA2+ SIGNALS; SPINES; COMPENSATION; DEPTH; DYNAMICS	The dynamic ability of neuronal dendrites to shape and integrate synaptic responses is the hallmark of information processing in the brain. Effectively studying this phenomenon requires concurrent measurements at multiple sites on live neurons. Substantial progress has been made by optical imaging systems that combine confocal and multiphoton microscopy with inertia-free laser scanning. However, all of the systems developed so far restrict fast imaging to two dimensions. This severely limits the extent to which neurons can be studied, as they represent complex three-dimensional structures. Here we present a new imaging system that utilizes a unique arrangement of acousto-optic deflectors to steer a focused, ultra-fast laser beam to arbitrary locations in three-dimensional space without moving the objective lens. As we demonstrate, this highly versatile random-access multiphoton microscope supports functional imaging of complex three-dimensional cellular structures such as neuronal dendrites or neural populations at acquisition rates on the order of tens of kilohertz.	[Reddy, Gaddum Duemani; Saggau, Peter] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Reddy, Gaddum Duemani; Fink, Rudy; Saggau, Peter] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Kelleher, Keith] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA	Rice University; Baylor College of Medicine; University of Houston System; University of Houston	Saggau, P (corresponding author), Rice Univ, Dept Bioengn, 6100 Main St,Suite 116 Keck Hall, Houston, TX 77005 USA.	psaggau@bcm.edu			NIA NIH HHS [R01 AG027577-03, R01 AG027577-01, R01 AG027577-02] Funding Source: Medline; NIBIB NIH HHS [T32 EB006350-02, T32 EB006350-01A1, R01 EB001048-01, R01 EB001048-03, R01 EB001048-02] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001048, T32EB006350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027577] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ambros-Ingerson J, 2005, HIPPOCAMPUS, V15, P302, DOI 10.1002/hipo.20051; Babin AA, 2002, QUANTUM ELECTRON+, V32, P308, DOI 10.1070/QE200203204ABEH002189; Bansal V, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2209562; Bullen A, 1997, BIOPHYS J, V73, P477, DOI 10.1016/S0006-3495(97)78086-X; Bullen A, 1999, BIOPHYS J, V76, P2272, DOI 10.1016/S0006-3495(99)77383-2; CHANG IC, 1994, ELECTRON LETT, V30, P1190, DOI 10.1049/el:19940787; Dufour P, 2006, APPL OPTICS, V45, P9246, DOI 10.1364/AO.45.009246; Durst ME, 2006, OPT EXPRESS, V14, P12243, DOI 10.1364/OE.14.012243; Escobar I, 2006, J OPT SOC AM A, V23, P3150, DOI 10.1364/JOSAA.23.003150; Frick A, 2003, J NEUROSCI, V23, P3243; Gobel W, 2007, NAT METHODS, V4, P73, DOI 10.1038/NMETH989; GOTTLIEB M, 1983, ELECTROOPITIC ACOUST; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hoogland TM, 2004, J NEUROSCI, V24, P8416, DOI 10.1523/JNEUROSCI.1677-04.2004; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; Iyer V, 2006, J NEUROPHYSIOL, V95, P535, DOI 10.1152/jn.00865.2005; Iyer V, 2003, J BIOMED OPT, V8, P460, DOI 10.1117/1.1580827; Kam Z., 1997, Bioimaging, V5, P40, DOI 10.1002/1361-6374(199703)5:1<40::AID-BIO4>3.3.CO;2-N; Kaplan A, 2001, OPT LETT, V26, P1078, DOI 10.1364/OL.26.001078; Koester HJ, 1999, BIOPHYS J, V77, P2226, DOI 10.1016/S0006-3495(99)77063-3; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Lechleiter JD, 2002, BIOPHYS J, V83, P2292, DOI 10.1016/S0006-3495(02)73989-1; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Lv XH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2190047; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; McConnell G, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2360593; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Mogilevtsev D, 1998, OPT LETT, V23, P1662, DOI 10.1364/OL.23.001662; Oku H, 2004, OPT EXPRESS, V12, P2138, DOI 10.1364/OPEX.12.002138; Oron D, 2005, OPT EXPRESS, V13, P1468, DOI 10.1364/OPEX.13.001468; Reddy GD, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2141504; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Saggau P, 2006, CURR OPIN NEUROBIOL, V16, P543, DOI 10.1016/j.conb.2006.08.011; Salome R, 2006, J NEUROSCI METH, V154, P161, DOI 10.1016/j.jneumeth.2005.12.010; SHEPPARD CJR, 1991, APPL OPTICS, V30, P3563, DOI 10.1364/AO.30.003563; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; Siegman A. E., 1986, LASER; TREACY EB, 1969, IEEE J QUANTUM ELECT, VQE 5, P454, DOI 10.1109/JQE.1969.1076303; Vucinic D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000699; Xu J., 1992, ACOUSTO OPTIC DEVICE; Xu JP, 1996, P SOC PHOTO-OPT INS, V2754, P104, DOI 10.1117/12.243118; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Zeng SQ, 2006, OPT LETT, V31, P1091, DOI 10.1364/OL.31.001091; Zhu LJ, 1999, APPL OPTICS, V38, P5350, DOI 10.1364/AO.38.005350	48	253	261	4	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					713	720		10.1038/nn.2116	http://dx.doi.org/10.1038/nn.2116			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18432198	Green Accepted			2022-12-24	WOS:000256133700018
J	Xu, J; Sornborger, AT; Lee, JK; Shen, P				Xu, Jie; Sornborger, Andrew T.; Lee, Jennifer K.; Shen, Ping			Drosophila TRPA channel modulates sugar-stimulated neural excitation, avoidance and social response	NATURE NEUROSCIENCE			English	Article							NEUROPEPTIDE-Y; IMAGING DATA; NERVOUS-SYSTEM; PAIN PATHWAY; MICE LACKING; RECEPTOR; EXPRESSION; BEHAVIOR; FAMILY; ANTINOCICEPTION	Drosophila melanogaster postfeeding larvae show food-averse migration toward food-free habitats before metamorphosis. This developmental switching from food attraction to aversion is regulated by a neuropeptide Y (NPY)-related brain signaling peptide. We used the fly larva model to delineate the neurobiological basis of age-restricted response to environmental stimuli. Here we provide evidence for a fructose-responsive chemosensory pathway that modulates food-averse migratory and social behaviors. We found that fructose potently elicited larval food-averse behaviors, and painless (pain), a transient receptor potential channel that is responsive to noxious stimuli, was required for the fructose response. A subset of pain-expressing sensory neurons have been identified that show pain-dependent excitation by fructose. Although evolutionarily conserved avoidance mechanisms are widely appreciated for their roles in stress coping and survival, their biological importance in animal physiology and development remains unknown. Our findings demonstrate how an avoidance mechanism is recruited to facilitate animal development.	[Xu, Jie; Lee, Jennifer K.; Shen, Ping] Univ Georgia, Dept Cell Biol, Athens, GA 30602 USA; [Xu, Jie; Sornborger, Andrew T.; Lee, Jennifer K.; Shen, Ping] Univ Georgia, Biomed & Hlth Sci Inst, Athens, GA 30602 USA; [Sornborger, Andrew T.] Univ Georgia, Fac Engn, Athens, GA 30602 USA; [Sornborger, Andrew T.] Univ Georgia, Dept Math, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Shen, P (corresponding author), Univ Georgia, Dept Cell Biol, 500 DW Brooks Dr, Athens, GA 30602 USA.	pshen@cellmate.cb.uga.edu		Shen, Ping/0000-0001-5024-3893	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB005432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014348] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA014348] Funding Source: Medline; NIBIB NIH HHS [EB005432] Funding Source: Medline; NIDDK NIH HHS [DK058348] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Alyokhin AV, 2001, J INSECT BEHAV, V14, P57, DOI 10.1023/A:1007849629409; Ashburner M., 1989, DROSOPHILA; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Broder J, 2007, J OPT SOC AM A, V24, P2921, DOI 10.1364/JOSAA.24.002921; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Brumovsky P, 2007, TRENDS PHARMACOL SCI, V28, P93, DOI 10.1016/j.tips.2006.12.003; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHIANG H. C., 1950, ECOL MONOGR, V20, P173, DOI 10.2307/1948580; COHEN B, 1991, MECH DEVELOP, V33, P229, DOI 10.1016/0925-4773(91)90030-A; Fan X, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2745263; Gibbs J, 2004, NEUROSCIENCE, V125, P703, DOI 10.1016/j.neuroscience.2004.01.044; Greco B, 2006, BEHAV BRAIN RES, V169, P325, DOI 10.1016/j.bbr.2006.02.002; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; JI RR, 1994, J NEUROSCI, V14, P6423; Kitamoto T, 2002, J NEUROGENET, V16, P205, DOI 10.1080/01677060216295; LAKESHARLAN R, 1991, J COMP NEUROL, V308, P188, DOI 10.1002/cne.903080206; Larhammar D, 1996, REGUL PEPTIDES, V62, P1, DOI 10.1016/0167-0115(95)00169-7; Li JJ, 2005, PAIN, V118, P232, DOI 10.1016/j.pain.2005.08.023; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; McVeigh P, 2005, PARASITOLOGY, V131, pS41, DOI 10.1017/S0031182005008851; MITRA P, 2008, OBSREVED BRAIN DYNAM; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 2005, PFLUG ARCH EUR J PHY, V451, P19, DOI 10.1007/s00424-005-1426-2; Moran MM, 2004, CURR OPIN NEUROBIOL, V14, P362, DOI 10.1016/j.conb.2004.05.003; Naveilhan P, 2001, NATURE, V409, P513, DOI 10.1038/35054063; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Roberts D. B, 1986, DROSOPHILA PRACTICAL; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shen P, 2001, J NEUROBIOL, V47, P16, DOI 10.1002/neu.1012; Sokolowski MB, 2003, NEURON, V39, P6, DOI 10.1016/S0896-6273(03)00398-2; Sornborger A, 2003, NEUROIMAGE, V18, P610, DOI 10.1016/S1053-8119(02)00045-9; Tatemoto K, 2004, HANDB EXP PHARM, V162, P1; THOMAS DB, 1995, SOUTHWEST ENTOMOL, V20, P61; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Thorsell A, 2002, NEUROPEPTIDES, V36, P182, DOI 10.1054/npep.2002.0897; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9	44	48	48	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					676	682		10.1038/nn.2119	http://dx.doi.org/10.1038/nn.2119			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18469811				2022-12-24	WOS:000256133700014
J	Jensen, P; Farago, AF; Awatramani, RB; Scott, MM; Deneris, ES; Dymecki, SM				Jensen, Patricia; Farago, Anna F.; Awatramani, Rajeshwar B.; Scott, Michael M.; Deneris, Evan S.; Dymecki, Susan M.			Redefining the serotonergic system by genetic lineage	NATURE NEUROSCIENCE			English	Article							NEURON DEVELOPMENT; HINDBRAIN; BRAIN; BOUNDARIES; FATE; RAT	Central serotonin-producing neurons are heterogeneous differing in location, morphology, neurotoxin sensitivity and associated clinical disorders - but the underpinnings of this heterogeneity are largely unknown, as are the markers that distinguish physiological subtypes of serotonergic neurons. Here we redefined serotonergic subtypes on the basis of genetic programs that are differentially enacted in progenitor cells. We uncovered a molecular framework for the serotonergic system that, having genetic lineages as its basis, is likely to have physiological relevance and will permit access to genetically defined subtypes for manipulation.	[Jensen, Patricia; Farago, Anna F.; Dymecki, Susan M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Awatramani, Rajeshwar B.] Northwestern Univ, Feinberg Med Sch, Dept Neurol, Chicago, IL 60611 USA; [Awatramani, Rajeshwar B.] Northwestern Univ, Feinberg Med Sch, Ctr Genet Med, Chicago, IL 60611 USA; [Jensen, Patricia; Farago, Anna F.; Awatramani, Rajeshwar B.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Harvard University; Harvard Medical School; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Case Western Reserve University	Dymecki, SM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dymecki@genetics.med.harvard.edu	Jensen, Patricia/Z-1523-2018	Jensen, Patricia/0000-0001-6459-7289	NICHD NIH HHS [P01 HD036379-120007, P01 HD036379-130007, P01 HD036379] Funding Source: Medline; NIDA NIH HHS [R21 DA023643-01, R21 DA023643, R21 DA023643-02] Funding Source: Medline; NIDDK NIH HHS [R01 DK067826, R01 DK 067826, R01 DK067826-04] Funding Source: Medline; NIMH NIH HHS [R01 MH062723, R01 MH62723] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023643] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Cordes SP, 2005, CLIN GENET, V68, P487, DOI 10.1111/j.1399-0004.2005.00534.x; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Kimmel RA, 2000, GENE DEV, V14, P1377; LIDOV HGW, 1982, BRAIN RES BULL, V8, P389, DOI 10.1016/0361-9230(82)90077-6; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Riikonen RS, 2005, BIOL PSYCHIAT, V57, P1565, DOI 10.1016/j.biopsych.2005.01.029; Scott MM, 2005, J NEUROSCI, V25, P2628, DOI 10.1523/JNEUROSCI.4979-04.2005; Simon HH, 2005, MOL CELL NEUROSCI, V28, P96, DOI 10.1016/j.mcn.2004.08.016; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; WALLACE JA, 1982, BRAIN RES BULL, V9, P117, DOI 10.1016/0361-9230(82)90127-7; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	15	182	183	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					417	419		10.1038/nn2050	http://dx.doi.org/10.1038/nn2050			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344997	Green Accepted			2022-12-24	WOS:000254359300011
J	Gras, C; Amilhon, B; Lepicard, EM; Poirel, O; Vinatier, J; Herbin, M; Dumas, S; Tzavara, ET; Wade, MR; Nomikos, GG; Hanoun, N; Saurini, F; Kemel, ML; Gasnier, B; Giros, B; El Mestikawy, S				Gras, Christelle; Amilhon, Benedicte; Lepicard, Eve M.; Poirel, Odile; Vinatier, Jacqueline; Herbin, Marc; Dumas, Sylvie; Tzavara, Eleni T.; Wade, Mark R.; Nomikos, George G.; Hanoun, Naima; Saurini, Francoise; Kemel, Marie-Louise; Gasnier, Bruno; Giros, Bruno; El Mestikawy, Salah			The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone	NATURE NEUROSCIENCE			English	Article							CHOLINERGIC CELL ABLATION; SYNAPTIC VESICLES; MOLECULAR-CLONING; BASAL GANGLIA; DOPAMINE; RELEASE; NEURONS; MOUSE; IDENTIFICATION; LOCALIZATION	Three subtypes of vesicular transporters accumulate glutamate into synaptic vesicles to promote its vesicular release. One of the subtypes, VGLUT3, is expressed in neurons, including cholinergic striatal interneurons, that are known to release other classical transmitters. Here we showed that disruption of the Slc17a8 gene (also known as Vglut3) caused an unexpected hypocholinergic striatal phenotype. Vglut3(-/-) mice were more responsive to cocaine and less prone to haloperidol-induced catalepsy than wild-type littermates, and acetylcholine release was decreased in striatum slices lacking VGLUT3. These phenotypes were associated with a colocalization of VGLUT3 and the vesicular acetylcholine transporter (VAChT) in striatal synaptic vesicles and the loss of a synergistic effect of glutamate on vesicular acetylcholine uptake. We propose that this vesicular synergy between two transmitters is the result of the unbalanced bioenergetics of VAChT, which requires anion co-entry for continuing vesicular filling. Our study reveals a previously unknown effect of glutamate on cholinergic synapses with potential functional and pharmacological implications.	[Gras, Christelle; Amilhon, Benedicte; Lepicard, Eve M.; Poirel, Odile; Vinatier, Jacqueline; Tzavara, Eleni T.; Giros, Bruno; El Mestikawy, Salah] Univ Paris 06, INSERM, U513, F-75005 Paris, France; [Gras, Christelle; Amilhon, Benedicte; Lepicard, Eve M.; Poirel, Odile; Vinatier, Jacqueline; Tzavara, Eleni T.; Giros, Bruno; El Mestikawy, Salah] Univ Paris 06, F-75005 Paris, France; [Herbin, Marc] MNHN, CNRS, UMR 7179, USM 301, F-75005 Paris, France; [Dumas, Sylvie] Helios Biosci, Fac Med, F-94010 Creteil, France; [Wade, Mark R.; Nomikos, George G.] Amgen Cambridge Res Ctr, Cambridge, MA 02139 USA; [Wade, Mark R.; Nomikos, George G.] Univ Paris 06, Fac Med, INSERM, UMR 677, Paris 13, France; [Kemel, Marie-Louise] Coll France, INSERM, U 667, F-75231 Paris, France; [Gasnier, Bruno] Univ Paris 07, CNRS, Inst Biol Physico Chim, UPR 1929, F-75005 Paris, France; [Giros, Bruno; El Mestikawy, Salah] McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr, Quebec City, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; McGill University	El Mestikawy, S (corresponding author), Univ Paris 06, INSERM, U513, 9 Quai St Bernard, F-75005 Paris, France.	salah.elmestikawy@snv.jussieu.fr	Kemel, Marie-Louise/M-4967-2018; hanoun, naima NH/M-6408-2014; Gasnier, Bruno/AAD-9124-2022; Amilhon, Bénédicte/AAZ-3182-2021; GIROS, Bruno/ABD-5790-2021	Gasnier, Bruno/0000-0003-4458-6296; GIROS, Bruno/0000-0001-5876-9822; el mestikawy, salah/0000-0002-6253-0002				Bankston LA, 1996, J BIOL CHEM, V271, P17132, DOI 10.1074/jbc.271.29.17132; BESSON MJ, 1969, P NATL ACAD SCI USA, V62, P741, DOI 10.1073/pnas.62.3.741; Blanchet F, 1998, NEUROSCIENCE, V85, P1025, DOI 10.1016/S0306-4522(97)00610-6; Bonsi P, 2007, AMINO ACIDS, V32, P189, DOI 10.1007/s00726-006-0320-3; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; Calabresi P, 2006, LANCET NEUROL, V5, P974, DOI 10.1016/S1474-4422(06)70600-7; Consolo S, 1996, EUR J NEUROSCI, V8, P2702, DOI 10.1111/j.1460-9568.1996.tb01565.x; Contant C, 1996, NEUROSCIENCE, V71, P937, DOI 10.1016/0306-4522(95)00507-2; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Duplus E, 2008, J NEUROCHEM, V104, P1321, DOI 10.1111/j.1471-4159.2007.05074.x; Ferguson SM, 2003, J NEUROSCI, V23, P9697; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Franklin K. B., 1997, MOUSE BRAIN STEREOTA; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Fujiyama F, 2004, EUR J NEUROSCI, V20, P3322, DOI 10.1111/j.1460-9568.2004.03807.x; Gasnier B, 2000, BIOCHIMIE, V82, P327, DOI 10.1016/S0300-9084(00)00221-2; Gras C, 2002, J NEUROSCI, V22, P5442; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; HAMON M, 1988, J PHARMACOL EXP THER, V246, P745; Herbin M, 2004, J COMP PHYSIOL A, V190, P895, DOI 10.1007/s00359-004-0545-0; Herzog E, 2004, NEUROSCIENCE, V123, P983, DOI 10.1016/j.neuroscience.2003.10.039; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hikida T, 2003, P NATL ACAD SCI USA, V100, P6169, DOI 10.1073/pnas.0631749100; Hikida T, 2001, P NATL ACAD SCI USA, V98, P13351, DOI 10.1073/pnas.231488998; Hioki H, 2004, CEREB CORTEX, V14, P1266, DOI 10.1093/cercor/bhh088; HITZEMANN R, 1993, J PHARMACOL EXP THER, V266, P431; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; Kashani A, 2007, NEUROBIOL AGING, V28, P568, DOI 10.1016/j.neurobiolaging.2006.02.010; KAWAGUCHI Y, 1992, J NEUROPHYSIOL, V67, P1669, DOI 10.1152/jn.1992.67.6.1669; Kawano M, 2006, J COMP NEUROL, V498, P581, DOI 10.1002/cne.21054; KEMEL ML, 1989, P NATL ACAD SCI USA, V86, P9006, DOI 10.1073/pnas.86.22.9006; Kitabatake Y, 2003, P NATL ACAD SCI USA, V100, P7965, DOI 10.1073/pnas.1032899100; Nguyen ML, 1998, BIOCHEMISTRY-US, V37, P13400, DOI 10.1021/bi9802263; Poulin AN, 2006, J COMP NEUROL, V498, P690, DOI 10.1002/cne.21081; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Roseth S, 1998, BIOCHEM PHARMACOL, V56, P1243, DOI 10.1016/S0006-2952(98)00200-7; SCATTON B, 1982, NATURE, V297, P422, DOI 10.1038/297422a0; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; SCHERMAN D, 1980, BIOCHIM BIOPHYS ACTA, V601, P664, DOI 10.1016/0005-2736(80)90567-2; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; Takamori S, 2002, EMBO REP, V3, P798, DOI 10.1093/embo-reports/kvf159; Tzavara ET, 2006, MOL PSYCHIATR, V11, P187, DOI 10.1038/sj.mp.4001763; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x; Zhou FM, 2002, J NEUROBIOL, V53, P590, DOI 10.1002/neu.10150	47	154	160	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					292	300		10.1038/nn2052	http://dx.doi.org/10.1038/nn2052			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18278042				2022-12-24	WOS:000253548300012
J	Narayanan, R; Johnston, D				Narayanan, Rishikesh; Johnston, Daniel			Long-term potentiation in rat hippocampal neurons is accompanied by spatially widespread changes in intrinsic oscillatory dynamics and excitability	NEURON			English	Article							DEPENDENT CHANGES; RESONANCE; NETWORKS; SELECTIVITY; PLASTICITY; MECHANISM; SYNCHRONY; CHANNELS; CURRENTS; CORTEX	Oscillations in neural activity are a prominent feature of many brain states. Individual hippocampal neurons exhibit intrinsic membrane potential oscillations and intrinsic resonance in the theta frequency range. We found that the subthreshold resonance frequency of CA1 pyramidal neurons was location dependent, varying more than 3-fold between the soma and the distal dendrites. Furthermore, activity- and NMDA-receptor-dependent long-term plasticity increased this resonance frequency through changes in h channel properties. The increase in resonance frequency and an associated reduction in excitability were nearly identical in the soma and the first 300 gm of the apical dendrites. These spatially widespread changes accompanying long-term synaptic potentiation also reduced the neuron's ability to elicit spikes evoked through a nonpotentiated synaptic pathway. Our results suggest that the frequency response of these neurons depends on the dendritic location of their inputs and that activity can regulate their response dynamics within an oscillating neural network.	[Narayanan, Rishikesh; Johnston, Daniel] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnston, D (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA.	djohnston@mail.clm.utexas.edu	Narayanan, Rishikesh/C-3191-2009	Narayanan, Rishikesh/0000-0002-1362-4635	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048432, R01MH094839, R37MH044754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037444] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH048432-15, R37 MH044754, R01 MH094839, R01 MH048432, MH48432, R37 MH044754-19, MH44754] Funding Source: Medline; NINDS NIH HHS [NS37444, P01 NS037444-09, P01 NS037444] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALONSO A, 1987, EXP BRAIN RES, V67, P502, DOI 10.1007/BF00247283; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLAND BH, 1993, PROG NEUROBIOL, V41, P157, DOI 10.1016/0301-0082(93)90007-F; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Carnevale NT, 2006, NEURON BOOK; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Guertin PA, 2006, J NEUROPHYSIOL, V95, P2024, DOI 10.1152/jn.00832.2005; Haedo RJ, 2006, J NEUROPHYSIOL, V96, P1860, DOI 10.1152/jn.00385.2006; HARRISWARRICK RM, 1991, ANNU REV NEUROSCI, V14, P39, DOI 10.1146/annurev.ne.14.030191.000351; HIRSCH HVB, 1970, SCIENCE, V168, P869, DOI 10.1126/science.168.3933.869; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P698, DOI 10.1152/jn.1996.76.2.698; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Leung LS, 1998, J NEUROPHYSIOL, V79, P1592, DOI 10.1152/jn.1998.79.3.1592; LEUNG LWS, 1991, BRAIN RES, V553, P261, DOI 10.1016/0006-8993(91)90834-I; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Magee JC, 1998, J NEUROSCI, V18, P7613; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Mortensen U, 2000, BIOL CYBERN, V82, P401, DOI 10.1007/s004220050594; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; Oestreich J, 2006, NEURON, V49, P577, DOI 10.1016/j.neuron.2006.01.027; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Ramirez JM, 2004, CURR OPIN NEUROBIOL, V14, P665, DOI 10.1016/j.conb.2004.10.011; Ricci AJ, 2005, J NEUROSCI, V25, P7831, DOI 10.1523/JNEUROSCI.1127-05.2005; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; STROHMANN B, 1994, J NEUROPHYSIOL, V71, P1361, DOI 10.1152/jn.1994.71.4.1361; TURIN GL, 1960, IRE T INFORM THEOR, V6, P311, DOI 10.1109/TIT.1960.1057571; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Ulrich D, 2002, J NEUROPHYSIOL, V87, P2753, DOI 10.1152/jn.2002.87.6.2753; Volgushev M, 1998, NEUROSCIENCE, V83, P15, DOI 10.1016/S0306-4522(97)00380-1; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	45	181	184	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 20	2007	56	6					1061	1075		10.1016/j.neuron.2007.10.033	http://dx.doi.org/10.1016/j.neuron.2007.10.033			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	248FP	18093527	Green Accepted, Bronze			2022-12-24	WOS:000252138000014
J	Labouebe, G; Lomazzi, M; Cruz, HG; Creton, C; Lujan, R; Li, M; Yanagawa, Y; Obata, K; Watanabe, M; Wickman, K; Boyer, SB; Slesinger, PA; Luscher, C				Labouebe, Gwenael; Lomazzi, Marta; Cruz, Hans G.; Creton, Cyril; Lujan, Rafael; Li, Meng; Yanagawa, Yuchio; Obata, Kunihiko; Watanabe, Masahiko; Wickman, Kevin; Boyer, Stephanie B.; Slesinger, Paul A.; Luescher, Christian			RGS2 modulates coupling between GABA(B) receptors and GIRK channels in dopamine neurons of the ventral tegmental area	NATURE NEUROSCIENCE			English	Article							GAMMA-HYDROXYBUTYRIC ACID; K+-CHANNEL; INWARD RECTIFIER; PROTEIN; EXPRESSION; REGULATORS; SUBUNITS; AGONISTS; CLONING; INHIBITION	Agonists of GABA(B) receptors exert a bi-directional effect on the activity of dopamine (DA) neurons of the ventral tegmental area, which can be explained by the fact that coupling between GABA(B) receptors and G protein-gated inwardly rectifying potassium (GIRK) channels is significantly weaker in DA neurons than in GABA neurons. Thus, low concentrations of agonists preferentially inhibit GABA neurons and thereby disinhibit DA neurons. This disinhibition might confer reinforcing properties on addictive GABA(B) receptor agonists such as gamma-hydroxybutyrate (GHB) and its derivatives. Here we show that, in DA neurons of mice, the low coupling efficiency reflects the selective expression of heteromeric GIRK2/3 channels and is dynamically modulated by a member of the regulator of G protein signaling (RGS) protein family. Moreover, repetitive exposure to GHB increases the GABA(B) receptor-GIRK channel coupling efficiency through downregulation of RGS2. Finally, oral self-administration of GHB at a concentration that is normally rewarding becomes aversive after chronic exposure. On the basis of these results, we propose a mechanism that might underlie tolerance to GHB.	Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva 4, Switzerland; Univ Castilla La Mancha, Fac Med CRIB, Dept Med Sci, Albacete 02006, Spain; Imperial Coll London, London W12 0NN, England; Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma, Japan; RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; Hokkaido Univ, Sch Med, Dept Anat, Kita Ku, Sapporo, Hokkaido 0608638, Japan; Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, CH-1211 Geneva, Switzerland	University of Geneva; Universidad de Castilla-La Mancha; Imperial College London; Gunma University; RIKEN; Hokkaido University; University of Minnesota System; University of Minnesota Twin Cities; Salk Institute; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, Michel-Servet 1, CH-1211 Geneva 4, Switzerland.	Christian.Luscher@medecine.unige.ch	Li, Meng/I-6941-2013; Lujan, Rafael/G-2555-2015; Watanabe, Masahiko/S-3614-2019; Lüscher, Christian/A-2496-2011; WATANABE, Masahiko/A-4055-2012	Watanabe, Masahiko/0000-0001-5037-7138; Lüscher, Christian/0000-0001-7917-4596; WATANABE, Masahiko/0000-0001-5037-7138; Lujan Miras, Rafael/0000-0003-2001-9545; Wickman, Kevin/0000-0002-5179-9540	MRC [MC_U120085817] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA011806] Funding Source: NIH RePORTER; Medical Research Council [MC_U120085817] Funding Source: Medline; NIDA NIH HHS [P50 DA011806, DA011806] Funding Source: Medline; NIMH NIH HHS [R01 MH061933, MH61933] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andriamampandry C, 2003, FASEB J, V17, P1691, DOI 10.1096/fj.02-0846fje; AXELROD D, 1983, J MICROSC-OXFORD, V129, P19, DOI 10.1111/j.1365-2818.1983.tb04158.x; Bettahi H, 2002, J BIOL CHEM, V277, P48282, DOI 10.1074/jbc.M209599200; Brebner K, 2002, ALCOHOL ALCOHOLISM, V37, P478, DOI 10.1093/alcalc/37.5.478; Chuang HH, 1998, P NATL ACAD SCI USA, V95, P11727, DOI 10.1073/pnas.95.20.11727; COLOMBO G, 1995, EUR J PHARMACOL, V285, P103, DOI 10.1016/0014-2999(95)00493-5; Cousins MS, 2002, DRUG ALCOHOL DEPEN, V65, P209, DOI 10.1016/S0376-8716(01)00163-6; Crunelli V, 2006, CURR OPIN PHARMACOL, V6, P44, DOI 10.1016/j.coph.2005.10.001; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Doupnik CA, 2004, METHOD ENZYMOL, V389, P131; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Gold SJ, 2003, EUR J NEUROSCI, V17, P971, DOI 10.1046/j.1460-9568.2003.02529.x; Gold SJ, 1997, J NEUROSCI, V17, P8024; Inanobe A, 1999, J NEUROSCI, V19, P1006; Jaen C, 2006, J BIOL CHEM, V281, P34549, DOI 10.1074/jbc.M603177200; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Karschin C, 1996, J NEUROSCI, V16, P3559; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 2003, EUR J NEUROSCI, V18, P2722, DOI 10.1111/j.1460-9568.2003.03013.x; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; Liao YJ, 1996, J NEUROSCI, V16, P7137; Luscher C, 2006, PLOS MED, V3, P2005, DOI 10.1371/journal.pmed.0030437; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Martellotta MC, 1997, PSYCHOPHARMACOLOGY, V132, P1, DOI 10.1007/s002130050312; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Pfaff T, 1999, EUR J NEUROSCI, V11, P2874, DOI 10.1046/j.1460-9568.1999.00704.x; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Schoots O, 1999, CELL SIGNAL, V11, P871, DOI 10.1016/S0898-6568(99)00059-5; Shea L, 1997, BIOCHEM PHARMACOL, V53, P519, DOI 10.1016/S0006-2952(96)00768-X; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Slesinger PA, 1996, NEURON, V16, P321, DOI 10.1016/S0896-6273(00)80050-1; Snead OC, 2005, NEW ENGL J MED, V352, P2721, DOI 10.1056/NEJMra044047; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Taymans JM, 2003, J NEUROCHEM, V84, P1118, DOI 10.1046/j.1471-4159.2003.01610.x; Torrecilla M, 2002, J NEUROSCI, V22, P4328, DOI 10.1523/JNEUROSCI.22-11-04328.2002; Traynor JR, 2005, MOL INTERV, V5, P30, DOI 10.1124/mi.5.1.7; Wallen A, 2003, ANN NY ACAD SCI, V991, P48; Wickman K, 2000, J NEUROSCI, V20, P5608, DOI 10.1523/JNEUROSCI.20-15-05608.2000; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x	49	161	166	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1559	1568		10.1038/nn2006	http://dx.doi.org/10.1038/nn2006			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17965710				2022-12-24	WOS:000251172900013
J	Narayan, R; Best, V; Ozmeral, E; McClaine, E; Dent, M; Shinn-Cunningham, B; Sen, K				Narayan, Rajiv; Best, Virginia; Ozmeral, Erol; McClaine, Elizabeth; Dent, Micheal; Shinn-Cunningham, Barbara; Sen, Kamal			Cortical interference effects in the cocktail party problem	NATURE NEUROSCIENCE			English	Article							MASKING LEVEL DIFFERENCES; PRIMARY AUDITORY-CORTEX; INFERIOR COLLICULUS; RECEPTIVE-FIELDS; NATURAL SOUNDS; NEURONS; DISCRIMINATION; RESPONSES; STIMULI; COMPLEX	Humans and animals must often discriminate between complex natural sounds in the presence of competing sounds (maskers). Although the auditory cortex is thought to be important in this task, the impact of maskers on cortical discrimination remains poorly understood. We examined neural responses in zebra finch (Taeniopygia guttata) field L (homologous to primary auditory cortex) to target birdsongs that were embedded in three different maskers (broadband noise, modulated noise and birdsong chorus). We found two distinct forms of interference in the neural responses: the addition of spurious spikes occurring primarily during the silent gaps between song syllables and the suppression of informative spikes occurring primarily during the syllables. Both effects systematically degraded neural discrimination as the target intensity decreased relative to that of the masker. The behavioral performance of songbirds degraded in a parallel manner. Our results identify neural interference that could explain the perceptual interference at the heart of the cocktail party problem.	Boston Univ, Hearing Res Ctr, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA; SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA	Boston University; Boston University; Boston University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Sen, K (corresponding author), Boston Univ, Hearing Res Ctr, 44 Cummington St, Boston, MA 02215 USA.	kamalsen@bu.edu	Best, Virginia/AAE-4279-2020	Shinn-Cunningham, Barbara/0000-0002-5096-5914; Ozmeral, Erol/0000-0001-9529-001X	NIDCD NIH HHS [1 R01 DC-007610-01A1] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007610] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Appeltants D, 2005, BEHAV PROCESS, V69, P331, DOI 10.1016/j.beproc.2005.01.010; Asari H, 2006, J NEUROSCI, V26, P7477, DOI 10.1523/JNEUROSCI.1563-06.2006; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Best V, 2005, J ACOUST SOC AM, V118, P3766, DOI 10.1121/1.2130949; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRONKHORST AW, 1992, J ACOUST SOC AM, V92, P3132, DOI 10.1121/1.404209; Bronkhorst AW, 2000, ACUSTICA, V86, P117; Brungart DS, 2001, J ACOUST SOC AM, V110, P2527, DOI 10.1121/1.1408946; CARHART R, 1969, J ACOUST SOC AM, V45, P694, DOI 10.1121/1.1911445; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Endepols H, 2003, BEHAV BRAIN RES, V145, P63, DOI 10.1016/S0166-4328(03)00098-6; Fitch RH, 1997, ANNU REV NEUROSCI, V20, P331, DOI 10.1146/annurev.neuro.20.1.331; FORTUNE ES, 1992, J COMP NEUROL, V325, P388, DOI 10.1002/cne.903250306; Furukawa S, 2000, J NEUROSCI, V20, P1216, DOI 10.1523/JNEUROSCI.20-03-01216.2000; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Haykin S, 2005, NEURAL COMPUT, V17, P1875, DOI 10.1162/0899766054322964; Hofer SB, 2003, J NEUROSCI, V23, P5732; Hulse SH, 1997, J COMP PSYCHOL, V111, P3, DOI 10.1037/0735-7036.111.1.3; Jiang D, 1997, J NEUROPHYSIOL, V77, P3085, DOI 10.1152/jn.1997.77.6.3085; Kidd G, 1998, J ACOUST SOC AM, V104, P422, DOI 10.1121/1.423246; Lane CC, 2005, J NEUROPHYSIOL, V94, P1180, DOI 10.1152/jn.01112.2004; LANGNER G, 1981, EXP BRAIN RES, V43, P11; Las L, 2005, J NEUROSCI, V25, P1503, DOI 10.1523/JNEUROSCI.4007-04.2005; Lewicki MS, 1996, J NEUROSCI, V16, P6987; Lin WY, 2001, J COMP PHYSIOL A, V187, P699, DOI 10.1007/s00359-001-0241-2; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; Machens CK, 2003, NAT NEUROSCI, V6, P341, DOI 10.1038/nn1036; McAlpine D, 1996, J ACOUST SOC AM, V100, P490, DOI 10.1121/1.415862; MULLER CM, 1985, EXP BRAIN RES, V59, P587; Narayan R, 2006, J NEUROPHYSIOL, V96, P252, DOI 10.1152/jn.01257.2005; Nelken I, 2003, BIOL CYBERN, V89, P397, DOI 10.1007/s00422-003-0445-3; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Neuert V, 2004, J NEUROSCI, V24, P5789, DOI 10.1523/JNEUROSCI.0450-04.2004; Nieder A, 2001, EUR J NEUROSCI, V13, P1033, DOI 10.1046/j.0953-816x.2001.01465.x; Palmer AR, 1999, J NEUROPHYSIOL, V81, P722, DOI 10.1152/jn.1999.81.2.722; PHILLIPS DP, 1985, HEARING RES, V18, P87, DOI 10.1016/0378-5955(85)90112-1; Pressnitzer D, 2001, J NEUROSCI, V21, P6377, DOI 10.1523/JNEUROSCI.21-16-06377.2001; Ramachandran R, 2000, JARO-J ASSOC RES OTO, V1, P144, DOI 10.1007/s101620010029; Ratnam R, 1998, J NEUROPHYSIOL, V80, P2848, DOI 10.1152/jn.1998.80.6.2848; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; SCHEICH H, 1979, J COMP PHYSIOL, V132, P257, DOI 10.1007/BF00614497; Sen K, 2001, J NEUROPHYSIOL, V86, P1445, DOI 10.1152/jn.2001.86.3.1445; Theunissen FE, 2000, J NEUROSCI, V20, P2315; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Verhey JL, 2003, EXP BRAIN RES, V153, P405, DOI 10.1007/s00221-003-1607-1; Wang L, 2007, J NEUROSCI, V27, P582, DOI 10.1523/JNEUROSCI.3699-06.2007; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536	50	57	59	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1601	1607		10.1038/nn2009	http://dx.doi.org/10.1038/nn2009			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17994016				2022-12-24	WOS:000251172900018
J	Urbain, N; Deschenes, M				Urbain, Nadia; Deschenes, Martin			Motor cortex gates vibrissal responses in a thalamocortical projection pathway	NEURON			English	Article							ZONA INCERTA; CORTICOTHALAMIC PROJECTIONS; SOMATOTOPIC MAPS; BRAIN-STEM; RAT; ORGANIZATION; CONNECTIONS; UNCERTAINTY; AFFERENTS; PRINCIPAL	Higher-order thalamic nuclei receive input from both the cerebral cortex and prethalamic sensory pathways. However, at rest these nuclei appear silent due to inhibitory input from extrathalamic regions, and it has therefore remained unclear how sensory gating of these nuclei takes place. In the rodent, the ventral division of the zona incerta. (Zlv) serves as a relay station within the paralemniscal thalamocortical projection pathway for whisker-driven motor activity. Most, perhaps all, Zlv neurons are GABAergic, and recent studies have shown that these cells participate in a feedforward inhibitory circuit that blocks sensory transmission in the thalamus. The present study provides evidence that the stimulation of the vibrissa motor cortex suppresses vibrissal responses in Zlv via an intraincertal GABAergic circuit. These results provide support for the proposal that sensory transmission operates via a top-down disinhibitory mechanism that is contingent on motor activity.	Ctr Rech Univ Laval Robert Giffard, Quebec City, PQ G1J 2G3, Canada	Laval University	Deschenes, M (corresponding author), Ctr Rech Univ Laval Robert Giffard, Quebec City, PQ G1J 2G3, Canada.	martin.deschenes@crulrg.ulaval.ca	Urbain, Nadia L/H-9988-2017	Urbain, Nadia L/0000-0002-0430-2351				Bartho P, 2002, EUR J NEUROSCI, V16, P999, DOI 10.1046/j.1460-9568.2002.02157.x; Bartho P, 2007, J NEUROSCI, V27, P1670, DOI 10.1523/JNEUROSCI.3768-06.2007; Bokor H, 2005, NEURON, V45, P929, DOI 10.1016/j.neuron.2005.01.048; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; Curtis JC, 2006, NEURON, V50, P524, DOI 10.1016/j.neuron.2006.05.004; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; Deschenes M, 2003, J NEUROSCI, V23, P6778; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Furuta T, 2006, J NEUROSCI, V26, P10548, DOI 10.1523/JNEUROSCI.1746-06.2006; Guillery RW, 2005, PROG BRAIN RES, V149, P235, DOI 10.1016/S0079-6123(05)49017-2; IZRAELI R, 1995, EXP BRAIN RES, V104, P41; JACQUIN MF, 1990, J NEUROPHYSIOL, V64, P3, DOI 10.1152/jn.1990.64.1.3; Kolmac C, 1999, ANAT EMBRYOL, V199, P265, DOI 10.1007/s004290050227; Kolmac CI, 1998, J COMP NEUROL, V396, P544, DOI 10.1002/(SICI)1096-9861(19980713)396:4<544::AID-CNE10>3.0.CO;2-G; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Lavallee P, 2005, J NEUROSCI, V25, P7489, DOI 10.1523/JNEUROSCI.2301-05.2005; Masri R, 2006, J NEUROPHYSIOL, V96, P2265, DOI 10.1152/jn.00476.2006; Mitchinson B, 2007, P R SOC B, V274, P1035, DOI 10.1098/rspb.2006.0347; Mitrofanis J, 2005, NEUROSCIENCE, V130, P1, DOI 10.1016/j.neuroscience.2004.08.017; Mitrofanis J, 1999, J COMP NEUROL, V412, P173; MIYASHITA E, 1994, EXP BRAIN RES, V99, P223; NICOLELIS MAL, 1995, NEUROSCIENCE, V65, P609, DOI 10.1016/0306-4522(94)00493-O; NICOLELIS MAL, 1992, BRAIN RES, V577, P134, DOI 10.1016/0006-8993(92)90546-L; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Power BD, 1999, J COMP NEUROL, V404, P554; Power BD, 1999, NEUROSCI LETT, V267, P9, DOI 10.1016/S0304-3940(99)00313-4; ROGER M, 1985, J COMP NEUROL, V241, P480, DOI 10.1002/cne.902410407; Shaw V, 2002, ANAT EMBRYOL, V206, P119, DOI 10.1007/s00429-002-0280-7; STERIADE M, 1982, BRAIN RES, V238, P13, DOI 10.1016/0006-8993(82)90767-3; STERIADE M, BRAINSTEM CONTROL WA; Taylor WR, 2002, J NEUROSCI, V22, P7712; Trageser JC, 2006, J NEUROPHYSIOL, V96, P1456, DOI 10.1152/jn.00423.2006; Trageser JC, 2004, J NEUROSCI, V24, P8911, DOI 10.1523/JNEUROSCI.3218-04.2004; Veinante P, 2000, J COMP NEUROL, V420, P233, DOI 10.1002/(SICI)1096-9861(20000501)420:2<233::AID-CNE6>3.0.CO;2-T; Veinante P, 2000, J COMP NEUROL, V424, P197, DOI 10.1002/1096-9861(20000821)424:2<197::AID-CNE1>3.0.CO;2-6; Veinante P, 1999, J NEUROSCI, V19, P5085; WELKER E, 1988, EXP BRAIN RES, V73, P411, DOI 10.1007/BF00248234; WILLIAMS MN, 1994, EUR J NEUROSCI, V6, P429, DOI 10.1111/j.1460-9568.1994.tb00286.x; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124	40	86	86	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 21	2007	56	4					714	725		10.1016/j.neuron.2007.10.023	http://dx.doi.org/10.1016/j.neuron.2007.10.023			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	236MH	18031687	Bronze			2022-12-24	WOS:000251306600013
J	Compe, E; Malerba, M; Soler, L; Marescaux, J; Borrelli, E; Egly, JM				Compe, Emmanuel; Malerba, Monica; Soler, Luc; Marescaux, Jacques; Borrelli, Emiliana; Egly, Jean-Marc			Neurological defects in trichothiodystrophy reveal a coactivator function of TFIIH	NATURE NEUROSCIENCE			English	Article							THYROID-HORMONE RECEPTORS; REPAIR SYNDROME TRICHOTHIODYSTROPHY; PROLIFERATOR-ACTIVATED RECEPTOR; MOLECULAR-BASIS; RAR-ALPHA; MICROCEPHALIC CEREBRUM; NUCLEAR RECEPTORS; BRAIN-DEVELOPMENT; RESPONSIVE GENES; XPD MUTATIONS	Mutations in the XPD subunit of the DNA repair/transcription factor TFIIH yield the rare genetic disorder trichothiodystrophy (TTD). Although this syndrome was initially associated with a DNA repair defect, individuals with TTD develop neurological features, such as microcephaly and hypomyelination that could be connected to transcriptional defects. Here we show that an XPD mutation in TTD mice results in a spatial and selective deregulation of thyroid hormone target genes in the brain. Molecular analyses performed on the mice brain tissue demonstrate that TFIIH is required for the stabilization of thyroid hormone receptors (TR) to their DNA-responsive elements. The limiting amounts of TFIIH found in individuals with TTD thus contribute to the deregulation of TR-responsive genes. The discovery of an unexpected stabilizing function for TFIIH deepens our understanding of the pathogenesis and neurological manifestations observed in TTD individuals.	Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France; Inst Rech Canc Appareil Digestif, F-67091 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Borrelli, E (corresponding author), Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries,BP 10142, F-67404 Strasbourg, France.	borrelli@uci.edu; egly@titus.u-strasbg.fr	Borrelli, Emiliana/M-8994-2018; Compe, Emmanuel/N-8718-2016; Compe, Emmanuel/U-1071-2019	Compe, Emmanuel/0000-0002-9189-7444				Anderson GW, 2001, FRONT NEUROENDOCRIN, V22, P1, DOI 10.1006/frne.2000.0208; Barradas PC, 2001, J NEUROSCI RES, V66, P254, DOI 10.1002/jnr.1218; Battistella PA, 1996, CHILD NERV SYST, V12, P110, DOI 10.1007/BF00819509; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Billon N, 2004, DEVELOPMENT, V131, P1211, DOI 10.1242/dev.01035; BOGAZZI F, 1994, J BIOL CHEM, V269, P11683; Botta E, 2002, HUM MOL GENET, V11, P2919, DOI 10.1093/hmg/11.23.2919; Botta E, 1998, AM J HUM GENET, V63, P1036, DOI 10.1086/302063; Bour G, 2005, P NATL ACAD SCI USA, V102, P16608, DOI 10.1073/pnas.0505556102; Bradsher J, 2000, J BIOL CHEM, V275, P2532, DOI 10.1074/jbc.275.4.2532; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; CHEN E, 1994, J INVEST DERMATOL, V103, pS154, DOI 10.1111/1523-1747.ep12399493; Cheng SW, 2000, COMB OPT (SER), V6, P137; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Compe E, 2005, MOL CELL BIOL, V25, P6065, DOI 10.1128/MCB.25.14.6065-6076.2005; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; DESVERGNE B, 1991, J BIOL CHEM, V266, P1008; Drane P, 2004, MOL CELL, V16, P187, DOI 10.1016/j.molcel.2004.10.007; Falk JD, 1999, J NEUROSCI RES, V57, P782, DOI 10.1002/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.0.CO;2-9; FARSETTI A, 1991, J BIOL CHEM, V266, P23226; Forrest D, 2002, CURR OPIN NEUROBIOL, V12, P49, DOI 10.1016/S0959-4388(02)00289-1; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Guan JZ, 2005, BIOCHEM J, V392, P389, DOI 10.1042/BJ20042102; Hashimoto K, 2001, P NATL ACAD SCI USA, V98, P3998, DOI 10.1073/pnas.051454698; INOUE T, 1990, J BIOL CHEM, V265, P19065; ITIN PH, 1990, J AM ACAD DERMATOL, V22, P705, DOI 10.1016/0190-9622(90)70096-Z; Keriel A, 2002, CELL, V109, P125, DOI 10.1016/S0092-8674(02)00692-X; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; LEHMANN AR, 1988, CANCER RES, V48, P6090; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; LIU HC, 1994, MOL ENDOCRINOL, V8, P1021, DOI 10.1210/me.8.8.1021; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; NOGUCHI T, 1991, COMP BIOCHEM PHYS C, V98, P239; NOGUCHI T, 1985, NEUROCHEM RES, V10, P1097, DOI 10.1007/BF00965884; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; Potter GB, 2001, J NEUROSCI, V21, P4373, DOI 10.1523/JNEUROSCI.21-12-04373.2001; Potter GB, 2001, GENE DEV, V15, P2687, DOI 10.1101/gad.916701; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Quignodon L, 2007, J MOL ENDOCRINOL, V39, P17, DOI 10.1677/JME-06-0054; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; SUGISAKI T, 1992, INT J DEV NEUROSCI, V10, P453, DOI 10.1016/0736-5748(92)90036-Y; Thompson CC, 1996, J NEUROSCI, V16, P7832; Vermeulen W, 2000, NAT GENET, V26, P307, DOI 10.1038/81603; Weeda G, 1997, AM J HUM GENET, V60, P320; Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	50	69	69	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1414	1422		10.1038/nn1990	http://dx.doi.org/10.1038/nn1990			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17952069				2022-12-24	WOS:000250508400019
J	Roberts, M; Delicato, LS; Herrero, J; Gieselmann, MA; Thiele, A				Roberts, Mark; Delicato, Louise S.; Herrero, Jose; Gieselmann, Mark A.; Thiele, Alexander			Attention alters spatial integration in macaque V1 in an eccentricity-dependent manner	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; CONTRAST RESPONSE FUNCTIONS; ORIENTATION SELECTIVITY; CONTEXTUAL INFLUENCES; RECEPTIVE-FIELD; SINGLE NEURONS; SIMPLE CELLS; MECHANISMS; V4; NORMALIZATION	Attention can selectively enhance neuronal responses and exclude external noise, but the neuronal computations that underlie these effects remain unknown. At the neuronal level, noise exclusion might result in altered spatial integration properties. We tested this proposal by recording neuronal activity and length tuning in neurons of the primary visual cortex of the macaque when attention was directed toward or away from stimuli presented in each neuron's classical receptive field. For cells with central-parafoveal receptive fields, attention reduced spatial integration, as demonstrated by a reduction in preferred stimulus length and in the size of the spatial summation area. Conversely, in cells that represented more peripheral locations, attention increased spatial integration by increasing the cell's summation area. This previously unknown dichotomy between central and peripheral vision could support accurate analysis of attended foveal objects and target selection for impending eye movements to peripheral objects.	Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Thiele, A (corresponding author), Newcastle Univ, Inst Neurosci, Henry Wellcome Bldg,Famlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	alex.thiele@ncl.ac.uk	Delicato, Louise/AAT-1921-2020; Roberts, Mark/C-7011-2018	Delicato, Louise/0000-0001-8271-2324; Thiele, Alexander/0000-0003-4894-0213; Roberts, Mark/0000-0001-7513-1281	Biotechnology and Biological Sciences Research Council [BBS/B/09325] Funding Source: Medline; Wellcome Trust [070380, 070380/Z/03/Z] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Angelucci A, 2002, PROG BRAIN RES, V136, P373; Angelucci A, 2002, J NEUROSCI, V22, P8633; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Buracas GT, 2007, J NEUROSCI, V27, P93, DOI 10.1523/JNEUROSCI.3162-06.2007; Carandini M, 1997, J NEUROSCI, V17, P8621; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Freeman E, 2001, NAT NEUROSCI, V4, P1032, DOI 10.1038/nn728; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Ito M, 1998, NEURON, V20, P1191, DOI 10.1016/S0896-6273(00)80499-7; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Lu ZL, 2002, J VISION, V2, DOI 10.1167/2.4.4; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Ringach D, 2004, COGNITIVE SCI, V28, P147, DOI 10.1016/j.cogsci.2003.11.003; Roberts MJ, 2005, J NEUROPHYSIOL, V93, P2062, DOI 10.1152/jn.00911.2004; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; Shapley R, 2003, NEURON, V38, P689, DOI 10.1016/S0896-6273(03)00332-5; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Thiele A, 2006, J NEUROSCI METH, V158, P207, DOI 10.1016/j.jneumeth.2006.05.032; Thiele A, 2004, P NATL ACAD SCI USA, V101, P9810, DOI 10.1073/pnas.0307754101; Thiele A, 1999, EUR J NEUROSCI, V11, P2044, DOI 10.1046/j.1460-9568.1999.00630.x; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Xing J, 2000, VISION RES, V40, P3065, DOI 10.1016/S0042-6989(00)00152-8; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936; Zenger B, 2000, VISION RES, V40, P3717, DOI 10.1016/S0042-6989(00)00218-2	40	99	101	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1483	1491		10.1038/nn1967	http://dx.doi.org/10.1038/nn1967			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17906622	Green Accepted			2022-12-24	WOS:000250508400027
J	Chen, Z; Kujawa, SG; Sewell, WF				Chen, Zhiqiang; Kujawa, Sharon G.; Sewell, William F.			Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors	NATURE NEUROSCIENCE			English	Article							SYNAPTIC-TRANSMISSION; TRAFFICKING; SYNAPSES; NEURONS; INTERNALIZATION; COCHLEA; NERVE	We report a robust regulation of surface AMPA receptors in mouse auditory neurons, both with application of glutamate receptor agonists in cultured neurons and in response to acoustic stimulation in vivo. The reversible reduction of surface AMPA receptors following acoustic stimulation correlated with changes in acoustic sensitivity. Thus we show that AMPA receptor cycling is important for optimizing synaptic transfer at one of the most exacting synapses in the body.	Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02114 USA; Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Dept Otolaryngol, Boston, MA 02114 USA; Massachusetts Eye & Ear Infirm, Dept Audiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School	Sewell, WF (corresponding author), Harvard Univ, Sch Med, Dept Otol & Laryngol, 243 Charles St, Boston, MA 02114 USA.	wfs@epl.meei.harvard.edu						Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; dAldin CG, 1997, INT J DEV NEUROSCI, V15, P619, DOI 10.1016/S0736-5748(96)00116-5; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; Kiang NYS, 1965, DISCHARGE PATTERNS S; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; LIBERMAN MC, 1982, SCIENCE, V216, P1239, DOI 10.1126/science.7079757; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Parks TN, 2000, HEARING RES, V147, P77, DOI 10.1016/S0378-5955(00)00122-2; Puel JL, 1995, PROG NEUROBIOL, V47, P449, DOI 10.1016/0301-0082(95)00028-3; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6	15	42	42	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1238	1240		10.1038/nn1974	http://dx.doi.org/10.1038/nn1974			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828255				2022-12-24	WOS:000249720800007
J	Singh, SR; Liu, W; Hou, SX				Singh, Shree Ram; Liu, Wei; Hou, Steven X.			The adult Drosophila malpighian tubules are maintained by multipotent stem cells	CELL STEM CELL			English	Article							SELF-RENEWAL; JAK-STAT; JAK/STAT; PROTEIN; GENE; ACTIVATION; NICHE; IDENTIFICATION; RECEPTOR; ENCODES	All animals must excrete the waste products of metabolism. Excretion is performed by the kidney in vertebrates and by the Malpighian tubules in Drosophila. The mammalian kidney has an inherent ability for recovery and regeneration after ischemic injury. Stem cells and progenitor cells have been proposed to be responsible for repair and regeneration of injured renal tissue. In Drosophila, the Malpighian tubules are thought to be very stable and no stem cells have been identified. We have identified multipotent stem cells in the region of lower tubules and ureters of the Malpighian tubules. Using lineage tracing and molecular marker labeling, we demonstrated that several differentiated cells in the Malpighian tubules arise from the stem cells and an autocrine JAK-STAT signaling regulates the stem cells' self-renewal. Identifying adult kidney stem cells in Drosophila may provide important clues for understanding mammalian kidney repair and regeneration during injury.	NCI, NIH, Mouse Canc Genet Program, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hou, SX (corresponding author), NCI, NIH, Mouse Canc Genet Program, Ft Detrick, MD 21702 USA.	shou@mail.ncifcrf.gov	Singh/B-7614-2008	Singh/0000-0001-6545-583X	NATIONAL CANCER INSTITUTE [Z01BC010738] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; BINARI R, 1994, GENE DEV, V8, P300, DOI 10.1101/gad.8.3.300; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618; Chen HW, 2002, GENE DEV, V16, P388, DOI 10.1101/gad.955202; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Denholm B, 2003, CURR BIOL, V13, P1052, DOI 10.1016/S0960-9822(03)00375-0; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Elger M, 2003, J AM SOC NEPHROL, V14, P1506, DOI 10.1097/01.ASN.0000067645.49562.09; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; FUSE N, 1994, GENE DEV, V8, P2270, DOI 10.1101/gad.8.19.2270; Haller H, 2005, KIDNEY INT, V68, P1932, DOI 10.1111/j.1523-1755.2005.00622.x; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Jung AC, 2005, J AM SOC NEPHROL, V16, P322, DOI 10.1681/ASN.2004090729; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kirilly D, 2005, DEV CELL, V9, P651, DOI 10.1016/j.devcel.2005.09.013; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; MOORE KL, 1968, DEV HUMAN CLIN ORIEN, P246; Nystul TG, 2006, CURR OPIN GENET DEV, V16, P463, DOI 10.1016/j.gde.2006.08.003; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; PUGATCHEVA OM, 2003, RUSS J DEV BIOL, V34, P269; Ricardo SD, 2005, NEPHROLOGY, V10, P276, DOI 10.1111/j.1440-1797.2005.00373.x; Saxen L., 1987, ORGANOGENESIS KIDNEY; SCHENKLING S, 1903, GENERA INSECTORUM, V13, P1; Singh SR, 2006, ONCOGENE, V25, P5933, DOI 10.1038/sj.onc.1209593; Skaer Helen, 1993, P941; SOROKIN L, 1995, DEV KIDNEY EPITHELIA, P163; Sozen MA, 1997, P NATL ACAD SCI USA, V94, P5207, DOI 10.1073/pnas.94.10.5207; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Wang H, 2006, DEV CELL, V10, P117, DOI 10.1016/j.devcel.2005.11.004; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wessing A., 1978, P1; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	43	136	142	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG	2007	1	2					191	203		10.1016/j.stem.2007.07.003	http://dx.doi.org/10.1016/j.stem.2007.07.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XS	18371350	Bronze, Green Accepted			2022-12-24	WOS:000251055100010
J	Bertaso, F; Zhang, C; Scheschonka, A; de Bock, F; Fontanaud, P; Marin, P; Huganir, RL; Betz, H; Bockaert, J; Fagni, L; Lerner-Natoli, M				Bertaso, Federica; Zhang, Chuansheng; Scheschonka, Astrid; de Bock, Frederic; Fontanaud, Pierre; Marin, Philippe; Huganir, Richard L.; Betz, Heinrich; Bockaert, Joeal; Fagni, Laurent; Lerner-Natoli, Mireille			PICK1 uncoupling from mGluR7a causes absence-like seizures	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PRESYNAPTIC ACTIVE ZONES; IN-VIVO; CALCIUM-CHANNELS; ADULT-RAT; SYNAPTIC-TRANSMISSION; SOMATOSENSORY CORTEX; PROTEIN INTERACTIONS; GABAERGIC TERMINALS; WAVE DISCHARGES	Absence epilepsy is a neurological disorder that causes a recurrent loss of consciousness and generalized spike-and-wave discharges on an electroencephalogram ( EEG). The role of metabotropic glutamate receptors (mGluRs) and associated scaffolding proteins in absence epilepsy has been unclear to date. We investigated a possible role for these proteins in absence epilepsy, focusing on the mGluR7a receptor and its PDZ-interacting protein, protein interacting with C kinase 1 (PICK1), in rats and mice. Injection of a cell-permeant dominant-negative peptide or targeted mutation of the mGluR7a C terminus, both of which disrupt the interaction between the receptor and PDZ proteins, caused behavioral symptoms and EEG discharges that are characteristic of absence epilepsy. Inactivation of the Pick1 gene also facilitated pharmacological induction of the absence epilepsy phenotype. The cortex and thalamus, which are known to participate in absence epilepsy, were involved, but the hippocampus was not. Our results indicate that disruption of the mGluR7a-PICK1 complex is sufficient to induce absence epilepsy-like seizures in rats and mice, thus providing, to the best of our knowledge, the first animal model of metabotropic glutamate receptor-PDZ protein interaction in absence epilepsy.	[Bertaso, Federica; de Bock, Frederic; Fontanaud, Pierre; Marin, Philippe; Bockaert, Joeal; Fagni, Laurent; Lerner-Natoli, Mireille] Inst Genom Fonctionnelle, CNRS, UMR5203, Montpellier, France; [Bertaso, Federica; de Bock, Frederic; Fontanaud, Pierre; Marin, Philippe; Bockaert, Joeal; Fagni, Laurent; Lerner-Natoli, Mireille] INSERM, U661, Montpellier, France; [Bertaso, Federica; de Bock, Frederic; Fontanaud, Pierre; Marin, Philippe; Bockaert, Joeal; Fagni, Laurent; Lerner-Natoli, Mireille] Univ Montpellier, F-34094 Montpellier 5, France; [Zhang, Chuansheng; Scheschonka, Astrid; Betz, Heinrich] Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Max Planck Society; Howard Hughes Medical Institute; Johns Hopkins University	Bockaert, J (corresponding author), Inst Genom Fonctionnelle, CNRS, UMR5203, Montpellier, France.	joel.bockaert@igf.cnrs.fr	Bertaso, Federica/C-9942-2019	Bertaso, Federica/0000-0003-3140-019X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS036715-08, R01 NS036715] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Alexander GM, 2006, EPILEPSY RES, V71, P1, DOI 10.1016/j.eplepsyres.2006.05.012; Andre V, 1998, EUR J NEUROSCI, V10, P2094, DOI 10.1046/j.1460-9568.1998.00223.x; Avanzini G, 1996, EPILEPSY RES, V26, P37, DOI 10.1016/S0920-1211(96)00037-X; Bertaso F, 2006, J NEUROCHEM, V99, P288, DOI 10.1111/j.1471-4159.2006.04121.x; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Bradley SR, 1998, J NEUROCHEM, V71, P636; Burette A, 1999, J COMP NEUROL, V411, P601; Cao GD, 2002, J NEUROSCI, V22, P5423; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; Dalezios Y, 2002, CEREB CORTEX, V12, P961, DOI 10.1093/cercor/12.9.961; Danober L, 1998, PROG NEUROBIOL, V55, P27, DOI 10.1016/S0301-0082(97)00091-9; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 2004, NAT REV DRUG DISCOV, V3, P1047, DOI 10.1038/nrd1578; Dev KK, 2000, J NEUROSCI, V20, P7252; Dietz GPH, 2005, BRAIN RES BULL, V68, P103, DOI 10.1016/j.brainresbull.2005.08.015; El Far O, 2002, BIOCHEM J, V365, P329, DOI 10.1042/BJ20020481; El Far O, 2000, EUR J NEUROSCI, V12, P4215, DOI 10.1046/j.1460-9568.2000.01309.x; Folbergrova J, 2003, EXP NEUROL, V180, P46, DOI 10.1016/S0014-4886(02)00047-X; Frankel WN, 2005, J NEUROSCI, V25, P3452, DOI 10.1523/JNEUROSCI.0231-05.2005; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Gasparini F, 1999, J PHARMACOL EXP THER, V289, P1678; Ghauri M, 1996, NEUROREPORT, V7, P1469, DOI 10.1097/00001756-199606170-00005; Hirbec H, 2002, J BIOL CHEM, V277, P15221, DOI 10.1074/jbc.C200112200; Hu RQ, 2001, BRAIN RES, V897, P27, DOI 10.1016/S0006-8993(01)02076-5; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Kinoshita A, 1998, J COMP NEUROL, V393, P332; Lafon-Cazal M, 1999, EUR J NEUROSCI, V11, P663, DOI 10.1046/j.1460-9568.1999.00475.x; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371; NOEBELS JL, 1990, EPILEPSY RES, V7, P129, DOI 10.1016/0920-1211(90)90098-G; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Perroy J, 2000, J NEUROSCI, V20, P7896; Perroy J, 2002, EMBO J, V21, P2990, DOI 10.1093/emboj/cdf313; Pietrobon D, 2005, CURR OPIN NEUROBIOL, V15, P257, DOI 10.1016/j.conb.2005.05.010; RAMAKERS GMJ, 1991, EPILEPSY RES, V9, P127, DOI 10.1016/0920-1211(91)90023-9; Sansig G, 2001, J NEUROSCI, V21, P8734, DOI 10.1523/JNEUROSCI.21-22-08734.2001; Snead OC, 2000, J NEUROSCI, V20, P6218, DOI 10.1523/JNEUROSCI.20-16-06218.2000; Somogyi P, 2003, EUR J NEUROSCI, V17, P2503, DOI 10.1046/j.1460-9568.2003.02697.x; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Turner JP, 1999, J PHYSIOL-LONDON, V519, P481, DOI 10.1111/j.1469-7793.1999.0481m.x; VANLUIJTELAAR ELJM, 1986, NEUROSCI LETT, V70, P393, DOI 10.1016/0304-3940(86)90586-0; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; WAN H, 1995, NEUROPHARMACOLOGY, V34, P1053, DOI 10.1016/0028-3908(95)00091-J; Xu JY, 2006, NEUROSIGNALS, V15, P190, DOI 10.1159/000098482; Zhang Y, 2002, J NEUROSCI, V22, P6362	50	68	69	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					940	948		10.1038/nn.2142	http://dx.doi.org/10.1038/nn.2142			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18641645	Green Accepted			2022-12-24	WOS:000257969100020
J	Lutter, M; Sakata, I; Osborne-Lawrence, S; Rovinsky, SA; Anderson, JG; Jung, S; Birnbaum, S; Yanagisawa, M; Elmquist, JK; Nestler, EJ; Zigman, JM				Lutter, Michael; Sakata, Ichiro; Osborne-Lawrence, Sherri; Rovinsky, Sherry A.; Anderson, Jason G.; Jung, Saendy; Birnbaum, Shari; Yanagisawa, Masashi; Elmquist, Joel K.; Nestler, Eric J.; Zigman, Jeffrey M.			The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress	NATURE NEUROSCIENCE			English	Article							OBESITY; MICE	We found that increasing ghrelin levels, through subcutaneous injections or calorie restriction, produced anxiolytic- and antidepressant-like responses in the elevated plus maze and forced swim test. Moreover, chronic social defeat stress, a rodent model of depression, persistently increased ghrelin levels, whereas growth hormone secretagogue receptor (Ghsr) null mice showed increased deleterious effects of chronic defeat. Together, these findings demonstrate a previously unknown function for ghrelin in defending against depressive-like symptoms of chronic stress.	[Sakata, Ichiro; Osborne-Lawrence, Sherri; Rovinsky, Sherry A.; Anderson, Jason G.; Elmquist, Joel K.; Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; [Lutter, Michael; Jung, Saendy; Birnbaum, Shari; Elmquist, Joel K.; Nestler, Eric J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Sakata, Ichiro; Osborne-Lawrence, Sherri; Rovinsky, Sherry A.; Anderson, Jason G.; Elmquist, Joel K.; Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Endocrinol & Metab, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zigman, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jeffrey.zigman@utsouthwestern.edu	Sakata, Ichiro/F-9194-2012; Yan, Shuo/B-8381-2009	Sakata, Ichiro/0000-0002-6067-0407; Zigman, Jeffrey/0000-0003-3477-1295	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056116, RL1DK081185, R01DK071320, K08DK068069, PL1DK081182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066172] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [K08 DK068069, R01 DK071320, PL1 DK081182, P01 DK056116, K08DK068069-01A2, P01DK56116, PL1 DK081182-01, RL1 DK081185-01, RL1 DK081185, R01DK71320, RL1DK081185] Funding Source: Medline; NIMH NIH HHS [P50MH66172, P50 MH066172] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Asakawa A, 2001, NEUROENDOCRINOLOGY, V74, P143, DOI 10.1159/000054680; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Jimerson DC, 2004, CNS SPECTRUMS, V9, P516, DOI 10.1017/S1092852900009603; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kristenssson E, 2006, REGUL PEPTIDES, V134, P114, DOI 10.1016/j.regpep.2006.02.003; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P155, DOI 10.1210/en.143.1.155; Lutter M, 2008, J NEUROSCI, V28, P3071, DOI 10.1523/JNEUROSCI.5584-07.2008; Mundinger TO, 2006, ENDOCRINOLOGY, V147, P2893, DOI 10.1210/en.2005-1182; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	12	439	459	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					752	753		10.1038/nn.2139	http://dx.doi.org/10.1038/nn.2139			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18552842	Green Accepted			2022-12-24	WOS:000257089400011
J	Taoudi, S; Gonneau, C; Moore, K; Sheridan, JM; Blackburn, CC; Taylor, E; Medvinsky, A				Taoudi, Samir; Gonneau, Christele; Moore, Kate; Sheridan, Julie M.; Blackburn, C. Clare; Taylor, Erin; Medvinsky, Alexander			Extensive hematopoietic stem cell generation in the AGM region via maturation of VE-cadherin(+)CD45(+) pre-definitive HSCs	CELL STEM CELL			English	Article							MOUSE EMBRYO; FETAL LIVER; YOLK-SAC; AORTA; EXPRESSION; RECONSTITUTION; PLACENTA; NICHE; LINES	Elucidating the mechanisms underlying hematopoietic stem cell (HSC) specification and expansion in the embryo has been hampered by the lack of analytical cell culture systems that recapitulate in vivo development. Here, we describe an ex vivo model that facilitates a rapid and robust emergence of multipotent long-term repopulating HSCs in the embryonic AGM region. Because this method includes a cell dissociation step prior to reconstruction of a three-dimensional functional tissue and preserves both stromal and hematopoietic elements, it allowed us to identify the direct ancestry of the rapidly expanding HSC pool. We demonstrate that extensive generation of definitive HSCs in the AGM occurs predominantly through the acquisition of stem characteristics by the VE-cadherin(+)CD45(+) population.	[Taoudi, Samir; Gonneau, Christele; Moore, Kate; Sheridan, Julie M.; Blackburn, C. Clare; Taylor, Erin; Medvinsky, Alexander] Univ Edinburgh, MRC, Ctr Regenerat Med, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Edinburgh	Medvinsky, A (corresponding author), Univ Edinburgh, MRC, Ctr Regenerat Med, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland.	a.medvinsky@ed.ac.uk	Blackburn, Clare/B-2847-2009; Blackburn, Clare/AAM-7954-2020	Blackburn, Clare/0000-0002-6326-640X; Blackburn, Clare/0000-0002-6326-640X; Sheridan, Julie/0000-0002-1478-3662; Taoudi, Samir/0000-0002-9036-9244	BBSRC [BB/D01347X/1] Funding Source: UKRI; Medical Research Council [G0700711B] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/D01347X/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Baumann CI, 2004, BLOOD, V104, P1010, DOI 10.1182/blood-2004-03-0989; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; DZIERZAK E, 1995, TRENDS GENET, V11, P359, DOI 10.1016/S0168-9525(00)89107-6; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Gilchrist DS, 2003, GENESIS, V36, P168, DOI 10.1002/gene.10209; GROBSTEIN C, 1953, SCIENCE, V118, P52, DOI 10.1126/science.118.3054.52; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Lyons AB, 1999, IMMUNOL CELL BIOL, V77, P509, DOI 10.1046/j.1440-1711.1999.00864.x; Matsuoka S, 2001, BLOOD, V97, P419, DOI 10.1182/blood.V97.2.419; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; MOSCONA A, 1952, J ANAT, V86, P287; MOSCONA H, 1952, J ANAT, V86, P278; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Ohneda O, 1998, BLOOD, V92, P908; Oostendorp RAJ, 2002, BLOOD, V99, P1183, DOI 10.1182/blood.V99.4.1183; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; Shannon JM, 2004, ANNU REV PHYSIOL, V66, P625, DOI 10.1146/annurev.physiol.66.032102.135749; Taoudi S, 2005, DEVELOPMENT, V132, P4179, DOI 10.1242/dev.01974; Taoudi S, 2007, P NATL ACAD SCI USA, V104, P9399, DOI 10.1073/pnas.0700984104; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; White A, 2007, BLOOD, V110, P1950, DOI 10.1182/blood-2007-01-070003; Xu MJ, 1998, BLOOD, V92, P2032, DOI 10.1182/blood.V92.6.2032.418k29_2032_2040	31	191	199	2	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL	2008	3	1					99	108		10.1016/j.stem.2008.06.004	http://dx.doi.org/10.1016/j.stem.2008.06.004			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	325XO	18593562	Bronze			2022-12-24	WOS:000257622300013
J	Zhou, J; Du, WL; Zhou, KC; Tai, YL; Yao, HL; Jia, YC; Ding, YQ; Wang, YZ				Zhou, Jian; Du, Wanlu; Zhou, Kechun; Tai, Yilin; Yao, Hailan; Jia, Yichang; Ding, Yuqiang; Wang, Yizheng			Critical role of TRPC6 channels in the formation of excitatory synapses	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINES; MEMORY; ACTIVATION; BDNF	The transient receptor potential canonical (TRPC) channels are Ca2+-permeable, nonselective cation channels with different biological functions, but their roles in brain are largely unknown. Here we report that TRPC6 was localized to excitatory synapses and promoted their formation via a CaMKIV-CREB-dependent pathway. TRPC6 transgenic mice showed enhancement in spine formation, and spatial learning and memory in Morris water maze. These results reveal a previously unknown role of TRPC6 in synaptic and behavioral plasticity.	[Zhou, Jian; Du, Wanlu; Zhou, Kechun; Tai, Yilin; Yao, Hailan; Jia, Yichang; Ding, Yuqiang; Wang, Yizheng] Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Lab Neural Signal Transduct, Shanghai 200031, Peoples R China; [Zhou, Jian; Du, Wanlu; Zhou, Kechun; Tai, Yilin; Yao, Hailan; Jia, Yichang] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Wang, YZ (corresponding author), Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Lab Neural Signal Transduct, Shanghai 200031, Peoples R China.	yzwang@ion.ac.cn		Ding, Yu-Qiang/0000-0003-1202-4635; Du, Wanlu/0000-0003-2612-7846				Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Pang PT, 2004, AGEING RES REV, V3, P407, DOI 10.1016/j.arr.2004.07.002; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	14	153	161	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					741	743		10.1038/nn.2127	http://dx.doi.org/10.1038/nn.2127			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18516035				2022-12-24	WOS:000257089400007
J	Svendsen, C				Svendsen, Clive			Stem cells and Parkinson's disease: Toward a treatment, not a cure	CELL STEM CELL			English	Editorial Material							DOPAMINE NEURONS; TRANSPLANTATION	Early clinical trials designed to treat Parkinson's disease by transplantation of fetal tissue containing dopamine neuron precursors yielded promising results, but the approach retains several limitations. Multiple recent papers describe longer-term outcomes in these patients, and two additional studies offer novel approaches that may lead to autologous sources of transplantable dopamine neurons.	Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Svendsen, C (corresponding author), Univ Wisconsin, Waisman Ctr, 1500 Highland Ave, Madison, WI 53705 USA.	cnsvendsen@wisc.edu						Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; KORDOWER JH, 2008, NAT MED         0406; LI JY, 2008, NAT MED         0406, DOI DOI 10.1038/NM1746; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; MENDEZ I, 2008, NAT MED         0406, DOI DOI 10.1038/NM1752; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; Tabar V, 2008, NAT MED, V14, P379, DOI 10.1038/nm1732; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012	12	16	18	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY	2008	2	5					412	413		10.1016/j.stem.2008.04.010	http://dx.doi.org/10.1016/j.stem.2008.04.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	300BM	18462691	Bronze			2022-12-24	WOS:000255799300005
J	Charlton, JJ; Allen, PB; Psifogeorgou, K; Chakravarty, S; Gomes, I; Neve, RL; Devi, LA; Greengard, P; Nestler, EJ; Zachariou, V				Charlton, Joanna J.; Allen, Patrick B.; Psifogeorgou, Kassi; Chakravarty, Sumana; Gomes, Ivone; Neve, Rachael L.; Devi, Lakshmi A.; Greengard, Paul; Nestler, Eric J.; Zachariou, Venetia			Multiple actions of spinophilin regulate mu opioid receptor function	NEURON			English	Article							PROTEIN-COUPLED RECEPTORS; NUCLEUS-ACCUMBENS; ANALGESIC TOLERANCE; MORPHINE ANALGESIA; DENDRITIC SPINES; BETA-ARRESTIN; OPIATE DRUGS; MICE LACKING; IN-VITRO; ADDICTION	Spinophilin, a dendritic spine-enriched scaffold protein, modulates synaptic transmission via multiple functions mediated by distinct domains of the protein. Here, we show that spinophilin is a key modulator of opiate action. Knockout of the spinophilin gene causes reduced sensitivity to the analgesic effects of morphine and early development of tolerance but a higher degree of physical dependence and increased sensitivity to the rewarding actions of the drug. At the cellular level, spinophilin associates with the mu opioid receptor (MOR) in striatum and modulates MOR signaling and endocytosis. Activation of MOR by opiate agonists such as fentanyl and morphine promotes these events, which feedback to suppress MOR responsiveness. Our findings support a potent physiological role of spinophilin in regulating MOR function and provide a potential new target for the treatment of opiate addiction.	[Charlton, Joanna J.; Psifogeorgou, Kassi; Zachariou, Venetia] Univ Crete, Dept Pharmacol, Iraklion 71409, Crete, Greece; [Allen, Patrick B.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Chakravarty, Sumana; Nestler, Eric J.; Zachariou, Venetia] Univ Texas SW Med Ctr Dallas, Dept Psychiat & Basic Neurosci, Dallas, TX 75390 USA; [Gomes, Ivone; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Neve, Rachael L.] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA; [Neve, Rachael L.] McLean Hosp, Belmont, MA 02478 USA; [Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA	University of Crete; Yale University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard University; McLean Hospital; Rockefeller University	Zachariou, V (corresponding author), Univ Crete, Dept Pharmacol, Iraklion 71409, Crete, Greece.	vzachar@med.uoc.gr	Chakravarty, Sumana/AAW-2823-2021; Devi P, Lakshmi/GXM-5982-2022; Zachariou, Venetia/L-2726-2016	Devi P, Lakshmi/0000-0001-9274-4776; Greengard, Paul/0000-0002-4437-0893	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008863, P01DA008227, R37DA008863, R56DA008863, P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [DA10044, R01 DA008863-17, DA008227, P01 DA010044-14S1, DA008863, R01 DA008863, P01 DA010044, P01 DA008227, R37 DA008863, R56 DA008863, P01 DA008227-18] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Allen PB, 2006, NEUROSCIENCE, V140, P897, DOI 10.1016/j.neuroscience.2006.02.067; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Arttamangkul S, 2006, J NEUROSCI, V26, P4118, DOI 10.1523/JNEUROSCI.0303-06.2006; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2004, MOL PHARMACOL, V66, P106, DOI 10.1124/mol.66.1.106; Brady AE, 2003, J BIOL CHEM, V278, P32405, DOI 10.1074/jbc.M304195200; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Contet C, 2004, CURR OPIN NEUROBIOL, V14, P370, DOI 10.1016/j.conb.2004.05.005; De Vries TJ, 2002, J NEUROSCI, V22, P3321; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; Eitan S, 2003, J NEUROSCI, V23, P8360; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Haberstock-Debic H, 2003, J NEUROSCI, V23, P4324; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Inturrisi CE, 2002, CLIN J PAIN, V18, pS3, DOI 10.1097/00002508-200207001-00002; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Kim KS, 2006, P NATL ACAD SCI USA, V103, P3908, DOI 10.1073/pnas.0508812103; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Kreek MJ, 2001, ANN NY ACAD SCI, V937, P27; Law PY, 1999, J PHARMACOL EXP THER, V289, P607; Li S, 2006, MOL PHARMACOL, V70, P1742, DOI 10.1124/mol.106.025783; Marker CL, 2004, J NEUROSCI, V24, P2806, DOI 10.1523/JNEUROSCI.5251-03.2004; Muller DL, 2004, J PHARMACOL EXP THER, V310, P774, DOI 10.1124/jpet.104.066548; Muly EC, 2004, CEREB CORTEX, V14, P1398, DOI 10.1093/cercor/bhh101; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Psifogeorgou K, 2007, J NEUROCHEM, V103, P617, DOI 10.1111/j.1471-4159.2007.04812.x; Richman JG, 2001, J BIOL CHEM, V276, P15003, DOI 10.1074/jbc.M011679200; Smith FD, 1999, J BIOL CHEM, V274, P19894, DOI 10.1074/jbc.274.28.19894; Terman GW, 2004, BRIT J PHARMACOL, V141, P55, DOI 10.1038/sj.bjp.0705595; Terry-Lorenzo RT, 2002, J BIOL CHEM, V277, P27716, DOI 10.1074/jbc.M203365200; UNTERWALD EM, 1993, SYNAPSE, V15, P33, DOI 10.1002/syn.890150104; Valjent E, 2006, P NATL ACAD SCI USA, V103, P2932, DOI 10.1073/pnas.0511030103; von Zastrow M, 2003, CURR OPIN NEUROBIOL, V13, P348, DOI 10.1016/S0959-4388(03)00069-2; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Zachariou V, 2006, NAT NEUROSCI, V9, P205, DOI 10.1038/nn1636; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhao H, 2006, MOL PHARMACOL, V69, P1421, DOI 10.1124/mol.105.020024	45	56	60	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2008	58	2					238	247		10.1016/j.neuron.2008.02.006	http://dx.doi.org/10.1016/j.neuron.2008.02.006			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292YX	18439408	Green Accepted, Bronze			2022-12-24	WOS:000255303100011
J	Haug, JS; He, XC; Grindley, JC; Wunderlich, JP; Gaudenz, K; Ross, JT; Paulson, A; Wagner, KP; Xie, YC; Zhu, RH; Yin, T; Perry, JM; Hembree, MJ; Redenbaugh, EP; Radice, GL; Seidel, C; Li, LH				Haug, Jeffrey S.; He, Xi C.; Grindley, Justin C.; Wunderlich, Joshua P.; Gaudenz, Karin; Ross, Jason T.; Paulson, Ariel; Wagner, Kathryn P.; Xie, Yucai; Zhu, Ruihong; Yin, Tong; Perry, John M.; Hembree, Mark J.; Redenbaugh, Erin P.; Radice, Glenn L.; Seidel, Christopher; Li, Linheng			N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells	CELL STEM CELL			English	Article							MURINE BONE-MARROW; PROGENITOR CELLS; NICHE; MICROENVIRONMENT; DIFFERENTIATION; MOBILIZATION; MAINTENANCE; CHEMOKINES; ADHESION; GENES	Osteoblasts expressing the homophilic adhesion molecule N-cadherin form a hematopoietic stem cell (HSC) niche. Therefore, we examined how N-cadherin expression in HSCs relates to their function. We found that bone marrow (BM) cells highly expressing N-cadherin (N-cadherin hi) are not stem cells, being largely devoid of a Lineage(-)Scal(+)cKit(+) population and unable to reconstitute hematopoietic lineages in irradiated recipient mice. Instead, long-term HSCs form distinct populations expressing N-cadherin at intermediate (N-cadherin(int)) or low (N-cadherin(lo)) levels. The minority N-cadherin(lo) population can robustly reconstitute the hematopoietic system, express genes that may prime them to mobilize, and predominate among HSCs mobilized from BM to spleen. The larger N-cadherin(int) population performs poorly in reconstitution assays when freshly isolated but improves in response to overnight in vitro culture. Their expression profile and lower cell-cycle entry rate suggest N-cadherinint cells are being held in reserve. Thus, differential N-cadherin expression reflects functional distinctions between two HSC subpopulations.	[Haug, Jeffrey S.; He, Xi C.; Grindley, Justin C.; Wunderlich, Joshua P.; Gaudenz, Karin; Ross, Jason T.; Paulson, Ariel; Wagner, Kathryn P.; Xie, Yucai; Zhu, Ruihong; Yin, Tong; Perry, John M.; Hembree, Mark J.; Redenbaugh, Erin P.; Seidel, Christopher; Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Radice, Glenn L.] Univ Penn, Sch Med, Ctr Res Reprod & Womens Hlth, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Li, Linheng] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Pennsylvania; Pennsylvania Medicine; University of Kansas; University of Kansas Medical Center	Li, LH (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	lil@stowers-institute.org		Li, Linheng/0000-0001-9963-430X				Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; BRONNERFRASER M, 1992, DEV BIOL, V153, P291, DOI 10.1016/0012-1606(92)90114-V; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Gupta R, 2007, SCIENCE, V316, P590, DOI 10.1126/science.1136031; Hosokawa K, 2007, BIOCHEM BIOPH RES CO, V363, P578, DOI 10.1016/j.bbrc.2007.09.014; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Janowska-Wieczorek A, 2000, EXP HEMATOL, V28, P1274, DOI 10.1016/S0301-472X(00)00532-4; Kasemeier-Kulesa JC, 2006, DEVELOPMENT, V133, P4839, DOI 10.1242/dev.02662; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; LERNER C, 1990, EXP HEMATOL, V18, P114; Luo Y, 2005, DEV DYNAM, V232, P336, DOI 10.1002/dvdy.20241; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Muguruma Y, 2006, BLOOD, V107, P1878, DOI 10.1182/blood-2005-06-2211; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pezzato E, 2003, J LEUKOCYTE BIOL, V74, P88, DOI 10.1189/jlb.0203086; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Tydell CC, 2007, J IMMUNOL, V179, P421, DOI 10.4049/jimmunol.179.1.421; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	40	109	114	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR	2008	2	4					367	379		10.1016/j.stem.2008.01.017	http://dx.doi.org/10.1016/j.stem.2008.01.017			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	293HT	18397756	Bronze			2022-12-24	WOS:000255327000013
J	Maillard, I; Koch, U; Dumortier, A; Shestova, O; Xu, L; Sai, H; Pross, SE; Aster, JC; Bhandoola, A; Radtke, F; Pear, WS				Maillard, Ivan; Koch, Ute; Dumortier, Alexis; Shestova, Olga; Xu, Lanwei; Sai, Hong; Pross, Seth E.; Aster, Jon C.; Bhandoola, Avinash; Radtke, Freddy; Pear, Warren S.			Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells	CELL STEM CELL			English	Article							SELF-RENEWAL; IN-VIVO; C-MYC; PROGENITOR CELLS; LINEAGE SPECIFICATION; MAMMALIAN NOTCH; FATE DECISIONS; HUMAN HOMOLOG; EX-VIVO; B-CELLS	Gain-of-function experiments have demonstrated the potential of Notch signals to expand primitive hematopoietic progenitors, but whether Notch physiologically regulates hematopoietic stem cell (HSC) homeostasis in vivo is unclear. To answer this question, we evaluated the effect of global deficiencies of canonical Notch signaling in rigorous HSC assays. Hematopoietic progenitors expressing dominant-negative Mastermind-like1 (DNMAML), a potent inhibitor of Notch-mediated transcriptional activation, achieved stable long-term reconstitution of irradiated hosts and showed a normal frequency of progenitor fractions enriched for long-term HSCs. Similar results were observed with cells lacking CSL/RBPJ, a DNA-binding factor that is required for canonical Notch signaling. Notch-deprived progenitors provided normal long-term reconstitution after secondary competitive transplantation. Furthermore, Notch target genes were expressed at low levels in primitive hematopoietic progenitors. Taken together, these results rule out an essential physiological role for cell-autonomous canonical Notch signals in HSC maintenance.	[Maillard, Ivan; Shestova, Olga; Xu, Lanwei; Sai, Hong; Pross, Seth E.; Pear, Warren S.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Maillard, Ivan] Univ Michigan, Ctr Stem Cell Biol, Inst Life Sci, Ann Arbor, MI 48109 USA; [Maillard, Ivan] Univ Michigan, Div Hematol Oncol, Dept Internal Med, Ann Arbor, MI 48109 USA; [Maillard, Ivan] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Maillard, Ivan] Univ Penn, Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Shestova, Olga; Xu, Lanwei; Sai, Hong; Pross, Seth E.; Bhandoola, Avinash; Pear, Warren S.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Shestova, Olga; Xu, Lanwei; Sai, Hong; Pross, Seth E.; Pear, Warren S.] Univ Penn, Sch Med, Inst Med & Engn, Philadelphia, PA 19104 USA; [Koch, Ute; Dumortier, Alexis; Radtke, Freddy] Swiss Inst Expt Canc Res, Ecole Polytech Fed Lausanne, CH-1066 Epalinges, Switzerland; [Aster, Jon C.] Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Pear, WS (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	wpear@mail.med.upenn.edu	Radtke, Freddy/Q-3198-2017	Radtke, Freddy/0000-0003-4315-4045; Koch, Ute/0000-0001-7914-7061; Maillard, Ivan/0000-0003-1312-6748	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047833] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI047833-07, R01 AI047833] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carlesso N, 1999, BLOOD, V93, P838, DOI 10.1182/blood.V93.3.838.403k29_838_848; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; DE SB, 1999, NATURE, V398, P518; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Harman BC, 2005, BLOOD, V106, P886, DOI 10.1182/blood-2004-12-4881; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jeffries S, 2002, MOL CELL BIOL, V22, P3927, DOI 10.1128/MCB.22.11.3927-3941.2002; Karanu FN, 2001, BLOOD, V97, P1960, DOI 10.1182/blood.V97.7.1960; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Maillard I, 2006, BLOOD, V107, P3511, DOI 10.1182/blood-2005-08-3454; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; MILNER LA, 1994, BLOOD, V83, P2057; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; Shawber C, 1996, DEVELOPMENT, V122, P3765; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Suzuki T, 2006, STEM CELLS, V24, P2456, DOI 10.1634/stemcells.2006-0258; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Varnum-Finney B, 2003, BLOOD, V101, P1784, DOI 10.1182/blood-2002-06-1862; Visan I, 2006, IMMUNOL REV, V209, P76, DOI 10.1111/j.0105-2896.2006.00360.x; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598	67	226	235	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR	2008	2	4					356	366		10.1016/j.stem.2008.02.011	http://dx.doi.org/10.1016/j.stem.2008.02.011			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	293HT	18397755	Bronze, Green Accepted			2022-12-24	WOS:000255327000012
J	Wang, R; King, T; Ossipov, MH; Rossomando, AJ; Vanderah, TW; Harvey, P; Cariani, P; Frank, E; Sah, DWY; Porreca, F				Wang, Ruizhong; King, Tamara; Ossipov, Michael H.; Rossomando, Anthony J.; Vanderah, Todd W.; Harvey, Pamela; Cariani, Peter; Frank, Eric; Sah, Dinah W. Y.; Porreca, Frank			Persistent restoration of sensory function by immediate or delayed systemic artemin after dorsal root injury	NATURE NEUROSCIENCE			English	Article							ADULT SPINAL-CORD; NEUROTROPHIC FACTOR; NERVE INJURY; RECEPTOR COMPONENTS; AXONAL REGENERATION; NEUROPATHIC PAIN; SCHWANN-CELLS; SCIATIC-NERVE; GDNF FAMILY; C-FOS	Dorsal root injury results in substantial and often irreversible loss of sensory functions as a result of the limited regenerative capacity of sensory axons and the inhibitory barriers that prevent both axonal entry into and regeneration in the spinal cord. Here, we describe previously unknown effects of the growth factor artemin after crush injury of the dorsal spinal nerve roots in rats. Artemin not only promoted re-entry of multiple classes of sensory fibers into the spinal cord and re-establishment of synaptic function and simple behavior, but it also, surprisingly, promoted the recovery of complex behavior. These effects occurred after a 2-week schedule of intermittent, systemic administration of artemin and persisted for at least 6 months following treatment, suggesting a substantial translational advantage. Systemic artemin administration produced essentially complete and persistent restoration of nociceptive and sensorimotor functions, and could represent a promising therapy that may effectively promote sensory neuronal regeneration and functional recovery after injury.	[Wang, Ruizhong; King, Tamara; Ossipov, Michael H.; Vanderah, Todd W.; Porreca, Frank] Univ Arizona, Dept Pharmacol, Coll Med, Tucson, AZ 85724 USA; [Rossomando, Anthony J.; Sah, Dinah W. Y.] Biogen Idec, Cambridge, MA 02142 USA; [Harvey, Pamela; Cariani, Peter; Frank, Eric] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	University of Arizona; Biogen; Tufts University	Porreca, F (corresponding author), Univ Arizona, Dept Pharmacol, Coll Med, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	frankp@u.arizona.edu		HARVEY, PAMELA/0000-0001-9102-8823	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064494] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS064494] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABBADIE C, 1992, BRAIN RES, V578, P17, DOI 10.1016/0006-8993(92)90224-W; Al-Qattan MM, 2003, ANN PLAS SURG, V51, P257, DOI 10.1097/01.SAP.0000063750.16982.E4; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Baloh RH, 1998, P NATL ACAD SCI USA, V95, P5801, DOI 10.1073/pnas.95.10.5801; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; BALOH RH, 1997, RET NEURON, V18, P793; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bennett DLH, 2000, J NEUROSCI, V20, P427, DOI 10.1523/JNEUROSCI.20-01-00427.2000; Blesch A, 2003, J COMP NEUROL, V467, P403, DOI 10.1002/cne.10934; Bradbury EJ, 1998, MOL CELL NEUROSCI, V12, P256, DOI 10.1006/mcne.1998.0719; CARLSTEDT T, 1985, BRAIN RES, V347, P188, DOI 10.1016/0006-8993(85)90911-4; Fraher JP, 2000, J ANAT, V196, P137; FUNAKOSHI H, 1993, J CELL BIOL, V123, P455, DOI 10.1083/jcb.123.2.455; Gardell LR, 2003, NAT MED, V9, P1383, DOI 10.1038/nm944; Hammarberg H, 1996, NEUROREPORT, V7, P857, DOI 10.1097/00001756-199603220-00004; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; Honore P, 1999, J NEUROSCI, V19, P7670, DOI 10.1523/JNEUROSCI.19-17-07670.1999; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; JOHNSON EM, 1988, TRENDS NEUROSCI, V11, P299, DOI 10.1016/0166-2236(88)90090-2; Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q; Malin SA, 2006, J NEUROSCI, V26, P8588, DOI 10.1523/JNEUROSCI.1726-06.2006; Neumann S, 2005, P NATL ACAD SCI USA, V102, P16848, DOI 10.1073/pnas.0508538102; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; OBLINGER MM, 1984, J NEUROSCI, V4, P1736; Orozco OE, 2001, EUR J NEUROSCI, V13, P2177, DOI 10.1046/j.0953-816x.2001.01596.x; Plunet W, 2002, J NEUROSCI RES, V68, P1, DOI 10.1002/jnr.10176; PRESLEY RW, 1990, J NEUROSCI, V10, P323; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Ramer LM, 2004, J NEUROSCI, V24, P10796, DOI 10.1523/JNEUROSCI.3337-04.2004; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Ramer MS, 2002, MOL CELL NEUROSCI, V19, P239, DOI 10.1006/mcne.2001.1067; Ramer MS, 2001, J NEUROCHEM, V77, P864, DOI 10.1046/j.1471-4159.2001.00288.x; ROBERTSON B, 1985, NEUROSCIENCE, V14, P895, DOI 10.1016/0306-4522(85)90152-6; Sah DWY, 2005, CURR TOP MED CHEM, V5, P577, DOI 10.2174/1568026054367593; Sah DWY, 2003, NAT REV DRUG DISCOV, V2, P460, DOI 10.1038/nrd1107; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Starkey ML, 2005, EXP NEUROL, V195, P524, DOI 10.1016/j.expneurol.2005.06.017; Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Wang R, 2003, NEUROSCIENCE, V121, P815, DOI 10.1016/S0306-4522(03)00491-3; Wong LF, 2006, NAT NEUROSCI, V9, P243, DOI 10.1038/nn1622; Woolf CJ, 2002, SCIENCE, V297, P1132, DOI 10.1126/science.1076247; WUJEK JR, 1983, J NEUROSCI, V3, P243; Yan H, 2003, DEV DYNAM, V227, P395, DOI 10.1002/dvdy.10294	46	74	85	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					488	496		10.1038/nn2069	http://dx.doi.org/10.1038/nn2069			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344995	Green Accepted			2022-12-24	WOS:000254359300021
J	Kurotani, T; Yamada, K; Yoshimura, Y; Crair, MC; Komatsu, Y				Kurotani, Tohru; Yamada, Kazumasa; Yoshimura, Yumiko; Crair, Michael C.; Komatsu, Yukio			State-dependent bidirectional modification of somatic inhibition in neocortical pyramidal cells	NEURON			English	Article							LONG-TERM DEPRESSION; AMPA RECEPTOR TRAFFICKING; E CALCIUM-CHANNEL; SYNAPTIC-TRANSMISSION; GABA(A) RECEPTORS; BLOCKER-RESISTANT; IN-VIVO; T-TYPE; SLEEP; PLASTICITY	Cortical pyramidal neurons alter their responses to input signals depending on behavioral state. We investigated whether changes in somatic inhibition contribute to these alterations. In layer 5 pyramidal neurons of rat visual cortex, repetitive firing from a depolarized membrane potential, which typically occurs during arousal, produced long-lasting depression of somatic inhibition. In contrast, slow membrane oscillations with firing in the depolarized phase, which typically occurs during slow-wave sleep, produced long-lasting potentiation. The depression is mediated by L-type Ca2+ channels and GABAA receptor endocytosis, whereas potentiation is mediated by R-type Ca2+ channels and receptor exocytosis. It is likely that the direction of modification is mainly dependent on the ratio of R- and L-type Ca2+ channel activation. Furthermore, somatic inhibition was stronger in slices prepared from rats during slow-wave sleep than arousal. This bidirectional modification of somatic inhibition may alter pyramidal neuron responsiveness in accordance with behavioral state.	[Kurotani, Tohru; Yamada, Kazumasa; Yoshimura, Yumiko; Komatsu, Yukio] Nagoya Univ, Environm Med Res Inst, Dept Neurosci, Nagoya, Aichi 4648601, Japan; [Kurotani, Tohru] RIKEN, Brain Sci Inst, Lab Cort Org & Systemat, Wako, Saitama 3510198, Japan; [Crair, Michael C.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Nagoya University; RIKEN; Yale University	Kurotani, T (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neurosci, Nagoya, Aichi 4648601, Japan.	kurotani@brain.riken.jp		Yoshimura, Yumiko/0000-0002-7526-4153	NEI NIH HHS [P30 EY000785-39, P30 EY000785, P30 EY000785-369006, R01 EY015788-03, R01 EY015788-06, P30 EY000785-38, P30 EY000785-389006, R01 EY015788-01A1, R01 EY015788-05, P30 EY000785-36, R01 EY015788-02, R01 EY015788-04, R01 EY015788, P30 EY000785-379006, P30 EY000785-37, R01 EY015788-07, R01 EY015788-06S1] Funding Source: Medline; NIMH NIH HHS [R01 MH062639-08, R01 MH062639-01, R01 MH062639-04, R01 MH062639-07, R01 MH062639-05, R01 MH062639-09, R01 MH062639-02, R01 MH062639-03, R01 MH062639-06A2, R01 MH062639] Funding Source: Medline; NINDS NIH HHS [T32 NS007224, T32 NS007224-26, T32 NS007224-27, T32 NS007224-25] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY000785, R01EY015788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007224] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; Barnes EM, 2000, LIFE SCI, V66, P1063, DOI 10.1016/S0024-3205(99)00469-5; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Cavazzini M, 2005, CELL CALCIUM, V38, P355, DOI 10.1016/j.ceca.2005.06.013; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Edeline JM, 2000, J NEUROPHYSIOL, V84, P934, DOI 10.1152/jn.2000.84.2.934; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Foehring RC, 2000, J NEUROPHYSIOL, V84, P2225, DOI 10.1152/jn.2000.84.5.2225; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; GRAMSBERGEN A, 1976, DEV PSYCHOBIOL, V9, P501, DOI 10.1002/dev.420090604; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hobson JA, 2005, NATURE, V437, P1254, DOI 10.1038/nature04283; Jouvenceau A, 2000, J NEUROPHYSIOL, V83, P671, DOI 10.1152/jn.2000.83.2.671; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kittler JT, 2000, J NEUROSCI, V20, P7972; Komatsu Y, 1996, J NEUROSCI, V16, P6342; KOMATSU Y, 1993, NEUROREPORT, V4, P907, DOI 10.1097/00001756-199307000-00017; Kurotani T, 2003, NEUROSCI LETT, V337, P1, DOI 10.1016/S0304-3940(02)01160-6; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; Ling DSF, 1999, J NEUROPHYSIOL, V82, P1793, DOI 10.1152/jn.1999.82.4.1793; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Magistretti J, 2000, EUR J NEUROSCI, V12, P2376, DOI 10.1046/j.1460-9568.2000.00125.x; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; McLean HA, 1996, J PHYSIOL-LONDON, V496, P471, DOI 10.1113/jphysiol.1996.sp021699; Nakashima YM, 1998, NEUROPHARMACOLOGY, V37, P957, DOI 10.1016/S0028-3908(98)00097-5; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Portas CM, 2000, NEURON, V28, P991, DOI 10.1016/S0896-6273(00)00169-0; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Sochivko D, 2003, NEUROSCIENCE, V116, P629, DOI 10.1016/S0306-4522(02)00777-7; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Willshaw D, 1990, NEURAL COMPUT, V2, P85, DOI 10.1162/neco.1990.2.1.85; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; YOKOYAMA CT, 1995, J NEUROSCI, V15, P6419; Yoshimura Y, 2003, J NEUROSCI, V23, P6557; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L	59	64	65	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2008	57	6					905	916		10.1016/j.neuron.2008.01.030	http://dx.doi.org/10.1016/j.neuron.2008.01.030			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281LV	18367091	Green Accepted, Bronze			2022-12-24	WOS:000254500000014
J	Lin, MT; Lujan, R; Watanabe, M; Adelman, JP; Maylie, J				Lin, Mike T.; Lujan, Rafael; Watanabe, Masahiko; Adelman, John P.; Maylie, James			SK2 channel plasticity contributes to LTP at Schaffer collateral-CA1 synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA2+-ACTIVATED POTASSIUM CHANNEL; SYNAPTIC PLASTICITY; SMALL-CONDUCTANCE; AMPA RECEPTORS; DENDRITIC SPINES; CALCIUM-CHANNELS; PROTEIN-KINASE; LATE-PHASE; I-H	Long-term potentiation (LTP) of synaptic strength at Schaffer collateral synapses has largely been attributed to changes in the number and biophysical properties of AMPA receptors (AMPARs). Small-conductance Ca2(+)-activated K+ channels (SK2 channels) are functionally coupled with NMDA receptors (NMDARs) in CA1 spines such that their activity modulates the shape of excitatory postsynaptic potentials (EPSPs) and increases the threshold for induction of LTP. Here we show that LTP induction in mouse hippocampus abolishes SK2 channel activity in the potentiated synapses. This effect is due to SK2 channel internalization from the postsynaptic density (PSD) into the spine. Blocking PKA or cell dialysis with a peptide representing the C-terminal domain of SK2 that contains three known PKA phosphorylation sites blocks the internalization of SK2 channels after LTP induction. Thus the increase in AMPARs and the decrease in SK2 channels combine to produce the increased EPSP underlying LTP.	[Lin, Mike T.; Adelman, John P.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Lujan, Rafael] Univ Castilla La Mancha, Dept Ciencias Med, Albacete 02006, Spain; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Maylie, James] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA	Oregon Health & Science University; Universidad de Castilla-La Mancha; Hokkaido University; Oregon Health & Science University	Adelman, JP (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	adelman@ohsu.edu; mayliej@ohsu.edu	WATANABE, Masahiko/A-4055-2012; Lujan, Rafael/G-2555-2015; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Watanabe, Masahiko/0000-0001-5037-7138; Lujan Miras, Rafael/0000-0003-2001-9545	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076752, F32MH080480, R01MH081860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038880] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH076752-03, F32 MH080480, R01 MH081860, R01 MH076752, R01 MH081860-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS038880-08, R01 NS038880] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown GP, 2000, J NEUROSCI, V20, P7880; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Otmakhova NA, 2004, J NEUROPHYSIOL, V92, P2027, DOI 10.1152/jn.00427.2004; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pereda AE, 1998, P NATL ACAD SCI USA, V95, P13272, DOI 10.1073/pnas.95.22.13272; Ren YJ, 2006, J BIOL CHEM, V281, P11769, DOI 10.1074/jbc.M513125200; Roth-Alpermann C, 2006, P NATL ACAD SCI USA, V103, P11039, DOI 10.1073/pnas.0600894103; Sailer CA, 2004, MOL CELL NEUROSCI, V26, P458, DOI 10.1016/j.mcn.2004.03.002; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stackman RW, 2002, J NEUROSCI, V22, P10163; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112	48	169	172	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					170	177		10.1038/nn2041	http://dx.doi.org/10.1038/nn2041			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18204442	Green Accepted			2022-12-24	WOS:000252712100011
J	Gielen, M; Le Goff, A; Stroebel, D; Johnson, JW; Neyton, J; Paoletti, P				Gielen, Marc; Le Goff, Anne; Stroebel, David; Johnson, Jon W.; Neyton, Jacques; Paoletti, Pierre			Structural Rearrangements of NR1/NR2A NMDA receptors during allosteric inhibition	NEURON			English	Article							N-TERMINAL DOMAIN; MOLECULAR DETERMINANTS; ZINC INHIBITION; ZN2+ INHIBITION; BINDING DOMAIN; DESENSITIZATION; MECHANISM; AFFINITY; PROTON; MODULATION	Ionotropic glutamate receptor (iGluR) subunits contain a large N-terminal domain (NTD) that precedes the agonist-binding domain (ABD) and participates in subunit oligomerization. In NMDA receptors (NMDARs), the NTDs of NR2A and NR2B subunits also form binding sites for the endogenous inhibitor Zn2+ ion. Although these allosteric sites have been characterized in detail, the molecular mechanisms by which the NTDs communicate with the rest of the receptor to promote its inhibition remain unknown. Here, we identify the ABD dimer interface as a major structural determinant that permits coupling between the NTDs and the channel gate. The strength of this interface also controls proton inhibition, another form of allosteric modulation of NMDARs. Conformational rearrangements at the ABD dimer interface thus appear to be a key mechanism conserved in all iGluR subfamilies, but have evolved to fulfill different functions: fast desensitization at AMPA and kainate receptors, allosteric inhibition at NMDARs.	[Gielen, Marc; Le Goff, Anne; Stroebel, David; Neyton, Jacques; Paoletti, Pierre] Ecole Normale Super, CNRS, Neurobiol Lab, F-75005 Paris, France; [Johnson, Jon W.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Paoletti, P (corresponding author), Ecole Normale Super, CNRS, Neurobiol Lab, 46 Rue Ulm, F-75005 Paris, France.	paoletti@biologie.ens.fr	Gielen, Marc/AAA-8760-2020; Paoletti, Pierre/L-7358-2013	Paoletti, Pierre/0000-0002-3681-4845; Gielen, Marc/0000-0003-0941-4325	NIMH NIH HHS [R01 MH045817-13, R01 MH045817-15, R01 MH045817-14, R01 MH045817, R01 MH045817-15S1, R01 MH045817-16] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045817] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Ayalon G, 2005, J BIOL CHEM, V280, P15053, DOI 10.1074/jbc.M408413200; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dingledine R, 1999, PHARMACOL REV, V51, P7; Erreger K, 2005, J PHYSIOL-LONDON, V569, P381, DOI 10.1113/jphysiol.2005.095497; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Ihle EC, 2000, MOL PHARMACOL, V58, P1204, DOI 10.1124/mol.58.6.1204; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jingami H, 2003, CURR OPIN NEUROBIOL, V13, P271, DOI 10.1016/S0959-4388(03)00067-9; Kew JNC, 1996, J PHYSIOL-LONDON, V497, P761, DOI 10.1113/jphysiol.1996.sp021807; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Lei SB, 2001, J NEUROPHYSIOL, V85, P2030, DOI 10.1152/jn.2001.85.5.2030; Low CM, 2003, MOL PHARMACOL, V63, P1212, DOI 10.1124/mol.63.6.1212; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; PAOLETTI P, 1995, NEURON, V15, P1109, DOI 10.1016/0896-6273(95)90099-3; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; Priel A, 2006, NEURON, V52, P1037, DOI 10.1016/j.neuron.2006.12.006; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; TRAYNELIS SF, 1991, J PHYSIOL-LONDON, V433, P727, DOI 10.1113/jphysiol.1991.sp018453; Traynelis SF, 2001, NEURON, V32, P960, DOI 10.1016/S0896-6273(01)00549-9; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894	40	96	96	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 10	2008	57	1					80	93		10.1016/j.neuron.2007.11.021	http://dx.doi.org/10.1016/j.neuron.2007.11.021			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	250YZ	18184566	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000252338600011
J	Wu, YM; Wang, WG; Diez-Sampedro, A; Richerson, GB				Wu, Yuanming; Wang, Wengang; Diez-Sampedro, Ana; Richerson, George B.			Nonvesicular inhibitory neurotransmission via reversal of the GABA transporter GAT-1	NEURON			English	Article							GAMMA-AMINOBUTYRIC-ACID; EXCITATORY AMINO-ACIDS; CENTRAL-NERVOUS-SYSTEM; RAT HIPPOCAMPAL SLICE; GRANULE CELLS; SYNAPTIC POTENTIALS; <H-3>GABA RELEASE; PYRAMIDAL NEURONS; NIPECOTIC ACID; GLUTAMATE	GABA transporters play an important but poorly understood role in neuronal inhibition. They can reverse, but this is widely thought to occur only under pathological conditions. Here we use a heterologous expression system to show that the reversal potential of GAT-1 under physiologically relevant conditions is near the normal resting potential of neurons and that reversal can occur rapidly enough to release GABA during simulated action potentials. We then use paired recordings from cultured hippocampal neurons and show that GABAergic transmission is not prevented by four methods widely used to block vesicular release. This nonvesicular neurotransmission was potently blocked by GAT-1 antagonists and was enhanced by agents that increase cytosolic [GABA] or [Na+] (which would increase GAT-1 reversal). We conclude that GAT-1 regulates tonic inhibition by clamping ambient [GABA] at a level high enough to activate high-affinity GABA(A) receptors and that transporter-mediated GABA release can contribute to phasic inhibition.	[Wu, Yuanming; Wang, Wengang; Diez-Sampedro, Ana; Richerson, George B.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Richerson, George B.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Richerson, George B.] Vet Affairs Med Ctr, Neurol Serv, West Haven, CT 06516 USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Richerson, GB (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	george.richerson@yale.edu	wu, yuanming/C-1011-2008	Richerson, George/0000-0001-5696-1554	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043288, P50NS006208] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS043288, NS43288, R01 NS043288-04, P50 NS006208-350054] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBUS U, 1983, TOXICON, V21, P97, DOI 10.1016/0041-0101(83)90053-3; ARONSON PS, 2003, MED PHYSL CELLULAR M, P50; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BELHAGE B, 1993, NEUROSCIENCE, V54, P1019, DOI 10.1016/0306-4522(93)90592-4; BERNATH S, 1988, NEUROSCIENCE, V27, P563, DOI 10.1016/0306-4522(88)90289-8; Bianchi MT, 2002, NEUROPHARMACOLOGY, V43, P492, DOI 10.1016/S0028-3908(02)00163-6; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; CAMMACK JN, 1994, NEURON, V13, P949, DOI 10.1016/0896-6273(94)90260-7; Cavelier P, 2005, PROG BIOPHYS MOL BIO, V87, P3, DOI 10.1016/j.pbiomolbio.2004.06.001; Cheng VY, 2006, ANESTHESIOLOGY, V105, P325, DOI 10.1097/00000542-200608000-00015; Deken SL, 2001, TRENDS NEUROSCI, V24, P623, DOI 10.1016/S0166-2236(00)01933-0; DINGLEDINE R, 1985, J PHYSIOL-LONDON, V366, P387, DOI 10.1113/jphysiol.1985.sp015804; DURING MJ, 1995, NATURE, V376, P174, DOI 10.1038/376174a0; Falkenburger BH, 2001, SCIENCE, V293, P2465, DOI 10.1126/science.1060645; Gaspary HL, 1998, J NEUROPHYSIOL, V80, P270, DOI 10.1152/jn.1998.80.1.270; GONZALES AL, 2007, IN PRESS J MEMBR BIO; HAGBERG H, 1985, J CEREBR BLOOD F MET, V5, P413, DOI 10.1038/jcbfm.1985.56; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; HARTUNG K, 1985, PFLUG ARCH EUR J PHY, V404, P119, DOI 10.1007/BF00585406; Hell JW, 1998, METHOD ENZYMOL, V296, P116; HONMOU O, 1995, EPILEPSY RES, V20, P193, DOI 10.1016/0920-1211(94)00076-9; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; Krause S, 2005, MOL PHARMACOL, V68, P1728, DOI 10.1124/mol.105.013870; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; LEVI G, 1993, TRENDS NEUROSCI, V16, P415, DOI 10.1016/0166-2236(93)90010-J; Lu CC, 1999, J GEN PHYSIOL, V114, P429, DOI 10.1085/jgp.114.3.429; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; OTSUKA M, 1971, J NEUROCHEM, V18, P287, DOI 10.1111/j.1471-4159.1971.tb00567.x; Overstreet LS, 2003, J NEUROSCI, V23, P2618; Overstreet LS, 2001, J NEUROPHYSIOL, V86, P596, DOI 10.1152/jn.2001.86.2.596; PEARCE BR, 1983, J NEUROCHEM, V40, P887, DOI 10.1111/j.1471-4159.1983.tb08064.x; Petroff OAC, 1996, ANN NEUROL, V39, P95, DOI 10.1002/ana.410390114; PHILLIS JW, 1994, BRAIN RES BULL, V34, P457, DOI 10.1016/0361-9230(94)90019-1; PIN JP, 1989, J NEUROSCI, V9, P648; Poncer JC, 2000, J PHYSIOL-LONDON, V528, P123, DOI 10.1111/j.1469-7793.2000.00123.x; Regehr WG, 1997, BIOPHYS J, V73, P2476, DOI 10.1016/S0006-3495(97)78276-6; Richerson GB, 2003, J NEUROPHYSIOL, V90, P1363, DOI 10.1152/jn.00317.2003; ROEPSTORFF A, 1992, NEUROSCI LETT, V146, P131, DOI 10.1016/0304-3940(92)90060-K; Rose CR, 1997, J PHYSIOL-LONDON, V499, P573, DOI 10.1113/jphysiol.1997.sp021951; Rose CR, 2002, NEUROSCIENTIST, V8, P532, DOI 10.1177/1073858402238512; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; ROTHMAN DL, 1993, P NATL ACAD SCI USA, V90, P5662, DOI 10.1073/pnas.90.12.5662; Saxena NC, 1996, MOL PHARMACOL, V49, P567; SCHWARTZ EA, 1982, J PHYSIOL-LONDON, V323, P211, DOI 10.1113/jphysiol.1982.sp014069; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; Sperk G, 2003, HIPPOCAMPUS, V13, P806, DOI 10.1002/hipo.10133; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; THOMPSON SM, 1992, J NEUROPHYSIOL, V67, P1698, DOI 10.1152/jn.1992.67.6.1698; TOSSMAN U, 1986, ACTA PHYSIOL SCAND, V127, P533, DOI 10.1111/j.1748-1716.1986.tb07938.x; TURNER TJ, 1989, BIOCHEMISTRY-US, V28, P586, DOI 10.1021/bi00428a026; Whitworth TL, 2001, BIOCHEM SOC T, V29, P736, DOI 10.1042/BST0290736; Wu YM, 2003, J NEUROPHYSIOL, V89, P2021, DOI 10.1152/jn.00856.2002; Wu YM, 2001, J NEUROSCI, V21, P2630, DOI 10.1523/JNEUROSCI.21-08-02630.2001; Wu YM, 2006, J NEUROPHYSIOL, V96, P2425, DOI 10.1152/jn.00545.2006; YUNGER LM, 1984, J PHARMACOL EXP THER, V228, P109; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhu L, 2005, J NEUROPHYSIOL, V93, P1557, DOI 10.1152/jn.00616.2004	63	186	188	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 6	2007	56	5					851	865		10.1016/j.neuron.2007.10.021	http://dx.doi.org/10.1016/j.neuron.2007.10.021			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241MA	18054861	Bronze, Green Accepted			2022-12-24	WOS:000251659300011
J	Di Cristo, G; Chattopadhyaya, B; Kuhlman, SJ; Fu, Y; Belanger, MC; Wu, CZ; Rutishauser, U; Maffei, L; Huang, ZJ				Di Cristo, Graziella; Chattopadhyaya, Bidisha; Kuhlman, Sandra J.; Fu, Yu; Belanger, Marie-Claude; Wu, Cai Zhi; Rutishauser, Urs; Maffei, Lamberto; Huang, Z. Josh			Activity-dependent PSA expression regulates inhibitory maturation and onset of critical period plasticity	NATURE NEUROSCIENCE			English	Article							CELL-ADHESION MOLECULE; PRIMARY VISUAL-CORTEX; GAMMA-AMINOBUTYRIC-ACID; POLYSIALIC ACID; GABAERGIC INNERVATION; SYNAPTIC PLASTICITY; CEREBRAL-CORTEX; ADULT; AXONS; NCAM	Functional maturation of GABAergic innervation in the developing visual cortex is regulated by neural activity and sensory inputs and in turn influences the critical period of ocular dominance plasticity. Here we show that polysialic acid (PSA), presented by the neural cell adhesion molecule, has a role in the maturation of GABAergic innervation and ocular dominance plasticity. Concentrations of PSA significantly decline shortly after eye opening in the adolescent mouse visual cortex; this decline is hindered by visual deprivation. The developmental and activity-dependent regulation of PSA expression is inversely correlated with the maturation of GABAergic innervation. Premature removal of PSA in visual cortex results in precocious maturation of perisomatic innervation by basket interneurons, enhanced inhibitory synaptic transmission, and earlier onset of ocular dominance plasticity. The developmental and activity-dependent decline of PSA expression therefore regulates the timing of the maturation of GABAergic inhibition and the onset of ocular dominance plasticity.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11734 USA; SUNY Stony Brook, Neurosci Program, Stony Brook, NY 11790 USA; Univ Montreal, CHU St Justine, Montreal, PQ H3T 1C5, Canada; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Inst Neuro Fisiol Ctr Nazl Ricerca, I-56124 Pisa, Italy	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Memorial Sloan Kettering Cancer Center	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11734 USA.	huangj@cshl.edu	Kuhlman, Sandra/Q-1211-2015	Kuhlman, Sandra/0000-0003-0450-7282; Huang, Z. Josh/0000-0003-0592-028X	NEI NIH HHS [R01 EY 13564-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013564] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Bouzioukh F, 2001, J NEUROSCI, V21, P4721, DOI 10.1523/JNEUROSCI.21-13-04721.2001; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Bruses JL, 1998, J CELL BIOL, V140, P1177, DOI 10.1083/jcb.140.5.1177; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Di Cristo G, 2004, NAT NEUROSCI, V7, P1184, DOI 10.1038/nn1334; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Dupuy ST, 1996, J NEUROSCI, V16, P6919; Echevarria D, 2000, DEV BRAIN RES, V123, P151, DOI 10.1016/S0165-3806(00)00089-4; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; El Maarouf A, 2003, J COMP NEUROL, V460, P203, DOI 10.1002/cne.10635; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Klostermann O, 1999, NEUROSCIENCE, V92, P1243, DOI 10.1016/S0306-4522(99)00009-3; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kurosawa N, 1997, J NEUROCHEM, V69, P494; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Minelli A, 2003, NEUROSCIENCE, V117, P337, DOI 10.1016/S0306-4522(02)00864-3; Morales B, 2002, J NEUROSCI, V22, P8084; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; Seki T, 1998, J NEUROSCI, V18, P3757; Soares S, 2000, J NEUROSCI, V20, P2551; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; Theodosis DT, 1999, J NEUROSCI, V19, P10228; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; Toki S, 2007, EUR J NEUROSCI, V25, P815, DOI 10.1111/j.1460-9568.2007.05288.x; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yamamoto N, 2000, J NEUROSCI, V20, P9145; YIN XH, 1995, DEVELOPMENT, V121, P3439	50	150	150	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1569	1577		10.1038/nn2008	http://dx.doi.org/10.1038/nn2008			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	18026099				2022-12-24	WOS:000251172900014
J	Mildner, A; Schmidt, H; Nitsche, M; Merkler, D; Hanisch, UK; Mack, M; Heikenwalder, M; Bruck, W; Priller, J; Prinz, M				Mildner, Alexander; Schmidt, Hauke; Nitsche, Mirko; Merkler, Doron; Hanisch, Uwe-Karsten; Mack, Matthias; Heikenwalder, Mathias; Brueck, Wolfgang; Priller, Josef; Prinz, Marco			Microglia in the adult brain arise from Ly-6C(hi)CCR2(+) monocytes only under defined host conditions	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; GREEN FLUORESCENT PROTEIN; MARROW-DERIVED MICROGLIA; BETA-AMYLOID DEPOSITION; NF-KAPPA-B; BONE-MARROW; HEMATOPOIETIC-CELLS; STEM-CELLS; IN-VIVO; AUTOIMMUNE ENCEPHALOMYELITIS	Microglia are crucially important myeloid cells in the CNS and constitute the first immunological barrier against pathogens and environmental insults. The factors controlling microglia recruitment from the blood remain elusive and the direct circulating microglia precursor has not yet been identified in vivo. Using a panel of bone marrow chimeric and adoptive transfer experiments, we found that circulating Ly-6C(hi)CCR2(+) monocytes were preferentially recruited to the lesioned brain and differentiated into microglia. Notably, microglia engraftment in CNS pathologies, which are not associated with overt blood-brain barrier disruption, required previous conditioning of brain (for example, by direct tissue irradiation). Our results identify Ly-6C(hi)CCR2(+) monocytes as direct precursors of microglia in the adult brain and establish the importance of local factors in the adult CNS for microglia engraftment.	Univ Gottingen, Inst Neuropathol, D-3400 Gottingen, Germany; Univ Gottingen, Dept Radiat Oncol, D-3400 Gottingen, Germany; Univ Regensburg, Dept Internal Med, D-8400 Regensburg, Germany; Univ Zurich Spital, Inst Neuropathol, Zurich, Switzerland; Univ Gottingen, Inst Multiple Sclerosis Res, D-3400 Gottingen, Germany; Charite Univ Med Berlin, Mol Psychiat Lab, Berlin, Germany	University of Gottingen; University of Gottingen; University of Regensburg; University of Zurich; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Prinz, M (corresponding author), Univ Gottingen, Inst Neuropathol, D-3400 Gottingen, Germany.	mprinz@med.uni-goettingen.de	mildner, alexander/AFK-2161-2022; Priller, Josef/ABW-3835-2022; Merkler, Doron/N-9157-2016; Nitsche, Mirko/K-8851-2019; mildner, alexander/AAF-9451-2022; Mildner, Alexander/ABG-6122-2020; mildner, alexander/GQA-3761-2022; Heikenwalder, Mathias/AAA-2269-2020	mildner, alexander/0000-0002-2019-8427; Merkler, Doron/0000-0002-0247-2007; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Priller, Josef/0000-0001-7596-0979				Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; BAKKER DA, 1987, J NEUROL SCI, V78, P125, DOI 10.1016/0022-510X(87)90055-4; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Biffi A, 2004, J CLIN INVEST, V113, P1118, DOI 10.1172/JCI200419205; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Furuya T, 2003, NEUROREPORT, V14, P629, DOI 10.1097/00001756-200303240-00021; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kokovay E, 2005, NEUROBIOL DIS, V19, P471, DOI 10.1016/j.nbd.2005.01.023; KONDO A, 1987, BRAIN RES, V425, P186, DOI 10.1016/0006-8993(87)90499-9; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Linard C, 2004, INT J RADIAT ONCOL, V58, P427, DOI 10.1016/j.ijrobp.2003.09.039; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; McMahon EJ, 2002, J NEUROIMMUNOL, V130, P32, DOI 10.1016/S0165-5728(02)00205-9; Merkler D, 2005, NMR BIOMED, V18, P395, DOI 10.1002/nbm.972; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Prinz M, 1999, J NEUROCHEM, V72, P2215, DOI 10.1046/j.1471-4159.1999.0722215.x; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; Remington LT, 2007, AM J PATHOL, V170, P1713, DOI 10.2353/ajpath.2007.060783; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Vallieres L, 2003, J NEUROSCI, V23, P5197; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wegiel J, 1998, BRAIN RES, V804, P135, DOI 10.1016/S0006-8993(98)00618-0; Wehner T, 2003, J NEUROSCI, V23, P5004; WILLIAMS AE, 1994, NEUROPATH APPL NEURO, V20, P47, DOI 10.1111/j.1365-2990.1994.tb00956.x; WSIRSKI FK, 2007, J CLIN INVEST, V117, P195; Yamamoto M, 2005, AM J PATHOL, V166, P1475, DOI 10.1016/S0002-9440(10)62364-4	50	788	805	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1544	1553		10.1038/nn2015	http://dx.doi.org/10.1038/nn2015			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	18026096				2022-12-24	WOS:000251172900011
J	Kiel, MJ; Radice, GL; Morrison, SJ				Kiel, Mark J.; Radice, Glenn L.; Morrison, Sean J.			Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance	CELL STEM CELL			English	Article							BONE-MARROW; SELF-RENEWAL; PROGENITOR CELLS; IN-VITRO; NICHE; DIFFERENTIATION; MICE; EXPRESSION; BIGLYCAN; LOCALIZATION	Recent studies have proposed that bone marrow hematopoietic stem cells (HSCs) are maintained via N-cadherin-mediated homophilic adhesion with osteoblasts. However, there is not yet any evidence that N-cadherin-expressing cells have HSC activity or that osteoblasts are required for HSC maintenance. We were unable to detect N-cadherin expression in highly purified HSCs by polymerase chain reaction, by using commercial anti-N-cadherin antibodies, or by beta-galactosidase staining of N-cadherin gene trap mice. Only N-cadherin-negative bone marrow cells exhibited HSC activity in irradiated mice. Finally, biglycan-deficient mice had significant reductions in trabecular bone and osteoblasts but showed no defects in hematopoiesis, HSC frequency, or function. Thus, reductions in osteoblasts do not necessarily lead to reductions in HSCs. Most bone marrow HSCs in wild-type and biglycan-deficient mice localized to sinusoids, and few localized within five cell diameters of the endosteum. These results question whether significant numbers of HSCs depend on N-cadherin-mediated adhesion to osteoblasts.	Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stem Cell Biol, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Penn, Sch Med, Dept Obstet & Gynecol, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329	NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [CA46592] Funding Source: Medline; NIAMS NIH HHS [P30 AR48310] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen XD, 2002, J BONE MINER RES, V17, P331, DOI 10.1359/jbmr.2002.17.2.331; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Hayashi R, 2007, STEM CELLS, V25, P289, DOI 10.1634/stemcells.2006-0167; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Li WM, 2004, EXP HEMATOL, V32, P1226, DOI 10.1016/j.exphem.2004.09.001; Luo Y, 2005, DEV DYNAM, V232, P336, DOI 10.1002/dvdy.20241; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Ohneda O, 1998, BLOOD, V92, P908; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; REDIES C, 1993, DEV DYNAM, V197, P26, DOI 10.1002/aja.1001970104; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; SUGIYAMA T, 2006, IN PRESS IMMUNITY; Suzuki N, 2006, P NATL ACAD SCI USA, V103, P2202, DOI 10.1073/pnas.0508928103; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; Tombran-Tink J, 2004, BIOCHEM BIOPH RES CO, V316, P573, DOI 10.1016/j.bbrc.2004.02.076; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Yao LB, 2005, BLOOD, V106, P4093, DOI 10.1182/blood-2005-02-0671; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	41	241	248	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG	2007	1	2					204	217		10.1016/j.stem.2007.06.001	http://dx.doi.org/10.1016/j.stem.2007.06.001			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XS	18371351	Bronze			2022-12-24	WOS:000251055100011
J	Larsson, J; Ohishi, M; Garrison, B; Aspling, M; Janzen, V; Adams, GB; Curto, M; McClatchey, AI; Schipani, E; Scadden, DT				Larsson, Jonas; Ohishi, Masanobu; Garrison, Brian; Aspling, Marie; Janzen, Viktor; Adams, Gregor B.; Curto, Marcello; McClatchey, Andrea I.; Schipani, Ernestina; Scadden, David T.			Nf2/merlin regulates hematopoietic stem cell behavior by altering microenvironmental architecture	CELL STEM CELL			English	Article							NF2 TUMOR-SUPPRESSOR; VASCULAR-PERMEABILITY FACTOR; PROGENITOR CELLS; MICE; ANGIOPOIETIN-1; ANGIOGENESIS; NICHE; TUMORIGENESIS; DEFICIENCY; MUTATION	Stem cell population size is highly regulated across species and tissue types, and alterations are associated with premature tissue failure or cancer. We assessed whether the tumor suppressor and mediator of cell contact inhibition Nf2/merlin plays a role in governing the hematopoietic stem cell pool by stem cell-autonomous or niche-determined processes. Hematopoietic stem cells in Nf2-deficient mice were increased in number and demonstrated a marked shift in location to the circulation. These changes were entirely dependent on changes in the microenvironment, with a marked increase in trabecular bone and marrow vascularity associated with increased VEGF, but without cell-autonomous alterations in stem cell characteristics. Nf2/merlin is critical for maintaining normal structure and function of the hematopoietic stem cell niche. It limits both bone and vascular components, and our model suggests that it thereby constrains stem cell number and position.	[Larsson, Jonas; Garrison, Brian; Aspling, Marie; Janzen, Viktor; Adams, Gregor B.; Scadden, David T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Larsson, Jonas; Garrison, Brian; Janzen, Viktor; Adams, Gregor B.; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ohishi, Masanobu; Schipani, Ernestina] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Scadden, DT (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	scadden.david@mgh.harvard.edu			National Institutes of Health [HL44851, HL081030, CA113733]; Department of Defense [W81XWH-05-1-0189]; EMBO; NATIONAL CANCER INSTITUTE [R01CA113733] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081030, R01HL044851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors would like to thank Marco Giovannini for providing the Nf2 floxed mice. This work was supported by National Institutes of Health Grants (HL44851, HL081030) to D.T.S. and (CA113733) to A.I.M., a Department of Defense Grant (W81XWH-05-1-0189) to A.I.M., and an EMBO postdoctoral grant to J.L.	Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chiusaroli R, 2003, ENDOCRINOLOGY, V144, P4106, DOI 10.1210/en.2003-0254; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Giovannini M, 2000, GENE DEV, V14, P1617; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; McLaughlin ME, 2007, P NATL ACAD SCI USA, V104, P3261, DOI 10.1073/pnas.0700044104; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Suzuki T, 2007, BIOCHEM BIOPH RES CO, V362, P1019, DOI 10.1016/j.bbrc.2007.08.099; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	23	37	40	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 7	2008	3	2					221	227		10.1016/j.stem.2008.06.005	http://dx.doi.org/10.1016/j.stem.2008.06.005			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	338QT	18682243	Green Accepted, Bronze			2022-12-24	WOS:000258523300016
J	Sharif-Naeini, R; Ciura, S; Bourque, CW				Sharif-Naeini, Reza; Ciura, Sorana; Bourque, Charles W.			TRPV1 gene required for thermosensory transduction and anticipatory secretion from vasopressin neurons during hyperthermia	NEURON			English	Article							CAPSAICIN RECEPTOR; BODY-TEMPERATURE; ION CHANNELS; HEAT; ACTIVATION; COLOCALIZATION; IDENTIFICATION; MECHANISMS; RELEASE; THIRST	Increases in core body temperature promote thermoregulatory cooling by stimulating sweat production and preemptive renal water reabsorption through the release of vasopressin (VP, antidiuretic hormone). The mechanism by which the hypothalamus orchestrates this anticipatory VP release during hyperthermia is unknown but has been linked to a central thermosensory mechanism. Here, we report that thermal stimuli spanning core body temperatures activate a calcium-permeable, ruthenium red- and SB366791 - sensitive nonselective cation conductance in hypothalamic VP neurons. This response is associated with a depolarizing receptor potential and an increase in action potential firing rate, indicating that these neurons are intrinsically thermosensitive. The thermosensitivity of VP neurons isolated from trpv1 knockout (Trpv1(-/-)) mice was significantly lower than that of wild-type counterparts. Moreover, Trpv1(-/-) mice showed an impaired VP response to hyperthermia in vivo. Channels encoded by the trpv1 gene thus confer thermosensitivity in central VP neurons and contribute to the thermal control of VP release in vivo.	[Sharif-Naeini, Reza; Ciura, Sorana; Bourque, Charles W.] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Ctr Res Neurosci,Res Inst, Montreal, PQ H3G 1A4, Canada	McGill University	Bourque, CW (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Ctr Res Neurosci,Res Inst, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	charles.bourque@mcgill.ca		Bourque, Charles/0000-0002-1594-742X				BOULANT JA, 1986, ANNU REV PHYSIOL, V48, P639, DOI 10.1146/annurev.ph.48.030186.003231; Bourque CW, 1998, PROG BRAIN RES, V119, P59; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; FORSLING ML, 1976, J PHYSIOL-LONDON, V257, P673, DOI 10.1113/jphysiol.1976.sp011391; Griffin JD, 1996, J PHYSIOL-LONDON, V492, P231, DOI 10.1113/jphysiol.1996.sp021304; Gunthorpe MJ, 2004, NEUROPHARMACOLOGY, V46, P133, DOI 10.1016/S0028-3908(03)00305-8; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liapi A, 2005, EUR J NEUROSCI, V22, P825, DOI 10.1111/j.1460-9568.2005.04270.x; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Liu LJ, 2007, J NEUROPHYSIOL, V97, P2001, DOI 10.1152/jn.00887.2006; Moriyama T, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-3; Naeini RS, 2006, NAT NEUROSCI, V9, P93, DOI 10.1038/nn1614; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rutter AR, 2005, NEUROREPORT, V16, P1735, DOI 10.1097/01.wnr.0000185958.03841.0f; SEGAR WE, 1968, J CLIN INVEST, V47, P2143, DOI 10.1172/JCI105900; Shibasaki M, 2006, J APPL PHYSIOL, V100, P1692, DOI 10.1152/japplphysiol.01124.2005; SZCZEPAN.E, 1974, AM J PHYSIOL, V226, P155, DOI 10.1152/ajplegacy.1974.226.1.155; TAKAMATA A, 1995, AM J PHYSIOL-REG I, V269, pR874, DOI 10.1152/ajpregu.1995.269.4.R874; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Verbalis JG, 2006, AM J MED, V119, pS21, DOI 10.1016/j.amjmed.2006.05.004; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wainwright A, 2004, J COMP NEUROL, V474, P24, DOI 10.1002/cne.20100; Zhang ZZ, 2006, EUR J NEUROSCI, V23, P1491, DOI 10.1111/j.1460-9568.2006.04670.x; Zhao YM, 2005, J PHYSIOL-LONDON, V564, P245, DOI 10.1113/jphysiol.2004.075473	41	63	65	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2008	58	2					179	185		10.1016/j.neuron.2008.02.013	http://dx.doi.org/10.1016/j.neuron.2008.02.013			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292YX	18439403	Bronze			2022-12-24	WOS:000255303100006
J	Chen, GB; Ye, ZH; Yu, XB; Zou, JH; Mali, P; Brodsky, RA; Cheng, LZ				Chen, Guibin; Ye, Zhaohui; Yu, Xiaobing; Zou, Jizhong; Mali, Prashant; Brodsky, Robert A.; Cheng, Linzhao			Trophoblast differentiation defect in human embryonic stem cells lacking PIG-A and GPI-anchored cell-surface proteins	CELL STEM CELL			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; GUIDANCE MOLECULE RGMA; SELF-RENEWAL; GENE; TROPHECTODERM; EXPRESSION; DRAGON; GLYCOSYLPHOSPHATIDYLINOSITOL; PROLIFERATION; HEMATOPOIESIS	Pluripotent human embryonic stem (hES) cells can differentiate into various cell types derived from the three embryonic germ layers and extraembryonic tissues such as trophoblasts. The mechanisms governing lineage choices of hES cells are largely unknown. Here, we report that we established two independent hES cell clones lacking a group of cell surface molecules, glycosyl-phosphatidyi-inositol-anchored proteins (GPI-APs). The GPI-AP deficiency in these two hES clones is due to the deficiency in the gene expression of PIG-A (phosphatidyi-inositol-glycan class A), which is required for the first step of GPI synthesis. GPI-AP-deficient hES cells were capable of forming embryoid bodies and initiating cell differentiation into the three embryonic germ layers. However, GPIAP-deficient hES cells failed to form trophoblasts after differentiation induction by embryoid body formation or by adding exogenous BMP4. The defect in trophoblast formation was due to the lack of GPI-anchored BMP coreceptors, resulting in the impairment of full BMP4 signaling activation in the GPI-AP-deficient hES cells. These data reveal that GPI-AP-enhanced full activation of BMP signaling is required for human trophoblast formation.	[Chen, Guibin; Ye, Zhaohui; Yu, Xiaobing; Zou, Jizhong; Mali, Prashant; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Stem Cell Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Chen, Guibin; Ye, Zhaohui; Yu, Xiaobing; Zou, Jizhong; Mali, Prashant; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Brodsky, Robert A.] Johns Hopkins Univ, Sch Med, Div Hematol, Dept Med, Baltimore, MD 21205 USA; [Ye, Zhaohui; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Grad Program Immunol, Baltimore, MD 21205 USA; [Mali, Prashant] Johns Hopkins Univ, Sch Med, Grad Program Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Cheng, LZ (corresponding author), Johns Hopkins Univ, Sch Med, Stem Cell Program, Inst Cell Engn, Baltimore, MD 21205 USA.	lcheng@welch.jhu.edu	Zou, Jizhong/B-4902-2011	Zou, Jizhong/0000-0003-1021-0549; Ye, Zhaohui/0000-0001-5272-9168	NCI NIH HHS [P01 CA070970, CA70970] Funding Source: Medline; NHLBI NIH HHS [T32 HL007525, HL73781, T32HL007525, R01 HL073781-03, R01 HL073781-05, R01 HL073781, F32 HL086168, F32HL086168, R01 HL073781-02, R01 HL073781-04, R01 HL073781-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA070970] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007525, F32HL086168, R01HL073781] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Brodsky RA, 1999, BLOOD, V93, P1749, DOI 10.1182/blood.V93.5.1749.405k09_1749_1756; BRULET P, 1982, P NATL ACAD SCI-BIOL, V79, P2328, DOI 10.1073/pnas.79.7.2328; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Dunn DE, 1999, ANN INTERN MED, V131, P401, DOI 10.7326/0003-4819-131-6-199909210-00002; Dunn DE, 1996, P NATL ACAD SCI USA, V93, P7938, DOI 10.1073/pnas.93.15.7938; Gerami-Naini B, 2004, ENDOCRINOLOGY, V145, P1517, DOI 10.1210/en.2003-1241; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hu R, 2005, BLOOD, V105, P3848, DOI 10.1182/blood-2004-04-1472; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Keller P, 2001, J EXP MED, V194, P581, DOI 10.1084/jem.194.5.581; Kinoshita T, 1997, J BIOCHEM-TOKYO, V122, P251; Lensch MW, 2006, BLOOD, V107, P2605, DOI 10.1182/blood-2005-07-2991; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Luzzatto L, 1997, CELL, V88, P1, DOI 10.1016/S0092-8674(00)81850-4; Minchiotti G, 2000, MECH DEVELOP, V90, P133, DOI 10.1016/S0925-4773(99)00235-X; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Rosti V, 1997, J CLIN INVEST, V100, P1028, DOI 10.1172/JCI119613; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Schenke-Layland K, 2007, STEM CELLS, V25, P1529, DOI 10.1634/stemcells.2006-0729; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Xia Y, 2005, ENDOCRINOLOGY, V146, P3614, DOI 10.1210/en.2004-1676; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhan XC, 2004, LANCET, V364, P163, DOI 10.1016/S0140-6736(04)16629-4; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zhou BY, 2007, STEM CELLS, V25, P779, DOI 10.1634/stemcells.2006-0128; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	46	38	41	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR	2008	2	4					345	355		10.1016/j.stem.2008.02.004	http://dx.doi.org/10.1016/j.stem.2008.02.004			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	293HT	18397754	Green Accepted, Bronze			2022-12-24	WOS:000255327000011
J	Fuentealba, P; Begum, R; Capogna, M; Jinno, S; Marton, LF; Csicsvari, J; Thomson, A; Somogyi, P; Klausberger, T				Fuentealba, Pablo; Begum, Rahima; Capogna, Marco; Jinno, Shozo; Marton, Laszlo F.; Csicsvari, Jozsef; Thomson, Alex; Somogyi, Peter; Klausberger, Thomas			Ivy cells: A population of nitric-oxide-producing, slow-spiking GABAergic neurons and their involvement in hippocampal network activity	NEURON			English	Article							DUAL INTRACELLULAR-RECORDINGS; LONG-TERM POTENTIATION; ADULT-RAT HIPPOCAMPUS; GATED K+ CHANNELS; PYRAMIDAL CELLS; NEOCORTICAL NEURONS; NEUROPEPTIDE-Y; DIFFERENTIAL MODULATION; POSITIVE INTERNEURONS; BEHAVING RAT	In the cerebral cortex, GABAergic interneurons are often regarded as fast-spiking cells. We have identified a type of slow-spiking interneuron that offers distinct contributions to network activity. "Ivy" cells, named after their dense and fine axons innervating mostly basal and oblique pyramidal cell dendrites, are more numerous than the parvalbumin-expressing basket, bistratified, or axo-axonic cells. Ivy cells express nitric oxide synthase, neuropeptide Y, and high levels of GABA(A) receptor alpha 1 subunit; they discharge at a low frequency with wide spikes in vivo, yet are distinctively phase-locked to behaviorally relevant network rhythms including theta, gamma, and ripple oscillations. Paired recordings in vitro showed that Ivy cells receive depressing EPSPs from pyramidal cells, which in turn receive slowly rising and decaying inhibitory input from Ivy cells. In contrast to fast-spiking interneurons operating with millisecond precision, the highly abundant Ivy cells express presynaptically acting neuromodulators and regulate the excitability of pyramidal cell dendrites through slowly rising and decaying GABAergic inputs.	[Fuentealba, Pablo; Capogna, Marco; Jinno, Shozo; Marton, Laszlo F.; Csicsvari, Jozsef; Somogyi, Peter; Klausberger, Thomas] Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; [Begum, Rahima; Thomson, Alex] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Jinno, Shozo] Kyushu Univ, Grad Sch Med Sci, Dept Anat & Neurobiol, Higashi Ku, Fukuoka 8128582, Japan; [Fuentealba, Pablo; Capogna, Marco; Jinno, Shozo; Marton, Laszlo F.; Csicsvari, Jozsef; Somogyi, Peter; Klausberger, Thomas] Sapientia Hungarian Univ Transylvania, EMTE, Fac Engn, Neural Syst Res Grp, RO-540485 Targu Mures, Romania; [Klausberger, Thomas] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria	University of Oxford; University of London; University College London; University of London School of Pharmacy; Kyushu University; Sapientia Hungarian University of Transylvania; Medical University of Vienna	Klausberger, T (corresponding author), Univ Oxford, MRC, Anat Neuropharmacol Unit, S Parks Rd, Oxford OX1 3TH, England.	thomas.klausberger@pharm.ox.ac.uk	Jinno, Shozo/CAH-3117-2022	Capogna, Marco/0000-0002-2742-5485	MRC [MC_U138169944, G0000207, G0401248, MC_U138162360] Funding Source: UKRI; Medical Research Council [G0000207, MC_U138162360, MC_U138197110, MC_U138169944, MC_UU_12020/3, MC_U138197106, MC_U138197107, G0401248] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Ali AB, 2007, J PHYSIOL-LONDON, V580, P149, DOI 10.1113/jphysiol.2006.124214; ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; Bacci A, 2002, P NATL ACAD SCI USA, V99, P17125, DOI 10.1073/pnas.012481899; Baude A, 2007, CEREB CORTEX, V17, P2094, DOI 10.1093/cercor/bhl117; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Burette A, 2002, J NEUROSCI, V22, P8961; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; COLMERS WF, 1987, J PHYSIOL-LONDON, V383, P285; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Czeh B, 2005, Prague Med Rep, V106, P261; Deuchars J, 1996, NEUROSCIENCE, V74, P1009, DOI 10.1016/S0306-4522(96)00251-5; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Jinno S, 2002, J COMP NEUROL, V449, P1, DOI 10.1002/cne.10251; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Li DP, 2002, J NEUROPHYSIOL, V88, P2664, DOI 10.1152/jn.00540.2002; Makara JK, 2007, J NEUROSCI, V27, P10211, DOI 10.1523/JNEUROSCI.2104-07.2007; Martina M, 1998, J NEUROSCI, V18, P8111; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Pawelzik H, 1999, EUR J NEUROSCI, V11, P3552, DOI 10.1046/j.1460-9568.1999.00772.x; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Price CJ, 2005, J NEUROSCI, V25, P6775, DOI 10.1523/JNEUROSCI.1135-05.2005; RALL W, 1967, J NEUROPHYSIOL, V30, P1169, DOI 10.1152/jn.1967.30.5.1169; RANCK FB, 1973, EXP NEUROL, V42, P461; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; SCHWARTZKROIN PA, 1985, J COMP NEUROL, V232, P205, DOI 10.1002/cne.902320206; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Stanic D, 2006, J COMP NEUROL, V499, P357, DOI 10.1002/cne.21046; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Szabadics J, 2007, P NATL ACAD SCI USA, V104, P14831, DOI 10.1073/pnas.0707204104; Szabadits E, 2007, J NEUROSCI, V27, P8101, DOI 10.1523/JNEUROSCI.1912-07.2007; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Yu D, 2005, J COMP NEUROL, V483, P278, DOI 10.1002/cne.20416	56	169	169	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2008	57	6					917	929		10.1016/j.neuron.2008.01.034	http://dx.doi.org/10.1016/j.neuron.2008.01.034			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281LV	18367092	Green Accepted, Bronze			2022-12-24	WOS:000254500000015
J	Navarrete, M; Araque, A				Navarrete, Marta; Araque, Alfonso			Endocannabinoids mediate neuron-astrocyte communication	NEURON			English	Article							CANNABINOID CB1 RECEPTOR; ENDOGENOUS CANNABINOIDS; IN-SITU; INTRACELLULAR CALCIUM; SYNAPTIC-TRANSMISSION; GLUTAMATE; CA2+; INCREASES; OSCILLATIONS; ACTIVATION	Cannabinoid receptors play key roles in brain function, and cannabinoid effects in brain physiology and drug-related behavior are thought to be mediated by receptors present in neurons. Neuron-astrocyte communication relies on the expression by astrocytes of neurotransmitter receptors. Yet, the expression of cannabinoid receptors by astrocytes in situ and their involvement in the neuron-astrocyte communication remain largely unknown. We show that hippocampal astrocytes express CB1 receptors that upon activation lead to phospholipase C-dependent Ca2+ mobilization from internal stores. These receptors are activated by endocannabinoids released by neurons, increasing astrocyte Ca2+ levels, which stimulate glutamate release that activates NMDA receptors in pyramidal neurons. These results demonstrate the existence of endocannabinoid-mediated neuron-astrocyte communication, revealing that astrocytes are targets of cannabinoids and might therefore participate in the physiology of cannabinoidrelated addiction. They also reveal the existence of an endocannabinoid-glutamate signaling pathway where astrocytes serve as a bridge for nonsynaptic interneuronal communication.	[Navarrete, Marta; Araque, Alfonso] CSIC, Inst Cajal, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Araque, A (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	araque@cajal.csic.es	Navarrete, Marta/E-9266-2013	Navarrete, Marta/0000-0003-2097-4788				Alger BE, 2002, PROG NEUROBIOL, V68, P247; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2002, J NEUROSCI, V22, P2443, DOI 10.1523/JNEUROSCI.22-07-02443.2002; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Catsicas M, 2001, J NEUROSCI, V21, P897, DOI 10.1523/JNEUROSCI.21-03-00897.2001; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Filipeanu CM, 1997, EUR J PHARMACOL, V336, pR1, DOI 10.1016/S0014-2999(97)01254-5; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Isokawa M, 2006, J NEUROPHYSIOL, V95, P3001, DOI 10.1152/jn.00975.2005; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; Lauckner JE, 2005, P NATL ACAD SCI USA, V102, P19144, DOI 10.1073/pnas.0509588102; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; Lograno MD, 2004, EUR J PHARMACOL, V494, P55, DOI 10.1016/j.ejphar.2004.04.039; MACKIE K, 1992, P NATL ACAD SCI USA, V89, P3825, DOI 10.1073/pnas.89.9.3825; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Molina-Holgado F, 2003, J NEUROSCI, V23, P6470; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Netzeband JG, 1999, J NEUROSCI, V19, P8765, DOI 10.1523/JNEUROSCI.19-20-08765.1999; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Porter JT, 1997, PROG NEUROBIOL, V51, P439, DOI 10.1016/S0301-0082(96)00068-8; Porter JT, 1996, J NEUROSCI, V16, P5073; Rodriguez JJ, 2001, J NEUROSCI, V21, P823, DOI 10.1523/JNEUROSCI.21-03-00823.2001; Rubovitch V, 2002, MOL BRAIN RES, V101, P93, DOI 10.1016/S0169-328X(02)00174-2; Salio C, 2002, NEUROSCI LETT, V329, P13, DOI 10.1016/S0304-3940(02)00549-9; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Sugiura T, 1997, J BIOCHEM-TOKYO, V122, P890; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Volterra A, 2002, SYNAPTIC TRANSMISSIO, P164; Walter L, 2003, GLIA, V44, P85, DOI 10.1002/glia.10270; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	54	368	377	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2008	57	6					883	893		10.1016/j.neuron.2008.01.029	http://dx.doi.org/10.1016/j.neuron.2008.01.029			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281LV	18367089	Bronze			2022-12-24	WOS:000254500000012
J	Han, YG; Spassky, N; Romaguera-Ros, M; Garcia-Verdugo, JM; Aguilar, A; Schneider-Maunoury, S; Alvarez-Buylla, A				Han, Young-Goo; Spassky, Nathalie; Romaguera-Ros, Miriam; Garcia-Verdugo, Jose-Manuel; Aguilar, Andrea; Schneider-Maunoury, Sylvie; Alvarez-Buylla, Arturo			Hedgehog signaling and primary cilia are required for the formation of adult neural stem cells	NATURE NEUROSCIENCE			English	Article							INTRAFLAGELLAR TRANSPORT PROTEINS; DENTATE GYRUS; SONIC HEDGEHOG; KINESIN-II; REPRESSOR FUNCTIONS; KIDNEY-DISEASE; IN-VIVO; MOUSE; MOTOR; MICE	Neural stem cells that continue to produce neurons are retained in the adult hippocampal dentate gyrus. The mechanisms by which embryonic neural progenitors expand and transform into postnatal neural stem cells, an essential process for the continual production of neurons throughout life, remain unknown. We found that radial astrocytes, the postnatal progenitors in the dentate gyrus, failed to develop after embryonic ablation of ciliary genes or Smoothened (Smo), an essential component for Sonic hedgehog (Shh) signaling. Postnatal dentate neurogenesis failed in these mutant mice, and the dentate gyrus became severely hypotrophic. In contrast, expression of a constitutively active Smo (SmoM2-YFP) resulted in a marked expansion of the dentate gyrus. Double-mutant analyses suggested that both wild-type Smo and SmoM2-YFP function through the primary cilia. We conclude that Shh signaling, acting through the primary cilia, has a critical role in the expansion and establishment of postnatal hippocampal progenitors.	[Han, Young-Goo; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, Inst Regenerat Med, San Francisco, CA 94143 USA; [Spassky, Nathalie; Aguilar, Andrea] Univ Paris 06, INSERM, Hop Piete Salpetriere, U711,IFR Neurosci, F-75013 Paris, France; [Romaguera-Ros, Miriam; Garcia-Verdugo, Jose-Manuel] Univ Valencia, Lab Morfol Celuar, Unidad Asociada, E-46100 Valencia, Spain; [Romaguera-Ros, Miriam; Garcia-Verdugo, Jose-Manuel] Ctr Invest Principle Felipe, E-46100 Valencia, Spain; [Schneider-Maunoury, Sylvie] Univ Paris 06, CNRS, UMR 7622, F-75005 Paris, France	University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Valencia; Prince Felipe Research Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Inst Regenerat Med, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu	Han, Young-Goo/N-2664-2018; Schneider-Maunoury, Sylvie/K-6795-2017; García-Verdugo, José Manuel/L-8421-2017; Spassky, Nathalie/E-3932-2016	Han, Young-Goo/0000-0002-4008-294X; Schneider-Maunoury, Sylvie/0000-0002-0797-4735; García-Verdugo, José Manuel/0000-0001-9872-6499; spassky, nathalie/0000-0003-4722-6464; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Aguilar, Andrea/0000-0002-6115-0040	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS028478, R01NS028478, R37NS028478] Funding Source: NIH RePORTER; NICHD NIH HHS [HD32116] Funding Source: Medline; NIDDK NIH HHS [P30 DK063720] Funding Source: Medline; NINDS NIH HHS [NS28478] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bagri A, 2002, DEVELOPMENT, V129, P4249; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Doetsch F, 1997, J NEUROSCI, V17, P5046; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Fukuda S, 2003, J NEUROSCI, V23, P9357; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Le Bot N, 1998, J CELL BIOL, V143, P1559, DOI 10.1083/jcb.143.6.1559; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Long FX, 2001, DEVELOPMENT, V128, P5099; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Matsuura K, 2002, CELL MOTIL CYTOSKEL, V52, P195, DOI 10.1002/cm.10051; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Miller MS, 2005, MOL BIOL CELL, V16, P3810, DOI 10.1091/mbc.E05-05-0404; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Muresan V, 1999, J NEUROSCI, V19, P1027; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; RICKMANN M, 1987, J COMP NEUROL, V264, P449, DOI 10.1002/cne.902640403; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	46	361	377	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					277	284		10.1038/nn2059	http://dx.doi.org/10.1038/nn2059			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18297065				2022-12-24	WOS:000253548300010
J	Brambrink, T; Foreman, R; Welstead, GG; Lengner, CJ; Wernig, M; Suh, H; Jaenisch, R				Brambrink, Tobias; Foreman, Ruth; Welstead, G. Grant; Lengner, Christopher J.; Wernig, Marius; Suh, Heikyung; Jaenisch, Rudolf			Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR TRANSPLANTATION; FIBROBLASTS; GENERATION; DIFFERENTIATION; MICE; MYC	Pluripotency can be induced in differentiated murine and human cells by retroviral transduction of Oct4, Sox2, Klf4, and c-Myc. We have devised a reprogramming strategy in which these four transcription factors are expressed from doxycycline (dox)-inducible lentiviral vectors. Using these inducible constructs, we derived induced pluripotent stem (PS) cells from mouse embryonic fibroblasts (MEFs) and found that transgene silencing is a prerequisite for normal cell differentiation. We have analyzed the timing of known pluripotency marker activation during mouse PS cell derivation and observed that alkaline phosphatase (AP) was activated first, followed by stage-specific embryonic antigen 1 (SSEA1). Expression of Nanog and the endogenous Oct4 gene, marking fully reprogrammed cells, was only observed late in the process. Importantly, the virally transduced cDNAs needed to be expressed for at least 12 days in order to generate PS cells. Our results are a step toward understanding some of the molecular events governing epigenetic reprogramming.	[Brambrink, Tobias; Foreman, Ruth; Welstead, G. Grant; Lengner, Christopher J.; Wernig, Marius; Suh, Heikyung; Jaenisch, Rudolf] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Foreman, Ruth; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		Lengner, Christopher/0000-0002-0574-5189	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA084198-08, R37 CA084198, R37-CA084198] Funding Source: Medline; NICHD NIH HHS [R01 HD045022, R01 HD045022-05, R01-HD045022] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTI S, 1987, CYTOMETRY, V8, P114, DOI 10.1002/cyto.990080203; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xia XF, 2007, STEM CELLS DEV, V16, P167, DOI 10.1089/scd.2006.0057; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	607	741	1	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB	2008	2	2					151	159		10.1016/j.stem.2008.01.004	http://dx.doi.org/10.1016/j.stem.2008.01.004			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	264PW	18371436	Green Accepted, Bronze			2022-12-24	WOS:000253301900010
J	Koenigs, M; Huey, ED; Raymont, V; Cheon, B; Solomon, J; Wassermann, EM; Grafman, J				Koenigs, Michael; Huey, Edward D.; Raymont, Vanessa; Cheon, Bobby; Solomon, Jeffrey; Wassermann, Eric M.; Grafman, Jordan			Focal brain damage protects against post-traumatic stress disorder in combat veterans	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; DOUBLE-BLIND; AMYGDALA; VIETNAM; ACTIVATION; PTSD	Post-traumatic stress disorder ( PTSD) is an often debilitating mental illness that is characterized by recurrent distressing memories of traumatic events. PTSD is associated with hypoactivity in the ventromedial prefrontal cortex ( vmPFC), hyperactivity in the amygdala and reduced volume in the hippocampus, but it is unknown whether these neuroimaging findings reflect the underlying cause or a secondary effect of the disorder. To investigate the causal contribution of specific brain areas to PTSD symptoms, we studied a unique sample of Vietnam War veterans who suffered brain injury and emotionally traumatic events. We found a substantially reduced occurrence of PTSD among those individuals with damage to one of two regions of the brain: the vmPFC and an anterior temporal area that included the amygdala. These results suggest that the vmPFC and amygdala are critically involved in the pathogenesis of PTSD.	[Koenigs, Michael; Huey, Edward D.; Raymont, Vanessa; Wassermann, Eric M.; Grafman, Jordan] Natl Inst Neurol Disorders & Stroke, Cognit Neurosci Sect, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Raymont, Vanessa; Cheon, Bobby] Natl Naval Med Ctr, Henry M Jackson Fdn, Vietnam Head Injury Study, Bethesda, MD 20889 USA; [Solomon, Jeffrey] Med Numer, Germantown, MD 20876 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed National Military Medical Center	Grafman, J (corresponding author), Natl Inst Neurol Disorders & Stroke, Cognit Neurosci Sect, US Natl Inst Hlth, 10 Ctr Dr,MSC 1440, Bethesda, MD 20892 USA.	grafmanj@ninds.nih.gov	Wassermann, Eric M./AAC-9064-2020	Wassermann, Eric M./0000-0003-0628-0210; Koenigs, Michael/0000-0002-5799-4881; Cheon, Bobby/0000-0001-6815-619X; Grafman, Jordan H./0000-0001-8645-4457	Intramural NIH HHS [Z01 NS003024-01, Z01 NS002792-19] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002977, ZIANS003024, ZIANS002792] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGGLETON JP, 1980, BRAIN RES, V190, P347, DOI 10.1016/0006-8993(80)90279-6; Aggleton JP., 2000, AMYGDALA FUNCTIONAL; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ayuso-Mateos JL., 2002, GLOBAL BURDEN POST T; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Cohen H, 2004, AM J PSYCHIAT, V161, P515, DOI 10.1176/appi.ajp.161.3.515; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Driessen M, 2004, BIOL PSYCHIAT, V55, P603, DOI 10.1016/j.biopsych.2003.08.018; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; First MB, 2002, STRUCTURED CLIN INTE; Fitzgerald PB, 2003, ARCH GEN PSYCHIAT, V60, P1002, DOI 10.1001/archpsyc.60.9.1002; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; Hendler T, 2003, NEUROIMAGE, V19, P587, DOI 10.1016/S1053-8119(03)00141-1; Henry TR, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.6_suppl_4.S3; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Likhtik E, 2005, J NEUROSCI, V25, P7429, DOI 10.1523/JNEUROSCI.2314-05.2005; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 2003, NEUROREPORT, V14, P913, DOI 10.1097/01.wnr.0000071767.24455.10; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Talairach J., 1988, COPLANAR STEREOTAXIC; Tranel D, 2005, BRAIN, V128, P2872, DOI 10.1093/brain/awh643; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wassermann EM, 2005, TRENDS COGN SCI, V9, P503, DOI 10.1016/j.tics.2005.09.001; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033	38	175	183	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					232	237		10.1038/nn2032	http://dx.doi.org/10.1038/nn2032			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18157125	Green Accepted, Green Published			2022-12-24	WOS:000252712100018
J	Tsay, D; Dudman, JT; Siegelbaum, SA				Tsay, David; Dudman, Joshua T.; Siegelbaum, Steven A.			HCN1 channels constrain synaptically evoked Ca2+ spikes in distal dendrites of CA1 pyramidal neurons	NEURON			English	Article							I-H; CALCIUM-CHANNEL; T-TYPE; PHARMACOLOGICAL PROPERTIES; VOLTAGE ATTENUATION; PACEMAKER CHANNELS; POTASSIUM CHANNELS; ACTION-POTENTIALS; PLASTICITY; TRANSMISSION	HCN1 hyperpolarization-activated cation channels act as an inhibitory constraint of both spatial learning and synaptic integration and long-term plasticity in the distal dendrites of hippocampal CA1 pyramidal neurons. However, as HCN1 channels provide an excitatory current, the mechanism of their inhibitory action remains unclear. Here we report that HCN1 channels also constrain CA1 distal dendritic Ca2+ spikes, which have been implicated in the induction of LTP at distal excitatory synapses. Our experimental and computational results indicate that HCN1 channels provide both an active shunt conductance that decreases the temporal integration of distal EPSPs; and a tonic depolarizing current that increases resting inactivation of T-type and N-type voltage-gated Ca2+ channels, which contribute to the Ca2+ spikes. This dual mechanism may provide a general means by which HCN channels regulate dendritic excitability.	[Tsay, David; Dudman, Joshua T.; Siegelbaum, Steven A.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Dept Neurosci, 1051 Riverside Dr, New York, NY 10032 USA.	sas8@columbia.edu		Dudman, Joshua/0000-0002-4436-1057	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036658] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS036658, R01 NS036658-09] Funding Source: Medline; PHS HHS [R01-36658] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Berger T, 2003, J NEUROPHYSIOL, V90, P2428, DOI 10.1152/jn.00377.2003; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; CAMEVALE NT, 2006, NEURON BOOK; Chen C, 2004, EUR J NEUROSCI, V19, P643, DOI 10.1111/j.0953-816X.2003.03174.x; Chevaleyre V, 2002, P NATL ACAD SCI USA, V99, P9538, DOI 10.1073/pnas.142213199; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Eller P, 2000, BRIT J PHARMACOL, V130, P669, DOI 10.1038/sj.bjp.0703352; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Felix R, 2003, BIOCHEM BIOPH RES CO, V311, P187, DOI 10.1016/j.bbrc.2003.09.197; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Golding NL, 2005, J PHYSIOL-LONDON, V568, P69, DOI 10.1113/jphysiol.2005.086793; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Kole MHP, 2007, J PHYSIOL-LONDON, V578, P507, DOI 10.1113/jphysiol.2006.122028; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Lee JH, 1999, J NEUROSCI, V19, P1912; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Magee JC, 2005, CURR OPIN NEUROBIOL, V15, P334, DOI 10.1016/j.conb.2005.05.013; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; MILLS LR, 1994, J NEUROSCI, V14, P6815; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Remondes M, 2003, LEARN MEMORY, V10, P247, DOI 10.1101/lm.59103; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rosenkranz JA, 2006, J NEUROSCI, V26, P3229, DOI 10.1523/JNEUROSCI.4333-05.2006; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Stuart G, 1998, J NEUROSCI, V18, P3501; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	53	158	163	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 20	2007	56	6					1076	1089		10.1016/j.neuron.2007.11.015	http://dx.doi.org/10.1016/j.neuron.2007.11.015			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	248FP	18093528	Green Accepted, Bronze			2022-12-24	WOS:000252138000015
J	Ferezou, I; Haiss, F; Gentet, LJ; Aronoff, R; Weber, B; Petersen, CCH				Ferezou, Isabelle; Haiss, Florent; Gentet, Luc J.; Aronoff, Rachel; Weber, Bruno; Petersen, Carl C. H.			Spatiotemporal dynamics of cortical sensorimotor integration in behaving mice	NEURON			English	Article							RAT BARREL CORTEX; VIBRISSAL MOTOR CORTEX; SENSORY RESPONSES; IN-VIVO; CORTICOTHALAMIC PROJECTIONS; FUNCTIONAL ARCHITECTURE; NEOCORTICAL NEURONS; RECEPTIVE-FIELDS; PYRAMIDAL CELLS; FIRING PATTERNS	Tactile information is actively acquired and processed in the brain through concerted interactions between movement and sensation. Somatosensory input is often the result of self-generated movement during the active touch of objects, and conversely, sensory information is used to refine motor control. There must therefore be important interactions between sensory and motor pathways, which we chose to investigate in the mouse whisker sensorimotor system. Voltage-sensitive dye was applied to the neocortex of mice to directly image the membrane potential dynamics of sensorimotor cortex with subcolumnar spatial resolution and millisecond temporal precision. Single brief whisker deflections evoked highly distributed depolarizing cortical sensory responses, which began in the primary somatosensory barrel cortex and subsequently excited the whisker motor cortex. The spread of sensory information to motor cortex was dynamically regulated by behavior and correlated with the generation of sensory-evoked whisker movement. Sensory processing in motor cortex may therefore contribute significantly to active tactile sensory perception.	[Ferezou, Isabelle; Gentet, Luc J.; Petersen, Carl C. H.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Sensory Proc, CH-1015 Lausanne, Switzerland; [Haiss, Florent; Weber, Bruno] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Zurich	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Sensory Proc, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Gentet, Luc J/H-5127-2017; Ferezou, Isabelle/B-4454-2012; Gentet, Luc/GNN-0460-2022; Weber, Bruno/E-4400-2013; Petersen, Carl/M-5123-2017; Haiss, Florent/L-1685-2015	Gentet, Luc J/0000-0001-6509-1001; Gentet, Luc/0000-0001-6509-1001; Petersen, Carl/0000-0003-3344-4495; Haiss, Florent/0000-0001-8351-3685; Aronoff, Rachel/0000-0001-5813-2899; Ferezou, Isabelle/0000-0001-7602-1295				Ahrens KF, 2004, J NEUROPHYSIOL, V92, P1700, DOI 10.1152/jn.00020.2004; Alloway KD, 2004, J COMP NEUROL, V480, P299, DOI 10.1002/cne.20339; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Aronoff R, 2006, J CELL MOL MED, V10, P333, DOI 10.1111/j.1582-4934.2006.tb00403.x; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; Berg RW, 2005, J NEUROPHYSIOL, V94, P699, DOI 10.1152/jn.01125.2004; Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006; Borgdorff AJ, 2007, J NEUROPHYSIOL, V97, P2992, DOI 10.1152/jn.00013.2007; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Bulkin DA, 2006, CURR OPIN NEUROBIOL, V16, P415, DOI 10.1016/j.conb.2006.06.008; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V541, P319, DOI 10.1113/jphysiol.2002.016857; Castro-Alamancos MA, 2006, J NEUROPHYSIOL, V96, P1691, DOI 10.1152/jn.00454.2006; CAVINESS VS, 1975, J COMP NEUROL, V164, P247, DOI 10.1002/cne.901640207; CHAPIN JK, 1982, EXP NEUROL, V78, P654, DOI 10.1016/0014-4886(82)90082-6; Civillico EF, 2006, J NEUROPHYSIOL, V96, P336, DOI 10.1152/jn.00128.2006; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Cramer NP, 2007, J NEUROPHYSIOL, V97, P2148, DOI 10.1152/jn.01187.2006; Cramer NP, 2006, J NEUROPHYSIOL, V96, P209, DOI 10.1152/jn.00071.2006; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Farkas T, 1999, NEUROSCIENCE, V90, P353, DOI 10.1016/S0306-4522(98)00451-5; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; FRANKLIN KBJ, 1996, MOUSER BRAIN STEREOT; Fu KMG, 2003, J NEUROSCI, V23, P7510; Gao PH, 2003, SOMATOSENS MOT RES, V20, P191, DOI 10.1080/08990220310001622924; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Haiss F, 2005, J NEUROSCI, V25, P1579, DOI 10.1523/JNEUROSCI.3760-04.2005; Harris JA, 1999, P NATL ACAD SCI USA, V96, P7587, DOI 10.1073/pnas.96.13.7587; Hattox A, 2003, NEURON, V39, P343, DOI 10.1016/S0896-6273(03)00391-X; Hentschke H, 2006, CEREB CORTEX, V16, P1142, DOI 10.1093/cercor/bhj056; Hoffer ZS, 2003, J COMP NEUROL, V466, P525, DOI 10.1002/cne.10895; IZRAELI R, 1995, EXP BRAIN RES, V104, P41; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; Kayser C, 2005, NEURON, V48, P373, DOI 10.1016/j.neuron.2005.09.018; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lavallee P, 2005, J NEUROSCI, V25, P7489, DOI 10.1523/JNEUROSCI.2301-05.2005; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lippert MT, 2007, J NEUROPHYSIOL, V98, P502, DOI 10.1152/jn.01169.2006; LOVICK TA, 1972, J PHYSL, V224, pP4; Macaluso E, 2006, NEUROSCIENTIST, V12, P327, DOI 10.1177/1073858406287908; Martuzzi R, 2007, CEREB CORTEX, V17, P1672, DOI 10.1093/cercor/bhl077; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; MIYASHITA E, 1994, EXP BRAIN RES, V99, P223; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Nguyen QT, 2005, NEURON, V45, P447, DOI 10.1016/j.neuron.2004.12.042; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Polley DB, 2004, NATURE, V429, P67, DOI 10.1038/nature02469; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; PORTER LL, 1983, J COMP NEUROL, V214, P279, DOI 10.1002/cne.902140306; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Sachdev RNS, 2002, J NEUROPHYSIOL, V87, P1440, DOI 10.1152/jn.00539.2001; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Seidemann E, 2002, SCIENCE, V295, P862, DOI 10.1126/science.1066641; SEMBA K, 1984, NEUROSCIENCE, V12, P761, DOI 10.1016/0306-4522(84)90168-4; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Slovin H, 2002, J NEUROPHYSIOL, V88, P3421, DOI 10.1152/jn.00194.2002; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stuttgen MC, 2006, J NEUROSCI, V26, P7933, DOI 10.1523/JNEUROSCI.1864-06.2006; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Trageser JC, 2006, J NEUROPHYSIOL, V96, P1456, DOI 10.1152/jn.00423.2006; Veinante P, 2000, J COMP NEUROL, V424, P197, DOI 10.1002/1096-9861(20000821)424:2<197::AID-CNE1>3.0.CO;2-6; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WHITE EL, 1977, J COMP NEUROL, V175, P455, DOI 10.1002/cne.901750405; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	88	455	459	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2007	56	5					907	923		10.1016/j.neuron.2007.10.007	http://dx.doi.org/10.1016/j.neuron.2007.10.007			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241MA	18054865	Bronze, Green Submitted			2022-12-24	WOS:000251659300015
J	Arganda, S; Guantes, R; De Polavieja, GG				Arganda, Sara; Guantes, Raul; De Polavieja, Gonzalo G.			Sodium pumps adapt spike bursting to stimulus statistics	NATURE NEUROSCIENCE			English	Article							T-SENSORY NEURONS; NEOCORTICAL PYRAMIDAL NEURONS; ACTIVITY-DEPENDENT INCREASE; CENTRAL-NERVOUS-SYSTEM; INFORMATION-TRANSMISSION; VARIANCE ADAPTATION; CONTRAST ADAPTATION; NEURAL INFORMATION; ELECTROGENIC PUMP; CONDUCTION BLOCK	Pump activity is a homeostatic mechanism that maintains ionic gradients. Here we examined whether the slow reduction in excitability induced by sodium-pump activity that has been seen in many neuronal types is also involved in neuronal coding. We took intracellular recordings from a spike-bursting sensory neuron in the leech Hirudo medicinalis in response to naturalistic tactile stimuli with different statistical distributions. We show that regulation of excitability by sodium pumps is necessary for the neuron to make different responses depending on the statistical context of the stimuli. In particular, sodium-pump activity allowed spike-burst sizes and rates to code not for stimulus values per se, but for their ratio with the standard deviation of the stimulus distribution. Modeling further showed that sodium pumps can be a general mechanism of adaptation to statistics on the time scale of 1 min. These results implicate the ubiquitous pump activity in the adaptation of neural codes to statistics.	Univ Autonoma Madrid, Fac Ciencias, Inst Nicolas Cabrera Fis Mat, Neural Processing Lab, E-28049 Madrid, Spain; Univ Autonoma Madrid, Fac Ciencias, Dept Condensed Matter Phys, E-28049 Madrid, Spain; Univ Autonoma Madrid, Fac Ciencias, Dept Theoret Phys, E-28049 Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Autonomous University of Madrid	De Polavieja, GG (corresponding author), Univ Autonoma Madrid, Fac Ciencias, Inst Nicolas Cabrera Fis Mat, Neural Processing Lab, C-16, E-28049 Madrid, Spain.	gonzalo.polavieja@uam.es	Carreras, Sara Arganda/B-2200-2017; Guantes, Raul/B-7271-2014	Carreras, Sara Arganda/0000-0002-9875-2379; Guantes, Raul/0000-0003-1916-944X; de Polavieja, Gonzalo/0000-0001-5359-3426				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Barlow H, 1982, THE SENSES; BAYLOR DA, 1969, J PHYSIOL-LONDON, V203, P571, DOI 10.1113/jphysiol.1969.sp008880; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Cataldo E, 2005, J COMPUT NEUROSCI, V18, P5, DOI 10.1007/s10827-005-5477-3; CATARSI S, 1990, J COMP PHYSIOL A, V167, P469, DOI 10.1007/BF00190817; CATARSI S, 1991, J EXP BIOL, V155, P261; Chubbuck JG, 1966, APL TECH DIGEST, V5, P18; Darbon P, 2003, J NEUROPHYSIOL, V90, P3119, DOI 10.1152/jn.00579.2003; DeBusk BC, 1997, J NEUROPHYSIOL, V78, P199, DOI 10.1152/jn.1997.78.1.199; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; FAIRHALL A, 2002, HDB BRAIN THEORY NEU, P90; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FRENCH AS, 1989, J NEUROPHYSIOL, V62, P768, DOI 10.1152/jn.1989.62.3.768; Gabbiani F, 1996, NATURE, V384, P564, DOI 10.1038/384564a0; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; GUSTAFSSON B, 1983, BRAIN RES, V275, P159, DOI 10.1016/0006-8993(83)90429-8; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; JANSEN JKS, 1973, J PHYSIOL-LONDON, V229, P635, DOI 10.1113/jphysiol.1973.sp010158; Kepecs A, 2002, J NEUROSCI, V22, P9053; Kiernan MC, 2004, J PHYSIOL-LONDON, V558, P341, DOI 10.1113/jphysiol.2004.063966; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; Kobayashi J, 1997, NEUROSCI LETT, V236, P171, DOI 10.1016/S0304-3940(97)00790-8; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Livingstone MS, 1996, COLD SPRING HARB SYM, V61, P27; Mar A, 1996, J NEUROSCI, V16, P4335; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Mozzachiodi R, 2001, NEUROSCIENCE, V107, P519, DOI 10.1016/S0306-4522(01)00365-7; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SCHLUE WR, 1991, J NEUROPHYSIOL, V65, P736, DOI 10.1152/jn.1991.65.3.736; Scuri R, 2005, J NEUROPHYSIOL, V94, P1066, DOI 10.1152/jn.00075.2005; Scuri R, 2002, J NEUROPHYSIOL, V88, P2490, DOI 10.1152/jn.01027.2001; Shapley R, 1997, CURR BIOL, V7, pR421, DOI 10.1016/S0960-9822(06)00207-7; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Shen KZ, 1998, J PHYSIOL-LONDON, V512, P449, DOI 10.1111/j.1469-7793.1998.449be.x; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Vaillend C, 2002, J NEUROPHYSIOL, V88, P2963, DOI 10.1152/jn.00244.2002; VANESSEN DC, 1973, J PHYSIOL-LONDON, V230, P509, DOI 10.1113/jphysiol.1973.sp010201; Walraven J, 1990, VISUAL PERCEPTION NE, P53; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549, DOI 10.1152/jn.1998.79.3.1549	50	32	33	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1467	1473		10.1038/nn1982	http://dx.doi.org/10.1038/nn1982			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17906619				2022-12-24	WOS:000250508400025
J	Lubin, FD; Sweatt, JD				Lubin, Farah D.; Sweatt, J. David			The I kappa B kinase regulates chromatin structure during reconsolidation of conditioned fear memories	NEURON			English	Article							LONG-TERM-MEMORY; HISTONE ACETYLTRANSFERASE ACTIVITY; INDUCED GENE-EXPRESSION; TRANSCRIPTION FACTOR; IKK-ALPHA; PROTEIN-SYNTHESIS; C-REL; ACTIVATION; ACETYLATION; RETRIEVAL	Previously formed memories are susceptible to disruption immediately after recall due to a necessity to be reconsolidated after retrieval. Protein translation mechanisms have been widely implicated as being necessary for memory reconsolidation, but gene transcription mechanisms have been much less extensively studied in this context. We found that retrieval of contextual conditioned fear memories activates the NF-kappa B pathway to regulate histone H3 phosphorylation and acetylation at specific gene promoters in hippocampus, specifically via IKK alpha and not the NF-kappa B DNA-binding complex. Behaviorally, we found that inhibition of IKK alpha regulation of either chromatin structure or NF-kappa B DNA-binding complex activity leads to impairments in fear memory reconsolidation, and that elevating histone acetylation rescues this memory deficit in the face of IKK blockade. These data provide insights into IKK-regulated transcriptional mechanisms in hippocampus that are necessary for memory reconsolidation.	Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Sweatt, JD (corresponding author), Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Dept Neurobiol, Birmingham, AL 35294 USA.	dsweatt@nrc.uab.edu		Sweatt, J. David/0000-0003-3567-485X	NIMH NIH HHS [R01 MH057014, MH57014, R01 MH057014-04A1] Funding Source: Medline; NINDS NIH HHS [F32 NS048811, NS048811, NS37444, P01 NS037444, F32 NS048811-04, P01 NS037444-090002] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037444, F32NS048811] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Albensi BC, 2000, SYNAPSE, V35, P151; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Anest V, 2004, J BIOL CHEM, V279, P31183, DOI 10.1074/jbc.M404380200; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Carayol N, 2006, J BIOL CHEM, V281, P31142, DOI 10.1074/jbc.M603417200; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Chwang WB, 2006, LEARN MEMORY, V13, P322, DOI 10.1101/lm.152906; Colvis CM, 2005, J NEUROSCI, V25, P10379, DOI 10.1523/JNEUROSCI.4119-05.2005; Dash PK, 2005, J NEUROCHEM, V93, P269, DOI 10.1111/j.1471-4159.2004.03016.x; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Duvarci S, 2005, EUR J NEUROSCI, V21, P283, DOI 10.1111/j.1460-9568.2004.03824.x; Ear T, 2005, J IMMUNOL, V175, P1834, DOI 10.4049/jimmunol.175.3.1834; Freudenthal R, 2005, EUR J NEUROSCI, V21, P2845, DOI 10.1111/j.1460-9568.2005.04126.x; Greene Warner C, 2004, Novartis Found Symp, V259, P208; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Hoberg JE, 2006, MOL CELL BIOL, V26, P457, DOI 10.1128/MCB.26.2.457-471.2006; Huang YF, 2002, J NEUROSCI, V22, P8422; Ito K, 2001, J BIOL CHEM, V276, P30208, DOI 10.1074/jbc.M103604200; Izquierdo I, 2004, SCIENCE, V304, P829, DOI 10.1126/science.1098139; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kubota T, 2000, AM J PHYSIOL-REG I, V279, pR404, DOI 10.1152/ajpregu.2000.279.2.R404; Kumar A, 2005, MOL CELL BIOL, V25, P5893, DOI 10.1128/MCB.25.14.5893-5903.2005; Lattal KM, 2004, P NATL ACAD SCI USA, V101, P4667, DOI 10.1073/pnas.0306546101; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee S, 2005, ENDOCRINOLOGY, V146, P2006, DOI 10.1210/en.2004-1268; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Levenson JM, 2004, J NEUROSCI, V24, P3933, DOI 10.1523/JNEUROSCI.5646-03.2004; Liou HC, 2003, BIOESSAYS, V25, P767, DOI 10.1002/bies.10306; Lubin FD, 2005, NEUROSCIENCE, V133, P969, DOI 10.1016/j.neuroscience.2005.03.028; Massa PE, 2005, J BIOL CHEM, V280, P14057, DOI 10.1074/jbc.M414401200; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Merlo E, 2005, LEARN MEMORY, V12, P23, DOI 10.1101/lm.82705; Miyajima A, 2003, J UROLOGY, V169, P1559, DOI 10.1097/01.ju.0000045686.21766.c1; Morais C, 2006, NEPHROL DIAL TRANSPL, V21, P3377, DOI 10.1093/ndt/gfl543; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Park GY, 2006, J BIOL CHEM, V281, P18684, DOI 10.1074/jbc.M600733200; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; SAKAI RR, 1995, REGUL PEPTIDES, V59, P183, DOI 10.1016/0167-0115(95)00111-N; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Viatour P, 2003, J BIOL CHEM, V278, P46541, DOI 10.1074/jbc.M306381200; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Weber CK, 2000, GASTROENTEROLOGY, V119, P1209, DOI 10.1053/gast.2000.19458; Wood MA, 2006, LEARN MEMORY, V13, P609, DOI 10.1101/lm.213906; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286; Yeh SH, 2002, J BIOL CHEM, V277, P46720, DOI 10.1074/jbc.M206258200; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	59	194	203	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 20	2007	55	6					942	957		10.1016/j.neuron.2007.07.039	http://dx.doi.org/10.1016/j.neuron.2007.07.039			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	219IQ	17880897	Bronze, Green Accepted			2022-12-24	WOS:000250078500011
J	Broxmeyer, HE				Broxmeyer, Hal E.			Mechanism unknown: Prostaglandin E2 may improve HSC therapies	CELL STEM CELL			English	Editorial Material							PROGENITOR CELLS; STEM; PROLIFERATION	A recent publication in Nature by North et al. (2007) has implicated the eicosanoid prostaglandin E2 in enhancement of hematopoietic stem cell function in zebrafish and in mice. This work may have practical therapeutic value, but much remains to be determined before this possibility is realized.	Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute	Broxmeyer, HE (corresponding author), Indiana Univ, Sch Med, Walther Oncol Ctr, 950 W Walnut St,R2-302, Indianapolis, IN 46202 USA.	hbroxmey@iupui.edu						Broxmeyer HE, 2006, METHOD ENZYMOL, V419, P439, DOI 10.1016/S0076-6879(06)19018-7; BROXMEYER HE, 2006, BLOOD BANKING TRANSF, P823; FEHER I, 1974, NATURE, V247, P550, DOI 10.1038/247550a0; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; LU L, 1986, BLOOD, V68, P126; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; PELUS LM, 1979, J EXP MED, V150, P277, DOI 10.1084/jem.150.2.277; SHAHEEN M, 2007, HEMATOLOGY BASIC PRI, P233	8	2	2	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG	2007	1	2					135	136		10.1016/j.stem.2007.05.008	http://dx.doi.org/10.1016/j.stem.2007.05.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XS	18371345	Bronze			2022-12-24	WOS:000251055100005
J	David, SV; Hayden, BY; Mazer, JA; Gallant, JL				David, Stephen V.; Hayden, Benjamin Y.; Mazer, James A.; Gallant, Jack L.			Attention to stimulus features shifts spectral tuning of V4 neurons during natural vision	NEURON			English	Article							MACAQUE AREA V4; SELECTIVE VISUAL-ATTENTION; STATE DEPENDENT ACTIVITY; SPATIAL ATTENTION; RECEPTIVE-FIELDS; CARTESIAN GRATINGS; NEURAL MECHANISMS; CORTEX; RESPONSES; V1	Previous neurophysiological studies suggest that attention can alter the baseline or gain of neurons in extrastriate visual areas but that it cannot change tuning. This suggests that neurons in visual cortex function as labeled lines whose meaning does not depend on task demands. To test this common assumption, we used a system identification approach to measure spatial frequency and orientation tuning in area V4 during two attentionally demanding visual search tasks, one that required fixation and one that allowed free viewing during search. We found that spatial attention modulates response baseline and gain but does not alter tuning, consistent with previous reports. In contrast, feature-based attention often shifts neuronal tuning. These tuning shifts are inconsistent with the labeled-line model and tend to enhance responses to stimulus features that distinguish the search target. Our data suggest that V4 neurons behave as matched filters that are dynamically tuned to optimize visual search.	[David, Stephen V.; Hayden, Benjamin Y.; Gallant, Jack L.] Univ Calif Berkeley, Program Neurosci, Berkeley, CA 94720 USA; [Mazer, James A.; Gallant, Jack L.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [David, Stephen V.] Univ Calif Berkeley, Bioengn Program, Berkeley, CA 94720 USA; [Hayden, Benjamin Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gallant, JL (corresponding author), Univ Calif Berkeley, Program Neurosci, Berkeley, CA 94720 USA.	gallant@berkeley.edu	Mazer, James/R-9886-2019; Hayden, Benjamin/J-7994-2013; Gallant, Jack L/C-4426-2011	Hayden, Benjamin/0000-0002-7678-4281; David, Stephen/0000-0003-4135-3104	National Science Foundation; National Eye Institute; NATIONAL EYE INSTITUTE [R01EY012241] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Science Foundation (S.V.D.) and the National Eye Institute (J.L.G.). The authors would like to thank Kate Gustavsen, Kathleen Hansen, and two anonymous reviewers for helpful comments on the manuscript.	Adrian ED, 1927, J PHYSIOL-LONDON, V63, P378, DOI 10.1113/jphysiol.1927.sp002410; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Cadieu C, 2007, J NEUROPHYSIOL, V98, P1733, DOI 10.1152/jn.01265.2006; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Compte A, 2006, CEREB CORTEX, V16, P761, DOI 10.1093/cercor/bhj021; Conner CE, 1997, J NEUROSCI, V17, P3201; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; David SV, 2006, J NEUROPHYSIOL, V96, P3492, DOI 10.1152/jn.00575.2006; David SV, 2005, NETWORK-COMP NEURAL, V16, P239, DOI 10.1080/09548980500464030; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Fallah M, 2007, P NATL ACAD SCI USA, V104, P4165, DOI 10.1073/pnas.0611722104; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; Gallant JL, 1996, J NEUROPHYSIOL, V76, P2718, DOI 10.1152/jn.1996.76.4.2718; Gallant JL, 2000, NEURON, V27, P227, DOI 10.1016/S0896-6273(00)00032-5; GATTASS R, 1988, J NEUROSCI, V8, P1831; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Hayden BY, 2005, NEURON, V47, P637, DOI 10.1016/j.neuron.2005.07.020; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lu ZL, 2004, J VISION, V4, P955, DOI 10.1167/4.10.10; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Marr D., 1982, VISION; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mehta SD, 2000, CEREB CORTEX, V10, P343, DOI 10.1093/cercor/10.4.343; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1994, J NEUROSCI, V14, P2178; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Ogawa T, 2004, J NEUROSCI, V24, P6371, DOI 10.1523/JNEUROSCI.0569-04.2004; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Rao RPN, 1997, NEURAL COMPUT, V9, P721, DOI 10.1162/neco.1997.9.4.721; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; ROSSI AF, 1995, VISION RES, V35, P621, DOI 10.1016/0042-6989(94)00156-G; Saenz M, 2003, VISION RES, V43, P629, DOI 10.1016/S0042-6989(02)00595-3; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Womelsdorf T, 2006, NAT NEUROSCI, V9, P1156, DOI 10.1038/nn1748; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024	54	115	115	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 14	2008	59	3					509	521		10.1016/j.neuron.2008.07.001	http://dx.doi.org/10.1016/j.neuron.2008.07.001			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339GG	18701075	Green Accepted, Bronze			2022-12-24	WOS:000258565500018
J	Montojo, CA; Courtney, SM				Montojo, Caroline A.; Courtney, Susan M.			Differential neural activation for updating rule versus stimulus information in working memory	NEURON			English	Article							PREFRONTAL CORTEX; SYSTEM; MAINTENANCE; COMPONENTS; NEURONS; NUMBERS; OBJECT	Establishing what information is actively maintained in working memory (WM) and how it is represented and controlled is essential to understanding how such information guides future behavior. WM has traditionally been investigated in terms of the maintenance of stimulus-specific information, such as locations or words. More recently, investigators have emphasized the importance of rules that establish relationships between those stimuli and the pending response. The current study used a mental arithmetic task with fMRI to test whether updating of numbers (i.e., stimuli) and updating of mathematical operations (i.e., rules) in WM relies on the same neural system. Results indicate that, while a common network is activated by both types of updating, rule updating preferentially activates prefrontal cortex while number updating preferentially activates parietal cortex. The results suggest that both numbers and rules are maintained in WM but that they are different types of information that are controlled independently.	[Montojo, Caroline A.; Courtney, Susan M.] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; [Courtney, Susan M.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA; [Courtney, Susan M.] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute	Courtney, SM (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.	courtney@jhu.edu			NIMH NIH HHS [R01 MH061625-03, R01 MH082957, R01 MH061625-05, R01 MH061625, R01 MH061625-04] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082957, R01MH061625] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Baddeley AD, 1999, MODELS WORKING MEMOR, P28, DOI DOI 10.1017/CBO9781139174909.005; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Brincat SL, 2004, NAT NEUROSCI, V7, P880, DOI 10.1038/nn1278; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Corbetta M, 2005, NEUROPSYCHOLOGIA, V43, P2041, DOI 10.1016/j.neuropsychologia.2005.03.020; Courtney S. M., 2007, WORKING MEMORY BEHAV, P369, DOI DOI 10.1093/ACPROF:OSO/9780198570394.003.0021; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Genovesio A, 2005, NEURON, V47, P307, DOI 10.1016/j.neuron.2005.06.006; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Kadosh RC, 2007, NEURON, V53, P307, DOI 10.1016/j.neuron.2006.12.025; Knops A, 2006, NEUROIMAGE, V29, P1, DOI 10.1016/j.neuroimage.2005.07.009; KOJIMA S, 1982, BRAIN RES, V248, P43, DOI 10.1016/0006-8993(82)91145-3; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Passingham D, 2004, CURR OPIN NEUROBIOL, V14, P163, DOI 10.1016/j.conb.2004.03.003; Pinel P, 1999, NEUROREPORT, V10, P1473, DOI 10.1097/00001756-199905140-00015; Roth JK, 2006, CEREB CORTEX, V16, P1595, DOI 10.1093/cercor/bhj096; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Sala J, 2003, NEUROPSYCHOLOGIA, V41, P341, DOI 10.1016/S0028-3932(02)00166-5; Shuman M, 2004, NEURON, V44, P557, DOI 10.1016/j.neuron.2004.10.008; Slagter HA, 2006, COGN AFFECT BEHAV NE, V6, P175, DOI 10.3758/CABN.6.3.175; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; WATANABE M, 1986, BRAIN RES, V382, P1, DOI 10.1016/0006-8993(86)90104-6; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	37	48	48	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 10	2008	59	1					173	182		10.1016/j.neuron.2008.05.012	http://dx.doi.org/10.1016/j.neuron.2008.05.012			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	327KU	18614038	Green Accepted, Bronze			2022-12-24	WOS:000257728800017
J	Brun, VH; Leutgeb, S; Wu, HQ; Schwarcz, R; Witter, MP; Moser, EI; Moser, MB				Brun, Vegard Heimly; Leutgeb, Stefan; Wu, Hui-Qiu; Schwarcz, Robert; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt			Impaired spatial representation in CA1 after lesion of direct input from entorhinal cortex	NEURON			English	Article							HIPPOCAMPAL PLACE CELLS; FREELY MOVING RATS; NEURONAL DEGENERATION; PYRAMIDAL NEURONS; FLUORO-JADE; LAYER-III; TOPOGRAPHIC ORGANIZATION; PATH-INTEGRATION; NMDA RECEPTORS; CORTICAL INPUT	Place-specific firing in the hippocampus is determined by path integration-based spatial representations in the grid-cell network of the medial entorhinal cortex. Output from this network is conveyed directly to CA1 of the hippocampus by projections from principal neurons in layer III, but also indirectly by axons from layer II to the dentate gyrus and CA3. The direct pathway is sufficient for spatial firing in CA1, but it is not known whether similar firing can also be supported by the input from CA3. To test this possibility, we made selective lesions in layer III of medial entorhinal cortex by local infusion of the neurotoxin gamma-acetylenic GABA. Firing fields in CA1 became larger and more dispersed after cell loss in layer III, whereas CA3 cells, which receive layer II input, still had sharp firing fields. Thus, the direct projection is necessary for precise spatial firing in the CA1 place cell population.	[Brun, Vegard Heimly; Leutgeb, Stefan; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway; [Brun, Vegard Heimly; Leutgeb, Stefan; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway; [Wu, Hui-Qiu; Schwarcz, Robert] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA; [Witter, Menno P.] Vrije Univ Amsterdam Med Ctr, Dept Anat & Neurosci, Neurosci Res Inst, NL-1007 MB Amsterdam, Netherlands	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University System of Maryland; University of Maryland Baltimore; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Moser, MB (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no	Brun, Vegard Heimly/ADZ-5405-2022; Schwarcz, Robert/P-3134-2018	Brun, Vegard Heimly/0000-0002-4136-3073; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016102] Funding Source: NIH RePORTER; NINDS NIH HHS [NS16102] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; BARNES CA, 1990, PROG BRAIN RES, V83, P287; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; BUZASAKI G, 1995, HIPPOCAMPUS, V5, P141; DAHL D, 1981, EUR J CELL BIOL, V24, P191; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Du F, 1998, NEUROSCIENCE, V82, P1165; Eisch AJ, 1998, SYNAPSE, V30, P329, DOI 10.1002/(SICI)1098-2396(199811)30:3<329::AID-SYN10>3.0.CO;2-V; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Gloveli T, 2003, NEUROBIOL DIS, V13, P203, DOI 10.1016/S0969-9961(03)00039-1; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Insausti R, 1997, HIPPOCAMPUS, V7, P146, DOI 10.1002/(SICI)1098-1063(1997)7:2<146::AID-HIPO4>3.0.CO;2-L; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; JUNG MW, 1994, J NEUROSCI, V14, P7347; KHURGEL M, 1995, NEUROBIOL DIS, V2, P23, DOI 10.1006/nbdi.1995.0003; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Leutgeb S, 2006, HIPPOCAMPUS, V16, P765, DOI 10.1002/hipo.20201; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; MIZUMORI SJY, 1989, J NEUROSCI, V9, P3915; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; MULLER RU, 1989, J NEUROSCI, V9, P4101; MULLER RU, 1987, J NEUROSCI, V7, P1935; Naber PA, 1999, EUR J NEUROSCI, V11, P4119, DOI 10.1046/j.1460-9568.1999.00835.x; Naber PA, 2001, HIPPOCAMPUS, V11, P99, DOI 10.1002/hipo.1028; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shao LR, 2004, J NEUROPHYSIOL, V92, P1366, DOI 10.1152/jn.00131.2004; Siddiqui AH, 2005, BRAIN RES, V1066, P129, DOI 10.1016/j.brainres.2005.10.066; Skaggs WE, 1993, ADV NEURAL INFORM PR, V5; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Steffenach HA, 2002, P NATL ACAD SCI USA, V99, P3194, DOI 10.1073/pnas.042700999; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; SWANSON LW, 1986, J NEUROSCI, V6, P3010; TAUBE JS, 1990, J NEUROSCI, V10, P436; TREVES A, 1991, NETWORK-COMP NEURAL, V2, P371, DOI 10.1088/0954-898X/2/4/004; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Witter M. P., 2004, RAT NERVOUS SYSTEM, V3rd, P637; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; WOUTERLOOD FG, 1991, PROG HISTOCHEM CYTOC, V22, P1; Wu HQ, 1998, EXP NEUROL, V153, P203, DOI 10.1006/exnr.1998.6908	68	250	252	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 24	2008	57	2					290	302		10.1016/j.neuron.2007.11.034	http://dx.doi.org/10.1016/j.neuron.2007.11.034			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256VQ	18215625	Bronze			2022-12-24	WOS:000252758400012
J	Seal, RP; Akil, O; Yi, E; Weber, CM; Grant, L; Yoo, J; Clause, A; Kandler, K; Noebels, JL; Glowatzki, E; Lustig, LR; Edwards, RH				Seal, Rebecca P.; Akil, Omar; Yi, Eunyoung; Weber, Christopher M.; Grant, Lisa; Yoo, Jong; Clause, Amanda; Kandler, Karl; Noebels, Jeffrey L.; Glowatzki, Elisabeth; Lustig, Lawrence R.; Edwards, Robert H.			Sensorineural deafness and seizures in mice lacking vesicular glutamate transporter 3	NEURON			English	Article							INNER HAIR-CELLS; INHIBITORY SYNAPSES; SYNAPTIC MEMBRANE; RIBBON SYNAPSES; EXPRESSION; IDENTIFICATION; SYSTEM; INNERVATION; EXOCYTOSIS; MATURATION	The expression of unconventional vesicular glutamate transporter VGLUT3 by neurons known to release a different classical transmitter has suggested novel roles for signaling by glutamate, but this distribution has raised questions about whether the protein actually contributes to glutamate release. We now report that mice lacking VGLUT3 are profoundly deaf due to the absence of glutamate release from hair cells at the first synapse in the auditory pathway. The early degeneration of some cochlear ganglion neurons in knockout mice also indicates an important developmental role for the glutamate released by hair cells before the onset of hearing. In addition, the mice exhibit primary, generalized epilepsy that is accompanied by remarkably little change in ongoing motor behavior. The glutamate release conferred by expression of VGLUT3 thus has an essential role in both function and development of the auditory pathway, as well as in the control of cortical excitability.	[Seal, Rebecca P.; Edwards, Robert H.] Univ Calif San Francisco, Sch Med, Dept Physiol & Neurol, San Francisco, CA 94143 USA; [Akil, Omar; Weber, Christopher M.; Lustig, Lawrence R.] Univ Calif San Francisco, Sch Med, Dept Otolaryngol, San Francisco, CA 94143 USA; [Yi, Eunyoung; Grant, Lisa; Glowatzki, Elisabeth] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Yoo, Jong; Noebels, Jeffrey L.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Clause, Amanda; Kandler, Karl] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA 15261 USA; [Clause, Amanda; Kandler, Karl] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Edwards, RH (corresponding author), Univ Calif San Francisco, Sch Med, Dept Physiol & Neurol, San Francisco, CA 94143 USA.	robert.edwards@ucsf.edu	Yi, Eunyoung/J-3173-2015; Weber, Christopher/C-1308-2008	Yi, Eunyoung/0000-0002-9592-0736; Clause, Amanda/0000-0002-2078-7280; Weber, Christopher/0000-0002-4285-8131; Kandler, Karl/0000-0002-6053-6400; Seal, Rebecca/0000-0003-4955-703X; Noebels, Jeffrey/0000-0002-2887-0839; Glowatzki, Elisabeth/0000-0003-3135-658X	NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH068085, R01MH050712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004199] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004199-10, R01 DC004199, R01 DC004199-09] Funding Source: Medline; NIMH NIH HHS [R01 MH050712, F32 MH068085, R01 MH050712-15] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Akil O, 2006, J NEUROSCI, V26, P13076, DOI 10.1523/JNEUROSCI.3746-06.2006; BOBBIN RP, 1979, EXP BRAIN RES, V34, P389; Boulland JL, 2004, J COMP NEUROL, V480, P264, DOI 10.1002/cne.20354; Brandt A, 2003, J NEUROSCI, V23, P10832; Brandt N, 2007, J NEUROSCI, V27, P3174, DOI 10.1523/JNEUROSCI.3965-06.2007; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; COMIS SD, 1979, EXP BRAIN RES, V36, P119; Croft BG, 2005, MOL BIOL CELL, V16, P306, DOI 10.1091/mbc.e04-07-0559; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Eglen SJ, 2003, NEURON, V40, P1053, DOI 10.1016/S0896-6273(03)00808-0; Eybalin M, 2004, EUR J NEUROSCI, V20, P2981, DOI 10.1111/j.1460-9568.2004.03772.x; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Furness DN, 2003, J NEUROSCI, V23, P11296; Gillespie DC, 2005, NAT NEUROSCI, V8, P332, DOI 10.1038/nn1397; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Gras C, 2005, NEUROPHARMACOLOGY, V49, P901, DOI 10.1016/j.neuropharm.2005.07.023; Gras C, 2002, J NEUROSCI, V22, P5442; Griesinger CB, 2005, NATURE, V435, P212, DOI 10.1038/nature03567; Griesinger CB, 2002, J NEUROSCI, V22, P3939, DOI 10.1523/JNEUROSCI.22-10-03939.2002; Harkany T, 2004, J NEUROSCI, V24, P4978, DOI 10.1523/JNEUROSCI.4884-03.2004; Hegarty JL, 1997, J NEUROSCI, V17, P1959; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hioki H, 2004, CEREB CORTEX, V14, P1266, DOI 10.1093/cercor/bhh088; Jero J, 2001, HEARING RES, V151, P106, DOI 10.1016/S0378-5955(00)00216-1; Johnson J, 2003, J NEUROSCI, V23, P518, DOI 10.1523/JNEUROSCI.23-02-00518.2003; Johnson SL, 2005, J PHYSIOL-LONDON, V563, P177, DOI 10.1113/jphysiol.2004.074740; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Katz E, 2004, J NEUROSCI, V24, P7814, DOI 10.1523/JNEUROSCI.2102-04.2004; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Knipper M, 1997, CELL TISSUE RES, V287, P23; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; Marcotti W, 2003, J PHYSIOL-LONDON, V552, P743, DOI 10.1113/jphysiol.2003.043612; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Nemzou RM, 2006, NEUROSCIENCE, V141, P1849, DOI 10.1016/j.neuroscience.2006.05.057; NOEBELS JL, 1979, SCIENCE, V204, P1334, DOI 10.1126/science.572084; Ottersen OP, 1998, PROG NEUROBIOL, V54, P127, DOI 10.1016/S0301-0082(97)00054-3; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Pyott SJ, 2004, J NEUROSCI, V24, P9469, DOI 10.1523/JNEUROSCI.3162-04.2004; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Rusch A, 2001, J NEUROSCI, V21, P9792, DOI 10.1523/JNEUROSCI.21-24-09792.2001; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; Sendin G, 2007, J NEUROSCI, V27, P3163, DOI 10.1523/JNEUROSCI.3974-06.2007; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Simmons DD, 1996, J COMP NEUROL, V370, P551, DOI 10.1002/(SICI)1096-9861(19960708)370:4<551::AID-CNE10>3.0.CO;2-M; Simmons DD, 2002, J NEUROBIOL, V53, P228, DOI 10.1002/neu.10130; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Takamori S, 2006, NEUROSCI RES, V55, P343, DOI 10.1016/j.neures.2006.04.016; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Tordera RM, 2007, EUR J NEUROSCI, V25, P281, DOI 10.1111/j.1460-9568.2006.05259.x; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	68	263	277	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 24	2008	57	2					263	275		10.1016/j.neuron.2007.11.032	http://dx.doi.org/10.1016/j.neuron.2007.11.032			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256VQ	18215623	Bronze, Green Accepted			2022-12-24	WOS:000252758400010
J	Northoff, G; Walter, M; Schulte, RF; Beck, J; Dydak, U; Henning, A; Boeker, H; Grimm, S; Boesiger, P				Northoff, Georg; Walter, Martin; Schulte, Rolf F.; Beck, Johannes; Dydak, Ulrike; Henning, Anke; Boeker, Heinz; Grimm, Simone; Boesiger, Peter			GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI	NATURE NEUROSCIENCE			English	Article							NEURONAL-ACTIVITY; FUNCTIONAL MRI; RESTING-STATE; MODULATION; BRAIN; ATTENUATION; ANXIETY; SIGNAL	The human anterior cingulate cortex (ACC) is part of the default-mode network that shows predominant negative blood oxygen level-dependent (BOLD) responses in functional magnetic resonance imaging (fMRI). We combined fMRI during emotional processing and resting-state magnetic resonance spectroscopy measurements and observed that the concentration of GABA in the ACC specifically correlated with the amount of negative BOLD responses in the very same region. Our findings show that default-mode network negative BOLD responses during emotions are mediated by GABA.	Univ Magdeburg, Dept Psychiat, D-39120 Magdeburg, Germany; Univ Zurich, ETH Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland; Univ Zurich, Dept Psychiat, CH-8029 Zurich, Switzerland	Otto von Guericke University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Northoff, G (corresponding author), Univ Magdeburg, Dept Psychiat, Leipziger Str 44, D-39120 Magdeburg, Germany.	georg.northoff@medizin.uni-magdeburg.de		Henning, Anke/0000-0002-2267-4861; Walter, Martin/0000-0001-7857-4483				Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Northoff G, 2004, HUM BRAIN MAPP, V21, P202, DOI 10.1002/hbm.20002; Northoff G, 2002, J COGNITIVE NEUROSCI, V14, P348, DOI 10.1162/089892902317361895; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; Raichle ME, 2005, J COMP NEUROL, V493, P167, DOI 10.1002/cne.20752; Schulte RF, 2006, NMR BIOMED, V19, P255, DOI 10.1002/nbm.1026; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193	15	276	280	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1515	1517		10.1038/nn2001	http://dx.doi.org/10.1038/nn2001			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17982452				2022-12-24	WOS:000251172900007
J	Qian, H; Buza-Vidas, N; Hyland, CD; Jensen, CT; Antonchuk, J; Mansson, R; Thoren, LA; Ekblorn, M; Alexander, WS; Jacobsen, SEW				Qian, Hong; Buza-Vidas, Natalija; Hyland, Craig D.; Jensen, Christina T.; Antonchuk, Jennifer; Mansson, Robert; Thoren, Lina A.; Ekblorn, Marja; Alexander, Warren S.; Jacobsen, Sten Eirik W.			Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells	CELL STEM CELL			English	Article							PROGENITOR CELLS; IN-VIVO; C-MPL; MICE LACKING; EXPANSION; PROLIFERATION; RECEPTOR; BCL-2; IDENTIFICATION; FAMILY	The role of cytokines, in regulation of hematopoietic stem cells (HSCs) remains poorly understood. Herein we demonstrate that thrombopoietin (THPO) and its receptor, MPL, are critically involved in postnatal steady-state HSC maintenance, reflected in a 150-fold reduction of HSCs in adult Thpo(-1-) mice. Further, whereas THPO and MPL proved not required for fetal HSC expansion, HSC expansion posttransplantation was highly MPL and THPO dependent. The distinct role of THPO in postnatal HSC maintenance is accompanied by accelerated HSC cell-cycle kinetics in Thpo-1- mice and reduced expression of the cyclin-dependent kinase inhibitors p57(KiP2) and p19(INK4D) as well as multiple Hox transcription factors. Although also predicted to be an HSC viability factor, BCL2 failed to rescue the HSC deficiency of Thpo(-1-) mice. Thus, THPO regulates posttransplantation HSC expansion as well as the maintenance of adult quiescent HSCs, of critical importance to avoid postnatal HSC exhaustion.	[Qian, Hong; Buza-Vidas, Natalija; Jensen, Christina T.; Mansson, Robert; Thoren, Lina A.; Ekblorn, Marja; Jacobsen, Sten Eirik W.] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol, Hematopoiet Stem Cell Lab, S-22184 Lund, Sweden; [Buza-Vidas, Natalija; Jensen, Christina T.; Jacobsen, Sten Eirik W.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Haematopoiet Stem Cell Lab, Headington OX3 9DS, England; [Hyland, Craig D.; Alexander, Warren S.] Walter & Eliza Hall Inst Med Res, Div Canc & Haematol, Parkville, Vic 3050, Australia; [Ekblorn, Marja] Univ Lund Hosp, Dept Haematol, S-22184 Lund, Sweden	Lund University; University of Oxford; Walter & Eliza Hall Institute; Lund University; Skane University Hospital	Jacobsen, SEW (corresponding author), Lund Univ, Lund Strateg Res Ctr Stem Cell Biol, Hematopoiet Stem Cell Lab, S-22184 Lund, Sweden.	sten.jacobsen@med.lu.se	Jacobsen, Sten Eirik W/D-3974-2018; Qian, Hong/D-5588-2014; Mansson, Robert/D-4372-2014	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Qian, Hong/0000-0002-2512-9199; Mansson, Robert/0000-0003-0738-0328	MRC [G0501838] Funding Source: UKRI; Medical Research Council [G0501838] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Ballmaier A, 2003, ANN NY ACAD SCI, V996, P17, DOI 10.1111/j.1749-6632.2003.tb03228.x; Borge OJ, 1996, BLOOD, V88, P2859, DOI 10.1182/blood.V88.8.2859.bloodjournal8882859; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Bradford GB, 1997, EXP HEMATOL, V25, P445; Bryder D, 2000, BLOOD, V96, P1748, DOI 10.1182/blood.V96.5.1748.h8001748_1748_1755; Buza-Vidas N, 2006, GENE DEV, V20, P2018, DOI 10.1101/gad.385606; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; CROSS M, 1991, CELL, V64, P271, DOI 10.1016/0092-8674(91)90638-F; deSauvage FJ, 1996, J EXP MED, V183, P651, DOI 10.1084/jem.183.2.651; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; Dormady SP, 2001, J HEMATOTH STEM CELL, V10, P125, DOI 10.1089/152581601750098372; Dykstra B, 2006, P NATL ACAD SCI USA, V103, P8185, DOI 10.1073/pnas.0602548103; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Fox N, 2002, J CLIN INVEST, V110, P389, DOI 10.1172/JCI200215430; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Iscove NN, 1997, CURR BIOL, V7, P805, DOI 10.1016/S0960-9822(06)00341-1; KAUSHANSKY K, 1995, THROMB HAEMOSTASIS, V74, P521; Kaushansky K, 2006, NEW ENGL J MED, V354, P2034, DOI 10.1056/NEJMra052706; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Kirito K, 2004, MOL CELL BIOL, V24, P6751, DOI 10.1128/MCB.24.15.6751-6762.2004; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Lyman SD, 1998, BLOOD, V91, P1101, DOI 10.1182/blood.V91.4.1101; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; METCALF D, 1993, BLOOD, V82, P3515; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nadin BM, 2003, BLOOD, V102, P2436, DOI 10.1182/blood-2003-01-0118; Nygren JM, 2006, J IMMUNOL, V177, P201, DOI 10.4049/jimmunol.177.1.201; OGAWA M, 1993, BLOOD, V81, P2844; Oostendorp RAJ, 1999, LEUKEMIA, V13, P499, DOI 10.1038/sj.leu.2401373; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; Puri MC, 2003, P NATL ACAD SCI USA, V100, P12753, DOI 10.1073/pnas.2133552100; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; Sitnicka E, 1996, BLOOD, V87, P4998, DOI 10.1182/blood.V87.12.4998.bloodjournal87124998; Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10; Sorrentino BP, 2004, NAT REV IMMUNOL, V4, P878, DOI 10.1038/nri1487; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Tschan MP, 1999, BRIT J HAEMATOL, V106, P644, DOI 10.1046/j.1365-2141.1999.01617.x; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	58	372	391	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC	2007	1	6					671	684		10.1016/j.stem.2007.10.008	http://dx.doi.org/10.1016/j.stem.2007.10.008			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	243GU	18371408	Bronze			2022-12-24	WOS:000251784300013
J	Quinn, JJ; Hitchcott, PK; Umeda, EA; Arnold, AP; Taylor, JR				Quinn, Jennifer J.; Hitchcott, Paul K.; Umeda, Elizabeth A.; Arnold, Arthur P.; Taylor, Jane R.			Sex chromosome coemplement regulates habit formation	NATURE NEUROSCIENCE			English	Article							GENE	Sex differences in brain function and behavior are regularly attributed to gonadal hormones. Some brain sexual dimorphisms, however, are direct actions of sex chromosome genes that are not mediated by gonadal hormones. We used mice in which sex chromosome complement (XX versus XY) and gonadal sex ( ovaries versus testes) were independent, and found that XX mice showed faster food-reinforced instrumental habit formation than XY mice, regardless of gonadal phenotype.	Yale Univ, Connecticut Mental Hlth Ctr, Abraham Ribicoff Res Facil, Div Mol Psychiat, New Haven, CT 06508 USA; Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA	Yale University; University of California System; University of California Los Angeles	Taylor, JR (corresponding author), Yale Univ, Connecticut Mental Hlth Ctr, Abraham Ribicoff Res Facil, Div Mol Psychiat, 34 Pk St, New Haven, CT 06508 USA.	jane.taylor@yale.edu		Arnold, Arthur/0000-0002-9908-9767	NIDA NIH HHS [DA16556, DA11717] Funding Source: Medline; NINDS NIH HHS [NS045966] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA016556, R01DA011717] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ARNOLD AP, 1984, ANNU REV NEUROSCI, V7, P413, DOI 10.1146/annurev.ne.07.030184.002213; Burgoyne PS, 1995, PHILOS T R SOC B, V350, P253, DOI 10.1098/rstb.1995.0159; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Carruth LL, 2002, NAT NEUROSCI, V5, P933, DOI 10.1038/nn922; De Vries GJ, 2002, J NEUROSCI, V22, P9005; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Gatewood JD, 2006, J NEUROSCI, V26, P2335, DOI 10.1523/JNEUROSCI.3743-05.2006; HITCHCOTT PK, 2007, CEREB CORTEX    0224, DOI DOI 10.1093/CERCOR/BH7010; LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635; Lynch WJ, 2002, PSYCHOPHARMACOLOGY, V164, P121, DOI 10.1007/s00213-002-1183-2; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	14	114	115	0	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1398	1400		10.1038/nn1994	http://dx.doi.org/10.1038/nn1994			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17952068				2022-12-24	WOS:000250508400015
J	Chao, HT; Zoghbi, HY; Rosenmund, C				Chao, Hsiao-Tuan; Zoghbi, Huda Y.; Rosenmund, Christian			MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number	NEURON			English	Article							LINKED MENTAL-RETARDATION; NMDA RECEPTOR SUBUNITS; CPG-BINDING PROTEIN-2; RETT-SYNDROME; MOUSE MODEL; HIPPOCAMPAL-NEURONS; NEUROLOGICAL SYMPTOMS; PLASTICITY; MUTATIONS; AUTISM	dMeCP2 is a transcriptional repressor critical for normal neurological function. Prior studies demonstrated that either loss or doubling of MeCP2 results in postnatal neurodevelopmental disorders. To understand the impact of MeCP2 expression on neuronal function, we studied the synaptic properties of individual neurons from mice that either lack or express twice the normal levels of MeCP2. Hippocampal glutamatergic neurons that lack MeCP2 display a 46% reduction in synaptic response, whereas neurons with doubling of MeCP2 exhibit a 2-fold enhancement in synaptic response. Further analysis shows that these changes were primarily due to the number of synapses formed. These results reveal that MeCP2 is a key rate-limiting factor in regulating glutamatergic synapse formation in early postnatal development and that changes in excitatory synaptic strength may underlie global network alterations in neurological disorders due to altered MeCP2 levels.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	hzoghbi@bcm.edu; rosenmun@bcm.edu	Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444; Zoghbi, Huda/0000-0002-0700-3349	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NICHD NIH HHS [P30 HD024064-15, HD053862, P30 HD024064, HD024064] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Belichenko PV, 1997, ACTA NEUROPATHOL, V93, P50, DOI 10.1007/s004010050582; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Carney RM, 2003, PEDIATR NEUROL, V28, P205, DOI 10.1016/S0887-8994(02)00624-0; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Couvert P, 2001, HUM MOL GENET, V10, P941, DOI 10.1093/hmg/10.9.941; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Friez MJ, 2006, PEDIATRICS, V118, pE1687, DOI 10.1542/peds.2006-0395; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Meloni I, 2000, AM J HUM GENET, V67, P982, DOI 10.1086/303078; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Niethammer M, 1996, J NEUROSCI, V16, P2157; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Rao A, 1998, J NEUROSCI, V18, P1217; Rett A, 1966, Wien Med Wochenschr, V116, P723; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shi Jinxiu, 2005, Hum Mutat, V25, P505, DOI 10.1002/humu.9338; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	44	364	377	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 4	2007	56	1					58	65		10.1016/j.neuron.2007.08.018	http://dx.doi.org/10.1016/j.neuron.2007.08.018			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920015	Green Accepted, Bronze			2022-12-24	WOS:000250289800010
J	Belova, MA; Paton, JJ; Morrison, SE; Salzman, CD				Belova, Marina A.; Paton, Joseph J.; Morrison, Sara E.; Salzman, C. Daniel			Expectation modulates neural responses to pleasant and aversive stimuli in primate amygdala	NEURON			English	Article							MACAQUE MONKEY AMYGDALA; BASOLATERAL AMYGDALA; PREDICTION ERROR; CORTICAL INPUTS; PARIETAL CORTEX; HUMAN BRAIN; REWARD; DOPAMINE; EMOTION; NEURONS	Animals and humans learn to approach and acquire pleasant stimuli and to avoid or defend against aversive ones. However, both pleasant and aversive stimuli can elicit arousal and attention, and their salience or intensity increases when they occur by surprise. Thus, adaptive behavior may require that neural circuits compute both stimulus valence-or value-and intensity. To explore how these computations may be implemented, we examined neural responses in the primate amygdala. to unexpected reinforcement during learning. Many amygdala neurons responded differently to reinforcement depending upon whether or not it was expected. In some neurons, this modulation occurred only for rewards or aversive stimuli, but not both. In other neurons, expectation similarly modulated responses to both rewards and punishments. These different neuronal populations may subserve two sorts of processes mediated by the amygdala: those activated by surprising reinforcements of both valences-such as enhanced arousal and attention-and those that are valence-specific, such as fear or rewardseeking behavior.	Columbia Univ, Dept Neurosci, New York, NY 10027 USA; Columbia Univ, Dept Psychiat, New York, NY 10027 USA; Columbia Univ, WM Keck Ctr Brain Plasticity & Cognit, New York, NY 10027 USA; Columbia Univ, Kavli Inst Brain Sci, New York, NY 10027 USA; Columbia Univ, Mahoney Ctr Brain & Behavior, New York, NY 10027 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Salzman, CD (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10027 USA.	cds2005@columbia.edu		Morrison, Sara/0000-0003-0334-1284; Paton, Joseph/0000-0002-1663-6455	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082017, K01MH001724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020656] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA020656, R01 DA020656-01A2] Funding Source: Medline; NIMH NIH HHS [R01 MH082017-01A1, K01 MH001724-02, K01 MH001724-06, K01 MH001724-03, K01 MH001724, K01 MH001724-01A1, R01 MH082017, K01 MH001724-05, K01 MH001724-04] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMARAL D G, 1992, P1; Anstrom KK, 2005, NEUROPSYCHOPHARMACOL, V30, P1832, DOI 10.1038/sj.npp.1300730; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Davis M., 2000, AMYGDALA, P213; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dickinson A., 1979, MECH LEARNING MOTIVA, P203; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Grace AA, 2002, PHYSIOL BEHAV, V77, P489, DOI 10.1016/S0031-9384(02)00909-5; Green DM, 1966, SIGNAL DETECTION THE; GROSSBERG S, 1984, BIOL PSYCHIAT, V19, P1075; Guarraci FA, 1999, BRAIN RES, V827, P28, DOI 10.1016/S0006-8993(99)01291-3; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Holland PC, 2006, J NEUROSCI, V26, P3791, DOI 10.1523/JNEUROSCI.0390-06.2006; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Kensinger EA, 2004, P NATL ACAD SCI USA, V101, P3310, DOI 10.1073/pnas.0306408101; Konorski J., 1967, INTEGRATIVE ACTIVITY; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Nader K, 1999, BEHAV NEUROSCI, V113, P891, DOI 10.1037/0735-7044.113.5.891; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Oya H, 2005, P NATL ACAD SCI USA, V102, P8351, DOI 10.1073/pnas.0500899102; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paz R, 2006, NAT NEUROSCI, V9, P1321, DOI 10.1038/nn1771; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Salzman CD, 2005, CURR OPIN NEUROBIOL, V15, P721, DOI 10.1016/j.conb.2005.10.016; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Stefanacci L, 2000, J COMP NEUROL, V421, P52, DOI 10.1002/(SICI)1096-9861(20000522)421:1<52::AID-CNE4>3.0.CO;2-O; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Sugase-Miyamoto Y, 2005, J NEUROSCI, V25, P11071, DOI 10.1523/JNEUROSCI.1796-05.2005; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006	55	266	268	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 20	2007	55	6					970	984		10.1016/j.neuron.2007.08.004	http://dx.doi.org/10.1016/j.neuron.2007.08.004			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	219IQ	17880899	Green Accepted, Bronze			2022-12-24	WOS:000250078500013
J	Lensch, MW; Schlaeger, TM; Zon, LI; Daley, GQ				Lensch, M. William; Schlaeger, Thorsten M.; Zon, Leonard I.; Daley, George Q.			Teratoma formation assays with human embryonic stem cells: A rationale for one type of human-animal chimera	CELL STEM CELL			English	Article							REPLACE NEURONS; LINE; DIFFERENTIATION; CARCINOMA; FETAL; OLIGODENDROCYTES; DERIVATIVES; GROWTH; MICE	Despite a long and valuable history, human-animal chimera research has often been questioned. Among the moral issues raised by chimeras is the concept that integration of human cells into anatomical locations such as the brain might endow animals with "human-like" capacities including self-awareness. We present a justification for one type of human-animal chimera experiment: the evaluation of hES cell developmental potency via teratoma, formation in immunodeficient mice. We argue that this experiment raises no significant moral concerns and should be the jurisdiction of animal care and use committees and exempt from formal review by the stem cell research oversight process.	Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Stem Cell Inst, Cambridge, MA 02138 USA; Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Childrens Hosp, Div Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu		Schlaeger, Thorsten/0000-0002-1599-9908	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; ANDREWS PW, 1984, LAB INVEST, V50, P147; Askanazy M., 1907, VERHANDL DEUTSH PATH, V11, P39; BAHRINGER RH, 2007, IN PRESS CELL STEM C, V1; BIRCH S, 1683, PHILOS T R SOC, V13, P281; BRINSTER RL, 1974, J EXP MED, V140, P1049, DOI 10.1084/jem.140.4.1049; Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; DELEY GQ, 2007, SCINCE, V315, P603; Deschamps JY, 2005, XENOTRANSPLANTATION, V12, P91, DOI 10.1111/j.1399-3089.2004.00199.x; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; GERTOW K, 2007, IN PRESS CURR PROT S; Greene M, 2005, SCIENCE, V309, P385, DOI 10.1126/science.1112207; HEGNER CA, 1913, MUNCHEN MED WCHNSCHR, V60, P2722; Hyun I, 2007, CELL STEM CELL, V1, P367, DOI 10.1016/j.stem.2007.09.006; *INT SOC STEM CELL, 2006, GUID COND HUM EMBR S; Isaacs H, 2004, J PEDIATR SURG, V39, P1003, DOI 10.1016/j.jpedsurg.2004.03.045; KAMELREID S, 1988, SCIENCE, V242, P1706, DOI 10.1126/science.2904703; Karpowicz P, 2004, NAT MED, V10, P331, DOI 10.1038/nm0404-331; Kerr DA, 2003, J NEUROSCI, V23, P5131; King 2Edmond, 1667, PHILOS T R SOC LOND, V2, P558; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; KLEPPNER SR, 1995, J COMP NEUROL, V357, P618, DOI 10.1002/cne.903570410; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MARTIN GR, 1974, CELL, V2, P163, DOI 10.1016/0092-8674(74)90090-7; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; MCBURNEY MW, 1976, J CELL PHYSIOL, V89, P441, DOI 10.1002/jcp.1040890310; Mueller D, 2005, J NEUROSCI RES, V82, P592, DOI 10.1002/jnr.20673; NAGY A, 1990, DEVELOPMENT, V110, P815; National Research Council, 2005, GUID HUM EMBR STEM C; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Paterakis KN, 2005, CLIN NEUROL NEUROSUR, V108, P67, DOI 10.1016/j.clineuro.2004.11.010; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Robert JS, 2006, FASEB J, V20, P838, DOI 10.1096/fj.05-4286lsf; SOLTER D, 1970, NATURE, V227, P503, DOI 10.1038/227503a0; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; STEVENS LC, 1968, J EMBRYOL EXP MORPH, V20, P329; Streiffer R, 2005, KENNEDY INST ETHIC J, V15, P347, DOI 10.1353/ken.2005.0030; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; TARKOWSKI AK, 1961, NATURE, V190, P857, DOI 10.1038/190857a0; TEILUM G, 1965, ACTA PATHOL MIC SC, V64, P407, DOI 10.1111/apm.1965.64.4.407; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Witschi Emil, 1948, CONTRIBUTIONS TO EMBRYOLOGY [CARNEGIE INST OF WASHINGTON PUBL], V32, P67; Yu N, 2002, NEW ENGL J MED, V346, P1545, DOI 10.1056/NEJMoa013452	49	98	101	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2007	1	3					253	258		10.1016/j.stem.2007.07.019	http://dx.doi.org/10.1016/j.stem.2007.07.019			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XT	18371359	Bronze			2022-12-24	WOS:000251055200007
J	Park, S; Park, JM; Kim, S; Kim, JA; Shepherd, JD; Smith-Hicks, CL; Chowdhury, S; Kaufmann, W; Kuhl, D; Ryazanov, AG; Huganir, RL; Linden, DJ; Worley, PF				Park, Sungjin; Park, Joo Min; Kim, Sangmok; Kim, Jin-Ah; Shepherd, Jason D.; Smith-Hicks, Constance L.; Chowdhury, Shoaib; Kaufmann, Walter; Kuhl, Dietmar; Ryazanov, Alexey G.; Huganir, Richard L.; Linden, David J.; Worley, Paul F.			Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD	NEURON			English	Article							LONG-TERM DEPRESSION; IMMEDIATE-EARLY GENE; MESSENGER-RNAS; SYNAPTIC PLASTICITY; AMPA RECEPTORS; MOUSE MODEL; FACTOR-II; GLUTAMATE RECEPTORS; RIBOSOMAL-PROTEINS; POSTSYNAPTIC SITES	Group I metabotropic glutamate receptors (mGluR) induce long-term depression (LTD) that requires protein synthesis. Here, we demonstrate that Arc/Arg3.1 is translationally induced within 5 min of mGluR activation, and this response is essential for mGluR-dependent LTD. The increase in Arc/Arg3.1 translation requires eEF2K, a Ca(2+)/calmodulin-dependent kinase that binds mGluR and dissociates upon mGluR activation, whereupon it phosphorylates eEF2. Phospho-eEF2 acts to slow the elongation step of translation and inhibits general protein synthesis but simultaneously increases Arc/Arg3.1 translation. Genetic deletion of eEF2K results in a selective deficit of rapid mGluR-dependent Arc/Arg3.1 translation and mGluR-LTD. This rapid translational mechanism is disrupted in the fragile X disease mouse (Fmr1 KO) in which mGluR-LTD does not require de novo protein synthesis but does require Arc/Arg3.1. We propose a model in which eEF2K-eEF2 and FMRP coordinately control the dynamic translation of Arc/Arg3.1 mRNA in dendrites that is critical for synapse-specific LTD.	[Park, Sungjin; Park, Joo Min; Kim, Sangmok; Kim, Jin-Ah; Chowdhury, Shoaib; Huganir, Richard L.; Linden, David J.; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Bethesda, MD 20205 USA; [Smith-Hicks, Constance L.; Kaufmann, Walter; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Bethesda, MD 20205 USA; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Bethesda, MD 20205 USA; [Shepherd, Jason D.] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Kuhl, Dietmar] Free Univ Berlin, Dept Biol Chem Pharm, D-14195 Berlin, Germany; [Ryazanov, Alexey G.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Massachusetts Institute of Technology (MIT); Northwell Health; Free University of Berlin; Rutgers State University New Brunswick; Rutgers State University Medical Center	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Bethesda, MD 20205 USA.	pworley@jhmi.edu	ryazanov, alexey/J-8081-2017; Kuhl, Dietmar/A-4689-2009; Shepherd, Jason/N-8555-2018	Kuhl, Dietmar/0000-0002-4772-6701; Shepherd, Jason/0000-0001-7384-8289	Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [R01 AG019890-05, R01 AG019890, AG019890] Funding Source: Medline; NIDA NIH HHS [P50 DA000266, P50 DA000266-37, DA00266] Funding Source: Medline; NIGMS NIH HHS [R01 GM057300-05, GM057300, R01 GM057300] Funding Source: Medline; NIMH NIH HHS [R37 MH051106, MH053608, MH068830, R01 MH053608, R37 MH051106-16, R01 MH051106, P50 MH068830-05, MH51106, R01 MH053608-14, R29 MH051106, P50 MH068830] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830, R01MH053608, R37MH051106, R01MH051106, R29MH051106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Asaki C, 2003, BRAIN RES, V972, P168, DOI 10.1016/S0006-8993(03)02523-X; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; BEGUERET J, 1977, MOL GEN GENET, V156, P141, DOI 10.1007/BF00283486; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Chotiner JK, 2003, NEUROSCIENCE, V116, P743, DOI 10.1016/S0306-4522(02)00797-2; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; Fernandez J, 2005, MOL CELL, V17, P405, DOI 10.1016/j.molcel.2004.12.024; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Gupta KC, 1997, BIOCHEM J, V321, P811, DOI 10.1042/bj3210811; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Iacoangeli A, 2008, P NATL ACAD SCI USA, V105, P734, DOI 10.1073/pnas.0803737105; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Marrone DF, 2008, J NEUROSCI, V28, P1030, DOI 10.1523/JNEUROSCI.4235-07.2008; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Mori Y, 2000, NAT NEUROSCI, V3, P1079, DOI 10.1038/80591; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; OBRIG TG, 1971, J BIOL CHEM, V246, P174; PERLMAN J, 1982, MOL CELL BIOL, V2, P1167, DOI 10.1128/MCB.2.10.1167; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Pinkstaff JK, 2001, P NATL ACAD SCI USA, V98, P2770, DOI 10.1073/pnas.051623398; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1987, FEBS LETT, V214, P331, DOI 10.1016/0014-5793(87)80081-9; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Taubenfeld SM, 2002, J NEUROCHEM, V81, P1348, DOI 10.1046/j.1471-4159.2002.00936.x; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; WALDEN WE, 1986, BIOCHEMISTRY-US, V25, P2033, DOI 10.1021/bi00356a030; Wang HD, 2004, NEUROSCIENTIST, V10, P456, DOI 10.1177/1073858404265866; Weiler IJ, 2004, P NATL ACAD SCI USA, V101, P17504, DOI 10.1073/pnas.0407533101; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5	58	381	387	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 10	2008	59	1					70	83		10.1016/j.neuron.2008.05.023	http://dx.doi.org/10.1016/j.neuron.2008.05.023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	327KU	18614030	Green Accepted, Bronze			2022-12-24	WOS:000257728800009
J	Konen, CS; Kastner, S				Konen, Christina S.; Kastner, Sabine			Two hierarchically organized neural systems for object information in human visual cortex	NATURE NEUROSCIENCE			English	Article							LATERAL OCCIPITAL COMPLEX; POSTERIOR PARIETAL CORTEX; TOPOGRAPHIC MAPS; AREA V4; SHAPE; REPRESENTATION; ATTENTION; NEURONS; MONKEY; SPACE	The primate visual system is broadly organized into two segregated processing pathways, a ventral stream for object vision and a dorsal stream for space vision. Here, evidence from functional brain imaging in humans demonstrates that object representations are not confined to the ventral pathway, but can also be found in several areas along the dorsal pathway. In both streams, areas at intermediate processing stages in extrastriate cortex (V4, V3A, MT and V7) showed object-selective but viewpoint- and size-specific responses. In contrast, higher-order areas in lateral occipital and posterior parietal cortex (LOC, IPS1 and IPS2) responded selectively to objects independent of image transformations. Contrary to the two-pathways hypothesis, our findings indicate that basic object information related to shape, size and viewpoint may be represented similarly in two parallel and hierarchically organized neural systems in the ventral and dorsal visual pathways.	[Konen, Christina S.; Kastner, Sabine] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA; [Konen, Christina S.] Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08540 USA; [Kastner, Sabine] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA	Princeton University; Princeton University; Princeton University	Konen, CS (corresponding author), Princeton Univ, Dept Psychol, Green Hall, Princeton, NJ 08540 USA.	ckonen@princeton.edu		Kastner, Sabine/0000-0002-9742-965X	NATIONAL EYE INSTITUTE [R01EY017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH062196, R01MH064043] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY017699] Funding Source: Medline; NIMH NIH HHS [R01 MH64043, P50 MH-62196] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Craighero L, 1996, NEUROREPORT, V8, P347, DOI 10.1097/00001756-199612200-00068; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; DESIMONE R, 1985, VISION RES, V25, P441, DOI 10.1016/0042-6989(85)90069-0; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Gallant JL, 1996, J NEUROPHYSIOL, V76, P2718, DOI 10.1152/jn.1996.76.4.2718; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Huk AC, 2002, J NEUROSCI, V22, P7195; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kastner S, 2007, J NEUROPHYSIOL, V97, P3494, DOI 10.1152/jn.00010.2007; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Kourtzi Z, 2002, NAT NEUROSCI, V5, P17, DOI 10.1038/nn780; Kourtzi Z, 2003, CEREB CORTEX, V13, P911, DOI 10.1093/cercor/13.9.911; Lehky SR, 2007, J NEUROPHYSIOL, V97, P307, DOI 10.1152/jn.00168.2006; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Nakamura H, 2001, J NEUROSCI, V21, P8174, DOI 10.1523/JNEUROSCI.21-20-08174.2001; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; Sakata Hideo, 2003, Adv Neurol, V93, P121; Sawamura H, 2005, J NEUROSCI, V25, P4294, DOI 10.1523/JNEUROSCI.0377-05.2005; Schluppeck D, 2005, J NEUROPHYSIOL, V94, P1372, DOI 10.1152/jn.01290.2004; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Ungerleider L.G., 1982, ANAL VISUAL BEHAV; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839	50	323	327	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					224	231		10.1038/nn2036	http://dx.doi.org/10.1038/nn2036			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18193041				2022-12-24	WOS:000252712100017
J	Louis, M; Huber, T; Benton, R; Sakmar, TP; Vosshall, LB				Louis, Matthieu; Huber, Thomas; Benton, Richard; Sakmar, Thomas P.; Vosshall, Leslie B.			Bilateral olfactory sensory input enhances chemotaxis behavior	NATURE NEUROSCIENCE			English	Article							C-ELEGANS; WORKING-MEMORY; DROSOPHILA; SMELL; LATERALIZATION; MECHANISMS; RECEPTORS; TRACKING; SYSTEM; CORTEX	Neural comparisons of bilateral sensory inputs are essential for visual depth perception and accurate localization of sounds in space. All animals, from single-cell prokaryotes to humans, orient themselves in response to environmental chemical stimuli, but the contribution of spatial integration of neural activity in olfaction remains unclear. We investigated this problem in Drosophila melanogaster larvae. Using high-resolution behavioral analysis, we studied the chemotaxis behavior of larvae with a single functional olfactory neuron on either the left or right side of the head, allowing us to examine unilateral or bilateral olfactory input. We developed new spectroscopic methods to create stable odorant gradients in which odor concentrations were experimentally measured. In these controlled environments, we observed that a single functional neuron provided sufficient information to permit larval chemotaxis. We found additional evidence that the overall accuracy of navigation is enhanced by the increase in the signal-to-noise ratio conferred by bilateral sensory input.	[Louis, Matthieu; Benton, Richard; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Huber, Thomas; Sakmar, Thomas P.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave, New York, NY 10065 USA.	leslie@rockefeller.edu	Louis, Matthieu/J-5566-2015; Sakmar, Thomas P/D-1833-2015; Huber, Thomas/A-8016-2008	Louis, Matthieu/0000-0002-2267-0262; Sakmar, Thomas P/0000-0002-2836-8953; Huber, Thomas/0000-0002-1844-262X; Vosshall, Leslie/0000-0002-6060-8099				Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BENHAMOU S, 1992, ANIM BEHAV, V43, P371, DOI 10.1016/S0003-3472(05)80097-1; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; BERG HC, 2004, E COIL MOTION; Bray D, 2007, CURR BIOL, V17, P12, DOI 10.1016/j.cub.2006.11.027; Cobb M, 1999, BIOL REV, V74, P425, DOI 10.1017/S0006323199005393; COBB M, 1992, P ROY SOC B-BIOL SCI, V248, P103, DOI 10.1098/rspb.1992.0048; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fraenkel GS, 1961, ORIENTATION ANIMALS; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Letzkus P, 2006, CURR BIOL, V16, P1471, DOI 10.1016/j.cub.2006.05.060; MONTE P, 1989, BEHAV GENET, V19, P267, DOI 10.1007/BF01065910; Ning QA, 1997, NEURON, V18, P359, DOI 10.1016/S0896-6273(00)81238-6; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; Quaranta A, 2007, CURR BIOL, V17, pR199, DOI 10.1016/j.cub.2007.02.008; Rajan R, 2006, SCIENCE, V311, P666, DOI 10.1126/science.1122096; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Samadani A, 2006, P NATL ACAD SCI USA, V103, P11549, DOI 10.1073/pnas.0601909103; Schrick K, 1997, GENETICS, V147, P19; THESEN A, 1993, J EXP BIOL, V180, P247; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VALLORTIGARA G, 1994, NEUROPSYCHOLOGIA, V32, P417, DOI 10.1016/0028-3932(94)90087-6; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Vetter RS, 2006, CHEM SENSES, V31, P359, DOI 10.1093/chemse/bjj040; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wallace DG, 2002, BEHAV BRAIN RES, V131, P185, DOI 10.1016/S0166-4328(01)00384-9; Zar J.R., 1999, BIOSTAT ANAL; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	47	123	124	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					187	199		10.1038/nn2031	http://dx.doi.org/10.1038/nn2031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18157126				2022-12-24	WOS:000252712100013
J	Lai, T; Jabaudon, D; Molyneaux, BJ; Azim, E; Arlotta, P; Menezes, JRL; Macklis, JD				Lai, Tina; Jabaudon, Denis; Molyneaux, Bradley J.; Azim, Eiman; Arlotta, Paola; Menezes, Joao R. L.; Macklis, Jeffrey D.			SOX5 controls the sequential generation of distinct corticofugal neuron subtypes	NEURON			English	Article							CEREBRAL CORTICAL DEVELOPMENT; CALRETININ-IMMUNOREACTIVITY; TRANSCRIPTION FACTORS; SUBCORTICAL TARGETS; AXONAL PROJECTIONS; LAYER NEURONS; CORTEX; NEOCORTEX; CELL; DIFFERENTIATION	The molecular mechanisms controlling the development of distinct subtypes of neocortical projection neurons, and CNS neuronal diversity more broadly, are only now emerging. We report that the transcription factor SOX5 controls the sequential generation of distinct corticofugal neuron subtypes by preventing premature emergence of normally later-born corticofugal neurons. SOX5 loss-of-function causes striking overlap of the identities of the three principal sequentially born corticofugal neuron subtypes: subplate neurons, corticothalamic neurons, and subcerebral projection neurons. In Sox5(-/-) cortex, subplate neurons aberrantly develop molecular hallmarks and connectivity of subcerebral projection neurons; corticothalamic neurons are imprecisely differentiated, while differentiation of subcerebral projection neurons is accelerated. Gain-of-function analysis reinforces the critical role of SOX5 in controlling the sequential generation of corticofugal neurons-SOX5 overexpression at late stages of corticogenesis causes re-emergence of neurons with corticofugal features. These data indicate that SOX5 controls the timing of critical fate decisions during corticofugal neuron production and thus subtype-specific differentiation and neocortical neuron diversity.	[Lai, Tina; Jabaudon, Denis; Molyneaux, Bradley J.; Azim, Eiman; Arlotta, Paola; Menezes, Joao R. L.; Macklis, Jeffrey D.] Harvard Univ, Sch Med, MGH HMS Ctr Nervous Syst Repair, Dept Neurosurg,Program Neurosci, Cambridge, MA 02138 USA; [Lai, Tina; Jabaudon, Denis; Molyneaux, Bradley J.; Azim, Eiman; Arlotta, Paola; Menezes, Joao R. L.; Macklis, Jeffrey D.] Harvard Univ, Sch Med, MGH HMS Ctr Nervous Syst Repair, Dept Neurol,Program Neurosci, Boston, MA 02114 USA; [Lai, Tina; Jabaudon, Denis; Molyneaux, Bradley J.; Azim, Eiman; Arlotta, Paola; Menezes, Joao R. L.; Macklis, Jeffrey D.] Massachusetts Gen Hosp, Nayef Al Rodhan Labs, Boston, MA 02114 USA; [Lai, Tina; Jabaudon, Denis; Molyneaux, Bradley J.; Azim, Eiman; Arlotta, Paola; Menezes, Joao R. L.; Macklis, Jeffrey D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Boston, MA 02114 USA; [Lai, Tina; Jabaudon, Denis; Molyneaux, Bradley J.; Azim, Eiman; Arlotta, Paola; Menezes, Joao R. L.; Macklis, Jeffrey D.] Harvard Univ, Harvard Stem Cell Inst, Boston, MA 02114 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Macklis, JD (corresponding author), Harvard Univ, Sch Med, MGH HMS Ctr Nervous Syst Repair, Dept Neurosurg,Program Neurosci, Cambridge, MA 02138 USA.	jeffrey_macklis@hms.harvard.edu	Jabaudon, Denis/B-8802-2014; Menezes, João R. L./D-5668-2012	Jabaudon, Denis/0000-0003-2438-4769; Azim, Eiman/0000-0002-1015-1772; Molyneaux, Bradley/0000-0002-3377-1229	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045523, R01NS022215, R01NS049553] Funding Source: NIH RePORTER; NINDS NIH HHS [NS49553, T32 NS22215, NS45523] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABOLTIZ F, 2003, BRAZ J MED, V36, P409; ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Berger UV, 2001, J COMP NEUROL, V433, P101, DOI 10.1002/cne.1128; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Deng JB, 2003, ANAT EMBRYOL, V207, P177, DOI 10.1007/s00429-003-0338-1; Desai AR, 2000, DEVELOPMENT, V127, P2863; FONSECA M, 1995, J COMP NEUROL, V361, P177, DOI 10.1002/cne.903610114; Fricker-Gates RA, 2002, J NEUROSCI, V22, P4045, DOI 10.1523/JNEUROSCI.22-10-04045.2002; Gawlas K, 2000, BBA-GENE STRUCT EXPR, V1494, P236, DOI 10.1016/S0167-4781(00)00237-2; Guillemot F, 2006, EUR J NEUROSCI, V23, P857, DOI 10.1111/j.1460-9568.2006.04626.x; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Heuer H, 2003, NEUROSCIENCE, V119, P43, DOI 10.1016/S0306-4522(03)00100-3; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hong CS, 2005, SEMIN CELL DEV BIOL, V16, P694, DOI 10.1016/j.semcdb.2005.06.005; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Lefebvre W, 2002, J BONE MINER METAB, V20, P121, DOI 10.1007/s007740200017; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MARINPADILLA M, 1992, J COMP NEUROL, V321, P223, DOI 10.1002/cne.903210205; MCCONNELL SK, 1994, J NEUROSCI, V14, P1892; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Meyer G, 2000, J NEUROSCI, V20, P1858; Molnar Z, 2006, EUR J NEUROSCI, V23, P921, DOI 10.1111/j.1460-9568.2006.04611.x; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; Perez-Alcala S, 2004, DEVELOPMENT, V131, P4455, DOI 10.1242/dev.01329; Rakic S, 2006, CEREB CORTEX, V16, pI35, DOI 10.1093/cercor/bhj172; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Schierle GS, 1997, CEREB CORTEX, V7, P130, DOI 10.1093/cercor/7.2.130; Smits P, 2004, J CELL BIOL, V164, P747, DOI 10.1083/jcb.200312045; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Super H, 2001, CEREB CORTEX, V11, P1101, DOI 10.1093/cercor/11.12.1101; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	51	216	220	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 24	2008	57	2					232	247		10.1016/j.neuron.2007.12.023	http://dx.doi.org/10.1016/j.neuron.2007.12.023			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256VQ	18215621	Bronze			2022-12-24	WOS:000252758400008
J	Hasson, U; Skippe, JI; Nusbaum, HC; Small, SL				Hasson, Uri; Skippe, Jeremy I.; Nusbaum, Howard C.; Small, Steven L.			Abstract coding of audiovisual speech: Beyond sensory representation	NEURON			English	Article							INFERIOR FRONTAL-CORTEX; PRIMARY AUDITORY-CORTEX; EVENT-RELATED FMRI; VISUAL SPEECH; FUNCTIONAL SPECIALIZATION; PERCEPTION; INFORMATION; INTEGRATION; ACTIVATION; REPETITION	Is there a neural representation of speech that transcends its sensory properties? Using fMRI, we investigated whether there are brain areas where neural activity during observation of sublexical audiovisual input corresponds to a listener's speech percept (what is "heard") independent of the sensory properties of the input. A target audiovisual stimulus was preceded by stimuli that (1) shared the target's auditory features (auditory overlap), (2) shared the target's visual features (visual overlap), or (3) shared neither the target's auditory or visual features but were perceived as the target (perceptual overlap). In two left-hemisphere regions (pars opercularis, planum polare), the target invoked less activity when it was preceded by the perceptually overlapping stimulus than when preceded by stimuli that shared one of its sensory components. This pattern of neural facilitation indicates that these regions code sublexical speech at an abstract level corresponding to that of the speech percept.	[Hasson, Uri; Skippe, Jeremy I.; Small, Steven L.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Hasson, Uri; Skippe, Jeremy I.; Nusbaum, Howard C.; Small, Steven L.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Nusbaum, Howard C.; Small, Steven L.] Univ Chicago, Ctr Cognit & Social Neurosci, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Hasson, U (corresponding author), Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	uhasson@uchicago.edu	Skipper, Jeremy I/Q-7052-2016; Skipper, Jeremy I/AAW-9475-2021; Hasson, Uri/C-1701-2012	Skipper, Jeremy I/0000-0002-5503-764X; Skipper, Jeremy I/0000-0002-5503-764X; Hasson, Uri/0000-0002-8530-5051; Hasson, Uri/0000-0002-3599-7168; Small, Steven/0000-0002-5293-6172	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003378] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC003378-10, R01-DC03378, R01 DC003378] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Barraclough NE, 2005, J COGNITIVE NEUROSCI, V17, P377, DOI 10.1162/0898929053279586; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Benson RR, 2006, NEUROIMAGE, V31, P342, DOI 10.1016/j.neuroimage.2005.11.029; Binder JR, 2004, NAT NEUROSCI, V7, P295, DOI 10.1038/nn1198; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Blumstein SE, 2005, J COGNITIVE NEUROSCI, V17, P1353, DOI 10.1162/0898929054985473; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; Burton MW, 2000, J COGNITIVE NEUROSCI, V12, P679, DOI 10.1162/089892900562309; Callan DE, 2006, NEUROIMAGE, V31, P1327, DOI 10.1016/j.neuroimage.2006.01.036; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cohen YE, 2007, J NEUROPHYSIOL, V97, P1470, DOI 10.1152/jn.00769.2006; Colin C, 2002, CLIN NEUROPHYSIOL, V113, P495, DOI 10.1016/S1388-2457(02)00024-X; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Crinion J, 2005, BRAIN, V128, P2858, DOI 10.1093/brain/awh659; DALE W, 1999, PROSTATE J, V1, P179, DOI DOI 10.1046/J.1525-1411.1999.14005.X; DEACON TW, 1992, BRAIN RES, V573, P8, DOI 10.1016/0006-8993(92)90109-M; Dehaene-Lambertz G, 2005, NEUROIMAGE, V24, P21, DOI 10.1016/j.neuroimage.2004.09.039; DiVirgilio G, 1997, HUM BRAIN MAPP, V5, P347, DOI 10.1002/(SICI)1097-0193(1997)5:5<347::AID-HBM3>3.0.CO;2-3; Duvernoy H.M, 1991, HUMAN BRAIN STRUCTUR; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Formisano E, 2003, CURR OPIN NEUROBIOL, V13, P174, DOI 10.1016/S0959-4388(03)00044-8; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Golestani N, 2004, NEUROIMAGE, V21, P494, DOI 10.1016/j.neuroimage.2003.09.071; Gough PM, 2005, J NEUROSCI, V25, P8010, DOI 10.1523/JNEUROSCI.2307-05.2005; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; HASSON U, 2007, IN PRESS BRAIN NETWO, DOI DOI 10.1093/CERCOR/BHM016; Hasson U, 2006, J COGNITIVE NEUROSCI, V18, P2013, DOI 10.1162/jocn.2006.18.12.2013; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Imada T, 2006, NEUROREPORT, V17, P957, DOI 10.1097/01.wnr.0000223387.51704.89; Jacquemot C, 2003, J NEUROSCI, V23, P9541; Jancke L, 2002, NEUROIMAGE, V15, P733, DOI 10.1006/nimg.2001.1027; Kayser C, 2007, J NEUROSCI, V27, P1824, DOI 10.1523/JNEUROSCI.4737-06.2007; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Meyer M, 2005, NEUROREPORT, V16, P1985, DOI 10.1097/00001756-200512190-00003; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; Morosan P, 2005, ANAT EMBRYOL, V210, P401, DOI 10.1007/s00429-005-0029-1; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Mottonen R, 2004, NEUROSCI LETT, V363, P112, DOI 10.1016/j.neulet.2004.03.076; Mottonen R, 2002, COGNITIVE BRAIN RES, V13, P417, DOI 10.1016/S0926-6410(02)00053-8; NELKEN I, 2006, DYNAMICS SPEECH PROD; Nusbaum H. C., 1986, PATTERN RECOGN, P113, DOI [DOI 10.1016/B978-0-12-631403-8.50009-6, 10.1016/B978-0-12-631403-8.50009-6]; Ojanen V, 2005, NEUROIMAGE, V25, P333, DOI 10.1016/j.neuroimage.2004.12.001; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Paulesu E, 2003, J NEUROPHYSIOL, V90, P2005, DOI 10.1152/jn.00926.2002; Paulesu E, 1997, NEUROREPORT, V8, P2011, DOI 10.1097/00001756-199705260-00042; Pekkola J, 2006, NEUROIMAGE, V29, P797, DOI 10.1016/j.neuroimage.2005.09.069; Pekkola J, 2005, NEUROREPORT, V16, P125, DOI 10.1097/00001756-200502080-00010; Pekkola J, 2006, HUM BRAIN MAPP, V27, P471, DOI 10.1002/hbm.20190; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Pourtois G, 2005, J COGNITIVE NEUROSCI, V17, P1043, DOI 10.1162/0898929054475181; Price C, 2005, TRENDS COGN SCI, V9, P271, DOI 10.1016/j.tics.2005.03.009; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romanski LM, 2002, NAT NEUROSCI, V5, P15, DOI 10.1038/nn781; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; Saad ZS, 2006, HUM BRAIN MAPP, V27, P417, DOI 10.1002/hbm.20247; SALDANA HM, 1993, PERCEPT PSYCHOPHYS, V54, P406, DOI 10.3758/BF03205276; SAMS M, 1991, NEUROSCI LETT, V127, P141, DOI 10.1016/0304-3940(91)90914-F; Simons JS, 2003, NEUROIMAGE, V19, P613, DOI 10.1016/S1053-8119(03)00096-X; Skipper JI, 2006, ACTION TO LANGUAGE VIA THE MIRROR NEURON SYSTEM, P250, DOI 10.1017/CBO9780511541599.009; SKIPPER JI, 2007, IN PRESS HEARING LIP, DOI DOI 10.1093/CERCOR/BHL147; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Taylor JE, 2006, HUM BRAIN MAPP, V27, P434, DOI 10.1002/hbm.20248; Thierry G, 2003, HUM BRAIN MAPP, V19, P37, DOI 10.1002/hbm.10101; Thompson WF, 2005, SEMIOTICA, V156, P203, DOI 10.1515/semi.2005.2005.156.203; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Viceic D, 2006, NEUROREPORT, V17, P1659, DOI 10.1097/01.wnr.0000239962.75943.dd; Vouloumanos A, 2001, J COGNITIVE NEUROSCI, V13, P994, DOI 10.1162/089892901753165890; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Wagner AD, 2000, CEREB CORTEX, V10, P1176, DOI 10.1093/cercor/10.12.1176; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108	83	65	66	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 20	2007	56	6					1116	1126		10.1016/j.neuron.2007.09.037	http://dx.doi.org/10.1016/j.neuron.2007.09.037			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	248FP	18093531	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000252138000018
J	Delaney, AJ; Crane, JW; Sah, P				Delaney, Andrew J.; Crane, James W.; Sah, Pankaj			Noradrenaline modulates transmission at a central synapse by a presynaptic mechanism	NEURON			English	Article							PROBABILITY FLUCTUATION ANALYSIS; VARIANCE-MEAN ANALYSIS; CENTRAL-NERVOUS-SYSTEM; TRANSMITTER RELEASE; CALCIUM-CHANNELS; INHIBITION; AMYGDALA; NEURONS; RAT; HIPPOCAMPUS	The lateral division of the central amygdala (CeAL) is the target of ascending fibers from the pain-responsive and stress-responsive nuclei in the brainstem. We show that single fiber inputs from the nociceptive pontine parabrachial nucleus onto CeAL neurons form suprathreshold glutamatergic synapses with multiple release sites. Noradrenaline, acting at presynaptic alpha 2 receptors, potently inhibits this synapse. This inhibition results from a decrease in the number of active release sites with no change in release probability. Introduction of a presynaptic scavenger of G beta gamma subunits blocked the effects of noradrenaline, and botulinum toxin A reduced its effects, showing a direct action of beta gamma subunits on the release machinery. These data illustrate a mechanism of presynaptic modulation where the output of a large multiple-release-site synapse is potently regulated by endogenously released noradrenaline and suggests that the CeA may be a target for the central nociceptive actions of noradrenaline.	[Delaney, Andrew J.; Crane, James W.; Sah, Pankaj] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	University of Queensland	Sah, P (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	pankaj.sah@uq.edu.au	Sah, Pankaj/C-8175-2009; Delaney, Andrew/H-4238-2018	Delaney, Andrew/0000-0001-8972-4870; Crane, James/0000-0002-4601-0189; Sah, Pankaj/0000-0001-5063-1589				Bellgowan PSF, 1996, BEHAV NEUROSCI, V110, P727; Bernard JF, 1996, PROG BRAIN RES, V107, P243; Berntson GG, 2003, EUR J NEUROSCI, V18, P2103, DOI 10.1046/j.1460-9568.2003.02967.x; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Chen XK, 2005, NAT NEUROSCI, V8, P1160, DOI 10.1038/nn1529; Chieng B, 1999, BRIT J PHARMACOL, V127, P1533, DOI 10.1038/sj.bjp.0702693; Clements JD, 2003, J NEUROSCI METH, V130, P115, DOI 10.1016/j.jneumeth.2003.09.019; Craig K.D., 2006, WALL MELLZACKS TXB P, V5th, P231; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; De Armentia ML, 2004, J NEUROPHYSIOL, V92, P1285, DOI 10.1152/jn.00211.2004; de Armentia ML, 2003, J NEUROSCI, V23, P6876; Delaney AJ, 2002, NEURON, V36, P475, DOI 10.1016/S0896-6273(02)01008-5; Dittman JS, 1996, J NEUROSCI, V16, P1623; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Dolezal V, 1996, BRAIN RES, V721, P101, DOI 10.1016/0006-8993(96)00169-2; FALLON JH, 1978, J COMP NEUROL, V180, P509, DOI 10.1002/cne.901800308; FIELDS HL, 2000, WALL MELZAKS TXB PAI, P125; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; Gerachshenko T, 2005, NAT NEUROSCI, V8, P597, DOI 10.1038/nn1439; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hein L, 2006, CELL TISSUE RES, V326, P541, DOI 10.1007/s00441-006-0285-2; HOSHINO S, 1990, FEBS LETT, V276, P227, DOI 10.1016/0014-5793(90)80548-W; Isaacson JS, 1998, J NEUROPHYSIOL, V80, P1571, DOI 10.1152/jn.1998.80.3.1571; JONES SL, 1991, PROG BRAIN RES, V88, P381; KATZ B, 1972, J PHYSIOL-LONDON, V224, P665, DOI 10.1113/jphysiol.1972.sp009918; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Morilak DA, 2005, PROG NEURO-PSYCHOPH, V29, P1214, DOI 10.1016/j.pnpbp.2005.08.007; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Nicola SM, 1997, J NEUROSCI, V17, P5697; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Rhudy JL, 2000, PAIN, V84, P65, DOI 10.1016/S0304-3959(99)00183-9; RICHE D, 1990, J COMP NEUROL, V293, P399, DOI 10.1002/cne.902930306; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sarhan M, 2005, J COMP NEUROL, V491, P418, DOI 10.1002/cne.20697; Saviane C, 2006, J NEUROSCI METH, V153, P250, DOI 10.1016/j.jneumeth.2005.11.003; Sawynok J, 2001, J PSYCHIATR NEUROSCI, V26, P21; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Silver RA, 2003, J NEUROSCI METH, V130, P127, DOI 10.1016/j.jneumeth.2003.09.030; Sindrup SH, 2005, BASIC CLIN PHARMACOL, V96, P399, DOI 10.1111/j.1742-7843.2005.pto_96696601.x; Talley EM, 1996, J COMP NEUROL, V372, P111, DOI 10.1002/(SICI)1096-9861(19960812)372:1<111::AID-CNE8>3.0.CO;2-6; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; YAKSH TL, 2006, WALL MELZACKS TXB PA, P371; Yoshimura M, 2006, J PHARMACOL SCI, V101, P107, DOI 10.1254/jphs.CRJ06008X; ZARDETTOSMITH AM, 1995, BRAIN RES BULL, V38, P253, DOI 10.1016/0361-9230(95)00097-X; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	54	87	88	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 6	2007	56	5					880	892		10.1016/j.neuron.2007.10.022	http://dx.doi.org/10.1016/j.neuron.2007.10.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241MA	18054863	Bronze			2022-12-24	WOS:000251659300013
J	Ginestier, C; Hur, MH; Charafe-Jauffret, E; Monville, F; Dutcher, J; Brown, M; Jacquemier, J; Viens, P; Kleer, CG; Liu, SL; Schott, A; Hayes, D; Birnbaum, D; Wicha, MS; Dontu, G				Ginestier, Christophe; Hur, Min Hee; Charafe-Jauffret, Emmanuelle; Monville, Florence; Dutcher, Julie; Brown, Marty; Jacquemier, Jocelyne; Viens, Patrice; Kleer, Celina G.; Liu, Suling; Schott, Anne; Hayes, Dan; Birnbaum, Daniel; Wicha, Max S.; Dontu, Gabriela			ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; ALDEHYDE DEHYDROGENASE-ACTIVITY; BREAST-CANCER; FUNCTIONAL-CHARACTERIZATION; PROSPECTIVE IDENTIFICATION; IN-VITRO; PROGENITOR; TRANSFORMATION; SUBPOPULATION; HIERARCHY	Application of stem cell biology to breast cancer research has been limited by the lack of simple methods for identification and isolation of normal and malignant stem cells. Utilizing in vitro and in vivo experimental systems, we show that normal and cancer human mammary epithelial cells with increased aldehyde dehydrogenase activity (ALDH) have stem/progenitor properties. These cells contain the subpopulation of normal breast epithelium with the broadest lineage differentiation potential and greatest growth capacity in a xenotransplant model. In breast carcinomas, high ALDH activity identifies the tumorigenic cell fraction, capable of self-renewal and of generating tumors that recapitulate the heterogeneity of the parental tumor. In a series of 577 breast carcinomas, expression of ALDH1 detected by immunostaining correlated with poor prognosis. These findings offer an important new tool for the study of normal and malignant breast stem cells and facilitate the clinical application of stem cell concepts.	Univ Michigan, Dept Internal Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Sungkyunkwan Univ, Cheil Gen Hosp, Seoul 100380, South Korea; Inst J Paoli I Calmettes, INSERM, UMR 599, Ctr Rech Cancerol Marseille,Lab Oncol Mol, F-13009 Marseille, France	University of Michigan System; University of Michigan; Sungkyunkwan University (SKKU); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Dontu, G (corresponding author), Univ Michigan, Dept Internal Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	gdontu@umich.edu	Liu, Suling/N-2796-2013; Ginestier, Christophe/M-8828-2017; Schott, Anne/AAD-1902-2019; liu, suling/AAF-5249-2019; Wicha, Max/AAE-7268-2019; Charafe-Jauffret, emmanuelle/P-6009-2017	Liu, Suling/0000-0002-0475-0242; Ginestier, Christophe/0000-0002-7477-3837; liu, suling/0000-0002-0475-0242; Dontu, Gabriela/0000-0002-2960-1446; Charafe-Jauffret, emmanuelle/0000-0002-0286-1299; Birnbaum, Daniel/0000-0001-7920-9883	NCI NIH HHS [CA66233, R01 CA101860-04, CA101860, R01 CA101860-02, 5 P 30 CA46592, R01 CA101860, R01 CA101860-03, R01 CA101860-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA101860, P30CA046592] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alexe Gabriela, 2006, Breast Cancer Res, V8, pR41, DOI 10.1186/bcr1512; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Boecker W, 2002, J PATHOL, V198, P458, DOI 10.1002/path.1241; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bonnett D, 1999, P NATL ACAD SCI USA, V96, P8639, DOI 10.1073/pnas.96.15.8639; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Ginestier C, 2002, AM J PATHOL, V161, P1223, DOI 10.1016/S0002-9440(10)64399-4; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Jacquemier J, 2005, CANCER RES, V65, P767; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kelly LM, 2002, ANNU REV GENOM HUM G, V3, P179, DOI 10.1146/annurev.genom.3.032802.115046; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lahad JP, 2005, J CLIN INVEST, V115, P1463, DOI 10.1172/JCI25455; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Magni M, 1996, BLOOD, V87, P1097, DOI 10.1182/blood.V87.3.1097.bloodjournal8731097; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Pearce DJ, 2005, STEM CELLS, V23, P752, DOI 10.1634/stemcells.2004-0292; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tlsty TD, 2001, SEMIN CANCER BIOL, V11, P97, DOI 10.1006/scbi.2000.0361; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x	48	2950	3159	7	282	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV	2007	1	5					555	567		10.1016/j.stem.2007.08.014	http://dx.doi.org/10.1016/j.stem.2007.08.014			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236AX	18371393	Green Accepted, Bronze			2022-12-24	WOS:000251276500013
J	Nikoletopoulou, V; Plachta, N; Allen, ND; Pinto, L; Gotz, M; Barde, YA				Nikoletopoulou, Vassiliki; Plachta, Nicolas; Allen, Nicolas D.; Pinto, Luisa; Goetz, Magdalena; Barde, Yves-Alain			Neurotrophin receptor-mediated death of misspecified neurons generated from embryonic stem cells lacking pax6	CELL STEM CELL			English	Article							CEREBRAL-CORTEX; MAMMALIAN TELENCEPHALON; TRANSCRIPTION FACTOR; MUTANT MICE; MOUSE; DIFFERENTIATION; ROLES; MIGRATION; IDENTITY; GENES	Pax6-positive radial glial (RG) cells are the progenitors of most glutamatergic neurons in the cortex, a lineage that can be recapitulated in vitro using embryonic stem (ES) cells. We show here that ES cells lacking Pax6, a transcription factor long known to be essential for cortical development, generate Mash1-positive RG cells that differentiate in GABAergic neurons. These neurons express high levels of the neurotrophin receptor p75(NTR) causing their rapid death. Pax6 function was also investigated following transplantation of ES cells in the developing chick telencephalon and in mice lacking both Pax6 and p75(NTR). Taken together, our results indicate that reliable predictions can be made with cultured ES cells when used to explore the role of genes impacting early aspects of mammalian neurogenesis. They also provide a novel opportunity to compare the molecular constituents of glutamatergic with those of GABA-ergic neurons and to explore the mechanisms of their generation.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Cardiff Univ, Sch Biosci, Cardiff CF10 3US, Wales; Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, D-85764 Neuherberg, Germany; Univ Munich, Inst Physiol, D-80336 Munich, Germany	University of Basel; Cardiff University; University of Munich	Barde, YA (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	yves.barde@unibas.ch	Barde, Yves/F-6019-2011; allen, nick d/A-4336-2010; Pinto, Luísa/A-7414-2010; Pinto, Luisa/GXF-0087-2022	Pinto, Luísa/0000-0002-7724-0446; Allen, Nicholas/0000-0003-4009-186X; Barde, Yves/0000-0002-7627-461X; Nikoletopoulou, Vassiliki/0000-0003-3646-992X				ALLENDOERFER KL, 1990, P NATL ACAD SCI USA, V87, P187, DOI 10.1073/pnas.87.1.187; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Cobos I, 2001, DEV BIOL, V239, P30, DOI 10.1006/dbio.2001.0422; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; Fode C, 2000, GENE DEV, V14, P67; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gschwendtner A, 2003, MOL CELL NEUROSCI, V24, P307, DOI 10.1016/S1044-7431(03)00167-2; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jimenez D, 2002, J NEUROCYTOL, V31, P719, DOI 10.1023/A:1025751914372; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kroll TT, 2005, P NATL ACAD SCI USA, V102, P7374, DOI 10.1073/pnas.0500819102; KUBOTA Y, 1994, JPN J PHYSIOL, V44, pS145; Majdan M, 1997, J NEUROSCI, V17, P6988; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Philips GT, 2005, DEV BIOL, V279, P308, DOI 10.1016/j.ydbio.2004.12.018; Plachta N, 2004, DEVELOPMENT, V131, P5449, DOI 10.1242/dev.01420; Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897; PORTEUS MH, 1994, J NEUROSCI, V14, P6370; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; SilosSantiago I, 1997, EUR J NEUROSCI, V9, P2045, DOI 10.1111/j.1460-9568.1997.tb01372.x; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; Stoykova A, 2000, J NEUROSCI, V20, P8042; Stoykova A, 2003, CEREB CORTEX, V13, P560, DOI 10.1093/cercor/13.6.560; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Talamillo A, 2003, DEV BIOL, V255, P151, DOI 10.1016/S0012-1606(02)00046-5; Toresson H, 2000, DEVELOPMENT, V127, P4361; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Warren N, 1999, CEREB CORTEX, V9, P627, DOI 10.1093/cercor/9.6.627; Yun K, 2001, DEVELOPMENT, V128, P193	36	42	42	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV	2007	1	5					529	540		10.1016/j.stem.2007.08.011	http://dx.doi.org/10.1016/j.stem.2007.08.011			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236AX	18371392	Bronze			2022-12-24	WOS:000251276500011
J	Pan, L; Chen, SY; Weng, CJ; Call, G; Zhu, DX; Tang, H; Zhang, N; Xie, T				Pan, Lei; Chen, Shuyi; Weng, Changjiang; Call, Gerald; Zhu, Dongxiao; Tang, Hong; Zhang, Nian; Xie, Ting			Stem cell aging is controlled both intrinsically and extrinsically in the Drosophila ovary	CELL STEM CELL			English	Article							LIFE-SPAN; SUPEROXIDE-DISMUTASE; E-CADHERIN; GERMLINE; NICHE; OVEREXPRESSION; MELANOGASTER; EXPRESSION; RECEPTOR; GENE	It is widely postulated that tissue aging could be, at least partially, caused by reduction of stem cell number, activity, or both. However, the mechanisms of controlling stem cell aging remain largely a mystery. Here, we use Drosophila ovarian germline stem cells (GSCs) as a model to demonstrate that age-dependent decline in the functions of stem cells and their niche contributes to overall stem cell aging. BMP signaling activity from the niche significantly decreases with age, and increasing BMP signaling can prolong GSC life span and promote their proliferation. In addition, the age-dependent E-cadherin decline in the stem cell-niche junction also contributes to stem cell aging. Finally, overexpression of SOD, an enzyme that helps eliminate free oxygen species, in either GSCs or their niche alone can prolong GSC life span and increase GSC proliferation. Therefore, this study demonstrates that stem cell aging is controlled extrinsically and intrinsically in the Drosophila ovary.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Chinese Acad Sci, Ctr Infect & Immun, Inst Biophys, Beijing 100101, Peoples R China; Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; Univ Kansas, Sch Med, Dept Biostat, Kansas City, KS 66160 USA; Midwestern Univ, Arizona Coll Osteopath Med, Dept Pharmacol, Glendale, AZ 85308 USA	Stowers Institute for Medical Research; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Midwestern University	Xie, T (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	tgx@stowers-institute.org	Zhu, Dongxiao/G-4049-2010; weng, changjiang/HHR-8479-2022	Pan, Lei/0000-0002-0500-8904; Call, Gerald/0000-0001-8290-1141	NIGMS NIH HHS [2R01 GM64428, R01 GM064428] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064428] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Casanueva MO, 2004, DEVELOPMENT, V131, P1881, DOI 10.1242/dev.01076; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cox DN, 2000, DEVELOPMENT, V127, P503; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Klichko VI, 1999, NEUROBIOL AGING, V20, P537, DOI 10.1016/S0197-4580(99)00090-1; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; LIN HF, 1994, DEVELOPMENT, V120, P947; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; NELLEN D, 1994, CELL, V78, P225, DOI 10.1016/0092-8674(94)90293-3; Neul JL, 1998, CELL, V95, P483, DOI 10.1016/S0092-8674(00)81616-5; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Sun JT, 2002, GENETICS, V161, P661; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Tower J, 2000, MECH AGEING DEV, V118, P1, DOI 10.1016/S0047-6374(00)00152-4; Tower J, 1996, BIOESSAYS, V18, P799, DOI 10.1002/bies.950181006; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Van Doren M, 1998, CURR BIOL, V8, P243; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Ward EJ, 2006, CURR BIOL, V16, P2352, DOI 10.1016/j.cub.2006.10.022; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 2005, DEV DYNAM, V232, P775, DOI 10.1002/dvdy.20317; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5	39	153	156	4	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT	2007	1	4					458	469		10.1016/j.stem.2007.09.010	http://dx.doi.org/10.1016/j.stem.2007.09.010			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XU	18371381	Bronze			2022-12-24	WOS:000251055300014
J	Zhao, XD; Han, X; Chew, JL; Liu, J; Chiu, KP; Choo, A; Orlov, YL; Sung, WK; Shahab, A; Kuznetsov, VA; Bourque, G; Oh, S; Ruan, Y; Ng, HH; Wei, CL				Zhao, Xiao Dong; Han, Xu; Chew, Joon Lin; Liu, Jun; Chiu, Kuo Ping; Choo, Andre; Orlov, Yuriy L.; Sung, Wing-Kin; Shahab, Atif; Kuznetsov, Vladimir A.; Bourque, Guillaume; Oh, Steve; Ruan, Yijun; Ng, Huck-Hui; Wei, Chia-Lin			Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells	CELL STEM CELL			English	Article							POLYCOMB TARGET GENES; DEVELOPMENTAL REGULATORS; CHROMATIN SIGNATURES; METHYLATION; TRANSCRIPTION; PLURIPOTENT; RECRUITMENT; PROMOTERS; PATTERNS; MEMORY	Epigenetic modifications are crucial for proper lineage specification and embryo development. To explore the chromatin modification landscapes in human ES cells, we profiled two histone modifications, H3K4me3 and H3K27me3, by ChIP coupled with the paired-end ditags sequencing strategy. H3K4me3 was found to be a prevalent mark and occurred in close proximity to the promoters of two-thirds of total human genes. Among the H3K27me3 loci identified 56% are associated with promoters and the vast majority of them are comodified by H3K4me3. By deep-transcript digital counting, 80% of H3K4me3 and 36% of comodified promoters were found to be transcribed. Remarkably, we observed that different combinations of histone methylations are associated with genes from distinct functional categories. These global histone methylation maps provide an epigenetic framework that enables the discovery of novel transcriptional networks and delineation of different genetic compartments of the pluripotent cell genome.	Genome Inst Singapore, Stem Cell & Dev Grp, Singapore 138672, Singapore; Genome Inst Singapore, Informat & Math Sci Grp, Singapore 138672, Singapore; Genome Inst Singapore, Genome Technol & Biol Grp, Singapore 138672, Singapore; Bioproc Technol Inst, Singapore 138668, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Natl Univ Singapore, Sch Comp, Singapore 117543, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore; National University of Singapore	Ng, HH (corresponding author), Genome Inst Singapore, Stem Cell & Dev Grp, Singapore 138672, Singapore.	nghh@gis.a-star.edu.sg; weicl@gis.a-star.edu.sg	Bourque, Guillaume/AFR-2927-2022; Ng, Huck Hui/A-1135-2009; Xu, Han/H-1963-2012; Chiu, Kuo-Ping/AAG-8855-2020; Orlov, Yuriy L/F-1520-2013	Bourque, Guillaume/0000-0002-3933-9656; Chiu, Kuo-Ping/0000-0001-9144-0674; Orlov, Yuriy L/0000-0003-0587-1609; Sung, Wing-Kin/0000-0001-7806-7086; Choo, Andre/0000-0001-9648-0755	NHGRI NIH HHS [1R01HG003521-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003521] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Choo A, 2006, J BIOTECHNOL, V122, P130, DOI 10.1016/j.jbiotec.2005.09.008; Gomez-Skarmeta JL, 2002, CURR OPIN GENET DEV, V12, P403, DOI 10.1016/S0959-437X(02)00317-9; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim SK, 2002, NAT GENET, V30, P430, DOI 10.1038/ng860; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kraus P, 2006, AM J MED GENET A, V140A, P1366, DOI 10.1002/ajmg.a.31252; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Ng P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl444; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Singec I, 2007, ANNU REV MED, V58, P313, DOI 10.1146/annurev.med.58.070605.115252; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; TOIHIS B, 2006, NAT GENET, V38, P694; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	51	452	463	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2007	1	3					286	298		10.1016/j.stem.2007.08.004	http://dx.doi.org/10.1016/j.stem.2007.08.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XT	18371363	Bronze			2022-12-24	WOS:000251055200011
J	Fiorillo, CD; Newsome, WT; Schultz, W				Fiorillo, Christopher D.; Newsome, William T.; Schultz, Wolfram			The temporal precision of reward prediction in dopamine neurons	NATURE NEUROSCIENCE			English	Article							DELAYED-RESPONSE TASK; PREFRONTAL CORTEX; MIDBRAIN DOPAMINE; SIGNAL; TIME; REPRESENTATION; MACAQUE; MONKEY; ERROR; MODEL	Midbrain dopamine neurons are activated when reward is greater than predicted, and this error signal could teach target neurons both the value of reward and when it will occur. We used the dopamine error signal to measure how the expectation of reward was distributed over time. Animals were trained with fixed-duration intervals of 1-16 s between conditioned stimulus onset and reward. In contrast to the weak responses that have been observed after short intervals (1-2 s), activations to reward increased steeply and linearly with the logarithm of the interval. Results with varied stimulus-reward intervals suggest that the neural expectation was substantial after just half an interval had elapsed. Thus, the neural expectation of reward in these experiments was not highly precise and the precision declined sharply with interval duration. The neural precision of expectation appeared to be at least qualitatively similar to the precision of anticipatory licking behavior.	[Fiorillo, Christopher D.; Newsome, William T.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Schultz, Wolfram] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	Stanford University; University of Cambridge	Fiorillo, CD (corresponding author), Stanford Univ, Dept Neurobiol, Fairchild Bldg,D209,299 Campus Dr W, Stanford, CA 94305 USA.	chris@monkeybiz.stanford.edu	Newsome, William T./W-7171-2019; Fiorillo, Christopher Dante/C-1718-2011; schultz, wolfram/H-8958-2016	Fiorillo, Christopher/0000-0002-7232-9505; schultz, wolfram/0000-0002-8530-4518	Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [G0001354] Funding Source: Medline; NEI NIH HHS [EY 05603] Funding Source: Medline; Wellcome Trust [095495] Funding Source: Medline; Medical Research Council [G0001354B] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY005603, R37EY005603] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BATESON M, 1995, ANIM BEHAV, V50, P431, DOI 10.1006/anbe.1995.0257; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berns GS, 1998, J COGNITIVE NEUROSCI, V10, P108, DOI 10.1162/089892998563815; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Brown J, 1999, J NEUROSCI, V19, P10502; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Contreras-Vidal JL, 1999, J COMPUT NEUROSCI, V6, P191, DOI 10.1023/A:1008862904946; Daw ND, 2006, NEURAL COMPUT, V18, P1637, DOI 10.1162/neco.2006.18.7.1637; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Ghose GM, 2002, NATURE, V419, P616, DOI 10.1038/nature01057; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GROSSBERG S, 1989, NEURAL NETWORKS, V2, P79, DOI 10.1016/0893-6080(89)90026-9; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Houk JC, 1995, MODELS INFORMATION P, P249; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Kacelnik A, 1998, J THEOR BIOL, V194, P289, DOI 10.1006/jtbi.1998.0763; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; O'Reilly RC, 2007, BEHAV NEUROSCI, V121, P31, DOI 10.1037/0735-7044.121.1.31; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Renoult L, 2006, EUR J NEUROSCI, V23, P3098, DOI 10.1111/j.1460-9568.2006.04824.x; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHULTZ W, 1987, J NEUROPHYSIOL, V57, P201, DOI 10.1152/jn.1987.57.1.201; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370	38	199	203	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					966	973		10.1038/nn.2159	http://dx.doi.org/10.1038/nn.2159			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18660807				2022-12-24	WOS:000257969100023
J	Groc, L; Choquet, D; Chaouloff, F				Groc, Laurent; Choquet, Daniel; Chaouloff, Francis			The stress hormone corticosterone conditions AMPAR surface trafficking and synaptic potentiation	NATURE NEUROSCIENCE			English	Article							RECEPTOR TRAFFICKING; NMDA RECEPTORS; BRAIN; TRANSMISSION; HIPPOCAMPUS; ADAPTATION; PLASTICITY	Corticosterone facilitates hippocampal glutamate transmission, but the cellular pathways by which AMPA receptor (AMPAR) signaling is adjusted remain elusive. Single quantum-dot imaging in live rat hippocampal neurons revealed that corticosterone triggers, via distinct corticosteroid receptors, time-dependent increases in GluR2-AMPAR surface mobility and synaptic surface GluR2 content. Furthermore, corticosterone potentiates the increase of synaptic surface GluR2 contents by a chemical long-term potentiation stimulus, revealing the influence that corticosterone has on AMPAR trafficking.	[Groc, Laurent; Choquet, Daniel] Univ Bordeaux 2, CNRS, UMR 5091, F-33077 Bordeaux, France; [Chaouloff, Francis] Univ Bordeaux 2, INSERM, U862, Equipe AVENIR Mecan Mol Adaptat, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Groc, L (corresponding author), Univ Bordeaux 2, CNRS, UMR 5091, F-33077 Bordeaux, France.	laurent.groc@u-bordeaux2.fr	Chaouloff, Francis/N-7003-2017; Choquet, Daniel/K-7893-2018; Choquet, Daniel/GOJ-8825-2022; Choquet, Daniel/E-4203-2013	Chaouloff, Francis/0000-0001-9036-4067; Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; 				de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Joels M, 2006, TRENDS PHARMACOL SCI, V27, P244, DOI 10.1016/j.tips.2006.03.007; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2005, J NEUROPHYSIOL, V94, P3479, DOI 10.1152/jn.00143.2005; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Wiegert O, 2006, LEARN MEMORY, V13, P110, DOI 10.1101/lm.87706	13	193	195	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					868	870		10.1038/nn.2150	http://dx.doi.org/10.1038/nn.2150			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18622402				2022-12-24	WOS:000257969100007
J	Desbordes, SC; Placantonakis, DG; Ciro, A; Socci, ND; Lee, G; Djaballah, H; Studer, L				Desbordes, Sabrina C.; Placantonakis, Dimitris G.; Ciro, Anthony; Socci, Nicholas D.; Lee, Gabsang; Djaballah, Hakim; Studer, Lorenz			High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells	CELL STEM CELL			English	Article							SMALL MOLECULES; PLURIPOTENCY; MAINTENANCE; ACTIVATION; DERIVATION; SURVIVAL; CULTURE; GROWTH	High-throughput screening (HTS) of chemical libraries has become a critical tool in basic biology and drug discovery. However, its implementation and the adaptation of high-content assays to human embryonic stem cells (hESCs) have been hampered by multiple technical challenges. Here we present a strategy to adapt hESCs to HTS conditions, resulting in an assay suitable for the discovery of small molecules that drive hESC self-renewal or differentiation. Use of this new assay has led to the identification of several marketed drugs and natural compounds promoting short-term hESC maintenance and compounds directing early lineage choice during differentiation. Global gene expression analysis upon drug treatment defines known and novel pathways correlated to hESC self-renewal and differentiation. Our results demonstrate feasibility of hESC-based HTS and enhance the repertoire of chemical compounds for manipulating hESC fate. The availability of high-content assays should accelerate progress in basic and translational hESC biology.	[Desbordes, Sabrina C.; Placantonakis, Dimitris G.; Lee, Gabsang; Studer, Lorenz] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA; [Ciro, Anthony; Djaballah, Hakim] Mem Sloan Kettering Canc Ctr, High Throughput Screening Core Facil, New York, NY 10021 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Placantonakis, Dimitris G.] Weill Cornell Med Coll, Dept Neurol Surg, New York, NY 10021 USA; [Desbordes, Sabrina C.; Lee, Gabsang; Studer, Lorenz] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Desbordes, SC (corresponding author), Ctr Regulacio Genom, Differentiat & Canc Program, C Dr Aiguader 88, Barcelona 08003, Spain.	sabrina.desbordes@crg.es; studerl@mskcc.org	Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; Placantonakis, Dimitris/0000-0003-1950-2978; Djaballah, Hakim/0000-0002-6039-0181	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS044231, R21NS053655] Funding Source: NIH RePORTER; NINDS NIH HHS [R21NS44231, R21 NS053655-01, R21 NS053655, R21 NS044231] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amit M, 2006, METHOD ENZYMOL, V420, P37, DOI 10.1016/S0076-6879(06)20003-X; Antczak C, 2007, J BIOMOL SCREEN, V12, P521, DOI 10.1177/1087057107300463; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Esmaeili F, 2006, REJUV RES, V9, P475, DOI 10.1089/rej.2006.9.475; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Saxe JP, 2007, CHEM BIOL, V14, P1019, DOI 10.1016/j.chembiol.2007.07.016; Tomishima MJ, 2007, STEM CELLS, V25, P39, DOI 10.1634/stemcells.2006-0173; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Wu X, 2004, J AM CHEM SOC, V126, P1590, DOI 10.1021/ja038950i; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	32	176	187	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN	2008	2	6					602	612		10.1016/j.stem.2008.05.010	http://dx.doi.org/10.1016/j.stem.2008.05.010			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	315HT	18522853	Bronze, Green Accepted			2022-12-24	WOS:000256870000018
J	Zhang, F; Prigge, M; Beyriere, F; Tsunoda, SP; Mattis, J; Yizhar, O; Hegemann, P; Deisseroth, K				Zhang, Feng; Prigge, Matthias; Beyriere, Florent; Tsunoda, Satoshi P.; Mattis, Joanna; Yizhar, Ofer; Hegemann, Peter; Deisseroth, Karl			Red-shifted optogenetic excitation: a tool for fast neural control derived from Volvox carteri	NATURE NEUROSCIENCE			English	Article							GREEN-ALGAE; CHANNELRHODOPSIN; CHANNEL; RHODOPSINS	The introduction of two microbial opsin- based tools, channelrhodopsin-2 (ChR2) and halorhodopsin (NpHR), to neuroscience has generated interest in fast, multimodal, cell type-specific neural circuit control. Here we describe a cation-conducting channelrhodopsin (VChR1) from Volvox carteri that can drive spiking at 589 nm, with excitation maximum red-shifted similar to 70 nm compared with ChR2. These results demonstrate fast photostimulation with yellow light, thereby defining a functionally distinct third category of microbial rhodopsin proteins.	[Prigge, Matthias; Beyriere, Florent; Tsunoda, Satoshi P.; Hegemann, Peter] Humboldt Univ, Inst Biol Expt Biophys, D-10115 Berlin, Germany; [Zhang, Feng; Mattis, Joanna; Yizhar, Ofer; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Zhang, Feng; Mattis, Joanna; Yizhar, Ofer; Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA	Humboldt University of Berlin; Stanford University; Stanford University	Hegemann, P (corresponding author), Humboldt Univ, Inst Biol Expt Biophys, Invalidenstr 42, D-10115 Berlin, Germany.	hegemape@rz.hu-berlin.de; deissero@stanford.edu	Tsunoda, Satoshi/AAN-7023-2021; YIZHAR, OFER/AAV-8497-2021; Macrae, Rhiannon/AAX-1536-2020	Beyriere, Florent/0000-0002-8367-3694; Yizhar, Ofer/0000-0003-4228-1448; Mattis, Joanna/0000-0003-0341-1270; Tsunoda, Satoshi/0000-0003-3636-1521	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH075957, R01 MH075957-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; ARAVANIS A, 2007, NEURAL ENG, V4, pS143; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Hoffmann M, 2006, J AM CHEM SOC, V128, P10808, DOI 10.1021/ja062082i; Kloppmann E, 2005, PROTEINS, V61, P953, DOI 10.1002/prot.20744; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	15	380	444	2	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					631	633		10.1038/nn.2120	http://dx.doi.org/10.1038/nn.2120			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18432196	Green Accepted			2022-12-24	WOS:000256133700007
J	Okun, M; Lampl, I				Okun, Michael; Lampl, Ilan			Instantaneous correlation of excitation and inhibition during ongoing and sensory-evoked activities	NATURE NEUROSCIENCE			English	Article							MEMBRANE-POTENTIAL DYNAMICS; AUDITORY-CORTEX; BARREL CORTEX; INFORMATION; NEURONS; SYSTEM; AWAKE	Temporal and quantitative relations between excitatory and inhibitory inputs in the cortex are central to its activity, yet they remain poorly understood. In particular, a controversy exists regarding the extent of correlation between cortical excitation and inhibition. Using simultaneous intracellular recordings in pairs of nearby neurons in vivo, we found that excitatory and inhibitory inputs are continuously synchronized and correlated in strength during spontaneous and sensory-evoked activities in the rat somatosensory cortex.	[Okun, Michael; Lampl, Ilan] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Lampl, I (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ilan.lampl@weizmann.ac.il		Okun, Michael/0000-0002-7795-5513; Lampl, Ilan/0000-0002-9380-0730				Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; DeWeese MR, 2006, J NEUROSCI, V26, P12206, DOI 10.1523/JNEUROSCI.2813-06.2006; Deweese MR, 2004, J NEUROPHYSIOL, V92, P1840, DOI 10.1152/jn.00197.2004; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Las L, 2005, J NEUROSCI, V25, P1503, DOI 10.1523/JNEUROSCI.4007-04.2005; Lestienne R, 2001, PROG NEUROBIOL, V65, P545, DOI 10.1016/S0301-0082(01)00019-3; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116	15	409	417	3	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					535	537		10.1038/nn.2105	http://dx.doi.org/10.1038/nn.2105			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18376400				2022-12-24	WOS:000255327300009
J	Feinberg, EH; VanHoven, MK; Bendesky, A; Wang, G; Fetter, RD; Shen, K; Bargmannl, CI				Feinberg, Evan H.; VanHoven, Miri K.; Bendesky, Andres; Wang, George; Fetter, Richard D.; Shen, Kang; Bargmannl, Cornelia I.			GFP reconstitution across synaptic partners (GRASP) defines cell contacts and Synapses in living nervous systems	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; ELECTRON-MICROSCOPIC EVIDENCE; CAENORHABDITIS-ELEGANS; C-ELEGANS; MOTOR-NEURONS; IMMUNOGLOBULIN SUPERFAMILY; HOMEODOMAIN PROTEIN; VISUAL-CORTEX; TETANUS TOXIN; SPECIFICITY	The identification of synaptic partners is challenging in dense nerve bundles, where many processes occupy regions beneath the resolution of conventional light microscopy. To address this difficulty, we have developed GRASP, a system to label membrane contacts and synapses between two cells in living animals. Two complementary fragments of GFP are expressed on different cells, tethered to extracellular domains of transmembrane carrier proteins. When the complementary GFP fragments are fused to ubiquitous transmembrane proteins, GFP fluorescence appears uniformly along membrane contacts between the two cells. When one or both GFP fragments are fused to synaptic transmembrane proteins, GFP fluorescence is tightly localized to synapses. GRASP marks known synaptic contacts in C. elegans, correctly identifies changes in mutants with altered synaptic specificity, and can uncover new information about synaptic locations as confirmed by electron microscopy. GRASP may prove particularly useful for defining connectivity in complex nervous systems.	[VanHoven, Miri K.; Wang, George; Shen, Kang] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Feinberg, Evan H.; Bendesky, Andres; Bargmannl, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10065 USA; [Fetter, Richard D.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Stanford University; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute	Shen, K (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	kangshen@stanford.edu; cori@rockefeller.edu		VanHoven, Miri/0000-0001-7714-1555; Bendesky, Andres/0000-0002-4220-3653; Bargmann, Cornelia/0000-0002-8484-0618	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM077391] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077391] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Ahmari SE, 2002, NEURON, V34, P333, DOI 10.1016/S0896-6273(02)00685-2; ARMSTRONG JD, 1995, NEURON, V15, P17, DOI 10.1016/0896-6273(95)90059-4; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; BRENNER S, 1974, GENETICS, V77, P71; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; CABOT JB, 1991, NEUROSCIENCE, V40, P805, DOI 10.1016/0306-4522(91)90014-F; CARD JP, 1990, J NEUROSCI, V10, P1974; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Combes D, 2003, EUR J NEUROSCI, V18, P497, DOI 10.1046/j.1460-9568.2003.02749.x; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; Mello C, 1995, METHOD CELL BIOL, V48, P451; MILLER DM, 1992, NATURE, V355, P841, DOI 10.1038/355841a0; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; PESCHANSKI M, 1985, J COMP NEUROL, V236, P29, DOI 10.1002/cne.902360104; Pflugrad A, 1997, DEVELOPMENT, V124, P1699; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; SCHWAB ME, 1976, BRAIN RES, V105, P213, DOI 10.1016/0006-8993(76)90422-4; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shen K, 2004, CURR OPIN NEUROBIOL, V14, P83, DOI 10.1016/j.conb.2004.01.007; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; Vaney DI, 2002, CURR OPIN NEUROBIOL, V12, P405, DOI 10.1016/S0959-4388(02)00337-9; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Vogel BE, 2001, DEVELOPMENT, V128, P883; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; WHITE JG, 1992, NATURE, V355, P838, DOI 10.1038/355838a0; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012	48	456	468	5	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 7	2008	57	3					353	363		10.1016/j.neuron.2007.11.030	http://dx.doi.org/10.1016/j.neuron.2007.11.030			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261JQ	18255029	Bronze			2022-12-24	WOS:000253075300006
J	Baca, SM; Marin-Burgin, A; Wagenaar, DA; Kristan, WB				Baca, Serapio M.; Marin-Burgin, Antonia; Wagenaar, Daniel A.; Kristan, William B., Jr.			Widespread inhibition proportional to excitation controls the gain of a leech behavioral circuit	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; LOCAL BENDING REFLEX; MEDICINAL LEECH; MOTOR NEURONS; FEEDFORWARD INHIBITION; VISUAL-CORTEX; SENSORY INFORMATION; BALANCED INHIBITION; SYNAPTIC INPUT; OUTPUT	Changing gain in a neuronal system has important functional consequences, but the underlying mechanisms have been elusive. Models have suggested a variety of neuronal and systems properties to accomplish gain control. Here, we show that the gain of the neuronal network underlying local bending behavior in leeches depends on widespread inhibition. Using behavioral analysis, intracellular recordings, and voltage-sensitive dye imaging, we compared the effects of blocking just the known lateral inhibition with blocking all GABAergic inhibition. This revealed an additional source of inhibition, which was widespread and increased in proportion to increasing stimulus intensity. In a model of the input/output functions of the three-layered local bending network, we showed that inhibiting all interneurons in proportion to the stimulus strength produces the experimentally observed change in gain. This relatively simple mechanism for controlling behavioral gain could be prevalent in vertebrate as well as invertebrate nervous systems.	[Baca, Serapio M.; Marin-Burgin, Antonia; Wagenaar, Daniel A.; Kristan, William B., Jr.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kristan, WB (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	wkristan@ucsd.edu	Wagenaar, Daniel A/B-4035-2010; Marin-Burgin, Antonia/V-6602-2019	Wagenaar, Daniel A/0000-0002-6222-761X; Marin-Burgin, Antonia/0000-0003-0684-9796	NIMH NIH HHS [F31 MH013037, MH43396, R01 MH043396, MH13037] Funding Source: Medline; NINDS NIH HHS [R01 NS035336, NS35336] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH013037, R01MH043396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035336] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2005, PROG BRAIN RES, V149, P147, DOI 10.1016/S0079-6123(05)49011-1; Baca SM, 2005, J NEUROPHYSIOL, V93, P3560, DOI 10.1152/jn.01263.2004; Berg RW, 2007, SCIENCE, V315, P390, DOI 10.1126/science.1134960; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Cacciatore TW, 1999, NEURON, V23, P449, DOI 10.1016/S0896-6273(00)80799-0; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; CLINE HT, 1985, BRAIN RES, V348, P359, DOI 10.1016/0006-8993(85)90457-3; CLINE HT, 1986, J NEUROSCI, V6, P2848; Conner CE, 1997, J NEUROSCI, V17, P3201; Doiron B, 2001, NEURAL COMPUT, V13, P227, DOI 10.1162/089976601300014691; Dunn FA, 2006, CURR OPIN NEUROBIOL, V16, P363, DOI 10.1016/j.conb.2006.06.013; Eccles J.C., 1969, INHIBITORY PATHWAYS; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Garcia-Perez E, 2004, J NEUROPHYSIOL, V92, P1783, DOI 10.1152/jn.01240.2003; GRANZOW B, 1986, BRAIN RES, V369, P321, DOI 10.1016/0006-8993(86)90543-3; GRANZOW B, 1985, J NEUROSCI, V5, P2035; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hatton GI, 1998, CELL BIOL INT, V22, P765, DOI 10.1006/cbir.1998.0386; Heckman CJ, 2005, MUSCLE NERVE, V31, P135, DOI 10.1002/mus.20261; Heckman CJ, 2003, TRENDS NEUROSCI, V26, P688, DOI 10.1016/j.tins.2003.10.002; HEINZEL HG, 1993, J NEUROSCI, V13, P1793; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; KRISTAN WB, 1982, J EXP BIOL, V96, P143; KRISTAN WB, 1995, J NEUROBIOL, V27, P380, DOI 10.1002/neu.480270310; KRISTAN WB, 1982, J EXP BIOL, V96, P161; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Lewis JE, 1998, J NEUROSCI, V18, P1571; Lewis JE, 1998, NATURE, V391, P76, DOI 10.1038/34172; LOCKERY SR, 1990, J NEUROSCI, V10, P1816; LOCKERY SR, 1990, J NEUROSCI, V10, P1811; LOCKERY SR, 1991, J COMP PHYSIOL A, V168, P165, DOI 10.1007/BF00218409; LUCAS BD, 1981, P 1981 IM UND WORKSH; Magloczky Z, 2005, TRENDS NEUROSCI, V28, P334, DOI 10.1016/j.tins.2005.04.002; Mamiya A, 2003, J NEUROSCI, V23, P9557; Marin- Burgin A, 2005, J NEUROSCI, V25, P2478, DOI 10.1523/JNEUROSCI.4787-04.2005; MASON A, 1982, J COMP PHYSIOL, V146, P527, DOI 10.1007/BF00609449; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; Misell LM, 1998, BEHAV BRAIN RES, V90, P13, DOI 10.1016/S0166-4328(97)00072-7; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Moss BL, 2005, J NEUROPHYSIOL, V94, P2575, DOI 10.1152/jn.00322.2005; MULLER KJ, 1981, NEUROBIOLOGY LEECH; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; NICHOLLS JG, 1970, J PHYSIOL-LONDON, V209, P647, DOI 10.1113/jphysiol.1970.sp009184; NICHOLLS JG, 1968, J NEUROPHYSIOL, V31, P740, DOI 10.1152/jn.1968.31.5.740; ORT CA, 1974, J COMP PHYSIOL, V94, P121, DOI 10.1007/BF00617838; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; RIBAK CE, 1979, SCIENCE, V205, P211, DOI 10.1126/science.109922; Salinas E, 1997, J NEUROPHYSIOL, V77, P3267, DOI 10.1152/jn.1997.77.6.3267; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Seutin V, 1999, TRENDS PHARMACOL SCI, V20, P268, DOI 10.1016/S0165-6147(99)01334-6; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; STENT GS, 1978, SCIENCE, V200, P1348, DOI 10.1126/science.663615; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; STUART AE, 1970, J PHYSIOL-LONDON, V209, P627, DOI 10.1113/jphysiol.1970.sp009183; STUART AE, 1969, SCIENCE, V165, P817, DOI 10.1126/science.165.3895.817; Taylor AL, 2003, J NEUROSCI, V23, P11402; Thomson EE, 2006, J NEUROSCI, V26, P8009, DOI 10.1523/JNEUROSCI.5472-05.2006; Vogels TP, 2005, J NEUROSCI, V25, P10786, DOI 10.1523/JNEUROSCI.3508-05.2005; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Wolfart J, 2005, NAT NEUROSCI, V8, P1760, DOI 10.1038/nn1591; YE M, 2000, VISION INTERFACE REA, P209; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Zoccolan D, 2002, J NEUROSCI, V22, P2283, DOI 10.1523/JNEUROSCI.22-06-02283.2002	69	40	43	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 24	2008	57	2					276	289		10.1016/j.neuron.2007.11.028	http://dx.doi.org/10.1016/j.neuron.2007.11.028			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256VQ	18215624	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000252758400011
J	Heissig, B; Lund, LR; Akiyama, H; Ohki, M; Morita, Y; Romer, J; Nakauchi, H; Okumura, K; Ogawa, H; Werb, Z; Dano, K; Hattori, K				Heissig, Beate; Lund, Leif R.; Akiyama, Haruyo; Ohki, Makiko; Morita, Yohei; Romer, John; Nakauchi, Hiromitsu; Okumura, Ko; Ogawa, Hideoki; Werb, Zena; Dano, Keld; Hattori, Koichi			The plasminogen fibrinolytic pathway is required for hematopoietic regeneration	CELL STEM CELL			English	Article							GROWTH-FACTOR; STEM-CELLS; C-KIT; TARGETED INACTIVATION; SIGNAL-TRANSDUCTION; ACTIVATOR; MARROW; MICE; RECRUITMENT; THERAPY	Hematopoietic stem cells within the bone marrow exist in a quiescent state. They can differentiate and proliferate in response to hematopoietic stress (e.g., myelosuppression), thereby ensuring a well-regulated supply of mature and immature hematopoietic cells within the circulation. However, little is known about how this stress response is coordinated. Here, we show that plasminogen (Pig), a classical fibrinolytic factor, is a key player in controlling this stress response. Deletion of Pig in mice prevented hematopoietic stem cells from entering the cell cycle and undergoing multilineage differentiation after myelosuppression, leading to the death of the mice. Activation of Pig by administration of tissue-type plasminogen activator promoted matrix metal loprotein ase-mediated release of Kit ligand from stromal cells, thereby promoting hematopoietic progenitor cell proliferation and differentiation. Thus, activation of the fibrinolytic cascade is a critical step in regulating the hematopoietic stress response.	[Heissig, Beate; Akiyama, Haruyo; Ohki, Makiko; Morita, Yohei; Nakauchi, Hiromitsu; Hattori, Koichi] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Heissig, Beate; Okumura, Ko; Ogawa, Hideoki; Hattori, Koichi] Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Lund, Leif R.; Romer, John; Dano, Keld] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of Tokyo; Juntendo University; Rigshospitalet; University of Copenhagen; University of California System; University of California San Francisco	Hattori, K (corresponding author), Univ Tokyo, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	hattoriko@yahoo.com	Morita, Yohei/N-1260-2014; Hattori, Koichi/AAF-6862-2021; Heissig, Beate/AAF-6771-2021	Morita, Yohei/0000-0003-4163-5080; Heissig, Beate/0000-0002-0348-5934	NIA NIH HHS [R01 AG023218, R01 AG023218-04, AG023218] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG023218] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; ANDREWS RG, 1992, BLOOD, V80, P920; Barker JE, 1997, EXP HEMATOL, V25, P542; BARKER JE, 1994, EXP HEMATOL, V22, P174; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; CAMIOLO SM, 1971, P SOC EXP BIOL MED, V138, P277; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Heissig B, 2005, J EXP MED, V202, P739, DOI 10.1084/jem.20050959; Heissig B, 2005, HEMATOLOGY, V10, P247, DOI 10.1080/10245330500067249; Heissig B, 2003, CURR OPIN HEMATOL, V10, P136, DOI 10.1097/00062752-200303000-00007; HELLMAN S, 1967, NATURE, V216, P65, DOI 10.1038/216065a0; Herren T, 2003, FRONT BIOSCI-LANDMRK, V8, pD1, DOI 10.2741/916; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Kijima T, 2002, CANCER RES, V62, P6304; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Lijnen HR, 1998, ARTERIOSCL THROM VAS, V18, P1035, DOI 10.1161/01.ATV.18.7.1035; Lijnen HR, 1998, THROMB HAEMOSTASIS, V79, P1171; Liu Z, 2005, J CLIN INVEST, V115, P879, DOI 10.1172/JCI200523977; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Selvarajan S, 2001, NAT CELL BIOL, V3, P267, DOI 10.1038/35060059; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Suelves M, 2002, BLOOD, V99, P2835, DOI 10.1182/blood.V99.8.2835; Wilcox RG, 1996, AM J CARDIOL, V78, P20, DOI 10.1016/S0002-9149(96)00739-4; Zou T, 2006, J NEUROPATH EXP NEUR, V65, P78, DOI 10.1097/01.jnen.0000195942.25163.f5	30	55	56	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC	2007	1	6					658	670		10.1016/j.stem.2007.10.012	http://dx.doi.org/10.1016/j.stem.2007.10.012			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	243GU	18371407	Green Accepted, Bronze			2022-12-24	WOS:000251784300012
J	Xiao, T; Baier, H				Xiao, Tong; Baier, Herwig			Lamina-specific axonal projections in the zebrafish tectum require the type IV collagen dragnet	NATURE NEUROSCIENCE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; RECEPTOR TYROSINE KINASES; CELL-ADHESION MOLECULE; CHICK OPTIC TECTUM; RETINOTECTAL SYSTEM; ALPORT-SYNDROME; CADHERIN EXPRESSION; BASEMENT-MEMBRANE; NERVOUS-SYSTEM; VISUAL-SYSTEM	The mechanisms underlying the precise targeting of tectal layers by ingrowing retinal axons are largely unknown. In zebrafish, individual axons choose one of four retinorecipient layers upon entering the tectum and remain restricted to this layer, despite continual remodeling and shifting of their terminal arbors. In dragnet mutants, by contrast, a large fraction of retinal axons aberrantly trespass between layers or form terminal arbors that span two layers. The dragnet gene, drg, encodes collagen IV alpha 5 (Col4a5), a basement membrane component lining the surface of the tectum. Heparan sulfate proteoglycans (HSPGs) are normally associated with the tectal basement membrane but are dispersed in the dragnet mutant tectum. Zebrafish boxer (extl3) mutants, which are deficient in HSPG synthesis, show laminar targeting defects similar to those in dragnet. Our results show that the collagen IV sheet anchors secreted factors at the surface of the tectum, which serve as guidance cues for retinal axons.	Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Baier, H (corresponding author), Univ Calif San Francisco, Dept Physiol, Program Neurosci, 1550 Fourth St, San Francisco, CA 94158 USA.	herwig.baier@ucsf.edu			NATIONAL EYE INSTITUTE [R01EY013855, R01EY012406] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY012406, R01-EY013855] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BARTSCH S, 1995, EUR J NEUROSCI, V7, P907, DOI 10.1111/j.1460-9568.1995.tb01078.x; Braisted JE, 1997, DEV BIOL, V191, P14, DOI 10.1006/dbio.1997.8706; Easter SS, 2002, RES PRO CEL, V40, P346; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; FROST DO, 1986, DEV BRAIN RES, V28, P109, DOI 10.1016/0165-3806(86)90070-2; GAZE RM, 1974, PROC R SOC SER B-BIO, V185, P301, DOI 10.1098/rspb.1974.0021; Halfter W, 1998, J COMP NEUROL, V397, P105, DOI 10.1002/(SICI)1096-9861(19980720)397:1<105::AID-CNE8>3.0.CO;2-4; Halfter W, 2002, J NEUROSCI, V22, P6029; Halfter W, 2001, DEV BIOL, V238, P79, DOI 10.1006/dbio.2001.0396; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; KAWAKAMI H, 1990, NEPHRON, V56, P214, DOI 10.1159/000186136; KRUSE J, 1985, NATURE, V316, P146, DOI 10.1038/316146a0; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; Lee JS, 2004, NAT REV GENET, V5, P923, DOI 10.1038/nrg1490; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; Liu Q, 1999, J COMP NEUROL, V410, P303, DOI 10.1002/(SICI)1096-9861(19990726)410:2<303::AID-CNE11>3.0.CO;2-B; METCALFE WK, 1990, DEVELOPMENT, V110, P491; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Miskevich F, 1998, MOL CELL NEUROSCI, V12, P240, DOI 10.1006/mcne.1998.0718; Mould AP, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-24; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Nakamura H, 2004, J NEUROBIOL, V59, P48, DOI 10.1002/neu.10339; PEREZ RG, 1993, DEV BIOL, V156, P278, DOI 10.1006/dbio.1993.1076; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; SANES JR, 1986, J CELL BIOL, V102, P420, DOI 10.1083/jcb.102.2.420; Schmidt JT, 2000, J NEUROBIOL, V42, P303, DOI 10.1002/(SICI)1097-4695(20000215)42:3<303::AID-NEU2>3.3.CO;2-1; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Sener RN, 1998, COMPUT MED IMAG GRAP, V22, P71, DOI 10.1016/S0895-6111(97)00039-6; SHIELDS GW, 1990, SCHIZOPHR RES, V3, P235, DOI 10.1016/0920-9964(90)90003-P; Son YJ, 1999, EUR J NEUROSCI, V11, P3457, DOI 10.1046/j.1460-9568.1999.00766.x; Stier H, 1998, EUR J NEUROSCI, V10, P1000, DOI 10.1046/j.1460-9568.1998.00110.x; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; VENSTROM K, 1995, MOL BIOL CELL, V6, P419, DOI 10.1091/mbc.6.4.419; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016; Wohrn JCP, 1998, J COMP NEUROL, V396, P20; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; YAMAGATA M, 1995, DEVELOPMENT, V121, P3763; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Yamagata M, 2006, MOL CELL NEUROSCI, V33, P296, DOI 10.1016/j.mcn.2006.08.001	49	90	91	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1529	1537		10.1038/nn2002	http://dx.doi.org/10.1038/nn2002			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17982451				2022-12-24	WOS:000251172900009
J	Disney, AA; Aoki, C; Hawken, MJ				Disney, Anita A.; Aoki, Chiye; Hawken, Michael J.			Gain modulation by nicotine in macaque V1	NEURON			English	Article							CAT VISUAL-CORTEX; CONTRAST RESPONSE FUNCTIONS; MONKEY STRIATE CORTEX; ACETYLCHOLINE-RECEPTORS; CHOLINERGIC MODULATION; SPATIAL ATTENTION; CEREBRAL-CORTEX; MACACA-FASCICULARIS; GABAERGIC NEURONS; CORTICAL-NEURONS	Acetylcholine is a ubiquitous cortical neuro-modulator implicated in cognition. In order to understand the potential for acetylcholine to play a role in visual attention, we studied nicotinic acetylcholine receptor (nAChR) localization and function in area V1 of the macaque. We found nAChRs presynaptically at thalamic synapses onto excitatory, but not inhibitory, neurons in the primary thalamorecipient layer 4c. Furthermore, consistent with the release enhancement suggested by this localization, we discovered that nicotine increases responsiveness and lowers contrast threshold in layer 4c neurons. We also found that nAChRs are expressed by GABAergic interneurons; in V1 but rarely by pyramidal neurons, and that nicotine suppresses visual responses outside layer 4c. All sensory systems incorporate gain control mechanisms, or processes which dynamically alter input/output relationships. We demonstrate that at the site of thalamic input to visual cortex, the effect of this nAChR-mediated gain is an enhancement of the detection of visual stimuli.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Disney, AA (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.	anita@nyu.edu	Aoki, Chiye/T-9405-2019	Aoki, Chiye/0000-0003-4010-9425; Disney, Anita/0000-0003-3390-0681	NEI NIH HHS [R01 EY008300, P30 EY013079-079003, P30-EY13079, P30 EY013079, R01 EY013145, R01-EY13145, EY15549, EY8300, R01 EY013145-04, R03 EY015549] Funding Source: Medline; NINDS NIH HHS [R01 NS041091-04, R25 NS080686, R01 NS041091, R01-NS41091] Funding Source: Medline; NATIONAL EYE INSTITUTE [R03EY015549, R01EY008300, R01EY013145, P30EY013079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041091] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AOKI C, 1992, VISUAL NEUROSCI, V8, P177, DOI 10.1017/S0952523800002832; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; BEAULIEU C, 1992, CEREB CORTEX, V2, P295, DOI 10.1093/cercor/2.4.295; BEAULIEU C, 1991, J COMP NEUROL, V304, P666, DOI 10.1002/cne.903040412; Brown DA, 1997, LIFE SCI, V60, P1137, DOI 10.1016/S0024-3205(97)00058-1; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Christophe E, 2002, J NEUROPHYSIOL, V88, P1318, DOI 10.1152/jn.2002.88.3.1318; Dani JA, 2000, EUR J PHARMACOL, V393, P31, DOI 10.1016/S0014-2999(00)00003-0; DeFelipe J, 1999, J COMP NEUROL, V412, P515, DOI 10.1002/(SICI)1096-9861(19990927)412:3<515::AID-CNE10>3.0.CO;2-1; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Disney AA, 2006, J COMP NEUROL, V499, P49, DOI 10.1002/cne.21096; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fenster CP, 1997, J NEUROSCI, V17, P5747; GALLAGHER M, 1995, CURR OPIN NEUROBIOL, V5, P161, DOI 10.1016/0959-4388(95)80022-0; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gulledge AT, 2007, J NEUROPHYSIOL, V97, P2215, DOI 10.1152/jn.00493.2006; Han ZY, 2000, EUR J NEUROSCI, V12, P3664, DOI 10.1046/j.1460-9568.2000.00262.x; Han ZY, 2003, J COMP NEUROL, V461, P49, DOI 10.1002/cne.10659; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Hsieh CY, 2000, BRAIN RES, V880, P51, DOI 10.1016/S0006-8993(00)02766-9; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Jack AI, 2006, NEURON, V51, P135, DOI 10.1016/j.neuron.2006.06.003; JASPER HH, 1971, SCIENCE, V172, P601, DOI 10.1126/science.172.3983.601; JimenezCapdeville ME, 1996, NEUROSCIENCE, V71, P567, DOI 10.1016/0306-4522(95)00439-4; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V70, P387, DOI 10.1152/jn.1993.70.1.387; Kawaguchi Y, 1997, J NEUROPHYSIOL, V78, P1743, DOI 10.1152/jn.1997.78.3.1743; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; Lambe EK, 2005, J NEUROSCI, V25, P5225, DOI 10.1523/JNEUROSCI.0719-05.2005; Lavine N, 1997, J COMP NEUROL, V380, P175, DOI 10.1002/(SICI)1096-9861(19970407)380:2<175::AID-CNE3>3.0.CO;2-0; Levy RB, 2006, J NEUROPHYSIOL, V95, P2155, DOI 10.1152/jn.00603.2005; Ling S, 2006, VISION RES, V46, P1210, DOI 10.1016/j.visres.2005.05.008; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; Meskenaite V, 1997, J COMP NEUROL, V379, P113; Metherate R, 2004, LEARN MEMORY, V11, P50, DOI 10.1101/lm.69904; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Mori T, 2001, MOL PHARMACOL, V59, P732, DOI 10.1124/mol.59.4.732; Mrzljak L, 1996, P NATL ACAD SCI USA, V93, P7337, DOI 10.1073/pnas.93.14.7337; MULLER CM, 1989, BRAIN RES, V487, P335, DOI 10.1016/0006-8993(89)90837-8; MURPHY PC, 1991, NEUROSCIENCE, V40, P13, DOI 10.1016/0306-4522(91)90170-S; Nelson CL, 2005, NEUROSCIENCE, V132, P347, DOI 10.1016/j.neuroscience.2004.12.007; PARKINSON D, 1988, EXP BRAIN RES, V73, P553, DOI 10.1007/BF00406614; PEARSON RCA, 1983, BRAIN RES, V259, P132, DOI 10.1016/0006-8993(83)91075-2; PRICE JL, 1983, BRAIN RES, V269, P352, DOI 10.1016/0006-8993(83)90145-2; Reitstetter R, 1999, J PHARMACOL EXP THER, V289, P656; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Rezvani AH, 2001, BIOL PSYCHIAT, V49, P258, DOI 10.1016/S0006-3223(00)01094-5; Roberts MJ, 2005, J NEUROPHYSIOL, V93, P2062, DOI 10.1152/jn.00911.2004; RUSSCHEN FT, 1985, J COMP NEUROL, V242, P1, DOI 10.1002/cne.902420102; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; SATO H, 1987, J NEUROPHYSIOL, V58, P765, DOI 10.1152/jn.1987.58.4.765; SATO H, 1987, J NEUROPHYSIOL, V58, P781, DOI 10.1152/jn.1987.58.4.781; SILLITO AM, 1983, BRAIN RES, V289, P143, DOI 10.1016/0006-8993(83)90015-X; Solomon SG, 2004, J NEUROSCI, V24, P148, DOI 10.1523/JNEUROSCI.3036-03.2004; Tigges M, 1997, J COMP NEUROL, V388, P130; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Turrini P, 2001, NEUROSCIENCE, V105, P277, DOI 10.1016/S0306-4522(01)00172-5; VANBREDERODE JFM, 1990, J COMP NEUROL, V298, P1, DOI 10.1002/cne.902980102; Vazquez J, 2001, AM J PHYSIOL-REG I, V280, pR598, DOI 10.1152/ajpregu.2001.280.2.R598; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; WOUTERLOOD FG, 1993, J NEUROSCI METH, V48, P75, DOI 10.1016/S0165-0270(05)80009-3; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; Xing DJ, 2005, J NEUROPHYSIOL, V94, P799, DOI 10.1152/jn.01139.2004; Zinke W, 2006, EUR J NEUROSCI, V24, P314, DOI 10.1111/j.1460-9568.2006.04882.x	66	231	232	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 21	2007	56	4					701	713		10.1016/j.neuron.2007.09.034	http://dx.doi.org/10.1016/j.neuron.2007.09.034			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	236MH	18031686	Green Accepted, Bronze			2022-12-24	WOS:000251306600012
J	Raizada, RDS; Poldrack, RA				Raizada, Rajeev D. S.; Poldrack, Russell A.			Selective amplification of stimulus differences during categorical processing of speech	NEURON			English	Article							AUDITORY-CORTEX; PERCEPTION; FMRI; BRAIN; DISCRIMINATION; MASKING; REPRESENTATIONS; IDENTIFICATION; ADAPTATION; BOUNDARIES	The brain's perceptual stimuli are constantly changing: some of these changes are treated as invariances and are suppressed, whereas others are selectively amplified, giving emphasis to the distinctions that matter most. The starkest form of such amplification is categorical perception. In speech, for example, a continuum of phonetic stimuli gets carved into perceptually distinct categories. We used fMR1 to measure the degree to which this process of selective amplification takes place. The most categorically processing area was the left supramarginal gyrus: stimuli from different phonetic categories, when presented together in a contrasting pair, were neurally amplified more than two-fold. Low-level auditory cortical areas, however, showed comparatively little amplification of changes that crossed category boundaries. Selective amplification serves to emphasize key stimulus differences, thereby shaping perceptual categories. The approach presented here provides a quantitative way to measure the degree to which such processing is taking place.	Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA; Univ Calif Los Angeles, Dept Psychol, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Raizada, RDS (corresponding author), Univ Washington, Inst Learning & Brain Sci, Box 357988, Seattle, WA 98195 USA.	raizada@u.washington.edu		Raizada, Rajeev/0000-0002-2784-1964				Benedict RHB, 2002, J COGNITIVE NEUROSCI, V14, P637, DOI 10.1162/08989290260045765; Benson RR, 2001, BRAIN LANG, V78, P364, DOI 10.1006/brln.2001.2484; Binder JR, 2004, NAT NEUROSCI, V7, P295, DOI 10.1038/nn1198; Blumstein SE, 2005, J COGNITIVE NEUROSCI, V17, P1353, DOI 10.1162/0898929054985473; BORNSTEIN MH, 1976, SCIENCE, V191, P201, DOI 10.1126/science.1246610; Boynton GM, 2003, J NEUROSCI, V23, P8781; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; Callan DE, 2003, NEUROIMAGE, V19, P113, DOI 10.1016/S1053-8119(03)00020-X; CAPLAN D, 1995, NEUROLOGY, V45, P293, DOI 10.1212/WNL.45.2.293; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; DehaeneLambertz G, 1997, NEUROREPORT, V8, P919, DOI 10.1097/00001756-199703030-00021; ETCOFF NL, 1992, COGNITION, V44, P227, DOI 10.1016/0010-0277(92)90002-Y; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Gelfand JR, 2003, NEURON, V38, P831, DOI 10.1016/S0896-6273(03)00285-X; Gelfand S. A., 2004, HEARING INTRO PSYCHO; Gerrits E, 2004, PERCEPT PSYCHOPHYS, V66, P363, DOI 10.3758/BF03194885; Griffiths TD, 2004, TRENDS NEUROSCI, V27, P181, DOI 10.1016/j.tins.2004.02.005; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Jacquemot C, 2003, J NEUROSCI, V23, P9541; Jiang X, 2006, NEURON, V50, P159, DOI 10.1016/j.neuron.2006.03.012; KUHL PK, 1983, J ACOUST SOC AM, V73, P1003, DOI 10.1121/1.389148; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mathiak K, 2002, J COGNITIVE NEUROSCI, V14, P902, DOI 10.1162/089892902760191126; May P, 1999, J COMPUT NEUROSCI, V6, P99, DOI 10.1023/A:1008896417606; McEvoy L, 1997, PSYCHOPHYSIOLOGY, V34, P308, DOI 10.1111/j.1469-8986.1997.tb02401.x; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Phillips C, 2000, J COGNITIVE NEUROSCI, V12, P1038, DOI 10.1162/08989290051137567; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; SMIAROWSKI RA, 1975, J ACOUST SOC AM, V57, P1169, DOI 10.1121/1.380575; WILSON RH, 1971, J ACOUST SOC AM, V49, P1254, DOI 10.1121/1.1912488; Zevin JD, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-4	38	80	80	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 21	2007	56	4					726	740		10.1016/j.neuron.2007.11.001	http://dx.doi.org/10.1016/j.neuron.2007.11.001			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	236MH	18031688	Bronze			2022-12-24	WOS:000251306600014
J	Schafer, RJ; Moore, T				Schafer, Robert J.; Moore, Tirin			Attention governs action in the primate frontal eye field	NEURON			English	Article							SACCADE TARGET SELECTION; SUPERIOR COLLICULUS; PERCEIVED POSITION; SPATIAL ATTENTION; MOTION SIGNALS; VISUAL-MOTION; MICROSTIMULATION; STIMULATION; MOVEMENTS; ENHANCEMENT	While the motor and attentional roles of the frontal eye field (FEF) are well documented, the relationship between them is unknown. We exploited the known influence of visual motion on the apparent positions of targets, and measured how this illusion affects saccadic eye movements during FEF microstimulation. Without microstimulation, saccades to a moving grating are biased in the direction of motion, consistent with the apparent position illusion. Here we show that microstimulation of spatially aligned FEF representations increases the influence of this illusion on saccades. Rather than simply impose a fixed-vector signal, subthreshold stimulation directed saccades away from the FEF movement field, and instead more strongly in the direction of visual motion. These results demonstrate that the attentional effects of FEF stimulation govern visually guided saccades, and suggest that the two roles of the FEF work together to select both the features of a target and the appropriate movement to foveate it.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Moore, T (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	tirin@stanford.edu		Schafer, Robert/0000-0002-0874-830X	NEI NIH HHS [R01 EY014924-03, R56 EY014924, R01 EY014924, R01 EY014924-04, R01 EY014924-01A1, EY14924, R01 EY014924-02] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014924, R56EY014924] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Armstrong KM, 2007, P NATL ACAD SCI USA, V104, P9499, DOI 10.1073/pnas.0701104104; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Awh E, 2006, TRENDS COGN SCI, V10, P124, DOI 10.1016/j.tics.2006.01.001; Barborica A, 2004, J NEUROSCI, V24, P3260, DOI 10.1523/JNEUROSCI.4702-03.2004; Bisley JW, 2001, J NEUROPHYSIOL, V85, P187, DOI 10.1152/jn.2001.85.1.187; BIZZI E, 1967, SCIENCE, V157, P1588, DOI 10.1126/science.157.3796.1588; Blanke O, 2000, NEUROREPORT, V11, P1907, DOI 10.1097/00001756-200006260-00021; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1990, NEUROSCI IN, P261; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Cavanaugh J, 2006, J NEUROSCI, V26, P11347, DOI 10.1523/JNEUROSCI.2376-06.2006; Chambers CD, 2005, TRENDS COGN SCI, V9, P542, DOI 10.1016/j.tics.2005.09.010; Cooke DF, 2003, J NEUROPHYSIOL, V90, P3317, DOI 10.1152/jn.00513.2003; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; Dodge R, 1900, PSYCHOL REV, V7, P454, DOI 10.1037/h0067215; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; Gardner JL, 2002, NAT NEUROSCI, V5, P892, DOI 10.1038/nn897; Gardner JL, 2001, J NEUROSCI, V21, P2075, DOI 10.1523/JNEUROSCI.21-06-02075.2001; GLIMCHER PW, 1993, J NEUROPHYSIOL, V69, P953, DOI 10.1152/jn.1993.69.3.953; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; GOLDREICH D, 1992, J NEUROPHYSIOL, V67, P625, DOI 10.1152/jn.1992.67.3.625; Green DM, 1966, SIGNAL DETECTION THE; Gross CG, 2003, PROG BRAIN RES, V144, P279, DOI 10.1016/S0079-6123(03)14401-9; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HE PY, 1992, VISION RES, V32, P2151, DOI 10.1016/0042-6989(92)90076-U; Histed MH, 2006, PLOS BIOL, V4, P826, DOI 10.1371/journal.pbio.0040134; Juan CH, 2004, P NATL ACAD SCI USA, V101, P15541, DOI 10.1073/pnas.0403507101; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KOWLER E, 1977, VISION RES, V17, P141, DOI 10.1016/0042-6989(77)90212-7; KRAUZLIS RJ, 1994, J NEUROPHYSIOL, V72, P150, DOI 10.1152/jn.1994.72.1.150; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Lisberger SG, 1998, J NEUROPHYSIOL, V79, P1918, DOI 10.1152/jn.1998.79.4.1918; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; Moore T, 2006, CURR OPIN NEUROBIOL, V16, P159, DOI 10.1016/j.conb.2006.03.009; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MOORE T, 2001, OUT MIND VARIETIES U, P35; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Murphey DK, 2007, CURR BIOL, V17, P862, DOI 10.1016/j.cub.2007.03.066; Murthy A, 2001, J NEUROPHYSIOL, V86, P2634, DOI 10.1152/jn.2001.86.5.2634; Nishida S, 1999, NATURE, V397, P610, DOI 10.1038/17600; Penfield W, 1950, CEREBRAL CORTEX MAN; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DA, 1969, J NEUROPHYSIOL, V32, P637, DOI 10.1152/jn.1969.32.5.637; Schiller PH, 2001, PROG BRAIN RES, V134, P127; SCHILLER PH, 1983, EXP BRAIN RES, V49, P381; Silvanto J, 2006, J NEUROPHYSIOL, V96, P941, DOI 10.1152/jn.00015.2006; SPARKS DL, 1983, J NEUROPHYSIOL, V49, P45, DOI 10.1152/jn.1983.49.1.45; STANTON GB, 1989, J COMP NEUROL, V282, P415, DOI 10.1002/cne.902820308; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005; Turatto M, 2007, VISION RES, V47, P166, DOI 10.1016/j.visres.2006.10.002; VITU F, 1990, PERCEPT PSYCHOPHYS, V47, P583, DOI 10.3758/BF03203111; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; Whitney D, 2002, TRENDS COGN SCI, V6, P211, DOI 10.1016/S1364-6613(02)01887-9; Whitney D, 2000, NAT NEUROSCI, V3, P954, DOI 10.1038/78878; Whitney D, 2006, J EXP PSYCHOL HUMAN, V32, P1380, DOI 10.1037/0096-1523.32.6.1380; Williams ZM, 2006, NAT NEUROSCI, V9, P562, DOI 10.1038/nn1662; Xiao Q, 2006, VISUAL NEUROSCI, V23, P49, DOI 10.1017/S0952523806231055; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	68	62	63	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 8	2007	56	3					541	551		10.1016/j.neuron.2007.09.029	http://dx.doi.org/10.1016/j.neuron.2007.09.029			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	229AV	17988636	Green Accepted, Bronze			2022-12-24	WOS:000250774600012
J	Midorikawa, M; Tsukamoto, Y; Berglund, K; Ishii, M; Tachibana, M				Midorikawa, Mitsuharu; Tsukamoto, Yoshihiko; Berglund, Ken; Ishii, Masaaki; Tachibana, Masao			Different roles of ribbon-associated and ribbon-free active zones in retinal bipolar cells	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; SYNAPTIC RIBBONS; TRANSMITTER RELEASE; CALCIUM CURRENT; VESICLE POOLS; EXOCYTOSIS; MODULATION; MEMBRANE; BASSOON; GABA	Synaptic ribbons with a halo of synaptic vesicles are seen at the active zones of sensory neurons that release transmitter tonically. Thus, ribbons are assumed to be a prerequisite for sustained exocytosis. By applying total internal reflection fluorescence microscopy to goldfish retinal bipolar cell terminals, we visualized Ca2+ entry sites, ribbons, and vesicle fusion events. Here we show that the main Ca2+ entry sites were located at ribbons, and that activation of the Ca2+ current induced immediate and delayed vesicle fusion events at ribbon- associated and ribbon-free 'hot spots', respectively. The activation of protein kinase C (PKC) specifically potentiated vesicle fusion at ribbon- free sites. Electron microscopy showed that PKC activation selectively increased the number of docked vesicles at ribbon- free sites, which faced neuronal processes with the postsynaptic density. Retinal bipolar cells have both ribbon- associated and ribbon- free active zones in their terminals and might send functionally distinct signals through ribbon-associated and ribbon-free synapses to postsynaptic neurons.	Hyogo Coll Med, Dept Biol, Nishinomiya, Hyogo 6638501, Japan; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Tokyo, Grad Sch Humanities & Sociol, Dept Psychol, Bunkyo Ku, Tokyo 1130033, Japan	Hyogo College of Medicine; Duke University; University of Tokyo	Tachibana, M (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Almers Lab, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	Itmasao@l.u-tokyo.ac.jp	Midorikawa, Mitsuharu/GSD-2712-2022	Ishii, Masaaki/0000-0002-0775-5401				ALLEN MB, 1969, ANNU REV MICROBIOL, V23, P29, DOI 10.1146/annurev.mi.23.100169.000333; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Berglund K, 2002, J NEUROSCI, V22, P4776, DOI 10.1523/JNEUROSCI.22-12-04776.2002; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Diggle P., 2003, STAT ANAL SPATIAL PO; Dowling J. E., 1987, RETINA APPROACHABLE; FEIGENSPAN A, 1994, J PHYSIOL-LONDON, V481, P325, DOI 10.1113/jphysiol.1994.sp020442; Gillette MA, 1996, J NEUROPHYSIOL, V76, P3070, DOI 10.1152/jn.1996.76.5.3070; Heidelberger R, 1998, J GEN PHYSIOL, V111, P225, DOI 10.1085/jgp.111.2.225; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Hull C, 2006, J NEUROPHYSIOL, V96, P2025, DOI 10.1152/jn.00364.2006; Job C, 1998, J CELL BIOL, V143, P1661, DOI 10.1083/jcb.143.6.1661; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; Lenzi D, 2001, BIOESSAYS, V23, P831, DOI 10.1002/bies.1118; Llobet A, 2003, J NEUROSCI, V23, P2706; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Minami N, 1998, J PHYSIOL-LONDON, V512, P219, DOI 10.1111/j.1469-7793.1998.219bf.x; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; OSBORNE NN, 1994, BRAIN RES, V637, P156, DOI 10.1016/0006-8993(94)91228-9; RAVIOLA E, 1982, J COMP NEUROL, V209, P233, DOI 10.1002/cne.902090303; ROBERTS WM, 1991, ANN NY ACAD SCI, V635, P221, DOI 10.1111/j.1749-6632.1991.tb36494.x; Sakaba T, 1997, NEUROSCI RES, V27, P357, DOI 10.1016/S0168-0102(97)01168-1; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; SUZUKI S, 1990, VISUAL NEUROSCI, V5, P223, DOI 10.1017/S0952523800000298; SUZUKI S, 1990, J PHYSIOL-LONDON, V421, P645, DOI 10.1113/jphysiol.1990.sp017967; TACHIBANA M, 1991, J NEUROSCI, V11, P2199; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; von Gersdorff H, 2001, NEURON, V29, P7, DOI 10.1016/S0896-6273(01)00175-1; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zenisek D, 2004, J NEUROSCI, V24, P9752, DOI 10.1523/JNEUROSCI.2886-04.2004; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zenisek D, 2003, J NEUROSCI, V23, P2538; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004	39	63	63	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1268	1276		10.1038/nn1963	http://dx.doi.org/10.1038/nn1963			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828257				2022-12-24	WOS:000249720800013
J	Hartmann, J; Dragicevic, E; Adelsberger, H; Henning, HA; Sumser, M; Abramowitz, J; Blum, R; Dietrich, A; Freichel, M; Flockerzi, V; Birnbaumer, L; Konnerth, A				Hartmann, Jana; Dragicevic, Elena; Adelsberger, Helmuth; Henning, Horst A.; Sumser, Martin; Abramowitz, Joel; Blum, Robert; Dietrich, Alexander; Freichel, Marc; Flockerzi, Veit; Birnbaumer, Lutz; Konnerth, Arthur			TRPC3 channels are required for synaptic transmission and motor coordination	NEURON			English	Article							CEREBELLAR PURKINJE-CELLS; METABOTROPIC GLUTAMATE-RECEPTOR; LONG-TERM DEPRESSION; INWARD CURRENT; NEUROTROPHIC FACTOR; NEURONS; MICE; ACTIVATION; BRAIN; LOCALIZATION	In the mammalian central nervous system, slow synaptic excitation involves the activation of metabotropic glutamate receptors (mGluRs). It has been proposed that C1-type transient receptor potential (TRPC1) channels underlie this synaptic excitation, but our analysis of TRPC1-deficient mice does not support this hypothesis. Here, we show unambiguously that it is TRPC3 that is needed for mGluR-dependent synaptic signaling in mouse cerebellar Purkinje cells. TRPC3 is the most abundantly expressed TRPC subunit in Purkinje cells. In mutant mice lacking TRPC3, both slow synaptic potentials and mGluR-mediated inward currents are completely absent, while the synaptically mediated Ca2+ release signals from intracellular stores are unchanged. Importantly, TRPC3 knockout mice exhibit an impaired walking behavior. Taken together, our results establish TRPC3 as a new type of postsynaptic channel that mediates mGluR-dependent synaptic transmission in cerebellar Purkinje cells and is crucial for motor coordination.	[Hartmann, Jana; Dragicevic, Elena; Adelsberger, Helmuth; Henning, Horst A.; Sumser, Martin; Konnerth, Arthur] Tech Univ Munich, Inst Neurosci, D-80802 Munich, Germany; [Hartmann, Jana; Dragicevic, Elena; Adelsberger, Helmuth; Henning, Horst A.; Sumser, Martin; Konnerth, Arthur] Tech Univ Munich, Ctr Integrated Prot Sci, D-80802 Munich, Germany; [Abramowitz, Joel; Birnbaumer, Lutz] NIEHS, Transmembrane Signaling Grp, Res Triangle Pk, NC 27709 USA; [Blum, Robert] Univ Munich, Inst Physiol, D-80336 Munich, Germany; [Dietrich, Alexander] Univ Marburg, Inst Pharmacol & Toxicol, D-35043 Marburg, Germany; [Freichel, Marc; Flockerzi, Veit] Univ Saarland, Inst Expt & Clin Pharmacol & Toxicol, D-66421 Homburg, Germany	Technical University of Munich; Technical University of Munich; University of Munich; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Munich; Philipps University Marburg; Saarland University	Konnerth, A (corresponding author), Tech Univ Munich, Inst Neurosci, D-80802 Munich, Germany.	arthur.konnerth@lrz.tum.de	Blum, Robert/E-8899-2013; Hartmann, Jana/C-1024-2008; Sumser, Martin/N-1747-2015; Abramowitz, Joel/A-2620-2015; Dietrich, Alexander/G-8619-2013	Blum, Robert/0000-0002-5270-3854; Sumser, Martin/0000-0002-1760-8026; Dietrich, Alexander/0000-0002-1168-8707; Hartmann, Jana/0000-0002-1033-7104	Deutsche Forschungsgemeinschaft [HA 5388/1-1, IRTG 1373, GRK 333]; Intramural Research Program of the NIH; National Institute of Environmental Health Sciences [Z01-ES101684]; Schiedel Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101684] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Schiedel Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the Deutsche Forschungsgemeinschaft (HA 5388/1-1; IRTG 1373, GRK 333), the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01-ES101684), and the Schiedel Foundation. A.K. is a Carl-von-Linde Senior Fellow of the Institute for Advanced Study of the TUM.	AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; Barski JJ, 2003, J NEUROSCI, V23, P3469; BATCHELOR AM, 1993, NEUROPHARMACOLOGY, V32, P11, DOI 10.1016/0028-3908(93)90124-L; Canepari M, 2001, J PHYSIOL-LONDON, V533, P765, DOI 10.1111/j.1469-7793.2001.00765.x; Canepari M, 2006, J PHYSIOL-LONDON, V573, P65, DOI 10.1113/jphysiol.2005.103770; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Durand G, 2006, PFLUG ARCH EUR J PHY, V451, P716, DOI 10.1007/s00424-005-1514-3; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EHRLICH BE, 1994, TRENDS PHARMACOL SCI, V15, P145, DOI 10.1016/0165-6147(94)90074-4; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Hartmann J, 2004, J NEUROSCI, V24, P5119, DOI 10.1523/JNEUROSCI.4193-03.2004; Hirono M, 1998, BIOCHEM BIOPH RES CO, V251, P753, DOI 10.1006/bbrc.1998.9465; Huang TY, 2007, ACM SIGPLAN NOTICES, V42, P11, DOI 10.1145/1273444.1254769; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Kamouchi M, 1999, J PHYSIOL-LONDON, V518, P345, DOI 10.1111/j.1469-7793.1999.0345p.x; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Knopfel T, 2000, EUR J NEUROSCI, V12, P2199, DOI 10.1046/j.1460-9568.2000.00122.x; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; LINDEN DJ, 1994, J NEUROPHYSIOL, V71, P1992, DOI 10.1152/jn.1994.71.5.1992; MARTIN LJ, 1992, NEURON, V9, P259, DOI 10.1016/0896-6273(92)90165-A; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; STAUB C, 1992, EUR J NEUROSCI, V4, P832, DOI 10.1111/j.1460-9568.1992.tb00193.x; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; Sugiyama T, 1999, BIOCHEM BIOPH RES CO, V265, P473, DOI 10.1006/bbrc.1999.1628; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tempia F, 2001, J NEUROPHYSIOL, V86, P1389, DOI 10.1152/jn.2001.86.3.1389; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819	37	304	307	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 14	2008	59	3					392	398		10.1016/j.neuron.2008.06.009	http://dx.doi.org/10.1016/j.neuron.2008.06.009			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339GG	18701065	Bronze, Green Accepted			2022-12-24	WOS:000258565500008
J	Zhang, XM; Li, L; McNaughton, PA				Zhang, Xuming; Li, Lin; McNaughton, Peter A.			Proinflammatory mediators modulate the heat-activated ion channel TRPV1 via the scaffolding protein AKAP79/150	NEURON			English	Article							CAPSAICIN RECEPTOR VR1; ROOT GANGLION NEURONS; VANILLOID RECEPTOR-1; KINASE-II; DIRECT PHOSPHORYLATION; THERMAL HYPERALGESIA; NOCICEPTIVE NEURONS; EVOKED ACTIVATION; SENSORY NEURONS; DESENSITIZATION	The ability of vertebrates to detect and avoid damaging extremes of temperature depends on activation of ion channels belonging to the thermo-TRIP family. Injury or inflammation causes the release of inflammatory mediators which lower the threshold for detection of painful levels of heat, a process known as heat hyperalgesia. These inflammatory mediators act by at least three distinct intracellular signaling pathways. Here, we show that modulation of the sensitivity of the heat-activated ion channel TRPV1 by the protein kinases PKA and PKC and by the phosphatase calcineurin depends on the formation of a signaling complex between these enzymes, the scaffolding protein AKAP79/150 and TRPV1. We identify a critical region in the TRPV1 C-terminal which mediates binding of AKAP79/150. If binding is prevented, then sensitization by both bradykinin and PGE(2) is abrogated. AKAP79/150 is therefore a final common element in heat hyperalgesia, on which the effects of multiple proinflammatory mediators converge.	[Zhang, Xuming; Li, Lin; McNaughton, Peter A.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	McNaughton, PA (corresponding author), Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England.	pam42@cam.ac.uk		McNaughton, Peter/0000-0003-1946-9610; Zhang, Xuming/0000-0002-5331-8675	BBSRC (UK); BBSRC [BB/F003072/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F003072/1, BB/C003217/1] Funding Source: researchfish	BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank those listed in Experimental Procedures for kind gifts of materials. We thank Dr. J. Huang who participated in some early experiments and Dr. H.C. Fan for helpful suggestions and comments on the MS. This work was supported by the BBSRC (UK).	Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; BREGMAN DB, 1989, J BIOL CHEM, V264, P4648; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Chai SH, 2007, J BIOL CHEM, V282, P22668, DOI 10.1074/jbc.M703624200; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; DARIANSMITH I, 1984, NERVOUS SYSTEM, P879; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Distler C, 2003, J NEUROPHYSIOL, V89, P2499, DOI 10.1152/jn.00713.2002; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Guler AD, 2002, J NEUROSCI, V22, P6408; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Huang JJ, 2006, SEMIN CELL DEV BIOL, V17, P638, DOI 10.1016/j.semcdb.2006.11.002; Jahnel R, 2001, EUR J BIOCHEM, V268, P5489, DOI 10.1046/j.1432-1033.2001.02500.x; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Koplas PA, 1997, J NEUROSCI, V17, P3525; LEISER M, 1986, J BIOL CHEM, V261, P1904; Lin CR, 2006, J PHARMACOL EXP THER, V319, P1096, DOI 10.1124/jpet.106.105569; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Lopshire JC, 1998, J NEUROSCI, V18, P6081; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Moriyama T, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-3; Navedo MF, 2008, CIRC RES, V102, pE1, DOI 10.1161/CIRCRESAHA.107.167809; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Novakova-Tousova K, 2007, NEUROSCIENCE, V149, P144, DOI 10.1016/j.neuroscience.2007.07.039; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; PERL ER, 1984, NERVOUS SYSTEM SEN 2, P915; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rathee PK, 2002, J NEUROSCI, V22, P4740, DOI 10.1523/JNEUROSCI.22-11-04740.2002; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Sandoz G, 2006, EMBO J, V25, P5864, DOI 10.1038/sj.emboj.7601437; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Southall MD, 2001, J BIOL CHEM, V276, P16083, DOI 10.1074/jbc.M011408200; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	61	198	206	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 14	2008	59	3					450	461		10.1016/j.neuron.2008.05.015	http://dx.doi.org/10.1016/j.neuron.2008.05.015			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339GG	18701070	Bronze, Green Submitted			2022-12-24	WOS:000258565500013
J	Magnusson, AK; Park, TJ; Pecka, M; Grothe, B; Koch, U				Magnusson, Anna K.; Park, Thomas J.; Pecka, Michael; Grothe, Benedikt; Koch, Ursula			Retrograde GABA signaling adjusts sound localization by balancing excitation and inhibition in the brainstem	NEURON			English	Article							LATERAL SUPERIOR OLIVE; RAT OLFACTORY-BULB; PRESYNAPTIC INHIBITION; SYNAPTIC-TRANSMISSION; AUDITORY-CORTEX; INFERIOR COLLICULUS; NEUROTRANSMITTER RELEASE; HOMEOSTATIC PLASTICITY; GABAERGIC NEURONS; GUINEA-PIG	Central processing of acoustic cues is critically dependent on the balance between excitation and inhibition. This balance is particularly important for auditory neurons in the lateral superior olive, because these compare excitatory inputs from one ear and inhibitory inputs from the other ear to compute sound source location. By applying GABA(B) receptor antagonists during sound stimulation in vivo, it was revealed that these neurons adjust their binaural sensitivity through GABA(B) receptors. Using an in vitro approach, we then demonstrate that these neurons release GABA during spiking activity. Consequently, GABA differentially regulates transmitter release from the excitatory and inhibitory terminals via feedback to presynaptic GABA(B) receptors. Modulation of the synaptic input strength, by putative retrograde release of neurotransmitter, may enable these auditory neurons to rapidly adjust the balance between excitation and inhibition, and thus their binaural sensitivity, which could play an important role as an adaptation to various listening situations.	[Magnusson, Anna K.; Pecka, Michael; Grothe, Benedikt; Koch, Ursula] Ludwig Maximilians Univ Munchen, Div Neurobiol, Dept Biol 2, D-82152 Martinsried, Germany; [Park, Thomas J.] Univ Illinois, Dept Biol Sci, Neurobiol Grp, Chicago, IL 60607 USA; [Pecka, Michael; Grothe, Benedikt] Bernstein Ctr Computat Neurosci, D-81377 Munich, Germany	University of Munich; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Magnusson, AK (corresponding author), Ludwig Maximilians Univ Munchen, Div Neurobiol, Dept Biol 2, Grosshadernerstr 2, D-82152 Martinsried, Germany.	anna.magnusson@ki.se; koch@zi.biologie.uni-muenchen.de	Grothe, Benedikt/A-7877-2010	Grothe, Benedikt/0000-0001-7317-0615; Pecka, Michael/0000-0001-8960-1651				Adam TJ, 1999, EXP BRAIN RES, V124, P489, DOI 10.1007/s002210050645; Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; Binns KE, 1997, J PHYSIOL-LONDON, V504, P629, DOI 10.1111/j.1469-7793.1997.629bd.x; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Caicedo A, 1999, EUR J NEUROSCI, V11, P51, DOI 10.1046/j.1460-9568.1999.00410.x; CANT NB, 1984, J COMP NEUROL, V227, P63, DOI 10.1002/cne.902270108; Chang EH, 2003, J NEUROPHYSIOL, V90, P1479, DOI 10.1152/jn.00386.2003; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Dittman JS, 1996, J NEUROSCI, V16, P1623; DURKIN MM, 1995, MOL BRAIN RES, V33, P7, DOI 10.1016/0169-328X(95)00101-W; DUTIA MB, 1992, EXP BRAIN RES, V88, P466; FINLAYSON PG, 1989, HEARING RES, V38, P221, DOI 10.1016/0378-5955(89)90067-1; Getzmann S, 2004, HEARING RES, V191, P14, DOI 10.1016/j.heares.2003.12.020; GLENDENNING KK, 1992, J COMP NEUROL, V319, P100, DOI 10.1002/cne.903190110; GonzalezHernandez T, 1996, J COMP NEUROL, V372, P309, DOI 10.1002/(SICI)1096-9861(19960819)372:2<309::AID-CNE11>3.0.CO;2-E; Gutierrez R, 2003, PROG NEUROBIOL, V71, P337, DOI 10.1016/j.pneurobio.2003.11.004; HELFERT RH, 1989, BRAIN RES, V501, P269, DOI 10.1016/0006-8993(89)90644-6; HELFERT RH, 1987, AM J ANAT, V179, P55, DOI 10.1002/aja.1001790108; HELFERT RH, 1992, J COMP NEUROL, V323, P305, DOI 10.1002/cne.903230302; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; HOLSTEIN GR, 1992, BRAIN RES, V581, P175, DOI 10.1016/0006-8993(92)90361-C; Isaacson JS, 2003, J NEUROSCI, V23, P2032; Isaacson JS, 1998, J NEUROPHYSIOL, V80, P1571, DOI 10.1152/jn.1998.80.3.1571; Isaacson JS, 2001, P NATL ACAD SCI USA, V98, P337, DOI 10.1073/pnas.021445798; Kaiser KMM, 2001, J PHYSIOL-LONDON, V535, P17, DOI 10.1111/j.1469-7793.2001.t01-1-00017.x; Korada S, 1999, J COMP NEUROL, V409, P664, DOI 10.1002/(SICI)1096-9861(19990712)409:4<664::AID-CNE10>3.0.CO;2-S; Kotak VC, 2005, J NEUROSCI, V25, P3908, DOI 10.1523/JNEUROSCI.5169-04.2005; Kotak VC, 2001, J NEUROPHYSIOL, V86, P536, DOI 10.1152/jn.2001.86.1.536; Lei SB, 2003, J PHYSIOL-LONDON, V546, P439, DOI 10.1113/jphysiol.2002.034017; Ludwig M, 2003, TRENDS NEUROSCI, V26, P255, DOI 10.1016/S0166-2236(03)00072-9; Magnusson AK, 2005, J PHYSIOL-LONDON, V568, P497, DOI 10.1113/jphysiol.2005.094763; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; MOORE MJ, 1983, J NEUROSCI, V3, P237; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; Nicoll RA, 2004, BIOCHEM PHARMACOL, V68, P1667, DOI 10.1016/j.bcp.2004.07.024; Park TJ, 2008, HEARING RES, V238, P58, DOI 10.1016/j.heares.2007.10.009; Park TJ, 1996, J NEUROSCI, V16, P6554; Peterson DC, 2007, HEARING RES, V232, P67, DOI 10.1016/j.heares.2007.06.009; ROBERTS RC, 1987, J COMP NEUROL, V258, P267, DOI 10.1002/cne.902580207; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; SANES DH, 1987, J NEUROSCI, V7, P3793; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Schmid S, 2001, J COMP NEUROL, V430, P160, DOI 10.1002/1096-9861(20010205)430:2<160::AID-CNE1022>3.3.CO;2-V; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takahashi T, 1998, J NEUROSCI, V18, P3138; Thompson AM, 2000, MICROSC RES TECHNIQ, V51, P330, DOI 10.1002/1097-0029(20001115)51:4<330::AID-JEMT4>3.0.CO;2-X; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Vucinic D, 2006, J NEUROPHYSIOL, V95, P1881, DOI 10.1152/jn.00918.2005; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Wu SH, 1998, HEARING RES, V122, P47, DOI 10.1016/S0378-5955(98)00085-9; Yang LC, 1999, J NEUROSCI, V19, P2313; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zilberter Y, 2005, NEUROSCIENTIST, V11, P334, DOI 10.1177/1073858405275827; Zilberter Y, 1999, NEURON, V24, P979, DOI 10.1016/S0896-6273(00)81044-2	64	75	76	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 10	2008	59	1					125	137		10.1016/j.neuron.2008.05.011	http://dx.doi.org/10.1016/j.neuron.2008.05.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	327KU	18614034	Bronze			2022-12-24	WOS:000257728800013
J	Bautista, DM; Sigal, YM; Milstein, AD; Garrison, JL; Zorn, JA; Tsuruda, PR; Nicoll, RA; Julius, D				Bautista, Diana M.; Sigal, Yaron M.; Milstein, Aaron D.; Garrison, Jennifer L.; Zorn, Julie A.; Tsuruda, Pamela R.; Nicoll, Roger A.; Julius, David			Pungent agents from Szechuan peppers excite sensory neurons by inhibiting two-pore potassium channels	NATURE NEUROSCIENCE			English	Article							K+ CHANNEL; TRPA1; TRESK; EXPRESSION; RECEPTORS; TASK-3; ANESTHETICS; NOCICEPTION; MODULATION; ACTIVATION	In traditional folk medicine, Xanthoxylum plants are referred to as 'toothache trees' because their anesthetic or counter-irritant properties render them useful in the treatment of pain. Psychophysical studies have identified hydroxy-alpha-sanshool as the compound most responsible for the unique tingling and buzzing sensations produced by Szechuan peppercorns or other Xanthoxylum preparations. Although it is generally agreed that sanshool elicits its effects by activating somatosensory neurons, the underlying cellular and molecular mechanisms remain a matter of debate. Here we show that hydroxy-alpha-sanshool excites two types of sensory neurons, including small-diameter unmyelinated cells that respond to capsaicin (but not mustard oil) as well as large-diameter myelinated neurons that express the neurotrophin receptor TrkC. We found that hydroxy-alpha-sanshool excites neurons through a unique mechanism involving inhibition of pH-and anesthetic-sensitive two-pore potassium channels (KCNK3, KCNK9 and KCNK18), providing a framework for understanding the unique and complex psychophysical sensations associated with the Szechuan pepper experience.	[Bautista, Diana M.; Sigal, Yaron M.; Tsuruda, Pamela R.; Nicoll, Roger A.; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Bautista, Diana M.; Sigal, Yaron M.; Tsuruda, Pamela R.; Nicoll, Roger A.; Julius, David] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, 600 16th St, San Francisco, CA 94143 USA.	julius@cmp.ucsf.edu		Milstein, Aaron/0000-0002-7186-5779	NIMH NIH HHS [R37 MH038256-25, R37 MH038256] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038256] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Brickley SG, 2007, J NEUROSCI, V27, P9329, DOI 10.1523/JNEUROSCI.1427-07.2007; Bryant BP, 1999, BRAIN RES, V842, P452, DOI 10.1016/S0006-8993(99)01878-8; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Feliciangeli S, 2007, CELL, V130, P563, DOI 10.1016/j.cell.2007.06.012; Fields H. L., 1987, PAIN; FOSTER S, 2000, E CENTRAL MED PLANTS; Funfschilling U, 2004, J COMP NEUROL, V480, P392, DOI 10.1002/cne.20359; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Han J, 2002, J PHYSIOL-LONDON, V542, P431, DOI 10.1113/jphysiol.2002.017590; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Julius David, 2005, Harvey Lect, V101, P89; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Kang DW, 2004, J PHYSIOL-LONDON, V554, P64, DOI 10.1113/jphysiol.2003.054387; Kato AS, 2007, J NEUROSCI, V27, P4969, DOI 10.1523/JNEUROSCI.5561-06.2007; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Koo JY, 2007, EUR J NEUROSCI, V26, P1139, DOI 10.1111/j.1460-9568.2007.05743.x; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Liu CH, 2004, ANESTH ANALG, V99, P1715, DOI 10.1213/01.ANE.0000136849.07384.44; McGee H, 2004, FLAVORING PLANTS HER; MCMAHON SB, 2006, WALL MELZACKS TXB PA, P49; Meyer RA, 2006, WALL MELZACKS TXB PA, V5, P3; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; SNYDER SH, 1977, SCI AM, V236, P44, DOI 10.1038/scientificamerican0377-44; Sugai E, 2005, BIOSCI BIOTECH BIOCH, V69, P1958, DOI 10.1271/bbb.69.1958; Sugai E, 2005, BIOSCI BIOTECH BIOCH, V69, P1951, DOI 10.1271/bbb.69.1951; Talley EM, 2002, J BIOL CHEM, V277, P17733, DOI 10.1074/jbc.M200502200; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016	42	171	185	6	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					772	779		10.1038/nn.2143	http://dx.doi.org/10.1038/nn.2143			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18568022	Green Accepted			2022-12-24	WOS:000257089400014
J	Greenberg, DS; Houweling, AR; Kerr, JND				Greenberg, David S.; Houweling, Arthur R.; Kerr, Jason N. D.			Population imaging of ongoing neuronal activity in the visual cortex of awake rats	NATURE NEUROSCIENCE			English	Article							WHOLE-CELL RECORDINGS; NETWORK STATES; IN-VIVO	It is unclear how the complex spatiotemporal organization of ongoing cortical neuronal activity recorded in anesthetized animals relates to the awake animal. We therefore used two-photon population calcium imaging in awake and subsequently anesthetized rats to follow action potential firing in populations of neurons across brain states, and examined how single neurons contributed to population activity. Firing rates and spike bursting in awake rats were higher, and pair-wise correlations were lower, compared with anesthetized rats. Anesthesia modulated population-wide synchronization and the relationship between firing rate and correlation. Overall, brain activity during wakefulness cannot be inferred using anesthesia.	[Greenberg, David S.; Kerr, Jason N. D.] Max Planck Inst Biol Cybernet, Network Imaging Grp, D-72076 Tubingen, Germany; [Greenberg, David S.] Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany; [Houweling, Arthur R.] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [Houweling, Arthur R.] Humboldt Univ, Bernstein Ctr Computat Neurosci, D-10115 Berlin, Germany; [Kerr, Jason N. D.] Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany	Max Planck Society; Max Planck Society; Erasmus University Rotterdam; Erasmus MC; Humboldt University of Berlin; Max Planck Society	Kerr, JND (corresponding author), Max Planck Inst Biol Cybernet, Network Imaging Grp, Spemannstr 41, D-72076 Tubingen, Germany.	jason@tuebingen.mpg.de		Kerr, Jason/0000-0001-9459-883X; Greenberg, David/0000-0002-8515-0459				de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; KERR JN, 2007, NEUROSCIENCE, V27, P13316; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302	15	296	298	6	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					749	751		10.1038/nn.2140	http://dx.doi.org/10.1038/nn.2140			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18552841				2022-12-24	WOS:000257089400010
J	Middleton, SJ; Racca, C; Cunningham, MO; Traub, RD; Monyer, H; Knopfel, T; Schofield, IS; Jenkins, A; Whittington, MA				Middleton, Steven J.; Racca, Claudia; Cunningham, Mark O.; Traub, Roger D.; Monyer, Hannah; Knopfel, Thomas; Schofield, Ian S.; Jenkins, Alistair; Whittington, Miles A.			High-frequency network oscillations in cerebellar cortex	NEURON			English	Article							GAMMA-OSCILLATIONS; GAP-JUNCTIONS; SOMATOSENSORY CORTEX; RAT CEREBELLUM; SYNCHRONIZATION; RECEPTOR; EXPRESSION; MECHANISM; BRAIN; HZ	Both cerebellum and neocortex receive input from the somatosensory system. Interaction between these regions has been proposed to underpin the correct selection and execution of motor commands, but it is not clear how such interactions occur. In neocortex, inputs give rise to population rhythms, providing a spatiotemporal coding strategy for inputs and consequent outputs. Here, we show that similar patterns of rhythm generation occur in cerebellum during nicotinic receptor subtype activation. Both gamma oscillations (30-80 Hz) and very fast oscillations (VFOs, 80-160 Hz) were generated by intrinsic cerebellar cortical circuitry in the absence of functional glutamatergic connections. As in neocortex, gamma rhythms were dependent on GABA(A) receptor-mediated inhibition, whereas VFOs required only nonsynaptically connected intercellular networks. The ability of cerebellar cortex to generate population rhythms within the same frequency bands as neocortex suggests that they act as a common spatiotemporal code within which corticocerebellar dialog may occur.	[Middleton, Steven J.; Racca, Claudia; Cunningham, Mark O.; Whittington, Miles A.] Univ Newcastle, Sch Med, Inst Neurosci, Newcastle upon Tyne NE2 4HH, Tyne & Wear, England; [Traub, Roger D.] Suny Downstate Med Ctr, Dept Physiol Pharmacol & Neurol, Brooklyn, NY 11203 USA; [Monyer, Hannah] Univ Hosp Neurol, Dept Clin Neurobiol, IZN, D-69120 Heidelberg, Germany; [Middleton, Steven J.; Knopfel, Thomas] RIKEN Brain Sci Inst, Lab Neuronal Circuit Dynam, Wako, Saitama 3510198, Japan; [Schofield, Ian S.; Jenkins, Alistair] Newcastle Gen Hosp, Reg Neurosci Ctr, Newcastle upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle University - UK; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Ruprecht Karls University Heidelberg; RIKEN; Newcastle General Hospital	Whittington, MA (corresponding author), Univ Newcastle, Sch Med, Inst Neurosci, Newcastle upon Tyne NE2 4HH, Tyne & Wear, England.	m.a.whittington@ncl.ac.uk	Knöpfel, Thomas/B-1128-2008	Knöpfel, Thomas/0000-0002-5718-0765; Whittington, Miles Adrian/0000-0002-0247-1362; Middleton, Steven/0000-0001-8875-8956; Cunningham, Mark/0000-0002-7389-9569	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044133] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS044133] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackerley R, 2006, J PHYSIOL-LONDON, V576, P503, DOI 10.1113/jphysiol.2006.114215; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Bauer M, 2006, J NEUROSCI, V26, P490, DOI 10.1523/JNEUROSCI.5228-04.2006; Belluardo N, 2000, BRAIN RES, V865, P121, DOI 10.1016/S0006-8993(00)02300-3; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chow CC, 1998, J COMPUT NEUROSCI, V5, P407, DOI 10.1023/A:1008889328787; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Cunningham MO, 2004, P NATL ACAD SCI USA, V101, P7152, DOI 10.1073/pnas.0402060101; DELAGARZA R, 1987, J PHARMACOL EXP THER, V240, P689; Dickson CT, 2000, J NEUROSCI, V20, P7846; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Fisahn A, 2002, NEURON, V33, P615, DOI 10.1016/S0896-6273(02)00587-1; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Graham A, 2002, NEUROSCIENCE, V113, P493, DOI 10.1016/S0306-4522(02)00223-3; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hamzei-Sichani F, 2007, P NATL ACAD SCI USA, V104, P12548, DOI 10.1073/pnas.0705281104; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Jaarsma D, 1997, PROG BRAIN RES, V114, P67; Jones MS, 2002, J NEUROPHYSIOL, V88, P1016, DOI 10.1152/jn.2002.88.2.1016; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kumari V, 2003, NEUROIMAGE, V19, P1002, DOI 10.1016/S1053-8119(03)00110-1; Louis ED, 2007, NEUROTOXICOLOGY, V28, P569, DOI 10.1016/j.neuro.2006.12.006; Mann-Metzer P, 2002, J NEUROPHYSIOL, V87, P149, DOI 10.1152/jn.00310.2001; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Martin-Ruiz CM, 2004, MOL BRAIN RES, V123, P81, DOI 10.1016/j.molbrainres.2004.01.003; Matsukawa H, 2003, J NEUROSCI, V23, P7677; Maxeiner S, 2003, NEUROSCIENCE, V119, P689, DOI 10.1016/S0306-4522(03)00077-0; Niedermeyer E, 2004, CLIN EEG NEUROSCI, V35, P112, DOI 10.1177/155005940403500213; Odeh F, 2005, J NEUROSCI, V25, P5680, DOI 10.1523/JNEUROSCI.0558-05.2005; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Quik M, 2000, J COMP NEUROL, V425, P58, DOI 10.1002/1096-9861(20000911)425:1<58::AID-CNE6>3.0.CO;2-X; REGAN LJ, 1991, J NEUROSCI, V11, P2259; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Shin SL, 2006, J NEUROPHYSIOL, V96, P3485, DOI 10.1152/jn.00570.2006; SOTELO C, 1972, J CELL BIOL, V53, P271, DOI 10.1083/jcb.53.2.271; Soteropoulos DS, 2006, J NEUROPHYSIOL, V95, P1194, DOI 10.1152/jn.00935.2005; Szabadics J, 2001, J NEUROSCI, V21, P5824, DOI 10.1523/JNEUROSCI.21-15-05824.2001; Szurhaj W, 2005, EUR J NEUROSCI, V21, P1223, DOI 10.1111/j.1460-9568.2005.03966.x; Tecchio F, 2007, NEUROIMAGE, V35, P185, DOI 10.1016/j.neuroimage.2006.12.002; Teubner B, 2000, J MEMBRANE BIOL, V176, P249, DOI 10.1007/s002320001094; Timofeev I, 1997, J PHYSIOL-LONDON, V504, P153, DOI 10.1111/j.1469-7793.1997.153bf.x; TOLBERT DL, 1989, DEV BRAIN RES, V45, P113; Traub RD, 2003, P NATL ACAD SCI USA, V100, P11047, DOI 10.1073/pnas.1934854100; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; Turner JR, 2005, J NEUROSCI, V25, P9258, DOI 10.1523/JNEUROSCI.2112-05.2005; Van Der Giessen RS, 2006, J COMP NEUROL, V495, P173, DOI 10.1002/cne.20873; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Yeh JJ, 2001, J NEUROCHEM, V77, P336, DOI 10.1046/j.1471-4159.2001.00259.x	53	104	104	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 12	2008	58	5					763	774		10.1016/j.neuron.2008.03.030	http://dx.doi.org/10.1016/j.neuron.2008.03.030			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	315IA	18549787	Green Accepted, Bronze			2022-12-24	WOS:000256870800013
J	Leucht, C; Stigloher, C; Wizenmann, A; Klafke, R; Folchert, A; Bally-Cuif, L				Leucht, Christoph; Stigloher, Christian; Wizenmann, Andrea; Klafke, Ruth; Folchert, Anja; Bally-Cuif, Laure			MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary	NATURE NEUROSCIENCE			English	Article							ZEBRAFISH GENE; BINDING-SITES; EXPRESSION; NEUROGENESIS; REVEALS; TRANSCRIPTION; FGF8; IDENTIFICATION; MAINTENANCE; INHIBITION	The midbrain-hindbrain boundary (MHB) is a long-lasting organizing center in the vertebrate neural tube that is both necessary and sufficient for the ordered development of midbrain and anterior hindbrain (midbrain-hindbrain domain, MH). The MHB also coincides with a pool of progenitor cells that contributes neurons to the entire MH. Here we show that the organizing activity and progenitor state of the MHB are co-regulated by a single microRNA, miR-9, during late embryonic development in zebrafish. Endogenous miR-9 expression, initiated at late stages, selectively spares the MHB. Gain-and loss-of-function studies, in silico predictions and sensor assays in vivo demonstrate that miR-9 targets several components of the Fgf signaling pathway, thereby delimiting the organizing activity of the MHB. In addition, miR-9 promotes progression of neurogenesis in the MH, defining the MHB progenitor pool. Together, these findings highlight a previously unknown mechanism by which a single microRNA fine-tunes late MHB coherence via its co-regulation of patterning activities and neurogenesis.	[Leucht, Christoph; Stigloher, Christian; Folchert, Anja; Bally-Cuif, Laure] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Dev Genet, Dept Zebrafish Neurogenet, D-85764 Neuherberg, Germany; [Wizenmann, Andrea] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Stem Cell Res, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Leucht, C (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Dev Genet, Dept Zebrafish Neurogenet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	leucht@topforscher.de; bally@helmholtz-muenchen.de	Stigloher, Christian/E-4762-2015	Stigloher, Christian/0000-0001-6941-2669; Bally-Cuif, Laure/0000-0001-6611-6274				Bae YK, 2005, DEVELOPMENT, V132, P1375, DOI 10.1242/dev.01710; BALLYCUIF L, 1993, DEVELOPMENT, V117, P543; Brand M, 1996, DEVELOPMENT, V123, P179; Cheesman SE, 2004, DEVELOPMENT, V131, P5221, DOI 10.1242/dev.01397; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; EKKER M, 1992, DEVELOPMENT, V116, P1001; Enright AJ, 2004, GENOME BIOL, V5; Fjose Anders, 2006, Birth Defects Research, V78, P150, DOI 10.1002/bdrc.20069; Geling A, 2004, DEVELOPMENT, V131, P1993, DOI 10.1242/dev.01093; Geling A, 2003, DEVELOPMENT, V130, P1591, DOI 10.1242/dev.00375; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hans S, 2004, DEVELOPMENT, V131, P2957, DOI 10.1242/dev.01167; Hirata H, 2001, EMBO J, V20, P4454, DOI 10.1093/emboj/20.16.4454; Hirate Y, 2006, CURR BIOL, V16, P421, DOI 10.1016/j.cub.2006.01.055; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kawakami Y, 2003, NAT CELL BIOL, V5, P513, DOI 10.1038/ncb989; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Lun K, 1998, DEVELOPMENT, V125, P3049; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; MOLVEN A, 1991, EMBO J, V10, P799, DOI 10.1002/j.1460-2075.1991.tb08012.x; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Muller M, 1996, DEV GENES EVOL, V206, P153, DOI 10.1007/s004270050041; Munchberg SR, 1999, MECH DEVELOP, V88, P233, DOI 10.1016/S0925-4773(99)00179-3; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Ninkovic J, 2005, DEVELOPMENT, V132, P75, DOI 10.1242/dev.01525; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Scholpp S, 2004, DEV GENES EVOL, V214, P285, DOI 10.1007/s00427-004-0409-1; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stigloher C, 2008, BRAIN RES BULL, V75, P266, DOI 10.1016/j.brainresbull.2007.10.032; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; Tallafuss A, 2003, DEVELOPMENT, V130, P4307, DOI 10.1242/dev.00662; Tonou-Fujimori N, 2002, MECH DEVELOP, V119, pS173, DOI 10.1016/S0925-4773(03)00112-6; Vaage S, 1969, Ergeb Anat Entwicklungsgesch, V41, P3; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Yan XQ, 2007, FEBS LETT, V581, P1587, DOI 10.1016/j.febslet.2007.03.022	49	241	254	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					641	648		10.1038/nn.2115	http://dx.doi.org/10.1038/nn.2115			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18454145				2022-12-24	WOS:000256133700010
J	Sakamoto, H; Matsuda, KI; Zuloaga, DG; Hongu, H; Wada, E; Wada, K; Jordan, CL; Breedlove, SM; Kawata, M				Sakamoto, Hirotaka; Matsuda, Ken-Ichi; Zuloaga, Damian G.; Hongu, Hisayuki; Wada, Etsuko; Wada, Keiji; Jordan, Cynthia L.; Breedlove, S. Marc; Kawata, Mitsuhiro			Sexually dimorphic gastrin releasing peptide system in the spinal cord controls male reproductive functions	NATURE NEUROSCIENCE			English	Article							NUCLEUS; IDENTIFICATION; BOMBESIN; NERVE	Neurons in the upper lumbar spinal cord project axons containing gastrin-releasing peptide (GRP) to innervate lower lumbar regions controlling erection and ejaculation. This system is vestigial in female rats and in males with genetic dysfunction of androgen receptors, but in male rats, pharmacological stimulation of spinal GRP receptors restores penile reflexes and ejaculation after castration. GRP offers new avenues for understanding potential therapeutic approaches to masculine reproductive dysfunction.	[Sakamoto, Hirotaka; Matsuda, Ken-Ichi; Hongu, Hisayuki; Kawata, Mitsuhiro] Kyoto Prefectural Univ Med, Dept Anat & Neurobiol, Kamigyo Ku, Kyoto 6028566, Japan; [Zuloaga, Damian G.; Jordan, Cynthia L.; Breedlove, S. Marc] Michigan State Univ, Dept Psychol, Program Neurosci, E Lansing, MI 48824 USA; [Zuloaga, Damian G.; Jordan, Cynthia L.; Breedlove, S. Marc] Michigan State Univ, Dept Zool, Program Neurosci, E Lansing, MI 48824 USA; [Wada, Etsuko; Wada, Keiji] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 1878502, Japan	Kyoto Prefectural University of Medicine; Michigan State University; Michigan State University; National Center for Neurology & Psychiatry - Japan	Sakamoto, H (corresponding author), Kyoto Prefectural Univ Med, Dept Anat & Neurobiol, Kamigyo Ku, Kawaramachi Hirokoji, Kyoto 6028566, Japan.	hsakamo@koto.kpu-mac.jp	SAKAMOTO, Hirotaka/C-3009-2015; Sakamoto, Hirotaka/AAE-3720-2021	Sakamoto, Hirotaka/0000-0002-6224-4591; Breedlove, S. Marc/0000-0003-4359-4315	NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH070343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028421] Funding Source: NIH RePORTER; NIMH NIH HHS [T32 MH070343-01, T32 MH070343] Funding Source: Medline; NINDS NIH HHS [R01 NS028421-17, R01 NS028421, NS28421] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANASTASI A, 1971, EXPERIENTIA, V27, P166, DOI 10.1007/BF02145873; BATTEY J, 1991, TRENDS NEUROSCI, V14, P524, DOI 10.1016/0166-2236(91)90005-F; CARROJUAREZ M, IN PRESS BRAIN RES B; Jensen RT, 2007, PHARMACOL REV, V60, P1, DOI [10.1124/pr.107.07108, DOI 10.1124/PR.107.07108]; Ladenheim EE, 1996, AM J PHYSIOL-REG I, V271, pR180, DOI 10.1152/ajpregu.1996.271.1.R180; Meston CM, 2000, ARCH GEN PSYCHIAT, V57, P1012, DOI 10.1001/archpsyc.57.11.1012; MORGAN C, 1981, J COMP NEUROL, V201, P415, DOI 10.1002/cne.902010308; PANULA P, 1988, ANN NY ACAD SCI, V547, P54, DOI 10.1111/j.1749-6632.1988.tb23875.x; Roesler R, 2004, EUR J NEUROSCI, V19, P1041, DOI 10.1111/j.0953-816X.2004.03175.x; SHINOHARA K, 1993, J NEUROSCI, V13, P793; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Truitt WA, 2002, SCIENCE, V297, P1566, DOI 10.1126/science.1073885; VIZZARD MA, 1995, J NEUROSCI, V15, P4033; Zoli M, 1996, PROG NEUROBIOL, V49, P363, DOI 10.1016/0301-0082(96)00020-2	15	74	76	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					634	636		10.1038/nn.2126	http://dx.doi.org/10.1038/nn.2126			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18488022	Green Accepted			2022-12-24	WOS:000256133700008
J	Myers, BR; Bohlen, CJ; Julius, D				Myers, Benjamin R.; Bohlen, Christopher J.; Julius, David			A yeast genetic screen reveals a critical role for the pore helix domain in TRP channel gating	NEURON			English	Article							RANDOM MUTAGENESIS REVEALS; CAPSAICIN RECEPTOR; K+ CHANNEL; 2-AMINOETHOXYDIPHENYL BORATE; MOLECULAR DETERMINANTS; POTASSIUM-CHANNEL; CATION CHANNEL; ION-CHANNEL; VOLTAGE; MUTATION	TRP cation channels function as cellular sensors in uni- and multicellular eukaryotes. Despite intensive study, the mechanisms of TRIP channel activation by chemical or physical stimuli remain poorly understood. To identify amino acid residues crucial for TRP channel gating, we developed an unbiased, high-throughput genetic screen in yeast that uncovered rare, constitutively active mutants of the capsaicin receptor, TRPV1. We show that mutations within the pore helix domain dramatically increase basal channel activity and responsiveness to chemical and thermal stimuli. Mutation of corresponding residues within two related TRPV channels leads to comparable effects on their activation properties. Our data suggest that conformational changes in the outer pore region are critical for determining the balance between open and closed states, providing evidence for a general role for this domain in TRIP channel activation.	[Myers, Benjamin R.; Bohlen, Christopher J.; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, 600 16th St, San Francisco, CA 94143 USA.	julius@cmp.ucsf.edu			NINDS NIH HHS [R37 NS047723-15, R37 NS047723-16, R37 NS047723-14, R37 NS047723, R37 NS047723-13] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047723] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahern CA, 2006, J GEN PHYSIOL, V128, P649, DOI 10.1085/jgp.200609654; Alagem N, 2003, BIOPHYS J, V85, P300, DOI 10.1016/S0006-3495(03)74475-0; Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Decaillot FM, 2003, NAT STRUCT BIOL, V10, P629, DOI 10.1038/nsb950; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gunthorpe MJ, 2000, J PHYSIOL-LONDON, V525, P747, DOI 10.1111/j.1469-7793.2000.t01-1-00747.x; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; JANCSO G, 1977, NATURE, V270, P741, DOI 10.1038/270741a0; Jerman JC, 2000, BRIT J PHARMACOL, V130, P916, DOI 10.1038/sj.bjp.0703390; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Julius David, 2005, Harvey Lect, V101, P89; Jung J, 2002, J BIOL CHEM, V277, P44448, DOI 10.1074/jbc.M207103200; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu J, 2000, NEURON, V28, P899, DOI 10.1016/S0896-6273(00)00162-8; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Navarro B, 1996, SCIENCE, V272, P1950, DOI 10.1126/science.272.5270.1950; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Oh U, 1996, J NEUROSCI, V16, P1659; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; Serrano R, 2001, CURR OPIN CELL BIOL, V13, P399, DOI 10.1016/S0955-0674(00)00227-1; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Su ZW, 2007, P NATL ACAD SCI USA, V104, P19607, DOI 10.1073/pnas.0708584104; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; WINTER J, 1987, NEUROSCI LETT, V80, P134, DOI 10.1016/0304-3940(87)90642-2; WOOD JN, 1988, J NEUROSCI, V8, P3208; Xiao R, 2008, CELL CALCIUM, V43, P334, DOI 10.1016/j.ceca.2007.06.004; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yeh BI, 2005, EMBO J, V24, P3224, DOI 10.1038/sj.emboj.7600795; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zhou XL, 2007, P NATL ACAD SCI USA, V104, P15555, DOI 10.1073/pnas.0704039104; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	65	100	104	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 8	2008	58	3					362	373		10.1016/j.neuron.2008.04.012	http://dx.doi.org/10.1016/j.neuron.2008.04.012			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	300HP	18466747	Green Accepted, Bronze			2022-12-24	WOS:000255815200010
J	Tan, WB; Janczewski, WA; Yang, P; Shao, XM; Callaway, EM; Feldman, JL				Tan, Wenbin; Janczewski, Wiktor A.; Yang, Paul; Shao, Xuesi M.; Callaway, Edward M.; Feldman, Jack L.			Silencing preBotzinger Complex somatostatin-expressing neurons induces persistent apnea in awake rat	NATURE NEUROSCIENCE			English	Article							PRE-BOTZINGER COMPLEX; MAMMALIAN NEURONS; RECEPTOR; DROSOPHILA; REGION; RHYTHM	Delineating neurons that underlie complex behaviors is of fundamental interest. Using adeno-associated virus 2, we expressed the Drosophila allatostatin receptor in somatostatin (Sst)-expressing neurons in the preBotzinger Complex (preBotC). Rapid silencing of these neurons in awake rats induced a persistent apnea without any respiratory movements to rescue their breathing. We hypothesize that breathing requires preBotC Sst neurons and that their sudden depression can lead to serious, even fatal, respiratory failure.	[Tan, Wenbin; Janczewski, Wiktor A.; Yang, Paul; Shao, Xuesi M.; Feldman, Jack L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Callaway, Edward M.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Salk Institute	Feldman, JL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Box 951763,650 Charles E Young Dr S, Los Angeles, CA 90095 USA.	feldman@ucla.edu	Tan, Wenbin/AAF-2037-2020; Callaway, Edward/D-4336-2011; feldman, jack/AAO-7505-2021; Tan, Wenbin/AAM-4661-2020	Tan, Wenbin/0000-0002-2334-8988; Callaway, Edward/0000-0002-6366-5267; feldman, jack/0000-0003-3692-9412; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040959, R01HL070029, R01HL037941, R37HL037941] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL37941, R01 HL070029-05A1, R01 HL040959, R01 HL070029, HL40959] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Birgul N, 1999, EMBO J, V18, P5892, DOI 10.1093/emboj/18.21.5892; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Chen Maida Lynn, 2004, Paediatr Respir Rev, V5, P182, DOI 10.1016/j.prrv.2004.04.009; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Lechner HAE, 2002, J NEUROSCI, V22, P5287; McKay LC, 2005, NAT NEUROSCI, V8, P1142, DOI 10.1038/nn1517; Pagliardini S, 2003, J NEUROSCI, V23, P9575; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Stornetta RL, 2003, J COMP NEUROL, V455, P499, DOI 10.1002/cne.10504; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Tenenbaum L, 2004, J GENE MED, V6, pS212, DOI 10.1002/jgm.506	14	220	221	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					538	540		10.1038/nn.2104	http://dx.doi.org/10.1038/nn.2104			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18391943	Green Accepted			2022-12-24	WOS:000255327300010
J	Albouy, G; Sterpenich, V; Balteau, E; Vandewalle, G; Desseilles, M; Dang-Vu, T; Darsaud, A; Ruby, P; Luppi, PH; Degueldre, C; Peigneux, P; Luxen, A; Maquet, P				Albouy, Genevieve; Sterpenich, Virginie; Balteau, Evelyne; Vandewalle, Gilles; Desseilles, Martin; Dang-Vu, Thanh; Darsaud, Annabelle; Ruby, Perrine; Luppi, Pierre-Herve; Degueldre, Christian; Peigneux, Philippe; Luxen, Andre; Maquet, Pierre			Both the hippocampus and striatum are involved in consolidation of motor sequence memory	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; EXPERIENCE-DEPENDENT CHANGES; TIME-COURSE; FUNCTIONAL-ANATOMY; ACQUISITION LEVEL; VISUOMOTOR SKILL; BASAL GANGLIA; SLEEP; SYSTEMS; IMPLICIT	Functional magnetic resonance imaging (fMRI) was used to investigate the cerebral correlates of motor sequence memory consolidation. Participants were scanned while training on an implicit oculomotor sequence learning task and during a single testing session taking place 30 min, 5 hr, or 24 hr later. During training, responses observed in hippocampus and striatum were linearly related to the gain in performance observed overnight, but not over the day. Responses in both structures were significantly larger at 24 hr than at 30 min or 5 hr. Additionally, the competitive interaction observed between these structures during training became cooperative overnight. These results stress the importance of both hippocampus and striatum in procedural memory consolidation. Responses in these areas during training seem to condition the overnight memory processing that is associated with a change in their functional interactions. These results show that both structures interact during motor sequence consolidation to optimize subsequent behavior.	[Albouy, Genevieve; Sterpenich, Virginie; Balteau, Evelyne; Vandewalle, Gilles; Desseilles, Martin; Dang-Vu, Thanh; Darsaud, Annabelle; Degueldre, Christian; Peigneux, Philippe; Luxen, Andre; Maquet, Pierre] Univ Liege, Cyclotron Res Ctr, B-4000 Liege, Belgium; [Albouy, Genevieve; Luppi, Pierre-Herve] CNRS, Inst Federatif Neurosci Lyon, Unite Mixte Rech 5167, F-69372 Lyon, France; [Albouy, Genevieve; Ruby, Perrine] Inst Natl Sante & Rech Med, Inst Federatif Neurosci Lyon, Unite 821, F-65500 Lyon, France; [Albouy, Genevieve; Ruby, Perrine; Luppi, Pierre-Herve] Univ Lyon 1, F-69622 Lyon, France	University of Liege; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Maquet, P (corresponding author), Univ Liege, Cyclotron Res Ctr, B-4000 Liege, Belgium.	pmaquet@ulg.ac.be	ALBOUY, Genevieve/P-4723-2019; Luppi, Pierre-Hervé/C-4333-2014; ALBOUY, Genevieve/K-5350-2015; luxen, andre/C-2116-2009; Ruby, Perrine Marie/K-8903-2017	ALBOUY, Genevieve/0000-0002-5437-023X; Luppi, Pierre-Hervé/0000-0002-0503-423X; ALBOUY, Genevieve/0000-0002-5437-023X; Dang Vu, Thien Thanh/0000-0002-7235-2721; Peigneux, Philippe/0000-0003-4745-1434; Vandewalle, Gilles/0000-0003-2483-2752; Desseilles, Martin/0000-0003-4748-3401; , Pierre/0000-0003-3106-3357; Sterpenich, Virginie/0000-0002-2125-833X				Albouy G, 2006, BRAIN RES, V1090, P163, DOI 10.1016/j.brainres.2006.03.076; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; AMBROSINI MV, 1992, PHYSIOL BEHAV, V51, P217, DOI 10.1016/0031-9384(92)90134-N; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cajochen C, 2004, BEHAV BRAIN RES, V151, P167, DOI 10.1016/j.bbr.2003.08.013; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Curran T, 1997, J COGNITIVE NEUROSCI, V9, P522, DOI 10.1162/jocn.1997.9.4.522; Degonda N, 2005, NEURON, V46, P505, DOI 10.1016/j.neuron.2005.02.030; Doyon J, 1996, EUR J NEUROSCI, V8, P637, DOI 10.1111/j.1460-9568.1996.tb01249.x; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Fletcher PC, 2005, CEREB CORTEX, V15, P1002, DOI 10.1093/cercor/bhh201; Foerde K, 2006, P NATL ACAD SCI USA, V103, P11778, DOI 10.1073/pnas.0602659103; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; GABRIELI JDE, 1993, BEHAV NEUROSCI, V107, P899, DOI 10.1037/0735-7044.107.6.899; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Grosbras MH, 2001, CEREB CORTEX, V11, P936, DOI 10.1093/cercor/11.10.936; Hauptmann B, 2002, COGNITIVE BRAIN RES, V13, P313, DOI 10.1016/S0926-6410(01)00124-0; Henke K, 2003, CONSCIOUS COGN, V12, P31, DOI 10.1016/S1053-8100(02)00006-5; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; KARNI A, 1995, NATURE, V377, P155; Kawashima R, 1998, EXP BRAIN RES, V122, P1, DOI 10.1007/s002210050485; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Kumaran D, 2006, NEURON, V49, P617, DOI 10.1016/j.neuron.2005.12.024; LECONTE P, 1973, BRAIN RES, V49, P367, DOI 10.1016/0006-8993(73)90428-9; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nagy H, 2007, NEUROPSYCHOLOGIA, V45, P1386, DOI 10.1016/j.neuropsychologia.2006.10.017; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Peigneux P, 2000, HUM BRAIN MAPP, V10, P179, DOI 10.1002/1097-0193(200008)10:4<179::AID-HBM30>3.0.CO;2-H; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Petit L, 1996, J NEUROSCI, V16, P3714; Poldrack RA, 1999, NEUROPSYCHOLOGY, V13, P564, DOI 10.1037/0894-4105.13.4.564; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Poldrack RA, 2004, NEUROBIOL LEARN MEM, V82, P324, DOI 10.1016/j.nlm.2004.05.003; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Press DZ, 2005, COGNITIVE BRAIN RES, V25, P375, DOI 10.1016/j.cogbrainres.2005.05.010; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; REBER PJ, 1994, LEARN MEMORY, V1, P217; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Seger CA, 2006, CEREB CORTEX, V16, P1546, DOI 10.1093/cercor/bhj092; Seger CA, 2006, NEUROSCIENTIST, V12, P285, DOI 10.1177/1073858405285632; Shohamy D, 2008, NEUROSCI BIOBEHAV R, V32, P219, DOI 10.1016/j.neubiorev.2007.07.008; Spencer RMC, 2006, CURR BIOL, V16, P1001, DOI 10.1016/j.cub.2006.03.094; Toni I, 1998, NEUROIMAGE, V8, P50, DOI 10.1006/nimg.1998.0349; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Yang JJ, 2003, NEUROPSYCHOLOGIA, V41, P818, DOI 10.1016/S0028-3932(02)00289-0; Zee DS., 1999, NEUROLOGY EYE MOVEME	61	301	303	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2008	58	2					261	272		10.1016/j.neuron.2008.02.008	http://dx.doi.org/10.1016/j.neuron.2008.02.008			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292YX	18439410	Bronze			2022-12-24	WOS:000255303100013
J	Min, IM; Pietramaggiori, G; Kim, FS; Passegue, E; Stevenson, KE; Wagers, AJ				Min, Irene M.; Pietramaggiori, Giorgio; Kim, Francis S.; Passegue, Emmanuelle; Stevenson, Kristen E.; Wagers, Amy J.			The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells	CELL STEM CELL			English	Article							GROWTH-RESPONSE GENE-1; SELF-RENEWAL; PROGENITOR CELLS; MICE LACKING; NGFI-A; IN-VITRO; DIFFERENTIATION; MOBILIZATION; BMI-1; EXPRESSION	EGR1 is a member of the immediate early response transcription factor family and functions in cell growth, development, and stress responses in many tissues. Here we report an additional role for EGR1 in regulating homeostasis of hernatopoietic stem cells (HSCs). HSCs normally express Egr1 at high levels, but dramatically downregulate its expression when induced to divide and migrate. Consistent with this finding, mice lacking Egr1 exhibit significant increases in steady-state levels of dividing HSCs in the bone marrow (BM), and a striking spontaneous mobilization of HSCs into the peripheral blood. These data identify EGR1 as a transcriptional regulator of stem cell migration that normally functions to promote HSC quiescence and retention in the niche. The ability of this single factor to regulate both proliferation and mobilization of HSCs suggests that EGR1 commands a genetic program that coordinates stem cell division and migration to maintain appropriate HSC number and function.	[Min, Irene M.; Pietramaggiori, Giorgio; Kim, Francis S.; Wagers, Amy J.] Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, Boston, MA 02115 USA; [Pietramaggiori, Giorgio] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Plast Surg, Boston, MA 02115 USA; [Stevenson, Kristen E.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Min, Irene M.; Pietramaggiori, Giorgio; Kim, Francis S.; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Min, Irene M.; Pietramaggiori, Giorgio; Kim, Francis S.; Wagers, Amy J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Passegue, Emmanuelle] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; University of California System; University of California San Francisco	Wagers, AJ (corresponding author), Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, Boston, MA 02115 USA.	amy.wagers@joslin.harvard.edu	Min, Irene/AAQ-4186-2021	Min, Irene/0000-0002-1057-4804; Passegue, Emmanuelle/0000-0002-3516-297X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007260] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK07260-30] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Allsopp RC, 2002, ONCOGENE, V21, P3270, DOI 10.1038/sj.onc.1205314; Arai F, 2005, INT J HEMATOL, V82, P371, DOI 10.1532/IJH97.05100; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Dinkel A, 1998, J EXP MED, V188, P2215, DOI 10.1084/jem.188.12.2215; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; FLEMING WH, 1993, P NATL ACAD SCI USA, V90, P3760, DOI 10.1073/pnas.90.8.3760; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Ito T, 2000, EXP HEMATOL, V28, P1269, DOI 10.1016/S0301-472X(00)00535-X; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Krishnaraju K, 2001, BLOOD, V97, P1298, DOI 10.1182/blood.V97.5.1298; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lee SL, 1996, MOL CELL BIOL, V16, P4566; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Schnell FJ, 2005, J IMMUNOL, V175, P2270, DOI 10.4049/jimmunol.175.4.2270; Schnell FJ, 2006, J IMMUNOL, V176, P4740, DOI 10.4049/jimmunol.176.8.4740; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Uchida N, 2003, EXP HEMATOL, V31, P1338, DOI 10.1016/j.exphem.2003.09.001; Winkler IG, 2006, EXP HEMATOL, V34, P996, DOI 10.1016/j.exphem.2006.04.005; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yang FC, 2001, P NATL ACAD SCI USA, V98, P5614, DOI 10.1073/pnas.101546898; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	52	223	228	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	APR	2008	2	4					380	391		10.1016/j.stem.2008.01.015	http://dx.doi.org/10.1016/j.stem.2008.01.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	293HT	18397757	Bronze			2022-12-24	WOS:000255327000014
J	Wong, DJ; Liu, H; Ridky, TW; Cassarino, D; Segal, E; Chang, HY				Wong, David J.; Liu, Helen; Ridky, Todd W.; Cassarino, David; Segal, Eran; Chang, Howard Y.			Module map of stem cell genes guides creation of epithelial cancer stem cells	CELL STEM CELL			English	Article							BREAST-CANCER; MYC ACTIVATION; SELF-RENEWAL; EXPRESSION; DIFFERENTIATION; TUMORIGENESIS; SIGNATURE; IDENTIFICATION; PLURIPOTENCY; MICROARRAYS	Self-renewal is a hallmark of stem cells and cancer, but existence of a shared sternness program remains controversial. Here, we construct a gene module map to systematically relate transcriptional programs in embryonic stem cells (ESCs), adult tissue stem cells, and human cancers. This map reveals two predominant gene modules that distinguish ESCs and adult tissue stem cells. The ESC-like transcriptional program is activated in diverse human epithelial cancers and strongly predicts metastasis and death. c-Myc, but not other oncogenes, is sufficient to reactivate the ESC-like program in normal and cancer cells. In primary human keratinocytes transformed by Ras and I kappa B alpha, c-Myc increases the fraction of tumor-initiating cells by 150-fold, enabling tumor formation and serial propagation with as few as 500 cells. c-Myc-enhanced tumor initiation is cell-autonomous and independent of genomic instability. Thus, activation of an ESC-like transcriptional program in differentiated adult cells may induce pathologic self-renewal characteristic of cancer stem cells.	[Wong, David J.; Liu, Helen; Ridky, Todd W.; Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Cassarino, David] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Weizmann Institute of Science; Stanford University	Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	eran.segal@weizmann.ac.il; howchang@stanford.edu	Segal, Eran/AAF-4855-2019	Segal, Eran/0000-0002-6859-1164; Ridky, Todd/0000-0001-8482-1284; Cassarino, David/0000-0001-8875-0858	NCI NIH HHS [R01 CA118750-02, R01-CA118750, R01 CA119176, R01-CA119176, R01 CA118750] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA119176, R01CA118750] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild A, 2005, P NATL ACAD SCI USA, V102, P15278, DOI 10.1073/pnas.0507477102; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; DESTFAZEKAS G, 1982, J IMMUNOL METHODS, V49, pR11; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Fortunel NO, 2003, SCIENCE, V302, P393; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lawlor ER, 2006, CANCER RES, V66, P4591, DOI 10.1158/0008-5472.CAN-05-3826; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Robbins PB, 2001, P NATL ACAD SCI USA, V98, P5193, DOI 10.1073/pnas.091484998; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Sinha S, 2008, GENOME RES, V18, P477, DOI 10.1101/gr.6828808; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Weinstein DC, 1999, ANNU REV CELL DEV BI, V15, P411, DOI 10.1146/annurev.cellbio.15.1.411; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104	42	528	547	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	APR	2008	2	4					333	344		10.1016/j.stem.2008.02.009	http://dx.doi.org/10.1016/j.stem.2008.02.009			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	293HT	18397753	Green Accepted, Bronze			2022-12-24	WOS:000255327000010
J	de Araujo, IE; Oliveira-Maia, AJ; Sotnikova, TD; Gainetdinov, RR; Caron, MG; Nicolelis, MAL; Simon, SA				de Araujo, Ivan E.; Oliveira-Maia, Albino J.; Sotnikova, Tatyana D.; Gainetdinov, Raul R.; Caron, Marc G.; Nicolelis, Miguel A. L.; Simon, Sidney A.			Food reward in the absence of taste receptor signaling	NEURON			English	Article							ORBITOFRONTAL CORTEX; NUCLEUS-ACCUMBENS; SINGLE NEURONS; DOPAMINE; SUCROSE; SWEET; MICE; EXPRESSION; PIMOZIDE; STIMULI	Food palatability and hedonic value play central roles in nutrient intake. However, postingestive effects can influence food preferences independently of palatability, although the neurobiological bases of such mechanisms remain poorly understood. Of central interest is whether the same brain reward circuitry that is responsive to palatable rewards also encodes metabolic value independently of taste signaling. Here we show that trpm5(-/-) mice, which lack the cellular machinery required for sweet taste transduction, can develop a robust preference for sucrose solutions based solely on caloric content. Sucrose intake induced dopamine release in the ventral striatum of these sweet-blind mice, a pattern usually associated with receipt of palatable rewards. Furthermore, single neurons in this same ventral striatal region showed increased sensitivity to caloric intake even in the absence of gustatory inputs. Our findings suggest that calorie-rich nutrients can directly influence brain reward circuits that control food intake independently of palatability or functional taste transduction.	[de Araujo, Ivan E.; Oliveira-Maia, Albino J.; Nicolelis, Miguel A. L.; Simon, Sidney A.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Simon, Sidney A.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA; [Sotnikova, Tatyana D.; Gainetdinov, Raul R.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [de Araujo, Ivan E.; Nicolelis, Miguel A. L.; Simon, Sidney A.] Duke Univ, Med Ctr, Ctr Neuroengn, Durham, NC 27710 USA; [Oliveira-Maia, Albino J.] Univ Porto, Inst Histol & Embriol, Fac Med, P-4200319 Oporto, Portugal; [Oliveira-Maia, Albino J.] Univ Porto, IBMC, Inst Cell & Mol Biol, P-4200319 Oporto, Portugal	Duke University; Duke University; Duke University; Duke University; Duke University; Universidade do Porto; Universidade do Porto	de Araujo, IE (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	iaraujo@jbpierce.org	Lima, Marta T/C-7042-2009; Gainetdinov, Raul R/G-5875-2011; Sotnikova, Tatyana D/T-9992-2017; Oliveira-Maia, AJ/B-7976-2009	Gainetdinov, Raul R/0000-0003-2951-6038; Oliveira-Maia, AJ/0000-0001-5071-3007; De Araujo, Ivan/0000-0003-3081-3339	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001065] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-01065] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; Bachmanov AA, 2001, CHEM SENSES, V26, P905, DOI 10.1093/chemse/26.7.905; BAILEY CS, 1986, PHYSIOL BEHAV, V38, P447, DOI 10.1016/0031-9384(86)90409-9; Berthoud HR, 2004, APPETITE, V43, P315, DOI 10.1016/j.appet.2004.04.009; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; de Araujo IE, 2006, NEURON, V51, P483, DOI 10.1016/j.neuron.2006.07.009; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; Figlewicz DP, 2003, AM J PHYSIOL-REG I, V284, pR882, DOI 10.1152/ajpregu.00602.2002; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; GEARY N, 1985, PHARMACOL BIOCHEM BE, V22, P787, DOI 10.1016/0091-3057(85)90528-3; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; HERNANDEZ L, 1988, LIFE SCI, V42, P1705, DOI 10.1016/0024-3205(88)90036-7; Hofer D, 1996, P NATL ACAD SCI USA, V93, P6631, DOI 10.1073/pnas.93.13.6631; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Kelley AE, 2005, PHYSIOL BEHAV, V86, P11, DOI 10.1016/j.physbeh.2005.06.018; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Maier A, 2007, P NATL ACAD SCI USA, V104, P5620, DOI 10.1073/pnas.0608489104; Pais-Vieira M, 2007, NEUROSCIENCE, V145, P225, DOI 10.1016/j.neuroscience.2006.11.058; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pecina S, 2006, NEUROSCIENTIST, V12, P500, DOI 10.1177/1073858406293154; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; ROLLS ET, 1989, EUR J NEUROSCI, V1, P53, DOI 10.1111/j.1460-9568.1989.tb00774.x; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Sclafani A, 2004, PHYSIOL BEHAV, V82, P89, DOI 10.1016/j.physbeh.2004.04.045; Sclafani A, 2001, APPETITE, V36, P79, DOI 10.1006/appe.2000.0370; Sclafani A, 2007, AM J PHYSIOL-REG I, V293, pR1504, DOI 10.1152/ajpregu.00364.2007; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Sotnikova TD, 2004, J NEUROCHEM, V91, P362, DOI 10.1111/j.1471-4159.2004.02721.x; Taha SA, 2005, J NEUROSCI, V25, P1193, DOI 10.1523/JNEUROSCI.3975-04.2005; Verhagen JV, 2003, J NEUROPHYSIOL, V90, P1514, DOI 10.1152/jn.00320.2003; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; XENAKIS S, 1981, PHARMACOL BIOCHEM BE, V15, P435, DOI 10.1016/0091-3057(81)90274-4; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	38	306	313	2	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2008	57	6					930	941		10.1016/j.neuron.2008.01.032	http://dx.doi.org/10.1016/j.neuron.2008.01.032			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281LV	18367093	Bronze			2022-12-24	WOS:000254500000016
J	Chiu, PH; Kayali, MA; Kishida, KT; Tomlin, D; Klinger, LG; Klinger, MR; Montague, PR				Chiu, Pearl H.; Kayali, M. Amin; Kishida, Kenneth T.; Tomlin, Damon; Klinger, Laura G.; Klinger, Mark R.; Montague, P. Read			Self responses along cingulate cortex reveal quantitative neural phenotype for high-functioning autism	NEURON			English	Article							MINDS	Attributing behavioral outcomes correctly to oneself or to other agents is essential for all productive social exchange. We approach this issue in high-functioning males with autism spectrum disorder (ASD) using two separate fMRI paradigms. First, using a visual imagery task, we extract a basis set for responses along the cingulate cortex of control subjects that reveals an agent-specific eigenvector (self eigenmode) associated with imagining oneself executing a specific motor act. Second, we show that the same self eigenmode arises during one's own decision (the self phase) in an interpersonal exchange game (iterated trust game). Third, using this exchange game, we show that ASD males exhibit a severely diminished cingulate self response when playing the game with a human partner. This diminishment covaries parametrically with their behaviorally assessed symptom severity, suggesting its value as an objective endophenotype. These findings may provide a quantitative assessment tool for high-functioning ASD.	[Chiu, Pearl H.; Kayali, M. Amin; Kishida, Kenneth T.; Montague, P. Read] Baylor Coll Med, Comp Psychiat Unit, Houston, TX 77030 USA; [Chiu, Pearl H.; Kayali, M. Amin; Kishida, Kenneth T.; Tomlin, Damon; Montague, P. Read] Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; [Chiu, Pearl H.; Montague, P. Read] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Klinger, Laura G.; Klinger, Mark R.] Univ Alabama, Dept Psychol, Tuscaloosa, AL 35487 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Alabama System; University of Alabama Tuscaloosa	Montague, PR (corresponding author), Baylor Coll Med, Comp Psychiat Unit, Houston, TX 77030 USA.	rmontague@cpu.bcm.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018882, F32MH078485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA11723, R01 DA011723] Funding Source: Medline; NIMH NIH HHS [T32 MH18882, T32 MH018882, F32 MH078485] Funding Source: Medline; NINDS NIH HHS [R01 NS045790] Funding Source: Medline; Autism Speaks [AS1947] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Autism Speaks		American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Baron-Cohen S, 2001, INT REV RES MENT RET, V23, P169; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; DENNETT DC, 2001, MINDS 1 FANTASIES RE; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; FRITH CD, 2006, NEURAL BASIS MENTALI, V4, P531; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Frith U., 2003, AUTISM EXPLAINING EN; GREENWALD A, 2003, GEN CLASS NO REGRET; Hill EL, 2003, PHILOS T R SOC B, V358, P281, DOI 10.1098/rstb.2002.1209; Iacoboni M, 2006, TRENDS COGN SCI, V10, P431, DOI 10.1016/j.tics.2006.08.002; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Kagel J., 1997, HDB EXPT EC; Kaufman A. S., 2004, KAUFMANN BRIEF INTEL, VSecond; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Klin A, 2002, AM J PSYCHIAT, V159, P895, DOI 10.1176/appi.ajp.159.6.895; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Montague PR, 2007, NEURON, V56, P14, DOI 10.1016/j.neuron.2007.09.020; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7	48	145	153	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 7	2008	57	3					463	473		10.1016/j.neuron.2007.12.020	http://dx.doi.org/10.1016/j.neuron.2007.12.020			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261JQ	18255038	Bronze, Green Accepted			2022-12-24	WOS:000253075300015
J	O'Neill, J; Senior, TJ; Allen, K; Huxter, JR; Csicsvari, J				O'Neill, Joseph; Senior, Timothy J.; Allen, Kevin; Huxter, John R.; Csicsvari, Jozsef			Reactivation of experience-dependent cell assembly patterns in the hippocampus	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SUBSEQUENT SLEEP EPISODES; CA1 PYRAMIDAL CELLS; SHARP WAVES; SYNAPTIC PLASTICITY; BEHAVING RAT; SEQUENTIAL EXPERIENCE; AWAKE STATE; MEMORY; NEURONS	The hippocampus is thought to be involved in episodic memory formation by reactivating traces of waking experience during sleep. Indeed, the joint firing of spatially tuned pyramidal cells encoding nearby places recur during sleep. We found that the sleep cofiring of rat CA1 pyramidal cells encoding similar places increased relative to the sleep session before exploration. This cofiring increase depended on the number of times that cells fired together with short latencies ( < 50 ms) during exploration, and was strongest between cells representing the most visited places. This is indicative of a Hebbian learning rule in which changes in firing associations between cells are determined by the number of waking coincident firing events. In contrast, cells encoding different locations reduced their cofiring in proportion to the number of times that they fired independently. Together these data indicate that reactivated patterns are shaped by both positive and negative changes in cofiring, which are determined by recent behavior.	[O'Neill, Joseph; Senior, Timothy J.; Allen, Kevin; Huxter, John R.; Csicsvari, Jozsef] Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England	University of Oxford	Csicsvari, J (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Mansfield Rd, Oxford OX1 3TH, England.	jozsef.csicsvari@pharm.ox.ac.uk		Allen, Kevin/0000-0001-5319-3721	Medical Research Council [MC_U138169944] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U138169944] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Battaglia FP, 2005, NEURAL NETWORKS, V18, P1280, DOI 10.1016/j.neunet.2005.08.011; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CASTRO CA, 1989, NATURE, V342, P545, DOI 10.1038/342545a0; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hirase H, 2001, P NATL ACAD SCI USA, V98, P9386, DOI 10.1073/pnas.161274398; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Jackson JC, 2006, J NEUROSCI, V26, P12415, DOI 10.1523/JNEUROSCI.4118-06.2006; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; MULLER RU, 1987, J NEUROSCI, V7, P1951; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Shen B, 1996, HIPPOCAMPUS, V6, P685; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; YLINEN A, 1995, J NEUROSCI, V15, P30	46	182	182	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					209	215		10.1038/nn2037	http://dx.doi.org/10.1038/nn2037			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18193040				2022-12-24	WOS:000252712100015
J	Kwon, HB; Castillo, PE				Kwon, Hyung-Bae; Castillo, Pablo E.			Long-term potentiation selectively expressed by NMDA receptors at hippocampal mossy fiber synapses	NEURON			English	Article							PROTEIN-KINASE-C; METABOTROPIC GLUTAMATE RECEPTORS; MEDIATED SYNAPTIC-TRANSMISSION; AMPA RECEPTORS; PYRAMIDAL CELLS; CA2+ RELEASE; CA3; TRAFFICKING; LTP; ACTIVATION	The mossy fiber to CA3 pyramidal cell synapse (mf-CA3) provides a major source of excitation to the hippocampus. Thus far, these glutamatergic synapses are well recognized for showing a presynaptic, NMDA receptor-independent form of LTP that is expressed as a long-lasting increase of transmitter release. Here, we show that in addition to this "classical" LTP, mf-CA3 synapses can undergo a form of LTP characterized by a selective enhancement of NMDA receptor-mediated transmission. This potentiation requires coactivation of NMDA and mGlu5 receptors and a postsynaptic calcium rise. Unlike classical LTP, expression of this mossy fiber LTP is due to a PKC-dependent recruitment of NMDA receptors specifically to the mf-CA3 synapse via a SNARE-dependent process. Having two mechanistically different forms of LTP may allow mf-CA3 synapses to respond with more flexibility to the changing demands of the hippocampal network.	[Kwon, Hyung-Bae; Castillo, Pablo E.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Castillo, PE (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA.	pcastill@aecom.yu.edu		Castillo, Pablo/0000-0002-9834-1801	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017392] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA017392-05, R01 DA017392] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Aniksztejn L, 1995, J NEUROPHYSIOL, V74, P2349, DOI 10.1152/jn.1995.74.6.2349; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Bayazitov L, 2000, BRAIN RES, V866, P188, DOI 10.1016/S0006-8993(00)02279-4; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; BERRETTA N, 1991, EUR J NEUROSCI, V3, P850, DOI 10.1111/j.1460-9568.1991.tb00096.x; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CLAIBORNE BJ, 1993, HIPPOCAMPUS, V3, P115, DOI 10.1002/hipo.450030202; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cravens CJ, 2006, EUR J NEUROSCI, V24, P1771, DOI 10.1111/j.1460-9568.2006.05044.x; DAW NW, 1993, ANNU REV NEUROSCI, V16, P207, DOI 10.1146/annurev.ne.16.030193.001231; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Fitzjohn SM, 2002, CELL CALCIUM, V32, P405, DOI 10.1016/S0143416002001999; Fritschy JM, 1998, J COMP NEUROL, V390, P194; GERBER G, 1989, J NEUROSCI, V9, P3606; GRIFFITH WH, 1990, J NEUROPHYSIOL, V63, P491, DOI 10.1152/jn.1990.63.3.491; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Gutierrez LM, 1997, J BIOL CHEM, V272, P2634, DOI 10.1074/jbc.272.5.2634; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Ho MTW, 2007, J NEUROSCI, V27, P11651, DOI 10.1523/JNEUROSCI.2671-07.2007; HSIA AY, 1995, NEUROPHARMACOLOGY, V34, P1567, DOI 10.1016/0028-3908(95)00115-M; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; Jia ZP, 1998, LEARN MEMORY, V5, P331; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Kapur A, 2001, NEUROSCIENCE, V107, P59, DOI 10.1016/S0306-4522(01)00293-7; KELSO SR, 1992, J PHYSIOL-LONDON, V449, P705, DOI 10.1113/jphysiol.1992.sp019110; Kishimoto Y, 2006, J NEUROSCI, V26, P1562, DOI 10.1523/JNEUROSCI.4142-05.2006; Kotecha SA, 2003, J BIOL CHEM, V278, P27742, DOI 10.1074/jbc.M301946200; Kotecha SA, 2003, INT REV NEUROBIOL, V54, P53; Lan JY, 2001, J NEUROSCI, V21, P6058, DOI 10.1523/JNEUROSCI.21-16-06058.2001; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Miller LDP, 1996, J NEUROPHYSIOL, V76, P554, DOI 10.1152/jn.1996.76.1.554; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Nakamura T, 2002, J PHYSIOL-LONDON, V543, P465, DOI 10.1113/jphysiol.2002.020362; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Nong Y, 2004, CURR OPIN NEUROBIOL, V14, P353, DOI 10.1016/j.conb.2004.05.001; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; OCONNOR JJ, 1994, NATURE, V367, P557, DOI 10.1038/367557a0; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; PETRALIA RS, 1994, J NEUROSCI, V14, P667; Rae MG, 2000, J NEUROSCI, V20, P8628; Rebola N, 2007, J NEUROSCI, V27, P3987, DOI 10.1523/JNEUROSCI.5182-06.2007; Reid CA, 2001, J NEUROSCI, V21, P2206, DOI 10.1523/JNEUROSCI.21-07-02206.2001; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Ross WN, 2005, CELL MOL NEUROBIOL, V25, P283, DOI 10.1007/s10571-005-3060-0; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schmitz D, 2003, NAT NEUROSCI, V6, P1058, DOI 10.1038/nn1116; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Skeberdis VA, 2001, NEUROPHARMACOLOGY, V40, P856, DOI 10.1016/S0028-3908(01)00005-3; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tovar KR, 2002, NEURON, V34, P253; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsukamoto M, 2003, J PHYSIOL-LONDON, V546, P665, DOI 10.1113/jphysiol.2002.033803; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; XIAO MY, 1995, NEUROSCIENCE, V68, P625, DOI 10.1016/0306-4522(95)00173-G; XIE XP, 1992, J NEUROPHYSIOL, V67, P1009, DOI 10.1152/jn.1992.67.4.1009; Xiong ZG, 1998, MOL PHARMACOL, V54, P1055, DOI 10.1124/mol.54.6.1055; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zhu Y, 2003, J PHARMACOL SCI, V92, P259; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	101	115	118	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 10	2008	57	1					108	120		10.1016/j.neuron.2007.11.024	http://dx.doi.org/10.1016/j.neuron.2007.11.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	250YZ	18184568	Green Accepted, Bronze			2022-12-24	WOS:000252338600013
J	Corneil, BD; Munoz, DP; Chapman, BB; Admans, T; Cushing, SL				Corneil, Brian D.; Munoz, Douglas P.; Chapman, Brendan B.; Admans, Tania; Cushing, Sharon L.			Neuromuscular consequences of reflexive covert orienting	NATURE NEUROSCIENCE			English	Article							SUPERIOR COLLICULUS; VISUAL RESPONSES; EYE-MOVEMENTS; MONKEY; INHIBITION; ATTENTION; NEURONS; REWARD; RETURN	Visual stimulus presentation activates the oculomotor network without requiring a gaze shift. Here, we demonstrate that primate neck muscles are recruited during such reflexive covert orienting in a manner that parallels activity recorded from the superior colliculus (SC). Our results indicate the presence of a brainstem circuit whereby reflexive covert orienting is prevented from shifting gaze, but recruits neck muscles, predicting that similarities between SC and neck muscle activity should extend to other cognitive processes that are known to influence SC activity.	[Corneil, Brian D.; Admans, Tania] Univ Western Ontario, Dept Physiol, CIHR, Grp Act & Percep, London, ON N6A 5C1, Canada; [Corneil, Brian D.; Admans, Tania] Univ Western Ontario, Dept Psychol, CIHR, Grp Act & Percep, London, ON N6A 5C1, Canada; [Corneil, Brian D.; Admans, Tania] Univ Western Ontario, Dept Pharmacol, CIHR, Grp Act & Percep, London, ON, Canada; [Corneil, Brian D.; Chapman, Brendan B.] Univ Western Ontario, Grad Program Neurosci, London, ON, Canada; [Munoz, Douglas P.] Queens Univ, Dept Med, CIHR Grp Sensory Motor Sysyt, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada; [Munoz, Douglas P.] Queens Univ, Dept Physiol, CIHR Grp Sensory Motor Sysyt, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada; [Munoz, Douglas P.] Queens Univ, Dept Psychol, CIHR Grp Sensory Motor Sysyt, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada; [Cushing, Sharon L.] Univ Toronto, Dept Otorhinolaryngol Head & Neck Surg, Toronto, ON M5G 2N2, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Queens University - Canada; Queens University - Canada; Queens University - Canada; University of Toronto	Corneil, BD (corresponding author), Univ Western Ontario, Dept Physiol, CIHR, Grp Act & Percep, London, ON N6A 5C1, Canada.	bcorneil@uwo.ca	Corneil, Brian D/K-6401-2013	Corneil, Brian D/0000-0002-4702-7089				Corneil BD, 2004, NEURON, V42, P831, DOI 10.1016/S0896-6273(04)00267-3; Corneil BD, 2007, J NEUROPHYSIOL, V97, P701, DOI 10.1152/jn.00670.2006; Dorris MC, 1998, J NEUROSCI, V18, P7015; Everling S, 1998, J NEUROPHYSIOL, V79, P511, DOI 10.1152/jn.1998.79.2.511; Fecteau JH, 2004, J NEUROPHYSIOL, V92, P1728, DOI 10.1152/jn.00184.2004; GRANTYN A, 1989, PROG BRAIN RES, V80, P159; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; Rodgers CK, 2006, J NEUROPHYSIOL, V95, P3502, DOI 10.1152/jn.00908.2005; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Scudder CA, 2002, EXP BRAIN RES, V142, P439, DOI 10.1007/s00221-001-0912-9; WURTZ RH, 1972, J NEUROPHYSIOL, V35, P575, DOI 10.1152/jn.1972.35.4.575	15	56	56	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					13	15		10.1038/nn2023	http://dx.doi.org/10.1038/nn2023			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18059264				2022-12-24	WOS:000252117900006
J	Falsig, J; Julius, C; Margalith, I; Schwarz, P; Heppner, FL; Aguzzi, A				Falsig, Jeppe; Julius, Christian; Margalith, Ilan; Schwarz, Petra; Heppner, Frank L.; Aguzzi, Adriano			A versatile prion replication assay in organotypic brain slices	NATURE NEUROSCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; ADULT TRANSGENIC MICE; SCRAPIE PRION; PROTEIN; PRP; MICROGLIA; AGENT; CELLS; IDENTIFICATION; INFECTIVITY	Methods enabling prion replication ex vivo are important for advancing prion studies. However, few such technologies exist, and many prion strains are not amenable to them. Here we describe a prion organotypic slice culture assay (POSCA) that allows prion amplification and titration ex vivo under conditions that closely resemble intracerebral infection. Thirty-five days after contact with prions, mouse cerebellar slices had amplified the abnormal isoform of prion protein, PrPSc, > 10(5)-fold. This is quantitatively similar to amplification in vivo, but fivefold faster. PrPSc accumulated predominantly in the molecular layer, as in infected mice. The POSCA detected replication of prion strains from disparate sources, including bovines and ovines, with variable detection efficiency. Pharmacogenetic ablation of microglia from POSCA slices led to a 15-fold increase in prion titers and PrPSc concentrations over those in microglia-containing slices, as well as an increase in susceptibility to infection. This suggests that the extensive microglial activation accompanying prion diseases represents an efficacious defensive reaction.	[Falsig, Jeppe; Julius, Christian; Margalith, Ilan; Schwarz, Petra; Heppner, Frank L.; Aguzzi, Adriano] Univ Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich	Aguzzi, A (corresponding author), Univ Zurich, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Aguzzi, Adriano/A-3351-2008; Heppner, Frank/ABH-8393-2020	Heppner, Frank/0000-0001-9816-8917; Aguzzi, Adriano/0000-0002-0344-6708	NINDS NIH HHS [R01 NS 046006, R01 NS046006-05, R01 NS046006] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046006] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Andreoletti O, 2002, J HISTOCHEM CYTOCHEM, V50, P1357, DOI 10.1177/002215540205001009; Baker CA, 2004, J NEUROVIROL, V10, P29, DOI 10.1080/13550280490261761; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Baker CA, 2002, J VIROL, V76, P10905, DOI 10.1128/JVI.76.21.10905-10913.2002; Beringue V, 2000, J PATHOL, V190, P495, DOI 10.1002/(SICI)1096-9896(200003)190:4&lt;495::AID-PATH535&gt;3.0.CO;2-T; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; CARP RI, 1982, INTERVIROLOGY, V17, P201, DOI 10.1159/000149289; Dandoy-Dron F, 1998, J BIOL CHEM, V273, P7691, DOI 10.1074/jbc.273.13.7691; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gogolla N, 2006, NAT PROTOC, V1, P1165, DOI 10.1038/nprot.2006.168; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Manuelidis L, 1997, SCIENCE, V277, P94, DOI 10.1126/science.277.5322.94; MANUELIDIS L, 1987, EMBO J, V6, P341, DOI 10.1002/j.1460-2075.1987.tb04760.x; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MICHEL B, 1987, REV NEUROL, V143, P526; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Rubsam LZ, 1998, CANCER RES, V58, P3873; Sigurdson CJ, 2006, J VIROL, V80, P12303, DOI 10.1128/JVI.01120-06; Solassol J, 2003, BRIT MED BULL, V66, P87, DOI 10.1093/bmb/66.1.87; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Williams A, 1997, EXP NEUROL, V144, P433, DOI 10.1006/exnr.1997.6424; [No title captured], DOI DOI 10.1007/BF01863914	34	112	114	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					109	117		10.1038/nn2028	http://dx.doi.org/10.1038/nn2028			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18066056	Green Accepted			2022-12-24	WOS:000252117900019
J	Li, XL; Gao, X; Liu, GF; Xiong, WC; Wu, J; Rao, Y				Li, Xiaoling; Gao, Xue; Liu, Guofa; Xiong, Wencheng; Wu, Jane; Rao, Yi			Netrin signal transduction and the guanine nucleotide exchange factor DOCK180 in attractive signaling	NATURE NEUROSCIENCE			English	Article							COMMISSURAL AXON GUIDANCE; FOCAL ADHESION KINASE; C-ELEGANS; COLORECTAL-CANCER; CELL-MIGRATION; CAENORHABDITIS-ELEGANS; GENETIC-ANALYSIS; NERVOUS-SYSTEM; MYOBLAST CITY; GUIDES CELL	Netrins are prototypical axon guidance cues whose attractive signaling requires the small GTPase Rac1. It remains unclear how Rac1 is regulated in the netrin pathway. DOCK180 is a member of a new family of guanine nucleotide exchange factors for Rho GTPases. Here we provide evidence implicating DOCK180 in netrin signal transduction. Netrin promoted the formation of a protein-protein interaction complex that included DOCK180 and the netrin receptor deleted in colorectal carcinoma (DCC). Inhibition of DOCK180 reduced activation of Rac1 by netrin. Both axon outgrowth and axon attraction induced by netrin were inhibited after DOCK180 knockdown in vertebrate neurons. The in vivo functional role of DOCK180 was demonstrated by its requirement for projection of commissural axons in the neural tube. These findings indicate that netrin stimulation recruits DOCK180 through DCC, which then activates small GTPases, suggesting an essential role for DOCK180 in mediating attractive responses by neurons to netrin-1.	[Li, Xiaoling; Gao, Xue; Liu, Guofa; Wu, Jane; Rao, Yi] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Xiong, Wencheng] Med Coll Georgia, Dept Neurol, Inst Mol Med & Genet, Program Dev Neurobiol, Augusta, GA 30912 USA; [Wu, Jane] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Wu, Jane] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Chicago, IL 60611 USA; [Rao, Yi] Beijing Univ, Sch Life Sci, Beijing 100871, Peoples R China	Northwestern University; Feinberg School of Medicine; University System of Georgia; Augusta University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Peking University	Wu, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol, 303 E Superior Ave, Chicago, IL 60611 USA.	jane-wu@northwestern.edu; y-rao@northwestern.edu		Li, Xiaoling/0000-0002-3408-7066	NATIONAL CANCER INSTITUTE [R01CA107193, R01CA114197] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA107193, R01 CA107193-03, R01 CA114197, R01 CA114197-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Causeret F, 2004, DEVELOPMENT, V131, P2841, DOI 10.1242/dev.01162; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; DeFelipe J., 1991, CAJALS DEGENERATION; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Liu GF, 2007, J NEUROSCI, V27, P957, DOI 10.1523/JNEUROSCI.4616-06.2007; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Merz DC, 2001, GENETICS, V158, P1071; Merz DC, 2000, J NEUROBIOL, V44, P281, DOI 10.1002/1097-4695(200008)44:2&lt;281::AID-NEU16&gt;3.0.CO;2-4; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; Nishihara H, 2002, BLOOD, V100, P3968, DOI 10.1182/blood-2001-11-0032; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Stoeckli ET, 1997, NEURON, V18, P209, DOI 10.1016/S0896-6273(00)80262-7; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu YC, 2002, DEV BIOL, V250, P145, DOI 10.1006/dbio.2002.0785; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Zhou WS, 2001, J VIS COMMUN IMAGE R, V12, P1, DOI 10.1006/jvci.2000.0459	50	83	85	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					28	35		10.1038/nn2022	http://dx.doi.org/10.1038/nn2022			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18066058	Green Accepted			2022-12-24	WOS:000252117900009
J	Zhou, KM; Dong, YM; Ge, Q; Zhu, D; Zhou, W; Lin, XG; Liang, T; Wu, ZX; Xu, T				Zhou, Ke-Ming; Dong, Yong-Ming; Ge, Qian; Zhu, Dan; Zhou, Wei; Lin, Xian-Guang; Liang, Tao; Wu, Zheng-Xing; Xu, Tao			PKA activation bypasses the requirement for UNC-31 in the docking of dense core vesicles from C. elegans neurons	NEURON			English	Article							READILY RELEASABLE POOL; ADRENAL CHROMAFFIN CELLS; PROTEIN-KINASE-C; CAENORHABDITIS-ELEGANS; CA2+-DEPENDENT EXOCYTOSIS; CALCIUM-DEPENDENCE; REGULATED EXOCYTOSIS; TRANSMITTER RELEASE; SECRETORY MACHINERY; INSULIN-SECRETION	The nematode C. elegans provides a powerful model system for exploring the molecular basis of synaptogenesis and neurotransmission. However, the lack of direct functional assays of release processes has largely prevented an in depth understanding of the mechanism of vesicular exocytosis and endocytosis in C. elegans. We address this technical limitation by developing direct electrophysiological assays, including membrane capacitance and amperometry measurements, in primary cultured C. elegans neurons. In addition, we have succeeded in monitoring the docking and fusion of single dense core vesicles (DCVs) employing total internal reflection fluorescence microscopy. With these approaches and mutant perturbation analysis, we provide direct evidence that UNC-31 is required for the docking of DCVs at the plasma membrane. Interestingly, the defect in DCV docking caused by UNC-31 mutation can be fully rescued by PKA activation. We also demonstrate that UNC-31 is required for UNC-13-mediated augmentation of DCV exocytosis.	Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430074, Peoples R China; Huazhong Univ Sci & Technol, Joint Lab Inst Biophys, Wuhan 430074, Peoples R China; Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Academy of Sciences; Institute of Biophysics, CAS	Wu, ZX (corresponding author), Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430074, Peoples R China.	ibbwuzx@mail.hust.edu.cn; xutao@ibp.ac.cn	Xu, Tao/G-5474-2010; Wu, Zheng-Xing/G-4695-2011; Dong, Yongming/H-9502-2013; Zhou, Keming/A-6638-2009	Dong, Yongming/0000-0002-6510-0913; 				Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Bai L, 2006, TRAFFIC, V7, P416, DOI 10.1111/j.1600-0854.2006.00394.x; Betz A, 1997, J BIOL CHEM, V272, P2520; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Bonanomi D, 2006, PROG NEUROBIOL, V80, P177, DOI 10.1016/j.pneurobio.2006.09.002; BRENNER S, 1974, GENETICS, V77, P71; Cai T, 2004, J NEUROSCI, V24, P3115, DOI 10.1523/JNEUROSCI.0101-04.2004; Charlie NK, 2006, GENETICS, V172, P943, DOI 10.1534/genetics.105.049577; Chen CF, 1997, J NEUROSCI, V17, P8687; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; COLE KS, 1968, MEMBRANES IONS IMPUL; Colquhoun David, 1995, P397; Deken SL, 2005, J NEUROSCI, V25, P5975, DOI 10.1523/JNEUROSCI.0804-05.2005; Estevez AY, 2003, J GEN PHYSIOL, V122, P207, DOI 10.1085/jgp.200308804; Evans GJO, 2001, J BIOL CHEM, V276, P47877, DOI 10.1074/jbc.M108186200; Fawcett GL, 2006, J BIOL CHEM, V281, P30725, DOI 10.1074/jbc.M605814200; Francis Michael M., 2006, V351, P175; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Goodman MB, 2000, J NEUROSCI METH, V100, P13, DOI 10.1016/S0165-0270(00)00224-7; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kang LJ, 2006, CELL METAB, V3, P463, DOI 10.1016/j.cmet.2006.04.012; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; MacDonald PE, 2005, DIABETES, V54, P736, DOI 10.2337/diabetes.54.3.736; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Sorensen JB, 2004, PFLUG ARCH EUR J PHY, V448, P347, DOI 10.1007/s00424-004-1247-8; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Stevens DR, 2005, CURR BIOL, V15, P2243, DOI 10.1016/j.cub.2005.10.055; Sun JY, 2004, J NEUROSCI METH, V134, P121, DOI 10.1016/j.jneumeth.2003.11.018; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Toonen RFG, 2006, P NATL ACAD SCI USA, V103, P18332, DOI 10.1073/pnas.0608507103; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wan QF, 2004, J GEN PHYSIOL, V124, P653, DOI 10.1085/jgp.200409082; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Waters J, 2000, J NEUROSCI, V20, P7863; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Xu T, 1997, BIOPHYS J, V73, P532, DOI 10.1016/S0006-3495(97)78091-3; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yang H, 2005, J GEN PHYSIOL, V125, P327, DOI 10.1085/jgp.200409230	64	61	71	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 21	2007	56	4					657	669		10.1016/j.neuron.2007.09.015	http://dx.doi.org/10.1016/j.neuron.2007.09.015			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	236MH	18031683	Bronze			2022-12-24	WOS:000251306600009
J	Boyle, M; Wong, C; Rocha, M; Jones, DL				Boyle, Monica; Wong, Chihunt; Rocha, Michael; Jones, D. Leanne			Decline in self-renewal factors contributes to aging of the stem cell niche in the Drosophila testis	CELL STEM CELL			English	Article							DEPENDENT KINASE INHIBITOR; BAG-OF-MARBLES; SOMATIC CONTROL; GERMLINE; PROLIFERATION; DIVISION; DIFFERENTIATION; BEHAVIOR; PROTEIN; DACAPO	Aging is characterized by compromised organ and tissue function. A decrease in stem cell number and/or activity could lead to the aging-related decline in tissue homeostasis. We have analyzed how the process of aging affects germ line stem cell (GSC) behavior in the Drosophila testis and report that significant changes within the stem cell microenvironment, or niche, occur that contribute to a decline in stem cell number over time. Specifically, somatic niche cells in testes from older males display reduced expression of the cell adhesion molecule DE-cadherin and a key self-renewal signal unpaired (upd). Loss of upd correlates with an overall decrease in stem cells residing within the niche. Conversely, forced expression of upd within niche cells maintains GSCs in older males. Therefore, our data indicate that age-related changes within stem cell niches may be a significant contributing factor to reduced tissue homeostasis and regeneration in older individuals.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego	Jones, DL (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ljones@salk.edu			NIA NIH HHS [R01 AG028092] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG028092] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Gonczy P, 1997, DEVELOPMENT, V124, P4361; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Helfand SL, 2003, BIOESSAYS, V25, P134, DOI 10.1002/bies.10225; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Le Bras S, 2006, DEV BIOL, V294, P92, DOI 10.1016/j.ydbio.2006.02.030; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; LIN HF, 1994, DEVELOPMENT, V120, P947; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; McGregor JR, 2002, DEVELOPMENT, V129, P705; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Meyer CA, 2002, DEVELOPMENT, V129, P319; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Wawersik M, 2005, NATURE, V436, P563, DOI 10.1038/nature03849; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Zhang XF, 2006, BIOL REPROD, V74, P119, DOI 10.1095/biolreprod.105.045591	38	198	201	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT	2007	1	4					470	478		10.1016/j.stem.2007.08.002	http://dx.doi.org/10.1016/j.stem.2007.08.002			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XU	18371382	Bronze			2022-12-24	WOS:000251055300015
J	Maingret, F; Coste, B; Hao, J; Giamarchi, A; Allen, D; Crest, M; Litchfield, DW; Adelman, JP; Delmas, P				Maingret, Francois; Coste, Bertrand; Hao, Jizhe; Giamarchi, Aurelie; Allen, Duane; Crest, Marcel; Litchfield, David W.; Adelman, John P.; Delmas, Patrick			Neurotransmitter modulation of small-conductance Ca2+-activated K+ channels by regulation of Ca2+ gating	NEURON			English	Article							ACTIVATED POTASSIUM CHANNELS; PROTEIN-KINASE CK2; SK CHANNELS; SIGNALING MICRODOMAINS; SYNAPTIC-TRANSMISSION; NMDA RECEPTORS; CALMODULIN; NEURONS; PLASTICITY; SUBUNIT	Small-conductance Ca2+-activated K+ (SK) channels are widely expressed in neuronal tissues where they underlie postspike hyperpolarizations, regulate spike-frequency adaptation, and shape synaptic responses. SK channels constitutively interact with calmodulin (CaM), which serves as Ca2+ sensor, and with protein kinase CK2 and protein phosphatase 2A, which modulate their Ca2+ gating. By recording coupled activities of Ca2+ and SK2 channels, we showed that SK2 channels can be inhibited by neurotransmitters independently of changes in the activity of the priming Ca2+ channels. This inhibition involves SK2-associated CK2 and results from a 3-fold reduction in the Ca2+ sensitivity of channel gating. CK2 phosphorylated SK2-bound CaM but not KCNQ2-bound CaM, thereby selectively regulating SK2 channels. We extended these observations to sensory neurons by showing that noradrenaline inhibits SK current and increases neuronal excitability in a CK2-dependent fashion. Hence, neurotransmitter-initiated signaling cascades can dynamically regulate Ca2+ sensitivity of SK channels and directly influence somatic excitability.	[Maingret, Francois; Coste, Bertrand; Hao, Jizhe; Giamarchi, Aurelie; Crest, Marcel; Delmas, Patrick] Univ Mediterranee, Ctr Rech Neurobiol & Neurophysiol Marseille, CNRS, UMR 6231, F-13916 Marseille 20, France; [Allen, Duane; Adelman, John P.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97329 USA; [Litchfield, David W.] Univ Western Ontario, Dept Biochem, Siebens Drake Res Inst, London, ON N6A 5C1, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Oregon Health & Science University; Western University (University of Western Ontario)	Delmas, P (corresponding author), Univ Mediterranee, Ctr Rech Neurobiol & Neurophysiol Marseille, CNRS, UMR 6231, Blvd Pierre Dramard, F-13916 Marseille 20, France.	patrick.delmas@univmed.fr	hao, jizhe/B-6791-2011; Litchfield, David/E-4636-2015; hao, jizhe/AFS-9867-2022	Litchfield, David/0000-0002-2425-6620; 	Agence Nationale de la Recherche [ANR-05-Neuro-031, ANR-05-PCOD]; Fondation Schlumberger; ARClnca-2006; Action Concertee Incitative Jeunes Chercheurs; UPSA; Equipe Fondation pour la Recherche Medicale 2007; French Ministry; NIH NRSA Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076752] Funding Source: NIH RePORTER	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Schlumberger(Schlumberger); ARClnca-2006; Action Concertee Incitative Jeunes Chercheurs; UPSA; Equipe Fondation pour la Recherche Medicale 2007; French Ministry; NIH NRSA Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank Prof. David A. Brown for valuable comments on an early version of this manuscript, Prof. B. Hille, K. Mackie, G.W.J. Moss, A.C. Dolphin, and F.C. Abogadie for cDNAs, and Drs M. Ruzzene and L.A. Pinna for the gift of MNA and NBC compounds. This study was supported by the CNRS and by grants from the Agence Nationale de la Recherche (ANR-05-Neuro-031, ANR-05-PCOD), Fondation Schlumberger, ARClnca-2006, Action Concertee Incitative Jeunes Chercheurs, UPSA, Equipe Fondation pour la Recherche Medicale 2007, and French Ministry (to P.D.) and by grants from NIH NRSA Award (to D.A.) and NIH (to J.P.A.).	Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Arrigoni G, 2004, BIOCHEMISTRY-US, V43, P12788, DOI 10.1021/bi049365c; Bahia PK, 2005, J NEUROSCI, V25, P3489, DOI 10.1523/JNEUROSCI.0597-05.2005; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Bond CT, 2005, CURR OPIN NEUROBIOL, V15, P305, DOI 10.1016/j.conb.2005.05.001; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Bond CT, 1999, ANN NY ACAD SCI, V868, P370, DOI 10.1111/j.1749-6632.1999.tb11298.x; Bourinet E, 1996, P NATL ACAD SCI USA, V93, P1486, DOI 10.1073/pnas.93.4.1486; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Delmas P, 2002, NEURON, V36, P787, DOI 10.1016/S0896-6273(02)01097-8; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Delmas P, 2000, NAT NEUROSCI, V3, P670, DOI 10.1038/76621; Dreixler JC, 2000, EUR J PHARMACOL, V401, P1, DOI 10.1016/S0014-2999(00)00401-5; Faber ESL, 2007, CLIN EXP PHARMACOL P, V34, P1077, DOI 10.1111/j.1440-1681.2007.04725.x; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Galarraga E, 2007, NEUROSCIENCE, V146, P537, DOI 10.1016/j.neuroscience.2007.01.032; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; Hosseini R, 2001, J PHYSIOL-LONDON, V535, P323, DOI 10.1111/j.1469-7793.2001.00323.x; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Lieberman DN, 1999, NAT NEUROSCI, V2, P125, DOI 10.1038/5680; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; LITCHFIELD DW, 2005, BIOCHEM J, V369, P1; Maingret F, 2008, J GEN PHYSIOL, V131, P211, DOI 10.1085/jgp.200709935; Martina M, 2007, J PHYSIOL-LONDON, V578, P143, DOI 10.1113/jphysiol.2006.116178; MAYLIE J, 2003, J PHYSL, V554, P255; Meggio F, 2004, BIOCHEMISTRY-US, V43, P12931, DOI 10.1021/bi048999g; Monaghan AS, 2004, J BIOL CHEM, V279, P1003, DOI 10.1074/jbc.M308070200; Mongan LC, 2005, NEUROSCIENCE, V131, P161, DOI 10.1016/j.neuroscience.2004.09.062; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Page KM, 1998, J NEUROSCI, V18, P4815; Penner CG, 1997, J CELL BIOCHEM, V64, P525; Pertovaara A, 2006, PROG NEUROBIOL, V80, P53, DOI 10.1016/j.pneurobio.2006.08.001; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; STORM JF, 1990, PROG BRAIN RES, V83, P161; Strassmaier T, 2005, J BIOL CHEM, V280, P21231, DOI 10.1074/jbc.M413125200; Vilk G, 1999, J BIOL CHEM, V274, P14406, DOI 10.1074/jbc.274.20.14406; Wagner EJ, 2001, J PHARMACOL EXP THER, V299, P21; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200	51	56	57	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 14	2008	59	3					439	449		10.1016/j.neuron.2008.05.026	http://dx.doi.org/10.1016/j.neuron.2008.05.026			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339GG	18701069	Bronze, Green Accepted			2022-12-24	WOS:000258565500012
J	Ramot, D; MacInnis, BL; Goodman, MB				Ramot, Daniel; MacInnis, Bronwyn L.; Goodman, Miriam B.			Bidirectional temperature-sensing by a single thermosensory neuron in C-elegans	NATURE NEUROSCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NUCLEOTIDE-GATED CHANNEL; THERMOTACTIC BEHAVIORAL PLASTICITY; SPATIAL SUMMATION; OLFACTORY NEURON; SENSORY NEURONS; ION CHANNELS; RECEPTOR; HEAT; SENSATION	Humans and other animals can sense temperature changes as small as 0.1 degrees C. How animals achieve such exquisite sensitivity is poorly understood. By recording from the C. elegans thermosensory neurons AFD in vivo, we found that cooling closes and warming opens ion channels. We found that AFD thermosensitivity, which exceeds that of most biological processes by many orders of magnitude, is achieved by nonlinear signal amplification. Mutations in genes encoding subunits of a cyclic guanosine monophosphate (cGMP)-gated ion channel (tax-4 and tax-2) and transmembrane guanylate cyclases (gcy-8, gcy-18 and gcy-23) eliminated both cooling- and warming-activated thermoreceptor currents, indicating that a cGMP-mediated pathway links variations in temperature to changes in ionic currents. The resemblance of C. elegans thermosensation to vertebrate photosensation and the sequence similarity between TAX-4 and TAX-2 and subunits of the rod phototransduction channel raise the possibility that nematode thermosensation and vertebrate vision are linked by conserved evolution.	[Ramot, Daniel; Goodman, Miriam B.] Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; [MacInnis, Bronwyn L.; Goodman, Miriam B.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ramot, Daniel] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Stanford University; Stanford University; Wellcome Trust Sanger Institute	Goodman, MB (corresponding author), Stanford Univ, Program Neurosci, 279 Campus Dr, Stanford, CA 94305 USA.	mbgoodman@stanford.edu	Goodman, Miriam B./H-3036-2019	Goodman, Miriam B./0000-0002-5810-1272	NINDS NIH HHS [R21 NS061147, R01 NS047715, R01 NS047715-01A1, R01 NS047715-04, R21 NS061147-02, R01 NS047715-02, R01 NS047715-03, R21 NS061147-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047715, R21NS061147] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Biron D, 2006, NAT NEUROSCI, V9, P1499, DOI 10.1038/nn1796; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; BRENNER S, 1974, GENETICS, V77, P71; Bucossi G, 1997, BIOPHYS J, V72, P1165, DOI 10.1016/S0006-3495(97)78765-4; BULLOCK TH, 1956, J PHYSIOL-LONDON, V134, P47, DOI 10.1113/jphysiol.1956.sp005624; Cassata G, 2000, NEURON, V25, P587, DOI 10.1016/S0896-6273(00)81062-4; Chi CA, 2007, J EXP BIOL, V210, P4043, DOI 10.1242/jeb.006551; Chung SH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-30; Clark DA, 2007, J NEUROSCI, V27, P6083, DOI 10.1523/JNEUROSCI.1032-07.2007; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colosimo ME, 2004, CURR BIOL, V14, P2245, DOI 10.1016/j.cub.2004.12.030; DARCY PK, 1994, MICROBIOL-UK, V140, P1619, DOI 10.1099/13500872-140-7-1619; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Goodman MB, 2000, J NEUROSCI METH, V100, P13, DOI 10.1016/S0165-0270(00)00224-7; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Hardy JD, 1937, J CLIN INVEST, V16, P533, DOI 10.1172/JCI100879; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; KENSHALO DR, 1967, J COMP PHYSIOL PSYCH, V63, P510, DOI 10.1037/h0024610; Kimura KD, 2004, CURR BIOL, V14, P1291, DOI 10.1016/j.cub.2004.06.060; Kodama E, 2006, GENE DEV, V20, P2955, DOI 10.1101/gad.1479906; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kuhara A, 2008, SCIENCE, V320, P803, DOI 10.1126/science.1148922; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Luo LJ, 2006, J EXP BIOL, V209, P4652, DOI 10.1242/jeb.02590; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; Nobile M, 1997, EXP BRAIN RES, V114, P138, DOI 10.1007/PL00005613; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; OHAGAN R, 2005, THESIS COLUMBIA U; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Ryu WS, 2002, J NEUROSCI, V22, P5727; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	44	114	119	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					908	915		10.1038/nn.2157	http://dx.doi.org/10.1038/nn.2157			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18660808	Green Accepted			2022-12-24	WOS:000257969100016
J	Beuming, T; Kniazeff, J; Bergmann, ML; Shi, L; Gracia, L; Raniszewska, K; Newman, AH; Javitch, JA; Weinstein, H; Gether, U; Loland, CJ				Beuming, Thijs; Kniazeff, Julie; Bergmann, Marianne L.; Shi, Lei; Gracia, Luis; Raniszewska, Klaudia; Newman, Amy Hauck; Javitch, Jonathan A.; Weinstein, Harel; Gether, Ulrik; Loland, Claus J.			The binding sites for cocaine and dopamine in the dopamine transporter overlap	NATURE NEUROSCIENCE			English	Article							TRANSMEMBRANE DOMAIN-I; HUMAN SEROTONIN TRANSPORTERS; NEUROTRANSMITTER TRANSPORTERS; SUBSTRATE TRANSPORT; BACTERIAL HOMOLOG; UPTAKE INHIBITORS; RECOGNITION; MODEL; ACID; IDENTIFICATION	Cocaine is a widely abused substance with psychostimulant effects that are attributed to inhibition of the dopamine transporter (DAT). We present molecular models for DAT binding of cocaine and cocaine analogs constructed from the high-resolution structure of the bacterial transporter homolog LeuT. Our models suggest that the binding site for cocaine and cocaine analogs is deeply buried between transmembrane segments 1, 3, 6 and 8, and overlaps with the binding sites for the substrates dopamine and amphetamine, as well as for benztropine-like DAT inhibitors. We validated our models by detailed mutagenesis and by trapping the radiolabeled cocaine analog [H-3] CFT in the transporter, either by cross-linking engineered cysteines or with an engineered Zn2+-binding site that was situated extracellularly to the predicted common binding pocket. Our data demonstrate the molecular basis for the competitive inhibition of dopamine transport by cocaine.	[Kniazeff, Julie; Bergmann, Marianne L.; Raniszewska, Klaudia; Gether, Ulrik; Loland, Claus J.] Univ Copenhagen, Panum Inst 18 6, Fac Hlth Sci, Dept Neurosci & Pharmacol,Mol Neuropharmacol Grp, DK-2200 Copenhagen, Denmark; [Beuming, Thijs; Shi, Lei; Gracia, Luis; Weinstein, Harel] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei; Weinstein, Harel] Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Newman, Amy Hauck] Natl Inst Drug Abuse, Med Chem Sect, Medicat Discovery Res Branch,NIH, Intramural Res Program,Dept Hlth & Human Servs, Baltimore, MD 21224 USA; [Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10023 USA; [Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10023 USA; [Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10023 USA	University of Copenhagen; Cornell University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Columbia University; Columbia University; Columbia University	Gether, U (corresponding author), Univ Copenhagen, Panum Inst 18 6, Fac Hlth Sci, Dept Neurosci & Pharmacol,Mol Neuropharmacol Grp, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	gether@sund.ku.dk	Loland, Claus/E-5975-2014; WEINSTEIN, HAREL/O-8245-2019; Shi, Lei/AAV-1321-2020	Loland, Claus/0000-0002-1773-1446; WEINSTEIN, HAREL/0000-0003-3473-9818; Shi, Lei/0000-0002-4137-096X; Kniazeff, Julie/0000-0002-0426-0999; Javitch, Jonathan/0000-0001-7395-2967; Gracia, Luis/0000-0001-5412-6563; Gether, Ulrik/0000-0002-0020-3807	Intramural NIH HHS [Z01 DA000389-12] Funding Source: Medline; NIDA NIH HHS [DA 22413, P01 DA12408, K05 DA022413, P01 DA012408] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, Z01DA000389, P01DA012408] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aguayo LG, 2006, MINI-REV MED CHEM, V6, P997, DOI 10.2174/138955706778195144; Barker EL, 1999, J NEUROSCI, V19, P4705; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CARROLL FI, 1992, J MED CHEM, V35, P969, DOI 10.1021/jm00084a001; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Chen R, 2005, J NEUROCHEM, V94, P352, DOI 10.1111/j.1471-4159.2005.03199.x; Chen R, 2006, P NATL ACAD SCI USA, V103, P9333, DOI 10.1073/pnas.0600905103; Desai RI, 2005, J NEUROSCI, V25, P1889, DOI 10.1523/JNEUROSCI.4778-04.2005; EDVARDSEN O, 1994, MOL BRAIN RES, V27, P265, DOI 10.1016/0169-328X(94)90009-4; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Huang X, 2007, BIOPHYS J, V93, P3627, DOI 10.1529/biophysj.107.110924; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; Katz JL, 2004, J PHARMACOL EXP THER, V309, P650, DOI 10.1124/jpet.103.060525; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Lee SH, 2000, MOL PHARMACOL, V57, P883; Lin ZC, 1999, MOL PHARMACOL, V56, P434, DOI 10.1124/mol.56.2.434; Lin ZC, 2002, MOL PHARMACOL, V61, P885, DOI 10.1124/mol.61.4.885; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Loland CJ, 2008, MOL PHARMACOL, V73, P813, DOI 10.1124/mol.107.039800; Newman AH, 2002, MED RES REV, V22, P429, DOI 10.1002/med.10014; Niv MY, 2005, J AM CHEM SOC, V127, P14072, DOI 10.1021/ja054195s; Nnadi Charles U, 2005, J Natl Med Assoc, V97, P1504; Ravna AW, 2003, J COMPUT AID MOL DES, V17, P367, DOI 10.1023/A:1026116017725; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Sen N, 2005, NEUROPHARMACOLOGY, V49, P780, DOI 10.1016/j.neuropharm.2005.08.014; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Uhl GR, 2003, EUR J PHARMACOL, V479, P71, DOI 10.1016/j.ejphar.2003.08.058; Ukairo OT, 2005, J PHARMACOL EXP THER, V314, P575, DOI 10.1124/jpet.105.085829; Vaughan RA, 2007, J BIOL CHEM, V282, P8915, DOI 10.1074/jbc.M610633200; Volz TJ, 2005, SYNAPSE, V58, P72, DOI 10.1002/syn.20183; White KJ, 2006, PROTEIN SCI, V15, P2411, DOI 10.1110/ps.062386106; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zomot E, 2005, J BIOL CHEM, V280, P25512, DOI 10.1074/jbc.M503864200; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	47	259	268	4	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					780	789		10.1038/nn.2146	http://dx.doi.org/10.1038/nn.2146			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18568020	Green Accepted			2022-12-24	WOS:000257089400015
J	Susskind, JM; Lee, DH; Cusi, A; Feiman, R; Grabski, W; Anderson, AK				Susskind, Joshua M.; Lee, Daniel H.; Cusi, Andree; Feiman, Roman; Grabski, Wojtek; Anderson, Adam K.			Expressing fear enhances sensory acquisition	NATURE NEUROSCIENCE			English	Article							FACIAL EXPRESSIONS; EMOTION; AMYGDALA; RECOGNITION; ACTIVATION; ANGER; FACE; MIND	It has been proposed that facial expression production originates in sensory regulation. Here we demonstrate that facial expressions of fear are configured to enhance sensory acquisition. A statistical model of expression appearance revealed that fear and disgust expressions have opposite shape and surface reflectance features. We hypothesized that this reflects a fundamental antagonism serving to augment versus diminish sensory exposure. In keeping with this hypothesis, when subjects posed expressions of fear, they had a subjectively larger visual field, faster eye movements during target localization and an increase in nasal volume and air velocity during inspiration. The opposite pattern was found for disgust. Fear may therefore work to enhance perception, whereas disgust dampens it. These convergent results provide support for the Darwinian hypothesis that facial expressions are not arbitrary configurations for social communication, but rather, expressions may have originated in altering the sensory interface with the physical world.	[Susskind, Joshua M.; Lee, Daniel H.; Cusi, Andree; Feiman, Roman; Grabski, Wojtek; Anderson, Adam K.] Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; [Anderson, Adam K.] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest	Susskind, JM (corresponding author), Univ Toronto, Dept Psychol, 100 St George St, Toronto, ON M5S 3G3, Canada.	josh@aclab.ac; anderson@psych.utoronto.ca						Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Anderson AK, 2003, J NEUROSCI, V23, P5627; ANDREW RJ, 1963, SCIENCE, V142, P1034, DOI 10.1126/science.142.3595.1034; Boiten F, 1996, PSYCHOPHYSIOLOGY, V33, P123, DOI 10.1111/j.1469-8986.1996.tb02116.x; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; Dailey MN, 2002, J COGNITIVE NEUROSCI, V14, P1158, DOI 10.1162/089892902760807177; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Eibl-Eibesfeldt I., 1973, SOCIAL COMMUNICATION, P163; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Ekman P., 1999, HDB COGNITION EMOTIO, P45, DOI [10.1017/S0140525X0800349X, DOI 10.1002/0470013494.CH3, 10.1002/0470013494.ch3]; Galati D, 1997, J PERS SOC PSYCHOL, V73, P1363, DOI 10.1037/0022-3514.73.6.1363; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Hess U, 2000, J NONVERBAL BEHAV, V24, P265, DOI 10.1023/A:1006623213355; IZARD CE, 1994, PSYCHOL BULL, V115, P288, DOI 10.1037/0033-2909.115.2.288; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Marsh AA, 2005, EMOTION, V5, P119, DOI 10.1037/1528-3542.5.1.119; Marsh AA, 2005, PERS SOC PSYCHOL B, V31, P73, DOI 10.1177/0146167204271306; Marsh AA, 2003, PSYCHOL SCI, V14, P373, DOI 10.1111/1467-9280.24461; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Pourtois G, 2005, NEUROIMAGE, V26, P149, DOI 10.1016/j.neuroimage.2005.01.015; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; Scherer K. R., 2001, APPRAISAL PROCESSES, DOI DOI 10.1016/S0166-4115(08)62387-0; SCHERER KR, 1994, J PERS SOC PSYCHOL, V66, P310, DOI 10.1037/0022-3514.66.2.310; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; STRACK F, 1988, J PERS SOC PSYCHOL, V54, P768, DOI 10.1037/0022-3514.54.5.768; Susskind JM, 2007, NEUROPSYCHOLOGIA, V45, P152, DOI 10.1016/j.neuropsychologia.2006.05.001; TOOBY J, 1990, ETHOL SOCIOBIOL, V11, P375, DOI 10.1016/0162-3095(90)90017-Z; Tracy JL, 2004, PSYCHOL SCI, V15, P194, DOI 10.1111/j.0956-7976.2004.01503008.x; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Whalen PJ, 1998, J NEUROSCI, V18, P411; ZAJONC RB, 1985, SCIENCE, V228, P15, DOI 10.1126/science.3883492; Zelano C, 2005, NEURON, V48, P431, DOI 10.1016/j.neuron.2005.10.009	36	301	305	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					843	850		10.1038/nn.2138	http://dx.doi.org/10.1038/nn.2138			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	318KD	18552843				2022-12-24	WOS:000257089400022
J	Ziemann, AE; Schnizler, MK; Albert, GW; Severson, MA; Howard, MA; Welsh, MJ; Wemmie, JA				Ziemann, Adam E.; Schnizler, Mikael K.; Albert, Gregory W.; Severson, Meryl A.; Howard, Matthew A., III; Welsh, Michael J.; Wemmie, John A.			Seizure termination by acidosis depends on ASIC1a	NATURE NEUROSCIENCE			English	Article							SENSING ION CHANNELS; CENTRAL-NERVOUS-SYSTEM; SPREADING DEPRESSION; HIPPOCAMPAL SLICES; CARBON DIOXIDE; NEURONS; EPILEPSY; BRAIN; RAT; CONTRIBUTES	Most seizures stop spontaneously; however, the molecular mechanisms that terminate seizures remain unknown. Observations that seizures reduced brain pH and that acidosis inhibited seizures indicate that acidosis halts epileptic activity. Because acid-sensing ion channel 1a (ASIC1a) is exquisitely sensitive to extracellular pH and regulates neuron excitability, we hypothesized that acidosis might activate ASIC1a, which would terminate seizures. Disrupting mouse ASIC1a increased the severity of chemoconvulsant-induced seizures, whereas overexpressing ASIC1a had the opposite effect. ASIC1a did not affect seizure threshold or onset, but shortened seizure duration and prevented seizure progression. CO2 inhalation, long known to lower brain pH and inhibit seizures, required ASIC1a to interrupt tonic-clonic seizures. Acidosis activated inhibitory interneurons through ASIC1a, suggesting that ASIC1a might limit seizures by increasing inhibitory tone. Our results identify ASIC1a as an important element in seizure termination when brain pH falls and suggest both a molecular mechanism for how the brain stops seizures and new therapeutic strategies.	[Ziemann, Adam E.; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Med Sci Training Program, Iowa City, IA 52242 USA; [Ziemann, Adam E.; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Schnizler, Mikael K.; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Albert, Gregory W.; Severson, Meryl A.; Howard, Matthew A., III] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurosurg, Iowa City, IA 52242 USA; [Howard, Matthew A., III; Welsh, Michael J.; Wemmie, John A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Neurosci Program, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Wemmie, John A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Wemmie, John A.] Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Welsh, MJ (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Med Sci Training Program, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu; john-wemmie@uiowa.edu		Howard, Matthew/0000-0003-3935-8889; Wemmie, John/0000-0001-7531-9065; Welsh, Michael/0000-0002-1646-6206	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS045549, R21NS058309] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [T32 GM007337] Funding Source: Medline; NIMH NIH HHS [R01 MH085724] Funding Source: Medline; NINDS NIH HHS [R21 NS058309-01A1, T32 NS045549-04, T32 NS045549, R21 NS058309, 1R21NS058309-01A1, T32NS045549] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON WW, 1987, J NEUROPHYSIOL, V57, P1; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Bernard C, 2006, MODELS OF SEIZURES AND EPILEPSY, P59, DOI 10.1016/B978-012088554-1/50008-6; Bolshakov KV, 2002, NEUROSCIENCE, V110, P723, DOI 10.1016/S0306-4522(01)00582-6; Bragin A, 1997, J NEUROSCI, V17, P2567; Buckmaster PS, 2002, J NEUROPHYSIOL, V88, P783, DOI 10.1152/jn.2002.88.2.783; CHAPMAN AG, 1977, J NEUROCHEM, V28, P1025, DOI 10.1111/j.1471-4159.1977.tb10665.x; Cole TB, 2000, EPILEPSY RES, V39, P153, DOI 10.1016/S0920-1211(99)00121-7; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; Dubberke R, 1998, PFLUG ARCH EUR J PHY, V437, P79, DOI 10.1007/s004240050750; Dulla CG, 2005, NEURON, V48, P1011, DOI 10.1016/j.neuron.2005.11.009; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; FISHER RS, 1989, BRAIN RES REV, V14, P245, DOI 10.1016/0165-0173(89)90003-9; FREUND TF, 1989, NEUROSCIENCE, V28, P539, DOI 10.1016/0306-4522(89)90003-1; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; GRUOL DL, 1980, BRAIN RES, V183, P247, DOI 10.1016/0006-8993(80)90138-9; HAGLUND MM, 1990, J NEUROPHYSIOL, V63, P225, DOI 10.1152/jn.1990.63.2.225; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Kaila Kai, 1998, P309; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; Kirchner A, 2006, EUR J NEUROSCI, V23, P1512, DOI 10.1111/j.1460-9568.2006.04665.x; KLOIBER O, 1993, NMR BIOMED, V6, P333, DOI 10.1002/nbm.1940060509; LENNOX WG, 1929, J CLIN INVEST, V4, P23; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Mares P, 2006, MODELS OF SEIZURES AND EPILEPSY, P153, DOI 10.1016/B978-012088554-1/50014-1; MEDUNA LJ, 1958, CARBON DIOXIDE THERA, P3; MITCHELL WG, 1956, SCIENCE, V123, P223, DOI 10.1126/science.123.3189.223; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Somjen George G., 1998, P373; SOMJEN GG, 1984, BRAIN RES, V311, P186, DOI 10.1016/0006-8993(84)91416-1; Spencer SS, 1996, EPILEPSIA, V37, P455, DOI 10.1111/j.1528-1157.1996.tb00591.x; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; TSCHIRGI RD, 1958, AM J PHYSIOL, V195, P7, DOI 10.1152/ajplegacy.1958.195.1.7; VELISEK L, 1994, EXP BRAIN RES, V101, P44, DOI 10.1007/BF00243215; Vukicevic M, 2004, AM J PHYSIOL-CELL PH, V287, pC682, DOI 10.1152/ajpcell.00127.2004; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; WANG RIH, 1955, J NEUROPHYSIOL, V18, P130, DOI 10.1152/jn.1955.18.2.130; Waxman SG, 2007, NAT NEUROSCI, V10, P405, DOI 10.1038/nn1857; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; WOODBURY DM, 1956, AM J PHYSIOL, V184, P202, DOI 10.1152/ajplegacy.1955.184.1.202; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103	50	264	276	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					816	822		10.1038/nn.2132	http://dx.doi.org/10.1038/nn.2132			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18536711	Green Accepted			2022-12-24	WOS:000257089400019
J	Belema-Bedada, F; Uchida, S; Martire, A; Kostin, S; Braun, T				Belema-Bedada, Fikru; Uchida, Shizuka; Martire, Alessandra; Kostin, Sawa; Braun, Thomas			Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2	CELL STEM CELL			English	Article							EXPRESSION; NEOVASCULARIZATION; POLARIZATION; CHEMOTAXIS; MECHANISMS; CHEMOKINES; MUSCLE; HEART; GENE; MICE	Circulating stem cells of different origin have been demonstrated to improve repair of various organs both after systemic and local application, although the mechanisms that cause these effects are still not fully understood. We have used a combination of DNA microarray analysis and in vitro migration assays to screen for molecules that mediate homing of long-term renewing adult bone marrow-derived multipotent mesenchymal stem cells (BM-MASCs). We show that the cytokine receptor CCR2 is necessary for organ-specific homing of bone marrow-derived MASCs to the heart in a transgenic mouse model and into hearts damaged by ischemia/reperfusion. Homing and migration of stem cells was dependent on the intracellular adaptor molecule FROUNT, which interacts with CCR2. FROUNT was required for polarization of MASCs, resulting in clustering of CCR2 and reorganization of the cytoskeleton. Recruited MASCs summoned by the CCR2 ligand MCP-1/CCL2 expressed SDF1, which might trap additional bone marrow-derived circulating cells to contribute to the complex process of homing and retention of circulating stem and progenitor cells to remodel diseased organs.	[Belema-Bedada, Fikru; Uchida, Shizuka; Martire, Alessandra; Kostin, Sawa; Braun, Thomas] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany	Max Planck Society	Braun, T (corresponding author), Max Planck Inst Heart & Lung Res, Pk Str 1, D-61231 Bad Nauheim, Germany.	thomas.braun@kerckhoff.mpg.de	Braun, Thomas/B-2310-2008; Uchida, Shizuka/AAC-6781-2019	Uchida, Shizuka/0000-0003-4787-8067; Braun, Thomas/0000-0002-6165-4804				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BELEMABEDADA F, 2008, CELLS TISSUES ORGANS, V188; Bochkov NP, 2007, B EXP BIOL MED+, V143, P122, DOI 10.1007/s10517-007-0031-0; Charo IF, 2003, MICROCIRCULATION, V10, P259, DOI 10.1038/sj.mn.7800191; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Daugherty BL, 1996, J EXP MED, V183, P2349, DOI 10.1084/jem.183.5.2349; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Ebelt H, 2007, STEM CELLS, V25, P236, DOI 10.1634/stemcells.2006-0374; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kolattukudy PE, 1998, AM J PATHOL, V152, P101; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Martire A, 2003, CARDIOVASC RES, V57, P523, DOI 10.1016/S0008-6363(02)00697-1; Meinhardt H, 1999, J CELL SCI, V112, P2867; Milner DJ, 1999, J MOL CELL CARDIOL, V31, P2063, DOI 10.1006/jmcc.1999.1037; Neuhaus P, 2003, MOL CELL BIOL, V23, P6037, DOI 10.1128/MCB.23.17.6037-6048.2003; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032; Povsic TJ, 2006, EXPERT OPIN BIOL TH, V6, P427, DOI 10.1517/14712598.6.5.427; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Schulze M, 2005, GENE DEV, V19, P1787, DOI 10.1101/gad.339305; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Spring H, 2005, P NATL ACAD SCI USA, V102, P18111, DOI 10.1073/pnas.0507158102; Terashima Y, 2005, NAT IMMUNOL, V6, P827, DOI 10.1038/ni1222; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Wong MM, 2003, SEMIN IMMUNOL, V15, P5, DOI 10.1016/S1044-5323(02)00123-9	32	207	225	2	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN	2008	2	6					566	575		10.1016/j.stem.2008.03.003	http://dx.doi.org/10.1016/j.stem.2008.03.003			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	315HT	18522849	Bronze			2022-12-24	WOS:000256870000014
J	Windrem, MS; Schanz, SJ; Guo, M; Tian, GF; Washco, V; Stanwood, N; Rasband, M; Roy, NS; Nedergaard, M; Havton, LA; Wang, S; Goldman, SA				Windrem, Martha S.; Schanz, Steven J.; Guo, Min; Tian, Guo-Feng; Washco, Vaughn; Stanwood, Nancy; Rasband, Matthew; Roy, Neeta S.; Nedergaard, Mailken; Havton, Leif A.; Wang, Su; Goldman, Steven A.			Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse	CELL STEM CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; SUBCORTICAL WHITE-MATTER; NEURAL PRECURSOR CELLS; BASIC-PROTEIN GENE; STEM-CELLS; PERIVENTRICULAR LEUKOMALACIA; OLIGODENDROCYTE PROGENITORS; MYELIN; TRANSPLANTATION; BRAIN	Congenitally hypomyelinated shiverer mice fail to generate compact myelin and die by 18-21 weeks of age. Using multifocal anterior and posterior fossa delivery of sorted fetal human glial progenitor cells into neonatal shiverer x rag2(-/-) mice, we achieved whole neuraxis myelination of the engrafted hosts, which in a significant fraction of cases rescued this otherwise lethal phenotype. The transplanted mice exhibited greatly prolonged survival with progressive resolution of their neurological deficits. Substantial myelination in multiple regions was accompanied by the acquisition of normal nodes of Ranvier and transcallosal conduction velocities, ultrastructurally normal and complete myelination of most axons, and a restoration of a substantially normal neurological phenotype. Notably, the resultant mice were cerebral chimeras, with murine gray matter but a predominantly human white matter glial composition. These data demonstrate that the neonatal transplantation of human glial progenitor cells can effectively treat disorders of congenital and perinatal hypomyelination.	[Windrem, Martha S.; Schanz, Steven J.; Guo, Min; Washco, Vaughn; Wang, Su; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Tian, Guo-Feng; Nedergaard, Mailken; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14642 USA; [Stanwood, Nancy] Univ Rochester, Med Ctr, Dept Obstet & Gynecol, Rochester, NY 14642 USA; [Rasband, Matthew] Baylor Univ, Dept Neurobiol, Coll Med, Houston, TX 77030 USA; [Roy, Neeta S.] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA; [Havton, Leif A.] Univ Calif Los Angeles, Med Ctr, Dept Neurol, Los Angeles, CA 90095 USA	University of Rochester; University of Rochester; University of Rochester; Baylor University; Cornell University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Goldman, SA (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.	steven_goldman@urmc.rochester.edu		Goldman, Steven/0000-0002-5498-4303; Rasband, Matthew/0000-0001-8184-2477	NINDS NIH HHS [R01 NS039559, R01 NS039559-09, R01NS039559] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039559] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARCHER DR, 1994, EXP NEUROL, V125, P268, DOI 10.1006/exnr.1994.1029; Archer DR, 1997, NAT MED, V3, P54, DOI 10.1038/nm0197-54; Back SA, 2001, J NEUROSCI, V21, P1302; Deguchi K, 1997, PEDIATR NEUROL, V16, P296, DOI 10.1016/S0887-8994(97)00041-6; Eftekharpour E, 2007, J NEUROSCI, V27, P3416, DOI 10.1523/JNEUROSCI.0273-07.2007; Garbern J, 2002, PRENATAL DIAG, V22, P1033, DOI 10.1002/pd.465; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; GUMPEL M, 1987, ANN NY ACAD SCI, V495, P71, DOI 10.1111/j.1749-6632.1987.tb23666.x; GUMPEL M, 1989, DEV NEUROSCI-BASEL, V11, P132, DOI 10.1159/000111894; Hammang JP, 1997, EXP NEUROL, V147, P84, DOI 10.1006/exnr.1997.6592; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Keyoung HM, 2007, NEUROSURG CLIN N AM, V18, P93, DOI 10.1016/j.nec.2006.10.009; Keyoung HM, 2001, NAT BIOTECHNOL, V19, P843, DOI 10.1038/nbt0901-843; LACHAPELLE F, 1984, DEV NEUROSCI-BASEL, V6, P325, DOI 10.1159/000112359; Learish RD, 1999, ANN NEUROL, V46, P716, DOI 10.1002/1531-8249(199911)46:5<716::AID-ANA6>3.0.CO;2-M; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Mitome M, 2001, BRAIN, V124, P2147, DOI 10.1093/brain/124.11.2147; Nave K.-A., 2004, MYELIN BIOL DISORDER, P1125; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Pellegatta S, 2006, NEUROBIOL DIS, V21, P314, DOI 10.1016/j.nbd.2005.07.016; POPKO B, 1987, CELL, V48, P713, DOI 10.1016/0092-8674(87)90249-2; POWERS J, 2004, LEUKODYSTROPHIES OVE, P663; Rasband MN, 2001, DEV BIOL, V236, P5, DOI 10.1006/dbio.2001.0326; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; READHEAD C, 1990, ANN NY ACAD SCI, V605, P280; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; ROACH A, 1985, CELL, V42, P149, DOI 10.1016/S0092-8674(85)80110-0; Roy NS, 2000, NAT MED, V6, P271; Schafer DP, 2006, CURR OPIN NEUROBIOL, V16, P508, DOI 10.1016/j.conb.2006.08.003; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; SNYDER EY, 1995, NATURE, V374, P367, DOI 10.1038/374367a0; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397; Yandava BD, 1999, P NATL ACAD SCI USA, V96, P7029, DOI 10.1073/pnas.96.12.7029; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128	38	222	236	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN	2008	2	6					553	565		10.1016/j.stem.2008.03.020	http://dx.doi.org/10.1016/j.stem.2008.03.020			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	315HT	18522848	Bronze, Green Accepted			2022-12-24	WOS:000256870000013
J	Tombola, F; Ulbrich, MH; Isacoff, EY				Tombola, Francesco; Ulbrich, Maximilian H.; Isacoff, Ehud Y.			The voltage-gated proton channel Hv1 has two pores, each controlled by one voltage sensor	NEURON			English	Article							SHAKER K+ CHANNEL; X-RAY-STRUCTURE; POTASSIUM CHANNEL; CHLORIDE CHANNEL; SODIUM-CHANNELS; MOLECULAR-BASIS; ION-PERMEATION; GATING PORE; DOMAIN; REVEALS	In voltage-gated channels, ions flow through a single pore located at the interface between membrane-spanning pore domains from each of four subunits, and the gates of the pore are controlled by four peripheral voltage-sensing domains. In a striking exception, the newly discovered voltage-gated Hv1 proton channels lack a homologous pore domain, leaving the location of the pore unknown. Also unknown are the number of subunits and the mechanism of gating. We find that Hv1 is a dinner and that each subunit contains its own pore and gate, which is controlled by its own voltage sensor. Our experiments show that the cytosolic domain of the channel is necessary and sufficient for dimerization and that the transmembrane part of the channel is functional also when monomerized. The results suggest a mechanism of gating whereby the voltage sensor and gate are one and the same.	[Tombola, Francesco; Ulbrich, Maximilian H.; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ehud@berkeley.edu	Tombola, Francesco/ABA-6002-2020; Ulbrich, Maximilian H/C-6929-2008; isacoff, ehud/AAP-1459-2020; Tombola, Francesco/C-7311-2011	Tombola, Francesco/0000-0002-9315-0352; Ulbrich, Maximilian/0000-0001-8123-1668; Isacoff, Ehud Y./0000-0003-4775-9359	NINDS NIH HHS [R01 NS035549, R01 NS035549-11, R01NS035549] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Das SK, 2007, CHEMBIOCHEM, V8, P994, DOI 10.1002/cbic.200600474; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 1998, J GEN PHYSIOL, V112, P503, DOI 10.1085/jgp.112.4.503; Durell SR, 2004, BIOPHYS J, V87, P2116, DOI 10.1529/biophysj.104.040618; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Imamura F, 2002, J BIOL CHEM, V277, P3640, DOI 10.1074/jbc.M106940200; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kohout SC, 2008, NAT STRUCT MOL BIOL, V15, P106, DOI 10.1038/nsmb1320; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; YU FH, 2004, SCI STKE	39	176	179	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 22	2008	58	4					546	556		10.1016/j.neuron.2008.03.026	http://dx.doi.org/10.1016/j.neuron.2008.03.026			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304PD	18498736	Green Accepted, Bronze			2022-12-24	WOS:000256120500009
J	Huxter, JR; Senior, TJ; Allen, K; Csicsvari, J				Huxter, John R.; Senior, Timothy J.; Allen, Kevin; Csicsvari, Jozsef			Theta phase-specific codes for two-dimensional position, trajectory and heading in the hippocampus	NATURE NEUROSCIENCE			English	Article							FREELY MOVING RATS; PLACE CELLS; PATH-INTEGRATION; MEMORY SEQUENCES; PYRAMIDAL CELLS; SYNAPTIC PLASTICITY; POPULATION ACTIVITY; DIRECTION CELLS; SLICE CULTURES; TEMPORAL CODE	Temporal coding is a means of representing information by the time, as opposed to the rate, at which neurons fire. Evidence of temporal coding in the hippocampus comes from place cells, whose spike times relative to theta oscillations reflect a rat's position while running along stereotyped trajectories. This arises from the backwards shift in cell firing relative to local theta oscillations (phase precession). Here we demonstrate phase precession during place-field crossings in an open-field foraging task. This produced spike sequences in each theta cycle that disambiguate the rat's trajectory through two-dimensional space and can be used to predict movement direction. Furthermore, position and movement direction were maximally predicted from firing in the early and late portions of the theta cycle, respectively. This represents the first direct evidence of a combined representation of position, trajectory and heading in the hippocampus, organized on a fine temporal scale by theta oscillations.	[Huxter, John R.; Senior, Timothy J.; Allen, Kevin; Csicsvari, Jozsef] Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England	University of Oxford	Csicsvari, J (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Mansfield Rd, Oxford OX1 3TH, England.	Jozsef.csicsvari@pharm.ox.ac.uk		Allen, Kevin/0000-0001-5319-3721	MRC [MC_U138169944] Funding Source: UKRI; Medical Research Council [MC_U138169944] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BURGESS N, 1994, NEURAL NETWORKS, V7, P1065, DOI 10.1016/S0893-6080(05)80159-5; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G., 2006, RHYTHMS BRAIN; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Fisher NI, 1995, STAT ANAL CIRCULAR D; Foster DJ, 2007, HIPPOCAMPUS, V17, P1093, DOI 10.1002/hipo.20345; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Golob EJ, 1999, J NEUROSCI, V19, P7198, DOI 10.1523/JNEUROSCI.19-16-07198.1999; GREENSTEIN YJ, 1988, BRAIN RES, V438, P331, DOI 10.1016/0006-8993(88)91358-3; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Jones MW, 2005, HIPPOCAMPUS, V15, P867, DOI 10.1002/hipo.20119; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; Lisman JE, 2005, NEURAL NETWORKS, V18, P1191, DOI 10.1016/j.neunet.2005.08.008; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Maaswinkel H, 1999, HIPPOCAMPUS, V9, P553, DOI 10.1002/(SICI)1098-1063(1999)9:5<553::AID-HIPO9>3.3.CO;2-7; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; Maurer AP, 2006, HIPPOCAMPUS, V16, P785, DOI 10.1002/hipo.20202; McNaughton BL, 1996, J EXP BIOL, V199, P173; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Muller R U, 1991, Hippocampus, V1, P243, DOI 10.1002/hipo.450010306; MULLER RU, 1989, J NEUROSCI, V9, P4101; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; SHARP PE, 1994, J NEUROSCI, V14, P2339; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; TAUBE JS, 1990, J NEUROSCI, V10, P420; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; WHISHAW IQ, 1971, PHYSIOL BEHAV, V6, P391, DOI 10.1016/0031-9384(71)90172-7; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yamaguchi Y, 2002, J NEUROPHYSIOL, V87, P2629, DOI 10.1152/jn.2002.87.6.2629; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	50	147	147	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					587	594		10.1038/nn.2106	http://dx.doi.org/10.1038/nn.2106			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18425124				2022-12-24	WOS:000255327300018
J	Koch, I; Schwarz, H; Beuchle, D; Goellner, B; Langegger, M; Aberle, H				Koch, Iris; Schwarz, Heinz; Beuchle, Dirk; Goellner, Bernd; Langegger, Maria; Aberle, Hermann			Drosophila ankyrin 2 is required for synaptic stability	NEURON			English	Article							HUMAN ERYTHROCYTE ANKYRIN; NEUROMUSCULAR-JUNCTION; ALPHA-SPECTRIN; BETA-SPECTRIN; AXONAL LOCALIZATION; 440-KD ANKYRIN(B); INITIAL SEGMENT; MAJOR ANKYRIN; PROTEIN; BRAIN	Synaptic connections are stabilized through transsynaptic adhesion complexes that are anchored in the underlying cytoskeleton. The Drosophila neuromuscular junction (NMJs) serves as a model system to unravel genes required for the structural remodeling of synapses. In a mutagenesis screen for regulators of synaptic stability, we recovered mutations in Drosophila ankyrin 2 (ank2) affecting two giant Ank2 isoforms that are specifically expressed in the nervous system and associate with the presynaptic membrane cytoskeleton. ank2 mutant larvae show severe deficits in the stability of NMJs, resulting in a reduction in overall terminal size, withdrawal of synaptic boutons, and disassembly of presynaptic active zones. In addition, lack of Ank2 leads to disintegration of the synaptic microtubule cytoskeleton. Microtubules and microtubule-associated proteins fail to extend into distant boutons. Interestingly, Ank2 functions downstream of spectrin in the anchorage of synaptic microtubules, providing the cytoskeletal scaffold that is essential for synaptic stability.	[Goellner, Bernd; Aberle, Hermann] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany; [Koch, Iris; Schwarz, Heinz; Beuchle, Dirk; Langegger, Maria; Aberle, Hermann] Max Planck Inst Dev Biol, Dept Genet 3, D-72076 Tubingen, Germany	University of Munster; Max Planck Society	Aberle, H (corresponding author), Univ Munster, Inst Neurobiol, Badestr 9, D-48149 Munster, Germany.	aberleh@uni-muenster.de	Aberle, Hermann/L-8461-2017	Aberle, Hermann/0000-0002-4864-6105				Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BENNETT V, 1981, P NATL ACAD SCI-BIOL, V78, P7550, DOI 10.1073/pnas.78.12.7550; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; BENNETT V, 1979, J BIOL CHEM, V254, P2533; BENNETT V, 1979, NATURE, V280, P468, DOI 10.1038/280468a0; BENNETT V, 1985, J CELL BIOCHEM, V29, P157, DOI 10.1002/jcb.240290210; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Beuchle D, 2007, MECH DEVELOP, V124, P390, DOI 10.1016/j.mod.2007.01.006; Beumer K, 2002, DEVELOPMENT, V129, P3381; Bouley M, 2000, J NEUROSCI, V20, P4515, DOI 10.1523/JNEUROSCI.20-12-04515.2000; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHAN W, 1993, J CELL BIOL, V123, P1463, DOI 10.1083/jcb.123.6.1463; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Das A, 2006, J CELL BIOL, V175, P325, DOI 10.1083/jcb.200602095; DAVIS JQ, 1984, J BIOL CHEM, V259, P3550; De Matteis MA, 1998, CURR OPIN CELL BIOL, V10, P542, DOI 10.1016/S0955-0674(98)80071-9; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; DUBREUIL RR, 1994, P NATL ACAD SCI USA, V91, P10285, DOI 10.1073/pnas.91.22.10285; Duncan JE, 2006, PLOS GENET, V2, P1275, DOI 10.1371/journal.pgen.0020124; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Featherstone DE, 2001, J NEUROSCI, V21, P4215, DOI 10.1523/JNEUROSCI.21-12-04215.2001; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; GRASSO G, 1996, DIS, V77, P94; Hedstrom KL, 2006, J NEUROCHEM, V98, P1345, DOI 10.1111/j.1471-4159.2006.04001.x; Hortsch M, 2002, MOL CELL NEUROSCI, V20, P43, DOI 10.1006/mcne.2002.1113; Hortsch M, 1998, J CELL BIOL, V142, P251, DOI 10.1083/jcb.142.1.251; Hulsmeier J, 2007, DEVELOPMENT, V134, P713, DOI 10.1242/dev.02758; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Hurd DD, 1996, GENETICS, V144, P1075; Jefford G, 2000, J BIOL CHEM, V275, P27726; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; KUNIMOTO M, 1991, J CELL BIOL, V115, P1319, DOI 10.1083/jcb.115.5.1319; LAMBERT S, 1990, P NATL ACAD SCI USA, V87, P1730, DOI 10.1073/pnas.87.5.1730; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; LETINSKY MS, 1976, J NEUROCYTOL, V5, P691, DOI 10.1007/BF01181582; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Marques G, 2006, INT REV NEUROBIOL, V75, P267, DOI 10.1016/S0074-7742(06)75012-7; Martin-Pena A, 2006, J NEUROSCI, V26, P10199, DOI 10.1523/JNEUROSCI.1223-06.2006; Otsuka AJ, 2002, J NEUROBIOL, V50, P333, DOI 10.1002/neu.10036; OTTO E, 1991, J CELL BIOL, V114, P241, DOI 10.1083/jcb.114.2.241; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Pielage J, 2008, NEURON, V58, P195, DOI 10.1016/j.neuron.2008.02.017; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; RILEY DA, 1977, BRAIN RES, V134, P279, DOI 10.1016/0006-8993(77)91073-3; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Ruiz-Canada C, 2006, INT REV NEUROBIOL, V75, P217, DOI 10.1016/S0074-7742(06)75010-3; Ruiz-Canada C, 2006, INT REV NEUROBIOL, V75, P1, DOI 10.1016/S0074-7742(06)75001-2; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sone M, 2000, DEVELOPMENT, V127, P4157; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; WERNIG A, 1980, J NEUROCYTOL, V9, P277, DOI 10.1007/BF01181538; Yamamoto M, 2006, CURR BIOL, V16, P1678, DOI 10.1016/j.cub.2006.06.061; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	70	93	93	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 24	2008	58	2					210	222		10.1016/j.neuron.2008.03.019	http://dx.doi.org/10.1016/j.neuron.2008.03.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292YX	18439406	Bronze			2022-12-24	WOS:000255303100009
J	Romero, E; Cha, GH; Verstreken, P; Ly, CV; Hughes, RE; Bellen, HJ; Botas, J				Romero, Eliana; Cha, Guang-Ho; Verstreken, Patrik; Ly, Cindy V.; Hughes, Robert E.; Bellen, Hugo J.; Botas, Juan			Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm	NEURON			English	Article							DISEASE TRANSGENIC MICE; DOSAGE-DEPENDENT MANNER; YAC128 MOUSE MODEL; KNOCK-IN MICE; MUTANT HUNTINGTIN; AXONAL-TRANSPORT; INCREASED SENSITIVITY; MORPHOLOGICAL-CHANGES; SYNAPTIC PLASTICITY; CALCIUM-CHANNEL	Huntington's disease (HD) is a dominantly inherited neurodegenerative disorder caused by expansion of a translated CAG repeat in the N terminus of the huntingtin (htt) protein. Here we describe the generation and characterization of a full-length HD Drosophila model to reveal a previously unknown disease mechanism that occurs early in the course of pathogenesis, before expanded htt is imported into the nucleus in detectable amounts. We find that expanded full-length htt (128Qhtt(FL)) leads to behavioral, neurodegenerative, and electrophysiological phenotypes. These phenotypes are caused by a Ca2+-dependent increase in neurotransmitter release efficiency in 128QhttFL animals. Partial loss of function in synaptic transmission (syntaxin, Snap, Rop) and voltage-gated Ca2+ channel genes suppresses both the electrophysiological and the neurodegenerative phenotypes. Thus, our data indicate that increased neurotransmission is at the root of neuronal degeneration caused by expanded full-length htt during early stages of pathogenesis.	[Romero, Eliana; Cha, Guang-Ho; Verstreken, Patrik; Bellen, Hugo J.; Botas, Juan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Verstreken, Patrik; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Ly, Cindy V.; Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Verstreken, Patrik; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Botas, Juan] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Hughes, Robert E.] Buck Inst, Novato, CA 94945 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Buck Institute for Research on Aging	Botas, J (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jbotas@bcm.tmc.edu	Verstreken, Patrik/AAC-7591-2022	Verstreken, Patrik/0000-0002-5073-5393; Cha, Guang-Ho/0000-0003-2639-1727; Bellen, Hugo/0000-0001-5992-5989	NINDS NIH HHS [R01 NS042179-01S2, F30 NS056520, NS42179, R01 NS042179, R56 NS042179] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS042179, R01NS042179, F30NS056520] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Cepeda C, 2003, J NEUROSCI, V23, P961; Cepeda C, 2001, J NEUROSCI RES, V66, P525, DOI 10.1002/jnr.1244; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Fergestad T, 2006, GENETICS, V172, P1031, DOI 10.1534/genetics.105.050625; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Gunawardena S, 2005, ARCH NEUROL-CHICAGO, V62, P46, DOI 10.1001/archneur.62.1.46; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hickey MA, 2003, CYTOGENET GENOME RES, V100, P276, DOI 10.1159/000072863; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P496, DOI 10.1098/rspb.1965.0017; Kawasaki F, 2000, J NEUROSCI, V20, P4885; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Laforet GA, 2001, J NEUROSCI, V21, P9112, DOI 10.1523/JNEUROSCI.21-23-09112.2001; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Li JY, 2003, TRENDS MOL MED, V9, P414, DOI 10.1016/j.molmed.2003.08.006; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Li SH, 2004, NEUROSCIENTIST, V10, P467, DOI 10.1177/1073858404266777; Lievens JC, 2002, MOL CELL NEUROSCI, V20, P638, DOI 10.1006/mcne.2002.1152; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marsh JL, 2004, BIOESSAYS, V26, P485, DOI 10.1002/bies.20029; Menalled LB, 2002, J NEUROSCI, V22, P8266; Menalled LB, 2002, TRENDS PHARMACOL SCI, V23, P32, DOI 10.1016/S0165-6147(00)01884-8; Menalled Liliana B, 2005, NeuroRx, V2, P465, DOI 10.1602/neurorx.2.3.465; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; NicNiocaill B, 2001, EUR J NEUROSCI, V13, P206, DOI 10.1046/j.0953-816X.2000.01379.x; ORDWAY RW, 1994, P NATL ACAD SCI USA, V91, P5715, DOI 10.1073/pnas.91.12.5715; Panov AV, 2005, MOL CELL BIOCHEM, V269, P143, DOI 10.1007/s11010-005-3454-9; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Sang TK, 2002, DEVELOPMENT, V129, P143; Sang Tzu-Kang, 2005, NeuroRx, V2, P438, DOI 10.1602/neurorx.2.3.438; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Smith R, 2005, CELL MOL LIFE SCI, V62, P1901, DOI 10.1007/s00018-005-5084-5; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Swayne LA, 2005, MOL CELL NEUROSCI, V30, P339, DOI 10.1016/j.mcn.2005.07.016; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Usdin MT, 1999, HUM MOL GENET, V8, P839, DOI 10.1093/hmg/8.5.839; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P3823, DOI 10.1093/hmg/ddi407; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Yu ZX, 2003, J NEUROSCI, V23, P2193; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; ZHENG W, 1995, J NEUROSCI, V15, P1132	67	111	112	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 10	2008	57	1					27	40		10.1016/j.neuron.2007.11.025	http://dx.doi.org/10.1016/j.neuron.2007.11.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	250YZ	18184562	Green Accepted, Bronze			2022-12-24	WOS:000252338600007
J	Saneyoshi, T; Wayman, G; Fortin, D; Davare, M; Hoshi, N; Nozaki, N; Natsume, T; Soderling, TR				Saneyoshi, Takeo; Wayman, Gary; Fortin, Dale; Davare, Monika; Hoshi, Naoto; Nozaki, Naohito; Natsume, Tohru; Soderling, Thomas R.			Activity-dependent synaptogenesis: Regulation by a CaM-kinase kinase/CaM-kinase I/beta PIX signaling complex	NEURON			English	Article							NUCLEOTIDE EXCHANGE FACTOR; DENDRITIC SPINE MORPHOGENESIS; POSTSYNAPTIC DENSITY PROTEINS; RESONANCE ENERGY-TRANSFER; LONG-TERM POTENTIATION; ACTIN-BASED PLASTICITY; BETA-PIX; SYNAPTIC PLASTICITY; MENTAL-RETARDATION; RHO-GTPASES	Neuronal activity augments maturation of mushroom-shaped spines to form excitatory synapses, thereby strengthening synaptic transmission. We have delineated a Ca2+-signaling pathway downstream of the NMDA receptor that stimulates calmodulin-dependent kinase kinase (CaMKK) and CaMKI to promote formation of spines and synapses in hippocampal neurons. CaMKK and CaMKI form a multiprotein signaling complex with the guanine nucleotide exchange factor (GEF) beta PIX and GIT1 that is localized in spines. CaMKI-mediated phosphorylation of Ser516 in beta PIX enhances its GEF activity, resulting in activation of Rac1, an established enhancer of spinogenesis. Suppression of CaMKK or CaMKI by pharmacological inhibitors, dominant-negative (dn) constructs and siRNAs, as well as expression of the beta PIX Ser516Ala mutant, decreases spine formation and mEPSC frequency. Constitutively-active Pak1, a downstream effector of Rac1, rescues spine inhibition by dnCaMKI or beta PIX S516A. This activity-dependent signaling pathway can promote synapse formation during neuronal development and in structural plasticity.	[Saneyoshi, Takeo; Wayman, Gary; Fortin, Dale; Davare, Monika; Hoshi, Naoto; Soderling, Thomas R.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Nozaki, Naohito] Kanagawa Dent Coll, Kanagawa 2388580, Japan; [Natsume, Tohru] Biol Informat Res Ctr, Natl Inst Adv Ind Sci & Technol, Tokyo 1350064, Japan	Oregon Health & Science University; Kanagawa Dental College; National Institute of Advanced Industrial Science & Technology (AIST)	Soderling, TR (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	soderlit@ohsu.edu	Saneyoshi, Takeo/AAF-5170-2019; Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582; Davare, Monika/0000-0003-1802-7597	NIDDK NIH HHS [DK007680, T32 DK007680, T32 DK007680-17] Funding Source: Medline; NIGMS NIH HHS [R01 GM041292, R01 GM041292-20, R01 GM048231, R37 GM048231, GM48231, R01 GM048231-12] Funding Source: Medline; NINDS NIH HHS [R01 NS027037-18, R01 NS027037, NS027037] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048231, R01GM041292, R37GM048231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027037] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Brunig I, 2004, NEUROPHARMACOLOGY, V47, P669, DOI 10.1016/j.neuropharm.2004.07.038; CAESER M, 1991, J COMP NEUROL, V307, P87, DOI 10.1002/cne.903070109; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Chahdi A, 2005, J BIOL CHEM, V280, P578, DOI 10.1074/jbc.M411130200; Collin C, 1997, J NEUROPHYSIOL, V77, P1614, DOI 10.1152/jn.1997.77.3.1614; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Davare MA, 2004, J BIOL CHEM, V279, P52191, DOI 10.1074/jbc.M409873200; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Feng QY, 2004, EMBO J, V23, P3492, DOI 10.1038/sj.emboj.7600331; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Kaech S, 1997, J NEUROSCI, V17, P9565; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kim S, 2003, J BIOL CHEM, V278, P6291, DOI 10.1074/jbc.M212287200; Ko J, 2003, J NEUROSCI, V23, P1667; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; Korkotian E, 2007, CELL CALCIUM, V42, P41, DOI 10.1016/j.ceca.2006.11.006; Kossel AH, 1997, J NEUROSCI, V17, P9634; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Ma XM, 2003, J NEUROSCI, V23, P10593; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Meng YH, 2004, NEUROPHARMACOLOGY, V47, P746, DOI 10.1016/j.neuropharm.2004.06.030; Mott HR, 2005, BIOCHEMISTRY-US, V44, P10977, DOI 10.1021/bi050374a; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Oertner TG, 2005, CELL CALCIUM, V37, P477, DOI 10.1016/j.ceca.2005.01.016; Park E, 2003, J BIOL CHEM, V278, P19220, DOI 10.1074/jbc.M301052200; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Roche JP, 2002, J NEUROSCI, V22, P6471, DOI 10.1523/jneurosci.22-15-06471.2002; Rosenberger G, 2006, EUR J CELL BIOL, V85, P265, DOI 10.1016/j.ejcb.2005.10.007; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Segal M, 2003, EUR J NEUROSCI, V17, P2573, DOI 10.1046/j.1460-9568.2003.02696.x; Shin EY, 2002, J BIOL CHEM, V277, P44417, DOI 10.1074/jbc.M203754200; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Suizu F, 2002, BIOCHEM J, V367, P335, DOI 10.1042/BJ20020536; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Tokumitsu H, 2003, J BIOL CHEM, V278, P10908, DOI 10.1074/jbc.M213183200; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; van Galen EJM, 2005, PROG BRAIN RES, V147, P295, DOI 10.1016/S0079-6123(04)47022-8; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	83	174	180	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 10	2008	57	1					94	107		10.1016/j.neuron.2007.11.016	http://dx.doi.org/10.1016/j.neuron.2007.11.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	250YZ	18184567	Green Accepted, Bronze			2022-12-24	WOS:000252338600012
J	Chen, G; Sima, J; Jin, M; Wang, KY; Xue, XJ; Zheng, W; Ding, YQ; Yuan, XB				Chen, Gang; Sima, Jian; Jin, Ming; Wang, Kai-yu; Xue, Xiao-jing; Zheng, Wang; Ding, Yu-qiang; Yuan, Xiao-bing			Semaphorin-3A guides radial migration of cortical neurons during development	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; CEREBRAL-CORTEX; GROWTH CONES; RECEPTOR; NEUROPILIN; PROTEIN; REELIN; BRAIN; NEOCORTEX	Postmitotic neurons in the developing cortex migrate along radial glial fibers to their proper location in the cortical plate and form the layered structure. Here we report that the radial migration of rat layer II/III cortical neurons requires guidance by the extracellular diffusible factor Semaphorin-3A (Sema3A). This factor is expressed in a descending gradient across the cortical layers, whereas its receptor neuropilin-1 (NP1) is highly expressed in migrating neurons. Downregulation or conditional knockout of NP1 in newborn cortical neurons impedes their radial migration by disrupting their radial orientation during migration without altering their cell fate. Studies in cultured cortical slices further show that the endogenous gradient of Sema3A is required for the proper migration of newborn neurons. In addition, transwell chemotaxis assays show that isolated newborn neurons are attracted by Sema3A. Thus, Sema3A may function as a chemoattractive guidance signal for the radial migration of newborn cortical neurons toward upper layers.	[Chen, Gang; Sima, Jian; Jin, Ming; Wang, Kai-yu; Xue, Xiao-jing; Zheng, Wang; Ding, Yu-qiang; Yuan, Xiao-bing] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Chen, Gang; Sima, Jian; Jin, Ming; Wang, Kai-yu; Xue, Xiao-jing; Zheng, Wang; Ding, Yu-qiang; Yuan, Xiao-bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Key State Lab Neurobiol, Shanghai 200031, Peoples R China; [Chen, Gang; Sima, Jian; Wang, Kai-yu; Xue, Xiao-jing; Zheng, Wang] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Yuan, XB (corresponding author), Chinese Acad Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yuanxb@ion.ac.cn		Ding, Yu-Qiang/0000-0003-1202-4635; Yuan, Xiaobing/0000-0002-1632-8460; Zheng, Wang/0000-0002-7050-6133; Sima, Jian/0000-0002-4127-1638				Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Behar TN, 2001, CEREB CORTEX, V11, P744, DOI 10.1093/cercor/11.8.744; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; FISHELL G, 1991, DEVELOPMENT, V113, P755; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; GUIARRO P, 2006, MOL CELL NEUROSCI, V33, P389; Gupta A, 2003, NEUROSIGNALS, V12, P173, DOI 10.1159/000074618; Gupta A, 2003, NAT NEUROSCI, V6, P1284, DOI 10.1038/nn1151; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Jossin Y, 2003, J NEUROSCI, V23, P9953; Khaibullina AA, 2004, DEV BRAIN RES, V148, P59, DOI 10.1016/j.devbrainres.2003.09.022; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kuo G, 2005, J NEUROSCI, V25, P8578, DOI 10.1523/JNEUROSCI.1656-05.2005; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Liebl DJ, 2003, J NEUROSCI RES, V71, P7, DOI 10.1002/jnr.10457; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Magdaleno S, 2002, NEURON, V33, P573, DOI 10.1016/S0896-6273(02)00582-2; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; Petreanu L, 2002, J NEUROSCI, V22, P6106; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rakic P, 1998, J AM ACAD CHILD PSY, V37, P116, DOI 10.1097/00004583-199801000-00026; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Sun W, 2002, MOL BRAIN RES, V103, P36, DOI 10.1016/S0169-328X(02)00168-7; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5; Tabata H, 2002, J NEUROSCI RES, V69, P723, DOI 10.1002/jnr.10345; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Van Der Zwaag B, 2002, DEV DYNAM, V225, P336, DOI 10.1002/dvdy.10159; Whitaker GB, 2001, J BIOL CHEM, V276, P25520, DOI 10.1074/jbc.M102315200; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xu HT, 2004, P NATL ACAD SCI USA, V101, P4296, DOI 10.1073/pnas.0303893101; Yamashita N, 2006, J NEUROSCI, V26, P13357, DOI 10.1523/JNEUROSCI.4276-06.2006; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075	50	188	192	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					36	44		10.1038/nn2018	http://dx.doi.org/10.1038/nn2018			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18059265				2022-12-24	WOS:000252117900010
J	Dudman, JT; Tsay, D; Siegelbaum, SA				Dudman, Joshua T.; Tsay, David; Siegelbaum, Steven A.			A role for synaptic inputs at distal dendrites: Instructive signals for hippocampal long-term plasticity	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; DIRECT CORTICAL INPUT; ENTORHINAL CORTEX; AREA CA1; SPATIAL SEGREGATION; ACTION-POTENTIALS; DIFFERENT FORMS; CALCIUM STORES; CA2+; LTP	Synaptic potentials originating at distal dendritic locations are severely attenuated when they reach the soma and, thus, are poor at driving somatic spikes. Nonetheless, distal inputs convey essential information, suggesting that such inputs may be important for compartmentalized dendritic signaling. Here we report a new plasticity rule in which stimulation of distal perforant path inputs to hippocampal CA1 pyramidal neurons induces long-term potentiation at the CA1 proximal Schaffer collateral synapses when the two inputs are paired at a precise interval. This subthreshold form of heterosynaptic plasticity occurs in the absence of somatic spiking but requires activation of both NMDA receptors and IP3 receptor-dependent release of Ca2+ from internal stores. Our results suggest that direct sensory information arriving at distal CA1 synapses through the perforant path provide compartmentalized, instructive signals that assess the saliency of mnemonic information propagated through the hippocampal circuit to proximal synapses.	[Dudman, Joshua T.; Tsay, David; Siegelbaum, Steven A.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	sas8@columbia.edu		Dudman, Joshua/0000-0002-4436-1057	NIMH NIH HHS [T32 MH015174, T32 MH015174-30] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015174] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AbdulGhani MA, 1996, J NEUROPHYSIOL, V76, P2691, DOI 10.1152/jn.1996.76.4.2691; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CAJAL SRY, 1911, HIST SYSTEME NERVEUX; COLBERT CM, 1993, BRAIN RES, V606, P87, DOI 10.1016/0006-8993(93)91573-B; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Doi T, 2005, J NEUROSCI, V25, P950, DOI 10.1523/JNEUROSCI.2727-04.2005; EMPSON RM, 1995, HIPPOCAMPUS, V5, P104, DOI 10.1002/hipo.450050203; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Frank LM, 2001, J NEUROPHYSIOL, V86, P2029, DOI 10.1152/jn.2001.86.4.2029; Frerking M, 2005, J NEUROPHYSIOL, V94, P1528, DOI 10.1152/jn.00108.2005; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Golding NL, 2005, J PHYSIOL-LONDON, V568, P69, DOI 10.1113/jphysiol.2005.086793; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Judge SJ, 2004, J NEUROPHYSIOL, V92, P1615, DOI 10.1152/jn.00848.2003; Kampa BM, 2004, J PHYSIOL-LONDON, V556, P337, DOI 10.1113/jphysiol.2003.058842; Lamsa K, 2005, NAT NEUROSCI, V8, P916, DOI 10.1038/nn1486; Levy WB, 1998, LEARN MEMORY, V4, P510, DOI 10.1101/lm.4.6.510; LEVY WB, 1995, HIPPOCAMPUS, V5, P137, DOI 10.1002/hipo.450050209; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; London M, 2002, NAT NEUROSCI, V5, P332, DOI 10.1038/nn826; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2003, J NEUROPHYSIOL, V89, P1910, DOI 10.1152/jn.00842.2002; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; Nakamura T, 2002, J PHYSIOL-LONDON, V543, P465, DOI 10.1113/jphysiol.2002.020362; Nakamura T, 2000, J NEUROSCI, V20, P8365, DOI 10.1523/JNEUROSCI.20-22-08365.2000; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Okubo Y, 2004, J NEUROSCI, V24, P9513, DOI 10.1523/JNEUROSCI.1829-04.2004; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; Otmakhova NA, 2000, ANN NY ACAD SCI, V911, P462; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; Raymond CR, 2006, J PHYSIOL-LONDON, V570, P97, DOI 10.1113/jphysiol.2005.098947; Raymond CR, 2002, J NEUROPHYSIOL, V88, P249, DOI 10.1152/jn.2002.88.1.249; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; STEWARD O, 1990, BRAIN RES, V516, P292, DOI 10.1016/0006-8993(90)90930-A; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; Svoboda K, 1999, NEURON, V22, P427, DOI 10.1016/S0896-6273(00)80698-4; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; Wohrl R, 2007, EUR J NEUROSCI, V25, P251, DOI 10.1111/j.1460-9568.2006.05274.x; YECKEL MF, 1990, P NATL ACAD SCI USA, V87, P5832, DOI 10.1073/pnas.87.15.5832	73	132	135	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2007	56	5					866	879		10.1016/j.neuron.2007.10.020	http://dx.doi.org/10.1016/j.neuron.2007.10.020			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241MA	18054862	Green Accepted, Bronze			2022-12-24	WOS:000251659300012
J	Klein, ME; Lioy, DT; Ma, L; Impey, S; Mandel, G; Goodman, RH				Klein, Matthew E.; Lioy, Daniel T.; Ma, Lin; Impey, Soren; Mandel, Gail; Goodman, Richard H.			Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA	NATURE NEUROSCIENCE			English	Article							RETT-SYNDROME; MICE; DUPLICATION; MATURATION; DROSOPHILA; MALES	Both increases and decreases in methyl CpG-binding protein 2 (MeCP2) levels cause neurodevelopmental defects. We found that MeCP2 translation is regulated by microRNA 132 (miR132). Block of miR132- mediated repression increased MeCP2 and brain- derived neurotrophic factor (BDNF) levels in cultured rat neurons and the loss of MeCP2 reduced BDNF and miR132 levels in vivo. This feedback loop may provide a mechanism for homeostatic control of MeCP2 expression.	Oregon Hlth & Sci Univ, Vollurn Inst, Portland, OR 97239 USA	Oregon Health & Science University	Goodman, RH (corresponding author), Oregon Hlth & Sci Univ, Vollurn Inst, L-474,3181 SW Sam Jackson Rd, Portland, OR 97239 USA.	goodmanr@ohsu.edu	klein, matthew/GPS-5798-2022					Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Fukuda T, 2005, J NEUROPATH EXP NEUR, V64, P537, DOI 10.1093/jnen/64.6.537; Jugloff DGM, 2005, NEUROBIOL DIS, V19, P18, DOI 10.1016/j.nbd.2004.11.002; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang H, 2006, J NEUROSCI, V26, P10911, DOI 10.1523/JNEUROSCI.1810-06.2006	15	355	386	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1513	1514		10.1038/nn2010	http://dx.doi.org/10.1038/nn2010			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17994015				2022-12-24	WOS:000251172900006
J	Bhandawat, V; Olsen, SR; Gouwens, NW; Schlief, ML; Wilson, RI				Bhandawat, Vikas; Olsen, Shawn R.; Gouwens, Nathan W.; Schlief, Michelle L.; Wilson, Rachel I.			Sensory processing in the Drosophila antennal lobe increases reliability and separability of ensemble odor representations	NATURE NEUROSCIENCE			English	Article							OLFACTORY NETWORK DYNAMICS; PRIMARY VISUAL-CORTEX; RESPONSE VARIABILITY; CORTICAL-NEURONS; SYSTEM; MELANOGASTER; ORGANIZATION; INFORMATION; BULB; FLY	Here we describe several fundamental principles of olfactory processing in the Drosophila melanogaster antennal lobe (the analog of the vertebrate olfactory bulb), through the systematic analysis of input and output spike trains of seven identified glomeruli. Repeated presentations of the same odor elicit more reproducible responses in second-order projection neurons (PNs) than in their presynaptic olfactory receptor neurons (ORNs). PN responses rise and accommodate rapidly, emphasizing odor onset. Furthermore, weak ORN inputs are amplified in the PN layer but strong inputs are not. This nonlinear transformation broadens PN tuning and produces more uniform distances between odor representations in PN coding space. In addition, portions of the odor response profile of a PN are not systematically related to their direct ORN inputs, which probably indicates the presence of lateral connections between glomeruli. Finally, we show that a linear discriminator classifies odors more accurately using PN spike trains than using an equivalent number of ORN spike trains.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu	Wilson, Rachel/E-2227-2012	Wilson, Rachel/0000-0001-8573-9266; Olsen, Shawn/0000-0002-9568-7057	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174, F32DC008741] Funding Source: NIH RePORTER; NIDCD NIH HHS [1F32DC008471-01A1, F32 DC008741, R01 DC008174, R01 DC008174-02] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bazhenov M, 2005, NEURON, V46, P483, DOI 10.1016/j.neuron.2005.03.022; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; Berry MJ, 1998, J NEUROSCI, V18, P2200; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DERBY CD, 1984, J NEUROPHYSIOL, V51, P906, DOI 10.1152/jn.1984.51.5.906; DUCHAMP A, 1982, CHEM SENSES, V7, P191, DOI 10.1093/chemse/7.2.191; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Laissue PP, 1999, J COMP NEUROL, V405, P543; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MATHEWS DF, 1972, J GEN PHYSIOL, V60, P166; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P7122, DOI 10.1073/pnas.0702133104; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Vogel A, 2005, J NEUROPHYSIOL, V93, P3548, DOI 10.1152/jn.01288.2004; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	48	223	225	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1474	1482		10.1038/nn1976	http://dx.doi.org/10.1038/nn1976			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17922008	Green Accepted			2022-12-24	WOS:000250508400026
J	Eiges, R; Urbach, A; Malcov, M; Frumkin, T; Schwartz, T; Amit, A; Yaron, Y; Eden, A; Yanuka, O; Benvenisty, N; Ben-Yosef, D				Eiges, Rachel; Urbach, Achia; Malcov, Mira; Frumkin, Tsvia; Schwartz, Tamar; Amit, Ami; Yaron, Yuval; Eden, Amir; Yanuka, Ofra; Benvenisty, Nissim; Ben-Yosef, Dalit			Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos	CELL STEM CELL			English	Article							FMR1 GENE; TRANSGENIC MICE; FULL-MUTATION; CGG REPEAT; DNA METHYLATION; INSTABILITY; DIFFERENTIATION; INACTIVATION; EXPRESSION; MODEL	We report on the establishment of a human embryonic stem cell (HESC) line from a preimplantation fragile X-affected embryo and demonstrate its value as an appropriate model to study developmentally regulated events that are involved in the pathogenesis of this disorder. Fragile X syndrome results from FMR1 gene inactivation due to a CGG expansion at the 5'UTR region of the gene. Early events in FMR1 silencing have not been fully characterized due to the lack of appropriate animal or cellular models. Here we show that, despite the presence of a full mutation, affected undifferentiated HESCs express FMR1 and are DNA unmethylated. However, epigenetic silencing by DNA methylation and histone modification occurs upon differentiation. Our unique cell system allows the dissection of the sequence by which these epigenetic changes are acquired and illustrates the importance of HESCs in unraveling developmentally regulated mechanisms associated with human genetic disorders.	Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Anim & Cell Biol, IL-91904 Jerusalem, Israel; Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Lis Matern Hosp,Racine IVF Unit, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Prenatal Diag Unit,Genet Inst, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Benvenisty, N (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.	nissimb@cc.huji.ac.il	/GLR-9975-2022	Urbach, Achia/0000-0001-9393-4504; eiges, rachel/0000-0001-8139-0933				BAKKER CE, 1994, CELL, V78, P23; Bontekoe CJM, 2001, HUM MOL GENET, V10, P1693, DOI 10.1093/hmg/10.16.1693; Bontekoe CJM, 1997, EUR J HUM GENET, V5, P293, DOI 10.1159/000484780; Brouwer JR, 2007, EXP CELL RES, V313, P244, DOI 10.1016/j.yexcr.2006.10.002; Burman RW, 1999, HUM MOL GENET, V8, P2293, DOI 10.1093/hmg/8.12.2293; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Dvash T, 2004, BEST PRACT RES CL OB, V18, P929, DOI 10.1016/j.bpobgyn.2004.06.005; Dvash T, 2004, HUM REPROD, V19, P2875, DOI 10.1093/humrep/deh529; Dvash T, 2006, PEDIATR RES, V60, P111, DOI 10.1203/01.pdr.0000228349.24676.17; Eberhart DE, 1996, SOMAT CELL MOLEC GEN, V22, P435, DOI 10.1007/BF02369435; Eiges R, 2002, FEBS LETT, V529, P135, DOI 10.1016/S0014-5793(02)03191-5; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Lavedan C, 1998, GENOMICS, V50, P229, DOI 10.1006/geno.1998.5299; Lavedan CN, 1997, HUM GENET, V100, P407, DOI 10.1007/s004390050525; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; Malcov M, 2007, REPROD BIOMED ONLINE, V14, P515, DOI 10.1016/S1472-6483(10)60901-7; Nolin SL, 1996, AM J HUM GENET, V59, P1252; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Panagopoulos I, 1999, HUM MUTAT, V14, P71, DOI 10.1002/(SICI)1098-1004(1999)14:1<71::AID-HUMU9>3.0.CO;2-5; Peier AM, 2002, GENOMICS, V80, P423, DOI 10.1006/geno.2002.6849; Pickering SJ, 2005, REPROD BIOMED ONLINE, V10, P390, DOI 10.1016/S1472-6483(10)61801-9; Pietrobono R, 2002, NUCLEIC ACIDS RES, V30, P3278, DOI 10.1093/nar/gkf434; Pietrobono R, 2005, HUM MOL GENET, V14, P267, DOI 10.1093/hmg/ddi024; Schulze D, 2000, IMECHE CONF TRANS, V2000, P97; SMEETS HJM, 1995, HUM MOL GENET, V4, P2103, DOI 10.1093/hmg/4.11.2103; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Tabolacci E, 2005, EUR J HUM GENET, V13, P641, DOI 10.1038/sj.ejhg.5201393; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Verlinsky Y, 2005, REPROD BIOMED ONLINE, V10, P105, DOI 10.1016/S1472-6483(10)60810-3; Willemsen R, 2002, HUM GENET, V110, P601, DOI 10.1007/s00439-002-0723-5; Wohrle D, 2001, AM J HUM GENET, V69, P504, DOI 10.1086/322739	41	224	231	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV	2007	1	5					568	577		10.1016/j.stem.2007.09.001	http://dx.doi.org/10.1016/j.stem.2007.09.001			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236AX	18371394	Bronze			2022-12-24	WOS:000251276500014
J	Goold, CP; Davis, GW				Goold, Carleton P.; Davis, Graeme W.			The BMP ligand Gbb gates the expression of synaptic horneostasis independent of synaptic growth control	NEURON			English	Article							PRESYNAPTIC TRANSMITTER RELEASE; BONE MORPHOGENETIC PROTEIN-7; TGF-BETA SUPERFAMILY; WISHFUL-THINKING; RETROGRADE SIGNAL; AXONAL-TRANSPORT; NERVOUS-SYSTEM; II-RECEPTOR; DROSOPHILA-MELANOGASTER; NEUROMUSCULAR-JUNCTION	Inhibition of postsynaptic glutamate receptors at the Drosophila NMJ initiates a compensatory increase in presynaptic release termed synaptic homeostasis. BMP signaling is necessary for normal synaptic growth and stability. It remains unknown whether BMPs have a specific role during synaptic homeostasis and, if so, whether BMP signaling functions as an instructive retrograde signal that directly modulates presynaptic transmitter release. Here, we demonstrate that the BMP receptor (Wit) and ligand (Gbb) are necessary for the rapid induction of synaptic homeostasis. We also provide evidence that both Wit and Gbb have functions during synaptic homeostasis that are separable from NMJ growth. However, further genetic experiments demonstrate that Gbb does not function as an instructive retrograde signal during synaptic homeostasis. Rather, our data indicate that Wit and Gbb function via the downstream transcription factor Mad and that Mad-mediated signaling is continuously required during development to confer competence of motoneurons to express synaptic homeostasis.	Univ Calif San Francisco, Program Neurosci, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Program Neurosci, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	gdavis@biochem.ucsf.edu			NINDS NIH HHS [NS39313, R01 NS039313-08, R01 NS039313] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039313] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Allen MJ, 1999, J NEUROSCI, V19, P9374; Baines RA, 2004, J NEUROSCI, V24, P6904, DOI 10.1523/JNEUROSCI.1978-04.2004; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cameron JS, 1998, NEURON, V21, P1045, DOI 10.1016/S0896-6273(00)80622-4; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Chesnutt C, 2004, DEV BIOL, V274, P334, DOI 10.1016/j.ydbio.2004.07.019; Chizhikov VV, 2005, DEV BIOL, V277, P287, DOI 10.1016/j.ydbio.2004.10.011; CULLCANDY SG, 1980, J PHYSIOL-LONDON, V299, P621, DOI 10.1113/jphysiol.1980.sp013145; Dattatreyamurty B, 2001, EXP NEUROL, V172, P273, DOI 10.1006/exnr.2001.7728; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; Jiang N, 2000, DEV BIOL, V226, P118, DOI 10.1006/dbio.2000.9832; Keshishian H, 2004, TRENDS NEUROSCI, V27, P143, DOI 10.1016/j.tins.2004.01.004; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Lee-Hoeflich ST, 2005, FEBS LETT, V579, P4615, DOI 10.1016/j.febslet.2005.06.088; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lo PCH, 1999, MECH DEVELOP, V86, P171, DOI 10.1016/S0925-4773(99)00108-2; Lopez-Coviella I, 2006, BRAIN RES, V1088, P49, DOI 10.1016/j.brainres.2006.02.073; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Murali D, 2005, DEVELOPMENT, V132, P913, DOI 10.1242/dev.01673; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nguyen M, 2000, MECH DEVELOP, V95, P201, DOI 10.1016/S0925-4773(00)00338-5; Nie ZP, 1999, J NEUROSCI, V19, P10270; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; PLOMP JJ, 1992, J PHYSIOL-LONDON, V458, P487, DOI 10.1113/jphysiol.1992.sp019429; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Raible DW, 2006, CURR OPIN CELL BIOL, V18, P698, DOI 10.1016/j.ceb.2006.09.003; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Rios I, 2004, DEVELOPMENT, V131, P3159, DOI 10.1242/dev.01188; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Sanyal S, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-20; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sun M, 2007, J NEUROSCI, V27, P7740, DOI 10.1523/JNEUROSCI.1604-07.2007; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Twombly V, 1996, DEVELOPMENT, V122, P1555; Wharton KA, 1999, GENETICS, V152, P629; Withers GS, 2000, EUR J NEUROSCI, V12, P106, DOI 10.1046/j.1460-9568.2000.00889.x; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	68	95	95	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 4	2007	56	1					109	123		10.1016/j.neuron.2007.08.006	http://dx.doi.org/10.1016/j.neuron.2007.08.006			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920019	Bronze, Green Accepted			2022-12-24	WOS:000250289800014
J	Soto, D; Coombs, ID; Kelly, L; Farrant, M; Cull-Candy, SG				Soto, David; Coombs, Ian D.; Kelly, Leah; Farrant, Mark; Cull-Candy, Stuart G.			Stargazin attenuates intracellular polyamine block of calcium-permeable AMPA receptors	NATURE NEUROSCIENCE			English	Article							FIBER-INTERNEURON SYNAPSES; LONG-TERM POTENTIATION; 2 DISTINCT MECHANISMS; GLUTAMATE RECEPTORS; KAINATE RECEPTORS; CA2+ PERMEABILITY; SUBUNIT; NEURONS; CHANNELS; TRAFFICKING	Endogenous polyamines profoundly affect the activity of various ion channels, including that of calcium-permeable AMPA-type glutamate receptors (CP-AMPARs). Here we show that stargazin, a transmembrane AMPAR regulatory protein ( TARP) known to influence transport, gating and desensitization of AMPARs, greatly reduces block of CP-AMPARs by intracellular polyamines. By decreasing CP-AMPAR affinity for cytoplasmic polyamines, stargazin enhances the charge transfer following single glutamate applications and eliminates the frequency-dependent facilitation seen with repeated applications. In cerebellar stellate cells, which express both synaptic CP-AMPARs and stargazin, we found that the rectification and unitary conductance of channels underlying excitatory postsynaptic currents were matched by those of recombinant AMPARs only when the latter were associated with stargazin. Taken together, our observations establish modulatory actions of stargazin that are specific to CP-AMPARs, and suggest that during synaptic transmission the activity of such receptors, and thus calcium influx, is fundamentally changed by TARPs.	UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Farrant, M (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	m.farrant@ucl.ac.uk	Soto, David/L-4403-2014	Soto, David/0000-0001-7995-3805; Coombs, Ian/0000-0003-1006-7471; Cull-Candy, Stuart G/0000-0002-0831-8326; Farrant, Mark/0000-0002-9918-0376	Wellcome Trust [074340] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Aizenman CD, 2002, NEURON, V34, P623, DOI 10.1016/S0896-6273(02)00674-8; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; Beierlein M, 2006, J NEUROSCI, V26, P9935, DOI 10.1523/JNEUROSCI.0958-06.2006; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bischofberger J, 2002, TRENDS NEUROSCI, V25, P600, DOI 10.1016/S0166-2236(02)02259-2; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Bowie D, 1998, J NEUROSCI, V18, P8175; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Colbourne F, 2003, P NATL ACAD SCI USA, V100, P2906, DOI 10.1073/pnas.2628027100; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Cu CH, 1998, NEUROPHARMACOLOGY, V37, P1381, DOI 10.1016/S0028-3908(98)00112-9; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Kott S, 2007, J NEUROSCI, V27, P3780, DOI 10.1523/JNEUROSCI.4185-06.2007; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Moss FJ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-23; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Sharp AH, 2001, NEUROSCIENCE, V105, P599, DOI 10.1016/S0306-4522(01)00220-2; Shin J, 2005, J NEUROPHYSIOL, V93, P2634, DOI 10.1152/jn.01054.2004; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Yamazaki M, 2004, NEUROSCI RES, V50, P369, DOI 10.1016/j.neures.2004.10.002; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	50	149	149	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1260	1267		10.1038/nn1966	http://dx.doi.org/10.1038/nn1966			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17873873	Green Accepted			2022-12-24	WOS:000249720800012
J	Pan, GJ; Tian, SL; Nie, J; Yang, CH; Ruotti, V; Wei, HR; Jonsdottir, GA; Stewart, R; Thomson, JA				Pan, Guangjin; Tian, Shulan; Nie, Jeff; Yang, Chuhu; Ruotti, Victor; Wei, Hairong; Jonsdottir, Gudrun A.; Stewart, Ron; Thomson, James A.			Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells	CELL STEM CELL			English	Article							POLYCOMB TARGET GENES; DEVELOPMENTAL REGULATORS; SACCHAROMYCES-CEREVISIAE; ACTIVE GENES; CHROMATIN; PLURIPOTENT; CODE; H3; DROSOPHILA; COMPLEX	We mapped Polycomb-associated H3K27 trimethylation (H3K27me3) and Trithorax-associated H3K4 trimethylation (H3K4me3) across the whole genome in human embryonic stem (ES) cells. The vast majority of H3K27me3 colocalized on genes modified with H3K4me3. These comodified genes displayed low expression levels and were enriched in developmental function. Another significant set of genes lacked both modifications and was also expressed at low levels in ES cells but was enriched for gene function in physiological responses rather than development. Comodified genes could change expression levels rapidly during differentiation, but so could a substantial number of genes in other modification categories. SOX2, POU5F1, and NANOG, plunpotency-associated genes, shifted from modification by H3K4me3 alone to colocalization of both modifications as they were repressed during differentiation. Our results demonstrate that H3K27me3 modifications change during early differentiation, both relieving existing repressive domains and imparting new ones, and that colocalization with H3K4me3 is not restricted to pluripotent cells.	Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA; WiCell Res Inst, Madison, WI 53707 USA; Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; Univ Wisconsin, Dept Anat, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; WiCell Research Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Thomson, JA (corresponding author), Univ Wisconsin, Genome Ctr Wisconsin, 425 Henry Mall, Madison, WI 53706 USA.	thomson@primate.wisc.edu	wei, hairong/GNM-7061-2022	wei, hairong/0000-0002-3551-4998; Pan, Guangjin/0000-0002-2378-7198				Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Cosgrove MS, 2005, BIOCHEM CELL BIOL, V83, P468, DOI 10.1139/O05-137; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JURGENS G, 1985, NATURE, V316, P153, DOI 10.1038/316153a0; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; WORKMAN C, 2002, GENOME BIOL, V0003	34	539	554	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2007	1	3					299	312		10.1016/j.stem.2007.08.003	http://dx.doi.org/10.1016/j.stem.2007.08.003			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XT	18371364	Bronze			2022-12-24	WOS:000251055200012
J	Okamoto, SI; Kang, YJ; Brechtel, CW; Siviglia, E; Russo, R; Clemente, A; Harrop, A; McKercher, S; Kaul, M; Lipton, SA				Okamoto, Shu-Ichi; Kang, Yeon-Joo; Brechtel, Christopher W.; Siviglia, Elisa; Russo, Rossella; Clemente, Arjay; Harrop, Anne; McKercher, Scott; Kaul, Marcus; Lipton, Stuart A.			HlV/gp120 decreases adult neural progenitor cell proliferation via checkpoint kinase-mediated cell-cycle withdrawal and G1 arrest	CELL STEM CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; COAT PROTEIN GP120; DENTATE GYRUS; CHEMOKINE RECEPTORS; STEM-CELLS; NEURONS; NEUROGENESIS; NEURODEGENERATION; INTEGRATION; CXCR4	Impaired adult neurogenesis has been observed in several neurodegenerative diseases, including human immunodeficiency virus (HIV-1)-associated dementia (HAD). Here we report that the HIV-envelope glycoprotein gp120, which is associated with HAD pathogenesis, inhibits proliferation of adult neural progenitor cells (aNPCs) in vitro and in vivo in the dentate gyrus of the hippocampus of HIV/gp120-transgenic mice. We demonstrate that HIV/gp120 arrests cell-cycle progression of aNPCs at the G1 phase via a cascade consisting of p38 mitogen-activated protein kinase (MAPK) -> MAPK-activated protein kinase 2 (a cell-cycle checkpoint kinase) -> Cdc25B/C. Our findings define a molecular mechanism that compromises adult neurogenesis in this neurodegenerative disorder.	Univ Calif San Diego, Ctr Neurosci Stem Cells & Aging, Burnham Inst Med Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Okamoto, SI (corresponding author), Univ Calif San Diego, Ctr Neurosci Stem Cells & Aging, Burnham Inst Med Res, La Jolla, CA 92093 USA.	sokamoto@burnham.org	Kaul, Marcus/AAS-8955-2020	Lipton, Stuart/0000-0002-3490-1259; Russo, Rossella/0000-0001-8758-6523	Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY09024] Funding Source: Medline; NINDS NIH HHS [R01 NS047973, R01 NS44326, P30 NS057096, R01 NS050621, R01 NS46994, R01 NS41207] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096, R01NS044326, R01NS041207, R01NS047973, R01NS050621, R01NS046994] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Harper SJ, 2003, EXPERT OPIN THER TAR, V7, P187, DOI 10.1517/14728222.7.2.187; Hayward P, 2004, LANCET NEUROL, V3, P325, DOI 10.1016/S1474-4422(04)00780-X; Jordan-Sciutto KL, 2002, J NEUROSCI, V22, P2185, DOI 10.1523/JNEUROSCI.22-06-02185.2002; Kaul M, 2007, CELL DEATH DIFFER, V14, P296, DOI 10.1038/sj.cdd.4402006; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Khan MZ, 2003, J NEUROVIROL, V9, P300, DOI 10.1080/13550280390201010; Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182; Krathwohl MD, 2004, J INFECT DIS, V190, P216, DOI 10.1086/422008; Krathwohl MD, 2004, STEM CELLS, V22, P109, DOI 10.1634/stemcells.22-1-109; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lu M, 2002, P NATL ACAD SCI USA, V99, P7090, DOI 10.1073/pnas.092013799; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Singh IN, 2005, NEUROSCIENCE, V135, P781, DOI 10.1016/j.neuroscience.2005.05.028; Smits VAJ, 2000, J BIOL CHEM, V275, P19375, DOI 10.1074/jbc.M001764200; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; Takenaka K, 1998, SCIENCE, V280, P599, DOI 10.1126/science.280.5363.599; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Tran PB, 2005, J NEUROIMMUNOL, V160, P68, DOI 10.1016/j.jneuroim.2004.11.001; Tran PB, 2004, J NEUROSCI RES, V76, P20, DOI 10.1002/jnr.20001; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Zhu XW, 2004, LANCET NEUROL, V3, P219, DOI 10.1016/S1474-4422(04)00707-0	40	92	95	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG	2007	1	2					230	236		10.1016/j.stem.2007.07.010	http://dx.doi.org/10.1016/j.stem.2007.07.010			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XS	18371353	Bronze			2022-12-24	WOS:000251055100013
J	Branco, T; Staras, K; Darcy, KJ; Goda, Y				Branco, Tiago; Staras, Kevin; Darcy, Kevin J.; Goda, Yukiko			Local dendritic activity sets release probability at hippocampal synapses	NEURON			English	Article							RECYCLING SYNAPTIC VESICLES; TRANSMITTER RELEASE; PYRAMIDAL CELLS; NONUNIFORM PROBABILITY; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES; QUANTAL ANALYSIS; MOTOR AXON; PLASTICITY; NEURONS	The arrival of an action potential at a synapse triggers neurotransmitter release with a limited probability, p,. Although p, is a fundamental parameter in defining synaptic efficacy, it is not uniform across all synapses, and the mechanisms by which a given synapse sets its basal release probability are unknown. By measuring p, at single presynaptic terminals in connected pairs of hippocampal neurons, we show that neighboring synapses on the same dendritic branch have very similar release probabilities, and p, is negatively correlated with the number of synapses on the branch. Increasing dendritic depolarization elicits a homeostatic decrease in p, and equalizing activity in the dendrite significantly reduces its variability. Our results indicate that local dendritic activity is the major determinant of basal release probability, and we suggest that this feedback regulation might be required to maintain synapses in their operational range.	[Branco, Tiago; Staras, Kevin; Darcy, Kevin J.; Goda, Yukiko] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England; [Branco, Tiago; Staras, Kevin; Darcy, Kevin J.; Goda, Yukiko] UCL, Cell Biol Unit, London WC1E 6BT, England; [Branco, Tiago; Goda, Yukiko] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London; University of London; University College London	Branco, T (corresponding author), UCL, MRC Lab Mol Cell Biol, Gower St, London WC1E 6BT, England.	t.branco@ucl.ac.uk; y.goda@ucl.ac.uk	Goda, Yukiko/AAR-5641-2020; Branco, Tiago/C-1503-2008; Goda, Yukiko/A-6576-2016	Goda, Yukiko/0000-0003-0352-9498; Goda, Yukiko/0000-0003-0352-9498; Staras, Kevin/0000-0003-4141-339X	Wellcome Trust 4 year PhD Programme in Neuroscience at UCL; Medical Research Council and National Institutes of Health; MRC [MC_U122669937] Funding Source: UKRI; Medical Research Council [MC_U122669937] Funding Source: researchfish	Wellcome Trust 4 year PhD Programme in Neuroscience at UCL(Wellcome Trust); Medical Research Council and National Institutes of Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Roth, M. London, J. Sjostrom, and D. Attwell for critical comments on a early version of the manuscript, and we thank B. Clark, M. Hausser, and M. London for he pful discussions. We also thank L. Collinson for serial sectioning, L. Yu for technical assistance, and A. Roth for help with the simulations. This work was supported by the Wellcome Trust 4 year PhD Programme in Neuroscience at UCL to T.B. and a Medical Research Council and National Institutes of Health grant to Y.G.	ATWOOD HL, 1971, J NEUROPHYSIOL, V34, P157, DOI 10.1152/jn.1971.34.1.157; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; BENNETT MR, 1986, J PHYSIOL-LONDON, V379, P257, DOI 10.1113/jphysiol.1986.sp016252; Biro AA, 2005, J NEUROSCI, V25, P223, DOI 10.1523/JNEUROSCI.3688-04.2005; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Cooper RL, 1996, J COMP NEUROL, V375, P583; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; DAVIS GW, 1995, J PHYSIOLOGY-PARIS, V89, P33, DOI 10.1016/0928-4257(96)80549-3; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Duguid I, 2006, CURR OPIN NEUROBIOL, V16, P312, DOI 10.1016/j.conb.2006.05.008; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; FRANK E, 1973, J PHYSIOL-LONDON, V233, P635, DOI 10.1113/jphysiol.1973.sp010327; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Huang EP, 1997, J NEUROPHYSIOL, V78, P2870, DOI 10.1152/jn.1997.78.6.2870; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; KATZ PS, 1993, J NEUROSCI, V13, P3075; KOERBER HR, 1991, J NEUROPHYSIOL, V65, P590, DOI 10.1152/jn.1991.65.3.590; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Larkman AU, 1997, J PHYSIOL-LONDON, V505, P457, DOI 10.1111/j.1469-7793.1997.457bb.x; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Maass W, 1999, NEURAL COMPUT, V11, P903, DOI 10.1162/089976699300016494; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; MULLER KJ, 1974, J PHYSIOL-LONDON, V238, P357, DOI 10.1113/jphysiol.1974.sp010529; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Rabinowitch I, 2006, J NEUROPHYSIOL, V96, P276, DOI 10.1152/jn.00074.2006; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; REDMAN S, 1983, J PHYSIOL-LONDON, V343, P135, DOI 10.1113/jphysiol.1983.sp014885; Reyes A, 1999, J NEUROSCI, V19, P3827; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; ROBITAILLE R, 1987, BRAIN RES REV, V12, P95, DOI 10.1016/0165-0173(87)90019-1; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Slutsky I, 2004, NEURON, V44, P835, DOI 10.1016/j.neuron.2004.11.013; SORRA KE, 1993, J NEUROSCI, V13, P3736; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; WALMSLEY B, 1988, J NEUROPHYSIOL, V60, P889, DOI 10.1152/jn.1988.60.3.889; Wierenga CJ, 2006, J NEUROPHYSIOL, V96, P2127, DOI 10.1152/jn.00107.2006; Wittner L, 2006, EUR J NEUROSCI, V24, P1286, DOI 10.1111/j.1460-9568.2006.04992.x; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	53	167	167	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 14	2008	59	3					475	485		10.1016/j.neuron.2008.07.006	http://dx.doi.org/10.1016/j.neuron.2008.07.006			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339GG	18701072	Bronze, Green Accepted			2022-12-24	WOS:000258565500015
J	Huang, ZJ; Di Cristo, G				Huang, Z. Josh; Di Cristo, Graziella			Time to change: Retina sends a messenger to promote plasticity in visual cortex	NEURON			English	Editorial Material							CRITICAL-PERIOD; GABA(A) RECEPTORS; MATURATION; EXPERIENCE	Maturation of GABA inhibitory circuitry in primary visual cortex activates the critical period of plasticity, but the underlying mechanisms are not well understood. In the August 8th issue of Cell, Sugiyama et al. demonstrate that visual experience promotes the passage of a retina-derived homeoprotein along the visual pathway, which nurtures subclasses of cortical interneurons implicated in regulating critical period plasticity.	[Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Di Cristo, Graziella] Univ Montreal, CHU St Justine, Montreal, PQ H3T 1C5, Canada	Cold Spring Harbor Laboratory; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	huangj@cshl.edu						Ali AB, 2008, CEREB CORTEX, V18, P1260, DOI 10.1093/cercor/bhm160; Baas D, 2000, MOL BRAIN RES, V78, P26, DOI 10.1016/S0169-328X(00)00060-7; Brunet I, 2007, TRENDS NEUROSCI, V30, P260, DOI 10.1016/j.tins.2007.03.010; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Klausberger T, 2002, J NEUROSCI, V22, P2513, DOI 10.1523/JNEUROSCI.22-07-02513.2002; Maizel A, 2002, DEVELOPMENT, V129, P3545; Morales B, 2002, J NEUROSCI, V22, P8084; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; SUGIYAMA S, 2008, CELL IN PRESS, V134; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	15	9	10	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 14	2008	59	3					355	358		10.1016/j.neuron.2008.07.029	http://dx.doi.org/10.1016/j.neuron.2008.07.029			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339GG	18701062	Bronze			2022-12-24	WOS:000258565500004
J	Rodriguez-Moreno, A; Paulsen, O				Rodriguez-Moreno, Antonio; Paulsen, Ole			Spike timing-dependent long-term depression requires presynaptic NMDA receptors	NATURE NEUROSCIENCE			English	Article							SOMATOSENSORY CORTEX; SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; BARREL CORTEX; POTENTIATION; COINCIDENCE; ACTIVATION; LTD	NMDA receptors are necessary for both synaptic potentiation and depression, but the precise location of these receptors has not been established. By loading MK-801 into pre- or postsynaptic neurons during paired recordings of synaptically connected layer 4 and layer 2/3 neurons in mouse barrel cortex, we found that synaptic potentiation requires postsynaptic, but not presynaptic, NMDA receptors, whereas synaptic depression requires presynaptic, but not postsynaptic, NMDA receptors.	[Rodriguez-Moreno, Antonio; Paulsen, Ole] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Rodriguez-Moreno, Antonio] Univ Pablo Olavide, Dept Physiol Anat & Cellular Biol, Seville 41013, Spain	University of Oxford; Universidad Pablo de Olavide	Rodriguez-Moreno, A (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, S Parks Rd, Oxford OX1 3PT, England.	arodmor@upo.es; ole.paulsen@dpag.ox.ac.uk	Paulsen, Ole/ABB-4843-2020; Rodriguez-Moreno, Antonio/I-5225-2015	Paulsen, Ole/0000-0002-2258-5455; Rodriguez-Moreno, Antonio/0000-0002-8078-6175	MRC [G0400571] Funding Source: UKRI; Alzheimers Research UK [ART-EG2004B-2] Funding Source: researchfish; Medical Research Council [G0400571] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Brasier DJ, 2008, J NEUROSCI, V28, P2199, DOI 10.1523/JNEUROSCI.3915-07.2008; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8	15	109	109	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					744	745		10.1038/nn.2125	http://dx.doi.org/10.1038/nn.2125			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18516036				2022-12-24	WOS:000257089400008
J	de Solages, C; Szapiro, G; Brunel, N; Hakim, V; Isope, P; Buisseret, P; Rousseau, C; Barbour, B; Lena, C				de Solages, Camille; Szapiro, German; Brunel, Nicolas; Hakim, Vincent; Isope, Philippe; Buisseret, Pierre; Rousseau, Charly; Barbour, Boris; Lena, Clement			High-frequency organization and synchrony of activity in the Purkinje cell layer of the cerebellum	NEURON			English	Article							SYNAPTIC CURRENTS; CANNABINOID RECEPTOR; OSCILLATIONS; CORTEX; INHIBITION; NEURONS; SYNAPSES; NETWORKS; PATTERN; COLLATERALS	The cerebellum controls complex, coordinated, and rapid movements, a function requiring precise timing abilities. However, the network mechanisms that underlie the temporal organization of activity in the cerebellum are largely unexplored, because in vivo recordings have usually targeted single units. Here, we use tetrode and multisite recordings to demonstrate that Purkinje cell activity is synchronized by a high-frequency (similar to 200 Hz) population oscillation. We combine pharmacological experiments and modeling to show how the recurrent inhibitory connections between Purkinje cells are sufficient to generate these oscillations. A key feature of these oscillations is a fixed population frequency that is independent of the firing rates of the individual cells. Convergence in the deep cerebellar nuclei of Purkinje cell activity, synchronized by these oscillations, likely organizes temporally the cerebellar output.	[de Solages, Camille; Szapiro, German; Isope, Philippe; Rousseau, Charly; Barbour, Boris; Lena, Clement] Ecole Normale Super, UMR 8544, Neurobiol Lab, F-75005 Paris, France; [Brunel, Nicolas] Univ Paris 05, UMR 8119, Lab Neurophys & Physiol, F-75006 Paris, France; [Hakim, Vincent] Ecole Normale Super, UMR 8550, Lab Phys Stat, F-75005 Paris, France; [Buisseret, Pierre] Museum Natl Hist Nat, Dept Regulat, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN)	Lena, C (corresponding author), Ecole Normale Super, UMR 8544, Neurobiol Lab, 46 Rue Ulm, F-75005 Paris, France.	lena@biologie.ens.fr	Léna, Clément/T-8458-2018; , clement/ADN-8076-2022; Léna, Clément/ABE-4862-2021; Léna, Clément/P-6929-2019	Léna, Clément/0000-0002-1431-7717; Léna, Clément/0000-0002-1431-7717; Léna, Clément/0000-0002-1431-7717; Isope, Philippe/0000-0002-0630-5935; hakim, vincent/0000-0001-7505-8192; Barbour, Boris/0000-0002-1911-0539				[Anonymous], [No title captured]; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bearzatto B, 2006, FASEB J, V20, P380, DOI 10.1096/fj.05-3785fje; BELL CC, 1969, J NEUROPHYSIOL, V32, P1044, DOI 10.1152/jn.1969.32.6.1044; BISHOP GA, 1982, J COMP NEUROL, V210, P1, DOI 10.1002/cne.902100102; BROOKHART JM, 1960, HDB PHYSL NEUROPHYSI, P1245; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Brunel N, 1999, NEURAL COMPUT, V11, P1621, DOI 10.1162/089976699300016179; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/j.neuron.2004.08.023; Cajal S. R., 1911, HISTOLOGIE SYSTEME N, V2; Cerminara NL, 2004, J NEUROSCI, V24, P4510, DOI 10.1523/JNEUROSCI.4530-03.2004; Cheron G, 2008, NEUROSCIENCE, V153, P1, DOI 10.1016/j.neuroscience.2008.01.074; Cheron G, 2004, J NEUROSCI, V24, P434, DOI 10.1523/JNEUROSCI.3197-03.2004; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; COLIN F, 1980, BRAIN RES, V187, P3, DOI 10.1016/0006-8993(80)90491-6; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; Dean I, 2003, J NEUROSCI, V23, P4457; Delescluse M, 2006, J NEUROSCI METH, V150, P16, DOI 10.1016/j.jneumeth.2005.05.023; DeZeeuw CI, 1997, J NEUROPHYSIOL, V77, P1747, DOI 10.1152/jn.1997.77.4.1747; Diana MA, 2002, J NEUROSCI, V22, P200, DOI 10.1523/JNEUROSCI.22-01-00200.2002; Dieudonne S, 2000, J NEUROSCI, V20, P1837; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; EBNER TJ, 1981, J NEUROPHYSIOL, V45, P948, DOI 10.1152/jn.1981.45.5.948; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Gauck V, 2000, J NEUROSCI, V20, P3006; Gianola S, 2003, J NEUROSCI, V23, P4613; Gifford AN, 1999, J PHARMACOL EXP THER, V288, P478; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HAWKES R, 1989, BRAIN RES, V476, P279, DOI 10.1016/0006-8993(89)91248-1; Heck DH, 2007, P NATL ACAD SCI USA, V104, P7658, DOI 10.1073/pnas.0609966104; Isope P, 2002, ANN NY ACAD SCI, V978, P164, DOI 10.1111/j.1749-6632.2002.tb07564.x; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Laine J, 1998, NEUROREPORT, V9, P2399, DOI 10.1097/00001756-199807130-00045; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Maex R, 2003, J NEUROSCI, V23, P10503; MAILLEUX P, 1992, NEUROSCIENCE, V48, P655, DOI 10.1016/0306-4522(92)90409-U; Mathiesen C, 1998, EUR J PHARMACOL, V353, P159, DOI 10.1016/S0014-2999(98)00401-4; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; ODONOGHUE DL, 1989, J NEUROSCI, V9, P2141; Orduz D, 2007, P NATL ACAD SCI USA, V104, P17831, DOI 10.1073/pnas.0707489104; Palay S. L., 1974, CEREBELLAR CORTEX CY; PELLET J, 1974, ARCH ITAL BIOL, V112, P163; Pouzat C, 1997, J NEUROSCI, V17, P9104; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Shin SL, 2006, J NEUROPHYSIOL, V96, P3485, DOI 10.1152/jn.00570.2006; Steuber V, 2007, NEURON, V54, P121, DOI 10.1016/j.neuron.2007.03.015; Takahashi KA, 2000, J NEUROPHYSIOL, V83, P1167, DOI 10.1152/jn.2000.83.3.1167; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; VINCENT P, 1992, J PHYSIOL-LONDON, V456, P453, DOI 10.1113/jphysiol.1992.sp019346; Wang XJ, 1996, J NEUROSCI, V16, P6402; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	57	136	137	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 12	2008	58	5					775	788		10.1016/j.neuron.2008.05.008	http://dx.doi.org/10.1016/j.neuron.2008.05.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	315IA	18549788	Bronze			2022-12-24	WOS:000256870800014
J	Jiang, Q; Lee, CYD; Mandrekar, S; Wilkinson, B; Cramer, P; Zelcer, N; Mann, K; Lamb, B; Willson, TM; Collins, JL; Richardson, JC; Smith, JD; Comery, TA; Riddell, D; Holtzman, DM; Tontonoz, P; Landreth, GE				Jiang, Qingguang; Lee, C. Y. Daniel; Mandrekar, Shweta; Wilkinson, Brandy; Cramer, Paige; Zelcer, Noam; Mann, Karen; Lamb, Bruce; Willson, Timothy M.; Collins, Jon L.; Richardson, Jill C.; Smith, Jonathan D.; Comery, Thomas A.; Riddell, David; Holtzman, David M.; Tontonoz, Peter; Landreth, Gary E.			ApoE promotes the proteolytic degradation of A beta	NEURON			English	Article							LIVER-X-RECEPTOR; INSULIN-DEGRADING ENZYME; CENTRAL-NERVOUS-SYSTEM; AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; HUMAN APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; IN-VIVO; CHOLESTEROL EFFLUX; DENSITY-LIPOPROTEIN	Apolipoprotein E is associated with age-related risk for Alzheimer's disease and plays critical roles in A beta homeostasis. We report that ApoE plays a role in facilitating the proteolytic clearance of soluble A beta from the brain. The endolytic degradation of A beta peptides within microglia by neprilysin and related enzymes is dramatically enhanced by ApoE. Similarly, A beta degradation extracellularly by insulin-degrading enzyme is facilitated by ApoE. The capacity of Apo to promote A beta degradation is dependent upon the ApoE isoform and its lipidation status. The enhanced expression of lipidated ApoE, through the activation of liver X receptors, stimulates A beta degradation. Indeed, aged Tg2576 mice treated with the LXR agonist GW3965 exhibited a dramatic reduction in brain A beta load. GW3965 treatment also reversed contextual memory deficits. These data demonstrate a mechanism through which ApoE facilitates the clearance of A beta from the brain and suggest that LXR agonists may represent a novel therapy for A beta.	[Jiang, Qingguang; Lee, C. Y. Daniel; Mandrekar, Shweta; Wilkinson, Brandy; Cramer, Paige; Landreth, Gary E.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Alzheimers Res Lab, Cleveland, OH 44106 USA; [Zelcer, Noam; Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Mann, Karen; Lamb, Bruce] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; [Willson, Timothy M.; Collins, Jon L.] GlaxoSmithKline, Discovery Res, Res Triangle Pk, NC 27709 USA; [Richardson, Jill C.] GlaxoSmithKline, Harlow CM19 5AW, Essex, England; [Smith, Jonathan D.] Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Comery, Thomas A.; Riddell, David] Wyeth Ayerst Res, Discovery Neurosci, Princeton, NJ 08543 USA; [Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Case Western Reserve University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Cleveland Clinic Foundation; GlaxoSmithKline; GlaxoSmithKline; Cleveland Clinic Foundation; Pfizer; Washington University (WUSTL)	Landreth, GE (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Alzheimers Res Lab, Cleveland, OH 44106 USA.	gel2@case.edu	Zelcer, Noam/C-6393-2009; Mandrekar-Colucci, Shweta/K-5787-2012; feinstein, doug/M-9414-2019; Smith, Jonathan D./H-9723-2013	Mandrekar-Colucci, Shweta/0000-0002-4296-302X; Richardson, Jill/0000-0001-6564-3187; Zelcer, Noam/0000-0001-6935-7532; Smith, Jonathan D./0000-0002-0415-386X	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL066088, HL30568, P01 HL030568, HL66088, R01 HL066082] Funding Source: Medline; NIA NIH HHS [F32AG24031, F32 AG024031, R01 AG030482, R01 AG030482-01, R01 AG013956, AG020202, AG13956, R37 AG013956, R01 AG020202] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, R01HL066082, R01HL066088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013956, R01AG030482, F32AG024031, R37AG013956, R01AG020202] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Burns MP, 2006, J NEUROCHEM, V98, P792, DOI 10.1111/j.1471-4159.2006.03925.x; Cao GQ, 2007, CURR ALZHEIMER RES, V4, P179, DOI 10.2174/156720507780362173; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Denis M, 2004, J BIOL CHEM, V279, P7384, DOI 10.1074/jbc.M306963200; Dergunov AD, 2000, BBA-MOL CELL BIOL L, V1484, P14, DOI 10.1016/S1388-1981(99)00196-1; Dolev I, 2004, P NATL ACAD SCI USA, V101, P13909, DOI 10.1073/pnas.0404458101; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2007, AM J PATHOL, V171, P241, DOI 10.2353/ajpath.2007.070105; Fisher CA, 1999, J LIPID RES, V40, P93; Fukumoto H, 2002, J BIOL CHEM, V277, P48508, DOI 10.1074/jbc.M209085200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harr SD, 1996, J NEUROCHEM, V66, P2429; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Hirsch-Reinshagen V, 2004, J BIOL CHEM, V279, P41197, DOI 10.1074/jbc.M407962200; Holtzman DM, 2004, J MOL NEUROSCI, V23, P247, DOI 10.1385/JMN:23:3:247; Holtzman DM, 2001, J MOL NEUROSCI, V17, P147, DOI 10.1385/JMN:17:2:147; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jiang XC, 2003, J BIOL CHEM, V278, P49072, DOI 10.1074/jbc.M304274200; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Koch S, 2001, J LIPID RES, V42, P1143; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Koldamova RP, 2003, J BIOL CHEM, V278, P13244, DOI 10.1074/jbc.M300044200; Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; LaDu MJ, 2006, BIOCHEMISTRY-US, V45, P381, DOI 10.1021/bi051765s; LADU MJ, 1995, J BIOL CHEM, V270, P9039, DOI 10.1074/jbc.270.16.9039; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Lefterov I, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-20; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Liang Y, 2004, J NEUROCHEM, V88, P623, DOI 10.1111/j.1471-4159.2004.02183.x; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; ROSES AD, 1995, ARZNEIMITTEL-FORSCH, V45-1, P413; Russo C, 1998, P NATL ACAD SCI USA, V95, P15598, DOI 10.1073/pnas.95.26.15598; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; Smith JD, 2004, J LIPID RES, V45, P635, DOI 10.1194/jlr.M300336-JLR200; Sun Y, 2003, J BIOL CHEM, V278, P27688, DOI 10.1074/jbc.M300760200; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Xu Q, 2000, J BIOL CHEM, V275, P31770, DOI 10.1074/jbc.M002796200; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Zander T, 2002, J NEUROCHEM, V81, P1052, DOI 10.1046/j.1471-4159.2002.00899.x; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zlokovic BV, 2005, BRAIN PATHOL, V15, P78	70	659	688	0	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 12	2008	58	5					681	693		10.1016/j.neuron.2008.04.010	http://dx.doi.org/10.1016/j.neuron.2008.04.010			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	315IA	18549781	Bronze, Green Accepted			2022-12-24	WOS:000256870800007
J	Qiu, W; Carson-Walter, EB; Liu, H; Epperly, M; Greenberger, JS; Zambetti, GP; Zhang, L; Yu, J				Qiu, Wei; Carson-Walter, Eleanor B.; Liu, Hongtao; Epperly, Michael; Greenberger, Joel S.; Zambetti, Gerard P.; Zhang, Lin; Yu, Jian			PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome	CELL STEM CELL			English	Article							BH3-ONLY PROTEINS PUMA; INDUCE APOPTOSIS; LYMPHOID-CELLS; STEM-CELLS; P53; RADIATION; MARKER; COLON; GENE; IDENTIFICATION	Radiation is one of the most effective cancer treatments. However, gastrointestinal (GI) syndrome is a major limiting factor in abdominal and pelvic radiotherapy. The loss of crypt stem cells or villus endothelial cells has been suggested to be responsible for radiation-induced intestinal damage. We report here a critical role of the BH3-only protein p53 upregulated modulator of apoptosis (PUMA) in the radiosensitivity of intestinal epithelium and pathogenesis of GI syndrome. PUMA was induced in a p53-dependent manner and mediated radiation-induced apoptosis via the mitochondrial pathway in the intestinal mucosa. PUMA-deficient mice exhibited blocked apoptosis in the intestinal progenitor and stem cells, enhanced crypt proliferation and regeneration, and prolonged survival following lethal doses of radiation. Unexpectedly, PUMA deficiency had little effect on radiation-induced intestinal endothelial apoptosis. Suppressing PUMA expression by antisense oligonucleotides provided significant intestinal radioprotection. Therefore, PUMA-mediated apoptosis in the progenitor and stem cell compartments is crucial for radiation-induced intestinal damage.	[Liu, Hongtao; Zhang, Lin] Univ Pittsburgh, Hillman Canc Ctr, Inst Canc, Dept Pharmacol, Pittsburgh, PA 15213 USA; [Qiu, Wei; Yu, Jian] Univ Pittsburgh, Hillman Canc Ctr, Inst Canc, Dept Pathol, Pittsburgh, PA 15213 USA; [Epperly, Michael; Greenberger, Joel S.] Univ Pittsburgh, Hillman Canc Ctr, Inst Canc, Dept Radiat Oncol, Pittsburgh, PA 15213 USA; [Carson-Walter, Eleanor B.] Univ Rochester, Dept Neurosurg, Rochester, NY 14642 USA; [Zambetti, Gerard P.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Rochester; St Jude Children's Research Hospital	Zhang, L (corresponding author), Univ Pittsburgh, Hillman Canc Ctr, Inst Canc, Dept Pharmacol, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	zhanglx@upmc.edu; yuj2@upmc.edu	Zhang, Lin/A-7389-2009; Yu, Jian/A-8301-2009; Zambetti, Gerard/N-8093-2018	Zhang, Lin/0000-0003-0018-3903; Yu, Jian/0000-0002-4021-1000; Zambetti, Gerard/0000-0002-0929-5007	NCI NIH HHS [R01 CA106348-04, R01 CA106348, CA106348, CA121105, R01 CA106348-05, P50 CA097190, R01 CA121105, 1 P50 CA097190] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA106348, R01CA121105, P50CA097190] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Booth D, 2001, J Natl Cancer Inst Monogr, P16; Carson-Walter EB, 2005, CLIN CANCER RES, V11, P7643, DOI 10.1158/1078-0432.CCR-05-1099; Ch'ang HJ, 2005, NAT MED, V11, P484, DOI 10.1038/nm1237; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; GE AZ, 1994, GENE, V138, P201, DOI 10.1016/0378-1119(94)90808-7; Giannakis M, 2006, J BIOL CHEM, V281, P11292, DOI 10.1074/jbc.M512118200; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hendry JH, 2001, SCIENCE, V294, p1411A; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kohli M, 2004, P NATL ACAD SCI USA, V101, P16897, DOI 10.1073/pnas.0403405101; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; MERRITT AJ, 1994, CANCER RES, V54, P614; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Sobol RW, 2003, J BIOL CHEM, V278, P39951, DOI 10.1074/jbc.M306592200; St Croix B, 2000, SCIENCE, V289, P1197; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; Suit HD, 2001, SCIENCE, V294, p1411A, DOI 10.1126/science.294.5546.1411a; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; Wu B, 2007, GUT, V56, P645, DOI 10.1136/gut.2006.101683; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yu J, 2007, ONCOGENE, V26, P4189, DOI 10.1038/sj.onc.1210196; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	35	167	177	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN	2008	2	6					576	583		10.1016/j.stem.2008.03.009	http://dx.doi.org/10.1016/j.stem.2008.03.009			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	315HT	18522850	Green Accepted, Bronze			2022-12-24	WOS:000256870000015
J	Mante, V; Bonin, V; Carandini, M				Mante, Valerio; Bonin, Vincent; Carandini, Matteo			Functional mechanisms shaping lateral geniculate responses to artificial and natural stimuli	NEURON			English	Article							RETINAL GANGLION-CELLS; CONTRAST GAIN-CONTROL; PRIMARY VISUAL-CORTEX; RECEPTIVE-FIELD ORGANIZATION; LIGHT ADAPTATION; THALAMOCORTICAL RELAY; SPATIAL SUMMATION; MACAQUE MONKEY; NEURAL CODE; CAT RETINA	Functional models of the early visual system should predict responses not only to simple artificial stimuli but also to sequences of complex natural scenes. An ideal testbed for such models is the lateral geniculate nucleus (LGN). Mechanisms shaping LGN responses include the linear receptive field and two fast adaptation processes, sensitive to luminance and contrast. We propose a compact functional model for these mechanisms that operates on sequences of arbitrary images. With the same parameters that fit the firing rate responses to simple stimuli, it predicts the bulk of the firing rate responses to complex stimuli, including natural scenes. Further improvements could result by adding a spiking mechanism, possibly one capable of bursts, but not by adding mechanisms of slow adaptation. We conclude that up to the LGN the responses to natural scenes can be largely explained through insights gained with simple artificial stimuli.	[Mante, Valerio; Bonin, Vincent; Carandini, Matteo] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	The Smith-Kettlewell Eye Research Institute	Mante, V (corresponding author), Smith Kettlewell Eye Res Inst, 1318 Fillmore St, San Francisco, CA 94115 USA.	valerio@monkeybiz.stanford.edu	Bonin, Vincent/AAQ-3833-2020; Carandini, Matteo/C-1922-2008; Carandini, Matteo/ABD-8296-2021	Carandini, Matteo/0000-0003-4880-7682; Carandini, Matteo/0000-0003-4880-7682; Bonin, Vincent/0000-0002-9437-8092				Alitto HJ, 2008, NEURON, V57, P135, DOI 10.1016/j.neuron.2007.11.019; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P759, DOI 10.1113/jphysiol.1974.sp010733; Beaudoin DL, 2007, J NEUROSCI, V27, P2636, DOI 10.1523/JNEUROSCI.4610-06.2007; Benardete EA, 1999, VISUAL NEUROSCI, V16, P355, DOI 10.1017/S0952523899162151; Bendat J.S., 2000, RANDOM DATA ANAL MEA; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; Bonin V, 2006, J NEUROSCI, V26, P6346, DOI 10.1523/JNEUROSCI.0284-06.2006; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRODIE SE, 1978, J GEN PHYSIOL, V72, P167, DOI 10.1085/jgp.72.2.167; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; CARANDINI M, 2007, J VIS, V7; CLELAND BG, 1988, J PHYSIOL-LONDON, V404, P591, DOI 10.1113/jphysiol.1988.sp017308; CLELAND BG, 1968, J PHYSIOL-LONDON, V198, P17, DOI 10.1113/jphysiol.1968.sp008591; COHEN HI, 1981, EXP BRAIN RES, V44, P207; Dahari R, 1996, J OPT SOC AM A, V13, P419, DOI 10.1364/JOSAA.13.000419; Dan Y, 1996, J NEUROSCI, V16, P3351; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DAWIS S, 1984, VISION RES, V24, P549, DOI 10.1016/0042-6989(84)90109-3; Demb JB, 2002, NEURON, V36, P781, DOI 10.1016/S0896-6273(02)01100-5; Denning KS, 2005, J NEUROSCI, V25, P3531, DOI 10.1523/JNEUROSCI.4417-04.2005; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Efron B., 1993, INTRO BOOTSTRAP, V57; ENROTHCU.C, 1973, J PHYSIOL-LONDON, V233, P271, DOI 10.1113/jphysiol.1973.sp010308; ENROTHCU.C, 1973, J PHYSIOL-LONDON, V233, P311, DOI 10.1113/jphysiol.1973.sp010309; ENROTHCUGELL C, 1975, J PHYSIOL-LONDON, V247, P579, DOI 10.1113/jphysiol.1975.sp010948; ENROTHCUGELL C, 1987, J PHYSIOL-LONDON, V384, P49, DOI 10.1113/jphysiol.1987.sp016443; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; Felsen G, 2005, NAT NEUROSCI, V8, P1643, DOI 10.1038/nn1608; FUORTES MGF, 1964, J PHYSIOL-LONDON, V172, P239, DOI 10.1113/jphysiol.1964.sp007415; GAUDIANO P, 1994, VISION RES, V34, P1767, DOI 10.1016/0042-6989(94)90131-7; GUIDO W, 1992, J NEUROPHYSIOL, V68, P2199, DOI 10.1152/jn.1992.68.6.2199; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; Kaplan E, 2001, PROG BRAIN RES, V134, P17; Kayser C, 2003, NEUROCOMPUTING, V52-4, P117, DOI 10.1016/S0925-2312(02)00789-0; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; LANKHEET MJM, 1993, VISION RES, V33, P1153, DOI 10.1016/0042-6989(93)90205-B; LANKHEET MJM, 1993, VISION RES, V33, P1173, DOI 10.1016/0042-6989(93)90206-C; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lee BB, 2003, J VISION, V3, P513, DOI 10.1167/3.7.5; Lesica NA, 2004, J NEUROSCI, V24, P10731, DOI 10.1523/JNEUROSCI.3059-04.2004; Lesica NA, 2007, NEURON, V55, P479, DOI 10.1016/j.neuron.2007.07.013; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MUKHERJEE P, 1995, J NEUROPHYSIOL, V74, P1222, DOI 10.1152/jn.1995.74.3.1222; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; PURPURA K, 1990, VISUAL NEUROSCI, V4, P75, DOI 10.1017/S0952523800002789; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; RODIECK RW, 1993, CONTRAST SENSITIVITY; Rust NC, 2005, NAT NEUROSCI, V8, P1647, DOI 10.1038/nn1606; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; SAHANI M, 2003, ADV NEURAL INFORM PR, V15, P109; SAITO H, 1986, VISION RES, V26, P391, DOI 10.1016/0042-6989(86)90182-3; SAUL AB, 1990, J NEUROPHYSIOL, V64, P206, DOI 10.1152/jn.1990.64.1.206; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Shapley R., 1984, VISUAL ADAPTATION RE, V3; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; SHAPLEY RM, 1979, J PHYSIOL-LONDON, V290, P141, DOI 10.1113/jphysiol.1979.sp012765; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Smith GD, 2000, J NEUROPHYSIOL, V83, P588, DOI 10.1152/jn.2000.83.1.588; Smyth D, 2003, J NEUROSCI, V23, P4746; SO YT, 1981, J NEUROPHYSIOL, V45, P107, DOI 10.1152/jn.1981.45.1.107; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Troy JB, 2002, PROG RETIN EYE RES, V21, P263, DOI 10.1016/S1350-9462(02)00002-2; Troy JB, 1999, VISUAL NEUROSCI, V16, P1089, DOI 10.1017/S0952523899166094; van Hateren JH, 2007, J VISION, V7, DOI 10.1167/7.3.3; van Hateren JH, 2002, J NEUROSCI, V22, P9945; VANHATEREN JH, 1993, VISION RES, V33, P257, DOI 10.1016/0042-6989(93)90163-Q; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Victor JD, 1999, NETWORK-COMP NEURAL, V10, pR1, DOI 10.1088/0954-898X/10/4/201; Wang X, 2007, NEURON, V55, P465, DOI 10.1016/j.neuron.2007.06.039; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Weliky M, 2003, NEURON, V37, P703, DOI 10.1016/S0896-6273(03)00022-9; Yeh TY, 1996, VISION RES, V36, P913, DOI 10.1016/0042-6989(95)00332-0	92	85	85	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 22	2008	58	4					625	638		10.1016/j.neuron.2008.03.011	http://dx.doi.org/10.1016/j.neuron.2008.03.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304PD	18498742	Bronze			2022-12-24	WOS:000256120500015
J	Efroni, S; Duttagupta, R; Cheng, J; Dehghani, H; Hoeppner, DJ; Dash, C; Bazett-Jones, DP; Le Grice, S; Mckay, RDG; Buetow, KH; Gingeras, TR; Misteli, T; Meshorer, E				Efroni, Sol; Duttagupta, Radharani; Cheng, Jill; Dehghani, Hesam; Hoeppner, Daniel J.; Dash, Chandravanu; Bazett-Jones, David P.; Le Grice, Stuart; McKay, Ronald D. G.; Buetow, Kenneth H.; Gingeras, Thomas R.; Misteli, Tom; Meshorer, Eran			Global transcription in pluripotent embryonic stem cells	CELL STEM CELL			English	News Item							RNA-POLYMERASE-II; GENE-EXPRESSION; DEVELOPMENTAL REGULATORS; SELF-RENEWAL; LIVING CELLS; FACTOR OCT4; HISTONE H3; CHROMATIN; MOUSE; DIFFERENTIATION	The molecular mechanisms underlying pluripotency and lineage specification from embryonic stem cells (ESCs) are largely unclear. Differentiation pathways may be determined by the targeted activation of lineage-specific genes or by selective silencing of genome regions. Here we show that the ESC genome is transcriptionally globally hyperactive and undergoes large-scale silencing as cells differentiate. Normally silent repeat regions are active in ESCs, and tissue specific genes are sporadically expressed at low levels. Whole-genome tiling arrays demonstrate widespread transcription in coding and noncoding regions in ESCs, whereas the transcriptional landscape becomes more discrete as differentiation proceeds. The transcriptional hyperactivity in ESCs is accompanied by disproportionate expression of chromatin-remodeling genes and the general transcription machinery. We propose that global transcription is a hallmark of pluripotent ESCs, contributing to their plasticity, and that lineage specification is driven by reduction of the transcribed portion of the genome.	[Misteli, Tom] NIH, NCI, Bethesda, MD 20892 USA; [Efroni, Sol; Buetow, Kenneth H.] NIH, NCI, Ctr Bioinformat, Bethesda, MD 20892 USA; [Duttagupta, Radharani; Cheng, Jill; Gingeras, Thomas R.] Affymetrix Inc, Santa Clara, CA 95051 USA; [Dehghani, Hesam; Bazett-Jones, David P.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Hoeppner, Daniel J.; McKay, Ronald D. G.] NIH, Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA; [Dash, Chandravanu; Le Grice, Stuart] NIH, NCI, Frederick, MD 21702 USA; [Meshorer, Eran] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91904 Jerusalem, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Affymetrix; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hebrew University of Jerusalem	Misteli, T (corresponding author), NIH, NCI, Bldg 10, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov; meshorer@cc.huji.ac.il	Dehghani, Hesam/D-1421-2010; Efroni, Sol/I-6752-2012	Dehghani, Hesam/0000-0001-6750-0040; Efroni, Sol/0000-0001-7927-6349; Gingeras, Thomas/0000-0001-9106-3573; Dash, Chandravanu/0000-0003-4466-8355; Meshorer, Eran/0000-0003-4777-986X	Intramural NIH HHS [Z01 BC010309-09, Z01 BC010495-05] Funding Source: Medline; NIDA NIH HHS [K99 DA024558, K99 DA024558-02, R00 DA024558] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010495, ZIABC010309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA024558] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aoto T, 2006, DEV BIOL, V298, P354, DOI 10.1016/j.ydbio.2006.04.450; Araki R, 2006, STEM CELLS, V24, P2522, DOI 10.1634/stemcells.2006-0005; Arney KL, 2004, J CELL SCI, V117, P4355, DOI 10.1242/jcs.01390; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Buszczak M, 2006, CELL, V125, P233, DOI 10.1016/j.cell.2006.04.004; Cao S, 2003, MOL CELL BIOL, V23, P5301, DOI 10.1128/MCB.23.15.5301-5307.2003; Dellaire G, 2004, METHOD ENZYMOL, V375, P456; Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; Golan-Mashiach M, 2004, FASEB J, V18, P147, DOI 10.1096/fj.04-2417fje; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Jorgensen HF, 2006, CELL CYCLE, V5, P1411, DOI 10.4161/cc.5.13.2927; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Kobayakawa S, 2007, GENES CELLS, V12, P447, DOI 10.1111/j.1365-2443.2007.01063.x; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; MESHORER E, 2007, DEV CELL, V22, P311; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2007, GENE DEV, V21, P2071, DOI 10.1101/gad.1615707; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Park SH, 2004, ULTRASTRUCT PATHOL, V28, P229, DOI 10.1080/01913120490515595; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Szutorisz H, 2005, BIOESSAYS, V27, P1286, DOI 10.1002/bies.20330; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Zipori D, 2004, NAT REV GENET, V5, P873, DOI 10.1038/nrg1475	58	470	479	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY	2008	2	5					437	447		10.1016/j.stem.2008.03.021	http://dx.doi.org/10.1016/j.stem.2008.03.021			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	300BM	18462694	Green Accepted, Bronze			2022-12-24	WOS:000255799300009
J	Papadia, S; Soriano, FX; Leveille, F; Martel, MA; Dakin, KA; Hansen, HH; Kaindl, A; Sifringer, M; Fowler, J; Stefovska, V; Mckenzie, G; Craigon, M; Corriveau, R; Ghazal, P; Horsburgh, K; Yankner, BA; Wyllie, DJA; Ikonomidou, C; Hardingham, GE				Papadia, Sofia; Soriano, Francesc X.; Leveille, Frederic; Martel, Marc-Andre; Dakin, Kelly A.; Hansen, Henrik H.; Kaindl, Angela; Sifringer, Marco; Fowler, Jill; Stefovska, Vanya; Mckenzie, Grahame; Craigon, Marie; Corriveau, Roderick; Ghazal, Peter; Horsburgh, Karen; Yankner, Bruce A.; Wyllie, David J. A.; Ikonomidou, Chrysanthy; Hardingham, Giles E.			Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses	NATURE NEUROSCIENCE			English	Article							CYSTEINE-SULFINIC ACID; PROMOTES OXIDATIVE STRESS; CELL-DEATH; APOPTOTIC NEURODEGENERATION; ALZHEIMERS-DISEASE; RESPONSE ELEMENT; GENE-EXPRESSION; NEURONAL DEATH; THIOREDOXIN; PROTEIN	Intrinsic antioxidant defenses are important for neuronal longevity. We found that in rat neurons, synaptic activity, acting via NMDA receptor (NMDAR) signaling, boosted antioxidant defenses by making changes to the thioredoxin-peroxiredoxin (Prx) system. Synaptic activity enhanced thioredoxin activity, facilitated the reduction of overoxidized Prxs and promoted resistance to oxidative stress. Resistance was mediated by coordinated transcriptional changes; synaptic NMDAR activity inactivated a previously unknown Forkhead box O target gene, the thioredoxin inhibitor Txnip. Conversely, NMDAR blockade upregulated Txnip in vivo and in vitro, where it bound thioredoxin and promoted vulnerability to oxidative damage. Synaptic activity also upregulated the Prx reactivating genes Sesn2 (sestrin 2) and Srxn1 (sulfiredoxin), via C/EBP beta and AP-1, respectively. Mimicking these expression changes was sufficient to strengthen antioxidant defenses. Trans-synaptic stimulation of synaptic NMDARs was crucial for boosting antioxidant defenses; chronic bath activation of all (synaptic and extrasynaptic) NMDARs induced no antioxidative effects. Thus, synaptic NMDAR activity may influence the progression of pathological processes associated with oxidative damage.	[Papadia, Sofia; Soriano, Francesc X.; Leveille, Frederic; Martel, Marc-Andre; Fowler, Jill; Horsburgh, Karen; Wyllie, David J. A.; Hardingham, Giles E.] Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH8 9XD, Midlothian, Scotland; [Dakin, Kelly A.; Yankner, Bruce A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Hansen, Henrik H.; Sifringer, Marco; Stefovska, Vanya; Ikonomidou, Chrysanthy] Tech Univ Dresden, Dept Pediat Neurol, D-01307 Dresden, Germany; [Kaindl, Angela] Charite, Dept Pediat Neurol, D-13353 Berlin, Germany; [Kaindl, Angela] Hop Robert Debre, Lab Neurol Dev, INSERM, U676, F-75019 Paris, France; [Mckenzie, Grahame] Hutchison MRC Res Ctr, MRC Canc Cell Unit, Cambridge CB2 0XZ, England; [Craigon, Marie; Ghazal, Peter] Univ Edinburgh, Div Pathway Med, Edinburgh EH16 4SB, Midlothian, Scotland; [Corriveau, Roderick] Coriell Inst Med Res, Camden, NJ 08103 USA; [Hardingham, Giles E.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland	University of Edinburgh; Harvard University; Harvard Medical School; Technische Universitat Dresden; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Edinburgh; Coriell Institute for Medical Research; University of Edinburgh	Hardingham, GE (corresponding author), Univ Edinburgh, Neurosci Res Ctr, Hugh Robson Bldg George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	giles.hardingham@ed.ac.uk	Wyllie, David J A/AAK-4678-2021; Soriano, Francesc X/U-7552-2017	Wyllie, David J A/0000-0002-4957-6049; Soriano, Francesc X/0000-0003-1678-7162; Hardingham, Giles/0000-0002-7629-5314; Horsburgh, Karen/0000-0002-9620-3691; Kaindl, Angela/0000-0001-9454-206X; Ghazal, Peter/0000-0003-0035-2228	Biotechnology and Biological Sciences Research Council [BB/D011388/1] Funding Source: Medline; NIA NIH HHS [P30 AG010161, P30AG10161] Funding Source: Medline; Wellcome Trust [078178] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG010161] Funding Source: NIH RePORTER; BBSRC [BB/D011388/1] Funding Source: UKRI; Medical Research Council [G0700704B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Adams SM, 2004, J NEUROSCI, V24, P9441, DOI 10.1523/JNEUROSCI.3290-04.2004; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Boulos S, 2007, J NEUROSCI RES, V85, P3089, DOI 10.1002/jnr.21429; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; ELNASR MS, 1990, EUR J PHARMACOL, V185, P19, DOI 10.1016/0014-2999(90)90206-L; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; Kapinya K, 2000, BRAIN RES, V872, P282, DOI 10.1016/S0006-8993(00)02503-8; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakayama K, 2005, J NEUROSCI, V25, P4040, DOI 10.1523/JNEUROSCI.4115-04.2005; Niehof M, 1997, MOL CELL BIOL, V17, P3600, DOI 10.1128/MCB.17.7.3600; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Olive M, 1996, J BIOL CHEM, V271, P2040, DOI 10.1074/jbc.271.4.2040; Olney JW, 2002, BRAIN PATHOL, V12, P488, DOI 10.1111/j.1750-3639.2002.tb00467.x; Osada S, 1996, J BIOL CHEM, V271, P3891; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papadia S, 2007, NEUROSCIENTIST, V13, P572, DOI 10.1177/1073858407305833; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; Sanchez-Font MF, 2003, CELL MOL LIFE SCI, V60, P1513, DOI 10.1007/s00018-003-3048-1; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Spires TL, 2005, FEBS J, V272, P2347, DOI 10.1111/j.1742-4658.2005.04677.x; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tovar KR, 1999, J NEUROSCI, V19, P4180; WESEMANN W, 1982, ARZNEIMITTEL-FORSCH, V32-2, P1243; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yao J, 2007, MOL CELL NEUROSCI, V35, P377, DOI 10.1016/j.mcn.2007.03.013; Yoshida T, 2005, ANN NY ACAD SCI, V1055, P1, DOI 10.1196/annals.1323.002; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	50	398	411	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					476	487		10.1038/nn2071	http://dx.doi.org/10.1038/nn2071			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344994	Green Accepted			2022-12-24	WOS:000254359300020
J	Yotsumoto, Y; Watanabe, T; Sasaki, Y				Yotsumoto, Yuko; Watanabe, Takeo; Sasaki, Yuka			Different dynamics of performance and brain activation in the time course of perceptual learning	NEURON			English	Article							SURFACE-BASED ANALYSIS; PRIMARY VISUAL-CORTEX; FMRI; SLEEP; AREAS; V1	Perceptual learning is regarded as a manifestation of experience-dependent plasticity in the sensory systems, yet the underlying neural mechanisms remain unclear. We measured the dynamics of performance on a visual task and brain activation in the human primary visual cortex (V1) across the time course of perceptual learning. Within the first few weeks of training, brain activation in a V1 subregion corresponding to the trained visual field quadrant and task performance both increased. However, while performance levels then saturated and were maintained at a constant level, brain activation in the corresponding areas decreased to the level observed before training. These findings indicate that there are distinct temporal phases in the time course of perceptual learning, related to differential dynamics of BOLD activity in visual cortex.	[Yotsumoto, Yuko; Sasaki, Yuka] Massachusetts Gen Hosp, Athinoula A Martinos Ctr, Biomed Imaging, Dept Radiol, Charlestown, MA 02129 USA; [Yotsumoto, Yuko; Watanabe, Takeo] Boston Univ, Dept Psychol, Boston, MA 02215 USA; [Sasaki, Yuka] CALTECH, ERATO, Shimojo Implicit Brain Funct Project, Pasadena, CA 91125 USA; [Yotsumoto, Yuko; Sasaki, Yuka] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Boston University; California Institute of Technology; Harvard University; Harvard Medical School	Sasaki, Y (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr, Biomed Imaging, Dept Radiol, 149 13th St, Charlestown, MA 02129 USA.	yuka@nmr.mgh.harvard.edu		Sasaki, Yuka/0000-0002-0061-0250	NCRR NIH HHS [P41 RR014075, P41RR14075] Funding Source: Medline; NEI NIH HHS [R01EY015980, R01 EY015980-01, R01 EY015980] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015980] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Burock MA, 2000, HUM BRAIN MAPP, V11, P249, DOI 10.1002/1097-0193(200012)11:4<249::AID-HBM20>3.3.CO;2-X; Censor N, 2006, VISION RES, V46, P4071, DOI 10.1016/j.visres.2006.07.022; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1999, OPTIMAL STIMULUS SE; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Fahle M, 2002, PERCEPTUAL LEARNING; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fize D, 2003, J NEUROSCI, V23, P7395; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1995, NATURE, V377, P155; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mukai I, 2007, J NEUROSCI, V27, P11401, DOI 10.1523/JNEUROSCI.3002-07.2007; Ofen N, 2007, VISION RES, V47, P1094, DOI 10.1016/j.visres.2007.01.023; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Schiltz C, 1999, NEUROIMAGE, V9, P46, DOI 10.1006/nimg.1998.0394; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Viswanathan A, 2007, NAT NEUROSCI, V10, P1308, DOI 10.1038/nn1977; Walker MP, 2005, CEREB CORTEX, V15, P1666, DOI 10.1093/cercor/bhi043; Wandell BA, 2005, PHILOS T R SOC B, V360, P693, DOI 10.1098/rstb.2005.1628; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601	28	215	221	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2008	57	6					827	833		10.1016/j.neuron.2008.02.034	http://dx.doi.org/10.1016/j.neuron.2008.02.034			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281LV	18367084	Green Accepted, Bronze			2022-12-24	WOS:000254500000007
J	Vizard, TN; O'Keeffe, GW; Gutierrez, H; Kos, CH; Riccardi, D; Davies, AM				Vizard, Thomas N.; O'Keeffe, Gerard W.; Gutierrez, Humberto; Kos, Claudine H.; Riccardi, Daniela; Davies, Alun M.			Regulation of axonal and dendritic growth by the extracellular calcium-sensing receptor	NATURE NEUROSCIENCE			English	Article							NEONATAL HYPERPARATHYROIDISM; CA2+-SENSING RECEPTOR; IN-VIVO; NEURONS; RAT; HYPERCALCEMIA; SIGNALS; CA2+; NGF; HOMEOSTASIS	The extracellular calcium-sensing receptor (CaSR) monitors the systemic, extracellular, free ionized-calcium level ([Ca2(+)](0)) in organs involved in systemic [Ca2+](0) homeostasis. However, CaSR is also expressed in the nervous system, where its role is unknown. We found large amounts of CaSR in perinatal mouse sympathetic neurons when their axons were innervating and branching extensively in their targets. Manipulating CaSR function in these neurons by varying [Ca2+](0), using CaSR agonists and antagonists, or expressing a dominant-negative CaSR markedly affected neurite growth in vitro. Sympathetic neurons lacking CaSR had smaller neurite arbors in vitro, and sympathetic innervation density was reduced in CaSR-deficient mice in vivo. Hippocampal pyramidal neurons, which also express CaSR, had smaller dendrites when transfected with dominant-negative CaSR in postnatal organotypic cultures. Our findings reveal a crucial role for CaSR in regulating the growth of neural processes in the peripheral and central nervous systems.	[Vizard, Thomas N.; O'Keeffe, Gerard W.; Gutierrez, Humberto; Riccardi, Daniela; Davies, Alun M.] Sch Biosci, Cardiff CF10 3US, S Glam, Wales; [Kos, Claudine H.] Tufts Univ, Vitamins & Carcenogenesis Lab, HNRCA, Boston, MA 02111 USA	Tufts University; United States Department of Agriculture (USDA)	Riccardi, D (corresponding author), Sch Biosci, Biomed Bldg,Museum Ave, Cardiff CF10 3US, S Glam, Wales.	riccardi@cf.ac.uk; daviesalun@cf.ac.uk	Riccardi, Daniela/A-4674-2010; Davies, Alun M/A-4334-2010	Riccardi, Daniela/0000-0002-7322-3163; Davies, Alun M/0000-0001-5841-8176; Gutierrez, Humberto/0000-0002-5021-8636; O'Keeffe, Gerard/0000-0001-5149-0933	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Wellcome Trust [071251] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Bai M, 1997, J CLIN INVEST, V99, P88, DOI 10.1172/JCI119137; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Chang WH, 1998, J BONE MINER RES, V13, P570, DOI 10.1359/jbmr.1998.13.4.570; Chattopadhyay N, 1997, DEV BRAIN RES, V100, P13, DOI 10.1016/S0165-3806(97)00009-6; Chikatsu N, 1999, CLIN ENDOCRINOL, V50, P537, DOI 10.1046/j.1365-2265.1999.00729.x; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; COLE DEC, 1990, J CRAN GENET DEV BIO, V10, P205; Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; Ferry S, 2000, EUR J NEUROSCI, V12, P872, DOI 10.1046/j.1460-9568.2000.00980.x; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Glebova NO, 2005, ANNU REV NEUROSCI, V28, P191, DOI 10.1146/annurev.neuro.28.061604.135659; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Gutierrez H, 2007, J NEUROSCI METH, V163, P24, DOI 10.1016/j.jneumeth.2007.02.002; HAMON B, 1986, EXP BRAIN RES, V64, P27; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hofer AM, 2000, NAT CELL BIOL, V2, P392, DOI 10.1038/35017020; JONES HC, 1988, J PHYSIOL-LONDON, V402, P579, DOI 10.1113/jphysiol.1988.sp017223; Kos CH, 2003, J CLIN INVEST, V111, P1021, DOI 10.1172/JCI200317416; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; Oda Y, 2000, J BIOL CHEM, V275, P1183, DOI 10.1074/jbc.275.2.1183; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; Riccardi D, 1998, AM J PHYSIOL-RENAL, V274, pF611, DOI 10.1152/ajprenal.1998.274.3.F611; SHOLL DA, 1953, J ANAT, V87, P387; Yano S, 2004, CELL CALCIUM, V35, P257, DOI 10.1016/j.ceca.2003.10.008; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882	33	89	93	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					285	291		10.1038/nn2044	http://dx.doi.org/10.1038/nn2044			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18223649	Green Accepted			2022-12-24	WOS:000253548300011
J	Alcamo, EA; Chirivella, L; Dautzenberg, M; Dobreva, G; Farinas, I; Grosschedl, R; McConnell, SK				Alcamo, Elizabeth A.; Chirivella, Laura; Dautzenberg, Marcel; Dobreva, Gergana; Farinas, Isabel; Grosschedl, Rudolf; McConnell, Susan K.			Satb2 regulates callosal projection neuron identity in the developing cerebral cortex	NEURON			English	Article							CORTICOSTRIATAL NEURONS; DENDRITIC MORPHOLOGY; PYRAMIDAL NEURONS; CORPUS-CALLOSUM; BINDING PROTEIN; MOUSE; RAT; CHROMATIN; CELL; SPECIFICATION	Satb2 is a DNA-binding protein that regulates chromatin organization and gene expression. In the developing brain, Satb2 is expressed in cortical neurons that extend axons across the corpus callosum. To assess the role of Satb2 in neurons, we analyzed mice in which the Satb2 locus was disrupted by insertion of a LacZ gene. In mutant mice, beta-galactosidase-labeled axons are absent from the corpus callosum and instead descend along the corticospinal tract. Stab2 mutant neurons acquire expression of Ctip2, a transcription factor that is necessary and sufficient for the extension of subcortical projections by cortical neurons. Conversely, ectopic expression of Satb2 in neural stem cells markedly decreases Ctip2 expression. Finally, we find that Satb2 binds directly to regulatory regions of Ctip2 and induces changes in chromatin structure. These data suggest that Satb2 functions as a repressor of Ctip2 and regulatory determinant of corticocortical connections in the developing cerebral cortex.	[Dautzenberg, Marcel; Dobreva, Gergana; Grosschedl, Rudolf] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; [Alcamo, Elizabeth A.; McConnell, Susan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Chirivella, Laura; Farinas, Isabel] Univ Valencia, Dept Biol Celular, Burjassot 46100, Spain; [Chirivella, Laura; Farinas, Isabel] Univ Valencia, Unidad Mixta CIPF UVEG, Burjassot 46100, Spain	Max Planck Society; Stanford University; University of Valencia; Prince Felipe Research Center; University of Valencia	Grosschedl, R (corresponding author), Max Planck Inst Immunobiol, D-79108 Freiburg, Germany.	grosschedl@immunbio.mpg.de; suemcc@stanford.edu	Chirivella, Laura/L-5932-2017; Farinas, Isabel/L-7118-2014	Chirivella, Laura/0000-0002-3637-5168; Farinas, Isabel/0000-0003-2903-4960; Dobreva, Gergana/0000-0002-4814-9416	NATIONAL EYE INSTITUTE [R01EY008411] Funding Source: NIH RePORTER; NEI NIH HHS [EY08411] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Ashwell KWS, 1997, INT J DEV NEUROSCI, V15, P883, DOI 10.1016/S0736-5748(97)00036-1; AULADELL C, 1995, NEUROSCIENCE, V64, P1091, DOI 10.1016/0306-4522(94)00393-J; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Barallobre MJ, 2000, DEVELOPMENT, V127, P4797; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Brown LL, 1998, J COMP NEUROL, V392, P468; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Canty AJ, 2006, P NATL ACAD SCI USA, V103, P15629, DOI 10.1073/pnas.0607350103; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; ENCODE, 2007, NATURE, V447, P799; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Finger JH, 2002, J NEUROSCI, V22, P10346; FRANTZ GD, 1994, J NEUROSCI, V14, P472; Fujimori KE, 2000, J COMP NEUROL, V417, P275, DOI 10.1002/(SICI)1096-9861(20000214)417:3<275::AID-CNE2>3.0.CO;2-7; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; KASPER EM, 1994, J COMP NEUROL, V339, P495, DOI 10.1002/cne.903390404; KOESTER SE, 1994, PROG BRAIN RES, V102, P207; KOESTER SE, 1993, DEV BIOL, V160, P1, DOI 10.1006/dbio.1993.1281; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Mintz CD, 2003, J COMP NEUROL, V464, P438, DOI 10.1002/cne.10809; Mitchell BD, 2005, J COMP NEUROL, V482, P17, DOI 10.1002/cne.20428; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Namciu SJ, 2004, MAMM GENOME, V15, P162, DOI 10.1007/s00335-003-2311-y; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; OZAKI HS, 1993, J COMP NEUROL, V336, P595, DOI 10.1002/cne.903360411; Ozaki HS, 1998, J COMP NEUROL, V400, P197, DOI 10.1002/(SICI)1096-9861(19981019)400:2<197::AID-CNE3>3.0.CO;2-4; Parmar M, 2002, MOL CELL NEUROSCI, V21, P645, DOI 10.1006/mcne.2002.1204; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Reiner A, 2003, J COMP NEUROL, V457, P420, DOI 10.1002/cne.10541; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; ROUILLER EM, 1991, HEARING RES, V56, P179, DOI 10.1016/0378-5955(91)90168-9; Shu TZ, 2003, DEVELOPMENT, V130, P2929, DOI 10.1242/dev.00514; SILVER J, 1982, J COMP NEUROL, V210, P10, DOI 10.1002/cne.902100103; STEFANKO S Z, 1980, Patologia Polska, V31, P263; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; Takeuchi A, 2007, CEREB CORTEX, V17, P1531, DOI 10.1093/cercor/bhl064; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; WOLFER DP, 1994, J COMP NEUROL, V345, P1, DOI 10.1002/cne.903450102; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075	58	440	449	4	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 7	2008	57	3					364	377		10.1016/j.neuron.2007.12.012	http://dx.doi.org/10.1016/j.neuron.2007.12.012			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261JQ	18255030	Bronze			2022-12-24	WOS:000253075300007
J	Ren, GW; Zhang, LY; Zhao, X; Xu, GW; Zhang, YY; Roberts, AI; Zhao, RC; Shi, YF				Ren, Guangwen; Zhang, Liying; Zhao, Xin; Xu, Guangwu; Zhang, Yingyu; Roberts, Arthur I.; Zhao, Robert Chunhua; Shi, Yufang			Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide	CELL STEM CELL			English	Article							VERSUS-HOST-DISEASE; NECROSIS-FACTOR-ALPHA; BONE-MARROW; LYMPHOCYTE-PROLIFERATION; INTERFERON-GAMMA; PROGENITOR CELLS; RECEPTOR CXCR3; INHIBITION; MODULATION; REACTIVITY	Mesenchymal stem cells (MSCs) can become potently immunosuppressive through unknown mechanisms. We found that the immunosuppressive function of MSCs is elicited by IFN gamma and the concomitant presence of any of three other proinflammatory cytokines, TNF alpha, IL-1 alpha, or IL-beta. These cytokine combinations provoke the expression of high levels of several chemokines and inducible nitric oxide synthase (iNOS) by MSCs. Chemokines drive T cell migration into proximity with MSCs, where T cell responsiveness is suppressed by nitric oxide (NO). This cytokine-induced immunosuppression was absent in MSCs derived from iNOS(-/-) or IFN gamma R1(-/-) mice. Blockade of chemokine receptors also abolished the immunosuppression. Administration of wild-type MSCs, but not IFNyR1(-/-) or iNOS(-/-) MSCs, prevented graft-versus-host disease in mice, an effect reversed by anti-IFN gamma or iNOS inhibitors. Wild-type MSCs also inhibited delayed-type hypersensitivity, while iNOS(-/-) MSCs aggravated it. Therefore, proinflammatory cytokines are required to induce immunosuppression by MSCs through the concerted action of chemokines and NO.	[Ren, Guangwen; Zhang, Liying; Zhao, Xin; Xu, Guangwu; Zhang, Yingyu; Roberts, Arthur I.; Shi, Yufang] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; [Zhao, Robert Chunhua] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Excellence Tissue Engn, Beijing 100005, Peoples R China; [Zhao, Robert Chunhua] Chinese Acad Med Sci, Sch Bas Med, Beijing 100005, Peoples R China; [Zhao, Robert Chunhua] Peking Union Med Coll, Beijing 100005, Peoples R China	Rutgers State University New Brunswick; Rutgers State University Medical Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shi, YF (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 661 Hoes Lane, Piscataway, NJ 08854 USA.	shiyu@umdnj.edu	Ren, Guangwen/H-5671-2011; Shi, Yufang/AAE-4431-2020; Ren, Gary/F-6724-2011; Ren, Guangwen/D-8895-2012	Shi, Yufang/0000-0001-8964-319X; Ren, Guangwen/0000-0003-2436-9593	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050222, P01AI057596] Funding Source: NIH RePORTER; NIAID NIH HHS [AI50222, AI057596] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Batten P, 2006, TISSUE ENG, V12, P2263, DOI 10.1089/ten.2006.12.2263; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen X, 2006, IMMUNOL CELL BIOL, V84, P413, DOI 10.1111/j.1440-1711.2006.01458.x; Dazzi F, 2006, BLOOD REV, V20, P161, DOI 10.1016/j.blre.2005.11.002; Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Djouad F, 2005, ARTHRITIS RHEUM-US, V52, P1595, DOI 10.1002/art.21012; Edwards TM, 2007, NEUROSCI BIOBEHAV R, V31, P413, DOI 10.1016/j.neubiorev.2006.11.001; Groh ME, 2005, EXP HEMATOL, V33, P928, DOI 10.1016/j.exphem.2005.05.002; Hattori K, 1998, BLOOD, V91, P4051, DOI 10.1182/blood.V91.11.4051.411k16_4051_4055; Hoffman RA, 2002, TRANSPLANTATION, V74, P836, DOI 10.1097/00007890-200209270-00018; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Inoue S, 2006, TRANSPLANTATION, V81, P1589, DOI 10.1097/01.tp.0000209919.90630.7b; Jacobsohn DA, 2002, EXPERT OPIN INV DRUG, V11, P1271, DOI 10.1517/13543784.11.9.1271; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Keating A, 2006, CURR OPIN HEMATOL, V13, P419, DOI 10.1097/01.moh.0000245697.54887.6f; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; Lazzeri E., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P109, DOI 10.2174/1568008053174723; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Le Blanc K, 2006, CURR OPIN IMMUNOL, V18, P586, DOI 10.1016/j.coi.2006.07.004; Loetscher M, 1998, EUR J IMMUNOL, V28, P3696, DOI 10.1002/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.0.CO;2-W; Lu L, 1996, CRIT REV ONCOL HEMAT, V22, P61, DOI 10.1016/1040-8428(96)88370-3; MCCARTHY PL, 1991, BLOOD, V78, P1915; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Meyer M, 2001, EUR J IMMUNOL, V31, P2521, DOI 10.1002/1521-4141(200108)31:8<2521::AID-IMMU2521>3.0.CO;2-Q; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Miszta-Lane H, 2006, MED HYPOTHESES, V67, P909, DOI 10.1016/j.mehy.2006.03.036; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Niedbala W, 2006, ANN RHEUM DIS, V65, P37, DOI 10.1136/ard.2006.058446; Plumas J, 2005, LEUKEMIA, V19, P1597, DOI 10.1038/sj.leu.2403871; Pommey S, 2006, B CANCER, V93, P901; Radvanyi LG, 1996, CELL IMMUNOL, V170, P260, DOI 10.1006/cimm.1996.0160; Rasmusson I, 2005, EXP CELL RES, V305, P33, DOI 10.1016/j.yexcr.2004.12.013; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; SHI YF, 1993, J IMMUNOL METHODS, V164, P149, DOI 10.1016/0022-1759(93)90307-S; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Tamada K, 2000, NAT MED, V6, P283; van Laar JM, 2006, RHEUMATOLOGY, V45, P1187, DOI 10.1093/rheumatology/kel158; Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH2163, DOI 10.1152/ajpheart.1998.274.6.H2163; Von Luttichau I, 2005, STEM CELLS DEV, V14, P329, DOI 10.1089/scd.2005.14.329; Wojakowski W, 2005, FOLIA HISTOCHEM CYTO, V43, P229; Xu GW, 2007, BIOCHEM BIOPH RES CO, V361, P745, DOI 10.1016/j.bbrc.2007.07.052; Xu GW, 2007, CELL RES, V17, P240, DOI 10.1038/cr.2007.4; Xu YH, 2007, BLOOD, V109, P4097, DOI 10.1182/blood-2006-09-047332; Yang YG, 1998, J CLIN INVEST, V102, P2126, DOI 10.1172/JCI4992; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	54	1426	1525	7	125	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB	2008	2	2					141	150		10.1016/j.stem.2007.11.014	http://dx.doi.org/10.1016/j.stem.2007.11.014			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	264PW	18371435	Bronze			2022-12-24	WOS:000253301900009
J	Arac, D; Boucard, AA; Ozkan, E; Strop, P; Newell, E; Sudhof, TC; Brunger, AT				Arac, Demet; Boucard, Antony A.; Ozkan, Engin; Strop, Pavel; Newell, Evan; Sudhof, Thomas C.; Brunger, Axel T.			Structures of neuroligin-1 and the Neuroligin-l/Neurexin-1 beta complex reveal specificprotein-protein and protein-Ca2+ interactions	NEURON			English	Article							CELL-ADHESION; ALPHA-NEUREXINS; CA2+ BINDING; X-RAY; BETA; AUTISM; LIGAND; GENE; ACETYLCHOLINESTERASE; CRYSTALLOGRAPHY	Neurexins and neuroligins provide trans-synaptic connectivity by the Ca2+-dependent interaction of their alternatively spliced extracellular domains. Neuroligins specify synapses in an activity-dependent manner, presumably by binding to neurexins. Here, we present the crystal structures of neuroligin-1 in isolation and in complex with neurexin-1 beta. Neuroligin-1 forms a constitutive dimer, and two neurexin-1 beta monomers bind to two identical surfaces on the opposite faces of the neuroligin-1 dimer to form a heterotetramer. The neuroligin-1/neurexin-1 beta complex exhibits a nanomolar affinity and includes a large binding interface that contains bound Ca2+. Alternatively spliced sites in neurexin-1 beta and in neuroligin-1 are positioned nearby the binding interface, explaining how they regulate the interaction. Structure-based mutations of neuroligin-1 at the interface disrupt binding to neurexin-1 beta, but not the folding of neuroligin-1 and confirm the validity of the binding interface of the neuroligin-1/neurexin1 beta complex. Our results provide molecular insights for understanding the role of cell-adhesion proteins in synapse function.	[Arac, Demet; Boucard, Antony A.; Strop, Pavel; Sudhof, Thomas C.; Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Arac, Demet; Ozkan, Engin; Strop, Pavel; Brunger, Axel T.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Arac, Demet; Ozkan, Engin; Strop, Pavel; Brunger, Axel T.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Arac, Demet; Strop, Pavel; Brunger, Axel T.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Arac, Demet; Strop, Pavel; Brunger, Axel T.] Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Newell, Evan] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Boucard, Antony A.; Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Boucard, Antony A.; Sudhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Brunger, AT (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	brunger@stanford.edu	Boucard, Antony/CAJ-3093-2022; Newell, Evan W/F-9711-2012; Boucard, Antony/ABA-9769-2020	Newell, Evan W/0000-0002-2889-243X; Brunger, Axel/0000-0001-5121-2036; Ozkan, Engin/0000-0002-0263-6729	NIMH NIH HHS [R37 MH52804-08] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH052804] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Comoletti D, 2007, STRUCTURE, V15, P693, DOI 10.1016/j.str.2007.04.010; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Garber K, 2007, SCIENCE, V317, P190, DOI 10.1126/science.317.5835.190; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Hoffman RC, 2004, BIOCHEMISTRY-US, V43, P1496, DOI 10.1021/bi035278t; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROCHEM, V71, P1339; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Philibert RA, 2000, GENE, V246, P303, DOI 10.1016/S0378-1119(00)00049-4; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sheckler LR, 2006, J BIOL CHEM, V281, P22896, DOI 10.1074/jbc.M603464200; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tsigelny I, 2000, PROTEIN SCI, V9, P180; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629	47	150	153	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 20	2007	56	6					992	1003		10.1016/j.neuron.2007.12.002	http://dx.doi.org/10.1016/j.neuron.2007.12.002			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	248FP	18093522	Bronze			2022-12-24	WOS:000252138000009
J	Cachope, R; Mackie, K; Triller, A; O'Brien, J; Pereda, AE				Cachope, Roger; Mackie, Ken; Triller, Antoine; O'Brien, John; Pereda, Alberto E.			Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoids	NEURON			English	Article							LONG-TERM POTENTIATION; GAP JUNCTIONAL COMMUNICATION; ENDOGENOUS CANNABINOIDS; METABOTROPIC GLUTAMATE; MAUTHNER CELL; CYCLIC-AMP; GABAERGIC NEUROTRANSMISSION; NEURONAL SUBPOPULATIONS; RETROGRADE INHIBITION; MIXED SYNAPSES	Endocannabinoids are well established as inhibitors of chemical synaptic transmission via presynaptic activation of the cannabinoid type 1 receptor (CB1R). Contrasting this notion, we show that dendritic release of endocannabinoids mediates potentiation of synaptic transmission at mixed (electrical and chemical) synaptic contacts on the goldfish Mauthner cell. Remarkably, the observed enhancement was not restricted to the glutamatergic component of the synaptic response but also included a parallel increase in electrical transmission. This effect involved the activation of CB1 receptors and was indirectly mediated via the release of dopamine from nearby varicosities, which in turn led to potentiation of the synaptic response via a cAMP-dependent protein kinase-mediated postsynaptic mechanism. Thus, endocannabinoid release can potentiate synaptic transmission, and its functional roles include the regulation of gap junction-mediated electrical synapses. Similar interactions between endocannabinoid and dopaminergic systems may be widespread and potentially relevant for the motor and rewarding effects of cannabis derivatives.	[Cachope, Roger; Pereda, Alberto E.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Mackie, Ken] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Triller, Antoine] Ecole Normale Super, F-75231 Paris, France; [O'Brien, John] Univ Texas Houston, Hlth Sci Ctr, Houston, TX 77030 USA	Yeshiva University; Albert Einstein College of Medicine; University of Washington; University of Washington Seattle; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Texas System; University of Texas Health Science Center Houston	Pereda, AE (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA.	apereda@aecom.yu.edu	Mackie, Kenneth P/B-7358-2011; Mackie, Ken/E-3715-2013; O'Brien, John/G-2522-2013; Cachope, Roger/K-2677-2012	Mackie, Ken/0000-0001-8501-6199; O'Brien, John/0000-0002-0270-3442; TRILLER, Antoine/0000-0002-7530-1233	NATIONAL EYE INSTITUTE [R01EY012857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R56DC003186, R01DC003186, R29DC003186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA021696, R01DA011322] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY012857, R01 EY012857-07, EY12857] Funding Source: Medline; NIDA NIH HHS [DA11322, K05 DA021696, R01 DA011322] Funding Source: Medline; NIDCD NIH HHS [R01 DC003186, R01 DC003186-11, R29 DC003186, R56 DC003186, DC03186] Funding Source: Medline; NINDS NIH HHS [NS0552827, R01 NS052827-04, R01 NS052827] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alger BE, 2002, PROG NEUROBIOL, V68, P247; Bash R, 2003, NEUROSIGNALS, V12, P39, DOI 10.1159/000068915; Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884; Brandes RP, 2002, BRIT J PHARMACOL, V136, P709, DOI 10.1038/sj.bjp.0704776; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; Brown SP, 2003, NAT NEUROSCI, V6, P1048, DOI 10.1038/nn1126; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Condorelli DF, 1998, EUR J NEUROSCI, V10, P1202, DOI 10.1046/j.1460-9568.1998.00163.x; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Cottone E, 2005, ANN NY ACAD SCI, V1040, P273, DOI 10.1196/annals.1327.041; FABER DS, 1988, P NATL ACAD SCI USA, V85, P8708, DOI 10.1073/pnas.85.22.8708; Fan SF, 2005, VISUAL NEUROSCI, V22, P55, DOI 10.1017/S0952523805221089; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; FUKAMI Y, 1965, J GEN PHYSIOL, V48, P581, DOI 10.1085/jgp.48.4.581; Galante M, 2004, J NEUROSCI, V24, P4865, DOI 10.1523/JNEUROSCI.0403-04.2004; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Glass M, 1997, J NEUROSCI, V17, P5327, DOI 10.1523/jneurosci.17-14-05327.1997; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hohmann AG, 2000, SYNAPSE, V37, P71, DOI 10.1002/(SICI)1098-2396(200007)37:1<71::AID-SYN8>3.3.CO;2-B; Jarrahian A, 2004, J PHARMACOL EXP THER, V308, P880, DOI 10.1124/jpet.103.057620; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; Kothmann WW, 2007, VISUAL NEUROSCI, V24, P363, DOI 10.1017/S095252380707037X; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kumar SS, 1999, J NEUROSCI, V19, P1620; Lauckner JE, 2005, P NATL ACAD SCI USA, V102, P19144, DOI 10.1073/pnas.0509588102; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; Maneuf YP, 1997, BRIT J PHARMACOL, V120, P1397, DOI 10.1038/sj.bjp.0701101; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; McIntosh HH, 1998, MOL BRAIN RES, V53, P163, DOI 10.1016/S0169-328X(97)00294-5; McPartland JM, 2007, MOL GENET GENOMICS, V277, P555, DOI 10.1007/s00438-007-0207-3; Mitropoulou G, 2003, J NEUROSCI RES, V72, P147, DOI 10.1002/jnr.10572; O'Brien J, 1998, J NEUROSCI, V18, P7625; ODA Y, 1995, J NEUROPHYSIOL, V74, P1056, DOI 10.1152/jn.1995.74.3.1056; Ohno-Shosaku T, 2002, EUR J NEUROSCI, V15, P953, DOI 10.1046/j.1460-9568.2002.01929.x; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Oropeza VC, 2005, BRAIN RES, V1046, P45, DOI 10.1016/j.brainres.2005.03.036; Oropeza VC, 2007, BRAIN RES, V1127, P36, DOI 10.1016/j.brainres.2006.09.110; Ouyang XS, 2005, MOL BRAIN RES, V135, P1, DOI 10.1016/j.molbrainres.2004.10.045; Pereda A, 2003, J NEUROSCI, V23, P7489; PEREDA A, 1992, P NATL ACAD SCI USA, V89, P12088, DOI 10.1073/pnas.89.24.12088; Pereda AE, 1998, P NATL ACAD SCI USA, V95, P13272, DOI 10.1073/pnas.95.22.13272; Pereda AE, 2004, BRAIN RES REV, V47, P227, DOI 10.1016/j.brainresrev.2004.06.010; Pereda AE, 1996, J NEUROSCI, V16, P983; PEREDA AE, 1994, J NEUROSCI, V14, P3704; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Rubovitch V, 2002, MOL BRAIN RES, V101, P93, DOI 10.1016/S0169-328X(02)00174-2; Smith M, 2003, P NATL ACAD SCI USA, V100, P4849, DOI 10.1073/pnas.0734299100; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Szabo B, 2002, EUR J NEUROSCI, V15, P2057, DOI 10.1046/j.1460-9568.2002.02041.x; TRILLER A, 1993, J COMP NEUROL, V338, P83, DOI 10.1002/cne.903380107; TUTTLE R, 1987, J COMP NEUROL, V265, P254, DOI 10.1002/cne.902650209; Upham BL, 2003, INT J CANCER, V104, P12, DOI 10.1002/ijc.10899; Urschel S, 2006, J BIOL CHEM, V281, P33163, DOI 10.1074/jbc.M606396200; Valenti M, 2005, J NEUROCHEM, V95, P662, DOI 10.1111/j.1471-4159.2005.03406.x; van der Stelt M, 2003, EUR J PHARMACOL, V480, P133, DOI 10.1016/j.ejphar.2003.08.101; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; VENANCE L, 1995, NATURE, V376, P590, DOI 10.1038/376590a0; Wallmichrath I, 2002, NEUROSCIENCE, V113, P671, DOI 10.1016/S0306-4522(02)00109-4; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; WOLSZON LR, 1989, J NEUROSCI, V9, P784; Wolszon LR, 1997, J NEUROPHYSIOL, V78, P2693, DOI 10.1152/jn.1997.78.5.2693; Yamaguchi F, 1996, GENOMICS, V35, P603, DOI 10.1006/geno.1996.0406; YANG XD, 1990, NATURE, V348, P542, DOI 10.1038/348542a0; Yazulla S, 2000, VISUAL NEUROSCI, V17, P391, DOI 10.1017/S0952523800173079	66	74	74	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 20	2007	56	6					1034	1047		10.1016/j.neuron.2007.11.014	http://dx.doi.org/10.1016/j.neuron.2007.11.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	248FP	18093525	Green Accepted, Bronze			2022-12-24	WOS:000252138000012
J	Dolen, G; Osterweil, E; Rao, BSS; Smith, GB; Auerbach, BD; Chattarji, S; Bear, MF				Dolen, Gul; Osterweil, Emily; Rao, B. S. Shankaranarayana; Smith, Gordon B.; Auerbach, Benjamin D.; Chattarji, Sumantra; Bear, Mark F.			Correction of fragile X syndrome in mice	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; PROTEIN-SYNTHESIS; MENTAL-RETARDATION; MOUSE MODEL; EPILEPTIFORM DISCHARGES; SYNAPTIC PLASTICITY; OCULAR DOMINANCE; ANTAGONIST MPEP; VISUAL-CORTEX	Fragile X syndrome (FXS) is the most common form of heritable mental retardation and the leading identified cause of autism. FXS is caused by transcriptional silencing of the FMR1 gene that encodes the fragile X mental retardation protein (FMRP), but the pathogenesis of the disease is unknown. According to one proposal, many psychiatric and neurological symptoms of FXS result from unchecked activation of mGluR5, a metabotropic glutamate receptor. To test this idea we generated Fmr1 mutant mice with a 50% reduction in mGluR5 expression and studied a range of phenotypes with relevance to the human disorder. Our results demonstrate that mGluR5 contributes significantly to the pathogenesis of the disease, a finding that has significant therapeutic implications for fragile X and related developmental disorders.	[Dolen, Gul; Osterweil, Emily; Smith, Gordon B.; Auerbach, Benjamin D.; Bear, Mark F.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Dolen, Gul] Brown Univ, Sch Med, Dept Neurosci, Providence, RI 02912 USA; [Dolen, Gul] Div Biol & Med, Providence, RI 02912 USA; [Rao, B. S. Shankaranarayana] Natl Inst Mental Hlth & Neurosci, Dept Neurophysiol, Bangalore 560002, Karnataka, India; [Chattarji, Sumantra] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560002, Karnataka, India	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; Brown University; National Institute of Mental Health & Neurosciences - India; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Bear, MF (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Howard Hughes Med Inst, E25-618, Cambridge, MA 02139 USA.	mbear@mit.edu	Dolen, Gul/J-3073-2015	Dolen, Gul/0000-0003-1780-995X; Shankaranarayana Rao, BS/0000-0002-8323-8211; Bear, Mark/0000-0002-9903-2541; Osterweil, Emily/0000-0003-0582-2284	NICHD NIH HHS [R01 HD046943, R01 HD046943-05] Funding Source: Medline; NIMH NIH HHS [P50 MH058880, P50 MH058880-090006] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAKKER CE, 1994, CELL, V78, P23; Bear MF, 2008, NEUROPSYCHOPHARMACOL, V33, P84, DOI 10.1038/sj.npp.1301610; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bernardet M, 2006, THESCIENTIFICWORLDJO, V6, P1164, DOI 10.1100/tsw.2006.220; Bjarnadottir TK, 2005, ANN NY ACAD SCI, V1040, P230, DOI 10.1196/annals.1327.031; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chuang SC, 2005, J NEUROSCI, V25, P8048, DOI 10.1523/JNEUROSCI.1777-05.2005; DUDEK SM, 1989, SCIENCE, V246, P673, DOI 10.1126/science.2573152; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Heidbreder CA, 2003, SYNAPSE, V50, P269, DOI 10.1002/syn.10261; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Jia ZP, 1998, LEARN MEMORY, V5, P331; Karachot L, 2001, J NEUROPHYSIOL, V86, P280, DOI 10.1152/jn.2001.86.1.280; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Lea PM, 2006, CNS DRUG REV, V12, P149, DOI 10.1111/j.1527-3458.2006.00149.x; LOESCH DZ, 1995, AM J MED GENET, V58, P249, DOI 10.1002/ajmg.1320580311; Lu YM, 1997, J NEUROSCI, V17, P5196; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; Merlin LR, 1998, J NEUROPHYSIOL, V80, P989, DOI 10.1152/jn.1998.80.2.989; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; Power AE, 2006, LEARN MEMORY, V13, P27, DOI 10.1101/lm.91206; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; ROBERTSON HA, 1980, EUR J PHARMACOL, V66, P249, DOI 10.1016/0014-2999(80)90149-1; Storto M, 2001, J ENDOCRINOL, V170, P71, DOI 10.1677/joe.0.1700071; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Tucker B, 2006, HUM MOL GENET, V15, P3446, DOI 10.1093/hmg/ddl422; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Zho WM, 2002, J NEUROSCI, V22, P8838	37	735	754	0	73	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 20	2007	56	6					955	962		10.1016/j.neuron.2007.12.001	http://dx.doi.org/10.1016/j.neuron.2007.12.001			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	248FP	18093519	Green Accepted, Bronze			2022-12-24	WOS:000252138000006
J	Liu, X; Krause, WC; Davis, RL				Liu, Xu; Krause, William C.; Davis, Ronald L.			GABA(A) receptor RDL inhibits Drosophila olfactory associative learning	NEURON			English	Article							MUSHROOM BODY NEURONS; MEMORY TRACE; CYCLODIENE RESISTANCE; MUTANT DROSOPHILA; MICE LACKING; SUBUNIT; SYSTEM; EXPRESSION; RETENTION; AMYGDALA	In both mammals and insects, neurons involved in learning are strongly modulated by the inhibitory neurotransmitter GABA. The GABA(A) receptor, (r) under bar esistance to (d) under bar ieldrin (Rdl), is highly expressed in the Drosophila mushroom bodies (MBs), a group of neurons playing essential roles in insect olfactory learning. Flies with increased or decreased expression of Rdl in the MBs were generated. Olfactory associative learning tests showed that Rdl overexpression impaired memory acquisition but not memory stability. This learning defect was due to disrupting the physiological state of the adult MB neurons rather than causing developmental abnormalities. Remarkably, Rdl knockdown enhanced memory acquisition but not memory stability. Functional cellular imaging experiments showed that Rdl overexpression abolished the normal calcium responses of the MBs to odors while Rdl knockdown increased these responses. Together, these data suggest that RDL negatively modulates olfactory associative learning, possibly by gating the input of olfactory information into the MBs.	[Liu, Xu; Krause, William C.; Davis, Ronald L.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Davis, Ronald L.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	rdavis@bcm.tmc.edu	Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019904, R37NS019904, R01NS052351] Funding Source: NIH RePORTER; NINDS NIH HHS [R37 NS019904, R01 NS052351-01A1, R01 NS019904-28, R01 NS019904, R01 NS052351-02, R01 NS052351-04, R01 NS052351-05, R01 NS019904-26, R01 NS019904-27, R01 NS052351, NS19904, R01 NS019904-25A2, R01 NS019904-29, R01 NS052351-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akalal DBG, 2006, LEARN MEMORY, V13, P659, DOI 10.1101/lm.221206; ANGLADE F, 1994, NEUROSCI LETT, V182, P247, DOI 10.1016/0304-3940(94)90808-7; Armstrong JD, 1998, LEARN MEMORY, V5, P102; Beck CDO, 2000, J NEUROSCI, V20, P2944; Brennan PA, 1998, NEUROSCIENCE, V87, P583, DOI 10.1016/S0306-4522(98)00182-1; Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313; BUCKINGHAM SD, 1994, NEUROSCI LETT, V181, P137, DOI 10.1016/0304-3940(94)90578-9; Chambers MS, 2003, J MED CHEM, V46, P2227, DOI 10.1021/jm020582q; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Chhatwal JP, 2005, J NEUROSCI, V25, P502, DOI 10.1523/JNEUROSCI.3301-04.2005; CHROBAK JJ, 1992, NEUROSCIENCE, V47, P833, DOI 10.1016/0306-4522(92)90033-X; Collinson N, 2002, J NEUROSCI, V22, P5572; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DeLorey TM, 1998, J NEUROSCI, V18, P8505; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; FFRENCHCONSTANT RH, 1993, J NEUROCHEM, V60, P2323, DOI 10.1111/j.1471-4159.1993.tb03523.x; FFRENCHCONSTANT RH, 1991, P NATL ACAD SCI USA, V88, P7209, DOI 10.1073/pnas.88.16.7209; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Harrison JB, 1996, CELL TISSUE RES, V284, P269, DOI 10.1007/s004410050587; Hosie AM, 2001, NEUROSCIENCE, V102, P709, DOI 10.1016/S0306-4522(00)00483-8; Hosie AM, 1997, TRENDS NEUROSCI, V20, P578, DOI 10.1016/S0166-2236(97)01127-2; Huff NC, 2005, LEARN MEMORY, V12, P456, DOI 10.1101/lm.6705; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Jasnow AM, 2001, BRAIN RES, V920, P142, DOI 10.1016/S0006-8993(01)03054-2; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; LEE HJ, 1993, FEBS LETT, V335, P315, DOI 10.1016/0014-5793(93)80409-N; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liu X, 2006, CURR OPIN NEUROBIOL, V16, P679, DOI 10.1016/j.conb.2006.09.003; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; MCGUIRE SE, 2004, SCI STKE, P16; MCNAMARA RK, 1993, BRAIN RES, V626, P63, DOI 10.1016/0006-8993(93)90563-3; Moron I, 2002, BEHAV BRAIN RES, V134, P425, DOI 10.1016/S0166-4328(02)00056-6; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Van Nobelen M, 2006, NEUROSCIENCE, V137, P707, DOI 10.1016/j.neuroscience.2005.08.061; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155; Zarrindast MR, 2004, EUR NEUROPSYCHOPHARM, V14, P59, DOI 10.1016/S0924-977X(03)00068-3; Zarrindast MR, 2002, J PSYCHOPHARMACOL, V16, P313, DOI 10.1177/026988110201600405; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	56	110	113	4	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 20	2007	56	6					1090	1102		10.1016/j.neuron.2007.10.036	http://dx.doi.org/10.1016/j.neuron.2007.10.036			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	248FP	18093529	Green Accepted, Bronze			2022-12-24	WOS:000252138000016
J	Xie, Z; Srivastava, DP; Photowala, H; Kai, L; Cahill, ME; Woolfrey, KM; Shum, CY; Surmeier, DJ; Penzes, P				Xie, Zhong; Srivastava, Deepak P.; Photowala, Huzefa; Kai, Li; Cahill, Michael E.; Woolfrey, Kevin M.; Shum, Cassandra Y.; Surmeier, D. James; Penzes, Peter			Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines	NEURON			English	Article							LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; DRIVING AMPA RECEPTORS; SYNAPTIC PLASTICITY; MENTAL-RETARDATION; NMDA RECEPTOR; IN-VIVO; MOLECULAR-MECHANISMS; SILENT SYNAPSES; KINASE-II	Activity-dependent rapid structural and functional modifications of central excitatory synapses contribute to synapse maturation, experience-dependent plasticity, and learning and memory and are associated with neuro-developmental and psychiatric disorders. However, the signal transduction mechanisms that link glutamate receptor activation to intracellular effectors that accomplish structural and functional plasticity are not well understood. Here we report that NMDA receptor activation in pyramidal neurons causes CaMKII-dependent phosphorylation of the guanine-nucleotide exchange factor (GEF) kalirin-7 at residue threonine 95, regulating its GEF activity, leading to activation of small GTPase Rac1 and rapid enlargement of existing spines. Kalirin-7 also interacts with AMPA receptors and controls their synaptic expression. By demonstrating that kalirin expression and spine localization are required for activity-dependent spine enlargement and enhancement of AMPAR-mediated synaptic transmission, our study identifies a signaling pathway that controls structural and functional spine plasticity.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Penzes, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	p-penzes@northwestern.edu	Penzes, Peter/L-3987-2016; Xie, Zhong/B-6829-2011	Penzes, Peter/0000-0001-5449-1640; Xie, Zhong/0000-0002-8348-4455; Srivastava, Deepak Prakash/0000-0001-6512-9065; Cahill, Michael/0000-0003-0574-2655	NIMH NIH HHS [MH071316, R01 MH071316-03, R01 MH071316-02, R01 MH071316-01A1, R01 MH071316-02S1, R01 MH071316] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071316] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison DW, 1998, J NEUROSCI, V18, P2423; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Connor S, 2006, SYNAPSE, V59, P378, DOI 10.1002/syn.20248; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Glantz LA, 2001, ARCH GEN PSYCHIAT, V58, P203, DOI 10.1001/archpsyc.58.2.203; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hill JJ, 2006, MOL PSYCHIATR, V11, P557, DOI 10.1038/sj.mp.4001792; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Leuner B, 2003, J NEUROSCI, V23, P659, DOI 10.1523/JNEUROSCI.23-02-00659.2003; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Millar JK, 2003, BIOCHEM BIOPH RES CO, V311, P1019, DOI 10.1016/j.bbrc.2003.10.101; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Pickett J, 2005, J NEUROPATH EXP NEUR, V64, P925, DOI 10.1097/01.jnen.0000186921.42592.6c; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wiens KM, 2005, J NEUROSCI, V25, P10627, DOI 10.1523/JNEUROSCI.1947-05.2005; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	49	283	288	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 21	2007	56	4					640	656		10.1016/j.neuron.2007.10.005	http://dx.doi.org/10.1016/j.neuron.2007.10.005			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	236MH	18031682	Green Accepted, Bronze			2022-12-24	WOS:000251306600008
J	Dahanukar, A; Lei, YT; Kwon, JY; Carlson, JR				Dahanukar, Anupama; Lei, Ya-Ting; Kwon, Jae Young; Carlson, John R.			Two Gr genes underlie sugar reception in Drosophila	NEURON			English	Article							CANDIDATE TASTE RECEPTORS; ODORANT RECEPTORS; SWEET TASTE; IN-VIVO; MELANOGASTER; EXPRESSION; NEURONS; PROJECTIONS; TREHALOSE; SYSTEM	We have analyzed the molecular basis of sugar reception in Drosophila. We define the response spectrum, concentration dependence, and temporal dynamics of sugar-sensing neurons. Using in situ hybridization and reporter gene expression, we identify members of the Gr5a-related taste receptor subfamily that are coexpressed in sugar neurons. Neurons expressing reporters of different Gr5a-related genes send overlapping but distinct projections to the brain and thoracic ganglia. Genetic analysis of receptor genes shows that Gr5a is required for response to one subset of sugars and Gr64a for response to a complementary subset. A Gr5a;Gr64a double mutant shows no physiological or behavioral responses to any tested sugar. The simplest interpretation of our results is that Gr5a and Gr64a are each capable of functioning independently of each other within individual sugar neurons and that they are the primary receptors used in the labellum to detect sugars.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu		Dahanukar, Anupama/0000-0003-0534-7700	NIDCD NIH HHS [R01 DC011697] Funding Source: Medline; NIGMS NIH HHS [R01 GM063364-06, R01 GM063364-04, GM63364, R01 GM063364-02, R01 GM063364-07, R01 GM063364-03, R01 GM063364-05, R01 GM063364, R01 GM063364-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011697] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHENG E, 1992, DROSOPHILA INFORM NE, V6; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Dethier VG, 1976, HUNGRY FLY; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; EDGECOMB RS, 1992, J COMP NEUROL, V315, P431, DOI 10.1002/cne.903150406; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; FUJISHIRO N, 1984, J INSECT PHYSIOL, V30, P317, DOI 10.1016/0022-1910(84)90133-1; Furuyama A, 1999, J INSECT PHYSIOL, V45, P249, DOI 10.1016/S0022-1910(98)00120-6; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Jiao Y, 2007, P NATL ACAD SCI USA, V104, P14110, DOI 10.1073/pnas.0702421104; Kim NC, 2002, ARCH PHARM RES, V25, P725, DOI 10.1007/BF02976987; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; RAY K, 1993, DEV BIOL, V155, P26, DOI 10.1006/dbio.1993.1003; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; RODRIGUES V, 1978, P INDIAN ACAD SCI B, V87, P147; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shanbhag SR, 2001, CELL TISSUE RES, V304, P423, DOI 10.1007/s004410100388; SHANBHAG SR, 1992, CELL TISSUE RES, V267, P273, DOI 10.1007/BF00302965; SHIRAIWA T, 2007, J VISUALIZED EXPT, V3; SLONE J, 2007, DROSOPHILA CURR BIOL, V17, P1; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1981, CELL TISSUE RES, V216, P513; TANIMURA T, 1981, J COMP PHYSIOL, V141, P265, DOI 10.1007/BF01342672; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; US Department of Agriculture Agricultural Research Service, 2006, USDA NAT NUTR DAT ST; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; WIECZOREK H, 1989, J COMP PHYSIOL A, V164, P825, DOI 10.1007/BF00616754	44	273	278	2	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 8	2007	56	3					503	516		10.1016/j.neuron.2007.10.024	http://dx.doi.org/10.1016/j.neuron.2007.10.024			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	229AV	17988633	Bronze, Green Accepted			2022-12-24	WOS:000250774600009
J	Morin, X; Jaouen, F; Durbec, P				Morin, Xavier; Jaouen, Florence; Durbec, Pascale			Control of planar divisions by the G-protein regulator LGN maintains progenitors in the chick neuroepithelium	NATURE NEUROSCIENCE			English	Article							HETEROTRIMERIC G-PROTEINS; ASYMMETRIC CELL DIVISIONS; DROSOPHILA NEUROBLAST; SPINDLE ORIENTATION; PLASMA-MEMBRANE; SIGNALING PATHWAYS; MAMMALIAN-CELLS; CEREBRAL-CORTEX; SIZE ASYMMETRY; GOLOCO MOTIF	The spatio-temporal regulation of symmetrical as opposed to asymmetric cell divisions directs the fate and location of cells in the developing CNS. In invertebrates, G-protein regulators control spindle orientation in asymmetric divisions, which generate progeny with different identities. We investigated the role of the G-protein regulator LGN (also called Gpsm2) in spindle orientation and cell-fate determination in the spinal cord neuroepithelium of the developing chick embryo. We show that LGN is located at the cell cortex and spindle poles of neural progenitors, and that it regulates spindle movements and orientation. LGN promotes planar divisions in the early spinal cord. Interfering with LGN function randomizes the plane of division. Notably, this does not affect cell fate, but frequently leads one daughter of proliferative symmetric divisions to exit the neuroepithelium prematurely and to proliferate aberrantly in the mantle zone. Hence, tight control of planar spindle orientation maintains neural progenitors in the neuroepithelium, and regulates the proper development of the nervous system.	Univ Aix Marseille 2, Marseille, France; CNRS, Inst Dev Biol, UMR6216, F-13288 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Morin, X (corresponding author), Univ Aix Marseille 2, Marseille, France.	morin@ibdml.univ-mrs.fr	morin, xavier/AAI-3306-2020	Morin, Xavier/0000-0001-9999-0355				Adams RJ, 1996, J NEUROSCI, V16, P7610; Bellaiche Y, 2005, CURR OPIN CELL BIOL, V17, P658, DOI 10.1016/j.ceb.2005.10.002; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2006, EUR J CELL BIOL, V85, P1233, DOI 10.1016/j.ejcb.2006.08.002; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Hilgers V, 2005, DEV BIOL, V284, P292, DOI 10.1016/j.ydbio.2005.05.021; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Kaushik R, 2003, MOL BIOL CELL, V14, P3144, DOI 10.1091/mbc.E03-04-0212; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; REINSCH S, 1994, J CELL BIOL, V126, P1509, DOI 10.1083/jcb.126.6.1509; Roszko I, 2006, DEV BIOL, V298, P212, DOI 10.1016/j.ydbio.2006.06.031; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Voronina E, 2006, DEV GROWTH DIFFER, V48, P549, DOI 10.1111/j.1440-169x.2006.00895.x; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Wilcock AC, 2007, DEVELOPMENT, V134, P1943, DOI 10.1242/dev.002519; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016; Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL SCI, V116, P887, DOI 10.1242/jcs.00297; Yu FW, 2002, MOL CELL BIOL, V22, P4230, DOI 10.1128/MCB.22.12.4230-4240.2002; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030	50	186	188	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1440	1448		10.1038/nn1984	http://dx.doi.org/10.1038/nn1984			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17934458				2022-12-24	WOS:000250508400022
J	Putzar, L; Goerendt, I; Lange, K; Rosler, F; Roder, B				Putzar, Lisa; Goerendt, Ines; Lange, Kathrin; Roesler, Frank; Roeder, Brigitte			Early visual deprivation impairs multisensory interactions in humans	NATURE NEUROSCIENCE			English	Article							INTEGRATION; EXPERIENCE; VISION; DETERMINES; BLIND	Animal studies have shown that visual deprivation during the first months of life permanently impairs the interactions between sensory systems. Here we report an analogous effect for humans who had been deprived of pattern vision for at least the first five months of their life as a result of congenital binocular cataracts. These patients showed reduced audiovisual interactions in later life, although their visual performance in control tasks was unimpaired. Thus, adequate ( multisensory) input during the first months of life seems to be a prerequisite in humans, as well as in animals, for the full development of cross-modal interactions.	Univ Hamburg, D-20146 Hamburg, Germany; Univ Dusseldorf, Dept Expt Psychol, D-40225 Dusseldorf, Germany; Univ Marburg, D-35032 Marburg, Germany	University of Hamburg; Heinrich Heine University Dusseldorf; Philipps University Marburg	Putzar, L (corresponding author), Univ Hamburg, Von Melle Pk 11, D-20146 Hamburg, Germany.	lisa.putzar@uni-hamburg.de		Lange, Kathrin/0000-0001-8230-5120				[Anonymous], 1994, DEV INTERSENSORY PER; CARLSON S, 1987, DEV BRAIN RES, V33, P101, DOI 10.1016/0165-3806(87)90180-5; Ellemberg D, 1999, VISION RES, V39, P3480, DOI 10.1016/S0042-6989(99)00078-4; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Hotting K, 2004, EXP BRAIN RES, V159, P370, DOI 10.1007/s00221-004-1965-3; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; Maurer D, 1999, SCIENCE, V286, P108, DOI 10.1126/science.286.5437.108; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Roder B, 2007, P NATL ACAD SCI USA, V104, P4753, DOI 10.1073/pnas.0607158104; Wallace M.T., 2004, COGNIT PROCESS, V5, P69, DOI [10.1007/s10339-004-0017-z, DOI 10.1007/S10339-004-0017-Z]; Wallace MT, 2007, J NEUROPHYSIOL, V97, P921, DOI 10.1152/jn.00497.2006; Wallace MT, 1997, J NEUROSCI, V17, P2429; Wallace MT, 2004, J NEUROSCI, V24, P9580, DOI 10.1523/JNEUROSCI.2535-04.2004	14	115	118	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1243	1245		10.1038/nn1978	http://dx.doi.org/10.1038/nn1978			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17873871				2022-12-24	WOS:000249720800009
J	Wilson, SI; Shafer, B; Lee, KJ; Dodd, J				Wilson, Sara I.; Shafer, Beth; Lee, Kevin J.; Dodd, Jane			A molecular program for contralateral trajectory: Rig-1 control by LIM homeodomain transcription factors	NEURON			English	Article							COMMISSURAL NEURON IDENTITY; AXON GUIDANCE; HOMEOBOX GENE; INSULIN GENE; PROTEIN; MIDLINE; INTERNEURONS; EXPRESSION; SLIT; SPECIFICATION	Despite increasing evidence for transcriptional control of neural connectivity, how transcription factors regulate discrete steps in axon guidance remains obscure. Projection neurons in the dorsal spinal cord relay sensory signals to higher brain centers. Some projection neurons send their axons ipsilaterally, whereas others, commissural neurons, send axons contralaterally. We show that two closely related LIM homeodomain proteins, Lhx2 and Lhx9, are expressed by a set of commissural relay neurons (dl1c neurons) and are required for the dl1c axon projection. Midline crossing by dl1c axons is lost in Lhx2/9 double mutants, a defect that results from loss of expression of Rig-1 from dl1c axons. Lhx2 binds to a conserved motif in the Rig-1 gene, suggesting that Lhx2/9 regulate directly the expression of Rig-1. Our findings reveal a link between the transcriptional programs that define neuronal subtype identity and the expression of receptors that guide distinctive aspects of their trajectory.	[Wilson, Sara I.; Shafer, Beth; Dodd, Jane] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Wilson, Sara I.; Shafer, Beth; Lee, Kevin J.; Dodd, Jane] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Lee, Kevin J.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Lee, Kevin J.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Dodd, J (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	jd18@columbia.edu		Lee, Kevin/0000-0001-9823-0952	The Christopher and Dana Reeve Foundation; EMBO long-term fellowship; The Gatsby Initiative in Brain Circuitry at Columbia University	The Christopher and Dana Reeve Foundation; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); The Gatsby Initiative in Brain Circuitry at Columbia University	We thank Georgina Nichols and Alison Dell for excellent technical support, and all of the following who generously provided reagents: Drs. Martyn Goulding (alpha FoxD3 antibodies), Jane Johnson (Math1<SUP>LacZ</SUP> Math1<SUP>nGFP</SUP>), Fujio Murakami (alpha Rig-1, alpha Robo1 alpha Robo2 antibodies), Denny Porter (Lhx2<SUP>-/+</SUP> mice), Marc Tessier-Lavigne (Rig-1<SUP>-/+</SUP> mice), Eric Turner (alpha Brn3a antibodies), and Tetsuichiro Saito (Barh12 cDNA). We thank Andy Furley, Wes Grueber, Tom Jessell, Avihu Klar, Brian McCabe, Carol Mason, Jeanette Perron, Peter Scheiffele, Marc Tessier-Lavigne, and the members of the Dodd and Jessell labs for discussions and comments on the manuscript. The work was supported by postdoctoral and research grant funding (to S.I.W. and J.D.) from The Christopher and Dana Reeve Foundation, an EMBO long-term fellowship (to S.I.W.), HHMI funding to the lab of Dr. T.M. Jessell (for K.J.L.), and a grant to J.D. from The Gatsby Initiative in Brain Circuitry at Columbia University.	Affolter M, 2008, CELL, V133, P1133, DOI 10.1016/j.cell.2008.06.008; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Birk OS, 2000, NATURE, V403, P909, DOI 10.1038/35002622; Brown AG, 1981, ORG SPINAL CORD; Bulfone A, 2000, HUM MOL GENET, V9, P1443, DOI 10.1093/hmg/9.9.1443; Butler SJ, 2007, DEVELOPMENT, V134, P439, DOI 10.1242/dev.02762; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Crowner D, 2002, DEVELOPMENT, V129, P1317; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Del Barrio MG, 2007, DEVELOPMENT, V134, P3427, DOI 10.1242/dev.005868; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Garcia-Frigola C, 2008, DEVELOPMENT, V135, P1833, DOI 10.1242/dev.020693; Geisen MJ, 2008, PLOS BIOL, V6, P1178, DOI 10.1371/journal.pbio.0060142; GERMAN MS, 1992, MOL CELL BIOL, V12, P1777, DOI 10.1128/MCB.12.4.1777; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Helms AW, 1998, DEVELOPMENT, V125, P919; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P435; Kobayashi Y, 1998, ANAT EMBRYOL, V197, P51; Labrador JP, 2005, CURR BIOL, V15, P1413, DOI 10.1016/j.cub.2005.06.058; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lee R, 2008, J NEUROSCI, V28, P5910, DOI 10.1523/JNEUROSCI.0632-08.2008; LIGHT AR, 1988, APPL NEUROPHYSIOL, V51, P78; Logan C, 1996, CURR BIOL, V6, P1006, DOI 10.1016/S0960-9822(02)00645-0; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Peng CY, 2007, NEURON, V53, P813, DOI 10.1016/j.neuron.2007.02.019; Polleux F, 2007, NAT REV NEUROSCI, V8, P331, DOI 10.1038/nrn2118; Porter FD, 1997, DEVELOPMENT, V124, P2935; Rincon-Limas DE, 2000, EMBO J, V19, P2602, DOI 10.1093/emboj/19.11.2602; ROBERSON MS, 1994, MOL CELL BIOL, V14, P2985, DOI 10.1128/MCB.14.5.2985; Rohr C, 2002, J CLIN INVEST, V109, P1073, DOI 10.1172/JCI200213961; Saba R, 2005, DEVELOPMENT, V132, P2147, DOI 10.1242/dev.01781; Saba R, 2003, J NEUROSCI, V23, P1987; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Saha B, 2007, J NEUROSCI, V27, P2290, DOI 10.1523/JNEUROSCI.5571-06.2007; Saito T, 1998, DEV BIOL, V199, P216, DOI 10.1006/dbio.1998.8889; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Seth A, 2006, DEVELOPMENT, V133, P725, DOI 10.1242/dev.02244; SILOSSANTIAGO I, 1992, J COMP NEUROL, V325, P514, DOI 10.1002/cne.903250405; Wang W, 2007, J NEUROSCI, V27, P6115, DOI 10.1523/JNEUROSCI.0180-07.2007; Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X	57	88	89	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 14	2008	59	3					413	424		10.1016/j.neuron.2008.07.020	http://dx.doi.org/10.1016/j.neuron.2008.07.020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339GG	18701067	Bronze			2022-12-24	WOS:000258565500010
J	Mellem, JE; Brockie, PJ; Madsen, DM; Maricq, AV				Mellem, Jerry E.; Brockie, Penelope J.; Madsen, David M.; Maricq, Andres V.			Action potentials contribute to neuronal signaling in C-elegans	NATURE NEUROSCIENCE			English	Article							CAENORHABDITIS-ELEGANS; GLUTAMATE-RECEPTOR; CHANNEL; ASCARIS; PHARYNX; SYSTEM	Small, high-impedance neurons with short processes, similar to those found in the soil nematode Caenorhabditis elegans, are predicted to transmit electrical signals by passive propagation. However, we have found that certain neurons in C. elegans fire regenerative action potentials. These neurons resembled Schmitt triggers, as their potential state appears to be bistable. Transitions between up and down states could be triggered by application of the neurotransmitter glutamate or brief current pulses.	[Mellem, Jerry E.; Brockie, Penelope J.; Madsen, David M.; Maricq, Andres V.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Maricq, AV (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	maricq@biology.utah.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035812] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS035812-12, NS35812, R01 NS035812] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Davis RE, 1996, PARASITOLOGY, V113, pS97, DOI 10.1017/S0031182000077921; DAVIS RE, 1989, J NEUROSCI, V9, P415; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Francis Michael M., 2006, V351, P175; Frokjaer-Jensen C, 2006, J NEUROBIOL, V66, P1125, DOI 10.1002/neu.20261; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Humphrey JA, 2007, CURR BIOL, V17, P624, DOI 10.1016/j.cub.2007.02.037; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Shtonda B, 2005, J EXP BIOL, V208, P2177, DOI 10.1242/jeb.01615; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	15	72	81	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					865	867		10.1038/nn.2131	http://dx.doi.org/10.1038/nn.2131			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18587393	Green Accepted			2022-12-24	WOS:000257969100006
J	Lin, SC; Nicolelis, MAL				Lin, Shih-Chieh; Nicolelis, Miguel A. L.			Neuronal ensemble bursting in the basal forebrain encodes salience irrespective of valence	NEURON			English	Article							INDUCED EXCITOTOXIC LESIONS; AMYGDALA CENTRAL NUCLEUS; EVENT-RELATED POTENTIALS; SOMATOSENSORY CORTEX; CHOLINERGIC SYSTEM; PREFRONTAL CORTEX; PRIMATE AMYGDALA; ATTENTION; BRAIN; TASK	Both reward- and punishment-related stimuli are motivationally salient and attract the attention of animals. However, it remains unclear how motivational salience is processed in the brain. Here, we show that both reward- and punishment-predicting stimuli elicited robust bursting of many noncholinergic basal forebrain (BF) neurons in behaving rats. The same BF neurons also responded with similar bursting to primary reinforcement of both valences. Reinforcement responses were modulated by expectation, with surprising reinforcement eliciting stronger BF bursting. We further demonstrate that BF burst firing predicted successful detection of near-threshold stimuli. Together, our results point to the existence of a salience-encoding system independent of stimulus valence. We propose that the encoding of motivational salience by ensemble bursting of noncholinergic BF neurons may improve behavioral performance by affecting the activity of widespread cortical circuits and therefore represents a novel candidate mechanism for top-down attention.	[Lin, Shih-Chieh; Nicolelis, Miguel A. L.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Lin, Shih-Chieh; Nicolelis, Miguel A. L.] Duke Univ, Ctr Neuroengn, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Biomed Engn, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27710 USA; [Nicolelis, Miguel A. L.] ELS IINN, BR-59066060 Natal, RN, Brazil	Duke University; Duke University; Duke University; Duke University	Lin, SC (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	sclin@neuro.duke.edu		Lin, Shih-Chieh/0000-0003-3693-5476	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01DE011451, R01 DE011451-11, R01 DE011451] Funding Source: Medline; NIMH NIH HHS [P50 MH060451, P50MH060451, P50 MH060451-070007] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alonso A, 1996, EUR J NEUROSCI, V8, P169, DOI 10.1111/j.1460-9568.1996.tb01178.x; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Burk JA, 2001, NEUROSCIENCE, V105, P899, DOI 10.1016/S0306-4522(01)00233-0; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dykes RW, 1997, CAN J PHYSIOL PHARM, V75, P535, DOI 10.1139/cjpp-75-5-535; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; FREUND TF, 1992, P NATL ACAD SCI USA, V89, P738, DOI 10.1073/pnas.89.2.738; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; GREEN DM, 1966, SIGNAL DETECTION THE; Gritti I, 1997, J COMP NEUROL, V383, P163; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Holland PC, 2007, BEHAV NEUROSCI, V121, P80, DOI 10.1037/0735-7044.121.1.80; Jolkkonen E, 2002, NEUROSCIENCE, V111, P133, DOI 10.1016/S0306-4522(01)00578-4; Kaczmarek LK, 1987, NEUROMODULATION BIOC; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Lee MG, 2004, J NEUROPHYSIOL, V92, P1182, DOI 10.1152/jn.01003.2003; Lin SC, 2006, J NEUROPHYSIOL, V96, P3209, DOI 10.1152/jn.00524.2006; Maddux JM, 2007, BEHAV NEUROSCI, V121, P63, DOI 10.1037/0735-7044.121.1.63; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; McGaughy J, 2002, J NEUROSCI, V22, P1905, DOI 10.1523/JNEUROSCI.22-05-01905.2002; MUIR JL, 1994, J NEUROSCI, V14, P2313; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; PAGE KJ, 1991, NEUROSCIENCE, V43, P457, DOI 10.1016/0306-4522(91)90308-B; PANG K, 1993, BEHAV NEUROSCI, V107, P1031; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; RICHARDSON RT, 1990, J NEUROSCI, V10, P2528; RIEKKINEN P, 1991, BRAIN RES, V559, P304, DOI 10.1016/0006-8993(91)90016-O; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Sambeth A, 2003, PSYCHOPHYSIOLOGY, V40, P60, DOI 10.1111/1469-8986.00007; Sarter M, 2002, EUR J NEUROSCI, V15, P1867, DOI 10.1046/j.1460-9568.2002.02004.x; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Semba K, 2000, BEHAV BRAIN RES, V115, P117, DOI 10.1016/S0166-4328(00)00254-0; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; VOYTKO ML, 1994, J NEUROSCI, V14, P167; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Weinberger NM, 2003, NEUROBIOL LEARN MEM, V80, P268, DOI 10.1016/S1074-7427(03)00072-8; Wenk GL, 1997, NEUROBIOL LEARN MEM, V67, P85, DOI 10.1006/nlme.1996.3757; WHALEN PJ, 1994, J NEUROSCI, V14, P1623, DOI 10.1523/JNEUROSCI.14-03-01623.1994; Wiest MC, 2005, J NEUROPHYSIOL, V93, P2966, DOI 10.1152/jn.00556.2004; WILSON FAW, 1990, J NEUROSCI, V10, P1254; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; Zaborszky L, 2003, FRONT BIOSCI-LANDMRK, V8, pD1146, DOI 10.2741/1112	54	122	122	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 10	2008	59	1					138	149		10.1016/j.neuron.2008.04.031	http://dx.doi.org/10.1016/j.neuron.2008.04.031			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	327KU	18614035	Green Accepted, Bronze			2022-12-24	WOS:000257728800014
J	McCann, CM; Tapia, JC; Kim, H; Coggan, JS; Lichtman, JW				McCann, Corey M.; Tapia, Juan Carlos; Kim, Han; Coggan, Jay S.; Lichtman, Jeff W.			Rapid and modifiable neurotransmitter receptor dynamics at a neuronal synapse in vivo	NATURE NEUROSCIENCE			English	Article							SUPERIOR CERVICAL-GANGLION; ACETYLCHOLINE-RECEPTORS; AMPA RECEPTORS; SUBMANDIBULAR GANGLION; HIPPOCAMPAL-NEURONS; SURFACE TRAFFICKING; NICOTINIC RECEPTORS; CILIARY GANGLION; MUSCLE-FIBERS; TRANSMISSION	Synaptic plasticity underlies the adaptability of the mammalian brain, but has been difficult to study in living animals. Here we imaged the synapses between pre- and postganglionic neurons in the mouse submandibular ganglion in vivo, focusing on the mechanisms that maintain and regulate neurotransmitter receptor density at postsynaptic sites. Normally, synaptic receptor densities were maintained by rapid exchange of receptors with nonsynaptic regions (over minutes) and by continual turnover of cell surface receptors (over hours). However, after ganglion cell axons were crushed, synaptic receptors showed greater lateral mobility and there was a precipitous decline in insertion. These changes led to near-complete loss of synaptic receptors and synaptic depression. Disappearance of postsynaptic spines and presynaptic terminals followed this acute synaptic depression. Therefore, neurotransmitter receptor dynamism associated with rapid changes in synaptic efficacy precedes long-lasting structural changes in synaptic connectivity.	[McCann, Corey M.; Tapia, Juan Carlos; Kim, Han; Lichtman, Jeff W.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Coggan, Jay S.] Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA	Harvard University; Salk Institute	Lichtman, JW (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	jeff@mcb.harvard.edu		Coggan, Jay S/0000-0002-2270-1989	NINDS NIH HHS [R01 NS020364-26, R01 NS020364] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020364] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akaaboune M, 2002, NEURON, V34, P865, DOI 10.1016/S0896-6273(02)00739-0; Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; AXELROD D, 1976, P NATL ACAD SCI USA, V73, P4594, DOI 10.1073/pnas.73.12.4594; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Brune JN, 2006, GEOLOGY, V34, P137, DOI 10.1130/G22127.1; Bruneau E, 2005, J NEUROSCI, V25, P9949, DOI 10.1523/JNEUROSCI.3169-05.2005; Bruneau EG, 2005, DEV BIOL, V288, P248, DOI 10.1016/j.ydbio.2005.09.041; Chang KT, 1999, J NEUROSCI, V19, P3701; Coggan JS, 2004, J NEUROBIOL, V60, P214, DOI 10.1002/neu.20022; Conroy WG, 2003, NEURON, V38, P759, DOI 10.1016/S0896-6273(03)00324-6; Gan WB, 2003, NAT NEUROSCI, V6, P956, DOI 10.1038/nn1115; Hutcheon B, 2004, EUR J NEUROSCI, V19, P2475, DOI 10.1111/j.0953-816X.2004.03349.x; JACOB MH, 1988, J NEUROSCI, V8, P3838; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KO PK, 1977, SCIENCE, V196, P540, DOI 10.1126/science.850796; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; LICHTMAN JW, 1977, J PHYSIOL-LONDON, V273, P155, DOI 10.1113/jphysiol.1977.sp012087; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MATTHEWS MR, 1975, J PHYSIOL-LONDON, V245, P91, DOI 10.1113/jphysiol.1975.sp010837; McCann CM, 2008, DEV NEUROBIOL, V68, P760, DOI 10.1002/dneu.20621; McCann CM, 2007, J NEUROSCI, V27, P6064, DOI 10.1523/JNEUROSCI.0627-07.2007; MERLIE JP, 1976, NATURE, V264, P74, DOI 10.1038/264074a0; NJA A, 1978, J PHYSIOL-LONDON, V277, P53; Parker MJ, 2004, J NEUROSCI, V24, P378, DOI 10.1523/JNEUROSCI.3865-03.2004; Prekeris R, 1999, J NEUROSCI, V19, P10324; PURVES D, 1975, J PHYSIOL-LONDON, V252, P429, DOI 10.1113/jphysiol.1975.sp011151; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; TITMUS MJ, 1990, PROG NEUROBIOL, V35, P1, DOI 10.1016/0301-0082(90)90039-J; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Turney SG, 1996, J NEUROSCI METH, V64, P199, DOI 10.1016/0165-0270(95)00135-2; Ullian EM, 1997, J NEUROSCI, V17, P7210	37	30	30	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					807	815		10.1038/nn.2145	http://dx.doi.org/10.1038/nn.2145			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18568021	Green Accepted			2022-12-24	WOS:000257089400018
J	Lee, D; Park, C; Lee, H; Lugus, JJ; Kim, SH; Arentson, E; Chung, YS; Gomez, G; Kyba, M; Lin, S; Janknecht, R; Lim, DS; Choi, K				Lee, Dongjun; Park, Changwon; Lee, Ho; Lugus, Jesse J.; Kim, Seok Hyung; Arentson, Elizabeth; Chung, Yun Shin; Gomez, Gustavo; Kyba, Michael; Lin, Shuo; Janknecht, Ralf; Lim, Dae-Sik; Choi, Kyunghee			ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELL; HEMATOPOIETIC DEVELOPMENT; ETS FAMILY; TRANSCRIPTION; PROTEIN; HEMANGIOBLAST; ACTIVATION; EXPRESSION; FLK1; VASCULOGENESIS	FLK1-expressing (FLK1(+)) mesoderm generates blood and vessels. Here, we show that combined BMP, Notch, and Wnt signaling is necessary for efficient FLK1(+) mesoderm formation from embryonic stem cells (ESCs). Inhibition of BMP, Notch, and Wnt signaling pathways greatly decreased the generation of FLK1(+) mesoderm and expression of the Ets transcription factor Er71. Enforced expression of ER71 in ESCs resulted in a robust induction of FLK1(+) mesoderm; rescued the generation of FLK1(+) mesoderm when blocked by BMP, Notch, and Wnt inhibition; and enhanced hematopoietic and endothelial cell generation. Er71-deficient mice had greatly reduced FLK1 expression, died early in gestation, and displayed severe blood and vessel defects that are highly reminiscent of the Flk1 null mouse phenotype. Collectively, we provide compelling evidence that ER71 functions downstream of BMP, Notch, and Wnt signals and regulates FLK1(+) mesoderm, blood, and vessel development.	[Lee, Dongjun; Lee, Ho; Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Natl Res Lab, Dept Biol Sci, Taejon 305701, South Korea; [Lee, Ho] Natl Canc Ctr, Goyangsi, Gyeonggi Do, South Korea; [Lugus, Jesse J.; Choi, Kyunghee] Washington Univ, Sch Med, Mol Cell Biol Program, St Louis, MO 63110 USA; [Park, Changwon; Lugus, Jesse J.; Kim, Seok Hyung; Arentson, Elizabeth; Chung, Yun Shin; Choi, Kyunghee] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Gomez, Gustavo; Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Kyba, Michael] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75235 USA; [Janknecht, Ralf] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Korea Advanced Institute of Science & Technology (KAIST); National Cancer Center - Korea (NCC); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Los Angeles; University of Texas System; University of Texas Southwestern Medical Center Dallas; Mayo Clinic	Lim, DS (corresponding author), Korea Adv Inst Sci & Technol, Natl Res Lab, Dept Biol Sci, Taejon 305701, South Korea.	daesiklim@kaist.ac.kr; kchoi@wustl.edu	Lee, Dongjun/ABF-4381-2021; Lim, Dae-Sik/C-1599-2011	Lim, Dae-Sik/0000-0003-2356-7555; Kyba, Michael/0000-0002-5579-7534; Janknecht, Ralf/0000-0003-1741-1562; Gomez, Gustavo/0000-0001-9294-4276; Lee, Dongjun/0000-0001-6828-401X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055337, R29HL055337, R01HL063736, R01HL081186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054508, Z01DK054508] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK054508] Funding Source: Medline; NHLBI NIH HHS [HL63736, R01 HL063736-09A1, R01 HL063736, HL55337, R01 HL055337-13, R01 HL055337, R01 HL081186, R29 HL055337] Funding Source: Medline; NIDDK NIH HHS [DK54508, R01 DK054508] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; Bussmann J, 2007, PLOS GENET, V3, P1425, DOI 10.1371/journal.pgen.0030140; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chung YS, 2002, DEVELOPMENT, V129, P5511, DOI 10.1242/dev.00149; De Haro L, 2005, GENOMICS, V85, P493, DOI 10.1016/j.ygeno.2004.12.003; De Haro L, 2002, NUCLEIC ACIDS RES, V30, P2972; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Faloon P, 2000, DEVELOPMENT, V127, P1931; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Im Hogune, 2004, Methods Mol Biol, V284, P129; Kappel A, 2000, BLOOD, V96, P3078; Knebel J, 2006, J CELL BIOCHEM, V99, P319, DOI 10.1002/jcb.20945; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Lugus JJ, 2007, DEVELOPMENT, V134, P393, DOI 10.1242/dev.02731; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Park C, 2006, DEVELOPMENT, V133, P3473, DOI 10.1242/dev.02499; Pham VN, 2007, DEV BIOL, V303, P772, DOI 10.1016/j.ydbio.2006.10.030; Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012; Schroeder T, 2006, MECH DEVELOP, V123, P570, DOI 10.1016/j.mod.2006.05.002; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; Sumanas S, 2005, BLOOD, V106, P534, DOI 10.1182/blood-2004-12-4653; SUMANAS S, 2008, IN PRESS BLOOD  0212, DOI DOI 10.1182/BLOOD-2007-09-110569; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Zeigler BM, 2006, DEVELOPMENT, V133, P4183, DOI 10.1242/dev.02596	39	237	247	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY	2008	2	5					497	507		10.1016/j.stem.2008.03.008	http://dx.doi.org/10.1016/j.stem.2008.03.008			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	300BM	18462699	Green Accepted, Bronze			2022-12-24	WOS:000255799300014
J	Schoppik, D; Nagel, KI; Lisberger, SG				Schoppik, David; Nagel, Katherine I.; Lisberger, Stephen G.			Cortical mechanisms of smooth eye movements revealed by dynamic covariations of neural and behavioral responses	NEURON			English	Article							NEURONAL INTERACTIONS; TIME-COURSE; MOTOR; MOTION; CORTEX; PERFORMANCE; DISCHARGE; PREMOTOR; SIGNALS; NOISE	Neural activity in the frontal eye fields controls smooth pursuit eye movements, but the relationship between single neuron responses, cortical population responses, and eye movements is not well understood. We describe an approach to dynamically link trial-to-trial fluctuations in neural responses to parallel variations in pursuit and demonstrate that individual neurons predict eye velocity fluctuations at particular moments during the course of behavior, while the population of neurons collectively tiles the entire duration of the movement. The analysis also reveals the strength of correlations in the eye movement predictions derived from pairs of simultaneously recorded neurons and suggests a simple model of cortical processing. These findings constrain the primate cortical code for movement, suggesting that either a few neurons are sufficient to drive pursuit at any given time or that many neurons operate collectively at each moment with remarkably little variation added to motor command signals downstream from the cortex.	[Schoppik, David; Nagel, Katherine I.; Lisberger, Stephen G.] Univ Calif San Francisco, Dept Physiol, Grad Program Neurosci, San Francisco, CA 94143 USA; [Lisberger, Stephen G.] Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Schoppik, David; Nagel, Katherine I.; Lisberger, Stephen G.] Univ Calif San Francisco, Dept Physiol, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schoppik, D (corresponding author), Univ Calif San Francisco, Dept Physiol, Grad Program Neurosci, Box 0444, San Francisco, CA 94143 USA.	schoppik@phy.ucsf.edu		Schoppik, David/0000-0001-7969-9632	Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [P50 MH077970, P50 MH077970-01, MH077970] Funding Source: Medline; NINDS NIH HHS [P01 NS034835, P01 NS034835-020001] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; Brody CD, 1999, NEURAL COMPUT, V11, P1527, DOI 10.1162/089976699300016124; Carey MR, 2005, NAT NEUROSCI, V8, P813, DOI 10.1038/nn1470; Carmena JM, 2005, J NEUROSCI, V25, P10712, DOI 10.1523/JNEUROSCI.2772-05.2005; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Churchland MM, 2006, J NEUROPHYSIOL, V96, P3130, DOI 10.1152/jn.00307.2006; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Dayan P., 2005, THEORETICAL NEUROSCI; Fiete IR, 2004, J NEUROPHYSIOL, V92, P2274, DOI 10.1152/jn.01133.2003; GERSTEIN GL, 1972, BIOPHYS J, V12, P453, DOI 10.1016/S0006-3495(72)86097-1; GOTTLIEB JP, 1994, J NEUROPHYSIOL, V72, P1634, DOI 10.1152/jn.1994.72.4.1634; GOTTLIEB JP, 1993, J NEUROPHYSIOL, V69, P786, DOI 10.1152/jn.1993.69.3.786; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Hirschberger M, 2007, EUR J OPER RES, V177, P1610, DOI 10.1016/j.ejor.2005.10.014; KEATING EG, 1991, EXP BRAIN RES, V86, P311; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Lee D, 1998, J NEUROSCI, V18, P1161; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; MacAvoy MG, 1991, CEREB CORTEX, V1, P95, DOI 10.1093/cercor/1.1.95; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Maynard EM, 1999, J NEUROSCI, V19, P8083; Medina JF, 2007, J NEUROSCI, V27, P6832, DOI 10.1523/JNEUROSCI.1323-07.2007; Medina JF, 2005, NEURON, V45, P157, DOI 10.1016/j.neuron.2004.12.017; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Osborne LC, 2007, J NEUROSCI, V27, P2987, DOI 10.1523/JNEUROSCI.5072-06.2007; Paninski L, 2004, J NEUROSCI, V24, P8551, DOI 10.1523/JNEUROSCI.0919-04.2004; Paninski L, 2004, J NEUROPHYSIOL, V91, P515, DOI 10.1152/jn.00587.2002; Ramachandran R, 2005, J NEUROPHYSIOL, V93, P2028, DOI 10.1152/jn.00832.2004; RIEHLE A, 1993, BEHAV BRAIN RES, V53, P35, DOI 10.1016/S0166-4328(05)80264-5; Rieke F., 1999, SPIKES EXPLORING NEU; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; Schoppik D, 2006, J NEUROSCI, V26, P7607, DOI 10.1523/JNEUROSCI.1719-06.2006; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Tanaka M, 2002, J NEUROPHYSIOL, V87, P2684, DOI 10.1152/jn.2002.87.6.2684; Tanaka M, 2002, J NEUROPHYSIOL, V87, P802, DOI 10.1152/jn.00409.2001; Tanaka M, 2001, NATURE, V409, P191, DOI 10.1038/35051582; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Theunissen FE, 2003, TRENDS NEUROSCI, V26, P61, DOI 10.1016/S0166-2236(02)00016-4; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wu MCK, 2006, ANNU REV NEUROSCI, V29, P477, DOI 10.1146/annurev.neuro.29.051605.113024; Wurtz RH, 2003, PROG BRAIN RES, V144, P47, DOI 10.1016/S0079-6123(03)14400-3; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0; [No title captured]	50	47	47	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2008	58	2					248	260		10.1016/j.neuron.2008.02.015	http://dx.doi.org/10.1016/j.neuron.2008.02.015			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292YX	18439409	Green Accepted, Bronze			2022-12-24	WOS:000255303100012
J	Pina, C; May, G; Soneji, S; Hong, D; Enver, T				Pina, Cristina; May, Gillian; Soneji, Shamit; Hong, Dengli; Enver, Tariq			MLLT3 regulates early human erythroid and megakaryocytic cell fate	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR GATA-1; FUSION PARTNER; GENE-EXPRESSION; LINEAGE COMMITMENT; REPOPULATING CELLS; TRANSGENIC MICE; EKLF GENE; PROGENITORS; LEUKEMIA	Regulatory mechanisms of human hematopoiesis remain largely uncharacterized. Through expression profiling of prospectively isolated stem and primitive progenitor cells as well as committed progenitors from cord blood (CB), we identified MLLT3 as a candidate regulator of erythroid/megakaryocytic (E/Meg) lineage decisions. Through the analysis of the hematopoietic potential of primitive cord blood cells in which MLLT3 expression has been knocked down, we identify a requirement for MLLT3 in the elaboration of the erythroid and megakaryocytic lineages. Conversely, forced expression of MLLT3 promotes the output of erythroid and megakaryocytic progenitors, and analysis of MLLT3 mutants suggests that this capacity of MLLT3 depends on its transcriptional regulatory activity. Gene expression and cis-regulatory element analyses reveal crossregulatory interactions between MLLT3 and E/Meg-affiliated transcription factor GATA-1. Taken together, the data identify MLLT3 as a regulator of early erythroid and megakaryocytic cell fate in the human system.	[Pina, Cristina; May, Gillian; Soneji, Shamit; Hong, Dengli; Enver, Tariq] Univ Oxford, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England	University of Oxford	Enver, T (corresponding author), Univ Oxford, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England.	tenver@gwmail.jr2.ox.ac.uk		Pina, Cristina/0000-0002-2575-6301	MRC [MC_U137973817] Funding Source: UKRI; Medical Research Council [MC_U137973817] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Bitoun E, 2007, HUM MOL GENET, V16, P92, DOI 10.1093/hmg/ddl444; Bose F, 2006, MOL CELL BIOL, V26, P3942, DOI 10.1128/MCB.26.10.3942-3954.2006; Caslini C, 2000, P NATL ACAD SCI USA, V97, P2797, DOI 10.1073/pnas.040574897; Chadwick K, 2005, BLOOD, V105, P1905, DOI 10.1182/blood-2004-03-0881; Collins EC, 2002, MOL CELL BIOL, V22, P7313, DOI 10.1128/MCB.22.20.7313-7324.2002; CROSSLEY M, 1994, J BIOL CHEM, V269, P15440; Deconinck AE, 2000, DEVELOPMENT, V127, P2031; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Donaldson C, 2001, BONE MARROW TRANSPL, V27, P365, DOI 10.1038/sj.bmt.1702810; Drynan LF, 2005, EMBO J, V24, P3136, DOI 10.1038/sj.emboj.7600760; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Georgantas RW, 2004, CANCER RES, V64, P4434, DOI 10.1158/0008-5472.CAN-03-3247; Glimm H, 2001, J CLIN INVEST, V107, P199, DOI 10.1172/JCI11519; Gothot A, 1997, BLOOD, V90, P4384, DOI 10.1182/blood.V90.11.4384.4384_4384_4393; Hemenway CS, 2001, ONCOGENE, V20, P3798, DOI 10.1038/sj.onc.1204478; IIDA S, 1993, ONCOGENE, V8, P3085; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P7976, DOI 10.1073/pnas.94.15.7976; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; NICOLIS S, 1991, NUCLEIC ACIDS RES, V19, P5285, DOI 10.1093/nar/19.19.5285; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Onodera K, 1997, P NATL ACAD SCI USA, V94, P4487, DOI 10.1073/pnas.94.9.4487; Park IK, 2002, BLOOD, V99, P488, DOI 10.1182/blood.V99.2.488; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Ronchi Antonella, 1997, Genes and Function, V1, P245; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; RUBNITZ JE, 1994, BLOOD, V84, P1747; Schoch C, 2003, BLOOD, V102, P2395, DOI 10.1182/blood-2003-02-0434; Shojaei F, 2005, DEV CELL, V8, P651, DOI 10.1016/j.devcel.2005.03.004; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Srinivasan RS, 2003, ONCOGENE, V22, P3395, DOI 10.1038/sj.onc.1206361; Starck J, 1999, MOL CELL BIOL, V19, P121; Starck J, 2003, MOL CELL BIOL, V23, P1390, DOI 10.1128/MCB.23.4.1390-1402.2003; Summers YJ, 2004, STEM CELLS, V22, P704, DOI 10.1634/stemcells.22-5-704; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zeisig DT, 2005, ONCOGENE, V24, P5525, DOI 10.1038/sj.onc.1208699; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200	59	48	48	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR	2008	2	3					264	273		10.1016/j.stem.2008.01.013	http://dx.doi.org/10.1016/j.stem.2008.01.013			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	274RD	18371451	Bronze			2022-12-24	WOS:000254017700013
J	Yamanaka, K; Chun, SJ; Boillee, S; Fujimori-Tonou, N; Yamashita, H; Gutmann, DH; Takahashi, R; Misawa, H; Cleveland, DW				Yamanaka, Koji; Chun, Seung Joo; Boillee, Severine; Fujimori-Tonou, Noriko; Yamashita, Hirofumi; Gutmann, David H.; Takahashi, Ryosuke; Misawa, Hidemi; Cleveland, Don W.			Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis	NATURE NEUROSCIENCE			English	Article							MOTOR-NEURONS; EXTEND SURVIVAL; RAT MODEL; ALS; MICE; MICROGLIA	Dominant mutations in superoxide dismutase cause amyotrophic lateral sclerosis (ALS), an adult-onset neurodegenerative disease that is characterized by the loss of motor neurons. Using mice carrying a deletable mutant gene, diminished mutant expression in astrocytes did not affect onset, but delayed microglial activation and sharply slowed later disease progression. These findings demonstrate that mutant astrocytes are viable targets for therapies for slowing the progression of non-cell autonomous killing of motor neurons in ALS.	[Yamanaka, Koji; Chun, Seung Joo; Boillee, Severine; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Yamanaka, Koji; Chun, Seung Joo; Boillee, Severine; Cleveland, Don W.] Univ Calif San Diego, Dept Med & Neurosci, La Jolla, CA 92093 USA; [Yamanaka, Koji; Fujimori-Tonou, Noriko; Yamashita, Hirofumi] RIKEN, Brain Sci Inst, Yamanaka Res Unit, Wako, Saitama 3510198, Japan; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto 6068507, Japan; [Misawa, Hidemi] Kyoritsu Univ Pharm, Dept Pharmacol, Minato Ku, Tokyo 1058512, Japan	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; RIKEN; Washington University (WUSTL); Kyoto University	Yamanaka, K (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	kyamanaka@brain.riken.jp; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; Yamanaka, Koji/H-5806-2011; Yamanaka, Koji/ABD-1034-2020; Boillee, Severine/J-4027-2017	Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035; Gutmann, David/0000-0002-3127-5045; BOILLEE, Severine/0000-0001-5518-9005; Cleveland, Don/0000-0002-1934-3682	NINDS NIH HHS [R37 NS027036-23, NS 27036, R01 NS027036, R37 NS027036, R37 NS027036-22] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027036, R37NS027036] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Son M, 2001, ANN NEUROL, V50, P273, DOI 10.1002/ana.1104; Vermeiren C, 2006, J NEUROCHEM, V96, P719, DOI 10.1111/j.1471-4159.2005.03577.x	15	804	843	4	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					251	253		10.1038/nn2047	http://dx.doi.org/10.1038/nn2047			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18246065	Green Accepted			2022-12-24	WOS:000253548300006
J	Lim, BK; Matsuda, N; Poo, MM				Lim, Byung Kook; Matsuda, Naoto; Poo, Mu-Ming			Ephrin-B reverse signaling promotes structural and functional synaptic maturation in vivo	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RECEPTOR TYROSINE KINASES; AXON BRANCH DYNAMICS; EPHB RECEPTORS; GLUTAMATERGIC SYNAPSE; SPINE MORPHOGENESIS; NEURAL DEVELOPMENT; NMDA RECEPTORS; GROWTH CONES; PLASTICITY	Ephrin-Eph signaling is involved in axon guidance during development, but it may also regulate synapse development after the axon has contacted the target cell. Here we report that the activation of ephrin-B reverse signaling in the developing Xenopus laevis optic tectum promotes morphological and functional maturation of retinotectal synapses. Elevation of ephrin-B signaling increased the number of retinotectal synapses and stabilized the axon arbors of retinal ganglion cells. It also enhanced basal synaptic transmission and activity-induced long-term potentiation (LTP) of retinotectal synapses. The functional effects were caused by a rapid enhancement of presynaptic glutamate release and a delayed increase in the postsynaptic glutamate responsiveness. The facilitated LTP induction occurred during the early phase of enhanced transmitter release and appeared to be causally related to the late-phase postsynaptic maturation via an NMDA receptor-dependent mechanism. This ephrin-B-dependent synapse maturation supports the notion that the ephrin/Eph protein families have multiple functions in neural development.	[Lim, Byung Kook; Matsuda, Naoto; Poo, Mu-Ming] Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu		Lim, Byungkook/0000-0002-3766-5415	NEI NIH HHS [EY014979] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014979] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Aoto J, 2007, J NEUROSCI, V27, P7508, DOI 10.1523/JNEUROSCI.0705-07.2007; Armstrong JN, 2006, J NEUROSCI, V26, P3474, DOI 10.1523/JNEUROSCI.4338-05.2006; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dingwell KS, 2000, J NEUROBIOL, V44, P246; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Jones TL, 1998, P NATL ACAD SCI USA, V95, P576, DOI 10.1073/pnas.95.2.576; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Lien CC, 2006, NAT NEUROSCI, V9, P372, DOI 10.1038/nn1649; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; Rodenas-Ruano A, 2006, DEV BIOL, V292, P34, DOI 10.1016/j.ydbio.2006.01.004; Ruthazer ES, 2006, J NEUROSCI, V26, P3594, DOI 10.1523/JNEUROSCI.0069-06.2006; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	50	93	96	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					160	169		10.1038/nn2033	http://dx.doi.org/10.1038/nn2033			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18193042				2022-12-24	WOS:000252712100010
J	White, RM; Sessa, A; Burke, C; Bowman, T; LeBlanc, J; Ceol, C; Bourque, C; Dovey, M; Goessling, W; Burns, CE; Zon, LI				White, Richard Mark; Sessa, Anna; Burke, Christopher; Bowman, Teresa; LeBlanc, Jocelyn; Ceol, Craig; Bourque, Caitlin; Dovey, Michael; Goessling, Wolfram; Burns, Caroline Erter; Zon, Leonard I.			Transparent adult zebrafish as a tool for in vivo transplantation analysis	CELL STEM CELL			English	Article							TOMOGRAPHY; IDENTIFICATION; PROLIFERATION; EXPRESSION; PROTEINS; SURVIVAL; MODEL; FISH	The zebrafish is a useful model for understanding normal and cancer stem cells, but analysis has been limited to embryogenesis due to the opacity of the adult fish. To address this, we have created a transparent adult zebrafish in which we transplanted either hematopoietic stem/progenitor cells or tumor cells. In a hematopoiesis radiation recovery assay, transplantation of GFP-labeled marrow cells allowed for striking in vivo visual assessment of engraftment from 2 hr-5 weeks posttransplant. Using FACS analysis, both transparent and wild-type fish had equal engraftment, but this could only be visualized in the transparent recipient. In a tumor engraftment model, transplantation of RAS-melanoma cells allowed for visualization of tumor engraftment, proliferation, and distant metastases in as little as 5 days, which is not seen in wild-type recipients until 3 to 4 weeks. This transparent adult zebrafish serves as the ideal combination of both sensitivity and resolution for in vivo stem cell analyses.	[White, Richard Mark; Zon, Leonard I.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [White, Richard Mark; Sessa, Anna; Burke, Christopher; Bowman, Teresa; LeBlanc, Jocelyn; Ceol, Craig; Bourque, Caitlin; Dovey, Michael; Goessling, Wolfram; Zon, Leonard I.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [White, Richard Mark; Dovey, Michael; Goessling, Wolfram; Zon, Leonard I.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Burns, Caroline Erter] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Zon, LI (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu		Goessling, Wolfram/0000-0001-9972-1569	NATIONAL CANCER INSTITUTE [R01CA103846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053298] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA103846-04, R01 CA103846-05, R01 CA103846] Funding Source: Medline; NIDDK NIH HHS [R01 DK053298-10, R01 DK053298, R01 DK053298-11] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Beckmann N, 2007, NMR BIOMED, V20, P154, DOI 10.1002/nbm.1153; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; CLOTHIER J, 1987, J CELL SCI, V88, P663; Creton R, 1997, CELL CALCIUM, V22, P439, DOI 10.1016/S0143-4160(97)90071-3; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Kaneko M, 2005, PLOS BIOL, V3, P313, DOI 10.1371/journal.pbio.0030034; Koo V, 2006, CELL ONCOL, V28, P127; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Le Guellec D, 2004, INT J DEV BIOL, V48, P217, DOI 10.1387/ijdb.15272388; Lee JH, 2007, NAT MED, V13, P95, DOI [10.1038/nm1467, 10.20659/jfp.13.1_95]; Lister JA, 1999, DEVELOPMENT, V126, P3757; Lyons SK, 2005, J PATHOL, V205, P194, DOI 10.1002/path.1697; Machida U, 1999, NEW ENGL J MED, V340, P810; Ninomiya M, 2007, LEUKEMIA, V21, P136, DOI 10.1038/sj.leu.2404432; Notting IC, 2005, INVEST OPHTH VIS SCI, V46, P1581, DOI 10.1167/iovs.04-0245; Paulus MJ, 2000, NEOPLASIA, V2, P62, DOI 10.1038/sj.neo.7900069; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Pickhardt PJ, 2005, P NATL ACAD SCI USA, V102, P3419, DOI 10.1073/pnas.0409915102; Rawls JF, 2001, DEV BIOL, V240, P301, DOI 10.1006/dbio.2001.0418; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Tai YC, 2005, J NUCL MED, V46, P455; Traver D, 2004, BLOOD, V104, P1298, DOI 10.1182/blood-2004-01-0100; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; UCHIDA N, 1994, BLOOD, V83, P3758; Wakamatsu Y, 2001, P NATL ACAD SCI USA, V98, P10046, DOI 10.1073/pnas.181204298; Welsh DK, 2005, CURR OPIN BIOTECH, V16, P73, DOI 10.1016/j.copbio.2004.12.006; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zacharakis G, 2005, P NATL ACAD SCI USA, V102, P18252, DOI 10.1073/pnas.0504628102	31	817	837	7	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB	2008	2	2					183	189		10.1016/j.stem.2007.11.002	http://dx.doi.org/10.1016/j.stem.2007.11.002			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	264PW	18371439	Green Accepted, Bronze			2022-12-24	WOS:000253301900013
J	Choi, PS; Zakhary, L; Choi, WY; Caron, S; Alvarez-Saavedra, E; Miska, EA; McManus, M; Harfe, B; Giraldez, AJ; Horvitz, RH; Schier, AF; Dulac, C				Choi, Philip S.; Zakhary, Lisa; Choi, Wen-Yee; Caron, Sophie; Alvarez-Saavedra, Ezequiel; Miska, Eric A.; McManus, Mike; Harfe, Brian; Giraldez, Antonio J.; Horvitz, Robert H.; Schier, Alexander F.; Dulac, Catherine			Members of the miRNA-200 family regulate olfactory Neurogenesis	NEURON			English	Article							RECEPTOR GENE-EXPRESSION; MICRORNA EXPRESSION; MAMMALIAN BRAIN; MESSENGER-RNA; ENZYME DICER; CELL-TYPES; EPITHELIUM; MOUSE; ZEBRAFISH; DIFFERENTIATION	MicroRNAs (miRNAs) are highly expressed in vertebrate neural tissues, but the contribution of specific miRNAs to the development and function of different neuronal populations is still largely unknown. We report that miRNAs are required for terminal differentiation of olfactory precursors in both mouse and zebrafish but are dispensable for proper function of mature olfactory neurons. The repertoire of miRNAs expressed in olfactory tissues contains over 100 distinct miRNAs. A subset, including the miR-200 family, shows high olfactory enrichment and expression patterns consistent with a role during olfactory neurogenesis. Loss of function of the miR-200 family phenocopies the terminal differentiation defect observed in absence of all miRNA activity in olfactory progenitors. Our data support the notion that vertebrate tissue differentiation is controlled by conserved subsets of organ-specific miRNAs in both mouse and zebrafish and provide insights into control mechanisms underlying olfactory differentiation in vertebrates.	[Choi, Philip S.; Zakhary, Lisa; Dulac, Catherine] Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Alvarez-Saavedra, Ezequiel; Miska, Eric A.; Horvitz, Robert H.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [McManus, Mike] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Harfe, Brian] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA; [Schier, Alexander F.] Broad Inst, Harvard Stem Cell Inst, Ctr Brain Sci, Div Sleep Med, Cambridge, MA 02139 USA; [Giraldez, Antonio J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Harvard University; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; State University System of Florida; University of Florida; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Schier, Alexander Franz/0000-0001-7645-5325; Giraldez, Antonio/0000-0002-6823-137X; Dulac, Catherine/0000-0001-5024-5418; Miska, Eric/0000-0002-4450-576X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049319] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056211, GM56211] Funding Source: Medline; NINDS NIH HHS [R01 NS049319, NS049319] Funding Source: Medline; Wellcome Trust [066790/B/02/Z] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beites CL, 2005, EXP CELL RES, V306, P309, DOI 10.1016/j.yexcr.2005.03.027; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Botchkarev VA, 2004, DIFFERENTIATION, V72, P512, DOI 10.1111/j.1432-0436.2004.07209005.x; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Cau E, 1997, DEVELOPMENT, V124, P1611; Cau E, 2002, DEVELOPMENT, V129, P1871; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Dulac C., 2004, HDB STEM CELLS, V2, P233; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Enright AJ, 2004, GENOME BIOL, V5; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hansen A, 2005, J NEUROCYTOL, V34, P183, DOI 10.1007/s11068-005-8353-1; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; HOLBROOK EH, 1995, J COMP NEUROL, V363, P129, DOI 10.1002/cne.903630111; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kawauchi S, 2005, DEVELOPMENT, V132, P5211, DOI 10.1242/dev.02143; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Kosik KS, 2005, NEURON, V47, P779, DOI 10.1016/j.neuron.2005.08.019; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LaMantia AS, 2000, NEURON, V28, P411, DOI 10.1016/S0896-6273(00)00121-5; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Ohta Y, 2000, ANN OTO RHINOL LARYN, V109, P1046, DOI 10.1177/000348940010901110; Oka Y, 2003, EUR J BIOCHEM, V270, P1995, DOI 10.1046/j.1432-1033.2003.03571.x; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; ROGERS KE, 1985, P NATL ACAD SCI USA, V82, P5218, DOI 10.1073/pnas.82.15.5218; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schier AF, 1997, DEVELOPMENT, V124, P327; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; SULLIVAN SL, 1995, NEURON, V15, P779, DOI 10.1016/0896-6273(95)90170-1; Sumanas Saulius, 2002, Briefings in Functional Genomics & Proteomics, V1, P239; Thelu J, 1998, J INVEST DERMATOL, V111, P903, DOI 10.1046/j.1523-1747.1998.00372.x; VAIOUKHIN V, 1999, P NATL ACAD SCI USA, V96, P8551; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	63	208	221	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 10	2008	57	1					41	55		10.1016/j.neuron.2007.11.018	http://dx.doi.org/10.1016/j.neuron.2007.11.018			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	250YZ	18184563	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000252338600008
J	Cui, H; Andersen, RA				Cui, He; Andersen, Richard A.			Posterior parietal cortex encodes autonomously selected motor plans	NEURON			English	Article							DECISION-MAKING; NEURAL PROSTHETICS; EYE FIELDS; AREA LIP; ATTENTION; MACAQUE; MONKEY; ACTIVATION; MOVEMENTS; INTENTION	The posterior parietal cortex (PPC) of rhesus; monkeys has been found to encode the behavioral meaning of categories of sensory stimuli. When animals are instructed with sensory cues to make either eye or hand movements to a target, PPC cells also show specificity depending on which effector (eye or hand) is instructed for the movement. To determine whether this selectivity retrospectively reflects the behavioral meaning of the cue or prospectively encodes the movement plan, we trained monkeys to autonomously choose to acquire a target in the absence of direct instructions specifying which effector to use. Activity in PPC showed strong specificity for effector choice, with cells in the lateral intraparietal area selective for saccades and cells in the parietal reach region selective for reaches. Such differential activity associated with effector choice under identical stimulus conditions provides definitive evidence that the PPC is prospectively involved in action selection and movement preparation.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Cui, H (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	hecui@vis.caltech.edu		Cui, He/0000-0001-6277-9804	NEI NIH HHS [R01 EY005522, R01 EY005522-27] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005522] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Andersen RA, 2004, TRENDS COGN SCI, V8, P486, DOI 10.1016/j.tics.2004.09.009; Baldauf D, 2006, VISION RES, V46, P4355, DOI 10.1016/j.visres.2006.08.021; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Calton JL, 2002, NAT NEUROSCI, V5, P580, DOI 10.1038/nn862; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Cohen JD, 2002, NEURON, V36, P193, DOI 10.1016/S0896-6273(02)00973-X; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Curtis CE, 2006, J NEUROPHYSIOL, V95, P3923, DOI 10.1152/jn.01120.2005; Deubel H, 1998, VIS COGN, V5, P81, DOI 10.1080/713756776; Dickinson AR, 2003, J NEUROPHYSIOL, V90, P2460, DOI 10.1152/jn.00788.2002; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GREEN DM, 1966, SIGNAL DETECTION THE; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Quiroga RQ, 2006, J NEUROSCI, V26, P3615, DOI 10.1523/JNEUROSCI.3468-05.2006; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Scherberger H, 2003, J NEUROSCI METH, V130, P1, DOI 10.1016/S0165-0270(03)00190-0; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Stoet G, 2004, NEURON, V42, P1003, DOI 10.1016/j.neuron.2004.06.003; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a	30	163	165	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 8	2007	56	3					552	559		10.1016/j.neuron.2007.09.031	http://dx.doi.org/10.1016/j.neuron.2007.09.031			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	229AV	17988637	Green Accepted, Bronze			2022-12-24	WOS:000250774600013
J	Yasuda, S; Tanaka, H; Sugiura, H; Okamura, K; Sakaguchi, T; Tran, U; Takemiya, T; Mizoguchi, A; Yagita, Y; Sakurai, T; De Robertis, EM; Yamagata, K				Yasuda, Shin; Tanaka, Hidekazu; Sugiura, Hiroko; Okamura, Ko; Sakaguchi, Taiki; Tran, Uyen; Takemiya, Takako; Mizoguchi, Akira; Yagita, Yoshiki; Sakurai, Takeshi; De Robertis, E. M.; Yamagata, Kanato			Activity-induced protocadherin arcadlin regulates dendritic spine number by triggering N-cadherin endocytosis via TAO2 beta and p38 MAP kinases	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; LONG-TERM POTENTIATION; ACTIVITY-DEPENDENT REGULATION; AMPA RECEPTOR TRAFFICKING; PARAXIAL PROTOCADHERIN; HIPPOCAMPAL SYNAPSES; SYNAPTIC PLASTICITY; MOUSE DEVELOPMENT; BETA-CATENIN; ADHESION	Synaptic activity induces changes in the number of dendritic spines. Here, we report a pathway of regulated endocytosis triggered by arcadlin, a protocadherin induced by electroconvulsive and other excitatory stimuli in hippocampal neurons. The homophilic binding of extracellular arcadlin domains activates TAO2 beta, a splice variant of the thousand and one amino acid protein kinase 2, cloned here by virtue of its binding to the arcadlin intracellular domain. TAO2 beta is a MAPKKK that activates the MEK3 MAPKK, which phosphorylates the p38 MAPK Activation of p38 feeds-back on TAO2 beta, phosphorylating a key serine required for triggering endocytosis of N-cadherin at the synapse. Arcadlin knockout increases the number of dendritic spines, and the phenotype is rescued by siRNA knockdown of N-cadherin. This pathway of regulated endocytosis of N-cadherin via protocadherin/TAO2 beta/ MEK3/p38 provides a molecular mechanism for transducing neuronal activity into changes in synaptic morphologies.	Tokyo Metropolitan Inst Neurosci, Dept Neuropharmacol, Tokyo 1838526, Japan; Osaka Univ, Sch Med, Dept Pharmacol, Suita, Osaka 5650871, Japan; Mie Univ, Sch Med, Dept Anat, Tsu, Mie 5148507, Japan; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; CUNY Mt Sinai Sch Med, Dept Neurosci, New York, NY 10128 USA	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Osaka University; Mie University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Tanaka, H (corresponding author), Tokyo Metropolitan Inst Neurosci, Dept Neuropharmacol, Tokyo 1838526, Japan.	htanaka@pharma1.med.osaka-u.ac.jp; kyamagat@tmin.ac.jp	Yagita, Yoshiki/S-6954-2016	Sakaguchi, Taiki/0000-0002-2661-0646	NICHD NIH HHS [R01 HD021502-21A1, R01 HD021502] Funding Source: Medline; NINDS NIH HHS [NS20147, R01 NS020147] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020147] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; Benson DL, 1998, J NEUROSCI, V18, P6892; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; Chen Z, 2003, J BIOL CHEM, V278, P22278, DOI 10.1074/jbc.M301173200; Chen Z, 1999, J BIOL CHEM, V274, P28803, DOI 10.1074/jbc.274.40.28803; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Huber O, 1999, J CELL SCI, V112, P4415; Irie Y, 2000, J BIOL CHEM, V275, P2647, DOI 10.1074/jbc.275.4.2647; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jungling K, 2006, J NEUROSCI, V26, P6968, DOI 10.1523/JNEUROSCI.1013-06.2006; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kim SH, 1998, DEVELOPMENT, V125, P4681; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Makarenkova H, 2005, BBA-GENE STRUCT EXPR, V1681, P150, DOI 10.1016/j.bbaexp.2004.11.001; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; Muller D, 2000, HIPPOCAMPUS, V10, P596, DOI 10.1002/1098-1063(2000)10:5<596::AID-HIPO10>3.3.CO;2-P; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Strehl S, 1998, GENOMICS, V53, P81, DOI 10.1006/geno.1998.5467; Sytnyk V, 2006, J CELL BIOL, V174, P1071, DOI 10.1083/jcb.200604145; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Troyanovsky RB, 2006, MOL BIOL CELL, V17, P3484, DOI 10.1091/mbc.E06-03-0190; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Uemura K, 2006, BIOCHEM BIOPH RES CO, V345, P951, DOI 10.1016/j.bbrc.2006.04.157; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamagata K, 1999, J BIOL CHEM, V274, P19473, DOI 10.1074/jbc.274.27.19473; Yamamoto A, 2000, GENESIS, V27, P49, DOI 10.1002/1526-968X(200006)27:2<49::AID-GENE10>3.0.CO;2-7; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	50	144	153	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 8	2007	56	3					456	471		10.1016/j.neuron.2007.08.020	http://dx.doi.org/10.1016/j.neuron.2007.08.020			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	229AV	17988630	Green Accepted, Bronze			2022-12-24	WOS:000250774600006
J	Jansen, P; Giehl, K; Nyengaard, JR; Teng, K; Lioubinski, O; Sjoegaard, SS; Breiderhoff, T; Gotthardt, M; Lin, F; Eilers, A; Petersen, CM; Lewin, GR; Hempstead, BL; Willnow, TE; Nykjaer, A				Jansen, Pernille; Giehl, Klaus; Nyengaard, Jens R.; Teng, Kenneth; Lioubinski, Oleg; Sjoegaard, Susanne S.; Breiderhoff, Tilman; Gotthardt, Michael; Lin, Fuyu; Eilers, Andreas; Petersen, Claus M.; Lewin, Gary R.; Hempstead, Barbara L.; Willnow, Thomas E.; Nykjaer, Anders			Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; AFFINITY NGF RECEPTOR; GANGLION-CELL NUMBER; SYMPATHETIC NEURONS; IN-VIVO; SPINAL-CORD; DEATH; P75; APOPTOSIS; SURVIVAL	Neurotrophins are essential for development and maintenance of the vertebrate nervous system. Paradoxically, although mature neurotrophins promote neuronal survival by binding to tropomyosin receptor kinases and p75 neurotrophin receptor (p75(NTR)), pro-neurotrophins induce apoptosis in cultured neurons by engaging sortilin and p75(NTR) in a death-signaling receptor complex. Substantial amounts of neurotrophins are secreted in pro-form in vivo, yet their physiological significance remains unclear. We generated a sortilin-deficient mouse to examine the contribution of the p75(NTR)/sortilin receptor complex to neuronal viability. In the developing retina, Sortilin 1 (Sort1)(-/-) mice showed reduced neuronal apoptosis that was indistinguishable from that observed in p75(NTR)-deficient (Ngfr(-/-)) mice. To our surprise, although sortilin deficiency did not affect developmentally regulated apoptosis of sympathetic neurons, it did prevent their age-dependent degeneration. Furthermore, in an injury protocol, lesioned corticospinal neurons in Sort1(-/-) mice were protected from death. Thus, the sortilin pathway has distinct roles in pro-neurotrophin-induced apoptotic signaling in pathological conditions, but also in specific stages of neuronal development and aging.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Aarhus Univ, MIND Ctr, Dept Med Biochem, DK-8000 Aarhus, Denmark; Univ Texas, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Dept Cell Biol, Dallas, TX 75390 USA; Aarhus Univ, MIND Ctr, Stereol & Elect Microscopy Res Lab, DK-8000 Aarhus, Denmark; Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Aarhus University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; Aarhus University; Cornell University	Willnow, TE (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	willnow@mdc-berlin.de; an@biokemi.au.dk	Breiderhoff, Tilman/X-9364-2019; Lewin, Gary R/B-8028-2011; Gotthardt, Michael/ABE-8274-2021	Breiderhoff, Tilman/0000-0002-1676-7498; Gotthardt, Michael/0000-0003-1788-3172; Teng, Kenneth/0000-0002-9392-2172; Willnow, Thomas/0000-0001-9515-7921; Nykjaer, Anders/0000-0001-6422-6736; Lewin, Gary/0000-0002-2890-6352	NINDS NIH HHS [NS30687] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030687] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREWS TJ, 1994, J NEUROCYTOL, V23, P234, DOI 10.1007/BF01275527; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bierl MA, 2007, NEUROBIOL AGING, V28, P122, DOI 10.1016/j.neurobiolaging.2005.11.008; Bonatz H, 2000, J NEUROSCI METH, V100, P105, DOI 10.1016/S0165-0270(00)00238-7; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; CHAKRABARTI S, 1990, BRAIN RES, V523, P11, DOI 10.1016/0006-8993(90)91630-Y; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Domeniconi M, 2007, MOL CELL NEUROSCI, V34, P271, DOI 10.1016/j.mcn.2006.11.005; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Gatzinsky KP, 2004, EUR J NEUROSCI, V20, P2848, DOI 10.1111/j.1460-9568.2004.03780.x; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Giehl KM, 1996, EUR J NEUROSCI, V8, P1167, DOI 10.1111/j.1460-9568.1996.tb01284.x; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Glebova NO, 2005, ANNU REV NEUROSCI, V28, P191, DOI 10.1146/annurev.neuro.28.061604.135659; Gonzalez-Hoyuela M, 2001, DEVELOPMENT, V128, P117; Harada C, 2006, DEV BIOL, V290, P57, DOI 10.1016/j.ydbio.2005.08.051; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hasan W, 2003, J NEUROBIOL, V57, P38, DOI 10.1002/neu.10250; Hermans-Borgmeyer I, 1999, MOL BRAIN RES, V65, P216, DOI 10.1016/S0169-328X(99)00022-4; HEUMANN R, 1984, EMBO J, V3, P3183, DOI 10.1002/j.1460-2075.1984.tb02277.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; JENSEN EBV, 1993, J MICROSC-OXFORD, V170, P35, DOI 10.1111/j.1365-2818.1993.tb03321.x; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kumar A, 2006, ENDOCRINOLOGY, V147, P4893, DOI 10.1210/en.2006-0027; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; LEE KF, 1994, DEVELOPMENT, V120, P1027; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Linggi MS, 2005, J BIOL CHEM, V280, P13801, DOI 10.1074/jbc.M410435200; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Majdan M, 1997, J NEUROSCI, V17, P6988; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; NYENGAARD JR, 1992, J MICROSC-OXFORD, V165, P427, DOI 10.1111/j.1365-2818.1992.tb01497.x; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Peng SY, 2004, J NEUROPATH EXP NEUR, V63, P641, DOI 10.1093/jnen/63.6.641; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; SCHMIDT RE, 1995, J NEUROCYTOL, V24, P189, DOI 10.1007/BF01181534; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; Yoon SO, 1998, J NEUROSCI, V18, P3273	50	211	244	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1449	1457		10.1038/nn2000	http://dx.doi.org/10.1038/nn2000			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17934455				2022-12-24	WOS:000250508400023
J	Wu, MF; Kwon, HY; Rattis, F; Blum, J; Zhao, C; Ashkenazi, R; Jackson, TL; Gaiano, N; Oliver, T; Reya, T				Wu, Mingfu; Kwon, Hyog Young; Rattis, Frederique; Blum, Jordan; Zhao, Chen; Ashkenazi, Rina; Jackson, Trachette L.; Gaiano, Nicholas; Oliver, Tim; Reya, Tannishtha			Imaging hematopoietic precursor division in real time	CELL STEM CELL			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; ASYMMETRIC CELL-DIVISION; NEURAL STEM-CELLS; DISPARATE DIFFERENTIATION; PHILADELPHIA-CHROMOSOME; LINEAGE COMMITMENT; PAIRED PROGENITORS; MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR; DAUGHTER CELL	Stem cells are thought to balance self-renewal and differentiation through asymmetric and symmetric divisions, but whether such divisions occur during hematopoietic development remains unknown. Using a Notch reporter mouse, in which GFP acts as a sensor for differentiation, we image hematopoietic precursors and show that they undergo both symmetric and asymmetric divisions. In addition we show that the balance between these divisions is not hardwired but responsive to extrinsic and intrinsic cues. Precursors in a prodifferentiation environment preferentially divide asymmetrically, whereas those in a prorenewal environment primarily divide symmetrically. Oncoproteins can also influence division pattern: although BCR-ABL predominantly alters the rate of division and death, NUP98-HOXA9 promotes symmetric division, suggesting that distinct oncogenes subvert different aspects of cellular function. These studies establish a system for tracking division of hematopoietic precursors and show that the balance of symmetric and asymmetric division can be influenced by the microenvironment and subverted by oncogenes.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA	Duke University; Duke University; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins University	Reya, T (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	t.reya@duke.edu	Kwon, Hyog/T-7915-2019	Kwon, Hyog/0000-0003-1663-5118	NIDDK NIH HHS [R01 DK063031-04, R01 DK072234-02, DK63031, R01 DK063031-01, DK072234, R01 DK072234-01A1, R01 DK063031-03, R01 DK063031-01S1, R01 DK072234, R01 DK063031-02, R01 DK063031, R01 DK063031-05] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072234, R01DK063031] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahuja HG, 2001, GENE CHROMOSOME CANC, V30, P410, DOI 10.1002/1098-2264(2001)9999:9999<::AID-GCC1108>3.0.CO;2-9; Amarante-Mendes GP, 1998, ONCOGENE, V16, P1383, DOI 10.1038/sj.onc.1201664; Beckmann J, 2007, BLOOD, V109, P5494, DOI 10.1182/blood-2006-11-055921; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; Brummendorf TH, 1998, J EXP MED, V188, P1117, DOI 10.1084/jem.188.6.1117; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; DEBRABANDER M, 1981, P NATL ACAD SCI-BIOL, V78, P5608; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Huang S, 1999, BLOOD, V94, P2595, DOI 10.1182/blood.V94.8.2595.420k37_2595_2604; Jan YN, 1998, NATURE, V392, P775, DOI 10.1038/33854; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; LEARY AG, 1985, BLOOD, V66, P327; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; MAYANI H, 1993, J CELL PHYSIOL, V157, P579, DOI 10.1002/jcp.1041570318; Mayotte N, 2002, BLOOD, V100, P4177, DOI 10.1182/blood-2002-04-1244; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nakamura T, 1996, NAT GENET, V12, P154, DOI 10.1038/ng0296-154; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nishiyama M, 1999, GENE CHROMOSOME CANC, V26, P215, DOI 10.1002/(SICI)1098-2264(199911)26:3<215::AID-GCC5>3.3.CO;2-T; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; SUDA T, 1984, P NATL ACAD SCI-BIOL, V81, P2520, DOI 10.1073/pnas.81.8.2520; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Thompson DL, 1998, J BONE MINER RES, V13, P195, DOI 10.1359/jbmr.1998.13.2.195; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Ueno H, 2003, NAT IMMUNOL, V4, P457, DOI 10.1038/ni916; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Yamamoto K, 2000, BRIT J HAEMATOL, V109, P423, DOI 10.1046/j.1365-2141.2000.02003.x; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	40	210	224	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV	2007	1	5					541	554		10.1016/j.stem.2007.08.009	http://dx.doi.org/10.1016/j.stem.2007.08.009			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236AX	18345353	Green Accepted, Bronze			2022-12-24	WOS:000251276500012
J	Hegedus, B; Dasgupta, B; Shin, JE; Emnett, RJ; Hart-Mahon, EK; Elghazi, L; Bernal-Mizrachi, E; Gutmann, DH				Hegedus, Balazs; Dasgupta, Biplab; Shin, Jung Eun; Emnett, Ryan J.; Hart-Mahon, Elizabeth K.; Elghazi, Lynda; Bernal-Mizrachi, Ernesto; Gutmann, David H.			Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and ras-dependent mechanisms	CELL STEM CELL			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; STEM-CELLS; NF1; GROWTH; SURVIVAL; KINASE; PROLIFERATION; INACTIVATION; NEUROGENESIS; EXPRESSION	Individuals with neurofibromatosis type 1 (NF1) develop abnormalities of both neuronal and glial cell lineages, suggesting that the NF1 protein neurofibromin is an essential regulator of neuroglial progenitor function. In this regard, Nf1-deficient embryonic telencephalic neurospheres exhibit increased self-renewal and prolonged survival as explants in vivo. Using a newly developed brain lipid binding protein (BLBP)-Cre mouse strain to study the role of neurofibromin in neural progenitor cell function in the intact animal, we now show that neuroglial progenitor Nf1 inactivation results in increased glial lineage proliferation and abnormal neuronal differentiation in vivo. Whereas the glial cell lineage abnormalities are recapitulated by activated Ras or Akt expression in vivo, the neuronal abnormalities were Ras- and Akt independent and reflected impaired cAMP generation in Nf1-deficient cells in vivo and in vitro. Together, these findings demonstrate that neurofibromin is required for normal glial and neuronal development involving separable Ras-dependent and cAMP-dependent mechanisms.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Gutmann, DH (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	gutmannd@wusti.edu	Hegedus, Balazs/B-6076-2008	Hegedus, Balazs/0000-0002-4341-4153; Shin, Jung Eun/0000-0002-8502-7979; Elghazi, Lynda/0000-0003-1755-9217; Gutmann, David/0000-0002-3127-5045	NATIONAL CANCER INSTITUTE [U01CA084314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK068028] Funding Source: NIH RePORTER; NCI NIH HHS [1-UO1-CA84314] Funding Source: Medline; NIDDK NIH HHS [R03 DK068028, R03 DK068028-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARNOLD D, 1994, P NATL ACAD SCI USA, V91, P9970, DOI 10.1073/pnas.91.21.9970; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; Bennett MR, 2003, J NEUROSCI, V23, P7207, DOI 10.1523/JNEUROSCI.23-18-07207.2003; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Chen YC, 2005, MOL CELL NEUROSCI, V28, P215, DOI 10.1016/j.mcn.2004.08.012; Dasgupta B, 2005, J NEUROSCI, V25, P5584, DOI 10.1523/JNEUROSCI.4693-04.2005; Dasgupta B, 2005, CANCER RES, V65, P2755, DOI 10.1158/0008-5472.CAN-04-4058; Dasgupta B, 2003, J NEUROSCI, V23, P8949; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; Dromard C, 2007, STEM CELLS, V25, P340, DOI 10.1634/stemcells.2005-0556; Fujioka T, 2004, J NEUROSCI, V24, P319, DOI 10.1523/JNEUROSCI.1065.03.2004; Giorgi M, 2004, BEHAV BRAIN RES, V154, P99, DOI 10.1016/j.bbr.2004.01.024; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Hsueh YP, 2001, J NEUROSCI, V21, P3764, DOI 10.1523/JNEUROSCI.21-11-03764.2001; Hyman SL, 2005, NEUROLOGY, V65, P1037, DOI 10.1212/01.wnl.0000179303.72345.ce; JACOBSON RD, 1986, J NEUROSCI, V6, P1843; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Klesse LJ, 1998, J NEUROSCI, V18, P10420; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Lakkis MM, 1999, DEV BIOL, V212, P80, DOI 10.1006/dbio.1999.9327; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Listernick R, 1999, AM J MED GENET, V89, P38, DOI 10.1002/(SICI)1096-8628(19990326)89:1<38::AID-AJMG8>3.0.CO;2-M; Lu NR, 1997, P NATL ACAD SCI USA, V94, P3357, DOI 10.1073/pnas.94.7.3357; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Ohta S, 2006, J NEUROSCI RES, V84, P1177, DOI 10.1002/jnr.21026; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Romero MI, 2007, J NEUROSCI, V27, P2124, DOI 10.1523/JNEUROSCI.4363-06.2007; Shea TB, 1997, J NEUROSCI RES, V48, P515, DOI 10.1002/(SICI)1097-4547(19970615)48:6<515::AID-JNR4>3.0.CO;2-D; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sundholm-Peters NL, 2004, J NEUROCYTOL, V33, P153, DOI 10.1023/B:NEUR.0000029654.70632.3a; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; Tong JY, 2002, NAT NEUROSCI, V5, P95, DOI 10.1038/nn792; VOGEL KS, 1995, CELL, V82, P733, DOI 10.1016/0092-8674(95)90470-0; Walker JA, 2006, GENE DEV, V20, P3311, DOI 10.1101/gad.1466806; Zhu Y, 2005, DEVELOPMENT, V132, P5577, DOI 10.1242/dev.02162; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	44	140	142	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT	2007	1	4					443	457		10.1016/j.stem.2007.07.008	http://dx.doi.org/10.1016/j.stem.2007.07.008			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XU	18371380	Bronze			2022-12-24	WOS:000251055300013
J	Todaro, M; Alea, MP; Di Stefano, AB; Cammareri, P; Vermeulen, L; Lovino, F; Tripodo, C; Russo, A; Gulotta, G; Medema, JP; Stassi, G				Todaro, Matilde; Alea, Mileidys Perez; Di Stefano, Anna B.; Cammareri, Patrizia; Vermeulen, Louis; Lovino, Flora; Tripodo, Claudio; Russo, Antonio; Gulotta, Gaspare; Medema, Jan Paul; Stassi, Giorgio			Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4	CELL STEM CELL			English	Article							STEM/PROGENITOR CELLS; AUTOCRINE PRODUCTION; SIGNAL-TRANSDUCTION; PROGENITOR CELLS; GENE-EXPRESSION; BREAST-CANCER; RECEPTOR; DIFFERENTIATION; IDENTIFICATION; CHEMOTHERAPY	A novel paradigm in tumor biology suggests that cancer growth is driven by stem-like cells within a tumor. Here, we describe the identification and characterization of such cells from colon carcinomas using the stem cell marker CD133 that accounts around 2% of the cells in human colon cancer. The CD133(+) cells grow in vitro as undifferentiated tumor spheroids, and they are both necessary and sufficient to initiate tumor growth in immunodeficient mice. Xenografts resemble the original human tumor maintaining the rare subpopulation of tumorigenic CD133(+) cells. Further analysis revealed that the CD133(+) cells produce and utilize IL-4 to protect themselves from apoptosis. Consistently, treatment with IL-4R alpha antagonist or anti-IL-4 neutralizing antibody strongly enhances the antitumor efficacy of standard chemotherapeutic drugs through selective sensitization of CD133(+) cells. Our data suggest that colon tumor growth is dictated by stem-like cells that are treatment resistant due to the autocrine production of IL-4.	Univ Amsterdam, Acad Med Ctr, Lab Expt Oncol & Radiobiol, NL-1105 AZ Amsterdam, Netherlands; Univ Palermo, Dept Surg & Oncol Sci, Cellular & Mol Pathophysiol Lab, I-90127 Palermo, Italy; Univ Palermo, Dept Surg & Oncol Sci, Oncol Unit, I-90127 Palermo, Italy; Univ Palermo, Dept GENURTO, I-90127 Palermo, Italy; Univ Palermo, Human Pathol Dept, I-90127 Palermo, Italy	University of Amsterdam; Academic Medical Center Amsterdam; University of Palermo; University of Palermo; University of Palermo; University of Palermo	Medema, JP (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Oncol & Radiobiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.p.medema@amc.uva.nl; gstassi@tiscali.it	Tripodo, Claudio/O-4536-2016; di stefano, anna barbara/ABA-2219-2021; Vermeulen, Louis/B-7488-2008; todaro, matilde/AAC-1003-2022; Stassi, Giorgio/AAC-1175-2022; di stefano, anna barbara AB/K-1447-2016; Tripodo, Claudio/AAB-6004-2022; Iovino, Flora/K-8834-2016	Tripodo, Claudio/0000-0002-0821-6231; Vermeulen, Louis/0000-0002-6066-789X; todaro, matilde/0000-0001-8686-8043; di stefano, anna barbara AB/0000-0003-4323-8564; Tripodo, Claudio/0000-0002-0821-6231; Iovino, Flora/0000-0002-6374-5582; Medema, Jan Paul/0000-0003-3045-2924; Cammareri, Patrizia/0000-0002-5888-6903; Gulotta, Gaspare/0000-0001-8683-6623				Aspord C, 2007, J EXP MED, V204, P1037, DOI 10.1084/jem.20061120; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Conticello C, 2004, J IMMUNOL, V172, P5467, DOI 10.4049/jimmunol.172.9.5467; DANCESCU M, 1992, J EXP MED, V176, P1319, DOI 10.1084/jem.176.5.1319; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; FONTI R, 1994, INT J COLORECTAL DIS, V9, P13, DOI 10.1007/BF00304294; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Grunewald SM, 1998, J IMMUNOL, V160, P4004; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kieslinger M, 2000, GENE DEV, V14, P232; Mentink-Kane MM, 2004, P NATL ACAD SCI USA, V101, P586, DOI 10.1073/pnas.0305064101; Morimoto M, 2006, J IMMUNOL, V176, P491, DOI 10.4049/jimmunol.176.1.491; MORRISON BW, 1992, J BIOL CHEM, V267, P11957; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Presnell SC, 2002, SEMIN CELL DEV BIOL, V13, P369, DOI 10.1016/S1084952102000939; Prokopchuk O, 2005, BRIT J CANCER, V92, P921, DOI 10.1038/sj.bjc.6602416; Rahaman SO, 2002, CANCER RES, V62, P1103; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stassi G, 2003, CANCER RES, V63, P6784; Todaro M, 2006, CANCER RES, V66, P1491, DOI 10.1158/0008-5472.CAN-05-2514; Watanabe T, 2006, CANCER RES, V66, P3370, DOI 10.1158/0008-5472.CAN-05-3834; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x	34	828	880	1	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT	2007	1	4					389	402		10.1016/j.stem.2007.08.001	http://dx.doi.org/10.1016/j.stem.2007.08.001			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XU	18371377	Bronze, Green Submitted			2022-12-24	WOS:000251055300009
J	Kobayashi, A; Valerius, MT; Mugford, JW; Carroll, TJ; Self, M; Oliver, G; McMahon, AP				Kobayashi, Akio; Valerius, M. Todd; Mugford, Joshua W.; Carroll, Thomas J.; Self, Michelle; Oliver, Guillermo; McMahon, Andrew P.			Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development	CELL STEM CELL			English	Article							METANEPHRIC MESENCHYME; RECOMBINASE ACTIVITY; MOUSE KIDNEY; STEM-CELLS; MORPHOGENESIS; GENES; NEPHROGENESIS; EXPRESSION; SYSTEM; GROWTH	Nephrons, the basic functional units of the kidney, are generated repetitively during kidney organogenesis from a mesenchymal progenitor population. Which cells within this pool give rise to nephrons and how multiple nephron lineages form during this protracted developmental process are unclear. We demonstrate that the Six2-expressing cap mesenchyme represents a multipotent nephron progenitor population. Six2-expressing cells give rise to all cell types of the main body of the nephron during all stages of nephrogenesis. Pulse labeling of Six2-expressing nephron progenitors at the onset of kidney development suggests that the Six2-expressing population is maintained by self-renewal. Clonal analysis indicates that at least some Six2-expressing cells are multipotent, contributing to multiple domains of the nephron. Furthermore, Six2 functions cell autonomously to maintain a progenitor cell status, as cap mesenchyme cells lacking Six2 activity contribute to ectopic nephron tubules, a mechanism dependent on a Wnt9b inductive signal. Taken together, our observations suggest that Six2 activity cell-autonomously regulates a multipotent nephron progenitor population.	[Kobayashi, Akio; Valerius, M. Todd; Mugford, Joshua W.; Carroll, Thomas J.; McMahon, Andrew P.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Self, Michelle; Oliver, Guillermo] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	Harvard University; St Jude Children's Research Hospital	McMahon, AP (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	mcmahon@mcb.harvard.edu	Wilson, Matthew H/K-3193-2013; Valerius, M. Todd/AAK-3063-2020; McMahon, Andrew P/ABE-7520-2020	Valerius, M. Todd/0000-0001-8143-9231; 	National Research Service Award (NRSA) [NIH-NIDDK F32DK060319]; Cancer Center Support [CA-21765]; American Lebanese Syrian Associated Charities (ALSAC); National Institutes of Health [NIH-NIDDK DK054364]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054364, R37DK054364, F32DK060319] Funding Source: NIH RePORTER	National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Kevin Eggan for 129/Sv x C57BL/6J F1 hybrid ES cells, Neal Copeland for reagents for BAC recombination, Brian Sauer for eGFPCre construct, and Daniel Metzger and Pierre Chambon for CreER<SUP>T2</SUP> construct. A. K. was supported by a Research Fellowship from the National Kidney Foundation. M.T.V. was supported by a National Research Service Award (NRSA) award (NIH-NIDDK F32DK060319). Work in G.O.'s laboratory was supported by Cancer Center Support (CA-21765) and the American Lebanese Syrian Associated Charities (ALSAC). Work in A.P.M.'s laboratory was supported by a grant from the National Institutes of Health (NIH-NIDDK DK054364). A.P.M. is a consultant for Merck. This consultancy does not relate to the work herein.	Barasch J, 1997, AM J PHYSIOL-RENAL, V273, pF757, DOI 10.1152/ajprenal.1997.273.5.F757; Barasch J, 1999, J CLIN INVEST, V103, P1299, DOI 10.1172/JCI4586; Barasch J, 1999, CELL, V99, P377, DOI 10.1016/S0092-8674(00)81524-X; Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Cebrian C, 2004, DEV DYNAM, V231, P601, DOI 10.1002/dvdy.20143; Cheng HT, 2003, DEVELOPMENT, V130, P5031, DOI 10.1242/dev.00697; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x; Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; He CJ, 1996, J CLIN INVEST, V97, P1242, DOI 10.1172/JCI118539; HERZLINGER D, 1992, DEVELOPMENT, V114, P565; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Le YZ, 1999, ANAL BIOCHEM, V270, P334, DOI 10.1006/abio.1999.4110; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nagy A., 2003, MANIPULATING MOUSE E; OLIVER G, 1995, DEVELOPMENT, V121, P693; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; PERANTONI AO, 1995, P NATL ACAD SCI USA, V92, P4696, DOI 10.1073/pnas.92.10.4696; Plisov SY, 2001, DEVELOPMENT, V128, P1045; QIAO J, 1995, DEVELOPMENT, V121, P3207; Reggiani L, 2007, GENE DEV, V21, P2358, DOI 10.1101/gad.450707; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Saxen L., 1987, ORGANOGENESIS KIDNEY; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Wang P, 2003, DEVELOPMENT, V130, P5019, DOI 10.1242/dev.00682; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189	45	647	660	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2008	3	2					169	181		10.1016/j.stem.2008.05.020	http://dx.doi.org/10.1016/j.stem.2008.05.020			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	338QT	18682239	Green Accepted, Bronze			2022-12-24	WOS:000258523300012
J	Raouf, A; Zhao, Y; To, K; Stingl, J; Delaney, A; Barbara, M; Iscove, N; Jones, S; McKinney, S; Emerman, J; Aparicio, S; Marra, M; Eaves, C				Raouf, Afshin; Zhao, Yun; To, Karen; Stingl, John; Delaney, Allen; Barbara, Mary; Iscove, Norman; Jones, Steven; McKinney, Steven; Emerman, Joanne; Aparicio, Samuel; Marra, Marco; Eaves, Connie			Transcriptome analysis of the normal human mammary cell commitment and differentiation process	CELL STEM CELL			English	Article							ADULT HUMAN BREAST; SINGLE STEM-CELL; STEM/PROGENITOR CELLS; EXPRESSION PATTERNS; GENE-EXPRESSION; BONE-MARROW; IN-VITRO; NOTCH; GLAND; CANCER	Mature mammary epithelial cells are generated from undifferentiated precursors through a hierarchical process, but the molecular mechanisms involved, particularly in the human mammary gland, are poorly understood. To address this issue, we isolated highly purified subpopulations of primitive bipotent and committed luminal progenitor cells as well as mature luminal and myoepithelial cells from normal human mammary tissue and compared their transcriptomes obtained using three different methods. Elements unique to each subset of mammary cells were identified, and changes that accompany their differentiation in vivo were shown to be recapitulated in vitro. These include a stage-specific change in NOTCH pathway gene expression during the commitment of bipotent progenitors to the luminal lineage. Functional studies further showed NOTCH3 signaling to be critical for this differentiation event to occur in vitro. Taken together, these findings provide an initial foundation for future delineation of mechanisms that perturb primitive human mammary cell growth and differentiation.	[Raouf, Afshin; Zhao, Yun; To, Karen; Stingl, John; Eaves, Connie] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Delaney, Allen; Jones, Steven; Marra, Marco] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Barbara, Mary; Iscove, Norman] Ontario Canc Inst, Div Stem Cell & Dev Biol, Toronto, ON M5G 2M9, Canada; [Emerman, Joanne] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z4, Canada; [Emerman, Joanne] Univ British Columbia, Dept Anat & Cell Biol, Vancouver, BC V6T 1Z4, Canada; [Marra, Marco; Eaves, Connie] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; [McKinney, Steven; Aparicio, Samuel] British Columbia Canc Agcy, Mol Oncol & Breast Canc Program, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of British Columbia; University of British Columbia; University of British Columbia; British Columbia Cancer Agency	Eaves, C (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	ceaves@bccrc.ca	Jones, Steven J/C-3621-2009; Marra, Marco A/B-5987-2008	Jones, Steven J/0000-0003-3394-2208; Marra, Marco A/0000-0001-7146-7175; Aparicio, Samuel/0000-0002-0487-9599; Eaves, Connie/0000-0002-3452-1926				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Allenspach EJ, 2002, CANCER BIOL THER, V1, P466, DOI 10.4161/cbt.1.5.159; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Bigas A, 1998, MOL CELL BIOL, V18, P2324, DOI 10.1128/MCB.18.4.2324; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bruneau BG, 2001, MOL CELL BIOL, V21, P1730, DOI 10.1128/MCB.21.5.1730-1736.2001; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Callahan R, 2004, J MAMMARY GLAND BIOL, V9, P145, DOI 10.1023/B:JOMG.0000037159.63644.81; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Howlin J, 2006, J MAMMARY GLAND BIOL, V11, P283, DOI 10.1007/s10911-006-9024-2; Hu YH, 2004, CANCER RES, V64, P7748, DOI 10.1158/0008-5472.CAN-04-1827; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Imren S, 2004, J CLIN INVEST, V114, P953, DOI 10.1172/JCI200421838; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Iscove NN, 2002, NAT BIOTECHNOL, V20, P940, DOI 10.1038/nbt729; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Kritikou EA, 2003, DEVELOPMENT, V130, P3459, DOI 10.1242/dev.00578; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Lewis MT, 1999, CELL TISSUE RES, V296, P549, DOI 10.1007/s004410051316; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Raafat A, 2004, ONCOGENE, V23, P9401, DOI 10.1038/sj.onc.1208187; Robertson N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r6; Russo J, 2004, MATURITAS, V49, P2, DOI 10.1016/j.maturitas.2004.04.011; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shi W, 2006, J MAMMARY GLAND BIOL, V11, P41, DOI 10.1007/s10911-006-9011-7; Smalley MJ, 1999, J HISTOCHEM CYTOCHEM, V47, P1513, DOI 10.1177/002215549904701203; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Stingl J, 2006, CELL CYCLE, V5, P1519, DOI 10.4161/cc.5.14.2983; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Tsai YC, 1996, CANCER RES, V56, P402; van Tuyl M, 2006, AM J PHYSIOL-LUNG C, V290, pL777, DOI 10.1152/ajplung.00293.2005; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Zhao Y, 2007, STEM CELLS, V25, P1681, DOI 10.1634/stemcells.2006-0794	50	263	269	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL	2008	3	1					109	118		10.1016/j.stem.2008.05.018	http://dx.doi.org/10.1016/j.stem.2008.05.018			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	325XO	18593563	Bronze			2022-12-24	WOS:000257622300014
J	Schmid, A; Hallermann, S; Kittel, RJ; Khorramshahi, O; Frolich, AMJ; Quentin, C; Rasse, TM; Mertel, S; Heckmann, M; Sigrist, SJ				Schmid, Andreas; Hallermann, Stefan; Kittel, Robert J.; Khorramshahi, Omid; Froelich, Andreas M. J.; Quentin, Christine; Rasse, Tobias M.; Mertel, Sara; Heckmann, Manfred; Sigrist, Stephan J.			Activity-dependent site-specific changes of glutamate receptor composition in vivo	NATURE NEUROSCIENCE			English	Article							PRESYNAPTIC RELEASE; RETROGRADE SIGNAL; QUANTAL SIZE; DROSOPHILA; MECHANISMS; SUBUNIT; PLASTICITY; SYNAPSE; TRAFFICKING; EXPRESSION	The subunit composition of postsynaptic non-NMDA-type glutamate receptors (GluRs) determines the function and trafficking of the receptor. Changes in GluR composition have been implicated in the homeostasis of neuronal excitability and synaptic plasticity underlying learning. Here, we imaged GluRs in vivo during the formation of new postsynaptic densities (PSDs) at Drosophila neuromuscular junctions coexpressing GluRIIA and GluRIIB subunits. GluR composition was independently regulated at directly neighboring PSDs on a submicron scale. Immature PSDs typically had large amounts of GluRIIA and small amounts of GluRIIB. During subsequent PSD maturation, however, the GluRIIA/GluRIIB composition changed and became more balanced. Reducing presynaptic glutamate release increased GluRIIA, but decreased GluRIIB incorporation. Moreover, the maturation of GluR composition correlated in a site-specific manner with the level of Bruchpilot, an active zone protein that is essential for mature glutamate release. Thus, we show that an activity-dependent, site-specific control of GluR composition can contribute to match pre-and postsynaptic assembly.	[Schmid, Andreas; Hallermann, Stefan; Kittel, Robert J.; Khorramshahi, Omid; Quentin, Christine; Mertel, Sara; Heckmann, Manfred; Sigrist, Stephan J.] Univ Wurzburg, Fac Med, Inst Clin Neurobiol, D-97080 Wurzburg, Germany; [Schmid, Andreas; Khorramshahi, Omid; Quentin, Christine; Mertel, Sara; Sigrist, Stephan J.] Univ Wurzburg, Deutsche Forschsgemeinshaft Res Ctr Expt Biomed, Rudolf Virchow Ctr, D-97078 Wurzburg, Germany; [Schmid, Andreas; Kittel, Robert J.; Froelich, Andreas M. J.; Quentin, Christine; Rasse, Tobias M.; Mertel, Sara; Sigrist, Stephan J.] Univ Gottingen, European Neurosci Inst Gottingen, D-37077 Gottingen, Germany; [Hallermann, Stefan; Kittel, Robert J.; Heckmann, Manfred] Univ Leipzig, Carl Ludwig Inst Physiol, Fac Med, D-04103 Leipzig, Germany	University of Wurzburg; University of Wurzburg; University of Gottingen; Leipzig University	Sigrist, SJ (corresponding author), Univ Wurzburg, Fac Med, Inst Clin Neurobiol, Zinklesweg 10, D-97080 Wurzburg, Germany.	stephan.sigrist@virchow.uni-wuerzburg.de	Kittel, Robert J/G-6404-2015	Kittel, Robert J/0000-0002-9199-4826; Hallermann, Stefan/0000-0001-9376-7048; Heckmann, Manfred/0000-0002-4874-1735				Akaaboune M, 2002, NEURON, V34, P865, DOI 10.1016/S0896-6273(02)00739-0; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bogdanik L, 2004, J NEUROSCI, V24, P9105, DOI 10.1523/JNEUROSCI.2724-04.2004; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BROADIE KS, 1993, J NEUROSCI, V13, P144; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen K, 2005, J NEUROSCI, V25, P6667, DOI 10.1523/JNEUROSCI.1527-05.2005; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; DiAntonio A, 1999, J NEUROSCI, V19, P3023; DiAntonio A, 2006, INT REV NEUROBIOL, V75, P165, DOI 10.1016/S0074-7742(06)75008-5; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Featherstone DE, 2005, J NEUROSCI, V25, P3199, DOI 10.1523/JNEUROSCI.4201-04.2005; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Holcman D, 2006, BIOPHYS J, V91, P2405, DOI 10.1529/biophysj.106.081935; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Nishikawa K, 1995, J NEUROSCI, V15, P7905; Pawlu C, 2004, NEURON, V42, P607, DOI 10.1016/S0896-6273(04)00269-7; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Reiff DF, 2002, J NEUROSCI, V22, P9399; Ruiz-Canada C, 2004, NEURON, V42, P567, DOI 10.1016/S0896-6273(04)00255-7; Schmid A, 2006, J NEUROSCI, V26, P11267, DOI 10.1523/JNEUROSCI.2722-06.2006; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Sigrist SJ, 2002, J NEUROSCI, V22, P7362; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Takahashi T, 2005, NEUROSCI RES, V53, P229, DOI 10.1016/j.neures.2005.07.005; Thiagarajan TC, 2007, NEUROPHARMACOLOGY, V52, P156, DOI 10.1016/j.neuropharm.2006.07.030; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Witzemann V, 1996, P NATL ACAD SCI USA, V93, P13286, DOI 10.1073/pnas.93.23.13286; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Zhong Y, 2004, J NEUROSCI, V24, P1439, DOI 10.1523/JNEUROSCI.0740-02.2004; ZHONG Y, 1992, J NEUROSCI, V12, P644	48	130	131	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					659	666		10.1038/nn.2122	http://dx.doi.org/10.1038/nn.2122			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18469810				2022-12-24	WOS:000256133700012
J	Engineer, CT; Perez, CA; Chen, YTH; Carraway, RS; Reed, AC; Shetake, JA; Jakkamsetti, V; Chang, KQ; Kilgard, MP				Engineer, Crystal T.; Perez, Claudia A.; Chen, YeTing H.; Carraway, Ryan S.; Reed, Amanda C.; Shetake, Jai A.; Jakkamsetti, Vikram; Chang, Kevin Q.; Kilgard, Michael P.			Cortical activity patterns predict speech discrimination ability	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; VOICED-VOICELESS DISTINCTION; FREQUENCY-MODULATED TONES; TIME PHONETIC PARAMETER; PRIMARY VISUAL-CORTEX; LANGUAGE DISCRIMINATION; TEMPORAL INFORMATION; SINGLE NEURONS; NEURAL-NETWORK; PERCEPTION	Neural activity in the cerebral cortex can explain many aspects of sensory perception. Extensive psychophysical and neurophysiological studies of visual motion and vibrotactile processing show that the firing rate of cortical neurons averaged across 50-500 ms is well correlated with discrimination ability. In this study, we tested the hypothesis that primary auditory cortex (A1) neurons use temporal precision on the order of 1-10 ms to represent speech sounds shifted into the rat hearing range. Neural discrimination was highly correlated with behavioral performance on 11 consonant-discrimination tasks when spike timing was preserved and was not correlated when spike timing was eliminated. This result suggests that spike timing contributes to the auditory cortex representation of consonant sounds.	[Engineer, Crystal T.; Perez, Claudia A.; Chen, YeTing H.; Carraway, Ryan S.; Reed, Amanda C.; Shetake, Jai A.; Jakkamsetti, Vikram; Chang, Kevin Q.; Kilgard, Michael P.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75080 USA	University of Texas System; University of Texas Dallas	Kilgard, MP (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, 800 W Campbell Rd, Richardson, TX 75080 USA.	novitski@utdallas.edu; kilgard@utdallas.edu	Jakkamsetti, Vikram/AAJ-8744-2020	Jakkamsetti, Vikram/0000-0001-6524-2893; Engineer, Crystal/0000-0002-2188-2335; Kilgard, Michael/0000-0002-6699-1818	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R15DC006624] Funding Source: NIH RePORTER; NIDCD NIH HHS [R15 DC006624, R15 DC006624-01, R15 DC006624-01S1] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahissar E, 2001, P NATL ACAD SCI USA, V98, P13367, DOI 10.1073/pnas.201400998; BERTONCINI J, 1987, J ACOUST SOC AM, V82, P31, DOI 10.1121/1.395570; BLUMSTEIN SE, 1979, J ACOUST SOC AM, V66, P1001, DOI 10.1121/1.383319; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Buonomano DV, 1999, NEURAL COMPUT, V11, P103, DOI 10.1162/089976699300016836; Cooke JE, 2007, HEARING RES, V231, P90, DOI 10.1016/j.heares.2007.06.002; DeWeese MR, 2005, NEURON, V48, P479, DOI 10.1016/j.neuron.2005.10.016; DEWSON JH, 1969, EXP NEUROL, V24, P579, DOI 10.1016/0014-4886(69)90159-9; DOOLING RJ, 1989, PERCEPT PSYCHOPHYS, V46, P65, DOI 10.3758/BF03208075; Engineer ND, 2004, J NEUROPHYSIOL, V92, P73, DOI 10.1152/jn.00059.2004; Foffani G, 2004, J NEUROSCI METH, V135, P107, DOI 10.1016/j.jneumeth.2003.12.011; Fowler CA, 2003, J MEM LANG, V49, P396, DOI 10.1016/S0749-596X(03)00072-X; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; HEFFNER HE, 1989, BEHAV NEUROSCI, V103, P158, DOI 10.1037/0735-7044.103.1.158; JONGMAN A, 1989, J ACOUST SOC AM, V85, P1718, DOI 10.1121/1.397961; KAWAHARA H, 1997, P IEEE INT C AC SPEE, V2, P1303; KLUENDER KR, 1987, SCIENCE, V237, P1195, DOI 10.1126/science.3629235; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; Liu J, 2005, J NEUROSCI, V25, P711, DOI 10.1523/JNEUROSCI.4034-04.2005; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; Narayan R, 2006, J NEUROPHYSIOL, V96, P252, DOI 10.1152/jn.01257.2005; Ohl FW, 1997, P NATL ACAD SCI USA, V94, P9440, DOI 10.1073/pnas.94.17.9440; Orduna I, 2005, BEHAV NEUROSCI, V119, P256, DOI 10.1037/0735-7044.119.1.256; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pruett JR, 2001, J NEUROPHYSIOL, V86, P2069, DOI 10.1152/jn.2001.86.4.2069; Qin L, 2004, BRAIN RES, V1024, P167, DOI 10.1016/j.brainres.2004.07.061; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; Reed P, 2003, J EXP ANAL BEHAV, V80, P205, DOI 10.1901/jeab.2003.80-205; Rennaker RL, 2005, J NEUROSCI METH, V142, P169, DOI 10.1016/j.jneumeth.2004.08.009; Rennaker RL, 2005, J NEUROSCI METH, V142, P97, DOI 10.1016/j.jneumeth.2004.07.018; RICHMOND BJ, 1990, J NEUROPHYSIOL, V64, P351, DOI 10.1152/jn.1990.64.2.351; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Rybalko N, 2006, EUR J NEUROSCI, V23, P1614, DOI 10.1111/j.1460-9568.2006.04688.x; Schnupp JWH, 2006, J NEUROSCI, V26, P4785, DOI 10.1523/JNEUROSCI.4330-05.2006; Sinnott JM, 1997, J ACOUST SOC AM, V102, P588, DOI 10.1121/1.419732; Steinschneider M, 1999, J NEUROPHYSIOL, V82, P2346, DOI 10.1152/jn.1999.82.5.2346; STEINSCHNEIDER M, 1995, BRAIN RES, V674, P147, DOI 10.1016/0006-8993(95)00008-E; Steinschneider M, 2005, CEREB CORTEX, V15, P170, DOI 10.1093/cercor/bhh120; Steinschneider M, 2003, J ACOUST SOC AM, V114, P307, DOI 10.1121/1.1582449; Tavabi K, 2007, EUR J NEUROSCI, V25, P3155, DOI 10.1111/j.1460-9568.2007.05572.x; Toro JM, 2005, J EXP PSYCHOL-ANIM B, V31, P95, DOI 10.1037/0097-7403.31.1.95; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Versnel H, 1998, J ACOUST SOC AM, V103, P2502, DOI 10.1121/1.422771; Walker KMM, 2008, J COGNITIVE NEUROSCI, V20, P135, DOI 10.1162/jocn.2008.20012; Wang L, 2007, J NEUROSCI, V27, P582, DOI 10.1523/JNEUROSCI.3699-06.2007; Weliky M, 2003, NEURON, V37, P703, DOI 10.1016/S0896-6273(03)00022-9; Wetzel W, 1998, NEUROSCI LETT, V252, P115, DOI 10.1016/S0304-3940(98)00561-8; Wong SW, 2003, SPEECH COMMUN, V41, P93, DOI 10.1016/S0167-6393(02)00096-1; Young ED, 2008, PHILOS T R SOC B, V363, P923, DOI 10.1098/rstb.2007.2151	50	152	153	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					603	608		10.1038/nn.2109	http://dx.doi.org/10.1038/nn.2109			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18425123	Green Accepted			2022-12-24	WOS:000255327300020
J	Shafer, OT; Kim, DJ; Dunbar-Yaffe, R; Nikolaev, VO; Lohse, MJ; Taghert, PH				Shafer, Orie T.; Kim, Dong Jo; Dunbar-Yaffe, Richard; Nikolaev, Viacheslav O.; Lohse, Martin J.; Taghert, Paul H.			Widespread receptivity to neuropeptide PDF throughout the neuronal circadian clock network of Drosophila revealed by real-time cyclic AMP imaging	NEURON			English	Article							SOMATOSTATIN RECEPTOR SUBTYPES; PACEMAKER NEURONS; LATERAL NEURONS; EPAC ACTIVATION; MESSENGER-RNA; CAMP; RAT; HORMONE; RHYTHMS; CELLS	The neuropeptide PDF is released by sixteen clock neurons in Drosophila and helps maintain circadian activity rhythms by coordinating a network of similar to 150 neuronal clocks. Whether PDF acts directly on elements of this neural network remains unknown. We address this question by adapting Epac1 -camps, a genetically encoded cAMP FRET sensor, for use in the living brain. We find that a subset of the PDF-expressing neurons respond to PDF with long-lasting cAMP increases and confirm that such responses require the PDF receptor. In contrast, an unrelated Drosophila neuropeptide, DH31, stimulates large cAMP increases in all PDF-expressing clock neurons. Thus, the network of similar to 150 clock neurons displays widespread, though not uniform, PDF receptivity. This work introduces a sensitive means of measuring cAMP changes in a living brain with subcellular resolution. Specifically, it experimentally confirms the longstanding hypothesis that PDF is a direct modulator of most neurons in the Drosophila clock network.	[Shafer, Orie T.; Kim, Dong Jo; Taghert, Paul H.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Nikolaev, Viacheslav O.; Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Dunbar-Yaffe, Richard] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada	Washington University (WUSTL); University of Wurzburg; University of Toronto; University Toronto Mississauga	Taghert, PH (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	taghertp@pcg.wustl.edu	Lohse, Martin J/A-7160-2012; Nikolaev, Vyacheslav/AAT-7746-2020	Lohse, Martin J/0000-0002-0599-3510; 	NIMH NIH HHS [R01 MH067122-05, MH067122, R01 MH067122, R01 MH067122-04] Funding Source: Medline; NINDS NIH HHS [R01 NS021749, 2F32NS053222-02, P30 NS057105-039005, F32 NS053222, NS057105, NS21749, P30 NS057105, R01 NS021749-21] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105, R01NS021749, F32NS053222] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE H, 1978, P SOC EXP BIOL MED, V159, P346; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; BEAUDET A, 1995, NEUROSCIENCE, V65, P551, DOI 10.1016/0306-4522(94)00486-O; Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Caberlotto L, 2000, J CHEM NEUROANAT, V20, P327, DOI 10.1016/S0891-0618(00)00107-1; Catalani E, 2004, NEUROSCIENCE, V128, P519, DOI 10.1016/j.neuroscience.2004.07.004; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DESOUZA NJ, 1983, MED RES REV, V3, P201, DOI 10.1002/med.2610030205; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Garzon M, 2002, NEUROSCIENCE, V114, P461, DOI 10.1016/S0306-4522(02)00249-X; Gouzenes L, 1998, J NEUROSCI, V18, P1879; GRAF O, 2005, J BIOL CHEM, V280, P31294; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Helboe L, 1999, INVEST OPHTH VIS SCI, V40, P2376; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; Johnson EC, 2004, J EXP BIOL, V207, P743, DOI 10.1242/jeb.00818; Johnson EC, 2003, J BIOL CHEM, V278, P52172, DOI 10.1074/jbc.M306756200; Kalamatianos T, 2004, J COMP NEUROL, V475, P19, DOI 10.1002/cne.20168; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Ludwig M, 1998, J NEUROENDOCRINOL, V10, P881; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Nikolaev VO, 2006, PHYSIOLOGY, V21, P86, DOI 10.1152/physiol.00057.2005; Nikolaev VO, 2005, J BIOL CHEM, V280, P1716, DOI 10.1074/jbc.C400505200; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Ponsioen B, 2007, EXP CELL RES, V313, P415, DOI 10.1016/j.yexcr.2006.10.029; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rieger D, 2003, J BIOL RHYTHM, V18, P377, DOI 10.1177/0748730403256997; Shafer OT, 2006, J COMP NEUROL, V498, P180, DOI 10.1002/cne.21021; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Taghert PH, 2006, J BIOL RHYTHM, V21, P445, DOI 10.1177/0748730406293910; Taghert PH, 2001, J NEUROSCI, V21, P6673, DOI 10.1523/JNEUROSCI.21-17-06673.2001; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812; Zars T., 2000, Science (Washington D C), V288, P672, DOI 10.1126/science.288.5466.672	57	224	228	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2008	58	2					223	237		10.1016/j.neuron.2008.02.018	http://dx.doi.org/10.1016/j.neuron.2008.02.018			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292YX	18439407	Green Accepted, Bronze			2022-12-24	WOS:000255303100010
J	Kaneko, M; Hanover, JL; England, PM; Stryker, MP				Kaneko, Megumi; Hanover, Jessica L.; England, Pamela M.; Stryker, Michael P.			TrkB kinase is required for recovery, but not loss, of cortical responses following monocular deprivation	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; CAT VISUAL-CORTEX; EXPERIENCE-DEPENDENT PLASTICITY; LONG-TERM POTENTIATION; NEUROTROPHIC FACTOR; CRITICAL PERIOD; MESSENGER-RNA; EXCITATORY SYNAPSES; PROTEIN-SYNTHESIS; INTRINSIC SIGNAL	Changes in visual cortical responses that are induced by monocular visual deprivation are a widely studied example of competitive, experience-dependent neural plasticity. It has been thought that the deprived-eye pathway will fail to compete against the open-eye pathway for limited amounts of brain-derived neurotrophic factor, which acts on TrkB and is needed to sustain effective synaptic connections. We tested this model by using a chemical-genetic approach in mice to inhibit TrkB kinase activity rapidly and specifically during the induction of cortical plasticity in vivo. Contrary to the model, TrkB kinase activity was not required for any of the effects of monocular deprivation. When the deprived eye was re-opened during the critical period, cortical responses to it recovered. This recovery was blocked by TrkB inhibition. These findings suggest a more conventional trophic role for TrkB signaling in the enhancement of responses or growth of new connections, rather than a role in competition.	[Kaneko, Megumi; Hanover, Jessica L.; Stryker, Michael P.] Univ Calif San Francisco, Wm Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Kaneko, Megumi; Hanover, Jessica L.; Stryker, Michael P.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [England, Pamela M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [England, Pamela M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stryker, MP (corresponding author), Univ Calif San Francisco, Wm Keck Fdn Ctr Integrat Neurosci, 513 Parnassus Ave,Room HSE-801,Box 0444, San Francisco, CA 94143 USA.	stryker@phy.ucsf.edu		Stryker, Michael/0000-0003-1546-5831	NATIONAL EYE INSTITUTE [T32EY007120, R37EY002874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077972] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY002874-24S2, R37 EY002874, T32 EY007120, R37-EY02874, T32-EY07120] Funding Source: Medline; NIMH NIH HHS [P50-MH077972, P50 MH077972] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aloyz R, 1999, LEARN MEMORY, V6, P216; BEAR MF, 1990, J NEUROSCI, V10, P909; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; BOZZI Y, 1995, NEUROSCIENCE, V69, P1133, DOI 10.1016/0306-4522(95)00321-9; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Galuske RAW, 2000, EUR J NEUROSCI, V12, P3315, DOI 10.1046/j.1460-9568.2000.00213.x; Gillespie DC, 2000, J NEUROSCI, V20, P9174; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kang HJ, 2000, NEUROSCI LETT, V282, P141, DOI 10.1016/S0304-3940(00)00893-4; Korte M, 2000, NEUROPHARMACOLOGY, V39, P717, DOI 10.1016/S0028-3908(99)00273-7; Krahe TE, 2005, NEURON, V48, P329, DOI 10.1016/j.neuron.2005.09.016; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Lessmann V, 1998, NEUROSCIENCE, V86, P399; Li YX, 1998, J NEUROSCI, V18, P10231; Liao DS, 2002, J NEUROSCI, V22, P9015; Lodovichi C, 2000, J NEUROSCI, V20, P2155; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; REITER HO, 1986, EXP BRAIN RES, V65, P182; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Schinder AF, 2000, NEURON, V25, P151, DOI 10.1016/S0896-6273(00)80879-X; SCHOUPS AA, 1995, DEV BRAIN RES, V86, P326, DOI 10.1016/0165-3806(95)00043-D; SHATZ CJ, 1997, MOL CELLULAR APPROAC, P509; Specht KM, 2002, CURR OPIN CELL BIOL, V14, P155, DOI 10.1016/S0955-0674(02)00317-4; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tyler WJ, 2006, J PHYSIOL-LONDON, V574, P787, DOI 10.1113/jphysiol.2006.111310; Ugolini G, 1995, BRAIN RES, V704, P121, DOI 10.1016/0006-8993(95)01191-9; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0	50	63	63	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					497	504		10.1038/nn2068	http://dx.doi.org/10.1038/nn2068			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18311133	Green Accepted			2022-12-24	WOS:000254359300022
J	Dunn, FA; Rieke, F				Dunn, Felice A.; Rieke, Fred			Single-photon absorptions evoke synaptic depression in the retina to extend the operational range of rod vision	NEURON			English	Article							MAMMALIAN RIBBON SYNAPSE; AGONIST BINDING-SITES; AMACRINE CELLS; BIPOLAR CELLS; GAIN-CONTROL; DEPOLARIZING BIPOLAR; NMDA RECEPTORS; VISUAL SIGNALS; RABBIT RETINA; AMPA	Adaptation or gain control allows sensory neurons to encode diverse stimuli using a limited range of output signals. Rod vision exemplifies a general challenge facing adaptational mechanisms-balancing the benefits of averaging to create a reliable signal for adaptation with the need to adapt rapidly and locally. The synapse between rod bipolar and All amacrine cells dominates adaptation at low light levels. We find that adaptation occurs independently at each synapse and completes in < 500 ms. This limited spatial and temporal integration suggests that the absorption of a single photon modulates gain. Indeed, responses to pairs of brief dim flashes showed directly that synaptic gain was depressed for 100-200 ms following transmission of a single-photon response. Presynaptic mechanisms mediated this synaptic depression. Thus, the division of light into discrete photons controls adaptation at this synapse, and gain varies with the irreducible statistical fluctuations in photon arrival.	[Dunn, Felice A.] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA; [Rieke, Fred] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Rieke, Fred] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rieke, F (corresponding author), Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA.	rieke@u.washington.edu			Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [EY11850, R01 EY011850, R01 EY011850-10] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011850] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; Barlow H.B., 1972, HDB SENSORY PHYSIOLO, VVIII, P1; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; Berntson A, 2004, VISUAL NEUROSCI, V21, P693, DOI 10.1017/S0952523804215048; Brown LG, 1998, VISION RES, V38, P1925, DOI 10.1016/S0042-6989(97)00400-8; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chavez AE, 2006, NATURE, V443, P705, DOI 10.1038/nature05123; Clements JD, 1998, J NEUROSCI, V18, P119; Cook DL, 2003, NATURE, V421, P66, DOI 10.1038/nature01248; DACHEUX RF, 1986, J NEUROSCI, V6, P331; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Dong CJ, 2003, J NEUROPHYSIOL, V89, P2159, DOI 10.1152/jn.01008.2002; Dunn FA, 2006, J NEUROSCI, V26, P3959, DOI 10.1523/JNEUROSCI.5148-05.2006; Dunn FA, 2006, CURR OPIN NEUROBIOL, V16, P363, DOI 10.1016/j.conb.2006.06.013; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; HEIDELBERGER R, 1994, NEUROREPORT, V5, P729, DOI 10.1097/00001756-199402000-00018; Kovacs I, 2004, NEUROCHEM INT, V44, P271, DOI 10.1016/S0197-0186(03)00137-2; Li W, 2002, VISUAL NEUROSCI, V19, P119, DOI 10.1017/S0952523802191115; Maldonado PE, 2007, NEUROSCIENCE, V144, P1536, DOI 10.1016/j.neuroscience.2006.11.021; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; Palmer MJ, 2003, J NEUROSCI, V23, P11332; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P897, DOI 10.1113/jphysiol.2003.059543; Rudd ME, 1996, SPATIAL VISION, V10, P125, DOI 10.1163/156856896X00097; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; STERLING P, 1988, J NEUROSCI, V8, P623; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Veruki ML, 2003, J PHYSIOL-LONDON, V549, P759, DOI 10.1113/jphysiol.2003.039982; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Weber M, 2001, J NEUROCHEM, V77, P1108, DOI 10.1046/j.1471-4159.2001.00340.x	35	54	54	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 27	2008	57	6					894	904		10.1016/j.neuron.2008.01.031	http://dx.doi.org/10.1016/j.neuron.2008.01.031			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281LV	18367090	Green Accepted, Bronze			2022-12-24	WOS:000254500000013
J	Li, XM; Dong, XP; Luo, SW; Zhang, B; Lee, DH; Ting, AKL; Neiswender, H; Kim, CH; Carpenter-Hyland, E; Gao, TM; Xiong, WC; Mei, L				Li, Xiao-Ming; Dong, Xian-Ping; Luo, Shi-Wen; Zhang, Bin; Lee, Dae-Hoon; Ting, Annie K. L.; Neiswender, Hannah; Kim, Chang-Hoon; Carpenter-Hyland, Ezekiel; Gao, Tian-Ming; Xiong, Wen-Cheng; Mei, Lin			Retrograde regulation of motoneuron differentiation by muscle beta-catenin	NATURE NEUROSCIENCE			English	Article							NEUROMUSCULAR-JUNCTIONS; SYNAPTIC DIFFERENTIATION; N-CADHERIN; SYNAPSES; NEUROTROPHINS; ROLES; GENE; NEUROTRANSMISSION; TRAFFICKING; WINGLESS	Synapse formation requires proper interaction between pre- and postsynaptic cells. In anterograde signaling, neurons release factors to guide postsynaptic differentiation. However, less is known about how postsynaptic targets retrogradely regulate presynaptic differentiation or function. We found that muscle-specific conditional knockout of beta-catenin (Ctnnb1, also known as beta-cat) in mice caused both morphologic and functional defects in motoneuron terminals of neuromuscular junctions (NMJs). In the absence of muscle beta-catenin, acetylcholine receptor clusters were increased in size and distributed throughout a wider region. Primary nerve branches were mislocated, whereas secondary or intramuscular nerve branches were elongated and reduced in number. Both spontaneous and evoked neurotransmitter release was reduced at the mutant NMJs. Furthermore, short-term plasticity and calcium sensitivity of neurotransmitter release were compromised in beta-catenin-deficient muscle. In contrast, the NMJ was normal in morphology and function in motoneuron-specific beta-catenin-deficient mice. Taken together, these observations indicate a role for muscle beta-catenin in presynaptic differentiation and function, identifying a previously unknown retrograde signaling in the synapse formation and synaptic plasticity.	[Li, Xiao-Ming; Dong, Xian-Ping; Luo, Shi-Wen; Zhang, Bin; Lee, Dae-Hoon; Ting, Annie K. L.; Neiswender, Hannah; Kim, Chang-Hoon; Carpenter-Hyland, Ezekiel; Xiong, Wen-Cheng; Mei, Lin] Med Coll Georgia, Dept Neurol, Inst Mol Med & Genet, Program Dev Neurobiol, Augusta, GA 30912 USA; [Gao, Tian-Ming; Mei, Lin] So Med Univ, Dept Anat & Neurobiol, Guangzhou 510515, Peoples R China	University System of Georgia; Augusta University; Southern Medical University - China	Mei, L (corresponding author), Med Coll Georgia, Dept Neurol, Inst Mol Med & Genet, Program Dev Neurobiol, 1120 15th St, Augusta, GA 30912 USA.	lmei@mcg.edu	Mei, Lin/G-8755-2012	Xiong, Wen-Cheng/0000-0001-9071-7598; Zhang, Bin/0000-0003-1323-8678; Kim, Changhoon/0000-0001-5971-863X; Dong, Xianping/0000-0002-4496-7104				Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bernstein M, 1999, CURR OPIN NEUROBIOL, V9, P364, DOI 10.1016/S0959-4388(99)80053-1; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Brault V, 2001, DEVELOPMENT, V128, P1253; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Dong XP, 2006, NEUROSIGNALS, V15, P53, DOI 10.1159/000094484; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HAMBURGER V, 1980, ANNU REV NEUROSCI, V3, P269, DOI 10.1146/annurev.ne.03.030180.001413; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Jontes JD, 2004, J NEUROSCI, V24, P9027, DOI 10.1523/JNEUROSCI.5399-04.2004; Kalinovsky A, 2004, CURR OPIN NEUROBIOL, V14, P272, DOI 10.1016/j.conb.2004.05.011; Koenen M, 2005, EMBO REP, V6, P570, DOI 10.1038/sj.embor.7400429; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin YR, 2005, CRYST GROWTH DES, V5, P579, DOI 10.1021/cg049747h; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; MCLACHLAN EM, 1981, J PHYSIOL-LONDON, V311, P307, DOI 10.1113/jphysiol.1981.sp013586; McMahan Uel J., 1992, Current Opinion in Cell Biology, V4, P869, DOI 10.1016/0955-0674(92)90113-Q; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; WANG T, 1995, J NEUROSCI, V15, P4796; Wang ZZ, 2003, J NEUROSCI, V23, P5161; Xiong WC, 2005, NEURON, V46, P521, DOI 10.1016/j.neuron.2005.05.008; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007	50	98	102	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					262	268		10.1038/nn2053	http://dx.doi.org/10.1038/nn2053			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18278041				2022-12-24	WOS:000253548300008
J	Li, W; Piech, V; Gilbert, CD				Li, Wu; Piech, Valentin; Gilbert, Charles D.			Learning to link visual contours	NEURON			English	Article							STRIATE CORTEX; INTRINSIC CONNECTIONS; LATERAL INTERACTIONS; INTEGRATION; ORIENTATION; CAT; SPECIFICITY; EXPERIENCE; ATTENTION; SALIENCY	In complex visual scenes, linking related contour elements is important for object recognition. This process, thought to be stimulus driven and hard wired, has substrates in primary visual cortex (V1). Here, however, we find contour integration in V1 to depend strongly on perceptual learning and top-down influences that are specific to contour detection. In naive monkeys, the information about contours embedded in complex backgrounds is absent in V1 neuronal responses and is independent of the locus of spatial attention. Training animals to find embedded contours induces strong contour-related responses specific to the trained retinotopic region. These responses are most robust when animals perform the contour detection task but disappear under anesthesia. Our findings suggest that top-down influences dynamically adapt neural circuits according to specific perceptual tasks. This may serve as a general neuronal mechanism of perceptual learning and reflect top-down mediated changes in cortical states.	[Li, Wu; Piech, Valentin; Gilbert, Charles D.] Rockefeller Univ, New York, NY 10065 USA; [Li, Wu] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Rockefeller University; Beijing Normal University	Li, W (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.	liwu@bnu.edu.cn; gilbert@rockefeller.edu	Li, Wu/G-9415-2011; Li, Wu/AHA-4320-2022	Li, Wu/0000-0002-2175-4579; 	NEI NIH HHS [R01 EY007968-19, R01 EY007968-17, R01 EY007968-18, R01 EY007968, R01 EY007968-13, R01 EY007968-11, EY07968, R01 EY007968-15, R01 EY007968-14, R01 EY007968-12, R01 EY007968-16] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007968] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; Bauer R, 2002, EXP BRAIN RES, V147, P145, DOI 10.1007/s00221-002-1178-6; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Effron B, 1993, INTRO BOOTSTRAP; Ernst UA, 2004, NEUROCOMPUTING, V58, P971, DOI 10.1016/j.neucom.2004.01.154; Fahle M, 1997, VISION RES, V37, P1885, DOI 10.1016/S0042-6989(96)00308-2; Fahle M, 1996, CURR BIOL, V6, P292, DOI 10.1016/S0960-9822(02)00479-7; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Freeman E, 2001, NAT NEUROSCI, V4, P1032, DOI 10.1038/nn728; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Ipata AE, 2006, NAT NEUROSCI, V9, P1071, DOI 10.1038/nn1734; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kourtzi Z, 2005, PLOS BIOL, V3, P1317, DOI 10.1371/journal.pbio.0030204; Kovacs I, 1999, P NATL ACAD SCI USA, V96, P12204, DOI 10.1073/pnas.96.21.12204; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Lee TS, 2002, NAT NEUROSCI, V5, P589, DOI 10.1038/nn860; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Li W, 2002, J NEUROPHYSIOL, V88, P2846, DOI 10.1152/jn.00289.2002; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Li ZP, 1998, NEURAL COMPUT, V10, P903, DOI 10.1162/089976698300017557; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; POLAT U, 1994, P NATL ACAD SCI USA, V91, P1206, DOI 10.1073/pnas.91.4.1206; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; ROCKLAND KS, 1982, J COMP NEUROL, V209, P41, DOI 10.1002/cne.902090105; Roelfsema PR, 2006, ANNU REV NEUROSCI, V29, P203, DOI 10.1146/annurev.neuro.29.051605.112939; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Saffell T, 2003, VISION RES, V43, P1365, DOI 10.1016/S0042-6989(03)00137-8; Schmidt KE, 1997, EUR J NEUROSCI, V9, P1083, DOI 10.1111/j.1460-9568.1997.tb01459.x; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Shani R, 2005, VISION RES, V45, P2009, DOI 10.1016/j.visres.2005.01.024; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Sigman M, 2000, NAT NEUROSCI, V3, P264, DOI 10.1038/72979; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; ULLMAN S, 1984, COGNITION, V18, P97, DOI 10.1016/0010-0277(84)90023-4; ULLMAN S, 1992, PHILOS T ROY SOC B, V337, P371, DOI 10.1098/rstb.1992.0115; VanRullen R, 2001, NEUROCOMPUTING, V38, P1003, DOI 10.1016/S0925-2312(01)00445-3; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Yen SC, 1998, VISION RES, V38, P719, DOI 10.1016/S0042-6989(97)00197-1	47	155	161	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 7	2008	57	3					442	451		10.1016/j.neuron.2007.12.011	http://dx.doi.org/10.1016/j.neuron.2007.12.011			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261JQ	18255036	Bronze, Green Accepted			2022-12-24	WOS:000253075300013
J	Trounson, A; Harvey, RP				Trounson, Alan; Harvey, Richard P.			A critical time for stem cell research in Australia	CELL STEM CELL			English	Article							CRYOPRESERVATION; LEUKEMIA; EMBRYO	Australia's strong historical foundation in stem cell science was boosted in 2002 by the formation of a virtual government-supported institute now called the Australian Stem Cell Centre. However, the inevitable "brain drain" and government and community expectations of quick commercial gains and rapid cures necessitate careful reconsideration of the identity and future of stem cell science in Australia.	[Trounson, Alan] Monash Univ, Fac Med, Monash Immunol & Stem Cell Labs, Clayton, Vic 3800, Australia; [Harvey, Richard P.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; [Harvey, Richard P.] Univ New S Wales, Fac Sci, Kensington, NSW 2053, Australia; [Harvey, Richard P.] Univ New S Wales, Fac Med, Kensington, NSW 2053, Australia	Monash University; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of New South Wales Sydney	Trounson, A (corresponding author), Monash Univ, Fac Med, Monash Immunol & Stem Cell Labs, Clayton, Vic 3800, Australia.	atrounson@cirm.ca.gov		Trounson, Alan/0000-0001-5469-0500; Harvey, Richard/0000-0002-9950-9792				BARTLETT PF, 1982, P NATL ACAD SCI-BIOL, V79, P2722, DOI 10.1073/pnas.79.8.2722; DUHRSEN U, 1988, BLOOD, V72, P2074; Finkel E, 2005, STEM CELLS CONTROVER; GROUNDS MD, 1987, CELL TISSUE RES, V250, P563; METCALF D, 2000, DOGGED PURSUIT BLOOD; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sinclair AH, 2007, CELL, V128, P221, DOI 10.1016/j.cell.2007.01.008; Taylor RA, 2006, NAT METHODS, V3, P179, DOI 10.1038/nmeth855; TO LB, 1984, BRIT J HAEMATOL, V58, P399, DOI 10.1111/j.1365-2141.1984.tb03987.x; TROUNSON A, 1983, NATURE, V305, P707, DOI 10.1038/305707a0; TROUNSON AO, 1981, SCIENCE, V212, P681, DOI 10.1126/science.7221557; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0	13	4	4	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB	2008	2	2					118	122		10.1016/j.stem.2008.01.019	http://dx.doi.org/10.1016/j.stem.2008.01.019			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	264PW	18371432	Bronze			2022-12-24	WOS:000253301900007
J	Quilodran, R; Rothe, M; Procyk, E				Quilodran, Rene; Rothe, Marie; Procyk, Emmanuel			Behavioral shifts and action valuation in the anterior cingulate cortex	NEURON			English	Article							PREFRONTAL CORTEX; NEURONAL-ACTIVITY; DECISION-MAKING; PERFORMANCE; TASK; MECHANISMS; CONFLICT; DOPAMINE; MODULATION; SELECTION	Rapid optimization of behavior requires decisions about when to explore and when to exploit discovered resources. The mechanisms that lead to fast adaptations and their interaction with action valuation are a central issue. We show here that the anterior cingulate cortex (ACC) encodes multiple feedbacks devoted to exploration and its immediate termination. In a task that alternates exploration and exploitation periods, the ACC monitored negative and positive outcomes relevant for different adaptations. In particular, it produced signals specific of the first reward, i.e., the end of exploration. Those signals disappeared in exploitation periods but immediately transferred to the initiation of trials-a transfer comparable to learning phenomena observed for dopaminergic neurons. Importantly, these were also observed for high gamma oscillations of local field potentials shown to correlate with brain imaging signal. Thus, mechanisms of action valuation and monitoring of events/actions are combined for rapid behavioral regulation.	[Quilodran, Rene; Rothe, Marie; Procyk, Emmanuel] INSERM, Stem Cell & Brain Res Inst, U846, F-69500 Bron, France; [Quilodran, Rene; Rothe, Marie; Procyk, Emmanuel] Univ Lyon 1, UMR S 846, F-69003 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Procyk, E (corresponding author), INSERM, Stem Cell & Brain Res Inst, U846, F-69500 Bron, France.	procyk@lyon.inserm.fr	procyk, emmanuel/H-3037-2014	procyk, emmanuel/0000-0001-7486-4993				Akkal D, 2002, EUR J NEUROSCI, V15, P887, DOI 10.1046/j.1460-9568.2002.01920.x; Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Buzsaki G., 2006, RHYTHMS BRAIN; Cohen J. D., 2004, COGNITIVE NEUROSCIEN, P71; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; DAW ND, 2005, RECENT BREAKTHROUGHS; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Duncan J, 2006, Q J EXP PSYCHOL, V59, P2, DOI 10.1080/17470210500260674; Edwards E, 2005, J NEUROPHYSIOL, V94, P4269, DOI 10.1152/jn.00324.2005; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Haruno M, 2006, NEURAL NETWORKS, V19, P1242, DOI 10.1016/j.neunet.2006.06.007; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; Kawato M, 2007, CURR OPIN NEUROBIOL, V17, P205, DOI 10.1016/j.conb.2007.03.004; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kondo H, 2004, NEUROIMAGE, V23, P670, DOI 10.1016/j.neuroimage.2004.06.014; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Mainy N, 2007, HUM BRAIN MAPP, V28, P183, DOI 10.1002/hbm.20264; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Procyk E, 2006, J NEUROSCI, V26, P11313, DOI 10.1523/JNEUROSCI.2157-06.2006; Roelofs A, 2006, P NATL ACAD SCI USA, V103, P13884, DOI 10.1073/pnas.0606265103; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; SHIMA K, 1991, J NEUROPHYSIOL, V65, P188, DOI 10.1152/jn.1991.65.2.188; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tanaka S, 2006, NEUROSCIENCE, V139, P153, DOI 10.1016/j.neuroscience.2005.08.070; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Vidal F, 2003, BIOL PSYCHOL, V64, P265, DOI 10.1016/S0301-0511(03)00097-8; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339	51	225	226	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 24	2008	57	2					314	325		10.1016/j.neuron.2007.11.031	http://dx.doi.org/10.1016/j.neuron.2007.11.031			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256VQ	18215627	Green Submitted, Bronze			2022-12-24	WOS:000252758400014
J	Giraud, AL; Kleinschmidt, A; Poeppel, D; Lund, TE; Frackowiak, RSJ; Laufs, H				Giraud, Anne-Lise; Kleinschmidt, Andreas; Poeppel, David; Lund, Torben E.; Frackowiak, Richard S. J.; Laufs, Helmut			Endogenous cortical rhythms determine cerebral specialization for speech perception and production	NEURON			English	Article							HUMAN AUDITORY-CORTEX; TEMPORAL INTEGRATION; HESCHLS GYRUS; VISUAL-CORTEX; OSCILLATIONS; LANGUAGE; LATERALIZATION; NEURONS; ORGANIZATION; ASYMMETRIES	Across multiple timescales, acoustic regularities of speech match rhythmic properties of both the auditory and motor systems. Syllabic rate corresponds to natural jaw-associated oscillatory rhythms, and phonemic length could reflect endogenous oscillatory auditory cortical properties. Hemispheric lateralization for speech could result from an asymmetry of cortical tuning, with left and right auditory areas differentially sensitive to spectro-temporal features of speech. Using simultaneous electroencephalographic (EEG) and functional magnetic resonance imaging (fMRI) recordings from humans, we show that spontaneous EEG power variations within the gamma range (phonemic rate) correlate best with left auditory cortical synaptic activity, while fluctuations within the theta range correlate best with that in the right. Power fluctuations in both ranges correlate with activity in the mouth premotor region, indicating coupling between temporal properties of speech perception and production. These data show that endogenous cortical rhythms provide temporal and spatial constraints on the neuronal mechanisms underlying speech perception and production.	[Giraud, Anne-Lise; Frackowiak, Richard S. J.] INSERM, U742, F-75005 Paris, France; [Giraud, Anne-Lise; Frackowiak, Richard S. J.] Univ Paris 06, F-75005 Paris, France; [Giraud, Anne-Lise; Frackowiak, Richard S. J.] Ecole Normale Super, Dept Etudes Cognit, F-75005 Paris, France; [Giraud, Anne-Lise; Kleinschmidt, Andreas; Laufs, Helmut] Univ Frankfurt, Dept Neurol, D-60590 Frankfurt, Germany; [Kleinschmidt, Andreas] CEA, INSERM, U562, F-91091 Gif Sur Yvette, France; [Poeppel, David] Univ Maryland, Cognit Neurosci Language Lab, College Pk, MD 20742 USA; [Lund, Torben E.] Copenhagen Univ Hosp, Danish Res Ctr Magnet Resonance, Hvidovre 2650, Denmark; [Frackowiak, Richard S. J.] UCL, Inst Neurol, Wellcome Trust, London WC1 3BG, England; [Frackowiak, Richard S. J.] IRCCS Santa Lucia, I-00179 Rome, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Goethe University Frankfurt; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University System of Maryland; University of Maryland College Park; University of Copenhagen; University of London; University College London; IRCCS Santa Lucia	Giraud, AL (corresponding author), INSERM, U742, F-75005 Paris, France.	anne-lise.giraud@ens.fr	Laufs, Helmut/I-8562-2014; Lund, Torben E/B-1919-2008; Frackowiak, Richard/H-4383-2011; Lund, Torben Ellegaard/GSD-5936-2022; Frackowiak, Richard S/I-1809-2013	Laufs, Helmut/0000-0003-0030-2781; Lund, Torben E/0000-0002-9002-4676; Frackowiak, Richard/0000-0002-3151-822X; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bair W, 2004, J NEUROSCI, V24, P7305, DOI 10.1523/JNEUROSCI.0554-04.2004; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Dorsaint-Pierre R, 2006, BRAIN, V129, P1164, DOI 10.1093/brain/awl055; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Freeman WJ, 2005, NEURAL NETWORKS, V18, P497, DOI 10.1016/j.neunet.2005.06.014; Friederici AD, 2004, BRAIN LANG, V89, P267, DOI 10.1016/S0093-934X(03)00351-1; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; GENTILUCCI M, 2006, IN PRESS NEUROSCI BI; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hutsler J, 2003, TRENDS NEUROSCI, V26, P429, DOI 10.1016/S0166-2236(03)00198-X; Lagarde J, 2006, EXP BRAIN RES, V173, P673, DOI 10.1007/s00221-006-0410-1; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Laufs H, 2006, NEUROIMAGE, V31, P1408, DOI 10.1016/j.neuroimage.2006.02.002; Liberman AM, 2000, TRENDS COGN SCI, V4, P187, DOI 10.1016/S1364-6613(00)01471-6; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; MacNeilage PF, 2001, CURR OPIN NEUROBIOL, V11, P696, DOI 10.1016/S0959-4388(01)00271-9; MacNeilage PF, 2000, SCIENCE, V288, P527, DOI 10.1126/science.288.5465.527; Mandelkow H, 2006, NEUROIMAGE, V32, P1120, DOI 10.1016/j.neuroimage.2006.04.231; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Obleser J, 2006, HUM BRAIN MAPP, V27, P562, DOI 10.1002/hbm.20201; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Ross B, 2005, J NEUROPHYSIOL, V94, P4082, DOI 10.1152/jn.00469.2005; Saberi K, 1999, NATURE, V398, P760, DOI 10.1038/19652; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Traub RD, 2003, J NEUROPHYSIOL, V89, P909, DOI 10.1152/jn.00573.2002; Vertes RP, 2005, HIPPOCAMPUS, V15, P923, DOI 10.1002/hipo.20118; White LJ, 1998, J ACOUST SOC AM, V103, P2051, DOI 10.1121/1.421352; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	37	293	296	3	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 20	2007	56	6					1127	1134		10.1016/j.neuron.2007.09.038	http://dx.doi.org/10.1016/j.neuron.2007.09.038			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	248FP	18093532	Bronze			2022-12-24	WOS:000252138000019
J	Mani, M; Lee, SY; Lucast, L; Cremona, O; Di Paolo, G; De Camlli, P; Ryan, TA				Mani, Meera; Lee, Sang Yoon; Lucast, Louise; Cremona, Ottavio; Di Paolo, Gilbert; De Camlli, Pietro; Ryan, Timothy A.			The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals	NEURON			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; INOSITOL POLYPHOSPHATE 5-PHOSPHATASES; HIPPOCAMPAL SYNAPSES; COATED VESICLES; KNOCKOUT MICE; BINDING; MEMBRANE; DOMAIN; ENDOPHILIN; PROTEINS	Phosphoinositides have been implicated in synaptic vesicle recycling largely based on studies of enzymes that regulate phosphoinositide synthesis and hydrolysis. One such enzyme is synaptojanin1, a multifunctional protein conserved from yeast to humans, which contains two phosphoinositol phosphatase domains and a proline-rich domain. Genetic ablation of synaptojanin1 leads to pleiotropic defects in presynaptic function, including accumulation of free clathrin-coated vesicles and delayed vesicle reavailability, implicating this enzyme in postendocytic uncoating of vesicles. To further elucidate the role of synaptojanin1 at nerve terminals, we performed quantitative synaptic vesicle recycling assays in synj1(-/-) neurons. Our studies show that synaptojanin1 is also required for normal vesicle endocytosis. Defects in both endocytosis and postendocytic vesicle reavailability can be fully restored upon reintroduction of synaptojanin1. However, expression of synaptojanin1 with mutations abolishing catalytic activity of each phosphatase domain reveals that the dual action of both domains is required for normal synaptic vesicle internalization and reavailability.	[Lee, Sang Yoon; Ryan, Timothy A.] Ajou Univ, Sch Med, Chron Inflammat Dis Res Ctr, Suwon 441749, South Korea; [Mani, Meera; Ryan, Timothy A.] Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; [Lee, Sang Yoon; Lucast, Louise; Cremona, Ottavio; De Camlli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, New Haven, CT 06510 USA; [Lee, Sang Yoon; Lucast, Louise; Cremona, Ottavio; De Camlli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA; [Cremona, Ottavio] FIRC Inst Mol Oncol Fdn, IFOM, Milan, Italy; [Cremona, Ottavio] Univ Vita Salute San Raffaele, Milan, Italy; [Di Paolo, Gilbert] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, Dept Pathol & Cell Biol, New York, NY 10032 USA	Ajou University; Cornell University; Howard Hughes Medical Institute; Yale University; Yale University; IFOM - FIRC Institute of Molecular Oncology; Vita-Salute San Raffaele University; Columbia University	Ryan, TA (corresponding author), Ajou Univ, Sch Med, Chron Inflammat Dis Res Ctr, Suwon 441749, South Korea.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020; Cremona, Ottavio/AAB-8793-2019	Cremona, Ottavio/0000-0001-9462-1040; Ryan, Timothy/0000-0003-2533-9548	NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036942, R01NS036251, R01NS056049, R01NS036942, R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER; NCI NIH HHS [CA46128, P01 CA046128] Funding Source: Medline; NIDA NIH HHS [P30 DA018343] Funding Source: Medline; NIGMS NIH HHS [GM07739, T32 GM007739] Funding Source: Medline; NINDS NIH HHS [R01 NS056049, NS056049, R37 NS036942, R01 NS036942, R01 NS036251, R37 NS036251, NS036251, NS036942] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; BECK KA, 1991, J BIOL CHEM, V266, P4442; Brett TJ, 2006, CURR OPIN CELL BIOL, V18, P395, DOI 10.1016/j.ceb.2006.06.014; Cestra G, 1999, J BIOL CHEM, V274, P32001, DOI 10.1074/jbc.274.45.32001; CHANG MP, 1993, EMBO J, V12, P2169, DOI 10.1002/j.1460-2075.1993.tb05865.x; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Gong LW, 2005, P NATL ACAD SCI USA, V102, P5204, DOI 10.1073/pnas.0501412102; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Haucke V, 2005, BIOCHEM SOC T, V33, P1285, DOI 10.1042/BST0331285; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Hughes WE, 2000, BIOCHEM J, V350, P337, DOI 10.1042/0264-6021:3500337; Irie F, 2005, NAT CELL BIOL, V7, P501, DOI 10.1038/ncb1252; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jefferson AB, 1996, BIOCHEMISTRY-US, V35, P7890, DOI 10.1021/bi9602627; Khvotchev M, 1998, J BIOL CHEM, V273, P2306, DOI 10.1074/jbc.273.4.2306; Kim WT, 2002, P NATL ACAD SCI USA, V99, P17143, DOI 10.1073/pnas.222657399; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Luthi A, 2001, J NEUROSCI, V21, P9101, DOI 10.1523/JNEUROSCI.21-23-09101.2001; MCPHERSON PS, 1994, P NATL ACAD SCI USA, V91, P6486, DOI 10.1073/pnas.91.14.6486; MCPHERSON PS, 1994, J BIOL CHEM, V269, P30132; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Morgan JR, 2001, NEURON, V32, P289, DOI 10.1016/S0896-6273(01)00467-6; Nemoto Y, 2001, J BIOL CHEM, V276, P41133, DOI 10.1074/jbc.M106404200; Nemoto Y, 1997, J BIOL CHEM, V272, P30817, DOI 10.1074/jbc.272.49.30817; Perera RM, 2006, P NATL ACAD SCI USA, V103, P19332, DOI 10.1073/pnas.0609795104; Ramjaun AR, 1996, J BIOL CHEM, V271, P24856, DOI 10.1074/jbc.271.40.24856; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 2001, J BIOL CHEM, V276, P40424, DOI 10.1074/jbc.M106338200; Rusk N, 2003, CURR BIOL, V13, P659, DOI 10.1016/S0960-9822(03)00241-0; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Schweizer FE, 2006, CURR OPIN NEUROBIOL, V16, P298, DOI 10.1016/j.conb.2006.05.006; Shin HW, 2004, TRENDS BIOCHEM SCI, V29, P513, DOI 10.1016/j.tibs.2004.08.007; Stefan CJ, 2005, MOL CELL BIOL, V25, P2910, DOI 10.1128/MCB.25.8.2910-2923.2005; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Sun YD, 2007, J CELL BIOL, V177, P355, DOI 10.1083/jcb.200611011; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tsujishita Y, 2001, CELL, V105, P379, DOI 10.1016/S0092-8674(01)00326-9; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Van Epps HA, 2004, J NEUROSCI, V24, P8641, DOI 10.1523/JNEUROSCI.2892-04.2004; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Whisstock JC, 2000, J BIOL CHEM, V275, P37055, DOI 10.1074/jbc.M006244200; Whisstock JC, 2002, IUBMB LIFE, V53, P15, DOI 10.1080/15216540210814; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	66	130	132	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 20	2007	56	6					1004	1018		10.1016/j.neuron.2007.10.032	http://dx.doi.org/10.1016/j.neuron.2007.10.032			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	248FP	18093523	Green Accepted, Bronze			2022-12-24	WOS:000252138000010
J	Milenkovic, N; Frahm, C; Gassmann, M; Griffel, C; Erdmann, B; Birchmeier, C; Lewin, GR; Garratt, AN				Milenkovic, Nevena; Frahm, Christina; Gassmann, Max; Griffel, Carola; Erdmann, Bettina; Birchmeier, Carmen; Lewin, Gary R.; Garratt, Alistair N.			Nociceptive tuning by stem cell factor/c-Kit signaling	NEURON			English	Article							NERVE GROWTH-FACTOR; DORSAL-ROOT GANGLION; C-KIT; CAPSAICIN RECEPTOR; POSITIVE NEURONS; SENSORY NEURONS; ADULT-RAT; SENSITIZATION; EXPRESSION; MICE	The molecular mechanisms regulating the sensitivity of sensory circuits to environmental stimuli are poorly understood. We demonstrate here a central role for stem cell factor (SCF) and its receptor, c-Kit, in tuning the responsiveness of sensory neurons to natural stimuli. Mice lacking SCF/c-Kit signaling displayed profound thermal hypoalgesia, attributable to a marked elevation in the thermal threshold and reduction in spiking rate of heat-sensitive nociceptors. Acute activation of c-Kit by its ligand, SCF, resulted in a reduced thermal threshold and potentiation of heat-activated currents in isolated small-diameter neurons and thermal hyperalgesia in mice. SCF-induced thermal hyperalgesia required the TRIP family cation channel TRPV1. Lack of c-Kit signaling during development resulted in hypersensitivity of discrete mechanoreceptive neuronal subtypes. Thus, c-Kit can now be grouped with a small family of receptor tyrosine kinases, including c-Ret and TrkA, that control the transduction properties of sensory neurons.	[Milenkovic, Nevena; Frahm, Christina; Griffel, Carola; Erdmann, Bettina; Birchmeier, Carmen; Lewin, Gary R.; Garratt, Alistair N.] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Gassmann, Max] Univ Zurich, Vetsuisse Fac, CH-8057 Zurich, Switzerland; [Gassmann, Max] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Lewin, GR (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.	glewin@mdc-berlin.de; agarratt@mdc-berlin.de	Garratt, Alistair/AAG-2715-2021; Garratt, Alistair N/D-9893-2013; Garratt, Alistair/HGC-0774-2022; Lewin, Gary R/B-8028-2011	Garratt, Alistair N/0000-0001-9631-3041; Lewin, Gary/0000-0002-2890-6352; Gassmann, Max/0000-0003-2750-8878				Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Bennett DLH, 1998, EUR J NEUROSCI, V10, P1282, DOI 10.1046/j.1460-9568.1998.00139.x; Besmer P, 1991, CURR OPIN CELL BIOL, V3, P939, DOI 10.1016/0955-0674(91)90111-B; Bonnington JK, 2003, J PHYSIOL-LONDON, V551, P433, DOI 10.1113/jphysiol.2003.039990; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Campana WM, 2003, EUR J NEUROSCI, V18, P1497, DOI 10.1046/j.1460-9568.2003.02875.x; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005; DURHAN LM, 1911, MOL GEN GENET, V6, P93; Galoyan SM, 2003, EUR J NEUROSCI, V18, P535, DOI 10.1046/j.1460-9568.2003.02775.x; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; GOLDSTEIN ME, 1991, J NEUROSCI RES, V30, P92, DOI 10.1002/jnr.490300111; HAYASHI SI, 1991, NUCLEIC ACIDS RES, V19, P1267, DOI 10.1093/nar/19.6.1267; HIRATA T, 1993, DEVELOPMENT, V119, P49; HIRATA T, 1995, DEV BRAIN RES, V85, P201, DOI 10.1016/0165-3806(94)00205-E; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; KESHET E, 1991, EMBO J, V10, P2425, DOI 10.1002/j.1460-2075.1991.tb07782.x; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Kress M, 1999, J NEUROPHYSIOL, V81, P2612, DOI 10.1152/jn.1999.81.6.2612; KRUGER L, 1989, J COMP NEUROL, V280, P291, DOI 10.1002/cne.902800210; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; LEWIN GR, 1993, J NEUROSCI, V13, P2136; LEWIN GR, 1994, EUR J NEUROSCI, V6, P1903, DOI 10.1111/j.1460-9568.1994.tb00581.x; LEWIN GR, 1994, J NEUROPHYSIOL, V71, P941, DOI 10.1152/jn.1994.71.3.941; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; Little CC, 1915, AM NAT, V49, P727, DOI 10.1086/279516; Lourenssen S, 2000, NEUROREPORT, V11, P1159, DOI 10.1097/00001756-200004270-00004; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Malin SA, 2006, J NEUROSCI, V26, P8588, DOI 10.1523/JNEUROSCI.1726-06.2006; MOTRO B, 1991, DEVELOPMENT, V113, P1207; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Obreja O, 2005, BRAIN, V128, P1634, DOI 10.1093/brain/awh490; PETTY BG, 1994, ANN NEUROL, V36, P244, DOI 10.1002/ana.410360221; Ramer MS, 2001, J NEUROCHEM, V77, P864, DOI 10.1046/j.1471-4159.2001.00288.x; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; Rifaat O. M., 1954, Genetica, V27, P286, DOI 10.1007/BF01664163; Ruschitzka FT, 2000, P NATL ACAD SCI USA, V97, P11609, DOI 10.1073/pnas.97.21.11609; RUSSELL ELIZABETH S., 1959, JOUR HEREDITY, V50, P19; Shu XQ, 1999, NEUROSCI LETT, V274, P159, DOI 10.1016/S0304-3940(99)00701-6; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Stucky CL, 2002, J PHYSIOL-LONDON, V545, P43, DOI 10.1113/jphysiol.2002.027656; Tkaczyk C, 2004, BLOOD, V104, P207, DOI 10.1182/blood-2003-08-2769; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Waskow C, 2002, IMMUNITY, V17, P277, DOI 10.1016/S1074-7613(02)00386-2; Waskow C, 2002, ADV EXP MED BIOL, V512, P1; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; WOOLF CJ, 1994, NEUROSCIENCE, V62, P327, DOI 10.1016/0306-4522(94)90366-2; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	60	48	49	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2007	56	5					893	906		10.1016/j.neuron.2007.10.040	http://dx.doi.org/10.1016/j.neuron.2007.10.040			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241MA	18054864	Bronze			2022-12-24	WOS:000251659300014
J	Bangasser, DA; Shors, TJ				Bangasser, Debra A.; Shors, Tracey J.			The hippocampus is necessary for enhancements and impairments of learning following stress	NATURE NEUROSCIENCE			English	Article							EXPERIENCE; AMYGDALA; FEMALES; NUCLEUS; NEURONS; MALES	The hippocampus is often considered to be an important site for stress and learning interactions; however, it has never been demonstrated whether these effects require the hippocampus. In the current study, hippocampal lesions prevented both enhancements of learning after stress in male rats and impairments of learning after stress in female rats without disrupting learning itself in either sex. Thus, the hippocampus is necessary for modifying learning in males and females after acute stressful experience.	Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Shors, TJ (corresponding author), Rutgers State Univ, Dept Psychol, 152 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	shors@rutgers.edu	Bangasser, Debra A/F-9036-2012	Bangasser, Debra A/0000-0003-2951-4921	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG019957] Funding Source: NIH RePORTER; NIA NIH HHS [AG19957-06] Funding Source: Medline; NIMH NIH HHS [R01 MH059970-07, R01 MH059970-05, R01 MH059970-06] Funding Source: Medline; PHS HHS [59970] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bangasser DA, 2005, BEHAV NEUROSCI, V119, P1459, DOI 10.1037/0735-7044.119.6.1459; Beylin AV, 2003, HORM BEHAV, V43, P124, DOI 10.1016/S0018-506X(02)00025-9; Leuner B, 2004, BIOL PSYCHIAT, V56, P964, DOI 10.1016/j.biopsych.2004.09.018; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Roozendaal B, 2003, P NATL ACAD SCI USA, V100, P1328, DOI 10.1073/pnas.0337480100; SAPOLSKY RM, 1984, P NATL ACAD SCI-BIOL, V81, P6174, DOI 10.1073/pnas.81.19.6174; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Shors TJ, 2001, J NEUROSCI, V21, P6292, DOI 10.1523/JNEUROSCI.21-16-06292.2001; Shors TJ, 2001, NEUROBIOL LEARN MEM, V75, P10, DOI 10.1006/nlme.1999.3956; Shors TJ, 1998, LEARN MEMORY, V5, P220; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; Tuvnes FA, 2003, J NEUROSCI, V23, P4345; Weiss C, 2005, LEARN MEMORY, V12, P138, DOI 10.1101/lm.89005; Wood GE, 1998, P NATL ACAD SCI USA, V95, P4066, DOI 10.1073/pnas.95.7.4066	15	80	85	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1401	1403		10.1038/nn1973	http://dx.doi.org/10.1038/nn1973			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	225HT	17906620	Green Accepted			2022-12-24	WOS:000250508400016
J	Read, JCA; Cumming, BG				Read, Jenny C. A.; Cumming, Bruce G.			Sensors for impossible stimuli may solve the stereo correspondence problem	NATURE NEUROSCIENCE			English	Article							BINOCULAR DISPARITY; VISUAL-CORTEX; SURFACE ORIENTATION; NEURAL MECHANISMS; ENERGY-MODEL; DEPTH; MACAQUE; NEURONS; POSITION; SELECTIVITY	One of the fundamental challenges of binocular vision is that objects project to different positions on the two retinas ( binocular disparity). Neurons in visual cortex show two distinct types of tuning to disparity, position and phase disparity, which are the results of differences in receptive field location and profile, respectively. Here, we point out that phase disparity does not occur in natural images. Why, then, should the brain encode it? We propose that phase-disparity detectors help to work out which feature in the left eye corresponds to a given feature in the right. This correspondence problem is plagued by false matches: regions of the image that look similar, but do not correspond to the same object. We show that phase-disparity neurons tend to be more strongly activated by false matches. Thus, they may act as 'lie detectors', enabling the true correspondence to be deduced by a process of elimination.	Univ Newcastle, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Read, JCA (corresponding author), Univ Newcastle, Inst Neurosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	j.c.a.read@ncl.ac.uk	Read, Jenny/A-7493-2013	Read, Jenny/0000-0002-9029-5185	NATIONAL EYE INSTITUTE [Z01EY000404] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 EY000404-06, NIH0013247660] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Anzai A, 1997, P NATL ACAD SCI USA, V94, P5438, DOI 10.1073/pnas.94.10.5438; Anzai A, 1999, J NEUROPHYSIOL, V82, P874, DOI 10.1152/jn.1999.82.2.874; Bredfeldt CE, 2006, J NEUROSCI, V26, P7581, DOI 10.1523/JNEUROSCI.5308-05.2006; Chen YH, 2004, NEURAL COMPUT, V16, P1545, DOI 10.1162/089976604774201596; COGAN AI, 1993, VISION RES, V33, P1959, DOI 10.1016/0042-6989(93)90021-N; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; Cumming BG, 1998, PERCEPTION, V27, P1367, DOI 10.1068/p271367; DEANGELIS GC, 1991, NATURE, V352, P156, DOI 10.1038/352156a0; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Fleet DJ, 1996, VISION RES, V36, P1839, DOI 10.1016/0042-6989(95)00313-4; FLEET DJ, 1994, 1994 IEEE INTERNATIONAL CONFERENCE ON SYSTEMS, MAN, AND CYBERNETICS - HUMANS, INFORMATION AND TECHNOLOGY, VOLS 1-3, P48, DOI 10.1109/ICSMC.1994.399810; FREEMAN RD, 1990, VISION RES, V30, P1661, DOI 10.1016/0042-6989(90)90151-A; HAEFNER R, 2005, SOC NEUROSCI ABSTR, V583; Hinkle DA, 2002, NAT NEUROSCI, V5, P665, DOI 10.1038/nn875; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; JEPSON AD, 1989, P CVPR 89 IEEE COMP, P389; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Livingstone MS, 1999, NAT NEUROSCI, V2, P825, DOI 10.1038/12199; MARR D, 1979, PROC R SOC SER B-BIO, V204, P301, DOI 10.1098/rspb.1979.0029; Nguyenkim JD, 2003, J NEUROSCI, V23, P7117, DOI 10.1523/JNEUROSCI.23-18-07117.2003; Nienborg H, 2004, J NEUROSCI, V24, P2065, DOI 10.1523/JNEUROSCI.3887-03.2004; Ning QA, 1997, NEURON, V18, P359, DOI 10.1016/S0896-6273(00)81238-6; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Orban GA, 2006, TRENDS NEUROSCI, V29, P466, DOI 10.1016/j.tins.2006.06.012; PARKER AJ, 1991, NATURE, V352, P109, DOI 10.1038/352109a0; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; POGGIO GF, 1985, VISION RES, V25, P397, DOI 10.1016/0042-6989(85)90065-3; Prince SJD, 1999, P ROY SOC B-BIOL SCI, V266, P1361, DOI 10.1098/rspb.1999.0788; Prince SJD, 1998, PERCEPTION, V27, P1345, DOI 10.1068/p271345; Prince SJD, 2000, VISION RES, V40, P1143, DOI 10.1016/S0042-6989(99)00241-2; Prince SJD, 2002, J NEUROPHYSIOL, V87, P209, DOI 10.1152/jn.00466.2000; QIAN N, 1994, NEURAL COMPUT, V6, P390, DOI 10.1162/neco.1994.6.3.390; Qian N, 1997, VISION RES, V37, P1811, DOI 10.1016/S0042-6989(96)00331-8; Read JCA, 2004, J NEUROPHYSIOL, V91, P1271, DOI 10.1152/jn.00588.2003; Read JCA, 2003, J NEUROPHYSIOL, V90, P2795, DOI 10.1152/jn.01110.2002; Read JCA, 2002, NEURAL COMPUT, V14, P1371, DOI 10.1162/089976602753712981; Read JCA, 2002, BIOL CYBERN, V86, P117, DOI 10.1007/s004220100280; ROGERS BJ, 1975, PERCEPTION, V4, P193, DOI 10.1068/p040193; ROHALY AM, 1993, J OPT SOC AM A, V10, P2433, DOI 10.1364/JOSAA.10.002433; SANGER TD, 1988, BIOL CYBERN, V59, P405, DOI 10.1007/BF00336114; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; Smallman HS, 1997, PERCEPTION, V26, P977, DOI 10.1068/p260977; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Tsai JJ, 2003, VISION RES, V43, P445, DOI 10.1016/S0042-6989(02)00510-2; TYLER CW, 1974, NATURE, V251, P140, DOI 10.1038/251140a0; von der Heydt R, 2000, VISION RES, V40, P1955, DOI 10.1016/S0042-6989(00)00044-4	46	64	69	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1322	1328		10.1038/nn1951	http://dx.doi.org/10.1038/nn1951			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828262	Green Accepted			2022-12-24	WOS:000249720800020
J	Deouell, LY; Heller, AS; Malach, R; D'Esposito, M; Knight, RT				Deouell, Leon Y.; Heller, Aaron S.; Malach, Rafael; D'Esposito, Mark; Knight, Robert T.			Cerebral responses to change in spatial location of unattended sounds	NEURON			English	Article							EVENT-RELATED POTENTIALS; AUDITORY CHANGE-DETECTION; MISMATCH NEGATIVITY; PLANUM TEMPORALE; CORTICAL-NEURONS; INTERAURAL TIME; SENSORY MEMORY; HUMAN BRAIN; CORTEX; LOCALIZATION	The neural basis of spatial processing in the auditory cortex has been controversial. Human fMRI studies suggest that a part of the planum temporale (PT) is involved in auditory spatial processing, but it was recently argued that this region is active only when the task requires voluntary spatial localization. If this is the case, then this region cannot harbor an ongoing spatial representation of the acoustic environment. In contrast, we show in three fMRI experiments that a region in the human medial PT is sensitive to background auditory spatial changes, even when subjects are not engaged in a spatial localization task, and in fact attend the visual modality. During such times, this area responded to rare location shifts, and even more so when spatial variation increased, consistent with spatially selective adaptation. Thus, acoustic space is represented in the human PT even when sound processing is not required by the ongoing task.	Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, Dept Psychol, IL-91905 Jerusalem, Israel; Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Psychol, Berkeley, CA 94720 USA; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; University of California System; University of California Berkeley; Weizmann Institute of Science	Deouell, LY (corresponding author), Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, Dept Psychol, IL-91905 Jerusalem, Israel.	msleon@huji.ac.il	Deouell, Leon Y./W-9624-2019	Heller, Aaron/0000-0002-0680-3248	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021135] Funding Source: NIH RePORTER; NINDS NIH HHS [NS21135] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adriani M, 2003, EXP BRAIN RES, V153, P591, DOI 10.1007/s00221-003-1616-0; Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Belin P, 2000, NAT NEUROSCI, V3, P965, DOI 10.1038/79890; Brechmann A, 2005, CEREB CORTEX, V15, P578, DOI 10.1093/cercor/bhh159; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Brunetti M, 2005, HUM BRAIN MAPP, V26, P251, DOI 10.1002/hbm.20164; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; Clarke S, 2002, EXP BRAIN RES, V147, P8, DOI 10.1007/s00221-002-1203-9; Csepe V, 2001, NEUROPSYCHOLOGIA, V39, P1194, DOI 10.1016/S0028-3932(01)00052-5; Deacon D, 1998, PSYCHOPHYSIOLOGY, V35, P413, DOI 10.1017/S004857729896053X; Deouell LY, 2006, EUR J NEUROSCI, V24, P1488, DOI 10.1111/j.1460-9568.2006.05025.x; Deouell LY, 1998, PSYCHOPHYSIOLOGY, V35, P745, DOI 10.1111/1469-8986.3560745; Deouell LY, 2000, BRAIN, V123, P353, DOI 10.1093/brain/123.2.353; Deouell LY, 2003, NEUROSCI LETT, V335, P171, DOI 10.1016/S0304-3940(02)01189-8; DEOUELL LY, 2007, IN PRESS J PSYCHOLPH; Dittmann-Balcar A, 2001, NEUROSCI LETT, V308, P119, DOI 10.1016/S0304-3940(01)01995-4; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; GIARD MH, 1995, J COGNITIVE NEUROSCI, V7, P133, DOI 10.1162/jocn.1995.7.2.133; Griffiths TD, 2004, TRENDS NEUROSCI, V27, P181, DOI 10.1016/j.tins.2004.02.005; Griffiths TD, 1999, NEUROIMAGE, V10, P84, DOI 10.1006/nimg.1999.0464; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hammershoi D, 2002, ACTA ACUST UNITED AC, V88, P303; Ilvonen TM, 2001, PSYCHOPHYSIOLOGY, V38, P622, DOI 10.1017/S0048577201000117; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; Krumbholz K, 2005, CEREB CORTEX, V15, P317, DOI 10.1093/cercor/bhh133; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Middlebrooks JC, 2002, NEUROSCIENTIST, V8, P73, DOI 10.1177/107385840200800112; Middlebrooks JC, 2002, NAT NEUROSCI, V5, P824, DOI 10.1038/nn0902-824; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Moller H, 1996, J AUDIO ENG SOC, V44, P451; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; NAATANEN R, 1991, PSYCHOPHYSIOLOGY, V28, P478, DOI 10.1111/j.1469-8986.1991.tb00735.x; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Naatanen R., 2018, ATTENTION BRAIN FUNC; Opitz B, 2005, EUR J NEUROSCI, V21, P531, DOI 10.1111/j.1460-9568.2005.03839.x; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Opitz B, 1999, PSYCHOPHYSIOLOGY, V36, P142, DOI 10.1017/S0048577299980848; Pavani F, 2002, CURR BIOL, V12, P1584, DOI 10.1016/S0960-9822(02)01143-0; Poremba A, 2003, SCIENCE, V299, P568, DOI 10.1126/science.1078900; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1997, ACTA OTO-LARYNGOL, P34; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; Rinne T, 2005, NEUROIMAGE, V26, P66, DOI 10.1016/j.neuroimage.2005.01.017; Rinne T, 2007, NEUROSCI LETT, V416, P247, DOI 10.1016/j.neulet.2007.01.077; RITTER W, 1995, EAR HEARING, V16, P52, DOI 10.1097/00003446-199502000-00005; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Rosburg T, 2003, COGNITIVE BRAIN RES, V16, P83, DOI 10.1016/S0926-6410(02)00222-7; Schroger E, 1996, NEUROREPORT, V7, P3005, DOI 10.1097/00001756-199611250-00041; Schroger E, 1996, HEARING RES, V96, P191, DOI 10.1016/0378-5955(96)00066-4; SCHROGER E, 1995, PSYCHOPHYSIOLOGY, V32, P55, DOI 10.1111/j.1469-8986.1995.tb03406.x; SEMPLE MN, 1983, HEARING RES, V10, P203, DOI 10.1016/0378-5955(83)90054-0; Shalgi S, 2007, NEUROPSYCHOLOGIA, V45, P1878, DOI 10.1016/j.neuropsychologia.2006.11.023; Smith KR, 2004, NEUROREPORT, V15, P1523, DOI 10.1097/01.wnr.0000130233.43788.4b; Sonnadara RR, 2006, BRAIN RES, V1071, P175, DOI 10.1016/j.brainres.2005.11.088; Stecker GC, 2003, J NEUROPHYSIOL, V89, P2889, DOI 10.1152/jn.00980.2002; Sussman E, 2003, PSYCHOPHYSIOLOGY, V40, P430, DOI 10.1111/1469-8986.00045; Tata MS, 2005, NEUROPSYCHOLOGIA, V43, P509, DOI 10.1016/j.neuropsychologia.2004.07.019; Tervaniemi M, 2000, HUM BRAIN MAPP, V10, P74, DOI 10.1002/(SICI)1097-0193(200006)10:2<74::AID-HBM30>3.0.CO;2-2; Thompson SK, 2006, NAT NEUROSCI, V9, P1096, DOI 10.1038/nn1755; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Warren JD, 2003, J NEUROSCI, V23, P5799; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Warren JE, 2005, TRENDS NEUROSCI, V28, P636, DOI 10.1016/j.tins.2005.09.010; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Woldorff MG, 1998, PSYCHOPHYSIOLOGY, V35, P283, DOI 10.1017/S0048577298961601; WOLDORFF MG, 1991, PSYCHOPHYSIOLOGY, V28, P30, DOI 10.1111/j.1469-8986.1991.tb03384.x; Woldorff MG, 1999, HUM BRAIN MAPP, V7, P49, DOI 10.1002/(SICI)1097-0193(1999)7:1<49::AID-HBM5>3.3.CO;2-A; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904; Zimmer U, 2006, NEUROPSYCHOLOGIA, V44, P454, DOI 10.1016/j.neuropsychologia.2005.05.021; Zimmer U, 2005, NEURON, V47, P893, DOI 10.1016/j.neuron.2005.07.019	83	85	87	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 20	2007	55	6					985	996		10.1016/j.neuron.2007.08.019	http://dx.doi.org/10.1016/j.neuron.2007.08.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	219IQ	17880900	Bronze			2022-12-24	WOS:000250078500014
J	Nikonov, SS; Brown, BM; Davis, JA; Zuniga, FI; Bragin, A; Pugh, EN; Craft, CM				Nikonov, Sergei S.; Brown, Bruce M.; Davis, Jason A.; Zuniga, Freddi I.; Bragin, Alvina; Pugh, Edward N., Jr.; Craft, Cheryl M.			Mouse cones require an arrestin for normal inactivation of phototransduction	NEURON			English	Article							PHOTORECEPTOR CELLS; 48-KDA PROTEIN; LIGHT; EXPRESSION; RHODOPSIN; MICE; PHOSPHORYLATION; TRANSLOCATION; EVOLUTION; KINETICS	Arrestins are proteins that arrest the activity of G protein-coupled receptors (GPCRs). While it is well established that normal inactivation of photoexcited rhodopsin, the GPCR of rod phototransduction, requires arrestin (Arr1), it has been controversial whether the same requirement holds for cone opsin inactivation. Mouse cone photoreceptors express two distinct visual arrestins: Arr1 and Arr4. By means of recordings from cones of mice with one or both arrestins knocked out, this investigation establishes that a visual arrestin is required for normal cone inactivation. Arrestin-independent inactivation is 70-fold more rapid in cones than in rods, however. Dual arrestin expression in cones could be a holdover from ancient genome duplication events that led to multiple isoforms of arrestin, allowing evolutionary specialization of one form while the other maintains the basic function.	[Nikonov, Sergei S.; Davis, Jason A.; Bragin, Alvina; Pugh, Edward N., Jr.] Univ Penn, Dept Ophthalmol, Sch Med, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Brown, Bruce M.; Zuniga, Freddi I.; Craft, Cheryl M.] Doheny Eye Inst, Mary D Allen Lab Vis Res, Los Angeles, CA 90033 USA; [Brown, Bruce M.; Zuniga, Freddi I.; Craft, Cheryl M.] Univ So Calif, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Craft, Cheryl M.] Univ So Calif, Dept Cell & Neurobiol, Keck Sch Med, Los Angeles, CA 90033 USA	University of Pennsylvania; Pennsylvania Medicine; Doheny Eye Institute; University of Southern California; University of Southern California	Pugh, EN (corresponding author), Univ Penn, Dept Ophthalmol, Sch Med, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA.	pugh@mail.med.upenn.edu; ccraft@usc.edu			RPB Foundation; Fred and Dorie Miller and the William Hansen Sandberg Memorial Foundation; Paul and Evanina Bell Mackall Foundation Trust;  [EY015851];  [GM799102];  [EY03040];  [EY02660];  [EY016453]; NATIONAL EYE INSTITUTE [R01EY015851, P30EY003040, R01EY002660, R01EY016453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM079910] Funding Source: NIH RePORTER	RPB Foundation; Fred and Dorie Miller and the William Hansen Sandberg Memorial Foundation; Paul and Evanina Bell Mackall Foundation Trust; ; ; ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge Drs. Xuemei Zhu, Marie Burns, Lauren Daniele, Jon Peet, Jasmine Zhao, Kebin Wu, and Rosanne Yetemian for their scientific contributions to this work and thank Drs. Jeannie Chen for Arr1<SUP>-/-</SUP> mice and Larry A. Donoso for the D9F2 antibody. C.M.C. is the Mary D. Allen Chair in Vision Research, Doheny Eye Institute (DEI) and Research to Prevent Blindness Senior Scientific Investigator. E.N.P.Jr. is Jules and Doris Stein Research to Prevent Blindness Professor. Support: EY015851 (C.M.C.), GM799102 (F.I.Z. and C.M.C.), EY03040 (DEI NIH Core Grant), EY02660, EY016453 (E.N.P.Jr.), RPB Foundation (C.M.C. and E.N.P.Jr.); Fred and Dorie Miller and the William Hansen Sandberg Memorial Foundation (C.M.C.), and the Paul and Evanina Bell Mackall Foundation Trust (E.N.P.Jr.).	Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chan S, 2007, INVEST OPHTH VIS SCI, V48, P1968, DOI 10.1167/iovs.06-1287; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chen CK, 2001, MOL VIS, V7, P305; Chen J, 1999, INVEST OPHTH VIS SCI, V40, P2978; CRAFT CM, 1994, J BIOL CHEM, V269, P4613; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Elias R, 2004, MOL VIS, V10, P672; Fersht AR., 1977, ENZYME STRUCTURE MEC; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hays WL., 1963, STAT PSYCHOLOGISTS; Horie T, 2005, J NEUROBIOL, V65, P241, DOI 10.1002/neu.20197; Jeon CJ, 1998, J NEUROSCI, V18, P8936; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Lyubarsky AL, 2002, VISION RES, V42, P401, DOI 10.1016/S0042-6989(01)00214-0; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Nikonov SS, 2005, J GEN PHYSIOL, V125, P287, DOI 10.1085/jgp.200409208; Nordstrom K, 2004, GENOMICS, V83, P852, DOI 10.1016/j.ygeno.2003.11.008; Peet JA, 2004, J CELL SCI, V117, P3049, DOI 10.1242/jcs.01167; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; Pierce EA, 1999, NAT GENET, V22, P248, DOI 10.1038/10305; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Reichenbach A, 1995, PROG RETIN EYE RES, V15, P139, DOI 10.1016/1350-9462(95)00008-9; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; Sidow A, 1996, CURR OPIN GENET DEV, V6, P715, DOI 10.1016/S0959-437X(96)80026-8; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Zhu XJ, 2005, INVEST OPHTH VIS SCI, V46; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003; Zhu XM, 2002, MOL VIS, V8, P462; Zhu XM, 2002, FEBS LETT, V524, P116, DOI 10.1016/S0014-5793(02)03014-4	41	104	104	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 14	2008	59	3					462	474		10.1016/j.neuron.2008.06.011	http://dx.doi.org/10.1016/j.neuron.2008.06.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	339GG	18701071	Bronze, Green Accepted			2022-12-24	WOS:000258565500014
J	Suh, YH; Pelkey, KA; Lavezzari, G; Roche, PA; Huganir, RL; McBain, CJ; Roche, KW				Suh, Young Ho; Pelkey, Kenneth A.; Lavezzari, Gabriela; Roche, Paul A.; Huganir, Richard L.; McBain, Chris J.; Roche, Katherine W.			Corequirement of PICK1 binding and PKC phosphorylation for stable surface expression of the metabotropic glutamate receptor mGluR7	NEURON			English	Article							LONG-TERM DEPRESSION; PROTEIN-COUPLED RECEPTORS; AMPA RECEPTORS; CA2+-DEPENDENT INACTIVATION; PRESYNAPTIC LOCALIZATION; SYNAPTIC-TRANSMISSION; SUBUNIT GLUR2; CALMODULIN; ALPHA; GLUTAMATE-RECEPTOR-7	The presynaptic metabotropic glutamate receptor (mGluR) mGluR7 modulates excitatory neurotransmission by regulating neurotransmitter release and plays a critical role in certain forms of synaptic plasticity. Although the dynamic regulation of mGluR7 surface expression governs a form of metaplasticity in the hippocampus, little is known about the molecular mechanisms regulating mGluR7 trafficking. We now show that mGluR7 surface expression is stabilized by both PKC phosphorylation and by receptor binding to the PDZ domain-containing protein PICK1. Phosphorylation of mGluR7 on serine 862 (S862) inhibits CaM binding, thereby increasing mGluR7 surface expression and receptor binding to PICK1. Furthermore, in mice lacking PICK1, PKC-dependent increases in mGluR7 phosphorylation and surface expression are diminished, and mGluR7-dependent plasticity at mossy fiber-interneuron hippocampal synapses is impaired. These data support a model in which PICK1 binding and PKC phosphorylation act together to stabilize mGluR7 on the cell surface in vivo.	[Suh, Young Ho; Lavezzari, Gabriela; Roche, Katherine W.] Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA; [Suh, Young Ho; Roche, Paul A.] NCI, Bethesda, MD 20892 USA; [Pelkey, Kenneth A.; McBain, Chris J.] NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Howard Hughes Medical Institute; Johns Hopkins University	Roche, KW (corresponding author), Natl Inst Neurol Disorders & Stroke, Bethesda, MD 20892 USA.	rochek@ninds.nih.gov	Roche, Katherine/W-9893-2019; Suh, Young Ho/AAJ-6405-2021	Suh, Young Ho/0000-0003-3979-1615; Roche, Paul/0000-0002-8949-9172; Roche, Katherine/0000-0001-7282-6539	Intramural NIH HHS [Z01 NS003036-01, Z99 NS999999] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC009404, ZIABC011035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003036] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Airas JM, 2001, FEBS LETT, V494, P60, DOI 10.1016/S0014-5793(01)02311-0; Ayala JE, 2008, NEUROPHARMACOLOGY, V54, P804, DOI 10.1016/j.neuropharm.2007.12.009; Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Boudin H, 2001, J BIOL CHEM, V276, P30270, DOI 10.1074/jbc.M102991200; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chavis P, 1998, NEURON, V20, P773, DOI 10.1016/S0896-6273(00)81015-6; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Coutinho V, 2002, NEUROSCIENTIST, V8, P551, DOI 10.1177/1073858402238514; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 2001, TRENDS PHARMACOL SCI, V22, P355, DOI 10.1016/S0165-6147(00)01684-9; Dev KK, 2000, J NEUROSCI, V20, P7252; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; El Far O, 2002, BIOCHEM J, V365, P329, DOI 10.1042/BJ20020481; El Far O, 2001, J BIOL CHEM, V276, P30662, DOI 10.1074/jbc.M102573200; El Far O, 2000, EUR J NEUROSCI, V12, P4215, DOI 10.1046/j.1460-9568.2000.01309.x; Enz R, 2003, BIOCHEM J, V372, P183, DOI 10.1042/BJ20021750; Fagni L, 2004, SEMIN CELL DEV BIOL, V15, P289, DOI 10.1016/j.semcdb.2003.12.018; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; Hanley JG, 2006, BIOCHEM SOC T, V34, P931, DOI 10.1042/BST0340931; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hirbec H, 2002, J BIOL CHEM, V277, P15221, DOI 10.1074/jbc.C200112200; Ho MTW, 2007, J NEUROSCI, V27, P11651, DOI 10.1523/JNEUROSCI.2671-07.2007; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kinoshita A, 1998, J COMP NEUROL, V393, P332; Laezza F, 1999, SCIENCE, V285, P1411, DOI 10.1126/science.285.5432.1411; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Lavezzari G, 2007, NEUROPHARMACOLOGY, V52, P100, DOI 10.1016/j.neuropharm.2006.07.011; Lei SB, 2004, J NEUROSCI, V24, P2112, DOI 10.1523/JNEUROSCI.4645-03.2004; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Nakajima Y, 1999, J BIOL CHEM, V274, P27573, DOI 10.1074/jbc.274.39.27573; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; Ohishi H, 1995, NEUROSCI LETT, V202, P85, DOI 10.1016/0304-3940(95)12207-9; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; PELKEY KA, 2007, J PHYSL, V586, P1495; Pelkey KA, 2007, NEUROPHARMACOLOGY, V52, P108, DOI 10.1016/j.neuropharm.2006.07.020; Pelkey KA, 2006, NEURON, V52, P497, DOI 10.1016/j.neuron.2006.08.032; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Perroy J, 2000, J NEUROSCI, V20, P7896; Perroy J, 2002, EMBO J, V21, P2990, DOI 10.1093/emboj/cdf313; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; PIN JP, 1995, CURR OPIN NEUROBIOL, V5, P342, DOI 10.1016/0959-4388(95)80047-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; Saugstad JA, 2002, J NEUROCHEM, V80, P980, DOI 10.1046/j.0022-3042.2002.00778.x; Schoepp DD, 2001, J PHARMACOL EXP THER, V299, P12; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Sorensen SD, 2002, MOL PHARMACOL, V61, P1303, DOI 10.1124/mol.61.6.1303; Sossa KG, 2006, MOL CELL NEUROSCI, V31, P574, DOI 10.1016/j.mcn.2005.11.011; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3	68	60	60	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 12	2008	58	5					736	748		10.1016/j.neuron.2008.03.028	http://dx.doi.org/10.1016/j.neuron.2008.03.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	315IA	18549785	Bronze, Green Accepted			2022-12-24	WOS:000256870800011
J	Cueni, L; Canepari, M; Lujan, R; Emmenegger, Y; Watanabe, M; Bond, CT; Franken, P; Adelman, JP; Luthi, A				Cueni, Lucius; Canepari, Marco; Lujan, Rafael; Emmenegger, Yann; Watanabe, Masahiko; Bond, Chris T.; Franken, Paul; Adelman, John P.; Luthi, Anita			T-type Ca2+ channels, SK2 channels and SERCAs gate sleep-related oscillations in thalamic dendrites	NATURE NEUROSCIENCE			English	Article							CA2+-ACTIVATED K+ CHANNELS; SMALL-CONDUCTANCE; POTASSIUM CHANNELS; DIFFERENTIAL DISTRIBUTION; RETICULAR NUCLEUS; IN-VITRO; NEURONS; MODULATION; CURRENTS; DETERMINANTS	T-type Ca2+ channels (T channels) underlie rhythmic burst discharges during neuronal oscillations that are typical during sleep. However, the Ca2+-dependent effectors that are selectively regulated by T currents remain unknown. We found that, in dendrites of nucleus reticularis thalami (nRt), intracellular Ca2+ concentration increases were dominated by Ca2+ influx through T channels and shaped rhythmic bursting via competition between Ca2+-dependent small-conductance (SK)-type K1 channels and Ca2+ uptake pumps. Oscillatory bursting was initiated via selective activation of dendritically located SK2 channels, whereas Ca2+ sequestration by sarco/endoplasmic reticulum Ca2+-ATPases (SERCAs) and cumulative T channel inactivation dampened oscillations. Sk2(-/-) (also known as Kcnn2) mice lacked cellular oscillations, showed a greater than threefold reduction in low-frequency rhythms in the electroencephalogram of non-rapid-eye-movement sleep and had disrupted sleep. Thus, the interplay of T channels, SK2 channels and SERCAs in nRt dendrites comprises a specialized Ca2+ signaling triad to regulate oscillatory dynamics related to sleep.	[Cueni, Lucius; Canepari, Marco; Luthi, Anita] Univ Basel, Div Pharmacol & Neurobiol Biozentrum, CH-4056 Basel, Switzerland; [Lujan, Rafael] Univ Castilla La Mancha, Crib Fac Med, Dept Ciencias Med, Albacete 02006, Spain; [Emmenegger, Yann; Franken, Paul] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Bond, Chris T.; Adelman, John P.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Luthi, Anita] Univ Lausanne, Fac Biol & Med, Dept Cell Biol & Morphol, CH-1005 Lausanne, Switzerland	University of Basel; Universidad de Castilla-La Mancha; University of Lausanne; Hokkaido University; Oregon Health & Science University; University of Lausanne	Luthi, A (corresponding author), Univ Basel, Div Pharmacol & Neurobiol Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	anita.luthi@unil.ch	Lujan, Rafael/G-2555-2015; Watanabe, Masahiko/S-3614-2019; Luthi, Anita/ABE-1411-2021; Canepari, Marco/AAJ-6709-2021; Canepari, Marco/H-6772-2012; WATANABE, Masahiko/A-4055-2012; Franken, Paul/A-9633-2018	Watanabe, Masahiko/0000-0001-5037-7138; Canepari, Marco/0000-0001-9759-2388; Canepari, Marco/0000-0001-9759-2388; WATANABE, Masahiko/0000-0001-5037-7138; Franken, Paul/0000-0002-2500-2921; Lujan Miras, Rafael/0000-0003-2001-9545; Luthi, Anita/0000-0002-4954-4143				AMZICA F, 1992, NEUROSCIENCE, V51, P285, DOI 10.1016/0306-4522(92)90315-S; AVANZINI G, 1989, J PHYSIOL-LONDON, V416, P111, DOI 10.1113/jphysiol.1989.sp017752; BAL T, 1993, J PHYSIOL-LONDON, V468, P669, DOI 10.1113/jphysiol.1993.sp019794; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Blethyn KL, 2006, J NEUROSCI, V26, P2474, DOI 10.1523/JNEUROSCI.3607-05.2006; Bond CT, 2005, CURR OPIN NEUROBIOL, V15, P305, DOI 10.1016/j.conb.2005.05.001; Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Canepari M, 2004, J NEUROSCI, V24, P3563, DOI 10.1523/JNEUROSCI.5374-03.2004; Contreras D, 2006, CNS NEUROL DISORD-DR, V5, P571, DOI 10.2174/187152706779025526; Crunelli V, 2006, CELL CALCIUM, V40, P175, DOI 10.1016/j.ceca.2006.04.022; Cui GH, 2004, J NEUROSCI, V24, P11079, DOI 10.1523/JNEUROSCI.2713-04.2004; Debarbieux F, 1998, J NEUROPHYSIOL, V79, P2911, DOI 10.1152/jn.1998.79.6.2911; Destexhe A, 1996, J NEUROSCI, V16, P169; Diana MA, 2007, J NEUROSCI, V27, P3823, DOI 10.1523/JNEUROSCI.4719-06.2007; DOMICH L, 1986, J PHYSIOL-LONDON, V379, P429, DOI 10.1113/jphysiol.1986.sp016262; Egger V, 2003, J NEUROSCI, V23, P7551; Fierro L, 1998, J PHYSIOL-LONDON, V510, P499, DOI 10.1111/j.1469-7793.1998.499bk.x; Franken P, 1999, SLEEP, V22, P155; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; Frazier CJ, 2001, J GEN PHYSIOL, V118, P457, DOI 10.1085/jgp.118.5.457; Fuentealba P, 2005, PROG NEUROBIOL, V75, P125, DOI 10.1016/j.pneurobio.2005.01.002; Gottesmann C, 1996, NEUROSCI BIOBEHAV R, V20, P367, DOI 10.1016/0149-7634(95)00055-0; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; Ivanov AI, 2000, J NEUROSCI, V20, P4930; Joho RH, 2006, EUR J NEUROSCI, V23, P1567, DOI 10.1111/j.1460-9568.2006.04672.x; Joksovic PM, 2005, J PHYSIOL-LONDON, V566, P125, DOI 10.1113/jphysiol.2005.086579; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kramar EA, 2004, J NEUROSCI, V24, P5151, DOI 10.1523/JNEUROSCI.0800-04.2004; Kuisle M, 2006, J PHYSIOL-LONDON, V575, P83, DOI 10.1113/jphysiol.2006.110486; Liguori R, 2001, BRAIN, V124, P2417, DOI 10.1093/brain/124.12.2417; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; Misquitta CM, 1999, CELL CALCIUM, V25, P277, DOI 10.1054/ceca.1999.0032; Munsch T, 1997, NEUROREPORT, V8, P2411, DOI 10.1097/00001756-199707280-00001; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; OGDEN D, 1995, PFLUG ARCH EUR J PHY, V429, P587, DOI 10.1007/BF00704165; Pape HC, 2004, PFLUG ARCH EUR J PHY, V448, P131, DOI 10.1007/s00424-003-1234-5; Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; Richter TA, 2005, J NEUROSCI, V25, P8267, DOI 10.1523/JNEUROSCI.1942-05.2005; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Talley EM, 1999, J NEUROSCI, V19, P1895; Uebachs M, 2006, J PHYSIOL-LONDON, V571, P519, DOI 10.1113/jphysiol.2005.103614; Vyazovskiy VV, 2002, BRAIN RES, V947, P204, DOI 10.1016/S0006-8993(02)02925-6	50	152	155	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					683	692		10.1038/nn.2124	http://dx.doi.org/10.1038/nn.2124			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18488023				2022-12-24	WOS:000256133700015
J	Kisilevsky, AE; Mulligan, SJ; Altier, C; Iftinca, MC; Varela, D; Tai, C; Chen, L; Hameed, S; Hamid, J; MacVicar, BA; Zamponi, GW				Kisilevsky, Alexandra E.; Mulligan, Sean J.; Altier, Christophe; Iftinca, Mircea C.; Varela, Diego; Tai, Chao; Chen, Lina; Hameed, Shahid; Hamid, Jawed; MacVicar, Brian A.; Zamponi, Gerald W.			D1 receptors physically interact with N-type calcium channels to regulate channel distribution and dendritic calcium entry	NEURON			English	Article							RAT PREFRONTAL CORTEX; STRIATAL CHOLINERGIC INTERNEURONS; DOPAMINE-RECEPTORS; CA2+ CHANNELS; D-2-LIKE RECEPTORS; NUCLEUS-ACCUMBENS; MOLECULAR-CLONING; PYRAMIDAL NEURONS; BRAIN DOPAMINE; MESSENGER-RNA	Dopamine signaling through D1 receptors in the prefrontal cortex (PFC) plays a critical role in the maintenance of higher cognitive functions, such as working memory. At the cellular level, these functions are predicated to involve alterations in neuronal calcium levels. The dendrites of PFC neurons express D1 receptors and N-type calcium channels, yet little information exists regarding their coupling. Here, we show that D1 receptors potently inhibit N-type channels in dendrites of rat PFC neurons. Using coimmunoprecipitation, we demonstrate the existence of a D1 receptor-N-type channel signaling complex in this region, and we provide evidence for a direct receptor-channel interaction. Finally, we demonstrate the importance of this complex to receptor-channel colocalization in heterologous systems and in PFC neurons. Our data indicate that the N-type calcium channel is an important physiological target of D1 receptors and reveal a mechanism for D1 receptor-mediated regulation of cognitive function in the PFC.	[Kisilevsky, Alexandra E.; Altier, Christophe; Iftinca, Mircea C.; Varela, Diego; Chen, Lina; Hameed, Shahid; Hamid, Jawed; Zamponi, Gerald W.] Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; [Mulligan, Sean J.] Univ Saskatchewan, Dept Physiol, Saskatoon, SK S7N 5E5, Canada; [Tai, Chao; MacVicar, Brian A.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada	University of Calgary; University of Saskatchewan; University of British Columbia	Zamponi, GW (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	zamponi@ucalgary.ca	Varela, Diego/AAG-7489-2019; MacVicar, Brian/AAI-7729-2020; MacVicar, Brian/P-1553-2015	Varela, Diego/0000-0002-9352-414X; MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623; Zamponi, Gerald W./0000-0002-0644-9066				Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; Beedle AM, 2004, NAT NEUROSCI, V7, P118, DOI 10.1038/nn1180; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787; BROWN NA, 1995, BRIT J PHARMACOL, V115, P459, DOI 10.1111/j.1476-5381.1995.tb16355.x; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; CARLEZON WA, 1995, PSYCHOPHARMACOLOGY, V122, P194, DOI 10.1007/BF02246095; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DEARRY A, 1990, NATURE, V347, P72, DOI 10.1038/347072a0; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FREMEAU RT, 1991, P NATL ACAD SCI USA, V88, P3772, DOI 10.1073/pnas.88.9.3772; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Gorelova NA, 2000, J NEUROPHYSIOL, V84, P75, DOI 10.1152/jn.2000.84.1.75; Gulledge AT, 2003, J NEUROSCI, V23, P11363; Gulledge AT, 2001, J NEUROPHYSIOL, V86, P586, DOI 10.1152/jn.2001.86.2.586; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HOEBEL BG, 1983, PSYCHOPHARMACOLOGY, V81, P158, DOI 10.1007/BF00429012; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Jarvis SE, 2007, CURR OPIN CELL BIOL, V19, P474, DOI 10.1016/j.ceb.2007.04.020; Khosravani H, 2005, FEBS LETT, V579, P6587, DOI 10.1016/j.febslet.2005.10.051; Koshikawa N, 1994, Rev Neurosci, V5, P331; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Lindvall O, 1978, Adv Biochem Psychopharmacol, V19, P1; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Momiyama T, 2001, J PHYSIOL-LONDON, V533, P479, DOI 10.1111/j.1469-7793.2001.0479a.x; MONSMA FJ, 1990, P NATL ACAD SCI USA, V87, P6723, DOI 10.1073/pnas.87.17.6723; Paspalas CD, 2005, J NEUROSCI, V25, P1260, DOI 10.1523/JNEUROSCI.3436-04.2005; PHILLIPS GD, 1994, PSYCHOPHARMACOLOGY, V114, P477, DOI 10.1007/BF02249339; Pisani A, 2000, J NEUROSCI, V20, part. no.; Rebois RV, 2003, RECEPTOR CHANNEL, V9, P169, DOI 10.1080/10606820308243; Schiff ML, 2000, NATURE, V408, P723, DOI 10.1038/35047093; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Seamans JK, 1995, BEHAV NEUROSCI, V109, P1063, DOI 10.1037/0735-7044.109.6.1063; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; SIMON H, 1981, J PHYSIOLOGY PARIS, V77, P81; So CH, 2005, MOL PHARMACOL, V68, P568, DOI 10.1124/mol.105.012229; Stefani A, 2002, EUR J NEUROSCI, V15, P815, DOI 10.1046/j.1460-9568.2002.01918.x; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Svensson E, 2003, EUR J NEUROSCI, V17, P447, DOI 10.1046/j.1460-9568.2003.02466.x; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Tepper JM, 1997, J NEUROSCI, V17, P2519; Tombler E, 2006, J BIOL CHEM, V281, P1827, DOI 10.1074/jbc.M508829200; WEINER DM, 1991, P NATL ACAD SCI USA, V88, P1859, DOI 10.1073/pnas.88.5.1859; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Wu JL, 2006, J NEUROCHEM, V98, P481, DOI 10.1111/j.1471-4159.2006.03901.x; Yan Z, 1997, J NEUROPHYSIOL, V77, P1003, DOI 10.1152/jn.1997.77.2.1003; Yang CR, 1996, J NEUROSCI, V16, P1904; Yang CR, 1999, NEUROPSYCHOPHARMACOL, V21, P161, DOI 10.1016/S0893-133X(98)00112-2; Zamponi GW, 1998, CURR OPIN NEUROBIOL, V8, P351, DOI 10.1016/S0959-4388(98)80060-3; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zamponi GW, 1998, P NATL ACAD SCI USA, V95, P4035, DOI 10.1073/pnas.95.7.4035; ZHOU QY, 1990, NATURE, V347, P76, DOI 10.1038/347076a0	66	82	83	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2008	58	4					557	570		10.1016/j.neuron.2008.03.002	http://dx.doi.org/10.1016/j.neuron.2008.03.002			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304PD	18498737	Bronze, Green Submitted			2022-12-24	WOS:000256120500010
J	Cho, RW; Park, JM; Wolff, SBE; Xu, D; Hopf, C; Kim, JA; Reddy, RC; Petralia, RS; Perin, MS; Linden, DJ; Worley, PF				Cho, Richard W.; Park, Joo Min; Wolff, Steffen B. E.; Xu, Desheng; Hopf, Carsten; Kim, Jin-ah; Reddy, Radhika C.; Petralia, Ronald S.; Perin, Mark S.; Linden, David J.; Worley, Paul F.			mGluR1/5-Dependent long-term depression requires the regulated ectodomain cleavage of neuronal pentraxin NPR by TACE	NEURON			English	Article							DHPG-INDUCED LTD; IONOTROPIC GLUTAMATE RECEPTORS; SYNAPSE-ASSOCIATED PROTEIN-97; CEREBELLAR PURKINJE NEURONS; ALPHA CONVERTING-ENZYME; KINASE-C INHIBITOR; GYRUS IN-VITRO; AMPA RECEPTORS; CA1 REGION; ACTIVATION CAUSES	Matrix metalloproteases (MMPs) play a role in remodeling the extracellular matrix during brain development and have been implicated in synaptic plasticity. Here, we report that a member of the neuronal pentraxin (NP) family, neuronal pentraxin receptor (NPR), undergoes regulated cleavage by the MMP tumor necrosis factor-a converting enzyme (TACE). NPR is enriched at excitatory synapses where it associates with AMPA-type glutamate receptors (AMPAR) and enhances synaptogenesis. However, in response to activation of group 1 mGluRs (mGluR1/5), TACE cleaves NPR and releases the pentraxin domain from its N-terminal transmembrane domain. Cleaved NPR rapidly accumulates in endosomes where it colocalizes with AMPAR. This process is necessary for mGluR1/5-dependent LTD in hippocampal and cerebellar synapses. These observations suggest that cleaved NPR functions to "capture" AMPAR for endocytosis and reveal a bifunctional role of NPs in both synapse strengthening and weakening.	[Cho, Richard W.; Park, Joo Min; Wolff, Steffen B. E.; Xu, Desheng; Hopf, Carsten; Kim, Jin-ah; Reddy, Radhika C.; Linden, David J.; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Petralia, Ronald S.] Natl Inst Deafness & Other Communicat Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA; [Perin, Mark S.] Cleveland Clin Fdn, Dept Neurosci, Cleveland, OH 44195 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Cleveland Clinic Foundation	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	pworley@jhmi.edu	Hopf, Carsten/A-3275-2015	Hopf, Carsten/0000-0003-0802-6451	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000003] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NINDS NIH HHS [R01 NS039156, R01 NS039156-08, 5R01NS039156-08] Funding Source: Medline; PHS HHS [R37MM51106] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; BEAR, 2000, MECH MEANING LONG; Beckmann G, 1998, J MOL BIOL, V275, P725, DOI 10.1006/jmbi.1997.1510; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Camodeca N, 1999, NEUROPHARMACOLOGY, V38, P1597, DOI 10.1016/S0028-3908(99)00093-3; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Del Bigio MR, 1999, NEUROPATH APPL NEURO, V25, P54; Dodds DC, 1997, J BIOL CHEM, V272, P21488, DOI 10.1074/jbc.272.34.21488; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Goodman Adam R., 1996, Cytokine and Growth Factor Reviews, V7, P191, DOI 10.1016/1359-6101(96)00019-6; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Huang LQ, 1999, NEUROSCI LETT, V274, P71, DOI 10.1016/S0304-3940(99)00561-3; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Kemp N, 1999, NEUROPHARMACOLOGY, V38, P495, DOI 10.1016/S0028-3908(98)00222-6; Khodakhah K, 1997, P NATL ACAD SCI USA, V94, P14009, DOI 10.1073/pnas.94.25.14009; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kirkpatrick LL, 2000, J BIOL CHEM, V275, P17786, DOI 10.1074/jbc.M002254200; Konopacki FA, 2007, NEUROSCIENCE, V150, P31, DOI 10.1016/j.neuroscience.2007.08.026; Leitges M, 2004, NEURON, V44, P585, DOI 10.1016/j.neuron.2004.10.024; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; McFarlane S, 2003, NEURON, V37, P559, DOI 10.1016/S0896-6273(03)00089-8; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; O'Brien JA, 2003, MOL PHARMACOL, V64, P731, DOI 10.1124/mol.64.3.731; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1; Schnabel R, 1999, NEUROPHARMACOLOGY, V38, P1585, DOI 10.1016/S0028-3908(99)00062-3; Schnabel R, 2001, BRIT J PHARMACOL, V132, P1095, DOI 10.1038/sj.bjp.0703905; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; SLA GM, 2007, NEURON, V55, P87; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Tomimatsu Y, 2002, LIFE SCI, V72, P355, DOI 10.1016/S0024-3205(02)02285-3; Tsui CC, 1996, J NEUROSCI, V16, P2463; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Xiao MY, 2001, NEUROPHARMACOLOGY, V41, P664, DOI 10.1016/S0028-3908(01)00134-4; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X	62	91	93	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 27	2008	57	6					858	871		10.1016/j.neuron.2008.01.010	http://dx.doi.org/10.1016/j.neuron.2008.01.010			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281LV	18367087	Green Accepted, Bronze			2022-12-24	WOS:000254500000010
J	Rhodes, KE; Gekas, C; Wang, Y; Lux, CT; Francis, CS; Chan, DN; Conway, S; Orkin, SH; Yoder, MC; Mikkola, HKA				Rhodes, Katrin E.; Gekas, Christos; Wang, Yanling; Lux, Christopher T.; Francis, Cameron S.; Chan, David N.; Conway, Simon; Orkin, Stuart H.; Yoder, Mervin C.; Mikkola, Hanna K. A.			The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation	CELL STEM CELL			English	Article							YOLK-SAC; DEFINITIVE HEMATOPOIESIS; UMBILICAL-CORD; MOUSE; EXPRESSION; ALLANTOIS; NICHE; BLOOD; MARKS; CD41	The mouse placenta was unveiled as an important reservoir for hematopoietic stem cells (HSCs), yet the origin of placental HSCs was unknown. By tracking developing HSCs by expression of Runx1-lacZ and CD41, we have found that HSCs emerge in large vessels in the placenta. Analysis of Ncx1(-/-) embryos, which lack a heartbeat, verified that HSC development is initiated in the placental vasculature independent of blood flow. However, fewer CD41+ hematopoietic cells were found in Ncx1(-/-) placentas than in controls, implying that some HSCs/progenitors colonize the placenta via circulation and/or HSC emergence is compromised without blood flow. Importantly, placentas from Ncx1(-/-) embryos possessed equal potential to generate myeloerythroid and B and T lymphoid cells upon explant culture, verifying intact multilineage hematopoietic potential, characteristic of developing HSCs. These data suggest that, in addition to providing a niche for a large pool of HSCs prior to liver colonization, the placenta is a true site of HSC generation.	[Rhodes, Katrin E.; Gekas, Christos; Wang, Yanling; Francis, Cameron S.; Chan, David N.; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Mikkola, Hanna K. A.] Univ Calif Los Angeles, Eli Edyth Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90095 USA; [Mikkola, Hanna K. A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Mikkola, Hanna K. A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Lux, Christopher T.; Conway, Simon; Yoder, Mervin C.] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Orkin, Stuart H.] Harvard Stem Cell Inst, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University	Mikkola, HKA (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	hmikkola@mcdb.ucla.edu	Gekas, Christos/M-3209-2015; Chan, David/F-1686-2013	Gekas, Christos/0000-0002-3429-4145; Yoder, Mervin/0000-0003-4354-7631; Lux, Christopher/0000-0002-8272-9545	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097766, R01HL063169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK069659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL63169, R01 HL063169, R01 HL097766, R01 HL063169-09] Funding Source: Medline; NIDDK NIH HHS [R21 DK069659, DK069659, R21 DK069659-03] Funding Source: Medline; NIGMS NIH HHS [GM07185, T32 GM007185] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Alvarez-Silva M, 2003, DEVELOPMENT, V130, P5437, DOI 10.1242/dev.00755; Baron MH, 2003, EXP HEMATOL, V31, P1160, DOI 10.1016/j.exphem.2003.08.019; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Bordignon C, 2006, NATURE, V441, P1100, DOI 10.1038/nature04962; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Cairo MS, 1997, BLOOD, V90, P4665, DOI 10.1182/blood.V90.12.4665.4665_4665_4678; Caprioli A, 1998, P NATL ACAD SCI USA, V95, P1641, DOI 10.1073/pnas.95.4.1641; Caprioli A, 2001, DEV BIOL, V238, P64, DOI 10.1006/dbio.2001.0362; Corbel C, 2002, DEV BIOL, V243, P301, DOI 10.1006/dbio.2001.0553; Corbel C, 2007, DEV BIOL, V301, P478, DOI 10.1016/j.ydbio.2006.08.069; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; DUVAL M, 1891, J ANAT, V27, P513; Duval M., 1891, J ANAT PHYSL NORMALE, V27, P24; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Fraser ST, 2002, EXP HEMATOL, V30, P1070, DOI 10.1016/S0301-472X(02)00887-1; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Inman KE, 2007, GENESIS, V45, P237, DOI 10.1002/dvg.20281; Jaffredo T, 2005, EXP HEMATOL, V33, P1029, DOI 10.1016/j.exphem.2005.06.005; Jiang FL, 2006, HUM MOL GENET, V15, P3293, DOI 10.1093/hmg/ddl405; Kiel MJ, 2006, IMMUNITY, V25, P862, DOI 10.1016/j.immuni.2006.11.005; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Koushik SV, 2001, FASEB J, V15, P1209, DOI 10.1096/fj.00-0696fje; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Lessard J, 2004, ONCOGENE, V23, P7199, DOI 10.1038/sj.onc.1207940; Li WM, 2003, BLOOD, V102, P4345, DOI 10.1182/blood-2003-03-0729; Lorsbach RB, 2004, BLOOD, V103, P2522, DOI 10.1182/blood-2003-07-2439; LUX CT, 2007, BLOOD PRESSURE, DOI DOI 10.1182/BLOOD-2007-08-107086; M Duval, 1891, J ANAT PHYSL, V27, P344; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; Matsubara A, 2005, J EXP MED, V202, P1483, DOI 10.1084/jem.20051325; Matsuoka S, 2001, BLOOD, V98, P6, DOI 10.1182/blood.V98.1.6; McGrath KE, 2003, BLOOD, V101, P1669, DOI 10.1182/blood-2002-08-2531; McKinney-Freeman SL, 2007, CURR OPIN HEMATOL, V14, P343, DOI 10.1097/MOH.0b013e3281900edd; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MELCHERS F, 1979, NATURE, V277, P219, DOI 10.1038/277219a0; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Ogura Y, 1998, BIOL REPROD, V58, P65, DOI 10.1095/biolreprod58.1.65; Oostendorp RAJ, 2002, BLOOD, V99, P1183, DOI 10.1182/blood.V99.4.1183; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Palis J, 1999, DEVELOPMENT, V126, P5073; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Taoudi S, 2005, DEVELOPMENT, V132, P4179, DOI 10.1242/dev.01974; Teitell MA, 2006, PEDIATR RES, V59, p33R, DOI 10.1203/01.pdr.0000205155.26315.c7; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yoder MC, 1997, P NATL ACAD SCI USA, V94, P6776, DOI 10.1073/pnas.94.13.6776; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Zeigler BM, 2006, DEVELOPMENT, V133, P4183, DOI 10.1242/dev.02596; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	63	212	225	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR	2008	2	3					252	263		10.1016/j.stem.2008.01.001	http://dx.doi.org/10.1016/j.stem.2008.01.001			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	274RD	18371450	Green Accepted, Bronze			2022-12-24	WOS:000254017700012
J	Weiler, N; Wood, L; Yu, JI; Solla, SA; Shepherd, GMG				Weiler, Nicholas; Wood, Lydia; Yu, Jianing; Solla, Sara A.; Shepherd, Gordon M. G.			Top-down laminar organization of the excitatory network in motor cortex	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL-ORGANIZATION; PYRAMIDAL NEURONS; CORTICAL COLUMN; LAYER-IV; RAT; CONNECTIVITY; CIRCUITS; PROJECTIONS; INPUT; CELLS	Cortical layering is a hallmark of the mammalian neocortex and a major determinant of local synaptic circuit organization in sensory systems. In motor cortex, the laminar organization of cortical circuits has not been resolved, although their input-output operations are crucial for motor control. Here, we developed a general approach for estimating layer-specific connectivity in cortical circuits and applied it to mouse motor cortex. From these data we computed a laminar presynaptic -> postsynaptic connectivity matrix, W-post,W-pre, revealing a complement of stereotypic pathways dominated by layer 2 outflow to deeper layers. Network modeling predicted, and experiments with disinhibited slices confirmed, that stimuli targeting upper, but not lower, cortical layers effectively evoked network-wide events. Thus, in motor cortex, descending excitation from a preamplifier-like network of upper-layer neurons drives output neurons in lower layers. Our analysis provides a quantitative wiring-diagram framework for further investigation of the excitatory networks mediating cortical mechanisms of motor control.	[Weiler, Nicholas; Yu, Jianing; Solla, Sara A.; Shepherd, Gordon M. G.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Solla, Sara A.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; Northwestern University	Shepherd, GMG (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Morton 5-660,303E Chicago Ave, Chicago, IL 60611 USA.	g-shepherd@northwestern.edu	Shepherd, Gordon/F-2679-2010; Weiler, Norbert/E-5356-2010	Weiler, Nicholas/0000-0001-6750-9248	NINDS NIH HHS [R01 NS061963-01, R01 NS061963] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061963] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alloway KD, 2008, CEREB CORTEX, V18, P979, DOI 10.1093/cercor/bhm138; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Briggs F, 2005, CEREB CORTEX, V15, P479, DOI 10.1093/cercor/bhh154; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; Callaway EM, 2004, NEURAL NETWORKS, V17, P625, DOI 10.1016/j.neunet.2004.04.004; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Castro-Alamancos MA, 2000, J NEUROSCI, V20, P9195; CAVINESS VS, 1975, J COMP NEUROL, V164, P247, DOI 10.1002/cne.901640207; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V62, P1149, DOI 10.1152/jn.1989.62.5.1149; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Donoghue JP, 1986, SENSORY MOTOR AREAS, P243; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Fregnac Y., 2006, MICROCIRCUITS INTERF, P393; Helmstaedter M, 2007, BRAIN RES REV, V55, P193, DOI 10.1016/j.brainresrev.2007.07.011; HIRSCH JA, 1995, J PHYSIOL-LONDON, V483, P183, DOI 10.1113/jphysiol.1995.sp020577; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; JONES EG, 1975, J COMP NEUROL, V160, P167, DOI 10.1002/cne.901600203; Kaneko T, 1995, J NEUROSCI, V15, P8362; Kaneko T, 2000, J COMP NEUROL, V423, P52, DOI 10.1002/1096-9861(20000717)423:1<52::AID-CNE5>3.0.CO;2-F; KANEKO T, 1994, J COMP NEUROL, V345, P172, DOI 10.1002/cne.903450203; KELLER A, 1993, CEREB CORTEX, V3, P430, DOI 10.1093/cercor/3.5.430; LEHKY SR, 1988, NATURE, V333, P452, DOI 10.1038/333452a0; Llinas R., 2002, I VORTEX NEURONS SEL; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Lubke J, 2007, BRAIN STRUCT FUNCT, V212, P3, DOI 10.1007/s00429-007-0144-2; Nelson Sacha B., 2002, Neuron, V36, P19, DOI 10.1016/S0896-6273(02)00944-3; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Schubert D, 2003, J NEUROSCI, V23, P2961; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shipp S, 2005, PHILOS T R SOC B, V360, P797, DOI 10.1098/rstb.2005.1630; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stepanyants A, 2008, CEREB CORTEX, V18, P13, DOI 10.1093/cercor/bhm027; STRICK PL, 1974, J COMP NEUROL, V153, P77, DOI 10.1002/cne.901530107; Tarczy-Hornoch K, 1999, CEREB CORTEX, V9, P833, DOI 10.1093/cercor/9.8.833; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Zhang ZW, 1997, J NEUROSCI, V17, P6365	50	213	215	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					360	366		10.1038/nn2049	http://dx.doi.org/10.1038/nn2049			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18246064	Green Accepted			2022-12-24	WOS:000253548300020
J	Kramer, H; Kavalali, ET				Kraemer, Helmut; Kavalali, Ege T.			Dynamin-independent synaptic vesicle retrieval?	NATURE NEUROSCIENCE			English	Editorial Material							ENDOCYTOSIS; MEMBRANE; FISSION; BODY; HYDROLYSIS; REQUIRES	A new study proposes that synaptic vesicle endocytosis at a large synaptic terminal is partly independent of dynamin and GTP hydrolysis, suggesting a new mechanism leading to vesicle fission and maintenance of neurotransmission.	[Kraemer, Helmut; Kavalali, Ege T.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Kramer, H (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kavalali@utsouthwestern.edu	Gimenez, Luis E Diaz/D-9291-2011	Kramer, Helmut/0000-0002-1167-2676	NEI NIH HHS [R01 EY010199-13, R01 EY010199] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010199] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Sun JY, 2004, J NEUROSCI METH, V134, P121, DOI 10.1016/j.jneumeth.2003.11.018; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Welsch S, 2007, FEBS LETT, V581, P2089, DOI 10.1016/j.febslet.2007.03.060; Wu W, 2007, P NATL ACAD SCI USA, V104, P10234, DOI 10.1073/pnas.0611512104; Xu JH, 2008, NAT NEUROSCI, V11, P45, DOI 10.1038/nn2021; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631	15	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					6	8		10.1038/nn0108-6	http://dx.doi.org/10.1038/nn0108-6			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18160955	Green Accepted, Green Submitted			2022-12-24	WOS:000252117900003
J	Nostro, MC; Cheng, X; Keller, GM; Gadue, P				Nostro, M. Cristina; Cheng, Xin; Keller, Gordon M.; Gadue, Paul			Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood	CELL STEM CELL			English	Article							BONE MORPHOGENETIC PROTEIN; PRIMITIVE STREAK; DEFINITIVE HEMATOPOIESIS; EXPRESSION DEFINES; YOLK-SAC; MESODERM; RECEPTOR; DIFFERENTIATION; GASTRULATION; COMMITMENT	The embryonic stem cell differentiation system was used to define the roles of the Activin/Nodal, BMP, and canonical Wnt signaling pathways at three distinct developmental stages during hematopoietic ontogeny: induction of a primitive streak-like population, formation of Flk1(+) mesoderm, and induction of hematopoietic progenitors. Activin/Nodal and Wnt, but not BMP, signaling are required for the induction of the primitive streak. Although BMP is not required for primitive streak induction, it displays a strong posteriorizing effect on this population. All three signaling pathways regulate induction of Flk1(+) mesoderm. The specification of Flk1(+) mesoderm to the hematopoietic lineages requires VEGF and Wnt, but not BMP or Activin/Nodal signaling. Specifically, Wnt signaling is essential for commitment of the primitive erythroid, but not the definitive lineages. These findings highlight dynamic changes in signaling requirements during blood cell development and identify a role for Wnt signaling in the establishment of the primitive erythroid lineage.	[Nostro, M. Cristina; Keller, Gordon M.] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada; [Cheng, Xin; Keller, Gordon M.; Gadue, Paul] Mt Sinai Sch Med, Dept Gen & Cell Med, New York, NY 10029 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Icahn School of Medicine at Mount Sinai	Keller, GM (corresponding author), Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada.	gkeller@uhnresearch.ca; paul.gadue@mssm.edu		Nostro, Maria Cristina/0000-0003-1166-8252; Keller, Gordon/0000-0001-9309-9297	NHLBI NIH HHS [F32 HL076058-01, F32 HL076058-03, F32 HL076058-02, F32 HL076058] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL076058] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Baron MH, 2005, CURR OPIN HEMATOL, V12, P217, DOI 10.1097/01.moh.0000163217.14462.58; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; CANDIA AF, 1992, DEVELOPMENT, V116, P1123; Choi K, 1998, DEVELOPMENT, V125, P725; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DIETERLENLIEVRE F, 1975, J EMBRYOL EXP MORPH, V33, P607; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JONES CM, 1995, DEVELOPMENT, V121, P3651; Kabrun N, 1997, DEVELOPMENT, V124, P2039; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kennedy M, 2003, METHOD ENZYMOL, V365, P39; KISPERT A, 1994, DEV BIOL, V161, P179, DOI 10.1006/dbio.1994.1019; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; LINTS TJ, 1993, DEVELOPMENT, V119, P969; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Miura S, 2006, DEVELOPMENT, V133, P3767, DOI 10.1242/dev.02552; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Natsume T, 1997, J BIOL CHEM, V272, P11535; Palis J, 1999, DEVELOPMENT, V126, P5073; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Park C, 2006, DEVELOPMENT, V133, P3473, DOI 10.1242/dev.02499; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Robertson SM, 2000, DEVELOPMENT, V127, P2447; Saga Y, 1996, DEVELOPMENT, V122, P2769; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Vonica A, 2002, DEV BIOL, V250, P112, DOI 10.1006/dbio.2002.0786; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	49	224	239	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN	2008	2	1					60	71		10.1016/j.stem.2007.10.011	http://dx.doi.org/10.1016/j.stem.2007.10.011			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	254RT	18371422	Green Accepted, Bronze			2022-12-24	WOS:000252606400012
J	Liu, BH; Wu, GK; Arbuckle, R; Tao, HW; Zhang, LI				Liu, Bao-hua; Wu, Guangying K.; Arbuckle, Robert; Tao, Huizhong W.; Zhang, Li I.			Defining cortical frequency tuning with recurrent excitatory circuitry	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; PRIMARY AUDITORY-CORTEX; RECEPTIVE-FIELDS; SIMPLE CELLS; BARREL CORTEX; ORIENTATION SELECTIVITY; THALAMOCORTICAL SYSTEM/; DIRECTION SELECTIVITY; SYNAPTIC INTEGRATION; GABA(B) RECEPTORS	Neurons in the recipient layers of sensory cortices receive excitatory input from two major sources: the feedforward thalamocortical and recurrent intracortical inputs. To address their respective functional roles, we developed a new method for silencing cortex by competitively activating GABA(A) while blocking GABA(B) receptors. In the rat primary auditory cortex, in vivo whole-cell recording from the same neuron before and after local cortical silencing revealed that thalamic input occupied the same area of frequency-intensity tonal receptive field as the total excitatory input, but showed a flattened tuning curve. In contrast, excitatory intracortical input was sharply tuned with a tuning curve that closely matched that of suprathreshold responses. This can be attributed to a selective amplification of cortical cells' responses at preferred frequencies by intracortical inputs from similarly tuned neurons. Thus, weakly tuned thalamocortical inputs determine the subthreshold responding range, whereas intracortical inputs largely define the tuning. Such circuits may ensure a faithful conveyance of sensory information.	Univ So Calif, Zilka Neurogenet Inst, Los Angeles, CA 90033 USA; Univ So Calif, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Zhang, LI (corresponding author), Univ So Calif, Zilka Neurogenet Inst, Los Angeles, CA 90033 USA.	liizhang@usc.edu	Wu, Guangying/E-8117-2010; Tao, Huizhong W/HDM-9767-2022	Wu, Guangying/0000-0002-7243-5412	NATIONAL EYE INSTITUTE [R21EY018718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC006814, R01DC008983] Funding Source: NIH RePORTER; NEI NIH HHS [R21 EY018718, R21 EY018718-01] Funding Source: Medline; NIDCD NIH HHS [R01 DC008983-01, R01 DC008983, R03 DC006814-03, R03 DC006814] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alonso JM, 2005, J NEUROPHYSIOL, V94, P26, DOI 10.1152/jn.01281.2004; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; CALFORD MB, 1981, J NEUROPHYSIOL, V45, P1013, DOI 10.1152/jn.1981.45.6.1013; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Fox K, 2003, J NEUROSCI, V23, P8380; GAMES KD, 1988, HEARING RES, V34, P1, DOI 10.1016/0378-5955(88)90047-0; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Miller LM, 2001, J NEUROSCI, V21, P8136, DOI 10.1523/JNEUROSCI.21-20-08136.2001; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; MILLER W, 1988, CABIOS, V4, P11; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Porter JT, 2004, J NEUROPHYSIOL, V92, P2762, DOI 10.1152/jn.00196.2004; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Roerig B, 2002, CEREB CORTEX, V12, P187, DOI 10.1093/cercor/12.2.187; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; VILLA AEP, 1991, EXP BRAIN RES, V86, P506, DOI 10.1007/BF00230524; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, J NEUROSCI, V25, P2983, DOI 10.1523/JNEUROSCI.4906-04.2005; Winer JA, 2005, TRENDS NEUROSCI, V28, P255, DOI 10.1016/j.tins.2005.03.009; Wu GY, 2006, NEURON, V52, P705, DOI 10.1016/j.neuron.2006.10.009; Yamauchi T, 2000, EUR J NEUROSCI, V12, P3433, DOI 10.1046/j.1460-9568.2000.00248.x; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhang YF, 1997, J NEUROPHYSIOL, V78, P3489, DOI 10.1152/jn.1997.78.6.3489; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004	41	135	136	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1594	1600		10.1038/nn2012	http://dx.doi.org/10.1038/nn2012			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17994013	Green Accepted			2022-12-24	WOS:000251172900017
J	Godinho, L; Williams, PR; Claassen, Y; Provost, E; Leach, SD; Kamermans, M; Wong, ROL				Godinho, Leanne; Williams, Philip R.; Claassen, Yvonne; Provost, Elayne; Leach, Steven D.; Kamermans, Maarten; Wong, Rachel O. L.			Nonapical symmetric divisions underlie horizontal cell layer formation in the developing retina in vivo	NEURON			English	Article							DEVELOPING ZEBRAFISH RETINA; EMBRYONIC MOUSE RETINA; REELER-LIKE PHENOTYPE; ROD PHOTORECEPTORS; ADULT GOLDFISH; AMACRINE CELLS; NEURONS ARISE; DANIO-RERIO; FISH RETINA; STEM-CELLS	Symmetric cell divisions have been proposed to rapidly increase neuronal number late in neurogenesis, but how critical this mode of division is to establishing a specific neuronal layer is unknown. Using in vivo time-lapse imaging methods, we discovered that in the laminated zebrafish retina, the horizontal cell (HC) layer forms quickly during embryonic development upon division of a precursor cell population. The precursor cells morphologically resemble immature, postmitotic HCs and express HC markers such as ptf1a and Prox1 prior to division. These precursors undergo nonapical symmetric division at the laminar location where mature HCs contact photoreceptors. Strikingly, the precursor cell type we observed generates exclusively HCs. We have thus identified a dedicated HC precursor, and our findings suggest a mechanism of neuronal layer formation whereby the location of mitosis could facilitate rapid contact between synaptic partners.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; Netherlands Inst Neurosci, Res Unit Retinal Signal Proc, NL-1105 BA Amsterdam, Netherlands; Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21287 USA; Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21287 USA; Johns Hopkins Med Inst, Dept Cell Biol, Baltimore, MD 21287 USA	Washington University (WUSTL); University of Washington; University of Washington Seattle; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Wong, ROL (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	wongr2@u.washington.edu			NEI NIH HHS [EY14368] Funding Source: Medline; NIDDK NIH HHS [DK52611] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014368] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Connaughton VP, 2004, J COMP NEUROL, V477, P371, DOI 10.1002/cne.20261; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Das T, 2003, NEURON, V37, P597, DOI 10.1016/S0896-6273(03)00066-7; Dermietzel R, 2000, J NEUROSCI, V20, P8331, DOI 10.1523/JNEUROSCI.20-22-08331.2000; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Easter SS, 1996, DEV BIOL, V180, P646; Fischer AJ, 2000, DEV BIOL, V220, P197, DOI 10.1006/dbio.2000.9640; Fujitani Y, 2006, DEVELOPMENT, V133, P4439, DOI 10.1242/dev.02598; Godinho L, 2005, DEVELOPMENT, V132, P5069, DOI 10.1242/dev.02075; Gonzalez JL, 1997, J NEUROSCI, V17, P9204; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HINDS JW, 1979, J COMP NEUROL, V187, P495, DOI 10.1002/cne.901870303; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; Jensen AM, 2001, DEVELOPMENT, V128, P95; JOHNS PR, 1977, J COMP NEUROL, V176, P343, DOI 10.1002/cne.901760304; JOHNS PR, 1981, NATURE, V293, P141, DOI 10.1038/293141a0; JOHNS PR, 1982, J NEUROSCI, V2, P178; Julian D, 1998, J COMP NEUROL, V394, P271; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Masai I, 2005, DEVELOPMENT, V132, P1539, DOI 10.1242/dev.01714; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Nakhai H, 2007, DEVELOPMENT, V134, P1151, DOI 10.1242/dev.02781; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Otteson DC, 2001, DEV BIOL, V232, P62, DOI 10.1006/dbio.2001.0163; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; RAPAPORT DH, 1985, AUST NZ J OPHTHALMOL, V13, P113, DOI 10.1111/j.1442-9071.1985.tb00412.x; RAPAPORT DH, 1991, J COMP NEUROL, V312, P341, DOI 10.1002/cne.903120303; RAYMOND PA, 1987, DEV BIOL, V122, P120, DOI 10.1016/0012-1606(87)90338-1; Robinson S R, 1985, Brain Res, V351, P101; ROMPANI S, 2007, IN PRESS P NATL ACAD; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Schmitt EA, 1999, J COMP NEUROL, V404, P515; SCHNITZER J, 1984, J NEUROSCI, V4, P2948; Shields CR, 2007, J COMP NEUROL, V501, P765, DOI 10.1002/cne.21282; Smirnov E B, 2004, Neurosci Behav Physiol, V34, P643, DOI 10.1023/B:NEAB.0000028299.76009.1c; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; WETTS R, 1989, DEV BIOL, V136, P254, DOI 10.1016/0012-1606(89)90146-2; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Yoneshima H, 1997, NEUROSCI RES, V29, P217, DOI 10.1016/S0168-0102(97)00088-6; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	45	93	93	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 21	2007	56	4					597	603		10.1016/j.neuron.2007.09.036	http://dx.doi.org/10.1016/j.neuron.2007.09.036			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	236MH	18031679	Bronze			2022-12-24	WOS:000251306600005
J	Heckscher, ES; Fetter, RD; Marek, KW; Albin, SD; Davis, GW				Heckscher, Elizabeth S.; Fetter, Richard D.; Marek, Kurt W.; Albin, Stephanie D.; Davis, Graeme W.			NF-kappa B, I kappa B, and IRAK control glutarnate receptor density at the drosophila NMJ	NEURON			English	Article							TRANSMEMBRANE PROTEIN TOLL; FEMALE STERILE MUTATIONS; GLUTAMATE-RECEPTOR; NEUROMUSCULAR-JUNCTION; SIGNALING PATHWAY; MORPHOGEN DORSAL; DEGRADATION ESTABLISHES; NUCLEAR-LOCALIZATION; MUSCLE DEVELOPMENT; 2ND CHROMOSOME	NF-kappa B signaling has been implicated in neurodegenerative disease, epilepsy, and neuronal plasticity. However, the cellular and molecular activity of NF-kappa B signaling within the nervous system remains to be clearly defined. Here, we show that the NF-kappa B and I kappa B homologs Dorsal and Cactus surround postsynaptic glutamate receptor (GluR) clusters at the Drosophila NMJ. We then show that mutations in dorsal, cactus, and IRAK/pelle kinase specifically impair GluR levels, assayed immunohistochemically and electrophysiologically, without affecting NMJ growth, the size of the postsynaptic density, or homeostatic plasticity. Additional genetic experiments support the conclusion that cactus functions in concert with, rather than in opposition to, dorsal and pelle in this process. Finally, we provide evidence that Dorsal and Cactus act posttranscriptionally, outside the nucleus, to control GluR density. Based upon our data we speculate that Dorsal, Cactus, and Pelle could function together, locally at the postsynaptic density, to specify GluR levels.	Univ Calif San Francisco, Dept Biochem & Biophys, Program Neurosci & Cell Biol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Neurosci & Cell Biol, 1550 4th St, San Francisco, CA 94158 USA.	gdavis@biochem.ucsf.edu		Albin, Stephanie/0000-0003-4070-7433	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059867, R01NS039313] Funding Source: NIH RePORTER; NINDS NIH HHS [NS39313, R01 NS059867, R01 NS039313, R01 NS039313-08] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albin SD, 2004, J NEUROSCI, V24, P6871, DOI 10.1523/JNEUROSCI.1538-04.2004; Ashmore LJ, 2003, J NEUROSCI, V23, P7810; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Beremendi A, 2005, NEUROSCIENCE, V134, P397, DOI 10.1016/j.neuroscience.2005.04.046; Bergmann A, 1996, MECH DEVELOP, V60, P109, DOI 10.1016/S0925-4773(96)00607-7; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cantera R, 1999, J NEUROBIOL, V38, P16, DOI 10.1002/(SICI)1097-4695(199901)38:1<16::AID-NEU2>3.0.CO;2-0; Cantera R, 1999, MOL CELL NEUROSCI, V13, P131, DOI 10.1006/mcne.1999.0739; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Edwards DN, 1997, DEVELOPMENT, V124, P3855; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Featherstone DE, 2005, J NEUROSCI, V25, P3199, DOI 10.1523/JNEUROSCI.4201-04.2005; Flores-Saaib RD, 2001, DEVELOPMENT, V128, P1869; Furukawa K, 1998, J NEUROCHEM, V70, P1876; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GILLESPIE SKH, 1994, MOL CELL BIOL, V14, P3559, DOI 10.1128/MCB.14.6.3559; Govind S, 1996, BIOCHEM SOC T, V24, P39, DOI 10.1042/bst0240039; Govind S, 1999, ONCOGENE, V18, P6875, DOI 10.1038/sj.onc.1203223; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; HACKER H, 2006, STEK 2006 RE13; Halfon MS, 1998, DEV BIOL, V199, P164, DOI 10.1006/dbio.1998.8915; HALFON MS, 1995, DEV BIOL, V169, P151, DOI 10.1006/dbio.1995.1134; HECHT PM, 1993, GENETICS, V135, P405; ISODA K, 1994, P NATL ACAD SCI USA, V91, P5350, DOI 10.1073/pnas.91.12.5350; ISODA K, 1992, GENE DEV, V6, P619, DOI 10.1101/gad.6.4.619; Kambris Zakaria, 2002, Gene Expression Patterns, V2, P311, DOI 10.1016/S1567-133X(02)00020-0; Kauppila S, 2003, ONCOGENE, V22, P4860, DOI 10.1038/sj.onc.1206715; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Mattson MP, 2000, CELL TISSUE RES, V301, P173, DOI 10.1007/s004419900154; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nicolai M, 2003, J NEUROBIOL, V57, P291, DOI 10.1002/neu.10277; Nicolas E, 1998, J BIOL CHEM, V273, P10463, DOI 10.1074/jbc.273.17.10463; NORRIS JL, 1992, GENE DEV, V6, P1654, DOI 10.1101/gad.6.9.1654; NOSE A, 1992, COLD SPRING HARB SYM, V57, P441, DOI 10.1101/SQB.1992.057.01.049; O'Mahony A, 2006, MOL CELL BIOL, V26, P7283, DOI 10.1128/MCB.00510-06; PAN D, 1992, EMBO J, V11, P1837, DOI 10.1002/j.1460-2075.1992.tb05235.x; PAN DJ, 1991, GENE DEV, V5, P1892, DOI 10.1101/gad.5.10.1892; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Qiu P, 1998, DEVELOPMENT, V125, P1909; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Reach M, 1996, DEV BIOL, V180, P353, DOI 10.1006/dbio.1996.0308; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; ROTH S, 1991, DEVELOPMENT, V112, P371; Roy S, 1997, DEVELOPMENT, V124, P3333; SchmidtUllrich R, 1996, DEVELOPMENT, V122, P2117; SCHUPBACH T, 1989, GENETICS, V121, P101; SCHUPBACH T, 1991, GENETICS, V129, P1119; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Shen BH, 1998, DEVELOPMENT, V125, P4719; Shen BH, 2002, DEVELOPMENT, V129, P1925; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Towb P, 2001, DEVELOPMENT, V128, P4729	64	55	56	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 20	2007	55	6					859	873		10.1016/j.neuron.2007.08.005	http://dx.doi.org/10.1016/j.neuron.2007.08.005			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	219IQ	17880891	Bronze, Green Accepted			2022-12-24	WOS:000250078500005
J	Seol, GH; Ziburkus, J; Huang, S; Song, L; Kim, IT; Takamiya, K; Huganir, RL; Lee, HK; Kirkwood, A				Seol, Geun Hee; Ziburkus, Jokubas; Huang, ShiYong; Song, Lihua; Kim, In Tae; Takamiya, Kogo; Huganir, Richard L.; Lee, Hey-Kyoung; Kirkwood, Alfredo			Neuromodulators control the polarity of spike-timing-dependent synaptic plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; PHOSPHORYLATION SITES; CORTICAL PLASTICITY; APICAL DENDRITES; RECEPTORS; LTD; MODULATION; GLUR1; TRAFFICKING; BACKPROPAGATION	Near coincidental pre- and postsynaptic action potentials induce associative long-term potentiation (LTP) or long-term depression (LTD), depending on the order of their timing. Here, we show that in visual cortex the rules of this spike-timing-dependent plasticity are not rigid, but shaped by neuromodulator receptors coupled to aderylyl cyclase (AC) and phospholipase C (PLC) signaling cascades. Activation of the AC and PLC cascades results in phosphorylation of postsynaptic glutamate receptors at sites that serve as specific "tags" for LTP and LTD. As a consequence, the outcome (i.e., whether LTP or LTD) of a given pattern of pre- and postsynaptic firing depends not only on the order of the timing, but also on the relative activation of neuromodulator receptors coupled to AC and PLC. These findings indicate that cholinergic and adrenergic neuromodulation associated with the behavioral state of the animal can control the gating and the polarity of cortical plasticity.	Johns Hopkins Univ, Mind Brain Inst, Baltimore, MD 21218 USA; Korea Univ, Dept Basic Nursing Sci, Seoul 136701, South Korea; Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Korea University; University of Houston System; University of Houston; University System of Maryland; University of Maryland College Park; Johns Hopkins University	Kirkwood, A (corresponding author), Johns Hopkins Univ, Mind Brain Inst, Baltimore, MD 21218 USA.	kirkwood@jhu.edu	Huang, Shiyong/D-5211-2009; Seol, Geun Hee/ABB-6189-2020	Huang, Shiyong/0000-0003-2976-5798; Seol, Geun Hee/0000-0002-2986-9688; Takamiya, Kogo/0000-0001-7240-6307; Lee, Hey-Kyoung/0000-0002-5554-983X; Ziburkus, Jokubas/0000-0002-1701-4367	NEI NIH HHS [R01 EY014882, R01 EY014882-04, R01 EY012124-10, R01-EY014882, R01 EY014882-03, R01 EY012124, R01 EY12124] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014882, R01EY012124] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akaneya Y, 2006, J NEUROSCI, V26, P10209, DOI 10.1523/JNEUROSCI.3028-06.2006; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Choi SY, 2005, J NEUROSCI, V25, P11433, DOI 10.1523/JNEUROSCI.4084-05.2005; Crozier RA, 2007, P NATL ACAD SCI USA, V104, P1383, DOI 10.1073/pnas.0609596104; Delgado JY, 2005, NEUROPHARMACOLOGY, V48, P936, DOI 10.1016/j.neuropharm.2005.01.008; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fischer QS, 2004, J NEUROSCI, V24, P9049, DOI 10.1523/JNEUROSCI.2409-04.2004; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Hardingham N, 2006, J NEUROSCI, V26, P7395, DOI 10.1523/JNEUROSCI.0652-06.2006; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Ho OH, 2004, J NEUROCHEM, V91, P1344, DOI 10.1111/j.1471-4159.2004.02815.x; Hoffman DA, 1999, J NEUROPHYSIOL, V81, P408, DOI 10.1152/jn.1999.81.1.408; Horne EA, 2007, J NEUROSCI, V27, P3523, DOI 10.1523/JNEUROSCI.4340-06.2007; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Krukowski AE, 2001, NAT NEUROSCI, V4, P424, DOI 10.1038/86084; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; Lin YW, 2003, J NEUROSCI, V23, P4173; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sandler VM, 1999, J NEUROPHYSIOL, V81, P216, DOI 10.1152/jn.1999.81.1.216; Sato H, 1999, NEUROSCIENCE, V94, P697, DOI 10.1016/S0306-4522(99)00334-6; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Sjostrom PJ, 2004, J NEUROPHYSIOL, V92, P3338, DOI 10.1152/jn.00376.2004; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Thore S, 2004, J BIOL CHEM, V279, P19396, DOI 10.1074/jbc.C400088200; Tsubokawa H, 1997, J NEUROSCI, V17, P5782; Tzounopoulos T, 2007, NEURON, V54, P291, DOI 10.1016/j.neuron.2007.03.026; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006	44	273	274	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 20	2007	55	6					919	929		10.1016/j.neuron.2007.08.013	http://dx.doi.org/10.1016/j.neuron.2007.08.013			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	219IQ	17880895	Green Accepted, Bronze			2022-12-24	WOS:000250078500009
J	Nassi, JJ; Callaway, EM				Nassi, Jonathan J.; Callaway, Edward M.			Specialized circuits from primary visual cortex to V2 and area MT	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; MIDDLE TEMPORAL AREA; MACAQUE STRIATE CORTEX; CENTRAL-NERVOUS-SYSTEM; CYTOCHROME-OXIDASE; LOCAL CIRCUITS; RABIES VIRUS; TRANSNEURONAL TRACER; PARALLEL PATHWAYS; SQUIRREL-MONKEY	Primary visual cortex recombines inputs from magnocellular (M) and parvocellular (P) streams to create functionally specialized outputs. Understanding these input-output relationships is complicated by the fact that layer 413, which provides outputs to dorsal visual areas, contains multiple cell types. Using a modified rabies virus that expresses green fluorescent protein, we show that layer 4B neurons projecting to MT are a majority spiny stellate, whereas those projecting to V2 are overwhelmingly pyramidal. Regardless of cell type, MT-projecting neurons have larger cell bodies, more dendritic length, and are deeper within layer 413. Furthermore, MT-projecting pyramidal neurons are located preferentially underneath cytochrome oxidase blobs, indicating that MT-projecting neurons of both types restrict their dendrites to M-recipient zones. We conclude that MT-projecting layer 4B neurons are specialized for the fast transmission of information from the M pathway, while V2-projecting neurons are likely to mediate slower computations involving mixed M and P signals.	Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	callaway@salk.edu	Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267; Nassi, Jonathan/0000-0002-3144-3846	NEI NIH HHS [R01 EY010742, R01 EY010742-16] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010742] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARONE P, 1995, CEREB CORTEX, V5, P22, DOI 10.1093/cercor/5.1.22; BLASDEL GG, 1983, J NEUROSCI, V3, P1389; Boyd JD, 1999, J COMP NEUROL, V409, P573, DOI 10.1002/(SICI)1096-9861(19990712)409:4<573::AID-CNE5>3.0.CO;2-R; BURKHALTER A, 1986, VISION RES, V26, P63, DOI 10.1016/0042-6989(86)90071-4; Callaway EM, 1998, J NEUROSCI, V18, P1505; Callaway EM, 1996, VISUAL NEUROSCI, V13, P907, DOI 10.1017/S0952523800009159; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; DESIMONE R, 1989, HDB NEUROPSYCHOLOGY, P267; DEYOE EA, 1988, TRENDS NEUROSCI, V11, P219, DOI 10.1016/0166-2236(88)90130-0; DIAMOND IT, 1985, J COMP NEUROL, V242, P584, DOI 10.1002/cne.902420408; Ding Y, 1997, VISUAL NEUROSCI, V14, P691, DOI 10.1017/S0952523800012657; Elston GN, 1997, CEREB CORTEX, V7, P432, DOI 10.1093/cercor/7.5.432; Etessami R, 2000, J GEN VIROL, V81, P2147, DOI 10.1099/0022-1317-81-9-2147; HENDRICKSON AE, 1978, J COMP NEUROL, V182, P123, DOI 10.1002/cne.901820108; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; HENDRY SHC, 1994, SCIENCE, V264, P575, DOI 10.1126/science.8160015; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; KOESTER SE, 1992, J NEUROSCI, V12, P1382; LACHICA EA, 1992, P NATL ACAD SCI USA, V89, P3566, DOI 10.1073/pnas.89.8.3566; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3371; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; MICHAEL CR, 1988, P NATL ACAD SCI USA, V85, P4914, DOI 10.1073/pnas.85.13.4914; Movshon JA, 1996, J NEUROSCI, V16, P7733; Nassi JJ, 2006, J NEUROSCI, V26, P12789, DOI 10.1523/JNEUROSCI.4044-06.2006; ROCKLAND KS, 1995, J COMP NEUROL, V355, P15, DOI 10.1002/cne.903550105; SHIPP S, 1989, EUR J NEUROSCI, V1, P309, DOI 10.1111/j.1460-9568.1989.tb00798.x; Sincich LC, 2007, CEREB CORTEX, V17, P935, DOI 10.1093/cercor/bhl004; Sincich LC, 2003, J NEUROSCI, V23, P5684; Sincich LC, 2002, SCIENCE, V295, P1734, DOI 10.1126/science.1067902; TIGGES J, 1981, J COMP NEUROL, V202, P539, DOI 10.1002/cne.902020407; TOOTELL RBH, 1985, J NEUROSCI, V5, P2786; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; WEISENHORN DMV, 1995, J COMP NEUROL, V362, P233, DOI 10.1002/cne.903620207; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Xiao YP, 2004, P NATL ACAD SCI USA, V101, P7147, DOI 10.1073/pnas.0402052101; Yabuta NH, 2001, SCIENCE, V292, P297, DOI 10.1126/science.1057916; Yabuta NH, 1998, J NEUROSCI, V18, P9489; YOSHIOKA T, 1994, VISUAL NEUROSCI, V11, P467, DOI 10.1017/S0952523800002406; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0	43	54	57	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 6	2007	55	5					799	808		10.1016/j.neuron.2007.07.037	http://dx.doi.org/10.1016/j.neuron.2007.07.037			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	216DB	17785186	Bronze, Green Accepted			2022-12-24	WOS:000249857000015
J	Xu, RH; Sampsell-Barron, TL; Gu, F; Root, S; Peck, RM; Pan, GJ; Yu, JY; Antosiewicz-Bourget, J; Tian, SL; Stewart, R; Thomson, JA				Xu, Ren-He; Sampsell-Barron, Tori L.; Gu, Feng; Root, Sierra; Peck, Ruthann M.; Pan, Guangjin; Yu, Junying; Antosiewicz-Bourget, Jessica; Tian, Shulan; Stewart, Ron; Thomson, James A.			NANOG is a direct target of TGF beta/Activin-mediated SMAD signaling in human ESCs	CELL STEM CELL			English	Article							HUMAN EMBRYONIC STEM; FIBROBLAST-GROWTH-FACTOR; FEEDER-FREE GROWTH; SELF-RENEWAL; MAINTAIN PLURIPOTENCY; CELL DIFFERENTIATION; DEFINED CONDITIONS; GENE-EXPRESSION; ACTIVATION; CULTURE	Self-renewal of human embryonic stem cells (ESCs) is promoted by FGF and TGF beta/Activin signaling, and differentiation is promoted by BMP signaling, but how these signals regulate genes critical to the maintenance of pluripotency has been unclear. Using a defined medium, we show here that both TGF beta and FGF signals synergize to inhibit BMP signaling; sustain expression of pluripotency-associated genes such as NANOG, OCT4, and SOX2; and promote long-term undifferentiated proliferation of human ESCs. We also show that both TGF beta- and BMP-responsive SMADs can bind with the NANOG proximal promoter. NANOG promoter activity is enhanced by TGF beta/Activin and FGF signaling and is decreased by BMP signaling. Mutation of putative SMAD binding elements reduces NANOG promoter activity to basal levels and makes NANOG unresponsive to BMP and TGF beta signaling. These results suggest that direct binding of TGF beta/Activin-responsive SMADs to the NANOG promoter plays an essential role in sustaining human ESC self-renewal.	[Xu, Ren-He; Gu, Feng; Root, Sierra] Univ Connecticut, Stem Cell Inst, Dept Genet & Dev Biol, Ctr Hlth, Farmington, CT 06030 USA; [Xu, Ren-He; Sampsell-Barron, Tori L.; Peck, Ruthann M.; Pan, Guangjin; Yu, Junying; Antosiewicz-Bourget, Jessica; Thomson, James A.] WiCell Res Inst, Madison, WI 53707 USA; [Yu, Junying; Antosiewicz-Bourget, Jessica; Thomson, James A.] Univ Wisconsin, Natl Primate Res Ctr, Madison, WI 53706 USA; [Tian, Shulan; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Thomson, James A.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	University of Connecticut; WiCell Research Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison	Xu, RH (corresponding author), Univ Connecticut, Stem Cell Inst, Dept Genet & Dev Biol, Ctr Hlth, Farmington, CT 06030 USA.	renhexu@uchc.edu; thomson@primate.wisc.edu	Xu, Ren-He/AAK-7392-2021; Xu, Ren-He/M-3125-2016	Sampsell, Tori/0000-0001-9032-7055; Gu, Feng/0000-0002-9019-2960	National Institutes of Health [P51 RR000167, P20 GM069981]; W.M. Keck Foundation; Connecticut Stem Cell Research [06SCB14, 06SCD02]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM069981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); Connecticut Stem Cell Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Tenneille Ludwig and Jenny Frane for providing TeSR1 media; Marian Piekarczyk, Leann Crandall, and Tiwanna Compton for laboratory support; and Deborah Faupel for editing the manuscript. We also thank Gudrun Jonsdottir and Karen Heidarsdottir from the WiCell Research Institute in Iceland for conducting the microarray experiments and Mark Kronenberg for helpful discussion on the EMSA. This work was supported by funding from private donations, National Institutes of Health grants P51 RR000167 and P20 GM069981, the W.M. Keck Foundation to J.A.T., and the Connecticut Stem Cell Research Grants 06SCB14 and 06SCD02 to R.-H.X. The contents in this work are solely the responsibility of the authors and do not necessarily represent the official views of the State of Connecticut. The authors declare competing financial interests. J.A.T. is a cofounder and shareholder of Cellular Dynamics International.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kang HB, 2005, STEM CELLS DEV, V14, P395, DOI 10.1089/scd.2005.14.395; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Ma Y, 2003, STEM CELLS, V21, P111, DOI 10.1634/stemcells.21-1-111; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wang LS, 2005, BLOOD, V105, P4598, DOI 10.1182/blood-2004-10-4065; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	42	364	390	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2008	3	2					196	206		10.1016/j.stem.2008.07.001	http://dx.doi.org/10.1016/j.stem.2008.07.001			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	338QT	18682241	Green Accepted, Bronze			2022-12-24	WOS:000258523300014
J	Bondue, A; Lapouge, G; Paulissen, C; Semeraro, C; Lacovino, M; Kyba, M; Blanpain, C				Bondue, Antoine; Lapouge, Gaelle; Paulissen, Catherine; Semeraro, Claudio; Lacovino, Michelina; Kyba, Michael; Blanpain, Cedric			Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification	CELL STEM CELL			English	Article							EMBRYONIC-STEM-CELL; WNT/BETA-CATENIN; CARDIAC MESODERM; SMOOTH-MUSCLE; TRANSCRIPTION FACTORS; VASCULAR DEVELOPMENT; MAMMALIAN HEART; SELF-RENEWAL; DIFFERENTIATION; EVOLUTION	During embryonic development, multipotent cardiovascular progenitor cells are specified from early mesoderm. Using mouse ESCs in which gene expression can be temporally regulated, we have found that transient expression of Mesp1 dramatically accelerates and enhances multipotent cardiovascular progenitor specification through an intrinsic and cell autonomous mechanism. Genome-wide transcriptional analysis indicates that Mesp1 rapidly activates and represses a discrete set of genes, and chromatin immunoprecipitation shows that Mesp1 directly binds to regulatory DNA sequences located in the promoter of many key genes in the core cardiac transcriptional machinery, resulting in their rapid up-regulation. Mesp1 also directly represses the expression of key genes regulating other early mesoderm and endoderm cell fates. Our results demonstrate that Mesp1 acts as a key regulatory switch during cardiovascular specification, residing at the top of the hierarchy of the gene network responsible for cardiovascular cell-fate determination.	[Bondue, Antoine; Lapouge, Gaelle; Paulissen, Catherine; Semeraro, Claudio; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Lacovino, Michelina; Kyba, Michael] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA	Universite Libre de Bruxelles; University of Texas System; University of Texas Southwestern Medical Center Dallas	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.	cedric.blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021	Kyba, Michael/0000-0002-5579-7534; iacovino, michelina/0000-0002-1076-3146				Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Davidson B, 2005, DEVELOPMENT, V132, P4811, DOI 10.1242/dev.02051; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Garry DJ, 2006, CELL, V127, P1101, DOI 10.1016/j.cell.2006.11.031; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kawamura A, 2008, MOL CELL BIOL, V28, P3236, DOI 10.1128/MCB.01754-07; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; McFadden DG, 2000, DEVELOPMENT, V127, P5331; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Morimoto M, 2007, DEVELOPMENT, V134, P1561, DOI 10.1242/dev.000836; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1998, MECH DEVELOP, V75, P53, DOI 10.1016/S0925-4773(98)00077-X; Saga Y, 1996, DEVELOPMENT, V122, P2769; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Satou Y, 2006, GENE DEV, V20, P2634, DOI 10.1101/gad.1485706; Schwartz RJ, 1999, DEVELOPMENT, V126, P4187; Takahashi Y, 2005, DEVELOPMENT, V132, P787, DOI 10.1242/dev.01597; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zaret KS, 2000, MECH DEVELOP, V92, P83, DOI 10.1016/S0925-4773(99)00326-3	46	279	296	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL	2008	3	1					69	84		10.1016/j.stem.2008.06.009	http://dx.doi.org/10.1016/j.stem.2008.06.009			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	325XO	18593560	Bronze			2022-12-24	WOS:000257622300011
J	Fujita, J; Crane, AM; Souza, MK; Dejosez, M; Kyba, M; Flavell, RA; Thomson, JA; Zwaka, TP				Fujita, Jun; Crane, Ana M.; Souza, Marion K.; Dejosez, Marion; Kyba, Michael; Flavell, Richard A.; Thomson, James A.; Zwaka, Thomas P.			Caspase activity mediates the differentiation of embryonic stem cells	CELL STEM CELL			English	Article							PLURIPOTENCY SUSTAINING FACTOR; DEVELOPMENTAL REGULATORS; NANOG; APOPTOSIS; ACTIVATION; GENERATION; POLYCOMB; CLONING; SYSTEM	Embryonic stem cells (ESCs) are capable of indefinite self-renewal while retaining the ability to differentiate to any of the three germ layers that give rise to all somatic cell types. An emerging view is that a core set of transcription factors, including Oct4, Sox2, and Nanog, form a robust autoregulatory circuit that maintains ESCs in a self-renewing state. To accommodate the capacity of such cells to undergo germ layer-specific differentiation, we predicted a posttranslational mechanism that could negatively regulate these core self-renewal factors. Here we report caspase-induced cleavage of Nanog in differentiating ESCs. Stem cells lacking the Casp3 gene showed marked defects in differentiation, while forced expression of a caspase cleavage-resistant Nanog mutant in ESCs strongly promoted self-renewal. These results link a major component of the programmed cell-death pathway to the regulation of ESC development.	[Fujita, Jun; Crane, Ana M.; Souza, Marion K.; Dejosez, Marion; Zwaka, Thomas P.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Zwaka, Thomas P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Zwaka, Thomas P.] Baylor Coll Med, Dept Human Mol Genet, Houston, TX 77030 USA; [Kyba, Michael] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Flavell, Richard A.] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [Flavell, Richard A.] Howard Hughes Med Inst, New Haven, CT 06520 USA; [Thomson, James A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Zwaka, TP (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	tpzwaka@bcm.edu		Kyba, Michael/0000-0002-5579-7534	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL096360, T32 HL092332-06, T32 HL092332] Funding Source: Medline; NIBIB NIH HHS [R01 EB005173, P20 EB007076-02, R01 EB005173-01, P20 EB007076] Funding Source: Medline; NIGMS NIH HHS [R01 GM077442, P01 GM081627, P01 GM81627, P01 GM081627-010004] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096360, T32HL092332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005173, P20EB007076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077442, P01GM081627] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Damjanov I, 1974, Curr Top Pathol, V59, P69; de Botton S, 2002, BLOOD, V100, P1310, DOI 10.1182/blood-2002-03-0686; De Maria R, 1999, BLOOD, V93, P796, DOI 10.1182/blood.V93.3.796.403k23_796_803; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; EVANS M, 2004, HDB STEM CELLS, P413; Ishizaki Y, 1998, J CELL BIOL, V140, P153, DOI 10.1083/jcb.140.1.153; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kamada S, 1998, P NATL ACAD SCI USA, V95, P8532, DOI 10.1073/pnas.95.15.8532; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kyba M, 2003, P NATL ACAD SCI USA, V100, P11904, DOI 10.1073/pnas.1734140100; Laugwitz KL, 2001, HUM GENE THER, V12, P2051, DOI 10.1089/10430340152677403; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pan GJ, 2003, CELL RES, V13, P499, DOI 10.1038/sj.cr.7290193; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Srinivasula SM, 1998, J BIOL CHEM, V273, P10107, DOI 10.1074/jbc.273.17.10107; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yamane T, 2005, P NATL ACAD SCI USA, V102, P3312, DOI 10.1073/pnas.0500167102; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200	33	211	217	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN	2008	2	6					595	601		10.1016/j.stem.2008.04.001	http://dx.doi.org/10.1016/j.stem.2008.04.001			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	315HT	18522852	Bronze, Green Accepted			2022-12-24	WOS:000256870000017
J	Schwarz, JM; Liang, SL; Thompson, SM; McCarthy, MM				Schwarz, Jaclyn M.; Liang, Shu-Ling; Thompson, Scott M.; McCarthy, Margaret M.			Estradiol induces hypothalamic dendritic spines by enhancing glutamate release: A mechanism for organizational sex differences	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; VENTROMEDIAL NUCLEUS; PHOSPHATIDYLINOSITOL 3-KINASE; MESSENGER-RNA; SYNAPTIC ORGANIZATION; SIGNALING PATHWAY; ESTROGEN; DIFFERENTIATION; RECEPTORS; PHOSPHORYLATION	The naturally occurring sex difference in dendritic spine number on hypothalamic neurons offers a unique opportunity to investigate mechanisms establishing synaptic patterning during perinatal sensitive periods. A major advantage of the rat as a model of sexual differentiation is that treatment of neonatal females with estradiol will permanently induce the male phenotype. During the development of other systems, exuberant innervation is followed by activity-dependent dent pruning necessary for elimination of spurious synapses. In contrast, we demonstrate that estradiol-induced organization in the hypothalamus involves the induction of new synapses on dendritic spines. Activation of estrogen receptors by estradiol triggers a nongenomic activation of PI3 kinase that results in enhanced glutamate release from presynaptic neurons. Subsequent activation of ionotropic glutamate receptors activates MAP kinases, thereby inducing dendritic spine formation. These results reveal a transineuronal mechanism by which estradiol acts during a sensitive period to establish a profound and lasting sex difference in hypothalamic synaptic patterning.	[Schwarz, Jaclyn M.; Liang, Shu-Ling; Thompson, Scott M.; McCarthy, Margaret M.] Univ Maryland, Program Neurosci, Baltimore, MD 21201 USA; [Liang, Shu-Ling; Thompson, Scott M.; McCarthy, Margaret M.] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA; [Thompson, Scott M.; McCarthy, Margaret M.] Univ Maryland, Dept Psychiat, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Schwarz, JM (corresponding author), Univ Maryland, Program Neurosci, Baltimore, MD 21201 USA.	jschw005@umaryland.edu	McCarthy, Margaret/O-2059-2017; Thompson, Scott M/K-8921-2015	McCarthy, Margaret/0000-0003-2243-4726; 	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052716, R01MH065488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS055518] Funding Source: NIH RePORTER; NIMH NIH HHS [R01MH052716, R01MH065488] Funding Source: Medline; NINDS NIH HHS [F31 NS055518, F31 NS055518-01A2] Funding Source: Medline; PHS HHS [F31NSO55518] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abraham IM, 2005, NEUROSCIENCE, V131, P945, DOI 10.1016/j.neuroscience.2004.10.046; Amateau SK, 2004, NAT NEUROSCI, V7, P643, DOI 10.1038/nn1254; Amateau SK, 2002, J NEUROENDOCRINOL, V14, P904, DOI 10.1046/j.1365-2826.2002.00858.x; Amateau SK, 2002, J NEUROSCI, V22, P8586; ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Brager DH, 2003, J NEUROSCI, V23, P10475; Calizo LH, 2000, J NEUROSCI, V20, P1589; Capogna M, 1996, J NEUROPHYSIOL, V76, P3149, DOI 10.1152/jn.1996.76.5.3149; CARRER HF, 1982, BRAIN RES, V240, P221, DOI 10.1016/0006-8993(82)90218-9; Cousin MA, 2003, J BIOL CHEM, V278, P29065, DOI 10.1074/jbc.M302386200; Cremona O, 2001, J CELL SCI, V114, P1041; de Vries G.J., 2002, HORMONES BRAIN BEHAV, P137, DOI [10.1016/B978, DOI 10.1016/B978-012532104-4/50066-4]; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Gong LW, 2005, P NATL ACAD SCI USA, V102, P5204, DOI 10.1073/pnas.0501412102; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; HAVERKAMP LJ, 1986, J NEUROSCI, V6, P1332; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Huang F, 2007, J NEUROSCI, V27, P9054, DOI 10.1523/JNEUROSCI.2410-07.2007; Iyengar S, 2002, J NEUROSCI, V22, P946, DOI 10.1523/JNEUROSCI.22-03-00946.2002; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Lee SJ, 2004, NEUROSCIENCE, V124, P549, DOI 10.1016/j.neuroscience.2003.11.035; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; MATSUMOTO A, 1980, BRAIN RES, V190, P238, DOI 10.1016/0006-8993(80)91173-7; MATSUMOTO A, 1986, NEUROENDOCRINOLOGY, V42, P232, DOI 10.1159/000124445; MATSUMOTO A, 1986, NEUROSCI LETT, V68, P165, DOI 10.1016/0304-3940(86)90135-7; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; MCCARTHY MM, 1993, ENDOCRINOLOGY, V133, P433, DOI 10.1210/en.133.2.433; MCEWEN BS, 1977, J STEROID BIOCHEM, V8, P593, DOI 10.1016/0022-4731(77)90267-9; MILLER LDP, 1991, DEV BRAIN RES, V61, P189; Mong JA, 1999, J NEUROSCI, V19, P1464; Mong JA, 2002, J NEUROENDOCRINOL, V14, P45, DOI 10.1046/j.1365-2826.2002.00737.x; Mori Y, 2004, CELL STRUCT FUNCT, V29, P101, DOI 10.1247/csf.29.101; Murphy DD, 1996, J NEUROSCI, V16, P4059; NAFTOLIN F, 1971, J CLIN ENDOCR METAB, V33, P368, DOI 10.1210/jcem-33-2-368; O'Malley D, 2007, EUR J NEUROSCI, V25, P673, DOI 10.1111/j.1460-9568.2007.05347.x; Opazo P, 2003, J NEUROSCI, V23, P3679; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Perrot-Sinal TS, 2001, ENDOCRINOLOGY, V142, P2238, DOI 10.1210/en.142.6.2238; Pyle JL, 1999, NEURON, V24, P803, DOI 10.1016/S0896-6273(00)81028-4; Quadros PS, 2002, ENDOCRINOLOGY, V143, P3727, DOI 10.1210/en.2002-211438; Rizzoli SO, 2002, J NEUROSCI, V22, P10680; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; Singh M, 1999, J NEUROSCI, V19, P1179; Speert DB, 2007, ENDOCRINOLOGY, V148, P3391, DOI 10.1210/en.2006-0845; Todd BJ, 2005, HORM BEHAV, V48, P512, DOI 10.1016/j.yhbeh.2005.07.011; Todd BJ, 2007, DEV NEUROBIOL, V67, P304, DOI 10.1002/dneu.20337; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Uht RM, 1997, ENDOCRINOLOGY, V138, P2900, DOI 10.1210/en.138.7.2900; Vasudevan N, 2007, ENDOCR REV, V28, P1, DOI 10.1210/er.2005-0021; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Yokomaku D, 2003, MOL ENDOCRINOL, V17, P831, DOI 10.1210/me.2002-0314; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhou Y, 1996, ENDOCRINOLOGY, V137, P2163, DOI 10.1210/en.137.5.2163; Znamensky V, 2003, J NEUROSCI, V23, P2340; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	65	108	109	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 22	2008	58	4					584	598		10.1016/j.neuron.2008.03.008	http://dx.doi.org/10.1016/j.neuron.2008.03.008			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304PD	18498739	Bronze, Green Accepted			2022-12-24	WOS:000256120500012
J	Braun, KM				Braun, Kristin M.			Cutaneous cancer stem cells: beta-catenin strikes again	CELL STEM CELL			English	Editorial Material							HAIR FOLLICLE BULGE	Cancer stem cells (CSCs) are a subpopulation of tumor cells that retain properties of tissue-specific stem cells, including the ability to self-renew. In a recent article in Nature, Malanchi et al. (2008) identified a population of CD34(+) cells in epidermal tumors that require beta-catenin signaling to maintain a CSC phenotype.	Barts & London Queen Marys Sch Med & Dent, Ctr Cutaneous Res, Inst Cell & Mol Sci, London E1 2AT, England	University of London; Queen Mary University London	Braun, KM (corresponding author), Barts & London Queen Marys Sch Med & Dent, Ctr Cutaneous Res, Inst Cell & Mol Sci, 4 Newark St, London E1 2AT, England.	k.braun@qmul.ac.uk			Medical Research Council [G0500502] Funding Source: Medline; MRC [G0500502] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Morris RJ, 2000, J CLIN INVEST, V106, P3, DOI 10.1172/JCI10508; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153	10	4	4	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY	2008	2	5					406	408		10.1016/j.stem.2008.04.011	http://dx.doi.org/10.1016/j.stem.2008.04.011			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	300BM	18462688	Bronze			2022-12-24	WOS:000255799300002
J	Cohen, CB; Brandhorst, B; Nagy, A; Leader, A; Dickens, B; Isasi, RM; Evans, D; Knoppers, BM				Cohen, Cynthia B.; Brandhorst, Bruce; Nagy, Andras; Leader, Arthur; Dickens, Bernard; Isasi, Rosario M.; Evans, Donald; Knoppers, Bartha M.			The use of fresh embryos in stem cell research ethical and policy issues	CELL STEM CELL			English	Article							LINES; DERIVATION	Fresh embryos resulting from in vitro fertilization, including many of poor quality, can provide sources of human embryonic stem cell lines. We consider why some donate such embryos for this research, address relevant ethical and policy issues, and present core guidelines for fresh embryo donation based on those of Canada.	[Cohen, Cynthia B.] Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA; [Brandhorst, Bruce] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Leader, Arthur] Univ Ottawa, Fac Med, Ottawa, ON K1H 8M5, Canada; [Isasi, Rosario M.; Knoppers, Bartha M.] Univ Montreal, Fac Droit, Montreal, PQ H3C 3J7, Canada; [Evans, Donald] Dunedin Sch MEd, Bioeth Ctr, Dunedin 9010, New Zealand; [Dickens, Bernard] Univ Toronto, Fac Law, Toronto, ON M5S 2C5, Canada	Georgetown University; Simon Fraser University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Ottawa; Universite de Montreal; University of Otago; University of Toronto	Cohen, CB (corresponding author), Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA.	ccohenp@aol.com	Nagy, Andras/G-6465-2013	Nagy, Andras/0000-0003-4311-0413				*AM SOC REPR MED E, 2004, FERTIL STERIL, V82, pS224; Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Baczkowski Tomasz, 2004, Reprod Biol, V4, P5; Bankowski BJ, 2005, FERTIL STERIL, V84, P823, DOI 10.1016/j.fertnstert.2005.02.057; Barratt CLR, 2004, LANCET, V364, P115, DOI 10.1016/S0140-6736(04)16649-X; Baylis F., 2007, MCGILL HLTH LAW PUBL, V1, P53; Chen H, 2005, HUM REPROD, V20, P2201, DOI 10.1093/humrep/dei010; Choudhary M, 2004, HUM REPROD, V19, P2091, DOI 10.1093/humrep/deh401; Cohen CB, 2001, BASIC BIOETH, P209; Dickens BM, 2007, INT J GYNECOL OBSTET, V96, P67, DOI 10.1016/j.ijgo.2006.10.005; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Elford K, 2004, FERTIL STERIL, V81, P1154, DOI 10.1016/j.fertnstert.2003.08.048; ELGENDY AR, 2005, INT ISLAMIC CODE MED, P328; Enzle Michael, 2008, HLTH LAW REV, V16, P86; Hoffman DI, 2003, FERTIL STERIL, V79, P1063, DOI 10.1016/S0015-0282(03)00172-9; Hyun I, 2007, CELL STEM CELL, V1, P367, DOI 10.1016/j.stem.2007.09.006; Lerou PH, 2008, NAT BIOTECHNOL, V26, P212, DOI 10.1038/nbt1378; Lysdahl H, 2006, REPROD BIOMED ONLINE, V12, P119, DOI 10.1016/S1472-6483(10)60990-X; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Nisker J, 2005, CAN MED ASSOC J, V173, P621, DOI 10.1503/cmaj.050453; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pera MF, 2008, NATURE, V451, P135, DOI 10.1038/451135a; Pickering SJ, 2005, REPROD BIOMED ONLINE, V10, P390, DOI 10.1016/S1472-6483(10)61801-9; Sjoblom P, 2006, FERTIL STERIL, V86, P848, DOI 10.1016/j.fertnstert.2006.03.040; Sjogren A, 2004, REPROD BIOMED ONLINE, V9, P326; Svanberg AS, 2001, ACTA OBSTET GYN SCAN, V80, P849, DOI 10.1034/j.1600-0412.2001.080009849.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; *UK HUM FERT EMBR, 2007, COD PRACT; Veeck LL, 2004, FERTIL STERIL, V82, P1418, DOI 10.1016/j.fertnstert.2004.03.068; Zhang X, 2006, STEM CELLS, V24, P2669, DOI 10.1634/stemcells.2006-0377	33	12	12	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY	2008	2	5					416	421		10.1016/j.stem.2008.04.002	http://dx.doi.org/10.1016/j.stem.2008.04.002			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	300BM	18462692	Bronze			2022-12-24	WOS:000255799300007
J	London, SE; Clayton, DF				London, Sarah E.; Clayton, David F.			Functional identification of sensory mechanisms required for developmental song learning	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ADULT ZEBRA FINCHES; ZENK GENE RESPONSE; TAENIOPYGIA-GUTTATA; SYNAPTIC PLASTICITY; NEURAL MECHANISMS; CONSPECIFIC SONG; BIRDSONG MEMORY; FOREBRAIN; EXPRESSION	A young male zebra finch (Taeniopygia guttata) learns to sing by copying the vocalizations of an older tutor in a process that parallels human speech acquisition. Brain pathways that control song production are well defined, but little is known about the sites and mechanisms of tutor song memorization. Here we test the hypothesis that molecular signaling in a sensory brain area outside of the song system is required for developmental song learning. Using controlled tutoring and a pharmacological inhibitor, we transiently suppressed the extracellular signal-regulated kinase signaling pathway in a portion of the auditory forebrain specifically during tutor song exposure. On maturation, treated birds produced poor copies of tutor song, whereas controls copied the tutor song effectively. Thus the foundation of normal song learning, the formation of a sensory memory of tutor song, requires a conserved molecular pathway in a brain area that is distinct from the circuit for song motor control.	[London, Sarah E.; Clayton, David F.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Clayton, David F.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Clayton, David F.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	London, SE (corresponding author), Univ Illinois, Inst Genom Biol, 2500N IGB,MC-195,1206 W Gregory Dr, Urbana, IL 61801 USA.	slondon@igb.uiuc.edu; dclayton@uiuc.edu	Clayton, David/B-2190-2008	Clayton, David/0000-0002-6395-3488; London, Sarah/0000-0002-7839-2644	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045264, R01NS051820, F32NS055413] Funding Source: NIH RePORTER; NINDS NIH HHS [F32 NS055413-01A2, R01 NS051820-13, R01 NS045264, R01 NS051820, NS045264] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adret P, 2004, ANN NY ACAD SCI, V1016, P303, DOI 10.1196/annals.1298.005; Apergis-Schoute AM, 2005, J NEUROSCI, V25, P5730, DOI 10.1523/JNEUROSCI.0096-05.2005; Basham ME, 1996, NEUROBIOL LEARN MEM, V66, P295, DOI 10.1006/nlme.1996.0071; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2001, EUR J NEUROSCI, V13, P2165, DOI 10.1046/j.0953-816x.2001.01588.x; Bolhuis JJ, 2000, P NATL ACAD SCI USA, V97, P2282, DOI 10.1073/pnas.030539097; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; Cheng HY, 2004, J NEUROSCI, V24, P7503, DOI 10.1523/JNEUROSCI.1405-04.2004; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1368, DOI 10.1073/pnas.89.4.1368; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Doupe AJ, 2004, ANN NY ACAD SCI, V1016, P495, DOI 10.1196/annals.1298.035; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EALES LA, 1987, ANIM BEHAV, V35, P1356, DOI 10.1016/S0003-3472(87)80008-8; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Gahr M, 2000, J COMP NEUROL, V426, P182; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hessler NA, 1999, J NEUROSCI, V19, P10461; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jin H, 1997, NEURON, V19, P1049, DOI 10.1016/S0896-6273(00)80396-7; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kim JJ, 2006, STRESS, V9, P1, DOI 10.1080/10253890600678004; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kruse AA, 2004, NEUROBIOL LEARN MEM, V82, P99, DOI 10.1016/j.nlm.2004.05.001; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; MELLO C, 1995, J NEUROSCI, V15, P6919; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Park KHJ, 2002, BEHAV BRAIN RES, V136, P185, DOI 10.1016/S0166-4328(02)00129-8; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Roper A, 2006, ETHOLOGY, V112, P458, DOI 10.1111/j.1439-0310.2005.01169.x; Sauro MD, 2003, STRESS, V6, P235, DOI 10.1080/10253890310001616482; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Stripling R, 1997, J NEUROSCI, V17, P3883; Sturdy CB, 2001, ANIM BEHAV, V62, P1207, DOI 10.1006/anbe.2001.1864; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Terpstra NJ, 2006, J COMP NEUROL, V494, P784, DOI 10.1002/cne.20831; Terpstra NJ, 2004, J NEUROSCI, V24, P4971, DOI 10.1523/JNEUROSCI.0570-04.2004; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7	49	153	153	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					579	586		10.1038/nn.2103	http://dx.doi.org/10.1038/nn.2103			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18391944	Green Accepted			2022-12-24	WOS:000255327300017
J	Anderson, SM; Famous, KR; Sadri-Vakili, G; Kumaresan, V; Schmidt, HD; Bass, CE; Terwilliger, EF; Cha, JHJ; Pierce, RC				Anderson, Sharon M.; Famous, Katie R.; Sadri-Vakili, Ghazaleh; Kumaresan, Vidhya; Schmidt, Heath D.; Bass, Caroline E.; Terwilliger, Ernest F.; Cha, Jang-Ho J.; Pierce, R. Christopher			CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; VENTRAL TEGMENTAL AREA; RECEPTOR STIMULATION INCREASES; INDUCED BEHAVIORAL SENSITIZATION; PRIMING-INDUCED REINSTATEMENT; NUCLEUS-ACCUMBENS; AMPA RECEPTOR; SYNAPTIC PLASTICITY; DRUG-SEEKING; SURFACE EXPRESSION	Increases in dopamine and glutamate transmission in the nucleus accumbens independently promote the reinstatement of cocaine seeking, an animal model of relapse. Here we have tested whether cocaine reinstatement in rats depends on interactions between accumbal dopamine and glutamate systems that are mediated by Ca2+/calmodulin-mediated kinase II (CaMKII). We show that stimulation of D1-like dopamine receptors in the nucleus accumbens shell reinstates cocaine seeking by activating L-type Ca2+ channels and CaMKII. Cocaine reinstatement is associated with D1-like dopamine receptor-dependent increases in accumbens shell CaMKII phosphorylated on Thr286 and glutamate receptor 1 (GluR1) phosphorylated on Ser831 (a known CaMKII phosphorylation site), in addition to increases in cell-surface expression of GluR1-containing AMPA receptors in the shell. Consistent with these findings, cocaine reinstatement is attenuated by intra-shell administration of AAV10-GluR1-C99, a vector that impairs the transport of GluR1-containing AMPA receptors. Thus, CaMKII may be an essential link between accumbens shell dopamine and glutamate systems involved in the neuronal plasticity underlying cocaine craving and relapse.	[Anderson, Sharon M.; Famous, Katie R.; Kumaresan, Vidhya; Schmidt, Heath D.; Pierce, R. Christopher] Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02118 USA; [Pierce, R. Christopher] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Sadri-Vakili, Ghazaleh] Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Bass, Caroline E.; Terwilliger, Ernest F.] Beth Israel Deaconess Med Ctr, Harvard Inst Med, Div Expt Med, Boston, MA 02115 USA; [Terwilliger, Ernest F.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Boston University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Pierce, RC (corresponding author), Boston Univ, Sch Med, Dept Pharmacol, 715 Albany St, Boston, MA 02118 USA.	rcpierce@bu.edu	Kumaresan, Vidhya/ABD-6847-2020	Kumaresan, Vidhya/0000-0002-3374-5741; Bass, Caroline/0000-0002-5856-6387	NIDA NIH HHS [DA16824, R21 DA18333, K02 DA18678, F30 DA19304, F32 DA017543, R01 DA15214] Funding Source: Medline; NIGMS NIH HHS [T32 GM008541-7] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA019304, F31DA016824, R01DA015214, R21DA018333, K02DA018678, F32DA017543] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anderson SM, 2003, PSYCHOPHARMACOLOGY, V168, P132, DOI 10.1007/s00213-002-1298-5; Bachtell RK, 2005, PSYCHOPHARMACOLOGY, V183, P41, DOI 10.1007/s00213-005-0133-1; Beurrier C, 2002, J NEUROSCI, V22, P5817; Boehm J, 2005, BIOCHEM SOC T, V33, P1354, DOI 10.1042/BST0331354; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; Chao SZ, 2002, J NEUROCHEM, V83, P704, DOI 10.1046/j.1471-4159.2002.01164.x; Chartoff EH, 2006, BIOL PSYCHIAT, V59, P1236, DOI 10.1016/j.biopsych.2005.09.024; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cooper DC, 2000, BRAIN RES, V880, P212, DOI 10.1016/S0006-8993(00)02868-7; Cornish JL, 1999, NEUROSCIENCE, V93, P1359, DOI 10.1016/S0306-4522(99)00214-6; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Edwards S, 2007, EUR J NEUROSCI, V25, P2201, DOI 10.1111/j.1460-9568.2007.05473.x; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Galarraga E, 1997, NEUROREPORT, V8, P2183, DOI 10.1097/00001756-199707070-00019; Gnegy ME, 2000, CRIT REV NEUROBIOL, V14, P91; Gonzalez-Islas C, 2003, J NEUROSCI, V23, P867; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Licata SC, 2003, J NEUROCHEM, V85, P14, DOI 10.1046/j.1471-4159.2003.01662.x; Licata SC, 2004, EUR J NEUROSCI, V19, P405, DOI 10.1111/j.0953-816X.2003.03110.x; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lu L, 2003, J NEUROCHEM, V85, P1604, DOI 10.1046/j.1471-4159.2003.01824.x; Lynch WJ, 2005, EUR J NEUROSCI, V22, P1214, DOI 10.1111/j.1460-9568.2005.04305.x; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; McFarland K, 2003, J NEUROSCI, V23, P3531; Park WK, 2002, J NEUROSCI, V22, P2916, DOI 10.1523/JNEUROSCI.22-07-02916.2002; Pierce RC, 1998, J PHARMACOL EXP THER, V286, P1171; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Scheggi S, 2002, NEUROSCIENCE, V109, P267, DOI 10.1016/S0306-4522(01)00483-3; Schmidt HD, 2006, NEUROSCIENCE, V142, P451, DOI 10.1016/j.neuroscience.2006.06.004; Schmidt HD, 2006, EUR J NEUROSCI, V23, P219, DOI 10.1111/j.1460-9568.2005.04524.x; Schmidt HD, 2005, EUR J PHARMACOL, V526, P65, DOI 10.1016/j.ejphar.2005.09.068; Self DW, 1998, J NEUROSCI, V18, P1848; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Suemaru J, 2000, SYNAPSE, V36, P155, DOI 10.1002/(SICI)1098-2396(20000601)36:3<155::AID-SYN1>3.0.CO;2-N; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Suto N, 2004, NEUROPSYCHOPHARMACOL, V29, P2149, DOI 10.1038/sj.npp.1300533; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	50	238	245	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					344	353		10.1038/nn2054	http://dx.doi.org/10.1038/nn2054			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18278040				2022-12-24	WOS:000253548300018
J	Stranahan, AM; Arumugam, TV; Cutler, RG; Lee, K; Egan, JM; Mattson, MP				Stranahan, Alexis M.; Arumugam, Thiruma V.; Cutler, Roy G.; Lee, Kim; Egan, Josephine M.; Mattson, Mark P.			Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; STRESS-INDUCED IMPAIRMENTS; SYNAPTIC PLASTICITY; ADULT NEUROGENESIS; GRANULE CELLS; CORTISOL-LEVELS; SPATIAL MEMORY; DENTATE GYRUS; RAT; HYPERGLYCEMIA	Many organ systems are adversely affected by diabetes, including the brain, which undergoes changes that may increase the risk of cognitive decline. Although diabetes influences the hypothalamic-pituitary-adrenal axis, the role of this neuroendocrine system in diabetes-induced cognitive dysfunction remains unexplored. Here we demonstrate that, in both insulin-deficient rats and insulin-resistant mice, diabetes impairs hippocampus-dependent memory, perforant path synaptic plasticity and adult neurogenesis, and the adrenal steroid corticosterone contributes to these adverse effects. Rats treated with streptozocin have reduced insulin and show hyperglycemia, increased corticosterone, and impairments in hippocampal neurogenesis, synaptic plasticity and learning. Similar deficits are observed in db/db mice, which are characterized by insulin resistance, elevated corticosterone and obesity. Changes in hippocampal plasticity and function in both models are reversed when normal physiological levels of corticosterone are maintained, suggesting that cognitive impairment in diabetes may result from glucocorticoid-mediated deficits in neurogenesis and synaptic plasticity.	[Stranahan, Alexis M.; Arumugam, Thiruma V.; Cutler, Roy G.; Lee, Kim; Mattson, Mark P.] NIA, Intramural Res Program, Neurosci Lab, Cellular & Mol Neurosci Sect, Baltimore, MD 21224 USA; [Egan, Josephine M.] NIA, Intramural Res Program, Diabet Sect, Lab Child Invest, Baltimore, MD 21224 USA; [Stranahan, Alexis M.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Princeton University	Mattson, MP (corresponding author), NIA, Intramural Res Program, Neurosci Lab, Cellular & Mol Neurosci Sect, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Arumugam, Thiruma Valavan/B-4898-2011; Arumugam, Thiruma/AAG-6958-2019; Arumugam, Thiruma/C-7969-2009; Cutler, Roy G./L-5572-2013; Mattson, Mark P/F-6038-2012; Stranahan, Alexis/AAF-3559-2020	Lee, Kim/0000-0002-5675-1896; Arumugam, Thiruma/0000-0002-3377-0939	NATIONAL INSTITUTE ON AGING [F31AG024690, ZIAAG000312, ZIAAG000315, ZIAAG000330, Z01AG000314, ZIAAG000317, Z01AG000313] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AG000312-07, Z01 AG000314-07, Z01 AG000313-07] Funding Source: Medline; NIA NIH HHS [F31 AG024690-01, F31 AG024690-03, F31AG024690-03, F31 AG024690-04, F31 AG024690, F31 AG024690-02] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alfarez DN, 2003, EUR J NEUROSCI, V17, P1928, DOI 10.1046/j.1460-9568.2003.02622.x; Biessels GJ, 1998, BRAIN RES, V800, P125, DOI 10.1016/S0006-8993(98)00510-1; Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chan O, 2005, AM J PHYSIOL-REG I, V289, pR235, DOI 10.1152/ajpregu.00674.2004; Desrocher M, 2004, CHILD NEUROPSYCHOL, V10, P36, DOI 10.1076/chin.10.1.36.26241; Elgh E, 2006, BIOL PSYCHIAT, V59, P155, DOI 10.1016/j.biopsych.2005.06.017; Fontan-Lozano A, 2007, J NEUROSCI, V27, P10185, DOI 10.1523/JNEUROSCI.2757-07.2007; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; GOULD E, 1992, J NEUROSCI, V12, P3642; Green MC, 2005, POLIT PSYCHOL, V26, P1, DOI 10.1111/j.1467-9221.2005.00407.x; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Kamal A, 1999, NEUROSCIENCE, V90, P737, DOI 10.1016/S0306-4522(98)00485-0; Karten YJG, 2006, HIPPOCAMPUS, V16, P312, DOI 10.1002/hipo.20165; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; KERR DS, 1989, SCIENCE, V245, P1505, DOI 10.1126/science.2781293; Korz V, 2003, J NEUROSCI, V23, P7281; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; LANGLEY SC, 1990, AM J PHYSIOL, V259, pR539, DOI 10.1152/ajpregu.1990.259.3.R539; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Li XL, 2002, NEUROSCIENCE, V113, P607, DOI 10.1016/S0306-4522(02)00162-8; MacLullich AMJ, 2005, PSYCHONEUROENDOCRINO, V30, P505, DOI 10.1016/j.psyneuen.2004.12.005; Magarinos AM, 2000, P NATL ACAD SCI USA, V97, P11056, DOI 10.1073/pnas.97.20.11056; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; MESSIER C, 2005, AGING S1, V26, pS26; Montaron MF, 2006, NEUROBIOL AGING, V27, P645, DOI 10.1016/j.neurobiolaging.2005.02.014; Moosavi M, 2007, BEHAV BRAIN RES, V176, P230, DOI 10.1016/j.bbr.2006.10.011; Oei NYL, 2006, STRESS, V9, P133, DOI 10.1080/10253890600965773; Oitzl MS, 1998, EUR J NEUROSCI, V10, P3759, DOI 10.1046/j.1460-9568.1998.00381.x; PAVLIDES C, 1993, HIPPOCAMPUS, V3, P183, DOI 10.1002/hipo.450030210; Piroli GG, 2007, NEUROENDOCRINOLOGY, V85, P71, DOI 10.1159/000101694; Reagan LP, 2001, P NATL ACAD SCI USA, V98, P2820, DOI 10.1073/pnas.051629798; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Sandeep TC, 2004, P NATL ACAD SCI USA, V101, P6734, DOI 10.1073/pnas.0306996101; SAPOLSKY RM, 1986, J NEUROSCI, V6, P2240; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; TOKUYAMA K, 1987, AM J PHYSIOL, V252, pE202, DOI 10.1152/ajpendo.1987.252.2.E202; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Watts LM, 2005, DIABETES, V54, P1846, DOI 10.2337/diabetes.54.6.1846; Wright RL, 2006, EUR J NEUROSCI, V24, P595, DOI 10.1111/j.1460-9568.2006.04948.x; Zhang WJ, 2008, ACTA NEUROL SCAND, V117, P205, DOI 10.1111/j.1600-0404.2007.00928.x	48	461	480	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					309	317		10.1038/nn2055	http://dx.doi.org/10.1038/nn2055			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18278039	Green Accepted			2022-12-24	WOS:000253548300014
J	Acharya, JK; Dasgupta, U; Rawat, SS; Yuan, CQ; Sanxaridis, PD; Yonamine, I; Karim, P; Nagashima, K; Brodsky, MH; Tsunoda, S; Acharya, U				Acharya, Jairaj K.; Dasgupta, Ujjaini; Rawat, Satinder S.; Yuan, Changqing; Sanxaridis, Parthena D.; Yonamine, Ikuko; Karim, Pusha; Nagashima, Kunio; Brodsky, Michael H.; Tsunoda, Susan; Acharya, Usha			Cell-nonautonomous function of ceramidase in photoreceptor homeostasis	NEURON			English	Article							RHODOPSIN-ARRESTIN COMPLEXES; DROSOPHILA-MELANOGASTER; SPHINGOSINE 1-PHOSPHATE; NEUTRAL CERAMIDASE; RETINAL DEGENERATION; VISUAL TRANSDUCTION; ENDOCYTOSIS; MEMBRANE; SPHINGOLIPIDS; APOPTOSIS	Neutral ceramidase, a key enzyme of sphingolipid metabolism, hydrolyzes ceramide to sphingosine. These sphingolipids are critical structural components of cell membranes and act as second messengers in diverse signal transduction cascades. Here, we have isolated and characterized functional null mutants of Drosophila ceramidase. We show that secreted ceramidase functions in a cell-nonautonomous manner to maintain photoreceptor homeostasis. In the absence of ceramidase, photoreceptors degenerate in a light-dependent manner, are defective in normal endocytic turnover of rhodopsin, and do not respond to light stimulus. Consistent with a cell-nonautonomous function, overexpression of ceramidase in tissues distant from photoreceptors suppresses photoreceptor degeneration in an arrestin mutant and facilitates membrane turnover in a rhodopsin null mutant. Furthermore, our results show that secreted ceramidase is internalized and localizes to endosomes. Our findings establish a role for a secreted sphingolipid enzyme in the regulation of photoreceptor structure and function.	[Dasgupta, Ujjaini; Rawat, Satinder S.; Yonamine, Ikuko; Karim, Pusha; Brodsky, Michael H.; Acharya, Usha] Univ Massachusetts, Sch Med, Program Mol Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Acharya, Jairaj K.; Yuan, Changqing] NCI, Lab Cell & Dev Signaling, Frederick, MD 21702 USA; [Sanxaridis, Parthena D.; Tsunoda, Susan] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Nagashima, Kunio] SAIC, Image Anal Lab, EM Facil, Frederick, MD 21702 USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Boston University; Science Applications International Corporation (SAIC); SAIC-Frederick	Acharya, U (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	usha.acharya@umassmed.edu		DASGUPTA, UJJAINI/0000-0002-2281-078X; Acharya, Jairaj/0000-0001-7366-4228	Intramural NIH HHS Funding Source: Medline; NEI NIH HHS [R01 EY013751, R01 EY016469-02, R01EY013751, R01EY16469, R01 EY016469-03, R01 EY016469, R01 EY016469-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010331] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016469, R01EY013751] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acharya U, 2006, J CELL BIOL, V173, P69, DOI 10.1083/jcb.200506159; Acharya U, 2005, CELL MOL LIFE SCI, V62, P128, DOI 10.1007/s00018-004-4254-1; Acharya U, 2004, P NATL ACAD SCI USA, V101, P1922, DOI 10.1073/pnas.0308693100; Acharya U, 2003, SCIENCE, V299, P1740, DOI 10.1126/science.1080549; Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P7276; Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; CHEN CS, 1995, J BIOL CHEM, V270, P13291, DOI 10.1074/jbc.270.22.13291; Chuang JZ, 2004, J CLIN INVEST, V114, P131, DOI 10.1172/JCI200421136; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; Dollar G, 2002, DEVELOPMENT, V129, P517; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Kumar JP, 1995, DEVELOPMENT, V121, P4359; KURADA P, 1995, NEURON, V14, P571, DOI 10.1016/0896-6273(95)90313-5; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Li CM, 2002, GENOMICS, V79, P218, DOI 10.1006/geno.2002.6686; Marks DL, 2005, METHODS, V36, P186, DOI 10.1016/j.ymeth.2004.12.001; Mitsutake S, 2007, BIOCHEM BIOPH RES CO, V359, P622, DOI 10.1016/j.bbrc.2007.05.160; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Newsome TP, 2000, DEVELOPMENT, V127, P851; Orem NR, 2006, J CELL SCI, V119, P3141, DOI 10.1242/jcs.03052; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Rohrbough J, 2004, J NEUROSCI, V24, P7789, DOI 10.1523/JNEUROSCI.1146-04.2004; Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Sisson JC, 2000, J CELL BIOL, V151, P905, DOI 10.1083/jcb.151.4.905; Spiegel S, 2003, BIOCHEM SOC T, V31, P1216; STARK WS, 1988, J NEUROCYTOL, V17, P499, DOI 10.1007/BF01189805; SUGITA M, 1972, SCIENCE, V178, P1100, DOI 10.1126/science.178.4065.1100; Tani M, 2003, J BIOL CHEM, V278, P10523, DOI 10.1074/jbc.M207932200; Thomas RL, 1999, J BIOL CHEM, V274, P30580, DOI 10.1074/jbc.274.43.30580; Webel R, 2000, J BIOL CHEM, V275, P24752, DOI 10.1074/jbc.M002668200; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yoshimura Y, 2002, J BIOCHEM, V132, P229, DOI 10.1093/oxfordjournals.jbchem.a003215; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	52	43	43	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 10	2008	57	1					69	79		10.1016/j.neuron.2007.10.041	http://dx.doi.org/10.1016/j.neuron.2007.10.041			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	250YZ	18184565	Green Accepted, Bronze			2022-12-24	WOS:000252338600010
J	Rebola, N; Lujan, R; Cunha, RA; Mulle, C				Rebola, Nelson; Lujan, Rafael; Cunha, Rodrigo A.; Mulle, Christophe			Adenosine A(2A) receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses	NEURON			English	Article							MEDIATED SYNAPTIC-TRANSMISSION; METABOTROPIC GLUTAMATE RECEPTORS; INDUCED LTP; ACTIVATION; MODULATION; PLASTICITY; STIMULATION; DEPRESSION; CURRENTS; MGLUR5	The physiological conditions under which adenosine A(2A) receptors modulate synaptic transmission are presently unclear. We show that A(2A) receptors are localized postsynaptically at synapses between mossy fibers and CA3 pyramidal cells and are essential for a form of long-term potentiation (LTP) of NMDA-EPSCs induced by short bursts of mossy fiber stimulation. This LTP spares AMPA-EPSCs and is likely induced and expressed postsynaptically. It depends on a postsynaptic Ca2+ rise, on G protein activation, and on Src kinase. In addition to A(2A) receptors, LTP of NMDA-EPSCs requires the activation of NMDA and mGluR5 receptors as potential sources of Ca2+ increase. LTP of NMDA-EPSCs displays a lower threshold for induction as compared with the conventional presynaptic mossy fiber LTP; however, the two forms of LTP can combine with stronger induction protocols. Thus, postsynaptic A(2A) receptors may potentially affect information processing in CA3 neuronal networks and memory performance.	[Rebola, Nelson; Mulle, Christophe] Univ Bordeaux 2, Bordeaux Neurosci Inst, UMR CNRS 5091, Lab Physiol Cellulaire Synapse, F-33076 Bordeaux, France; [Rebola, Nelson; Cunha, Rodrigo A.] Univ Coimbra, Fac Med, Inst Biochem, Ctr Neurosci Coimbra, P-3004504 Coimbra, Portugal; [Lujan, Rafael] Univ Castilla La Mancha, Fac Med CRIB, Dept Ciencias Med, Albacete 02006, Spain	UDICE-French Research Universities; Universite de Bordeaux; Universidade de Coimbra; Universidad de Castilla-La Mancha	Mulle, C (corresponding author), Univ Bordeaux 2, Bordeaux Neurosci Inst, UMR CNRS 5091, Lab Physiol Cellulaire Synapse, F-33076 Bordeaux, France.	mulle@u-bordeaux2.fr	Lujan, Rafael/G-2555-2015; Cunha, Rodrigo A/E-7475-2015	Cunha, Rodrigo A/0000-0003-2550-6422; Mulle, Christophe/0000-0003-2709-6615; Lujan Miras, Rafael/0000-0003-2001-9545				BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Ciruela F, 2006, J NEUROSCI, V26, P2080, DOI 10.1523/JNEUROSCI.3574-05.2006; CorreiadeSa P, 1996, J NEUROPHYSIOL, V76, P3910, DOI 10.1152/jn.1996.76.6.3910; Cunha RA, 2001, NEUROCHEM INT, V38, P107, DOI 10.1016/S0197-0186(00)00034-6; Diogenes MJ, 2004, J NEUROSCI, V24, P2905, DOI 10.1523/JNEUROSCI.4454-03.2004; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Harney SC, 2006, J NEUROSCI, V26, P1128, DOI 10.1523/JNEUROSCI.2753-05.2006; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Kishimoto Y, 2006, J NEUROSCI, V26, P1562, DOI 10.1523/JNEUROSCI.4142-05.2006; Kotecha SA, 2003, J BIOL CHEM, V278, P27742, DOI 10.1074/jbc.M301946200; Kotecha SA, 2003, INT REV NEUROBIOL, V54, P53; Kukley M, 2005, J NEUROSCI, V25, P2832, DOI 10.1523/JNEUROSCI.4260-04.2005; Lei SB, 2003, J NEUROSCI, V23, P9786; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lopes LV, 2002, NEUROSCIENCE, V112, P319, DOI 10.1016/S0306-4522(02)00080-5; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Macdonald DS, 2005, J NEUROSCI, V25, P11374, DOI 10.1523/JNEUROSCI.3871-05.2005; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Marchal C, 2004, J PHYSIOL-LONDON, V561, P27, DOI 10.1113/jphysiol.2004.069922; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; Moore KA, 2003, P NATL ACAD SCI USA, V100, P14397, DOI 10.1073/pnas.1835831100; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; OCONNOR JJ, 1994, NATURE, V367, P557, DOI 10.1038/367557a0; OCONNOR JJ, 1995, J NEUROSCI, V15, P2013, DOI 10.1523/JNEUROSCI.15-03-02013.1995; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; PERKEL DJ, 1993, NEURON, V11, P817, DOI 10.1016/0896-6273(93)90111-4; Pinheiro PS, 2007, P NATL ACAD SCI USA, V104, P12181, DOI 10.1073/pnas.0608891104; Pinto-Duarte A, 2005, J NEUROCHEM, V93, P595, DOI 10.1111/j.1471-4159.2005.03071.x; Rajji T, 2006, J NEUROSCI, V26, P908, DOI 10.1523/JNEUROSCI.4194-05.2006; Rebola N, 2005, NEUROSCIENCE, V132, P893, DOI 10.1016/j.neuroscience.2005.01.014; Rebola N, 2007, J NEUROSCI, V27, P3987, DOI 10.1523/JNEUROSCI.5182-06.2007; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Tebano MT, 2005, J NEUROCHEM, V95, P1188, DOI 10.1111/j.1471-4159.2005.03455.x; Wirkner K, 2004, NEUROPHARMACOLOGY, V46, P994, DOI 10.1016/j.neuropharm.2004.01.008; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	41	265	271	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 10	2008	57	1					121	134		10.1016/j.neuron.2007.11.023	http://dx.doi.org/10.1016/j.neuron.2007.11.023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	250YZ	18184569	Bronze			2022-12-24	WOS:000252338600014
J	Lengerke, C; Schmitt, S; Bowman, TV; Jang, IH; Maouche-Chretien, L; McKinney-Freeman, S; Davidson, AJ; Hammerschmidt, M; Rentzsch, F; Green, JBA; Zon, LI; Daley, GQ				Lengerke, Claudia; Schmitt, Sabine; Bowman, Teresa V.; Jang, Il Ho; Maouche-Chretien, Leila; McKinney-Freeman, Shannon; Davidson, Alan J.; Hammerschmidt, Matthias; Rentzsch, Fabian; Green, Jeremy B. A.; Zon, Leonard I.; Daley, George Q.			BMP and Wnt specify hematopoietic fate by activation of the Cdx-Hox pathway	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELL; BONE MORPHOGENETIC PROTEIN-4; ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; DEFINITIVE HEMATOPOIESIS; PRIMITIVE ERYTHROPOIESIS; COMMON PRECURSOR; MOUSE EMBRYO; ZEBRAFISH; DIFFERENTIATION	The formation of blood in the embryo is dependent on bone morphogenetic protein (BMP), but how BMP signaling intersects with other regulators of hematopoietic development is unclear. Using embryonic stem (ES) cells, we show that BMP4 first induces ventral-posterior (V-P) mesoderm and subsequently directs mesodermal cells toward blood fate by activating Wnt3a and upregulating Cdx and Hox genes. When BMP signaling is blocked during this latter phase, enforced expression of either Cdx1 or Cdx4 rescues hematopoietic development, thereby placing BMP4 signaling upstream of the Cdx-Hox pathway. Wnt signaling cooperates in BMP-induced hemogenesis, and the Wnt effector LEF1 mediates BMP4 activation of Cdx genes. Our data suggest that BMP signaling plays two distinct and sequential roles during blood formation, initially as an inducer of mesoderm, and later to specify blood via activation of Wnt signaling and the Cdx-Hox pathway.	[Lengerke, Claudia; Schmitt, Sabine; Bowman, Teresa V.; Jang, Il Ho; Maouche-Chretien, Leila; McKinney-Freeman, Shannon; Zon, Leonard I.; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA; [Lengerke, Claudia; Schmitt, Sabine; Bowman, Teresa V.; Jang, Il Ho; Maouche-Chretien, Leila; McKinney-Freeman, Shannon; Zon, Leonard I.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lengerke, Claudia; Schmitt, Sabine; Bowman, Teresa V.; Jang, Il Ho; Maouche-Chretien, Leila; McKinney-Freeman, Shannon; Zon, Leonard I.; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Maouche-Chretien, Leila] Univ Paris 05, Inst Cochin, CNRS, F-75014 Paris, France; [Maouche-Chretien, Leila] INSERM, U567, F-75014 Paris, France; [Davidson, Alan J.] Ctr Regenerat Med & Technol, Boston, MA 02114 USA; [Hammerschmidt, Matthias; Rentzsch, Fabian] Max Planck Inst Immunobiol, D-79011 Freiburg, Germany; [Green, Jeremy B. A.] Kings Coll London, Dept Carniofacial Dev, London WC2R 2LS, England; [Lengerke, Claudia] Univ Tubingen, Med Ctr 2, Dept Hematol Oncol, D-72076 Tubingen, Germany; [Lengerke, Claudia; Schmitt, Sabine; Bowman, Teresa V.; Jang, Il Ho; Maouche-Chretien, Leila; McKinney-Freeman, Shannon; Zon, Leonard I.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Brigham & Women's Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Max Planck Society; University of London; King's College London; Eberhard Karls University of Tubingen; Harvard University; Dana-Farber Cancer Institute	Daley, GQ (corresponding author), Childrens Hosp, Div Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	maouche, leila/E-3887-2017; McKinney-Freeman, Shannon/N-8161-2018; Green, Jeremy/F-3630-2010; Lengerke, Claudia/AAV-8745-2021	McKinney-Freeman, Shannon/0000-0001-8061-2557; Green, Jeremy/0000-0002-6102-2620; Lengerke, Claudia/0000-0001-5442-2805; Jang, Il Ho/0000-0002-0820-3035; CHRETIEN, LEILA/0000-0001-5747-9719				Bansal D, 2006, P NATL ACAD SCI USA, V103, P16924, DOI 10.1073/pnas.0604579103; Beland M, 2004, MOL CELL BIOL, V24, P5028, DOI 10.1128/MCB.24.11.5028-5038.2004; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Choi K, 1998, DEVELOPMENT, V125, P725; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Davidson AJ, 2006, DEV BIOL, V292, P506, DOI 10.1016/j.ydbio.2006.01.003; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; DUSH MK, 1992, DEV BIOL, V151, P273, DOI 10.1016/0012-1606(92)90232-6; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Farrington SM, 1997, MECH DEVELOP, V62, P197, DOI 10.1016/S0925-4773(97)00664-3; Favier B, 1997, MOL HUM REPROD, V3, P115, DOI 10.1093/molehr/3.2.115; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Galceran J, 2001, P NATL ACAD SCI USA, V98, P8668, DOI 10.1073/pnas.151258098; Gruss P, 1991, CURR OPIN GENET DEV, V1, P204, DOI 10.1016/S0959-437X(05)80071-1; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Hogan BM, 2006, CURR BIOL, V16, P506, DOI 10.1016/j.cub.2006.01.047; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Ikeya M, 2001, MECH DEVELOP, V103, P27, DOI 10.1016/S0925-4773(01)00338-0; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kumano G, 1999, DEVELOPMENT, V126, P5327; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Li F, 2001, BLOOD, V98, P335, DOI 10.1182/blood.V98.2.335; Lickert H, 2000, DEVELOPMENT, V127, P3805; Lickert H, 2002, DEV DYNAM, V225, P216, DOI 10.1002/dvdy.10149; Lohnes D, 2003, BIOESSAYS, V25, P971, DOI 10.1002/bies.10340; Lugus JJ, 2007, DEVELOPMENT, V134, P393, DOI 10.1242/dev.02731; Marom K, 2005, DEV BIOL, V282, P442, DOI 10.1016/j.ydbio.2005.03.024; Marshall CJ, 2000, BLOOD, V96, P1591, DOI 10.1182/blood.V96.4.1591.h8001591_1591_1593; McReynolds LJ, 2007, BLOOD, V110, P3881, DOI 10.1182/blood-2007-04-085753; MEYER BI, 1993, DEVELOPMENT, V117, P191; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mullins MC, 1996, DEVELOPMENT, V123, P81; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Park C, 2006, DEVELOPMENT, V133, P3473, DOI 10.1242/dev.02499; Perlingeiro RCR, 2003, STEM CELLS, V21, P272, DOI 10.1634/stemcells.21-3-272; Pilon N, 2006, DEV BIOL, V289, P55, DOI 10.1016/j.ydbio.2005.10.005; Pilon N, 2007, DEVELOPMENT, V134, P2315, DOI 10.1242/dev.001206; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P840, DOI 10.1073/pnas.0607196104; Pyati UJ, 2005, DEVELOPMENT, V132, P2333, DOI 10.1242/dev.01806; Schmerer M, 2003, BLOOD, V102, P3196, DOI 10.1182/blood-2003-04-1094; Scholl C, 2007, J CLIN INVEST, V117, P1037, DOI 10.1172/JCI30182; Shimizu T, 2005, DEV BIOL, V279, P125, DOI 10.1016/j.ydbio.2004.12.007; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Szeto DR, 2004, DEVELOPMENT, V131, P3751, DOI 10.1242/dev.01236; TAM PPL, 1987, DEVELOPMENT, V99, P109; van Nes J, 2006, DEVELOPMENT, V133, P419, DOI 10.1242/dev.02216; Vogeli KM, 2006, NATURE, V443, P337, DOI 10.1038/nature05045; Walmsley M, 2002, DEVELOPMENT, V129, P5683, DOI 10.1242/dev.00169; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Zafonte BT, 2007, BLOOD, V109, P516, DOI 10.1182/blood-2006-02-004564; Zambidis ET, 2006, TRENDS CARDIOVAS MED, V16, P95, DOI 10.1016/j.tcm.2006.01.005; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	67	164	177	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN	2008	2	1					72	82		10.1016/j.stem.2007.10.022	http://dx.doi.org/10.1016/j.stem.2007.10.022			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	254RT	18371423	Bronze			2022-12-24	WOS:000252606400013
J	Mcnab, F; Klingberg, T				McNab, Fiona; Klingberg, Torkel			Prefrontal cortex and basal ganglia control access to working memory	NATURE NEUROSCIENCE			English	Article							SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; CAPACITY; ATTENTION; PERFORMANCE; SET	Our capacity to store information in working memory might be determined by the degree to which only relevant information is remembered. The question remains as to how this selection of relevant items to be remembered is accomplished. Here we show that activity in the prefrontal cortex and basal ganglia preceded the filtering of irrelevant information and that activity, particularly in the globus pallidus, predicted the extent to which only relevant information is stored. The preceding frontal and basal ganglia activity were also associated with inter-individual differences in working memory capacity. These findings reveal a mechanism by which frontal and basal ganglia activity exerts attentional control over access to working memory storage in the parietal cortex in humans, and makes an important contribution to inter-individual differences in working memory capacity.	[McNab, Fiona; Klingberg, Torkel] Karolinska Inst, Stockholm Brain Inst, MR Centrum, S-17176 Stockholm, Sweden	Karolinska Institutet	Klingberg, T (corresponding author), Karolinska Inst, Stockholm Brain Inst, MR Centrum, N8 00, S-17176 Stockholm, Sweden.	Torkel.Klingberg@ki.se		Klingberg, Torkel/0000-0002-3175-2171				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Bleckley MK, 2003, PSYCHON B REV, V10, P884, DOI 10.3758/BF03196548; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Conway ARA, 1996, MEMORY, V4, P577, DOI 10.1080/741940997; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Grabli D, 2004, BRAIN, V127, P2039, DOI 10.1093/brain/awh220; Gruber AJ, 2006, J COMPUT NEUROSCI, V20, P153, DOI 10.1007/s10827-005-5705-x; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Lewis SJG, 2004, EUR J NEUROSCI, V19, P755, DOI 10.1111/j.1460-9568.2004.03108.x; Menon V, 2000, NEUROREPORT, V11, P3641, DOI 10.1097/00001756-200011090-00048; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Mushiake H, 1995, J NEUROPHYSIOL, V74, P2754, DOI 10.1152/jn.1995.74.6.2754; Postle BR, 1999, COGNITIVE BRAIN RES, V8, P107, DOI 10.1016/S0926-6410(99)00010-5; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; SCHNEIDER JS, 1984, BIOL PSYCHIAT, V19, P1693; Suss HM, 2002, INTELLIGENCE, V30, P261, DOI 10.1016/S0160-2896(01)00100-3; Taylor PE, 1996, TRANSPLANT P, V28, P281; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447	29	705	727	4	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					103	107		10.1038/nn2024	http://dx.doi.org/10.1038/nn2024			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18066057				2022-12-24	WOS:000252117900018
J	Roesch, MR; Calu, DJ; Schoenbaum, G				Roesch, Matthew R.; Calu, Donna J.; Schoenbaum, Geoffrey			Dopamine neurons encode the better option in rats deciding between differently delayed or sized rewards	NATURE NEUROSCIENCE			English	Article							ORBITAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; IMPULSIVE CHOICE; DORSOLATERAL STRIATUM; QUANTITATIVE-ANALYSIS; NUCLEUS-ACCUMBENS; PREDICTION ERROR; REINFORCEMENT; AMYGDALA; LESIONS	The dopamine system is thought to be involved in making decisions about reward. Here we recorded from the ventral tegmental area in rats learning to choose between differently delayed and sized rewards. As expected, the activity of many putative dopamine neurons reflected reward prediction errors, changing when the value of the reward increased or decreased unexpectedly. During learning, neural responses to reward in these neurons waned and responses to cues that predicted reward emerged. Notably, this cue-evoked activity varied with size and delay. Moreover, when rats were given a choice between two differently valued outcomes, the activity of the neurons initially reflected the more valuable option, even when it was not subsequently selected.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Roesch, MR (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, 20 Penn St HSF-2 S251, Baltimore, MD 21201 USA.	mroes001@umaryland.edu		Calu, Donna/0000-0003-2377-9494	NIA NIH HHS [R01 AG027097, R01 AG027097-01A2, R01-AG027097] Funding Source: Medline; NIDA NIH HHS [K01 DA021609, R01 DA015718-05, R01 DA015718, K01-DA021609, R01-DA015718] Funding Source: Medline; NIMH NIH HHS [F31 MH080514, F31-MH085014] Funding Source: Medline; NINDS NIH HHS [T32 NS007375, T32-NS07375] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH080514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015718, K01DA021609] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Baxter MG, 2000, J NEUROSCI, V20, P4311; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; BUNNEY BS, 1973, NATURE-NEW BIOL, V245, P123, DOI 10.1038/newbio245123a0; Cardinal RN, 2000, PSYCHOPHARMACOLOGY, V152, P362, DOI 10.1007/s002130000536; Cardinal RN, 2004, ANN NY ACAD SCI, V1021, P33, DOI 10.1196/annals.1308.004; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Evenden JL, 1996, PSYCHOPHARMACOLOGY, V128, P161, DOI 10.1007/s002130050121; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Haber SN, 2000, J NEUROSCI, V20, P2369; Hatfield T, 1996, J NEUROSCI, V16, P5256; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Ho MY, 1999, PSYCHOPHARMACOLOGY, V146, P362, DOI 10.1007/PL00005482; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Kalenscher T, 2005, CURR BIOL, V15, P594, DOI 10.1016/j.cub.2005.02.052; Kawagoe R, 2004, J NEUROPHYSIOL, V91, P1013, DOI 10.1152/jn.00721.2003; Kheramin S, 2004, PSYCHOPHARMACOLOGY, V175, P206, DOI 10.1007/s00213-004-1813-y; Kiyatkin EA, 1998, NEUROSCIENCE, V85, P1285, DOI 10.1016/S0306-4522(98)00054-2; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; LOWENSTEIN G, 1992, CHOICE OVER TIME; Lu L, 2005, NAT NEUROSCI, V8, P212, DOI 10.1038/nn1383; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Niv Y, 2006, NAT NEUROSCI, V9, P987, DOI 10.1038/nn0806-987; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Parkinson JA, 2000, PROG BRAIN RES, V126, P263; Roesch MR, 2007, J NEUROSCI, V27, P245, DOI 10.1523/JNEUROSCI.4080-06.2007; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SKIRBOLL LR, 1979, SCIENCE, V206, P80, DOI 10.1126/science.482929; THALER R, 1981, ECON LETT, V8, P201, DOI 10.1016/0165-1765(81)90067-7; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tobler PN, 2003, J NEUROSCI, V23, P10402; Wade TR, 2000, PSYCHOPHARMACOLOGY, V150, P90; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	47	420	421	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1615	1624		10.1038/nn2013	http://dx.doi.org/10.1038/nn2013			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	18026098	Green Accepted			2022-12-24	WOS:000251172900020
J	Gunnersen, JM; Kim, MH; Fuller, SJ; De Silva, M; Britto, JM; Hammond, VE; Davies, PJ; Petrou, S; Faber, ESL; Sah, P; Tan, SS				Gunnersen, Jenny M.; Kim, Mary H.; Fuller, Stephanie J.; De Silva, Melanie; Britto, Joanne M.; Hammond, Vicki E.; Davies, Philip J.; Petrou, Steve; Faber, E. S. Louise; Sah, Pankaj; Tan, Seong-Seng			Sez-6 proteins affect dendritic arborization patterns and excitability of cortical pyramidal neurons	NEURON			English	Article							GENE-EXPRESSION PATTERNS; IN-VIVO; MENTAL-RETARDATION; SPINE DENSITY; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; APICAL DENDRITES; SEMAPHORIN 3A; ADULT CORTEX; GROWTH	Development of appropriate dendritic arbors is crucial for neuronal information transfer. We show, using seizure-related gene 6 (sez-6) null mutant mice, that Sez-6 is required for normal dendritic arborization of cortical neurons. Deep-layer pyramidal neurons in the somatosensory cortex of sez-6 null mice exhibit an excess of short dendrites, and cultured cortical neurons lacking Sez-6 display excessive neurite branching. Overexpression of individual Sez-6 isoforms in knockout neurons reveals opposing actions of membrane-bound and secreted Sez-6 proteins, with membrane-bound Sez-6 exerting an antibranching effect under both basal and depolarizing conditions. Layer V pyramidal neurons in knockout brain slices show reduced excitatory postsynaptic responses and a reduced dendritic spine density, reflected by diminished punctate staining for postsynaptic density 95 (PSD-95). In behavioral tests, the sez-6 null mice display specific exploratory, motor, and cognitive deficits. In conclusion, cell-surface protein complexes involving Sez-6 help to sculpt the dendritic arbor, in turn enhancing synaptic connectivity.	Univ Melbourne, Howard Florey Inst, Brain Dev Lab, Parkville, Vic 3010, Australia; Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Queensland	Gunnersen, JM (corresponding author), Univ Melbourne, Howard Florey Inst, Brain Dev Lab, Parkville, Vic 3010, Australia.	jenny.gunnersen@florey.edu.au; stan@florey.edu.au	davies, philip j/H-5963-2012; Sah, Pankaj/C-8175-2009; Petrou, Steven/M-8332-2013	Petrou, Steven/0000-0002-4960-6375; Sah, Pankaj/0000-0001-5063-1589; Gunnersen, Jenny/0000-0002-6310-7724; Faber, Luli/0000-0001-9015-9805				Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Chen YC, 2005, J NEUROBIOL, V64, P4, DOI 10.1002/neu.20150; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Goldshmit Y, 2004, EUR J NEUROSCI, V20, P2260, DOI 10.1111/j.1460-9568.2004.03698.x; Gunnersen JM, 2002, MOL CELL NEUROSCI, V19, P560, DOI 10.1006/mcne.2001.1098; Gutierrez H, 2004, DEVELOPMENT, V131, P3717, DOI 10.1242/dev.01209; Haas K, 2006, P NATL ACAD SCI USA, V103, P12127, DOI 10.1073/pnas.0602670103; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Havik B, 2007, NEUROSCIENCE, V148, P925, DOI 10.1016/j.neuroscience.2007.07.024; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Kim MH, 2002, MECH DEVELOP, V118, P171, DOI 10.1016/S0925-4773(02)00238-1; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Moore AW, 2002, SCIENCE, V297, P1355, DOI 10.1126/science.1072387; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Niblock MM, 2000, J NEUROSCI, V20, P4165; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Quitsch A, 2005, J NEUROSCI, V25, P479, DOI 10.1523/JNEUROSCI.2699-04.2005; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; RICCIO RV, 1985, DEV BRAIN RES, V19, P173, DOI 10.1016/0165-3806(85)90189-0; Sahay A, 2005, J NEUROSCI, V25, P3613, DOI 10.1523/JNEUROSCI.5255-04.2005; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; SHIMIZUNISHIKAWA K, 1995, MOL BRAIN RES, V28, P201, DOI 10.1016/0169-328X(94)00203-Q; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; SUETSUGU M, 1980, ACTA NEUROPATHOL, V50, P207, DOI 10.1007/BF00688755; Sugimura K, 2004, NEURON, V43, P809, DOI 10.1016/j.neuron.2004.08.016; Swann JW, 2000, HIPPOCAMPUS, V10, P617, DOI 10.1002/1098-1063(2000)10:5<617::AID-HIPO13>3.0.CO;2-R; Tailby C, 2005, P NATL ACAD SCI USA, V102, P4631, DOI 10.1073/pnas.0402747102; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tunggal J, 2003, J CELL SCI, V116, P803, DOI 10.1242/jcs.00293; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Wakana S, 2000, BRAIN RES, V857, P286, DOI 10.1016/S0006-8993(99)02406-3; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu GY, 1999, J NEUROSCI, V19, P4472; Yu ZL, 2007, J NEUROSCI RES, V85, P166, DOI 10.1002/jnr.21103; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244	55	96	103	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 21	2007	56	4					621	639		10.1016/j.neuron.2007.09.018	http://dx.doi.org/10.1016/j.neuron.2007.09.018			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	236MH	18031681	Bronze			2022-12-24	WOS:000251306600007
J	Serulle, Y; Zhang, S; Ninan, I; Puzzo, D; McCarthy, M; Khatri, L; Arancio, O; Ziff, EB				Serulle, Yafell; Zhang, Shuang; Ninan, Ipe; Puzzo, Daniela; McCarthy, Maria; Khatri, Latika; Arancio, Oftavio; Ziff, Edward B.			A GluR1-cGKII interaction regulates AMPA receptor trafficking	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; NITRIC-OXIDE; GLUR1 SUBUNIT; SYNAPTIC PLASTICITY; ACID RECEPTOR; INTERCELLULAR MESSENGER; PHOSPHORYLATION SITES; SURFACE EXPRESSION; GUANYLYL CYCLASE	Trafficking of AMPA receptors (AMPARs) is regulated by specific interactions of the subunit intracellular C-terminal domains (CTDs) with other proteins, but the mechanisms involved in this process are still unclear. We have found that the GIuR1 CTD binds to cGMP-dependent protein kinase II (cGKII) adjacent to the kinase catalytic site. Binding of GluR1 is increased when cGKII is activated by cGKP. cGKII and GluR1 form a complex in the brain, and cGKII in this complex phosphorylates GluR1 at S845, a site also phosphorylated by PKA. Activation of cGKII by cGMP increases the surface expression of AMPARs at extrasynaptic sites. Inhibition of cGKII activity blocks the surface increase of GIuR1 during chemLTP and reduces LTP in the hippocampal slice. This work identifies a pathway, downstream from the NMDA receptor (NMDAR) and nitric oxide (NO), which stimulates GluR1 accumulation in the plasma membrane and plays an important role in synaptic plasticity.	NYU, Sch Med, Program Neurosci & Physiol, New York, NY 10016 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Taub Inst, New York, NY 10032 USA	New York University; New York University; Columbia University; Columbia University	Ziff, EB (corresponding author), NYU, Sch Med, Program Neurosci & Physiol, New York, NY 10016 USA.	edward.ziff@med.nyu.edu	arancio, ottavio/AAB-7959-2019; Puzzo, Daniela/AAF-5026-2019	Puzzo, Daniela/0000-0002-9542-2251; arancio, ottavio/0000-0001-6335-164X; Ninan, Ipe/0000-0001-9774-6455; Ziff, Edward/0000-0001-7389-8649	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007308, 5 T32 GM 07308] Funding Source: Medline; NIMH NIH HHS [R01 MH067229-04, R01 MH067229, R01 MH067229-01, R01 MH067229-02, MH 067229, R01 MH067229-03, R01 MH067229-05] Funding Source: Medline; NINDS NIH HHS [NS 049442, R01 NS049442] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boehm J, 2005, BIOCHEM SOC T, V33, P1354, DOI 10.1042/BST0331354; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; BOHME GA, 1991, EUR J PHARMACOL, V199, P379, DOI 10.1016/0014-2999(91)90505-K; BON C, 1992, EUR J NEUROSCI, V4, P420, DOI 10.1111/j.1460-9568.1992.tb00891.x; Bon CLM, 2003, J NEUROSCI, V23, P1941; Bon CLM, 2001, EUR J NEUROSCI, V14, P585, DOI 10.1046/j.0953-816x.2001.01680.x; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BUTTS NK, 1994, J STRENGTH COND RES, V8, P265; Chien WL, 2003, MOL PHARMACOL, V63, P1322, DOI 10.1124/mol.63.6.1322; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Feil R, 2005, REV NEUROSCIENCE, V16, P23; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; HALEY JE, 1992, NEURON, V8, P211, DOI 10.1016/0896-6273(92)90288-O; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HEMMINGS HC, 1984, J BIOL CHEM, V259, P4491; Hering H, 2003, J NEUROSCI, V23, P3262; Hofmann F, 2000, J CELL SCI, V113, P1671; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huang Y, 2005, NEURON, V46, P533, DOI 10.1016/j.neuron.2005.03.028; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Kim CH, 2005, NAT NEUROSCI, V8, P985, DOI 10.1038/nn1432; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lisman JE, 2001, CURR BIOL, V11, pR788, DOI 10.1016/S0960-9822(01)00472-9; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lu YF, 1999, J NEUROSCI, V19, P10250; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; MANDERS EMM, 1992, J CELL SCI, V103, P857; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; ODELL TJ, 1994, SCIENCE, V265, P542, DOI 10.1126/science.7518615; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Paxinos G., 1998, MOUSE BRAIN STEREOTA; Pfeifer A, 1999, Rev Physiol Biochem Pharmacol, V135, P105, DOI 10.1007/BFb0033671; Puzzo D, 2005, J NEUROSCI, V25, P6887, DOI 10.1523/JNEUROSCI.5291-04.2005; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; Shen L, 2000, J NEUROSCI, V20, P7932; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Son H, 1998, LEARN MEMORY, V5, P231; Son H, 1996, CELL, V87, P1015, DOI 10.1016/S0092-8674(00)81796-1; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Taylor MK, 2002, J BIOL CHEM, V277, P37242, DOI 10.1074/jbc.M202060200; Vaandrager AB, 1996, J BIOL CHEM, V271, P7025, DOI 10.1074/jbc.271.12.7025; Wall ME, 2003, P NATL ACAD SCI USA, V100, P2380, DOI 10.1073/pnas.0534892100; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Wang X, 1997, J NEUROCHEM, V68, P443; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhao JK, 1997, J BIOL CHEM, V272, P31929, DOI 10.1074/jbc.272.50.31929; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368	73	140	146	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 21	2007	56	4					670	688		10.1016/j.neuron.2007.09.016	http://dx.doi.org/10.1016/j.neuron.2007.09.016			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	236MH	18031684	Green Accepted, Bronze			2022-12-24	WOS:000251306600010
J	Nishiyama, H; Fukaya, M; Watanabe, M; Linden, DJ				Nishiyama, Hiroshi; Fukaya, Masahiro; Watanabe, Masahiko; Linden, David J.			Axonal motility and its modulation by activity are branch-type specific in the intact adult cerebellum	NEURON			English	Article							VESICULAR GLUTAMATE TRANSPORTER; HIPPOCAMPAL PYRAMIDAL NEURONS; CLIMBING FIBER INNERVATION; DENDRITIC SPINE STABILITY; HARMALINE-INDUCED TREMOR; GROWTH CONE MOTILITY; IN-VIVO; PURKINJE-CELLS; VISUAL-CORTEX; PHOSPHATE TRANSPORTER	We performed two-photon in vivo imaging of cerebellar climbing fibers (CFs; the terminal arbor of olivocerebellar axons) in adult mice. CF ascending branches innervate Purkinje cells while CIF transverse branches show a near complete failure to form conventional synapses. Time-lapse imaging over hours or days revealed that ascending branches were very stable. However, transverse branches were highly dynamic, exhibiting rapid elongation and retraction and varicosity turnover. Thus, different branches of the same axon, with different innervation patterns, display branch type-specific motility in the adult cerebellum. Furthermore, dynamic changes in transverse branch length were almost completely suppressed by pharmacological stimulation of olivary firing.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan	Johns Hopkins University; Hokkaido University	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	dlinden@jhmi.edu	Watanabe, Masahiko/S-3614-2019; WATANABE, Masahiko/A-4055-2012	Watanabe, Masahiko/0000-0001-5037-7138; WATANABE, Masahiko/0000-0001-5037-7138	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH051106, P50MH068830] Funding Source: NIH RePORTER; NIMH NIH HHS [P50 MH068830-010003, R37 MH051106, R37 MH51106, P50 MH068830, R37 MH051106-15] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Bengtsson F, 2007, J NEUROPHYSIOL, V98, P1697, DOI 10.1152/jn.00057.2007; BERNARD JF, 1984, EXP BRAIN RES, V57, P128; Broekman MLD, 2006, NEUROSCIENCE, V138, P501, DOI 10.1016/j.neuroscience.2005.11.057; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Gras C, 2002, J NEUROSCI, V22, P5442; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HAMORI J, 1966, EXP BRAIN RES, V1, P65; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Ibarretxe G, 2007, J NEUROSCI, V27, P7684, DOI 10.1523/JNEUROSCI.1070-07.2007; Ichikawa R, 2002, J NEUROSCI, V22, P8487; Ito M, 1984, CEREBELLUM NEURAL CO; Jones TA, 1997, NEUROBIOL LEARN MEM, V68, P13, DOI 10.1006/nlme.1997.3774; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kollo M, 2006, J NEUROSCI, V26, P2684, DOI 10.1523/JNEUROSCI.5257-05.2006; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; LeDoux MS, 2002, EXP BRAIN RES, V145, P457, DOI 10.1007/s00221-002-1127-4; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; LLINAS R, 1973, EXP BRAIN RES, V18, P69; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Matsui K, 2005, J NEUROSCI, V25, P7538, DOI 10.1523/JNEUROSCI.1927-05.2005; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Miyazaki T, 2004, J NEUROSCI, V24, P1734, DOI 10.1523/JNEUROSCI.4208-03.2004; Nishiyama H, 2004, J NEUROSCI, V24, P3926, DOI 10.1523/JNEUROSCI.5610-03.2004; Oldenbeuving AW, 1999, EUR J NEUROSCI, V11, P3809, DOI 10.1046/j.1460-9568.1999.00796.x; Palay S. L., 1974, CEREBELLAR CORTEX CY; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; POPOV VI, 1992, NEUROSCIENCE, V48, P53, DOI 10.1016/0306-4522(92)90337-2; POPOV VI, 1992, NEUROSCIENCE, V48, P45, DOI 10.1016/0306-4522(92)90336-Z; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; ROSSI F, 1991, J COMP NEUROL, V308, P513, DOI 10.1002/cne.903080403; Ruthazer ES, 2006, J NEUROSCI, V26, P3594, DOI 10.1523/JNEUROSCI.0069-06.2006; SASAKI K, 1989, EUR J NEUROSCI, V1, P572, DOI 10.1111/j.1460-9568.1989.tb00364.x; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; SCHEIBEL ME, 1954, J COMP NEUROL, V101, P733, DOI 10.1002/cne.901010305; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; SUGIHARA I, 1995, EUR J NEUROSCI, V7, P521, DOI 10.1111/j.1460-9568.1995.tb00657.x; Sugihara I, 1999, J COMP NEUROL, V414, P131; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	58	62	62	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 8	2007	56	3					472	487		10.1016/j.neuron.2007.09.010	http://dx.doi.org/10.1016/j.neuron.2007.09.010			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	229AV	17988631	Green Accepted, Bronze			2022-12-24	WOS:000250774600007
J	Singec, I; Snyder, EY				Singec, Ilyas; Snyder, Evan Y.			Quo vadis brain repair? A long axonal journey in the adult CNS	CELL STEM CELL			English	Editorial Material							NEURONS	Recently in Nature Neuroscience, Gaillard et al. (2007) study axonal projections from embryonic cortical explants grafted into acutely damaged adult motor cortex. After attempting to rule out fusion of donor tissue with pre-existing host circuitry, the authors report robust long-distance donor axonal projections and synaptic integration into target regions appropriate for the motor system.	Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Singec, I (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	isingec@burnham.org; esnyder@burnham.org		SINGEC, ILYAS/0000-0003-3941-1838				Bentlage C, 1999, EXP NEUROL, V159, P177, DOI 10.1006/exnr.1999.7110; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; GAILLARD A, 2007, INPRESS NAT NEUROSCI, DOI DOI 10.1038/NN1970; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663	10	3	3	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT	2007	1	4					355	356		10.1016/j.stem.2007.09.012	http://dx.doi.org/10.1016/j.stem.2007.09.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XU	18371370	Bronze			2022-12-24	WOS:000251055300002
J	Singh, KK; Park, KJ; Hong, EJ; Kramer, BM; Greenberg, ME; Kaplan, DR; Miller, FD				Singh, Karun K.; Park, Katya J.; Hong, Elizabeth J.; Kramer, Bianca M.; Greenberg, Michael E.; Kaplan, David R.; Miller, Freda D.			Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; P75 NEUROTROPHIN RECEPTOR; SYMPATHETIC NEURONS; WALLERIAN DEGENERATION; TARGET INNERVATION; IN-VIVO; RAT EYE; TRKA; BDNF; SURVIVAL	The mechanisms that regulate the pruning of mammalian axons are just now being elucidated. Here, we describe a mechanism by which, during developmental sympathetic axon competition, winning axons secrete brain-derived neurotrophic factor (BDNF) in an activity-dependent fashion, which binds to the p75 neurotrophin receptor (p75NTR) on losing axons to cause their degeneration and, ultimately, axon pruning. Specifically, we found that pruning of rat and mouse sympathetic axons that project to the eye requires both activity-dependent BDNF and p75NTR. p75NTR and BDNF are also essential for activity-dependent axon pruning in culture, where they mediate pruning by directly causing axon degeneration. p75NTR, which is enriched in losing axons, causes axonal degeneration by suppressing TrkA-mediated signaling that is essential for axonal maintenance. These data provide a mechanism that explains how active axons can eliminate less-active, competing axons during developmental pruning by directly promoting p75NTR-mediated axonal degeneration.	[Singh, Karun K.; Park, Katya J.; Kramer, Bianca M.; Miller, Freda D.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Singh, Karun K.; Park, Katya J.; Kramer, Bianca M.; Kaplan, David R.; Miller, Freda D.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Park, Katya J.; Kaplan, David R.] Hosp Sick Children, Cell Biol Grp, Toronto, ON M5G 1X8, Canada; [Hong, Elizabeth J.; Greenberg, Michael E.] Childrens Hosp, Boston, MA 02115 USA; [Hong, Elizabeth J.; Greenberg, Michael E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kaplan, David R.; Miller, Freda D.] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; [Miller, Freda D.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Toronto; University of Toronto	Miller, FD (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	fredam@sickkids.ca	Kramer, Bianca/M-3356-2014	Kramer, Bianca/0000-0002-5965-6560	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Atwal JK, 2003, J NEUROSCI, V23, P7602; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; CAMPENOT RB, 1991, J NEUROSCI, V11, P1126; CAMPENOT RB, 1981, SCIENCE, V214, P579, DOI 10.1126/science.7292000; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Cao LX, 2007, CURR BIOL, V17, P911, DOI 10.1016/j.cub.2007.04.040; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; COGGESHALL RE, 1984, J NEUROSCI METH, V12, P125, DOI 10.1016/0165-0270(84)90011-6; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; Dhanoa NK, 2006, EXP NEUROL, V198, P416, DOI 10.1016/j.expneurol.2005.12.022; Friedman WJ, 1998, NEUROSCIENCE, V84, P101, DOI 10.1016/S0306-4522(97)00526-5; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; Hibbert AP, 2006, MOL CELL NEUROSCI, V32, P387, DOI 10.1016/j.mcn.2006.06.001; HILL CE, 1989, INT J DEV NEUROSCI, V7, P539, DOI 10.1016/0736-5748(89)90013-0; Kaplan DR, 2003, NAT NEUROSCI, V6, P435, DOI 10.1038/nn0503-435; Kohn J, 1999, J NEUROSCI, V19, P5393; Korhonen JM, 1999, J BIOL CHEM, V274, P37307, DOI 10.1074/jbc.274.52.37307; LAWRENCE JM, 1979, BRAIN RES, V168, P13, DOI 10.1016/0006-8993(79)90124-0; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MA Y, 1992, J CELL BIOL, V117, P135, DOI 10.1083/jcb.117.1.135; MacInnis BL, 2005, MOL CELL NEUROSCI, V28, P430, DOI 10.1016/j.mcn.2004.10.003; MacPhee IJ, 1997, J BIOL CHEM, V272, P23547, DOI 10.1074/jbc.272.38.23547; Majdan M, 1999, INT J DEV NEUROSCI, V17, P153, DOI 10.1016/S0736-5748(99)00016-7; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Michael GJ, 1997, J NEUROSCI, V17, P8476; Miller FD, 2001, CELL MOL LIFE SCI, V58, P1045, DOI 10.1007/PL00000919; MILLER FD, 1994, DEV BIOL, V161, P206, DOI 10.1006/dbio.1994.1021; MYTILINEOU C, 1976, BRAIN RES, V109, P382, DOI 10.1016/0006-8993(76)90538-2; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897; PURVES D, 1988, NATURE, V336, P123, DOI 10.1038/336123a0; Singh KK, 2005, NEURON, V45, P837, DOI 10.1016/j.neuron.2005.01.049; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; VIDOVIC M, 1987, DEV BRAIN RES, V32, P133, DOI 10.1016/0165-3806(87)90146-5; VIDOVIC M, 1988, J AUTONOM NERV SYST, V22, P57, DOI 10.1016/0165-1838(88)90154-3; Yeo TT, 1997, J NEUROSCI, V17, P7594; Yiu G, 2003, CURR OPIN NEUROBIOL, V13, P545, DOI 10.1016/j.conb.2003.09.006; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	45	164	167	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					649	658		10.1038/nn.2114	http://dx.doi.org/10.1038/nn.2114			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18382462				2022-12-24	WOS:000256133700011
J	Ajemian, R; Green, A; Bullock, D; Sergio, L; Kalaska, J; Grossberg, S				Ajemian, Robert; Green, Andrea; Bullock, Daniel; Sergio, Lauren; Kalaska, John; Grossberg, Stephen			Assessing the function of motor cortex: Single-neuron models of how neural response is modulated by limb biomechanics	NEURON			English	Article							VOLUNTARY ARM MOVEMENTS; PRIMATE CORTICOMOTONEURONAL CELLS; DIRECTIONAL ISOMETRIC FORCE; POSTERIOR PARIETAL NEURONS; DIRECT CORTICAL CONTROL; DORSAL PREMOTOR CORTEX; 3-DIMENSIONAL SPACE; MUSCLE-ACTIVITY; VISUAL TARGETS; SYSTEMATIC CHANGES	Do neurons in primary motor cortex encode the generative details of motor behavior, such as individual muscle activities, or do they encode high-level movement attributes? Resolving this question has proven difficult, in large part because of the sizeable uncertainty inherent in estimating or measuring the joint torques and muscle forces that underlie movements made by biological limbs. We circumvented this difficulty by considering single-neuron responses in an isometric task, where joint torques and muscle forces can be straightforwardly computed from limb geometry. The response for each neuron was modeled as a linear function of a "preferred" joint torque vector, and this model was fit to individual neural responses across variations in limb posture. The resulting goodness of fit suggests that neurons in motor cortex do encode the kinetics of motor behavior and that the neural response properties of "preferred direction" and "gain" are dual components of a unitary response vector.	[Ajemian, Robert] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Green, Andrea; Kalaska, John] Univ Montreal, Dept Physiol, Grp Rech Syst Nerveux Cent FRSQ, Montreal, PQ H3C 3J7, Canada; [Bullock, Daniel; Grossberg, Stephen] Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA; [Bullock, Daniel; Grossberg, Stephen] Ctr Excellence Learning Educ Sci & Technol, Boston, MA 02215 USA; [Sergio, Lauren] York Univ, Sch Kinesiol & Hlth Sci, N York, ON M3J 1P3, Canada	Massachusetts Institute of Technology (MIT); Universite de Montreal; Boston University; York University - Canada	Ajemian, R (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ajemian@mit.edu; kalaskaj@physio.umontreal.ca	Sergio, Lauren/AAK-3274-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046033] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS046033] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ajemian R, 2000, J NEUROPHYSIOL, V84, P2191, DOI 10.1152/jn.2000.84.5.2191; Ajemian R, 2001, CEREB CORTEX, V11, P1124, DOI 10.1093/cercor/11.12.1124; Amis A. A., 1979, Engineering in Medicine, V8, P41, DOI 10.1243/EMED_JOUR_1979_008_010_02; AN KN, 1981, J BIOMECH, V14, P659, DOI 10.1016/0021-9290(81)90048-8; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; ASHE J, 1994, CEREB CORTEX, V4, P590, DOI 10.1093/cercor/4.6.590; Baraduc P, 2001, CEREB CORTEX, V11, P906, DOI 10.1093/cercor/11.10.906; Bennett KMB, 1996, J NEUROPHYSIOL, V75, P1826, DOI 10.1152/jn.1996.75.5.1826; Boline J, 2005, EXP BRAIN RES, V167, P148, DOI 10.1007/s00221-005-0016-z; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Bullock D, 1998, CEREB CORTEX, V8, P48, DOI 10.1093/cercor/8.1.48; BULLOCK D, 1988, PSYCHOL REV, V95, P49, DOI 10.1037/0033-295X.95.1.49; Cabel DW, 2001, J NEUROPHYSIOL, V86, P2102, DOI 10.1152/jn.2001.86.4.2102; CAMINITI R, 1990, J NEUROSCI, V10, P2039; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; CHENEY PD, 1985, J NEUROPHYSIOL, V53, P786, DOI 10.1152/jn.1985.53.3.786; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; Crammond DJ, 1996, EXP BRAIN RES, V108, P45; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; EVARTS EV, 1983, J NEUROPHYSIOL, V49, P1199, DOI 10.1152/jn.1983.49.5.1199; EVARTS EV, 1969, J NEUROPHYSIOL, V32, P375, DOI 10.1152/jn.1969.32.3.375; Ferrier D, 1873, Br Med J, V1, P457; Fetz E. E., 1990, PROG BRAIN RES, V80, P437; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; Fisher NI, 1995, STAT ANAL CIRCULAR D; FRITSCH GT, 1870, ARCH ANAT PHYSL MED, V300, P32; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; GEORGOPOULOS AP, 1984, EXP BRAIN RES, V54, P446; GEORGOPOULOS AP, 1992, SCIENCE, V256, P1692, DOI 10.1126/science.256.5064.1692; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; GEORGOPOULOS AP, 1995, TRENDS NEUROSCI, V18, P506, DOI 10.1016/0166-2236(95)92775-L; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Graham KM, 2003, J MORPHOL, V255, P301, DOI 10.1002/jmor.10064; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; Grossberg S., 1986, NEURAL DYNAMICS ADAP; Herter TM, 2007, J NEUROPHYSIOL, V97, P2887, DOI 10.1152/jn.00757.2006; HOCHERMAN S, 1991, EXP BRAIN RES, V83, P285; Kakei S, 2003, NEUROSCI RES, V46, P1, DOI 10.1016/S0168-0102(03)00031-2; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KALASKA JF, 1989, J NEUROSCI, V9, P2080; KALASKA JF, 1985, EXP BRAIN RES, V59, P197; KETTNER RE, 1988, J NEUROSCI, V8, P2938; Kurtzer I, 2005, NAT NEUROSCI, V8, P498, DOI 10.1038/nn1420; LACQUANITI F, 1995, CEREB CORTEX, V5, P391, DOI 10.1093/cercor/5.5.391; Loeb GE, 1996, TRENDS NEUROSCI, V19, P137, DOI 10.1016/S0166-2236(96)80020-8; McKiernan BJ, 2000, J NEUROPHYSIOL, V83, P99, DOI 10.1152/jn.2000.83.1.99; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Morrow MM, 2003, J NEUROPHYSIOL, V89, P2279, DOI 10.1152/jn.00632.2002; MURRAY WM, 1995, J BIOMECH, V28, P513, DOI 10.1016/0021-9290(94)00114-J; MUSSAIVALDI FA, 1988, NEUROSCI LETT, V91, P106, DOI 10.1016/0304-3940(88)90257-1; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; Park MC, 2004, J NEUROPHYSIOL, V92, P2968, DOI 10.1152/jn.00649.2003; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Phillips C G, 1975, Can J Neurol Sci, V2, P209; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; SALINAS E, 1995, J NEUROSCI, V15, P6461; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; SANGER TD, 1994, NEURAL COMPUT, V6, P29, DOI 10.1162/neco.1994.6.1.29; SCHWARTZ AB, 1988, J NEUROSCI, V8, P2913; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; Scott SH, 2001, NATURE, V413, P161, DOI 10.1038/35093102; Scott SH, 2000, NAT NEUROSCI, V3, P964, DOI 10.1038/79888; Sergio LE, 1998, J NEUROPHYSIOL, V80, P1577, DOI 10.1152/jn.1998.80.3.1577; Sergio LE, 1997, J NEUROPHYSIOL, V78, P1170, DOI 10.1152/jn.1997.78.2.1170; Sergio LE, 2005, J NEUROPHYSIOL, V94, P2353, DOI 10.1152/jn.00989.2004; Sergio LE, 2003, J NEUROPHYSIOL, V89, P212, DOI 10.1152/jn.00016.2002; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; Taira M, 1996, EXP BRAIN RES, V109, P367; TANAKA S, 1994, NEUROSCI LETT, V180, P83, DOI 10.1016/0304-3940(94)90493-6; Taylor CSR, 2003, NEUROSCIENTIST, V9, P332, DOI 10.1177/1073858403257037; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Trainin E, 2007, J NEUROPHYSIOL, V97, P3736, DOI 10.1152/jn.01064.2006; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; WINTERS JM, 1993, J BIOMECH, V26, P143, DOI 10.1016/0021-9290(93)90045-G; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Wu W, 2006, EXP BRAIN RES, V175, P197, DOI 10.1007/s00221-006-0556-x; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zhang KC, 1999, J NEUROSCI, V19, P3122; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	86	31	31	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 8	2008	58	3					414	428		10.1016/j.neuron.2008.02.033	http://dx.doi.org/10.1016/j.neuron.2008.02.033			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	300HP	18466751	Bronze			2022-12-24	WOS:000255815200014
J	Kole, MHP; Ilschner, SU; Kampa, BM; Williams, SR; Ruben, PC; Stuart, GJ				Kole, Maarten H. P.; Ilschner, Susanne U.; Kampa, Bjoern M.; Williams, Stephen R.; Ruben, Peter C.; Stuart, Greg J.			Action potential generation requires a high sodium channel density in the axon initial segment	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; CEREBELLAR PURKINJE-CELLS; GATED ION CHANNELS; SPIKE INITIATION; DENDRITES; VOLTAGE; SITE; PROPAGATION; RANVIER; CHANDELIER	The axon initial segment ( AIS) is a specialized region in neurons where action potentials are initiated. It is commonly assumed that this process requires a high density of voltage-gated sodium ( Na(+)) channels. Paradoxically, the results of patch-clamp studies suggest that the Na(+) channel density at the AIS is similar to that at the soma and proximal dendrites. Here we provide data obtained by antibody staining, whole-cell voltage-clamp and Na(+) imaging, together with modeling, which indicate that the Na(+) channel density at the AIS of cortical pyramidal neurons is similar to 50 times that in the proximal dendrites. Anchoring of Na(+) channels to the cytoskeleton can explain this discrepancy, as disruption of the actin cytoskeleton increased the Na(+) current measured in patches from the AIS. Computational models required a high Na(+) channel density (similar to 2,500 pS mu m(-2)) at the AIS to account for observations on action potential generation and backpropagation. In conclusion, action potential generation requires a high Na(+) channel density at the AIS, which is maintained by tight anchoring to the actin cytoskeleton.	[Kole, Maarten H. P.; Ilschner, Susanne U.; Kampa, Bjoern M.; Williams, Stephen R.; Ruben, Peter C.; Stuart, Greg J.] Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia; [Williams, Stephen R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Ruben, Peter C.] Simon Fraser Univ, Sch Kinesiol, Burnaby, BC V5A 1S6, Canada	Australian National University; John Curtin School of Medical Research; MRC Laboratory Molecular Biology; Simon Fraser University	Stuart, GJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Garran Rd, Canberra, ACT 0200, Australia.	greg.stuart@anu.edu.au	stuart, greg j/F-7328-2011; Kampa, Bjoern/A-1612-2008; Kampa, Bjoern/GWC-5714-2022; Kampa, Bjoern M/D-6213-2015	Kampa, Bjoern/0000-0002-4343-2634; Kampa, Bjoern M/0000-0002-4343-2634; Kole, Maarten/0000-0002-3883-5682; Williams, Stephen/0000-0001-5352-7947; stuart, greg/0000-0001-9395-2219	Medical Research Council [MC_U105170644] Funding Source: Medline; MRC [MC_U105170644] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akemann W, 2006, J NEUROSCI, V26, P4602, DOI 10.1523/JNEUROSCI.5204-05.2006; Baranauskas G, 2006, J NEUROSCI, V26, P671, DOI 10.1523/JNEUROSCI.2283-05.2006; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Boiko T, 2003, J NEUROSCI, V23, P2306; Canavier CC, 1999, J COMPUT NEUROSCI, V6, P49, DOI 10.1023/A:1008809000182; Carnevale NT, 2006, NEURON BOOK; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; DODGE FA, 1973, IBM J RES DEV, V17, P219, DOI 10.1147/rd.173.0219; Eccles, 2013, PHYSL SYNAPSES; FATT P, 1957, J NEUROPHYSIOL, V20, P61, DOI 10.1152/jn.1957.20.1.61; FUORTES MGF, 1957, J GEN PHYSIOL, V40, P735, DOI 10.1085/jgp.40.5.735; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Howard A, 2005, TRENDS NEUROSCI, V28, P310, DOI 10.1016/j.tins.2005.04.004; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Komai S, 2006, NAT NEUROSCI, V9, P1125, DOI 10.1038/nn1752; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; LASSERROSS N, 1992, P ROY SOC B-BIOL SCI, V247, P35, DOI 10.1098/rspb.1992.0006; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; MILTON RL, 1990, J NEUROSCI, V10, P885; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P301, DOI 10.1113/jphysiol.1983.sp014582; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; NEUMCKE B, 1982, J PHYSIOL-LONDON, V329, P163, DOI 10.1113/jphysiol.1982.sp014296; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; PETERS A, 1968, J CELL BIOL, V39, P604, DOI 10.1083/jcb.39.3.604; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; Rush AM, 2005, J PHYSIOL-LONDON, V564, P803, DOI 10.1113/jphysiol.2005.083089; SHRAGER P, 1989, BRAIN RES, V483, P149, DOI 10.1016/0006-8993(89)90046-2; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; SLOPER JJ, 1979, PHILOS T R SOC B, V285, P173, DOI 10.1098/rstb.1979.0004; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; WOLLNER DA, 1986, P NATL ACAD SCI USA, V83, P8424, DOI 10.1073/pnas.83.21.8424; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	50	428	439	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					178	186		10.1038/nn2040	http://dx.doi.org/10.1038/nn2040			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18204443				2022-12-24	WOS:000252712100012
J	Sauvage, MM; Fortin, NJ; Owens, CB; Yonelinas, AP; Eichenbaum, H				Sauvage, Magdalena M.; Fortin, Norbert J.; Owens, Cullen B.; Yonelinas, Andrew P.; Eichenbaum, Howard			Recognition memory: opposite effects of hippocampal damage on recollection and familiarity	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; FACILITATION; COMPONENTS; AMNESIA; CORTEX	A major controversy in memory research concerns whether recognition is subdivided into distinct cognitive mechanisms of recollection and familiarity that are supported by different neural substrates. Here we developed a new associative recognition protocol for rats that enabled us to show that recollection is reduced, whereas familiarity is increased following hippocampal damage. These results provide strong evidence that these processes are qualitatively different and that the hippocampus supports recollection and not familiarity.	[Sauvage, Magdalena M.; Fortin, Norbert J.; Owens, Cullen B.; Yonelinas, Andrew P.; Eichenbaum, Howard] Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Eichenbaum, H (corresponding author), Boston Univ, Ctr Memory & Brain, 2 Cummington St, Boston, MA 02215 USA.	hbe@bu.edu		Sauvage, Magdalena/0000-0002-7586-6410; Fortin, Norbert/0000-0002-6793-6984; Yonelinas, Andrew/0000-0002-9580-4997	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH071702, R01MH052090] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 71702, P50 MH071702-01A2, MH 52090, R01 MH052090, P50 MH071702, R01 MH052090-05] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aggleton JP, 2005, NEUROPSYCHOLOGIA, V43, P1810, DOI 10.1016/j.neuropsychologia.2005.01.019; Birrell JM, 2000, J NEUROSCI, V20, P4320; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum Howard, 1994, P147; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Giovanello KS, 2006, NEUROPSYCHOLOGIA, V44, P1859, DOI 10.1016/j.neuropsychologia.2006.03.004; Parks CM, 2007, PSYCHOL REV, V114, P188, DOI 10.1037/0033-295X.114.1.188; Quamme JR, 2007, HIPPOCAMPUS, V17, P192, DOI 10.1002/hipo.20257; Reinitz MT, 1996, MEM COGNITION, V24, P129, DOI 10.3758/BF03200875; Saksida LM, 2007, CEREB CORTEX, V17, P108, DOI 10.1093/cercor/bhj128; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Wais PE, 2006, NEURON, V49, P459, DOI 10.1016/j.neuron.2005.12.020; Wixted JT, 2007, PSYCHOL REV, V114, P152, DOI 10.1037/0033-295X.114.1.152; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Yonelinas AP, 2001, PHILOS T R SOC B, V356, P1363, DOI 10.1098/rstb.2001.0939	15	131	131	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					16	18		10.1038/nn2016	http://dx.doi.org/10.1038/nn2016			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18037884	Green Accepted			2022-12-24	WOS:000252117900007
J	Andrews-Hanna, JR; Snyder, AZ; Vincent, JL; Lustig, C; Head, D; Raichle, ME; Buckner, RL				Andrews-Hanna, Jessica R.; Snyder, Abraham Z.; Vincent, Justin L.; Lustig, Cindy; Head, Denise; Raichle, Marcus E.; Buckner, Randy L.			Disruption of large-scale brain systems in advanced aging	NEURON			English	Article							FUNCTIONAL CONNECTIVITY; RESTING-STATE; DEFAULT-MODE; ALZHEIMERS-DISEASE; WHITE-MATTER; WORKING-MEMORY; AGE; DIFFUSION; NETWORK; ATTENTION	Cognitive decline is commonly observed in advanced aging even in the absence of disease. Here we explore the possibility that normal aging is accompanied by disruptive alterations in the coordination of large-scale brain systems that support high-level cognition. In 93 adults aged 18 to 93, we demonstrate that aging is characterized by marked reductions in normally present functional correlations within two higher-order brain systems. Anterior to posterior components within the default network were most severely disrupted with age. Furthermore, correlation reductions were severe in older adults free from Alzheimer's disease (AD) pathology as determined by amyloid imaging, suggesting that functional disruptions were not the result of AD. Instead, reduced correlations were associated with disruptions in white matter integrity and poor cognitive performance across a range of domains. These results suggest that cognitive decline in normal aging arises from functional disruption in the coordination of large-scale brain systems that support cognition.	[Andrews-Hanna, Jessica R.; Vincent, Justin L.; Buckner, Randy L.] Harvard Univ, Ctr Brain Sci, Dept Psychol, Cambridge, MA 02138 USA; [Andrews-Hanna, Jessica R.; Vincent, Justin L.; Buckner, Randy L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Snyder, Abraham Z.; Head, Denise; Raichle, Marcus E.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Snyder, Abraham Z.; Raichle, Marcus E.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Lustig, Cindy] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Head, Denise] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Buckner, Randy L.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02155 USA; [Buckner, Randy L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard University; Massachusetts General Hospital; Washington University (WUSTL); Washington University (WUSTL); University of Michigan System; University of Michigan; Washington University (WUSTL); Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Buckner, RL (corresponding author), Harvard Univ, Ctr Brain Sci, Dept Psychol, Cambridge, MA 02138 USA.	rbuckner@wjh.harvard.edu	Patanaik, Amiya/G-4336-2010; Vincent, Justin L/B-5033-2012; Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026	NATIONAL INSTITUTE ON AGING [F32AG005886, P01AG003991, R01AG021910, P50AG005681, T32AG000030] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG003991-249005, P50 AG05681, P01 AG003991-229005, P01 AG003991-219005, F32 AG005886-03, F32 AG005886, AG00030, P01 AG003991-239005, P50 AG005681, F32 AG005886-02, P01 AG003991, AG03991, P01 AG003991-259005, AG05886, T32 AG000030, P50 AG005681-25, AG21910] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aizenstein HJ, 2004, J COGNITIVE NEUROSCI, V16, P786, DOI 10.1162/089892904970681; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Backman L, 2000, AM J PSYCHIAT, V157, P635; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Buckner RL, 2000, J COGNITIVE NEUROSCI, V12, P24, DOI 10.1162/089892900564046; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Conturo TE, 1996, MAGNET RESON MED, V35, P399, DOI 10.1002/mrm.1910350319; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; De Luca M, 2005, EXP BRAIN RES, V167, P587, DOI 10.1007/s00221-005-0059-1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Grady CL, 2003, HIPPOCAMPUS, V13, P572, DOI 10.1002/hipo.10114; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Lustig C, 2004, NEURON, V42, P865, DOI 10.1016/j.neuron.2004.04.002; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Maccotta L, 2001, NEUROIMAGE, V14, P1105, DOI 10.1006/nimg.2001.0912; MATSUNAMI K, 1984, J NEUROPHYSIOL, V52, P676, DOI 10.1152/jn.1984.52.4.676; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MYERS RE, 1962, J COMP NEUROL, V118, P1, DOI 10.1002/cne.901180102; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Pfefferbaum A, 2005, NEUROIMAGE, V26, P891, DOI 10.1016/j.neuroimage.2005.02.034; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raz N., 2000, HDB AGING COGNITION, V2nd, P1; Reuter-Lorenz PA, 2002, TRENDS COGN SCI, V6, P394, DOI 10.1016/S1364-6613(02)01957-5; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; Talairach J, 1988, CO PLANAR STEREOTAXI; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wu T, 2007, NEUROSCI LETT, V422, P164, DOI 10.1016/j.neulet.2007.06.011; Zar J. H., 1996, BIOSTATISTICAL ANAL	54	1097	1125	1	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2007	56	5					924	935		10.1016/j.neuron.2007.10.038	http://dx.doi.org/10.1016/j.neuron.2007.10.038			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241MA	18054866	Green Accepted, Bronze			2022-12-24	WOS:000251659300016
J	Fox, MD; Snyder, AZ; Vincent, JL; Raichle, ME				Fox, Michael D.; Snyder, Abraham Z.; Vincent, Justin L.; Raichle, Marcus E.			Intrinsic fluctuations within cortical systems account for intertrial variability in human Behavior	NEURON			English	Article							BRAIN ACTIVITY FLUCTUATIONS; FUNCTIONAL CONNECTIVITY; OSCILLATORY ACTIVITY; NEURONAL-ACTIVITY; VISUAL-CORTEX; MOTOR CORTEX; BLOOD-FLOW; NOISE; FMRI; DYNAMICS	The resting brain is not silent, but exhibits organized fluctuations in neuronal activity even in the absence of tasks or stimuli. This intrinsic brain activity persists during task performance and contributes to variability in evoked brain responses. What is unknown is if this intrinsic activity also contributes to variability in behavior. In the current fMRI study, we identify a relationship between human brain activity in the left somatornotor cortex and spontaneous trial-to-trial variability in button press force. We then demonstrate that 74% of this brain-behavior relationship is attributable to ongoing fluctuations in intrinsic activity similar to those observed during resting fixation. In addition to establishing a functional and behavioral significance of intrinsic brain activity, these results lend new insight into the origins of variability in human behavior.	Washington Univ, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Fox, MD (corresponding author), Washington Univ, Dept Radiol, St Louis, MO 63110 USA.	foxm@npg.wustl.edu	Vincent, Justin L/B-5033-2012; Fox, Michael D./AAZ-3928-2020	Fox, Michael D./0000-0001-8848-6399	NINDS NIH HHS [NS06833, F30 NS054398-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS054398, P50NS006833, P01NS006833] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALPORT A, 1990, FDN COGNITIVE SCI, P631; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Bruns A, 2000, NEUROREPORT, V11, P1509, DOI 10.1097/00001756-200005150-00028; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cramer SC, 2002, HUM BRAIN MAPP, V16, P197, DOI 10.1002/hbm.10040; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; DETTMERS C, 1995, J NEUROPHYSIOL, V74, P802, DOI 10.1152/jn.1995.74.2.802; DREVETS WC, 1995, NATURE, V373, P249, DOI 10.1038/373249a0; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ergenoglu T, 2004, COGNITIVE BRAIN RES, V20, P376, DOI 10.1016/j.cogbrainres.2004.03.009; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Gilden DL, 2001, PSYCHOL REV, V108, P33, DOI 10.1037/0033-295X.108.1.33; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Kampe KKW, 2000, HUM BRAIN MAPP, V9, P106, DOI 10.1002/(SICI)1097-0193(200002)9:2<106::AID-HBM5>3.0.CO;2-Y; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Laufs H, 2006, NEUROIMAGE, V31, P1408, DOI 10.1016/j.neuroimage.2006.02.002; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; LINAS R, 2001, I VORTEX NEURONS SEL; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lund TE, 2006, NEUROIMAGE, V29, P54, DOI 10.1016/j.neuroimage.2005.07.005; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; McAvoy MP, 2001, NEUROIMAGE, V13, pS198; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Pashler HE, 1998, PSYCHOL ATTENTION; Pessoa L, 2005, P NATL ACAD SCI USA, V102, P5612, DOI 10.1073/pnas.0500566102; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Salenius S, 2003, CURR OPIN NEUROBIOL, V13, P678, DOI 10.1016/j.conb.2003.10.008; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sapir A, 2005, P NATL ACAD SCI USA, V102, P17810, DOI 10.1073/pnas.0504678102; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Shu YS, 2003, J NEUROSCI, V23, P10388; TALAIRACH J, 1988, CO PLANAR STEROTAXIC; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P579, DOI 10.3758/BF03196615; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263	68	603	610	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 4	2007	56	1					171	184		10.1016/j.neuron.2007.08.023	http://dx.doi.org/10.1016/j.neuron.2007.08.023			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	222IN	17920023	Bronze			2022-12-24	WOS:000250289800018
J	Qyang, Y; Martin-Puig, S; Chiravuri, M; Chen, S; Xu, H; Bu, L; Jiang, X; Lin, L; Granger, A; Moretti, A; Caron, L; Wu, X; Clarke, J; Taketo, MM; Laugwitz, KL; Moon, RT; Gruber, P; Evans, SM; Ding, S; Chien, KR				Qyang, Yibing; Martin-Puig, Silvia; Chiravuri, MUrali; Chen, Shuibing; Xu, Huansheng; Bu, Lei; Jiang, Xin; Lin, Lizhu; Granger, Anne; Moretti, Alessandra; Caron, Leslie; Wu, Xu; Clarke, Jonathan; Taketo, Makoto M.; Laugwitz, Karl-Ludwig; Moon, Randall T.; Gruber, Peter; Evans, Sylvia M.; Ding, Sheng; Chien, Kenneth R.			The renewal and differentiation of Isl1(+) cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; SMOOTH-MUSCLE; SIGNALING PATHWAY; OUTFLOW TRACT; HEART FIELD; LINEAGES; CARDIOMYOCYTE; EXPRESSION; MOUSE; CARDIOGENESIS	Isl1(+) cardiovascular progenitors and their downstream progeny play a pivotal role in cardiogenesis and lineage diversification of the heart. The mechanisms that control their renewal and differentiation are largely unknown. Herein, we show that the Wnt/beta-catenin pathway is a major component by which cardiac mesenchymal cells modulate the prespecification, renewal, and differentiation of isl1(+) cardiovascular progenitors. This microenvironment can be reconstituted by a Wnt3a-secreting feeder layer with ES cell-derived, embryonic, and postnatal isl1(+) cardiovascular progenitors. In vivo activation of beta-catenin signaling in isl1(+) progenitors of the secondary heart field leads to their massive accumulation, inhibition of differentiation, and outflow tract (OFT) morphogenic defects. In addition, the mitosis rate in OFT myocytes is significantly reduced following beta-catenin deletion in isl1(+) precursors. Agents that manipulate Wnt signals can markedly expand isl1(+) progenitors from human neonatal hearts, a key advance toward the cloning of human isl1(+) heart progenitors.	Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Univ Calif San Diego, Skaggs Sch Pharm, La Jolla, CA 92093 USA; Childrens Hosp Philadelphia, Cardiac Ctr, Philadelphia, PA 19104 USA; Tech Univ Munich, Klinikum Rechts Isar, Med Klin, D-81675 Munich, Germany; Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98109 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98109 USA; Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Scripps Research Institute; University of California System; University of California San Diego; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Technical University of Munich; Kyoto University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Harvard University	Chien, KR (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charles River Pl-CPZN 3208,185 Cambridge St, Boston, MA 02114 USA.	kchien@partners.org	GRANGER, Anne/A-9748-2010; Moretti, Alessandra/O-9271-2015; Evans, Sylvia/G-1980-2015; Bu, Lei/F-4461-2011; Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019; Caron, Leslie/AAE-3511-2022	Moretti, Alessandra/0000-0001-5782-7832; Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; Caron, Leslie/0000-0003-4118-2974; Qyang, Yibing/0000-0002-0332-2449; BU, LEI/0000-0003-4476-2157; Martin-Puig, Silvia/0000-0003-3048-6729	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chien KR, 2005, CELL, V120, P533, DOI 10.1016/j.cell.2005.02.006; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Dominguez I, 2001, DEV BIOL, V235, P303, DOI 10.1006/dbio.2001.0317; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kunick C, 2004, BIOORG MED CHEM LETT, V14, P413, DOI 10.1016/j.bmcl.2003.10.062; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Plotkin B, 2003, J PHARMACOL EXP THER, V305, P974, DOI 10.1124/jpet.102.047381; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Singh AM, 2007, CIRCULATION, V115, P617, DOI 10.1161/CIRCULATIONAHA.106.642298; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Tzahor E, 2001, GENE DEV, V15, P255, DOI 10.1101/gad.871501; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568	34	245	272	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG	2007	1	2					165	179		10.1016/j.stem.2007.05.018	http://dx.doi.org/10.1016/j.stem.2007.05.018			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XS	18371348	Bronze			2022-12-24	WOS:000251055100008
J	Kwon, Y; Shim, HS; Wang, XY; Montell, C				Kwon, Young; Shim, Hye-Seok; Wang, Xiaoyue; Montell, Craig			Control of thermotactic behavior via coupling of a TRP channel to a phospholipase C signaling cascade	NATURE NEUROSCIENCE			English	Article							RETINAL-DEGENERATION; DROSOPHILA; PHOTOTRANSDUCTION; PHOSPHATASE; GENE	In animals such as the fruitfly, even minor deviations in environmental temperature can have major impacts on development and lifespan. Here we demonstrated that the ability of Drosophila melanogaster larvae to discriminate between the optimal temperature of 18 degrees C and slightly higher temperatures (19-24 degrees C) depended on the TRPA1 channel, which functioned downstream of a phospholipase C-dependent signaling cascade similar to that used in fly phototransduction. We propose that activation of TRPA1 through a signaling cascade promotes amplification of small differences in temperature and facilitates adaptation to temperatures within the comfortable range.	[Kwon, Young; Shim, Hye-Seok; Wang, Xiaoyue; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA; [Kwon, Young; Shim, Hye-Seok; Wang, Xiaoyue; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Montell, Craig/AAH-3357-2021; Wang, Xiaoyue/D-1046-2010	Montell, Craig/0000-0001-5637-1482; Kwon, Young/0000-0002-8937-3182	NEI NIH HHS [EY010852] Funding Source: Medline; NIGMS NIH HHS [GM085335] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085335] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; Kwon Y, 2006, CURR BIOL, V16, P723, DOI 10.1016/j.cub.2006.02.057; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1	13	123	125	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					871	873		10.1038/nn.2170	http://dx.doi.org/10.1038/nn.2170			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18660806				2022-12-24	WOS:000257969100008
J	Adlard, PA; Cherny, RA; Finkelstein, DI; Gautier, E; Robb, E; Cortes, M; Volitakis, I; Liu, X; Smith, JP; Perez, K; Laughton, K; Li, QX; Charman, SA; Nicolazzo, JA; Wilkins, S; Deleva, K; Lynch, T; Kok, G; Ritchie, CW; Tanzi, RE; Cappai, R; Masters, CL; Barnham, KJ; Bush, AI				Adlard, Paul A.; Cherny, Robert A.; Finkelstein, David I.; Gautier, Elisabeth; Robb, Elysia; Cortes, Mikhalina; Volitakis, Irene; Liu, Xiang; Smith, Jeffrey P.; Perez, Keyla; Laughton, Katrina; Li, Qiao-Xin; Charman, Susan A.; Nicolazzo, Joseph A.; Wilkins, Simon; Deleva, Karolina; Lynch, Toni; Kok, Gaik; Ritchie, Craig W.; Tanzi, Rudolph E.; Cappai, Roberto; Masters, Colin L.; Barnham, Kevin J.; Bush, Ashley I.			Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial A beta	NEURON			English	Article							AMYLOID-BETA; IN-VIVO; DISEASE; PROTEIN; ZINC; TAU; OLIGOMERS; PATHOLOGY; MODEL; SYNAPTOPHYSIN	As a disease-modifying approach for Alzheimer's disease (AD), clioquinol (CQ) targets beta-amyloid (A beta) reactions with synaptic Zn and Cu yet promotes metal uptake. Here we characterize the second-generation 8-hydroxy quinoline analog PBT2, which also targets metal-induced aggregation of AB, but is more effective as a Zn/Cu ionophore and has greater blood-brain barrier permeability. Given orally to two types of amyloid-bearing transgenic mouse models of AD, PBT2 outperformed CQ by markedly decreasing soluble interstitial brain AB within hours and improving cognitive performance to exceed that of normal littermate controls within days. Nontransgenic mice were unaffected by PBT2. The current data demonstrate that ionophore activity, inhibition of in vitro metal-mediated AB reactions, and blood-brain barrier permeability are indices that predict a potential disease-modifying drug for AD. The speed of recovery of the animals underscores the acutely reversible nature of the cognitive deficits associated with transgenic models of AD.	[Adlard, Paul A.; Cherny, Robert A.; Finkelstein, David I.; Robb, Elysia; Cortes, Mikhalina; Volitakis, Irene; Liu, Xiang; Smith, Jeffrey P.; Perez, Keyla; Laughton, Katrina; Li, Qiao-Xin; Wilkins, Simon; Deleva, Karolina; Lynch, Toni; Cappai, Roberto; Masters, Colin L.; Barnham, Kevin J.; Bush, Ashley I.] Mental Hlth Res Inst, Oxidat Biol Lab, Parkville, Vic 3052, Australia; [Adlard, Paul A.; Cherny, Robert A.; Laughton, Katrina; Li, Qiao-Xin; Cappai, Roberto; Barnham, Kevin J.; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Finkelstein, David I.; Wilkins, Simon; Masters, Colin L.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Cappai, Roberto; Barnham, Kevin J.] Univ Melbourne, Bio Mol Sci & Biotechnol Inst 21, Melbourne, Vic 3010, Australia; [Cherny, Robert A.; Gautier, Elisabeth; Kok, Gaik] Prana Biotechnol Ltd, Parkville, Vic 3052, Australia; [Charman, Susan A.; Nicolazzo, Joseph A.] Monash Univ, Monash Inst Pharmaceut Sci, Ctr Drug Candidate Optimisat, Parkville, Vic 3052, Australia; [Ritchie, Craig W.] UCL Royal Free & Univ Coll Med Sch, Dept Mental Hlth Sci, Metab & Clin Trials Unit, London WC1E 6BT, England; [Tanzi, Rudolph E.] Massachusetts Gen Hosp, Genet & Aging Res Unit, Charlestown, MA 02129 USA	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; Monash University; University of London; University College London; UCL Medical School; Harvard University; Massachusetts General Hospital	Bush, AI (corresponding author), Mental Hlth Res Inst, Oxidat Biol Lab, Parkville, Vic 3052, Australia.	abush@mhri.edu.au	Finkelstein, David/B-9617-2009; Bush, Ashley/Y-2457-2019; Tanzi, Rudolph/AAE-9622-2019; Bush, Ashley I/A-1186-2007; Wilkins, Simon/D-1174-2009; Charman, Susan A/E-2221-2011; Cappai, Roberto/B-3347-2010	Finkelstein, David/0000-0002-8167-4917; Bush, Ashley/0000-0001-8259-9069; Tanzi, Rudolph/0000-0002-7032-1454; Bush, Ashley I/0000-0001-8259-9069; Wilkins, Simon/0000-0001-7712-4114; Charman, Susan A/0000-0003-1753-8213; Cappai, Roberto/0000-0002-9505-8496				Abraha A, 2000, J CELL SCI, V113, P3737; Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Ballard C, 2001, INT J GERIATR PSYCH, V16, P494, DOI 10.1002/gps.368; Barnham KJ, 2004, FASEB J, V18, P1427, DOI 10.1096/fj.04-1890fje; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; Borchardt T, 1999, BIOCHEM J, V344, P461, DOI 10.1042/0264-6021:3440461; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Callahan LM, 1999, J NEUROPATH EXP NEUR, V58, P275, DOI 10.1097/00005072-199903000-00007; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Eikelenboom P, 1999, DEMENT GERIATR COGN, V10, P319, DOI 10.1159/000017162; Frederickson CJ, 2006, J NEUROSCI METH, V154, P19, DOI 10.1016/j.jneumeth.2005.11.014; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; LANNFELT L, 2008, LANCET NEUR IN PRESS; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Lee JY, 2004, NEUROBIOL AGING, V25, P1315, DOI 10.1016/j.neurobiolaging.2004.01.005; Masters CL, 2006, BRAIN, V129, P2823, DOI 10.1093/brain/awl251; Maynard CJ, 2006, J INORG BIOCHEM, V100, P952, DOI 10.1016/j.jinorgbio.2006.02.010; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Opazo C, 2006, AGING CELL, V5, P69, DOI 10.1111/j.1474-9726.2006.00196.x; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Puglielli L, 2005, J CLIN INVEST, V115, P2556, DOI 10.1172/JCI23610; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Stoltenberg M, 2007, NEUROSCIENCE, V150, P357, DOI 10.1016/j.neuroscience.2007.09.025; Strozyk D, 2009, NEUROBIOL AGING, V30, P1069, DOI 10.1016/j.neurobiolaging.2007.10.012; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Zhang B, 2008, J BIOL CHEM, V283, P11866, DOI 10.1074/jbc.M800199200	45	552	568	1	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 10	2008	59	1					43	55		10.1016/j.neuron.2008.06.018	http://dx.doi.org/10.1016/j.neuron.2008.06.018			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	327KU	18614028	Bronze			2022-12-24	WOS:000257728800007
J	Kreher, SA; Mathew, D; Kim, J; Carlson, JR				Kreher, Scott A.; Mathew, Dennis; Kim, Junhyong; Carlson, John R.			Translation of sensory input into behavioral output via an olfactory system	NEURON			English	Article							DROSOPHILA ANTENNAL LOBE; ODOR DISCRIMINATION; C-ELEGANS; CHEMOTAXIS BEHAVIOR; CHEMOSENSORY SYSTEM; MELANOGASTER MEIGEN; MOLECULAR-BASIS; CELLULAR BASIS; RECEPTOR; REPRESENTATIONS	We investigate the logic by which sensory input is translated into behavioral output. First we provide a functional analysis of the entire odor receptor repertoire of an olfactory system. We construct tuning curves for the 21 functional odor receptors of the Drosophila larva and show that they sharpen at lower odor doses. We construct a 21-dimensional odor space from the responses of the receptors and find that the distance between two odors correlates with the extent to which one odor masks the other. Mutational analysis shows that different receptors mediate the responses to different concentrations of an odorant. The summed response of the entire receptor repertoire correlates with the strength of the behavioral response. The activity of a small number of receptors is a surprisingly powerful predictor of behavior. Odors that inhibit more receptors are more likely to be repellents. Odor space is largely conserved between two dissimilar olfactory systems.	[Kim, Junhyong] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Kreher, Scott A.; Mathew, Dennis; Carlson, John R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Kim, Junhyong] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Yale University; University of Pennsylvania	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu	Mathew, Dennis/AAF-7036-2020; Mathew, Dennis/A-7654-2012	Mathew, Dennis/0000-0002-2096-6334	NIDCD NIH HHS [R01 DC004729-05, R01 DC004729-06, R01 DC002174-22, R01 DC002174-20, R01 DC002174-21, R01 DC004729, R01 DC002174] Funding Source: Medline; NIGMS NIH HHS [1-P20-GM-6912-1] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004729, R01DC002174] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; AYYUB C, 1990, J NEUROGENET, V6, P243, DOI 10.3109/01677069009107114; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; BOECKH J, 1965, COLD SPRING HARB SYM, V30, P263, DOI 10.1101/SQB.1965.030.01.028; Cobb M, 1999, BIOL REV, V74, P425, DOI 10.1017/S0006323199005393; Cobb M, 2000, P ROY SOC B-BIOL SCI, V267, P2119, DOI 10.1098/rspb.2000.1258; COBB M, 1992, P ROY SOC B-BIOL SCI, V248, P103, DOI 10.1098/rspb.1992.0048; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hertweck H, 1931, Z WISS ZOOL ABT A, V139, P559; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Louis M, 2008, NAT NEUROSCI, V11, P187, DOI 10.1038/nn2031; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Masuda-Nakagawa LM, 2005, P NATL ACAD SCI USA, V102, P19027, DOI 10.1073/pnas.0509643102; MONTE P, 1989, BEHAV GENET, V19, P267, DOI 10.1007/BF01065910; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Oppliger FY, 2000, J INSECT PHYSIOL, V46, P135, DOI 10.1016/S0022-1910(99)00109-2; Python F, 2002, J COMP NEUROL, V453, P157, DOI 10.1002/cne.10383; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; Ramaekers A, 2005, CURR BIOL, V15, P982, DOI 10.1016/j.cub.2005.04.032; RODRIGUES V, 1978, P INDIAN ACAD SCI B, V87, P147; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; SANCHEZ MGD, 2005, J COMP PHYSIOL A, V191, P189; Schneider D., 1968, Symposia of the Zoological Society of London, VNo. 23, P279; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; SINGH RN, 1984, INT J INSECT MORPHOL, V13, P255, DOI 10.1016/0020-7322(84)90001-1; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Stortkuhl KF, 1999, J NEUROSCI, V19, P4839; *TNO, 2004, VOL COMP FOOD QUAL Q; UMANO K, 1992, J AGR FOOD CHEM, V40, P599, DOI 10.1021/jf00016a014; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X	58	176	183	3	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 10	2008	59	1					110	124		10.1016/j.neuron.2008.06.010	http://dx.doi.org/10.1016/j.neuron.2008.06.010			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	327KU	18614033	Green Accepted, Bronze			2022-12-24	WOS:000257728800012
J	Emes, RD; Pocklington, AJ; Anderson, CNG; Bayes, A; Collins, MO; Vickers, CA; Croning, MDR; Malik, BR; Choudhary, JS; Armstrong, JD; Grant, SGN				Emes, Richard D.; Pocklington, Andrew J.; Anderson, Christopher N. G.; Bayes, Alex; Collins, Mark O.; Vickers, Catherine A.; Croning, Mike D. R.; Malik, Bilal R.; Choudhary, Jyoti S.; Armstrong, J. Douglas; Grant, Seth G. N.			Evolutionary expansion and anatomical specialization of synapse proteome complexity	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; IN-SITU HYBRIDIZATION; NMDA-RECEPTOR; POSTSYNAPTIC DENSITY-95; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; MULTIPROTEIN COMPLEXES; MOLECULAR CONSTITUENTS; SIGNALING COMPLEXES; FILAMENTOUS GROWTH	Understanding the origins and evolution of synapses may provide insight into species diversity and the organization of the brain. Using comparative proteomics and genomics, we examined the evolution of the postsynaptic density (PSD) and membrane-associated guanylate kinase (MAGUK)-associated signaling complexes (MASCs) that underlie learning and memory. PSD and MASC orthologs found in yeast carry out basic cellular functions to regulate protein synthesis and structural plasticity. We observed marked changes in signaling complexity at the yeast-metazoan and invertebrate-vertebrate boundaries, with an expansion of key synaptic components, notably receptors, adhesion/cytoskeletal proteins and scaffold proteins. A proteomic comparison of Drosophila and mouse MASCs revealed species-specific adaptation with greater signaling complexity in mouse. Although synaptic components were conserved amongst diverse vertebrate species, mapping mRNA and protein expression in the mouse brain showed that vertebrate-specific components preferentially contributed to differences between brain regions. We propose that the evolution of synapse complexity around a core proto-synapse has contributed to invertebrate-vertebrate differences and to brain specialization.	[Anderson, Christopher N. G.; Bayes, Alex; Collins, Mark O.; Croning, Mike D. R.; Choudhary, Jyoti S.; Grant, Seth G. N.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Emes, Richard D.] Keele Univ, Inst Sci & Technol Med, Stoke On Trent ST4 7QB, Staffs, England; [Pocklington, Andrew J.; Malik, Bilal R.; Armstrong, J. Douglas] Univ Edinburgh, Inst Adapt & Neural Computat, Sch Informat, Edinburgh EH1 2QL, Midlothian, Scotland; [Vickers, Catherine A.] Univ Edinburgh, Div Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; [Vickers, Catherine A.] Okinawa Inst Sci & Technol, Neurobiol Res Unit, Okinawa, Japan	Wellcome Trust Sanger Institute; Keele University; University of Edinburgh; University of Edinburgh; Okinawa Institute of Science & Technology Graduate University	Grant, SGN (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	sg3@sanger.ac.uk	Collins, Mark/A-3752-2012; Collins, Mark/AAB-7484-2021; Choudhary, Jyoti/S-1232-2017; Emes, Richard D/C-5341-2008; Bayés, Àlex/H-2854-2015	Collins, Mark/0000-0002-7656-4975; Choudhary, Jyoti/0000-0003-0881-5477; Emes, Richard D/0000-0001-6855-5481; Bayés, Àlex/0000-0002-5265-6306; Malik, Bilal/0000-0001-5522-4990; Armstrong, Douglas/0000-0002-5397-3864; Pocklington, Andrew/0000-0002-2137-0452; Grant, Seth/0000-0001-8732-8735	MRC [G90/112, G90/93] Funding Source: UKRI; Medical Research Council [G90/93, G90/112] Funding Source: Medline; Wellcome Trust [077155] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Dosemeci A, 2007, MOL CELL PROTEOMICS, V6, P1749, DOI 10.1074/mcp.M700040-MCP200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elion EA, 2005, SCIENCE, V307, P687, DOI 10.1126/science.1109500; Erdman S, 2001, GENETICS, V159, P919; Grant SGN, 2005, HUM MOL GENET, V14, pR225, DOI 10.1093/hmg/ddi330; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harashima T, 2006, MOL CELL, V22, P819, DOI 10.1016/j.molcel.2006.05.011; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Husi H, 2001, J NEUROCHEM, V77, P281, DOI 10.1046/j.1471-4159.2001.t01-1-00248.x; Imai JH, 2007, J COMP NEUROL, V501, P316, DOI 10.1002/cne.21246; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Laumonnier F, 2007, AM J HUM GENET, V80, P205, DOI 10.1086/511441; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Moore BR, 2004, BIOL REV, V79, P301, DOI 10.1017/S1464793103006225; Nakazawa T, 2006, EMBO J, V25, P2867, DOI 10.1038/sj.emboj.7601156; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Palecek SP, 2002, MICROBIOL-SGM, V148, P893, DOI 10.1099/00221287-148-4-893; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Pocklington AJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100041; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Ruiz-Canada C, 2002, J NEUROCHEM, V82, P1490, DOI 10.1046/j.1471-4159.2002.01092.x; Ryan TJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-6; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Truman James W., 1993, P1245; Velthuis AJWT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-129; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yamauchi T, 2002, MASS SPECTROM REV, V21, P266, DOI 10.1002/mas.10033; Yoshimura Y, 2004, J NEUROCHEM, V88, P759, DOI 10.1046/j.1471-4159.2003.02136.x; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102	50	145	148	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					799	806		10.1038/nn.2135	http://dx.doi.org/10.1038/nn.2135			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18536710	Green Accepted			2022-12-24	WOS:000257089400017
J	Kaneko, M; Stellwagen, D; Malenka, RC; Stryker, MP				Kaneko, Megumi; Stellwagen, David; Malenka, Robert C.; Stryker, Michael P.			Tumor necrosis factor-alpha mediates one component of competitive, experience-dependent plasticity in developing visual cortex	NEURON			English	Article							OCULAR-DOMINANCE PLASTICITY; CRITICAL PERIOD PLASTICITY; KITTEN STRIATE CORTEX; CORTICAL PLASTICITY; MONOCULAR DEPRIVATION; BINOCULAR INTERACTION; INTRINSIC SIGNAL; MOLECULAR-BASIS; MUTANT MICE; MOUSE	Rapid, experience-dependent plasticity in developing visual cortex is thought to be competitive. After monocular visual deprivation, the reduction in response of binocular neurons to one eye is matched by a corresponding increase to the other. Chronic optical imaging in mice deficient in TNF alpha reveals the normal initial loss of deprived-eye responses, but the subsequent increase in response to the open eye is absent. This mutation also blocks homeostatic synaptic scaling of mEPSCs in visual cortex in vitro, without affecting LTP. In monocular cortex, thought not to be subject to competition, responses in TNF alpha mutants are as reduced as in the binocular zone. Pharmacological inhibition of endogenous TNF alpha in wild-type mice phenocopies the knockout. These findings suggest that experience-dependent competition in developing visual cortex is the outcome of two distinct, noncompetitive processes, a loss of deprived-eye responses followed by an apparently homeostatic increase in responses dependent on TNF alpha signaling.	[Kaneko, Megumi; Stryker, Michael P.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Stellwagen, David; Malenka, Robert C.] Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Stryker, MP (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	stryker@phy.ucsf.edu		Stryker, Michael/0000-0003-1546-5831	NEI NIH HHS [R01 EY002874, R01 EY002874-26, R01 EY002874-25S1] Funding Source: Medline; NIMH NIH HHS [P50 MH077972-030003, P50 MH077972-020003, P50 MH077972, P50 MH077972-010003] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077972] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bear MF, 1999, J NEUROBIOL, V41, P83, DOI 10.1002/(SICI)1097-4695(199910)41:1<83::AID-NEU11>3.0.CO;2-Z; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; Crozier RA, 2007, P NATL ACAD SCI USA, V104, P1383, DOI 10.1073/pnas.0609596104; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fischer QS, 2004, J NEUROSCI, V24, P9049, DOI 10.1523/JNEUROSCI.2409-04.2004; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Gordon JA, 1996, NEURON, V17, P491, DOI 10.1016/S0896-6273(00)80181-6; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Mataga N, 2002, P NATL ACAD SCI USA, V99, P7717, DOI 10.1073/pnas.102088899; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; OLSON CR, 1975, J NEUROPHYSIOL, V38, P26, DOI 10.1152/jn.1975.38.1.26; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Rao Y, 2004, EUR J NEUROSCI, V20, P837, DOI 10.1111/j.1460-9568.2004.03499.x; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Taha S, 2002, NEURON, V36, P483, DOI 10.1016/S0896-6273(02)00966-2; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0	49	298	304	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 12	2008	58	5					673	680		10.1016/j.neuron.2008.04.023	http://dx.doi.org/10.1016/j.neuron.2008.04.023			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	315IA	18549780	Bronze, Green Accepted			2022-12-24	WOS:000256870800006
J	Chen, G; Lu, HD; Roe, AW				Chen, Gang; Lu, Haidong D.; Roe, Anna W.			A map for horizontal disparity in monkey V2	NEURON			English	Article							CAT VISUAL-CORTEX; FUNCTIONAL-ORGANIZATION; AREA V2; ORIENTATION SELECTIVITY; CORTICAL CONNECTIONS; BINOCULAR DISPARITY; NEURAL MECHANISMS; MACAQUE MONKEYS; STRIATE CORTEX; ALERT MACAQUE	The perception of visual depth is determined by integration of spatial disparities of inputs from the two eyes. Single cells in visual cortex of monkeys are known to respond to specific binocular disparities; however, little is known about their functional organization. We now show, using intrinsic signal optical imaging and single-unit physiology, that, in the thick stripe compartments of the second visual area (V2), there is a clustered organization of Near cells and Far cells, and moreover, there are topographic maps for Near to Far disparities within V2. Our findings suggest that maps for visual disparity are calculated in V2, and demonstrate parallels in functional organization between the thin, pale, and thick stripes of V2.	[Chen, Gang; Lu, Haidong D.; Roe, Anna W.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA	Vanderbilt University	Roe, AW (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA.	anna.roe@vanderbilt.edu	chen, gang/H-3169-2012	Roe, Anna Wang/0000-0003-4146-9705	NATIONAL EYE INSTITUTE [R01EY011744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023002] Funding Source: NIH RePORTER; NEI NIH HHS [EY 11744, R01 EY011744, R01 EY011744-08] Funding Source: Medline; NIDA NIH HHS [R21 DA023002, R21 DA023002-02] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Adams DL, 2001, J NEUROPHYSIOL, V86, P2195, DOI 10.1152/jn.2001.86.5.2195; Anzai A, 1999, J NEUROPHYSIOL, V82, P874, DOI 10.1152/jn.1999.82.2.874; BAIZER JS, 1977, J NEUROPHYSIOL, V40, P1024, DOI 10.1152/jn.1977.40.5.1024; Bakin JS, 2000, J NEUROSCI, V20, P8188; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; Cumming BG, 1999, J NEUROSCI, V19, P5602; Cumming BG, 2002, NATURE, V418, P633, DOI 10.1038/nature00909; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; DeAngelis GC, 2003, J NEUROPHYSIOL, V89, P1094, DOI 10.1152/jn.00717.2002; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; DEYOE EA, 1985, NATURE, V317, P58, DOI 10.1038/317058a0; Felleman DJ, 1997, J COMP NEUROL, V379, P21, DOI 10.1002/(SICI)1096-9861(19970303)379:1<21::AID-CNE3>3.0.CO;2-K; FERSTER D, 1981, J PHYSIOL-LONDON, V311, P623, DOI 10.1113/jphysiol.1981.sp013608; Fitzgibbon A, 1999, IEEE T PATTERN ANAL, V21, P476, DOI 10.1109/34.765658; Gonzalez F, 1998, PROG NEUROBIOL, V55, P191, DOI 10.1016/S0301-0082(98)00012-4; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hinkle DA, 2005, J NEUROPHYSIOL, V94, P2726, DOI 10.1152/jn.00341.2005; HUBEL DH, 1987, J NEUROSCI, V7, P3378; HUBEL DH, 1970, NATURE, V225, P41, DOI 10.1038/225041a0; Julesz B., 1971, FDN CYCLOPEAN PERCEP; MALACH R, 1994, CEREB CORTEX, V4, P151, DOI 10.1093/cercor/4.2.151; Nienborg H, 2007, NAT NEUROSCI, V10, P1608, DOI 10.1038/nn1991; Nienborg H, 2006, J NEUROSCI, V26, P9567, DOI 10.1523/JNEUROSCI.2256-06.2006; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P221, DOI 10.1152/jn.1986.56.1.221; PETERHANS E, 1993, EUR J NEUROSCI, V5, P509, DOI 10.1111/j.1460-9568.1993.tb00517.x; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; Ponce CR, 2008, NAT NEUROSCI, V11, P216, DOI 10.1038/nn2039; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; Ramsden BM, 2001, CEREB CORTEX, V11, P648, DOI 10.1093/cercor/11.7.648; ROE A, 2003, PRIMATE VISUAL SYSTE; Roe AW, 2005, P NATL ACAD SCI USA, V102, P3869, DOI 10.1073/pnas.0500097102; ROE AW, 1995, J NEUROSCI, V15, P3689; Roe AW, 2005, ANAT REC PART A, V287A, P1213, DOI 10.1002/ar.a.20248; Sereno ME, 2002, NEURON, V33, P635, DOI 10.1016/S0896-6273(02)00598-6; SHIPP S, 1989, EUR J NEUROSCI, V1, P333, DOI 10.1111/j.1460-9568.1989.tb00799.x; SHIPP S, 1985, NATURE, V315, P322, DOI 10.1038/315322a0; Shmuel A, 2005, J NEUROSCI, V25, P2117, DOI 10.1523/JNEUROSCI.4137-04.2005; Stepniewska I, 1996, J COMP NEUROL, V371, P129; Swindale NV, 2004, NETWORK-COMP NEURAL, V15, P217, DOI 10.1088/0954-898X/15/4/001; Thomas OM, 2002, NAT NEUROSCI, V5, P472, DOI 10.1038/nn837; Ts'o DY, 2001, VISION RES, V41, P1333, DOI 10.1016/S0042-6989(01)00076-1; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Wang J, 2006, SMALL, V2, P129, DOI 10.1002/smll.200500231; Watanabe M, 2002, J NEUROPHYSIOL, V87, P1960, DOI 10.1152/jn.00780.2000; Xiao YP, 2003, NATURE, V421, P535, DOI 10.1038/nature01372; Xu XM, 2004, J NEUROSCI, V24, P6237, DOI 10.1523/JNEUROSCI.1144-04.2004; Xu XM, 2004, P NATL ACAD SCI USA, V101, P2566, DOI 10.1073/pnas.0308745101; ZEKI S, 1989, EUR J NEUROSCI, V1, P494, DOI 10.1111/j.1460-9568.1989.tb00356.x	54	73	77	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAY 8	2008	58	3					442	450		10.1016/j.neuron.2008.02.032	http://dx.doi.org/10.1016/j.neuron.2008.02.032			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	300HP	18466753	Green Accepted, Bronze			2022-12-24	WOS:000255815200016
J	Terao, M; Watanabe, J; Yagi, A; Nishida, S				Terao, Masahiko; Watanabe, Junji; Yagi, Akihiro; Nishida, Shin'ya			Reduction of stimulus visibility compresses apparent time intervals	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; PARIETAL CORTEX; NEURAL BASIS; REPRESENTATION; SPACE; SUPPRESSION; PERCEPTION; DETECTORS	The neural mechanisms underlying visual estimation of subsecond durations remain unknown, but perisaccadic underestimation of interflash intervals may provide a clue as to the nature of these mechanisms. Here we found that simply reducing the flash visibility, particularly the visibility of transient signals, induced similar time underestimation by human observers. Our results suggest that weak transient responses fail to trigger the proper detection of temporal asynchrony, leading to increased perception of simultaneity and apparent time compression.	[Terao, Masahiko; Watanabe, Junji; Nishida, Shin'ya] NTT Corp, NTT, Commun Sci Lab, Atsugi, Kanagawa 2430198, Japan; [Terao, Masahiko; Yagi, Akihiro] Kwansei Gakuin Univ, Grad Sch Human, Nishinomiya, Hyogo 6628501, Japan; [Watanabe, Junji] Japan Sci & Technol Agcy, Atsugi, Kanagawa 2430198, Japan	Nippon Telegraph & Telephone Corporation; Kwansei Gakuin University; Japan Science & Technology Agency (JST)	Terao, M (corresponding author), NTT Corp, NTT, Commun Sci Lab, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	masahiko_terao@mac.com						Burr D, 2006, CURR BIOL, V16, pR847, DOI 10.1016/j.cub.2006.08.075; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Ibbotson MR, 2007, CEREB CORTEX, V17, P1129, DOI 10.1093/cercor/bhl022; Ibbotson MR, 2006, CURR BIOL, V16, pR834, DOI 10.1016/j.cub.2006.08.081; Kitazawa S., 2007, ATTENTION PERFORM, P73; KULIKOWSKI JJ, 1973, J PHYSIOL-LONDON, V232, P149, DOI 10.1113/jphysiol.1973.sp010261; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Nishida S, 2002, CURR BIOL, V12, P359, DOI 10.1016/S0960-9822(02)00698-X; Reutimann J, 2004, J NEUROSCI, V24, P3295, DOI 10.1523/JNEUROSCI.4098-03.2004; TREISMAN M, 1990, PERCEPTION, V19, P705, DOI 10.1068/p190705; UCHIKAWA K, 1995, J OPT SOC AM A, V12, P661, DOI 10.1364/JOSAA.12.000661; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300	15	62	62	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					541	542		10.1038/nn.2111	http://dx.doi.org/10.1038/nn.2111			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18408716				2022-12-24	WOS:000255327300011
J	Pratt, KG; Dong, W; Aizenman, CD				Pratt, Kara G.; Dong, Wei; Aizenman, Carlos D.			Development and spike timing-dependent plasticity of recurrent excitation in the Xenopus optic tectum	NATURE NEUROSCIENCE			English	Article							ACTIVITY IN-VIVO; NICOTINIC ACETYLCHOLINE-RECEPTOR; DEVELOPING RETINOTECTAL SYSTEM; LASER-PULSE PHOTOLYSIS; SYNAPTIC-TRANSMISSION; SUPERIOR COLLICULUS; CORTICAL SIMPLE; VISUAL-CORTEX; TIME REGION; INHIBITION	Much of the information processing in the brain occurs at the level of local circuits; however, the mechanisms underlying their initial development are poorly understood. We sought to examine the early development and plasticity of local excitatory circuits in the optic tectum of Xenopus laevis tadpoles. We found that retinal input recruits persistent, recurrent intratectal synaptic excitation that becomes more temporally compact and less variable over development, thus increasing the temporal coherence and precision of tectal cell spiking. We also saw that patterned retinal input can sculpt recurrent activity according to a spike timing-dependent plasticity rule, and that impairing this plasticity during development results in abnormal refinement of the temporal characteristics of recurrent circuits. This plasticity is a previously unknown mechanism by which patterned retinal activity allows intratectal circuitry to self-organize, optimizing the temporal response properties of the tectal network, and provides a substrate for rapid modulation of tectal neuron receptive-field properties.	[Pratt, Kara G.; Dong, Wei; Aizenman, Carlos D.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Aizenman, CD (corresponding author), Brown Univ, Dept Neurosci, Box G-LN, Providence, RI 02912 USA.	carlos_aizenman@brown.edu		Dong, Wei/0000-0002-8151-9407				Aizenman CD, 2007, J NEUROPHYSIOL, V97, P2949, DOI 10.1152/jn.00452.2006; Aizenman CD, 2003, NEURON, V39, P831, DOI 10.1016/S0896-6273(03)00527-0; Aizenman CD, 2002, NEURON, V34, P623, DOI 10.1016/S0896-6273(02)00674-8; Akerman CJ, 2006, J NEUROSCI, V26, P5117, DOI 10.1523/JNEUROSCI.0319-06.2006; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Buonomano DV, 2003, P NATL ACAD SCI USA, V100, P4897, DOI 10.1073/pnas.0736909100; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Cline HT, 1996, COLD SPRING HARB SYM, V61, P95; Debski EA, 2002, CURR OPIN NEUROBIOL, V12, P93, DOI 10.1016/S0959-4388(02)00295-7; Edwards JA, 1999, J NEUROPHYSIOL, V81, P895, DOI 10.1152/jn.1999.81.2.895; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Grewer C, 1999, BIOCHEMISTRY-US, V38, P7837, DOI 10.1021/bi9827767; Grusser O.-J, 1976, P297; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; HOLT CE, 1983, NATURE, V301, P150, DOI 10.1038/301150a0; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Jayaraman V, 1999, BIOCHEMISTRY-US, V38, P11406, DOI 10.1021/bi991219x; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; LAZAR G, 1973, J ANAT, V116, P347; Lazar Gy., 1967, Journal fuer Hirnforschung, V9, P329; Lee PH, 1997, P NATL ACAD SCI USA, V94, P13299, DOI 10.1073/pnas.94.24.13299; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lopez JM, 2002, J COMP NEUROL, V453, P418, DOI 10.1002/cne.10419; MCCORMICK DA, 1995, J NEUROSCI, V15, P5739; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Nakagawa H, 1997, VISUAL NEUROSCI, V14, P263, DOI 10.1017/S0952523800011408; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Pratt KG, 2007, J NEUROSCI, V27, P8268, DOI 10.1523/JNEUROSCI.1738-07.2007; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; Rajan I, 1998, J NEUROSCI, V18, P7836; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Saito Y, 2003, J NEUROSCI, V23, P5854; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SPARKS DL, 1986, PHYSIOL REV, V66, P118, DOI 10.1152/physrev.1986.66.1.118; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Sutula TP, 2007, PROG BRAIN RES, V163, P541, DOI 10.1016/S0079-6123(07)63029-5; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; UDIN SB, 1985, J COMP NEUROL, V232, P25, DOI 10.1002/cne.902320103; Vislay-Meltzer R, 2006, NEURON, V50, P101, DOI 10.1016/j.neuron.2006.02.016; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000; Yao HS, 2007, NAT NEUROSCI, V10, P772, DOI 10.1038/nn1895; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	49	56	56	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					467	475		10.1038/nn2076	http://dx.doi.org/10.1038/nn2076			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344990				2022-12-24	WOS:000254359300019
J	Terashima, A; Pelkey, KA; Rah, JC; Suh, YH; Roche, KW; Collingridge, GL; McBain, CJ; Isaac, JTR				Terashima, Akira; Pelkey, Kenneth A.; Rah, Jong-Cheol; Suh, Young Ho; Roche, Katherine W.; Collingridge, Graham L.; McBain, Chris J.; Isaac, John T. R.			An essential role for PICK1 in NMDA receptor-dependent bidirectional synaptic plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; CA2+-PERMEABLE AMPA RECEPTORS; DOMAIN-CONTAINING PROTEIN; KINASE-C-ALPHA; BINDING-PROTEIN; PKC PHOSPHORYLATION; SUBUNIT COMPOSITION; PDZ DOMAINS; CA1 REGION; AREA CA1	PICK1 is a calcium-sensing, PDZ domain-containing protein that interacts with GluR2 and GluR3 AMPA receptor (AMPAR) subunits and regulates their trafficking. Although PICK1 has been principally implicated in long-term depression (LTD), PICK1 overexpression in CA1 pyramidal neurons causes a CaMK- and PKC-dependent potentiation of AMPAR-mediated transmission and an increase in synaptic GluR2-lacking AMPARs, mechanisms associated with NMDA receptor (NMDAR)-dependent long-term potentiation (LTP). Here, we directly tested whether PICK1 participates in both hippocampal NMDAR-dependent LTP and LTD. We show that the PICK1 potentiation of AMPAR-mediated transmission is NMDAR dependent and fully occludes LTP. Conversely, blockade of PICK1 PDZ interactions or lack of PICK1 prevents LTP. These observations demonstrate an important role for PICK1 in LTP. In addition, deletion of PICK1 or blockade of PICK1 PDZ binding prevented NMDAR-dependent LTD. Thus, PICK1 plays a critical role in bidirectional NMDAR-dependent long-term synaptic plasticity in the hippocampus.	[Terashima, Akira; Rah, Jong-Cheol; Isaac, John T. R.] Natl Inst Neurol Disorders & Stroke, Dev Synapt Plast Sect, NIH, Bethesda, MD 20892 USA; [Terashima, Akira; Collingridge, Graham L.; Isaac, John T. R.] Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synspt Plat, Bristol BS8 1TD, Avon, England; [Pelkey, Kenneth A.; McBain, Chris J.] NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA; [Suh, Young Ho; Roche, Katherine W.] Natl Inst Neurol Disorders & Stroke, Receptor Biol Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Bristol; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Isaac, JTR (corresponding author), Natl Inst Neurol Disorders & Stroke, Dev Synapt Plast Sect, NIH, 35 Convent Dr, Bethesda, MD 20892 USA.	isaacj@ninds.nih.gov	Collingridge, Graham L/C-4605-2015; collingridge, graham/AAI-8362-2020; Roche, Katherine/W-9893-2019	Collingridge, Graham L/0000-0002-9572-5359; Rah, Jong-Cheol/0000-0003-3780-0522; Roche, Katherine/0000-0001-7282-6539	MRC [G0601813] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002994, ZIANS003035, Z01NS003011] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 NS003011-03] Funding Source: Medline; Medical Research Council [G0601813] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Cao M, 2007, J NEUROSCI, V27, P12945, DOI 10.1523/JNEUROSCI.2040-07.2007; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dev KK, 2000, J NEUROSCI, V20, P7252; Dev KK, 2006, TRENDS PHARMACOL SCI, V27, P574, DOI 10.1016/j.tips.2006.09.007; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Duprat F, 2003, PHILOS T ROY SOC B, V358, P715, DOI 10.1098/rstb.2002.1215; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Gray EE, 2007, J NEUROPHYSIOL, V98, P2488, DOI 10.1152/jn.00473.2007; Groc L, 2006, CELL TISSUE RES, V326, P423, DOI 10.1007/s00441-006-0254-9; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hjelmstad GO, 1997, NEURON, V19, P1309, DOI 10.1016/S0896-6273(00)80421-3; Ho MTW, 2007, J NEUROSCI, V27, P11651, DOI 10.1523/JNEUROSCI.2671-07.2007; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Jensen V, 2003, J PHYSIOL-LONDON, V553, P843, DOI 10.1113/jphysiol.2003.053637; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lauri SE, 2007, NEUROPHARMACOLOGY, V52, P1, DOI 10.1016/j.neuropharm.2006.06.017; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Musleh W, 1997, P NATL ACAD SCI USA, V94, P9451, DOI 10.1073/pnas.94.17.9451; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Palmer MJ, 2004, J NEUROSCI, V24, P4903, DOI 10.1523/JNEUROSCI.0170-04.2004; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sossa KG, 2006, MOL CELL NEUROSCI, V31, P574, DOI 10.1016/j.mcn.2005.11.011; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wikstrom MA, 2003, NEUROPHARMACOLOGY, V45, P828, DOI 10.1016/S0028-3908(03)00336-8; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	73	136	139	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 27	2008	57	6					872	882		10.1016/j.neuron.2008.01.028	http://dx.doi.org/10.1016/j.neuron.2008.01.028			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281LV	18367088	Green Accepted, Bronze			2022-12-24	WOS:000254500000011
J	Gallardo, G; Schlueter, OM; Suedhof, TC				Gallardo, Gilbert; Schlueter, Oliver M.; Suedhof, Thomas C.			A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and A beta peptides	NATURE NEUROSCIENCE			English	Article							FAMILIAL PARKINSONS-DISEASE; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; TRANSGENIC MICE; LEWY BODIES; MOUSE MODEL; PLAQUE-FORMATION; GENE; DEGENERATION; PROTEIN	Pathogenic aggregates of alpha-synuclein are thought to contribute to the development of Parkinson's disease. Inclusion bodies containing alpha-synuclein are present in Parkinson's disease and other neurodegenerative diseases, including Alzheimer's disease. Moreover, alpha-synuclein mutations are found in cases of familial Parkinson's disease, and transgenic overexpression of alpha-synuclein causes neurodegeneration in mice. The molecular mechanisms involved, however, remain incompletely understood. Here we show that, in transgenic mice, alpha-synuclein induced neurodegeneration involves activation of the ubiquitin/proteasome system, a massive increase in apolipoprotein E ( ApoE) levels and accumulation of insoluble mouse Ab. ApoE was not protective, but was injurious, as deletion of ApoE delayed the neurodegeneration caused by alpha-synuclein and suppressed the accumulation of Ab. Our data reveal a molecular link between central pathogenic mechanisms implicated in Parkinson's disease and Alzheimer's disease and suggest that intracellular alpha-synuclein is pathogenic, at least in part, by activation of extracellular signaling pathways involving ApoE.	[Gallardo, Gilbert; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Schlueter, Oliver M.] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Schlueter, Oliver M.] European Neurosci Inst, D-37075 Gottingen, Germany; [Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Max Planck Society; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gallardo, G (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	gilbert.gallardo@utsouthwestern.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069585] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R01 MH069585] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2006, NEUROBIOL DIS, V23, P120, DOI 10.1016/j.nbd.2006.02.004; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Dewachter I, 2000, J NEUROSCI, V20, P6452, DOI 10.1523/JNEUROSCI.20-17-06452.2000; Dolev I, 2004, P NATL ACAD SCI USA, V101, P13909, DOI 10.1073/pnas.0404458101; El-Agnaf OMA, 1998, FEBS LETT, V440, P67, DOI 10.1016/S0014-5793(98)01419-7; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; Fernagut PO, 2004, NEUROBIOL DIS, V17, P123, DOI 10.1016/j.nbd.2004.07.001; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; HALL SM, 1993, J NEUROCYTOL, V22, P480, DOI 10.1007/BF01181567; Holtzman DM, 2004, J MOL NEUROSCI, V23, P247, DOI 10.1385/JMN:23:3:247; Horsburgh K, 1999, J NEUROPATH EXP NEUR, V58, P227, DOI 10.1097/00005072-199903000-00002; Huang XM, 2004, NEUROLOGY, V62, P2198, DOI 10.1212/01.WNL.0000130159.28215.6A; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuo YM, 2000, MOL MED, V6, P430, DOI 10.1007/BF03401785; Lee MK, 2002, ANTIVIR RES, V53, P99, DOI 10.1016/S0166-3542(01)00196-6; Li YJ, 2004, NEUROLOGY, V62, P2005, DOI 10.1212/01.WNL.0000128089.53030.AC; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snyder H, 2004, J MOL NEUROSCI, V24, P425, DOI 10.1385/JMN:24:3:425; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Springer W, 2006, CURR NEUROL NEUROSCI, V6, P432, DOI 10.1007/s11910-996-0025-8; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; Tandon Anurag, 2000, Current Opinion in Neurology, V13, P377, DOI 10.1097/00019052-200008000-00003; Tsuang DW, 2002, ARCH NEUROL-CHICAGO, V59, P1622, DOI 10.1001/archneur.59.10.1622	47	110	117	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					301	308		10.1038/nn2058	http://dx.doi.org/10.1038/nn2058			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18297066				2022-12-24	WOS:000253548300013
J	Ivey, KN; Muth, A; Amold, J; King, FW; Yeh, RF; Fish, JE; Hsiao, EC; Schwartz, RJ; Conklin, BR; Bernstein, HS; Srivastava, D				Ivey, Kathryn N.; Muth, Alecia; Amold, Joshua; King, Frank W.; Yeh, Ru-Fang; Fish, Jason E.; Hsiao, Edward C.; Schwartz, Robert J.; Conklin, Bruce R.; Bernstein, Harold S.; Srivastava, Deepak			MicroRNA regulation of cell lineages in mouse and human embryonic stem cells	CELL STEM CELL			English	Article							OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; IN-VITRO; CARDIOGENESIS; DICER; TRANSCRIPTION; TARGETS; TWIST; DHAND	Cell fate decisions of pluripotent embryonic stem (ES) cells are dictated by activation and repression of lineage-specific genes. Numerous signaling and transcriptional networks progressively narrow and specify the potential of ES cells. Whether specific microRNAs help refine and limit gene expression and, thereby, could be used to manipulate ES cell differentiation has largely been unexplored. Here, we show that two serum response factor (SRF)-dependent muscle-specific microRNAs, miR-1 and miR-133, promote mesoderm formation from ES cells but have opposing functions during further differentiation into cardiac muscle progenitors. Furthermore, miR-1 and miR-133 were potent repressors of nonmuscle gene expression and cell fate during mouse and human ES cell differentiation. miR-1's effects were in part mediated by translational rep ression of the Notch ligand Delta-like 1 (Dll-1). Our findings indicate that muscle-specific miRNAs reinforce the silencing of nonmuscle genes during cell lineage commitment and suggest that miRNAs may have general utility in regulating cell-fate decisions from pluripotent ES cells.	[Ivey, Kathryn N.; Muth, Alecia; Amold, Joshua; Fish, Jason E.; Hsiao, Edward C.; Conklin, Bruce R.; Srivastava, Deepak] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Ivey, Kathryn N.; Muth, Alecia; Amold, Joshua; King, Frank W.; Fish, Jason E.; Bernstein, Harold S.; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Ivey, Kathryn N.; Muth, Alecia; Amold, Joshua; Fish, Jason E.; Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Yeh, Ru-Fang] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94158 USA; [Hsiao, Edward C.; Conklin, Bruce R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; [Schwartz, Robert J.] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Srivastava, D (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1640 Owens St, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu	Conklin, Bruce/E-4738-2019	Fish, Jason/0000-0003-0640-7277; Conklin, Bruce/0000-0003-1463-6061	NCRR NIH HHS [C06 RR018928, C06RR018928] Funding Source: Medline; NHLBI NIH HHS [R01 HL057181-13, R01 HL057181-12, R01 HL057181, T32 HL007544, R21 HL085377, R01 HL057181-11, HL085377, HL007544] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL085377, T32HL007544, R01HL057181] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Dudoit S, 2003, BIOTECHNIQUES, P45; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; Niu Z, 2005, J BIOL CHEM, V280, P32531, DOI 10.1074/jbc.M501372200; Pfendler KC, 2005, STEM CELLS DEV, V14, P162, DOI 10.1089/scd.2005.14.162; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Saga Y, 1996, DEVELOPMENT, V122, P2769; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Weinhold B, 2000, EMBO J, V19, P5835, DOI 10.1093/emboj/19.21.5835; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	36	481	520	0	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR	2008	2	3					219	229		10.1016/j.stem.2008.01.016	http://dx.doi.org/10.1016/j.stem.2008.01.016			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	274RD	18371447	Green Accepted, Bronze			2022-12-24	WOS:000254017700009
J	Belin, D; Everitt, BJ				Belin, David; Everitt, Barry J.			Cocaine seeking habits depend upon doparnine-dependent serial connectivity linking the ventral with the dorsal striatum	NEURON			English	Article							NUCLEUS-ACCUMBENS CORE; PAVLOVIAN APPROACH BEHAVIOR; BASOLATERAL AMYGDALA; DRUG-ADDICTION; NEURAL SYSTEMS; DIFFERENTIAL CONTROL; 2ND-ORDER SCHEDULE; PREFRONTAL CORTEX; DOPAMINE RELEASE; MEMORY-CIRCUITS	A neuroanatomical principle of striatal organization has been established through which ventral domains, including the nucleus accumbens, exert control over dorsal striatal processes mediated by so-called "spiraling," striato-nigro-striatal, circuitry. We have investigated the functional significance of this circuitry in the control over a cocaine-seeking habit by using an intrastriatal disconnection procedure that combined a selective, unilateral lesion of the nucleus accumbens core and infusion of a dopamine receptor antagonist into the contralateral dorsolateral striatum, thereby disrupting striato-midbrain-striatal serial connectivity bilaterally. We show that this disconnection selectively decreased drug-seeking behavior in rats extensively trained under a second-order schedule of cocaine reinforcement. These data thereby define the importance of interactions between ventral and dorsal domains of the striatum, mediated by dopaminergic transmission, in the neural mechanisms underlying the development and performance of cocaine-seeking habits that are a key characteristic of drug addiction.	[Belin, David; Everitt, Barry J.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Belin, D (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	bdb26@cam.ac.uk	Belin, David/E-1231-2014	Belin, David/0000-0002-7383-372X; Everitt, Barry/0000-0003-4431-6536	MRC [G0600196] Funding Source: UKRI; Medical Research Council [G0600196, G0001354, G9536855] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [G0001354B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		ADAMS CD, 1981, Q J EXP PSYCHOL-B, V33, P109, DOI 10.1080/14640748108400816; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Arroyo M, 1998, PSYCHOPHARMACOLOGY, V140, P331, DOI 10.1007/s002130050774; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Baxter MG, 2000, J NEUROSCI, V20, P4311; Caine SB, 2001, BEHAV NEUROSCI, V115, P880, DOI 10.1037//0735-7044.115.4.880; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Christakou A, 2001, BEHAV NEUROSCI, V115, P812, DOI 10.1037//0735-7044.115.4.812; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Di Ciano P, 2004, J NEUROSCI, V24, P7167, DOI 10.1523/JNEUROSCI.1581-04.2004; Di Ciano P, 2003, BEHAV NEUROSCI, V117, P952, DOI 10.1037/0735-7044.117.5.952; Di Ciano P, 2001, NEUROPSYCHOPHARMACOL, V25, P341, DOI 10.1016/S0893-133X(01)00235-4; Everitt BJ, 2007, ANN NY ACAD SCI, V1121, P576, DOI 10.1196/annals.1401.022; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Everitt BJ, 2000, PSYCHOPHARMACOLOGY, V153, P17, DOI 10.1007/s002130000566; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; EVERITT BJ, 1991, NEUROSCIENCE, V42, P1, DOI 10.1016/0306-4522(91)90145-E; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Floresco SB, 1997, J NEUROSCI, V17, P1880; Fuchs RA, 2006, J NEUROSCI, V26, P3584, DOI 10.1523/JNEUROSCI.5146-05.2006; GAFFAN D, 1990, J NEUROSCI, V10, P3479; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Goldberg S R, 1981, NIDA Res Monogr, V37, P241; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Haber SN, 2000, J NEUROSCI, V20, P2369; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Han JS, 1997, J NEUROSCI, V17, P3913; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Ito R, 2002, J NEUROSCI, V22, P6247; Ito R, 2000, J NEUROSCI, V20, P7489; Kelley AE, 1997, P NATL ACAD SCI USA, V94, P12174, DOI 10.1073/pnas.94.22.12174; Kelley AE, 2005, PHYSIOL BEHAV, V86, P11, DOI 10.1016/j.physbeh.2005.06.018; Koob GF, 2006, NEUR ADD; Lee JLC, 2006, J NEUROSCI, V26, P5881, DOI 10.1523/JNEUROSCI.0323-06.2006; Letchworth SR, 2001, J NEUROSCI, V21, P2799, DOI 10.1523/JNEUROSCI.21-08-02799.2001; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Parkinson JA, 2000, BEHAV NEUROSCI, V114, P42, DOI 10.1037/0735-7044.114.1.42; Pelloux Y, 2007, PSYCHOPHARMACOLOGY, V194, P127, DOI 10.1007/s00213-007-0805-0; Porrino LJ, 2004, J NEUROSCI, V24, P3554, DOI 10.1523/JNEUROSCI.5578-03.2004; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; See RE, 2007, PSYCHOPHARMACOLOGY, V194, P321, DOI 10.1007/s00213-007-0850-8; Setlow B, 2002, BEHAV NEUROSCI, V116, P267, DOI 10.1037//0735-7044.116.2.267; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TAKAHASHI Y, 2007, IN PRESS FRONTIERS I; Vanderschuren LJMJ, 2005, EUR J PHARMACOL, V526, P77, DOI 10.1016/j.ejphar.2005.09.037; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Volkow ND, 2002, NEUROBIOL LEARN MEM, V78, P610, DOI 10.1006/nlme.2002.4099; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Whitelaw RB, 1996, PSYCHOPHARMACOLOGY, V127, P213, DOI 10.1007/BF02805996; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	61	497	509	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 7	2008	57	3					432	441		10.1016/j.neuron.2007.12.019	http://dx.doi.org/10.1016/j.neuron.2007.12.019			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261JQ	18255035	Bronze			2022-12-24	WOS:000253075300012
J	Sakaba, T				Sakaba, Takeshi			Two Ca2+-dependent steps controlling synaptic vesicle fusion and replenishment at the cerebellar basket cell terminal	NEURON			English	Article							ASYNCHRONOUS TRANSMITTER RELEASE; FROG NEUROMUSCULAR-JUNCTION; PRESYNAPTIC CALCIUM CURRENT; SINGLE GABAERGIC BOUTONS; PRINCIPAL NEURON SYNAPSE; RAT COLLICULAR CULTURES; SQUID GIANT SYNAPSE; NEUROTRANSMITTER RELEASE; AUDITORY SYNAPSE; PURKINJE-CELLS	Cerebellar basket cells inhibit postsynaptic Purkinje cells in a rapid and precise manner. To investigate the mechanisms of transmitter release underlying this rapid inhibition, Ca2+ uncaging was employed to measure the intracellular Ca2+ dependence of transmitter release and the kinetics of synaptic vesicle pool transitions in immature basket cell synapses at room temperature. Vesicle release properties distinct from those previously observed at excitatory synapses were seen, including a relatively high intracellular Ca2+ sensitivity of vesicle fusion, rapid vesicle pool mobilization with few reluctant vesicles, and vesicle replenishment driven by unusually high Ca2+ levels from both local and residual Ca2+ sources during action potential trains. These results suggest that inhibitory basket cell synapses are optimized for rapid and precise temporal and spatial Ca2+ coordination of synaptic vesicle fusion and replenishment, which may contribute to the unique physiology of inhibitory synaptic transmission, including phasic release during action potential trains and tonic release by residual intracellular Ca2+.	Max Planck Inst Biophys Chem, Res Grp Biophys Synapt Transmss, D-37077 Gottingen, Germany	Max Planck Society	Sakaba, T (corresponding author), Max Planck Inst Biophys Chem, Res Grp Biophys Synapt Transmss, D-37077 Gottingen, Germany.	tsakaba@gwdg.de		Sakaba, Takeshi/0000-0003-0688-7717				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ADLER EM, 1991, J NEUROSCI, V11, P1496; Angleson JK, 2001, J NEUROPHYSIOL, V85, P287, DOI 10.1152/jn.2001.85.1.287; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P665, DOI 10.1113/jphysiol.1972.sp010053; BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; BEVAN S, 1984, J PHYSIOL-LONDON, V348, P1; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; BORGES S, 1995, P NATL ACAD SCI USA, V92, P6896, DOI 10.1073/pnas.92.15.6896; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Brenowitz S, 1998, NEURON, V20, P135, DOI 10.1016/S0896-6273(00)80441-9; Caillard O, 2000, P NATL ACAD SCI USA, V97, P13372, DOI 10.1073/pnas.230362997; Crowley JJ, 2007, J NEUROSCI, V27, P5448, DOI 10.1523/JNEUROSCI.1186-07.2007; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dittman JS, 2000, J NEUROSCI, V20, P1374; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Forti L, 2000, J PHYSIOL-LONDON, V527, P33, DOI 10.1111/j.1469-7793.2000.00033.x; Frerking M, 1997, J NEUROPHYSIOL, V78, P1293, DOI 10.1152/jn.1997.78.3.1293; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Griesinger CB, 2005, NATURE, V435, P212, DOI 10.1038/nature03567; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Han X, 2006, J CELL BIOL, V172, P281, DOI 10.1083/jcb.200510012; Harvey VL, 2006, J PHYSIOL-LONDON, V577, P127, DOI 10.1113/jphysiol.2006.112482; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hefft S, 2002, J PHYSIOL-LONDON, V539, P201, DOI 10.1113/jphysiol.2001.013455; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Jarvis SE, 2001, TRENDS PHARMACOL SCI, V22, P519, DOI 10.1016/S0165-6147(00)01800-9; Jones MV, 2001, BIOPHYS J, V81, P2660, DOI 10.1016/S0006-3495(01)75909-7; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kirischuk S, 1999, P NATL ACAD SCI USA, V96, P7520, DOI 10.1073/pnas.96.13.7520; Kirischuk S, 2003, J PHYSIOL-LONDON, V548, P753, DOI 10.1113/jphysiol.2002.037036; Kirischuk S, 2002, J NEUROPHYSIOL, V88, P2172, DOI 10.1152/jn.2002.88.4.2172; Kirischuk S, 2002, J PHYSIOL-LONDON, V543, P99, DOI 10.1113/jphysiol.2002.021576; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Kreitzer AC, 2000, J NEUROSCI, V20, P1348; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; Kushmerick C, 2006, J NEUROSCI, V26, P1366, DOI 10.1523/JNEUROSCI.3889-05.2006; LANDIS DMD, 1974, J COMP NEUROL, V155, P93, DOI 10.1002/cne.901550107; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Meinrenken CJ, 2003, J PHYSIOL-LONDON, V547, P665, DOI 10.1113/jphsiol.2002.032714; Millar AG, 2005, J NEUROSCI, V25, P3113, DOI 10.1523/JNEUROSCI.4717-04.2005; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Moulder KL, 2005, J NEUROSCI, V25, P3842, DOI 10.1523/JNEUROSCI.5231-04.2005; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Pellizzari R, 1996, J BIOL CHEM, V271, P20353, DOI 10.1074/jbc.271.34.20353; Pouzat C, 1997, J NEUROSCI, V17, P9104; Ragozzino D, 1996, MOL PHARMACOL, V50, P1024; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Sakaba T, 2005, SCIENCE, V309, P491, DOI 10.1126/science.1112645; Saviane C, 2006, NATURE, V439, P983, DOI 10.1038/nature04509; Scheuss V, 2002, J NEUROSCI, V22, P728, DOI 10.1523/JNEUROSCI.22-03-00728.2002; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Southan AP, 1998, J NEUROSCI, V18, P948; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3; Stewart BA, 2000, P NATL ACAD SCI USA, V97, P13955, DOI 10.1073/pnas.250491397; Taschenberger H, 2005, J PHYSIOL-LONDON, V568, P513, DOI 10.1113/jphysiol.2005.093468; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Tucker T, 1995, NEURON, V15, P1323, DOI 10.1016/0896-6273(95)90011-X; Vincent P, 1996, J PHYSIOL-LONDON, V494, P183, DOI 10.1113/jphysiol.1996.sp021484; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wolfel M, 2007, J NEUROSCI, V27, P3198, DOI 10.1523/JNEUROSCI.4471-06.2007; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	89	62	63	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 7	2008	57	3					406	419		10.1016/j.neuron.2007.11.029	http://dx.doi.org/10.1016/j.neuron.2007.11.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261JQ	18255033	Green Submitted, Bronze			2022-12-24	WOS:000253075300010
J	Jin, JZ; Weng, C; Yeh, CI; Gordon, JA; Ruthazer, ES; Stryker, MP; Swadlow, HA; Alonso, JM				Jin, Jianzhong Z.; Weng, Chong; Yeh, Chun-I; Gordon, Joshua A.; Ruthazer, Edward S.; Stryker, Michael P.; Swadlow, Harvey A.; Alonso, Jose-Manuel			On and off domains of geniculate afferents in cat primary visual cortex	NATURE NEUROSCIENCE			English	Article							REVERSED-CONTRAST CHARTS; OFF-CENTER INPUTS; GANGLION-CELLS; RECEPTIVE-FIELDS; ON-CENTER; LAMINAR ORGANIZATION; ORIENTATION COLUMNS; STRIATE CORTEX; GENICULOCORTICAL AFFERENTS; ALPHA-GANGLION	On- and off-center geniculate afferents form two major channels of visual processing that are thought to converge in the primary visual cortex. However, humans with severely reduced on responses can have normal visual acuity when tested in a white background, which indicates that off channels can function relatively independently from on channels under certain conditions. Consistent with this functional independence of channels, we demonstrate here that on- and off-center geniculate afferents segregate in different domains of the cat primary visual cortex and that off responses dominate the cortical representation of the area centralis. On average, 70% of the geniculate afferents converging at the same cortical domain had receptive fields of the same contrast polarity. Moreover, off-center afferents dominated the representation of the area centralis in the cortex, but not in the thalamus, indicating that on- and off-center afferents are balanced in number, but not in the amount of cortical territory that they cover.	[Jin, Jianzhong Z.; Weng, Chong; Yeh, Chun-I; Swadlow, Harvey A.; Alonso, Jose-Manuel] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA; [Yeh, Chun-I; Swadlow, Harvey A.; Alonso, Jose-Manuel] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; [Gordon, Joshua A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Gordon, Joshua A.; Ruthazer, Edward S.; Stryker, Michael P.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Ruthazer, Edward S.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	State University of New York (SUNY) System; SUNY Optometry; University of Connecticut; Columbia University; University of California System; University of California San Francisco; McGill University	Alonso, JM (corresponding author), SUNY Coll Optometry, Dept Biol Sci, 33 W 42 St, New York, NY 10036 USA.	jalonso@sunyopt.edu	Ruthazer, Edward/H-4782-2019; Ruthazer, Edward S/P-5935-2014; Gordon, Joshua A/E-6778-2012	Ruthazer, Edward/0000-0003-0452-3151; Ruthazer, Edward S/0000-0003-0452-3151; Gordon, Joshua A/0000-0002-5488-8266; YEH, CHUN-I/0000-0002-2375-0723; Stryker, Michael/0000-0003-1546-5831	NEI NIH HHS [R37 EY002874-24S2, EY 02874, R01 EY005253-22, R01 EY002874, EY 05253, R01 EY005253, R37 EY002874] Funding Source: Medline; NIMH NIH HHS [R01 MH064024, MH 64024] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005253, R37EY002874, R37EY005253, R01EY002874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064024] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Aronov D, 2003, J NEUROPHYSIOL, V89, P3304, DOI 10.1152/jn.00826.2002; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; BERMAN NEJ, 1989, NEUROSCIENCE, V32, P721, DOI 10.1016/0306-4522(89)90293-5; BOWLING DB, 1986, J PHYSIOL-LONDON, V375, P561, DOI 10.1113/jphysiol.1986.sp016133; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chatterjee S, 2003, NATURE, V426, P668, DOI 10.1038/nature02163; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; CONLEY M, 1984, J NEUROSCI, V4, P171; CONWAY JL, 1983, J NEUROPHYSIOL, V50, P1330, DOI 10.1152/jn.1983.50.6.1330; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; FAMIGLIETTI EV, 1977, SCIENCE, V198, P1267, DOI 10.1126/science.73223; FREUND TF, 1985, J COMP NEUROL, V242, P263, DOI 10.1002/cne.902420208; Gheorghita F, 2006, J NEUROSCI, V26, P10057, DOI 10.1523/JNEUROSCI.1263-06.2006; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY AL, 1985, J COMP NEUROL, V233, P159, DOI 10.1002/cne.902330203; KRETZ R, 1986, J COMP NEUROL, V251, P135, DOI 10.1002/cne.902510110; LEVAY S, 1982, NATURE, V300, P350, DOI 10.1038/300350a0; MCCONNELL SK, 1984, P NATL ACAD SCI-BIOL, V81, P1590, DOI 10.1073/pnas.81.5.1590; MILLER KD, 1992, NEUROREPORT, V3, P73, DOI 10.1097/00001756-199201000-00019; MILLER KD, 1994, J NEUROSCI, V14, P409; Nakagama H, 2000, BIOL CYBERN, V83, P85, DOI 10.1007/s004220000148; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; PEICHL L, 1989, J COMP NEUROL, V286, P120, DOI 10.1002/cne.902860108; PEICHL L, 1987, PROC R SOC SER B-BIO, V231, P169, DOI 10.1098/rspb.1987.0040; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Pettersen KH, 2006, J NEUROSCI METH, V154, P116, DOI 10.1016/j.jneumeth.2005.12.005; RACZKOWSKI D, 1990, J COMP NEUROL, V302, P500, DOI 10.1002/cne.903020307; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; SCHILLER PH, 1986, NATURE, V322, P824, DOI 10.1038/322824a0; SCHILLER PH, 1978, J NEUROPHYSIOL, V41, P788, DOI 10.1152/jn.1978.41.3.788; STRYKER MP, 1983, J NEUROSCI, V3, P1943; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; WEHRHAHN C, 1992, J NEUROSCI, V12, P2247; Westheimer G, 2003, OPTOMETRY VISION SCI, V80, P749, DOI 10.1097/00006324-200311000-00011; Westheimer G, 2003, OPTOMETRY VISION SCI, V80, P745, DOI 10.1097/00006324-200311000-00010; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; ZAHS KR, 1988, J NEUROPHYSIOL, V59, P1410, DOI 10.1152/jn.1988.59.5.1410; ZEMON V, 1988, VISUAL NEUROSCI, V1, P145, DOI 10.1017/S0952523800001085	50	121	121	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					88	94		10.1038/nn2029	http://dx.doi.org/10.1038/nn2029			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18084287	Green Accepted			2022-12-24	WOS:000252117900016
J	Kim, N; Burden, SJ				Kim, Natalie; Burden, Steven J.			MuSK controls where motor axons grow and form synapses	NATURE NEUROSCIENCE			English	Article							NEUROMUSCULAR-JUNCTION FORMATION; ACETYLCHOLINE-RECEPTOR CLUSTERS; NERVE MUSCLE JUNCTIONS; TYROSINE KINASE MUSK; SKELETAL-MUSCLE; IN-VIVO; CHOLINE-ACETYLTRANSFERASE; STRIATED-MUSCLE; MESSENGER-RNA; MUTANT MICE	Motor axons approach muscles that are regionally prespecialized, as acetylcholine receptors are clustered in the central region of muscle before and independently of innervation. This muscle prepattern requires MuSK, a receptor tyrosine kinase that is essential for synapse formation. It is not known how muscle prepatterning is established, and whether motor axons recognize this prepattern. Here we show that expression of Musk is prepatterned in muscle and that early Musk expression in developing myotubes is sufficient to establish muscle prepatterning. We further show that ectopic Musk expression promotes ectopic synapse formation, indicating that muscle prepatterning normally has an instructive role in directing where synapses will form. In addition, ectopic Musk expression stimulates synapse formation in the absence of Agrin and rescues the lethality of Agrn mutant mice, demonstrating that the postsynaptic cell, and MuSK in particular, has a potent role in regulating the formation of synapses.	[Kim, Natalie; Burden, Steven J.] NYU, Helen L & Martin S Kimmel Ctr, Mol Neurobiol Program, Sch Med,Biol & Med Skirball Inst Biomol Med, New York, NY 10016 USA	New York University	Burden, SJ (corresponding author), NYU, Helen L & Martin S Kimmel Ctr, Mol Neurobiol Program, Sch Med,Biol & Med Skirball Inst Biomol Med, 540 First Ave, New York, NY 10016 USA.	burden@saturn.med.nyu.edu	Tuluc, Petronel/C-2527-2011	Burden, Steven/0000-0002-3550-6891	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036193, R01NS027963, R01NS036193] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 36193, R01 NS027963-10, R01 NS027963] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; BENNETT MR, 1974, J PHYSIOL-LONDON, V241, P515, DOI 10.1113/jphysiol.1974.sp010670; BENNETT MR, 1975, COLD SPRING HARB SYM, V40, P409, DOI 10.1101/SQB.1976.040.01.039; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Campagna JA, 1995, NEURON, V15, P1365, DOI 10.1016/0896-6273(95)90014-4; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Dimitropoulou A, 2005, MOL CELL NEUROSCI, V28, P292, DOI 10.1016/j.mcn.2004.09.013; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; FONTAINE B, 1988, EMBO J, V7, P603, DOI 10.1002/j.1460-2075.1988.tb02853.x; Fu AKY, 2001, MOL BRAIN RES, V96, P21, DOI 10.1016/S0169-328X(01)00253-4; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Glass DJ, 1996, COLD SPRING HARB SYM, V61, P435; Glass DJ, 1997, CURR OPIN NEUROBIOL, V7, P379, DOI 10.1016/S0959-4388(97)80066-9; Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112; Hesser BA, 1999, FEBS LETT, V442, P133, DOI 10.1016/S0014-5793(98)01641-X; Jaworski A, 2006, J NEUROSCI, V26, P655, DOI 10.1523/JNEUROSCI.4506-05.2006; Jones G, 1999, J NEUROSCI, V19, P3376; Kandel E., 2000, PRINCIPLES NEURAL SC; Lacazette E, 2003, J CELL BIOL, V161, P727, DOI 10.1083/jcb.200210156; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin YR, 2005, CRYST GROWTH DES, V5, P579, DOI 10.1021/cg049747h; MINTY AJ, 1982, CELL, V30, P185, DOI 10.1016/0092-8674(82)90024-1; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Moore C, 2001, P NATL ACAD SCI USA, V98, P14655, DOI 10.1073/pnas.251291598; Nguyen QT, 1996, CURR OPIN NEUROBIOL, V6, P104, DOI 10.1016/S0959-4388(96)80015-8; Panzer JA, 2006, J NEUROSCI, V26, P934, DOI 10.1523/JNEUROSCI.3656-05.2006; Sander A, 2001, J CELL BIOL, V155, P1287, DOI 10.1083/jcb.200105034; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; SLATER CR, 1982, DEV BIOL, V94, P11, DOI 10.1016/0012-1606(82)90063-X; SLATER CR, 1982, DEV BIOL, V94, P23, DOI 10.1016/0012-1606(82)90064-1; Strochlic L, 2005, BIOESSAYS, V27, P1129, DOI 10.1002/bies.20305; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; Watty A, 2000, P NATL ACAD SCI USA, V97, P4585, DOI 10.1073/pnas.080061997; WILLIAMS PE, 1971, J CELL SCI, V9, P751; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; ZHANG M, 1995, DEV DYNAM, V204, P168, DOI 10.1002/aja.1002040207	44	155	160	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					19	27		10.1038/nn2026	http://dx.doi.org/10.1038/nn2026			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18084289	Green Accepted			2022-12-24	WOS:000252117900008
J	Sachse, S; Rueckert, E; Keller, A; Okada, R; Tanaka, NK; Ito, K; Vosshall, LB				Sachse, Silke; Rueckert, Erroll; Keller, Andreas; Okada, Ryuichi; Tanaka, Nobuaki K.; Ito, Kei; Vosshall, Leslie B.			Activity-dependent plasticity in an olfactory circuit	NEURON			English	Article							DROSOPHILA ANTENNAL LOBE; GREEN FLUORESCENT PROTEIN; SENSORY MAP; IN-VIVO; ODOR REPRESENTATION; RECEPTOR REPERTOIRE; PROJECTION NEURONS; ADULT DROSOPHILA; MOLECULAR-BASIS; OUTPUT NEURONS	Olfactory sensory neurons (OSNs) form synapses with local interneurons and second-order projection neurons to form stereotyped olfactory glomeruli. This primary olfactory circuit is hard-wired through the action of genetic cues. We asked whether individual glomeruli have the capacity for stimulus-evoked plasticity by focusing on the carbon dioxide (CO2) circuit in Drosophila. Specialized OSNs detect this gas and relay the information to a dedicated circuit in the brain. Prolonged exposure to CO2 induced a reversible volume increase in the CO2-specific glomerulus. OSNs showed neither altered morphology nor function after chronic exposure, but one class of inhibitory local interneurons showed significantly increased responses to CO2. Two-photon imaging of the axon terminals of a single PN innervating the CO2 glomerulus showed significantly decreased functional output following CO2 exposure. Behavioral responses to CO2 were also reduced after such exposure. We suggest that activity-dependent functional plasticity may be a general feature of the Drosophila olfactory system.	[Sachse, Silke; Keller, Andreas; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Rueckert, Erroll] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Rueckert, Erroll] Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; [Okada, Ryuichi; Tanaka, Nobuaki K.; Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Rockefeller University; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; University of Tokyo	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10065 USA.	leslie@mail.rockefeller.edu	Sachse, Silke/M-8484-2014	Sachse, Silke/0000-0002-9769-8067; Vosshall, Leslie/0000-0002-6060-8099; Keller, Andreas/0000-0001-5491-2214	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005036] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC05036] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; Christensen TA, 1998, ANN NY ACAD SCI, V855, P475, DOI 10.1111/j.1749-6632.1998.tb10608.x; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Devaud JM, 2003, J NEUROBIOL, V56, P13, DOI 10.1002/neu.10215; Devaud JM, 2001, J NEUROSCI, V21, P6274, DOI 10.1523/JNEUROSCI.21-16-06274.2001; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Elmore T, 2003, J NEUROSCI, V23, P9906; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hickmott PW, 2005, NAT NEUROSCI, V8, P140, DOI 10.1038/nn1384; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; Keller A, 2007, P NATL ACAD SCI USA, V104, P5614, DOI 10.1073/pnas.0605321104; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Laissue PP, 1999, J COMP NEUROL, V405, P543; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lei H, 2002, NAT NEUROSCI, V5, P557, DOI 10.1038/nn859; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; Liu SJ, 2006, J NEUROSCI, V26, P9332, DOI 10.1523/JNEUROSCI.2929-06.2006; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Pelz D, 2006, J NEUROBIOL, V66, P1544, DOI 10.1002/neu.20333; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Winnington AP, 1996, J COMP NEUROL, V365, P479, DOI 10.1002/(SICI)1096-9861(19960212)365:3<479::AID-CNE10>3.0.CO;2-M; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	62	139	140	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2007	56	5					838	850		10.1016/j.neuron.2007.10.035	http://dx.doi.org/10.1016/j.neuron.2007.10.035			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241MA	18054860	Bronze			2022-12-24	WOS:000251659300010
J	Kim, MJ; Futai, K; Jo, J; Hayashi, Y; Cho, K; Sheng, M				Kim, Myung Jong; Futai, Kensuke; Jo, Jihoon; Hayashi, Yasunori; Cho, Kwangwook; Sheng, Morgan			Synaptic accumulation of PSD-95 and synaptic function regulated by phosphorylation of serine-295 of PSD-95	NEURON			English	Article							LONG-TERM POTENTIATION; AMPA RECEPTORS; EXCITATORY SYNAPSES; SMALL GTPASES; PLASTICITY; DEPRESSION; PROTEINS; RAC; RHO; IDENTIFICATION	The scaffold protein PSD-95 promotes the maturation and strengthening of excitatory synapses, functions that require proper localization of PSD-95 in the postsynaptic density (PSD). Here we report that phosphorylation of ser-295 enhances the synaptic accumulation of PSD-95 and the ability of PSD-95 to recruit surface AMPA receptors and potentiate excitatory postsynaptic currents. We present evidence that a Rac1-JNK1 signaling pathway mediates ser-295 phosphorylation and regulates synaptic content of PSD-95. Ser-295 phosphorylation is suppressed by chronic elevation, and increased by chronic silencing, of synaptic activity. Rapid dephosphorylation of ser-295 occurs in response to NMDA treatment that causes chemical long-term depression (LTD). Overexpression of a phosphomimicking mutant (S295D) of PSD-95 inhibited NMDA-induced AMPA receptor internalization and blocked the induction of LTD. The data suggest that synaptic strength can be regulated by phosphorylation-dephosphorylation of ser-295 of PSD-95 and that synaptic depression requires the dephosphorylation of ser-295.	MIT, Howard Hughes Med Inst, RIKEN, MIT Neurosci Res Ctr,Picower Inst Learning & Memo, Cambridge, MA 02139 USA; Univ Bristol, Fac Med & Dent, MRC Ctr Synapt Plact, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol BS1 3NY, Avon, England	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; University of Bristol	Sheng, M (corresponding author), MIT, Howard Hughes Med Inst, RIKEN, MIT Neurosci Res Ctr,Picower Inst Learning & Memo, Cambridge, MA 02139 USA.	msheng@mit.edu	Hayashi, Yasunori/AAF-1408-2019; Hayashi, Yasunori/C-2249-2008	Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Yasunori/0000-0002-7560-3004; Cho, Kwangwook/0000-0001-6724-7073; Sheng, Morgan/0000-0002-8703-5366	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076936] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/D013232/2] Funding Source: Medline; NIDA NIH HHS [DA017310] Funding Source: Medline; NIMH NIH HHS [MH076936] Funding Source: Medline; BBSRC [BB/D013232/2] Funding Source: UKRI	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Bingol B, 2004, NEUROPHARMACOLOGY, V47, P755, DOI 10.1016/j.neuropharm.2004.07.028; Brecht S, 2005, EUR J NEUROSCI, V21, P363, DOI 10.1111/j.1460-9568.2005.03857.x; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gardoni F, 2006, EUR J NEUROSCI, V24, P2694, DOI 10.1111/j.1460-9568.2006.05140.x; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Jaffe H, 2004, BIOCHEM BIOPH RES CO, V321, P210, DOI 10.1016/j.bbrc.2004.06.122; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Moran LB, 2004, NEUROGENETICS, V5, P95, DOI 10.1007/s10048-004-0172-5; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Stein V, 2003, J NEUROSCI, V23, P5503; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	35	202	204	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 8	2007	56	3					488	502		10.1016/j.neuron.2007.09.007	http://dx.doi.org/10.1016/j.neuron.2007.09.007			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	229AV	17988632	Bronze			2022-12-24	WOS:000250774600008
J	Yao, Y; Wu, Y; Yin, C; Ozawa, R; Aigaki, T; Wouda, RR; Noordermeer, JN; Fradkin, LG; Hing, H				Yao, Ying; Wu, Yuping; Yin, Chong; Ozawa, Rie; Aigaki, Toshiro; Wouda, Rene R.; Noordermeer, Jasprina N.; Fradkin, Lee G.; Hing, Huey			Antagonistic roles of Wnt5 and the Drl receptor in patterning the Drosophila antennal lobe	NATURE NEUROSCIENCE			English	Article							OLFACTORY GLOMERULI; TYROSINE KINASE; NEURONS; AXONS; RYK; MAP; CONNECTIONS; GENES; BRAIN	Numerous studies have shown that ingrowing olfactory axons exert powerful inductive influences on olfactory map development. From an overexpression screen, we have identified wnt5 as a potent organizer of the olfactory map in Drosophila melanogaster. Loss of wnt5 resulted in severe derangement of the glomerular pattern, whereas overexpression of wnt5 resulted in the formation of ectopic midline glomeruli. Cell type-specific cDNA rescue and mosaic experiments showed that wnt5 functions in olfactory neurons. Mutation of the derailed (drl) gene, encoding a receptor for Wnt5, resulted in derangement of the glomerular map, ectopic midline glomeruli and the accumulation of Wnt5 at the midline. We show here that drl functions in glial cells, where it acts upstream of wnt5 to modulate its function in glomerular patterning. Our findings establish wnt5 as an anterograde signal that is expressed by olfactory axons and demonstrate a previously unappreciated, yet powerful, role for glia in patterning the Drosophila olfactory map.	Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; Tokyo Metropolitan Univ, Tokyo 1920397, Japan; Leiden Univ, Med Ctr, Dept Mol & Cell Biol, Dev Neurobiol Lab, NL-2300 RC Leiden, Netherlands	University of Illinois System; University of Illinois Urbana-Champaign; Tokyo Metropolitan University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hing, H (corresponding author), Univ Illinois, Neurosci Program, 601 S Goodwin Ave, Urbana, IL 61801 USA.	hing@life.uiuc.edu	wu, Yuping/B-5104-2012		NIDCD NIH HHS [DC5408-01] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005408] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Ang LH, 2006, DEV BIOL, V293, P178, DOI 10.1016/j.ydbio.2006.01.030; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; DURA JM, 1995, FEBS LETT, V370, P250, DOI 10.1016/0014-5793(95)00847-3; Dynes JL, 1998, NEURON, V20, P1081, DOI 10.1016/S0896-6273(00)80490-0; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fradkin LG, 2004, DEV BIOL, V272, P362, DOI 10.1016/j.ydbio.2004.04.034; GRAZIADEI PPC, 1980, BRAIN RES, V201, P39, DOI 10.1016/0006-8993(80)90773-8; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hassan B, 2006, PLOS BIOL, V4, P2411, DOI 10.1371/journal.pbio.0040432; HOFBAUER A, 1991, EINE BIBLIOTHEK MONO; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; Key B, 2002, CHEM SENSES, V27, P245, DOI 10.1093/chemse/27.3.245; Lattemann M, 2007, NEURON, V53, P169, DOI 10.1016/j.neuron.2006.12.024; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin DM, 1999, CURR OPIN NEUROBIOL, V9, P74, DOI 10.1016/S0959-4388(99)80009-9; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Miyasaka N, 2005, DEVELOPMENT, V132, P1283, DOI 10.1242/dev.01698; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; OLAND LA, 1990, J NEUROSCI, V10, P2096; Oland LA, 1996, J NEUROBIOL, V30, P92; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SCHNEIDERMAN AM, 1982, NATURE, V298, P844, DOI 10.1038/298844a0; Simon AF, 1998, MECH DEVELOP, V76, P45, DOI 10.1016/S0925-4773(98)00104-X; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOUT RP, 1980, NEUROSCIENCE, V5, P2175, DOI 10.1016/0306-4522(80)90134-7; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Taillebourg E, 2005, DEV GENES EVOL, V215, P158, DOI 10.1007/s00427-004-0457-6; Toba G, 1999, GENETICS, V151, P725; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zhang DS, 2006, GENESIS, V44, P189, DOI 10.1002/dvg.20202	37	31	32	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1423	1432		10.1038/nn1993	http://dx.doi.org/10.1038/nn1993			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17934456				2022-12-24	WOS:000250508400020
J	Schwartz, G; Taylor, S; Fisher, C; Harris, R; Ii, MJB				Schwartz, Greg; Taylor, Sam; Fisher, Clark; Harris, Rob; II, Michael J. Berry			Svnchronized firing among retinal ganglion cells signals motion reversal	NEURON			English	Article							NONLINEAR SPATIAL SUMMATION; PURSUIT EYE-MOVEMENTS; CONTRAST GAIN-CONTROL; SMOOTH-PURSUIT; AMACRINE CELLS; BIPOLAR CELLS; MOVING TARGETS; CATFISH RETINA; PREDICTION; RESPONSES	We show that when a moving object suddenly reverses direction, there is a brief, synchronous burst of firing within a population of retinal ganglion cells. This burst can be driven by either the leading or trailing edge of the object. The latency is constant for movement at different speeds, objects of different size, and bright versus dark contrasts. The same ganglion cells that signal a motion reversal also respond to smooth motion. We show that the brain can build a pure reversal detector using only a linear filter that reads out synchrony from a group of ganglion cells. These results indicate that not only can the retina anticipate the location of a smoothly moving object, but that it can also signal violations in its own prediction. We show that the reversal response cannot be explained by models of the classical receptive field and suggest that nonlinear receptive field subunits may be responsible.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08542 USA; Princeton Univ, Dept Phys, Princeton, NJ 08542 USA; Univ Sussex, Dept Life Sci, Brighton BN1 9RH, E Sussex, England	Princeton University; Princeton University; University of Sussex	Ii, MJB (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08542 USA.	berry@princeton.edu		Fisher, Clark/0000-0003-0707-1613; Schwartz, Greg/0000-0001-8909-4397	NEI NIH HHS [R01 EY014196-08, R01 EY14196, R01 EY014196] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014196] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Ahlfors SP, 1999, J NEUROPHYSIOL, V82, P2545, DOI 10.1152/jn.1999.82.5.2545; BARLOW HB, 1977, J PHYSIOL-LONDON, V269, P177, DOI 10.1113/jphysiol.1977.sp011898; BARNES GR, 1991, J PHYSIOL-LONDON, V439, P439, DOI 10.1113/jphysiol.1991.sp018675; BECKER W, 1985, EXP BRAIN RES, V57, P562; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Brouwer AM, 2003, EXP BRAIN RES, V152, P368, DOI 10.1007/s00221-003-1556-8; Carpenter RHS, 1988, MOVEMENTS EYES; CLARKE PGH, 1972, BRAIN RES, V36, P453, DOI 10.1016/0006-8993(72)90754-8; DELUCIA PR, 1985, PERCEPT MOTOR SKILL, V61, P143, DOI 10.2466/pms.1985.61.1.143; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fukushima K, 2002, EXP BRAIN RES, V145, P104, DOI 10.1007/s00221-002-1088-7; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Green DM, 1966, SIGNAL DETECTION THE; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Heinen SJ, 1997, VISUAL NEUROSCI, V14, P853, DOI 10.1017/S0952523800011597; Ishikane H, 2005, NAT NEUROSCI, V8, P1087, DOI 10.1038/nn1497; Kettner RE, 1997, J NEUROPHYSIOL, V77, P2115, DOI 10.1152/jn.1997.77.4.2115; Klam F, 2001, EXP BRAIN RES, V139, P233, DOI 10.1007/s002210100759; KRAUZLIS RJ, 1994, J NEUROPHYSIOL, V72, P150, DOI 10.1152/jn.1994.72.1.150; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; MacAvoy MG, 1991, CEREB CORTEX, V1, P95, DOI 10.1093/cercor/1.1.95; MACKAY DM, 1968, NATURE, V217, P677, DOI 10.1038/217677a0; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; MCILWAIN JT, 1966, EXP BRAIN RES, V1, P265; Medina JF, 2005, NEURON, V45, P157, DOI 10.1016/j.neuron.2004.12.017; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Miller RF, 2006, J NEUROPHYSIOL, V95, P3171, DOI 10.1152/jn.00090.2005; Neuenschwander S, 1996, NATURE, V379, P728, DOI 10.1038/379728a0; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P249, DOI 10.1113/jphysiol.2004.063503; Pang JJ, 2002, J NEUROSCI, V22, P4693, DOI 10.1523/JNEUROSCI.22-11-04693.2002; PAVEL M, 1992, VISION RES, V32, P2177, DOI 10.1016/0042-6989(92)90078-W; PAVEL M, 1990, PREDICTIVE CONTROL E; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; ROBINSON DA, 1965, J PHYSIOL-LONDON, V180, P569, DOI 10.1113/jphysiol.1965.sp007718; RODIECK RW, 1965, J NEUROPHYSIOL, V28, P819, DOI 10.1152/jn.1965.28.5.819; Roska B, 1998, J NEUROSCI, V18, P3451; SAKAI HM, 1987, J NEUROPHYSIOL, V58, P1329, DOI 10.1152/jn.1987.58.6.1329; SAKAI HM, 1987, J NEUROPHYSIOL, V58, P1307, DOI 10.1152/jn.1987.58.6.1307; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; SHAPLEY RM, 1981, J PHYSIOL-LONDON, V318, P161; SHAPLEY RM, 1979, J PHYSIOL-LONDON, V290, P141, DOI 10.1113/jphysiol.1979.sp012765; SMEETS JBJ, 1995, BIOL CYBERN, V73, P519, DOI 10.1007/BF00199544; Suh M, 2000, J NEUROPHYSIOL, V84, P1835, DOI 10.1152/jn.2000.84.4.1835; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; VICTOR JD, 1988, J PHYSIOL-LONDON, V405, P289, DOI 10.1113/jphysiol.1988.sp017334; Zhang I, 2001, NEUROREPORT, V12, P1371, DOI 10.1097/00001756-200105250-00017	49	74	76	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 20	2007	55	6					958	969		10.1016/j.neuron.2007.07.042	http://dx.doi.org/10.1016/j.neuron.2007.07.042			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	219IQ	17880898	Green Accepted, Bronze			2022-12-24	WOS:000250078500012
J	Hermann, PC; Huber, SL; Herrler, T; Aicher, A; Ellwart, JW; Guba, M; Bruns, CJ; Heeschen, C				Hermann, Patrick C.; Huber, Stephan L.; Herrler, Tanja; Aicher, Alexandra; Ellwart, Joachim W.; Guba, Markus; Bruns, Christiane J.; Heeschen, Christopher			Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer	CELL STEM CELL			English	Article							CHEMOKINE RECEPTOR CXCR4; IDENTIFICATION; EXPRESSION; CARCINOMA; AC133; HEMATOPOIESIS; MECHANISMS; MARKERS; LUNG	Pancreatic adenocarcinoma is currently the fourth leading cause for cancer-related mortality. Stem cells have been implicated in pancreatic tumor growth, but the specific role of these cancer stem cells in tumor biology, including metastasis, is still uncertain. We found that human pancreatic cancer tissue contains cancer stem cells defined by CD133 expression that are exclusively tumorigenic and highly resistant to standard chemotherapy. In the invasive front of pancreatic tumors, a distinct subpopulation of CD133(+) CXCR4(+) cancer stem cells was identified that determines the metastatic phenotype of the individual tumor. Depletion of the cancer stem cell pool for these migrating cancer stem cells virtually abrogated the metastatic phenotype of pancreatic tumors without affecting their tumorigenic potential. In conclusion, we demonstrate that a subpopulation of migrating CD133(+) CXCR4(+) cancer stem cells is essential for tumor metastasis. Strategies aimed at modulating the SDF-1/CXCR4 axis may have important clinical applications to inhibit metastasis of cancer stem cells.	Univ Munich, Dept Surg, D-81377 Munich, Germany; Helmholtz Ctr Environm & Hlth, Inst Mol Immunol, D-81377 Munich, Germany; Goethe Univ Frankfurt, Dept Internal Med 3, D-60590 Frankfurt, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Goethe University Frankfurt	Heeschen, C (corresponding author), Univ Munich, Dept Surg, Marchioninistr 15, D-81377 Munich, Germany.	christopher.heeschen@med.uni-muenchen.de	Aicher, Alexandra/GZK-8031-2022; Guba, Markus/M-4309-2019; Hermann, Patrick/Y-6254-2019	Hermann, Patrick/0000-0003-0418-0478; Heeschen, Christopher/0000-0002-1158-8554; Aicher, Alexandra/0000-0002-8920-9577				Ahlgren JD, 1996, CANCER-AM CANCER SOC, V78, P654; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bachelder RE, 2002, CANCER RES, V62, P7203; Barnett SC, 1998, CARCINOGENESIS, V19, P1529, DOI 10.1093/carcin/19.9.1529; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Denham M, 2006, STEM CELLS, V24, P918, DOI 10.1634/stemcells.2005-0151; Dick JE, 2005, ANN NY ACAD SCI, V1044, P1, DOI 10.1196/annals.1349.001; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fargeas CA, 2003, STEM CELLS, V21, P506, DOI 10.1634/stemcells.21-4-506; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Loetscher P, 2000, Adv Immunol, V74, P127; Matano E, 2000, BRIT J CANCER, V82, P1772, DOI 10.1054/bjoc.1999.1139; Moll R, 1998, Subcell Biochem, V31, P205; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Prindull G, 2005, EXP HEMATOL, V33, P738, DOI 10.1016/j.exphem.2005.03.002; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rosenberg L, 1997, INT J PANCREATOL, V22, P81; Rothenberg ML, 1996, CANCER, V78, P627; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Schneider GP, 2002, CLIN CANCER RES, V8, P3955; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zagzag D, 2005, CANCER RES, V65, P6178, DOI 10.1158/0008-5472.CAN-04-4406; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	39	2104	2258	8	223	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP	2007	1	3					313	323		10.1016/j.stem.2007.06.002	http://dx.doi.org/10.1016/j.stem.2007.06.002			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XT	18371365	Bronze			2022-12-24	WOS:000251055200013
J	Nystul, T; Spradling, A				Nystul, Todd; Spradling, Allan			An epithelial niche in the Drosophila Ovary undergoes long-range stem cell replacement	CELL STEM CELL			English	Article							SELF-RENEWAL; SPERMATOGENESIS; FOLLICLE; TRANSPLANTATION; IDENTIFICATION; EPIDERMIS; HEDGEHOG	Adult epithelial stem cells are thought to reside in specific niches, where they are maintained by adhesion to stromal cells and by intercellular signals. In niches that harbor multiple adjacent stem cells, such as those maintaining Drosophila germ cells, lost stem cells are replaced by division of neighboring stem cells or reversion of transit cells. We have characterized the Drosophila follicle stem cell (FSC) niche as a model of the epithelial niche to learn whether nonneighboring cells can also generate stem cell replacements. Exactly two stroma-free FSC niches holding single FSCs are located in fixed locations on opposite edges of the Drosophila ovariole. FSC daughters regularly migrate across the width of the ovariole to the other niche before proliferating and contributing to the follicle cell monolayer. Crossmigrating FSC daughters compete with the resident FSC for niche occupancy and are the source of replacement FSCs. The ability of stem cell daughters to target a distant niche and displace its resident stem cell suggests that precancerous mutations might spread from niche to niche within stem cell-based tissues.	Carnegie Inst Washington, Howard Hughes Med Inst, Res Labs, Baltimore, MD 21218 USA; Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21218 USA	Carnegie Institution for Science; Howard Hughes Medical Institute; Carnegie Institution for Science	Spradling, A (corresponding author), Carnegie Inst Washington, Howard Hughes Med Inst, Res Labs, 3520 San Martin Dr, Baltimore, MD 21218 USA.	spradling@ciwemb.edu	Nystul, Todd/AAA-7344-2022	Nystul, Todd/0000-0002-6250-2394	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bateman J, 2001, CURR BIOL, V11, P1317, DOI 10.1016/S0960-9822(01)00420-1; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Forbes AJ, 1996, DEVELOPMENT, V122, P1125; Frydman HM, 2001, DEVELOPMENT, V128, P3209; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kirilly D, 2005, DEV CELL, V9, P651, DOI 10.1016/j.devcel.2005.09.013; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nystul TG, 2006, CURR OPIN GENET DEV, V16, P463, DOI 10.1016/j.gde.2006.08.003; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Robinson DN, 1996, TRENDS CELL BIOL, V6, P474, DOI 10.1016/0962-8924(96)84945-2; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Song XQ, 2003, DEVELOPMENT, V130, P3259, DOI 10.1242/dev.00524; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Waters JM, 2007, SEMIN CELL DEV BIOL, V18, P245, DOI 10.1016/j.semcdb.2007.02.003; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 2005, DEV DYNAM, V232, P775, DOI 10.1002/dvdy.20317; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099	32	138	140	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP	2007	1	3					277	285		10.1016/j.stem.2007.07.009	http://dx.doi.org/10.1016/j.stem.2007.07.009			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XT	18371362	Bronze			2022-12-24	WOS:000251055200010
J	Demidov, ON; Timofeev, O; Lwin, HNY; Kek, C; Appella, E; Bulavin, DV				Demidov, Oleg N.; Timofeev, Oleg; Lwin, Hnin N. Y.; Kek, Calvina; Appella, Ettore; Bulavin, Dmitry V.			Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestine	CELL STEM CELL			English	Article							RADIATION-INDUCED APOPTOSIS; BETA-CATENIN; IN-VIVO; IONIZING-RADIATION; SIGNALING PATHWAYS; MICE DEFICIENT; SELF-RENEWAL; COLON-CANCER; DNA-DAMAGE; APC	Colorectal cancer is one of the major causes of cancer-related deaths. To gain further insights into the mechanisms underlying its development, we investigated the role of Wip1 phosphatase, which is highly expressed in intestinal stem cells, in the mouse model of APC(Min)-driven polyposis. We found that Wip1 removal increased the life span of APC(Min) mice through a significant suppression of polyp formation. This protection was dependent on the p53 tumor suppressor, which plays a putative role in the regulation of apoptosis of intestinal stem cells. Activation of apoptosis in stem cells of Wip1-deficient mice, but not wild-type APC(Min) mice, increased when the Wnt pathway was constitutively activated. We propose, therefore, that the Wip1 phosphatase regulates homeostasis of intestinal stem cells. In turn, Wip1 loss suppresses APC(Min)-driven polyposis by lowering the threshold for p53-dependent apoptosis of stem cells, thus preventing their conversion into tumor-initiating stem cells.	Inst Mol & Cell Biol, Cell Cycle Control & Tumorigenesis Grp, Proteos 138673, Singapore; NCI, NIH, Ctr Canc Res, Cell Biol Lab, Bethesda, MD 20892 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bulavin, DV (corresponding author), Inst Mol & Cell Biol, Cell Cycle Control & Tumorigenesis Grp, 61 Biopolis Dr, Proteos 138673, Singapore.	dvbulavin@imcb.a-star.edu.sg	Demidov, Oleg/U-2050-2017; Demidov, Oleg/AAC-4462-2021	Demidov, Oleg/0000-0003-4323-7174; Demidov, Oleg/0000-0003-4323-7174; Timofeev, Oleg/0000-0002-3114-6403	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; Booth C, 1999, EXP CELL RES, V249, P359, DOI 10.1006/excr.1999.4483; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corpet DE, 2003, CANCER EPIDEM BIOMAR, V12, P391; Damalas A, 1999, EMBO J, V18, P3054, DOI 10.1093/emboj/18.11.3054; Demidov ON, 2007, ONCOGENE, V26, P2502, DOI 10.1038/sj.onc.1210032; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Grossmann J, 1998, AM J PATHOL, V153, P53, DOI 10.1016/S0002-9440(10)65545-9; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Ishizuka S, 2003, NUCLEIC ACIDS RES, V31, P6198, DOI 10.1093/nar/gkg840; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Leedham SJ, 2005, STEM CELL REV, V1, P233, DOI 10.1385/SCR:1:3:233; LEVY DB, 1994, CANCER RES, V54, P5953; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Martin K, 1998, J CELL SCI, V111, P2297; MERRITT AJ, 1994, CANCER RES, V54, P614; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nannenga B, 2006, MOL CARCINOGEN, V45, P594, DOI 10.1002/mc.20195; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oren M, 2001, Harvey Lect, V97, P57; POLAKIS P, 1997, BIOCHIM BIOPHYS ACTA, V1332, P127; Potten CS, 2006, E SCHERING RES FDN W, V60, P81; POTTEN CS, 1995, GUT, V36, P864, DOI 10.1136/gut.36.6.864; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Potten CS, 1998, BRIT J CANCER, V78, P993, DOI 10.1038/bjc.1998.618; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Reitmair AH, 1996, CANCER RES, V56, P2922; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rozen S, 2000, Methods Mol Biol, V132, P365; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Shreeram S, 2006, J EXP MED, V203, P2793, DOI 10.1084/jem.20061563; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Wilson JW, 1998, AM J PATHOL, V153, P899, DOI 10.1016/S0002-9440(10)65631-3	49	90	95	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG	2007	1	2					180	190		10.1016/j.stem.2007.05.020	http://dx.doi.org/10.1016/j.stem.2007.05.020			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XS	18371349	Bronze			2022-12-24	WOS:000251055100009
J	Dykstra, B; Kent, D; Bowie, M; McCaffrey, L; Hamilton, M; Lyons, K; Lee, SJ; Brinkman, R; Eaves, C				Dykstra, Brad; Kent, David; Bowie, Michelle; McCaffrey, Lindsay; Hamilton, Melisa; Lyons, Kristin; Lee, Shang-Jung; Brinkman, Ryan; Eaves, Connie			Long-term propagation of distinct hematopoietic differentiation programs in vivo	CELL STEM CELL			English	Article							STEM-CELL DIFFERENTIATION; SELF-RENEWAL CAPACITY; COLONY-FORMING CELLS; PROGENITOR CELLS; BONE-MARROW; GENE-EXPRESSION; STOCHASTIC-MODEL; MOUSE; MICE; COMPARTMENT	Heterogeneity in the differentiation behavior of hematopoietic stem cells is well documented but poorly understood. To investigate this question at a clonal level, we isolated a subpopulation of adult mouse bone marrow that is highly enriched for multilineage in vivo repopulating cells and transplanted these as single cells, or their short-term clonal progeny generated in vitro, into 352 recipients. Of the mice, 93 showed a donor-derived contribution to the circulating white blood cells for at least 4 months in one of four distinct patterns. Serial transplantation experiments indicated that two of the patterns were associated with extensive self-renewal of the original cell transplanted. However, within 4 days in vitro, the repopulation patterns subsequently obtained in vivo shifted in a clone-specific fashion to those with less myeloid contribution. Thus, primitive hematopoietic cells can maintain distinct repopulation properties upon serial transplantation in vivo, although these properties can also alter rapidly in vitro.	British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; Univ British Columbia, Dept Med Genet Med & Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada; Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Stem Cell Biol, NL-9713 AV Groningen, Netherlands	British Columbia Cancer Agency; University of British Columbia; University of Groningen	Eaves, C (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	ceaves@bccrc.ca	Kent, David/F-1084-2013; Kent, David/AAZ-4916-2021; Brinkman, Ryan/B-1108-2008	Kent, David/0000-0001-7871-8811; Brinkman, Ryan/0000-0002-9765-2990	NHLBI NIH HHS [P01 HL-55435] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL055435] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABKOWITZ JL, 1995, P NATL ACAD SCI USA, V92, P2031, DOI 10.1073/pnas.92.6.2031; Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Audet J, 2002, BIOTECHNOL BIOENG, V80, P393, DOI 10.1002/bit.10399; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; Dykstra B, 2006, P NATL ACAD SCI USA, V103, P8185, DOI 10.1073/pnas.0602548103; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; FULOP GM, 1986, J IMMUNOL, V136, P4438; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jones RJ, 1996, BLOOD, V88, P487, DOI 10.1182/blood.V88.2.487.bloodjournal882487; JONES RJ, 1990, NATURE, V347, P188, DOI 10.1038/347188a0; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; KELLER G, 1990, J EXP MED, V171, P1407, DOI 10.1084/jem.171.5.1407; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim M, 2003, ANN NY ACAD SCI, V996, P195, DOI 10.1111/j.1749-6632.2003.tb03247.x; Kirkland MA, 2004, EXP HEMATOL, V32, P511, DOI 10.1016/j.exphem.2004.02.013; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Lessard J, 2004, ONCOGENE, V23, P7199, DOI 10.1038/sj.onc.1207940; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; Miyamoto T, 2005, INT J HEMATOL, V81, P361, DOI 10.1532/IJH97.05003; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morita Y, 2006, BLOOD, V108, P2850, DOI 10.1182/blood-2006-03-010207; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Muller-Sieburg CE, 2006, CURR OPIN HEMATOL, V13, P243, DOI 10.1097/01.moh.0000231421.00407.65; Ortiz M, 1999, IMMUNITY, V10, P173, DOI 10.1016/S1074-7613(00)80018-7; Pal NR, 1996, NEURAL NETWORKS, V9, P787, DOI 10.1016/0893-6080(95)00094-1; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park IK, 2002, BLOOD, V99, P488, DOI 10.1182/blood.V99.2.488; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; PLOEMACHER RE, 1989, BLOOD, V74, P2755; R Development Core Team, 2006, R LANG ENV STAT COMP; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Roeder I, 2005, BLOOD, V105, P609, DOI 10.1182/blood-2004-01-0282; Rossi DJ, 2007, EXP GERONTOL, V42, P385, DOI 10.1016/j.exger.2006.11.019; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Serafini M, 2007, J EXP MED, V204, P129, DOI 10.1084/jem.20061115; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; SPANGRUDE GJ, 1992, INT J CELL CLONING, V10, P277, DOI 10.1002/stem.5530100505; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Szilvassy SJ, 2003, EXP HEMATOL, V31, P331, DOI 10.1016/S0301-472X(03)00005-5; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; TRENTIN JJ, 1971, AM J PATHOL, V65, P621; TREVISAN M, 1995, J EXP MED, V181, P93, DOI 10.1084/jem.181.1.93; Uchida N, 2003, EXP HEMATOL, V31, P1338, DOI 10.1016/j.exphem.2003.09.001; Wagers AJ, 2006, STEM CELLS, V24, P1087, DOI 10.1634/stemcells.2005-0396; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zhong JF, 2005, P NATL ACAD SCI USA, V102, P2448, DOI 10.1073/pnas.0409459102; Zhong RK, 1996, J IMMUNOL, V157, P138	57	416	431	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG	2007	1	2					218	229		10.1016/j.stem.2007.05.015	http://dx.doi.org/10.1016/j.stem.2007.05.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XS	18371352	Bronze			2022-12-24	WOS:000251055100012
J	Eggan, K				Eggan, Kevin			Short-circuiting epiblast development	CELL STEM CELL			English	Editorial Material							HUMAN EMBRYONIC STEM; MOUSE EMBRYO; CELL-LINES; FATE	Although human and mouse embryonic stem cells share many characteristics, their behaviors are not identical. Two recent papers describe the derivation of stem cell lines from mouse epiblast that may provide an explanation for the unique character of human embryonic stem cells.	Harvard Univ, Stowers Med Inst, Cambridge, MA 02138 USA; Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Stowers Institute for Medical Research; Harvard University; Harvard University	Eggan, K (corresponding author), Harvard Univ, Stowers Med Inst, 7 Divin Ave, Cambridge, MA 02138 USA.	eggan@mcb.harvard.edu	Eggan, Kevin/P-7119-2018					BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1827	8	2	2	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG	2007	1	2					131	132		10.1016/j.stem.2007.07.018	http://dx.doi.org/10.1016/j.stem.2007.07.018			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XS	18371343	Bronze			2022-12-24	WOS:000251055100003
J	Ruzankina, Y; Pinzon-Guzman, C; Asare, A; Ong, T; Pontano, L; Cotsarelis, G; Zediak, VP; Velez, M; Bhandoola, A; Brown, EJ				Ruzankina, Yaroslava; Pinzon-Guzman, Carolina; Asare, Amma; Ong, Tony; Pontano, Laura; Cotsarelis, George; Zediak, Valerie P.; Velez, Marielena; Bhandoola, Avinash; Brown, Eric J.			Deletion of the developmentallv essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss	CELL STEM CELL			English	Article							EARLY EMBRYONIC LETHALITY; GENOME MAINTENANCE; SECKEL-SYNDROME; DNA-REPAIR; SENESCENCE; CYCLE; PROGENITORS; DISRUPTION; EXPRESSION; STABILITY	Developmental abnormalities, cancer, and premature aging each have been linked to defects in the DNA damage response (DDR). Mutations in the ATR checkpoint regulator cause developmental defects in mice (pregastrulation lethality) and humans (Seckel syndrome). Here we show that eliminating ATR in adult mice leads to defects in tissue homeostasis and the rapid appearance of age-related phenotypes, such as hair graying, alopecia, kyphosis, osteoporosis, thymic involution, fibrosis, and other abnormalities. Histological and genetic analyses indicate that ATR deletion causes acute cellular loss in tissues in which continuous cell proliferation is required for maintenance. Importantly, thymic involution, alopecia, and hair graying in ATR knockout mice were associated with dramatic reductions in tissue-specific stem and progenitor cells and exhaustion of tissue renewal and homeostatic capacity. In aggregate, these studies suggest that reduced regenerative capacity in adults via deletion of a developmentally essential DDR gene is sufficient to cause the premature appearance of age-related phenotypes.	Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Brown, EJ (corresponding author), Abramson Family Canc Res Inst, Dept Canc Biol, 421 Curie Blvd, Philadelphia, PA 19104 USA.	brownej@mail.med.upenn.edu		Asare, Amma/0000-0002-4865-6864	NIA NIH HHS [R01 AG027376-02, R01 AG027376-03S1, R01 AG027376-01, R01 AG027376, 1R01AG027376-01, R01 AG027376-03] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG027376] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Arnold SR, 1999, PEDIATR DEVEL PATHOL, V2, P180, DOI 10.1007/s100249900107; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; BOSCHERINI B, 1981, EUR J PEDIATR, V137, P237, DOI 10.1007/BF00441325; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; BUTLER MG, 1987, AM J MED GENET, V27, P645, DOI 10.1002/ajmg.1320270318; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chao C, 2006, EMBO J, V25, P2615, DOI 10.1038/sj.emboj.7601167; Chen JC, 2004, EXP HEMATOL, V32, P1025, DOI 10.1016/j.exphem.2004.08.001; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; FATHIZADEH A, 1979, J AM ACAD DERMATOL, V1, P52, DOI 10.1016/S0190-9622(79)70004-1; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kipling D, 2004, SCIENCE, V305, P1426, DOI 10.1126/science.1102587; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Min H, 2004, J IMMUNOL, V173, P245, DOI 10.4049/jimmunol.173.1.245; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nabarra B, 1996, EXP GERONTOL, V31, P489, DOI 10.1016/0531-5565(95)02038-1; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; O'Driscoll M, 2003, CELL CYCLE, V2, P194, DOI 10.4161/cc.2.3.404; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Pelicci PG, 2004, J CLIN INVEST, V113, P4, DOI 10.1172/JCI200420750; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zediak VP, 2005, SEMIN IMMUNOL, V17, P337, DOI 10.1016/j.smim.2005.05.004	41	528	538	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL	2007	1	1					113	126		10.1016/j.stem.2007.03.002	http://dx.doi.org/10.1016/j.stem.2007.03.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	230JK	18371340	Green Accepted, Bronze			2022-12-24	WOS:000250872600006
J	de Villers-Sidani, E; Simpson, KL; Lu, YF; Lin, RCS; Merzenich, MM				de Villers-Sidani, Etienne; Simpson, Kimberly L.; Lu, Y-F; Lin, Rick C. S.; Merzenich, Michael M.			Manipulating critical period closure across different sectors of the primary auditory cortex	NATURE NEUROSCIENCE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; PRIMARY VISUAL-CORTEX; MONOCULAR DEPRIVATION; SOMATOSENSORY CORTEX; TEMPORAL PLASTICITY; BARREL CORTEX; RAT; MOUSE; PARVALBUMIN; NEOCORTEX	During early brain development and through 'adult' experience-dependent plasticity, neural circuits are shaped to represent the external world with high fidelity. When raised in a quiet environment, the rat primary auditory cortex (A1) has a well-defined 'critical period', lasting several days, for its representation of sound frequency. The addition of environmental noise extends the critical period duration as a variable function of noise level. It remains unclear whether critical period closure should be regarded as a unified, externally gated event that applies for all of A1 or if it is controlled by progressive, local, activity-driven changes in this cortical area. We found that rearing rats in the presence of a spectrally limited noise band resulted in the closure of the critical period for A1 sectors representing the noise-free spectral bands, whereas the critical period appeared to remain open in noise-exposed sectors, where the cortex was still functionally and physically immature.	[de Villers-Sidani, Etienne; Merzenich, Michael M.] Univ Calif San Francisco, Dept Otolaryngol, Coleman Lab, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Simpson, Kimberly L.; Lu, Y-F; Lin, Rick C. S.] Univ Mississippi, Med Ctr, Dept Anat, Jackson, MS 39216 USA; [Simpson, Kimberly L.; Lu, Y-F; Lin, Rick C. S.] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA	University of California System; University of California San Francisco; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	de Villers-Sidani, E (corresponding author), Univ Calif San Francisco, Dept Otolaryngol, Coleman Lab, WM Keck Ctr Integrat Neurosci, 513 Parnassus Ave,Room HSE-808,Box 0732, San Francisco, CA 94143 USA.	etienne@phy.ucsf.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835, F32NS010414, R01NS010414] Funding Source: NIH RePORTER; NIMH NIH HHS [P50 MH077970-010006, P50 MH077970] Funding Source: Medline; NINDS NIH HHS [F32 NS010414, NS-10414, R01 NS010414-33, P01 NS034835-09, R01 NS010414, P02 NS34835-09, P01 NS034835] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alonso JM, 2005, J NEUROPHYSIOL, V94, P26, DOI 10.1152/jn.01281.2004; Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Bao SW, 2003, J NEUROSCI, V23, P10765; Bartoletti A, 2004, NAT NEUROSCI, V7, P215, DOI 10.1038/nn1201; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; Best C.T., 1994, DEV SPEECH PERCEPTIO; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Brosch M, 1999, EUR J NEUROSCI, V11, P3517, DOI 10.1046/j.1460-9568.1999.00770.x; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Chang EF, 2005, P NATL ACAD SCI USA, V102, P16460, DOI 10.1073/pnas.0508239102; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Daw MI, 2007, NAT NEUROSCI, V10, P453, DOI 10.1038/nn1866; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; DELRIO JA, 1994, DEV BRAIN RES, V81, P247, DOI 10.1016/0165-3806(94)90311-5; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DEVENECIA RK, 1994, DEV BRAIN RES, V81, P135, DOI 10.1016/0165-3806(94)90077-9; EGGERMONT JJ, 1992, J NEUROPHYSIOL, V68, P1216, DOI 10.1152/jn.1992.68.4.1216; Eggermont JJ, 2007, HEARING RES, V229, P69, DOI 10.1016/j.heares.2007.01.008; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Gao WJ, 2000, J COMP NEUROL, V422, P140, DOI 10.1002/(SICI)1096-9861(20000619)422:1<140::AID-CNE9>3.0.CO;2-0; Gao WJ, 1999, J NEUROSCI, V19, P7940; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Gordon JA, 1996, J NEUROSCI, V16, P3274; HENDRICKSON AE, 1991, J COMP NEUROL, V307, P626, DOI 10.1002/cne.903070409; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hooks BM, 2007, NEURON, V56, P312, DOI 10.1016/j.neuron.2007.10.003; Jiao YY, 2006, J NEUROSCI, V26, P8691, DOI 10.1523/JNEUROSCI.2478-06.2006; Kilgard MP, 2001, J NEUROPHYSIOL, V86, P326, DOI 10.1152/jn.2001.86.1.326; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Marco P, 1997, BRAIN RES BULL, V44, P47, DOI 10.1016/S0361-9230(97)00090-7; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; MICHEVA KD, 1995, J COMP NEUROL, V361, P574, DOI 10.1002/cne.903610403; MOORE DR, 1991, AUDIOLOGY, V30, P91; Pallas SL, 2001, TRENDS NEUROSCI, V24, P417, DOI 10.1016/S0166-2236(00)01853-1; PEARSON HE, 1981, DEV BRAIN RES, V1, P127, DOI 10.1016/0165-3806(81)90099-7; RICE FL, 1977, J COMP NEUROL, V171, P545, DOI 10.1002/cne.901710408; Schlaggar B L, 1993, Perspect Dev Neurobiol, V1, P81; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Xu H, 2007, J NEUROSCI, V27, P9417, DOI 10.1523/JNEUROSCI.1992-07.2007; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zheng WM, 1999, SCIENCE, V284, P962, DOI 10.1126/science.284.5416.962	48	100	100	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					957	965		10.1038/nn.2144	http://dx.doi.org/10.1038/nn.2144			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18604205	Green Accepted			2022-12-24	WOS:000257969100022
J	Waung, MW; Pfeiffer, BE; Nosyreva, ED; Ronesi, JA; Huber, KM				Waung, Maggie W.; Pfeiffer, Brad E.; Nosyreva, Elena D.; Ronesi, Jennifer A.; Huber, Kimberly M.			Rapid translation of Arc/Arg3.1 selectively mediates mGluR-dependent LTD through persistent increases in AMPAR endocytosis rate	NEURON			English	Article							LONG-TERM DEPRESSION; X MENTAL-RETARDATION; IMMEDIATE-EARLY GENE; CYTOSKELETON-ASSOCIATED PROTEIN; ARC MESSENGER-RNA; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; MOUSE MODEL; INCREASED EXPRESSION; HIPPOCAMPAL-NEURONS	Salient stimuli that modify behavior induce transcription of activity-regulated cytoskeleton-associated protein (Arc/Arg3.1) and transport Arc mRNA into dendrites, suggesting that local Arc translation mediates synaptic plasticity that encodes such stimuli. Here, we demonstrate that long-term synaptic depression (LTD) in hippocampal neurons induced by group 1 metabotropic glutamate receptors (mGluRs) relies on rapid translation of Arc. mGluR-LTD induction causes long-term increases in AMPA receptor endocytosis rate and dendritic synthesis of Arc, a component of the AMPAR endocytosis machinery. Knockdown of Arc prevents mGluRs from triggering AMPAR endocytosis or LTD, and acute blockade of new Arc synthesis with antisense oligonucleotides blocks mGluR-LTD and AMPAR trafficking. In contrast, LTD induced by NMDA receptors does not persistently alter AMPAR endocytosis rate, induce Arc synthesis, or require Arc protein. These data demonstrate a role for local Arc synthesis specifically in mGluR-LTD and suggest that mGluR-LTD may be one consequence of Arc mRNA induction during experience.	[Waung, Maggie W.; Pfeiffer, Brad E.; Nosyreva, Elena D.; Ronesi, Jennifer A.; Huber, Kimberly M.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Huber, KM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	kimberly.huber@utsouthwestern.edu	Huber, Kimberly/X-5534-2019		NICHD NIH HHS [R01 HD052731, R01 HD052731-01A2, HD052731] Funding Source: Medline; NIGMS NIH HHS [T32 GM08014, T32 GM008014] Funding Source: Medline; NINDS NIH HHS [F31 NS050992, R01 NS045711, NS045711, R01 NS045711-06, 1F31NS050992] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045711, F31NS050992] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chaouloff F, 2007, J NEUROSCI, V27, P7130, DOI 10.1523/JNEUROSCI.1150-07.2007; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; FOSNAUGH JS, 1995, J NEUROCHEM, V64, P2377; Gusev PA, 2005, J NEUROSCI, V25, P9384, DOI 10.1523/JNEUROSCI.0832-05.2005; Guzowski JF, 2006, P NATL ACAD SCI USA, V103, P1077, DOI 10.1073/pnas.0505519103; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Iacoangeli A, 2008, P NATL ACAD SCI USA, V105, P734, DOI 10.1073/pnas.0803737105; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kelly MP, 2002, NEUROSCIENCE, V110, P617, DOI 10.1016/S0306-4522(01)00605-4; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Kemp A, 2007, TRENDS NEUROSCI, V30, P111, DOI 10.1016/j.tins.2007.01.002; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; McIntyre CK, 2005, P NATL ACAD SCI USA, V102, P10718, DOI 10.1073/pnas.0504436102; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Mikkelsen JD, 2006, NEUROSCI LETT, V403, P239, DOI 10.1016/j.neulet.2006.04.040; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; Montag-Sallaz M, 1999, J NEUROBIOL, V38, P234, DOI 10.1002/(SICI)1097-4695(19990205)38:2<234::AID-NEU6>3.0.CO;2-G; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Nosyreva ED, 2005, J NEUROSCI, V25, P2992, DOI 10.1523/JNEUROSCI.3652-04.2005; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Ons S, 2004, J NEUROCHEM, V89, P1111, DOI 10.1111/j.1471-4159.2004.02396.x; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Volk LJ, 2007, J NEUROSCI, V27, P11624, DOI 10.1523/JNEUROSCI.2266-07.2007; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893	56	350	354	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 10	2008	59	1					84	97		10.1016/j.neuron.2008.05.014	http://dx.doi.org/10.1016/j.neuron.2008.05.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	327KU	18614031	Green Accepted, Bronze			2022-12-24	WOS:000257728800010
J	Nowak, JA; Polak, L; Pasolli, HA; Fuchs, E				Nowak, Jonathan A.; Polak, Lisa; Pasolli, H. Amalia; Fuchs, Elaine			Hair follicle stem cells are specified and function in early skin morphogenesis	CELL STEM CELL			English	Article							LABEL-RETAINING CELLS; BULGE; EPIDERMIS; RENEWAL; SOX9; DIFFERENTIATION; PROLIFERATION; POPULATIONS; INDUCTION; DISTINCT	In adult skin, epithelial hair follicle stem cells (SCs) reside in a quiescent niche and are essential for cyclic bouts of hair growth. Niche architecture becomes pronounced postnatally at the start of the first hair cycle. Whether SCs; exist or function earlier is unknown. Here we show that slow-cycling cells appear early in skin development, express SC markers and later give rise to the adult SC population. To test whether these early slow-cycling cells function as SCs, we use Sox9-Cre for genetic marking and K14-Cre to embryonically ablate Sox9, an essential adult SC gene. We find that the progeny of Sox9-expressing cells contribute to all skin epithelial lineages and Sox9 is required for SC specification. In the absence of early SCs, hair follicle and sebaceous gland morphogenesis is blocked, and epidermal wound repair is compromised. These findings establish the existence of early hair follicle SCs and reveal their physiological importance in tissue morphogenesis.	[Nowak, Jonathan A.; Polak, Lisa; Pasolli, H. Amalia; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchsib@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Pasolli, Hilda Amalia/0000-0003-3899-3530	NATIONAL CANCER INSTITUTE [T32CA009673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452, R01AR031737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [T32 CA009673] Funding Source: Medline; NIAMS NIH HHS [R01 AR031737-27, R01 AR031737-21S1, R01 AR050452, R01 AR031737-23, R01 AR031737-26, R01 AR031737-19, R01 AR031737-25, R01 AR031737-27S1, R01 AR031737, R01 AR031737-22, R01 AR031737-20, R01 AR031737-21, R01 AR050452-05, R01 AR031737-24] Funding Source: Medline; NIGMS NIH HHS [T32 GM007739] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064	33	392	405	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL	2008	3	1					33	43		10.1016/j.stem.2008.05.009	http://dx.doi.org/10.1016/j.stem.2008.05.009			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	325XO	18593557	Green Accepted, Bronze			2022-12-24	WOS:000257622300008
J	Pascual, A; Hidalgo-Figueroa, M; Piruat, JI; Pintado, CO; Gomez-Diaz, R; Lopez-Barneo, J				Pascual, Alberto; Hidalgo-Figueroa, Maria; Piruat, Jose I.; Pintado, C. Oscar; Gomez-Diaz, Raquel; Lopez-Barneo, Jose			Absolute requirement of GDNF for adult catecholaminergic neuron survival	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR; DOPAMINERGIC-NEURONS; SUBCOMMISSURAL ORGAN; FUNCTIONAL RECOVERY; PARKINSON-DISEASE; SUBSTANTIA-NIGRA; LOCUS-COERULEUS; MOUSE MODEL; MICE; DEGENERATION	GDNF is a potent neurotrophic factor that protects catecholaminergic neurons from toxic damage and induces fiber outgrowth. However, the actual role of endogenous GDNF in the normal adult brain is unknown, even though GDNF-based therapies are considered promising for neurodegenerative disorders. We have generated a conditional GDNF-null mouse to suppress GDNF expression in adulthood, hence avoiding the developmental compensatory modifications masking its true physiologic action. After Gdnf ablation, mice showed a progressive hypokinesia and a selective decrease of brain tyrosine hydroxylase (Th) mRNA, accompanied by pronounced catecholaminergic cell death, affecting most notably the locus coeruleus, which practically disappears; the substantia nigra; and the ventral tegmental area. These data unequivocally demonstrate that GDNF is indispensable for adult catecholaminergic neuron survival and also show that, under physiologic conditions, downregulation of a single trophic factor can produce massive neuronal death.	[Pascual, Alberto; Hidalgo-Figueroa, Maria; Piruat, Jose I.; Pintado, C. Oscar; Gomez-Diaz, Raquel; Lopez-Barneo, Jose] Univ Seville, Hosp Univ Virgen Rocio, Inst Biomed Sevilla, Consejo Super Invest Cient, Seville 41013, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Lopez-Barneo, J (corresponding author), Univ Seville, Hosp Univ Virgen Rocio, Inst Biomed Sevilla, Consejo Super Invest Cient, Ave Manuel Siurot S-N, Seville 41013, Spain.	lbarneo@us.es	Gómez-Díaz, Raquel/D-9886-2013; IBIS, NEUROBIOLOGIA/O-9922-2015; Pascual, Alberto/L-2014-2019; Pintado, Carmelo Oscar/M-2219-2018; Pascual, Alberto P/E-9609-2015; Hidalgo-Figueroa, Maria/AAA-9529-2019; IBIS, NEURONAL/O-9910-2015	Gómez-Díaz, Raquel/0000-0002-1423-1315; Pascual, Alberto/0000-0001-5459-6207; Pascual, Alberto P/0000-0001-5459-6207; Hidalgo-Figueroa, Maria/0000-0001-5241-0931; 				Akerud P, 2001, J NEUROSCI, V21, P8108, DOI 10.1523/JNEUROSCI.21-20-08108.2001; Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; Arjona V, 2003, NEUROSURGERY, V53, P321, DOI 10.1227/01.NEU.0000073315.88827.72; BJORKLUND A, 1984, HDB CHEM NEUROANAT 1, P123; Boger HA, 2006, EXP NEUROL, V202, P336, DOI 10.1016/j.expneurol.2006.06.006; Boger HA, 2007, J NEUROSCI, V27, P8816, DOI 10.1523/JNEUROSCI.1067-07.2007; Chao CC, 2003, NEUROBIOL AGING, V24, P105, DOI 10.1016/S0197-4580(02)00047-7; Check E, 2007, NAT MED, V13, P770, DOI 10.1038/nm0707-770; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Espejo EF, 1998, NEURON, V20, P197, DOI 10.1016/S0896-6273(00)80449-3; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Franklin BJ, 1996, MOUSE BRAIN STEREOTA; Galarza M, 2002, NEUROSURG REV, V25, P205, DOI 10.1007/s10143-002-0208-y; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Granholm AC, 2000, J NEUROSCI, V20, P3182, DOI 10.1523/JNEUROSCI.20-09-03182.2000; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Jain S, 2006, J NEUROSCI, V26, P11230, DOI 10.1523/JNEUROSCI.1876-06.2006; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LINDVALL O, 1978, CELL TISSUE RES, V190, P383; MATZUK MM, 1985, ANN NEUROL, V18, P552, DOI 10.1002/ana.410180507; Mejias R, 2006, J NEUROSCI, V26, P4500, DOI 10.1523/JNEUROSCI.0122-06.2006; Meredith GE, 2006, MOVEMENT DISORD, V21, P1595, DOI 10.1002/mds.21010; Minguez-Castellanos A, 2007, J NEUROL NEUROSUR PS, V78, P825, DOI 10.1136/jnnp.2006.106021; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Rosenblad C, 1998, NEUROSCIENCE, V82, P129; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sedelis M, 2001, BEHAV BRAIN RES, V125, P109, DOI 10.1016/S0166-4328(01)00309-6; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Srinivasan J, 2003, EUR J NEUROSCI, V17, P2586, DOI 10.1046/j.1460-9568.2003.02684.x; Toledo-Aral JJ, 2003, J NEUROSCI, V23, P141; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Tome M, 2004, CELL TISSUE RES, V317, P65, DOI 10.1007/s00441-004-0900-z; Trupp M, 1997, J NEUROSCI, V17, P3554; Villadiego J, 2005, J NEUROSCI, V25, P4091, DOI 10.1523/JNEUROSCI.4312-04.2005; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	44	253	259	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					755	761		10.1038/nn.2136	http://dx.doi.org/10.1038/nn.2136			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18536709	Green Submitted			2022-12-24	WOS:000257089400012
J	Mckay, R; Kittappa, R				McKay, Ron; Kittappa, Raja			Will stem cell biology generate new therapies for Parkinson's disease?	NEURON			English	Editorial Material							DOPAMINE NEURONS; DEGENERATION; PATHOLOGY; MICE	Three papers recently published in Nature Medicine provide the most detailed analyses of fetal midbrain grafts in patients with Parkinson's disease. Some of the results are surprising and suggest a new wave of questions aimed at both the value of cell therapy and the nature of the disease itself.	[McKay, Ron; Kittappa, Raja] Natl Inst Neurol Disorders & Stroke, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Mckay, R (corresponding author), Natl Inst Neurol Disorders & Stroke, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	ronmckay@mail.nih.gov			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002981, Z01NS002981] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Braak H, 2008, NAT MED, V14, P483, DOI 10.1038/nm0508-483; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Gu XF, 2005, NEURON, V46, P433, DOI 10.1016/j.neuron.2005.03.025; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105	14	25	28	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUN 12	2008	58	5					659	661		10.1016/j.neuron.2008.05.016	http://dx.doi.org/10.1016/j.neuron.2008.05.016			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	315IA	18549778	Bronze			2022-12-24	WOS:000256870800004
J	Yang, Y; Cao, P; Yang, Y; Wang, SR				Yang, Yan; Cao, Peng; Yang, Yang; Wang, Shu-Rong			Corollary discharge circuits for saccadic modulation of the pigeon visual system	NATURE NEUROSCIENCE			English	Article							ACCESSORY OPTIC-SYSTEM; PURSUIT EYE-MOVEMENTS; OPTOKINETIC NYSTAGMUS; RETICULAR-FORMATION; NEURONS; PROJECTIONS; NUCLEUS; MONKEY; CELLS; TIME	A saccadic eye movement causes a variety of transient perceptual sequelae that might be the results of corollary discharge. Here we describe the neural circuits for saccadic corollary discharge that modulates activity throughout the pigeon visual system. Saccades in pigeons caused inhibition that was mediated by corollary discharge followed by enhancement of firing activity in the telencephalic hyperpallium, visual thalamus and pretectal nucleus lentiformis mesencephali (nLM) with opposite responses in the accessory optic nucleus (nBOR). Inactivation of thalamic neurons eliminated saccadic responses in telencephalic neurons, and inactivation of both the nLM and the nBOR abolished saccadic responses in thalamic neurons. Saccade-related omnipause neurons in the brainstem raphe complex inhibited the nBOR and excited the nLM, whereas inactivation of raphe neurons eliminated saccadic responses in both optokinetic and thalamic neurons. It seems that saccadic responses in telencephalic neurons are generated by corollary discharge signals from brainstem neurons that are transmitted through optokinetic and thalamic neurons. These signals might have important roles in visual perception.	[Yang, Yan; Cao, Peng; Yang, Yang; Wang, Shu-Rong] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Lab Visual Informat Proc, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Wang, SR (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Lab Visual Informat Proc, 15 Datun Rd, Beijing 100101, Peoples R China.	wangsr@sun5.ibp.ac.cn	Yang, Yan/A-8505-2016	Yang, Yan/0000-0002-9139-5532; Yang, Yang/0000-0001-6612-8865				BAGNOLI P, 1983, J COMP NEUROL, V214, P103, DOI 10.1002/cne.902140111; BRECHA N, 1979, SCIENCE, V203, P913, DOI 10.1126/science.570303; Brecht M, 2004, J NEUROPHYSIOL, V92, P424, DOI 10.1152/jn.00639.2003; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; ButtnerEnnever JA, 1996, J COMP NEUROL, V366, P348, DOI 10.1002/(SICI)1096-9861(19960304)366:2<348::AID-CNE12>3.0.CO;2-L; Cao P, 2006, BRAIN RES, V1069, P159, DOI 10.1016/j.brainres.2005.11.063; Cao P, 2004, J NEUROSCI, V24, P7690, DOI 10.1523/JNEUROSCI.2384-04.2004; CLEMENT G, 1984, EXP BRAIN RES, V55, P49; Everling S, 1998, J NEUROPHYSIOL, V79, P511, DOI 10.1152/jn.1998.79.2.511; Fischer WH, 1998, VISUAL NEUROSCI, V15, P197, DOI 10.1017/S0952523898151106; GIOANNI H, 1983, EXP BRAIN RES, V50, P237; GUNTURKUN O, 1991, J COMP NEUROL, V314, P721, DOI 10.1002/cne.903140407; Horn AKE, 2006, PROG BRAIN RES, V151, P127, DOI 10.1016/S0079-6123(05)51005-7; Ibbotson MR, 2007, CEREB CORTEX, V17, P1129, DOI 10.1093/cercor/bhl022; Karten H.J., 1967, STEREOTAXIC ATLAS BR; KELLER EL, 1974, J NEUROPHYSIOL, V37, P316, DOI 10.1152/jn.1974.37.2.316; Koshiba M, 2005, NEUROSCI RES, V52, P235, DOI 10.1016/j.neures.2005.03.017; Kusunoki M, 2003, J NEUROPHYSIOL, V89, P1519, DOI 10.1152/jn.00519.2002; Lee D, 1998, J NEUROPHYSIOL, V79, P922, DOI 10.1152/jn.1998.79.2.922; Lisberger SG, 1998, J NEUROPHYSIOL, V79, P1918, DOI 10.1152/jn.1998.79.4.1918; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P733, DOI 10.1152/jn.1978.41.3.733; Luksch H, 2003, REV NEUROSCIENCE, V14, P85; Luque MA, 2005, BRAIN RES REV, V49, P388, DOI 10.1016/j.brainresrev.2004.10.002; MCKENNA OC, 1985, BRAIN BEHAV EVOLUT, V26, P91, DOI 10.1159/000118770; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Mustari MJ, 1997, J NEUROPHYSIOL, V77, P116, DOI 10.1152/jn.1997.77.1.116; Niu YQ, 2006, J PHYSIOL-LONDON, V577, P805, DOI 10.1113/jphysiol.2006.120071; PETTIGREW JD, 1990, NATURE, V343, P362, DOI 10.1038/343362a0; REINER A, 1982, J COMP NEUROL, V204, P165, DOI 10.1002/cne.902040206; Reppas JB, 2002, NEURON, V35, P961, DOI 10.1016/S0896-6273(02)00823-1; Ross J, 1996, BEHAV BRAIN RES, V80, P1, DOI 10.1016/0166-4328(96)00012-5; Royal DW, 2006, EXP BRAIN RES, V168, P62, DOI 10.1007/s00221-005-0093-z; SCHIFF D, 1990, EXP BRAIN RES, V79, P225, DOI 10.1007/BF00608231; Schmidt M, 1996, J COMP NEUROL, V369, P520, DOI 10.1002/(SICI)1096-9861(19960610)369:4<520::AID-CNE3>3.0.CO;2-6; Shimizu T, 1999, BEHAV BRAIN RES, V98, P183, DOI 10.1016/S0166-4328(98)00083-7; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; Thiele A, 2002, SCIENCE, V295, P2460, DOI 10.1126/science.1068788; Toledo CAB, 1995, BRAIN RES, V705, P341, DOI 10.1016/0006-8993(95)01243-5; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; WANG SR, 1990, VISUAL NEUROSCI, V5, P479, DOI 10.1017/S0952523800000602; WOHLSCHLAGER A, 1993, J COMP PSYCHOL, V107, P313, DOI 10.1037/0735-7036.107.3.313; Wurtz RH, 2003, PROG BRAIN RES, V144, P47, DOI 10.1016/S0079-6123(03)14400-3; Wylie DRW, 1998, J COMP NEUROL, V391, P456; Yarrow K, 2001, NATURE, V414, P302, DOI 10.1038/35104551	45	24	24	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					595	602		10.1038/nn.2107	http://dx.doi.org/10.1038/nn.2107			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18391942				2022-12-24	WOS:000255327300019
J	Karadottir, R; Hamilton, NB; Bakiri, Y; Attwell, D				Karadottir, Ragnhildur; Hamilton, Nicola B.; Bakiri, Yamina; Attwell, David			Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter	NATURE NEUROSCIENCE			English	Article							RAT SPINAL-CORD; PROGENITOR CELLS; NG2 PROTEOGLYCAN; PHYSIOLOGICAL-PROPERTIES; NG2-POSITIVE CELLS; ALPHA-RECEPTOR; ADULT CNS; AREA CA1; BRAIN; GLUTAMATE	A defining feature of glial cells has been their inability to generate action potentials. We show here that there are two distinct types of morphologically identical oligodendrocyte precursor glial cells (OPCs) in situ in rat CNS white matter. One type expresses voltage-gated sodium and potassium channels, generates action potentials when depolarized and senses its environment by receiving excitatory and inhibitory synaptic input from axons. The other type lacks action potentials and synaptic input. We found that when OPCs suffered glutamate-mediated damage, as occurs in cerebral palsy, stroke and spinal cord injury, the action potential-generating OPCs were preferentially damaged, as they expressed more glutamate receptors, and received increased spontaneous glutamatergic synaptic input in ischemia. These data challenge the idea that only neurons generate action potentials in the CNS and imply that the development of therapies for demyelinating disorders will require defining which OPC type can carry out remyelination.	[Karadottir, Ragnhildur; Hamilton, Nicola B.; Bakiri, Yamina; Attwell, David] UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Karadottir, R (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.	rk385@cam.ac.uk	Hamilton, Nicola/C-2108-2008; Messier, Claude/A-2322-2008; Attwell, David/ABE-6750-2020; Hamilton-Whitaker, Nicola/H-8867-2012	Messier, Claude/0000-0002-4791-1763; Hamilton-Whitaker, Nicola/0000-0002-0168-8068; Karadottir, Ragnhildur Thora/0000-0001-9675-2722	MRC [G0300723] Funding Source: UKRI; Medical Research Council [G0300723B] Funding Source: researchfish; Medical Research Council [G0800784, G0300723] Funding Source: Medline; Wellcome Trust [075232, 065424] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Allen NJ, 2004, J PHYSIOL-LONDON, V561, P485, DOI 10.1113/jphysiol.2004.070490; Allen NJ, 2005, J NEUROSCI, V25, P848, DOI 10.1523/JNEUROSCI.4157-04.2005; Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Back SA, 2001, J NEUROSCI, V21, P1302; BARRES BA, 1990, NEURON, V4, P507, DOI 10.1016/0896-6273(90)90109-S; Chittajallu R, 2005, J NEUROSCI, V25, P8601, DOI 10.1523/JNEUROSCI.2122-05.2005; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Follett PL, 2000, J NEUROSCI, V20, P9235; Fukuda A, 1998, J NEUROPHYSIOL, V79, P430, DOI 10.1152/jn.1998.79.1.430; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; Horner PJ, 2000, J NEUROSCI, V20, P2218; Horner PJ, 2002, J NEUROCYTOL, V31, P469, DOI 10.1023/A:1025739630398; Karadottir R, 2007, NEUROSCIENCE, V145, P1426, DOI 10.1016/j.neuroscience.2006.08.070; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Karadottir R, 2006, NAT PROTOC, V1, P1977, DOI 10.1038/nprot.2006.261; KAWASAKI K, 1990, J NEUROPHYSIOL, V63, P385, DOI 10.1152/jn.1990.63.3.385; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.3.CO;2-Z; Kondo RP, 2000, J MOL CELL CARDIOL, V32, P1859, DOI 10.1006/jmcc.2000.1220; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Li S, 1999, J Neurosci, V19, pRC16; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Marie Y, 2001, LANCET, V358, P298, DOI 10.1016/S0140-6736(01)05499-X; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Newell EW, 2005, J PHYSIOL-LONDON, V567, P869, DOI 10.1113/jphysiol.2005.092056; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2002, J NEUROCYTOL, V31, P437, DOI 10.1023/A:1025783412651; Patt S, 1996, NEUROSCIENCE, V71, P601, DOI 10.1016/0306-4522(95)00468-8; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; VORNOV JJ, 1991, EXP NEUROL, V114, P11, DOI 10.1016/0014-4886(91)90079-R; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	40	251	254	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					450	456		10.1038/nn2060	http://dx.doi.org/10.1038/nn2060			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18311136	Green Accepted			2022-12-24	WOS:000254359300017
J	Murphy, GJ; Rieke, F				Murphy, Gabe J.; Rieke, Fred			Signals and noise in an inhibitory interneuron diverge to control activity in nearby retinal ganglion cells	NATURE NEUROSCIENCE			English	Article							INNER PLEXIFORM LAYER; AII AMACRINE CELLS; MAMMALIAN RETINA; VISUAL-CORTEX; RABBIT RETINA; ROD PATHWAYS; LIGHT RESPONSES; PRIMATE RETINA; MOUSE RETINA; CAT RETINA	Information about sensory stimuli is represented by spatiotemporal patterns of neural activity. The complexity of the central nervous system, however, frequently obscures the origin and properties of signals and noise that underlie these activity patterns. We minimized this constraint by examining mechanisms governing correlated activity in mouse retinal ganglion cells (RGCs) under conditions in which light-evoked responses traverse a specific circuit, the rod bipolar pathway. Signals and noise in this circuit produced correlated synaptic input to neighboring On and Off RGCs. Temporal modulation of light intensity did not alter the degree to which noise in the input to nearby RGCs was correlated, and action potential generation in individual RGCs was largely insensitive to differences in network noise generated by dynamic and static light stimuli. Together, these features enable noise in shared circuitry to diminish simultaneous action potential generation in neighboring On and Off RGCs under a variety of conditions.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Phys & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Murphy, GJ (corresponding author), Univ Washington, Howard Hughes Med Inst, 1705 NE Pacific St,HSB J187,Box 357290, Seattle, WA 98195 USA.	gjmurphy@u.washington.edu		Murphy, Gabe/0000-0002-9321-8556	NATIONAL EYE INSTITUTE [R01EY011850] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY011850-10, EY-11850, R01 EY011850] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARNETT D, 1981, J PHYSIOL-LONDON, V317, P29, DOI 10.1113/jphysiol.1981.sp013812; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Callaway EM, 2004, NEURAL NETWORKS, V17, P625, DOI 10.1016/j.neunet.2004.04.004; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; CHUN MH, 1993, J COMP NEUROL, V332, P421, DOI 10.1002/cne.903320404; Cohen ED, 1998, J NEUROPHYSIOL, V80, P2975, DOI 10.1152/jn.1998.80.6.2975; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; DACHEUX RF, 1986, J NEUROSCI, V6, P331; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Demb JB, 2004, J NEUROPHYSIOL, V92, P2510, DOI 10.1152/jn.00108.2004; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Dunn FA, 2006, J NEUROSCI, V26, P3959, DOI 10.1523/JNEUROSCI.5148-05.2006; FAMIGLIETTI EV, 1975, BRAIN RES, V84, P293, DOI 10.1016/0006-8993(75)90983-X; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Gegenfurtner KR, 2003, ANNU REV NEUROSCI, V26, P181, DOI 10.1146/annurev.neuro.26.041002.131116; GINSBURG KS, 1984, J PHYSIOL-LONDON, V351, P433, DOI 10.1113/jphysiol.1984.sp015254; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; KOLB H, 1979, J NEUROCYTOL, V8, P295, DOI 10.1007/BF01236124; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; NELSON R, 1982, J NEUROPHYSIOL, V47, P928, DOI 10.1152/jn.1982.47.5.928; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Pang JJ, 2007, J PHYSIOL-LONDON, V580, P397, DOI 10.1113/jphysiol.2006.120790; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; Press W. H., 1992, ART SCI COMPUTING; Protti DA, 1997, J NEUROSCI, V17, P6075; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; Shu YS, 2003, J NEUROSCI, V23, P10388; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; Trexler EB, 2005, J NEUROPHYSIOL, V93, P1476, DOI 10.1152/jn.00597.2004; Tsukamoto Y, 2007, J NEUROSCI, V27, P6261, DOI 10.1523/JNEUROSCI.5646-06.2007; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Xin DY, 1999, VISUAL NEUROSCI, V16, P653, DOI 10.1017/S0952523899164058	48	69	69	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					318	326		10.1038/nn2045	http://dx.doi.org/10.1038/nn2045			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18223648	Green Accepted			2022-12-24	WOS:000253548300015
J	Hasson, U; Furman, O; Clark, D; Dudai, Y; Davachi, L				Hasson, Uri; Furman, Orit; Clark, Dav; Dudai, Yadin; Davachi, Lila			Enhanced intersubject correlations during movie viewing correlate with successful episodic encoding	NEURON			English	Article							CORTICAL ACTIVITY; MEMORY; BRAIN; RETRIEVAL; CORTEX; MINDS; COMPREHENSION; RECOGNITION; ORIENTATION; ACTIVATION	While much has been learned regarding the neural substrates supporting episodic encoding using highly controlled experimental protocols, relatively little is known regarding the neural bases of episodic encoding of real-world events. In an effort to examine this issue, we measured fMRI activity while observers viewed a novel TV sitcom. Three weeks later, subsequent memory (SM) for the narrative content of movie events was assessed. We analyzed the encoding data for intersubject correlations (ISC) based on subjects' subsequent memory (ISC-SM) performance to identify brain regions whose BOLD response is significantly more correlated across subjects during portions of the movie that are successfully as compared to unsuccessfully encoded. These regions include the parahippocampal gyrus, superior temporal gyrus, anterior temporal poles, and the temporal-parietal junction. Further analyses reveal (1) that these correlated regions can display distinct activation profiles and (2) that the results seen with the ISC-SM analysis are complementary to more traditional linear models and allow analysis of complex time course data. Thus, the ISC-SM analysis extends traditional subsequent memory findings to a rich, dynamic and more ecologically valid situation.	[Hasson, Uri; Davachi, Lila] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Hasson, Uri; Clark, Dav; Davachi, Lila] NYU, Dept Psychol, New York, NY 10003 USA; [Furman, Orit; Dudai, Yadin] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	New York University; New York University; Weizmann Institute of Science	Davachi, L (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	lila.davachi@nyu.edu		Furman, Orit/0000-0001-6823-9542; Davachi, Lila/0000-0003-4317-0889; Hasson, Uri/0000-0002-3599-7168; Clark, Dav/0000-0002-3982-4416	NIMH NIH HHS [R01 MH074692-03, R01 MH074692] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074692] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; [Anonymous], 1983, CANADIAN PSYCHOL; [Anonymous], 1996, MEMORY REAL WORLD; AVRAHAMI J, 1994, COGNITION, V53, P239, DOI 10.1016/0010-0277(94)90050-7; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Bartlett F.C., 1932, REMEMBERING STUDY EX; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Boring EG, 1916, J AM INST CRIM LAW C, V6, P820, DOI 10.2307/1133108; Buckner RL, 2000, ACTA PSYCHOL, V105, P127, DOI 10.1016/S0001-6918(00)00057-3; CARROLL JM, 1976, SCIENCE, V191, P1053, DOI 10.1126/science.1251216; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Davachi L, 2001, J COGNITIVE NEUROSCI, V13, P1059, DOI 10.1162/089892901753294356; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Dudai Y., 2002, MEMORY KEYWORDS CONC; EISENSTEIN S, 1947, FILM SENSE; Ferstl EC, 2005, J COGNITIVE NEUROSCI, V17, P724, DOI 10.1162/0898929053747658; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FRISK V, 1990, NEUROPSYCHOLOGIA, V28, P349, DOI 10.1016/0028-3932(90)90061-R; Furman O, 2007, LEARN MEMORY, V14, P457, DOI 10.1101/lm.550407; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; Hanson C, 1996, J COGNITIVE NEUROSCI, V8, P119, DOI 10.1162/jocn.1996.8.2.119; HANSON C, 1989, J EXP PSYCHOL GEN, V118, P136, DOI 10.1037/0096-3445.118.2.136; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kumaran D, 2005, J NEUROSCI, V25, P7254, DOI 10.1523/JNEUROSCI.1103-05.2005; MILNER B, 1958, Res Publ Assoc Res Nerv Ment Dis, V36, P244; Mitchell JP, 2008, CEREB CORTEX, V18, P262, DOI 10.1093/cercor/bhm051; Mitchell JP, 2004, J NEUROSCI, V24, P4912, DOI 10.1523/JNEUROSCI.0481-04.2004; Morin E., 2005, CINEMA IMAGINARY MAN; Nakamura K, 1996, BEHAV BRAIN RES, V77, P53, DOI 10.1016/0166-4328(95)00227-8; Neisser U., 1988, REMEMBERING RECONSID; Neisser Ulric., 1978, PRACTICAL ASPECTS ME, P3; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Ochsner KN, 2004, CURR OPIN NEUROBIOL, V14, P254, DOI 10.1016/j.conb.2004.03.011; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Puce A, 2007, NEUROPSYCHOLOGIA, V45, P93, DOI 10.1016/j.neuropsychologia.2006.04.017; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; SANQUIST TF, 1980, PSYCHOPHYSIOLOGY, V17, P568, DOI 10.1111/j.1469-8986.1980.tb02299.x; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Schmithorst VJ, 2006, NEUROIMAGE, V29, P254, DOI 10.1016/j.neuroimage.2005.07.020; Suddendorf T, 2005, LEARN MOTIV, V36, P110, DOI 10.1016/j.lmot.2005.02.010; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Uncapher MR, 2006, NEURON, V52, P547, DOI 10.1016/j.neuron.2006.08.011; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wilson SM, 2008, CEREB CORTEX, V18, P230, DOI 10.1093/cercor/bhm049; WINOCUR G, 1976, NEUROPSYCHOLOGIA, V14, P97, DOI 10.1016/0028-3932(76)90011-7; Xu J, 2005, NEUROIMAGE, V25, P1002, DOI 10.1016/j.neuroimage.2004.12.013; Zacks JM, 2001, PSYCHOL BULL, V127, P3, DOI 10.1037//0033-2909.127.1.3; Zacks JM, 2001, NAT NEUROSCI, V4, P651, DOI 10.1038/88486	63	181	183	4	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 7	2008	57	3					452	462		10.1016/j.neuron.2007.12.009	http://dx.doi.org/10.1016/j.neuron.2007.12.009			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261JQ	18255037	Green Accepted, Bronze			2022-12-24	WOS:000253075300014
J	Fouse, SD; Shen, Y; Pellegrini, M; Cole, S; Meissner, A; Van Neste, L; Jaenisch, R; Fan, GP				Fouse, Shaun D.; Shen, Yin; Pellegrini, Matteo; Cole, Steve; Meissner, Alexander; Van Neste, Leander; Jaenisch, Rudolf; Fan, Guoping			Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3K4/K27 trimethylation	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; X-LINKED GENES; DNA METHYLATION; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; TRANSCRIPTIONAL NETWORKS; EPIGENETIC REGULATION; MAMMALIAN DEVELOPMENT; GENOME	We report here genome-wide mapping of DNA methylation patterns at proximal promoter regions in mouse embryonic stem (mES) cells. Most methylated genes are differentiation associated and repressed in mES cells. By contrast, the unmethylated gene set includes many housekeeping and pluripotency genes. By crossreferencing methylation patterns to genome-wide mapping of histone H3 lysine (K) 4/27 trimethylation and binding of Oct4, Nanog, and Polycomb proteins on gene promoters, we found that promoter DNA methylation is the only marker of this group present on similar to 30% of genes, many of which are silenced in mES cells. In demethylated mutant mES cells, we saw upregulation of a subset of X-linked genes and developmental genes that are methylated in wild-type mES cells, but lack either H3K4 and H3K27 trimethylation or association with Polycomb, Oct4, or Nanog. Our data suggest that in mES cells promoter methylation represents a unique epigenetic program that complements other regulatory mechanisms to ensure appropriate gene expression.	[Fouse, Shaun D.; Shen, Yin; Fan, Guoping] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90095 USA; [Cole, Steve] Univ Calif Los Angeles, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Van Neste, Leander] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Whitehead Institute	Fan, GP (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.	gfan@mednet.ucla.edu	Albertini, David/AAD-3856-2021	Albertini, David/0000-0001-6536-2828; Pellegrini, Matteo/0000-0001-9355-9564; Fan, Guoping/0000-0001-5235-6410	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH070204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044405, R01NS051411, R56NS051411] Funding Source: NIH RePORTER; NIMH NIH HHS [F31 MH070204, 1F31MH070204] Funding Source: Medline; NINDS NIH HHS [R01 NS044405-05, R01 NS044405, R56 NS051411, R01 NS051411, NS051411, NS044405, R01 NS051411-03] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Chuang JC, 2005, MOL CANCER THER, V4, P1515, DOI 10.1158/1535-7163.MCT-05-0172; CROSS SH, 1994, NAT GENET, V6, P236, DOI 10.1038/ng0394-236; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Feng JA, 2007, PEDIATR RES, V61, p58R, DOI 10.1203/pdr.0b013e3180457635; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hattori N, 2004, GENOME RES, V14, P1733, DOI 10.1101/gr.2431504; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kremenskoy M, 2003, BIOCHEM BIOPH RES CO, V311, P884, DOI 10.1016/j.bbrc.2003.10.078; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; MacLean JA, 2005, CELL, V120, P369, DOI 10.1016/j.cell.2004.12.022; MacLean JA, 2006, GENESIS, V44, P122, DOI 10.1002/gene.20193; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Panning B, 1996, GENE DEV, V10, P1991, DOI 10.1101/gad.10.16.1991; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Shen Y, 2006, HUM MOL GENET, V15, P2623, DOI 10.1093/hmg/ddl188; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; ZIBERMAN D, 2007, NAT GENET, V39, P61	55	332	340	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB	2008	2	2					160	169		10.1016/j.stem.2007.12.011	http://dx.doi.org/10.1016/j.stem.2007.12.011			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	264PW	18371437	Green Accepted, Bronze			2022-12-24	WOS:000253301900011
J	Vyazovskiy, VV; Cirelli, C; Pfister-Genskow, M; Faraguna, U; Tononi, G				Vyazovskiy, Vladyslav V.; Cirelli, Chiara; Pfister-Genskow, Martha; Faraguna, Ugo; Tononi, Giulio			Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPUS IN-VIVO; CORTICAL SYNCHRONIZATION; RECEPTOR TRAFFICKING; SLOW WAVES; BRAIN TEMPERATURE; AMPA RECEPTORS; PLASTICITY; RAT; HOMEOSTASIS	Plastic changes occurring during wakefulness aid in the acquisition and consolidation of memories. For some memories, further consolidation requires sleep, but whether plastic processes during wakefulness and sleep differ is unclear. We show that, in rat cortex and hippocampus, GluR1-containing AMPA receptor ( AMPAR) levels are high during wakefulness and low during sleep, and changes in the phosphorylation states of AMPARs, CamKII and GSK3 beta are consistent with synaptic potentiation during wakefulness and depression during sleep. Furthermore, slope and amplitude of cortical evoked responses increase after wakefulness, decrease after sleep and correlate with changes in slow-wave activity, a marker of sleep pressure. Changes in molecular and electrophysiological indicators of synaptic strength are largely independent of the time of day. Finally, cortical long-term potentiation can be easily induced after sleep, but not after wakefulness. Thus, wakefulness appears to be associated with net synaptic potentiation, whereas sleep may favor global synaptic depression, thereby preserving an overall balance of synaptic strength.	[Vyazovskiy, Vladyslav V.; Cirelli, Chiara; Pfister-Genskow, Martha; Faraguna, Ugo; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; [Faraguna, Ugo] Scuola Normale S Anna, I-56127 Pisa, Italy	University of Wisconsin System; University of Wisconsin Madison	Cirelli, C (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	ccirelli@wisc.edu; gtononi@wisc.edu	Tononi, Giulio/B-8387-2009; Faraguna, Ugo/J-6805-2012	Faraguna, Ugo/0000-0002-4814-7218; Vyazovskiy, Vladyslav/0000-0002-4336-6681	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER; NIH HHS [DP1 OD000579] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Borbely A.A., 2005, PRINCIPLES PRACTICE; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; CAIN DP, 1994, BRAIN RES, V658, P135, DOI 10.1016/S0006-8993(09)90019-1; Campbell IG, 2002, J NEUROPHYSIOL, V88, P1073, DOI 10.1152/jn.2002.88.2.1073; Cirelli C, 2000, J NEUROSCI, V20, P9187; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; CZAMECKI A, 2007, J PHYSIOL-LONDON, V578, P471; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; Fox CJ, 2006, HIPPOCAMPUS, V16, P907, DOI 10.1002/hipo.20230; GEOL A, 2006, NAT NEUROSCI, V9, P1001; GIUDITTA A, 1995, BEHAV BRAIN RES, V69, P157, DOI 10.1016/0166-4328(95)00012-I; Glazewski S, 1998, NEUROPHARMACOLOGY, V37, P581, DOI 10.1016/S0028-3908(98)00039-2; HALL RD, 1970, EXP BRAIN RES, V11, P93; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Kauer JA, 2006, NAT NEUROSCI, V9, P593, DOI 10.1038/nn0506-593; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kopp C, 2006, J NEUROSCI, V26, P12456, DOI 10.1523/JNEUROSCI.2702-06.2006; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McDermott CM, 2003, J NEUROSCI, V23, P9687; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; RACINE RJ, 1995, BRAIN RES, V702, P87, DOI 10.1016/0006-8993(95)01025-0; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Steriade M, 1976, Prog Neurobiol, V6, P155; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 2005, BRAINSTEM CONTROL WA, P728; Tartar JL, 2006, EUR J NEUROSCI, V23, P2739, DOI 10.1111/j.1460-9568.2006.04808.x; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2007, SLEEP, V30, P1631, DOI 10.1093/sleep/30.12.1631; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	50	534	545	2	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					200	208		10.1038/nn2035	http://dx.doi.org/10.1038/nn2035			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18204445				2022-12-24	WOS:000252712100014
J	Haefner, RM; Cumming, BG				Haefner, Ralf M.; Cumming, Bruce G.			Adaptation to natural binocular disparities in primate V1 explained by a generalized energy model	NEURON			English	Article							CATS VISUAL-CORTEX; HORIZONTAL-DISPARITY; RECEPTIVE-FIELDS; COMPLEX CELLS; NEURAL MECHANISMS; MACAQUE V1; DEPTH DISCRIMINATION; OCULAR DOMINANCE; STRIATE CORTEX; NEURONS	Sensory processing in the brain is thought to have evolved to encode naturally occurring stimuli efficiently. We report an adaptation in binocular cortical neurons that reflects the tight constraints imposed by the geometry of 3D vision. We show that the widely used binocular energy model predicts that neurons dedicate part of their dynamic range to impossible combinations of left and right images. Approximately 42% of the neurons we record from V1 of awake monkeys behave in this way (a powerful confirmation of the model), while about 58% deviate from the model in a manner that concentrates more of their dynamic range on stimuli that obey the constraints of binocular geometry. We propose a simple extension of the energy model, using multiple subunits, that explains the adaptation we observe, as well as other properties of binocular neurons that have been hard to account for, such as the response to anticorrelated stereograms.	[Haefner, Ralf M.; Cumming, Bruce G.] NEI, NIH, Sensorimotor Res Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Haefner, RM (corresponding author), NEI, NIH, Sensorimotor Res Lab, 49 Convent Dr,Bldg 49-2A50, Bethesda, MD 20892 USA.	ralf.haefner@gmail.com	Haefner, Ralf/C-3996-2009	Haefner, Ralf M/0000-0002-5031-0379	Intramural NIH HHS [Z01 EY000404-06] Funding Source: Medline; NATIONAL EYE INSTITUTE [Z01EY000404] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Anzai A, 1999, J NEUROPHYSIOL, V82, P891, DOI 10.1152/jn.1999.82.2.891; Anzai A, 1999, J NEUROPHYSIOL, V82, P874, DOI 10.1152/jn.1999.82.2.874; Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; BLAKEMORE C, 1971, SCIENCE, V171, P286, DOI 10.1126/science.171.3968.286; Bredfeldt CE, 2002, J NEUROSCI, V22, P1976, DOI 10.1523/JNEUROSCI.22-05-01976.2002; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; CORMACK LK, 1993, VISUAL NEUROSCI, V10, P585, DOI 10.1017/S0952523800005290; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; Cumming BG, 2002, NATURE, V418, P633, DOI 10.1038/nature00909; DEANGELIS GC, 1991, NATURE, V352, P156, DOI 10.1038/352156a0; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fleet DJ, 1996, VISION RES, V36, P1839, DOI 10.1016/0042-6989(95)00313-4; FREEMAN RD, 1990, VISION RES, V30, P1661, DOI 10.1016/0042-6989(90)90151-A; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; LEVAY S, 1988, VISUAL NEUROSCI, V1, P395, DOI 10.1017/S0952523800004168; Lippert J, 2001, NEUROREPORT, V12, P3205, DOI 10.1097/00001756-200110290-00013; Nieder A, 2000, J NEUROPHYSIOL, V83, P2967, DOI 10.1152/jn.2000.83.5.2967; Nieder A, 2001, J NEUROSCI, V21, P4514, DOI 10.1523/JNEUROSCI.21-12-04514.2001; NIKARA T, 1968, EXP BRAIN RES, V6, P353; Ning QA, 1997, NEURON, V18, P359, DOI 10.1016/S0896-6273(00)81238-6; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P243, DOI 10.1152/jn.1986.56.1.243; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P221, DOI 10.1152/jn.1986.56.1.221; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; POGGIO GF, 1988, J NEUROSCI, V8, P4531; POGGIO GF, 1995, CEREB CORTEX, V5, P193, DOI 10.1093/cercor/5.3.193; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; Prince SJD, 2002, J NEUROPHYSIOL, V87, P209, DOI 10.1152/jn.00466.2000; Read JCA, 2004, NEURAL COMPUT, V16, P1983, DOI 10.1162/0899766041732440; Read JCA, 2004, J NEUROPHYSIOL, V91, P1271, DOI 10.1152/jn.00588.2003; Read JCA, 2002, VISUAL NEUROSCI, V19, P735, DOI 10.1017/S0952523802196052; Read JCA, 2003, J NEUROPHYSIOL, V90, P946, DOI 10.1152/jn.01068.2002; Read JCA, 2007, NAT NEUROSCI, V10, P1322, DOI 10.1038/nn1951; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Smith EL, 1997, J NEUROPHYSIOL, V78, P351, DOI 10.1152/jn.1997.78.1.351; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; WAGNER H, 1993, NATURE, V364, P796, DOI 10.1038/364796a0	46	43	48	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 10	2008	57	1					147	158		10.1016/j.neuron.2007.10.042	http://dx.doi.org/10.1016/j.neuron.2007.10.042			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	250YZ	18184571	Green Accepted, Bronze			2022-12-24	WOS:000252338600016
J	Brack, AS; Conboy, IM; Conboy, MJ; Shen, J; Rando, TA				Brack, Andrew S.; Conboy, Irina M.; Conboy, Michael J.; Shen, Jeanne; Rando, Thomas A.			A temporal switch from Notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis	CELL STEM CELL			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; MFA-MEDIATED SUPPRESSION; BETA-CATENIN; SKELETAL-MUSCLE; SATELLITE CELLS; SELF-RENEWAL; P19 CELLS; KINASE; DIFFERENTIATION; FATE	The temporal switch from progenitor cell proliferation to differentiation is essential for effective adult tissue repair. We previously reported the critical role of Notch signaling in the proliferative expansion of myogenic progenitors in mammalian postnatal myogenesis. We now show that the onset of differentiation is due to a transition from Notch signaling to Wnt signaling in myogenic progenitors and is associated with an increased expression of Wnt in the tissue and an increased responsiveness of progenitors to Wnt. Crosstalk between these two pathways occurs via GSK3 beta, which is maintained in an active form by Notch but is inhibited by Wnt in the canonical Wnt signaling cascade. These results demonstrate that the temporal balance between Notch and Wnt signaling orchestrates the precise progression of muscle precursor cells along the myogenic lineage pathway, through stages of proliferative expansion and then differentiation, during postnatal myogenesis.	[Brack, Andrew S.; Conboy, Irina M.; Conboy, Michael J.; Shen, Jeanne; Rando, Thomas A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Surg, Stanford, CA 94305 USA; [Rando, Thomas A.] VA Palo Alto Hlth Care Syst, GRECC & Neurol Serv, Palo Alto, CA 94304 USA	Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Surg, Stanford, CA 94305 USA.	rando@stanford.edu		Rando, Thomas/0000-0001-5843-8564	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023806, F32AG005902, R37AG023806] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000392] Funding Source: NIH RePORTER; NIA NIH HHS [F32 AG005902, R01 AG023806, AG23806, AG05902] Funding Source: Medline; NIH HHS [DP1 OD000392] Funding Source: Medline; NINDS NIH HHS [R01 NS036409, NS36409] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Charge SBP, 2002, AM J PHYSIOL-CELL PH, V283, pC1228, DOI 10.1152/ajpcell.00206.2002; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; Holowacz T, 2006, DEV DYNAM, V235, P633, DOI 10.1002/dvdy.20672; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kim L, 2002, DEV CELL, V3, P523, DOI 10.1016/S1534-5807(02)00269-1; Kim L, 2000, CURR OPIN GENET DEV, V10, P508, DOI 10.1016/S0959-437X(00)00120-9; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Pan WJ, 2006, J CELL SCI, V119, P4850, DOI 10.1242/jcs.03257; Pan WJ, 2005, P NATL ACAD SCI USA, V102, P17378, DOI 10.1073/pnas.0505922102; Patel S, 2004, BIOCHEM SOC T, V32, P803, DOI 10.1042/BST0320803; Petropoulos H, 2002, J BIOL CHEM, V277, P15393, DOI 10.1074/jbc.M112141200; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; ROSENBLATT JD, 1995, CELL DEV BIOL, V31, P773, DOI DOI 10.1007/BF02634119; RUEL L, 1993, NATURE, V362, P557, DOI 10.1038/362557a0; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; WANG QM, 1994, J BIOL CHEM, V269, P14566; Wesley CS, 1999, MOL CELL BIOL, V19, P5743; Yuan HD, 1999, J BIOL CHEM, V274, P30419, DOI 10.1074/jbc.274.43.30419; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653; Zhao P, 2004, DEV DYNAM, V229, P380, DOI 10.1002/dvdy.10457	36	438	462	1	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN	2008	2	1					50	59		10.1016/j.stem.2007.10.006	http://dx.doi.org/10.1016/j.stem.2007.10.006			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	254RT	18371421	Bronze			2022-12-24	WOS:000252606400011
J	Olveczky, BP; Baccus, SA; Meister, M				Oelveczky, Bence P.; Baccus, Stephen A.; Meister, Markus			Retinal adaptation to object motion	NEURON			English	Article							TEMPORAL CONTRAST ADAPTATION; VISUAL CORTICAL-NEURONS; GANGLION-CELLS; BIPOLAR CELLS; SELECTIVE ADAPTATION; VARIANCE ADAPTATION; SYNAPTIC DEPRESSION; TIME-COURSE; IN-VIVO; SALAMANDER	Due to fixational eye movements, the image on the retina is always in motion, even when one views a stationary scene. When an object moves within the scene, the corresponding patch of retina experiences a different motion trajectory than the surrounding region. Certain retinal ganglion cells respond selectively to this condition, when the motion in the cell's receptive field center is different from that in the surround. Here we show that this response is strongest at the very onset of differential motion, followed by gradual adaptation with a time course of several seconds. Different subregions of a ganglion cell's receptive field can adapt independently. The circuitry responsible for differential motion adaptation lies in the inner retina. Several candidate mechanisms were tested, and the adaptation most likely results from synaptic depression at the synapse from bipolar to ganglion cell. Similar circuit mechanisms may act more generally to emphasize novel features of a visual stimulus.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Meister, M (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	meister@fas.harvard.edu		Olveczky, Bence/0000-0003-2499-2705; Meister, Markus/0000-0003-2136-6506	NATIONAL EYE INSTITUTE [R01EY014737, R01EY010020] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY010020-08A1, R01 EY014737, R01 EY010020, R01 EY014737-02, R01 EY010020-07, R01 EY014737-01, R01 EY014737-03, R01 EY010020-09, R01 EY010020-10, R01 EY014737-04, R01 EY010020-11, R01 EY014737-05, R01 EY010020-06] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abrams RA, 2003, PSYCHOL SCI, V14, P427, DOI 10.1111/1467-9280.01458; Aizenman CD, 2000, PROG BRAIN RES, V124, P257; [Anonymous], EYE MOVEMENTS THEIR; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; BARLOW HB, 1963, NATURE, V200, P1345, DOI 10.1038/2001345a0; Barlow HB., 1990, VISION CODING EFFICI, P363; Best AR, 2004, J NEUROSCI, V24, P652, DOI 10.1523/JNEUROSCI.4220-03.2004; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; Chance FS, 1998, J NEUROSCI, V18, P4785; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Clifford CWG, 2002, PROG NEUROBIOL, V68, P409, DOI 10.1016/S0301-0082(02)00154-5; Cook PB, 1998, J NEUROSCI, V18, P2301; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; Engbert R, 2004, PSYCHOL SCI, V15, P431, DOI 10.1111/j.0956-7976.2004.00697.x; ENROTHCU.C, 1973, J PHYSIOL-LONDON, V233, P271, DOI 10.1113/jphysiol.1973.sp010308; GIASCHI D, 1993, J NEUROPHYSIOL, V70, P2024, DOI 10.1152/jn.1993.70.5.2024; Gollisch T, 2004, J NEUROSCI, V24, P7435, DOI 10.1523/JNEUROSCI.0398-04.2004; Hare WA, 1996, J NEUROPHYSIOL, V76, P2005, DOI 10.1152/jn.1996.76.3.2005; Hoffmann M, 1999, VISION RES, V39, P437, DOI 10.1016/S0042-6989(98)00186-2; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Manookin MB, 2006, NEURON, V50, P453, DOI 10.1016/j.neuron.2006.03.039; MANTEUFFEL G, 1977, NATURWISSENSCHAFTEN, V64, P533, DOI 10.1007/BF00483559; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MCGUIRE BA, 1984, J NEUROSCI, V4, P2920; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SKAVENSKI AA, 1979, VISION RES, V19, P675, DOI 10.1016/0042-6989(79)90243-8; SMIMAKIS SM, 1997, NATURE, V386, P69; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; Van Wezel RJA, 2002, J NEUROPHYSIOL, V88, P3469, DOI 10.1152/jn.00276.2002; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; VU ET, 1992, SCIENCE, V255, P1710, DOI 10.1126/science.1553559; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336	42	51	51	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	NOV 21	2007	56	4					689	700		10.1016/j.neuron.2007.09.030	http://dx.doi.org/10.1016/j.neuron.2007.09.030			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	236MH	18031685	Green Accepted, Bronze			2022-12-24	WOS:000251306600011
J	Sun, P; Ueno, K; Waggoner, RA; Gardner, JL; Tanaka, K; Cheng, K				Sun, Pei; Ueno, Kenichi; Waggoner, R. Allen; Gardner, Justin L.; Tanaka, Keiji; Cheng, Kang			A temporal frequency-dependent functional architecture in human V1 revealed by high-resolution fMRI	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE COLUMNS; PRIMARY VISUAL-CORTEX; MONKEY; CAT; SELECTIVITY; CONTRAST; NEURONS; MAPS	Although cortical neurons with similar functional properties often cluster together in a columnar organization, only ocular dominance columns, the columnar structure representing segregated anatomical input (from one of the two eyes), have been found in human primary visual cortex (V1). It has yet to be shown whether other columnar organizations that arise only from differential responses to stimulus properties also exist in human V1. Using high-resolution functional magnetic resonance imaging, we have found such a functional architecture containing domains that respond preferentially to either low or high temporal frequency.	RIKEN, Brain Sci Inst, Lab Cognit Braion Mapping, Wako, Saitama 3510198, Japan; NYU, Ctr Neural Sci, New York, NY 10003 USA; NYU, Dept Psychol, New York, NY 10003 USA	RIKEN; New York University; New York University	Sun, P (corresponding author), RIKEN, Brain Sci Inst, Lab Cognit Braion Mapping, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	psun@brain.riken.jp	Waggoner, Allen/F-2654-2010; Cheng, Kang/A-6448-2016; Sun, Pei/B-5191-2013; Ueno, Kenichi/A-9395-2014; Tanaka, Keiji/N-5917-2015	Waggoner, Allen/0000-0002-4921-7521; Sun, Pei/0000-0003-4184-1079; Tanaka, Keiji/0000-0002-1910-3427; Gardner, Justin/0000-0003-2220-5050				Baker TI, 2005, J NEUROPHYSIOL, V94, P775, DOI 10.1152/jn.01093.2004; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; Carandini M, 2004, J VISION, V4, P130, DOI 10.1167/4.3.1; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; Grinvald A, 2000, NAT NEUROSCI, V3, P105, DOI 10.1038/72045; HAMMETT ST, 1992, VISION RES, V32, P285, DOI 10.1016/0042-6989(92)90139-A; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; HORTON JC, 1990, ARCH OPHTHALMOL-CHIC, V108, P1025, DOI 10.1001/archopht.1990.01070090127054; ROJER AS, 1990, BIOL CYBERN, V62, P381, DOI 10.1007/BF00197644; Shmuel A, 2007, NEUROIMAGE, V35, P539, DOI 10.1016/j.neuroimage.2006.12.030; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; TOOTELL RBH, 1988, J NEUROSCI, V8, P1594; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3	15	41	41	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1404	1406		10.1038/nn1983	http://dx.doi.org/10.1038/nn1983			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17934459				2022-12-24	WOS:000250508400017
J	Pocock, R; Hobert, O				Pocock, Roger; Hobert, Oliver			Oxygen levels affect axon guidance and neuronal migration in Caenorhabditis elegans	NATURE NEUROSCIENCE			English	Article							HYPOXIA-INDUCIBLE FACTOR; C-ELEGANS; RECEPTOR; DAF-2; MAINTENANCE; HOMEOSTASIS; EXPRESSION; LONGEVITY; OUTGROWTH; PROTEIN	Oxygen deprivation can cause severe defects in human brain development, yet the precise cellular and molecular consequences of varying oxygen levels on nervous system development are unknown. We found that hypoxia caused specific axon pathfinding and neuronal migration defects in C. elegans that result from the stabilization of the transcription factor HIF-1 (hypoxia-inducible factor 1) in neurons and muscle. Stabilization of HIF-1 through removal of the proteasomal HIF-1 degradatory pathway phenocopies the hypoxia-induced neuronal defects. Hypoxia-mediated defects in nervous system development depended on signaling through the insulin-like receptor DAF-2, which serves to control the level of reactive oxygen species that also affects axon pathfinding. Hypoxia exerted its effect on axon pathfinding, at least in part, through HIF-1-dependent regulation of the Eph receptor VAB-1. HIF-1 mediated upregulation of VAB-1 protected embryos from hypoxia-induced lethality, but increased VAB-1 levels elicited aberrant axon pathfinding. Similar genetic pathways may cause aberrant human brain development under hypoxic conditions.	[Pocock, Roger; Hobert, Oliver] Columbia Univ, Ctr Med, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Pocock, R (corresponding author), Columbia Univ, Ctr Med, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	rp2184@columbia.edu; or38@columbia.edu	Pocock, Roger/AAQ-8526-2020	Pocock, Roger/0000-0002-5515-3608; Hobert, Oliver/0000-0002-7634-2854	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Arpino Carla, 2005, Ann Ist Super Sanita, V41, P229; Berger R, 1999, BRAIN RES REV, V30, P107, DOI 10.1016/S0165-0173(99)00009-0; Bishop T, 2004, PLOS BIOL, V2, P1549, DOI 10.1371/journal.pbio.0020289; Boulin T, 2006, CURR BIOL, V16, P1871, DOI 10.1016/j.cub.2006.08.056; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Bulow HE, 2004, NEURON, V42, P367, DOI 10.1016/S0896-6273(04)00246-6; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; El-Khodor BF, 2000, BEHAV BRAIN RES, V107, P171, DOI 10.1016/S0166-4328(99)00119-9; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Hobert O, 2003, CURR OPIN NEUROBIOL, V13, P70, DOI 10.1016/S0959-4388(03)00002-3; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Inder T E, 2000, Semin Neonatol, V5, P3, DOI 10.1053/siny.1999.0112; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; O'Driscoll CM, 2005, NEUROSCIENCE, V131, P321, DOI 10.1016/j.neuroscience.2004.11.015; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Ratcliffe PJ, 2000, NAT MED, V6, P1315, DOI 10.1038/82113; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Shen C, 2003, ANN NY ACAD SCI, V995, P191, DOI 10.1111/j.1749-6632.2003.tb03222.x; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; VANFLETEREN JR, 1995, FASEB J, V9, P1355, DOI 10.1096/fasebj.9.13.7557026; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje	28	71	88	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					894	900		10.1038/nn.2152	http://dx.doi.org/10.1038/nn.2152			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18587389				2022-12-24	WOS:000257969100014
J	Lagali, PS; Balya, D; Awatramani, GB; Munch, TA; Kim, DS; Busskamp, V; Cepko, CL; Roska, B				Lagali, Pamela S.; Balya, David; Awatramani, Gautam B.; Muench, Thomas A.; Kim, Douglas S.; Busskamp, Volker; Cepko, Constance L.; Roska, Botond			Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration	NATURE NEUROSCIENCE			English	Article							GANGLION-CELLS; MAMMALIAN RETINA; INNER RETINA; LATERAL INHIBITION; WILD-TYPE; MOUSE; VISION; RESPONSES; MICE; NEURONS	Genetically encoded optical neuromodulators create an opportunity for circuit-specific intervention in neurological diseases. One of the diseases most amenable to this approach is retinal degeneration, where the loss of photoreceptors leads to complete blindness. To restore photosensitivity, we genetically targeted a light-activated cation channel, channelrhodopsin-2, to second-order neurons, ON bipolar cells, of degenerated retinas in vivo in the Pde6b(rd1) (also known as rd1) mouse model. In the absence of 'classical' photoreceptors, we found that ON bipolar cells that were engineered to be photosensitive induced light-evoked spiking activity in ganglion cells. The rescue of light sensitivity was selective to the ON circuits that would naturally respond to increases in brightness. Despite degeneration of the outer retina, our intervention restored transient responses and center-surround organization of ganglion cells. The resulting signals were relayed to the visual cortex and were sufficient for the animals to successfully perform optomotor behavioral tasks.	[Lagali, Pamela S.; Balya, David; Awatramani, Gautam B.; Muench, Thomas A.; Busskamp, Volker; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland; [Kim, Douglas S.; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Kim, Douglas S.; Cepko, Constance L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Friedrich Miescher Institute for Biomedical Research; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Maulbeerstr 66, CH-4058 Basel, Switzerland.	botond.roska@fmi.ch	Busskamp, Volker/E-6339-2015; Roska, Botond/AAD-7268-2021	Busskamp, Volker/0000-0001-7517-8944; Munch, Thomas/0000-0002-8884-6961; Kim, Douglas/0000-0001-9029-314X	NEI NIH HHS [R01 EY008064] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008064] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Awatramani GB, 2000, J NEUROSCI, V20, P7087, DOI 10.1523/JNEUROSCI.20-18-07087.2000; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; BELGUM JH, 1987, J PHYSIOL-LONDON, V388, P233, DOI 10.1113/jphysiol.1987.sp016612; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; COLLINS RD, 1995, J NEUROSCI METH, V60, P95, DOI 10.1016/0165-0270(94)00224-5; Cook PB, 1998, NAT NEUROSCI, V1, P714, DOI 10.1038/3714; Dedek K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001714; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; FARBER DB, 1994, PROG RETIN EYE RES, V13, P31, DOI 10.1016/1350-9462(94)90004-3; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Gianfranceschi L, 1999, VISION RES, V39, P569, DOI 10.1016/S0042-6989(98)00169-2; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Ma YP, 2005, VISUAL NEUROSCI, V22, P119, DOI 10.1017/S0952523805222010; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mao BQ, 1998, VISUAL NEUROSCI, V15, P425; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsui K, 1998, J NEUROSCI, V18, P4500; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Pang JJ, 2004, J PHYSIOL-LONDON, V558, P249, DOI 10.1113/jphysiol.2004.063503; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Shields CR, 2003, J NEUROPHYSIOL, V89, P2449, DOI 10.1152/jn.00916.2002; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Strettoi E, 2002, J NEUROSCI, V22, P5492; Strettoi E, 2003, VISION RES, V43, P867, DOI 10.1016/S0042-6989(02)00594-1; Taylor WR, 1999, VISUAL NEUROSCI, V16, P285, DOI 10.1017/S0952523899162096; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Weiland JD, 2005, ANNU REV BIOMED ENG, V7, P361, DOI 10.1146/annurev.bioeng.7.060804.100435; Wong AA, 2006, GENES BRAIN BEHAV, V5, P389, DOI 10.1111/j.1601-183X.2005.00173.x; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996	50	400	434	1	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2008	11	6					667	675		10.1038/nn.2117	http://dx.doi.org/10.1038/nn.2117			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304UD	18432197				2022-12-24	WOS:000256133700013
J	Griffiths, S; Scott, H; Glover, C; Bienemann, A; Ghorbel, MT; Uney, J; Brown, MW; Warburton, EC; Bashir, ZI				Griffiths, Sarah; Scott, Helen; Glover, Colin; Bienemann, Alison; Ghorbel, Mohamed T.; Uney, James; Brown, Malcolm W.; Warburton, E. Clea; Bashir, Zafar I.			Expression of long-term depression underlies visual recognition memory	NEURON			English	Article							DEPENDENT SYNAPTIC PLASTICITY; AMPA RECEPTOR TRAFFICKING; PERIRHINAL CORTEX; NMDA-RECEPTORS; POTENTIATION; TRANSMISSION; FAMILIARITY; IMPAIRMENT; ENDOCYTOSIS; ABLATIONS	The modifications occurring in the brain during learning and memory are still poorly understood but may involve long-lasting changes in synaptic transmission (synaptic plasticity). In perirhinal cortex, a lasting decrement in neuronal responsiveness is associated with visual familiarity discrimination, leading to the hypothesis that long-term depression (LTD)-like synaptic plasticity may underlie recognition memory. LTD relies on internalization of AMPA receptors (AMPARs) through interaction between their GluR2 subunits and AP2, the clathrin adaptor protein required for endocytosis. We demonstrate that a peptide that blocks interactions between GluR2 and AP2 blocks LTD in perirhinal cortex in vitro. Viral transduction of this peptide in perirhinal cortex produced striking deficits in visual recognition memory. Furthermore, there was a deficit of LTD in perirhinal cortex slices from virally transduced, recognition memory-deficient animals. These results suggest that internalization of AMPA receptors, a process critical for the expression of LTD in perirhinal cortex, underlies visual recognition memory.	[Griffiths, Sarah; Scott, Helen; Ghorbel, Mohamed T.; Brown, Malcolm W.; Warburton, E. Clea; Bashir, Zafar I.] Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; [Scott, Helen; Glover, Colin; Bienemann, Alison; Uney, James] Univ Bristol, Henry Wellcome Labs Integrat Neurosci, Bristol BS1 3NY, Avon, England; [Glover, Colin] GlaxoSmithKline, Psychiat DTG, Harlow CM19 5AW, Essex, England; [Ghorbel, Mohamed T.] Bristol Royal Infirm & Gen Hosp, Bristol Heart Inst, Bristol BS2 8HW, Avon, England	University of Bristol; University of Bristol; GlaxoSmithKline; Bristol Royal Infirmary; University of Bristol	Bashir, ZI (corresponding author), Univ Bristol, Dept Anat, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.	z.i.bashir@bristol.ac.uk	Scott, Helen L/A-6307-2009; Warburton, Elizabeth Clea/B-4044-2019	Scott, Helen L/0000-0003-2656-4034; Warburton, Elizabeth Clea/0000-0002-2129-2060; Bashir, Zafar/0000-0003-3650-2136	Medical Research Council [G9713086, G0401403] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [G0601841B] Funding Source: researchfish; MRC [G9713086, G0401403] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; Abraham WC, 2002, J NEUROSCI, V22, P9626; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; BROWN MW, 1987, BRAIN RES, V409, P158, DOI 10.1016/0006-8993(87)90753-0; Brown MW, 2002, PHILOS T R SOC B, V357, P1083, DOI 10.1098/rstb.2002.1097; Burwell RD, 2001, J COMP NEUROL, V437, P17, DOI 10.1002/cne.1267; Cain DP, 1996, REV NEUROSCIENCE, V7, P215; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Cho K, 2000, NAT NEUROSCI, V3, P150, DOI 10.1038/72093; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 1996, BEHAV BRAIN RES, V80, P9, DOI 10.1016/0166-4328(96)00006-X; FAHY FL, 1993, EXP BRAIN RES, V96, P457; GAFFAN D, 1992, BEHAV NEUROSCI, V106, P30, DOI 10.1037/0735-7044.106.1.30; Gerlai R, 1998, BEHAV BRAIN RES, V95, P37, DOI 10.1016/S0166-4328(98)00002-3; Henley JM, 2003, NEUROSCI RES, V45, P243, DOI 10.1016/S0168-0102(02)00229-8; Howarth JL, 2007, MOL THER, V15, P1100, DOI 10.1038/sj.mt.6300163; IZQUIERDO I, 1995, NEUROBIOL LEARN MEM, V63, P19, DOI 10.1006/nlme.1995.1002; Kemp A, 2007, TRENDS NEUROSCI, V30, P111, DOI 10.1016/j.tins.2007.01.002; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Kittler JT, 2005, P NATL ACAD SCI USA, V102, P14871, DOI 10.1073/pnas.0506653102; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Maren S, 2005, NEURON, V47, P783, DOI 10.1016/j.neuron.2005.08.009; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Murray EA, 1999, TRENDS COGN SCI, V3, P142, DOI 10.1016/S1364-6613(99)01303-0; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Suzuki WA, 1996, CURR OPIN NEUROBIOL, V6, P179, DOI 10.1016/S0959-4388(96)80071-7; SUZUKI WA, 1993, J NEUROSCI, V13, P2430, DOI 10.1523/JNEUROSCI.13-06-02430.1993; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Warburton EC, 2003, NEURON, V38, P987, DOI 10.1016/S0896-6273(03)00358-1; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Zhu XO, 1996, NEUROREPORT, V7, P1871, DOI 10.1097/00001756-199607290-00037; Ziakopoulos Z, 1999, NEUROSCIENCE, V92, P459, DOI 10.1016/S0306-4522(98)00764-7	58	117	118	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 24	2008	58	2					186	194		10.1016/j.neuron.2008.02.022	http://dx.doi.org/10.1016/j.neuron.2008.02.022			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292YX	18439404	Bronze			2022-12-24	WOS:000255303100007
J	Liu, F; Day, M; Muniz, LC; Bitran, D; Arias, R; Revilla-Sanchez, R; Grauer, S; Zhang, G; Kelley, C; Pulito, V; Sung, A; Mervis, RF; Navarra, R; Hirst, WD; Reinhart, PH; Marquis, KL; Moss, SJ; Pangalos, MN; Brandon, NJ				Liu, Feng; Day, Mark; Muniz, Luis C.; Bitran, Daniel; Arias, Robert; Revilla-Sanchez, Raquel; Grauer, Steve; Zhang, Guoming; Kelley, Cody; Pulito, Virginia; Sung, Amy; Mervis, Ronald F.; Navarra, Rachel; Hirst, Warren D.; Reinhart, Peter H.; Marquis, Karen L.; Moss, Stephen J.; Pangalos, Menelas N.; Brandon, Nicholas J.			Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CA1 PYRAMIDAL CELLS; DENDRITIC SPINE DENSITY; ELEMENT-BINDING PROTEIN; SPATIAL MEMORY; INHIBITORY AVOIDANCE; MESSENGER-RNA; FEMALE MICE; RAT-BRAIN; ADULT-RAT	Estrogens have long been implicated in influencing cognitive processes, yet the molecular mechanisms underlying these effects and the roles of the estrogen receptors alpha (ER alpha) and beta (ER beta) remain unclear. Using pharmacological, biochemical and behavioral techniques, we demonstrate that the effects of estrogen on hippocampal synaptic plasticity and memory are mediated through ER beta. Selective ER beta agonists increased key synaptic proteins in vivo, including PSD-95, synaptophysin and the AMPA-receptor subunit GluR1. These effects were absent in ER beta knockout mice. In hippocampal slices, ER beta activation enhanced long-term potentiation, an effect that was absent in slices from ER beta knockout mice. ER beta activation induced morphological changes in hippocampal neurons in vivo, including increased dendritic branching and increased density of mushroom-type spines. An ER beta agonist, but not an ER alpha agonist, also improved performance in hippocampus-dependent memory tasks. Our data suggest that activation of ER beta can regulate hippocampal synaptic plasticity and improve hippocampus-dependent cognition.	[Bitran, Daniel] Coll Holy Cross, Dept Psychol, Worcester, MA 01610 USA; [Revilla-Sanchez, Raquel; Moss, Stephen J.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Mervis, Ronald F.] Univ S Florida, Ctr Excellence Aging & Brain Repair, Neurostruct Res Labs Inc, Tampa, FL 33637 USA	College of the Holy Cross; University of Pennsylvania; State University System of Florida; University of South Florida		daym1@wyeth.com; liuf2@wyeth.com		Brandon, Nicholas/0000-0002-3917-0096; Hirst, Warren/0000-0003-0389-8891	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046478, P01NS054900, R01NS056359, R01NS051195, R01NS048045] Funding Source: NIH RePORTER; Medical Research Council Funding Source: Medline; NINDS NIH HHS [NS056359, P01NS054900, NS051195, NS046478, NS048045] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MM, 2004, J COMP NEUROL, V474, P419, DOI 10.1002/cne.20148; Barco A, 2003, EXPERT OPIN THER TAR, V7, P101, DOI 10.1517/14728222.7.1.101; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boulware MI, 2005, J NEUROSCI, V25, P5066, DOI 10.1523/JNEUROSCI.1427-05.2005; Cyr M, 2001, NEUROPSYCHOPHARMACOL, V25, P242, DOI 10.1016/S0893-133X(01)00233-0; Day M, 2005, BEHAV BRAIN RES, V164, P128, DOI 10.1016/j.bbr.2005.05.011; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Frye CA, 2002, BRAIN RES, V956, P285, DOI 10.1016/S0006-8993(02)03559-X; Gazzaley AH, 1996, J NEUROSCI, V16, P6830; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; Herrick SP, 2006, BRAIN RES, V1121, P46, DOI 10.1016/j.brainres.2006.08.084; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Lee SJ, 2004, NEUROSCIENCE, V124, P549, DOI 10.1016/j.neuroscience.2003.11.035; Lein PJ, 2007, ENVIRON HEALTH PERSP, V115, P556, DOI 10.1289/ehp.9773; Li CJ, 2004, P NATL ACAD SCI USA, V101, P2185, DOI 10.1073/pnas.0307313101; MacLennan AH, 2006, MENOPAUSE, V13, P28, DOI 10.1097/01.gme.0000191204.38664.61; Maki PM, 2002, NEUROPSYCHOLOGIA, V40, P518, DOI 10.1016/S0028-3932(01)00126-9; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Milner TA, 2005, J COMP NEUROL, V491, P81, DOI 10.1002/cne.20724; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; Moriarty K, 2006, ENDOCRINOLOGY, V147, P5557, DOI 10.1210/en.2006-0729; Morrison JH, 2002, PROG BRAIN RES, V136, P467; Neigh GN, 2004, EUR J NEUROSCI, V20, P1865, DOI 10.1111/j.1460-9568.2004.03649.x; Ostlund H, 2003, ANN NY ACAD SCI, V1007, P54, DOI 10.1196/annals.1286.006; Pfaff DW, 2000, J STEROID BIOCHEM, V74, P365, DOI 10.1016/S0960-0760(00)00114-X; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Rhodes ME, 2006, NEUROBIOL LEARN MEM, V85, P183, DOI 10.1016/j.nlm.2005.10.003; Rissman EF, 2002, P NATL ACAD SCI USA, V99, P3996, DOI 10.1073/pnas.012032699; Rissman EF, 1997, HORM BEHAV, V31, P232, DOI 10.1006/hbeh.1997.1390; ROY EJ, 1977, STEROIDS, V30, P657, DOI 10.1016/0039-128X(77)90055-1; Rudick CN, 2003, ENDOCRINOLOGY, V144, P179, DOI 10.1210/en.2002-220581; Sandstrom NJ, 2001, BEHAV NEUROSCI, V115, P384, DOI 10.1037//0735-7044.115.2.384; Savonenko AV, 2003, NEUROSCIENCE, V119, P821, DOI 10.1016/S0306-4522(03)00213-6; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Smith CC, 2006, J NEUROSCI, V26, P8517, DOI 10.1523/JNEUROSCI.5279-05.2006; Wang SX, 2003, J BIOL CHEM, V278, P2713, DOI 10.1074/jbc.M208411200; Woolley CS, 1997, J NEUROSCI, V17, P1848; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Yaffe K, 2000, LANCET, V356, P708, DOI 10.1016/S0140-6736(00)02628-3; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhou Y, 1996, ENDOCRINOLOGY, V137, P2163, DOI 10.1210/en.137.5.2163	50	380	393	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					334	343		10.1038/nn2057	http://dx.doi.org/10.1038/nn2057			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18297067				2022-12-24	WOS:000253548300017
J	Salazar, H; Llorente, I; Jara-Oseguera, A; Garcia-Villegas, R; Munari, M; Gordon, SE; Islas, LD; Rosenbaum, T				Salazar, Hector; Llorente, Itzel; Jara-Oseguera, Andres; Garcia-Villegas, Refugio; Munari, Mika; Gordon, Sharona E.; Islas, Leon D.; Rosenbaum, Tamara			A single N-terminal cysteine in TRPV1 determines activation by pungent compounds from onion and garlic	NATURE NEUROSCIENCE			English	Article							ION-CHANNEL; COVALENT MODIFICATION; CAPSAICIN RECEPTOR; VANILLOID RECEPTOR; ANKYRIN REPEATS; S-NITROSYLATION; TRPA1; CHEMISTRY; ALLIUM; PAIN	Some members of the transient receptor potential (TRP) family of cation channels mediate sensory responses to irritant substances. Although it is well known that TRPA1 channels are activated by pungent compounds found in garlic, onion, mustard and cinnamon extracts, activation of TRPV1 by these extracts remains controversial. Here we establish that TRPV1 is activated by pungent extracts from onion and garlic, as well as by allicin, the active compound in these preparations, and participates together with TRPA1 in the pain-related behavior induced by this compound. We found that in TRPV1 these agents act by covalent modification of cysteine residues. In contrast to TRPA1 channels, modification of a single cysteine located in the N-terminal region of TRPV1 was necessary and sufficient for all the effects we observed. Our findings point to a conserved mechanism of activation in TRP channels, which provides new insights into the molecular basis of noxious stimuli detection.	[Salazar, Hector; Llorente, Itzel; Jara-Oseguera, Andres; Rosenbaum, Tamara] Univ Nacl Autonoma Mexico, Dept Biofis, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Jara-Oseguera, Andres; Islas, Leon D.] Univ Nacl Autonoma Mexico, Dept Fisiol, Fac Med, Mexico City 04510, DF, Mexico; [Garcia-Villegas, Refugio] Estudios Avanzados Inst Politecn Nacl, Ctr Invest, Dept Fisiol Biofis & Neurosci, Mexico City 07360, DF, Mexico; [Munari, Mika; Gordon, Sharona E.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; CIO - Centro de Investigaciones en Optica A.C.; University of Washington; University of Washington Seattle	Rosenbaum, T (corresponding author), Univ Nacl Autonoma Mexico, Dept Biofis, Inst Fisiol Celular, Circuito Exterior S-N,Ciudad Univ, Mexico City 04510, DF, Mexico.	trosenba@ifc.unam.mx	Islas, Leon D/AAW-9845-2020	Islas, Leon D/0000-0002-7461-5214; Garcia-Villegas, Refugio/0000-0001-8468-6676; Jara Oseguera, Andres/0000-0001-5921-9320; Rosenbaum, Tamara/0000-0002-4791-3195	NATIONAL EYE INSTITUTE [R01EY017564] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY017564, R01 EY017564-04] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; BLOCK E, 1985, SCI AM, V252, P114, DOI 10.1038/scientificamerican0385-114; Block E, 1996, ADV EXP MED BIOL, V401, P155; CALVEY EM, 1994, J CHROMATOGR SCI, V32, P93, DOI 10.1093/chromsci/32.3.93; Calvey EM, 1998, PHYTOCHEMISTRY, V49, P359, DOI 10.1016/S0031-9422(98)00191-5; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Cortright DN, 2007, BBA-MOL BASIS DIS, V1772, P978, DOI 10.1016/j.bbadis.2007.03.003; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; JARA A, 2007, BIOPHYS J, V92, P3901; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Jones MG, 2004, J EXP BOT, V55, P1903, DOI 10.1093/jxb/erh138; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Matalon S, 2003, AM J PHYSIOL-LUNG C, V285, pL1184, DOI 10.1152/ajplung.00281.2003; Michels KB, 2002, ANN EPIDEMIOL, V12, P21, DOI 10.1016/S1047-2797(01)00238-1; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Susankova K, 2006, MOL PHARMACOL, V70, P383, DOI 10.1124/mol.106.023069; Szallasi A, 1999, PHARMACOL REV, V51, P159; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vyklicky L, 2002, NEUROSCIENCE, V111, P435, DOI 10.1016/S0306-4522(02)00051-9; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821	35	158	164	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					255	261		10.1038/nn2056	http://dx.doi.org/10.1038/nn2056			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18297068	Green Accepted			2022-12-24	WOS:000253548300007
J	Arevian, AC; Kapoor, V; Urban, NN				Arevian, Armen C.; Kapoor, Vikrant; Urban, Nathaniel N.			Activity-dependent gating of lateral inhibition in the mouse olfactory bulb	NATURE NEUROSCIENCE			English	Article							ODORANT MOLECULAR-FEATURES; GRANULE CELLS; DENDRODENDRITIC INHIBITION; HORIZONTAL CONNECTIONS; RESPONSE PROPERTIES; REPRESENTATIONS; ORGANIZATION; MAPS; DISCRIMINATION; COMBINATORIAL	Lateral inhibition is a circuit motif found throughout the nervous system that often generates contrast enhancement and center-surround receptive fields. We investigated the functional properties of the circuits mediating lateral inhibition between olfactory bulb principal neurons (mitral cells) in vitro. We found that the lateral inhibition received by mitral cells is gated by postsynaptic firing, such that a minimum threshold of postsynaptic activity is required before effective lateral inhibition is recruited. This dynamic regulation allows the strength of lateral inhibition to be enhanced between cells with correlated activity. Simulations show that this regulation of lateral inhibition causes decorrelation of mitral cell activity that is evoked by similar stimuli, even when stimuli have no clear spatial structure. These results show that this previously unknown mechanism for specifying lateral inhibitory connections allows functional inhibitory connectivity to be dynamically remapped to relevant populations of neurons.	[Arevian, Armen C.; Urban, Nathaniel N.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Arevian, Armen C.; Kapoor, Vikrant; Urban, Nathaniel N.] Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Kapoor, Vikrant; Urban, Nathaniel N.] Carnegie Mellon Univ, Dept Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Urban, NN (corresponding author), Univ Pittsburgh, Ctr Neurosci, A210 Langley Hall, Pittsburgh, PA 15260 USA.	nurban@cmu.edu	Urban, Nathaniel/A-4974-2008	Urban, Nathaniel/0000-0002-0365-9068	NIDCD NIH HHS [F30 DC 008274, R01 DC 005798, F30 DC008274-02, R01 DC005798, F30 DC008274-03, F30 DC008274-01A2, F30 DC008274] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F30DC008274, R01DC005798] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Bosking WH, 1997, J NEUROSCI, V17, P2112; Carlson GC, 2000, J NEUROSCI, V20, P2011; Dietz SB, 2005, J PHYSIOL-LONDON, V569, P475, DOI 10.1113/jphysiol.2005.095844; Egana JI, 2005, NEUROSCIENCE, V134, P1069, DOI 10.1016/j.neuroscience.2005.04.027; Egger V, 2005, J NEUROSCI, V25, P3521, DOI 10.1523/JNEUROSCI.4746-04.2005; Egger V, 2006, SEMIN CELL DEV BIOL, V17, P424, DOI 10.1016/j.semcdb.2006.04.006; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, CURR OPIN NEUROBIOL, V11, P468, DOI 10.1016/S0959-4388(00)00236-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; Johnson BA, 2004, J COMP NEUROL, V480, P234, DOI 10.1002/cne.20335; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kapoor V, 2006, J NEUROSCI, V26, P11709, DOI 10.1523/JNEUROSCI.3371-06.2006; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Linster C, 2005, J NEUROPHYSIOL, V93, P3410, DOI 10.1152/jn.01285.2004; Llinas R.R., 2004, SYNAPTIC ORG BRAIN; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Meister M, 2001, J NEUROSCI, V21, P1351; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; PRICE JL, 1970, J CELL SCI, V7, P125; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Schoppa NE, 2002, NAT NEUROSCI, V5, P1194, DOI 10.1038/nn953; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Schoppa NE, 1999, NAT NEUROSCI, V2, P1106, DOI 10.1038/16033; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Takahashi YK, 2004, J NEUROPHYSIOL, V92, P2413, DOI 10.1152/jn.00236.2004; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	42	128	130	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					80	87		10.1038/nn2030	http://dx.doi.org/10.1038/nn2030			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18084286	Green Accepted			2022-12-24	WOS:000252117900015
J	Colonnese, MT; Phillips, MA; Constantine-Paton, M; Kaila, K; Jasanoff, A				Colonnese, Matthew T.; Phillips, Marnie A.; Constantine-Paton, Martha; Kaila, Kai; Jasanoff, Alan			Development of hemodynamic responses and functional connectivity in rat somatosensory cortex	NATURE NEUROSCIENCE			English	Article							CEREBRAL BLOOD-FLOW; FETAL-BRAIN ACTIVITY; VISUAL-CORTEX; POSTNATAL-DEVELOPMENT; OXYGEN-CONSUMPTION; BOLD; FMRI; INFANTS; STIMULATION; ACTIVATION	Functional magnetic resonance imaging (fMRI) is a valuable method for probing postnatal circuit refinement and plasticity. However, its use during early development has been hindered by uncertainty as to the nature of neurovascular coupling in young individuals. Here we used somatosensory stimulation in rats to determine age-related parameters of the blood oxygenation level-dependent (BOLD) signal from its apparent inception on postnatal day 13 to adulthood. By comparing fMRI measurements with electrophysiological recordings, we determined that the regional BOLD response in these animals undergoes a systematic decline in latency and growth in amplitude over this period. We found no evidence of negative BOLD at any age. Maturation of hemodynamic responses correlated with age-dependent increases in susceptibility to inhibition of carbonic anhydrase. With knowledge of the infant BOLD response characteristics, we showed that interhemispheric and higher-order cortical stimulus responses are enhanced during the first several weeks after birth.	[Colonnese, Matthew T.; Constantine-Paton, Martha] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Phillips, Marnie A.; Constantine-Paton, Martha; Jasanoff, Alan] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Constantine-Paton, Martha] MIT, Dept Biol, Cambridge, MA 02139 USA; [Kaila, Kai] Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; [Jasanoff, Alan] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Helsinki; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Colonnese, MT (corresponding author), MIT, McGovern Inst Brain Res, 150 Albany St,NW14-2213, Cambridge, MA 02139 USA.	colonnese@inmed.univ-mrs.fr	Kaila, Kai K/R-8528-2016	Kaila, Kai K/0000-0003-0668-5955; Colonnese, Matthew/0000-0002-2480-1270				Anderson AW, 2001, MAGN RESON IMAGING, V19, P1, DOI 10.1016/S0730-725X(00)00231-9; APKON M, 1995, J PHYSIOL-LONDON, V484, P743, DOI 10.1113/jphysiol.1995.sp020700; ARMSTRONGJAMES M, 1975, J PHYSIOL-LONDON, V246, P501, DOI 10.1113/jphysiol.1975.sp010902; BINMOLLER FJ, 1992, GLIA, V6, P127, DOI 10.1002/glia.440060207; Born P, 1998, PEDIATR RES, V44, P578, DOI 10.1203/00006450-199810000-00018; BRION LP, 1988, ANAL BIOCHEM, V175, P289, DOI 10.1016/0003-2697(88)90391-0; Brown GG, 2003, J CEREBR BLOOD F MET, V23, P829, DOI 10.1097/01.WCB.0000071887.63724.B2; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; Buxton R., 2002, INTRO FUNCTIONAL MAG; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DAHLGREN N, 1981, ACTA PHYSIOL SCAND, V111, P475, DOI 10.1111/j.1748-1716.1981.tb06766.x; Dehaene-Lambertz G, 2002, SCIENCE, V298, P2013, DOI 10.1126/science.1077066; Duong TQ, 2001, P NATL ACAD SCI USA, V98, P10904, DOI 10.1073/pnas.191101098; Erberich SG, 2003, NEUROIMAGE, V20, P683, DOI 10.1016/S1053-8119(03)00370-7; Fulford J, 2004, HUM BRAIN MAPP, V22, P116, DOI 10.1002/hbm.20019; GRAMSBERGEN A, 1976, DEV PSYCHOBIOL, V9, P501, DOI 10.1002/dev.420090604; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; HIMWICH WA, 1970, DEV NEUROBIOLOGY; Hykin J, 1999, LANCET, V354, P645, DOI 10.1016/S0140-6736(99)02901-3; KAUR C, 1989, ACTA ANAT, V136, P204; KELLY PAT, 1995, J CEREBR BLOOD F MET, V15, P766, DOI 10.1038/jcbfm.1995.96; Kourtzi Z, 2006, MAGN RESON IMAGING, V24, P359, DOI 10.1016/j.mri.2005.12.025; Liu ZHM, 2004, MAGN RESON MED, V52, P277, DOI 10.1002/mrm.20148; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Mueggler T, 2001, MAGNET RESON MED, V46, P292, DOI 10.1002/mrm.1190; Muramoto S, 2002, J COMPUT ASSIST TOMO, V26, P894, DOI 10.1097/00004728-200211000-00007; NEHLIG A, 1989, J CEREBR BLOOD F MET, V9, P579, DOI 10.1038/jcbfm.1989.83; Olavarria JF, 2006, J COMP NEUROL, V496, P495, DOI 10.1002/cne.20938; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; Ramos-Cabrer P, 2005, NMR BIOMED, V18, P440, DOI 10.1002/nbm.978; Richter W, 2003, NEUROIMAGE, V20, P1122, DOI 10.1016/S1053-8119(03)00347-1; RODMAN HR, 1993, J NEUROPHYSIOL, V70, P1115, DOI 10.1152/jn.1993.70.3.1115; ROWAN RA, 1981, AM J ANAT, V160, P247, DOI 10.1002/aja.1001600303; Ruusuvuori E, 2004, J NEUROSCI, V24, P2699, DOI 10.1523/JNEUROSCI.5176-03.2004; Sanders RD, 2005, BRIT J ANAESTH, V95, P393, DOI 10.1093/bja/aei182; Schuchmann S, 2006, NAT MED, V12, P817, DOI 10.1038/nm1422; Sheth SA, 2004, NEURON, V42, P347, DOI 10.1016/S0896-6273(04)00221-1; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Stout RW, 2001, COMPARATIVE MED, V51, P524; SWENSON ER, 1978, RESP PHYSIOL, V35, P129, DOI 10.1016/0034-5687(78)90018-X; VORSTRUP S, 1984, J CLIN INVEST, V74, P1634, DOI 10.1172/JCI111579; WISTRAND PJ, 1981, ACTA PHYSIOL SCAND, V113, P417, DOI 10.1111/j.1748-1716.1981.tb06918.x; Wu CC, 1997, J COMP NEUROL, V384, P323, DOI 10.1002/(SICI)1096-9861(19970804)384:3<323::AID-CNE1>3.0.CO;2-5; Yamada H, 1997, NEUROREPORT, V8, P3775, DOI 10.1097/00001756-199712010-00024	49	92	92	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					72	79		10.1038/nn2017	http://dx.doi.org/10.1038/nn2017			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18037883				2022-12-24	WOS:000252117900014
J	Chauvet, S; Cohen, S; Yoshida, Y; Fekrane, L; Livet, J; Gayet, O; Segu, L; Buhot, MC; Jessell, TM; Henderson, CE; Mann, F				Chauvet, Sophie; Cohen, Sarnia; Yoshida, Yutaka; Fekrane, Lylia; Livet, Jean; Gayet, Odile; Segu, Louis; Buhot, Marie-Christine; Jessell, Thomas M.; Henderson, Christopher E.; Mann, Fanny			Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development	NEURON			English	Article							ENDOTHELIAL GROWTH-FACTOR; WORKING-MEMORY TASKS; SEMAPHORIN 3A; EXPRESSION PATTERNS; MAMMALIAN FOREBRAIN; COLORECTAL-CANCER; SPATIAL REFERENCE; MAMMILLARY BODY; NERVOUS-SYSTEM; TUMOR-CELLS	The establishment of functional neural circuits requires the guidance of axons in response to the actions of secreted and cell-surface molecules such as the semaphorins. Semaphorin 3E and its receptor PlexinD1 are expressed in the brain, but their functions are unknown. Here, we show that Sema3E/PlexinD1 signaling plays an important role in initial development of descending axon tracts in the forebrain. Early errors in axonal projections are reflected in behavioral deficits in Sema3E null mutant mice. Two distinct signaling mechanisms can be distinguished downstream of Sema3E. On cortico-fugal and striatonigral neurons expressing PlexinD1 but not Neuropilin-1, Sema3E acts as a repellent. In contrast, on subiculo-mammillary neurons coexpressing PlexinD1 and Neuropilin-1, Sema3E acts as an attractant. The extracellular domain of Neuropilin-1 is sufficient to convert repulsive signaling by PlexinD1 to attraction. Our data therefore reveal a "gating" function of neuropilins in semaphorin-plexin signaling during the assembly of forebrain neuronal circuits.	[Chauvet, Sophie; Cohen, Sarnia; Fekrane, Lylia; Mann, Fanny] UnivMediterranee, Dev Biol Inst Marseille Luminy, CNRS, UMR 6216, F-13288 Marseille 09, France; [Yoshida, Yutaka; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Yoshida, Yutaka; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Neurosci, New York, NY 10032 USA; [Henderson, Christopher E.] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Henderson, Christopher E.] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Henderson, Christopher E.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Yoshida, Yutaka; Jessell, Thomas M.; Henderson, Christopher E.] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA; [Livet, Jean] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Gayet, Odile] INSERM, U624, F-13288 Marseille 09, France; [Segu, Louis; Buhot, Marie-Christine] CNRS, UMR 5106, Cognit Neurosci Lab, F-33405 Talence, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University; Columbia University; Harvard University; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Mann, F (corresponding author), UnivMediterranee, Dev Biol Inst Marseille Luminy, CNRS, UMR 6216, Case 907,Parc Sci Luminy, F-13288 Marseille 09, France.	mann@ibdml.univ-mrs.fr	Mann, Fanny/G-2786-2016; livet, jean/C-2766-2012	Mann, Fanny/0000-0003-4839-4347; livet, jean/0000-0003-3079-4908; Henderson, Christopher/0000-0002-9936-3279	Howard Hughes Medical Institute Funding Source: Medline; Wellcome Trust Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wellcome Trust(Wellcome TrustEuropean Commission)		Bachelder RE, 2003, CANCER RES, V63, P5230; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Bagri A, 2002, ADV EXP MED BIOL, V515, P13; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; BERACOCHEA DJ, 1991, NEUROREPORT, V2, P793, DOI 10.1097/00001756-199112000-00016; Bielenberg DR, 2004, J CLIN INVEST, V114, P1260, DOI 10.1172/JCI200421378; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Carroll P, 2001, DEV DYNAM, V221, P431, DOI 10.1002/dvdy.1163; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Castellani V, 2004, MOL CELL NEUROSCI, V26, P89, DOI 10.1016/j.mcn.2004.01.010; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; Christensen C, 2005, CANCER RES, V65, P6167, DOI 10.1158/0008-5472.CAN-04-4309; Christensen CRL, 1998, CANCER RES, V58, P1238; Conejo NM, 2004, BRAIN RES, V1011, P107, DOI 10.1016/j.brainres.2004.03.025; De Wit J, 2005, MOL CELL NEUROSCI, V29, P40, DOI 10.1016/j.mcn.2004.12.009; de Wit J, 2006, TRAFFIC, V7, P1060, DOI 10.1111/j.1600-0854.2006.00442.x; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Finger JH, 2002, J NEUROSCI, V22, P10346; FISHELL G, 1987, J NEUROSCI, V7, P1969; Fujisawa H, 1997, CELL TISSUE RES, V290, P465, DOI 10.1007/s004410050954; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Joosten E A, 1987, Brain Res, V433, P121; Junghans D, 2004, DEVELOPMENT, V131, P4425, DOI 10.1242/dev.01313; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Kishi T, 2000, J COMP NEUROL, V419, P205, DOI 10.1002/(SICI)1096-9861(20000403)419:2<205::AID-CNE5>3.0.CO;2-0; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lopez-Bendito G, 2007, J NEUROSCI, V27, P3395, DOI 10.1523/JNEUROSCI.4605-06.2007; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; Martin JH, 2005, NEUROSCIENTIST, V11, P161, DOI 10.1177/1073858404270843; Miyazaki N, 1999, NEUROSCIENCE, V93, P401, DOI 10.1016/S0306-4522(99)00134-7; Oster SF, 2004, SEMIN CELL DEV BIOL, V15, P125, DOI 10.1016/j.semcdb.2003.09.006; Roodink I, 2005, CANCER RES, V65, P8317, DOI 10.1158/0008-5472.CAN-04-4366; Santin LJ, 2003, PHYSIOL BEHAV, V78, P733, DOI 10.1016/S0031-9384(03)00060-X; Santin LJ, 1999, BEHAV BRAIN RES, V102, P137, DOI 10.1016/S0166-4328(99)00011-X; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Shimizu M, 2000, J CELL BIOL, V148, P1283, DOI 10.1083/jcb.148.6.1283; Skaliora I, 1998, EUR J NEUROSCI, V10, P1215, DOI 10.1046/j.1460-9568.1998.00128.x; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; STANFIELD BB, 1987, J NEUROSCI, V7, P3350, DOI 10.1523/jneurosci.07-10-03350.1987; Steinbach K, 2002, EXP CELL RES, V279, P52, DOI 10.1006/excr.2002.5595; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Toyofuku T, 2007, EMBO J, V26, P1373, DOI 10.1038/sj.emboj.7601589; Van Der Zwaag B, 2002, DEV DYNAM, V225, P336, DOI 10.1002/dvdy.10159; Wang L, 2006, FASEB J, V20, P1513, DOI 10.1096/fj.05-5504fje; Watakabe A, 2006, J COMP NEUROL, V499, P258, DOI 10.1002/cne.21106; Wen ZX, 2006, CURR OPIN NEUROBIOL, V16, P52, DOI 10.1016/j.conb.2005.12.005; Wolman MA, 2004, J NEUROSCI, V24, P8428, DOI 10.1523/JNEUROSCI.2349-04.2004; Worzfeld T, 2004, EUR J NEUROSCI, V19, P2622, DOI 10.1111/j.0953-816X.2004.03401.x; Yamada Y, 2001, BLOOD, V97, P1671, DOI 10.1182/blood.V97.6.1671; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211	66	182	186	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	DEC 6	2007	56	5					807	822		10.1016/j.neuron.2007.10.019	http://dx.doi.org/10.1016/j.neuron.2007.10.019			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241MA	18054858	Bronze, Green Accepted			2022-12-24	WOS:000251659300008
J	Amodio, DM; Jost, JT; Master, SL; Yee, CM				Amodio, David M.; Jost, John T.; Master, Sarah L.; Yee, Cindy M.			Neurocognitive correlates of liberalism and conservatism	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE; ERROR-DETECTION; CONFLICT	Political scientists and psychologists have noted that, on average, conservatives show more structured and persistent cognitive styles, whereas liberals are more responsive to informational complexity, ambiguity and novelty. We tested the hypothesis that these profiles relate to differences in general neurocognitive functioning using event-related potentials, and found that greater liberalism was associated with stronger conflict-related anterior cingulate activity, suggesting greater neurocognitive sensitivity to cues for altering a habitual response pattern.	NYU, Dept Psychol, New York, NY 10003 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	New York University; University of California System; University of California Los Angeles	Amodio, DM (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	david.amodio@nyu.edu	sarinopoulos, isidoros/B-5453-2010	Jost, John/0000-0002-2844-4645				Adorno Theodor W, 1950, AUTHORITARIAN PERSON; Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Block J, 2006, J RES PERS, V40, P734, DOI 10.1016/j.jrp.2005.09.005; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; DeHaven RN, 2005, CURR TOP MED CHEM, V5, P303, DOI 10.2174/1568026053544542; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kaplan JT, 2007, NEUROPSYCHOLOGIA, V45, P55, DOI 10.1016/j.neuropsychologia.2006.04.024; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Knutson KM, 2006, SOC NEUROSCI-UK, V1, P25, DOI 10.1080/17470910600670603; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]	14	316	320	1	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1246	1247		10.1038/nn1979	http://dx.doi.org/10.1038/nn1979			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	214FG	17828253				2022-12-24	WOS:000249720800010
J	Logothetis, NK; Kayser, C; Oeltermann, A				Logothetis, Nikos K.; Kayser, Christoph; Oeltermann, Axel			In vivo measurement of cortical impedance spectrum in monkeys: Implications for signal propagation	NEURON			English	Article							LOCAL-FIELD POTENTIALS; RABBIT CEREBRAL CORTEX; CATS VISUAL CORTEX; ELECTRODE POLARIZATION; METAL MICROELECTRODES; ELECTRICAL-ACTIVITY; EVOKED-POTENTIALS; FREQUENCY RANGES; HIGH-RESOLUTION; EEG PHENOMENA	To combine insights obtained from electric field potentials (LFPs) and neuronal spiking activity (MILIA) we need a better understanding of the relative spatial summation of these indices of neuronal activity. Compared to MUA, the LFP has greater spatial coherence, resulting in lower spatial specificity and lower stimulus selectivity. A differential propagation of low- and high-frequency electric signals supposedly underlies this phenomenon, which could result from cortical tissue specifically attenuating higher frequencies, i.e., from a frequency-dependent impedance spectrum. Here we directly measure the cortical impedance spectrum in vivo in monkey primary visual cortex. Our results show that impedance is independent of frequency, is homogeneous and tangentially isotropic within gray matter, and can be theoretically predicted assuming a pure-resistive conductor. We propose that the spatial summation of LFP and MUA is determined by the size of these signals' generators and the nature of neural events underlying them, rather than by biophysical properties of gray matter.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Manchester, Div Imaging Sci & Biomed Engn, Manchester M13 9PT, Lancs, England	Max Planck Society; University of Manchester	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	nikos.logothetis@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019; Kayser, Christoph/A-3203-2012	Kayser, Christoph/0000-0001-7362-5704				Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Adrian ED, 1926, J PHYSIOL-LONDON, V61, P151, DOI 10.1113/jphysiol.1926.sp002281; Aidley D.J., 1989, PHYSL EXCITABLE CELL; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Bedard C, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051911; Bedard C, 2004, BIOPHYS J, V86, P1829, DOI 10.1016/S0006-3495(04)74250-2; Braitenberg V, 1998, CORTEX STAT GEOMETRY; BUCHWALD JS, 1965, NATURE, V205, P1012, DOI 10.1038/2051012a0; BULLOCK TH, 1989, ELECTROEN CLIN NEURO, V73, P479, DOI 10.1016/0013-4694(89)90258-7; Bullock TH, 1997, P NATL ACAD SCI USA, V94, P1, DOI 10.1073/pnas.94.1.1; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Chrobak JJ, 2000, HIPPOCAMPUS, V10, P457, DOI 10.1002/1098-1063(2000)10:4<457::AID-HIPO12>3.0.CO;2-Z; CREUTZFELDT OD, 1966, ELECTROEN CLIN NEURO, V20, P1, DOI 10.1016/0013-4694(66)90136-2; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Destexhe A, 1998, J NEUROSCI, V18, P9099; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1990, NEOXORTEX, P389; Douglas RJ, 1989, NEURAL COMPUT, V1, P480, DOI 10.1162/neco.1989.1.4.480; ECCLES JC, 1951, ELECTROEN CLIN NEURO, V3, P449, DOI 10.1016/0013-4694(51)90033-8; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; Freeman WJ, 1975, MASS ACTION NERVOUS; FREYGANG WH, 1955, J CELL COMPAR PHYSL, V45, P377, DOI 10.1002/jcp.1030450305; Frien A, 2000, EUR J NEUROSCI, V12, P1453, DOI 10.1046/j.1460-9568.2000.00025.x; FROMM GH, 1967, CLIN NEUROPHYSIOL, V22, P159; Geddes LA, 1997, ANN BIOMED ENG, V25, P1, DOI 10.1007/BF02738534; GEDDES LA, 1971, MED BIOL ENG, V9, P511, DOI 10.1007/BF02474708; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; HAVSTAD JW, 1976, THESIS STANFORD U ST; Helmholtz H., 1879, ANN PHYS CHEM, V243, P337, DOI DOI 10.1002/ANDP.18792430702; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JOHNSTON D, 1995, FND CELLULAR NEUROPH; Kayser C, 2004, EUR J NEUROSCI, V19, P485, DOI 10.1111/j.0953-816X.2003.03122.x; KLIVINGTON KA, 1967, SCIENCE, V157, P211, DOI 10.1126/science.157.3785.211; KLIVINGTON KA, 1968, J NEUROPHYSIOL, V61, P565; Koch C., 1998, METHODS NEURONAL MOD, DOI 10.1016/s0898-1221(98)91179-8; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; LEBIHAN D, 1991, JMRI-J MAGN RESON IM, V1, P7, DOI 10.1002/jmri.1880010103; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; LI CL, 1968, EXP NEUROL, V20, P544, DOI 10.1016/0014-4886(68)90108-8; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Logothetis NK, 2002, NEURON, V35, P227, DOI 10.1016/S0896-6273(02)00775-4; Lopez-Aguado L, 2001, NEUROSCIENCE, V108, P249, DOI 10.1016/S0306-4522(01)00417-1; LORENTE de NO R, 1947, Stud Rockefeller Inst Med Res Repr, V132, P384; MARSAN CA, 1965, ISRAEL J MED SCI, V1, P104; McIntyre CC, 2001, ANN BIOMED ENG, V29, P227, DOI 10.1114/1.1352640; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Morocutti C, 1966, Arch Psychiatr Nervenkr (1970), V208, P234; Nadasdy Z, 1998, NEURONAL ENSEMBLES: STRATEGIES FOR RECORDING AND DECODING, P17; NICHOLSON PW, 1965, EXP NEUROL, V13, P386, DOI 10.1016/0014-4886(65)90126-3; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nunez P., 1994, NEOCORTICAL DYNAMICS; Nunez P.L., 1981, ELECT FIELDS BRAIN; Peters A., 1991, FINE STRUCTURE NERVO; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; RANCK JB, 1963, EXP NEUROL, V7, P144, DOI 10.1016/S0014-4886(63)80005-9; RANCK JB, 1963, EXP NEUROL, V7, P153, DOI 10.1016/S0014-4886(63)80006-0; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; ROBINSON DA, 1968, PR INST ELECTR ELECT, V56, P1065, DOI 10.1109/PROC.1968.6458; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Schwan H. P, 1963, PHYS TECHNIQUES BIOL, P323, DOI DOI 10.1002/JCP.1030660505; SCHWAN HP, 1968, REV SCI INSTRUM, V39, P481, DOI 10.1063/1.1683413; SCHWAN HP, 1966, BIOPHYSIK, V3, P181, DOI 10.1007/BF01191612; SCHWAN HP, 1968, ANN NY ACAD SCI, V148, P191, DOI 10.1111/j.1749-6632.1968.tb20349.x; Schwan HP, 1999, ANN NY ACAD SCI, V873, P1, DOI 10.1111/j.1749-6632.1999.tb09443.x; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 1996, P NATL ACAD SCI USA, V93, P2533, DOI 10.1073/pnas.93.6.2533; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; Tuch DS, 1999, ANN NY ACAD SCI, V888, P314, DOI 10.1111/j.1749-6632.1999.tb07965.x; VANHARREVELD A, 1963, AM J PHYSIOL, V205, P203, DOI 10.1152/ajplegacy.1963.205.1.203; VANHARREVELD A, 1956, AM J PHYSIOL, V187, P180, DOI 10.1152/ajplegacy.1956.187.1.180; Warburg E., 1899, ANN PHYS CHEM, V303, P493, DOI [DOI 10.1002/ANDP.18993030302, 10.1002/andp.18993030302]; WATANABE S, 1966, EXP BRAIN RES, V1, P272; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103; Woelbern T, 2002, NEUROREPORT, V13, P1881, DOI 10.1097/00001756-200210280-00010	79	290	292	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	SEP 6	2007	55	5					809	823		10.1016/j.neuron.2007.07.027	http://dx.doi.org/10.1016/j.neuron.2007.07.027			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	216DB	17785187	Bronze			2022-12-24	WOS:000249857000016
J	Walker, E; Ohishi, M; Davey, RE; Zhang, W; Cassar, PA; Tanaka, TS; Der, SD; Morris, Q; Hughes, TR; Zandstra, PW; Stanford, WL				Walker, Emily; Ohishi, Minako; Davey, Ryan E.; Zhang, Wen; Cassar, Paul A.; Tanaka, Tetsuya S.; Der, Sandy D.; Morris, Quaid; Hughes, Timothy R.; Zandstra, Peter W.; Stanford, William L.			Prediction and testing of novel transcriptional networks regulating embryonic stem cell self-renewal and commitment	CELL STEM CELL			English	Article							MOLECULAR SIGNATURE; GENE; DIFFERENTIATION; EXPRESSION; NANOG; OCT4; PLURIPOTENCY; OCT-3/4; BINDING; SOX2	Stem cell fate is governed by the integration of intrinsic and extrinsic positive and negative signals upon inherent transcriptional networks. To identify novel embryonic stem cell (ESC) regulators and assemble transcriptional networks controlling ESC fate, we performed temporal expression microarray analyses of ESCs after the initiation of commitment and integrated these data with known genome-wide transcription factor binding. Effects of forced under- or overexpression of predicted novel regulators, defined as differentially expressed genes with potential binding sites for known regulators of pluripotency, demonstrated greater than 90% correspondence with predicted function, as assessed by functional and high-content assays of self-renewal. We next assembled 43 theoretical transcriptional networks in ESCs, 82% (23 out of 28 tested) of which were supported by analysis of genome-wide expression in Oct4 knockdown cells. By using this integrative approach, we have formulated novel networks describing gene repression of key developmental regulators in undifferentiated ESCs and successfully predicted the outcomes of genetic manipulation of these networks.	Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S3G9, Canada; Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ Toronto, Inst Med Sci, Toronto, ON, Canada; Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Stanford, WL (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, 164 Coll St, Toronto, ON M5S3G9, Canada.	william.stanford@utoronto.ca	Morris, Quaid/ABE-8343-2020	Tanaka, Tetsuya/0000-0002-0406-0217; Morris, Quaid/0000-0002-2760-6999; Stanford, William/0000-0002-5813-8016				Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Beckers J, 1999, MECH DEVELOP, V84, P165, DOI 10.1016/S0925-4773(99)00065-9; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chua G, 2004, CURR OPIN MICROBIOL, V7, P638, DOI 10.1016/j.mib.2004.10.009; Chua G, 2006, P NATL ACAD SCI USA, V103, P12045, DOI 10.1073/pnas.0605140103; Davey RE, 2006, STEM CELLS, V24, P2538, DOI 10.1634/stemcells.2006-0216; DUSH MK, 1992, DEV BIOL, V151, P273, DOI 10.1016/0012-1606(92)90232-6; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fortunel NO, 2003, SCIENCE, V302, P393; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Ivanova NB, 2003, SCIENCE, V302; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kobayashi K, 2006, CANCER RES, V66, P8331, DOI 10.1158/0008-5472.CAN-06-0756; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Nemeth MJ, 2006, P NATL ACAD SCI USA, V103, P13783, DOI 10.1073/pnas.0604006103; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishimoto M, 2005, MOL CELL BIOL, V25, P5084, DOI 10.1128/MCB.25.12.5084-5094.2005; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; PEASE S, 1990, DEV BIOL, V141, P344, DOI 10.1016/0012-1606(90)90390-5; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; SCHOORLEMMER J, 1994, MOL CELL BIOL, V14, P1122, DOI 10.1128/MCB.14.2.1122; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; To C, 2004, NUCLEIC ACIDS RES, V32, pD557, DOI 10.1093/nar/gkh106; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Viswanathan S, 2003, BIOTECHNOL BIOENG, V84, P505, DOI 10.1002/bit.10799; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, P6718, DOI 10.1093/nar/gkl1020; Zakin L, 2005, DEVELOPMENT, V132, P2489, DOI 10.1242/dev.01822; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	54	75	80	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL	2007	1	1					71	86		10.1016/j.stem.2007.04.002	http://dx.doi.org/10.1016/j.stem.2007.04.002			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	230JK	18371337	Bronze			2022-12-24	WOS:000250872600003
J	Hyun, I; Hochedlinger, K; Jaenisch, R; Yamanaka, S				Hyun, Insoo; Hochedlinger, Konrad; Jaenisch, Rudolf; Yamanaka, Shinya			New Advances in iPS Cell Research Do Not Obviate the Need for Human Embryonic Stem Cells	CELL STEM CELL			English	Editorial Material							FIBROBLASTS		Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Harvard Stem Cell Inst, Ctr Regenerat Med, Boston, MA 02114 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Case Western Reserve University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Kyoto University; Japan Science & Technology Agency (JST)	Hyun, I (corresponding author), Case Western Reserve Univ, Sch Med, Dept Bioeth, 10900 Euclid Ave, Cleveland, OH 44106 USA.	insoo.hyun@case.edu		Jung, Kyu Won/0000-0002-3700-8677; Testa, Giuseppe/0000-0002-9104-0918				*ASS PRESS, 2007, BUSH REM STEM CELL R; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; *DEP HLTH HUM SERV, 2007, HHS NIH PLAN IMPL EX; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944	7	120	129	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT	2007	1	4					367	368		10.1016/j.stem.2007.09.006	http://dx.doi.org/10.1016/j.stem.2007.09.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	232XU	18383627	Bronze			2022-12-24	WOS:000251055300007
